FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hu, M
   Sabelman, EE
   Tsai, C
   Tan, J
   Hentz, VR
AF Hu, M
   Sabelman, EE
   Tsai, C
   Tan, J
   Hentz, VR
TI Improvement of schwann cell attachment and proliferation on modified
   hyaluronic acid strands by polylysine
SO TISSUE ENGINEERING
LA English
DT Article
ID GUIDANCE CHANNELS; COLLAGEN; RECEPTOR; BINDING; REGENERATION; PROTEINS;
   PEPTIDES; SYSTEM; NERVE
AB Hyaluronic acid (HyA) has the intrinsic ability to promote cell proliferation and reduce scar formation. However, the clinical use of HyA has so far been limited because of its water solubility and nonadhesive characteristics. Increasing interest in HyA as a clinically useful biomaterial has prompted our study of altering HyA's physical properties to render it a potential component of nerve grafts. In this study, strands of HyA were cross-linked by glutaraldehyde (Glut), coated with polylysine, and then inoculated with Schwann cells (SCs). Results in vivo and in vitro demonstrated that cross-linked HyA strands were water insoluble and thus less biodegradable. Poly-D-lysine-resurfaced strands showed significant SC attachment of 350-400 cells/mm(2), compared to uncoated controls (0-10 cells/mm(2), p < 0.01). Fibroblast control groups showed an attachment of 40-100 cells/mm(2) on coated strands. Immunostaining for proliferating cells showed SCs as +++ and fibroblasts as +. Cells neither adhered to nor proliferated on the modified HyA strands that were not resurfaced. The results suggest that polylysine promotes SC attachment and proliferation to glutaraldehyde-cross-linked HyA strands, the product being a three-dimensional composite with low solubility that may have potential application in nerve grafts.
C1 VA Hlth Care Syst, Rehabil R&D Ctr, Palo Alto, CA 94304 USA.
   Stanford Univ, Sch Med, Funct Restorat Dept, Stanford, CA 94305 USA.
RP Hu, M (reprint author), VA Hlth Care Syst, Rehabil R&D Ctr, 3801 Miranda Ave 153, Palo Alto, CA 94304 USA.
CR AEBISCHER P, 1989, J NEUROSCI, V9, P3590
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Huang LLH, 1998, J BIOMED MATER RES, V39, P630, DOI 10.1002/(SICI)1097-4636(19980315)39:4<630::AID-JBM18>3.3.CO;2-U
   IWATA H, 1993, CLIN ORTHOP RELAT R, P285
   KAUPPILA T, 1993, EXP NEUROL, V123, P181, DOI 10.1006/exnr.1993.1151
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   LEE MM, 1996, ANAL BIOCHEM, V233, P216
   Levi ADO, 1997, EXP NEUROL, V143, P25, DOI 10.1006/exnr.1996.6344
   Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853
   Loomans EEMG, 1997, ANAL BIOCHEM, V248, P117, DOI 10.1006/abio.1997.2119
   LOVE CS, 1991, J CARDIAC SURG, V6, P499, DOI 10.1111/j.1540-8191.1991.tb00351.x
   Love J W, 1992, J Heart Valve Dis, V1, P232
   LYNN LH, 1994, MATRIX BIO, V14, P147
   Mahanthappa NK, 1996, J NEUROSCI, V16, P4673
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Miller D, 1980, J Am Intraocul Implant Soc, V6, P13
   NIKAM SS, 1995, MOL CELL NEUROSCI, V6, P337, DOI 10.1006/mcne.1995.1026
   Nothias F, 1997, EUR J NEUROSCI, V9, P1553, DOI 10.1111/j.1460-9568.1997.tb01513.x
   SWANN DA, 1978, JOINTS SYNOVIAL FLUI, P407
   THOMAS E, 1994, J HAND SURG A, V19, P420
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   TURLEY EA, 1985, J CELL SCI, V78, P133
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15
NR 29
TC 34
Z9 43
U1 1
U2 8
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2000
VL 6
IS 6
BP 585
EP 593
DI 10.1089/10763270050199532
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 377JY
UT WOS:000165511500001
PM 11103080
DA 2018-10-19
ER

PT J
AU Rah, DK
AF Rah, DK
TI Art of replacing craniofacial bone defects
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE biomaterial; bone; substitute
ID HYDROXYAPATITE CEMENT; POROUS HYDROXYAPATITE; DEMINERALIZED BONE; GRAFT
   SUBSTITUTE; RECONSTRUCTION; HYDROXYLAPATITE; AUGMENTATION; SURGERY;
   CRANIOPLASTY; INDUCTION
AB in the history of medicine, many surgeons have been tried to reconstruct lost tissue and correct deformity, attempts to use implant materials have probably paralleled those involving autogenous tissue. Recently there has been an acceleration in the understanding of the requirements and potentials of implant materials caused by collaboration between material scientists, biomaterials engineers, clinicians, and clinical investigators. Alloplastic materials have become an essential part of reconstructing the function and contour of the craniofacial skeleton. Bone is a specialized form of connective tissue, which provides support, and protects vital rind delicate organs. Bone is embryologically derived from mesenchymal tissue through membranous and endochondral ossification. In the clinical field, the need for bone graft has been increased due to trauma, tumor, craniosynostosis, and pure esthetic bone surgery. Various types of bone grafts have been used to repair craniofacial bone defects over many years, but the autogenous graft has many disadvantages, such as, limited donor sites, donor morbidity, pain, growth deformity and resorption. Many surgeons working in a number of centers around the world have created substitutes and simpler methods for bone replacement. As the alloplatic bone substitute has been advanced, many synthetic substitutes are replaced by bone in vice over time. The ideal material should be cost effective, non-toxic, non-antigenic, non-carcinogenic, and inert in the body fluids, be easily shaped at the operating table, and maintain its desired Form and consistency in situ. This article reviews several of the more commonly used materials for craniofacial reconstruction and summarizes their mechanical properties and clinical aspects.
C1 Yonsei Univ, Coll Med, Dept Plast Surg, Seoul 120752, South Korea.
RP Rah, DK (reprint author), Yonsei Univ, Coll Med, Dept Plast Surg, CPO Box 8044, Seoul 120752, South Korea.
CR BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   Burstein FD, 1999, PLAST RECONSTR SURG, V104, P1270, DOI 10.1097/00006534-199910000-00005
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   Chow KMC, 2000, CLEFT PALATE-CRAN J, V37, P385, DOI 10.1597/1545-1569(2000)037<0385:VEGPOE>2.3.CO;2
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CORNELL CN, 1992, TECH ORTHOP, V7, P55
   Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679
   ELLENBOGEN R, 1975, JAMA-J AM MED ASSOC, V234, P308, DOI 10.1001/jama.234.3.308
   FREEMAN BS, 1983, BIOMATERIALS RECONST, P494
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   GABRIEL SE, 1997, NEW ENGL J MED, V336, P719
   GLOWACKI J, 1981, LANCET, V1, P959
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   HARVEY WK, 1985, J ORAL MAXIL SURG, V43, P277, DOI 10.1016/0278-2391(85)90287-3
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   HOLMES RE, 1990, PLASTIC SURG, P698
   Hubli EH, 1998, ANN PLAS SURG, V41, P81, DOI 10.1097/00000637-199807000-00015
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KEPES ER, 1972, J AMER MED ASSOC, V222, P576, DOI 10.1001/jama.222.5.576
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Maniker A, 1998, NEUROSURGERY, V43, P953, DOI 10.1097/00006123-199810000-00134
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   MILNE IS, 1973, ANAESTHESIA, V28, P538, DOI 10.1111/j.1365-2044.1973.tb00522.x
   Neigel JM, 1996, OPHTHAL PLAST RECONS, V12, P108, DOI 10.1097/00002341-199606000-00005
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   PICKERING CAC, 1986, BRIT MED J, V292, P1362, DOI 10.1136/bmj.292.6532.1362
   PIECUCH JF, 1983, J ORAL MAXIL SURG, V41, P801, DOI 10.1016/S0278-2391(83)80047-0
   RAWLINGS CE, 1988, J NEUROSURG, V69, P269, DOI 10.3171/jns.1988.69.2.0269
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V89, P731, DOI 10.1097/00006534-199204000-00025
   Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002
   SALYER KE, 1987, CLIN PLAST SURG, V14, P27
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   SALYER KE, 1995, PLAST RECONSTR SURG, V96, P770, DOI 10.1097/00006534-199509001-00002
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   Stelnicki EJ, 1996, J CRANIOFAC SURG, V7, P192, DOI 10.1097/00001665-199605000-00006
   Suh H, 1995, ASAIO J, V41, P652
   Valdevit A, 2000, J BIOMED MATER RES, V53, P62
   Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
   ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005
NR 43
TC 20
Z9 20
U1 0
U2 14
PU YONSEI UNIV COLLEGE MEDICINE
PI SEOUL
PA C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL
   120-752, SOUTH KOREA
SN 0513-5796
J9 YONSEI MED J
JI Yonsei Med. J.
PD DEC
PY 2000
VL 41
IS 6
BP 756
EP 765
DI 10.3349/ymj.2000.41.6.756
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 396LK
UT WOS:000166637700008
PM 11204826
OA Bronze
DA 2018-10-19
ER

PT J
AU Janatova, J
AF Janatova, J
TI Activation and control of complement, inflammation, and infection
   associated with the use of biomedical polymers
SO ASAIO JOURNAL
LA English
DT Review
ID ACUTE-RENAL-FAILURE; SINGLE-CHAIN FV; EXTRACORPOREAL-CIRCULATION;
   HEMODIALYSIS MEMBRANES; HOST-DEFENSE; GRANULOCYTE ACTIVATION;
   CARDIOPULMONARY BYPASS; INHIBITS COMPLEMENT; OXYGEN RADICALS;
   HUMAN-SERUM
AB It is generally acknowledged that artificial biomaterials are much less immunologically active than transplants or tissue derived biomaterials. However, activation of both the coagulation cascade and the complement system is a common occurrence when human blood is exposed to biomaterial surfaces during extracorporeal procedures, such as renal hemodialysis or cardiopulmonary bypass. Both individual and collective activation of these cascades often produce local and systemic effects. A number of complement activation products function as the mediators of inflammation. They serve as ligands for specific receptors on polymorphonuclear leukocytes, monocytes, macrophages, mast cells, and other cells. Such an interaction leads to induction of cellular responses in adhered cells, including release of oxidative products, lysosomal enzymes, or both, which often contribute to a number of pathologic conditions. Most pathogens invading the human body are attacked by the immune system directly following entry, especially when they are in contact with blood. However, bacteria and parasites have developed a large number of specific strategies to overcome immune defense among others by avoiding either recognition or eradication by complement. In this aspect, of concern are several microorganisms responsible for formation of antibiotic resistant biofilms on biomaterial surfaces, namely Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   Univ Utah, Ctr Biopolymers Interfaces, Salt Lake City, UT 84112 USA.
RP Janatova, J (reprint author), Univ Utah, Dept Bioengn, 50 S Cent Campus Dr,Room 2480, Salt Lake City, UT 84112 USA.
CR ANWAR H, 1992, FEMS MICROBIOL LETT, V92, P235, DOI 10.1111/j.1574-6968.1992.tb05267.x
   BOHLER J, 1993, NEPHROL DIAL TRANSPL, V8, P1359
   BROWN EJ, 1985, CURR TOP MICROBIOL, V121, P159
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CHENOWETH DE, 1978, P NATL ACAD SCI USA, V75, P3943, DOI 10.1073/pnas.75.8.3943
   CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85
   CHEUNG AK, 1992, J AM SOC NEPHROL, V2, P1328
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   CHEUNG AK, 1991, KIDNEY INT, V40, P1123, DOI 10.1038/ki.1991.324
   CHOI NH, 1989, MOL IMMUNOL, V26, P835
   CLAS F, 1985, CURR TOP MICROBIOL, V121, P19
   COOPER NR, 1991, IMMUNOL TODAY, V12, P327, DOI 10.1016/0167-5699(91)90010-Q
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241
   Evans MJ, 1995, MOL IMMUNOL, V32, P1183, DOI 10.1016/0161-5890(95)00099-2
   Fadul JEM, 1998, J CLIN APHERESIS, V13, P167, DOI 10.1002/(SICI)1098-1101(1998)13:4<167::AID-JCA5>3.0.CO;2-N
   FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331
   FISHELSON Z, 1994, SPRINGER SEMIN IMMUN, V15, P345, DOI 10.1007/BF01837365
   FISHELSON Z, 1985, IMMUNOL LETT, V11, P261, DOI 10.1016/0165-2478(85)90107-5
   Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499
   FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430
   GICLAS PC, 1997, T SOC BIOMAT, V20, P269
   Haeffner-Cavaillon N, 1988, Contrib Nephrol, V62, P86
   HAEFFNERCAVAILLON N, 1987, J IMMUNOL, V139, P794
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAKIM RM, 1994, NEW ENGL J MED, V331, P1338, DOI 10.1056/NEJM199411173312003
   HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272
   HAMMERSCHMIDT DE, 1987, COMPLEMENT HLTH DIS, P267
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   Higgins PJ, 1997, J IMMUNOL, V158, P2872
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172
   HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5
   HUGLI T E, 1986, Complement, V3, P111
   HUGLI TE, 1980, IMMUNOASSAYS CLIN LA, P443
   Jaber BL, 1998, BLOOD PURIFICAT, V16, P325, DOI 10.1159/000014352
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   Janatova J, 1998, MOL IMMUNOL, V35, P361, DOI 10.1016/S0161-5890(98)90655-1
   JANATOVA J, 1990, FASEB Journal, V4, pA1871
   JANATOVA J, 1983, ANN NY ACAD SCI, V421, P218, DOI 10.1111/j.1749-6632.1983.tb18111.x
   JANATOVA J, 1997, SURF BIOM 97 S NOT, P102
   JANATOVA J, 1995, T SOC BIOMAT, V18, P190
   JANATOVA J, 1996, 5 WORLD BIOM C PROGR, V1, P335
   JANATOVA J, 1988, METHOD ENZYMOL, V162, P579
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   JOINER KA, 1984, ANNU REV IMMUNOL, V2, P461, DOI 10.1146/annurev.iy.02.040184.002333
   JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221
   JOKIRANTA TS, 1995, SCAND J IMMUNOL, V42, P9, DOI 10.1111/j.1365-3083.1995.tb03620.x
   KAM CM, 1992, J IMMUNOL, V149, P163
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X
   KOTWAL GJ, 1996, IMMUNOLOGIST, V4, P157
   Lazar HL, 1999, CIRCULATION, V100, P1438, DOI 10.1161/01.CIR.100.13.1438
   LIN YS, 1992, BIOMATERIALS, V13, P497
   Lucchesi BR, 1997, IMMUNOPHARMACOLOGY, V38, P27, DOI 10.1016/S0162-3109(97)00060-X
   MOORE FD, 1994, ADV IMMUNOL, V56, P267, DOI 10.1016/S0065-2776(08)60454-X
   MORGAN BP, 1990, COMPLMENT CLIN ASPEC
   Morikis D, 1998, PROTEIN SCI, V7, P619, DOI 10.1002/pro.5560070311
   MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321
   MULLIGAN MS, 1992, J IMMUNOL, V148, P1479
   MURPHY BF, 1988, J CLIN INVEST, V81, P1858, DOI 10.1172/JCI113531
   Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000
   Nilsson B, 1998, BLOOD, V92, P1661
   Pascual M, 1996, KIDNEY INT, V49, P309, DOI 10.1038/ki.1996.47
   Peek GJ, 1999, ASAIO J, V45, P250, DOI 10.1097/00002480-199907000-00003
   PODACK ER, 1978, J IMMUNOL, V120, P1841
   REID KBM, 1986, ESSAYS BIOCHEM, V22, P27
   REID KBM, 1995, IMMUNOLOGIST, V3, P206
   Rinder CS, 1999, CIRCULATION, V100, P553, DOI 10.1161/01.CIR.100.5.553
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   ROLLINS SA, 1991, J IMMUNOL, V146, P2345
   Rosenkranz AR, 1999, J AM SOC NEPHROL, V10, P128
   SACKS T, 1978, J CLIN INVEST, V61, P1161, DOI 10.1172/JCI109031
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 1996, BIOCHEM PHARMACOL, V51, P797, DOI 10.1016/0006-2952(95)02398-4
   Sahu A, 1999, BIOCHEM PHARMACOL, V57, P1439, DOI 10.1016/S0006-2952(99)00044-1
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   SCHAEFER RM, 1990, MINER ELECTROL METAB, V16, P73
   SCHIFFL H, 1995, ASAIO J, V41, pM709, DOI 10.1097/00002480-199507000-00104
   Shiga Y, 1998, ARTIF ORGANS, V22, P1067, DOI 10.1046/j.1525-1594.1998.06170.x
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SWIFT AJ, 1994, CLIN DIAGN LAB IMMUN, V1, P585
   TAYLOR PW, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P49
   Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8
   THYLEN P, 1995, AM J NEPHROL, V15, P392, DOI 10.1159/000168872
   THYLEN P, 1992, AM J NEPHROL, V12, P393, DOI 10.1159/000168488
   Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259
   VOGT W, 1986, Complement, V3, P177
   VOGT W, 1989, MOL IMMUNOL, V26, P1133, DOI 10.1016/0161-5890(89)90057-6
   WAGNER E, 1998, HUMAN COMPLEMENT SYS, P527
   WAGNER JL, 1984, ANAL BIOCHEM, V136, P75, DOI 10.1016/0003-2697(84)90308-7
   WALTON DF, 1995, CLIN DIALYSIS, P93
   Wang H, 1999, TRANSPLANTATION, V68, P1643, DOI 10.1097/00007890-199912150-00007
   WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955
   WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562
   WIEDMER T, 1991, BLOOD, V78, P2880
   WURZNER R, 1991, COMPLEMENT INFLAMMAT, V8, P328
   Wurzner R, 1999, MOL IMMUNOL, V36, P249, DOI 10.1016/S0161-5890(99)00049-8
NR 101
TC 36
Z9 38
U1 1
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1058-2916
EI 1538-943X
J9 ASAIO J
JI Asaio J.
PD NOV-DEC
PY 2000
VL 46
IS 6
BP S53
EP S62
DI 10.1097/00002480-200011000-00038
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 374LU
UT WOS:000165347300037
PM 11110295
OA Bronze
DA 2018-10-19
ER

PT J
AU Galassi, G
   Brun, P
   Radice, M
   Cortivo, R
   Zanon, GF
   Genovese, P
   Abatangelo, G
AF Galassi, G
   Brun, P
   Radice, M
   Cortivo, R
   Zanon, GF
   Genovese, P
   Abatangelo, G
TI In vitro reconstructed dermis implanted in human wounds: degradation
   studies of the HA-based supporting scaffold
SO BIOMATERIALS
LA English
DT Article
DE chronic ulcers; surgical wounds; artificial dermis; hyaluronan esters
ID CULTURED AUTOLOGOUS KERATINOCYTES; HUMAN EPIDERMAL-CELLS; EPITHELIAL
   AUTOGRAFTS; FULL-THICKNESS; SKIN; FIBROBLASTS; GROWTH; ULCERS;
   EXPERIENCE; INVITRO
AB The objective of the present study was to demonstrate the safety and efficacy of a dermal replacement for cutaneous wounds of diverse origin. Autologous fibroblasts were cultured in fleece scaffolds made from benzyl esters of hyaluronic acid and applied onto cutaneous lesions. The cases presented are (1) skin removal for multiple epithelioma and (2) chronic deep decubitus ulcer. Dermal-like tissue applied by the surgeon elicited no adverse reactions, and was fully integrated and well-vascularized by 1-3 weeks. In Case I, the material was fully integrated after 1 week, and after 3 weeks an epidermal autograft was overlaid which showed good take with excellent integration observed after 4 weeks. At 12 months, skin demonstrated visual normo-elastic properties and no signs of excessive scarring. In Case 2, 2-3 weeks after the dermal implant was applied, the wound was invaded with granulation tissue and healing occurred by secondary intention. The ulcer was healed by 8 weeks, with the biomaterial completely resorbed and a complete re-epithelialization over the dermal-like tissue. These results suggest that autologous fibroblast culture in hyaluronan-derived scaffolds may be successfully grafted in diverse cutaneous pathologies and constitute a suitable bed for further epidermal implantation. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Padua, Fac Med, Inst Histol & Embryol, I-35121 Padua, Italy.
   Sant Anna Hosp, Clin Plast Surg, Ferrara, Italy.
   Univ Padua, Fac Med, Dept Pediat Surg, Padua, Italy.
   Sant Anna Hosp, Dept Rehabil Med, Ferrara, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Fac Med, Inst Histol & Embryol, Viale G Colombo 3, I-35121 Padua, Italy.
CR BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BOYCE S, 1988, J BIOMED MATER RES, V22, P933
   BRIGGAMAN RA, 1968, J INVEST DERMATOL, V51, P454, DOI 10.1038/jid.1968.155
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   COULOMB B, 1989, J INVEST DERMATOL, V92, P122, DOI 10.1111/1523-1747.ep13071335
   CUONO C, 1986, LANCET, V1, P1123
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   Fusenig N. E., 1994, KERATINOCYTE HDB, P71
   GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   HANSBROUGH JF, 1993, WOUNDS, V5, P174
   Harris PA, 1999, LANCET, V353, P35, DOI 10.1016/S0140-6736(05)74873-X
   HUNDYADI J, 1988, PLAST RECONSTR SURG, V89, P268
   JONES G, 1979, J NEURAL SCI, V43, P456
   KAISER HW, 1994, BURNS, V20, P23, DOI 10.1016/0305-4179(94)90101-5
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   KREJCI NC, 1991, J INVEST DERMATOL, V97, P843, DOI 10.1111/1523-1747.ep12491522
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   LEARY T, 1991, J INVEST DERMATOL, V99, P422
   LEIGH IM, 1994, KERATINOCYTE HDB, P43
   LIMOVA M, 1995, WOUNDS, V7, P170
   MACKENZIE IC, 1994, KERATINOCYTE HDB, P243
   PHILLIPS TJ, 1994, WOUNDS, V6, P113
   PRUNIERAS M, 1979, ANN CHIR PLAST ESTH, V24, P357
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 27
TC 73
Z9 77
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2000
VL 21
IS 21
BP 2183
EP 2191
DI 10.1016/S0142-9612(00)00147-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 348EL
UT WOS:000088972500010
PM 10985492
DA 2018-10-19
ER

PT J
AU Sieminski, AL
   Gooch, KJ
AF Sieminski, AL
   Gooch, KJ
TI Biomaterial-microvasculature interactions
SO BIOMATERIALS
LA English
DT Article
DE endothelial cells; microvasculature; microarchitecture; tissue
   engineering; cell adhesion; transport
ID ENCAPSULATES SUBCUTANEOUS IMPLANTS; ANGIOGENESIS IN-VITRO;
   ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; MEMBRANE MICROARCHITECTURE;
   BASEMENT-MEMBRANE; GEOMETRIC CONTROL; VASCULAR GRAFT; ADIPOSE-TISSUE;
   GROWTH
AB The utility of implanted sensors, drug-delivery systems, immunoisolation devices, engineered cells, and engineered tissues can be limited by inadequate transport to and from the circulation. As the primary function of the microvasculature is to facilitate transport between the circulation and the surrounding tissue, interactions between biomaterials and the microvasculature have been explored to understand the mechanisms controlling transport to implanted objects and ultimately improve it. This review surveys work on biomaterial-microvasculature interactions with a focus on the use of biomaterials to regulate the structure and function of the microvasculature. Several applications in which biomaterial-microvasculature interactions play a crucial role are briefly presented. These applications provide motivation and framework for a more in-depth discussion of general principles that appear to govern biomaterial-microvasculature interactions (i.e., the microarchitecture and physio-chemical properties of a biomaterial as well as the local biochemical environment). (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Gooch, KJ (reprint author), Univ Penn, Dept Bioengn, 117 Hayden Hall, Philadelphia, PA 19104 USA.
RI Gooch, Keith/E-3135-2011
CR ALHENDY A, 1995, HUM GENE THER, V6, P65
   Aoki T, 1995, J BIOMAT SCI-POLYM E, V7, P539, DOI 10.1163/156856295X00463
   BATTEGAY EJ, 1995, J MOL MED-JMM, V73, P333
   Beger C, 1998, DIABETES, V47, P559, DOI 10.2337/diabetes.47.4.559
   Black AF, 1998, FASEB J, V12, P1331
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   Boudreau J, 1999, BIOCHEM J, V339, P481
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   CUONO CB, 1987, PLAST RECONSTR SURG, V80, P626, DOI 10.1097/00006534-198710000-00029
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DVORAK HF, 1987, LAB INVEST, V57, P673
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500
   GOOCH KJ, 1998, ANN BIOMED ENG, V26, pS141
   GOUGH DA, 1995, DIABETES, V44, P1005, DOI 10.2337/diab.44.9.1005
   Griffith LG, 1997, ANN NY ACAD SCI, V831, P382
   Haralabopoulos GC, 1997, AM J PHYSIOL-CELL PH, V273, pC239
   HOFFMAN D, 1993, EXP NEUROL, V122, P100, DOI 10.1006/exnr.1993.1111
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Hoying JB, 1996, IN VITRO CELL DEV-AN, V32, P409
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hunter SK, 1999, ASAIO J, V45, P37, DOI 10.1097/00002480-199901000-00009
   INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   JOSEPH JM, 1994, CELL TRANSPLANT, V3, P355, DOI 10.1177/096368979400300502
   KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   MACIAG T, 1982, J CELL BIOL, V94, P511, DOI 10.1083/jcb.94.3.511
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   Masuda S, 1997, ASAIO J, V43, pM530
   Matsuda T, 1990, ASAIO Trans, V36, pM565
   Matsuda T, 1996, J BIOMED MATER RES, V32, P165
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   MESSINA LM, 1992, P NATL ACAD SCI USA, V89, P12018, DOI 10.1073/pnas.89.24.12018
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119
   NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   Patel N, 1998, FASEB J, V12, P1447
   Powers MJ, 1998, MICROSC RES TECHNIQ, V43, P379, DOI 10.1002/(SICI)1097-0029(19981201)43:5<379::AID-JEMT4>3.3.CO;2-S
   ROSEN EM, 1997, REGULATION ANGIOGENE, V79
   Rosengren A, 1999, J BIOMED MATER RES, V46, P458, DOI 10.1002/(SICI)1097-4636(19990915)46:4<458::AID-JBM3>3.0.CO;2-I
   SALTZMAN WM, 1997, PRINCIPLES TISSUE EN, P228
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   SHAKADO S, 1995, HEPATOLOGY, V22, P696
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.0.CO;2-C
   Squinto S P, 1994, In Vivo, V8, P771
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   THOMPSON JA, 1989, P NATL ACAD SCI USA, V86, P7928, DOI 10.1073/pnas.86.20.7928
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Tresco P A, 1992, Cell Transplant, V1, P255
   VERNON RB, 1995, IN VITRO CELL DEV-AN, V31, P120
   WEI YZ, 1995, STEM CELLS, V13, P541, DOI 10.1002/stem.5530130512
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
NR 69
TC 88
Z9 94
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2000
VL 21
IS 22
BP 2233
EP 2241
DI 10.1016/S0142-9612(00)00149-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358DK
UT WOS:000089541800003
PM 11026629
DA 2018-10-19
ER

PT J
AU Massia, SP
   Stark, J
   Letbetter, DS
AF Massia, SP
   Stark, J
   Letbetter, DS
TI Surface-immobilized dextran limits cell adhesion and spreading
SO BIOMATERIALS
LA English
DT Article
DE surface modification; immobilized dextran; cell-resistant surface;
   engineered biomaterials
ID PLASMA-PROTEINS; PEPTIDE; BIOMATERIALS; POLYSACCHARIDE; POLYETHYLENE;
   DEGRADATION; ADSORPTION; POLYMERS; NETWORKS
AB Dextran has recently been investigated as an alternative to polyethylene glycol (PEG) for low protein-binding, cell-resistant coatings on biomaterial surfaces. Although anti-fouling properties of surface-grafted dextran and PEG are quite similar, the multivalent properties of dextran are advantageous when high-density surface immobilization of biologically active molecules to low protein-binding surface coatings is desired. The preferred methods of dextran immobilization for biomaterial applications should be simple with minimal toxicity. In this report, a method is described for covalent immobilization of dextran to material surfaces which involves low residual toxicity reagents in mild aqueous reaction conditions. 70kDa MW dextran was immobilized on glass and polyethylene terephthalate (PET) surfaces. 3T3 fibroblast cell adhesion was compared on untreated, aminated, and dextran-coated materials. Dextran coatings effectively limited cell adhesion and spreading on glass and PET surfaces in the presence of serum-borne cell adhesion proteins. With dextran-based surface coatings, it will be possible to develop well-defined surface modifications that promote specific cell interactions and perhaps better performance in long-term biomaterial implants. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Arizona State Univ, Dept Chem Bio & Mat Engn, Tempe, AZ 85287 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Massia, SP (reprint author), Arizona State Univ, Dept Chem Bio & Mat Engn, POB 876006, Tempe, AZ 85287 USA.
RI Zhou, Feng/E-9510-2011
FU NHLBI NIH HHS [HL60450]
CR BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   CREPON B, 1991, BIOMATERIALS, V12, P550, DOI 10.1016/0142-9612(91)90049-G
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DRUMHELLER PD, 1994, BIOTECHNOL BIOENG, V43, P772, DOI 10.1002/bit.260430812
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   Frazier RA, 1997, LANGMUIR, V13, P7115, DOI 10.1021/la970382v
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirtenstein M, 1980, Dev Biol Stand, V46, P109
   Holland NB, 1998, NATURE, V392, P799
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KONDOH A, 1993, J APPL POLYM SCI, V47, P1983, DOI 10.1002/app.1993.070471108
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   SALZMAN EW, 1983, J AM SOC ARTIF INT O, V6, P60
   Shankar Ravi, 1994, P67
   SOSA JM, 1980, ANAL CHEM, V52, P910, DOI 10.1021/ac50056a031
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   WILSON MB, 1976, J IMMUNOL METHODS, V12, P171
NR 28
TC 159
Z9 165
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2000
VL 21
IS 22
BP 2253
EP 2261
DI 10.1016/S0142-9612(00)00151-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358DK
UT WOS:000089541800005
PM 11026631
DA 2018-10-19
ER

PT J
AU Kao, WYJ
AF Kao, WYJ
TI Evaluation of leukocyte adhesion on polyurethanes: the effects of shear
   stress and blood proteins
SO BIOMATERIALS
LA English
DT Article
DE complement; C3 complement protein; rotating disc; fibronectin;
   polyethyleneglycol
ID VIVO MACROPHAGE ADHESION; BIO-MEDICAL POLYMERS; GIANT-CELL FORMATION;
   STAPHYLOCOCCUS-EPIDERMIDIS; COMPLEMENT ACTIVATION; THEORETICAL-ANALYSIS;
   FLOW; BIOCOMPATIBILITY; MECHANISMS; BIOMATERIALS
AB Leukocytes are a central cell type in directing host inflammatory and immune processes; thus, its response to biomaterials is extremely important in understanding material-host interaction. Blood contacting biomaterials may activate the complement cascade, thus promote leukocyte adhesion and activation to the biomaterial surface. We hypothesize that the extent of complement-mediated leukocyte activation is modulated by the material chemical formulation and the presence of fluid shear stress. Medical-grade polyurethanes with or without 4,4'-butyldiene bis(6-tert-butyl-m-cresol) antioxidant additives and a rotating disk system were utilized to study cell adhesion under a well-characterized shear stress held. Radioimmunoassay and ELISA were employed to assess the extent of complement activity. The results showed that adherent leukocyte densities decreased with increasing shear stress and that leukocyte adhesion was decreased significantly further by the presence of the antioxidant in the polyurethanes. Cell adhesion under how conditions was abolished when complement C3 protein was depleted from the test medium. An increase in complement Factor H adsorption was observed at high shear region; however, no change in the complete complement activation was observed in the presence of shear stress as indicated by the protein S-terminal complement complex level. Based on these results, oligopeptides designed from C3a, C5a, and fibronectin were grafted onto a cell-nonadhesive polymer surface to probe the molecular mechanisms of leukocyte adhesion as mediated by protein-receptor complexation. The results showed that C3a-derived peptides mediated higher adherent macrophage density when compared to that mediated by C5a- and fibronectin-derived peptides. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
RP Kao, WYJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
FU NHLBI NIH HHS [HL-47300, HL-25239, HL-09601]
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANDERSON JM, 1988, ASAIO, V11, P101
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   CHEUNG AK, 1994, NEPHROL DIAL TRANSPL, V9, P96
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CRAWFORD EK, 1990, CANCER RES, V50, P4578
   DAILY JW, 1960, J BASIC ENG, V3, P217
   EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003
   GIDDENS DP, 1993, CARDIOVASC PATHOL, V2, pS167
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAMMER DA, 1993, BLOOD CELLS, V19, P261
   HUGLI TE, 1989, CURR TOP MICROBIOL I, V153, P181
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Hynes R. O., 1990, FIBRONECTIN
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOHNSTON SD, 1994, SEMIN VET MED SURG, V9, P2
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   Levich VG, 1962, PHYSICOCHEM HYDRODYN, P57
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   *NIH, 1979, NIH PUBL, P68
   PETSCHEK H, 1968, T AM SOC ART INT ORG, V14, P256
   ROSS GD, 1989, CURR OPIN IMMUNOL, V2, P50, DOI 10.1016/0952-7915(89)90097-6
   RUDOLPH R, 1990, CLIN PLAST SURG, V17, P457
   RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119
   SANDERSON SD, 1995, J MED CHEM, V38, P3669, DOI 10.1021/jm00018a028
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   SLACK SM, 1993, THROMB HAEMOSTASIS, V70, P129
   SLACK SM, 1993, CARDIOVASC PATHOL, V2, pS11
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WEWERS MD, 1992, CYTOKINES HLTH DIS, P235
   WILLEMS GM, 1993, BLOOD, V82, P497
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 43
TC 25
Z9 28
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2000
VL 21
IS 22
BP 2295
EP 2303
DI 10.1016/S0142-9612(00)00156-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358DK
UT WOS:000089541800010
PM 11026636
DA 2018-10-19
ER

PT J
AU Chang, CC
   Rosenson-Schloss, RS
   Bhoj, TD
   Moghe, PV
AF Chang, CC
   Rosenson-Schloss, RS
   Bhoj, TD
   Moghe, PV
TI Leukocyte chemosensory migration on vascular prosthetic biomaterial is
   mediated by an integrin beta(2) receptor chain
SO BIOMATERIALS
LA English
DT Article
DE leukocytes; cell migration; vascular biomaterial; CD18 integrin;
   chemokine; ePTFE
ID HUMAN-NEUTROPHILS; MAC-1 CD11B/CD18; EXPANDED POLYTETRAFLUOROETHYLENE;
   POLYMORPHONUCLEAR LEUKOCYTES; DOWN-REGULATION; CROSS-LINKING;
   HUMAN-BLOOD; IN-VITRO; ADHESION; ACTIVATION
AB The ability of adherent activated leukocytes to migrate on implanted prosthetic biomaterial surfaces may be an early rate-limiting step in eliminating periprosthetic infection. The goal of this study was to explore the molecular mechanism governing leukocyte migration on the implantable cardiovascular prosthetic biomaterial, expanded polytetrafluoroethylene (ePTFE), in response to stimulation by the soluble chemokine, N-formyl-methionyl-leucyl-phenylalanine (fMLP). We used a population level migration assay to study the migration of polymorphonuclear leukocytes (PMN) on ePTFE, overlaid by a gelatin/agar composite. A theoretical random walk model was applied to describe fMLP-induced PMN migration on ePTFE in terms of an objective random cell migration coefficient, mu. Our results show that following stimulation with 0-10(-7) M fMLP, the value of mu ranged from 5.43 x 10(-9) to 1.08 x 10(-7) cm(2)/s, with a maximum value obtained at 10(-8) M fMLP. We probed the expression levels of various beta(2) integrin receptor subunits and their contribution to the migratory function of ePTFE-adherent PMN over a wide range of fMLP concentration. We found that the expression of the integrin beta-chain, CD18, was also maximized at 10(-8) M fMLP, along with only slight changes in the expression of integrin alpha-chains (CD11a,b,c). We report that treatment with antibodies against either beta or combined alpha chains, but not individual a chains, inhibited PMN attachment to ePTFE at 10(-8) M fMLP, suggesting the likely role of combined beta(2) receptor subunits in early adhesion events following stimulation. However, treatment with only anti-CD18 significantly lowered PIMN migration on ePTFE (mu = 5.98 x 10(-9) cm(2)/s), and this degree of inhibition was much greater than that elicited by the combined treatment with antibodies recognizing all possible alpha-chains. Overall, we conclude that migratory behavior of chemokinetically stimulated PMN on ePTFE is mediated by the integrin beta chain pool, and is only weakly regulated by the integrin alpha chain. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Busch Campus,98 Brett Rd, Piscataway, NJ 08854 USA.
CR Abramowitz M., 1965, HDB MATH FUNCTIONS, P295
   Barnett CC, 1998, AM J PHYSIOL-CELL PH, V274, pC1634, DOI 10.1152/ajpcell.1998.274.6.C1634
   BEEKHUIZEN H, 1993, J IMMUNOL, V150, P950
   Benton LD, 1996, J SURG RES, V64, P116, DOI 10.1006/jsre.1996.0316
   Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213
   CARLOS TM, 1994, BLOOD, V84, P2068
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623
   DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545
   DUNN GA, 1981, BIOL CHEMOTACTIC RES, P1
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   Gao JX, 1996, IMMUNOLOGY, V88, P463, DOI 10.1046/j.1365-2567.1996.d01-662.x
   HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776
   ISSEKUTZ AC, 1992, IMMUNOLOGY, V76, P655
   KATZ DA, 1994, SURGERY, V116, P446
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Lopez S, 1998, CELL ADHES COMMUN, V5, P151, DOI 10.3109/15419069809040288
   MARTZ E, 1987, HUM IMMUNOL, V18, P3, DOI 10.1016/0198-8859(87)90110-8
   Merritt K, 1999, J BIOMED MATER RES, V44, P261, DOI 10.1002/(SICI)1097-4636(19990305)44:3<261::AID-JBM4>3.0.CO;2-M
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   PIZZOFERRATO A, 1986, TECHNIQUES BIOCOMPAT, P109
   REMOLDODONNELL E, 1995, BLOOD, V85, P337
   REMOLDODONNELL E, 1994, J IMMUNOL, V152, P3595
   RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138
   ROTHMAN C, 1983, ANN BIOMED ENG, V11, P451, DOI 10.1007/BF02584219
   SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785
   SMITH C, 1990, LEUKOCYTE ADHESION M, P171
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   SPRINGER TA, 1986, CIBA F SYMP, V118, P102, DOI 10.1002/9780470720998.ch8
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   WALZOG B, 1994, J LEUKOCYTE BIOL, V56, P625
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WOODMAN RC, 1993, BLOOD, V82, P2188
   YEO EL, 1994, BLOOD, V83, P2498
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 39
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2000
VL 21
IS 22
BP 2305
EP 2313
DI 10.1016/S0142-9612(00)00157-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358DK
UT WOS:000089541800011
PM 11026637
DA 2018-10-19
ER

PT J
AU Carr, AB
   Gerard, DA
   Larsen, PE
AF Carr, AB
   Gerard, DA
   Larsen, PE
TI Histomorphometric analysis of implant Anchorage for 3 types of dental
   implants following 6 months of healing in baboon jaws
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE animal study; biomaterials; bone; dental implants; histomorphometry
ID TITANIUM IMPLANTS; SURFACE
AB In an effort to better understand the supporting anatomy for unloaded endosseous dental implants, this study focused on the histomorphometric analysis of 3 different types of implants placed into nonhuman primate jaws and allowed to heal for 6 months. This report describes data from 24 screw-type dental implants placed in edentulated (2 months healing time) posterior arches of 4 adult female baboons. Three different implants were placed and allowed to heal for 6 months prior to processing for evaluation: commercially pure titanium (n = 8), titanium alloy (n = 8), and titanium plasma-sprayed (n = 8). Circumferential bone-implant interface sampling from 6 regions along the entire length of each implant was obtained for evaluation of percent bone-implant contact (%BIC) and percent bone area (%BA) within 3 mm of the implant Data were collected (reliability of 1.6% for both parameters) and analyzed by an observer blinded to implant material using IMAGE analysis software for differences between jaws, implant biomaterials, and jaw/biomaterial (analysis of variance, pairwise comparison using least squares method with Bonferroni adjustment). The results indicated that the overall mean %BIC was 55.8 and mean %BA was 48.1. Maxillary and mandibular differences for both parameters were statistically significantly different: %BIC in maxilla 50.8, in mandible 60.8; %BA in maxilla 43,6 in mandible 52.6 (both significant at the P < .05 level). The biomaterial analyses revealed no significant differences between the different implants for %BIC or %BA. The trend observed-that mandibular values were greater than maxillary values for the overall jaw comparisons-was found to be consistent at the jaw/biomaterial level, although the small sample size limited statistical power. These data, along with data from a previous 3-month study, provide insight into baseline supporting anatomy for dental implants.
C1 Mayo Clin, Mayo Grad Sch Med, Dept Dent Specialties, Rochester, MN 55905 USA.
   Univ Tennessee, Med Ctr, Dept Oral & Maxillofacial Surg, Knoxville, TN USA.
   Ohio State Univ, Coll Dent, Sect Oral & Maxillofacial Surg, Columbus, OH 43210 USA.
RP Carr, AB (reprint author), Mayo Clin, Mayo Grad Sch Med, Dept Dent Specialties, 200 1st St SW, Rochester, MN 55905 USA.
OI Carr, Alan/0000-0002-7944-4143
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Albrektsson T., 1993, Clinical Materials, V12, P1, DOI 10.1016/0267-6605(93)90021-X
   ARVIDSON K, 1990, International Journal of Oral and Maxillofacial Implants, V5, P127
   BHASKAR SN, 1976, ORBANS ORAL HISTOLOG, P234
   Brunski J B, 1988, J Dent Educ, V52, P775
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BRUNSKI JB, 1989, MATER RES SOC S P, V110, P505
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carr A B, 1995, Int J Oral Maxillofac Implants, V10, P167
   Carr AB, 1997, INT J ORAL MAX IMPL, V12, P777
   Caulier H, 1997, INT J ORAL MAX IMPL, V12, P380
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Ettinger R L, 1993, Int J Oral Maxillofac Implants, V8, P420
   KELLER JC, 1987, J BIOMED MATER RES, V21, P305, DOI 10.1002/jbm.820210304
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   LUM LB, 1988, J PROSTHET DENT, V60, P700, DOI 10.1016/0022-3913(88)90403-9
   OLIVE J, 1990, International Journal of Oral and Maxillofacial Implants, V5, P390
   Piattelli A, 1998, J PERIODONTOL, V69, P178, DOI 10.1902/jop.1998.69.2.178
   Sackett DL, 1991, CLIN EPIDEMIOLOGY BA
   STEFLIK DE, 1994, INT J ORAL MAXILLOF, V9, P501
   Sullivan D Y, 1996, Int J Oral Maxillofac Implants, V11, P179
   TERLINCK J, 1991, INT J ORAL MAXILLOF, V6, P55
   Weinlaender M, 1992, Int J Oral Maxillofac Implants, V7, P491
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
NR 26
TC 14
Z9 15
U1 0
U2 1
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD NOV-DEC
PY 2000
VL 15
IS 6
BP 785
EP 791
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 385RH
UT WOS:000166017100003
PM 11151576
DA 2018-10-19
ER

PT J
AU Gloeckner, DC
   Sacks, MS
   Billiar, KL
   Bachrach, N
AF Gloeckner, DC
   Sacks, MS
   Billiar, KL
   Bachrach, N
TI Mechanical evaluation and design of a multilayered collagenous repair
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE submucosa; mechanical behavior; biocomposite; biaxial mechanical
   testing; fiber kinematics
ID SMALL-INTESTINAL SUBMUCOSA; TISSUE SELECTION SITES; FIBER ARCHITECTURE;
   VASCULAR GRAFT; DOG-MODEL; BEHAVIOR; DEVICE
AB One method of fabricating implantable biomaterials is to utilize biologically derived, chemically modified tissues to form constructs that are both biocompatible and remodelable. Rigorous mechanical characterization is a necessary component in material evaluation to ensure that the constructs will withstand in vivo loading. In this study we performed an in-depth biaxial mechanical and quantitative structural analysis of GraftPatch (GP), a biomaterial constructed by assembling chemically treated layers of porcine small intestinal submucosa (SIS). The mechanical behavior of GP was compared to both native SIS and to glutaraldehyde-treated bovine pericardium (GLBP) as a reference biomaterial. Under biaxial loading, GP was found to be stiffer than native SIS and mechanically anisotropic, with the preferred fiber direction demonstrating greater stiffness. Quantitative structural analysis using small-angle light scattering indicated a uniform fiber structure similar to GLBP and SIS. To enable test-protocol-independent quantitative comparisons, the biaxial mechanical data were fit to an orthotropic constitutive model, which indicated a similar degree of mechanical anisotropy between the three groups. We also demonstrate how the constitutive model can be used to design layered biocomposite materials that can undergo large deformations. (C) 2000 John Wiley & Sons, Inc.
C1 Dept Bioengn, Tissue Mech Lab, Pittsburgh, PA 15261 USA.
   Organogenesis Inc, Canton, MA USA.
RP Sacks, MS (reprint author), Dept Bioengn, Tissue Mech Lab, 749 Benedum Hall,3700 OHara St, Pittsburgh, PA 15261 USA.
CR ABRAHAM GAR, 1998, Patent No. 09432
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   BILLIAR K, IN PRESS J BIOMECH E
   BILLIAR K, 2000, J BIOMECH ENG, V122, P22
   Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   BILLIRA K, 1996, 5 WORLD BIOM C TOR U
   Christensen RM, 1979, MECH COMPOSITE MAT, P348
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   FUNG Y, 1965, BIOMECHANICS MECH PR, P525
   FUNG Y, 1965, PRENTICE HALL INT SE, P525
   HERBERT ST, 1993, ANN BIOMED ENG, V21, P727, DOI 10.1007/BF02368651
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   KANG T, 1995, J BIOMECH ENG-T ASME, V117, P86, DOI 10.1115/1.2792274
   LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   ORBERG J, 1983, CONNECT TISSUE RES, V11, P285, DOI 10.3109/03008208309004861
   ORBERG JW, 1982, CONNECT TISSUE RES, V9, P187, DOI 10.3109/03008208209160260
   PRESS WH, 1988, NUMERICAL RECIPES C
   RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265
   SACKS MA, 1999, ASME IMECE, V43, P101
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   SACKS MS, IN PRESS J BIOMECH E
   SACKS MS, IN PRESS COMPUT MECH
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 34
TC 36
Z9 40
U1 2
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2000
VL 52
IS 2
BP 365
EP 373
DI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 345JM
UT WOS:000088812900017
PM 10951377
OA Green Published
DA 2018-10-19
ER

PT J
AU Hu, J
   Fraser, R
   Russell, JJ
   Ben-Nissan, B
   Vago, R
AF Hu, J
   Fraser, R
   Russell, JJ
   Ben-Nissan, B
   Vago, R
TI Australian coral as a biomaterial: Characteristics
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
ID MECHANICAL-PROPERTIES; BONE INGROWTH; HYDROXYAPATITE
AB In order to produce effective implants, the materials used must be biocompatible. Hydroxyapatite (HAp) is a bioactive material similar to the mineral component of teeth and bone which is often used for orbital implants and bone graft applications. HAp can be manufactured from corals via hydrothermal conversion. Coral is particularly useful as a starting material for hydroxyapatite production because of its porous nature. When a porous structure is used tissue ingrowth can occur readily and hence an excellent mechanical bond can be achieved. A large pore size and a high degree of pore interconnections are desirable implant properties. In the present paper a comparison of the properties of four different species of Australian coral has been made to determine the most favourable species to use as a starting material for hydrothermal conversion.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
   Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
RP Ben-Nissan, B (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, Sydney, NSW 2007, Australia.
CR Albee FH, 1920, ANN SURG, V71, P32
   DEJONG WF, 1926, REC TAV CHIM, V45, P415
   Elsinger E C, 1996, J Foot Ankle Surg, V35, P396
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   MARTIN RB, 1989, BIOMATERIALS, V10, P481, DOI 10.1016/0142-9612(89)90090-2
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   Ravaglioli A., 1992, BIOCERAMICS
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   RUBIN PAD, 1994, OPHTHALMIC PLAST REC, V10, P96, DOI 10.1097/00002341-199406000-00005
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   SZABO G, 1993, ORTHOPEDICS, V16, P197
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
NR 13
TC 23
Z9 23
U1 0
U2 1
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD NOV
PY 2000
VL 16
IS 6
BP 591
EP 595
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 376NQ
UT WOS:000165464000009
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI New biomaterial unites the benefits of ceramics and metals
SO MATERIALS WORLD
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU I O M COMMUNICATIONS LTD INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0967-8638
J9 MATER WORLD
JI Mater. World
PD NOV
PY 2000
VL 8
IS 11
BP 9
EP 9
PG 1
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 373GN
UT WOS:000165280700020
DA 2018-10-19
ER

PT J
AU Mayne, AH
   Bayliss, SC
   Barr, P
   Tobin, M
   Buckberry, LD
AF Mayne, AH
   Bayliss, SC
   Barr, P
   Tobin, M
   Buckberry, LD
TI Biologically interfaced porous silicon devices
SO PHYSICA STATUS SOLIDI A-APPLIED RESEARCH
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Porous Semiconductors - Science and
   Technology (PSST-2000)
CY MAR 12-17, 2000
CL MADRID, SPAIN
ID NANOSTRUCTURED SEMICONDUCTORS; HIPPOCAMPAL-NEURONS; IN-VITRO; CELL;
   FABRICATION; TRANSISTOR; CHEMISTRY; TOXICITY; DYE
AB PS has been shown to be an excellent candidate biomaterial following studies showing its biostability and non-toxicity. These favourable properties, coupled with the case of its topographical manipulation, and its optoelectronic properties, make it an ideal material for the design of biologically interfaced devices (BIDs). Possible potential applications for PS in BIDs falls into three main areas: (i) in vitro biosensors, (ii) the development of intelligent implantible medical devices and (iii) biologically interfaced neural networks. The majority of these applications rely on the ability of PS to directly interface with living cells. In order to achieve this the cells must adhere to the solid-state device in a pattern appropriate to the circuitry. Here we report the use of confocal microscopy to image B50 cells on FS substrates in order to obtain cell patterning information. We also report the quantification of silicic acid and silica toxicity on B50 cells in culture, a study confirming that suggested by-products of PS manufacture are not toxic. Finally, preliminary findings on the effect of nerve growth factor (NGF) on the morphology of B50 cells in culture are presented.
C1 De Montfort Univ, Dept Chem, Solid State Res Ctr & Biotechnol Res, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Solid State Res Ctr, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Dept Chem, Leicester LE1 9BH, Leics, England.
   Daresbury Lab Synchrotron Radiat Source, Warrington WA4 4AD, Cheshire, England.
RP Mayne, AH (reprint author), De Montfort Univ, Dept Chem, Solid State Res Ctr & Biotechnol Res, Leicester LE1 9BH, Leics, England.
RI Tobin, Mark/B-8208-2015
OI Tobin, Mark/0000-0003-1862-0649
CR Bayliss S, 1997, THIN SOLID FILMS, V297, P308, DOI 10.1016/S0040-6090(96)09416-3
   Bayliss SC, 1997, J MATER SCI LETT, V16, P737, DOI 10.1023/A:1018581014416
   Bayliss SC, 2000, J POROUS MAT, V7, P191, DOI 10.1023/A:1009686704506
   BUCKBERRY LD, 1994, ATLA-ALTERN LAB ANIM, V22, P72
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   CURTIS A, 1996, EXP BIOL ONLINE, V1, P1430
   CURTIS A, 1998, BIOMATERIALS, V18, P1573
   DESILVA MS, 1995, BIOSENS BIOELECTRON, V10, P675, DOI 10.1016/0956-5663(95)96958-2
   FROMHERZ P, 1991, SCIENCE, V252, P1290, DOI 10.1126/science.1925540
   FROMHERZ P, 1991, BIOCHIM BIOPHYS ACTA, V1068, P149, DOI 10.1016/0005-2736(91)90203-K
   Grattarola M, 1996, J MATER SCI-MATER M, V7, P363, DOI 10.1007/BF00154550
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   Janshoff A, 1998, J AM CHEM SOC, V120, P12108, DOI 10.1021/ja9826237
   LARRSON P, 1996, BIOMATERIALS, V17, P605
   Meyer E, 1997, EUR J NEUROSCI, V9, P778, DOI 10.1111/j.1460-9568.1997.tb01426.x
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Nakashima H, 1998, J OCCUP HEALTH, V40, P270, DOI 10.1539/joh.40.270
   Nordsletten L, 1996, BIOMATERIALS, V17, P1521, DOI 10.1016/0142-9612(96)89777-8
   Perry CC, 1998, J INORG BIOCHEM, V69, P181, DOI 10.1016/S0162-0134(97)10017-4
   PINE J, 1995, J NEUROSCI METH, V32, P93
   SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0
   Shanklin DR, 1998, IMMUNOL RES, V18, P125, DOI 10.1007/BF02788777
   SVESSON I, 1997, AM J IND MED, V31, P335
   UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x
   Vassanelli S, 1999, J NEUROSCI, V19, P6767
NR 26
TC 84
Z9 84
U1 0
U2 17
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0031-8965
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Res.
PD NOV
PY 2000
VL 182
IS 1
BP 505
EP 513
DI 10.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-#
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 381HM
UT WOS:000165756500083
DA 2018-10-19
ER

PT J
AU Rosengren, A
   Wallman, L
   Bengtsson, M
   Laurell, T
   Danielsen, N
   Bjursten, LM
AF Rosengren, A
   Wallman, L
   Bengtsson, M
   Laurell, T
   Danielsen, N
   Bjursten, LM
TI Tissue reactions to porous silicon: A comparative biomaterial study
SO PHYSICA STATUS SOLIDI A-APPLIED RESEARCH
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Porous Semiconductors - Science and
   Technology (PSST-2000)
CY MAR 12-17, 2000
CL MADRID, SPAIN
ID PERIPHERAL-NERVES; ELECTRODES
AB This study addresses cellular reactions in soft tissue induced by implants of porous and planar silicon, oxidised (pr,rous) titanium and polished (planar) titanium. The implants were inserted in rat abdominal wall lot 1, 6 or 12 weeks. All types of implants for the different times were sectioned and stained for EDI and ED2 positive cells. All implant types displayed the same density of EDI and ED2 positive macrophages but the capsule formation was different for the different implants. The planar implants displayed an increased in capsule formation over time and the porous implants displayed a constant capsule thickness over time.
C1 Univ Lund, Dept Elect Measurements, S-22100 Lund, Sweden.
   Univ Lund, Univ Hosp MAS, Dept Expt Res, S-22100 Lund, Sweden.
   Univ Lund, Dept Physiol Sci, S-22100 Lund, Sweden.
RP Wallman, L (reprint author), Univ Lund, Dept Elect Measurements, POB 118, S-22100 Lund, Sweden.
RI Laurell, Thomas/B-5524-2013
OI Laurell, Thomas/0000-0002-2486-3607
CR Andrade J D, 1973, Med Instrum, V7, P110
   EDELL DJ, 1986, IEEE T BIO-MED ENG, V33, P203, DOI 10.1109/TBME.1986.325892
   KOWACS GTA, 1992, IEEE T BIOMED ENG, V39, P893
   Navarro X, 1998, J PERIPHER NERV SYST, V3, P91
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Rosengren A, 1999, J MATER SCI-MATER M, V10, P75, DOI 10.1023/A:1008964819101
   Wallman L, 1999, IEEE T BIO-MED ENG, V46, P1065, DOI 10.1109/10.784137
   Zhao Q, 1997, BIOMATERIALS, V18, P75, DOI 10.1016/S0142-9612(96)00112-3
NR 8
TC 27
Z9 27
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0031-8965
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Res.
PD NOV
PY 2000
VL 182
IS 1
BP 527
EP 531
DI 10.1002/1521-396X(200011)182:1<527::AID-PSSA527>3.0.CO;2-K
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 381HM
UT WOS:000165756500086
DA 2018-10-19
ER

PT J
AU Battistoni, C
   Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
AF Battistoni, C
   Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
TI Surface characterization of biocompatible hydroxyapatite coatings
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE biomaterial; hydroxyapatite; titanium; XPS; SAM; SEM
ID TITANIUM IMPLANT MATERIALS; SPECTROSCOPIC CHARACTERIZATION
AB The coatings of hydroxyapatite are widely used for orthopaedic and dental prostheses, Nevertheless, their chemical, biological and mechanical properties still can be improved by the development of new preparation technologies. Here we report a surface characterization of hydroxyapatite coatings prepared by different deposition techniques. The layers of hydroxyapatite are grown on commercial titanium substrates by using sol-gel and electrodeposition techniques, The biocompatibility of the samples is tested upon in vitro treatment as a function of the exposure time, Surface chemical composition and morphology of the coatings are studied by means of x-ray photoelectron spectroscopy (XPS), scanning Auger microscopy (SAM) and scanning electron microscopy (SEM), Quantitative XPS analysis and surface chemical and physical images reveal different features (cleanness, homogeneity, roughness) of the coatings and different surface modifications induced by the interaction with osteoblast cells. Copyright (C) 2000 John Wiley & Sons, Ltd.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo, RM, Italy.
RP Mattogno, G (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo, RM, Italy.
RI Casaletto, Maria Pia/P-6715-2017; Kaciulis, Saulius/G-5252-2010
OI Casaletto, Maria Pia/0000-0002-2236-5671; Kaciulis,
   Saulius/0000-0002-9868-7626; INGO, Gabriel Maria/0000-0002-5414-2077
CR Battistoni C, 1995, J ELECTRON SPECTROSC, V76, P399, DOI 10.1016/0368-2048(95)02511-1
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   CIRILLI F, 1997, P ECASIA 97, P1063
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Demri B, 1997, APPL SURF SCI, V108, P245, DOI 10.1016/S0169-4332(96)00576-4
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Gardella JA, 1996, J ELECTRON SPECTROSC, V81, P227, DOI 10.1016/0368-2048(96)03054-X
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HENCH LL, 1993, INTRO BIOCERAMICS
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LEGEROS R, 1983, SCANNING ELECT MICRO, V1, P407
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   MONTENERO A, 2000, J MATER SCI, V35, P1
   MOULDER JF, 1995, HDB XRAY PHOTOELECTR, P213
   Radin S, 1998, J BIOMED MATER RES, V39, P234, DOI 10.1002/(SICI)1097-4636(199802)39:2<234::AID-JBM10>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RIMONDINI L, 1999, REPORT CNR MSTA2 FIN
   SEAH MP, 1990, PRACTICAL SURFACE AN, P240
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   WILSON J, 1994, BIOCERAMICS, V8
NR 26
TC 40
Z9 41
U1 1
U2 14
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD NOV
PY 2000
VL 29
IS 11
BP 773
EP 781
DI 10.1002/1096-9918(200011)29:11<773::AID-SIA928>3.3.CO;2-U
PG 9
WC Chemistry, Physical
SC Chemistry
GA 376VB
UT WOS:000165476500008
DA 2018-10-19
ER

PT J
AU Schuster, MD
   Kocher, AA
   Spanier, T
   Ankersmit, JH
   Schuster, NB
   Oz, MC
   Itescu, S
AF Schuster, MD
   Kocher, AA
   Spanier, T
   Ankersmit, JH
   Schuster, NB
   Oz, MC
   Itescu, S
TI Induction of CD40 ligand expression in human T cells by left ventricular
   assist device (LVAD) biomaterial leads to B cell activation and
   allosensitization
SO CIRCULATION
LA English
DT Meeting Abstract
C1 Columbia Univ, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 31
PY 2000
VL 102
IS 18
SU S
MA 3949
BP 818
EP 818
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 367QE
UT WOS:000090072303941
DA 2018-10-19
ER

PT J
AU Cacciafesta, P
   Humphris, ADL
   Jandt, KD
   Miles, MJ
AF Cacciafesta, P
   Humphris, ADL
   Jandt, KD
   Miles, MJ
TI Human plasma fibrinogen adsorption on ultraflat titanium oxide surfaces
   studied with atomic force microscopy
SO LANGMUIR
LA English
DT Article
ID SCANNING PROBE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; PROTEIN
   ADSORPTION; IN-SITU; AQUEOUS CONDITIONS; SPECTROSCOPY; SCIENCE; SILICON;
   WATER; HSA
AB Conformational changes of proteins adsorbing on biomaterial surfaces affect biocompatibility. Titanium is among the most successful biomaterials; however, the mechanisms leading to its biocompatibility are not yet understood. The primary objective of this study was to investigate the conformation of human plasma fibrinogen (HPF) adsorbed on titanium oxide surfaces. A method for preparing ultraflat titanium substrates was developed. This allowed high-resolution investigation of both the titanium oxide surfaces and the adsorbed state of HPF. The titanium oxide surfaces were first imaged with an atomic force microscope in air and subsequently incubated in a solution of HPF in phosphate buffer and imaged in fluid with tapping mode AFM. The titanium oxide surfaces exhibited a root-mean squared (RMS) roughness of (0.29 +/- 0.03) nm over (1.00 x 1.00) mu m(2) areas. Different degrees of molecular order were found on the titanium oxide Surface. In crystalline surface areas square lattices with parameters a(0) = b(0) approximate to 0.5 nm were resolved, which is consistent with the (001) planes of the titanium dioxide TiO2 rutile. Repetitive scanning of TiO2 surface areas resulted in the abrasion of the outermost TiO2 layers by the AFM tip to a depth varying between 0.3 and 1.0 nm. When imaging adsorbed HPF, individual molecules and aggregates, often joined through their D domains, were resolved, and the typical HPF multiglobular structure was observed. The mean length and height of single molecules were (46 +/- 3) nm and (1.4 +/- 0.2) nm, respectively. Additional features (chain segments) adjacent to the D and E domains were resolved and attributed to the a chains and their C-termini. The combination of AFM and the ultraflat titanium preparation method has proven successful for the high-resolution study of both the TiO2 surface and the adsorbed HPF.
C1 Univ Bristol, Dept Oral & Dent Sci, Dent Mat Sci & Biomat Sect, Bristol Dent Hosp, Bristol BS1 2LY, Avon, England.
   Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England.
RP Jandt, KD (reprint author), Univ Bristol, Dept Oral & Dent Sci, Dent Mat Sci & Biomat Sect, Bristol Dent Hosp, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603; Miles, Mervyn/0000-0001-7762-6827
CR BERMUDEZ VM, 1982, J VAC SCI TECHNOL, V20, P51, DOI 10.1116/1.571308
   BERMUDEZ VM, 1982, J VAC SCI TECHNOL, V20, P741, DOI 10.1116/1.571447
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BRASH JL, 1995, ACS S SERIES, V602, pCH1
   CACCIAFESTA P, UNPUB
   Chen XY, 1996, ANAL CHEM, V68, P1451, DOI 10.1021/ac950844e
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   FENG L, 1995, ACS SYM SER, V602, pCH5
   FRITZ M, 1995, P SOC PHOTO-OPT INS, V2384, P150, DOI 10.1117/12.205923
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   HANTGAN RR, 1994, HEMOSTASIS THROMBOSI, pCH14
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   HEINZELMANN H, 1992, Z PHYS B CON MAT, V88, P321, DOI 10.1007/BF01470920
   Henrich V. E., 1994, SURFACE SCI METAL OX
   HLADY V, 1998, BIOPOLYMERS INTERFAC, P181
   HORBETT TA, 1996, BIOMATERIALS SCI INT, pCH3
   HUMPHRIS A, UNPUB
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   JANDT KD, IN PRESS COLLOIDS B
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1985, TISSUE INTEGRATED PR, pCH4
   Katagiri M, 1999, SURF SCI, V431, P260, DOI 10.1016/S0039-6028(99)00462-8
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Lewis KB, 1996, COLLOID SURFACE B, V7, P259, DOI 10.1016/0927-7765(96)01268-4
   LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137
   MAGONOV SN, 1996, SURFACT ANAL STM AFM, pCH2
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   PARSEGIAN VA, 1983, J PROSTHET DENT, V49, P838, DOI 10.1016/0022-3913(83)90360-8
   Pearson W. B., 1967, HDB LATTICE SPACINGS, V2
   PRUTTON M, 1987, SURFACE PHYSICS
   RASMUSSON JR, 1994, SCANNING MICROSCOPY, V8, P481
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Schultze H. E., 1966, MOL BIOL HUMAN PROTE
   SHAW DJ, 1999, INTRO COLLOID SURFAC, pCH7
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Taatjes DJ, 1997, CELL BIOL INT, V21, P715, DOI 10.1006/cbir.1997.0216
   VEKLICH YI, 1993, J BIOL CHEM, V268, P13577
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   WEIS TP, 1991, APPL PHYS LETT, V59, P35
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
NR 51
TC 151
Z9 153
U1 5
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 17
PY 2000
VL 16
IS 21
BP 8167
EP 8175
DI 10.1021/la000362k
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 362VX
UT WOS:000089799900042
DA 2018-10-19
ER

PT J
AU Luo, Y
   Kirker, KR
   Prestwich, GD
AF Luo, Y
   Kirker, KR
   Prestwich, GD
TI Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug
   delivery
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE glycosaminoglycan; biocompatible; poly(ethylene glycol); crosslinker;
   drug release
ID CHEMICAL MODIFICATION; OPHTHALMIC VEHICLES; SODIUM HYALURONATE;
   GROWTH-FACTORS; DERIVATIVES; RELEASE; BIODEGRADATION; MICROSPHERES;
   MOTILITY; SYSTEM
AB A new hyaluronic acid (HA)-based hydrogel film was prepared and evaluated for use in drug delivery. This biocompatible material crosslinks and gels in minutes, and the dried film swells and rehydrates to a flexible hydrogel in seconds. HA was first converted to the adipic dihydrazide derivative and then crosslinked with the macromolecular homobifunctional reagent poly(ethylene glycol)-propiondialdehyde to give a polymer network. After gelation, a solvent casting method was used to obtain a HA hydrogel film. The dried film swelled sevenfold in volume in buffer, reaching equilibrium in less than 100 s. Scanning electron microscopy (SEM) of the hydrogel films showed a condensed and featureless structure before swelling, but a porous microstructure when hydrated. The thermal behavior of the hydrogel films was characterized by differential scanning calorimetry. The enzymatic degradation of the HA hydrogel films by hyaluronidase was studied using both SEM and a spectrophotometric assay. Drug release from the hydrogel film was evaluated in vitro using selected anti-bacterial and anti-inflammatory drugs. This novel biomaterial can be employed for controlled release of therapeutic agents at wound sites. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.
   Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 30 S 2000 E,Room 201, Salt Lake City, UT 84112 USA.
EM gprestwich@deans.pharm.utah.edu
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BAKOS D, 1997, ADV MED PHYSICS BIOP, P54
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENEDETTI LM, 1990, J CONTROL RELEASE, V13, P33, DOI 10.1016/0168-3659(90)90072-2
   Burns JW, 1996, FERTIL STERIL, V66, P814, DOI 10.1016/S0015-0282(16)58642-7
   Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135
   Collis L, 1998, FEBS LETT, V440, P444, DOI 10.1016/S0014-5793(98)01505-1
   DAVIDSON J M, 1991, Clinical Materials, V8, P171, DOI 10.1016/0267-6605(91)90027-D
   De Iaco PA, 1998, FERTIL STERIL, V69, P318
   Dowthwaite GP, 1998, J HISTOCHEM CYTOCHEM, V46, P641, DOI 10.1177/002215549804600509
   Ford J. L., 1989, PHARM THERMAL ANAL T
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x
   Gowland G, 1996, CLIN DRUG INVEST, V11, P245, DOI 10.2165/00044011-199611040-00008
   Gustafson S, 1997, CHEM BIOL MED APPL H, P291
   HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   ILLUM L, 1994, J CONTROL RELEASE, V29, P133, DOI 10.1016/0168-3659(94)90129-5
   Juhlin L, 1997, J INTERN MED, V242, P61, DOI 10.1046/j.1365-2796.1997.00175.x
   Kelly RM, 1999, DRUG DEV IND PHARM, V25, P15, DOI 10.1081/DDC-100102137
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   LARSEN NE, 1991, COSMETIC AND PHARMACEUTICAL APPLICATIONS OF POLYMERS, P147
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   LAURENT TC, 1964, ACTA CHEM SCAND, V18, P274, DOI 10.3891/acta.chem.scand.18-0274
   LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001
   Miller JA, 1997, J BIOMED MATER RES, V38, P25, DOI 10.1002/(SICI)1097-4636(199721)38:1<25::AID-JBM4>3.0.CO;2-J
   Moore AR, 1995, INT J TISSUE REACT, V17, P153
   MORIMOTO K, 1991, PHARMACEUT RES, V8, P471, DOI 10.1023/A:1015894910416
   PAPINI D, 1993, J CONTROL RELEASE, V27, P47, DOI 10.1016/0168-3659(93)90056-B
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   POUYANI T, 1994, J AM CHEM SOC, V116, P7515, DOI 10.1021/ja00096a007
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Prestwich GD, 1998, WENN GR INT, V72, P43
   PRESTWICH GD, 2000, IN PRESS NEW FRONTIE
   Preswich GD, 1998, PHARM SCI TECHNOL TO, V1, P42
   PRISELL PT, 1992, INT J PHARM, V85, P51, DOI 10.1016/0378-5173(92)90133-M
   Rehakova M, 1996, J BIOMED MATER RES, V30, P369, DOI 10.1002/(SICI)1097-4636(199603)30:3<369::AID-JBM11>3.0.CO;2-F
   Rochira M, 1996, INT J PHARM, V144, P19, DOI 10.1016/S0378-5173(96)04686-8
   SAETTONE MF, 1994, J OCUL PHARMACOL, V10, P83, DOI 10.1089/jop.1994.10.83
   SAETTONE MF, 1991, INT J PHARM, V72, P131, DOI 10.1016/0378-5173(91)90051-O
   SHAH CB, 1991, ACS SYM SER, V480, P116
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   WICHTERL O, 1969, J POLYM SCI POL SYM, P4677
   YUI N, 1992, J CONTROL RELEASE, V22, P105
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
NR 51
TC 337
Z9 348
U1 9
U2 235
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD OCT 3
PY 2000
VL 69
IS 1
BP 169
EP 184
DI 10.1016/S0168-3659(00)00300-X
PG 16
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 366LL
UT WOS:000090006800013
PM 11018555
DA 2018-10-19
ER

PT J
AU Cimpan, MR
   Matre, R
   Cressey, LI
   Tysnes, B
   Lie, SA
   Gjertsen, BT
   Skaug, N
AF Cimpan, MR
   Matre, R
   Cressey, LI
   Tysnes, B
   Lie, SA
   Gjertsen, BT
   Skaug, N
TI The effect of heat- and auto-polymerized denture base polymers on
   clonogenicity, apoptosis, and necrosis in fibroblasts: denture base
   polymers induce apoptosis and necrosis
SO ACTA ODONTOLOGICA SCANDINAVICA
LA English
DT Article
DE apoptosis; clonogenicity; denture base polymers; necrosis
ID RESIDUAL MONOMER CONTENT; CELL-DEATH; L929 CELLS; CYTOTOXICITY;
   EXPRESSION; PATHWAYS; ONCOSIS; STRESS
AB Eluates from poly(methyl methacrylate)-based denture base polymers have recently been found to enhance death by apoptosis and necrosis in U-937 human monoblastoid cells. The present study investigated the potential of such polymers to induce apoptosis and/or necrosis and to alter clonogenicity in L929 murine fibroblasts. A fibroblast cell line was chosen because the impairment of fibroblasts subjacent to denture bases may result in a weaker or more permeable mucosa. Two aspects were addressed: the effect of direct contact with the denture base polymers and the effect of eluates extracted from the polymers. For this purpose L929 fibroblasts were seeded on disks manufactured from three heat-polymerized and four autopolymerized denture base polymers or in different concentrations of their eluates. The effects were evaluated by light, fluorescent, confocal and electron microscopy, counting of colonies, and flow cytometry. Disks and eluates of all polymers enhanced cell death by apoptosis and necrosis in L929 cells and decreased their clonogenic potential in a dose-dependent manner. Apoptosis was the main form of cell death. In general, the deleterious effects were stronger when cells were plated directly on the polymer disks than in the eluates. The autopolymerized polymers, except one, yielded higher percentages of apoptosis and necrosis than the heat-polymerized polymers. The results of the study indicated that poly(methyl methacrylate)-based denture base polymers trigger death-signals in L929 fibroblasts and open doors for possible modulation of the cell/biomaterial interaction.
C1 Univ Bergen, Fac Dent, Dept Odontol Dent Biomat, N-5009 Bergen, Norway.
   Univ Bergen, Fac Med, Gade Inst, Dept Microbiol & Immunol, Bergen, Norway.
   Sogn & Fjordane Coll, Fac Hlth Studies, Forde, Norway.
   Univ Bergen, Fac Med, Dept Anat & Cell Biol, Bergen, Norway.
   Univ Bergen, Fac Med, Div Stat, Bergen, Norway.
   Univ Bergen, Fac Dent, Dept Odontol Oral Microbiol, Bergen, Norway.
   Univ Bergen, Ctr Int Hlth, Bergen, Norway.
RP Cimpan, MR (reprint author), Univ Bergen, Fac Dent, Dept Odontol Dent Biomat, Aarstadveien 17, N-5009 Bergen, Norway.
RI Gjertsen, Bjorn T/O-1542-2015
OI Gjertsen, Bjorn T/0000-0001-9358-9704
CR ANNUSAVICE KJ, 1996, PHILLIPS SCI DENT MA, P237
   BARBIERO G, 1995, FUND CLIN IMMUNOL, V3, P88
   BEREZNOWSKI Z, 1994, INT J BIOCHEM, V26, P1119, DOI 10.1016/0020-711X(94)90134-1
   *BIPM, 1995, GUID EXPR UNC MEAS, P9
   Bonelli G, 1996, EXP CELL RES, V228, P292, DOI 10.1006/excr.1996.0329
   BOWEN RL, 1979, J DENT RES, V58, P1493, DOI 10.1177/00220345790580051301
   Brunet CL, 1998, CELL DEATH DIFFER, V5, P107, DOI 10.1038/sj.cdd.4400334
   Cimpan MR, 2000, EUR J ORAL SCI, V108, P59, DOI 10.1034/j.1600-0722.2000.00730.x
   CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195
   COLIGAN J, 1995, CURRENT PROTOCOLS IM
   Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
   EMERIT J, 1984, HDB FREE RADICALS AN, P177
   EVAN GI, 1992, CELL, V69, P19
   FADY C, 1995, J INTERF CYTOK RES, V15, P71, DOI 10.1089/jir.1995.15.71
   FRESHNEY RI, 1987, CULTURE ANIMAL CELLS, P227
   GJERTSEN BT, 1994, J CELL SCI, V107, P3363
   HAY RJ, 1992, ANIMAL CELL CULTURE, P101
   HENSTENPETTERSEN A, 1981, ACTA ODONTOL SCAND, V39, P101, DOI 10.3109/00016358109162267
   *ISO, 1988, DENT DENT BAS POL, P1
   ISO International Organization for Standardization, 1992, BIOL EV MED DEV TEST, P1
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   KOOPMAN G, 1994, BLOOD, V84, P1415
   Lefebvre C A, 1995, Int J Prosthodont, V8, P122
   MAJNO G, 1995, AM J PATHOL, V146, P3
   NORUSIS MJ, 1998, GUIDE DATA ANAL, P301
   PENNING LC, 1994, CANCER RES, V54, P5561
   Polla BS, 1996, FREE RADICAL RES, V25, P125, DOI 10.3109/10715769609149917
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SanchezAlcazar JA, 1997, J BIOL CHEM, V272, P30167, DOI 10.1074/jbc.272.48.30167
   Schuster G S, 1995, Int J Prosthodont, V8, P580
   SCULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15
   Sheridan PJ, 1997, INT J PROSTHODONT, V10, P73
   TERAKADO M, 1984, J DENT RES, V63, P901, DOI 10.1177/00220345840630061801
   TROTTER J, 1998, WINMDI 2 7
   Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116
   Vallittu PK, 1998, EUR J ORAL SCI, V106, P588, DOI 10.1046/j.0909-8836.1998.eos106109.x
   Vallittu PK, 1995, DENT MATER, V11, P338, DOI 10.1016/0109-5641(95)80031-X
   WATAHA JC, 1993, DENT MATER, V9, P172, DOI 10.1016/0109-5641(93)90116-8
   Wilson A. P., 1992, ANIMAL CELL CULTURE, P263
NR 39
TC 24
Z9 27
U1 0
U2 4
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0001-6357
J9 ACTA ODONTOL SCAND
JI Acta Odontol. Scand.
PD OCT
PY 2000
VL 58
IS 5
BP 217
EP 228
DI 10.1080/000163500750051773
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 381EG
UT WOS:000165748900007
PM 11144873
DA 2018-10-19
ER

PT J
AU Yasuda, HY
   Mahara, S
   Umakoshi, Y
   Imazato, S
   Ebisu, S
AF Yasuda, HY
   Mahara, S
   Umakoshi, Y
   Imazato, S
   Ebisu, S
TI Microstructure and mechanical property of synthesized hydroxyapatite
   prepared by colloidal process
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; biomaterial; colloidal process; bone; sintering
ID POLYCRYSTALLINE
AB Synthesized hydroxyapatite (HAp) was prepared by the colloidal process. Mixed slurry composed of 25 vol% HAp powder and 75 vol% aqueous solution containing a small amount of polycarboxylic acid ammonium as dispersant was produced. Viscosity of the HAp slurry, microstructure and mechanical property of the synthesized HAp prepared by this process depends on the quantity of dispersant. A mainly uniform microstructure was obtained in both green and sintered HAP with 2 wt% dispersant by preventing the agglomeration of powder in the slurry. A homogeneous microstructure was maintained even after annealing at temperatures between 1200 and 1400 degrees C, Maximum bending strength of 88.5 MPa was also obtained at an optimum dispersant concentration. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan.
   Osaka Univ, Fac Dent, Dept Conservat Dent, Suita, Osaka 5650871, Japan.
RP Umakoshi, Y (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-1 Yamada-oka, Suita, Osaka 5650871, Japan.
CR AKSAY IA, 1983, J AM CERAM SOC C, V66, P190
   CESARANO J, 1988, J AM CERAM SOC, V71, P250, DOI 10.1111/j.1151-2916.1988.tb05855.x
   DEWITH G, 1981, J MATER SCI, V16, P1592
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Lelievre F, 1996, J MATER SCI-MATER M, V7, P489, DOI 10.1007/BF00705430
   PREMACHANDRAN RS, 1994, POWDER TECHNOL, V79, P53, DOI 10.1016/0032-5910(93)02793-A
   TORIYAMA M, 1995, J MATER SCI, V30, P3216, DOI 10.1007/BF01209240
   WAKAI F, 1990, J AM CERAM SOC, V73, P457, DOI 10.1111/j.1151-2916.1990.tb06537.x
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 9
TC 24
Z9 24
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2000
VL 21
IS 20
BP 2045
EP 2049
DI 10.1016/S0142-9612(00)00090-9
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 343QH
UT WOS:000088712700004
PM 10966013
DA 2018-10-19
ER

PT J
AU Jabbari, E
   Khakpour, M
AF Jabbari, E
   Khakpour, M
TI Morphology of and release behavior from porous polyurethane microspheres
SO BIOMATERIALS
LA English
DT Article
DE polyurethane microspheres; suspension polycondensation; morphology; pore
   size; chain-extending agent
ID POLY(L-LACTIC ACID) FOAMS; INTERFACIAL POLYCONDENSATION; MICROPOROUS
   MEMBRANE; POLYMER IMPLANTS; DRUG-RELEASE; REPAIR; RABBIT;
   RECONSTRUCTION; MICROCAPSULES; REPLACEMENT
AB A novel biomaterial application of porous microspheres is for sustained delivery of biologically active agents. Recent studies have pointed out the importance of biomaterial porosity in promoting biocompatibility and controlling release rate of active agents. The objective of this research was to investigate the effect of chain-extending agent on the porosity and release behavior of polyurethane (PU) microspheres prepared using a two-step suspension polycondensation method with methylene diphenyl diisocyanate (MDI) as the isocyanate, polyethylene glycol (PEG400) as the diol, and 1,4-butanediol as the chain-extending agent. Chain-extending agent was used to increase the ratio of hard to soft segments of the PU network, and its effect on microsphere morphology was studied with scanning electron microscopy. According to the results, porosity was significantly affected by the amount of chain-extending agent. The pore size decreased as the concentration of chain-extending agent increased from zero to 50 mole%. With further increase of chain-extending agent to 60 and 67%, PU chains became stiffer and formation of pores was inhibited. Therefore, pore morphology was significantly affected by variations in the amount of chain-extending agent. The release behavior of microspheres was investigated with diazinon as the active agent. After an initial burst, corresponding to 3% of the incorporated amount of active agent, the release rate was zero order. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Amirkabir Univ Technol, Sch Biomed Engn, Lab Biomat & Controlled Delivery Syst Biol Act Ag, Tehran 15914, Iran.
RP Jabbari, E (reprint author), Amirkabir Univ Technol, Sch Biomed Engn, Lab Biomat & Controlled Delivery Syst Biol Act Ag, Hafez Ave No 424, Tehran 15914, Iran.
EM ejabari@cic.aku.ac.ir
CR ARSHADY R, 1993, POLYM ENG SCI, V33, P865, DOI 10.1002/pen.760331402
   ARSHADY R, 1988, J MICROENCAPSUL, V5, P101, DOI 10.3109/02652048809056474
   ARSHADY R, 1989, J MICROENCAPSUL, V6, P1, DOI 10.3109/02652048909019897
   ARSHADY R, 1989, J MICROENCAPSUL, V6, P13, DOI 10.3109/02652048909019898
   Barrett K. E. J., 1975, DISPERSION POLYM ORG
   BEESTMAN G B, 1983, Encapsulation by interfacial polycondensation: US, Patent No. [4417916 [P], 4417916]
   Benoit J. P., 1996, MICROENCAPSULATION M, P133
   BRAUNWALD NS, 1965, SURGERY, V57, P741
   DAHME M, 1981, Patent No. 4299723
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1073, DOI 10.1007/BF01410672
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   DOMB AJ, 1994, POLYM SITE SPECIFIC
   Ehtezazi T, 1999, J CONTROL RELEASE, V57, P301, DOI 10.1016/S0168-3659(98)00118-7
   Elchidana PA, 1999, J CONTROL RELEASE, V59, P279, DOI 10.1016/S0168-3659(98)00162-X
   ELEMA H, 1990, COLLOID POLYM SCI, V268, P1082, DOI 10.1007/BF01410673
   ELNOKALY MA, 1992, ACS S SERIES SAN FRA
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   ICHIKAWA K, 1994, J APPL POLYM SCI, V54, P1321, DOI 10.1002/app.1994.070540914
   Imanidis G, 1999, EUR J PHARM BIOPHARM, V47, P283, DOI 10.1016/S0939-6411(99)00004-1
   KLOMPMAKER J, 1992, BIOMATERIALS, V13, P625, DOI 10.1016/0142-9612(92)90031-I
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Langdon C J, 1985, J Microencapsul, V2, P1, DOI 10.3109/02652048509049572
   Lelah M. D., 1986, POLYURETHANES MED
   LEONG KW, 1997, SYNTHETIC BIODEGRADA, P97
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   LUCKHAM PF, 1994, CONTROLLED PARTICLE
   LYMAN DL, 1972, STEP GROWTH POLYM
   Maa YF, 1996, J CONTROL RELEASE, V38, P219, DOI 10.1016/0168-3659(95)00123-9
   Mahabadi HK, 1996, MACROMOL SYMP, V111, P133, DOI 10.1002/masy.19961110114
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MESSNER K, 1993, J BIOMED MATER RES, V27, P1165, DOI 10.1002/jbm.820270907
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MORGAN PW, 1981, J MACROMOL SCI CHEM, VA15, P683, DOI 10.1080/00222338108056761
   PEARSON RG, 1985, J POLYM SCI POL CHEM, V23, P9, DOI 10.1002/pol.1985.170230102
   POEHLEIN GW, 1987, ENCY POLYM SCI ENG, V6
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   SANTOSUSSO TM, 1978, Patent No. 4083831
   Schaal M., 1994, Modern Power Systems, V14, p25, 27
   SCHER HB, 1981, Patent No. 4285720
   SHANTHA KL, 1993, J APPL POLYM SCI, V50, P1863, DOI 10.1002/app.1993.070501102
   THOMPSON MW, 1985, POLYM COLLOIDS
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WHITE RA, 1981, BIOMATERIALS, V2, P171, DOI 10.1016/0142-9612(81)90046-6
   YADAV SK, 1990, AICHE J, V36, P431, DOI 10.1002/aic.690360312
   YUI N, 1986, MAKROMOL CHEM-RAPID, V7, P747
NR 49
TC 56
Z9 64
U1 3
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2000
VL 21
IS 20
BP 2073
EP 2079
DI 10.1016/S0142-9612(00)00135-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 343QH
UT WOS:000088712700008
PM 10966017
DA 2018-10-19
ER

PT J
AU Morra, M
   Cassinelli, C
AF Morra, M
   Cassinelli, C
TI Force measurements on cell repellant and cell adhesive alginic acid
   coated surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE cell resistance; surface modification; polysaccharides; atomic force
   microscope; alginic acid
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; POLYETHYLENE OXIDE;
   MOLECULAR-CONFORMATION; BIOMATERIAL SURFACES; HYDRATION FORCES;
   POLYSACCHARIDE; MODEL; MICROSCOPE; SOLVATION
AB The atomic force microscope (AFM) was used to acquire force versus distance curves between the cantilever tip and samples bearing a surface overlayer of covalently linked alginic acid. The alginic acid coating resists cell-adhesion in in vitro experiments involving a normal and a tumor cell line. However, the surface becomes cell adhesive when alginic acid coated samples are subjected to glow discharge treatment. Force curves show in both cases the typical features resulting from the interaction between the cantilever tip and a hydrophilic, compressible polymer overlayer, suggesting that in both cases a diffuse interface with water exists. Following some recent findings on oligoethylene-glycol-terminated self-assembled-monolayers, it is suggested that conformational and molecular aspects of hydrophilic surface layers, rather than steric repulsion effects, could play a significant role in the mechanism that controls resistance to bio-adhesion. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Nobil Bio Ric, I-14018 Villafranca, Italy.
CR ALBERTS B, 1984, MOL BIOL CELL, P44
   Besseling NAM, 1997, LANGMUIR, V13, P2113, DOI 10.1021/la960672w
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   BUDIAMAN ER, 1987, J DAIRY SCI, V70, P534, DOI 10.3168/jds.S0022-0302(87)80038-3
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4
   DAVID S, 1997, MOL SUPORAMOLECULAR
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   FOWKES FM, 1985, SURFACE INTERFACIAL, V1, P337
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HURRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Lee LH, 1996, LANGMUIR, V12, P1681, DOI 10.1021/la950725u
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 1996, J COLLOID INTERF SCI, V182, P312, DOI 10.1006/jcis.1996.0469
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   MORRA M, IN PRESS J BIOM SCI
   NAGAOKA S, 1987, ASAIO, V10, P76
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Pavesio A, 1997, Med Device Technol, V8, P20
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
NR 32
TC 12
Z9 12
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT
PY 2000
VL 18
IS 3-4
BP 249
EP 259
DI 10.1016/S0927-7765(99)00151-4
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 345HG
UT WOS:000088810100007
DA 2018-10-19
ER

PT J
AU Weihe, S
   Wehmoller, M
   Schliephake, H
   Hassfeld, S
   Tschakaloff, A
   Raczkowsky, J
   Eufinger, H
AF Weihe, S
   Wehmoller, M
   Schliephake, H
   Hassfeld, S
   Tschakaloff, A
   Raczkowsky, J
   Eufinger, H
TI Synthesis of CAD/CAM, robotics and biomaterial implant fabrication:
   single-step reconstruction in computer aided frontotemporal bone
   resection
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE biodegradable carrier; computer aided design (CAD); computer aided
   manufacturing (CAM); cranioplasty; polylactide (PLA); robotics; tissue
   engineering; titanium
ID SURGERY; DEFECTS; PROSTHESES
AB The preoperative manufacturing of individual skull implants, developed by an interdisciplinary research group at Ruhr-University Bochum, is based on the use of titanium as the most common material for implants at present. Using the existing technology for materials that can be milled or moulded, customized implants may be manufactured as well. The goal of the study was to examine biodegradable materials and to evaluate the practicability of intraoperative instrument navigation and robotics. Data acquisition of an adult sheep's head was performed with helical computer tomography (CT). The data were transferred onto a computer aided design/computer aided manufacturing system (CAD/CAM system), and two complex defects in the frontotemporal skull were designed. Standard individual titanium implants were milled for both of the defects. Additionally, for one of the defects a resection template, as well as a mould for the biodegradable poly(D,L-lactide) (PDLLA) implant, were fabricated by the CAD/CAM system. A surgeon carried out the first bone resection (#1) for the prefabricated titanium implant using the resection template and an oscillating saw. The robot system Staubli RX90CR, modified for clinical use, carried out the other resection (#2). Both titanium implants and the PDLLA implant were inserted in their respective defects to compare the precision of their fit. A critical comparison of both implant materials and both resection types shows that fabrication of a PDLLA implant and robot resection are already possible. At present, the titanium implant and resection using a template are more convincing due to the higher precision and practicability.
C1 Ruhr Univ Bochum, Dept Oral & Maxillofacial Surg, Bochum, Germany.
   Ruhr Univ Bochum, Inst Prod Syst & Proc Tech, Bochum, Germany.
   Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany.
   Univ Heidelberg, Dept Oral & Maxillofacial Surg, Heidelberg, Germany.
   DEGIMA Med Prod GmbH, Pinneberg, Germany.
   Univ Karlsruhe, Inst Proc Control & Robot, Karlsruhe, Germany.
RP Weihe, S (reprint author), Ruhr Univ Bochum Klinikum, Klin Mund Kiefer & Plast Gesichtschirurg, Schornau 23-25, D-44892 Bochum, Germany.
EM stephan.weihe@ruhr-uni-bochum.de
CR Burghart C, 1998, INT CONGR SER, V1165, P569
   Eufinger H, 1998, J CRANIO MAXILL SURG, V26, P373, DOI 10.1016/S1010-5182(98)80070-X
   EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7
   EUFINGER H, 1995, J CRANIO MAXILL SURG, V23, P175, DOI 10.1016/S1010-5182(05)80007-1
   Haers PE, 1998, J CRANIO MAXILL SURG, V26, P363, DOI 10.1016/S1010-5182(98)80069-3
   Hassfeld S, 1997, Mund Kiefer Gesichtschir, V1, P316
   HASSFELD S, 1995, INT J ORAL MAX SURG, V24, P111
   Hassfeld S, 1998, Comput Aided Surg, V3, P183, DOI 10.3109/10929089809148143
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Miki T, 1996, INT J ORAL MAX SURG, V25, P402, DOI 10.1016/S0901-5027(06)80042-1
   Schliephake H, 1997, Mund Kiefer Gesichtschir, V1, P115
   Schliephake H, 1998, J ORAL MAXIL SURG, V56, P616, DOI 10.1016/S0278-2391(98)90463-3
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   Tschakaloff A, 1996, DTSCH Z MUND KIEFER, V20, P47
   Viljanen VV, 1997, INT J ORAL MAX SURG, V26, P389, DOI 10.1016/S0901-5027(97)80804-1
   VONOEPEN R, 1995, ENTWICKLUNG SPEZIELL, P78
   WEHMOLLER M, 1995, INT J ORAL MAX SURG, V24, P90, DOI 10.1016/S0901-5027(05)80868-9
NR 17
TC 34
Z9 35
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD OCT
PY 2000
VL 29
IS 5
BP 384
EP 388
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 369TL
UT WOS:000165083000016
PM 11071246
DA 2018-10-19
ER

PT J
AU Dadsetan, M
   Mirzadeh, H
   Sharifi-Sanjani, N
AF Dadsetan, M
   Mirzadeh, H
   Sharifi-Sanjani, N
TI IR laser surface modification of polyethylene terephthalate as a
   biomaterial
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE IR laser; surface modification; polyethylene terephthalate; biomaterial;
   platelet adhesion
ID IN-VITRO; GRAFT-POLYMERIZATION; BLOOD COMPATIBILITY; INDUCED AAM;
   POLYMERS; POLY(ETHYLENE-TEREPHTHALATE); RADIATION; PLATELET;
   BIOCOMPATIBILITY; IRRADIATION
AB There have been a number of attempts to create a novel surface that reduces the adverse effects of blood interaction with material. Among various techniques, laser-induced surface modification is highly suitable for this purpose. This paper presents surface modification of polyethylene terephthalate (PET) using CO(2) pulsed laser. The changes in surface properties were investigated by SEM, attenuated total reflectance infrared spectroscopy (ATR-FTIR) and water drop contact angle measurements. The complicated microstructures on the PET surface were observed in SEM micrographs. ATR-IR spectra showed that the crystallinity decreased in the surface region as a result of laser irradiation. The water drop contact angle also decreased with increasing the laser pulses. The haemocompatibility of CO(2) laser irradiated PET was examined in vitro, evaluating its capability of inducing platelet adhesion in comparison with the unmodified PET The number of adhered platelets was determined by platelet-rich plasma method and lactate dehydrogenase activity measurements. Platelet adhesion on the untreated PET was relatively high. Laser irradiation of PET surface reduced the number of adherent platelets and prevented platelet spreading on the surface. The extent of platelet adhesion was correlated to the number of laser pulses.
C1 Atom Energy Org Iran, Laser Res Ctr, Tehran, Iran.
   Iran Polymer Inst, Dept Polymer Biomat, Tehran 14977, Iran.
   Univ Tehran, Fac Sci, Dept Chem, Tehran, Iran.
CR ANDREW JE, 1983, APPL PHYS LETT, V43, P717, DOI 10.1063/1.94488
   CENNI E, 1995, BIOMATERIALS, V16, P973, DOI 10.1016/0142-9612(95)94903-X
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Dadsetan M, 1999, RADIAT PHYS CHEM, V56, P597, DOI 10.1016/S0969-806X(99)00293-5
   DUNN DS, 1990, MACROMOLECULES, V23, P770, DOI 10.1021/ma00205a013
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   IKADA Y, 1981, RADIAT PHYS CHEM, V18, P1207, DOI 10.1016/0146-5724(81)90312-5
   LIN JC, 1995, BIOMATERIALS, V16, P1017
   LINDHOUT T, 1995, J MATER SCI-MATER M, V6, P367, DOI 10.1007/BF00120306
   MATHEW J, 1993, BIOMATERIALS, V14, P57, DOI 10.1016/0142-9612(93)90076-E
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Mirzadeh H, 1998, IRAN POLYM J, V7, P5
   Mirzadeh H., 1994, Clinical Materials, V16, P177, DOI 10.1016/0267-6605(94)90115-5
   Ploymers Dawids S., 1989, POLYM THEIR PROPERTI, p49~62
   Saito N, 1997, J POLYM SCI POL CHEM, V35, P747, DOI 10.1002/(SICI)1099-0518(199703)35:4<747::AID-POLA20>3.0.CO;2-M
   SHALABY SW, 1984, POLYM BIOMATERIALS, P135
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   UCHIDA E, 1989, J POLYM SCI POL CHEM, V27, P527, DOI 10.1002/pola.1989.080270213
   WATANABE H, 1993, POLYM INT, V31, P247, DOI 10.1002/pi.4990310306
NR 21
TC 5
Z9 5
U1 2
U2 8
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD OCT
PY 2000
VL 9
IS 4
BP 203
EP 209
PG 7
WC Polymer Science
SC Polymer Science
GA 400QN
UT WOS:000166883200001
DA 2018-10-19
ER

PT J
AU Banerjee, R
   Puniyani, RR
   Bellare, JR
AF Banerjee, R
   Puniyani, RR
   Bellare, JR
TI Analysis of dynamic surface properties of therapeutic surfactants and
   lung phospholipids
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE surfactant; surface tension
ID RESPIRATORY-DISTRESS-SYNDROME; PULMONARY SURFACTANT; BUBBLE; ADSORPTION;
   STABILITY; CALCIUM; TENSION; FILMS
AB Exogenous surfactant is a specialized biomaterial used for substitution of the lipoprotein mixture normally present in lungs-pulmonary surfactant. Respiratory Distress Syndrome is a disease of preterm infants mainly caused by a deficiency of mature lung surfactant. Pulmonary surfactant is known to stabilize small alveoli and prevent them from collapsing during expiration due to its unique surface properties. A pulsating bubble surfactometer was used for in vitro analysis of surface parameters of therapeutic surfactants and of test formulations to be used for exogenous therapy in Respiratory Distress Syndrome. Surface parameters that were considered for comparison were minimum surface tension (gamma (min)) at three different frequencies (20, 40 and 60 cpm), adsorption at two extreme bubble radii (R-min and R-max), stability index at the three frequencies, recruitment index and the surface viscoelastic parameters. Survanta, ALEC and Exosurf were compared with formulations consisting of the main phospholipids of pulmonary surfactant, namely dipalmitoyl phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) as well as binary mixtures of these phospholipids in the ratio 2:3. Survanta performed much better than the non-protein therapeutic surfactants in all parameters and at all three frequencies. Exosurf had a very low stability index and a very low modulus of surface dilatational elasticity at all three frequencies. The test compounds showed a frequency dependence in their performance. At 20 cpm, PC:PG (2:3) was the best test combination. It achieved a gamma (min) and stability index equivalent to Survanta at this frequency. None of the test compounds were comparable to Survanta at 40 and 60 cpm. These findings may have important therapeutic implications for exogenous surfactants.
C1 Indian Inst Technol, Sch Biomed Engn, Bombay 400076, Maharashtra, India.
   Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
CR ADAMSON AW, 1967, PHYSICAL CHEM SURFAC, P131
   AMIRKHANIAN JD, 1993, BIOCHIM BIOPHYS ACTA, V1168, P315, DOI 10.1016/0005-2760(93)90188-F
   Arnold C, 1996, PEDIATRICS, V97, P1
   BANGHAM AD, 1984, COLLOID SURFACE, V10, P337, DOI 10.1016/0166-6622(84)80034-7
   BANGHAM AD, 1979, BIOCHIM BIOPHYS ACTA, V573, P552, DOI 10.1016/0005-2760(79)90229-7
   BIANCO H, 1993, J COLLOID INTERF SCI, V158, P295, DOI 10.1006/jcis.1993.1260
   CLEMENTS JA, 1961, J APPL PHYSIOL, V16, P444
   Clements JA, 1982, United States Patent, Patent No. 4312860
   CORCORAN JD, 1994, ARCH DIS CHILD, V71, pF165, DOI 10.1136/fn.71.3.F165
   CUMMINGS JJ, 1992, AM REV RESPIR DIS, V145, P999, DOI 10.1164/ajrccm/145.5.999
   Dico AS, 1997, BIOPHYS J, V73, P2595, DOI 10.1016/S0006-3495(97)78289-4
   ENHORNING G, 1977, J APPL PHYSIOL, V43, P198
   HAFNER D, 1995, BRIT J PHARMACOL, V115, P451
   HALL SB, 1993, J APPL PHYSIOL, V75, P468
   HALL SB, 1992, AM REV RESPIR DIS, V145, P24, DOI 10.1164/ajrccm/145.1.24
   HALLMAN M, 1985, PEDIATR RES, V19, P286, DOI 10.1203/00006450-198503000-00006
   Holm BA, 1996, PEDIATR RES, V39, P805, DOI 10.1203/00006450-199605000-00010
   JOBE AH, 1993, NEW ENGL J MED, V328, P861
   KING RJ, 1972, AM J PHYSIOL, V223, P715
   Kitching S, 1996, J COLLOID INTERF SCI, V177, P58, DOI 10.1006/jcis.1996.0006
   KOYABASHI T, 1990, RESP PHYSL, V80, P181
   MARTIN GI, 1992, CLIN PERINATOL, V19, P461
   MAYLSA K, 1981, COLLOID SURFACE, V3, P329
   MEBAN C, 1980, BIOL NEONATE, V37, P308
   NOTTER RH, 1982, EXP LUNG RES, V3, P109, DOI 10.3109/01902148209063286
   OWEN MJ, 1968, J COLLOID INTERF SCI, V27, P46, DOI 10.1016/0021-9797(68)90008-8
   OWEN MJ, 1967, J COLLOID INTERF SCI, V24, P141, DOI 10.1016/0021-9797(67)90211-1
   PASTRANA B, 1991, BIOCHEMISTRY-US, V30, P10058, DOI 10.1021/bi00105a033
   PETTY TL, 1977, AM REV RESPIR DIS, V115, P531
   PUTZ G, 1994, J APPL PHYSIOL, V76, P1425
   REYNOLDS MS, 1989, CLIN PHARMACY, V8, P559
   ROBERTSON B, 1980, LUNG, V58, P57
   SCARPELLI EM, 1992, AM J PERINAT, V9, P414, DOI 10.1055/s-2007-999278
   Schubring C, 1976, J Perinat Med, V4, P72, DOI 10.1515/jpme.1976.4.2.72
   TAKAHASHI A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P43, DOI 10.1016/0005-2760(90)90216-K
   YU SH, 1984, BIOCHIM BIOPHYS ACTA, V776, P37, DOI 10.1016/0005-2736(84)90248-7
   YU SH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P264, DOI 10.1016/0005-2760(93)90228-2
   YU SH, 1994, BBA-LIPID LIPID MET, V1211, P350, DOI 10.1016/0005-2760(94)90160-0
NR 38
TC 3
Z9 3
U1 2
U2 3
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2000
VL 15
IS 2
BP 140
EP 159
DI 10.1106/8T7E-NPCN-UN8N-JX99
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 367GR
UT WOS:000090053800004
PM 11081642
DA 2018-10-19
ER

PT J
AU Lowe, AB
   Vamvakaki, M
   Wassall, MA
   Wong, L
   Billingham, NC
   Armes, SP
   Lloyd, AW
AF Lowe, AB
   Vamvakaki, M
   Wassall, MA
   Wong, L
   Billingham, NC
   Armes, SP
   Lloyd, AW
TI Well-defined sulfobetaine-based statistical copolymers as potential
   antibioadherent coatings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(sulfobetaine); antibioadherent; cell adhesion; biomaterial;
   statistical copolymers
ID IN-VITRO EVALUATION; N-MODIFIED BETAINES; BLOCK-COPOLYMERS; LENS
   MATERIALS; CRYOPROTECTANTS; SURFACES
AB The potential use of novel poly(sulfobetaine) copolymers as antibioadherent coatings was investigated using Pseudomonas aeruginosa as a model microorganism and human macrophages and 3T3 mouse embryonic fibroblasts. Two well-defined statistical copolymers with narrow molecular weight distributions were prepared by group transfer copolymerization of n-butyl methacrylate (nBuMA) with either 10 or 30 mol % 2-(dimethylamino)ethyl methacrylate (DMAEMA). Sulfobetainized nBuMA-DMAEMA copolymers (poly[sulfobetaine-stat-nBuMA]) were obtained by treating these precursor polymers with 1,3-propanesultone under mild conditions. Both proton NMR spectroscopy and elemental microanalyses indicated that essentially all the DMAEMA residues were derivatized in both copolymers. Poly(methyl methacrylate) (PMMA) discs were coated with the sulfobetainized nBuMA-DMAEMA copolymers and the bioadherent properties of these coated materials were compared with those of PMMA. Statistically significantly fewer (p < .05) bacteria, macrophages, and fibroblasts adhered to the poly(sulfobetaine-stat-nBuMA)-coated PMMA than to the uncoated PMMA. The poly(sulfobetaine-stat-nBuMA) copolymer containing the higher proportion (30 mol %) sulfobetainized DMAEMA residues proved to be the more effective antibioadherent coating. The antibioadherent properties of these coating materials may allow the cost-effective production of dirt-resistant, easy to clean work surfaces, bioinert coatings for medical devices, and antifouling coatings for marine, agricultural, and industrial applications. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Drug Delivery & Biomat Grp, Brighton BN2 4GJ, E Sussex, England.
   Univ Sussex, Sch Chem Phys & Environm Sci, Brighton BN1 9QJ, E Sussex, England.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Drug Delivery & Biomat Grp, Brighton BN2 4GJ, E Sussex, England.
EM a.w.lloyd@brighton.ac.uk
RI Vamvakaki, Maria/A-4443-2014; Lowe, Andrew/C-4684-2015; Lowe,
   Andrew/B-6809-2009; Lloyd, Andrew/D-1369-2011
OI Lowe, Andrew/0000-0002-7874-2050; Lloyd, Andrew/0000-0003-2778-8195;
   Armes, Steven/0000-0002-8289-6351
CR Andrews CS, 1997, INVEST OPHTH VIS SCI, V38, P2401
   Andrews CS, 1996, VISION RES, V36, P325
   BoulangePetermann L, 1996, BIOFOULING, V10, P275, DOI 10.1080/08927019609386287
   Butun V, 1997, J MATER CHEM, V7, P1693, DOI 10.1039/a703566g
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Dexter SC, 1996, B ELECTROCHEM, V12, P1
   Ernst R., 1982, AMPHOTERIC SURFACTAN, P71
   Faragher RGA, 1996, KLUWER INT SER ENG C, P285
   Filipec M, 1997, INVEST OPHTH VIS SCI, V38, P883
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   Hanlon GW, 1997, INVEST OPHTH VIS SCI, V38, P885
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   JASS J, 1997, CHEM IND, V17, P682
   Lloyd AW, 1997, INVEST OPHTH VIS SCI, V38, P884
   Lloyd AW, 1996, INT J PHARM, V131, P257, DOI 10.1016/0378-5173(95)04361-6
   Lloyd AW, 1996, VISION RES, V36, P73
   LLOYD AW, 1992, CRYO-LETT, V13, P337
   LLOYD AW, 1992, J PHARM PHARMACOL, V44, P507, DOI 10.1111/j.2042-7158.1992.tb03655.x
   Lowe AB, 1996, CHEM COMMUN, P1555, DOI 10.1039/cc9960001555
   STOREY R, 1977, PHYTOCHEMISTRY, V16, P447, DOI 10.1016/S0031-9422(00)94326-7
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tuzar Z, 1997, MACROMOLECULES, V30, P2509, DOI 10.1021/ma9615617
   Vamvakaki M, 1998, POLYMER, V39, P2331, DOI 10.1016/S0032-3861(97)00504-1
NR 25
TC 79
Z9 81
U1 3
U2 48
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2000
VL 52
IS 1
BP 88
EP 94
DI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337NV
UT WOS:000088369000011
PM 10906678
DA 2018-10-19
ER

PT J
AU Torricelli, P
   Fini, M
   Giavaresi, G
   Rocca, M
   Pierini, G
   Giardino, R
AF Torricelli, P
   Fini, M
   Giavaresi, G
   Rocca, M
   Pierini, G
   Giardino, R
TI Isolation and characterization of osteoblast cultures from normal and
   osteopenic sheep for biomaterials evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE osteoblast; cell cultures; sheep; biomaterials; osteopenia
ID IN-VITRO; OSTEOPOROTIC WOMEN; TRABECULAR BONE; CELLS; EXPRESSION;
   BEHAVIOR; HYDROXYAPATITE; PROLIFERATION; OSTEOCALCIN; PROTEINS
AB Being very useful in the analysis of bone cell differentiation and activity, osteoblast cultures are also used in the in vitro biocompatibility study of new materials. The aim of this work was to evaluate sheer osteoblast cultures derived from normal and ovariectomized animals, and then to assess the in vitro biomaterial behavior on these cultures, taking into account the quality of bone where orthopedic devices are clinically used. For this purpose, we characterized sheep osteoblast cultures, isolated from iliac crest bone of normal (NB osteoblast culture) and osteopenic after ovariectomy (OB osteoblast culture) sheep. Moreover, we studied cell behavior when cultured on different biomaterials (titanium and two biological glasses, RKKP and AP40). Cell characterization at baseline demonstrated that both cultures (NB and OB) showed normal osteoblastic behavior. On the contrary, osteoblasts derived from osteopenic bone and cultivated on AP40 for 6 days revealed a different behavior in terms of both cell morphology and metabolic activity. Statistical analysis (one-way analysis of variance and Scheffe's post hoc multiple-comparison tests) revealed significant differences in Ca level (p < 0.0005), MTT test (p < 0.0005) and OC production (p < 0.05). These in vitro tests demonstrated that sheep osteoblast cultures can be useful when determining biocompatibility and osteointegration of orthopedic materials, and also when evaluating for the presence of osteoporosis. (C) 2000 John Wiley & Sons, Inc.
C1 Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Serv Chirurg Sperimentale, I-40136 Bologna, Italy.
   Univ Bologna, Dept Forens Med, Bologna, Italy.
   Univ Bologna, Chair Pathophysiol, Bologna, Italy.
RP Torricelli, P (reprint author), Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Serv Chirurg Sperimentale, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016; TORRICELLI, PAOLA/J-5298-2016
OI Fini, Milena/0000-0002-3732-3570; TORRICELLI, PAOLA/0000-0001-7494-9970;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR Aarden EM, 1996, HISTOCHEM CELL BIOL, V106, P495, DOI 10.1007/BF02473312
   Collignon H, 1997, ARCH PHYSIOL BIOCHEM, V105, P158, DOI 10.1076/apab.105.2.158.12924
   COLLIN P, 1992, CALCIFIED TISSUE INT, V50, P175, DOI 10.1007/BF00298797
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   FINI M, 2000, J MATER SCI-MATER M, V11, P1
   GARVEY BT, 1995, J BIOMED MATER RES, V29, P987, DOI 10.1002/jbm.820290810
   Giavaresi G, 2000, BONE, V26, P297, DOI 10.1016/S8756-3282(99)00267-7
   HALSTEAD LR, 1992, CALCIFIED TISSUE INT, V50, P93, DOI 10.1007/BF00297304
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X
   Johnson RB, 1997, J PERIODONTOL, V68, P864, DOI 10.1902/jop.1997.68.9.864
   Kassem M, 1997, APMIS, V105, P7
   LOMRI A, 1990, J BONE MINER RES, V5, P1149
   MARIE PJ, 1989, J CLIN ENDOCR METAB, V69, P272, DOI 10.1210/jcem-69-2-272
   MARIE PJ, 1989, IN VITRO CELL DEV B, V25, P373
   MODROWSKI D, 1993, CELL TISSUE RES, V271, P499, DOI 10.1007/BF02913733
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   MORIKE M, 1993, J CELL PHYSIOL, V157, P439, DOI 10.1002/jcp.1041570302
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   PIZZOFERRATO A, 1985, BIOMATERIALS, V6, P346
   Rivard CH, 1996, ANN CHIR, V50, P651
   SAMMONS RL, 1994, BIOMATERIALS, V15, P536, DOI 10.1016/0142-9612(94)90020-5
   Sasse T, 1998, CALCIFIED TISSUE INT, V62, P140, DOI 10.1007/s002239900407
   Sell S, 1998, CALCIFIED TISSUE INT, V62, P51, DOI 10.1007/s002239900394
   Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3
   THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L
   THORNDYKE EA, 1998, FRONT BIOSCI, V16, P17
   Torricelli Paola, 2000, Artificial Cells Blood Substitutes and Immobilization Biotechnology, V28, P181, DOI 10.3109/10731190009118580
   Tsuang YH, 1997, ANAT RECORD, V247, P164
   TURNER AS, 1995, BONE, V17, pS395, DOI 10.1016/8756-3282(95)00317-7
   TURNER AS, 1995, BONE, V17, pS421, DOI 10.1016/8756-3282(95)00321-4
   WONG MM, 1994, OSTEOPOROSIS INT, V4, P21, DOI 10.1007/BF02352257
NR 32
TC 17
Z9 20
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2000
VL 52
IS 1
BP 177
EP 182
DI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337NV
UT WOS:000088369000023
PM 10906690
DA 2018-10-19
ER

PT J
AU van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
AF van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
TI Cell-cycle control in cell-biomaterial interactions: Expression of p53
   and Ki67 in human umbilical vein endothelial cells in direct contact and
   extract testing of biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article; Proceedings Paper
CT Society-for-Biomaterials 24th Annual Meeting
CY APR 22-26, 1998
CL SAN DIEGO, CALIFORNIA
SP Soc Biomat
DE cell cycle; p53; endothelial cell; biomaterials testing methods
ID FOCAL ADHESION KINASE; BREAST-CANCER; GROWTH ARREST; DNA-DAMAGE; HUMAN
   BONE; PROTEIN; APOPTOSIS; PROLIFERATION; INDUCTION; KI-67
AB Current biocompatibility testing involves the demonstration of cell proliferation, which is usually interpreted as a sign of positive biocompatibility when the materials sustain cell proliferation. As the field of biomaterials research is rapidly moving toward tissue-engineered devices and hybrid organs, control of cell function has become a main topic. Cell function, which involves specific differentiation pathways, cannot be separated from cell-cycle control. The study of cell-cycle control is an important extension of routine proliferation assays and has extensive roots in developmental and tumor biology. We studied the expression of the tumour suppressor gene p53 and the proliferation-associated antigen Ki67 of endothelial cells in response to biomaterial contact. Cells were seeded in six- or 24-well plates, in which one or three 12-mm-diameter biomaterial disks were laid down. After 48- and 72-h incubation periods, cells were processed for flow cytometry, immunofluorescence, or Western blotting. The following materials were used: titanium, NiCr alloy, and CoCr alloy. Cells were also exposed to 24-h (ISO-norm) extracts in 25-cm(2) culture flasks (600,000 cells) for 24 and 48 h. For extract testing, serially diluted Ni-ion suspensions were also used. Human umbilical vein endothelial cells adhered to metal surfaces and started forming a monolayer within 3 days. Ki67 expression was positive in more than 60% after 2 days and decreased markedly after 3 days of adhesion. During this time cells developed focal contacts and produced a fibronectin matrix. p53 expression could be demonstrated with Western blotting and flow cytometry, but not with immunofluorescence. Differences due to both culturing time and material were found in expression patterns with both methods. Inverse correlations between Ki67 and p53 expression were detected, which are probably based on culture kinetics. The results indicate that expression of p53 and also Ki67 is clearly influenced by biomaterials in direct contact testing, despite the absence of obvious morphological differences. The p53 marker can be used for defining cell function in more detail, although the correlation with specific physiological function has still to be clarified. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP van Kooten, TG (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
CR Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3
   BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104
   Cayrol C, 1997, M S-MED SCI, V13, P1259, DOI 10.4267/10608/544
   Chiarugi V, 1996, TUMORI, V82, P205
   CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997
   CIAPETTI G, 1994, BIOMATERIALS, V15, P63, DOI 10.1016/0142-9612(94)90199-6
   COATES PJ, 1995, J PATHOL, V176, P19, DOI 10.1002/path.1711760105
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   DEKKER A, 1994, CELL MATER, V4, P101
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973
   Foreman KE, 1996, AM J PATHOL, V149, P795
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Gadbois DM, 1997, CANCER RES, V57, P3174
   GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264
   Granville DJ, 1998, LAB INVEST, V78, P893
   Hansen R, 1997, CURR OPIN GENET DEV, V7, P46, DOI 10.1016/S0959-437X(97)80108-6
   HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877
   Heslin MJ, 1998, CANCER-AM CANCER SOC, V83, P490, DOI 10.1002/(SICI)1097-0142(19980801)83:3<490::AID-CNCR18>3.0.CO;2-R
   HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165
   Jansen RLH, 1998, BRIT J CANCER, V78, P460, DOI 10.1038/bjc.1998.515
   LANDBERG G, 1990, EXP CELL RES, V187, P111, DOI 10.1016/0014-4827(90)90124-S
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   Lehr HA, 1996, APPL IMMUNOHISTOCHEM, V4, P117
   Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   Magnelli L, 1997, BIOCHEM MOL MED, V62, P3, DOI 10.1006/bmme.1997.2616
   MATEO MS, 1995, J CLIN PATHOL, V48, P151, DOI 10.1136/jcp.48.2.151
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Mothersill C, 1997, CARCINOGENESIS, V18, P1241, DOI 10.1093/carcin/18.6.1241
   Murti PR, 1998, J ORAL PATHOL MED, V27, P191
   Nigro JM, 1997, CANCER RES, V57, P3635
   OPAS M, 1991, IN VITRO CELL DEV B, V27, P878
   OREN M, 1994, SEMIN CANCER BIOL, V5, P221
   PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662
   Prives C, 1999, J PATHOL, V187, P112
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Renzing J, 1996, J CELL SCI, V109, P1105
   RENZING J, 1995, ONCOGENE, V10, P1865
   ROBAYE B, 1991, AM J PATHOL, V138, P447
   ROMER LH, 1995, J IMMUNOL, V154, P6582
   SAUTER ER, 1994, CARCINOGENESIS, V15, P2269, DOI 10.1093/carcin/15.10.2269
   Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601
   SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513
   Smith KJ, 1998, AM J DERMATOPATH, V20, P302, DOI 10.1097/00000372-199806000-00015
   Storck J, 1996, BIOMATERIALS, V17, P1791, DOI 10.1016/0142-9612(95)00360-6
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   VERHEIJEN R, 1989, J CELL SCI, V92, P531
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135
   Wataha JC, 1997, J BIOMED MATER RES, V36, P145, DOI 10.1002/(SICI)1097-4636(199708)36:2<145::AID-JBM2>3.0.CO;2-K
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   WynfordThomas D, 1997, EUR J CANCER, V33, P716, DOI 10.1016/S0959-8049(97)00064-6
   Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yonish-Rouach E, 1996, BEHRING I MITT, V97, P60
   ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242
NR 58
TC 15
Z9 15
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2000
VL 52
IS 1
BP 199
EP 209
DI 10.1002/1097-4636(200010)52:1<199::AID-JBM26>3.0.CO;2-Z
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337NV
UT WOS:000088369000026
PM 10906693
DA 2018-10-19
ER

PT J
AU Costantino, PD
   Chaplin, JM
   Wolpoe, ME
   Catalano, PJ
   Sen, C
   Bederson, JB
   Govindaraj, S
AF Costantino, PD
   Chaplin, JM
   Wolpoe, ME
   Catalano, PJ
   Sen, C
   Bederson, JB
   Govindaraj, S
TI Applications of fast-setting hydroxyapatite cement: Cranioplasty
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article
ID RECONSTRUCTION; DEFECTS; BONE
AB A variety of autogenous and synthetic materials have been used to repair cranial defects resulting from traumatic and iatrogenic causes. In theory, the ideal material should be readily available and safe. It should adequately protect the underlying central nervous system, resist cerebrospinal fluid fistula formation, and be easily contoured. One promising synthetic biomaterial that has been used for cranioplasty is hydroxyapatite cement. This biomaterial has successfully restored cranial contour in most patients in whom it has been used; however, difficulties have arisen because of the material's prolonged water solubility. When exposed to cerebrospinal fluid or blood, inadequate setting of the cement occurs, resulting in loss of its structural integrity. This problem can be alleviated with the use of fast-setting hydroxyapatite cement, which hardens 6 to 12 times faster than the traditional cement. We present, to the best of our knowledge, the first series of the use of this material in 21 patients requiring cranioplasty. The advantages and limitations of fast-setting hydroxyapatite cement will be discussed.
C1 Mt Sinai Med Ctr, Dept Otolaryngol, Cranial Base Surg Program, New York, NY 10029 USA.
   Mt Sinai Med Ctr, Dept Neurosurg, New York, NY 10029 USA.
RP Costantino, PD (reprint author), Mt Sinai Med Ctr, Dept Otolaryngol, Cranial Base Surg Program, Box 1189,8th Floor,1 Gustave L Levy Pl, New York, NY 10029 USA.
CR Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   KAMERER DB, 1994, AM J OTOL, V15, P47
   Kveton JF, 1996, LARYNGOSCOPE, V106, P1241, DOI 10.1097/00005537-199610000-00014
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Miyamoto Y, 1997, J BIOMED MATER RES, V37, P457
   NICKELL WB, 1972, ARCH SURG-CHICAGO, V105, P431
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
NR 11
TC 59
Z9 59
U1 0
U2 7
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD OCT
PY 2000
VL 123
IS 4
BP 409
EP 412
DI 10.1067/mhn.2000.107679
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 363JT
UT WOS:000089833100010
PM 11020176
DA 2018-10-19
ER

PT J
AU Pirttijarvi, TSM
   Andersson, MA
   Salkinoja-Salonen, MS
AF Pirttijarvi, TSM
   Andersson, MA
   Salkinoja-Salonen, MS
TI Properties of Bacillus cereus and other bacilli contaminating
   biomaterial-based industrial processes
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT 17th International Conference of the
   International-Committee-on-Food-Microbiology-and-Hygiene - Food Micro 99
CY SEP 13-17, 1999
CL VELDHOVEN, NETHERLANDS
SP Int Life Sci Inst, Europe
DE Bacillus; Bacillus cereus; food hygiene; food packaging; paperboard;
   lecithinase; nitrate reductase; emetic toxin; whole cell fatty acids;
   ribotyping
ID FOOD-PACKAGING PAPER; FATTY-ACID ANALYSIS; TOXIN PRODUCTION;
   PSYCHROTROPHIC BACILLUS; DAIRY-INDUSTRY; BOARD MACHINES; STRAINS; MILK;
   IDENTIFICATION; SPOROTHERMODURANS
AB This paper is an overview on bacilli in industrial processes, with focus on food grade paper and paperboard production. Paperboards mainly contain sporeforming bacteria belonging to the genera Bacillus, Paenibacillus and Brevibacillus, usually found in quantities from < 50 to 250 cfu g(-1) homogenized paperboard. Of those frequently found, Bacillus cereus group, B. licheniformis, B. subtilis and Brevibacillus brevis are important for food hygiene because of their hydrolytic activities on food components and the ability of some strains to produce food poisoning toxins or to grow at refrigerated temperatures. We found that the phenotypic properties (lecithinase activity, nitrate reduction) used in standard methods (e.g., LSO, FDA, IDF) to recognize B. cereus, were unreliable for industrial isolates. Whole cell fatty acid composition of a group of the industrial isolates deviated so much from those in a widely used commercial database that the strains were not or only poorly recognized as B. cereus. Industrial isolates, including toxigenic ones, often missed one or more of these characters, even in cases where 100% 16S rDNA identity was found with B. cereus or with B. thuringiensis. 11-Methyldodecanoic acid and trans-9-hexadecenoic acid were found without exception in over 200 industrial B. cereus group isolates and in over 30 culture collection strains. The detection of these fatty acids is a secure method for the identification of B. cereus. Negative reaction for starch hydrolysis and for BCET-RPLA test and a specific ribotype were found in all B. cereus strains producing the emetic toxin. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Helsinki, Dept Appl Chem & Microbiol, Bioctr, FIN-00014 Helsinki, Finland.
RP Pirttijarvi, TSM (reprint author), Univ Helsinki, Dept Appl Chem & Microbiol, Bioctr, POB 56, FIN-00014 Helsinki, Finland.
EM tuija.pirttijarvi@helsinki.fi
CR AGATA N, 1994, FEMS MICROBIOL LETT, V121, P31, DOI 10.1016/0378-1097(94)90141-4
   Andersson A, 1999, INT J FOOD MICROBIOL, V47, P147, DOI 10.1016/S0168-1605(99)00009-4
   ANDERSSON A, 1998, THESIS CHALMERS U TE
   Andersson MA, 1998, APPL ENVIRON MICROB, V64, P1338
   ANDERSSON MA, 1999, THESIS U HELSINKI HE
   *AOAC, 1995, OFF METH AN AOAC INT, V1, P52
   Baillie LWJ, 2000, ENCY FOOD MICROBIOLO, V1, P129
   Beattie SH, 2000, ENCY FOOD MICROBIOLO, V1, P141
   BROWN KL, 1995, INT S ADV AS PROC PA
   CHRISTIANSSON A, 1989, APPL ENVIRON MICROB, V55, P2595
   Cosentino S, 1997, INT J FOOD MICROBIOL, V38, P235, DOI 10.1016/S0168-1605(97)00107-4
   Damgaard PH, 1996, LETT APPL MICROBIOL, V23, P146
   DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P47, DOI 10.1016/S0723-2020(87)80009-7
   *FDA, 1991, FABR SINGL SERV CONT
   Gilbert R.J., 1976, MICROBIOLOGY AGR FIS, V4, P197
   GRANUM PE, 1997, FOOD MICROBIOLOGY FU, P327
   GRIFFITHS MW, 1990, J FOOD PROTECT, V53, P790, DOI 10.4315/0362-028X-53.9.790
   Hallaksela AM, 1991, SCAND J FOREST RES, V6, P365, DOI 10.1080/02827589109382674
   HOLBROOK R, 1980, CAN J MICROBIOL, V26, P753, DOI 10.1139/m80-131
   Huemer IA, 1998, INT DAIRY J, V8, P851, DOI 10.1016/S0958-6946(98)00129-0
   Husmark U., 1993, THESIS CHALMERS U TE
   *IDF, 1998, 1811998 IDF
   *ISO, 1993, 7932 ISO INT ORG STA
   JACKSON SG, 1995, LETT APPL MICROBIOL, V21, P103, DOI 10.1111/j.1472-765X.1995.tb01017.x
   Jensen N, 1999, FOOD AUST, V51, P33
   JENSON I, 2000, ENCY FOOD MICROBIOLO, V1, P149
   Kamei T., 1991, Packaging Technology & Science, V4, P185, DOI 10.1002/pts.2770040405
   KAMPFER P, 1994, SYST APPL MICROBIOL, V17, P86
   KANEDA T, 1977, BACTERIOL REV, V41, P391
   Klijn N, 1997, INT DAIRY J, V7, P421, DOI 10.1016/S0958-6946(97)00029-0
   KNEIFEL W, 1994, ARCH LEBENSMITTELHYG, V45, P38
   KOTZEKIDOU P, 2000, ENCY FOOD MICROBIOLO, P124
   Kramer J. M., 1989, Foodborne bacterial pathogens., P21
   Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373
   LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871
   MAY OW, 1991, TAPPI J, V74, P67
   MAY OW, 1994, TAPPI J, V77, P41
   MEER RR, 1991, J FOOD PROTECT, V54, P969, DOI 10.4315/0362-028X-54.12.969
   MOSSO MA, 1989, J FOOD PROTECT, V52, P184, DOI 10.4315/0362-028X-52.3.184
   *NMKL, 1997, 67 NMKL NORD COMM FO
   Pettersson B, 1996, INT J SYST BACTERIOL, V46, P759, DOI 10.1099/00207713-46-3-759
   Pirttijarvi TSM, 1998, INT J FOOD MICROBIOL, V44, P31, DOI 10.1016/S0168-1605(98)00117-2
   Pirttijarvi TSM, 1996, J APPL BACTERIOL, V81, P445
   Pirttijarvi TSM, 1999, SYST APPL MICROBIOL, V22, P133, DOI 10.1016/S0723-2020(99)80036-8
   PRIEST FG, 1989, BIOTECHNOLOGY HDB, V2, P27
   RHODEHAJEL EJ, 1995, FOOD DRUG ADM BACTER
   RONNER U, 1992, NATO ADV SCI INST SE, V223, P403
   ROSENKVIST H, 1995, INT J FOOD MICROBIOL, V26, P353, DOI 10.1016/0168-1605(94)00147-X
   Rowan NJ, 1997, J FOOD PROTECT, V60, P1089, DOI 10.4315/0362-028X-60.9.1089
   RUSUL G, 1995, INT J FOOD MICROBIOL, V25, P131, DOI 10.1016/0168-1605(94)00086-L
   Salkinoja-Salonen MS, 1999, APPL ENVIRON MICROB, V65, P4637
   Setlow P., 1997, FOOD MICROBIOLOGY FU, P30
   SHINAGAWA K, 1990, INT J FOOD MICROBIOL, V10, P125, DOI 10.1016/0168-1605(90)90061-9
   SHINAGAWA K, 1993, NETH MILK DAIRY J, V47, P89
   Suominen I, 1997, J IND MICROBIOL BIOT, V19, P104, DOI 10.1038/sj.jim.2900424
   SUTHERLAND AD, 1993, J DAIRY RES, V60, P569, DOI 10.1017/S0022029900027916
   Te Giffel M. C., 1997, International Journal of Food Microbiology, V34, P307, DOI 10.1016/S0168-1605(96)01204-4
   teGiffel MC, 1996, FOOD MICROBIOL, V13, P53, DOI 10.1006/fmic.1996.0007
   VAISANEN O, 1989, SYST APPL MICROBIOL, V12, P103
   VAISANEN O, 1989, J IND MICROBIOL, V4, P419, DOI 10.1007/BF01569637
   Vaisanen OM, 1998, J APPL MICROBIOL, V84, P1069
   VAISANEN OM, 1991, J APPL BACTERIOL, V71, P130
   VAISANEN OM, 1991, J APPL BACTERIOL, V70, P315, DOI 10.1111/j.1365-2672.1991.tb02942.x
   Van Netten P, 1995, CULTURE MEDIA FOOD M, P35
   VANNETTEN P, 1990, J APPL BACTERIOL, V69, P73, DOI 10.1111/j.1365-2672.1990.tb02913.x
   VARNAM AH, 1991, FOODBORNE PATHOG DIS, P267
   WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263
   Yamazaki K, 1996, BIOSCI BIOTECH BIOCH, V60, P543, DOI 10.1271/bbb.60.543
   1995, CATEGORIZATION BIOL
NR 69
TC 40
Z9 40
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD SEP 25
PY 2000
VL 60
IS 2-3
SI SI
BP 231
EP 239
DI 10.1016/S0168-1605(00)00313-5
PG 9
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA 357NQ
UT WOS:000089508100012
PM 11016612
DA 2018-10-19
ER

PT J
AU Wang, JH
   Yao, CH
   Chuang, WY
   Young, TH
AF Wang, JH
   Yao, CH
   Chuang, WY
   Young, TH
TI Development of biodegradable polyesterurethane membranes with different
   surface morphologies for the culture of osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyesterurethane membranes; osteoblasts; biodegradation; surface
   properties
ID IN-VITRO; BEHAVIOR; RESPONSES; INVITRO; SYSTEM
AB To evaluate the biocompatibility of biodegradable polyesterurethane membranes with different surface morphologies for their possible use as orthopedic biomaterials, rat osteoblasts were cultured on smooth, sunken, and particulate polyesterurethane membranes. A close interaction between cells and exposed particles on the particulate membranes was found. Cells on the particulate surfaces were well spread and flattened and had the greatest adhesion while cells on the smooth surfaces were more rounded, less spread, and less adhered. In addition, in order to investigate their in vivo degradation rates, the morphologic changes in retrieved membranes from 2, 4, and 8 weeks after subcutaneous implantation were observed by scanning electron microscopy and their average molecular weight changes were determined by gel permeation chromatography. These analyses showed that smooth membranes, compared with the two other surface membrane types, had the greatest rate and degree of molecular weight change. In contrast, the molecular weight of particulate membranes, which favor the osteoblast culture, had not changed significantly at 8 weeks postimplantation. Thus particulate polyesterurethane membrane surfaces may be of use as an orthopedic biomaterial, and polyesterurethane membranes certainly provide an ideal system for further study of the relative contributions to biocompatibility and degradation derived from surface morphology. (C) 2000 John Wiley & Sons, Inc.
C1 Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei 10016, Taiwan.
   Chungtai Inst Hlth Sci & Technol, Dept Radiol Technol, Taichung, Taiwan.
   Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Coll Engn, Taipei 10016, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei 10016, Taiwan.
OI Wang, Jyh- Horng/0000-0002-1531-5297
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BULTE AMW, 1993, J APPL POLYM SCI, V50, P13, DOI 10.1002/app.1993.070500103
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Kesting RE, 1985, SYNTHETIC POLYM MEMB, P238
   LELAH MD, 1986, POLYURETHANE MED, P35
   Liao DC, 1997, SYNTHETIC MET, V87, P61, DOI 10.1016/S0379-6779(97)80098-7
   Nunes SP, 1996, J MEMBRANE SCI, V111, P93, DOI 10.1016/0376-7388(95)00281-2
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rehman I, 1996, J MATER SCI-MATER M, V7, P17, DOI 10.1007/BF00121184
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   WARRER K, 1992, J CLIN PERIODONTOL, V19, P633, DOI 10.1111/j.1600-051X.1992.tb01711.x
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 1997, J MEMBRANE SCI, V128, P55, DOI 10.1016/S0376-7388(96)00329-8
NR 17
TC 21
Z9 21
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2000
VL 51
IS 4
BP 761
EP 770
DI 10.1002/1097-4636(20000915)51:4<761::AID-JBM26>3.3.CO;2-U
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 330PK
UT WOS:000087970300026
PM 10880126
DA 2018-10-19
ER

PT J
AU Gutensohn, K
   Beythien, C
   Bau, J
   Fenner, T
   Grewe, P
   Koester, R
   Padmanaban, K
   Kuehnl, P
AF Gutensohn, K
   Beythien, C
   Bau, J
   Fenner, T
   Grewe, P
   Koester, R
   Padmanaban, K
   Kuehnl, P
TI In vitro analyses of diamond-like carbon coated stents: Reduction of
   metal ion release, platelet activation, and thrombogenicity
SO THROMBOSIS RESEARCH
LA English
DT Article
DE intracoronary stents; biocompatability; DLC
ID ATOMIC-ABSORPTION SPECTROMETRY; CORONARY-ARTERY DISEASE; IN-VITRO;
   BALLOON ANGIOPLASTY; ADHESION MOLECULES; CORROSION PRODUCTS;
   FLOW-CYTOMETRY; INVIVO; MODEL; BIOCOMPATIBILITY
AB Coronary artery stents can induce platelet activation by shear forces, contact to the biomaterial, and release of metal ions. This activation is one important trigger for thrombosis. Coating of stents is a possible approach to prevent this side effect. The purpose of this study was to evaluate in vitro the biocompatibility of stents coated with diamondlike carbon (DLC). Semiquantitative energy-dispersive X-ray microanalyses showed a complete coverage of the DLC stents. Flow cytometric analyses revealed a significantly higher increase of mean channel fluorescence intensity for the activation-dependent antigens CD62p and CD63 in non-coated compared to DLC-coated stents (p<0.05). Atomic adsorption spectrophotometry analyses revealed a significant release of nickel and chromium metal ions by non-coated stents over a storage period of 96 hours in human plasma (p<0.05). In contrast, only minimal concentrations of released ions could be detected in the case of DLC-coated stents. Similar observations were made with inductively coupled plasma mass spectrometry analyses. Here, high concentrations of molybdenum and manganese ions were released from non-coated stents (p<0.05), while release of these ions from DLC-coated stents was virtually undetectable (p=0.1 for molybdenum and p=0.4 for manganese). Coating of intracoronary stents with diamond-like carbon significantly improves biocompatibility. This biocompatible coating may therefore contribute to a reduction in thrombogenicity. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Hamburg, Univ Hosp Eppendorf, Dept Transfus Med & Transplantat Immunol, D-20246 Hamburg, Germany.
   Univ Hosp Eppendorf, Dept Cardiol, D-20246 Hamburg, Germany.
   Univ Hosp Bochum, Dept Cardiol, Bochum, Germany.
   Fenner Labs, Hamburg, Germany.
RP Gutensohn, K (reprint author), Univ Hamburg, Univ Hosp Eppendorf, Dept Transfus Med & Transplantat Immunol, Martinistr 521, D-20246 Hamburg, Germany.
CR ALBELDA SM, 1994, FASEB J, V8, P504
   ANGERER J, 1991, CHROMIUM WHOLE BLOOD
   ANGERER J, 1991, NICKEL BLOOD ANAL HA
   BAILEY SR, 1994, TXB INTERVENTIONAL C, P754
   BEYTHIEN C, 1994, THROMB RES, V75, P581, DOI 10.1016/0049-3848(94)90170-8
   Bittl JA, 1996, NEW ENGL J MED, V335, P1290, DOI 10.1056/NEJM199610243351707
   Bittl JA, 1996, J AM COLL CARDIOL, V28, P368, DOI 10.1016/0735-1097(96)00183-0
   COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   CURRIER JW, 1995, J AM COLL CARDIOL, V25, P516, DOI 10.1016/0735-1097(95)98445-J
   DELMASCHIO A, 1993, ANN HEMATOL, V67, P23, DOI 10.1007/BF01709662
   FANG Z, 1989, J ANAL ATOM SPECTROM, V4, P83, DOI 10.1039/ja9890400083
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Gawaz M, 1996, CIRCULATION, V94, P279, DOI 10.1161/01.CIR.94.3.279
   GINSBERG MH, 1988, THROMB HAEMOSTASIS, V59, P1
   GREENE ND, 1966, J MATER, V1, P345
   Grewe PH, 1997, Z KARDIOL, V86, P990, DOI 10.1007/s003920050141
   Gutensohn K, 1997, THROMB RES, V86, P49, DOI 10.1016/S0049-3848(97)00044-3
   HAMBURGER SA, 1990, BLOOD, V75, P550
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   INOUE T, 1996, CIRCULATION, V94, P1518
   ITOH T, 1995, CORONARY ARTERY DIS, V6, P645, DOI 10.1097/00019501-199508000-00009
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KOLLER A, 1982, ACTA PHYSIOL HUNG, V59, P287
   LEMAITRE DT, 1996, INTERVENTIONAL CARDI, P1
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   LUX F, 1974, J RADIOANAL CHEM, V19, P289, DOI 10.1007/BF02518564
   Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1
   Michelson AD, 1996, BLOOD, V87, P4925
   Olesik JW, 1996, ANAL CHEM, V68, pA469
   RADZIUK B, 1995, J ANAL ATOM SPECTROM, V10, P127, DOI 10.1039/ja9951000127
   REULING N, 1990, J BIOMED MATER RES, V24, P979, DOI 10.1002/jbm.820240802
   RINDER CS, 1992, BLOOD, V79, P1201
   ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995
   RUF A, 1995, SEMIN THROMB HEMOST, V21, P146, DOI 10.1055/s-2007-1000389
   RUSS JC, 1976, X-RAY SPECTROM, V5, P212, DOI 10.1002/xrs.1300050410
   Ruygrok PN, 1996, CIRCULATION, V94, P882, DOI 10.1161/01.CIR.94.5.882
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SHATTIL SJ, 1987, BLOOD, V70, P307
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   *STAND COMM AM ASS, 1998, STAND BLOOD BANKS TR
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   TSCHOEPE D, 1993, CIRCULATION, V88, P37, DOI 10.1161/01.CIR.88.1.37
   WEYRICH A, 1994, J CLIN INVEST, V91, P2620
   Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x
   WOODMAN JL, 1984, J BIOMED MATER RES, V18, P99, DOI 10.1002/jbm.820180110
   WORWARD S, 1986, HDB BIOMATERIALS EVA, P367
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 51
TC 197
Z9 203
U1 2
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD SEP 15
PY 2000
VL 99
IS 6
BP 577
EP 585
DI 10.1016/S0049-3848(00)00295-4
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 350AB
UT WOS:000089076900009
PM 10974344
DA 2018-10-19
ER

PT J
AU Holland, NB
   Marchant, RE
AF Holland, NB
   Marchant, RE
TI Individual plasma proteins detected on rough biomaterials by phase
   imaging AFM
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE fibrinogen; AFM; polymer biomaterials; protein adsorption
ID ATOMIC-FORCE MICROSCOPY; SCANNING-TUNNELING-MICROSCOPY; TOTAL
   INTERNAL-REFLECTION; VON-WILLEBRAND-FACTOR; 3-DIMENSIONAL STRUCTURE;
   GLOBULAR-PROTEINS; DEPENDENT CHANGES; FIBRINOGEN; FLUORESCENCE;
   FIBRONECTIN
AB In the past several years, atomic force microscopy (AFM) has provided topographic images of adsorbed plasma proteins in situ at unprecedented resolution. Imaging has been limited to adsorbed protein on relatively smooth model substrates such as mica, graphite, or self-assembled monolayers on which the small height of the protein can be observed from the background. The inherent roughness of biomaterial surfaces has prevented observation of adsorbed proteins in topographic images. We report imaging isolated fibrinogen molecules adsorbed on National Heart Lung and Blood Institute (NHLBI) reference materials polydimethylsiloxane and low-density polyethylene in situ using phase imaging AFM. Fibrinogen, a plasma protein important for blood coagulation and platelet aggregation, was adsorbed from dilute solution onto reference biomaterial surfaces at sub-monolayer coverage. Tapping mode AFM was used to image the samples. For polydimethylsiloxane, the lateral size of the surface features is much greater than the dimensions of proteins. This allowed adsorbed proteins to be observed in topographic images. The phase imaging signal of tapping mode AFM provides information on differences in material properties of the surface, and was used to distinguish individual protein molecules from the underlying polymer surface. On the low-density polyethylene surface, characteristic topographical features are of the same magnitude as the protein molecules, so that protein cannot be distinguished from the surface using topographic images. However, phase images were used to successfully locate and characterize the distribution of the protein. Phase imaging was not able to distinguish fibrinogen adsorbed onto expanded polytetrafluoroethylene. The utility and Limitations of the phase imaging technique for characterizing protein adsorption to rough surfaces is discussed. (C) 2000 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Marchant, RE (reprint author), Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RI Holland, Nolan/F-6933-2011
OI Holland, Nolan/0000-0002-0752-6887
FU NHLBI NIH HHS [HL-58540]
CR BRASH JL, 1987, PHYSIOCHEMICAL BIOCH, V343
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   CORNELIUS RM, 1992, J COLLOID INTERF SCI, V150, P121, DOI 10.1016/0021-9797(92)90273-O
   Creeth A, 1996, J CHEM SOC FARADAY T, V92, P589, DOI 10.1039/ft9969200589
   EPPELL SJ, 1993, LANGMUIR, V9, P2281, DOI 10.1021/la00033a007
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   HOLLAND NB, 1996, THESIS CASE W RESERV
   HORBETT TA, 1995, PROTEINS INTERFACES, V602, pR2
   HUBNER B, 1992, ULTRAMICROSCOPY, V42, P1519, DOI 10.1016/0304-3991(92)90476-Z
   IWAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459, DOI 10.1016/S0021-9797(85)80020-5
   KELLER DJ, 1992, SURF SCI, V268, P333, DOI 10.1016/0039-6028(92)90973-A
   Leggett GJ, 1996, J ELECTRON SPECTROSC, V81, P249, DOI 10.1016/0368-2048(95)02527-8
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   Lewis KB, 1996, COLLOID SURFACE B, V7, P259, DOI 10.1016/0927-7765(96)01268-4
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P87, DOI 10.1016/0021-9797(83)90316-8
   MARCHANT RE, 1992, J COLLOID INTERF SCI, V148, P261, DOI 10.1016/0021-9797(92)90135-9
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   REIF M, 1997, SCIENCE, V276, P1109
   Salzman E. W., 1994, HEMOSTASIS THROMBOSI, P1469
   SIEDLECKI CA, 1994, J BIOMED MATER RES, V28, P971, DOI 10.1002/jbm.820280902
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Siedlecki CA, 1996, BLOOD, V88, P2939
   SIT PS, IN PRESS THROMB HAEM
   SLACK SM, 1995, ACS SYM SER, V602, P1
   WATTS TH, 1986, NATURE, V320, P179, DOI 10.1038/320179a0
   Wilson DL, 1996, J VAC SCI TECHNOL B, V14, P2407, DOI 10.1116/1.588870
   WILSON DL, 1995, LANGMUIR, V11, P265, DOI 10.1021/la00001a045
   ZIMMERMANN RM, 1990, J COLLOID INTERF SCI, V139, P268, DOI 10.1016/0021-9797(90)90462-W
NR 30
TC 58
Z9 62
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2000
VL 51
IS 3
BP 307
EP 315
DI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 329PA
UT WOS:000087914500003
PM 10880071
DA 2018-10-19
ER

PT J
AU Trindade, MCD
   Schurman, DJ
   Maloney, WJ
   Goodman, SB
   Smith, RL
AF Trindade, MCD
   Schurman, DJ
   Maloney, WJ
   Goodman, SB
   Smith, RL
TI G-protein activity requirement for polymethylmethacrylate and titanium
   particle-induced fibroblast interleukin-6 and monocyte chemoattractant
   protein-1 release in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE particle; G protein; cytokine/chemokine; fibroblast; total joint
   arthroplasty
ID SENSITIVE G-PROTEIN; C-C CHEMOKINES; TOTAL HIP-ARTHROPLASTY; MACROPHAGES
   IN-VITRO; BONE-RESORPTION; PERTUSSIS-TOXIN; PERIPROSTHETIC OSTEOLYSIS;
   CHEMOTACTIC CYTOKINES; PHOSPHOLIPASE-C; WEAR DEBRIS
AB Periprosthetic granulomatous membranes consisting of fibroblasts, macrophages, lymphocytes, foreign body giant cells, and abundant particulate debris occur at sites of implant loosening. Previous studies demonstrate that fibroblasts respond to particulate debris through the release of interleukin-g (IL-6), prostaglandin E-2, and matrix metalloproteinases in vitro. C-C chemokines are observed in granulomatous tissue surrounding loosened prosthetic implants and are released by macrophages and fibroblasts in response to particle challenge in vitro. This study tested the hypothesis that G protein activity is required for fibroblast activation by titanium and polymethylmethacrylate (PMMA) particles, and that inhibition of G protein activity would alter IL-6 and and monocyte chemoattractant protein-1 (MCP-1) release from activated fibroblasts. The specific inhibitor of G protein activity, pertussis toxin, was added to the fibroblasts to examine the effects of G protein activity with respect to the production of IL-6 and MCP-1 by orthopedic biomaterial-challenged fibroblasts in vitro. Interleukin-1 beta (IL-1 beta), a proven activator of MCP-1 and interleukin-6, was used as a positive control. Exposure of fibroblasts to titanium and polymethylmethacrylate (PMMA) particles resulted in a dose-dependent release of MCP-1 and IL-6. Challenge with PMMA particles at doses of 0.150%, 0.300%, and 0.600% vol/vol increased the release of interleukin-6 by 7-, 19-, and 22-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone at 24 h. Challenge with PMMA particles at doses of 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of MCP-1-6 by 2.5-, 3.6-, 4.3-, and 4.5-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone. Challenge with titanium particles at concentrations of 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of interleukin-6 by 2.6-, 6.4-, 9.6-, and 10.0-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone at 24 h. Challenge with titanium particles at concentrations of 0.038%, 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of MCP-1 by 2.9-, 3.1-, 5.8-, 5.4-, and 5.8-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone. Pretreatment of fibroblasts with pertussis toxin inhibited the release of interleukin-6 and MCP-1 from PMMA and titanium particle challenged fibroblasts in a dose-dependent manner. PMMA particle induced fibroblast IL-6 release was inhibited by 23.6% and 35.3% with 20- and 200-ng/mL doses of pertussis toxin, respectively Titanium particle induced fibroblast IL-6 release was inhibited by 48.2% and 56.3% with 20- and 200-ng/mL doses of pertussis toxin, respectively. PMMA particle-induced fibroblast MCP-1 release was inhibited by 36.0%, 50.4%, and 60.1% with 2-, 20- and 200-ng/mL doses of pertussis toxin, respectively. Titanium particle-induced fibroblast MCP-1 release was inhibited by 15.5%, 53.2%, and 64.6% with 2-, 20-, and 200-ng/mL doses of pertussis toxin, respectively. This study suggests that fibroblasts localized in periprosthetic membranes are a source of macrophage chemoattractant factors and proinflammatory mediators that may influence granuloma formation and lead to periprosthetic bone resorption. Furthermore, this study shows that G proteins are involved in particle-induced fibroblast activation, as evidenced by decrease levels of particle induced IL-6 and MCP-1 release following pertussis toxin treatment. (C) 2000 John Wiley & Sons, Inc.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Trindade, MCD (reprint author), Stanford Univ, Med Ctr, Div Orthopaed Surg, 300 Pasteur Dr,R-144, Palo Alto, CA 94301 USA.
EM trindade@leland.stanford.edu
CR AKAHOSHI T, 1993, ARTHRITIS RHEUM-US, V36, P762, DOI 10.1002/art.1780360605
   Blaine TA, 1997, J BONE JOINT SURG AM, V79A, P1519, DOI 10.2106/00004623-199710000-00009
   BRIELAND JK, 1995, AM J RESP CELL MOL, V12, P104, DOI 10.1165/ajrcmb.12.1.7811465
   CHIBA J, 1996, T ORTHOP RES SOC, V21, P514
   Christopoulos A., 1999, Life Sciences, V64, P1
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   Dessauer CW, 1996, CLIN SCI, V91, P527, DOI 10.1042/cs0910527
   DRISCOLL KE, 1994, EXP LUNG RES, V20, P473, DOI 10.3109/01902149409031733
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   FROKJAER J, 1995, ACTA ORTHOP SCAND, V66, P303, DOI 10.3109/17453679508995549
   FRONDOZA CG, 1993, J BIOMED MATER RES, V27, P611, DOI 10.1002/jbm.820270508
   GILALBAROVA J, 1992, J BONE JOINT SURG BR, V74, P825
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING MB, 1990, CLIN ORTHOP RELAT R, P245
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   GONZALEZ O, 1997, T ORTHOP RES SOC, V21, P504
   GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Goodman SB, 1997, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199704000-00017
   GREIS PE, 1994, J ORTHOPAED RES, V12, P286, DOI 10.1002/jor.1100120219
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   Howie D W, 1990, J Arthroplasty, V5, P337, DOI 10.1016/S0883-5403(08)80093-9
   Ishiguro N, 1997, J BIOMED MATER RES, V35, P399, DOI 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JIANG YL, 1992, J IMMUNOL, V148, P2423
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, V218, P123
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   MALONEY WJ, 1998, J BIOMED MATER RES, V41, P497
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   MATEO RB, 1994, AM J PHYSIOL, V266, pR1840
   MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17
   Morelli S, 1996, MOL CELL ENDOCRINOL, V122, P207, DOI 10.1016/0303-7207(96)03886-5
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   NIWA M, 1969, J BACTERIOL, V97, P1069
   Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173
   PARIS S, 1987, J BIOL CHEM, V262, P1970
   RAGAB AA, 1998, T ORTHOP RES SOC, V23, P355
   RITCHIE CK, 1997, T ORTHOP RES SOC, V22, P1
   Rollins BJ, 1997, BLOOD, V90, P909
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SCHMALZRIED TP, 1993, J ARTHROPLASTY, V8, P179
   SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24334, DOI 10.1074/jbc.270.41.24334
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782
   Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639
   SUN DH, 1997, T ORTHOP RES SOC, V22, P324
   SUN DH, 1997, T SOC BIOMATER, V20, P259
   TAUB DD, 1993, CYTOKINE, V5, P175, DOI 10.1016/1043-4666(93)90001-L
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   Trindade MCD, 1999, J BIOMED MATER RES, V48, P434, DOI 10.1002/(SICI)1097-4636(1999)48:4<434::AID-JBM6>3.0.CO;2-Y
   TRINDADE MCD, 1999, T ORTHOP RES SOC, V24, P897
   UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113
   VAES G, 1988, CLIN ORTHOP RELAT R, P239
   VANDAMME J, 1994, J IMMUNOL, V152, P5495
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   YASZAY B, 1999, T SOC BIOMATER, V22, P481
   YASZAY B, 1999, T ORTHOP RES SOC, V24, P901
   Zickus C, 1998, MEDIAT INFLAMM, V7, P269, DOI 10.1080/09629359890956
NR 74
TC 24
Z9 24
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2000
VL 51
IS 3
BP 360
EP 368
DI 10.1002/1097-4636(20000905)51:3<360::AID-JBM9>3.0.CO;2-E
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 329PA
UT WOS:000087914500009
PM 10880077
DA 2018-10-19
ER

PT J
AU Abraham, GA
   Murray, J
   Billiar, K
   Sullivan, SJ
AF Abraham, GA
   Murray, J
   Billiar, K
   Sullivan, SJ
TI Evaluation of the porcine intestinal collagen layer as a biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen biomaterial; porcine submucosa; soft-tissue repair
ID ABDOMINAL-WALL DEFECTS; DERMAL SHEEP COLLAGEN; TISSUE REGENERATING
   CAPACITY; MARLEX MESH; BOVINE PERICARDIUM; INCISIONAL HERNIAS; ACELLULAR
   MATRIX; DOG-MODEL; REPAIR; SUBMUCOSA
AB The submucosal layer of the small intestine has been investigated as a source of collagenous tissue with the potential to be used as a biomaterial because of its inherent strength and biocompatibility. In this study we utilized a novel method for processing the tissue to generate an acellular intestinal collagen layer (ICL). This nondetergent, nonenzymatic chemical cleaning protocol removes cells and cellular debris without damaging the native collagen structure. Multilayer laminates of ICL crosslinked with a water-soluble carbodiimide (EDC) were evaluated as a tissue repair material in a rabbit abdominal hernia model. The ICL laminates provided the requisite physical properties and did not lead to adhesion formation. No immune response to the porcine collagen was detectable, and this material did not show any calcification in either the rabbit model or in the juvenile rat model. (C) 2000 John Wiley Sr Sons, Inc.
C1 Organogenesis Inc, Canton, MA 02021 USA.
RP Sullivan, SJ (reprint author), Organogenesis Inc, 150 Dan Rd, Canton, MA 02021 USA.
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   BILLIAR K, IN PRESS BIOMATERIAL
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   HardinYoung J, 1996, BIOTECHNOL BIOENG, V49, P675, DOI 10.1002/(SICI)1097-0290(19960320)49:6<675::AID-BIT9>3.0.CO;2-L
   HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   JENKINS SD, 1983, SURGERY, V94, P392
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P249, DOI 10.1016/0142-9612(91)90208-R
   Kemp P D, 1995, Tissue Eng, V1, P71, DOI 10.1089/ten.1995.1.71
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Klinge U, 1996, LANGENBECK ARCH CHIR, V381, P323
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   LAMB JP, 1983, SURGERY, V93, P643
   LARSON GM, 1984, SURG CLIN N AM, V64, P335
   Law NW, 1988, CLIN MATER, V3, P95
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LEWIS RT, 1984, CAN J SURG, V27, P155
   LIAKAKOS T, 1994, BRIT J SURG, V81, P248, DOI 10.1002/bjs.1800810230
   Mako WJ, 1997, J HEART VALVE DIS, V6, P316
   Matsumoto H, 1996, J VET MED SCI, V58, P685, DOI 10.1292/jvms.58.685
   MEDDINGS RN, 1993, J PEDIATR SURG, V28, P660, DOI 10.1016/0022-3468(93)90025-G
   MOLLOY RG, 1991, BRIT J SURG, V78, P242, DOI 10.1002/bjs.1800780237
   *ORG INC, 1996, K970561
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 37
TC 71
Z9 113
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2000
VL 51
IS 3
BP 442
EP 452
DI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 329PA
UT WOS:000087914500019
PM 10880087
OA Green Published
DA 2018-10-19
ER

PT J
AU Stanislawski, L
   Soheili-Majd, E
   Perianin, A
   Goldberg, M
AF Stanislawski, L
   Soheili-Majd, E
   Perianin, A
   Goldberg, M
TI Dental restorative biomaterials induce glutathione depletion in cultured
   human gingival fibroblast: Protective effect of N-acetyl cysteine
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE dental biomaterials; fibroblasts; glutathione; antioxidant
   N-acetylcysteine
ID GLASS-IONOMER CEMENTS; IN-VITRO; FREE-RADICALS; ACETYLCYSTEINE;
   COMPONENTS; COMPOSITE; TOXICITY; RELEASE; INVITRO; ACID
AB Eight biomaterials eluted from four different types of dental restorative biomaterials, that is, from glass ionomer cement (GIC: Ketac-fil and Fuji II), resin-modified glass ionomer cement (RM-GIC: Fuji II LC and Photac-fil), composite (Z100 MP and Tetric-flow), and compomer (Compoglass F and F-2000), were studied for their cytotoxic properties in relation to glutathione (GSH) content in cultured human gingival fibroblasts. Z100 MP, Tetric-flow, and Compoglass F were less cytotoxic than the others, with a toxic concentration of 50% (TC 50) > 24% (of eluate), as determined by the MTT test. F-2000, Tetric-flow, and the other biomaterials were relatively more cytotoxic (TC 50 = 9-16%). With the exception of Z100 MP, all the biomaterials induced a depletion of cellular glutathione (GSH) that was variable depending upon the biomaterial eluates. The strongest GSH depletion was with F-2000, Fuji II, and Photac-fil. GSH depletion, with Compoglass and F-2000, was rapid-detectable after one h of cell treatment and complete within 3 h-whereas a longer period of incubation was required for the other biomaterials. Interestingly, the drug cytotoxic effects induced by all the biomaterials were prevented by cell treatment with the antioxidant N-acetylcysteine (NAC). This study provides evidence that the cytotoxic property of dental restorative biomaterials is associated with depletion of the glutathione level in gingival fibroblasts. While the molecular mechanisms of this phenomenon require further investigations, our data suggest that NAC may be useful in preventing the cellular damage induced by dental restorative biomaterials. (C) 2000 John Wiley & Sons, Inc.
C1 Fac Chirurg Dent, Histol Lab, F-92120 Montrouge, France.
   Inst Cochin Genet Mol, F-75014 Paris, France.
RP Stanislawski, L (reprint author), Fac Chirurg Dent, Histol Lab, 1 Rue Maurice Arnoux, F-92120 Montrouge, France.
CR ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X
   BEREZNOWSKI Z, 1994, INT J BIOCHEM, V26, P1119, DOI 10.1016/0020-711X(94)90134-1
   Consiglio R, 1998, ARCH ORAL BIOL, V43, P65, DOI 10.1016/S0003-9969(97)00087-3
   Deneke S.M., 1989, AM J PHYSIOL, V257, P163
   FERRACANE JL, 1990, DENT MATER, V6, P282, DOI 10.1016/S0109-5641(05)80012-0
   GERZINA TM, 1994, J ORAL REHABIL, V21, P463, DOI 10.1111/j.1365-2842.1994.tb01160.x
   Gillissen A, 1998, RESP MED, V92, P609, DOI 10.1016/S0954-6111(98)90506-6
   Hamid A, 1997, J ORAL REHABIL, V24, P20, DOI 10.1046/j.1365-2842.1997.00490.x
   Hamid A, 1998, J ORAL REHABIL, V25, P94, DOI 10.1046/j.1365-2842.1998.00247.x
   HANKS CT, 1988, J ORAL PATHOL MED, V17, P396, DOI 10.1111/j.1600-0714.1988.tb01304.x
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501
   KAMPBELL A, 1999, FREE RADICAL BIO MED, V26, P1166
   MCCARTHY TJ, 1994, FUND APPL TOXICOL, V22, P543, DOI 10.1006/faat.1994.1061
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P771
   Neal R, 1998, TOXICOLOGY, V130, P167, DOI 10.1016/S0300-483X(98)00104-8
   OSSENI RA, 1990, BIOL CLOCKS MECH APP, P111
   RATANASATHIEN S, 1995, J DENT RES, V74, P1602, DOI 10.1177/00220345950740091601
   RICE GC, 1986, CANCER RES, V46, P6105
   SIDHU SK, 1995, AM J DENT, V8, P59
   Stanislawski L, 1999, J BIOMED MATER RES, V48, P277, DOI 10.1002/(SICI)1097-4636(1999)48:3<277::AID-JBM11>3.0.CO;2-T
   Starcevic SL, 1997, COMP BIOCHEM PHYS C, V117, P211, DOI 10.1016/S0742-8413(97)00056-X
   Steenvoorden DPT, 1997, PHOTOCHEM PHOTOBIOL, V66, P665, DOI 10.1111/j.1751-1097.1997.tb03204.x
   TYRRELL RM, 1988, PHOTOCHEM PHOTOBIOL, V47, P405, DOI 10.1111/j.1751-1097.1988.tb02744.x
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   Weijl NI, 1997, CANCER TREAT REV, V23, P209, DOI 10.1016/S0305-7372(97)90012-8
   Weltin D, 1996, BIOCHEM PHARMACOL, V51, P1123, DOI 10.1016/0006-2952(96)83389-2
   Wilson A D, 1990, Int J Prosthodont, V3, P425
NR 28
TC 38
Z9 39
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2000
VL 51
IS 3
BP 469
EP 474
DI 10.1002/1097-4636(20000905)51:3<469::AID-JBM22>3.0.CO;2-B
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 329PA
UT WOS:000087914500022
PM 10880090
DA 2018-10-19
ER

PT J
AU Bellantone, M
   Coleman, NJ
   Hench, LL
AF Bellantone, M
   Coleman, NJ
   Hench, LL
TI Bacteriostatic action of a novel four-component bioactive glass
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; sol-gel; antimicrobial; bacteriostatic; silver
ID SILVER IONS; IN-VITRO; GEL; HYDROXYAPATITE; MICROORGANISMS; SURFACE;
   APATITE
AB Bacterial adhesion to biomaterials causing biomaterial-centered infection and poor tissue integration is a problem that limits the extensive use of many biomaterial devices in clinical applications. Bioactive materials are those biomaterials that form a compliant, mechanically stable bond with host tissue. Sol-gel-derived glasses in the three-component system SiO2-CaO-P2O5 exhibit bioactivity that is dependent on composition and texture (i.e., specific surface area, pore size, structure, and distribution). The in vitro bioactivity and antibacterial action of a novel sol-gel-derived glass, AgBG, in the system SiO2-CaO-P2O5-Ag2O are compared with those of its three-component counterpart, BG. The incorporation of 3-wt % Ag2O conferred antimicrobial properties to the glass without compromising its bioactivity. AgBG exhibited a marked bacteriostatic effect on E. coli MG1655 with a minimum inhibiting concentration of 0.2 mg (biomaterial)/mL (culture solution), above which bacterial growth was reduced to 0.01% of that of the control culture. In comparison, BG did not possess antimicrobial properties over the concentration range investigated (0.1-40.0 mg/mL). (C) 2000 John Wiley & Sons, Inc.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
RP Bellantone, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
RI Coleman, Nichola/D-1847-2009
OI Coleman, Nichola/0000-0002-3484-977X
CR *AM SOC MICR, 1981, MAN METH GEN BACT
   [Anonymous], 1995, 9277 ISO
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bell R., 1970, DISCUSS FARADAY SOC, V50, P55, DOI DOI 10.1039/DF9705000055
   BRINKER CJ, 1984, BETTER CERAMICS CHEM, V32
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1986, SILICON BIOCH, P123
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P773, DOI 10.1023/A:1008923523428
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   Gaskell P., 1970, DISCUSS FARADAY SOC, V50, P82
   Geyer G, 1999, HNO, V47, P25, DOI 10.1007/s001060050354
   Grier N., 1983, DISINFECTION STERILI
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hench L. L., 1998, SOL GEL SILICA PROCE
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HUGHES SF, 1992, CURR OPIN ORTHOP, V3, P69
   HUGHES SPF, 1988, J HOSP INFECT, V11, P41, DOI 10.1016/0195-6701(88)90021-7
   Jansen B, 1994, J Biomater Appl, V9, P55, DOI 10.1177/088532829400900103
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   LUSVARDI G, 1998, S 11 MAT CLIN APPL F, P271
   MILLER JC, 1988, STAT ANAL CHEM
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   OHTSUKI C, 1992, J NONCRYST SOLIDS, V143, P35
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P385, DOI 10.1023/A:1013231529439
   SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Stoor P, 1996, MICROB ECOL HEALTH D, V9, P109, DOI 10.1002/(SICI)1234-987X(199605)9:3<109::AID-MEH417>3.3.CO;2-M
   Thompson M., 1983, HDB INDUCTIVELY COUP
   WELLS TNC, 1995, BIOCHEMISTRY-US, V34, P7896, DOI 10.1021/bi00024a014
   WILSON J, 1993, INTRO BIOCERAMICS, P63
NR 38
TC 136
Z9 138
U1 1
U2 33
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2000
VL 51
IS 3
BP 484
EP 490
DI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 329PA
UT WOS:000087914500024
PM 10880092
DA 2018-10-19
ER

PT J
AU Goodman, PD
   Hall, MW
   Sukavaneshvar, S
   Solen, KA
AF Goodman, PD
   Hall, MW
   Sukavaneshvar, S
   Solen, KA
TI In vitro model for studying the effects of hemodynamics on device
   induced thromboembolism in human blood
SO ASAIO JOURNAL
LA English
DT Article
AB Biomateria related thromboembolism is a complex phenomenon, affected by such variables as biomaterial surface chemistry, hemodynamics, and individual donor variations. Thus, isolation of the individual variables would greatly facilitate the understanding and inhibition of this phenomenon. A low volume in vitro model with this potential has been developed, with the initial focus on studying the influence of hemodynamics on thromboembolism (TE) in human blood. Patterned after a larger in vitro model for bovine blood used successfully in our laboratory, the smaller model directed fresh human blood in a single pass through 1/32 inch ID PVC tubing and a flow cell at 3 ml/min. The flow cell consisted of alternating abrupt expansions and contractions of cylindrical tubing that could be modified to study the effects of hemodynamic parameters on TE. Thrombus growth in the flow cell was monitored visually by transillumination microscopy. Emboli from the flow cell were detected continuously by a light-scattering microemboli detector (LSMD), and their strength was assessed by using the constant-pressure filtration (CPF) method. Preliminary studies confirmed the potential of this model. Thrombi were observed visually in the flow cell at sites of high vorticity and at flow separation and reattachment points and were also observed to embolize. Emboli were detected by the LSMD downstream of the flow cell in significantly greater numbers than upstream and were coincident with the embolization of thrombi observed visually. Emboli collected downstream of the flow cell occluded the CPF fillers at 50 mm Hg, suggesting that they possessed sufficient strength to occlude microvessels. This model may be used to aid in developing a computer model of thromboembolism, which could subsequently be refined with clinical data.
C1 Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA.
RP Solen, KA (reprint author), Brigham Young Univ, Dept Chem Engn, 350 CB, Provo, UT 84602 USA.
CR ANDRESEN DM, 1994, MICROSURG, V15, P413, DOI 10.1002/micr.1920150609
   KARINO T, 1979, MICROVASC RES, V17, P217, DOI 10.1016/S0026-2862(79)80001-1
   REYNOLDS LO, 1990, T ASAIO, V36, pM185
   SOLEN KA, 1986, CHEM ENG COMMUN, V47, P163, DOI 10.1080/00986448608911761
   Sukavaneshvar S, 1998, ASAIO J, V44, pM393, DOI 10.1097/00002480-199809000-00013
NR 5
TC 9
Z9 9
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD SEP-OCT
PY 2000
VL 46
IS 5
BP 576
EP 578
DI 10.1097/00002480-200009000-00013
PG 3
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 354KP
UT WOS:000089329900013
PM 11016510
OA Bronze
DA 2018-10-19
ER

PT J
AU Bruining, MJ
   Blaauwgeers, HGT
   Kuijer, R
   Jongsma, FHM
   de Brabander, J
   Nuijts, RMMA
   Koole, LH
AF Bruining, MJ
   Blaauwgeers, HGT
   Kuijer, R
   Jongsma, FHM
   de Brabander, J
   Nuijts, RMMA
   Koole, LH
TI Tailoring of new polymeric biomaterials for the repair of medium-sized
   corneal perforations
SO BIOMACROMOLECULES
LA English
DT Article
ID CYANOACRYLATE TISSUE ADHESIVE; POLY(2-HYDROXYETHYL METHACRYLATE);
   IN-VITRO; DEGRADATION; PROTECTION; NETWORKS
AB The aim of this study was to investigate whether polymeric biomaterials can be designed such that they become suitable for surgical closure of medium-sized perforations in the cornea, the transparent tissue in the front of the eye. Such a biomaterial must meet stringent requirements in terms of hydrophilicity, strength, transparency, flexibility, and biocompatibility. Four different copolymers of n-butyl methacrylate (BMA) and hexa(ethylene glycol) methacrylate (HEGMA) were prepared and characterized. Poly(BMA) was made as a reference material. Physicochemical properties were measured (contact angles, glass-transition temperatures, thermal degradation. water uptake and swelling), and cytotoxicity in vitro was assessed with a MTT test. Moreover, the interaction between the materials and cultured human corneal epithelial cells was studied. The copolymers may be useful for temporary closure of corneal perforations.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Acad Hosp Maastricht, Dept Ophthalmol, Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
CR BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776
   Bruining MJ, 1999, J BIOMED MATER RES, V47, P189, DOI 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Crawford GJ, 1996, J REFRACT SURG, V12, P525
   Gebhardt BM, 1999, CORNEA, V18, P314, DOI 10.1097/00003226-199905000-00013
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Lou X, 1999, J BIOMED MATER RES, V47, P404, DOI 10.1002/(SICI)1097-4636(19991205)47:3<404::AID-JBM16>3.0.CO;2-F
   Macsai MS, 1998, CORNEA, V17, P227, DOI 10.1097/00003226-199803000-00020
   Moschos M, 1997, DOC OPHTHALMOL, V93, P237, DOI 10.1007/BF02569064
   Nuyts RMMA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1427
   Orlin Stephen E., 1998, CLAO Journal, V24, P186
   Reisin Irina, 1996, CLAO Journal, V22, P146
   Sangwan VS, 1999, CORNEA, V18, P707, DOI 10.1097/00003226-199911000-00014
   Sharma A, 1999, CORNEA, V18, P366, DOI 10.1097/00003226-199905000-00020
   Tsuk AG, 1997, J BIOMED MATER RES, V34, P299
   Ziegelaar BW, 1999, BIOMATERIALS, V20, P1979, DOI 10.1016/S0142-9612(99)00019-8
NR 16
TC 9
Z9 9
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FAL
PY 2000
VL 1
IS 3
BP 418
EP 423
DI 10.1021/bm000009t
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 433HZ
UT WOS:000168755100019
PM 11710132
DA 2018-10-19
ER

PT J
AU Comut, AA
   Shortkroff, S
   Zhang, XY
   Spector, M
AF Comut, AA
   Shortkroff, S
   Zhang, XY
   Spector, M
TI Association of fibroblast orientation around titanium in vitro with
   expression of a muscle actin
SO BIOMATERIALS
LA English
DT Article
DE fibroblast; contraction; actin
ID COLLAGEN GEL CONTRACTION; TRANSFORMING GROWTH-FACTOR-BETA-1;
   GROWTH-FACTOR; IN-VITRO; GAMMA-INTERFERON; CELLS; DIFFERENTIATION;
   MYOFIBROBLASTS; QUIESCENT; LIGAMENT
AB The objective of this study was to investigate the association of cell orientation around a biomaterial with expression of a contractile actin isoform, Selected cytokines and a fungal metabolite known to alter the cytoskeleton were used to modulate the fibroblast orientation around titanium in vitro and the synthesis of a specific muscle actin in order to reveal an association between these processes. A novel culture system using a fibronectin-coated silicone surface was employed to evaluate the orientation of human gingival fibroblasts around titanium discs. Round glass cover slips, 25 mm in diameter, were coated with polydimethylsiloxane. During the heat-induced polymerization process, two commercially pure titanium discs, 5 mm in diameter, were placed on the silicone at a distance of approximately 0.5 mm apart. The rubbery consistency of the silicone stabilized the metal discs on the cover slip and eliminated the risk of developing a lip at the edge of the titanium sample. The cover slip was then heated to complete polymerization of the silicone and subsequently coated with fibronectin. One hundred thousand human gingival fibroblasts were plated onto each glass cover slip containing the titanium discs. The cells were treated with one of the following prior to seeding on the cover slips: transforming growth factor-beta 1 (TGF-beta 1), platelet-derived growth factor-BB (PDGF-BB), interferon-gamma (IFN-gamma) for cytochalasin-D. Untreated cells served as controls. The orientation of the cells at the surface of the titanium discs was evaluated microscopically and the cell content of a-smooth muscle actin (SMA) was determined by Western blot analysis and immunohistochemistry. A notable finding was the high correlation between the percentage of cells oriented perpendicular to the titanium surface and SMA synthesis. TGF-beta 1, IFN-gamma and cytochalasin-D increased synthesis of SMA while PDGF-BB decreased it. The findings support the proposition that SMA-enabled cell contraction may play a role in the orientation of cells to a biomaterial surface. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA.
   Harvard Univ, Sch Dent Med, Dept Restorat Dent, Boston, MA 02115 USA.
RP Spector, M (reprint author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA.
OI Spector, Myron/0000-0003-3328-4858
CR ALBERTS B, 1983, MOL BIOL CELL, P549
   Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534
   Battikhi T, 1999, INFECT IMMUN, V67, P1220
   BELLOWS CG, 1980, J CELL SCI, V44, P59
   BELLOWS CG, 1982, J CELL SCI, V58, P125
   COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C
   GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T
   Ham A. W., 1969, HISTOLOGY
   HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Havers C., 1691, OSTEOLOGIA NOVA
   Kurosaka H, 1998, INVEST OPHTH VIS SCI, V39, P699
   Lew AM, 1999, BIOCHEM J, V341, P647, DOI 10.1042/0264-6021:3410647
   Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426
   MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894
   Mueller SM, 1999, J BIOMED MATER RES, V45, P157, DOI 10.1002/(SICI)1097-4636(19990605)45:3<157::AID-JBM1>3.0.CO;2-B
   Murray MM, 1999, J ORTHOP RES, V17, P18, DOI 10.1002/jor.1100170105
   PITTET B, 1994, PLAST RECONSTR SURG, V93, P1224, DOI 10.1097/00006534-199405000-00018
   Riley SG, 1999, J LAB CLIN MED, V134, P304, DOI 10.1016/S0022-2143(99)90211-1
   RONNOVJESSEN L, 1993, LAB INVEST, V68, P696
   RUDOLPH R, 1978, PLAST RECONSTR SURG, V62, P185, DOI 10.1097/00006534-197808000-00006
   SAPPINO AP, 1990, LAB INVEST, V63, P144
   Schneider TO, 1999, J ORTHOPAED RES, V17, P192, DOI 10.1002/jor.1100170207
   SHARPEY W, 1956, ELEMENTS ANATOMY J Q, V1
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044
   TINGSTROM A, 1992, J CELL SCI, V102, P315
   Togo T, 1999, J CELL SCI, V112, P719
   Yokozeki M, 1999, FEBS LETT, V442, P61, DOI 10.1016/S0014-5793(98)01626-3
NR 32
TC 14
Z9 14
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2000
VL 21
IS 18
BP 1887
EP 1896
DI 10.1016/S0142-9612(00)00066-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334XZ
UT WOS:000088212800007
PM 10919692
DA 2018-10-19
ER

PT J
AU Choong, SKS
   Wood, S
   Whitfield, HN
AF Choong, SKS
   Wood, S
   Whitfield, HN
TI A model to quantify encrustation on ureteric stents, urethral catheters
   and polymers intended for urological use
SO BJU INTERNATIONAL
LA English
DT Article
DE encrustation model; ureteric stents; urethral catheters; biomaterial
ID IN-VITRO; URINE; MACROMOLECULES; AGGREGATION; SILICONE; STONES; GROWTH;
   LATEX
AB Objective To validate an encrustation model and to quantify encrustation on currently used urological devices and polymers intended for urological use.
   Materials and methods An encrustation model was validated: (i) to measure the amount of calcium leaching from the glass model and from the polymer used; (ii) to determine whether the use of a single-source or pooled urine produced similar results; (iii) to determine in vitro encrustation; and (iv) to compare the results of in vivo implantation of the same materials into the bladders of rodents with the in vitro results. A test polymer (a ureteric stent, a urethral catheter or a biomaterial) and a control silicone polymer were housed separately but received human urine from the same reservoir and under the same conditions (pH 6.0 and 37 degrees C) for 5 days. The amount of calcium encrustation on each polymer was measured using atomic absorption spectroscopy. Each experiment was repeated at least four times and the results expressed as an encrustation index, defined as the ratio of encrustation of the test and reference polymers.
   Results The amount of calcium leaching from the glass model and polymers tested was insignificant. The use of a single-source or pooled urine gave the same results in the encrustation model. The in vitro results correlated with in vivo implantation of disks into the bladders of rats. Among the commonly used ureteric stents tested, the Cook C-Flex ureteric stents encrusted least. Hydrogel-coated ureteric stents encrusted more than uncoated stents. The Bard polytetrafluoroethylene short-term urethral catheter encrusted more than the Bard hydrogel-coated long-term catheter. A plasma-activated surface modification of a synthetic biomaterial with hyaluronic acid encrusted less than silicone, a long-term biomaterial widely regarded as the 'gold standard'.
   Conclusion This validated encrustation model is the first to quantify encrustation on currently available ureteric stents and urethral catheters. A novel coating for a biomaterial was identified using the encrustation model, and which encrusted less than silicone.
C1 Inst Urol & Nephrol, Stone Unit, London, England.
RP Choong, SKS (reprint author), 10 Elliott Sq, London NW3 3SU, England.
CR ANDERSON RU, 1979, JAMA-J AM MED ASSOC, V242, P451, DOI 10.1001/jama.242.5.451
   BOEVE ER, 1994, WORLD J UROL, V12, P43, DOI 10.1007/BF00182050
   BROCKLEHURST JC, 1978, BRIT J UROL, V50, P102, DOI 10.1111/j.1464-410X.1978.tb03035.x
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   Cox A J, 1987, Eng Med, V16, P37
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   EDWARDS LE, 1983, BRIT J UROL, V55, P53, DOI 10.1111/j.1464-410X.1983.tb07079.x
   EDYVANE KA, 1987, CLIN CHIM ACTA, V167, P329, DOI 10.1016/0009-8981(87)90353-6
   FINLAYSON B, 1973, INVEST UROL, V10, P429
   Gepi-Attee S, 1997, P I MECH ENG H, V211, P475, DOI 10.1243/0954411981534592
   GLEESON MJ, 1989, T AM SOC ART INT ORG, V35, P495
   GRIFFITH DP, 1976, INVEST UROL, V13, P351
   HALLSON PC, 1978, BRIT J UROL, V50, P442, DOI 10.1111/j.1464-410X.1978.tb06188.x
   HARTSTEIN AI, 1981, INFECT CONT HOSP EP, V2, P380, DOI 10.1017/S0195941700055533
   HEDELIN H, 1985, J UROLOGY, V133, P529, DOI 10.1016/S0022-5347(17)49047-1
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   HOUNSLOW M, 1992, 7 INT S UR AUSTR, P117
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   KITAMURA T, 1982, KIDNEY INT, V21, P379, DOI 10.1038/ki.1982.33
   KohlerOckmore J, 1996, BRIT J UROL, V77, P347, DOI 10.1046/j.1464-410X.1996.09074.x
   Kunin C M, 1987, Am J Med, V82, P405, DOI 10.1016/0002-9343(87)90438-4
   LANGLEY SEM, 1993, THESIS U LONDON ENGL
   LEAL JJ, 1977, INVEST UROL, V14, P278
   MONSON T, 1974, J UROLOGY, V111, P220, DOI 10.1016/S0022-5347(17)59932-2
   NACEY JN, 1985, BRIT J UROL, V57, P325, DOI 10.1111/j.1464-410X.1985.tb06354.x
   Neave H. R., 1978, STAT TABLES
   ROBERTSO.WG, 1973, CLIN CHIM ACTA, V43, P31, DOI 10.1016/0009-8981(73)90114-9
   SEABURY JC, 1968, J UROLOGY, V100, P90, DOI 10.1016/S0022-5347(17)62482-0
   SRINIVASAN V, 1972, J UROLOGY, V108, P473, DOI 10.1016/S0022-5347(17)60777-8
   TIDD MJ, 1976, BRIT J UROL, V48, P285, DOI 10.1111/j.1464-410X.1976.tb10224.x
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   WILKSCH J, 1983, BRIT J UROL, V55, P48, DOI 10.1111/j.1464-410X.1983.tb07078.x
NR 32
TC 39
Z9 39
U1 2
U2 10
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD SEP
PY 2000
VL 86
IS 4
BP 414
EP 421
DI 10.1046/j.1464-410X.2000.00861.x
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 355TC
UT WOS:000089401100002
PM 10971264
OA Bronze
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
AF Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
TI Effect of chloride ion on the anodic polarization behavior of the
   Zr65Al7.5Ni10Cu17.5 amorphous alloy in phosphate buffered solution
SO CORROSION SCIENCE
LA English
DT Article
DE biomaterial; zirconium-based amorphous alloy; polarization; X-ray
   photoelectron spectroscopy; chloride ion
ID AL-ZR ALLOYS; CORROSION BEHAVIOR; PITTING CORROSION; ZIRCONIUM; FILMS;
   IRON; XPS
AB The corrosion behavior of the Zr65Al7.5Ni10Cu17.5 amorphous alloy was investigated in a phosphate buffered saline solution and in phosphate-citric acid buffered solutions with various chloride-ion concentrations from 0 to 1.0 M, to examine the performance of the alloy as a biomaterial. The surface condition of the non-polarized and polarized alloy in the passive region was characterized using X-ray photoelectron spectroscopy. The susceptibility of this alloy to pitting corrosion was small at a small amount of chloride ion, but it increased with the chloride-ion concentration. Phosphate ion adsorbed on zirconium oxide in the surface raised the susceptibility to the pitting corrosion. On the other hand, phosphate ion is hardly adsorbed by aluminum oxide, so aluminum oxide in the surface diminished the susceptibility to the pitting corrosion. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Natl Res Inst Met, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Res Inst Met, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Andreeva V. V., 1961, J APPL CHEM-USSR, V11, P390
   ASAMI K, 1993, CORROS SCI, V34, P445, DOI 10.1016/0010-938X(93)90116-X
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P169
   Bhattarai J, 1997, CORROS SCI, V39, P355, DOI 10.1016/S0010-938X(97)83351-3
   BURLEIGH TD, 1987, CORROSION, V43, P471, DOI 10.5006/1.3583887
   ELMONEIM AA, 1997, P 44 ZAIR TO KANK, P373
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   KNITTEL DR, 1984, CORROSION, V40, P9, DOI 10.5006/1.3579296
   Li XY, 1997, CORROS SCI, V39, P1365, DOI 10.1016/S0010-938X(97)00035-8
   Masumoto K., 1984, AMORPHOUS ALLOY PROP, P284
   MCCORMICK LD, 1984, J ELECTROCHEM SOC, V131, P530, DOI 10.1149/1.2115621
   Pelavin M., 1970, Journal of Physical Chemistry, V74, P1116, DOI 10.1021/j100700a027
   POURBAIX N, 1974, ATLAS ELECTROCHEMICA
   TURN JC, 1983, CORROSION, V39, P271, DOI 10.5006/1.3581912
   Wagner C.D., 1990, PRACTICAL SURFACE AN, V1, P595
   WAGNER CD, 1979, HDB XRAY PHOT SPECTR
   YAU TL, 1995, CHEM ENG PROG, V1, P42
   YOSHIOKA H, 1992, CORROS SCI, V33, P425, DOI 10.1016/0010-938X(92)90071-A
   YOSHIOKA H, 1991, ELECTROCHIM ACTA, V36, P1227, DOI 10.1016/0013-4686(91)85113-L
   Zhang T, 1998, MATER T JIM, V39, P1230, DOI 10.2320/matertrans1989.39.1230
NR 22
TC 76
Z9 80
U1 2
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD SEP
PY 2000
VL 42
IS 9
BP 1651
EP 1660
DI 10.1016/S0010-938X(00)00022-6
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 335ZU
UT WOS:000088277800012
DA 2018-10-19
ER

PT J
AU Su, BY
   Henry, ZA
   Zhang, HB
   Onks, DO
AF Su, BY
   Henry, ZA
   Zhang, HB
   Onks, DO
TI Frequency response of non-linear single degree-of-freedom systems for
   biomaterials
SO JOURNAL OF AGRICULTURAL ENGINEERING RESEARCH
LA English
DT Article
AB Frequency response of viscoelastic biomaterials was modelled as a single-degree-of-freedom system with hysteretic damping. A laboratory-constructed mechanical vibration system was used to test the system with tobacco leaves. The experimental results for an excitation cam eccentricity of 0.15 mm matched the theoretical calculations with a value of the coefficient of determination of 0.997, indicating that a true representation of the spring constant and damping coefficient could be obtained from the test data. Increased tension force on the leaf during vibration increased the spring constant which coincided with an increased slope in the quasi-static force-deformation curve as force increased. The results indicate that this might be used as a rapid method for the evaluation of the elastic properties of the tobacco leaf. When the tobacco leaf is considered as a typical viscoelastic biomaterial, this approach also provides a potential method for the study of the elastic properties of other similar materials. (C) 2000 Silsoe Research Institute.
C1 Civil Aviat Inst China, Tianjin, Peoples R China.
   Univ Tennessee, Tennessee Agr Expt Stn, Knoxville, TN USA.
   Yunnan Polytech Univ, Kunming, Peoples R China.
   Univ Tennessee, Middle Tennessee Expt Stn, Spring Hill, TN USA.
RP Henry, ZA (reprint author), Civil Aviat Inst China, Tianjin, Peoples R China.
CR ARMSTRONG P, 1990, T ASAE, V33, P1353
   BILANSKI WK, 1997, P JOINT INT C AGR EN
   BOWER DR, 1976, T ASAE, V19, P185
   COOKE JR, 1973, J AGR ENG RES, V18, P141, DOI 10.1016/0021-8634(73)90023-1
   FINNEY E E JR, 1968, Transactions of the ASAE (American Society of Agricultural Engineers), V11, P94
   Finney E. E. Jr., 1970, Transactions. American Society of Agricultural Engineers, V13, P177
   FOUTZ TL, 1988, THESIS N CAROLINA ST
   HENRY ZA, 2000, J AGR ENG RES
   HUANG L, 1993, T ASAE, V36, P1423
   LILJEDAHL LA, 1994, T ASAE, V37, P904
   MISAJI K, 1995, JAPAN SOC MECH ENG C, V38, P697
   NASHIF A, 1985, VIBRATION DAMPING
   PELEG K, 1979, INT J MECH SCI, V21, P75, DOI 10.1016/0020-7403(79)90035-3
   YONG YC, 1979, T ASAE, V22, P1463
NR 14
TC 0
Z9 0
U1 0
U2 1
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0021-8634
J9 J AGR ENG RES
JI J. Agr. Eng. Res.
PD SEP
PY 2000
VL 77
IS 1
BP 45
EP 52
DI 10.1006/jaer.2000.0564
PG 8
WC Agricultural Engineering
SC Agriculture
GA 359GN
UT WOS:000089603300003
DA 2018-10-19
ER

PT J
AU Al-Saffar, N
   Revell, PA
AF Al-Saffar, N
   Revell, PA
TI Differential expression of transforming growth factor-alpha and
   macrophage colony-stimulating factor/colony-stimulating factor-1R
   (c-fms) by multinucleated giant cells involved in pathological bone
   resorption at the site of orthopaedic implants
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; MONOCYTES MACROPHAGES; FEMORAL OSTEOLYSIS;
   INTERFERON-GAMMA; FACTOR RECEPTORS; GM-CSF; INVITRO; ADHESION; CULTURE;
   REPLACEMENTS
AB The immunologic response to prosthetic biomaterial particles is characterized by macrophage-rich inflammatory infiltrate, formation of multinucleated giant cells, and aseptic loosening at the site of arthroplasty. We investigated the in vivo expression and tissue distribution of transforming growth factor alpha, macrophage colony-stimulating factor, and the receptor for colony-stimulating factor-1 at the site of bone erosion in patients with clinically failed orthopaedic implants (n = 30). The: expression was further compared with that detected in the inflamed synovial membranes from patients with rheumatoid arthritis or osteoarthritis (n = 15) and one patient with osteoclastoma (giant cell tumour of bone). Immunostaining of the tissue demonstrated positivity for transforming growth factor alpha within the inflammatory macrophage and multinucleated giant cell infiltrate in the diseased synovial membrane and the bone-implant interface. A comparative analysis between the synovium and retrieval interface membranes (pseudosynovium) revealed a high level of expression of transforming growth factor alpha, with intense membrane staining on multinucleated giant cells in all failed arthroplasties with pseudosynovium. In addition, the frequency, antigenic phenotype, and pattern of transforming growth factor alpha expression on multinucleated giant cells in the interface were markedly similar to those observed for multinucleated giant cells in osteoclastoma. Multinucleated giant cells within the interface lacked the expression of macrophage colony-stimulating factor and colony-stimulating factor-1 receptor, whereas those at the bone surfaces exhibited strong immunoreactivity. The predominant expression of transforming growth factor alpha by multinucleated giant cells in the bone-implant interface and its similarity to osteoclastoma highlight the importance of assessing transforming growth factor alpha as a possible contributor to the development of bone-resorbing giant cells at the site of failed orthopaedic implants.
C1 UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, London NW3 2PF, England.
   UCL Royal Free & Univ Coll Med Sch, Interdisciplinary Res Ctr Biomed Mat, London NW3 2PF, England.
RP Al-Saffar, N (reprint author), UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
EM alsaffar@rfc.ucl.ac.uk
CR AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   BROWN IW, 1985, J BONE JOINT SURG BR, V67, P218
   CHAMBERS TJ, 1985, J PATHOL, V145, P297, DOI 10.1002/path.1711450403
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   ELFORD PR, 1987, CALCIFIED TISSUE INT, V41, P151, DOI 10.1007/BF02563795
   ELLIOTT MJ, 1990, J IMMUNOL, V145, P167
   FAIS S, 1994, LAB INVEST, V71, P737
   FELIX R, 1990, ENDOCRINOLOGY, V127, P2592, DOI 10.1210/endo-127-5-2592
   GOETZ DD, 1994, J BONE JOINT SURG AM, V76A, P1121, DOI 10.2106/00004623-199408000-00002
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1988, J BONE MINER RES, V3, P117
   HASEGAWA T, 1993, J PATHOL, V170, P305, DOI 10.1002/path.1711700314
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x
   HOFSTETTER W, 1992, P NATL ACAD SCI USA, V89, P9637, DOI 10.1073/pnas.89.20.9637
   IBBOTSON KJ, 1985, SCIENCE, V228, P1007, DOI 10.1126/science.3859011
   IBBOTSON KJ, 1983, SCIENCE, V221, P1292, DOI 10.1126/science.6577602
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KADOYA Y, 1994, BONE MINER, V27, P85, DOI 10.1016/S0169-6009(08)80211-5
   Kadoya Y, 1996, J ORTHOPAED RES, V14, P473, DOI 10.1002/jor.1100140318
   KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269
   KOROVESSIS P, 1994, CLIN ORTHOP RELAT R, P155
   KREIPE H, 1988, AM J PATHOL, V130, P232
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684
   MASSAGUE J, 1983, J BIOL CHEM, V258, P3614
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807
   NESTOR JJ, 1985, BIOCHEM BIOPH RES CO, V129, P226, DOI 10.1016/0006-291X(85)91426-3
   REVELL PA, 1982, BONE JOINT DISEASE, P73
   SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759
   STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206
   STERN PH, 1985, J CLIN INVEST, V76, P2016, DOI 10.1172/JCI112202
   TAKAHASHI N, 1986, J CLIN INVEST, V78, P894, DOI 10.1172/JCI112677
   TOBLER A, 1992, BLOOD, V79, P45
   TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
NR 41
TC 24
Z9 25
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD SEP
PY 2000
VL 18
IS 5
BP 800
EP 807
DI 10.1002/jor.1100180518
PG 8
WC Orthopedics
SC Orthopedics
GA 378ZQ
UT WOS:000165616800017
PM 11117303
DA 2018-10-19
ER

PT J
AU John, G
   Morita, M
AF John, G
   Morita, M
TI Synthesis of polymer network scaffolds and microspheres based on
   poly(epsilon-caprolactone-co-glycolic acid-co-L-serine)
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Bionic Design Workshop
CY FEB 22-23, 1999
CL TOKYO, JAPAN
DE polydepsipeptide; epsilon-caprolactone; degradable network; hydrogel;
   microspheres
ID GELS; CELLS
AB Polydepsipeptide networks and cross-linked beads have been prepared by UV photopolymerization of acrylated poly(epsilon -caprolactone-co-glycolic acid-co-L-serine) [PCL (Glc-Ser)]. The acrylated PCL(Glc-Ser) cross-linked polymer networks obtained were glassy and transparent, and the gel content was approximately 85%. The network showed relatively low swelling in water but is easily swelled in chloroform and in dimethyl sulfoxide. The acrylate polymers on copolymerization with 2-hydroxyethyl methacrylate (HEMA) resulted in cross-linked networks [PCL(Glc-Ser)/HEMA], which were swelling in water and in DMSO showing the potential of the polymer in hydrogel applications. The modified PCL(Glc-Ser) beads prepared by UV initiated suspension polymerization and were characterized by optical microscopy. These degradable networks and beads may be useful as polymer scaffolds for biomaterial applications. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Hokkaido Natl Ind Res Inst, Biosci & Chem Div, Sapporo, Hokkaido 0628517, Japan.
   Japan Small Business Corp, Minato Ku, Tokyo 1058453, Japan.
RP John, G (reprint author), Hokkaido Natl Ind Res Inst, Biosci & Chem Div, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.
CR BELL CL, 1995, ADV POLYM SCI, V122, P128
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BRANNONPEPPAS L, 1994, ACS S SER, V573
   DAVE V, 1995, MACROMOLECULES, V28, P3531, DOI 10.1021/ma00114a006
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   HRKACH JS, 1996, ACS S SER, V627
   John G, 1997, J POLYM SCI POL CHEM, V35, P1901, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1901::AID-POLA4>3.0.CO;2-Q
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P70
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   YOSHIDA M, 1990, J BIOMED MATER RES, V24, P1173, DOI 10.1002/jbm.820240904
NR 15
TC 6
Z9 6
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2000
VL 13
IS 1-2
SI SI
BP 91
EP 95
DI 10.1016/S0928-4931(00)00181-8
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 367BA
UT WOS:000090040600014
DA 2018-10-19
ER

PT J
AU Hincke, MT
   Gautron, J
   Panheleux, M
   Garcia-Ruiz, J
   McKee, MD
   Nys, Y
AF Hincke, MT
   Gautron, J
   Panheleux, M
   Garcia-Ruiz, J
   McKee, MD
   Nys, Y
TI Identification and localization of lysozyme as a component of eggshell
   membranes and eggshell matrix
SO MATRIX BIOLOGY
LA English
DT Article
DE eggshell; lysozyme; calcite
ID EXTRACELLULAR-MATRIX; UTERINE FLUID; EGG-SHELL; PROTEIN; HEN;
   MICROSTRUCTURE; OVOCLEIDIN-17; SALT
AB The avian eggshell is a composite biomaterial composed of non-calcifying eggshell membranes and the overlying calcified shell matrix. The calcified shell forms in a uterine fluid where the concentration of different protein species varies between the initial, rapid calcification and terminal phases of eggshell deposition. The role of these avian eggshell matrix proteins during shell formation is poorly understood. The properties of the individual components must be determined in order to gain insight into their function during eggshell mineralization. In this study, we have identified lysozyme as a component of the uterine fluid by microsequencing, and used western blotting, immunofluorescence and colloidal-gold immunocytochemistry to document its localization in the eggshell membranes and the shell matrix. Furthermore, Northern blotting and RT-PCR indicates that there is a gradient to the expression of lysozyme message by different regions of the oviduct, with significant albeit low levels expressed in the isthmus and uterus. Lysozyme protein is abundant in the limiting membrane that circumscribes the egg white and forms the innermost layer of the shell membranes. It is also present in the shell membranes, and in the matrix of the calcified shell. Calcite crystals grown in the presence of purified hen lysozyme exhibited altered crystal morphology. Therefore, in addition to its well-known anti-microbial properties that could add to the protective function of the eggshell during embryonic development, shell matrix lysozyme may also be a structural protein which in soluble form influences calcium carbonate deposition during calcification. (C) 2000 Elsevier Science B.V./International Society of Matrix Biology. All rights reserved.
C1 Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   INRA, Rech Avicoles Stn, F-37380 Nouzilly, France.
   McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   Univ Granada, CSIC, Granada 18002, Spain.
   McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
RP Hincke, MT (reprint author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.
EM mhincke@uottawa.ca
RI Gautron, Joel/A-1753-2017
OI Gautron, Joel/0000-0001-7800-0578; Garcia-Ruiz, Juan
   Manuel/0000-0002-4743-8718
CR ARIAS JL, 1992, ARCH BIOCHEM BIOPHYS, V298, P293, DOI 10.1016/0003-9861(92)90126-H
   ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162
   ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3
   ARIAS JL, 2000, IN PRESS P WORLDS PO
   BAKER J. R., 1962, BIOCHEM JOUR, V82, P352
   BELLAIRS R, 1969, Z ZELLFORSCH MIK ANA, V96, P237, DOI 10.1007/BF00338771
   Burley RW, 1989, AVIAN EGG CHEM BIOL
   CANFIELD RE, 1963, J BIOL CHEM, V238, P2698
   Dennis JE, 1996, J MORPHOL, V228, P287, DOI 10.1002/(SICI)1097-4687(199606)228:3<287::AID-JMOR2>3.0.CO;2-#
   DOMINGUEZVERA JM, 2000, IN PRESS POULTRY SCI, V79
   Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8
   Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220
   GAUTRON J, 2000, IN PRESS MINERALIZED
   GREENWALD R A, 1976, Seminars in Arthritis and Rheumatism, V6, P35, DOI 10.1016/S0049-0172(76)80004-2
   GREENWALD RA, 1975, BIOCHIM BIOPHYS ACTA, V385, P435, DOI 10.1016/0304-4165(75)90375-X
   GUENTHER HL, 1974, BIOCHIM BIOPHYS ACTA, V372, P321, DOI 10.1016/0304-4165(74)90194-9
   HAMES BD, 1981, GEL ELECT PROTEINS P
   HAMILTON RMG, 1986, FOOD MICROSTRUCT, V5, P99
   HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593
   Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915
   Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814
   HINCKE MT, 1992, BRIT POULTRY SCI, V33, P505, DOI NO_DOI
   JOLLES J, 1963, BIOCHIM BIOPHYS ACTA, V78, P668, DOI 10.1016/0006-3002(63)91033-3
   JUNG A, 1980, P NATL ACAD SCI-BIOL, V77, P5759, DOI 10.1073/pnas.77.10.5759
   KALIN O, 2000, IN PRESS POULTRY SCI
   KUETTNER KE, 1975, CLIN ORTHOP RELAT R, P316
   Mann K, 1999, BIOCHEM MOL BIOL INT, V47, P997
   Mann K, 1999, FEBS LETT, V463, P12, DOI 10.1016/S0014-5793(99)01586-0
   MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105
   Moss JM, 1997, ARCH BIOCHEM BIOPHYS, V339, P172, DOI 10.1006/abbi.1996.9828
   Moss JM, 1997, ARCH BIOCHEM BIOPHYS, V348, P49, DOI 10.1006/abbi.1997.0365
   NYS Y, 1987, BRIT POULTRY SCI, V28, P57, DOI 10.1080/00071668708416936
   Nys Y, 1999, POULT AVIAN BIOL REV, V10, P143
   NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236
   PARSONS AH, 1982, POULTRY SCI, V61, P2013, DOI 10.3382/ps.0612013
   PICARD J, 1973, BIOCHIM BIOPHYS ACTA, V320, P427, DOI 10.1016/0304-4165(73)90324-3
   Pines M, 1995, MATRIX BIOL, V14, P765, DOI 10.1016/S0945-053X(05)80019-8
   Sambrook J., 1989, MOL CLONING LAB MANU
   SHARP RM, 1984, BIOPHYS J, V46, P175, DOI 10.1016/S0006-3495(84)84010-2
   SIMONS PCM, 1963, Z ZELLFORSCH MIK ANA, V59, P555, DOI 10.1007/BF00368728
   TAN CK, 1992, HISTOL HISTOPATHOL, V7, P339
   TERMINE JD, 1970, ARCH BIOCHEM BIOPHYS, V140, P307, DOI 10.1016/0003-9861(70)90071-8
   Thomas BR, 1998, ACTA CRYSTALLOGR D, V54, P226, DOI 10.1107/S0907444997010676
   VADEHRA DV, 1972, COMP BIOCHEM PHYSIOL, V43, P503, DOI 10.1016/0305-0491(72)90133-2
   VANDAMME MPI, 1994, ARCH BIOCHEM BIOPHYS, V310, P16, DOI 10.1006/abbi.1994.1134
   VIRDI A S, 1991, Biochemical Society Transactions, V19, p374S
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
NR 47
TC 144
Z9 152
U1 0
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD SEP
PY 2000
VL 19
IS 5
BP 443
EP 453
DI 10.1016/S0945-053X(00)00095-0
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 357ZP
UT WOS:000089533000007
PM 10980420
DA 2018-10-19
ER

PT J
AU Loza, HC
   Rincon, MLE
   Fernandez, JR
AF Loza, HC
   Rincon, MLE
   Fernandez, JR
TI Comparative study of the wear resistance of Al2O3-coated MA956
   superalloy
SO REVISTA DE METALURGIA
LA English
DT Article
DE wear; MA956; alumina coating; UHMWPE
ID CORROSION BEHAVIOR; MA-956 SUPERALLOY; JOINT PROSTHESES; HIP;
   POLYETHYLENE; DEBRIS
AB Preoxidation of the MA956 superalloy, proposed as a prosthetic biomaterial, generates a compact and inert a-alumina surface layer. The aim of this study is to assess the Near resistance provided by this alumina layer on the MA956 alloy in comparison with the same coated alloy ansi Versus high density Polyethylene. Comparative wear tests were carried out in both dry and wet conditions using the couples MA956/MA956, MA956/UHMWPE (ultra high molecular weight polyethylene) and 316LVM/UHMWPE. The results corresponding to the couples MA956/MA956, with and without alumina layer, show that the load has more significant effect than the rotation speed on the weight loss and on the roughness. On the other hand the alumina surface layer provides a clear wear protection. The weight losses of the MA956 specimen in this couple are ten times lower when testing under wet conditions than under dry conditions. The MA956/UHMWPE couple behaves much better than the 316LVM/UHMWPE, as it presents the lowest values of friction coefficient and weight losses of the MA956 specimen. These are only delectable after 70,000 cycles under a 70 MPa contact pressure. This couple offers the best guarantee of a prolonged service life for articulated parts in a prosthesis.
C1 CSIC, CENIM, E-28040 Madrid, Spain.
RP Loza, HC (reprint author), CSIC, CENIM, Avda Gregorio del Amo 8, E-28040 Madrid, Spain.
CR AMSTUTZ HC, 1996, CLIN ORTHOP S, V329, P11, DOI DOI 10.1097/00003086-199608001-00003
   Bosdorf K, 1995, BIOMED TECH, V40, P356, DOI 10.1515/bmte.1995.40.12.356
   Boynton EL, 1995, CAN J SURG, V38, P507
   DOORN PF, 1996, CLIN ORTHOP S, V329, P206
   Doorn PF, 1996, CLIN ORTHOP S, V329, P187
   DORRE E, 1978, BIOMED TECH, V23, P305, DOI 10.1515/bmte.1978.23.12.305
   ESCUDERO ML, 1995, BIOMATERIALS, V16, P735, DOI 10.1016/0142-9612(95)99703-O
   Escudero ML, 1996, J BIOMED MATER RES, V31, P313
   ESCUDERO ML, 1994, BIOMATERIALS, V15, P1175, DOI 10.1016/0142-9612(94)90239-9
   Gardes P, 1996, REV CHIR ORTHOP, V82, P306
   Pizzoferrato A, 1994, Chir Organi Mov, V79, P245
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   Ruiz J, 1999, J BIOMED MATER RES, V46, P179, DOI 10.1002/(SICI)1097-4636(199908)46:2<179::AID-JBM6>3.0.CO;2-S
   SCHEY JA, 1996, CLIN ORTHOP S, V329, P115
   SEMLITSCH M, 1995, ARCH ORTHOP TRAUM SU, V114, P61, DOI 10.1007/BF00422826
   TUSZYNSKI R, 1995, FRICTION WEAR TESTIN, P459
   WROBLEWSKI BM, 1979, J BONE JOINT SURG BR, V61, P498
   Zichner L, 1997, ORTHOPADE, V26, P129
NR 18
TC 0
Z9 0
U1 0
U2 1
PU CENIM
PI MADRID
PA AVDA. GREGORIO DEL AMO, 8, 28040 MADRID, SPAIN
SN 0034-8570
J9 REV METAL MADRID
JI Rev. Metal.
PD SEP-OCT
PY 2000
VL 36
IS 5
BP 331
EP 338
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 386EY
UT WOS:000166048800002
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Denstedt, JD
   Reid, G
   Sofer, M
AF Denstedt, JD
   Reid, G
   Sofer, M
TI Advances in ureteral stent technology
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA BIOFILMS; CONDITIONING FILM DEPOSITION;
   URINARY-TRACT INFECTION; IN-VIVO; MICROBIAL BIOFILMS;
   SURFACE-PROPERTIES; ADHESION; CATHETERS; BIOCOMPATIBILITY; ENCRUSTATION
AB This review focuses on technological advances and relevant research related to ureteral stents. The importance of physical and chemical biomaterial type, biocompatibility, material coatings such as hydrogels, and infection related to indwelling ureteral stents are discussed. Recent in vitro and in vivo research has focused on materials that will reduce encrustation and bacterial biofilm formation. The adsorption of antimicrobials onto devices holds promise of reducing infection rates, but multidrug resistant bacteria, short leaching times and adverse side effects make it essential that alternative strategies be investigated. Just so, encrustation limits the long-term use of urinary materials, and a better understanding of factors involved in encrustation are needed to reduce the problem.
C1 Univ Western Ontario, St Josephs Hlth Care London, Div Urol, London, ON N6A 4V2, Canada.
   Univ Western Ontario, Lawson Res Inst, London, ON, Canada.
   Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.
RP Denstedt, JD (reprint author), Univ Western Ontario, St Josephs Hlth Care London, Div Urol, 268 Grosvenor St, London, ON N6A 4V2, Canada.
CR Ahmed M, 1999, J ENDOUROL, V13, P221, DOI 10.1089/end.1999.13.221
   Bitschay J., 1956, HIST UROLOGY EGYPT, P76
   BLENKINSOPP SA, 1992, APPL ENVIRON MICROB, V58, P3770
   Brewer AV, 1999, J ENDOUROL, V13, P269, DOI 10.1089/end.1999.13.269
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Candela JV, 1997, J ENDOUROL, V11, P45, DOI 10.1089/end.1997.11.45
   Characklis W., 1990, BIOFILMS, P3
   Choong Simon, 1997, Journal of Endourology, V11, pS50
   Compan V, 1996, BIOMATERIALS, V17, P1243, DOI 10.1016/0142-9612(96)84945-3
   CORMIO L, 1995, J UROLOGY, V153, P494, DOI 10.1097/00005392-199502000-00069
   CULKIN DJ, 1992, UROLOGY, V40, P385, DOI 10.1016/0090-4295(92)90397-F
   FERRIE BG, 1986, BRIT J UROL, V58, P549, DOI 10.1111/j.1464-410X.1986.tb05465.x
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   GIBBONS RP, 1982, UROL CLIN N AM, V9, P85
   GILCHRIST T, 1991, BIOMATERIALS, V12, P76, DOI 10.1016/0142-9612(91)90136-X
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GRAHAM DT, 1984, J BIOMED MATER RES, V18, P1125, DOI 10.1002/jbm.820180914
   Greer L, 1998, INT J NON-EQUILIB PR, V11, P1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HEPPERLEN TW, 1978, J UROLOGY, V119, P731, DOI 10.1016/S0022-5347(17)57613-2
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   KORHONEN P, 1991, UROL RES, V19, P127, DOI 10.1007/BF00368190
   Kulik E, 1996, J BIOMED MATER RES, V30, P295, DOI 10.1002/(SICI)1097-4636(199603)30:3<295::AID-JBM4>3.0.CO;2-L
   Kulkarni RP, 1999, BJU INT, V83, P755
   Leveillee RJ, 1998, J UROLOGY, V160, P1877, DOI 10.1016/S0022-5347(01)62436-4
   Lumiaho J, 1999, J ENDOUROL, V13, P107, DOI 10.1089/end.1999.13.107
   MACALUSO JN, 1989, J UROLOGY, V142, P701, DOI 10.1016/S0022-5347(17)38858-4
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   Minhas S, 1999, BJU INT, V84, P762
   Morris CE, 1997, APPL ENVIRON MICROB, V63, P1570
   NACEY JN, 1986, J UROLOGY, V136, P706, DOI 10.1016/S0022-5347(17)45032-4
   NICKEL JC, 1986, UROLOGY, V28, P512, DOI 10.1016/0090-4295(86)90155-X
   Nissenkorn I, 2000, J UROLOGY, V163, P528, DOI 10.1016/S0022-5347(05)67917-7
   Pandian SS, 1998, BRIT J UROL, V82, P791
   Pariente JL, 1999, BIOMATERIALS, V20, P523, DOI 10.1016/S0142-9612(98)00198-7
   Pauer W, 1999, J UROLOGY, V162, P319, DOI 10.1016/S0022-5347(05)68549-7
   PHAN CN, 1993, BRIT J UROL, V72, P17, DOI 10.1111/j.1464-410X.1993.tb06448.x
   PRATTTERPSTRA IH, 1989, J COLLOID INTERF SCI, V129, P568, DOI 10.1016/0021-9797(89)90471-2
   Printzen G, 1996, INJURY, V27, P9
   Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1992, INT BIODETER BIODEGR, V30, P105, DOI 10.1016/0964-8305(92)90057-U
   REID G, 1995, SURF SCI REP, V21, P251, DOI 10.1016/0167-5729(94)00006-9
   REID G, 1994, INT BIODETER BIODEGR, V34, P73, DOI 10.1016/0964-8305(95)00011-9
   REID G, 1994, SURF INTERFACE ANAL, V21, P581, DOI 10.1002/sia.740210812
   REID G, 1995, COLLOID SURFACE B, V5, P171, DOI 10.1016/0927-7765(95)01208-Z
   Reid G, 1996, FEMS IMMUNOL MED MIC, V16, P159
   Reid G, 1998, URINARY TRACT INFECT, P111
   REID G, 2000, IN PRESS J INT ANTIM
   REID G, 1999, HDB BACTERIAL ADHESI, P345
   Reid KA, 1995, ENVIRON CHEM, V1, P269
   SALTZMAN B, 1988, UROL CLIN N AM, V15, P481
   Schlick RW, 1998, J ENDOUROL, V12, P451, DOI 10.1089/end.1998.12.451
   Sidhu H, 1999, J CLIN MICROBIOL, V37, P1503
   SIEMSSEN PA, 1991, BRIT J UROL, V67, P83, DOI 10.1111/j.1464-410X.1991.tb15075.x
   SOBOH F, 1995, ANTIMICROB AGENTS CH, V39, P1281, DOI 10.1128/AAC.39.6.1281
   Sterioff S, 1997, MAYO CLIN PROC, V72, P377, DOI 10.4065/72.4.377
   Tieszer C, 1998, J UROLOGY, V160, P876, DOI 10.1016/S0022-5347(01)62825-8
   Tieszer C, 1998, J BIOMED MATER RES, V43, P321, DOI 10.1002/(SICI)1097-4636(199823)43:3<321::AID-JBM14>3.0.CO;2-I
   UYEN HMW, 1989, BIOMATER ARTIF CELL, V17, P385, DOI 10.3109/10731198909118853
   Velraeds MC, 1998, J MED MICROBIOL, V49, P790
   Velraeds MMC, 1996, COLLOID SURFACE B, V8, P51, DOI 10.1016/S0927-7765(96)01297-0
   Velraeds MMC, 1996, APPL ENVIRON MICROB, V62, P1958
   Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101
   YAMAGUCHI O, 1992, UROLOGY, V40, P326, DOI 10.1016/0090-4295(92)90381-6
   ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6
NR 70
TC 44
Z9 46
U1 0
U2 8
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD SEP
PY 2000
VL 18
IS 4
BP 237
EP 242
DI 10.1007/PL00007074
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 361PJ
UT WOS:000089731200002
PM 11000305
DA 2018-10-19
ER

PT J
AU Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
AF Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
TI Injection molding of a starch/EVOH blend aimed as an alternative
   biomaterial for temporary applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE starch; biodegradable; biomaterial; injection molding; SCORIM; design of
   experiments
ID SHEAR CONTROLLED ORIENTATION; PHYSICAL PROPERTY RELATIONSHIPS; MOLDED
   ISOTACTIC POLYPROPYLENE; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   DEGRADATION; INVITRO
AB Biodegradable polymers show great potential to be used as materials for temporary implants and bone replacement applications in orthopedics. However, its use in high load-bearing applications will depend on the successful development of biodegradable implants with a mechanical performance matching that of human bone. This article describes the optimization of the injection molding process of an alternative biodegradable starch-based polymer aimed at biomedical applications. A blend of starch with a copolymer of ethylene-vinyl alcohol (SEVA-C) was studied. Both conventional injection molding and shear controlled orientation (SCORIM) were optimized with the support of design of experiments and analysis of variance techniques. The mechanical characterization was performed by tensile testing. The structure developed within the moldings was assessed by wide-angle X-ray diffraction and differential scanning calorimetry. Increases up to 30% in the tangent modulus and 20% in the ultimate tensile strength compared with conventional molding were achieved with the application of SCORIM. The holding pressure and the frequency of the shear applied have the strongest influence on the morphology development and consequently on the mechanical performance. The solidification of SEVA-C at high cavity pressures enhances stiffness for long durations of the shearing stage in SCORIM. However, the effect of viscous heating of SEVA-C is important and ought to be considered. A decrease of the material phase miscibility in SEVA-C occurs as result of the shear fields imposed. The microstructure evaluation suggests that the mechanical properties enhancement in SCORIM molded SEVA-C is attributable to preferred orientation developed during processing. (C) 2000 John Wiley & Sons, Inc.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
RP Kalay, G (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Sousa,
   Rui/0000-0003-0362-7418; Cunha M., Antonio/0000-0003-3860-7732
CR Allan P. S., 1990, COMPOSITES MANUFACTU, V1, P79
   ALLAN PS, 1987, PLAST RUB PROC APPL, V7, P3
   ALLAN PS, Patent No. 2170140
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Bonfield W., 1996, BIOCERAMICS, V9, P11
   HASTINGS G, 1991, COMPOSITES MAT BIOME, P23
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Isaac D. H., 1994, Clinical Materials, V15, P79, DOI 10.1016/0267-6605(94)90073-6
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P241, DOI 10.1002/(SICI)1099-0488(19970130)35:2<241::AID-POLB5>3.0.CO;2-V
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P265
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P415, DOI 10.1002/(SICI)1099-0488(199702)35:3<415::AID-POLB2>3.0.CO;2-R
   Kalay G, 1996, POLYMER, V37, P2077, DOI 10.1016/0032-3861(96)85852-6
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Montgomery D. C., 1991, DESIGN ANAL EXPT
   OGBONNA CI, 1995, J APPL POLYM SCI, V58, P2131, DOI 10.1002/app.1995.070581126
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1998, ANTEC 98 PLASTICS MY
   REIS RL, 1997, ADV POLYM TECHNOL, V4, P276
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   ROSS JP, 1998, TAGUCHI TECHNIQUES Q
   SCHMIDT SR, 1994, UNDERSTANDING IND DE
   SIMMONS S, 1995, J APPL POLYM SCI, V58, P2259, DOI 10.1002/app.1995.070581215
   SOLTESZ U, 1988, ANN NY ACAD SCI, P137
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   Williams D., 1990, CONCISE ENCY MED DEN
   1991, Patent No. 2025
NR 33
TC 35
Z9 35
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 2000
VL 77
IS 6
BP 1303
EP 1315
DI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
PG 13
WC Polymer Science
SC Polymer Science
GA 320BF
UT WOS:000087380600015
DA 2018-10-19
ER

PT J
AU Ayyala, RS
   Michelini-Norris, B
   Flores, A
   Haller, E
   Margo, CE
AF Ayyala, RS
   Michelini-Norris, B
   Flores, A
   Haller, E
   Margo, CE
TI Comparison of different biomaterials for glaucoma drainage devices -
   Part 2
SO ARCHIVES OF OPHTHALMOLOGY
LA English
DT Article
ID IMPLANT
AB Background: Inflammation associated with biomaterials may contribute to the failure of glaucoma drainage devices.
   Objective: To compare the inflammatory reaction associated with the insertion of Krupin silicone, Molteno polypropylene, and Acrosof end plates in the subconjunctival space of rabbits.
   Methods: Similar-sized glaucoma end plates made of 3 different biomaterials were sutured to the sclera in the superotemporal quadrant of the rabbit eye. Thirty eyes of 15 albino New Zealand rabbits were randomly assigned to the 3 groups. Conjunctival vascular hyperemia was graded in a masked fashion among the 3 groups. At the end of 3 weeks, the enucleated eyes were examined histologically and by scanning electron microscopy.
   Results: Molteno polypropylene was associated with more inflammation both in clinical observations and based on histological grading. Silicone and Acrosof were associated with less intense inflammation. One polypropylene end plate was extruded on day 21.
   Conclusions: Polypropylene appears to be more inflammatory than silicone. Flexible biomaterials appear to be less inflammatory than rigid ones.
   Clinical Relevance: Bleb failure following glaucoma drainage device implantation could be related to the biomaterial-associated inflammation. Choosing a biomaterial with the least inflammatory potential might enhance the success rate of the glaucoma drainage device.
C1 Tulane Univ, Sch Med, Dept Ophthalmol, Med Ctr, New Orleans, LA 70112 USA.
   Med Ctr Louisiana, Dept Ophthalmol, New Orleans, LA USA.
   Univ S Florida, Dept Ophthalmol, Tampa, FL USA.
   Univ S Florida, Dept Pathol, Tampa, FL USA.
   Watson Clin, Dept Ophthalmol, Lakeland, FL USA.
RP Ayyala, RS (reprint author), Tulane Univ, Sch Med, Dept Ophthalmol, Med Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.
OI Haller, Edward/0000-0002-8535-2181
CR Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1
   Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233
   BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Molteno A, 1988, GLAUCOMA, P192
   SIEGNER SW, 1995, OPHTHALMOLOGY, V102, P1298, DOI 10.1016/S0161-6420(95)30871-8
NR 6
TC 72
Z9 75
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0003-9950
J9 ARCH OPHTHALMOL-CHIC
JI Arch. Ophthalmol.
PD AUG
PY 2000
VL 118
IS 8
BP 1081
EP 1084
DI 10.1001/archopht.118.8.1081
PG 4
WC Ophthalmology
SC Ophthalmology
GA 343KZ
UT WOS:000088702700009
PM 10922202
OA Bronze
DA 2018-10-19
ER

PT J
AU Anselme, K
   Linez, P
   Bigerelle, M
   Le Maguer, D
   Le Maguer, A
   Hardouin, P
   Hildebrand, HF
   Iost, A
   Leroy, JM
AF Anselme, K
   Linez, P
   Bigerelle, M
   Le Maguer, D
   Le Maguer, A
   Hardouin, P
   Hildebrand, HF
   Iost, A
   Leroy, JM
TI The relative influence of the topography and chemistry of TiAl6V4
   surfaces on osteoblastic cell behaviour
SO BIOMATERIALS
LA English
DT Article
DE surface chemistry; surface topography; titanium alloy; cell
   proliferation; cell adhesion; osteoblast
ID TITANIUM SURFACE; IN-VITRO; BIOMATERIAL SURFACES; IMPLANT SURFACES; LINE
   MC3T3-E1; BONE; FIBROBLASTS; ALLOY; CYTOCOMPATIBILITY; STERILIZATION
AB Proliferation and adhesion of mouse (MC3T3-E1) osteoblastic cells and primary human osteoblastic cells were carried out on Ti6Al4V titanium alloy samples with varied surface roughnesses. Mechanically or manually polished surfaces were prepared to produce respectively non-oriented or oriented residual polishing grooves. Sand-blasted surfaces were prepared using 500 mu m or 3 mm alumina particles. Surface roughness parameters showed a negative correlation in comparison to proliferation and adhesion parameters. X-ray microprobe chemical surface microanalysis showed complete disturbance of the surface element composition of the Ti6Al4V alloy following sand-blasting treatment. An AlOx-enriched layer was observed on sample surfaces. This may lead to the suspicion that the concomittant effect of surface roughness amplitude and AlOx surface concentration has an effect on osteoblastic cell proliferation and adhesion. These findings show the significance of chemical surface analysis after any surface treatment of titanium-based implants before any biological use. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Inst Calot, IRMS, F-62608 Berck Sur Mer, France.
   Fac Med Lille, GRB, F-59045 Lille, France.
   ENSAM, F-59046 Lille, France.
   ENSCL, F-59652 Villeneuve Dascq, France.
RP Anselme, K (reprint author), Inst Calot, IRMS, Rue Dr Calot, F-62608 Berck Sur Mer, France.
RI IOST, alain/D-8909-2011
OI IOST, alain/0000-0003-2185-4673; Maxence, Bigerelle/0000-0002-4144-245X;
   Anselme, Karine/0000-0002-6669-205X
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   ANSELME K, 1994, CELL MATER, V4, P113
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ASK M, 1988, APPL SURF SCI, V35, P283
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   BRUNETTE DM, 1991, BONE-BIOMATERIAL INTERFACE, P170
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MAURER AM, 1994, J BIOMED MATER RES, V28, P241, DOI 10.1002/jbm.820280215
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   RAE T, 1986, BIOMATERIALS, V7, P30, DOI 10.1016/0142-9612(86)90085-2
   Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Swart K M, 1992, J Oral Implantol, V18, P130
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wang JY, 1997, CLIN ORTHOP RELAT R, P216
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   YAO JL, 1995, J BONE MINER RES, V10, P1417
NR 37
TC 284
Z9 294
U1 5
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2000
VL 21
IS 15
BP 1567
EP 1577
DI 10.1016/S0142-9612(00)00042-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323KJ
UT WOS:000087564300006
PM 10885729
DA 2018-10-19
ER

PT J
AU Joschek, S
   Nies, B
   Krotz, R
   Gopferich, A
AF Joschek, S
   Nies, B
   Krotz, R
   Gopferich, A
TI Chemical and physicochemical characterization of porous hydroxyapatite
   ceramics made of natural bone
SO BIOMATERIALS
LA English
DT Article
DE ceramic; hydroxyapatite; bone; characterization; composition
ID PHOSPHATE CERAMICS; BEHAVIOR; SUBSTITUTE; IMPLANTS; RAMAN; PH
AB The properties of a porous hydroxyapatite ceramic produced by sintering of bovine bone were investigated by using a number of physicochemical methods such as scanning electron microscopy (SEM), SEM in combination with energy dispersive X-ray spectroscopy (SEM-EDX), mercury intrusion porosimetry, krypton-adsorption, contact angle measurements, wide angle X-ray diffraction, Fourier transform infrared spectroscopy, thermal analysis, inductively coupled plasma optical atom emissions spectroscopy and flame atomic absorption spectroscopy. The results indicate that there are considerable differences between the ceramic and native bone. However, the most important properties with respect to the use of such ceramics as a biomaterial for filling bone defects namely the high porosity (greater than or equal to 57 +/- 2%) and the interconnecting pore system are maintained. While macropores with an average diameter of approx. 300 mu m contribute 97% to porosity, micropores with an average diameter of 1.3 mu m account for only 3% of the total porosity. The surface area was found to be approx. 0.1 m(2)/g. The contact angles of water (44.6 +/- 15.4 degrees, n = 5) and tetrahydro-furane (10 degrees) allow the processing of the ceramic to a drug carrier by incubation with aqueous or organic drug solutions. The ceramic is highly crystalline with crystal sizes of 1-7 mu m and contains crystal bridges. The investigation of its chemical composition revealed small amounts of other inorganic compounds such as Ca4O(PO4)(2), NaCaPO4, Ca-3(PO4)(2), CaO, and MgO. Besides trace amounts of aluminum, iron, magnesium, potassium, silica, sodium, vanadium and zinc it contains probably carbonated apatite. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
   Merck, Biomat R&D, D-64271 Darmstadt, Germany.
   Hardtwald Apotheke, D-69207 Sandhausen, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RI Goepferich, Achim/G-1151-2016
OI Goepferich, Achim/0000-0002-7646-0252
CR AOKI H, 1991, SCI MED APPL HYDROXY, P1
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Bauer HJ, 1994, OSTEOPOROSIS INT, V2, P106
   BOSKEY AL, 1984, ORTHOP CLIN N AM, V15, P597
   *CDC, 1988, MMWR-MORBID MORTAL W, V37, P597
   DENISSEN HW, 1980, DENTAL IMPLANTS, P35
   DINGELDEIN E, 1994, OSTEOSYNTHESE INT, V2, P112
   DRIESSENS FCM, 1988, ADV BIOMATER, V8, P105
   DRIESSENS FMC, 1982, MINERAL ASPECTS DENT, P154
   FRAME JW, 1980, J ORAL SURG, V38, P176
   FRIEDENBERG ZB, 1963, SURG GYNECOL OBSTET, V116, P588
   Gerngross H, 1982, Aktuelle Traumatol, V12, P146
   HEISE U, 1990, INT ORTHOP, V14, P329
   HING KA, 1995, BIOCERAMICS, V8, P75
   HOFMANN GO, 1992, ALLOGENE KNOCHENTRAN, P131
   Hulbert S., 1971, BIOMATERIALS, P3
   JACKSON SA, 1978, CALC TISS RES, V25, P217, DOI 10.1007/BF02010772
   JARCHO M, 1978, J DENT RES, V57, P917, DOI 10.1177/00220345780570091801
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   JEROSCH J, 1990, UNFALLCHIRURG, V93, P334
   KATSUMASA T, 1982, ANN SURG, V196, P100
   KAYA N, 1988, KONA, V6, P86
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O, P4
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   MEYER RJ, 1961, GMELINS HDB ANORGANI, V8, P857
   MEYER RJ, 1957, GMELINS HDB ANORGANI, V8, P192
   MISRA DN, 1978, CALC TISS RES, V26, P139, DOI 10.1007/BF02013248
   MITTELMEIER H, 1987, HEFTE UNFALLHEILKD, V179, P227
   MONTAZEM A, 1993, OPERATIVE BEHANDLUNG, P120
   NEUMAN WF, 1953, CHEM REV, V53, P1, DOI 10.1021/cr60164a001
   Nunes CR, 1997, J BIOMED MATER RES, V36, P560
   NYQUIST RA, 1997, SPECTRUM-J STATE GOV, V61, P373
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   OSBORN JF, 1985, IMPLANTATWERKSTOFF H, P17
   OSBORN JF, 1987, ZAHNARZTL MITT, P2
   PIETSCH EHE, 1939, GMELINS HDB ANORGANI, V59, P303
   PIETSCH EHE, 1957, GMELINS HDB ANORGANI, V8, P302
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   RAHN BA, 1986, BIOL BIOMECHANICAL P, P21
   REY C, 1990, Biomaterials, V11, P13
   REY C, 1991, BIOCERAMICS, V4, P57
   RICHTER A, 1953, B SOC CHIM FR, V5, P148
   Roesgen M, 1991, Unfallchirurgie, V17, P44, DOI 10.1007/BF02588176
   RUCKER G, 1988, INSTRUMENTELLE PHARM, P109
   SAALFELD U, 1994, BIOMATERIALS, V15, P905, DOI 10.1016/0142-9612(94)90115-5
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SELLIER T, 1986, OSTEOPLASTIKEN ARTIF, P46
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   TUDOR AM, 1993, SPECTROCHIM ACTA A, V49, P675, DOI 10.1016/0584-8539(93)80089-S
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384
   Winslow D.N., 1984, SURF COLLOID SCI, P259
   WOLFF R, 1986, OSTEOPLASTIKEN ARTIF, P23
   WOOD NV, 1947, SCIENCE, V105, P531, DOI 10.1126/science.105.2733.531
   YAMASHITA K, 1989, INORGANIC PHOSPHATE, P24
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 59
TC 242
Z9 252
U1 5
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2000
VL 21
IS 16
BP 1645
EP 1658
DI 10.1016/S0142-9612(00)00036-3
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 327VB
UT WOS:000087813700003
PM 10905406
DA 2018-10-19
ER

PT J
AU Oleschuk, RD
   McComb, ME
   Chow, A
   Ens, W
   Standing, KG
   Perreault, H
   Marois, Y
   King, M
AF Oleschuk, RD
   McComb, ME
   Chow, A
   Ens, W
   Standing, KG
   Perreault, H
   Marois, Y
   King, M
TI Characterization of plasma proteins adsorbed onto biomaterials by
   MALDI-TOFMS
SO BIOMATERIALS
LA English
DT Article
DE MALDI; TOFMS; plasma protein; biomaterial; biocompatible
ID LASER-DESORPTION IONIZATION; MASS-SPECTROMETRY; SAMPLE SUPPORT;
   POLYURETHANE MEMBRANE; ADSORPTION; SURFACES; RESONANCE; BLOOD; PEPTIDES;
   POLYMER
AB The analysis of plasma proteins adsorbed onto a polyurethane (PU) biomaterial was performed using matrix-assisted laser desorption/ionization time-of-fight mass spectrometry (MALDI-TOFMS). This article marks the first study on MALDI-TOFMS analysis of multiple proteins adsorbed from plasma, in vitro, onto the surface of a biomaterial to easily enable their characterization. Plasma standards from three different hosts were placed in contact with non-porous PU, a model biomaterial. Following the use of washing protocols developed in our laboratory, the biomaterial was analyzed, directly, with MALDI-TOFMS. Proteins with molecular weights (M-r) ranging from ca. 6.5 to 150 kDa were observed in the mass spectra and characterized upon comparison with proteins of known M-r. The proteins observed were tentatively identified as those known to adsorb onto PU, both in vitro and in vivo. In an attempt to model in vivo sorption, the PU biomaterial was exposed to freshly collected canine plasma, in vitro, for different lengths of lime. Corresponding MALDI-TOFMS spectra displayed increasing protein signal for a number of different proteins with increasing times of exposure to plasma. This method provided qualitative and semi-quantitative analysis of the proteins adsorbed onto the biomaterial surface. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.
   Univ Manitoba, Dept Phys, Winnipeg, MB R3T 2N2, Canada.
   Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.
   Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.
   Boston Univ, Sch Med, Dept Biophys, Boston, MA 02118 USA.
   Univ Manitoba, Dept Phys, Winnipeg, MB R3T 2N2, Canada.
   Inst Biomat, Quebec City, PQ G1L 3L5, Canada.
RP Perreault, H (reprint author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.
RI Standing, Kenneth/E-2416-2011
OI /0000-0002-4249-485X
CR ANDERSON SC, 1993, CLIN CHEM CONCEPTS A
   ANDRADE JD, 1985, SURFACE INTERFACIAL
   BAIRE RE, 1978, ARTIF ORGANS, V2, P422
   BELLISSIMO JA, 1984, T AM SOC ART INT ORG, V30, P359
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   BRAYBROOK JH, 1997, BIOMATERIALS ENG SER
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   CHAURAND M, 1999, ANAL CHEM, V71, P5263
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   DONG DE, 1983, POLYM PREP-ACS, V24, P40
   GOODMAN SL, 1989, T SOC BIOMATERIALS, V15, P201
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Holland NB, 1998, NATURE, V392, P799
   JANATOVA J, 1977, 23 ANN M SOC BIOM US
   JESPERSEN S, 1995, J MASS SPECTROM, V30, P357, DOI 10.1002/jms.1190300219
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEONARD EF, 1991, J BIOMAT SCI-POLYM E, V3, P95, DOI 10.1163/156856292X00105
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   McComb ME, 1997, RAPID COMMUN MASS SP, V11, P1716, DOI 10.1002/(SICI)1097-0231(19971015)11:15<1716::AID-RCM59>3.3.CO;2-Q
   McComb ME, 1998, ANAL CHEM, V70, P5142, DOI 10.1021/ac9805753
   MCCOMB ME, UNPUB J AM SOC MASS
   MCCOMB ME, 1998, P 46 ASMS C, P175
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NELSON RW, 1994, ANAL CHEM, V66, P1408, DOI 10.1021/ac00081a008
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   OLESCHUK RD, 1998, SEPARATION ISOLATION
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   PUTNAM FW, 1984, PLASMA PROTEINS, V4, pCH1
   RATNER BD, 1988, POLYM MED, V3, P87
   SCHLEUDER D, 1999, ANAL CHEM, V71, P3228
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   STREENIVASAN K, 1992, J APPL POLYM SCI, V45, P2105
   STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008
   TAKAHARA A, 1993, J BIOMAT SCI-POLYM E, V5, P183
   TANG X, 1988, INT J MASS SPECTROM, V85, P43, DOI 10.1016/0168-1176(88)83004-0
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   Walker AK, 1999, ANAL CHEM, V71, P268, DOI 10.1021/ac980750f
   Walker AK, 2000, J AM SOC MASS SPECTR, V11, P62, DOI 10.1016/S1044-0305(99)00117-8
   Worrall TA, 1998, ANAL CHEM, V70, P750, DOI 10.1021/ac970969e
   XIANG F, 1994, RAPID COMMUN MASS SP, V8, P199, DOI 10.1002/rcm.1290080215
   YOUNG BR, 1988, J COLLOID INTERF SCI, V28, P124
NR 46
TC 50
Z9 50
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2000
VL 21
IS 16
BP 1701
EP 1710
DI 10.1016/S0142-9612(00)00054-5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 327VB
UT WOS:000087813700008
PM 10905411
DA 2018-10-19
ER

PT J
AU Zhang, S
   Wright, G
   Yang, Y
AF Zhang, S
   Wright, G
   Yang, Y
TI Materials and techniques for electrochemical biosensor design and
   construction
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE biomaterial; biosensor; immobilisation; biological recognition;
   copolymers; biocompatibility
ID PROTEIN SURFACE INTERACTIONS; CARBON-PASTE ELECTRODE; AMPEROMETRIC
   BIOSENSORS; GLUCOSE BIOSENSORS; DNA BIOSENSORS; IN-VIVO;
   ELECTROPOLYMERIZED FILMS; MINIATURIZED BIOSENSORS; CATALYTIC ELECTRODE;
   POLYETHYLENE OXIDE
AB New developments in biosensor design are appearing at a high rate as these devices play increasingly important roles in daily life. This review aims to highlight recent developments in materials and techniques for electrochemical biosensor design and construction. Rapid growth in biomaterials, especially the availability and application of a vast range of polymers and copolymers associated with new sensing techniques have led to remarkable innovation in the design and construction of biosensors, significant improvements in sensor function and the emergence of new types of biosensor. Nevertheless, in vivo applications remain limited by functional deterioration due to surface fouling by biological components. However, new copolymers based upon biomembrane mimicry have been extensively investigated during the last two decades, raising hopes that the problems related to interactions between foreign surfaces and biological fluids and tissues may soon be solved. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Univ Keele, Ctr Sci & Technol Med, WE Dunn Unit, Keele ST5 5BG, Staffs, England.
RP Zhang, S (reprint author), Univ Keele, Ctr Sci & Technol Med, WE Dunn Unit, Keele ST5 5BG, Staffs, England.
CR ALBERY WJ, 1984, J CHEM SOC CHEM COMM, P234, DOI 10.1039/c39840000234
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   Anzai J, 1995, DENKI KAGAKU, V63, P1141
   Atanasov P, 1996, ELECTROANAL, V8, P158
   BARTLETT PN, 1993, J ELECTROANAL CHEM, V362, P1
   BERGVELD P, 1972, IEEE T BIO-MED ENG, VBM19, P342, DOI 10.1109/TBME.1972.324137
   CARDOSI MF, 1991, ADV BIOSENSORS
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   Cespedes F, 1996, FOOD TECHNOL BIOTECH, V34, P143
   CHEN CY, 1993, ELECTROANAL, V5, P269, DOI 10.1002/elan.1140050402
   Chen Q, 1998, ELECTROANAL, V10, P94, DOI 10.1002/(SICI)1521-4109(199802)10:2<94::AID-ELAN94>3.0.CO;2-A
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Coon DR, 1997, ANAL CHEM, V69, P4120, DOI 10.1021/ac970171v
   Cosnier S, 1997, ELECTROANAL, V9, P1387, DOI 10.1002/elan.1140091803
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P225
   DONALD LE, 1996, ANNU REV MATER SCI, V26, P365
   ElRhazi M, 1997, QUIM ANAL, V16, P49
   FISCHER U, 1995, ACTA ANAESTH SCAND, V39, P21, DOI 10.1111/j.1399-6576.1995.tb04252.x
   FRASER D, 1997, BIOSENSORS BODY CONT, P10
   GOPEL W, 1991, SENSORS COMP SURVEY, V2
   Healey BG, 1997, ANAL BIOCHEM, V251, P270, DOI 10.1006/abio.1997.2254
   Hianik T, 1997, CHEM ANAL-WARSAW, V42, P901
   Hianik T, 1998, BIOELECTROCH BIOENER, V47, P47, DOI 10.1016/S0302-4598(98)00162-7
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   JAEGFELDT H, 1981, ANAL CHEM, V53, P1979, DOI 10.1021/ac00236a007
   Jaffari SA, 1996, BIOSENS BIOELECTRON, V11, P1167, DOI 10.1016/0956-5663(96)82339-6
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Khan GF, 1996, SENSOR ACTUAT B-CHEM, V36, P484, DOI 10.1016/S0925-4005(97)80117-7
   Khan GF, 1996, J ELECTROCHEM SOC, V143, P3336, DOI 10.1149/1.1837208
   Khan GF, 1996, BIOSENS BIOELECTRON, V11, P1221
   KOBAYASHI M, 1984, SYNTHETIC MET, V9, P77, DOI 10.1016/0379-6779(84)90044-4
   KOHRAUSCH F, 1985, WIED ANN, V26, P161
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   Kranz C, 1998, ELECTROANAL, V10, P546, DOI 10.1002/(SICI)1521-4109(199807)10:8<546::AID-ELAN546>3.0.CO;2-#
   Kriz CB, 1996, ANAL CHEM, V68, P1966, DOI 10.1021/ac951227t
   Kroger S, 1997, ANAL CHIM ACTA, V347, P9, DOI 10.1016/S0003-2670(96)00634-4
   LENZ RW, 1988, J POLYM SCI POL CHEM, V26, P3241, DOI 10.1002/pola.1988.080261211
   Linek V., 1985, COMPREHENSIVE BIOTEC, V4, P363
   LOFAS S, 1995, PURE APPL CHEM, V67, P829, DOI 10.1351/pac199567050829
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lorenzo E, 1998, BIOSENS BIOELECTRON, V13, P319, DOI 10.1016/S0956-5663(97)00138-3
   Lotzbeyer T, 1996, SENSOR ACTUAT B-CHEM, V33, P50, DOI 10.1016/0925-4005(96)01834-5
   Madaras MB, 1996, ANAL CHEM, V68, P3832, DOI 10.1021/ac960239r
   Marrazza G, 1999, ANAL CHIM ACTA, V387, P297, DOI 10.1016/S0003-2670(99)00051-3
   MILLAN KM, 1994, ANAL CHEM, V66, P2943, DOI 10.1021/ac00090a023
   MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0
   Muguruma H, 1999, TRAC-TREND ANAL CHEM, V18, P62, DOI 10.1016/S0165-9936(98)00098-3
   MULCHANDANI A, 1995, CRIT REV BIOTECHNOL, V15, P105, DOI 10.3109/07388559509147402
   Muller C, 1997, SENSOR ACTUAT B-CHEM, V40, P71, DOI 10.1016/S0925-4005(97)00016-6
   NAARMANN H, 1987, SYNTHETIC MET, V22, P1, DOI 10.1016/0379-6779(87)90564-9
   Nikolelis DP, 1999, ELECTROANAL, V11, P7, DOI 10.1002/(SICI)1521-4109(199901)11:1<7::AID-ELAN7>3.0.CO;2-F
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   Nussbaum P, 1997, PURE APPL OPT, V6, P617, DOI 10.1088/0963-9659/6/6/004
   Padeste C, 1996, J ELECTROCHEM SOC, V143, P3890, DOI 10.1149/1.1837312
   Palecek E, 1998, BIOSENS BIOELECTRON, V13, P621, DOI 10.1016/S0956-5663(98)00017-7
   Ramsden JJ, 1997, J MOL RECOGNIT, V10, P109, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<109::AID-JMR361>3.0.CO;2-D
   RATCLIFFE NM, 1990, ANAL CHIM ACTA, V239, P257, DOI 10.1016/S0003-2670(00)83859-3
   Shirakawa H., 1982, Japanese Journal of Applied Physics, Supplement, P473
   SHOICHET MS, 1994, BIOTECHNOL BIOENG, V43, P563, DOI 10.1002/bit.260430705
   Silber A, 1996, BIOSENS BIOELECTRON, V11, P215, DOI 10.1016/0956-5663(96)88408-9
   Silber A, 1996, SENSOR ACTUAT B-CHEM, V30, P127, DOI 10.1016/0925-4005(95)01759-3
   Sirkar K, 1998, ANAL CHEM, V70, P2888, DOI 10.1021/ac971236x
   Skladal P, 1997, CHEM LISTY, V91, P105
   Slomkowski S, 1996, ACS SYM SER, V627, P172
   SMITH LC, 1993, MED SCI SYMP SER, V2, P89
   Sorochinskii VV, 1996, BIOSENS BIOELECTRON, V11, P45, DOI 10.1016/0956-5663(96)83712-2
   Steinschaden A, 1997, SENSOR ACTUAT B-CHEM, V44, P365, DOI 10.1016/S0925-4005(97)00227-X
   Sugimura H, 1997, JPN J APPL PHYS 2, V36, pL968, DOI 10.1143/JJAP.36.L968
   Thorp HH, 1998, TRENDS BIOTECHNOL, V16, P117, DOI 10.1016/S0167-7799(97)01162-1
   Trojanowicz M, 1995, MIKROCHIM ACTA, V121, P167, DOI 10.1007/BF01248249
   TURNER AFP, 1997, ANN CHIM, V87, P244
   Tvarozek V, 1998, VACUUM, V50, P251, DOI 10.1016/S0042-207X(98)00050-5
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UMEZAWA Y, 1980, MICR 3 S IONS EL MAT, P344
   UPDIKE SJ, 1967, NATURE, V214, P986, DOI 10.1038/214986a0
   VADGAMA P, 1986, ANALYST, V111, P803, DOI 10.1039/an9861100803
   VADGAMA P, 1992, ANALYST, V117, P1657, DOI 10.1039/an9921701657
   Van Regenmortel MHV, 1998, J MOL RECOGNIT, V11, P163
   Vidal JC, 1999, ANALYST, V124, P319, DOI 10.1039/a805533e
   Vreeke MS, 1996, ELECTROANAL, V8, P55, DOI 10.1002/elan.1140080112
   Wang J, 1998, BIOSENS BIOELECTRON, V13, P757, DOI 10.1016/S0956-5663(98)00039-6
   Wang J, 1997, ANAL CHIM ACTA, V347, P1, DOI 10.1016/S0003-2670(96)00598-3
   Wang J, 1996, J AM CHEM SOC, V118, P7667, DOI 10.1021/ja9608050
   WEBER SG, 1989, ANAL CHEM, V61, P295, DOI 10.1021/ac00179a004
   Wink T, 1997, ANALYST, V122, pR43, DOI 10.1039/a606964i
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   Yamato H, 1997, SYNTHETIC MET, V87, P231, DOI 10.1016/S0379-6779(97)80114-2
   Zhai JH, 1997, BIOTECHNOL ADV, V15, P43, DOI 10.1016/S0734-9750(97)00003-7
   Zhang S, 1996, MED BIOL ENG COMPUT, V34, P313, DOI 10.1007/BF02511245
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
   Zhang SF, 1996, BIOSENS BIOELECTRON, V11, P1019, DOI 10.1016/0956-5663(96)87661-5
   ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0
   ZWAAL RFA, 1978, BIOCHIM BIOPHYS ACTA, V515, P163, DOI 10.1016/0304-4157(78)90003-5
NR 95
TC 168
Z9 173
U1 2
U2 80
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD AUG
PY 2000
VL 15
IS 5-6
BP 273
EP 282
DI 10.1016/S0956-5663(00)00076-2
PG 10
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 357QK
UT WOS:000089512200007
PM 11219739
DA 2018-10-19
ER

PT J
AU Kohles, SS
   Vernino, AR
   Clagett, JA
   Yang, JC
   Severson, S
   Holt, RA
AF Kohles, SS
   Vernino, AR
   Clagett, JA
   Yang, JC
   Severson, S
   Holt, RA
TI A morphometric evaluation of allograft matrix combinations in the
   treatment of osseous defects in a baboon model
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
DE morphology; bone grafts; collagen; osseous defects; baboons
ID FREEZE-DRIED BONE; ATTACHMENT APPARATUS FORMATION; HISTOLOGIC
   EVALUATION; CLINICAL-EVALUATION; RIDGE AUGMENTATION; REGENERATION;
   COLLAGEN; HYDROXYLAPATITE; HUMANS; GRAFT
AB Recent and ongoing research efforts have been made to increase the efficacy of biomaterials as structural fillers during in vivo bony reconstructions. Although the selection of the possible material choices has grown, a biomaterial that can be physically molded to the defect/void space as well as offer biomimetic tissue regeneration has yet to be made available. With the potential success of demineralized freeze-dried bone allografts (DFDBA) combined with tendonous collagen as an effective filling material, further research should help to elucidate its use. The purpose of this study was to evaluate the regenerative healing response of five allograft mixtures via the morphology of filled, periodontal defects. Critical size mandibular and maxillary osseous defects were surgically created in six adult baboons. The filling response of four combinations of DFDBA and tendon collagen was compared with an all-collagen graft after 3 months of implantation. The overall results indicate that all combinations of DFDBA and collagen provided a better fill response than the all-collagen matrix (P < 0.05). Statistically, however, all of the combinations were similar (P > 0.05) with a 60:40 collagen to DFDBA mass ratio resulting in the largest defect fill response.
C1 Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
   Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.
   Univ Oklahoma, Dept Periodont, Oklahoma City, OK USA.
RP Vernino, AR (reprint author), Worcester Polytech Inst, Dept Biomed Engn, 100 Inst Rd, Worcester, MA 01609 USA.
OI Kohles, Sean/0000-0002-5869-7715
CR BAKER RD, 1979, J ORAL SURG, V37, P486
   BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   BLUMENTHAL NM, 1993, J PERIODONTOL, V64, P925, DOI 10.1902/jop.1993.64.10.925
   BLUMENTHAL NM, 1993, FOR CLIN INN AM AC P
   BLUMENTHAL NM, 1994, DENT J, V63, P35
   BOWEN JA, 1989, J PERIODONTOL, V60, P647, DOI 10.1902/jop.1989.60.12.647
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   BOWERS GM, 1989, J PERIODONTOL, V60, P675, DOI 10.1902/jop.1989.60.12.675
   BOWERS GM, 1989, J PERIODONTOL, V60, P683, DOI 10.1902/jop.1989.60.12.683
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Davis W H, 1975, J Maxillofac Surg, V3, P103, DOI 10.1016/S0301-0503(75)80026-9
   DRURY GI, 1991, J PERIODONTOL, V62, P652, DOI 10.1902/jop.1991.62.11.652
   Frank H., 1994, STAT CONCEPTS APPL
   GONGLOFF RK, 1985, J ORAL MAXIL SURG, V43, P570, DOI 10.1016/0278-2391(85)90122-3
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   KENT JN, 1979, J ORAL SURG, V37, P637
   Kohles SS, 2000, J BIOMED MATER RES, V49, P479, DOI 10.1002/(SICI)1097-4636(20000315)49:4<479::AID-JBM6>3.0.CO;2-6
   MELLONIG JT, 1976, J PERIODONTOL, V47, P125, DOI 10.1902/jop.1976.47.3.125
   MELLONIG JT, 1984, INT J PERIODONT REST, V4, P41
   MERCIER P, 1992, J ORAL MAXIL SURG, V50, P210, DOI 10.1016/0278-2391(92)90314-P
   OBRIEN TP, 1994, J PERIODONTOL, V65, P17, DOI 10.1902/jop.1994.65.1.17
   QUINTERO G, 1982, J PERIODONTOL, V53, P726, DOI 10.1902/jop.1982.53.12.726
   TIDSTROM KD, 1990, J ORAL MAXIL SURG, V48, P336, DOI 10.1016/0278-2391(90)90427-4
   VERNINO AR, 1995, INT J PERIODONT REST, V15, P85
   WANG JH, 1975, J ORAL SURG, V33, P596
NR 26
TC 8
Z9 9
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD AUG
PY 2000
VL 67
IS 2
BP 156
EP 162
DI 10.1007/s00223001127
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 337XA
UT WOS:000088387400011
PM 10920221
DA 2018-10-19
ER

PT J
AU Bundy, K
   Schlegel, U
   Rahn, B
   Geret, V
   Perren, S
AF Bundy, K
   Schlegel, U
   Rahn, B
   Geret, V
   Perren, S
TI An improved peel test method for measurement of adhesion to biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID STRENGTH
AB Adhesion of tissues to biomaterials is desirable to prevent bacterial proliferation and for epithelial/transmucosal sealing of transcutaneous appliances, but can be counter-productive elsewhere, e.g. implants contacting tendons or maxillofacial subcutaneous tissue. It is therefore important to gauge adhesion strength of tissues to bio materials before clinical use. Peel-testing is widely used for industrial product adhesion monitoring, but has rarely been applied biomedically. Here we describe peel-testing instrumentation designed for testing adherence of soft tissues to biomaterials. It offers the advantage that a 90 degrees angle between peel and substrate is maintained, simplifying determination of applied normal forces separating tissue layers from material surfaces. The device is portable and can be brought directly to the specimen removal site. This minimizes time delays between explantation and testing, maintaining the tissue/biomaterial interface in the freshest possible state closely approximating in vivo conditions, and so avoids measurement artifacts. So far, the instrument has been used to test adhesion of tape to a biomaterial surface (for determining the device's technical performance), assess strength of tissue adhesives, and measure adhesion of subcutaneous tissue to orthopaedic biomaterials. However, its versatility suggests additional applications for the peel-tester where adhesion of soft tissue to biomaterials is of interest. (C) 2000 Kluwer Academic Publishers.
C1 Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
   AO Res Inst, CH-7270 Davos, Switzerland.
RP Bundy, K (reprint author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
CR [Anonymous], 1990, 85101 ISO
   *ASTM, C90695 ASTM
   *ASTM, D187695 ASTM
   *ASTM, D316793 ASTM
   *ASTM, D90393 ASTM
   *ASTM, D380793 ASTM
   *ASTM, D333096 ASTM
   *ASTM, D178191 ASTM
   *ASTM, D291893 ASTM
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BUNDY K, 1991, 28 ANN TECHN M SOC E, P175
   BUNDY K, 1991, T 17 ANNN M SOC BIOM, P229
   BUNDY K, 1993, T 39 ANN ORS M, P513
   BUNDY K, 1992, T 4 WORLD BIOM C APR, P348
   BUNDY K, 1991, BIOFOULING, V4, P246
   *ISO, 1993, 1139 ISO
   *ISO, 1997, 4578 ISO
   *ISO, 1990, 85102 ISO
   *ISO, 1997, 813 ISO
   Kurzweg H, 1998, J MATER SCI-MATER M, V9, P9, DOI 10.1023/A:1008822309486
   SIERRA DH, 1992, J APPL BIOMATER, V3, P147, DOI 10.1002/jab.770030210
   TORIUMI ADM, 1992, PLASTIC RECONSTRUCTI, V89, P973
NR 22
TC 20
Z9 23
U1 2
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2000
VL 11
IS 8
BP 517
EP 521
DI 10.1023/A:1008965926086
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 341FQ
UT WOS:000088580700008
PM 15348003
DA 2018-10-19
ER

PT J
AU Mi, FL
   Sung, HW
   Shyu, SS
AF Mi, FL
   Sung, HW
   Shyu, SS
TI Synthesis and characterization of a novel chitosan-based network
   prepared using naturally occurring crosslinker
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE genipin; chitosan; naturally occurring crosslinker; swelling
ID IN-VITRO EVALUATION; BIOLOGICAL TISSUE FIXATION; CROSS-LINKING REAGENT;
   RELEASE CHARACTERISTICS; CONTROLLED DELIVERY; GEL BEADS; MICROSPHERES;
   GLUTARALDEHYDE; CYTOTOXICITY; BIOMATERIAL
AB Novel chitosan-based polymeric networks were synthesized and characterized by FTIR, UV and C-13 NMR. A naturally occurring crosslinking reagent-genipin, which has been used in herbal medicine and in the fabrication of food dyes, was used to prepare crosslinked chitosan hydrogel. The hetercreyclic compound of genipin crosslinked chitosan was formed by a nucleophilic attack by amino group on the olefinic carbon atom at C-3 of deoxyloganin aglycone, followed by opening of the dihydropyran ring and attack by the secondary amine group on the intermediate aldehyde group. Additional, secondary amide linkages could be established in the genipin crosslinked chitosan network by the reaction of ester group of genipin with amino group of chitosan. This bifunctional Linkages of genipin with amino group of chitosan leads to form crosslinked networks. Genipin reacted with nucleophilic reagent such as ckitosan could further go through a polymerization to form oligomer-bridge in the crosslinked network. The finally formed chitosan networks are blue color, elastic and exhibits pH-dependent swelling characteristics. The swelling ratio of the chitosan hydrogel increased at pH lower than 3 and higher than 11 due to the hydrolysis of amide Linkage in the genipin crosslinked chitosan network by acid or alkaline, followed by the protonation of amine group or ionization of carboxyl acid group in the network. (C) Wiley John Wiley & Sons, Inc.
C1 Natl Cent Univ, Dept Chem Engn, Div Polymer, Chungli 320, Taiwan.
   Chinese Naval Acad, Dept Math Phys & Chem, Div Chem, Kaohsiung 813, Taiwan.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
RP Shyu, SS (reprint author), Natl Cent Univ, Dept Chem Engn, Div Polymer, Chungli 320, Taiwan.
CR AKAO T, 1994, BIOL PHARM BULL, V17, P1573
   Akbuga J, 1996, J MICROENCAPSUL, V13, P161, DOI 10.3109/02652049609052904
   Andrady AL, 1997, J POLYM SCI POL PHYS, V35, P517, DOI 10.1002/(SICI)1099-0488(199702)35:3<517::AID-POLB10>3.0.CO;2-K
   Angelis A.A.D., 1998, MACROMOLECULES, V31, P1595
   Chanda J, 1996, BIOMATERIALS, V17, P1087, DOI 10.1016/0142-9612(96)85909-6
   FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2
   HASSAN EE, 1992, PHARMACEUT RES, V9, P390, DOI 10.1023/A:1015803321609
   JAMEELA SR, 1994, J BIOMAT SCI-POLYM E, V6, P621, DOI 10.1163/156856294X00563
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   Kurita K, 1998, MACROMOLECULES, V31, P4764, DOI 10.1021/ma980272a
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 1999, J APPL POLYM SCI, V74, P1868, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
   Mi FL, 1999, J POLYM SCI POL PHYS, V37, P1551, DOI 10.1002/(SICI)1099-0488(19990715)37:14<1551::AID-POLB1>3.3.CO;2-8
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   NISHIOKA Y, 1990, CHEM PHARM BULL, V38, P2871, DOI 10.1248/cpb.38.2871
   OHYA Y, 1992, J BIOACT COMPAT POL, V7, P242, DOI 10.1177/088391159200700302
   OHYA Y, 1994, J MACROMOL SCI PURE, VA31, P629, DOI 10.1080/10601329408545334
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   SUNG HW, 1999, BIOMATER SCI POLYM E, V10, P63
   THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M
   TOIMA T, 1998, J POLYM SCI A, V36, P1965
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   WEI YC, 1992, J POLYM SCI POL CHEM, V30, P2187, DOI 10.1002/pola.1992.080301013
NR 26
TC 172
Z9 174
U1 1
U2 97
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD AUG 1
PY 2000
VL 38
IS 15
BP 2804
EP 2814
DI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y
PG 11
WC Polymer Science
SC Polymer Science
GA 334TT
UT WOS:000088202300021
DA 2018-10-19
ER

PT J
AU Lee, MH
AF Lee, MH
TI Biocompatibility of a modified metallic surface of pure Ti and Ti-6Al-4V
   alloy with the connective tissue of mouse
SO METALS AND MATERIALS-KOREA
LA English
DT Article
DE alkali treatment; biocompatibility; mouse abdominal connective tissue;
   thickness of fibrous capsule; macrophages
ID SOFT-TISSUE; TITANIUM; BIOMATERIALS; BEHAVIOR
AB The surface of implantable biomaterials is in direct contact with the host tissue and plays a critical role in determining biocompatibility. In order to improve the integration of implants, some attempts have been made to coat the surface of the biomaterial with calcium phosphate. In this investigation pure Ti, Ti-6Al-4V alloy and alkali treated specimens were used as implanted materials in the abdominal wall of mice. The implants were kept there for 3 months and then their biocompatibility was evaluated by optical microscope. Surface structural changes of specimens due to the alkali treatment and soaking in Hank's solution were analyzed by XRD, SEM and XPS. Alkali treated specimens formed a dense and uniform bone-like apatite layer on the specimen surface when they were soaked in Hank's solution. The average thickness of the fibrous capsule formed around the implant was much thinner for the alkali-treated specimens than the others. The number of macrophages was much less for the alkali-treated specimens than the others. The results of this evaluation indicate that alkali treated pure Ti and the Ti-6Al-4V alloy have better biocompatibility compared to the other metals tested.
C1 Kwang Yang Coll, Dept Met Engn, Kwangyang 545800, South Korea.
RP Lee, MH (reprint author), Kwang Yang Coll, Dept Met Engn, 223-1 Duckrye Ri, Kwangyang 545800, South Korea.
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   BAIER RE, 1975, ADV CHEM, V145, P1
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Kim HM, 1998, J JPN I MET, V62, P1102, DOI 10.2320/jinstmet1952.62.11_1102
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   Mery Carlos C., 1996, Biological Research, V29, P361
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SCHREIBER H, 1990, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V23, P23
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TURNER RFB, 1991, BIOMATERIALS, V12, P361, DOI 10.1016/0142-9612(91)90003-S
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   WOLFAARDT JF, 1992, J PROSTHET DENT, V68, P331, DOI 10.1016/0022-3913(92)90340-G
   ZHANG X, 1994, J JAPAN SOC POWDER P, V4, P664
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 18
TC 4
Z9 4
U1 0
U2 3
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1225-9438
J9 MET MATER-KOREA
JI Met. Mater.-Korea
PD AUG
PY 2000
VL 6
IS 4
BP 373
EP 379
DI 10.1007/BF03028085
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 350EA
UT WOS:000089086700013
DA 2018-10-19
ER

PT J
AU Pavcnik, D
   Uchida, BT
   Timmermans, H
   Corless, CL
   Keller, FS
   Rosch, J
AF Pavcnik, D
   Uchida, BT
   Timmermans, H
   Corless, CL
   Keller, FS
   Rosch, J
TI Aortic and venous valve for percutaneous insertion
SO MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
LA English
DT Article
DE aortic valve; venous valve; stents and prostheses; interventional
   procedures; experimental; biomaterial
ID STENT FILTER; PLACEMENT; PROGRESS; WORK
AB The purpose of this paper is to present in vitro and in vivo experimental evaluation of a new, artificial, bicuspid, aortic and venous valve. Valves were constructed from square stents with barbs covered by porcine small intestine submucosa (SIS). A valve 15 mm in diameter was tested in a flow model (2.5 l/min) with pressure measurement. A 100-ml rubber bag attached to a side arm of the flow model simulated heart ejection fraction. In acute (n=6) and short-term (n=3) experiments conducted in four swine and four dogs, valves ranging from 16 - 28mm in diameter were placed into the ascending aorta through 10 F sheaths; three were placed subcoronary and six in a supracoronary position. Function and stability of the valves were studied with pressure measurements and aortograms. Three short term animals were sacrificed for gross and histologic evaluation at one, two and four weeks respectively. In an acute experiment, venous valves with four barbs were placed into the IVC through an 8 F guiding catheter in three dogs. For longer-term testing, valves were placed into the IVCs and iliac veins of three young swine. The animals were followed up after two weeks with venograms, then were sacrificed for gross and histologic evaluation.
C1 Oregon Hlth Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA.
RP Pavcnik, D (reprint author), Oregon Hlth Sci Univ, Dotter Intervent Inst, L342,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
CR ANDERSEN HR, 1992, EUR HEART J, V13, P704, DOI 10.1093/oxfordjournals.eurheartj.a060238
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Kato N, 1997, J VASC INTERV RADIOL, V8, P27, DOI 10.1016/S1051-0443(97)70509-8
   Moazami N, 1996, ASAIO J, V42, pM381, DOI 10.1097/00002480-199609000-00016
   MOULOPOULOS SD, 1980, J THORAC CARDIOV SUR, V80, P38
   Pavcnik D, 1999, CARDIOVASC INTER RAD, V22, P239, DOI 10.1007/s002709900374
   PAVCNIK D, 1992, RADIOLOGY, V183, P151, DOI 10.1148/radiology.183.1.1549662
   PAVCNIK D, 1993, CARDIOVASC INTER RAD, V16, P308, DOI 10.1007/BF02629163
   PAVCNIK D, 1991, RADIOLOGY P, V181, P126
   PAVCNIK D, IN PRESS J VASC INTE
   Ricco J B, 1988, Ann Vasc Surg, V2, P242, DOI 10.1016/S0890-5096(07)60009-0
   SOCHMAN J, IN PRESS CARDIOVASC
   Sochman Jan, 1995, Cor et Vasa, V37, P327
   TEITELBAUM GP, 1988, INVEST RADIOL, V23, P527, DOI 10.1097/00004424-198807000-00009
   UFLACKER R, 1993, 1993 ANN M W ANG INT, P30
   WALLACE MJ, 1986, AM J ROENTGENOL, V147, P1247, DOI 10.2214/ajr.147.6.1247
NR 16
TC 7
Z9 7
U1 0
U2 2
PU ISIS MEDICAL MEDIA LTD
PI OXFORD
PA 59 ST ALDATES, OXFORD OX1 1ST, ENGLAND
SN 1364-5706
J9 MINIM INVASIV THER
JI Minim. Invasive Ther. Allied Technol.
PD AUG
PY 2000
VL 9
IS 3-4
BP 287
EP 292
PG 6
WC Surgery
SC Surgery
GA 354GY
UT WOS:000089322400016
PM 20156026
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Self-assembling peptides arise as possible biomaterial for generating
   nerve cells
SO MRS BULLETIN
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD AUG
PY 2000
VL 25
IS 8
BP 7
EP 8
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 346GH
UT WOS:000088862100013
DA 2018-10-19
ER

PT J
AU Vogelin, E
   Jones, NF
   Huang, JI
   Brekke, JH
   Toth, JM
AF Vogelin, E
   Jones, NF
   Huang, JI
   Brekke, JH
   Toth, JM
TI Practical illustrations in tissue engineering: Surgical considerations
   relevant to the implantation of osteoinductive devices
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 1999 Portland Bone Symposium
CY AUG 04-07, 1999
CL PORTLAND, OREGON
ID BONE MORPHOGENETIC PROTEIN-2; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA;
   EXPERIMENTAL SPINAL-FUSION; RHBMP-2; BMP-2
AB This paper provides practical illustrations in the use of osteoinductive devices (biomaterial carriers coupled with osteoinductive morphogens) for bone tissue engineering. We discuss the considerations relative to the implantation of these devices that may induce tissues that are located outside the boundaries of the osteoinductive device as well as outside boundaries of the normal skeletal envelope. Five reports of osteoinductive devices generating such tissues are reviewed. Histologic and radiographic data from a sixth example are presented and compared with histologic and radiographic findings typical of two varieties of myositis ossificans, A theory is advanced that osteoinductive implants may induce ectopic tissues that resemble fibro-osseous pathologies. Finally characteristics of tissue-engineered bone graft substitutes that may contribute to development of these pathologies and device characteristics that may obviate these ectopic tissues are considered.
C1 Univ Bern, Inselspital, Abt Handchirurg, CH-3010 Bern, Switzerland.
   Univ Calif Los Angeles, Sch Med, Dept Orthopaed Surg, Los Angeles, CA USA.
   Med Coll Wisconsin, Dept Orthopaed Surg, Milwaukee, WI 53226 USA.
   THM Biomed Inc, Duluth, MN 55802 USA.
RP Brekke, JH (reprint author), THM Biomed Inc, Waterfront Plaza,Suite 608,325 Lake Ave S, Duluth, MN 55802 USA.
CR ASPENBERG P, 1996, ACTA ORTHOP SCAND, V687, P3
   Boden SD, 1996, ENDOCRINOLOGY, V137, P3401, DOI 10.1210/en.137.8.3401
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BREKKE JH, 1998, BIOCERAMICS, V11, P57
   Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230
   Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605
   Gannon FH, 1998, CLIN ORTHOP RELAT R, P19
   GANON FH, 1997, HUM PATHOL, V28, P339
   GOLDMAN AB, 1981, DIAGNOSIS BONE JOINT, V3, P2512
   Harris M O, 1995, CHEM ECOLOGY INSECTS, V2, P3
   HOLLINGER JO, 1998, TISSUE ENG APPL MAXI, P17
   Honda Y, 1997, CALCIFIED TISSUE INT, V60, P297, DOI 10.1007/s002239900232
   KAPLAN FS, 1990, CALCIFIED TISSUE INT, V47, P117, DOI 10.1007/BF02555995
   Kaplan FS, 1998, CLIN ORTHOP RELAT R, P134
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   Kirker-Head CA, 1998, CLIN ORTHOP RELAT R, P205
   Kusuma S, 1999, J HAND SURG-BRIT EUR, V24B, P128, DOI 10.1054/jhsb.1998.0046
   Lanchoney TF, 1998, CLIN ORTHOP RELAT R, P38
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Reilly TM, 1998, CLIN ORTHOP RELAT R, P95
   ROSENBERG AE, 1994, ROBBINS PATHOLOGIC B, P1264
   ROSS EM, 1985, GOODMAN GILMANS PHAR, P35
   Sandhu HS, 1996, SPINE, V21, P2115, DOI 10.1097/00007632-199609150-00012
   Sandhu HS, 1997, SPINE, V22, P1171, DOI 10.1097/00007632-199706010-00001
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804
   TAKAOKA K, 1996, BONE MORPHOGENETIC P, P83
   URIST MR, 1978, ARCH PATHOL LAB MED, V102, P312
   VANIO S, 1993, CELL, V75, P45
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
NR 31
TC 11
Z9 11
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD AUG
PY 2000
VL 6
IS 4
BP 449
EP 460
DI 10.1089/107632700418155
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 350KK
UT WOS:000089099700014
PM 10992440
DA 2018-10-19
ER

PT J
AU Chu, CL
   Zhu, JC
   Yin, ZD
   Li, MW
   Wang, SD
   Xing, SZ
AF Chu, CL
   Zhu, JC
   Yin, ZD
   Li, MW
   Wang, SD
   Xing, SZ
TI Hot pressing of hydroxyapatite (HA)-Ti material and stability of HA
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE hydroxyapatite(HA); titanium; biomaterial; functionally graded material
AB Hot pressing of hydroxyapatite(HA)-Ti system material and the stability of HA component were investigated to supply the foundation of optimizing sintering procedure of HA-Ti functionally graded material(FGM). The results show that the HA powders used have excellent thermal stability and no decomposition is observed at 1300 degrees C. The existence of Ti can promote the dehydration and decomposition of HA. However, no new compounds form between HA and Ti. By selecting sintering parameters properly, ideal HA-Ti material can be acquired. The relative densities of the mixtures of HA and Ti are always lower than those of pure HA or Ti, which may be caused by the decomposition of HA in the mixtures.
C1 Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
   SE Univ, Anal & Testing Ctr, Nanjing 210018, Peoples R China.
   Nanjing Med Univ, Stomatol Hosp, Nanjing 210018, Peoples R China.
OI Zhu, Jingchuan/0000-0002-6075-2373
CR *AM MET SOC, 1994, HDB MET
   AOKI H, 1991, SCI MED APPL HYDROXY
   BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chang CK, 1998, J INORG MATER, V13, P71
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   CHU CL, 1999, CHINESE J NONFERROUS, V9, P57
   CHU CL, 1999, FUNCTIONAL MAT, V30, P606
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Lamy D, 1996, J MATER RES, V11, P680
   LANDUYT PV, 1995, J MAT SCI MAT MED, P8
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   PAUCHIU E, 1993, J MAT SCI MAT MED, P150
   ROGIER R, 1991, J MATER SCI, V26, P5664, DOI 10.1007/BF00553672
   ROYER A, 1993, J MATER SCI-MATER M, V4, P76, DOI 10.1007/BF00122982
   RUYS AJ, 1995, J MATER SCI-MATER M, V6, P297, DOI 10.1007/BF00120274
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
   ZHANG S, 1993, J MAT SCI MAT MED, P25
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 19
TC 20
Z9 26
U1 0
U2 3
PU ALLERTON PRESS INC
PI NEW YORK
PA 150 FIFTH AVE, NEW YORK, NY 10011 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD AUG
PY 2000
VL 10
IS 4
BP 505
EP 510
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 343GQ
UT WOS:000088693700020
DA 2018-10-19
ER

PT J
AU Suh, H
   Hwang, YS
   Park, JC
   Cho, BK
AF Suh, H
   Hwang, YS
   Park, JC
   Cho, BK
TI Calcification of leaflets from porcine aortic valves crosslinked by
   ultraviolet irradiation
SO ARTIFICIAL ORGANS
LA English
DT Article
DE calcification; crosslinking; ultraviolet irradiation;
   glutaraldehyde-pretreatment; [Ca]/[P] molar ratio
ID BIOPROSTHETIC HEART-VALVES; PHYSICAL CROSS-LINKING; COLLAGEN-FIBERS;
   GLUTARALDEHYDE; REPLACEMENT; MECHANISMS; PREVENTION; BIOMATERIAL;
   DURABILITY; INHIBITION
AB Glutaraldehyde (GA)-pretreated porcine aortic valves are generally used as a bioprosthetic valve, but gradual calcification of the leaflets often occurs. It has been hypothesized that the crosslinking agent, GA, stabilizes and perhaps modifies phosphorus-rich calcifiable structures in the bioprosthetic tissue. This is supported by our findings that calcium deposition is induced rapidly in GA-pretreated leaflets in comparison with ultraviolet (UV) irradiated leaflets. After 3 days of in vitro calcification test, calcium levels were 257.6 +/- 23.5 mu g/cm(3) in GA-pretreated, 57.7 +/- 10.2 mu g/cm(3) in the control, and 108.6 +/- 7.6 mu g/cm(3) in 24 h UV irradiated leaflets. The calcium level in all test groups increased as time proceeds and the calcium level of GA-pretreated leaflets was significantly higher than the control and UV irradiated leaflets during test. This rapid calcium deposition on the GA-pretreated leaflets may be due to residual aldehyde groups after pretreatment. The exposure time of UV irradiation was not significantly correlated with the extent of calcification. After 14 days of the test, calcium levels in leaflets UV irradiated for 1, 2, 4, and 24 h were 502.6 +/- 12.3 mu g/cm(3), 547.5 +/- 34.1 mu g/cm(3), 564.3 +/- 26.1 mu g/cm(3), and 543.0 +/- 55.5 mu g/cm(3). In all test groups, [Ca]/[P] molar ratio decreased toward that of hydroxyapatite as the predominant mineral phase as time proceeds. This study suggests that UV irradiation can be considerable as an efficient crosslinking method to surmount the side effects induced by GA-pretreatment and may endow tissue with mechanical property.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   Yonsei Univ, Coll Med, Dept Cardiovasc Surg, Seoul 120752, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, 134 Shinchon Dong, Seoul 120752, South Korea.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHAVAPIL M, 1982, J BIOMED MATER RES, V16, P245
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   COHN LH, 1985, J THORAC CARDIOV SUR, V90, P872
   COOPER DR, 1966, BIOCHEM J, V98, P655, DOI 10.1042/bj0980655
   COPPER DR, 1965, BIOCHEM J, V97, P139
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   IONESCU MI, 1982, ANN THORAC SURG, V34, P265, DOI 10.1016/S0003-4975(10)62496-4
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee CH, 1998, J BIOMED MATER RES, V42, P30, DOI 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   MAGILLIGAN DJ, 1985, J THORAC CARDIOV SUR, V89, P499
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Park JC, 2000, ARTIF ORGANS, V24, P158, DOI 10.1046/j.1525-1594.2000.06482-2.x
   PATHAK Y, 1996, BIOMATERIALS SCI INT, P272
   Sableman E., 1985, BIOCOMPATIBILITY TIS, P27
   SAMACHSON J, 1969, NATURE, V221, P1247, DOI 10.1038/2211247a0
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SIMIONESCU A, 1991, J BIOMED MATER RES, V25, P1495, DOI 10.1002/jbm.820251207
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   SUH H, 1998, BIOMATER RES, V2, P95
   SUH H, 1998, BIOMATER RES, V2, P1
   TOMAZIC BB, 1994, J BIOMED MATER RES, V28, P35, DOI 10.1002/jbm.820280106
   TOMIMATSU Y, 1971, J COLLOID INTERF SCI, V36, P51, DOI 10.1016/0021-9797(71)90239-6
   Vyavahare N, 1997, CIRCULATION, V95, P479
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
NR 36
TC 6
Z9 6
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JUL
PY 2000
VL 24
IS 7
BP 555
EP 563
DI 10.1046/j.1525-1594.2000.06562.x
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 338VY
UT WOS:000088445000008
PM 10916067
DA 2018-10-19
ER

PT J
AU Hallab, N
   Jacobs, JJ
   Black, J
AF Hallab, N
   Jacobs, JJ
   Black, J
TI Hypersensitivity to metallic biomaterials: a review of leukocyte
   migration inhibition assays
SO BIOMATERIALS
LA English
DT Review
DE hypersensitivity; metallic biomaterials; leukocyte migration inhibition
   assays
ID PACEMAKER CONTACT SENSITIVITY; HIGH ENDOTHELIAL VENULES; TOTAL JOINT
   REPLACEMENTS; LYMPHOCYTE MIGRATION; CORROSION PRODUCTS; STAINLESS-STEEL;
   NICKEL RELEASE; DERMATITIS; INVITRO; VITALLIUM
AB Metal hypersensitivity is a well-established phenomenon occurring in a variety of domestic and workplace settings. Degradation products of metallic biomaterials may mediate metal hypersensitivity. However, little is known about the short- and long-term pharmacodynamics and bioavailability of circulating metal degradation products in vivo. Mechanisms by which in vivo metal sensitivity reactions occur have not been well characterized and the degree to which metal sensitivity may be a predisposing factor for eliciting an overaggressive immune response remains clinically unpredictable. In vitro leukocyte migration inhibition assays have been used for investigating cell-mediated hypersensitivity reactions to biomaterial and biomaterial degradation products. This review provides a historical and technical summary of four in vitro techniques used for determination of leukocyte migration activity: (1) membrane migration or Boyden chamber, (2) capillary tube, (3) leukocyte migration using agarose technique, and (4) collagen gels. It is difficult to determine which, if any, of these techniques is singularly best suited for the investigation of suspected biomaterial-related symptoms in patients. However, Boyden chamber membrane migration testing is recommended for clinical investigations, principally because a high degree of standardized investigator independent materials and methodologies is necessary for compiling and comparing the results of patients tested at various times over the length of an extended study. Ultimately, in vitro migration inhibition testing has the potential to provide a reliable means for predicting some complications and thus enhancing the outcome for patients receiving metallic implants. Continuing improvements in migration inhibition testing methods, used alone or in combination with other immunologic assays, will likely improve assessment of patients susceptible to biomaterial antigen-induced delayed-type hypersensitivity responses. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Rush Presbyterian St Lukes Med Ctr, Dept Orthopaed Surg, Chicago, IL 60612 USA.
   IMN Biomat, King Of Prussia, PA 19406 USA.
RP Hallab, N (reprint author), Rush Presbyterian St Lukes Med Ctr, Dept Orthopaed Surg, 1653 W Congress Pkwy, Chicago, IL 60612 USA.
OI Jacobs, Joshua/0000-0003-3902-7334
CR ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   ANGLE CR, 1995, METAL TOXICOLOGY, P71
   ARONSON JOSEPH D., 1931, JOUR EXP MED, V54, P387, DOI 10.1084/jem.54.3.387
   BARRANCO VP, 1972, J AMER MED ASSOC, V220, P1244, DOI 10.1001/jama.1972.03200090066016
   BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   BEER DJ, 1980, CELL IMMUNOL, V55, P381, DOI 10.1016/0008-8749(80)90169-0
   BENSON MKD, 1975, BRIT MED J, V4, P374, DOI 10.1136/bmj.4.5993.374
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BLACK J, 1984, BIOMATERIALS, V5, P12
   BLACK J, 1996, ENCY APPL PHYSICS, P141
   Black J., 1988, ORTHOPAEDIC BIOMATER
   BOYAN BD, 1993, BIOL MAT MECH CONSID
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   BOYDEN VS, 1961, IMMUNOLOGY, V4, P244
   BRAVO I, 1990, J BIOMED MATER RES, V24, P1059, DOI 10.1002/jbm.820240808
   BRENAN M, 1984, J IMMUNOL METHODS, V74, P31, DOI 10.1016/0022-1759(84)90364-8
   BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004
   BRUZE M, 1994, J AM ACAD DERMATOL, V31, P579, DOI 10.1016/S0190-9622(94)70219-5
   BUCHET S, 1992, CONTACT DERMATITIS, V26, P46, DOI 10.1111/j.1600-0536.1992.tb00867.x
   BUCKLEY JJ, 1951, B JOHNS HOPKINS HOSP, V89, P303
   BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713
   CARPENTER RR, 1968, J RETICULOENDOTH SOC, V5, P472
   CARPENTER RR, 1963, J IMMUNOL, V91, P803
   CHESS L, 1974, J IMMUNOL, V113, P1122
   CLAUSEN JE, 1971, ACTA ALLERGOL, V26, P56, DOI 10.1111/j.1398-9995.1971.tb01399.x
   CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245, DOI 10.3109/17453677708988763
   DINH PN, 1980, ACTA VIROL, V24, P427
   DIXON HM, 1936, ARCH PATHOL, V34, P173
   ELVES MW, 1975, BRIT MED J, V4, P376, DOI 10.1136/bmj.4.5993.376
   FAVOUR CB, 1947, P SOC EXP BIOL MED, V65, P269
   FISHER AA, 1977, CUTIS, V19, P285
   Foussereau J, 1966, Trans St Johns Hosp Dermatol Soc, V52, P220
   GANGAROSA EJ, 1955, J EXP MED, V425, P425
   GAWKRODGER DJ, 1993, CONTACT DERMATITIS, P28
   GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Gitelman H.J., 1989, ALUMINUM HLTH CRITIC
   GORDON PM, 1994, CONTACT DERMATITIS, V30, P181, DOI 10.1111/j.1600-0536.1994.tb00709.x
   GUIMARAENS D, 1994, CONTACT DERMATITIS, V30, P124, DOI 10.1111/j.1600-0536.1994.tb00590.x
   HALLAB NJ, 1998, T 24 ANN SOC BIOM SA
   HALPIN DS, 1975, J BONE JOINT SURG BR, V57, P451
   Hanks JH, 1940, J IMMUNOL, V38, P159
   HARRINGTON JT, 1973, J IMMUNOL, V110, P752
   HAUDRECHY P, 1994, CONTACT DERMATITIS, V31, P249, DOI 10.1111/j.1600-0536.1994.tb01997.x
   HELTON J, 1994, J AM ACAD DERMATOL, V31, P205
   HENSTENPETTERSEN A, 1993, BRIS MYER Z, P353
   HOLGERS KM, 1992, CONTACT DERMATITIS, V27, P1, DOI 10.1111/j.1600-0536.1992.tb05189.x
   HUBLER WR, 1983, CONTACT DERMATITIS, V9, P377, DOI 10.1111/j.1600-0536.1983.tb04432.x
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   Jacobs JJ, 1994, ADV OPERATIVE ORTHOP, V2, P279
   JACOBS JJ, 1992, T 4 WORLD BIOM C BER, P266
   JACOBS JJ, 1994, T ORTHOP RES SOC NEW, P838
   JACOBS JJ, IN PRESS J BONE JT S
   JALKANEN ST, 1985, BLOOD, V66, P577
   KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x
   KETCHEL MM, 1955, J EXP MED, V101, P647, DOI 10.1084/jem.101.6.647
   KETCHEL MM, 1953, ANAT REC, V117, P551
   KETCHEL MM, 1953, SCIENCE, V118, P79, DOI 10.1126/science.118.3055.79
   KING L, 1993, NEW ENGL J MED, V329, P1583, DOI 10.1056/NEJM199311183292121
   KIRCHHEIMER WF, 1948, SOC P EXP BIOL, V68, P407
   KORENBLAT PE, 1992, CONTACT DERMATITIS
   Kuby J, 1991, IMMUNOLOGY
   LAEIJENDECKER R, 1994, J AM ACAD DERMATOL, V30, P205, DOI 10.1016/S0190-9622(94)70018-4
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LANGARD S, 1986, HDB TOXICOLOGY METAL, V2, P185
   LEAHY RH, 1952, J EXP MED, V96, P549, DOI 10.1084/jem.96.6.549
   Leber T., 1888, FORTSCHR MED, V6, P460
   LIDEN C, 1995, METAL TOXICOLOGY, P447
   LIU DY, 1985, CELL IMMUNOL, V90, P605, DOI 10.1016/0008-8749(85)90225-4
   LYELL A, 1978, LANCET, V23, P657
   McCutcheon M, 1923, AM J PHYSIOL, V66, P180
   MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319
   McCUTCHEON MORTON, 1936, ARCH PATH, V21, P749
   MERCHANT DJ, 1952, P SOC EXP BIOL MED, V80, P69
   MERLE C, 1992, CONTACT DERMATITIS, V27, P257, DOI 10.1111/j.1600-0536.1992.tb03259.x
   Merritt K, 1996, CLIN ORTHOP RELAT R, P71
   MERRITT K, 1980, ACTA ORTHOP SCAND, V51, P403, DOI 10.3109/17453678008990816
   MERRITT K, 1981, INT J DERMATOL, V20, P89, DOI 10.1111/j.1365-4362.1981.tb00408.x
   Merritt K, 1985, ASTM STP, P195
   MERRITT K, 1984, ROLE MED MAT BOTH IM
   MILLER JM, 1951, J EXP MED, V93, P1
   MILLER JM, 1949, P SOC EXP BIOL MED, V70, P738
   Moen JK, 1936, J EXP MED, V64, P339, DOI 10.1084/jem.64.3.339
   Nakamura S, 1997, ACTA ORTHOP SCAND, V68, P495, DOI 10.3109/17453679708996269
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   Opie EL, 1924, J IMMUNOL, V9, P231
   Oyeyinka GO, 1995, MECH AGEING DEV, V85, P83, DOI 10.1016/0047-6374(95)01650-3
   PARKER AW, 1993, AM J KNEE SURG, V6, P129
   PETERS MS, 1984, CONTACT DERMATITIS, V11, P214, DOI 10.1111/j.1600-0536.1984.tb00986.x
   PINKSTON JA, 1973, STAIN TECHNOL, V54, P233
   POSS R, 1984, CLIN ORHTOP, P182
   REPO H, 1980, CLIN EXP IMMUNOL, V39, P442
   Rich AR, 1928, P SOC EXP BIOL MED, V25, P596
   Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115
   ROCHA B, 1984, SCAND J IMMUNOL, V19, P297, DOI 10.1111/j.1365-3083.1984.tb00934.x
   ROCKLIN RE, 1977, J IMMUNOL, V119, P249
   ROOKER GD, 1980, J BONE JOINT SURG BR, V62, P502
   ROSTOKER G, 1987, J BONE JOINT SURG AM, V69A, P1408
   SAMITZ MH, 1973, JAMA-J AM MED ASSOC, V223, P1159, DOI 10.1001/jama.1973.03220100053023
   SCHOR SL, 1983, J CELL BIOL, V96, P1089, DOI 10.1083/jcb.96.4.1089
   SINIBALDI K, 1976, CLIN ORTHOP RELAT R, P257
   SOBORG M, 1967, ACTA MED SCAND, V181, P247
   SPIECHOWICZ E, 1984, CONTACT DERMATITIS, V10, P206, DOI 10.1111/j.1600-0536.1984.tb00101.x
   STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X
   Sunderman F W, 1979, Biol Trace Elem Res, V1, P63, DOI 10.1007/BF02783844
   SUNDERMAN FW, 1989, ANN CLIN LAB SCI, V19, P1
   THOMAS RHM, 1987, BMJ-BRIT MED J, V294, P106, DOI 10.1136/bmj.294.6564.106
   UHR JW, 1958, J EXP MED, V108, P905, DOI 10.1084/jem.108.6.905
   VILAPLANA J, 1994, CONTACT DERMATITIS, V30, P80, DOI 10.1111/j.1600-0536.1994.tb00568.x
   Wang JY, 1997, J ORTHOP RES, V15, P688, DOI 10.1002/jor.1100150510
   WILKINSON PC, 1969, NATURE, V222, P244, DOI 10.1038/222244a0
   Williams DF, 1981, SYSTEMIC ASPECTS BIO, P169
   WOODMAN JL, 1984, J BIOMED MATER RES, V18, P99, DOI 10.1002/jbm.820180110
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   YANG J, 1994, J BIOMED MATER RES, V28, P1249, DOI 10.1002/jbm.820281102
   Yang J, 1996, J BIOMED MATER RES, V31, P71, DOI 10.1002/(SICI)1097-4636(199605)31:1<71::AID-JBM9>3.0.CO;2-N
   Zinsser H, 1921, J EXP MED, V34, P495, DOI 10.1084/jem.34.5.495
NR 117
TC 53
Z9 55
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2000
VL 21
IS 13
BP 1301
EP 1314
DI 10.1016/S0142-9612(99)00235-5
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315BF
UT WOS:000087092200001
PM 10850924
DA 2018-10-19
ER

PT J
AU Bareille, R
   Lafage-Proust, MH
   Faucheux, C
   Laroche, N
   Wenz, R
   Dard, M
   Amedee, J
AF Bareille, R
   Lafage-Proust, MH
   Faucheux, C
   Laroche, N
   Wenz, R
   Dard, M
   Amedee, J
TI Various evaluation techniques of newly formed bone in porous
   hydroxyapatite loaded with human bone marrow cells implanted in an
   extra-osseous site
SO BIOMATERIALS
LA English
DT Article
DE osteogenesis; in situ analysis; lamellar bone; osteoblast; acid
   phosphatase
ID STROMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; BIOACTIVE GLASS;
   BIOMATERIALS; CERAMICS; SURFACE; OSTEOBLASTS; EXPRESSION; INGROWTH;
   BIOPSIES
AB The purpose of this work was to develop qualitative methods for in situ analysis of bone formation in an osteoconductive hydroxyapatite matrix (ENDOBON(R)), loaded with human bone marrow cells (HBMSC) implanted subcutaneously in athymic mice. Samples were taken before implantation (T0), 1, 2, 4 and 6 weeks after implantation. Bone-biomaterial interaction were investigated on undecalcified sections by histological, cytochemical, immunological and molecular biology methodologies. Histological observations were performed in order to observe inflammatory cells, vessels, newly formed bone, woven and lamellar bone. Enzymohistochemistry was carried out to detect positive tartrate resistant acid phosphatase activity (TRAP+). Immunohistochemistry using antibodies against type I collagen and osteocalcin permitted us to characterize the content of the matrix elaborated within the implant. Moreover, in situ hybridization was carried out to discriminate, the implanted human cells from the murine cells, and to evaluate the function of these human cells in osteogenesis. Results demonstrated an early formation of lamellar bone only in the pores of the studied HAP loaded with HBMSC. This bone contained a matrix showing positive reaction for type I collagen and osteocalcin. In situ hybridization identified some of these cells as human cells. At 6 weeks, examination of histological results showed persistance of lamellar bone in the implants. We only found TRAP+ activity in the materials loaded with human bone marrow cells. Molecular hybridization no longer revealed positive cells for the human DNA probe. All these results indicate that the various evaluation techniques performed on undecalcified sections, permit us to evaluate the response of human bone marrow cells in HAP implanted into mice. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Victor Segalen Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
   Fac Med, Lab Biochim & Biol Tissu Osseux, St Etienne, France.
   Merck Biomat, Res & Dev, Darmstadt, Germany.
RP Amedee, J (reprint author), Univ Victor Segalen Bordeaux 2, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM joelle.amedee@bordeaux.inserm.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
CR AKAHANE M, 1997, BIOCERAMICS, V10, P97
   AOKI H, 1991, SCI MED APPL HYDROXY
   BAB I, 1988, BONE MINER, V4, P373
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P293
   CARANDO S, 1989, BONE, V10, P139, DOI 10.1016/8756-3282(89)90012-4
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CHAPPARD D, 1983, BASIC APPL HISTOCHEM, V27, P75
   DARD M, 1994, ACTA ODONTO STOMATOL, V185, P61
   FAUCHEUX C, 1994, J MATER SCI-MATER M, V5, P635, DOI 10.1007/BF00120345
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402
   MISHIMA K, 1997, BIOCERAMICS, V10, P595
   Neo M, 1998, J BIOMED MATER RES, V39, P1, DOI 10.1002/(SICI)1097-4636(199801)39:1<1::AID-JBM1>3.0.CO;2-U
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   OKA M, 1997, BIOCERAMICS, V10, P147
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   OKUMURA M, 1991, BIOMATERIALS, V12, P411, DOI 10.1016/0142-9612(91)90010-8
   Okumura Motoaki, 1992, Bio-Medical Materials and Engineering, V2, P191
   ONO I, 1989, PLAST RECONSTR SURG, V90, P870
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Piattelli A, 1997, BIOMATERIALS, V18, P545, DOI 10.1016/S0142-9612(96)00172-X
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   TROSTER SD, 1993, JB ORTHOPADIE, P231
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979
   Yamazaki Y, 1996, J BIOMED MATER RES, V30, P1
   Yoshikawa T, 1996, BIO-MED MATER ENG, V6, P345
   YOSHIKAWA T, 1997, BIOCERAMICS, V10, P117
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 38
TC 28
Z9 28
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2000
VL 21
IS 13
BP 1345
EP 1352
DI 10.1016/S0142-9612(00)00015-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315BF
UT WOS:000087092200005
PM 10850928
DA 2018-10-19
ER

PT J
AU Park, YS
   Ito, Y
AF Park, YS
   Ito, Y
TI Micropattern-immobilization of heparin to regulate cell growth with
   fibroblast growth factor
SO CYTOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1998 Joint International Meeting of the
   Japanese-Association-for-Animal-Cell-Technology/European-Society-for-Ani
   mal-Cell-Technology (JAACT/ESACT)
CY JUL 26-30, 1998
CL KYOTO, JAPAN
SP Japanese Assoc Anim Cell Technol, European Soc Anim Cell Technol
DE biomaterial; cell growth; fibroblast growth facor; heparin;
   pattern-immobilization
ID ARTIFICIAL JUXTACRINE STIMULATION; PROTEIN FIXATION; POLYMER;
   ENHANCEMENT; INSULIN
AB Heparin was immobilized on a polystyrene plate in a specific pattern by photolithography. Heparin was coupled with azidoaniline. The derivatized heparin was cast on the polystyrene plate from aqueous solution. After drying, the plate was photo-irradiated in the presence of a photomask. The micropatterning was confirmed by staining with a dye, ethydium bromide. Since heparin has negative charges, the cationic dye was adsorbed on the regions where heparin was immobilized. In the presence fibroblast growth factor (FGF), the growth of mouse fibroblast STO cells was enhanced only on the heparin-immobilized regions. This result indicated that micropattern-immobilized heparin activated FGF for cell growth activity.
C1 NAIST, Grad Sch Mat Sci, Ikoma 6300101, Japan.
   Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan.
   PRESTO, JST, Kyoto 6120237, Japan.
RP Ito, Y (reprint author), NAIST, Grad Sch Mat Sci, Ikoma 6300101, Japan.
RI Ito, Yoshihiro/F-4370-2012
CR CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0
   CHEN G, 1998, BIOCONJUG CHEM, V8, P730
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   DIGRABRIELE AD, 1998, NATURE, V393, P812
   Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, J BIOMAT SCI-POLYM E, V9, P879, DOI 10.1163/156856298X00217
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   ITO Y, 1987, BIOMATERIALS APPL, V2, P235
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240
NR 17
TC 16
Z9 17
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD JUL
PY 2000
VL 33
IS 1-3
BP 117
EP 122
DI 10.1023/A:1008154326954
PG 6
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 359FG
UT WOS:000089600400016
PM 19002818
DA 2018-10-19
ER

PT J
AU Mack, D
   Rohde, H
   Dobinsky, S
   Riedewald, J
   Nedelmann, M
   Knobloch, JKM
   Elsner, HA
   Feucht, HH
AF Mack, D
   Rohde, H
   Dobinsky, S
   Riedewald, J
   Nedelmann, M
   Knobloch, JKM
   Elsner, HA
   Feucht, HH
TI Identification of three essential regulatory gene loci governing
   expression of Staphylococcus epidermidis polysaccharide intercellular
   adhesin and biofilm formation
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBRINOGEN-BINDING-PROTEIN; TRANSPOSON
   MUTANTS; PRIMARY ATTACHMENT; ADHERENCE; HEMAGGLUTINATION; ACCUMULATION;
   STRAINS; MODEL; SLIME
AB The formation of adherent multilayered biofilms embedded into a glycocalyx represents an essential factor in the pathogenesis of Staphylococcus epidermidis biomaterial-related infections. Using biofilm-producing S. epidermidis 1457 and transposon Tn917 carried on plasmid pTVlts, we isolated nine isogenic biofilm-negative transposon mutants. Transduction by S, epidermidis phage 71 was used to prove the genetic linkage of transposon insertions and altered phenotypes, Mapping of the different transposon insertions by Southern hybridization and pulsed-field gel electrophoresis indicated that these were inserted in four unlinked genetic loci, According to their phenotypes, including quantitative differences in biofilm production in different growth media, in the amount of the polysaccharide intercellular adhesin (PW) produced, in the hemagglutination titers, and in the altered colony morphology, the mutants could be separated into four phenotypic classes corresponding with the genetic classes. Synthesis of PIA was not detectable with class I and II mutants, whereas the amount of PIA produced reflected the residual degree of biofilm production of class III and IV mutants in different growth media. Chromosomal DNA flanking the transposon insertions of five class I mutants was cloned and sequenced, and the insertions were mapped to different locations of icaADBC, representing the synthetic genes for PIA, Expression of icaADBC from a xylose-dependent promoter in the different Isogenic mutant classes reconstituted biofilm production in all mutants. In a Northern blot analysis no icaADBC-specific transcripts were observed in RNA isolated from mutants of classes II, III, and IV. Apparently, in addition to icaADBC, three other gene loci have a direct or indirect regulatory influence on expression of the synthetic genes for PIA on the level of transcription.
C1 Univ Hamburg, Hosp Eppendorf, Inst Med Mikrobiol & Immunol, D-20246 Hamburg, Germany.
RP Mack, D (reprint author), Univ Hamburg, Hosp Eppendorf, Inst Med Mikrobiol & Immunol, Martinistr 52, D-20246 Hamburg, Germany.
EM dmack@ukc.uni-hamburg.de
RI Knobloch, Johannes/D-6456-2011
OI Knobloch, Johannes/0000-0002-2591-6387
CR Bisno AL, 1994, INFECT ASS INDWELLIN
   CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Favero MS, 1996, AM J INFECT CONTROL, V24, P380
   Fey PD, 1999, J INFECT DIS, V179, P1561, DOI 10.1086/314762
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gutierrez JA, 1996, J BACTERIOL, V178, P4166, DOI 10.1128/jb.178.14.4166-4175.1996
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Heilmann C, 1998, ZBL BAKT-INT J MED M, V287, P69
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   HUSSAIN M, 1993, FEMS MICROBIOL LETT, V104, P191, DOI 10.1016/0378-1097(93)90596-T
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, 1994, ZBL BAKT S, V26, P411
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   MACK D, 2000, HDB STUDYING BACTERI, P307
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MULLER E, 1993, INFECT IMMUN, V61, P551
   Nedelmann M, 1998, ZBL BAKT-INT J MED M, V287, P85
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Pei L, 1999, INFECT IMMUN, V67, P4525
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   SCHWARZKOPF A, 1993, J CLIN MICROBIOL, V31, P2281
   SHAW JH, 1985, J BACTERIOL, V164, P782
   Thylefors JD, 1998, INFECT CONT HOSP EP, V19, P581
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TOJO M, 1988, J INFECT DIS, V158, P268
   UDO EE, 1990, FEMS MICROBIOL LETT, V72, P183, DOI 10.1016/0378-1097(90)90369-2
   UDO EE, 1990, J MED MICROBIOL, V31, P207, DOI 10.1099/00222615-31-3-207
   *US DEP HHS, 1997, AM J INFECT CONTROL, V24, P477
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
NR 46
TC 90
Z9 96
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JUL
PY 2000
VL 68
IS 7
BP 3799
EP 3807
DI 10.1128/IAI.68.7.3799-3807.2000
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 326AT
UT WOS:000087710200002
PM 10858187
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Gutensohn, K
   Beythien, C
   Koester, R
   Bau, J
   Fenner, T
   Grewe, P
   Padmanaban, K
   Schaefer, P
   Kuehnl, P
AF Gutensohn, K
   Beythien, C
   Koester, R
   Bau, J
   Fenner, T
   Grewe, P
   Padmanaban, K
   Schaefer, P
   Kuehnl, P
TI In vitro biocompatibility analyses of stents coated with diamond-like
   carbon by flow cytometry, cell growth assays and electron microscopy
SO INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND
   TRANSFUSIONSMEDIZIN
LA English
DT Article
DE stent; diamond-like carbon; thrombogenicity; flow cytometry; electron
   microscopy
ID CORONARY-ARTERY DISEASE; ACTIVATED PLATELETS; BALLOON ANGIOPLASTY; BLOOD
   COMPATIBILITY; MONOCLONAL-ANTIBODY; SMOOTH-MUSCLE; CULTURE;
   IMPLANTATION; EXPRESSION; THROMBOSIS
AB Background: Coronary artery stents can induce platelet activation by shear forces and contact to the biomaterial. This activation is one important trigger for thrombosis. Coating of stents is a possible approach to prevent this side effect. The purpose of this study was to evaluate in vitro the biocompatibility of stents coated with diamondlike carbon (DLC). Materials and Methods: For in vitro testing, DLC-coated stents were compared with noncoated 316L stainless steel stents. For this purpose, cell culture assays, videomorphometric, electron microscopic and flow-cytometric techniques were applied. Results: Growth assays with smooth muscle cells and endothelial cells revealed that DLC did not affect proliferation rates and did not have cytotoxic effects. Video-based morphometry and scanning electron microscopy showed an ultrasmooth surface and homogenous expansion patterns of the DLC stents. For analysis of platelet antigens in a circulating loop model, flow cytometry was applied. Our experiments showed no significant changes in mean channel fluorescence intensity for the structural antigens CD41a (p = 0.6) and CD42b (p = 0.1). In contrast, the expression of the activation-dependent antigens CD62p and CD63 increased significantly in noncoated stents compared to DLC-coated stents (p < 0.05). Conclusion: Coating of intracoronary stents with DLC significantly reduces platelet activation. Hereby, biocompatibility is improved.
C1 Univ Hamburg, Hosp Eppendorf, Transfus Med & Transplantat Immunol Abt, D-20246 Hamburg, Germany.
RP Gutensohn, K (reprint author), Univ Hamburg, Hosp Eppendorf, Transfus Med & Transplantat Immunol Abt, Martinistr 52, D-20246 Hamburg, Germany.
EM gutensohn@uke.uni-hamburg.de
CR ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   BAILEY SR, 1994, TXB INTERVENTIONAL C, P754
   BEYTHIEN C, 1994, THROMB RES, V75, P581, DOI 10.1016/0049-3848(94)90170-8
   Bittl JA, 1996, NEW ENGL J MED, V335, P1290, DOI 10.1056/NEJM199610243351707
   Bittl JA, 1996, J AM COLL CARDIOL, V28, P368, DOI 10.1016/0735-1097(96)00183-0
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V91, P80, DOI 10.1097/00006534-199301000-00011
   COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Gawaz M, 1996, CIRCULATION, V94, P279, DOI 10.1161/01.CIR.94.3.279
   Grewe PH, 1997, Z KARDIOL, V86, P990, DOI 10.1007/s003920050141
   Gutensohn K, 1997, THROMB RES, V86, P49, DOI 10.1016/S0049-3848(97)00044-3
   Gutensohn K, 1998, TRANSFUS SCI, V19, P17, DOI 10.1016/S0955-3886(98)00005-8
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   HELLUMS JD, 1981, RHEOLOGY BLOOD BLOOD, P160
   IP JH, 1991, J AM COLL CARDIOL, V17, pB77
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KOSTER R, 1995, ANGIOLOGY, V46, P99, DOI 10.1177/000331979504600202
   LEMAITRE D, 1996, INTERVENTIONAL CARDI
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   Macaya C, 1996, J AM COLL CARDIOL, V27, P255, DOI 10.1016/0735-1097(95)00473-4
   Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   Michelson AD, 1996, BLOOD, V87, P4925
   NIEUWENHUIS HK, 1987, BLOOD, V70, P838
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995
   ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   RUF A, 1995, SEMIN THROMB HEMOST, V21, P146, DOI 10.1055/s-2007-1000389
   Ruygrok PN, 1996, CIRCULATION, V94, P882, DOI 10.1161/01.CIR.94.5.882
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SHAPIRO HM, 1994, PRACTICAL FLOW CYTOM
   SHATTIL SJ, 1987, BLOOD, V70, P307
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
NR 38
TC 8
Z9 8
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1424-5485
J9 INFUS THER TRANSFUS
JI Infus. Ther. Transfus. Med.-Infusionsther. Transfusionsmed.
PD JUL
PY 2000
VL 27
IS 4
BP 200
EP 206
PG 7
WC Hematology; Immunology
SC Hematology; Immunology
GA 348XH
UT WOS:000089011400005
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Carrera, A
   Cordon, A
   Jorge-Herrero, E
   Rocha, A
   Salvador, J
   Mendez, J
   Castillo-Olivares, JL
   Millan, I
   Sainz, N
AF Paez, JMG
   Carrera, A
   Cordon, A
   Jorge-Herrero, E
   Rocha, A
   Salvador, J
   Mendez, J
   Castillo-Olivares, JL
   Millan, I
   Sainz, N
TI Uniaxial and biaxial tensile strength of calf pericardium used in the
   construction of bioprostheses: Biomaterial selection criteria
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE selection; bovine pericardium; bioprosthesis
ID NATIVE BOVINE PERICARDIUM; MECHANICAL HEART-VALVE; FIBER ARCHITECTURE;
   TISSUE; BEHAVIOR; SITES
AB Using morphological and mechanical criteria and applying a method involving paired samples that is widely employed in epidemiology, we obtained an excellent prediction of the mechanical behavior of the calf pericardium used in the construction of cardiac bioprostheses. The method of selection employed in this study may be a highly useful tool for guaranteeing the mechanical resistance of calf pericardium, with a very low level of error.
C1 Clin Puerta de Hierro, Serv Med Prevent, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Madrid, Spain.
RI Sainz, Nekane/G-3136-2016; Jorge Herrero, EDUARDO/F-7240-2010
OI Sainz, Nekane/0000-0002-8438-6929; 
CR BARBENEL JC, 1989, BLOOD FLOW ARTIFICIA
   BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Bortolotti U, 1988, Eur J Cardiothorac Surg, V2, P458, DOI 10.1016/1010-7940(88)90052-8
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   CHRISTIE CW, 1982, FINITE ELEMENT BIOME
   GRUKEMEIER GL, 1994, J CARDIOVASC SURG, V108, P709
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   MAUSNER JS, 1985, EPIDEMIOLOGY INTRO
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   SHOEN FJ, 1987, CIRCULATION, V76, P618
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TIMOSCHENKO S, 1970, RESISTENCIA MAT, V2
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   TROWBRIDGE EA, 1988, J THORAC CARDIOV SUR, V95, P577
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   WHEATLEY DJ, 1987, J THORAC CARDIOV SUR, V94, P367
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P366, DOI 10.1016/0142-9612(94)90249-6
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P374, DOI 10.1016/0142-9612(94)90250-X
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 28
TC 12
Z9 12
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2000
VL 15
IS 1
BP 47
EP 64
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 345JR
UT WOS:000088813300003
DA 2018-10-19
ER

PT J
AU Voskerician, G
   Anderson, JM
   Ziats, NP
AF Voskerician, G
   Anderson, JM
   Ziats, NP
TI High molecular weight kininogen inhibition of endothelial cell function
   on biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE high-molecular-weight kininogen; endothelial cells; cell adhesion; cell
   proliferation; cell migration; vascular grafts; biomaterials
ID SULFONATED POLYURETHANE SURFACES; HUMAN PLASMA-PROTEINS; VASCULAR
   GRAFTS; SINGLE-CHAIN; BINDING-SITE; FACTOR-XII; ADSORPTION; ADHESION;
   ACTIVATION; POLYMERS
AB Synthetic vascular grafts implanted into humans fail to develop a complete endothelial lining. Ln previous studies, we have shown that high-molecular-weight kininogens (HMWK) adsorb to the surfaces of biomaterials. In addition, it has been demonstrated that these proteins modulate cellular function. Ln the present study, we report on the adhesion and proliferation of human umbilical-vein endothelial cells (HUVEC) on tissue culture polystyrene, glass, polyurethane, and Mylar(TM) surfaces coated with human HMWK, either single-chain HMWK (SC-HMWK) or double-chain HMWK (DC-HMWK). Surfaces coated with fibronectin served as a positive control for these experiments. Parallel experiments were performed in which HUVEC were allowed to migrate from crosslinked dextran microcarrier beads (Cytodex 2) onto HMWK-coated surfaces. Our results indicate that HMWK-coated surfaces inhibit endothelial cell adhesion, proliferation, and migration at 24 and 72 h, and this inhibition is concentration dependent. To determine a potential mechanism for this inhibitory phenomenon, cells were stained for cytoskeletal actin filaments using rhodamine-phalloidin. Endothelial cells on HMWK-coated surfaces displayed F-actin filament reorganization/disassembly, characterized by the absence of peripheral actin bands in focal adhesion contacts. We conclude that HMWK inhibit endothelial cell adhesion, proliferation, and migration on a variety of biomaterial surfaces. This inhibitory effect may play a role in promoting the lack of endothelialization in synthetic vascular grafts, which is thought to play a significant role in the failure of these devices. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 51, 1-9, 2000.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Ziats, NP (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL33849, HL48771]
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Asakura S, 1998, J BIOCHEM-TOKYO, V124, P473, DOI 10.1093/oxfordjournals.jbchem.a022138
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   Colman RW, 1999, ARTERIOSCL THROM VAS, V19, P2245, DOI 10.1161/01.ATV.19.9.2245
   Cornelius RM, 1997, J BIOMED MATER RES, V37, P314
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   Davies L. B., 1998, TISSUE ENG VASCULAR, P3
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174
   HASAN AAK, 1994, J BIOL CHEM, V269, P31822
   HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256
   Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615
   HASAN AAK, 1995, BLOOD, V85, P3134
   HENDERSON LM, 1994, BLOOD, V84, P474
   HERWALD H, 1995, J BIOL CHEM, V270, P14634
   Khan M, 1995, BLOOD, V86, P121
   KUSUMAN J, 1999, CLIN IMMUNOL, V92, P246
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU SM, 1995, EXP CELL RES, V217, P1, DOI 10.1006/excr.1995.1056
   Margolius HS, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.1.S14
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Schmaier A. H., 1998, THROMBOSIS HEMORRHAG, P105
   SCHMEIDERLSHAPI.KT, 1992, P NATL ACAD SCI USA, V88, P4382
   SCOTT CF, 1985, J BIOL CHEM, V260, P856
   Shuster CB, 1998, MICROCIRCULATION, V5, P239
   Slack SM, 1995, ACS SYM SER, V602, P112
   Voskerician G, 1997, Biomed Sci Instrum, V33, P172
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
   Wang Q, 1997, J CELL PHYSIOL, V172, P171, DOI 10.1002/(SICI)1097-4652(199708)172:2<171::AID-JCP4>3.0.CO;2-L
   WEISEL JW, 1994, J BIOL CHEM, V269, P10100
   Yung LYL, 1999, BLOOD, V94, P2716
   Ziats Nicholas P., 1994, Journal of Vascular Surgery, V20, P132
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
   ZIATS NP, 1993, J VASC SURG, V17, P710, DOI 10.1016/0741-5214(93)90115-3
   ZIATS NP, 1996, T SOC BIOMATER, V19, P653
NR 37
TC 8
Z9 8
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2000
VL 51
IS 1
BP 1
EP 9
DI 10.1002/(SICI)1097-4636(200007)51:1<1::AID-JBM1>3.0.CO;2-Q
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315WK
UT WOS:000087135800001
PM 10813738
DA 2018-10-19
ER

PT J
AU Badylak, S
   Meurling, S
   Chen, M
   Spievack, A
   Simmons-Byrd, A
AF Badylak, S
   Meurling, S
   Chen, M
   Spievack, A
   Simmons-Byrd, A
TI Resorbable bioscaffold for esophageal repair in a dog model
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE tissue engineering; extracellular matrix; small intestinal submucosa;
   urinary bladder submucosa; esophagus
ID SMALL-INTESTINAL SUBMUCOSA; ACHILLES-TENDON REPAIR; AUGMENTATION
   CYSTOPLASTY; URINARY-BLADDER; FULL-THICKNESS; CAROTID-ARTERY; GRAFT;
   REGENERATION; ENDOPROSTHESES; BIOMATERIAL
AB Purpose: Porcine-derived, xenogeneic extracellular matrix (ECM) derived from either the small intestinal submucosa (SIS) or urinary bladder submucosa (UBS) was used as a tissue scaffold for esophageal repair in a dog model.
   Methods: Patch defects measuring approximately 5 cm in length and encompassing 40% to 50% of the circumference of the esophagus or complete circumferential segmental defects measuring 5 cm in length were created by surgical resection in healthy adult female dogs. The defects were repaired with ECM scaffolds derived from either SIS or UBS. The animals were kept alive for periods ranging from 4 days to 15 months.
   Results: The xenogeneic scaffolds used for repair of the patch defects were resorbed completely within 30 to 60 days and showed replacement by skeletal muscle, which was oriented appropriately and contiguous with adjacent normal esophageal skeletal muscle, organized collagenous connective tissue, and a complete and intact squamous epithelium. No signs of clinical esophageal dysfunction were seen in any of the animals with the patch defect repair. The xenogeneic scaffolds configured into tubes for repair of the segmental defects all showed stricture within 45 days of surgery.
   Conclusion: These ECMs show promise as a treatment option for esophageal repair, but stricture remains problematic for complete tube grafts. Copyright (C) 2000 by W.B. Saunders Company.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Univ Uppsala Hosp, Dept Pediat Surg, Uppsala, Sweden.
   Univ Med & Dent New Jersey, Dept Surg, Camden, NJ USA.
   Harvard Univ, Dept Surg, Cambridge, MA 02138 USA.
RP Badylak, S (reprint author), Purdue Univ, Dept Biomed Engn, Potter Bldg,Room 204, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Alcantara PSM, 1997, INT SURG, V82, P249
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BADYLAK SF, 1987, ADV EXP MED BIOL, V234
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   BELL E, 1993, TISSUE ENG CURRENT P, P179
   Botto LD, 1997, AM J MED GENET, V71, P8, DOI 10.1002/(SICI)1096-8628(19970711)71:1<8::AID-AJMG2>3.0.CO;2-V
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CHEN M, 1998, 2 SIS S ORL FL DEC 2
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   De Palma G D, 1999, Minerva Chir, V54, P213
   Ellis F H Jr, 1999, Surg Oncol Clin N Am, V8, P279
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fujimaki M, 1997, Nihon Geka Gakkai Zasshi, V98, P786
   Gawad KA, 1999, AM J GASTROENTEROL, V94, P1490
   GLEESON MJ, 1992, J UROLOGY, V148, P1377, DOI 10.1016/S0022-5347(17)36916-1
   GORHAM SD, 1989, EUR UROL, V16, P440
   HAIGHT C, 1957, J THORACIC SURG, V34, P121
   HARRIS J, 1995, TERATOLOGY, V52, P15, DOI 10.1002/tera.1420520104
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hills KS, 1998, EUR J GASTROEN HEPAT, V10, P371, DOI 10.1097/00042737-199805000-00003
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   HODDE JP, 1998, 2 SIS S ORL FL DEC 2
   Inoue H, 1998, CAN J GASTROENTEROL, V12, P355, DOI 10.1155/1998/535978
   Kim SS, 1999, J PEDIATR SURG, V34, P124, DOI 10.1016/S0022-3468(99)90241-5
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   KROPP BP, 1996, J UROLOGY, V156, P1
   KROPP JP, 1995, MUSCLE MATRIX BLADDE, P229
   KYYRONEN P, 1988, J EPIDEMIOL COMMUN H, V42, P257, DOI 10.1136/jech.42.3.257
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Mayoral W, 1999, Gastrointest Endosc Clin N Am, V9, P423
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1994, J MICROSURG, V15, P588
   Rittler M, 1997, AM J MED GENET, V73, P162, DOI 10.1002/(SICI)1096-8628(1997)73:2<162::AID-AJMG10>3.0.CO;2-S
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   TSUJI I, 1963, J UROLOGY, V89, P214, DOI 10.1016/S0022-5347(17)64531-2
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Watson A, 1998, EUR J GASTROEN HEPAT, V10, P363, DOI 10.1097/00042737-199805000-00001
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 54
TC 183
Z9 202
U1 1
U2 22
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0022-3468
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PD JUL
PY 2000
VL 35
IS 7
BP 1097
EP 1103
DI 10.1053/jpsu.2000.7834
PG 7
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 330FZ
UT WOS:000087953300017
PM 10917304
DA 2018-10-19
ER

PT J
AU Hudson, TW
   Evans, GRD
   Schmidt, CE
AF Hudson, TW
   Evans, GRD
   Schmidt, CE
TI Engineering strategies for peripheral nerve repair
SO ORTHOPEDIC CLINICS OF NORTH AMERICA
LA English
DT Article
ID RAT SCIATIC-NERVE; SEMIPERMEABLE GUIDANCE CHANNELS; CULTURED
   SCHWANN-CELLS; LAMININ-CONTAINING GEL; GROWTH-FACTOR;
   EXTRACELLULAR-MATRIX; REGENERATION INVIVO; ENTUBULATION REPAIR;
   COLLAGEN; GRAFTS
AB Tissue engineering in the peripheral nervous system unites efforts by physicians, engineers, and biologists to create either natural or synthetic tubular nerve guidance channels as alternatives to nerve autografts for the repair of peripheral nerve defects. Guidance channels help direct axons sprouting from the regenerating nerve end, provide a conduit for diffusion of neurotropic and neurotrophic factors secreted by the damaged nerve stumps, and minimize infiltration of fibrous tissue. In addition to efforts to control these physical characteristics of nerve guidance channels, researchers are optimizing the incorporation of biologic factors and engineering interactive biomaterial that can specifically stimulate the regeneration process. Current and future research will ultimately result in biologically active and interactive nerve guidance channels that can support and enhance peripheral nerve regeneration over longer, more clinically relevant defect lengths.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR AEBISCHER P, 1989, J NEUROSCI, V9, P3590
   AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Albert E., 1885, WIEN MED PRESSE, V26, P1285
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Brown RE, 1996, J RECONSTR MICROSURG, V12, P149, DOI 10.1055/s-2007-1006468
   CAJAL SRR, 1905, TRAB LAB INBEST BIOL, V4, P119
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   CAMPBELL JJ, 1993, BRAIN RES, V603, P264, DOI 10.1016/0006-8993(93)91246-O
   Cheng ET, 1998, MICROSURG, V18, P35, DOI 10.1002/(SICI)1098-2752(1998)18:1<35::AID-MICR9>3.0.CO;2-T
   CHIU DTW, 1990, PLAST RECONSTR SURG, V86, P928, DOI 10.1097/00006534-199011000-00015
   CORDEIRO PG, 1989, PLAST RECONSTR SURG, V83, P1013, DOI 10.1097/00006534-198906000-00014
   DANIELSEN N, 1995, BRAIN RES, V681, P105, DOI 10.1016/0006-8993(95)00300-F
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   DUBEY N, 1996, 1996 AM I CHEM ENG A
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W
   FERRARA G, 1608, NUOV SELV CIR DIV PA
   FIELDS RD, 1986, EXP NEUROL, V92, P48, DOI 10.1016/0014-4886(86)90124-X
   Friedman W A, 1991, Neurosurg Clin N Am, V2, P43
   FURNISH EJ, 1998, FRONTIERS TISSUE ENG
   Genden EM, 1998, SURGERY, V124, P448, DOI 10.1016/S0039-6060(98)70152-7
   GLUCK T, 1880, ARCH KLIN CHIR, V25, P606
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Gulati AK, 1995, BRAIN RES, V705, P118, DOI 10.1016/0006-8993(95)01144-7
   GULATI AK, 1994, ACTA NEUROCHIR, V126, P158, DOI 10.1007/BF01476427
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   HALL SM, 1986, NEUROPATH APPL NEURO, V12, P27, DOI 10.1111/j.1365-2990.1986.tb00679.x
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Ho PR, 1998, ARCH OTOLARYNGOL, V124, P761, DOI 10.1001/archotol.124.7.761
   HUBER GC, 1895, J MORPHOL, V11, P629
   Ide C, 1996, NEUROSCI RES, V25, P101
   JOHNSON PC, 1982, MUSCLE NERVE, V5, P335, DOI 10.1002/mus.880050410
   Kakinoki R, 1997, INT ORTHOP, V21, P332, DOI 10.1007/s002640050179
   KEELEY R, 1993, RESTOR NEUROL NEUROS, V5, P353, DOI 10.3233/RNN-1993-55606
   Kirk EG, 1915, J AMER MED ASSOC, V65, P486
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   LETIEVANT JJE, 1973, TRAITE SECTIONS NERV
   LEVI ADO, 1994, J NEUROSCI, V14, P1309
   LIONS WR, 1949, ATLAS PERIPHERAL NER
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   LUNDBORG G, 1986, SCAND J PLAST RECONS, V20, P279, DOI 10.3109/02844318609004486
   Lundborg G, 1988, NERVE INJURY REPAIR
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   MACKENZIE JAJ, 1909, SURG GYNECOL OBSTET, V9, P30
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MACKINNON SE, 1986, J HAND SURG-AM, V11A, P888, DOI 10.1016/S0363-5023(86)80244-1
   MACKINNON SE, 1988, SURG PERIPHERAL NERV
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1988, BRAIN RES, V447, P325, DOI 10.1016/0006-8993(88)91135-3
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Medinaceli L, 1982, EXP NEUROL, V77, P634
   MILLESI H, 1967, CHIR PLAST RECONSTR, V3, P47
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Munro CA, 1998, MUSCLE NERVE, V21, P1095, DOI 10.1002/(SICI)1097-4598(199808)21:8<1095::AID-MUS20>3.0.CO;2-S
   Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4
   Payr E, 1900, ARCH KLIN CHIR, V62, P67
   POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9
   RAIVICH G, 1993, INT J DEV NEUROSCI, V11, P311, DOI 10.1016/0736-5748(93)90003-V
   ROBINSON PH, 1991, MICROSURG, V12, P412, DOI 10.1002/micr.1920120608
   ROSEN JM, 1990, ANN PLAS SURG, V25, P375, DOI 10.1097/00000637-199011000-00006
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SEDDON HJ, 1947, BRIT J SURG, V35, P15
   SEDDON HJ, 1947, LANCET, V1, P418
   Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   TAKAHASHI M, 1988, ACTA PATHOL JAPON, V38, P1489
   TONG XJ, 1994, BRAIN RES, V663, P155, DOI 10.1016/0006-8993(94)90473-1
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   VALENTINI RF, 1995, BIOMEDICAL ENG HDB
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   WANG KK, 1993, J RECONSTR MICROSURG, V9, P39, DOI 10.1055/s-2007-1006637
   WANG KK, 1993, MICROSURG, V14, P608, DOI 10.1002/micr.1920140914
   Weiss P, 1944, J EXP ZOOL, V95, P233, DOI 10.1002/jez.1400950205
   WEISS P, 1946, J NEUROSURG, V3, P375, DOI 10.3171/jns.1946.3.5.0375
   WILLIAMS LR, 1985, J COMP NEUROL, V231, P209, DOI 10.1002/cne.902310208
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WILLIAMS LR, 1987, EXP NEUROL, V97, P555, DOI 10.1016/0014-4886(87)90113-0
NR 87
TC 86
Z9 105
U1 1
U2 24
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0030-5898
J9 ORTHOP CLIN N AM
JI Orthop. Clin. North Am.
PD JUL
PY 2000
VL 31
IS 3
BP 485
EP +
DI 10.1016/S0030-5898(05)70166-8
PG 14
WC Orthopedics
SC Orthopedics
GA 340GJ
UT WOS:000088524500013
PM 10882473
DA 2018-10-19
ER

PT J
AU Felicio-Fernandes, G
   Laranjeira, MCM
AF Felicio-Fernandes, G
   Laranjeira, MCM
TI Calcium phosphate biomaterials from marine algae. Hydrothermal synthesis
   and characterisation
SO QUIMICA NOVA
LA English
DT Article
DE hydroxyapatite; calcium phosphate ceramics; algae
ID BIOCOMPATIBLE WHISKERS; CARBONATED APATITES; HYDROXYAPATITE; BONE;
   HYDROLYSIS; CORAL; HYDROXYLAPATITE; IMMOBILIZATION; STOICHIOMETRY;
   MONETITE
AB Calcium phosphate compounds such as Hydroxyapatite (HAp) were prepared by hydrothermal synthesis with phycogenic CaCO3 as starting material. Material obtained was characterised by usual methods (XRD, FTIR, TG, N-2-adsorption, SEM and EDX) in order to study its physical-chemical characteristics. The prepared HAp showed that it may be suitable for use as a biomaterial.
C1 Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
RP Felicio-Fernandes, G (reprint author), Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil.
CR Bet MR, 1997, QUIM NOVA, V20, P475, DOI 10.1590/S0100-40421997000500006
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BOULTON MI, 1991, MATER LETT, V12, P1
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   BROWN WE, 1979, J PHYS CHEM-US, V83, P1385, DOI 10.1021/j100474a006
   CALVERT PD, 1996, MAT SCI TECHNOL B, V17, P51
   CHICZ RM, 1989, ANAL CHEM, V61, P1742, DOI 10.1021/ac00190a030
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Correia RN, 1996, J MATER SCI-MATER M, V7, P501, DOI 10.1007/BF00705432
   DEMAEYER EAP, 1993, INORG CHEM, V32, P5709, DOI 10.1021/ic00077a011
   DEMAEYER EAP, 1994, INORG CHEM, V33, P5999, DOI 10.1021/ic00104a006
   DEMAEYER EAP, 1995, INORG CHEM, V34, P2085
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   DRIESSENS FCM, 1983, Z ANORG ALLG CHEM, V504, P195, DOI 10.1002/zaac.19835040925
   EANES ED, 1983, CALCIUM BIOL, P200
   ELDEEB ME, 1988, J ORAL MAXILLOFAC SU, V40, P955
   EYSEL W, 1975, Z KRISTALLOGR, V141, P11, DOI 10.1524/zkri.1975.141.1-2.11
   EYSEL W, 1973, J CRYST GROWTH, V20, P245, DOI 10.1016/0022-0248(73)90012-2
   FELICIOFERNANDE.G, UNPUB
   FERNANDEZ VL, 1992, J AM CHEM SOC, V114, P9634, DOI 10.1021/ja00050a051
   GONZALEZ R, 1993, QUIM NOVA, V16, P509
   GREGG SJ, 1982, ADSORPTION SURFACE A, P130
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   HOLMES R, 1984, CLIN ORTHOPAEDICS, V188, P252
   Iijima M, 1996, CALCIFIED TISSUE INT, V59, P377, DOI 10.1007/s002239900143
   KANDORI K, 1995, CHEM MATER, V7, P26, DOI 10.1021/cm00049a007
   KASPERK C, 1988, DEUT ZAHNAERZTL Z, V43, P116
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   Kawachi EY, 1998, BIOMATERIALS, V19, P2329, DOI 10.1016/S0142-9612(98)00148-3
   KENNEY EB, 1986, J PERIODONTOL, V57, P76, DOI 10.1902/jop.1986.57.2.76
   KOHN D, 1992, MAT SCI TECHNOLOGY C, V14, P70
   LEE KY, 1994, J CATAL, V145, P223, DOI 10.1006/jcat.1994.1026
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   MA QY, 1994, ENVIRON SCI TECHNOL, V28, P1219, DOI 10.1021/es00056a007
   MA QY, 1993, ENVIRON SCI TECHNOL, V27, P1803, DOI 10.1021/es00046a007
   MATSUMURA Y, 1994, J CATAL, V148, P323, DOI 10.1006/jcat.1994.1213
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   Murata H, 1996, CARIES RES, V30, P465, DOI 10.1159/000262361
   MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218
   NADAL M, 1970, J CHIM PHYS PCB, V67, P1161, DOI 10.1051/jcp/1970671161
   NAKAMOTO K, 1986, INFRARED RAMAN SPECT, P106
   NANCOLLAS GH, 1989, ANAT RECORD, V224, P234, DOI 10.1002/ar.1092240213
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   NEUMAN WF, 1953, CHEM REV, V53, P1, DOI 10.1021/cr60164a001
   Oliveira Eurico C., 1996, Anais da Academia Brasileira de Ciencias, V68, P17
   PERLOFF A, 1960, INORG SYN, V6, P16, DOI 10.1002/9780470132371.ch6
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Reichert J, 1996, J MATER SCI, V31, P1231, DOI 10.1007/BF00353102
   Ross P E, 1989, Sci Am, V261, P34
   ROY DM, 1974, MATER RES BULL, V9, P35, DOI 10.1016/0025-5408(74)90005-1
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   ROY DM, 1975, Patent No. 3929971
   SHIMABAYASHI S, 1981, CHEM PHARM BULL, V29, P2116
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   SUCHANEK W, 1995, J MATER RES, V10, P521, DOI 10.1557/JMR.1995.0521
   Tucker BE, 1996, BIOMATERIALS, V17, P631, DOI 10.1016/0142-9612(96)88714-X
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WILLIAMS DF, 1992, MAT SCI TECHNOLOGY C, V14, P259
   WOLKE JCG, 1993, P 1993 NAT THERM SPR, P619
   XU YP, 1994, ENVIRON SCI TECHNOL, V28, P1472, DOI 10.1021/es00057a015
   Yasukawa A, 1996, J MATER CHEM, V6, P1401, DOI 10.1039/jm9960601401
   YASUKAWA A, 1994, POLYHEDRON, V13, P3079
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   YSHIKAWA T, 1995, J MATER CHEM, V5, P1963
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
NR 71
TC 36
Z9 38
U1 1
U2 20
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
J9 QUIM NOVA
JI Quim. Nova
PD JUL-AUG
PY 2000
VL 23
IS 4
BP 441
EP 446
DI 10.1590/S0100-40422000000400002
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 341UU
UT WOS:000088609600001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zhang, M
   Lorimor, JC
AF Zhang, M
   Lorimor, JC
TI Manure solids separation by filtration with four crop residues
SO TRANSACTIONS OF THE ASAE
LA English
DT Article
DE biomaterial; biofilter; animal waste; water quality; liquid-solids
   separation
AB Laboratory research was conducted to determine the effectiveness of using five crop residues as filters to separate solids from liquid swine manure. Solids removal efficiencies and plugging characteristics were examined Oat straw, soybean stubble, and corn stover were found to be effective filter materials; corncobs and ground corncobs were not. As expected, solids removal efficiencies were higher for manure with 6.0% solids initially than for manure with 1.4% solids, but plugging occurred sooner. Most of the separation occurred within the top portion of the filters.
C1 Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.
RP Lorimor, JC (reprint author), Iowa State Univ, Dept Agr & Biosyst Engn, 200A Davidson Hall, Ames, IA 50011 USA.
CR American Public Health Association, 1992, STAND METH EX WAT WA
   Dickenson T. C., 1997, FILTERS FILTRATION H
   HUIJSMANS J, 1984, T ASAE, V27, P1854
   MOORE JA, 1975, T ASAE, V18, P694
   PURCHAS D, 1996, HDB FILTER MEDIA
   Purchas D. B., 1971, IND FILTRATION LIQUI, P209
   Rushton A., 1996, SOLID LIQUID FILTRAT
   Wu Chen Solid-liquid, 1997, CHEM ENG         FEB, P66
   Zhang R. H., 1997, Applied Engineering in Agriculture, V13, P385
NR 9
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC AGRICULTURAL ENGINEERS
PI ST JOSEPH
PA 2950 NILES RD, ST JOSEPH, MI 49085-9659 USA
SN 0001-2351
J9 T ASAE
JI Trans. ASAE
PD JUL-AUG
PY 2000
VL 43
IS 4
BP 981
EP 985
PG 5
WC Agricultural Engineering
SC Agriculture
GA 358ZU
UT WOS:000089587700024
DA 2018-10-19
ER

PT J
AU Connors, D
   Gies, D
   Lin, H
   Gruskin, E
   Mustoe, TA
   Tawil, NJ
AF Connors, D
   Gies, D
   Lin, H
   Gruskin, E
   Mustoe, TA
   Tawil, NJ
TI Increase in wound breaking strength in rats in the presence of
   positively charged dextran beads correlates with an increase in
   endogenous transforming growth factor-beta 1 and its receptor TGF-beta
   RI in close proximity to the wound
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID SOFT-TISSUE REPAIR; ION-EXCHANGE BEADS; PDGF-BB; EXPRESSION; CELLS;
   BIOMATERIAL; STIMULATION; INHIBITORS; SECRETION; EFFICACY
AB We have previously shown that positively charged beads (DEAE A25) increase wound breaking strength in linear incisions in rats and nonhuman primates at days 10-14 post-wounding, The increased wound strength may result in part. from a stimulation of cells adjacent to the DEAE A25 beads to produce growth factors important for wound heating. In this report, we investigate this hypothesis by comparing the relative expression levels of transforming growth factor-beta 1 and its receptor transforming growth factor-beta receptor type I in DEAE A25-treated and contralateral untreated rat linear incisions. DEAE A25-treated incisions were stronger than untreated control wounds at 3 days post-wounding, and the difference in breaking strength reached statistical significance at days 5, 7 and 10. Immunohistochemical analysis revealed a significant increase in transforming growth factor-beta 1 and transforming growth factor-beta receptor type I expression in DEAE A25-treated incisions, up to 7 days post-wounding, as compared to untreated control wounds. FAGS analysis revealed that macrophage cell lines exposed to DEAE A25 in vitro upregulate transforming growth factor-beta 1 and transforming growth factor-beta receptor type I expression by 2-3 fold. Therefore, the increase in expression of transforming growth factor-beta 1 and transforming growth factor-beta receptor type I in DEAE A25-treated incisions may be due to an increase in the concentration of macrophages adjacent to DEAE A25 beads, as well as the stimulation of individual macrophages to produce greater amounts of transforming growth factor-beta 1 and transforming growth factor-beta receptor type I. This study also supports the significance of transforming growth factor-beta 1 in wound healing.
C1 Northwestern Univ, Sch Med, Div Plast Surg, Chicago, IL 60611 USA.
   Life Sci, N Haven, CT USA.
RP Mustoe, TA (reprint author), Northwestern Univ, Sch Med, Div Plast Surg, 707 N Fairbanks Court,Suite 811, Chicago, IL 60611 USA.
CR AMMANN AJ, 1990, ANN NY ACAD SCI, V593, P124, DOI 10.1111/j.1749-6632.1990.tb16105.x
   ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020
   BECK LS, 1993, J CLIN INVEST, V92, P2841, DOI 10.1172/JCI116904
   Buckmire MA, 1998, J SURG RES, V80, P52, DOI 10.1006/jsre.1998.5326
   Burgess E, 1998, PLAST RECONSTR SURG, V102, P2395, DOI 10.1097/00006534-199812000-00019
   Christoforou C, 1998, J BIOMED MATER RES, V42, P376, DOI 10.1002/(SICI)1097-4636(19981205)42:3<376::AID-JBM5>3.0.CO;2-G
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   Galiano RD, 1996, ANN PLAS SURG, V36, P608, DOI 10.1097/00000637-199606000-00008
   Herrick S, 1997, LAB INVEST, V77, P281
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   LU X, 1998, ONCOGENE, V30, P441
   MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O
   MASSAGUE J, 1992, CANCER SURV, V12, P81
   McCulloch RK, 1998, INT J BIOCHEM CELL B, V30, P1265, DOI 10.1016/S1357-2725(98)00056-9
   MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130
   MOSES HL, 1985, CANCER CELL, V3, P65
   Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.3.CO;2-0
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   PICKER LJ, 1995, BLOOD, V86, P1408
   PIERCE GF, 1995, J CLIN INVEST, V96, P1336, DOI 10.1172/JCI118169
   Roberts A.B., 1990, HDB EXPT PHARM PEPTI, P419
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   ROBERTS AB, 1993, GROWTH FACTORS, V8, P1
   ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119
   Servold S A, 1991, Clin Podiatr Med Surg, V8, P937
   SHIPLEY GD, 1986, CANCER RES, V46, P2068
   Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x
   SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017
   Steed DL, 1998, CLIN PLAST SURG, V25, P397
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   Tawil NJ, 1999, WOUND REPAIR REGEN, V7, P389, DOI 10.1046/j.1524-475X.1999.00389.x
   tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139
   Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443
   Vogt PM, 1998, PLAST RECONSTR SURG, V102, P117, DOI 10.1097/00006534-199807000-00018
   WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135
   Wlaschek M, 1997, BRIT J DERMATOL, V137, P646, DOI 10.1111/j.1365-2133.1997.tb03804.x
   Wu LC, 1999, J SURG RES, V85, P43, DOI 10.1006/jsre.1999.5354
   Yoshizawa M, 1998, J CELL PHYSIOL, V176, P565, DOI 10.1002/(SICI)1097-4652(199809)176:3<565::AID-JCP13>3.0.CO;2-Z
NR 42
TC 15
Z9 15
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JUL-AUG
PY 2000
VL 8
IS 4
BP 292
EP 303
DI 10.1046/j.1524-475X.2000.00292.x
PG 12
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 351KU
UT WOS:000089157000008
PM 11013021
DA 2018-10-19
ER

PT J
AU Weiner, S
   Addadi, L
   Wagner, HD
AF Weiner, S
   Addadi, L
   Wagner, HD
TI Materials design in biology
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT IUMRS-ICAM 1999 Meeting
CY JUN, 1999
CL BEIJING, PEOPLES R CHINA
SP IUMRS, ICAM
DE biomaterial; biomineralization; isotropy; biomechanics
ID LAMELLAR BONE; ORGANIC MATRIX; MINERALIZATION; ORGANIZATION; CRYSTALS;
   SPICULE; DENTIN
AB The materials formed by organisms are often the products of hundreds of millions of years of fine-tuning by evolution. They thus incorporate some neat solutions to complex structural problems. Here, we examine four different mineralized biological materials that all appear to fulfill a multipurpose function. They are the crossed lamellar structure of mollusk shells, the skeleton of sea urchins, the lamellar bone type of vertebrates, and the biogenic silica deposited by a wide variety of organisms. They all have very different structures and compositions, but are all structurally designed to reduce the extent of mechanical anisotropy. The strategies for reducing anisotropy are manifold, including features that to date have not been incorporated into synthetic materials. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.
   Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.
RP Weiner, S (reprint author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821
   Akiva U, 1998, J MATER SCI, V33, P1497, DOI 10.1023/A:1004303926771
   Ameye L, 1998, HISTOCHEM CELL BIOL, V110, P285, DOI 10.1007/s004180050290
   BENSON S, 1983, EXP CELL RES, V148, P249, DOI 10.1016/0014-4827(83)90204-5
   Boggild OB, 1930, K DAN VIDENSK SELSK, V9, P233
   Currey JD, 1984, MECH ADAPTATIONS BON
   DERICQLES A, 1991, COMP MICROSTRUCTURE, P1
   Enlow D. E., 1958, Texas Journal of Science, V10, P187
   GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330
   KAUFMAN PB, 1981, COMP HISTOLOGICL S 2, P409
   KuhnSpearing LT, 1996, J MATER SCI, V31, P6583, DOI 10.1007/BF00356266
   LARAIA VJ, 1990, P MRS S, V174, P117
   LEES S, 1992, CONNECT TISSUE RES, V28, P263, DOI 10.3109/03008209209016820
   LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516
   LIU D, 2000, J BIOMECH, V32, P647
   Lowenstam HA, 1989, BIOMINERALIZATION
   LUI D, 2000, J MAT MED, V11, P49
   Parkhouse JG, 1998, P ROY SOC A-MATH PHY, V454, P1889, DOI 10.1098/rspa.1998.0239
   PERRY CC, 1984, PROC R SOC SER B-BIO, V222, P427, DOI 10.1098/rspb.1984.0075
   RASMUSSEN ST, 1976, J DENT RES, V55, P154, DOI 10.1177/00220345760550010901
   RIGGS CM, 1993, ANAT EMBRYOL, V187, P239
   Sangster A.G., 1981, SILICON SILICEOUS ST, P383
   Simpson T.L, 1981, SILICON SILICEOUS ST
   SU X, 2000, UNPUB MICROSTRUCTURA
   Thompson DW, 1942, GROWTH FORM
   TOWE KM, 1967, SCIENCE, V157, P1048, DOI 10.1126/science.157.3792.1048
   Uozumi S., 1972, Journal Fac Sci Hokkaido Univ (Geol Miner), V15, P447
   Vincent JFV., 1982, STRUCTURAL BIOMATERI
   Wainwright S. A., 1976, MECH DESIGN ORGANISM
   Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   WEINER S, 1979, CALCIFIED TISSUE INT, V29, P137
   WEINER S, 1997, BONE, V20, P271
   Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X
NR 39
TC 128
Z9 134
U1 3
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 30
PY 2000
VL 11
IS 1
BP 1
EP 8
DI 10.1016/S0928-4931(00)00141-7
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 336YU
UT WOS:000088331200002
DA 2018-10-19
ER

PT J
AU Zhou, BL
AF Zhou, BL
TI Bio-inspired study of structural materials
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT IUMRS-ICAM 1999 Meeting
CY JUN, 1999
CL BEIJING, PEOPLES R CHINA
SP IUMRS, ICAM
DE bio-inspired; bionic; biomimetic; structural materials
ID COMPOSITES
AB The terminology of materials study inspired by biological systems or phenomena is analyzed at first. It is pointed that the term "bio-inspired" may be better than the terms "bionic" or "biomimetic", since the former is relatively easy to be accepted. The new trends of bio-inspired study of structural materials are analyzed in short. Some progress in bio-inspired design and processing of materials in this institute (IMRCAS) are summarized briefly in this talk, such as biomimetic design of worst bonding interface for composites; dumbell-like whiskers simulating animal bone; fractal tree reinforcement by mimicry of branched roots in soil; etc.
   The possibility of modification and recovery of materials by nonequilibrium bio-inspired treatment are further explored, including the nonequilibrium process under transient heating, dissipative structure and self-organization process of open system, inspiration by living process, influence of high intensive electropulsing on the working Life of materials, a possible way of fatigue recovery of materials and the healing effect of electropulsing in metals. Some tentative practice in biomaterial modification are also studied such as the reformed bamboo reinforced aluminium laminates, etc. A discussion on the methodology of bio-inspired study of materials consists briefly in the last part of the talk. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Chinese Acad Sci, Int Ctr Mat Phys, Inst Met Res, Shenyang 110015, Peoples R China.
RP Zhou, BL (reprint author), Chinese Acad Sci, Int Ctr Mat Phys, Inst Met Res, 72 Wenhua Rd, Shenyang 110015, Peoples R China.
RI Sanguansri, Luz/B-6630-2011
OI Sanguansri, Luz/0000-0003-1908-7604
CR CHENG HM, 1995, 22 BIENN C CARB U CA, P306
   FU SY, 1993, SCRIPTA METALL MATER, V29, P1541, DOI 10.1016/0956-716X(93)90274-V
   Fut S. Y., 1992, SMART MATER STRUCT, V1, P180
   JIA X, 1994, 94 FALL S CHIN MAT R, P21
   LI SH, 1994, J MATER SCI, V29, P5990, DOI 10.1007/BF00366884
   OUYANG RB, 1987, PROG PHYS, V7, P313
   Qin R. S., 1996, Biomimetics, V4, P121
   QIN RS, 1996, 96 S CHIN MAT RES SO
   SHEN KH, 1982, PRIGOGINE THEORY DIS
   Sui Guoxin, 1996, Acta Metallurgica Sinica, V32, P97
   TANG DW, 1991, APPL PHYS LETT, V59, P3113, DOI 10.1063/1.105755
   TIAN XB, 1994, ACTA METALL SINICA, V30, P180
   yifu Shen, 1996, CHIN J MAT RES, V10, p[165, 165]
   ZHAO XP, 1994, ACTA METALL SINICA, V30, P187
   ZHOU BL, 1995, COMPOS ENG, V5, P1261, DOI 10.1016/0961-9526(95)00061-Q
   Zhou BL, 1996, MATER CHEM PHYS, V45, P114, DOI 10.1016/0254-0584(96)80087-3
   Zhou BL, 1997, INT J THERMOPHYS, V18, P481, DOI 10.1007/BF02575177
   ZHOU BL, 1997, 3 INT C FRACT STRENG, P765
   ZHOU BL, IUMRSICA94, P117
   ZHOU BL, 1998, 5 AS THERM PROP C AU
   ZHOU BL, 1991, C MRS INT 90, P137
   ZHOU BL, 1997, CHIN J MAT RES, V11, P576
   ZHOU BL, 1994, JOM              FEB, P57
NR 23
TC 39
Z9 49
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 30
PY 2000
VL 11
IS 1
BP 13
EP 18
DI 10.1016/S0928-4931(00)00136-3
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 336YU
UT WOS:000088331200004
DA 2018-10-19
ER

PT J
AU Young, TH
   Lin, DT
   Chen, LY
AF Young, TH
   Lin, DT
   Chen, LY
TI Human monocyte adhesion and activation on crystalline polymers with
   different morphology and wettability in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE surface morphology; surface wettability; monocyte; adhesion; activation
ID INTERLEUKIN-1 GENERATION; CYTOKINE PRODUCTION; EVAL MEMBRANES; SURFACES;
   GROWTH; MACROPHAGES; IMPLANTS; INVITRO; CELLS; TNF
AB This study evaluated the effects of crystalline polyamide (Nylon-66), poly(ethylene-co-vinyl alcohol) (PEVA), and poly(vinylidene fluoride) (PVDF) polymers with nonporous and porous morphologies on the ability of monocytes to adhere and subsequently activate to produce IL-1 beta, IL-6, and tumor necrosis factor alpha. The results indicated monocyte adhesion and activation on a material might differ to a great extent, depending on the surface morphology and wettability. As the polymer wettability increases, the ability of monocytes to adhere increases but the ability to produce cytokines decreases. Similarly, these polymers, when prepared with porous surfaces, enhance monocyte adhesion but suppress monocyte release of cytokines. Therefore, the hydrophobic PVDF with a nonporous surface stimulates the most activity in adherent monocytes but shows the greatest inhibition of monocyte adhesion when compared with all of the other membranes. In contrast, the hydrophilic Nylon-66, which has a porous surface, is a relatively better substrate fur this work. Therefore, monocyte behavior on a biomaterial may be influenced by a specific surface property. Based on this result, we propose that monocyte adhesion is regulated by a different mechanism than monocyte activation. Consequently, the generation of cytokines by monocytes is not proportional to the number of cells adherent to the surface. (C) 2000 John Wiley & Sons, Inc.
C1 Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Coll Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Coll Med, Dept Lab Med, Taipei 10016, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
OI LIN, DONG-TSAMN/0000-0002-5773-3200
CR ANDERSON JM, 1988, ASAIO, V11, P101
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRUIL A, 1992, BIOMATERIALS, V13, P915, DOI 10.1016/0142-9612(92)90114-4
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Cheng LP, 1998, POLYMER, V39, P2135, DOI 10.1016/S0032-3861(97)00518-1
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DINARELLO CA, 1985, J CLIN IMMUNOL, V5, P287, DOI 10.1007/BF00918247
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   KATAOKA K, 1985, MAKROMOL CHEM S, V9, P53
   Kesting R.E., 1985, SYNTHETIC POLYM MEMB
   LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804
   Lin DT, 1998, J MEMBRANE SCI, V140, P185, DOI 10.1016/S0376-7388(97)00281-0
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   PERTOFT H, 1980, J IMMUNOL METHODS, V33, P221, DOI 10.1016/0022-1759(80)90209-4
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   RANTER B, 1997, J BIOMED MATER RES, V21, P59
   VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727
   WARD RA, 1994, NEPHROL DIAL TRANSPL, V9, P46
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 28
TC 21
Z9 21
U1 2
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2000
VL 50
IS 4
BP 490
EP 498
DI 10.1002/(SICI)1097-4636(20000615)50:4<490::AID-JBM4>3.0.CO;2-N
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 308UX
UT WOS:000086732200004
PM 10756307
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Behar-Cohen, F
   Tabatabay, C
   Savoldelli, M
   D'Hermies, F
   Chauvaud, D
   Heller, J
   Gurny, R
AF Einmahl, S
   Behar-Cohen, F
   Tabatabay, C
   Savoldelli, M
   D'Hermies, F
   Chauvaud, D
   Heller, J
   Gurny, R
TI A viscous bioerodible poly(ortho ester) as a new biomaterial for
   intraocular application
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; poly(ortho esters); biodegradable polymers; intraocular;
   biocompatibility
ID GLAUCOMA FILTERING SURGERY; EXPERIMENTAL PROLIFERATIVE
   VITREORETINOPATHY; SUSTAINED-RELEASE; DRUG-DELIVERY; 5-FLUOROURACIL;
   BIOCOMPATIBILITY; DEXAMETHASONE; DEGRADATION; POLYMER; ACID
AB The biocompatibility of a viscous, hydrophobic, bioerodible poly(ortho ester) (POE) intended for intraocular application was investigated. POE was evaluated as a blank carrier and as containing modulators of degradation. Each formulation was injected intracamerally and intravitreally in rabbit eyes, and clinical and histological examinations were performed postoperatively for 2 weeks. In the case of intracameral injections, polymer biocompatibility appeared to depend on the amount injected in the anterior chamber. When 50 mu L was administered, the polymer degraded within 2 weeks, and clinical observations showed good biocompatibility of POE with no toxicity to the ocular tissues or increase in intraocular pressure. The injection of a larger volume, 100 mu L, of POE, appeared inappropriate because of direct contact of polymeric material with the corneal endothelium, and triggered reversible edema and inflammation in the anterior chamber of the eye that regressed after a few days. After intravitreal administration, POE was well tolerated and no inflammatory reaction developed during the observation period. The polymer degraded slowly, appearing as a round whitish bubble in the vitreous cavity. The presence of modulators of degradation both improved POE biocompatibility and prolonged polymer lifetime in the eye. POE appears to be a promising biomaterial for clinical intraocular application. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   Hotel Dieu Paris, Dept Ophthalmol, F-75004 Paris, France.
   Adv Polymer Syst, Redwood City, CA 94063 USA.
RP Gurny, R (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
CR Alward WLM, 1996, AM J OPHTHALMOL, V121, P349
   ARAIE M, 1990, GRAEF ARCH CLIN EXP, V228, P573, DOI 10.1007/BF00918493
   BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   BERNATCHEZ SF, 1993, J BIOMED MATER RES, V27, P677, DOI 10.1002/jbm.820270515
   BLUMENKRANZ MS, 1989, RETINA, P401
   Chang MR, 1998, J OCUL PHARMACOL TH, V14, P75, DOI 10.1089/jop.1998.14.75
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   Enyedi LB, 1996, CURR EYE RES, V15, P549, DOI 10.3109/02713689609000766
   GIORDANO GG, 1993, INVEST OPHTH VIS SCI, V34, P2743
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HASHIZOE M, 1994, ARCH OPHTHALMOL-CHIC, V112, P1380, DOI 10.1001/archopht.1994.01090220130035
   HELLER J, 1993, ADV POLYM SCI, V107, P41
   LEE DA, 1988, INVEST OPHTH VIS SCI, V29, P1692
   LEWIS H, 1991, AM J OPHTHALMOL, V111, P15, DOI 10.1016/S0002-9394(14)76890-4
   Maurice D, 1984, PHARM EYE, V69, P19
   MCRAE SM, 1983, AM J OPHTHALMOL, V95, P332
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   PATITSAS CJ, 1992, OPHTHALMOLOGY, V99, P594
   PEYMAN GA, 1987, INT OPHTHALMOL, V10, P133, DOI 10.1007/BF00139338
   RUBSAMEN PE, 1994, ARCH OPHTHALMOL-CHIC, V112, P407, DOI 10.1001/archopht.1994.01090150137036
   TAHERY MM, 1989, J OCUL PHARMACOL, V5, P155, DOI 10.1089/jop.1989.5.155
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
   WIEDEMANN P, 1992, CURR OPIN OPHTHALMOL, V3, P357, DOI 10.1097/00055735-199206000-00010
   Yang CS, 1998, ARCH OPHTHALMOL-CHIC, V116, P69, DOI 10.1001/archopht.116.1.69
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   ZIGNANI M, 1998, P INT S CONTROL REL, V25, P715
   ZIGNANI M, 1997, P INT S CONTR REL BI, V24, P907
NR 30
TC 34
Z9 37
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2000
VL 50
IS 4
BP 566
EP 573
DI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 308UX
UT WOS:000086732200012
PM 10756315
DA 2018-10-19
ER

PT J
AU Collier, JH
   Camp, JP
   Hudson, TW
   Schmidt, CE
AF Collier, JH
   Camp, JP
   Hudson, TW
   Schmidt, CE
TI Synthesis and characterization of polypyrrole-hyaluronic acid composite
   biomaterials for tissue engineering applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE conductive polymer; polypyrrole; hyaluronic acid; tissue engineering;
   biomaterial; glycosaminoglycan; angiogenesis
ID GROWTH; FILMS; COLLAGEN; MOTILITY; POLYMER; ANIONS; HYBRID
AB New tissue engineering technologies will rely on biomaterials that physically support tissue growth and stimulate specific cell functions. The goal of this study was to create a biomaterial that combines inherent biological properties which can specifically trigger desired cellular responses (e.g., angiogenesis) with electrical properties which have been shown to improve the regeneration of several tissues including bone and nerve. To this end, composites of the biologically active polysaccharide hyaluronic acid (HA) and the electrically conducting polymer polypyrrole (PP) were synthesized and characterized. Electrical conductivity of the composite biomaterial (PP/HA) was measured by a four-point probe technique, scanning electron microscopy was used to characterize surface topography, X-ray photoelectron spectroscopy and reflectance infrared spectroscopy were used to evaluate surface and bulk chemistry, and an assay with biotinylated hyaluronic acid binding protein was used to determine surface HA content. PP/HA materials were also evaluated for in vitro cell compatibility and tissue response in rats. Smooth, conductive, FIA-containing PP films were produced; these films retained HA on their surfaces for several days in vitro, and promoted vascularization in vivo. PP/HA composite biomaterials are promising candidates for tissue engineering and wound-healing applications that may benefit from both electrical stimulation and enhanced vascularization. (C) 2000 John Wiley & Sons, inc.
C1 Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   BOYLE A, 1990, J ELECTROANAL CHEM, V279, P179, DOI 10.1016/0022-0728(90)85175-5
   CARBONETTO S, 1983, J NEUROSCI, V3, P2324
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   DIAZ AF, 1978, HDB CONDUCTING POLYM
   ERICKSON CA, 1983, J CELL SCI, V61, P299
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   GENIES EM, 1992, ELECTROCHIM ACTA, V37, P1015, DOI 10.1016/0013-4686(92)85217-9
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Langer R, 1992, EXS, V61, P327
   LAURENT TC, 1992, FASEB J, V6, P2397
   LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4
   LI HC, 1995, MACROMOL CHEM PHYSIC, V196, P1801, DOI 10.1002/macp.1995.021960601
   NAGY JI, 1995, J NEUROSCI, V15, P241
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin MC, 1996, BIOSENS BIOELECTRON, V11, P161, DOI 10.1016/0956-5663(96)83723-7
   TENGBLAD A, 1979, Biochimica et Biophysica Acta, V578, P281
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   VORK FTA, 1990, ELECTROCHIM ACTA, V35, P567, DOI 10.1016/0013-4686(90)87045-4
   WAGNER SF, 1992, INTRO STAT
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
NR 25
TC 237
Z9 246
U1 5
U2 101
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2000
VL 50
IS 4
BP 574
EP 584
DI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 308UX
UT WOS:000086732200013
PM 10756316
DA 2018-10-19
ER

PT J
AU Vacheethasanee, K
   Marchant, RE
AF Vacheethasanee, K
   Marchant, RE
TI Surfactant polymers designed to suppress bacterial (Staphylococcus
   epidermidis) adhesion on biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE S. epidermidis; bacterial adhesion; poly(ethylene oxide) surfactant
   polymers; dextran surfactant polymers; rotating disk system
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; PROTEIN ADSORPTION; PLASMA-PROTEINS;
   CELL-ADHESION; POLYETHYLENE; HEPARIN; POLYSTYRENE; ENUMERATION;
   VITRONECTIN; FIBRONECTIN
AB We describe a series of surfactant polymers designed as surface-modifying agents for the suppression of bacterial adhesion on biomaterials. The surfactant polymers consist of a poly(vinyl amine) backbone with hydrophilic poly(ethylene oxide) (PEO) and hydrophobic hexanal (Hex) side chains (PVAm/PEO:Hex). Surface modification is accomplished by simple dip coating from aqueous solution, from which surfactant polymers undergo spontaneous surface-induced assembly on hydrophobic biomaterials. The stability of PVAm/PEO:Hex on pyrolytic graphite (HOPG) and polyethylene (PE) was demonstrated by the absence of detectable desorption under flow conditions of pure water over a 24-h period. PEO surfactant polymers with four different PEO:Hex ratios (1:1.4, 1:2.5, 1:4.6, and 1:10.7) and a dextran surfactant polymer were compared with respect to S. epidermidis adhesion under dynamic flow conditions. Suppression of S. epidermidis adhesion was achieved for all modified surfaces over the shear range 0-15 dyn/cm(2). The effectiveness depended on the surfactant polymer composition such that S. epidermidis adhesion to modified surfaces decreased significantly with increasing PEO packing density. Modified HOPG was more effective in reducing bacterial adhesion compared with the corresponding modification on PE, which we attribute to the presence of defects in surfactant polymer assembly on PE. Our results are discussed from the perspective of critical factors, such as optimal PEO packing density and hydration thickness, that contribute to the effectiveness of surfactant polymers to shield a biomaterial from adhesive bacterial interactions. (C) 2000 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Marchant, RE (reprint author), Case Western Reserve Univ, Dept Macromol Sci, 10900 Euclid Ave,Wickenden Bldg, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL47300]
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   DEGENNES PG, 1988, PHYSICAL BASIS CELL, P40
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Dunkirk S G, 1991, J Biomater Appl, V6, P131, DOI 10.1177/088532829100600203
   EVANSHURRELL JA, 1993, FEMS MICROBIOL LETT, V107, P77
   HAMILTON WC, 1972, J COLLOID INTERF SCI, V40, P219, DOI 10.1016/0021-9797(72)90011-2
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Holland NB, 1998, NATURE, V392, P799
   HOLLAND NB, 1999, THESIS CASE W RESERV
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   KRONVALL G, 1977, ACTA PATH MICRO IM B, V85, P249
   LASIC DD, 1997, CHEM BIOL APPL, P31
   Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OWENS NF, 1987, J CELL SCI, V87, P667
   PAULSSON M, 1994, J BIOMED MATER RES, V28, P311, DOI 10.1002/jbm.820280305
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Qiu YX, 1998, MACROMOLECULES, V31, P165, DOI 10.1021/ma9707401
   REILLY LM, 1984, J VASC SURG, V1, P36, DOI 10.1067/mva.1984.avs0010036
   RUSSELL PB, 1987, J CLIN MICROBIOL, V25, P1083
   SIERACKI ME, 1985, APPL ENVIRON MICROB, V49, P799
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VACHEETHASANEE K, IN PRESS HDB STUDYIN
   VACHEETHASANEE K, IN PRESS COMB LIKE S
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
NR 35
TC 60
Z9 63
U1 2
U2 27
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2000
VL 50
IS 3
BP 302
EP 312
DI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 298QN
UT WOS:000086150800003
PM 10737871
DA 2018-10-19
ER

PT J
AU Redey, SA
   Nardin, M
   Bernache-Assolant, D
   Rey, C
   Delannoy, P
   Sedel, L
   Marie, PJ
AF Redey, SA
   Nardin, M
   Bernache-Assolant, D
   Rey, C
   Delannoy, P
   Sedel, L
   Marie, PJ
TI Behavior of human osteoblastic cells on stoichiometric hydroxyapatite
   and type A carbonate apatite: Role of surface energy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE osteoblast; biomaterial; hydroxyapatite; carbonate apatite; wettability;
   osteogenesis
ID FTIR SPECTROSCOPY; ADHESION; BONE; DIFFERENTIATION; ATTACHMENT;
   SUBSTRATA
AB To determine the role of physicochemical characteristics of the surface of dense ceramics on osteoconduction, we studied the proliferation and differentiation of human trabecular (HT) osteoblastic cells, extracellular collagenous matrix production, and biologic apatite formation on stoichiometric hydroxyapatite (HA) and type A carbonate apatite (CA). The surface physicochemical characteristics (composition, roughness) of HA and CA carefully were determined by Fourier-transformed infrared, X-ray photoelectron, and Raman spectroscopies, and by FTIR microscopy, before and after cell culture. On both HA and CA substrates, HT cells attached, proliferated, and differentiated. Cell proliferation did not differ on HA and CA. However, the initial cell attachment and spreading of HT cells were much lower on CA compared to HA. Physicochemical and biologic analyses showed that collagenous synthesis by HT cells after 6 weeks of culture also was lower on CA than on HA. Quantitative histologic analysis confirmed that the collagenous matrix production was lower on CA than on HA. Measurement of wettability showed that the polar interaction energy with water was significantly lower on CA than on HA. The lower cell attachment and collagen production on CA compared to HA clearly were related to the low affinity of HT cells for the CA surface. This study shows that the surface energy of the biomaterial greatly influences the initial cell attachment and spreading of human osteoblastic cells at the surface and affects collagenous matrix deposition on the biomaterial. This suggests that the enhancement of polar components of the surface of dense biomaterials may improve osteoblastic cell attachment and, thereby, osteoconduction. (C) 2000 John Wiley & Sons, Inc.
C1 Hop Lariboisiere, INSERM, U 349, F-75475 Paris 10, France.
   Inst Chim Surfaces & Interfaces, CNRS, UPR 9069, F-68057 Mulhouse, France.
   INP ENSCT UPRESA 5071, Lab Interface & Mat, F-31400 Toulouse, France.
   Fac Med Lariboisiere St Louis, LRO, F-75010 Paris, France.
RP Marie, PJ (reprint author), Hop Lariboisiere, INSERM, U 349, 2 Rue Ambroise Pare, F-75475 Paris 10, France.
CR AMBROSE EJ, 1951, PROC R SOC LON SER-A, V205, P47, DOI 10.1098/rspa.1951.0016
   AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   APFELBAUM F, 1992, J INORG BIOCHEM, V45, P277, DOI 10.1016/0162-0134(92)84016-G
   BAJPAI PK, 1995, BIOMEDICAL ENG HDB, P552
   BALMAIN N, 1982, CALCIFIED TISSUE INT, V34, pS93
   BONEL G, 1964, CR HEBD ACAD SCI, V258, P923
   Bonel G, 1988, Ann N Y Acad Sci, V523, P115, DOI 10.1111/j.1749-6632.1988.tb38506.x
   BONEL G, 1975, PHYSICOCHIMIE CRISTA, P117
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   CAMPBELL AA, 1991, COLLOID SURFACE, V54, P25, DOI 10.1016/0166-6622(91)80046-Q
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dupre A., 1869, THEORIE MECANIQUE CH, P369
   ELFEKI H, 1991, CALCIFIED TISSUE INT, V45, P277
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P248
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GRAVES GA, 1972, ENG MED, V1, P91
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   HENCH LL, 1995, CHEM IND, V7, P547
   HOTT M, 1987, STAIN TECHNOL, V62, P51, DOI 10.3109/10520298709107965
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   LeGeros R. Z., 1970, DEV APPL SPEC      B, V7B, P3
   LEGEROS RZ, 1972, B SOC CHIM FR, P1712
   LEGROS R, 1986, J CHEM RES SYNOP, V1, P8
   MARIE PJ, 1989, IN VITRO CELL DEV B, V25, P373
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   MEYER U, 1993, CELL MATER, V3, P129
   NAKAMOTO K, 1986, INFRARED RAMAN SPECT, P88
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69
   NEUMAN WF, 1956, J AM CHEM SOC, V78, P4263, DOI 10.1021/ja01598a023
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   REGNIER P, 1994, AM MINERAL, V79, P809
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHULTZ J, 1992, MODERN APPROACHES WE, P73
   SCHULTZ J, 1981, 27 INT S MACR, P289
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 40
TC 168
Z9 173
U1 2
U2 41
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2000
VL 50
IS 3
BP 353
EP 364
DI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 298QN
UT WOS:000086150800009
PM 10737877
DA 2018-10-19
ER

PT J
AU Hampp, NA
AF Hampp, NA
TI Bacteriorhodopsin: mutating a biomaterial into an optoelectronic
   material
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
ID RETINAL PROTEINS; HALOBACTERIUM-HALOBIUM; PURPLE MEMBRANE; RESOLUTION;
   RHODOPSIN; MECHANISM; EVENTS
AB Bacteriorhodopsin (BR) is the key protein for the halobacterial photosynthetic capabilities and is one of the very rare molecules which occur in crystalline form in nature. Since its discovery, which was reported in 1971, many efforts have been made to exploit the obvious technical potential of this molecule. Successful application of gene technology methods for the modification of the physical function of a biomolecule was first demonstrated with BR. This approach points the way to a new class of materials derived from evolutionary optimized biomaterials by genetic re-engineering. Mutated BRs proved to have significant advantages over the wild type in optical applications. The current status of potential technical applications of BR is reviewed. BR is employed as a photoelectric, photochromic or energy-converting element. First systems now exist which demonstrate the successful integration of this new material into existing technologies. Analyzing the patents filed, which claim the processing or application of BR, gives an indication to areas where further technical uses are to be expected in the near future.
C1 Univ Marburg, Fachbereich Chem, Inst Chem Phys, D-35032 Marburg, Germany.
   Univ Marburg, Wissenschaftliches Zentrum Mat Wissensch, D-35032 Marburg, Germany.
RP Hampp, NA (reprint author), Univ Marburg, Fachbereich Chem, Inst Chem Phys, D-35032 Marburg, Germany.
CR BALDWIN JM, 1988, J MOL BIOL, V202, P585, DOI 10.1016/0022-2836(88)90288-4
   BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343
   BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X
   EISENBACH M, 1977, FEBS LETT, V81, P77, DOI 10.1016/0014-5793(77)80932-0
   Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367
   HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1016/S0022-2836(05)80151-2
   HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Hong FT, 1997, MAT SCI ENG C-BIOMIM, V4, P267, DOI 10.1016/S0928-4931(97)00011-8
   KESZTHELYI L, 1997, BIOELECTROCHEM PRINC, V4, P457
   Khodonov AA, 1996, BIOORG KHIM+, V22, P745
   KOYAMA K, 1994, SCIENCE, V265, P762, DOI 10.1126/science.265.5173.762
   LANYI JK, 1981, TRENDS BIOCHEM SCI, V6, P60, DOI 10.1016/0968-0004(81)90022-0
   Lanyi JK, 1997, J BIOL CHEM, V272, P31209, DOI 10.1074/jbc.272.50.31209
   MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   NI B, 1990, GENE, V90, P169, DOI 10.1016/0378-1119(90)90456-2
   NUSS MC, 1985, CHEM PHYS LETT, V117, P1, DOI 10.1016/0009-2614(85)80393-6
   OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0
   OESTERHELT D, 1976, FEBS LETT, V64, P20, DOI 10.1016/0014-5793(76)80238-4
   OESTERHELT D, 1991, Q REV BIOPHYS, V24, P425, DOI 10.1017/S0033583500003863
   OESTERHELT D, 1992, J BIOENERG BIOMEMBR, V24, P181, DOI 10.1007/BF00762676
   Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0
   SKULACHEV VP, 1993, Q REV BIOPHYS, V26, P177, DOI 10.1017/S0033583500004066
   SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0
   TRISSL HW, 1977, NATURE, V266, P655, DOI 10.1038/266655a0
   VSEVOLODOV NN, 1994, TRENDS BIOTECHNOL, V12, P81, DOI 10.1016/0167-7799(94)90110-4
NR 27
TC 44
Z9 46
U1 0
U2 12
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2000
VL 53
IS 6
BP 633
EP 639
DI 10.1007/s002539900311
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 334BB
UT WOS:000088164300001
PM 10919318
DA 2018-10-19
ER

PT J
AU Kim, HM
   Kim, Y
   Park, SJ
   Rey, C
   Lee, HM
   Glimcher, MJ
   Ko, JS
AF Kim, HM
   Kim, Y
   Park, SJ
   Rey, C
   Lee, HM
   Glimcher, MJ
   Ko, JS
TI Thin film of low-crystalline calcium phosphate apatite formed at low
   temperature
SO BIOMATERIALS
LA English
DT Article
DE low-crystalline apatite; thin film; biomaterial; low temperature; cell
   culture
ID TRANSFORM INFRARED-SPECTROSCOPY; IN-VITRO; BONE; ENVIRONMENT; COATINGS;
   CHICKEN; PHASE; IONS
AB Surface modification of biomaterials to improve biocompatibility without changing their bulk properties is desired for many clinical applications and has become an emerging technology in biomaterial research and industry. In the present study, a simple method of coating the solid surfaces of metals, organic tissue matrices, glasses, inorganic ceramics as well as organic polymers with a thin film of low-crystalline apatite crystals (LCA) was developed. Acidic solution containing calcium and phosphate ions was neutralized with alkaline solution to form calcium phosphate precipitates at low temperature. Precipitates of solid calcium phosphate particles were, then, removed by filtration. Concentration of free ions in the filtered ion solution which were not involved in the formation of calcium phosphate precipitate was high enough to induce the heterogeneous nucleation on the solid surfaces at low temperature. Thin layers of calcium phosphate crystals were formed on the surfaces of metals, glasses, inorganic ceramics, organic polymers including hydrophobic ones, and biological tissue matrices with this solution. The thin layer of crystals consisted of poorly crystalline calcium phosphate apatite crystals which contain high amount of labile ions like bone crystals and did not dissolve in the physiologic solutions. Various cells attached to this crystal layer and proliferated well. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Seoul Natl Univ, Coll Dent, Lab Hard Tissue Engn, Dept Oral Anat, Seoul 110749, South Korea.
   Seoul Natl Univ, Coll Dent, Dent Res Inst, Seoul 110749, South Korea.
   CNRS, Inst Polytech Toulouse, Lab Physicochim Solides, F-31400 Toulouse, France.
   Childrens Hosp, Lab Study Skeletal Dis & Rehabil, Boston, MA 02115 USA.
   Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Kim, HM (reprint author), Seoul Natl Univ, Coll Dent, Lab Hard Tissue Engn, Dept Oral Anat, 28-22 YeonKung Dong, Seoul 110749, South Korea.
CR AMLER MH, 1988, J PERIODONTOL, V58, P759
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Cornell C. N., 1998, CLIN ORTHOP S, V355, pS267
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Eanes E. D., 1992, CALCIFICATION BIOL S, P1
   EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   ELLIOTT J. C., 1994, STUDIES INORGANIC CH, V18, P111
   GALGUT P N, 1990, Clinical Materials, V6, P105, DOI 10.1016/0267-6605(90)90002-D
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   Kim HM, 1996, CALCIFIED TISSUE INT, V59, P58, DOI 10.1007/s002239900086
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KIM HM, 1995, J BONE MINER RES, V10, P1589
   Klug H. P., 1974, XRAY DIFFRACTION PRO
   KUHNSPEARING L, 1996, P ANN M MIN MET MAT
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   LEES SL, 1983, CALCIFIED TISSUE INT, V35, P815
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P108
   Li P, 1997, J BIOMED MATER RES, V34, P79, DOI 10.1002/(SICI)1097-4636(199701)34:1<79::AID-JBM11>3.0.CO;2-K
   Matsuoka H, 1998, J BIOMED MATER RES, V42, P278, DOI 10.1002/(SICI)1097-4636(199811)42:2<278::AID-JBM13>3.0.CO;2-F
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   POSNER AS, 1979, SKELETAL RES, P167
   REY C, 1992, INT CONGR SER, V1002, P5
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1995, J BONE MINER RES, V10, P1577
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   REY C, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P181
   Rhee SH, 1998, J AM CERAM SOC, V81, P3029
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Wen HB, 1998, J BIOMED MATER RES, V41, P227, DOI 10.1002/(SICI)1097-4636(199808)41:2<227::AID-JBM7>3.0.CO;2-K
   WENG J, 1993, BIOMATERIALS, V14, P578, DOI 10.1016/0142-9612(93)90174-Z
   WILLIS JB, 1960, SPECTROCHIM ACTA, V16, P259, DOI 10.1016/0371-1951(60)80089-6
NR 36
TC 89
Z9 93
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2000
VL 21
IS 11
BP 1129
EP 1134
DI 10.1016/S0142-9612(99)00265-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 307MC
UT WOS:000086656200006
PM 10817265
DA 2018-10-19
ER

PT J
AU Rabin, Y
AF Rabin, Y
TI The effect of temperature-dependent thermal conductivity in heat
   transfer simulations of frozen biomaterials
SO CRYO-LETTERS
LA English
DT Article
DE thermal conductivity; temperature dependency; cryogenic temperatures;
   frozen biomaterial; thermal analysis
AB The thermal conductivity value of pure water ice is inversely proportional to the temperature and decreases about 5-fold as the temperature increases from the liquid nitrogen boiling temperature (77K) to the freezing point of pure water. The temperature dependency of the thermal conductivity is typically overlooked in bioheat transfer simulations. A closed-form solution of the one-dimensional temperature distribution in frozen water and blood is presented in this study, based on a new thermal conductivity model. Results indicate that temperatures are overestimated by up to 38K, and heat fluxes through the frozen region boundaries are underestimated by a factor of 2, when the temperature dependency of the thermal conductivity is neglected.
C1 Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
RP Rabin, Y (reprint author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
CR ALEXIADES V, 1993, MATH MODELING METLIN, P65
   BUDMAN H, 1995, J BIOMECH ENG-T ASME, V117, P193, DOI 10.1115/1.2796001
   Chato J. C., 1985, HEAT TRANSFER MED BI, V1, P413
   COOPER T E, 1971, Cryobiology, V7, P183, DOI 10.1016/0011-2240(70)90020-9
   Dean J. W., 1963, ADV CRYOGEN ENG, V8, P263
   FLETCHER NH, 1970, CHEM PHYSICS ICE, pCH6
   FUKUSAKO S, 1990, INT J THERMOPHYS, V11, P353, DOI 10.1007/BF01133567
   HONG JS, 1994, MAGN RESON IMAGING, V12, P1021, DOI 10.1016/0730-725X(94)91233-M
   Jakob M., 1929, Zeitschrift fur Technische Physik, V10, P623
   Rabin Y, 1997, J BIOMECH ENG-T ASME, V119, P146, DOI 10.1115/1.2796073
   Rabin Y, 1996, CRYOBIOLOGY, V33, P276, DOI 10.1006/cryo.1996.0028
   RATCLIFFE EH, 1962, PHILOS MAG, V7, P1197, DOI 10.1080/14786436208209120
   SMITH DJ, 1999, P 5 ASME JSME JOINT
NR 13
TC 29
Z9 30
U1 0
U2 2
PU CRYO LETTERS
PI LONDON
PA C/O ROYAL VETERINARY COLLEGE, ROYAL COLLEGE ST, LONDON NW1 0TU, ENGLAND
SN 0143-2044
J9 CRYO-LETT
JI Cryo-Lett.
PD JUN-JUL
PY 2000
VL 21
IS 3
BP 163
EP 170
PG 8
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 344JC
UT WOS:000088754600005
DA 2018-10-19
ER

PT J
AU Montdargent, B
   Letourneur, D
AF Montdargent, B
   Letourneur, D
TI Toward new biomaterials
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article; Proceedings Paper
CT Risk and Prevention Conferene
CY FEB 24-25, 2000
CL PARIS, FRANCE
ID CARBOXYMETHYL BENZYLAMIDE DEXTRAN; STAPHYLOCOCCUS-AUREUS ADHESION;
   MOLECULAR-WEIGHT KININOGEN; CENTRAL VENOUS CATHETERS; ANTI-DNA
   ANTIBODIES; DERIVATIZED DEXTRANS; PHOSPHORYLATED POLYSTYRENE; PROTEIN
   ADSORPTION; AFFINITY-CHROMATOGRAPHY; COMPLEMENT ACTIVATION
AB Polymers are widely used for a large range of medical devices used as biomaterials on a temporary, intermittent, and long-term basis. II is now well accepted that the initial rapid adsorption of proteins to polymeric surfaces affects the performance of these biomaterials. However, protein adsorption to a polymer surface can be modulated by an appropriate design of the interface. Extensive study has shown that these interactions can be minimized by coating with a highly hydrated layer (hydrogel), by grafting on the surface different biomolecules, or by creating domains with chemical functions (charges, hydrophilic groups). Our laboratory has investigated the latter approach over the past 2 decades, in particular the synthesis and the biological activities of polymers to improve the biocompatibility of blood-contacting devices. These soluble and insoluble polymers were obtained by chemical substitution of macromolecular chains with suitable groups able to develop specific interactions with biological components. Applied to compatibility with the blood and the immune systems, this concept has been extended to interactions of polymeric biomaterials with eukaryotic and prokaryotic cells. The design of new biomaterials with low bacteria attachment is thus under intensive study. After a brief overview of current trends in the surface modifications of biocompatible materials, we will describe how biospecific polymers can be obtained and review our recent results on the inhibition of bacterial adhesion using one type of functionalized polymer obtained by random substitution. This strategy applied to existing or new materials, seems promising for thr limitation of biomaterial-associated infections (Infect Control Hosp Epidemiol 2000;21: 104-110).
C1 Univ Paris 13, CNRS UMR 7540, Inst Galilee, LRM, F-93430 Villetaneuse, France.
RP Letourneur, D (reprint author), Univ Paris 13, CNRS UMR 7540, Inst Galilee, LRM, 99 Av JB Clement, F-93430 Villetaneuse, France.
RI Didier, letourneur/H-5268-2012
OI Didier, letourneur/0000-0003-2197-9468
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193
   An YJ, 2000, J CONTROL RELEASE, V64, P205, DOI 10.1016/S0168-3659(99)00143-1
   ANDRADE J D, 1992, Clinical Materials, V11, P19, DOI 10.1016/0267-6605(92)90026-P
   Bach A, 1999, INFECTION, V27, pS11, DOI 10.1007/BF02561611
   Bagheri-Yarmand R, 1998, CELL GROWTH DIFFER, V9, P497
   Bagheri-Yarmand R, 1999, CANCER RES, V59, P507
   Bagheri-Yarmand R, 1998, BRIT J CANCER, V78, P111, DOI 10.1038/bjc.1998.451
   BAGHERIYARMAND R, 1992, ANTICANCER RES, V12, P1641
   Bittoun P, 1999, BIOCHEM PHARMACOL, V57, P1399, DOI 10.1016/S0006-2952(99)00051-9
   BLONDIN C, IN PRESS CRIT REV TH
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   BRASH JL, 1988, BLOOD, V71, P932
   Burrows LL, 1999, WORLD J UROL, V17, P402, DOI 10.1007/s003450050166
   Cansell M, 1999, J BIOMED MATER RES, V44, P140, DOI 10.1002/(SICI)1097-4636(199902)44:2<140::AID-JBM3>3.0.CO;2-5
   CANSELL M, 2000, BIOMATERIALS, P337
   CARRE V, 1995, BBA-GEN SUBJECTS, V1243, P175, DOI 10.1016/0304-4165(94)00144-M
   Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO;2-H
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Clairbois AS, 1998, J CHROMATOGR B, V706, P55, DOI 10.1016/S0378-4347(97)00513-6
   CLAIRBOIS AS, 1998, INT J BIOCHROM, V4, P1
   Cornelius RM, 1997, BIOMATERIALS, V18, P429, DOI 10.1016/S0142-9612(96)00148-2
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   CREPON B, 1987, BIOMATERIALS, V8, P248, DOI 10.1016/0142-9612(87)90111-6
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   de Raucourt E, 1998, J BIOMED MATER RES, V41, P49, DOI 10.1002/(SICI)1097-4636(199807)41:1<49::AID-JBM6>3.0.CO;2-Q
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Francois P, 1999, J BIOMAT SCI-POLYM E, V10, P1207, DOI 10.1163/156856299X00027
   Glantz POJ, 1999, ACTA ODONTOL SCAND, V57, P238, DOI 10.1080/000163599428634
   GUPTA A, 1999, NAT MED, V5, P153
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Hsu LC, 1996, PERFUSION-UK, V11, P256, DOI 10.1177/026765919601100311
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1111/j.1574-6968.1999.tb13514.x
   Imbert E, 1997, J CHROMATOGR B, V698, P59, DOI 10.1016/S0378-4347(97)00271-5
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   JACOBS H, 1988, ARTIF ORGANS, V12, P506, DOI 10.1111/j.1525-1594.1988.tb02814.x
   John SF, 1996, FEMS MICROBIOL LETT, V144, P241, DOI 10.1016/0378-1097(96)00352-7
   Jozefowicz M, 1997, BIOMATERIALS, V18, P1633, DOI 10.1016/S0142-9612(97)00145-2
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LETOURNEUR D, 1992, BIOMATERIALS, V13, P59, DOI 10.1016/0142-9612(92)90096-7
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LETOURNEUR D, 1993, IN VITRO CELL DEV-AN, V29A, P67
   Logeart D, 1996, J BIOMED MATER RES, V30, P501, DOI 10.1002/(SICI)1097-4636(199604)30:4<501::AID-JBM8>3.3.CO;2-F
   Logeart-Avramoglou D, 1999, J BIOMED MATER RES, V48, P578, DOI 10.1002/(SICI)1097-4636(1999)48:4<578::AID-JBM26>3.0.CO;2-8
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   MIGONNEY V, 1988, BIOMATERIALS, V9, P145, DOI 10.1016/0142-9612(88)90113-5
   MIGONNEY V, 1995, J BIOMAT SCI-POLYM E, V7, P265
   Migonney V, 1997, BIOMATERIALS, V18, P1077, DOI 10.1016/S0142-9612(97)00032-X
   Migonney V, 1997, J BIOMAT SCI-POLYM E, V8, P533, DOI 10.1163/156856297X00434
   NEYTS J, 1995, BIOCHEM PHARMACOL, V50, P743, DOI 10.1016/0006-2952(95)00193-4
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P3, DOI 10.1016/0142-9612(91)90123-R
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Prigent-Richard S, 1998, J BIOMED MATER RES, V40, P275, DOI 10.1002/(SICI)1097-4636(199805)40:2<275::AID-JBM12>3.0.CO;2-P
   Raad I, 1999, SUPPORT CARE CANCER, V7, P386, DOI 10.1007/s005200050297
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RATNER BD, 1993, CARDIOVASC PATHOL S, V2, P87
   REID G, 1994, J IND MICROBIOL, V13, P90, DOI 10.1007/BF01584104
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   RUBENS FD, 1993, THROMB HAEMOSTASIS, V69, P130
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Seddiki N, 1997, BBA-MOL BASIS DIS, V1362, P47, DOI 10.1016/S0925-4439(97)00057-4
   SERASCANSELL M, 1998, FRONTIERS BIOMEDICAL, V1, P95
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   Spencer RC, 1999, J HOSP INFECT, V43, pS127, DOI 10.1016/S0195-6701(99)90075-0
   STANISLAWSKI L, 1993, J BIOMED MATER RES, V27, P619, DOI 10.1002/jbm.820270509
   Suci PA, 1998, BIOMATERIALS, V19, P327, DOI 10.1016/S0142-9612(97)00108-7
   Sun XL, 2000, J BIOMED MATER RES, V49, P66, DOI 10.1002/(SICI)1097-4636(200001)49:1<66::AID-JBM9>3.3.CO;2-O
   TARDIEU M, 1992, J CELL PHYSIOL, V150, P194, DOI 10.1002/jcp.1041500126
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   THOMAS H, 1995, BIOMATERIALS, V16, P1163, DOI 10.1016/0142-9612(95)93581-W
   Thomas H, 1996, MOL IMMUNOL, V33, P643, DOI 10.1016/0161-5890(96)00028-4
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VAUDAUX P, 1992, J BIOMAT SCI-POLYM E, V4, P89
   Vaudaux Pierre E., 1994, P1
   Wadstrom T, 1989, J Invest Surg, V2, P353, DOI 10.3109/08941938909018261
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   YAMADA KM, 1989, FIBRONECTIN, P48
   Yung LYL, 1999, IMMUNOPHARMACOLOGY, V43, P281, DOI 10.1016/S0162-3109(99)00134-4
   Zoutman D, 1999, INFECT CONT HOSP EP, V20, P752, DOI 10.1086/501577
NR 87
TC 33
Z9 33
U1 1
U2 19
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD JUN
PY 2000
VL 21
IS 6
BP 404
EP 410
DI 10.1086/501782
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 325GK
UT WOS:000087667700011
PM 10879573
DA 2018-10-19
ER

PT J
AU Porter, BD
   Oldham, JB
   He, SL
   Zobitz, ME
   Payne, RG
   An, KN
   Currier, BL
   Mikos, AG
   Yaszemski, MJ
AF Porter, BD
   Oldham, JB
   He, SL
   Zobitz, ME
   Payne, RG
   An, KN
   Currier, BL
   Mikos, AG
   Yaszemski, MJ
TI Mechanical properties of a biodegradable bone regeneration scaffold
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article; Proceedings Paper
CT Bioengineering Conference
CY JUN 16-20, 1999
CL BIG SKY, MONTANA
DE bone regeneration; tissue engineering; biodegradable polymers;
   mechanical strength
ID POLY(PROPYLENE FUMARATE); DEGRADATION
AB Poly (Propylene Fumarate) (PFF), a novel, bulk erosion, biodegradable polymer, has been shown to have osteoconductive effect in vivo when used as a bone regeneration scaffold (Peter, S. J., Suggs, L. J., Yaszemski, M. J., Engel, P. S., and Mikos, A. J., 1999, J. Biomater. Sci. Polym. Ed., 10, pp. 363-373). The material properties of the polymer allow it to be injected into irregularly shaped voids in vivo and provide mechanical stability as well as function as a bone regeneration scaffold. We fabricated a series of biomaterial composites, comprised of varying quantities of PPF, NaCl and beta -tricalcium phosphate (beta -TCP), into the shape of right circular cylinders and tested the mechanical properties in four-point bending and compression. The mean modulus of elasticity in compression (E-c) was 1204.2 MPa (SD 32.2) and the mean modulus of elasticity in bending (E-b) was 1274.7 MPa (SD 125.7). All of the moduli were on the order of magnitude of trabecular bone. Changing the level of NaCl from 20 to 40 percent, by mass, did not decrease E-c and E-b significantly, but did decrease bending and compressive strength significantly. Increasing the beta -TCP from 0.25 g/g PPF to 0.5 g/g PPF increase all of the measured mechanical properties of PPF/NVP camposites. These results indicate that this biodegradable polymer composite is an attractive candidate for use as a replacement scaffold for trabecular bone.
C1 Mayo Clin & Mayo Fdn, Dept Orthoped Surg & Bioengn, Rochester, MN 55905 USA.
   Rice Univ, Inst Biosci & Bioengn, Dept Bioengn, Houston, TX 77005 USA.
RP Porter, BD (reprint author), Mayo Clin & Mayo Fdn, Dept Orthoped Surg & Bioengn, 200 1st St SW, Rochester, MN 55905 USA.
CR GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 7
TC 61
Z9 64
U1 1
U2 12
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUN
PY 2000
VL 122
IS 3
BP 286
EP 288
DI 10.1115/1.429659
PG 3
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 404QB
UT WOS:000167111000013
PM 10923298
DA 2018-10-19
ER

PT J
AU Jiao, YK
   Gorb, S
   Scherge, M
AF Jiao, YK
   Gorb, S
   Scherge, M
TI Adhesion measured on the attachment pads of Tettigonia viridissima
   (Orthoptera, Insecta)
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE adhesion; epidermal secretion; biomaterial; cuticle; attachment device;
   cricket; Tettigonia viridissima
ID COLEOPTERA; SURFACES; ORIGIN; SETAE
AB The tarsi of the cricket Tettigonia viridissima bear flexible attachment pads that are able to deform, replicating the profile of a surface to which they are apposed. This attachment system is supplemented by a secretion produced by epidermal cells and transported onto the surface of the pad through the pore canals of the pad cuticle. This study shows that the secretion alone is necessary, but not sufficient, for adhesion. To account for the full adhesive force, the deformation of the pad and the resulting changes in contact area were considered. In two series of experiments, the adhesive properties of the secretion and the adhesion of the whole pad were measured using a force tester, the sensitivity of which ranged from micronewtons to centinewtons.
   The adhesive forces of the secretion measured between a smooth sapphire ball with a diameter of 1.47 mm and a flat silicon surface ranged from 0.1 to 0.6 mN. In a control experiment on the silicon surface without secretion, no adhesive force was measured. There was no dependence of the adhesive force on the applied compressive force.
   When an intact pad was pulled off a flat silicon surface, the adhesive force increased with increasing applied compressive force, but it did not increase further once the applied force exceeded a certain value. The saturated adhesive force, ranging from 0.7 to 1.2 mN, was obtained at applied forces of 0.7-1.5 mN. The hemispherical surface of the pad had a larger contact area and demonstrated greater adhesion under a larger applied force. Adhesion became saturated when a pad was deformed such that contact area was maximal. The tenacity (the adhesive force per unit area) was 1.7-2.2 mN mm(-2).
C1 Max Planck Inst Dev Biol, Dept Biochem, Biol Microtribol Grp, D-72076 Tubingen, Germany.
   Tech Univ Ilmenau, Microtribol Grp, Inst Phys, D-98684 Ilmenau, Germany.
RP Gorb, S (reprint author), Max Planck Inst Dev Biol, Dept Biochem, Biol Microtribol Grp, Spemannstr 35, D-72076 Tubingen, Germany.
CR BAUCHHENSS E, 1977, International Journal of Insect Morphology and Embryology, V6, P225, DOI 10.1016/0020-7322(77)90010-1
   BAUCHHENSS E, 1979, ZOOMORPHOLOGIE, V93, P99, DOI 10.1007/BF00994125
   Bauchhenss E., 1979, THESIS U MUNCHEN
   Bowden F. P., 1986, FRICTION LUBRICATION
   Brainerd EL, 1994, AM ZOOL, V34, P128
   DAHL F, 1884, ARCH NATURGESCH, V50, P146
   Dewitz H., 1884, ARCH GES PHYSL, V33, P440
   Dewitz H., 1883, ZOOL ANZ, V6, P273
   DIXON AFG, 1990, J EXP BIOL, V152, P243
   EDWARDS JS, 1970, PROC R ENTOMOL SOC A, V45, P1
   GHASIBAYAT A, 1980, ZOOL ANZ, V205, P76
   GHASIBAYAT A, 1980, ZOOL ANZ, V204, P13
   GHASIBAYAT A, 1980, NACHRICHTENBL BAYER, P58
   Gillett JD, 1932, P R SOC LOND B-CONTA, V111, P364, DOI 10.1098/rspb.1932.0061
   Gorb SN, 1998, J INSECT PHYSIOL, V44, P1053, DOI 10.1016/S0022-1910(98)00068-7
   HASENFUSS I, 1977, ZOOMORPHOLOGIE, V87, P51, DOI 10.1007/BF02568741
   Hasenfuss I., 1978, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V99, P115
   Hasenfuss I., 1977, VERH DTSCH ZOOL GES, V277, P277
   Hennig W., 1973, HDB ZOOLOGIE, VIV, P1
   HENNING B, 1974, Z MORPHOL TIERE, V79, P323
   Hertz H., 1881, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRIL.1882.92.156>
   HILLER U, 1968, Zeitschrift fuer Morphologie der Tiere, V62, P307, DOI 10.1007/BF00401561
   ISHII S, 1987, APPL ENTOMOL ZOOL, V22, P222, DOI 10.1303/aez.22.222
   KENDALL MD, 1970, Z ZELLFORSCH MIK ANA, V109, P112, DOI 10.1007/BF00364935
   Kosaki A, 1996, JPN J APPL ENTOMOL Z, V40, P47
   LEES AD, 1988, J EXP BIOL, V136, P209
   MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0
   Rabinowicz E., 1995, FRICTION WEAR MAT
   ROMBOUTS JE, 1984, ZOOL ANZ, V7, P619
   ROTH LM, 1952, J EXP ZOOL, V119, P483, DOI 10.1002/jez.1401190307
   RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302
   RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x
   Scherge M, 1999, TRIBOL LETT, V6, P215, DOI 10.1023/A:1019119925494
   Simmermacher G., 1884, Z WISS ZOOL, V40, P481
   SLIFER ELEANOR H., 1950, ANN ENT SOC AMERICA, V43, P173
   STORK NE, 1983, J NAT HIST, V17, P829, DOI 10.1080/00222938300770641
   STORK NE, 1983, J NAT HIST, V17, P583, DOI 10.1080/00222938300770481
   STORK NE, 1980, J EXP BIOL, V88, P91
   WALKER G, 1985, J ZOOL, V205, P297, DOI 10.1111/j.1469-7998.1985.tb03536.x
   West T., 1862, T LINN SOC LOND, V23, P393
NR 40
TC 149
Z9 162
U1 0
U2 32
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD JUN
PY 2000
VL 203
IS 12
BP 1887
EP 1895
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 329ZR
UT WOS:000087938800011
PM 10821745
DA 2018-10-19
ER

PT J
AU Chang, CC
   Lieberman, SM
   Moghe, PV
AF Chang, CC
   Lieberman, SM
   Moghe, PV
TI Quantitative analysis of the regulation of leukocyte chemosensory
   migration by a vascular prosthetic biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EXPANDED POLYTETRAFLUOROETHYLENE; NEUTROPHIL ACTIVATION; HUMAN-BLOOD;
   IN-VITRO; CHEMOTAXIS; EXPRESSION; ASSAY; HEMODIALYSIS; INFECTION;
   RELEASE
AB The need for improved, infection-resistant vascular biomaterials calls for more objective evaluation of the immune pathophysiology of implantable prosthetic materials. In this study we have developed a new strategy to quantitatively characterize population-averaged responses of immune cell migration on vascular prosthetic materials. This approach, incorporating a chemokinetically regulated "biomaterial-gel" sandwich configuration, was applied to quantify both random and directed modes of the chemosensory migration of human neutrophil leukocytes on expanded polytetrafluoroethylene (ePTFE). Our studies show that (a) microporous, synthetic materials like ePTFE suppress the basal rate of random cell migration relative to that reported on non-porous control surfaces; (b) stimulation with chemoattractant (formyl peptide) can significantly elevate rates of random and directed migration on ePTFE; and (c) protein conditioning of ePTFE with albumin or immunoglobulin G can differentially modulate the rates and relative proportion of random and directional components of leukocyte migration response to chemoattractant. This, to our knowledge, is the first objective quantitation of chemokinetically regulated cell migration on implantable prosthetic materials. (C) 2000 Kluwer Academic Publishers.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
EM moghe@rci.rutgers.edu
OI Lieberman, Scott/0000-0003-4082-7582
CR Abramowitz M., 1965, HDB MATH FUNCTIONS
   ALEXANDER JW, 1967, ANN SURG, V165, P192, DOI 10.1097/00000658-196702000-00005
   ALT W, 1980, J MATH BIOL, V9, P147, DOI 10.1007/BF00275919
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Benton LD, 1996, J SURG RES, V64, P116, DOI 10.1006/jsre.1996.0316
   BHAT DJ, 1980, SURGERY, V87, P445
   BUETTNER HM, 1989, AICHE J, V35, P459, DOI 10.1002/aic.690350314
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   CHANG CC, 1999, UNPUB J BIOMED MAT R
   CONSTANTINIDES A, 1987, CHEM ENG SERIES
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   CRISTOL JP, 1994, NEPHROL DIAL TRANSPL, V9, P389
   CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P289
   DUNN GA, 1981, BIOL CHEMOTACTIC RES, P1
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   FINN A, 1993, AGENTS ACTIONS, V38, pC44, DOI 10.1007/BF01991132
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Kaplan S S, 1990, ASAIO Trans, V36, pM172
   KATZ DA, 1994, SURGERY, V116, P446
   LAUFFENBURGER D, 1983, J IMMUNOL, V131, P940
   LAUFFENBURGER DA, 1983, AGENTS ACTIONS S, V12
   Merritt K, 1999, J BIOMED MATER RES, V44, P261, DOI 10.1002/(SICI)1097-4636(19990305)44:3<261::AID-JBM4>3.0.CO;2-M
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   PIZZOFERRATO A, 1986, TECHNIQUES BIOCOMPAT, V2, P109
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 31
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2000
VL 11
IS 6
BP 337
EP 344
DI 10.1023/A:1008925722623
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 319XW
UT WOS:000087371700002
PM 15348014
DA 2018-10-19
ER

PT J
AU Schildhauer, TA
   Bauer, TW
   Josten, C
   Muhr, G
AF Schildhauer, TA
   Bauer, TW
   Josten, C
   Muhr, G
TI Open reduction and augmentation of internal fixation with an injectable
   skeletal cement for the treatment of complex calcaneal fractures
SO JOURNAL OF ORTHOPAEDIC TRAUMA
LA English
DT Article
DE calcaneus fracture; histology; calcium phosphate cement; open reduction
   with internal fixation; osteoconductive biomaterial
ID INTRAARTICULAR FRACTURES; OPERATIVE TREATMENT; BONE-CEMENT; REPAIR;
   PLATE
AB Objectives: To describe the surgical handling, potential complications, and remodeling of an injectable, osteoconductive calcium phosphate cement (Norian SRS) for joint depression-type calcaneal fractures in humans, and to illustrate the clinical efficacy of this cement with special reference to early postoperative full weight bearing.
   Design: Prospective cohort study.
   Setting: Level I trauma centers in Bochum and Leipzig, Germany.
   Intervention: Thirty-six joint depression type calcaneal fractures in thirty-two patients were augmented with the calcium phosphate cement after standard open reduction with internal fixation. Postoperative full weight bearing was allowed progressively earlier, and as the study progressed, the last patients were bearing full weight as early as three weeks postoperatively. Biopsies for histologic analysis were performed at time of hardware removal after one year (seven biopsies) or in case of infection at time of debridement (five biopsies).
   Main outcome measures: Clinical outcome was evaluated according to a calcaneal scoring system. Data were compared and statistically analyzed between patients with postoperative full weight bearing after eight to twelve weeks and three to six weeks, respectively. Histologic findings are described.
   Results: Cement injection averaged ten cubic centimeters and could easily be performed under fluoroscopic control. Progressively earlier full weight-bearing was achieved without loss of reduction. There was no statistical difference in clinical outcome scores in patients with full weight bearing before or after six weeks postoperatively. The infection rate was 11 percent, possibly related to the skin incisions. The biopsies from clinically satisfactory cases showed nearly complete bone apposition, areas of vascular penetration, and reversal lines illustrating progressive cycles of resorption and new bone formation. Biopsy specimens from infected cases showed bone and cement surrounded by either fibrous tissue or acute inflammation without extensive bone apposition,
   Conclusions: Calcium phosphate cement augmentation of standard open reduction with internal fixation in joint-depression type calcaneal fractures allows postoperative full weight bearing as early as three weeks postoperatively. The injectable bone cement can easily be handled surgically under fluoroscopic control and has proved to be remodelable.
C1 Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Chirurg Klin & Poliklin, D-4630 Bochum, Germany.
   Cleveland Clin Fdn, Dept Pathol Anat, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Orthopaed Surg, Cleveland, OH 44195 USA.
   Univ Leipzig, Unfall & Wiederherstellungschirurg, Chirurg Klin & Poliklin, D-7010 Leipzig, Germany.
RP Schildhauer, TA (reprint author), Univ Washington, Harborview Med Ctr, Dept Orthopaed, Box 359798,325 9Th Ave, Seattle, WA 98104 USA.
OI Bauer, Thomas/0000-0003-0976-2119
CR Bauer G, 1996, CHIRURG, V67, P1129, DOI 10.1007/s001040050114
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BAUMGAERTEL FR, 1993, CLIN ORTHOP RELAT R, P132
   BENIRSCHKE SK, 1993, CLIN ORTHOPAEDICS, V292, P128
   BEZES H, 1993, CLIN ORTHOPAEDICS, V290, P55
   Burdeaux BD, 1997, FOOT ANKLE INT, V18, P685, DOI 10.1177/107110079701801102
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Freeman BJC, 1998, J BONE JOINT SURG BR, V80B, P139, DOI 10.1302/0301-620X.80B1.7987
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P42
   HALL RL, 1993, CLIN ORTHOPAEDICS, V290, P27
   ISON IC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P215
   Jupiter JB, 1997, J ORTHOP TRAUMA, V11, P110, DOI 10.1097/00005131-199702000-00008
   Kankare J, 1998, J ORTHOP TRAUMA, V12, P413, DOI 10.1097/00005131-199808000-00008
   Kerr PS, 1996, INJURY, V27, P35, DOI 10.1016/0020-1383(95)00165-4
   Kerr PS, 1996, INJURY, V27, P39, DOI 10.1016/0020-1383(95)00166-2
   Kiyoshige Y, 1997, ACTA ORTHOP SCAND, V68, P408, DOI 10.3109/17453679708996190
   Kopylov P, 1996, J HAND SURG-BRIT EUR, V21B, P768, DOI 10.1016/S0266-7681(96)80184-7
   *ORTH TRAUM ASS CO, 1996, J ORTHOP TRAUMA S1, V10, P109
   RAIKIN SM, 1998, CLIN ORTHOP RELAT R, V353, P231
   Sanders R, 1992, J Orthop Trauma, V6, P252, DOI 10.1097/00005131-199206000-00022
   SANDERS R, 1995, ORTHOP CLIN N AM, V26, P203
   SANDERS R, 1993, CLIN ORTHOPAEDICS, V290, P87
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   Song KS, 1997, J ORTHOP TRAUMA, V11, P435, DOI 10.1097/00005131-199708000-00013
   Stankewich CJ, 1996, J ORTHOP RES, V14, P786, DOI 10.1002/jor.1100140516
   Thordarson DB, 1999, J BONE JOINT SURG AM, V81A, P239, DOI 10.2106/00004623-199902000-00011
   Thordarson DB, 1996, FOOT ANKLE INT, V17, P2, DOI 10.1177/107110079601700102
   Tornetta P, 1996, J ORTHOP TRAUMA, V10, P63, DOI 10.1097/00005131-199601000-00009
   Tornetta P, 1998, J ORTHOP TRAUMA, V12, P469, DOI 10.1097/00005131-199809000-00007
   ZWIPP H, 1993, CLIN ORTHOPAEDICS, V290, P76
NR 31
TC 91
Z9 99
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0890-5339
EI 1531-2291
J9 J ORTHOP TRAUMA
JI J. Orthop. Trauma
PD JUN-JUL
PY 2000
VL 14
IS 5
BP 309
EP 317
DI 10.1097/00005131-200006000-00001
PG 9
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 334DW
UT WOS:000088171300001
PM 10926236
DA 2018-10-19
ER

PT J
AU Woerly, S
AF Woerly, S
TI Restorative surgery of the central nervous system by means of tissue
   engineering using NeuroGel implants
SO NEUROSURGICAL REVIEW
LA English
DT Review
DE restorative surgery; neurotransplantation; tissue engineering;
   hydrogels; biohybrid polymers; axonal regeneration; functional recovery;
   genetically altered cells; cell entrapment
ID SPINAL-CORD INJURY; ADRENAL-MEDULLARY TISSUE; CULTURED SCHWANN-CELLS;
   ADULT MAMMALIAN CNS; PARKINSONS-DISEASE; EXTRACELLULAR-MATRIX; AXONAL
   REGENERATION; NEURAL TISSUE; PROGENITOR CELLS; GENE-THERAPY
AB A novel approach aimed at restoring tissue structure and function and enhancing axonal recovery in damaged parts of the central nervous system is described. In contrast to contemporary neurotransplantation technologies which focus on tissue reconstruction of neural parenchyma by cell replacement, this approach is based on repair by tissue engineering. The technique involves the implantation of a 3-dimensional polymer hydrogel into the site of injury. The physical properties of the hydrogel induce the organisation of migrating wound-healing cells and regenerating axons within its 3-dimensional structure. Two complementary approaches are described and illustrated using results obtained in vivo and in vitro: (1) implantation into the brain and spinal cord of the polymer hydrogel NeuroGel, which has a defined macromolecular structure that enhances tissue-building capabilities, and the implantation of advanced hydrogel derivatives carrying biologically active molecules to promote selective cell interactions, and (2) biohybrid hydrogels that contain entrapped developing neural tissue cells, embryonic carcinoma-derived neurons, or genetically modified cells which secrete neurotrophic factors. These techniques create bioartificial tissues with neural tissue specificity. The potential of this biomaterial-based approach to neural tissue engineering for restorative neurosurgery is discussed.
C1 Organogel Canada Ltee, Quebec City, PQ G1P 4R7, Canada.
RP Woerly, S (reprint author), Organogel Canada Ltee, 1400 Blvd Parc Technol, Quebec City, PQ G1P 4R7, Canada.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   AHLSKOG JE, 1993, MAYO CLIN PROC, V68, P578, DOI 10.1016/S0025-6196(12)60373-5
   Anderson PN, 1998, PROG BRAIN RES, V117, P211
   APPUZO ML, 1990, NEUROSURGERY, V26, P746
   APPUZO ML, 1996, NEUROSURGERY, V38, P625
   ARD MD, 1993, GLIA, V9, P248, DOI 10.1002/glia.440090403
   AUBERT I, 1995, CURR OPIN NEUROBIOL, V5, P625, DOI 10.1016/0959-4388(95)80068-9
   BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169
   Bakay R A, 1993, Acta Neurochir Suppl (Wien), V58, P8
   Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   BECERRA JL, 1995, NEURORADIOLOGY, V37, P307
   BELL E, 1991, J CELL BIOCHEM, V45, P239, DOI 10.1002/jcb.240450302
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31
   BERRY M, 1988, CURR OPIN NEUROL NEU, V1, P1068
   BIGNAMI A, 1991, ADV EXP MED BIOL, V296, P197
   BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7
   BLOTTNER D, 1994, ACTA ANAT, V150, P235
   Borlongan CV, 1996, NEUROL RES, V18, P297
   Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I
   Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T
   Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8
   Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754
   Bunge R P, 1997, Adv Neurol, V72, P305
   Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9
   Cheng HW, 1998, NEUROSCI LETT, V242, P69, DOI 10.1016/S0304-3940(98)00050-0
   CORKHILL PH, 1990, CRIT REV BIOCOMPAT, V5, P363
   Cortez N, 2000, J NEUROSCI RES, V59, P39, DOI 10.1002/(SICI)1097-4547(20000101)59:1<39::AID-JNR6>3.3.CO;2-E
   COTMAN CW, 1976, J SUPRAMOL STR CELL, V4, P319, DOI 10.1002/jss.400040303
   DAS GD, 1989, BRAIN RES BULL, V22, P7, DOI 10.1016/0361-9230(89)90123-8
   DIERINGER N, 1995, PROG NEUROBIOL, V46, P97, DOI 10.1016/0301-0082(94)00063-N
   Duconseille E, 1998, RESTOR NEUROL NEUROS, V13, P193
   Duconseille E, 1999, RESTOR NEUROL NEUROS, V15, P305
   DURING MJ, 1994, SCIENCE, V266, P1399, DOI 10.1126/science.266.5189.1399
   EASTLUND T, 1995, CELL TRANSPLANT, V4, P455, DOI 10.1016/0963-6897(95)00035-V
   EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   FINE A, 1994, CELL TRANSPLANT, V3, P113, DOI 10.1177/096368979400300201
   FISHER LJ, 1993, PHYSIOL REV, V73, P583
   Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944
   FORNO LS, 1991, ACTA NEUROPATHOL, V81, P691, DOI 10.1007/BF00296383
   FREED WJ, 1990, EXP NEUROL, V110, P139, DOI 10.1016/0014-4886(90)90026-O
   FREUND TF, 1985, J NEUROSCI, V5, P603
   Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224
   FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J
   Frisen J, 1997, HISTOL HISTOPATHOL, V12, P857
   GARRONE R, 1993, CR SOC BIOL, V187, P114
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Graham N B, 1998, Med Device Technol, V9, P18
   Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6
   GUTH L, 1985, EXP NEUROL, V88, P1, DOI 10.1016/0014-4886(85)90109-8
   HAMORI J, 1990, J EXP BIOL, V153, P251
   HARVEY AR, 1994, RESTOR NEUROL NEUROS, V6, P221, DOI 10.3233/RNN-1994-6306
   HARVEY AR, 1993, INT J DEV NEUROSCI, V11, P569, DOI 10.1016/0736-5748(93)90046-G
   HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215
   HATTEN ME, 1990, SEMIN NEUROSCI, V2, P455
   HIRSCH EC, 1990, ANN NEUROL, V27, P676, DOI 10.1002/ana.410270615
   Holtz Anders, 1995, Upsala Journal of Medical Sciences, V100, P93
   HORVAT JC, 1991, RESTOR NEUROL NEUROS, V2, P289, DOI 10.3233/RNN-1991-245618
   Houle JD, 1998, EXP NEUROL, V154, P602, DOI 10.1006/exnr.1998.6954
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   HUGHES JT, 1984, PARAPLEGIA, V22, P131, DOI 10.1038/sc.1984.25
   HUGHES JT, 1991, NEUROL CLIN, V9, P551
   HURTIG H, 1989, ANN NEUROL, V25, P607, DOI 10.1002/ana.410250613
   ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449
   Iza M, 2000, POLYMER, V41, P5885, DOI 10.1016/S0032-3861(99)00776-4
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807
   KAKULAS BA, 1992, HDB CLIN NEUROLOGY, V17, P21
   Karpati G, 1996, TRENDS NEUROSCI, V19, P49
   KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1
   KORDOWER JH, 1991, ANN NEUROL, V29, P405, DOI 10.1002/ana.410290411
   KOUTOUZIS TK, 1994, CRIT REV NEUROBIOL, V8, P125
   KUNKELBAGDEN E, 1992, EXP NEUROL, V116, P40, DOI 10.1016/0014-4886(92)90174-O
   Laws E R Jr, 1995, Clin Neurosurg, V42, P480
   Li Y, 1997, EXP NEUROL, V145, P397, DOI 10.1006/exnr.1997.6502
   LIESI P, 1983, J CELL BIOL, V96, P920, DOI 10.1083/jcb.96.3.920
   LINDVALL O, 1995, CELL TRANSPLANT, V4, P393, DOI 10.1016/0963-6897(95)00022-P
   Lindvall O, 1998, MOVEMENT DISORD, V13, P83
   LINDVALL O, 1989, J NEUROL NEUROSUR PS, P39
   LINDVALL O, 1994, FUNCTIONAL NEURAL TR, P103
   Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9
   LOH NK, 1999, P INT M NEUR TRANSPL
   MADRI JA, 1992, LAB INVEST, V66, P519
   Mandel RJ, 1999, EXP NEUROL, V159, P47, DOI 10.1006/exnr.1999.7159
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   MARKWALD RR, 1987, MEAD JOHNSON S, V29, P7
   MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409
   MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401
   MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3
   MAZUR JM, 1991, CLIN ORTHOP RELAT R, P54
   McNeill TH, 1999, NEUROSCIENCE, V90, P1349, DOI 10.1016/S0306-4522(98)00482-5
   Mocchetti I, 1996, EXP NEUROL, V141, P154, DOI 10.1006/exnr.1996.0149
   Montgomery CT, 1996, EXP NEUROL, V137, P277, DOI 10.1006/exnr.1996.0026
   Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008
   Napieralski JA, 1996, J COMP NEUROL, V373, P484
   Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5
   Packer RJ, 2000, J NEUROSURG, V92, P249, DOI 10.3171/jns.2000.92.2.0249
   PAINO CL, 1994, J NEUROCYTOL, V23, P433, DOI 10.1007/BF01207115
   PANNI MK, 1994, DEV BRAIN RES, V81, P325, DOI 10.1016/0165-3806(94)90319-0
   Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675
   Peduzzi J., 1999, J NEUROTRAUM, V16, P1010
   PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235
   Pincus DW, 1998, NEUROSURGERY, V42, P858, DOI 10.1097/00006123-199804000-00103
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Plant GW, 1998, CELL TRANSPLANT, V7, P381, DOI 10.1016/S0963-6897(98)00016-5
   Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945
   Qureshi NH, 1999, CRIT REV ONCOGENESIS, V10, P261
   Rabchevsky AG, 1998, MENT RETARD DEV D R, V4, P187, DOI 10.1002/(SICI)1098-2779(1998)4:3<187::AID-MRDD6>3.0.CO;2-L
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Rosenfeld J V, 1993, Ann Acad Med Singapore, V22, P464
   ROSENFELD JV, 1991, AUST NZ J MED, V21, P477, DOI 10.1111/j.1445-5994.1991.tb01357.x
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1
   SCHREYER DJ, 1987, DEV BRAIN RES, V35, P291, DOI 10.1016/0165-3806(87)90054-X
   SCHVARCZ JR, 1990, STEREOT FUNCT NEUROS, V54-5, P277, DOI 10.1159/000100223
   Schwaiger FW, 1998, PROG BRAIN RES, V117, P197
   Scott D E, 1997, Va Med Q, V124, P249
   SHAO YP, 1994, GLIA, V11, P147, DOI 10.1002/glia.440110209
   Shi R, 1996, J NEUROPHYSIOL, V76, P1572
   Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
   Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309
   STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1
   Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634
   SYKOV AE, 1999, GLIA, V25, P56
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   TURNER DA, 1993, NEUROSURGERY, V33, P1031
   Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8
   Tuszynski MH, 1999, J NEUROTRAUM, V16, P523, DOI 10.1089/neu.1999.16.523
   VICK RS, 1992, J NEUROTRAUM, V9, P93103
   Vives KP, 1999, J NEURO-ONCOL, V42, P289, DOI 10.1023/A:1006163328765
   VRACKO R, 1974, AM J PATHOL, V77, P314
   WALACE MC, 1987, SURG NEUROL, V27, P209
   Wang ZH, 1996, ACTA NEUROPATHOL, V91, P180, DOI 10.1007/s004010050411
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Woerly S, 1996, NEUROSCI LETT, V205, P197, DOI 10.1016/0304-3940(96)12349-1
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1997, MATER SCI FORUM, V250, P53, DOI 10.4028/www.scientific.net/MSF.250.53
   Woerly S., 1995, Journal of Neural Transplantation and Plasticity, V5, P245
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   WOERLY S, 1993, NEUROSURG REV, V16, P93, DOI 10.1007/BF00258238
   WOERLY S, 1993, CELL TRANSPLANT, V2, P229, DOI 10.1177/096368979300200307
   WOERLY S, 1990, NEUROCHIRURGIE, V36, P71
   WOERLY S, 1995, P 2 INT C CELL ENG S, P115
   WOERLY S, 1990, BIOMATERIALS, P1197
   WOERLY S, 1999, J NEURTRAUMA, V16, P1011
   WOLBURG H, 1986, Z NATURFORSCH C, V41, P1147
   WRATHALL JR, 1982, ACTA NEUROPATHOL, V57, P59, DOI 10.1007/BF00688878
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479
NR 160
TC 43
Z9 50
U1 0
U2 13
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0344-5607
J9 NEUROSURG REV
JI Neurosurg. Rev.
PD JUN
PY 2000
VL 23
IS 2
BP 59
EP 77
PG 19
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 334RM
UT WOS:000088199500001
PM 10926098
DA 2018-10-19
ER

PT J
AU Arai, T
   Lundborg, G
   Dahlin, LB
AF Arai, T
   Lundborg, G
   Dahlin, LB
TI Bioartificial nerve graft for bridging extended nerve defects in rat
   sciatic nerve based on resorbable guiding filaments
SO SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND
   SURGERY
LA English
DT Article
DE nerve regeneration; axonal growth; nerve graft; silicone chamber;
   resorbable filaments; biomaterial
ID IMPLANTED SILICONE TUBES; MATRIX FORMATION; FIBRIN MATRIX; REGENERATION;
   MACROPHAGES; LAMININ; REPAIR; COMPONENTS; CHAMBERS
AB A long defect (15 mm) in rat sciatic nerve was repaired with a bioartificial nerve graft composed of a silicone tube and seven synthetic filaments of five types (polyamide, catgut, polydioxanone, and two types of polyglactin, normal and quickly-absorbed) inserted longitudinally into the tube. In all cases in which filaments were used a regenerating bridge was obtained in the tube after three months in contrast to empty silicone tubes, in which no structure was observed. There was a 6% similar to 46% recovery of isometric muscle contractility of the anterior tibial and gastrocnemius muscles with positive pinch reflex test in most cases. Myelinated axons were seen in the regenerating tissue between the filaments but not directly in contact with them, and there were varying numbers of macrophages close to the filaments. Silicone tubes with filaments, regardless of type of filament, induced nerve tissue to regenerate and resulted in functional recovery through a 15 mm nerve gap not achieved with empty tubes. Nerve promoting factors may be applied to the filaments and the model is a valuable tool for further development of artificial nerve grafts.
C1 Univ Lund, Malmo Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden.
   Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.
RP Dahlin, LB (reprint author), Univ Lund, Malmo Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden.
CR DAHLIN L, 1999, MAT MED, V10, P1
   Dahlin LB, 1996, RESTOR NEUROL NEUROS, V9, P141, DOI 10.3233/RNN-1996-9302
   DAHLIN LB, 1995, BRAIN RES, V679, P274, DOI 10.1016/0006-8993(95)00249-P
   DAHLIN LB, 1999, HAND SURG, V3, P165
   Danielsen N, 1990, Restor Neurol Neurosci, V1, P253, DOI 10.3233/RNN-1990-13412
   IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1
   KANJE M, 1988, BRAIN RES, V439, P116, DOI 10.1016/0006-8993(88)91467-9
   KANJE M, 1995, RESTOR NEUROL NEUROS, V8, P181, DOI 10.3233/RNN-1995-8403
   KERNS JM, 1993, EXP NEUROL, V122, P28, DOI 10.1006/exnr.1993.1104
   KLJAVIN IJ, 1991, CELL MATER, V1, P17
   LUNDBORG G, 1991, J HAND SURG-BRIT EUR, V16B, P473, DOI 10.1016/0266-7681(91)90097-8
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   Lundborg G, 1996, SCAND J PLAST RECONS, V30, P105, DOI 10.3109/02844319609056391
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   MILLESI H, 1984, CLIN PLAST SURG, V11, P105
   PERRY VH, 1992, BIOESSAYS, V14, P401, DOI 10.1002/bies.950140610
   Scherman P, 2000, SCAND J PLAST RECONS, V34, P1
   Terada N, 1997, J MATER SCI-MATER M, V8, P391, DOI 10.1023/A:1018593219113
   Terada N, 1997, RESTOR NEUROL NEUROS, V11, P65, DOI 10.3233/RNN-1997-111207
   TERADA N, 1997, SCAND J PLAST RECONS, V1, P1
   Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498
   WILLIAMS LR, 1985, J COMP NEUROL, V231, P209, DOI 10.1002/cne.902310208
   ZENG L, 1995, RESTOR NEUROL NEUROS, V8, P107, DOI 10.3233/RNN-1995-8301
   ZHAO Q, 1992, J HAND SURG-BRIT EUR, V17B, P257, DOI 10.1016/0266-7681(92)90110-N
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
NR 26
TC 35
Z9 37
U1 0
U2 4
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-4311
J9 SCAND J PLAST RECONS
JI Scand. J. Plast. Reconstr. Surg. Hand Surg.
PD JUN
PY 2000
VL 34
IS 2
BP 101
EP 108
PG 8
WC Surgery
SC Surgery
GA 326FC
UT WOS:000087721200002
PM 10900623
DA 2018-10-19
ER

PT J
AU Steffen, HJ
   Schmidt, J
   Gonzalez-Elipe, A
AF Steffen, HJ
   Schmidt, J
   Gonzalez-Elipe, A
TI Biocompatible surfaces by immobilization of heparin on diamond-like
   carbon films deposited on various substrates
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE DLC films; functionalization; immobilization; biomaterials;
   haemocompatibility; heparin; plasma surface modification; bioactive DLC
   and polymer surface; vascular grafts
ID ENDOTHELIAL-CELL GROWTH; AMORPHOUS-CARBON; GLOW-DISCHARGE; IN-VITRO;
   FIBRONECTIN; POLYMERS; COMPATIBILITY; SPECTROSCOPY; COATINGS; BINDING
AB Although graphitic carbon has been known and used as a biomaterial for a very long time, the excellent biocompatibility of diamond-like carbon (DLC) films has been addressed only in a few cases. We anticipate the combination of bioinert DLC films and surface-immobilized bioactive biomolecules with antithrombogenic properties, such as the polysaccharide heparin, as a straightforward concept to optimize the haemocompatibility of a nide variety of materials. Therefore, to assess this property in view of an application as vascular grafts, surface analytical studies on DLC-coated and heparinized polymer and silicon substrates were performed. The DLC films were deposited an polytetrafluoroethylene (PTFE), PTFE vascular prostheses, polystyrene and silicon wafers by an energetic acetylene plasma beam and subsequently exposed to an ammonia plasma before heparin was covalently coupled to such functionalized surfaces by an end-point attachment method, The biochemical characterization by thrombin tests revealed, in accordance with XPS measurements, a high amount of heparin on the surface and an extended blood coagulation time. Thus, the efficiency of the plasma treatment for functionalization and successful improvement of the haemocompatibility of DLC films could be shown. Copyright (C) 2000 John Wiley & Sons, Ltd.
C1 Mannheim Univ Appl Sci, Inst Mat Sci & Surface Engn, D-68163 Mannheim, Germany.
   Univ Seville, Inst Ciencia Mat Sevilla, Seville 41092, Spain.
RP Steffen, HJ (reprint author), Mannheim Univ Appl Sci, Inst Mat Sci & Surface Engn, D-68163 Mannheim, Germany.
RI Gonzalez-Elipe, Agustin R/C-7419-2015
OI Gonzalez-Elipe, Agustin R/0000-0002-6417-1437
CR AEBISCHER P, 1992, MAT SCI TECHNOLOGY, V14, P130
   al-Lamee K, 2000, Med Device Technol, V11, P12
   ALLAMEE K, 1998, MED DEVICE TECHNOL, V15, P24
   ALLRED RE, 1983, POLYM PREPR-ACS, V24, P223
   BAQUEY C, 1992, MAT SCI TECHNOLOGY, V14, P111
   Bhat VD, 1998, J BIOMED MATER RES, V41, P377, DOI 10.1002/(SICI)1097-4636(19980905)41:3<377::AID-JBM6>3.3.CO;2-Q
   Briggs D., 1992, PRACTICAL SURFACE AN, V1, P437
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   DEKKER A, 1993, CLIN MATER, V13, P101, DOI 10.1016/0267-6605(93)90096-P
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241
   HAYWOOD B, 1990, ADV MAT PROCESS, V138
   HOFFMAN AS, 1987, BLOOD CONTACT NATURA, P96
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   JOZEFOWICZ M, 1986, POLYM MED, P41
   Kang IK, 1997, BIOMATERIALS, V18, P1099, DOI 10.1016/S0142-9612(97)00035-5
   Kang IK, 1996, J MATER SCI-MATER M, V7, P135, DOI 10.1007/BF00121251
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   KIM SW, 1987, BLOOD CONTACT NATURA, P116
   KIRKPATRICK CJ, 1991, CELL MATER, V1, P93
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Larm O., 1989, HEPARIN CHEM BIOL PR, P597
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   PIZZOFERRATO A, 1995, ENCY HDB BIOMATERI A, V1, P329
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   Riesenfeld J, 1995, Med Device Technol, V6, P24
   RITCHIE RO, 1992, J BIOMED MATER RES, V26, P69, DOI 10.1002/jbm.820260107
   Sanchez J, 1997, J BIOMED MATER RES, V37, P37, DOI 10.1002/(SICI)1097-4636(199710)37:1<37::AID-JBM5>3.3.CO;2-O
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   SBARBATI R, 1991, INT J ARTIF ORGANS, V14, P491
   SHARP WV, 1987, MODERN VASCULAR GRAF, P215
   Sheu MS, 1995, ENCY HDB BIOMATERI A, V1, P865
   SHIM HS, 1976, J BIOENG, V1, P45
   SINARD J M, 1990, Perfusion (London), V5, P239, DOI 10.1177/026765919000500402
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   STEFFEN HJ, 1991, PHYS REV B, V44, P3981, DOI 10.1103/PhysRevB.44.3981
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tietze L, 2000, MRS BULL, V25, P33
   Voet D., 1995, BIOCHEMISTRY
   Weiler M, 1996, PHYS REV B, V53, P1594, DOI 10.1103/PhysRevB.53.1594
   WEILER M, 1997, APPL PHYS LETT, V71, P1
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   WILLIAMS D, 1993, MED DEVICE TECHNOL, V11, P8
   WILLIAMS D, 1995, MED DEVICE TECHNOL, V1, P6
   WILLIAMS D, 1993, MED DEVICE TECHNOL, V10, P8
NR 50
TC 40
Z9 41
U1 0
U2 20
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN
PY 2000
VL 29
IS 6
BP 386
EP 391
DI 10.1002/1096-9918(200006)29:6<386::AID-SIA882>3.0.CO;2-0
PG 6
WC Chemistry, Physical
SC Chemistry
GA 328FA
UT WOS:000087837200006
DA 2018-10-19
ER

PT J
AU McPherson, TB
   Liang, H
   Record, RD
   Badylak, SF
AF McPherson, TB
   Liang, H
   Record, RD
   Badylak, SF
TI Ga1 alpha(1,3) Ga1 epitope in porcine small intestinal submucosa
SO TISSUE ENGINEERING
LA English
DT Article
ID ALPHA-GALACTOSYL EPITOPES; AUGMENTATION CYSTOPLASTY; DOG-MODEL;
   ANTIBODIES; IGG; RESIDUES; IDENTIFICATION; ACTIVATION; MONKEYS; GRAFT
AB Small intestinal submucosa (SIS) is a naturally occurring, acellular biomaterial derived from porcine jejunum, which promotes constructive tissue remodeling when applied as a xenogeneic graft material. Galactosyl-alpha(1,3)galactose (Gal) is a cell-associated epitope responsible for hyperacute rejection of porcine whole-organ xenografts in primates. Because SIS is harvested from porcine tissue, it may contain the Gal epitope. The goals of this study were to determine if Gal is present in SIS and, if it is present, to determine if human serum complement can be activated in vitro following exposure to porcine-derived SIS. SIS was probed for Gal by immunohistochemical methods and by lectin-peroxidase staining. SIS stained strongly positive with human serum, which contains naturally occurring antibodies to Gal, followed by anti-immunoglobulin G (IgG) or anti-IgM peroxidase conjugate. Blocking with the lectin I-B-4, which is specific for the Gal epitope, decreased the intensity of staining. Exposure of SIS to alpha-galactosidase reduced staining to negligible amounts. The Gal epitope is distributed transmurally throughout the SIS material. Subtyping of the immunoglobulins that bind to SIS showed that IgG(2) is the major immunoglobulin of human plasma that binds to SIS. SIS did not activate complement in vitro as measured by radioimmunoassay for C3a.
C1 Purdue Univ, Dept Biomed Engn, Ctr Biomed Engn, W Lafayette, IN 47907 USA.
   St Louis Coll Pharm, St Louis, MO USA.
RP Badylak, SF (reprint author), Purdue Univ, Dept Biomed Engn, Ctr Biomed Engn, Potter Bldg, W Lafayette, IN 47907 USA.
EM badylak@ecn.purdue.edu
OI Ritchie, Rae/0000-0002-0693-0693; Badylak, Stephen/0000-0003-3555-0689
FU NHLBI NIH HHS [HL 60359]
CR ABBAS AK, 1997, CELLULAR MOL IMMUNOL, P315
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   COOPER DKC, 1996, FRONT BIOSCI, V1, P248
   GABRIELLI A, 1991, CLIN EXP IMMUNOL, V86, P367
   GALILI U, 1988, J BIOL CHEM, V263, P17755
   GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401
   GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519
   GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573
   GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I
   GALILI U, 1987, J BIOL CHEM, V262, P4683
   GOLDBERG L, 1995, TRANSPLANT P, V27, P249
   HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   JOZIASSE DH, 1991, J BIOL CHEM, V266, P6991
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   KOREN E, 1992, TRANSPLANT P, V24, P598
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   MICHAELSEN TE, 1992, MOL IMMUNOL, V29, P319, DOI 10.1016/0161-5890(92)90018-S
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SPIRO RG, 1984, J BIOL CHEM, V259, P9858
   THALL A, 1990, BIOCHEMISTRY-US, V29, P3959, DOI 10.1021/bi00468a024
   TOBIN H, 1987, J EXP MED, V166, P419
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yu PB, 1996, J IMMUNOL, V157, P5163
NR 30
TC 80
Z9 87
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2000
VL 6
IS 3
BP 233
EP 239
DI 10.1089/10763270050044416
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 329BQ
UT WOS:000087886600004
PM 10941218
DA 2018-10-19
ER

PT J
AU Mendelsohn, JD
   Barrett, CJ
   Chan, VV
   Pal, AJ
   Mayes, AM
   Rubner, MF
AF Mendelsohn, JD
   Barrett, CJ
   Chan, VV
   Pal, AJ
   Mayes, AM
   Rubner, MF
TI Fabrication of microporous thin films from polyelectrolyte multilayers
SO LANGMUIR
LA English
DT Article
ID HETEROSTRUCTURES; IMMOBILIZATION; MICROCAPSULES; LAYERS
AB A simple process has been developed to create large area, highly uniform microporous thin films. Multilayers of weak polyelectrolytes were assembled onto silicon substrates by the sequential adsorption of poly(acrylic acid) and poly(allylamine) from aqueous solution. These multilayers were then immersed briefly into acidic solution (pH approximate to 2.4) to effect a substantial and irreversible transformation of the film morphology. The resulting microporous structures are 2-3 times the thickness of the original films, possess a correspondingly reduced relative density of 1/2 to 1/3, and are stable against further rearrangement under ambient; conditions. In addition, the microporous films may undergo a secondary reorganization in neutral water, leading to a morphology with more discrete throughpores. A mechanism is proposed for these transformations based on interchain ionic bond breakage and reformation in this highly protonating environment;, leading to an insoluble precipitate on the substrate which undergoes spinodal decomposition with the solvent. FTIR (Fourier transform infrared spectroscopy) analysis supports the underlying chemical basis of this pH-induced phase separation, and AFM (atomic force microscopy), in situ ellipsometry, and SEM (scanning electron microscopy) have been used to monitor the morphological changes. The unique combination of properties exhibited by these microporous films makes them potential candidates for microelectronic and biomaterial applications.
C1 MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Rubner, MF (reprint author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
RI Barrett, Christopher/B-7474-2008
CR Baur JW, 1996, MATER RES SOC SYMP P, V413, P583
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   KLITZING RV, 1995, LANGMUIR, V11, P3554
   Kotz J, 1996, POLYM MAT ENCY, V8, P5762
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   MICHAELS AS, 1965, J PHYS CHEM-US, V69, P1456, DOI 10.1021/j100889a004
   MICHAELS AS, 1965, IND ENG CHEM, V57, P32, DOI 10.1021/ie50670a007
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Onitsuka O, 1996, J APPL PHYS, V80, P4067, DOI 10.1063/1.363369
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   POMMERSHEIM R, 1994, MACROMOL CHEM PHYSIC, V195, P1557, DOI 10.1002/macp.1994.021950508
   Rilling P, 1997, J MEMBRANE SCI, V129, P283, DOI 10.1016/S0376-7388(97)00042-2
   Scranton AB, 1995, ADV POLYM SCI, V122, P1
   SHIRATORI S, IN PRESS MACROMOLECU
   Wu A, 1999, J AM CHEM SOC, V121, P4883, DOI 10.1021/ja9833624
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
NR 19
TC 567
Z9 571
U1 6
U2 175
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 30
PY 2000
VL 16
IS 11
BP 5017
EP 5023
DI 10.1021/la000075g
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 318VG
UT WOS:000087304100039
DA 2018-10-19
ER

PT J
AU Kim, JE
   Kim, SR
   Lee, SH
   Lee, CH
   Kim, DD
AF Kim, JE
   Kim, SR
   Lee, SH
   Lee, CH
   Kim, DD
TI The effect of pore formers on the controlled release of cefadroxil from
   a polyurethane matrix
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE cefadroxil; pore former; polyurethane; polymeric matrix; controlled
   release
ID COLONIZATION; BIOMATERIALS; RESISTANCE; DELIVERY; POLYMERS
AB The effect of various pore formers on the controlled release of an antibacterial agent from a polymeric device was examined in order to develop a novel biomaterial that prevents bacterial adhesion and growth on its surface. Cefadroxil was chosen as the model antibiotic and was incorporated into a polyurethane matrix by the solvent-casting method. Polyethylene glycol (PEG) 1450, D-mannitol, or bovine serum albumin (BSA) was used as a pore former. The amount of cefadroxil released from various formulations at 37 degrees C was measured by HPLC. The morphological change of matrices before and after release studies was investigated by scanning electron microscopy (SEM). The duration of antimicrobial activities of matrices against Escherichia coli and Bacillus subtilis was evaluated by measuring the diameters of the inhibition zone. Changing the weight fraction and particle size of the pore formers/drug mixtures could control the release of cefadroxil from the matrix. The release rate of cefadroxil increased as the loading dose of the pore former increased (15 < 20 < 25%). Cefadroxil released from these devices exhibited antibacterial activity for 5-6 days. These results imply that an antibiotic-loaded polymeric device that could prevent bacterial infection on its surface can be formulated using appropriate pore formers. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
RP Kim, DD (reprint author), Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
RI Kim, Dae Duk/D-8864-2013
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BUCK RE, 1977, ANTIMICROB AGENTS CH, V11, P324, DOI 10.1128/AAC.11.2.324
   Gebelein C. G., 1988, APPL BIOACTIVE POLYM
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   GRISTINA AG, 1991, HIGH PERFORMANCE BIO, P143
   HARTSTEIN AI, 1977, ANTIMICROB AGENTS CH, V12, P93, DOI 10.1128/AAC.12.1.93
   KENNEDY JF, 1974, ANTIMICROB AGENTS CH, V6, P777, DOI 10.1128/AAC.6.6.777
   Kim DD, 1998, PHARMACEUT RES, V15, P783
   Lelah M. D., 1986, POLYURETHANES MED
   LEVY RJ, 1989, 4 INT S REC ADV DRUG
   RHINE WD, 1980, J PHARM SCI, V69, P265, DOI 10.1002/jps.2600690305
   SAMPATH LA, 1995, J HOSP INFECT, V30, P201, DOI 10.1016/S0195-6701(95)90315-1
   SANDERS LM, 1986, J PHARM SCI, V75, P356, DOI 10.1002/jps.2600750407
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   SUGARMAN S, 1984, INFECT ASS PROSTHETI
   Sung KC, 1998, INT J PHARM, V172, P17, DOI 10.1016/S0378-5173(98)00156-2
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT
   TENRISAVER B, 1986, DRUGS, V32, P1
   UCHIDA T, 1988, CHEM PHARM BULL, V36, P2135
   UCHIDA T, 1992, CHEM PHARM BULL, V40, P463, DOI 10.1248/cpb.40.463
NR 21
TC 28
Z9 29
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD MAY 15
PY 2000
VL 201
IS 1
BP 29
EP 36
DI 10.1016/S0378-5173(00)00388-4
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 327MA
UT WOS:000087796600004
PM 10867262
DA 2018-10-19
ER

PT J
AU Xie, H
   Shaffer, BS
   Wadia, Y
   Gregory, KW
AF Xie, H
   Shaffer, BS
   Wadia, Y
   Gregory, KW
TI Use of reconstructed small intestine submucosa for urinary tract
   replacement
SO ASAIO JOURNAL
LA English
DT Article
ID URETERAL REPLACEMENT; TUBE GRAFTS; TISSUE
AB We used reconstructed SIS (ReSIS), a photocrosslinked biomaterial, to create grafts in various shapes and sizes. Sheets of ReSIS were placed in 14 swine to repair bladder defects, and ReSIS tubes were placed in six swine to replace a segment of excised ureter. Histologic analysis of the bladder repair revealed transitional urothelial cells lining the ReSIS by 1 week. After 2 weeks, fibroblasts and mononuclear cells had infiltrated the ReSIS, neovascularization had occurred, and the urothelial lining was more complex, containing multiple cell layers. After 4 weeks, a definite submucosa was present and the ReSIS was starting to degrade. An initial muscular regeneration was demonstrated at 12 weeks. No foreign body reaction, calcification, or sedimentation was noted in any animal. The ureteral implants showed identical histologic changes, without obstruction or leakage of the replaced segment The ReSIS allowed rapid urothelial regeneration, ingrowth of new blood vessels, and the orderly deposition and organization of new collagen. Our study demonstrates that the photocrosslinking technique used to create larger sheets and tubes of this biomaterial (ReSIS) does not detract from the positive attributes of the SIS and should improve its usefulness in accomplishing larger bladder augmentations and ureter replacements.
C1 Providence St Vincent Med Ctr, Oregon Med Laser Ctr, Portland, OR 97225 USA.
   Providence St Vincent Med Ctr, Dept Urol, Portland, OR 97225 USA.
RP Xie, H (reprint author), Providence St Vincent Med Ctr, Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.
CR Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Baltaci S, 1998, UROLOGY, V51, P400, DOI 10.1016/S0090-4295(97)00632-8
   Dahms SE, 1997, UROLOGY, V50, P818, DOI 10.1016/S0090-4295(97)00391-9
   HOLMES SAV, 1993, BRIT J UROL, V71, P378, DOI 10.1111/j.1464-410X.1993.tb15976.x
   HOMANN W, 1984, UROL INT, V39, P95, DOI 10.1159/000280953
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Mitchell ME, 1987, DIAL PED UROL, V10, P1
   Peters JJ, 1996, UROLOGY, V48, P379, DOI 10.1016/S0090-4295(96)00163-X
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Sabanegh ES, 1996, UROLOGY, V48, P312, DOI 10.1016/S0090-4295(96)00185-9
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 14
TC 14
Z9 18
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD MAY-JUN
PY 2000
VL 46
IS 3
BP 268
EP 272
DI 10.1097/00002480-200005000-00005
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 346RF
UT WOS:000088884300005
PM 10826734
DA 2018-10-19
ER

PT J
AU Gretzer, C
   Thomsen, P
AF Gretzer, C
   Thomsen, P
TI Secretion of IL-1 and H2O2 by human mononuclear cells in vitro
SO BIOMATERIALS
LA English
DT Article
DE mononuclear cells; differentiation; hydrogen peroxide; interleukin-1
   alpha; biomaterial; particles
ID TUMOR NECROSIS FACTOR; HUMAN-MONOCYTES; HYDROGEN-PEROXIDE; BIOMATERIAL
   INTERACTION; MONOCLONAL-ANTIBODY; SUPEROXIDE RELEASE; RESPIRATORY BURST;
   PERIPHERAL-BLOOD; IN-VITRO; MACROPHAGES
AB The secretion of hydrogen peroxide (H2O2) and interleukin-1 alpha (IL-1 alpha) was evaluated during in vitro culturing of human monocytes. The oxidative metabolism and cytokine secretion were correlated to the cell distribution (number of surface-associated cells), the DNA content and their integrity, evaluated by lactate dehydrogenase (LDH) assay. The differentiation of cultured monocytes was determined by the expression of CD14, 27E10 and RM3/1. After 24 h cultivation, unstimulated cells had a low production of H2O2 and IL-1 alpha. A four-fold increase in the production of H2O2 was detected with 5 and 10 mu g/ml of lipopolysaccharide (LPS) and polystyrene (PS) particles. PS particles induced a concentration-dependent increase in IL-1 alpha after 24 h. In contrast, cultivation for 48 h, did not result in any measurable production of H2O2, irrespective of the type of stimulus. A decreased viability of monocytes was shown after stimulation with PS particles in high concentrations. Our results indicate that the phenotype expression, adhesion, integrity and secretory pattern of human monocytes is dependent on the culture time and the type and concentration of stimulus. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Gothenburg Univ, Inst Anat & Cell Biol, S-41390 Gothenburg, Sweden.
RP Gretzer, C (reprint author), Gothenburg Univ, Inst Anat & Cell Biol, Medicinaregatan 3, S-41390 Gothenburg, Sweden.
OI Thomsen, Peter/0000-0003-3910-6665
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   AOTSUKA S, 1991, ANN RHEUM DIS, V50, P27, DOI 10.1136/ard.50.1.27
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BABIOR BM, 1984, BLOOD, V64, P959
   BAQUEY C, 1991, BIORHEOLOGY, V28, P463
   BAZIL V, 1991, J IMMUNOL, V147, P1567
   Becker S, 1998, J TOXICOL ENV HEAL A, V55, P455, DOI 10.1080/009841098158278
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   BRANDSLUND I, 1982, J IMMUNOL METHODS, V48, P199, DOI 10.1016/0022-1759(82)90194-6
   CAMARERO VCPC, 1990, J CELL PHYSIOL, V145, P481, DOI 10.1002/jcp.1041450313
   DINARELLO CA, 1991, BLOOD, V77, P1627
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   GUILBAULT GG, 1966, ANAL CHEM, V38, pR527
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LONNEMANN G, 1989, EUR J IMMUNOL, V19, P1531, DOI 10.1002/eji.1830190903
   MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NATHAN CF, 1989, BLOOD, V73, P301
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   PERTOFT H, 1980, J IMMUNOL METHODS, V33, P221, DOI 10.1016/0022-1759(80)90209-4
   REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   SAVIO IJA, 1993, CLIN MAT, V15, P101
   SCHINDLER R, 1990, BLOOD, V75, P40
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZWADLO G, 1987, EXP CELL BIOL, V55, P295
   ZWADLO G, 1986, J IMMUNOL, V137, P512
NR 48
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2000
VL 21
IS 10
BP 1047
EP 1055
DI 10.1016/S0142-9612(99)00279-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302DL
UT WOS:000086350100010
PM 10768757
DA 2018-10-19
ER

PT J
AU Giardino, R
   Aldini, NN
   Torricelli, P
   Fini, M
   Giavaresi, G
   Rocca, M
   Martini, L
AF Giardino, R
   Aldini, NN
   Torricelli, P
   Fini, M
   Giavaresi, G
   Rocca, M
   Martini, L
TI A resorbable biomaterial shaped as a tubular chamber and containing stem
   cells: a pilot study on artificial bone regeneration
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE bone defects; artificial bone regeneration; stem cells; rabbits
ID GUIDED TISSUE REGENERATION; RADIUS DEFECTS; MARROW; MEMBRANES; FRACTURE;
   RABBITS; MATRIX
AB In a previous study, we showed how healing of non-union defects in rabbit radii can be achieved by means of a tubular resorbable chamber, in comparison with untreated defects. in the present study we placed bone marrow stem cells inside the chamber. Bone marrow was obtained by percutaneous aspiration from the iliac crest in 9 adult New Zealand rabbits. Stem cells were separated by the centrifugation technique. In the same animals, a defect of 10 mm was created in both radii. On the left side, the defect was treated with the poly-DL-Lactide chamber, in which a suspension of autologous cells was injected; on the right side, only autologous cells were used. Radiological and histomorphometric data were compared within this study as well as with the results of our previous study. At 3, 6 and 9 months, there was no healing on the right side. On the left side, progressive bone formation with reunion of the stumps was observed in the chamber. We conclude that stem cells can accelerate bone healing when contained in the tubular chamber.
C1 Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurgia Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Bologna, Sch Med, Bologna, Italy.
RP Giardino, R (reprint author), Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurgia Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BLUHM AE, 1995, J ORAL MAXIL SURG, V53, P163, DOI 10.1016/0278-2391(95)90395-X
   BRUNELLI GA, 1995, CLIN ORTHOP RELAT R, P241
   CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318
   CAPLAN AI, 1997, PRINCIPLES TISSUE EN, P604
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   Connolly JF, 1998, CLIN ORTHOP RELAT R, V355, P257
   Eickholz P, 1997, J CLIN PERIODONTOL, V24, P92, DOI 10.1111/j.1600-051X.1997.tb00473.x
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   GARG NK, 1993, ACTA ORTHOP SCAND, V64, P671, DOI 10.3109/17453679308994595
   Giardino R, 1998, INT J ARTIF ORGANS, V21, P473
   Giardino R, 1997, BIOMATERIALS, V18, P907, DOI 10.1016/S0142-9612(97)00014-8
   Giardino R, 1997, INT J ARTIF ORGANS, V20, P76
   Giardino R, 1999, J TRAUMA, V47, P303, DOI 10.1097/00005373-199908000-00014
   HEALEY JH, 1990, CLIN ORTHOP RELAT R, P280
   JAN SW, 1993, ACTA ORTHOP SCAND, V64, P557
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, P229
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   LUNSJO K, 1998, HIP INT, V8, P102
   Meinig RP, 1997, J ORTHOP TRAUMA, V11, P551, DOI 10.1097/00005131-199711000-00002
   MEINIG RP, 1996, J ORTHOP TRAUMA, V10, P1978
   Mendicino S S, 1996, J Foot Ankle Surg, V35, P452
   MULLER T, 1997, ACTA ORTHOP BELG, V63, P170
   NIEDZWIEDZKI T, 1993, BIOMATERIALS, V14, P115, DOI 10.1016/0142-9612(93)90221-M
   NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853
   NYMAN R, 1995, ACTA ORTHOP SCAND, V66, P169, DOI 10.3109/17453679508995515
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   PALEY D, 1986, CLIN ORTHOP RELAT R, P300
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   SIMON JP, 1998, HIP INT, V8, P51
   Sutherland AG, 1997, J HOSP INFECT, V35, P215, DOI 10.1016/S0195-6701(97)90209-7
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   TIEDEMAN JJ, 1991, CLIN ORTHOP RELAT R, P294
   Torricelli P, 1999, INT ORTHOP, V23, P178, DOI 10.1007/s002640050341
   Zellin G, 1997, SCAND J PLAST RECONS, V31, P97, DOI 10.3109/02844319709085475
   Ziccardi V B, 1996, N Y State Dent J, V62, P48
NR 36
TC 13
Z9 13
U1 0
U2 4
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAY
PY 2000
VL 23
IS 5
BP 331
EP 337
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 325VP
UT WOS:000087697400008
PM 10872852
DA 2018-10-19
ER

PT J
AU Radice, M
   Brun, P
   Cortivo, R
   Scapinelli, R
   Battaliard, C
   Abatangelo, G
AF Radice, M
   Brun, P
   Cortivo, R
   Scapinelli, R
   Battaliard, C
   Abatangelo, G
TI Hyaluronan-based biopolymers as delivery vehicles for
   bone-marrow-derived mesenchymal progenitors
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hyaluronan esters; marrow stromal mesenchymal cells; tissue engineering;
   osteochondral defect; immunohistochemistry
ID ARTICULAR-CARTILAGE; IN-VITRO; TISSUE; CHONDROCYTES; DEFECTS; CELLS;
   BIOCOMPATIBILITY; DIFFERENTIATION; SCAFFOLDS
AB The tolerability and safety of hyaluronan-based three-dimensional scaffolds as a culture vehicle for mesenchymal progenitor cells was investigated in this pilot study. The proliferation patterns and extracellular matrix production of rabbit and human mesenchymal, bone-marrow-derived progenitors first were characterized in vitro. Subsequently rabbit autologous cells were cultured in this hyaluronan-based scaffold and implanted in a full-thickness osteochondral lesion. In vitro histologic findings showed that mesenchymal progenitor cells adhered and proliferated onto the hyaluronan-derived scaffold. Human stem cells were shown to produce the main extracellular matrix molecules, accompanied by an occasional synthesis of mature type II collagen. bl vivo data demonstrated that the biomaterial, with or without mesenchymal progenitors, did not elicit any inflammatory response and was completely degraded within 4 months after implantation. With regard to the efficacy of this cell therapy, even among the small number of animals tested there was histologic evidence that lesions filled with the biomaterial, either seeded or unseeded with cells, achieved a faster and better healing compared to empty controls. The present data suggest that the hyaluronan-based scaffolds are well tolerated and safe and may be a valuable delivery vehicle for tissue engineering in the repair of articular cartilage defects. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Padua, Inst Histol & Embryol, I-35121 Padua, Italy.
   Univ Padua, Clin Orthoped & Trauma Surg, I-35100 Padua, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Inst Histol & Embryol, Via G Colombo 3, I-35121 Padua, Italy.
CR BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Goldberg VM, 1998, J SPORT TRAUMATOL, V20, P81
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   HANSBROUGH JF, 1993, WOUNDS, V5, P174
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 28
TC 151
Z9 156
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 101
EP 109
DI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600002
PM 10679672
DA 2018-10-19
ER

PT J
AU Hendricks, SK
   Kwok, C
   Shen, MC
   Horbett, TA
   Ratner, BD
   Bryers, JD
AF Hendricks, SK
   Kwok, C
   Shen, MC
   Horbett, TA
   Ratner, BD
   Bryers, JD
TI Plasma-deposited membranes for controlled release of antibiotic to
   prevent bacterial adhesion and biofilm formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE Pseudomonas aeruginosa; bacterial adhesion; biofilm formation;
   controlled release antibiotic; triglyme antiadhesion coating
ID POLYETHYLENE OXIDE; PROTEIN ADSORPTION; SURFACES; COLONIZATION;
   SURFACTANTS; COATINGS; POLYMER
AB Bacterial infection on implanted medical devices is a significant clinical problem caused by the adhesion of bacteria to the biomaterial surface followed by biofilm formation and recruitment of other cells lines such as blood platelets, leading to potential thrombosis and thromboembolisms. To minimize biofilm formation and potential device-based infections, a polyurethane (Biospan) matrix was developed to release, in a controlled manner, an antibiotic (ciprofloxacin(T)) locally at the implant interface. One material set consisted of the polyetherurethane (PEU) base matrix radiofrequency glow discharge plasma deposited with triethylene glycol dimethyl ether (triglyme); the other set had an additional coating of poly(butyl methyacrylate) (pBMA). Triglyme served as a nonfouling coating, whereas the pBMA served as a controlled porosity release membrane. The pBMA-coated PEU contained and released ciprofloxacin(T) in a controlled manner. The efficacy of the modified PEU polymers against Pseudomonas aeruginosa suspensions was evaluated under flow conditions in a parallel plate flow cell. Bacterial adhesion and colonization, if any, to the test polymers were examined by direct microscopic image analysis and corroborated with destructive sampling, followed by direct cell counting. The rate of initial bacterial cell adhesion to triglyme-coated PEU was 0.77%, and to the pBMA-coated PEU releasing ciproaoxacin(T) was 6% of the observed adhesion rates for the control PEU. However, the rate of adherent cell accumulation due to cell growth and replication was approximately the same for the triglyme-coated PEU and the PEU controls, but was zero for the pBMA-coated PEU releasing ciprofloxacin(T). (C) 2000 John Wiley & Sons, Inc.
C1 Univ Connecticut, Ctr Hlth, Ctr Biomat, Farmington, CT 06030 USA.
   Montana State Univ, Dept Chem Engn, Bozeman, MT 59717 USA.
   Univ Washington, NSF, Engn Res Ctr, Engineered Biomat Ctr, Seattle, WA 98195 USA.
RP Bryers, JD (reprint author), Univ Connecticut, Ctr Hlth, Ctr Biomat, Farmington, CT 06030 USA.
CR ANDRADE JD, 1988, BIOMATERIALS, V9, P76, DOI 10.1016/0142-9612(88)90074-9
   APPLEGATE DH, 1991, BIOTECHNOL BIOENG, V37, P17, DOI 10.1002/bit.260370105
   ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005
   Bailey JE, 1986, BIOCH ENG FUNDAMENTA
   BRAATZ JA, 1992, J BIOMAT SCI-POLYM E, V3, P451, DOI 10.1163/156856292X00439
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Characklis W. G., 1990, BIOFILMS
   CHARACKLIS WG, 1989, DAHL C LIF SCI RES
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Dunkirk S G, 1991, J Biomater Appl, V6, P131, DOI 10.1177/088532829100600203
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HENDRICKS SK, 1998, THESIS MONTANA STATE
   Hobbie J. E., 1977, APPL ENVIRON MICROB, V33, P1255
   HUMPHRIES M, 1987, FEMS MICROBIOL ECOL, V45, P297, DOI 10.1111/j.1574-6968.1987.tb02380.x
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   Klein J, 1986, Pharm Unserer Zeit, V15, P65, DOI 10.1002/pauz.19860150302
   KWOK CS, J CONTROL REL
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   RUSSEL KH, 1978, INTERMEDIATE PHYSICS, P10
   Segreti J, 1989, Infect Dis Clin North Am, V3, P357
   SHEU MS, 1992, THESIS U WASHINGTON
   Sjollema J., 1988, Biofouling, V1, P101
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   SULLAM PM, 1990, INFECT IMMUN, V58, P3802
NR 32
TC 68
Z9 69
U1 2
U2 20
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 160
EP 170
DI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600010
PM 10679680
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Busscher, HJ
TI Initial adhesion and surface growth of Staphylococcus epidermidis and
   Pseudomonas aeruginosa on biomedical polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial-centered infections; biofilm formation; bacterial adhesion;
   bacterial surface growth; parallel plate flow chamber
ID MICROBIAL ADHESION; BACTERIAL ADHESION; FLOW CHAMBER; INTERFACES;
   INFECTION
AB The infection risk of biomaterials implants varies between different materials and is determined by an interplay of adhesion and surface growth of the infecting organisms. In this study, we compared initial adhesion and surface growth of Staphylococcus epidermidis HBH2 102 and Pseudomonas aeruginosa AK1 on poly(dimethylsiloxane), Teflon, polyethylene, polypropylene, polyurethane, poly(ethylene terephthalate), poly(methyl methacrylate), and glass. Initial adhesion was measured in situ in a parallel plate now chamber with microorganisms suspended in phosphate-buffered saline, while subsequent surface growth was followed in full and in 20 times diluted growth medium, initial adhesion of both bacterial strains was similar to all biomaterials in full growth medium, generation times of surface growing S. epidermidis ranged from 17 to 38 min with no relation to wettability, while in diluted growth medium generation times increased from 44 to 98 min with increasing surface wettability. For P. aeruginosa no influence of surface wettability on generation times was observed, but generation times increased with decreasing desorption rates, maximal generation times being 47 min and minimal values down to 30 min. Generally, generation times of adhering bacteria were shorter than of planktonic bacteria. In conclusion, surface grow th of initially adhering bacteria is influenced by biomaterials surface properties to a greater extent than initial adhesion. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Dept Biomed Engn, NL-9712 KZ Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anwar H., 1992, ASM NEWS, V58, P665
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BOUTTIER S, 1994, COLLOID SURFACE B, V2, P57, DOI 10.1016/0927-7765(94)80018-9
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   ESCHER A, 1990, BIOFILMS, P445
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash MB, 1997, MICROBIOL-UK, V143, P2569, DOI 10.1099/00221287-143-8-2569
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOEDEMAKER HOT, 1997, BIOMEDICAL MAT RES G, P109
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
NR 16
TC 117
Z9 121
U1 3
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 208
EP 214
DI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600016
PM 10679686
DA 2018-10-19
ER

PT J
AU Uludag, H
   D'Augusta, D
   Golden, J
   Li, J
   Timony, G
   Riedel, R
   Wozney, JM
AF Uludag, H
   D'Augusta, D
   Golden, J
   Li, J
   Timony, G
   Riedel, R
   Wozney, JM
TI Implantation of recombinant human bone morphogenetic proteins with
   biomaterial carriers: A correlation between protein pharmacokinetics and
   osteoinduction in the rat ectopic model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE recombinant human bone morphogenetic proteins; osteoinduction;
   biomaterial carriers; pharmacokinetics; protein delivery
ID MATRIX GELATIN; SIALIC-ACID; CELL-LINES; IN-VITRO; DIFFERENTIATION;
   REGENERATION; MEMBERS; CULTURE; RHBMP-2; GROWTH
AB This study was carried out to determine the effect of recombinant human bone morphogenetic protein (rhBMP) pharmacokinetics (PK) on rhBMP-induced osteoinductive activity. It was our working hypothesis that the PK of a rhBMP significantly affects its osteoinductive activity. The PK of various rhBMPs (rhBMP-2, rhBMP-4, rhBMP-6, and chemically modified rhBMP-2) implanted with four biomaterial carries (Helistat(R), hDBM, Osteograf/N(R), and Dexon(R)) was determined using I-125-labeled proteins in the rat ectopic assay. A select combination of rhBMP and carriers then was evaluated in the rat ectopic assay for osteoinductive activity using a semi-quantitative histologic scoring system. The results indicate that initial protein retention is dependent on protein isoelectric point (pI); proteins with a higher pi yielded a higher implant retention. Subsequent PK was not strongly dependent on the pI or on the carrier. Because of the difference in early retention, the rhBMP-carrier combinations exhibited a >100-fold difference in implant-retained protein dose. When rhBMP-2 and rhBMP-4 were implanted with the carriers, more rhBMP-2 was retained in an implant, and the osteoinductive potency of rhBMP-2 typically was higher than rhBMP-4 at low implantation doses. We conclude that protein pi plays a significant role in the local retention of implanted rhBMP and that higher retention yields a higher osteoinductive activity. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada.
   Genet Inst Inc, Andover, MA 01810 USA.
RP Uludag, H (reprint author), Univ Alberta, Dept Biomed Engn, 10-102 Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.
CR Boden SD, 1996, ENDOCRINOLOGY, V137, P3401, DOI 10.1210/en.137.8.3401
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Ferrari J, 1998, BIOTECHNOL BIOENG, V60, P589, DOI 10.1002/(SICI)1097-0290(19981205)60:5<589::AID-BIT9>3.3.CO;2-B
   GRAMER MJ, 1995, BIO-TECHNOL, V13, P692, DOI 10.1038/nbt0795-692
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, P93
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Klotz I. M., 1967, METHOD ENZYMOL, V11, P576
   LINDHOLM TS, 1993, ANN CHIR GYNAECOL FE, V82, P3
   MANDENHALL W, 1979, INTRO PROBABILITY ST, P484
   RATHORE S, 1995, PROTEIN SCI, V4, P140
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   ROSEN V, 1994, J BONE MINER RES, V9, P1759
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SMITH JL, 1995, J CONTROL RELEASE, V36, P183, DOI 10.1016/0168-3659(95)00046-B
   Steinijans V. W., 1993, Clinical Research and Regulatory Affairs, V10, P203, DOI 10.3109/10601339309079568
   Uludag H, 1999, BIOTECHNOL BIOENG, V65, P668, DOI 10.1002/(SICI)1097-0290(19991220)65:6<668::AID-BIT7>3.0.CO;2-8
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   ULUDAG H, 1999, NY ACAD SCI, V875, P369
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   YAMASHITA K, 1992, ARCH HISTOL CYTOL, V55, P31, DOI 10.1679/aohc.55.31
   YAMASHITA K, 1992, ACTA ANAT, V143, P261
   Yeung B, 1997, ANAL CHEM, V69, P2510, DOI 10.1021/ac9611172
NR 31
TC 152
Z9 155
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 227
EP 238
DI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600018
PM 10679688
DA 2018-10-19
ER

PT J
AU Khouw, IMSL
   van Wachem, PB
   Plantinga, JA
   Haagmans, BL
   de Leij, LFMH
   van Luyn, MJA
AF Khouw, IMSL
   van Wachem, PB
   Plantinga, JA
   Haagmans, BL
   de Leij, LFMH
   van Luyn, MJA
TI Foreign-body reaction to dermal sheep collagen in
   interferon-gamma-receptor knock-out mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE foreign-body reaction; IFN-gamma-receptor knockout mice; macrophages and
   giant cells; MHC class II
ID MONOCLONAL-ANTIBODY GK1.5; T-CELL; TISSUE REACTION; IFN-GAMMA; IN-VIVO;
   MONOCYTES MACROPHAGES; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; DEFICIENT
   MICE; CROSS-LINKING
AB This study was performed to gain more insight into the role of interferon-gamma (IFN-gamma), a potent macrophage activator, in the foreign-body reaction to hexamethylenediisocyanate-crosslinked dermal sheep collagen (HDSC). Because the results of earlier studies aimed at modulating the foreign-body reaction in AO rats by local or systemic treatment with anti-IFN-gamma were not completely unambiguous, we extended our in investigations to IFN-gamma-receptor knock-out (KO) mice. Several parameters (i.e., macrophages, giant cells, T-cells, B-cells, granulocytes, expression of MHC class II, stroma formation, and degradation and calcification of the biomaterial) were compared between wild-type (WT) and KO mice. Remarkably, the foreign-body reaction was very similar in WT and KO mice. in both, giant cells were formed, but in contrast to previous results in AO rats, phagocytosis of HDSC bundles occurred hardly at all up to 9 weeks, and MHC class II expression was minimal. Stroma formation and vascularization were high and calcification occurred. T-cells comprised less than 1%; a few plasma cells were present in the KO mice at later time points. Granulocytes, mainly eosinophils, were present at all explantation time points. Because of the similar results in WT and KO mice, we question whether IFN-gamma plays a role at all in the foreign-body reaction in mice. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Med Biol Branch, Dept Pathol & Lab Med, NL-9712 KZ Groningen, Netherlands.
   Univ Utrecht, Dept Infect Dis & Immunol, Virol Unit, Utrecht, Netherlands.
   Univ Groningen Hosp, Med Biol Branch, Dept Pathol & Lab Med, Groningen, Netherlands.
RP Khouw, IMSL (reprint author), Univ Groningen, Med Biol Branch, Dept Pathol & Lab Med, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
OI Haagmans, Bart/0000-0001-6221-2015
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Anderson S, 1999, AM J RESP CELL MOL, V20, P371, DOI 10.1165/ajrcmb.20.3.3317
   Baumgarth N, 1996, J VIROL, V70, P4411
   Coers W, 1998, J HISTOCHEM CYTOCHEM, V46, P1385, DOI 10.1177/002215549804601207
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243
   Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3
   Dai WJ, 1997, J IMMUNOL, V158, P5297
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x
   DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
   DURHAM SR, 1992, J IMMUNOL, V148, P2390
   GRANSTEIN RD, 1990, J INVEST DERMATOL, V95, pS75, DOI 10.1111/1523-1747.ep12874789
   Hoffmann R, 1997, UNFALLCHIRURG, V100, P658, DOI 10.1007/s001130050172
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   JIRANEK W, 1995, J BONE JOINT SURG AM, V77A, P1650, DOI 10.2106/00004623-199511000-00003
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KHOUW IMS, IN PRESS J BIOMED MA
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x
   Majewski S, 1996, J INVEST DERMATOL, V106, P1114, DOI 10.1111/1523-1747.ep12340161
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   PORTOLES P, 1989, J IMMUNOL, V142, P4169
   SHEEHAN DC, 1980, THEORY PRACTICE HIST, P227
   SWIHART K, 1995, J EXP MED, V181, P961, DOI 10.1084/jem.181.3.961
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   vandenBroek MF, 1995, IMMUNOL REV, V148, P5
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANLUYN MJA, 1994, J MATER SCI-MATER M, V5, P671, DOI 10.1007/BF00120354
   VANWACHEM PB, 1991, CELL MATER, V1, P251
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VECCHI A, 1994, EUR J CELL BIOL, V63, P247
   WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367
   Wilson RA, 1996, IMMUNOLOGY, V87, P275, DOI 10.1046/j.1365-2567.1996.465550.x
NR 37
TC 9
Z9 9
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 259
EP 266
DI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600021
PM 10679691
DA 2018-10-19
ER

PT J
AU Smith, RA
   Mosesson, MW
   Daniels, AU
   Gartner, TK
AF Smith, RA
   Mosesson, MW
   Daniels, AU
   Gartner, TK
TI Adhesion of microvascular endothelial cells to metallic implant surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EPIDERMAL GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; BIOMATERIAL SURFACES;
   ORTHOPEDIC IMPLANTS; MORPHOLOGIC ASPECTS; CELLULAR-RESPONSES; LEUKOCYTE
   ADHESION; ALPHA-CHAIN; FIBRINOGEN; RECEPTOR
AB The objective of this study was to explore the molecular mechanisms of adhesion of endothelial cells (ECs) to implant grades of titanium alloy (Ti) and stainless steel (SS), compared to tissue culture polystyrene (PS). The idea is that promotion of EC adhesion to implant surfaces during the initial stages of healing may be critical in the formation of a capillary bed intimately associated with the implant surface. Ultimately this could be expected in turn to promote bone formation close to the surface and a more stable implant/bone interface. Surfaces were coated with either peak 1 fibrinogen gamma A gamma A, fibrinogen Fr I-9, fibrinogen fragment D1, fibronectin, vitronectin, or fetal calf serum and then post-coated with bovine serum albumin (BSA) to block non-specific cell adhesion. Surfaces with BSA alone and no other protein coating were also evaluated. Fibronectin coating maximized cell adhesion on all three surfaces, and adhesion was highest on PS. BSA blocked cell adhesion to PS (and most adhesion to SS) much better than to Ti. These results provide evidence that BSA adsorption on the metal surface is unable to effectively block the adhesion of the cells to the Ti. These data may provide a basis for understanding in vivo observations that soft tissue becomes attached to a Ti surface more rapidly and with more bone formation than to SS. Evidence is also presented that alpha(v)beta(3) plays an important role in adhesion of ECs to the Ti surface. These experiments also provide preliminary data which may reflect some of the features of initial EC adhesion to metal implants. (C) 2000 Kluwer Academic Publishers.
C1 Univ Tennessee, Campbell Clin, Dept Orthopaed Surg, Memphis, TN 38163 USA.
   Univ Memphis, Dept Biol, Memphis, TN 38152 USA.
   Univ Wisconsin, Sch Med, Dept Med, Sinai Samaritan Med Ctr, Milwaukee, WI 53233 USA.
RP Smith, RA (reprint author), Univ Tennessee, Campbell Clin, Dept Orthopaed Surg, Memphis, TN 38163 USA.
CR ALBELDA SM, 1989, J CLIN INVEST, V83, P1992, DOI 10.1172/JCI114109
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140
   BENNETT JS, 1988, J BIOL CHEM, V263, P12948
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P766, DOI 10.1002/jor.1100100604
   CHANG MC, 1995, THROMB HAEMOSTASIS, V74, P764
   CHEN CS, 1991, BLOOD, V77, P2200
   CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   ChristofidouSolomidou M, 1997, AM J PATHOL, V151, P975
   CLARK RAF, 1985, WOUND REPAIR PLASMA, P197
   CLIFF WJ, 1963, PHILOS T ROY SOC B, V246, P305, DOI 10.1098/rstb.1963.0008
   Felding-Habermann Brunhilde, 1993, Current Opinion in Cell Biology, V5, P864, DOI 10.1016/0955-0674(93)90036-P
   FRELINGER AL, 1991, J BIOL CHEM, V266, P17106
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GRONOWICZ G, 1995, T 41 ANN M ORTH RES, P782
   HAPGOOD J, 1983, P NATL ACAD SCI-BIOL, V80, P6451, DOI 10.1073/pnas.80.21.6451
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473
   JENNINGS LK, 1985, BLOOD, V65, P1112
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAWAGUCHI S, 1993, J ORTHOPAED RES, V11, P386, DOI 10.1002/jor.1100110310
   Keith A, 1927, Proc R Soc Med, V21, P301
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   MOORADIAN DL, 1992, J SURG RES, V53, P74, DOI 10.1016/0022-4804(92)90016-S
   MOSESSON MW, 1974, J BIOL CHEM, V249, P4656
   OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   POBER JS, 1991, LAB INVEST, V64, P301
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   PODESTA EJ, 1983, P NATL ACAD SCI-BIOL, V80, P3986, DOI 10.1073/pnas.80.13.3986
   PODOR TJ, 1988, ENDOTHELIAL CELL, V1, P127
   SCHECHTER Y, 1979, NATURE, V278, P835, DOI 10.1038/278835a0
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   SINHA RK, 1995, T 41 ANN M ORTH RES, P139
   Smith RA, 1997, J BIOL CHEM, V272, P22080, DOI 10.1074/jbc.272.35.22080
   SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217
   TAUBENFELD SM, 1995, THROMB HAEMOSTASIS, V74, P923
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   VERRIER S, 1995, 12 EUR C BIOM PORT P, P190
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
NR 46
TC 10
Z9 10
U1 1
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2000
VL 11
IS 5
BP 279
EP 285
DI 10.1023/A:1008953112683
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 295GM
UT WOS:000085958400003
PM 15348024
DA 2018-10-19
ER

PT J
AU Irigaray, JL
   Oudadesse, H
   Sauvage, T
AF Irigaray, JL
   Oudadesse, H
   Sauvage, T
TI Biotransformation of implanted coral in some animals studied by neutron
   activation analysis
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Modern Trends in Activation Analysis
   (MTAA-10)
CY APR 19-23, 1999
CL NIH, BETHESDA, MARYLAND
SP Natl Inst Stand & Technol
HO NIH
AB In vivo behavior of biomaterial is dependent on the site of implantation. Characterization by atomic element transfers versus the implantation duration is a quantitative approach to the phenomenon. Here, bioactive coral is implanted in ovine, porcine and rabbit thighbones and not in sheep jawbones as previously reported. Biopsies extracted between 1 and 24 weeks are analysed by fast neutron activation. Mineral composition of the coral is greatly modified: Ca, P, Mg and Sr concentrations become comparable to those of mature bone some months after the implantation. Results suggest a bioactive resorption followed by apatite formation.
C1 Univ Blaise Pascal, CNRS, Lab Phys Corpusculaire Clermont Ferrand, IN2P3, F-63177 Clermont Ferrand, France.
RP Irigaray, JL (reprint author), Univ Blaise Pascal, CNRS, Lab Phys Corpusculaire Clermont Ferrand, IN2P3, F-63177 Clermont Ferrand, France.
CR BATHIA S, 1986, CHEM ENG SCI, V41, P1311
   ELFADL H, 1990, THESIS U BLAISE PASC
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   *INOTEB, 2656920 INOTEB BP
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   OUDADESSE H, 1998, THESIS U BLAISE PASC
   PASCAL P, 1958, NOUVEAU TRAITE CHIMI, V11
   PASCAL P, 1958, NOUVEAU TRAITE CHIMI, V6
   Pascal P., 1958, NOUVEAU TRAITE CHIMI, VIV
   Watson G. N., 1962, TREATISE THEORY BESS
NR 10
TC 2
Z9 3
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD MAY
PY 2000
VL 244
IS 2
BP 317
EP 319
DI 10.1023/A:1006754702817
PG 3
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 338GK
UT WOS:000088410600014
DA 2018-10-19
ER

PT J
AU Rauz, S
   Stavrou, P
   Murray, PI
AF Rauz, S
   Stavrou, P
   Murray, PI
TI Evaluation of foldable intraocular lenses in patients with uveitis
SO OPHTHALMOLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 09-14, 1999
CL FT LAUDERDALE, FL
SP Assoc Res Vis & Ophthalmol, Natl Hlth Public Serv Award, Childrens Hosp, Res Fdn
ID EXTRACAPSULAR CATARACT-EXTRACTION; POSTERIOR CAPSULE OPACIFICATION;
   POSTOPERATIVE CELLULAR REACTION; FUCHS HETEROCHROMIC CYCLITIS;
   BLOOD-AQUEOUS BARRIER; POLY(METHYL METHACRYLATE); PARS PLANITIS;
   FOLLOW-UP; SURGERY; IMPLANTATION
AB Objective: To evaluate various foldable posterior chamber intraocular lenses (IOLs) after phacoemulsification in patients with uveitis.
   Design: A prospective, noncomparative, interventional case series.
   Participants: Forty-nine consecutive patients (60 eyes) with various types of uveitis (anterior, n = 20; posterior, n = 1; panuveitis, n = 37, intermediate, n = 2).
   Interventions All patients underwent phacoemulsification with foldable posterior chamber IOL implantation. All eyes were free of active inflammation at the time of surgery. A variety of IOL biomaterials were implanted: acrylic (n = 30), silicone (n = 17), and hydrogel (n = 13),
   Main Outcome Measures: Detailed examination was performed by one masked observer. Several parameters were compared for each implant biomaterial, including level of best corrected Snellen visual acuity at final follow-up, presence of posterior synechiae, anterior capsular phimosis, posterior capsule opacification, and the degree of cellular deposits on the IOL optic.
   Results: There were 26 males and 23 females, aged 9 to 83 years (mean, 48 years). Follow-up ranged from 1 to 33 months (mean, 17.03 months). At final follow-up, 56 eyes (93.3%) had an improvement in visual acuity compared with preoperative levels as follows: 34 eyes (56.6%) achieved an improvement of four or more Snellen lines, and 44 eyes (73.3%) achieved 20/30 or better. Giant cells, observed on the IOL optic in 19 eyes (31.7%), were most often seen on the acrylic biomaterial at the 1-month follow-up, although this was not found to be statistically significant. Scratch marks produced by the lens-introducing forceps were seen in 24 eyes (40.0%), mainly on the acrylic and hydrogel optics. Posterior capsule opacification (PCO) occurred in 49 eyes (81.7%), with only 5 eyes requiring laser capsulotomy, There was no association between PCO and the various lens biomaterials, Other causes for reduced visual acuity included glaucomatous optic neuropathy (n = 5) and cystoid macular edema (n = 8).
   Conclusions: The use of foldable IOLs in eyes with uveitis is safe, but the optimal biomaterial has yet to be found. (C) 2000 by the American Academy of Ophthalmology.
C1 Univ Birmingham, Div Immun & Infect, Acad Unit Ophthalmol, Birmingham, W Midlands, England.
RP Murray, PI (reprint author), City Hosp NHS Trust, Birmingham & Midland Eye Ctr, Acad Unit Ophthalmol, Div Immun & Infect, Birmingham B18 7QU, W Midlands, England.
EM P.I.Murray@bham.ac.uk
OI Rauz, Saaeha/0000-0003-4627-3496; Murray, Philip/0000-0001-8491-3795
CR AMON M, 1994, EYE, V8, P649, DOI 10.1038/eye.1994.161
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   BORGIOLI DM, 1992, OPHTHALMOLOGY, V99, P1248
   BRADY DG, 1994, J CATARACT REFR SURG, V20, P310, DOI 10.1016/S0886-3350(13)80583-4
   CHUNG YM, 1990, OPHTHALMIC SURG LAS, V21, P272
   COLMAN RW, 1987, ANN NY ACAD SCI, V516, P253, DOI 10.1111/j.1749-6632.1987.tb33046.x
   Dana MR, 1997, OPHTHALMOLOGY, V104, P1387, DOI 10.1016/S0161-6420(97)30126-2
   DAVISON JA, 1993, J CATARACT REFR SURG, V19, P582, DOI 10.1016/S0886-3350(13)80004-1
   FOSTER CS, 1989, OPHTHALMOLOGY, V96, P281, DOI 10.1016/S0161-6420(89)32898-3
   FOSTER RE, 1992, OPHTHALMOLOGY, V99, P1234
   GEE SS, 1989, AM J OPHTHALMOL, V108, P310, DOI 10.1016/0002-9394(89)90122-0
   HANSEN SO, 1993, J CATARACT REFR SURG, V19, P77, DOI 10.1016/S0886-3350(13)80287-8
   HEGER H, 1994, ACTA OPHTHALMOL, V72, P478
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   HOOPER PL, 1990, SURV OPHTHALMOL, V35, P120, DOI 10.1016/0039-6257(90)90068-7
   JAKEMAN CM, 1990, EYE, V4, P543, DOI 10.1038/eye.1990.75
   JONES NP, 1995, OPHTHALMIC SURG LAS, V26, P49
   KOCHOUNIAN HH, 1994, ARCH OPHTHALMOL-CHIC, V112, P395, DOI 10.1001/archopht.1994.01090150125034
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1255, DOI 10.1016/S0886-3350(96)80079-4
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1342, DOI 10.1016/S0886-3350(96)80095-2
   Krishna R, 1998, OPHTHALMOLOGY, V105, P1765, DOI 10.1016/S0161-6420(98)99051-0
   LICHTER PR, 1989, OPHTHALMOLOGY, V96, P279, DOI 10.1016/S0161-6420(89)32894-6
   LIN CL, 1994, J CATARACT REFR SURG, V20, P550, DOI 10.1016/S0886-3350(13)80236-2
   LUMME P, 1994, ACTA OPHTHALMOL, V72, P16
   Majima K, 1996, OPHTHALMIC SURG LAS, V27, P946
   MCDONNELL PJ, 1983, OPHTHALMOLOGY, V90, P1548
   Mester U, 1998, J CATARACT REFR SURG, V24, P380, DOI 10.1016/S0886-3350(98)80327-1
   MICHELSON JB, 1990, OPHTHALMOLOGY, V97, P1023
   Milazzo S, 1996, J CATARACT REFR SURG, V22, P1351, DOI 10.1016/S0886-3350(96)80096-4
   MONDINO BJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P989
   MONDINO BJ, 1985, INVEST OPHTH VIS SCI, V26, P905
   Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8
   NISHI O, 1991, J CATARACT REFR SURG, V17, P471, DOI 10.1016/S0886-3350(13)80854-1
   NISHI O, 1993, J CATARACT REFR SURG, V19, P544, DOI 10.1016/S0886-3350(13)80621-9
   NISHI O, 1995, BRIT J OPHTHALMOL, V79, P934, DOI 10.1136/bjo.79.10.934
   OHMI S, 1993, J CATARACT REFR SURG, V19, P640, DOI 10.1016/S0886-3350(13)80016-8
   OKADA K, 1991, J CATARACT REFR SURG, V17, P319, DOI 10.1016/S0886-3350(13)80828-0
   ONEILL D, 1995, OPHTHALMOLOGY, V102, P1362, DOI 10.1016/S0161-6420(95)30863-9
   Oshika T, 1996, J CATARACT REFR SURG, V22, P1360, DOI 10.1016/S0886-3350(96)80098-8
   PERCIVAL P, 1991, DEV OPHTHALMOL, V22, P80
   PERCIVAL SPB, 1993, J CATARACT REFR SURG, V19, P760, DOI 10.1016/S0886-3350(13)80346-X
   Pfister DR, 1996, AM J OPHTHALMOL, V121, P572, DOI 10.1016/S0002-9394(14)75435-2
   PHILIPSON B, 1992, J CATARACT REFR SURG, V18, P71, DOI 10.1016/S0886-3350(13)80386-0
   Ravalico G, 1997, OPHTHALMOLOGY, V104, P1084, DOI 10.1016/S0161-6420(97)30181-X
   Ridley H, 1965, Trans Ophthalmol Soc U K, V85, P519
   SIEVERS H, 1984, AM J OPHTHALMOL, V97, P743, DOI 10.1016/0002-9394(84)90507-5
   Stavrou P, 1994, Ocul Immunol Inflamm, V2, P161, DOI 10.3109/09273949409057072
   TESSLER HH, 1993, OPHTHALMOLOGY, V100, P1206
   THOMPSON JR, 1993, BRIT J OPHTHALMOL, V77, P115, DOI 10.1136/bjo.77.2.115
   Toldos JJM, 1996, J CATARACT REFR SURG, V22, P269, DOI 10.1016/S0886-3350(96)80230-6
   UMEZAWA S, 1993, J CATARACT REFR SURG, V19, P371, DOI 10.1016/S0886-3350(13)80308-2
   YGGE J, 1990, OPHTHALMOLOGY, V97, P1216
   Zambarakji HJ, 1997, EYE, V11, P635, DOI 10.1038/eye.1997.168
   ZETTERSTROM C, 1992, ACTA OPHTHALMOL, V70, P91
NR 55
TC 51
Z9 60
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD MAY
PY 2000
VL 107
IS 5
BP 909
EP 919
DI 10.1016/S0161-6420(00)00056-7
PG 11
WC Ophthalmology
SC Ophthalmology
GA 310JM
UT WOS:000086822800032
PM 10811083
DA 2018-10-19
ER

PT J
AU Babensee, JE
   McIntire, LV
   Mikos, AG
AF Babensee, JE
   McIntire, LV
   Mikos, AG
TI Growth factor delivery for tissue engineering
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE tissue engineering; growth factors; controlled release; bone; nerve;
   liver
ID BONE MORPHOGENETIC PROTEIN-2; PERIPHERAL-NERVE REGENERATION;
   CONTROLLED-RELEASE POLYMERS; IN-VITRO; BIODEGRADABLE HYDROGELS;
   HEPATOCYTE TRANSPLANTATION; NEUROACTIVE MOLECULES; POLYETHYLENE-GLYCOL;
   SPINAL-CORD; CELLS
AB A tissue-engineered implant is a biologic-biomaterial combination in which some component of tissue has been combined with a biomaterial to create a device for the restoration or modification of tissue or organ function. Specific growth factors, released from a delivery device or from co-transplanted cells. would aid in the induction of host paraenchymal cell infiltration and improve engraftment of co-delivered cells for more efficient tissue regeneration or ameliorate disease states. The characteristic properties of growth factors are described to provide a biological basis for their use in tissue engineered devices. The principles of polymeric device development for therapeutic growth factor delivery in the context of tissue engineering are outlined. A review of experimental evidence illustrates examples of growth factor delivery from devices such as micropaticles. scaffolds, and encapsulated cells, for their use in the application areas of musculoskeletal tissue, neural tissue, and hepatic tissue.
C1 Rice Univ, Inst Biosci & Bioengn, Dept Bioengn, Houston, TX 77005 USA.
RP Mikos, AG (reprint author), Rice Univ, Inst Biosci & Bioengn, Dept Bioengn, Houston, TX 77005 USA.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU NHLBI NIH HHS [R37-HL18672]; NIAMS NIH HHS [R29-AR42539]; NINDS NIH HHS
   [P01-NS23326]
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   Anderson J. M., 1998, FRONTIERS TISSUE ENG, P152
   Arm DM, 1996, BIOMATERIALS, V17, P703, DOI 10.1016/0142-9612(96)86740-8
   Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   BAE YH, 1998, FRONTIERS TISSUE ENG, P261
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Belcheva N, 1999, BIOCONJUGATE CHEM, V10, P932, DOI 10.1021/bc990001k
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
   BOWENPOPE DF, 1984, BLOOD, V64, P458
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   CAPLAN AI, 1990, CLIN ORTHOP RELAT R, P257
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   EMERICH DF, 1994, EXP NEUROL, V130, P141, DOI 10.1006/exnr.1994.1193
   Fausto N, 1991, Prog Growth Factor Res, V3, P219, DOI 10.1016/0955-2235(91)90008-R
   Fournier N, 1996, BIOMATERIALS, V17, P1659, DOI 10.1016/0142-9612(96)87645-9
   GOMBOTZ WR, 1993, J BIOMAT SCI-POLYM E, V5, P49
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hong L, 1998, J BIOMAT SCI-POLYM E, V9, P1001
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Isobe M, 1999, J BIOMED MATER RES, V45, P36, DOI 10.1002/(SICI)1097-4636(199904)45:1<36::AID-JBM5>3.0.CO;2-I
   Ito Y, 1998, J BIOMAT SCI-POLYM E, V9, P879, DOI 10.1163/156856298X00217
   KAUFMANN PM, 1994, TRANSPLANT P, V26, P3343
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kim HD, 1997, BIOMATERIALS, V18, P1175
   Kim TH, 1997, TRANSPLANT P, V29, P858, DOI 10.1016/S0041-1345(96)00169-8
   KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898
   Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103
   Krewson CE, 1996, BRAIN RES, V727, P169
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LANGER R, 1991, J CELL BIOCHEM, V45, P340, DOI 10.1002/jcb.240450406
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   LIDNER MD, 1995, EXP NEUROL, V132, P62
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   LU L, IN PRESS J BIOMED MA
   McKay I., 1993, GROWTH FACTORS PRACT
   Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Nicoll SB, 1997, BIOMATERIALS, V18, P853, DOI 10.1016/S0142-9612(97)00008-2
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   PETER SJ, IN PRESS J BIOMED MA
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   Renier ML, 1997, J BIOMED MATER RES, V34, P95, DOI 10.1002/(SICI)1097-4636(199701)34:1<95::AID-JBM13>3.0.CO;2-O
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   RICORDI C, 1989, SURGERY, V105, P218
   Santos EM, 1998, J BIOMED MATER RES, V41, P87, DOI 10.1002/(SICI)1097-4636(199807)41:1<87::AID-JBM11>3.0.CO;2-E
   Sautter J, 1998, EXP NEUROL, V149, P230, DOI 10.1006/exnr.1997.6718
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schmitt JM, 1998, J BIOMED MATER RES, V41, P584, DOI 10.1002/(SICI)1097-4636(19980915)41:4<584::AID-JBM10>3.3.CO;2-N
   SCHOICHET MS, 1995, TRIP, V3, P374
   SICKEL BR, 1995, J NEUROSCI RES, V40, P318
   Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309
   Starr PA, 1999, CELL TRANSPLANT, V8, P37, DOI 10.1177/096368979900800113
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1
   TAN SA, 1996, CIBA F SYMP, V196, P211
   TONG XJ, 1994, BRAIN RES, V663, P155, DOI 10.1016/0006-8993(94)90473-1
   TRSCO PA, 1994, J CONTROL RELEASE, V28, P253
   TUSZYNSKI MH, 1998, CELL TRANSPLANT, V7, P185
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Vejsada R, 1998, NEUROSCIENCE, V84, P129, DOI 10.1016/S0306-4522(97)00497-1
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WHANG K, IN PRESS J CONTROLLE
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Yamamoto M, 1998, J BIOMAT SCI-POLYM E, V9, P439, DOI 10.1163/156856298X00550
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
NR 90
TC 286
Z9 292
U1 5
U2 73
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARMACEUT RES
JI Pharm. Res.
PD MAY
PY 2000
VL 17
IS 5
BP 497
EP 504
DI 10.1023/A:1007502828372
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 327ME
UT WOS:000087797000001
PM 10888299
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Contreras, LA
   Bujan, J
AF Bellon, JM
   Contreras, LA
   Bujan, J
TI Ultrastructural alterations of polytetrafluoroethylene prostheses
   implanted in abdominal wall provoked by infection: Clinical and
   experimental study
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID EXPANDED POLYTETRAFLUOROETHYLENE; POLYPROPYLENE MESH; GORE-TEX; REPAIR;
   DEFECTS; MARLEX; PATCH; RECONSTRUCTION
AB Infection of an expanded polytetrafluoroethylene (ePTFE) prosthesis after implant is a major drawback of its use in current clinical practice. The aim of the present study was to compare the behavior of such prostheses implanted into New Zealand rabbits with that of prostheses infected after clinical implant. Experimental implants of ePTFE Soft Tissue Patch were performed to repair defects (7 x 5 cm) created in the abdominal wall of 10 rabbits. Prior to implant the prostheses were contaminated with Staphylococcus aureus. Five animals implanted with noncontaminated ePTFE prostheses served as controls. All the animals were sacrificed at 30 days after implant, For the clinical study, specimens were taken from three ePTFE implants that had been found to be infected after intervention. The clinical and experimental implant specimens were processed for light microscopy and scanning electron microscopy. Macroscopic and microscopic examination of experimental and clinical implants revealed alterations to the ePTFE structure, such as areas of fragmentation, fracture lines, and detachment of fine layers of ePTFE that harbored numerous Staphylococcus colonies. Neoformed tissue around contaminated implants was arranged more loosely, and on occasion large spaces between fibers gave rise to an "unknitted" appearance with respect to the control implants. It may be concluded that microporous ePTFE prostheses show similar behavior following experimental or clinical implant in the presence of infection. Irreversible changes to the structure of the prosthesis are produced owing to colonization of the biomaterial by microorganisms, which in most cases necessitates total replacement of the prosthesis.
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Madrid 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Crta Madrid Barcelona,Km 33-600, Madrid 28871, Spain.
OI BELLON, JUAN M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476
CR Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bellon JM, 1997, WORLD J SURG, V21, P402, DOI 10.1007/PL00012261
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   BRANDT CP, 1995, SURGERY, V118, P736, DOI 10.1016/S0039-6060(05)80043-1
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   DEYSINE M, 1992, AM J SURG, V163, P422, DOI 10.1016/0002-9610(92)90045-S
   EDLICH RF, 1968, J SURG RES, V8, P585, DOI 10.1016/0022-4804(68)90013-9
   GILSDORF RB, 1975, AM J SURG, V130, P634, DOI 10.1016/0002-9610(75)90411-0
   LAW NW, 1991, SURGERY, V109, P652
   MURPHY JL, 1989, CAN J SURG, V32, P244
   PAILLER JL, 1990, MONIT HOSP, V27, P1
   SMITH S, 1989, J PEDIATR SURG, V24, P519, DOI 10.1016/S0022-3468(89)80496-8
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
NR 14
TC 31
Z9 33
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD MAY
PY 2000
VL 24
IS 5
BP 528
EP 532
DI 10.1007/s002689910085
PG 5
WC Surgery
SC Surgery
GA 302HJ
UT WOS:000086359400006
PM 10787071
DA 2018-10-19
ER

PT J
AU Dietz, AC
   Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
AF Dietz, AC
   Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
TI Modulation of mouse immune responses by prosthetic biomaterial particles
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 US FDA, CDRH, Div Life Sci, Rockville, MD 20852 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 20
PY 2000
VL 14
IS 6
SU S
BP A1156
EP A1156
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 307FQ
UT WOS:000086643101438
DA 2018-10-19
ER

PT J
AU Ji, J
   Feng, LX
   Qiu, YX
   Yu, XJ
   Barbosa, MA
AF Ji, J
   Feng, LX
   Qiu, YX
   Yu, XJ
   Barbosa, MA
TI Self-assembly and surface structure of an amphiphilic graft copolymer,
   polystyrene-graft-omega-stearyl-poly(ethylene oxide)
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE biomaterial; amphiphilic copolymer; self-assembly; surface structure
ID PROTEIN ADSORPTION; ALBUMIN; PLASMA
AB Surface properties of the polystyrene-graff-omega-stearyl-poly(ethylene oxide) (PS-g-SPEO) have been characterized by X-ray photoelectron spectroscopy (XPS), differential scanning calorimetry (DSC), contact angle, and spin probe techniques. The XPS results indicate that the surface and bulk composition of the PS-g-SPEO copolymers differ remarkably from each other. The stearyl and EO components enrich at the copolymer/air interfaces due to the self-assembly of the stearyl groups. At the PS-g-SPEO-72.6 surface (the x in PS-g-SPEO-x indicates the bulk density of the SPEO in wt%), the self-assembly of the hydrophobic stearyl groups is strong enough to form a stable liquid crystalline phase as indicated by DSC, At polymer/water interfaces, PS-g-SPEO-72.6 presents a hydrophilic surface with low PEO mobility, whereas PS-g-SPEO-50.6 and PS-g-SPEO-31.0 present the hydrophobic surface with high PEO mobility. The two different types of the surfaces, with different characters in surface energy, surface mobility of PEG, and surface architecture of SPEO, will be quite valuable as models for detecting the synergistic action of the PEO chains and the stearyl groups (specific ligand for albumin binding) in protein solutions. (C) 2000 Academic Press.
C1 Inst Biomed Engn, Lab Biomat, P-4150180 Porto, Portugal.
   Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4100 Porto, Portugal.
RP Ji, J (reprint author), Inst Biomed Engn, Lab Biomat, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   BOTS JGF, 1986, BIOMATERIALS, V7, P393, DOI 10.1016/0142-9612(86)90011-6
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   Cameron G. G., 1989, COMPREHENSIVE POLYM, P517
   Duncan AC, 1997, BIOMATERIALS, V18, P1585, DOI 10.1016/S0142-9612(97)00100-2
   Gombotz W. R., 1992, POLYETHYLENE GLYCOL, P247
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HARRIS JM, 1997, POLYM PREPR, V38, P520
   Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u
   HUBBELL JA, 1997, POLYM PREPR AM CHEM, V38, P528
   JI J, IN PRESS POLYMER
   Ji JA, 1998, MACROMOL RAPID COMM, V19, P473, DOI 10.1002/marc.1998.030190907
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LIDE DR, 1996, HDB CHEM PHYSICS
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   QIU YX, 1992, MAKROMOL CHEM, V173, P1377
   RANTER BD, 1985, SURFACE INTERFACIAL, V1, P374
   TAKAHARA A, 1989, Journal of Biomaterials Science Polymer Edition, V1, P17, DOI 10.1163/156856289X00037
   van Oss CJ, 1994, INTERFACIAL FORCES A, P170
   WU D, 1995, SCI CHINA SER B, V25, P1121
   WU D, 1995, SCI CHINA SER B, V26, P409
NR 25
TC 17
Z9 21
U1 0
U2 9
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 2000
VL 224
IS 2
BP 255
EP 260
DI 10.1006/jcis.2000.6729
PG 6
WC Chemistry, Physical
SC Chemistry
GA 304EG
UT WOS:000086469500005
DA 2018-10-19
ER

PT J
AU Kenausis, GL
   Voros, J
   Elbert, DL
   Huang, NP
   Hofer, R
   Ruiz-Taylor, L
   Textor, M
   Hubbell, JA
   Spencer, ND
AF Kenausis, GL
   Voros, J
   Elbert, DL
   Huang, NP
   Hofer, R
   Ruiz-Taylor, L
   Textor, M
   Hubbell, JA
   Spencer, ND
TI Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces:
   Attachment mechanism and effects of polymer architecture on resistance
   to protein adsorption
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SOLID-LIQUID INTERFACES; POLY(ETHYLENE OXIDE); BLOCK-COPOLYMER;
   POLYELECTROLYTE ADSORPTION; POLYETHYLENE OXIDE; KINETICS; CHAINS;
   SPECTROSCOPY; COATINGS; AGENT
AB The generation of surfaces and interfaces that are able to withstand protein adsorption is a major challenge in the design of blood-contacting materials for both medical implants and bioaffinity sensors. Poly(ethylene glycol)-derived materials are generally considered to be particularly effective candidates for the fabrication of protein-resistant materials. Most metallic biomaterials are covered by a protective, stable oxide film; converting such oxide surfaces, which are known to strongly interact with proteins, into noninteractive surfaces requires a specific design of the surface/interface architecture. A class of copolymers based on poly(L-lysine)g-poly(ethylene glycol) (PLL g-PEG) was found to spontaneously adsorb from aqueous solutions onto several metal oxide surfaces, such as TiO2, Si0.4Ti0.6O2 and Nb2O5, as measured by the in situ optical waveguide lightmode spectroscopy technique and by ex situ X-ray photoelectron spectroscopy. The resulting adsorbed layers are highly effective in reducing the adsorption both of blood serum and of individual proteins such as fibrinogen, which is known to play a major role in the cascade of events that lead to biomaterial-surface-induced blood coagulation and thrombosis. Adsorbed protein levels as low as <5 ng/cm(2) could be achieved for an optimized polymer architecture. The modified surfaces are stable to desorption under flow conditions at 37 degrees C and pH 7.4 in HEPES [4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid] and PBS (phosphate-buffered saline) buffers. The adsorbed layer of copolymer is thought to form a comblike structure at the surface, with positively charged primary amine groups of the PLL bound to the negatively charged metal oxide surface, while the hydrophilic and uncharged PEG side chains are exposed to the solution phase. Copolymer architecture is an important factor in the resulting protein resistance; it is discussed on the basis of packing-density considerations and the corresponding radii of gyration of the different PEG chain lengths studied. This surface functionalization technology is believed to be of value for use in both the biomaterial and biosensor areas, as the chosen macromolecules are biocompatible and the application is straightforward and cost-effective.
C1 ETH Zurich, Surface Sci & Technol Lab, CH-8092 Zurich, Switzerland.
   ETH Zurich, Dept Mat, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
RP Spencer, ND (reprint author), ETH Zurich, Surface Sci & Technol Lab, CH-8092 Zurich, Switzerland.
RI Spencer, NIcholas/A-5843-2008; Hubbell, Jeffrey/A-9266-2008; Elbert,
   Donald/B-2040-2008; Textor, Marcus/A-6200-2012
OI Spencer, NIcholas/0000-0002-7873-7905; Hubbell,
   Jeffrey/0000-0003-0276-5456; Elbert, Donald/0000-0001-6480-9536; Textor,
   Marcus/0000-0002-0178-1801
CR AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   BALAZS AC, 1991, J CHEM PHYS, V95, P3798, DOI 10.1063/1.460830
   BJORLING M, 1992, MACROMOLECULES, V25, P3956
   Bogdanov AA, 1996, BIOCONJUGATE CHEM, V7, P144, DOI 10.1021/bc950089b
   BOGDANOV AA, 1993, RADIOLOGY, V187, P701, DOI 10.1148/radiology.187.3.8497616
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   CLAESSON P, 1993, COLLOID SURFACE A, V77, P109, DOI 10.1016/0927-7757(93)80107-P
   Clegg JA, 1990, BIOCONJUGATE CHEM, V1, P425, DOI 10.1021/bc00006a009
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   FreijLarsson C, 1996, BIOMATERIALS, V17, P2199, DOI 10.1016/0142-9612(96)00050-6
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GOMBOTZ WR, 1988, SURFACES SYNTHESIS C
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P304
   HOOGEVEEN NG, 1994, FARADAY DISCUSS, V98, P161, DOI 10.1039/fd9949800161
   Hoogeveen NG, 1996, J COLLOID INTERF SCI, V182, P146, DOI 10.1006/jcis.1996.0445
   Hoogeveen NG, 1996, J COLLOID INTERF SCI, V182, P133, DOI 10.1006/jcis.1996.0444
   HUBBELL JA, 1993, Patent No. 5232984
   HUBBELL JA, 1995, Patent No. 5462990
   HUBBELL JA, 1996, Patent No. 5567440
   ISREALS R, 1995, MACROMOLECULES, V28, P1626
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JUKUBAUSKAS HL, 1986, J COATING TECHNOL, V58, P71
   KAWAGUCHI M, 1992, ADV COLLOID INTERFAC, V37, P219, DOI 10.1016/0001-8686(92)80085-C
   Kawaguchi S, 1997, POLYMER, V38, P2885, DOI 10.1016/S0032-3861(96)00859-2
   KOSMAS MK, 1990, MACROMOLECULES, V23, P2061, DOI 10.1021/ma00209a031
   KOYO H, 1993, POLYM J, V25, P141, DOI 10.1295/polymj.25.141
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Kurrat R, 1997, REV SCI INSTRUM, V68, P2172, DOI 10.1063/1.1148069
   KURRAT R, 1998, THESIS ETH ZURICH ZU
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Leonard E. F., 1987, BLOOD CONTACT NATURA, V516
   MARQUES CM, 1990, MACROMOLECULES, V23, P268, DOI 10.1021/ma00203a046
   MARTI A, 1997, THESIS ETH ZURICH ZU
   MARZIO EAD, 1995, MACROMOLECULES, V28, P2930
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   PEFFERKORN E, 1992, J MACROMOL SCI PURE, V29, P147, DOI 10.1080/10101329208054576
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   Ramsden JJ, 1998, J CHEM SOC FARADAY T, V94, P783, DOI 10.1039/a708384j
   RAMSDEN JJ, 1995, J AM CHEM SOC, V117, P8511, DOI 10.1021/ja00138a003
   RYSER HJP, 1988, J CELL PHYSIOL, V135, P277, DOI 10.1002/jcp.1041350215
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   STUART MAC, 1991, ADV COLLOID INTERFAC, V34, P477, DOI 10.1016/0001-8686(91)80056-P
   TIRRELL M, 1991, POLYM J, V23, P641, DOI 10.1295/polymj.23.641
   TRIPP CP, 1996, LANGMUIR, V12, P2
   TSAI WB, 1999, SELECTIVELY DEPLETED, V22, P266
   vanderLinden CC, 1996, MACROMOLECULES, V29, P1000, DOI 10.1021/ma9506905
   VOROS J, 1999, UNPUB COLLOIDS SURF
   XU RL, 1994, LANGMUIR, V10, P2977, DOI 10.1021/la00021a022
NR 53
TC 484
Z9 485
U1 11
U2 248
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD APR 13
PY 2000
VL 104
IS 14
BP 3298
EP 3309
DI 10.1021/jp993359m
PG 12
WC Chemistry, Physical
SC Chemistry
GA 306MD
UT WOS:000086599700039
DA 2018-10-19
ER

PT J
AU Vansteenkiste, SO
   Corneillie, SI
   Schacht, EH
   Chen, X
   Davies, MC
   Moens, M
   Van Vaeck, L
AF Vansteenkiste, SO
   Corneillie, SI
   Schacht, EH
   Chen, X
   Davies, MC
   Moens, M
   Van Vaeck, L
TI Direct measurement of protein adhesion at biomaterial surfaces by
   scanning force microscopy
SO LANGMUIR
LA English
DT Article
ID POLYURETHANE SURFACES; POLY(ETHYLENE GLYCOL); PLASMON RESONANCE; CHAIN
   EXTENDERS; ADSORPTION; XPS; COPOLYMERS; MONOLAYERS; ALBUMIN; SIMS
AB The adsorption of human serum albumin (HSA) onto tailor-made polyurethane biomaterial coatings was measured in a liquid environment by scanning force microscopy (SFM). The adhesion of HSA onto polyurethane films was probed by adhesion force measurements with protein-coated SFM tips. Results reveal that HSA adsorbs readily onto hydrophobic polyurethane surfaces. Adsorption time profiles of the HSA deposition were elucidated by dynamic in situ force-distance measurements. The introduction of poly(ethylene glycol) (PEG) grafts, present at the biomaterial interface, inhibited all interactions with HSA. Latter results were explained by the combined effects of steric repulsion forces, minimal interfacial free energy, and high chain mobility of the hydrated PEG grafts. These phenomena were in excellent agreement with measurements obtained in surface plasmon resonance experiments.
C1 State Univ Ghent, Inst Biomed Technol, Dept Organ Chem, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
   Univ Nottingham, Dept Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Instelling Antwerp, Dept Chem, B-2610 Wilrijk, Belgium.
RP Vansteenkiste, SO (reprint author), State Univ Ghent, Inst Biomed Technol, Dept Organ Chem, Polymer Mat Res Grp, Krijgslaan 281 S4BIS, B-9000 Ghent, Belgium.
OI Davies, Martyn/0000-0001-7695-0596
CR Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Arnsdorf MF, 1996, J CARDIOVASC ELECTR, V7, P639, DOI 10.1111/j.1540-8167.1996.tb00572.x
   Atsushi Ikai, 1996, SURF SCI REP, V26, P261
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   Bottomley L.A., 1996, ANAL CHEM, V68, P185
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   Cappella B, 1997, IEEE Eng Med Biol Mag, V16, P58, DOI 10.1109/51.582177
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chen X, 1998, APPL PHYS A-MATER, V66, pS631, DOI 10.1007/s003390051213
   CHEN X, 1997, LANGMUIR, V3, P44106
   CHRISTENSON HK, 1992, LONG RANGE ATTRACTIO
   CORNEILLE SL, 1998, THESIS U GENT BELGIU
   Corneillie S, 1998, POLYM INT, V46, P251, DOI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
   DAVIES MC, 1997, BIOCOMPATIBILITY ASS, P65
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRAINGER D, 1987, ADV BIOMEDICAL POLYM, P229
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   GREEN RJ, 1999, UNPUB LANGMUIR
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HEARN MJ, 1987, SURF INTERFACE ANAL, V10, P384, DOI 10.1002/sia.740100803
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HOH JH, 1992, J AM CHEM SOC, V114, P4917, DOI 10.1021/ja00038a075
   HORBETT TA, 1995, ACS SYM SER, V602, pR2
   Israelachvili J, 1997, P NATL ACAD SCI USA, V94, P8378, DOI 10.1073/pnas.94.16.8378
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Ito T, 1997, LANGMUIR, V13, P4323, DOI 10.1021/la9609783
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEE UG, 1994, SCIENCE, V6, P771
   LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.physchem.44.1.369
   Majewski J, 1997, J PHYS CHEM B, V101, P3122, DOI 10.1021/jp962623y
   MALMSTEN M, 1990, LANGMUIR, V6, P1572, DOI 10.1021/la00100a008
   MCPHERSON TB, 1995, ACS SYM SER, V602, pR2
   MISSIRLIS Y, 1991, MODERN ASPECTS PROTE
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   PAYNTER RW, 1984, POLYM BIOMATERIALS, P121
   RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171
   Sagvolden G, 1998, LANGMUIR, V14, P5984, DOI 10.1021/la980271b
   Shao ZF, 1996, ADV PHYS, V45, P1, DOI 10.1080/00018739600101467
   Shard AG, 1997, MACROMOLECULES, V30, P3051, DOI 10.1021/ma9519021
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   VANDERVEGTE EW, 1997, LANGMUIR, V3, P44357
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   VINCKIER A, 1995, ULTRAMICROSCOPY, V57, P337, DOI 10.1016/0304-3991(94)00194-R
   WU S, 1982, POLYM INTERFACE ADHE, P178
   YOON SC, 1986, MACROMOLECULES, V19, P1068, DOI 10.1021/ma00158a023
NR 48
TC 27
Z9 27
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 4
PY 2000
VL 16
IS 7
BP 3330
EP 3336
DI 10.1021/la981740c
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 299YC
UT WOS:000086225200051
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Alves, A
   Kohler, H
   Kriegsmann, J
   Bittinger, F
   Otto, M
   Williams, DF
   Eloy, R
AF Kirkpatrick, CJ
   Alves, A
   Kohler, H
   Kriegsmann, J
   Bittinger, F
   Otto, M
   Williams, DF
   Eloy, R
TI Biomaterial-induced sarcoma - A novel model to study preneoplastic
   change
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID TRANSGENIC MICE; COLORECTAL TUMORIGENESIS; TUMOR PROGRESSION; MUTATIONS
   OCCUR; FOREIGN-BODY; ANIMAL-MODEL; RATS; CARCINOGENESIS; GENE; P53
AB In the study of carcinogenesis most interest has focused on carcinomas, as they represent the majority of human cancers, The recognition of the adenomacarcinoma sequence both in humans and in animal experimental models has given the field of basic ontology the opportunity to elucidate individual mechanisms in the multistep development of carcinoma. The relative scarcity of human sarcomas coupled with the lack of adequate animal models has hampered understanding of the molecular genetic steps involved, We present an experimental model in the rat in which a high incidence of malignant mesenchymal tumors arise around a subcutaneously implanted biomaterial. Nine commercially available biomaterials were implanted in a total of 490 rats of the Fischer strain for 2 years, On average, macroscopic tumors were found in 25.8% of implantation sites over a period from 26 to 110 weeks after implantation, The most frequent tumors mere malignant fibrous histiocytomas and pleomorphic sarcomas, although fibrosarcomas, leiomyosarcomas, and angiosarcomas readily developed, the latter especially around polyurethane implants. Of particular interest are the results of a detailed histological study of the capsules around the implanted biomaterials without tumors. Here a spectrum of change from focal proliferative lesions through preneoplastic proliferation to incipient sarcoma could be observed, A parallel immunohistochemical study of peri-implant capsules showed that proliferating cell nuclear antigen was of particular help in identifying these atypical proliferative lesions. To our knowledge this is the first description of a sarcoma model in which preneoplastic lesions can be readily identified and also reproducibly induced, This model provides the molecular biologist with defined stages in the development of mesenchymal ma lignancy, with which the multistage tumorigenesis hypothesis can be tested, analogous to the well-known adenoma-carcinoma sequence.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Biomatech, Chasse Sur Rhone, France.
   Univ Liverpool, Inst Clin Engn, Liverpool L69 3BX, Merseyside, England.
RP Kirkpatrick, CJ (reprint author), Univ Mainz Klinikum, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
CR BAKER SJ, 1990, CANCER RES, V50, P7717
   BISCHOFF F, 1964, PROG EXP TUMOR RES, V5, P85
   BRAND I, 1977, J NATL CANCER I, V58, P1443
   BRAND KG, 1975, J NATL CANCER I, V55, P319
   BRAND KG, 1975, CANCER RES, V35, P279
   BRAND KG, 1975, J NATL CANCER I, V54, P1259
   BRAND KG, 1976, CANCER RES, V36, P3681
   Case CP, 1996, CLIN ORTHOP RELAT R, pS269
   CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P
   CLARKE AR, 1995, ONCOGENE, V11, P1913
   CORALLINI A, 1993, CANCER RES, V53, P5569
   DEZSO B, 1990, J CANCER RES CLIN, V116, P372, DOI 10.1007/BF01612920
   ENGEL A, 1992, PLAST RECONSTR SURG, V89, P571, DOI 10.1097/00006534-199203000-00037
   FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001
   HEATH JC, 1960, BRIT J CANCER, V14, P478, DOI 10.1038/bjc.1960.52
   HENDRICK MJ, 1994, J AM VET MED ASSOC, V205, P1425
   HENDRICK MJ, 1992, CANCER RES, V52, P5391
   James SJ, 1997, BIOMATERIALS, V18, P667, DOI 10.1016/S0142-9612(96)00189-5
   KASS PH, 1993, J AM VET MED ASSOC, V203, P396
   KIM SH, 1993, J CELL BIOL, V123, P877, DOI 10.1083/jcb.123.4.877
   Lewis C G, 1995, J Arthroplasty, V10, P75, DOI 10.1016/S0883-5403(06)80067-7
   LINDGREN V, 1989, P NATL ACAD SCI USA, V86, P5025, DOI 10.1073/pnas.86.13.5025
   MACDONALD GC, 1983, P SOC EXP BIOL MED, V172, P89
   MADARNAS P, 1992, ANTICANCER RES, V12, P113
   MEACHIM G, 1982, J BIOMED MATER RES, V16, P407, DOI 10.1002/jbm.820160409
   NAKAMURA T, 1994, J BIOMED MATER RES, V28, P17, DOI 10.1002/jbm.820280104
   Papadimitrakopoulou VA, 1996, CANCER METAST REV, V15, P53, DOI 10.1007/BF00049487
   Pogribny IP, 1997, CANCER LETT, V115, P31, DOI 10.1016/S0304-3835(97)04708-3
   POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0
   RACHKO D, 1983, P SOC EXP BIOL MED, V172, P382
   Shibata MA, 1996, CANCER RES, V56, P2998
   TANAKA T, 1994, CANCER RES, V54, P2359
   THOMASSEN MJ, 1978, J NATL CANCER I, V61, P359
   WEINBERGER MA, 1985, J NATL CANCER I, V75, P681
   WOLF RF, 1994, ANN SURG ONCOL, V1, P314, DOI 10.1007/BF02303570
NR 35
TC 64
Z9 64
U1 0
U2 11
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD APR
PY 2000
VL 156
IS 4
BP 1455
EP 1467
DI 10.1016/S0002-9440(10)65014-6
PG 13
WC Pathology
SC Pathology
GA 303GJ
UT WOS:000086413900036
PM 10751369
DA 2018-10-19
ER

PT J
AU Abou Younes, F
   Potel, C
   De Belleval, JF
   Gherbezza, JM
   Bonan, C
   Devauchelle, B
   Grebe, R
AF Abou Younes, F
   Potel, C
   De Belleval, JF
   Gherbezza, JM
   Bonan, C
   Devauchelle, B
   Grebe, R
TI An ultrasound method to investigate soft tissue reaction to biomaterial
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Proceedings Paper
CT XXVth Congress of the Societe-de-Biomecanique and XIth Congress of the
   Societe-Canadienne-de-Biomecanique
CY AUG 23-26, 2000
CL MONTREAL, CANADA
SP Soc Biomecan, Soc Canadienne Biomecan
C1 Univ Technol Compiegne, Ctr Royallieu, F-60205 Compiegne, France.
   IUT Aisne, Dept OGP Soissons, F-02880 Cuffies, France.
   Hop Nord, Serv Chirurg Maxillofaciale, F-80054 Amiens, France.
RP Abou Younes, F (reprint author), Univ Technol Compiegne, Ctr Royallieu, BP 20529, F-60205 Compiegne, France.
CR ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   Guittet C, 1999, IEEE T BIO-MED ENG, V46, P740, DOI 10.1109/10.764950
   KOHLES SS, 1994, J BIOMECH, V27, P137, DOI 10.1016/0021-9290(94)90202-X
   SUN Z, 1999, IEEE T ULTRASONICS, V16, P1134
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SWETS ZEITLINGER PUBLISHERS
PI LISSE
PA P O BOX 825, 2160 SZ LISSE, NETHERLANDS
SN 1381-3455
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD APR
PY 2000
VL 108
IS 1-2
BP 10
EP 10
PG 1
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA 364FX
UT WOS:000089882600010
DA 2018-10-19
ER

PT J
AU Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
AF Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
TI Effect of mechanical forces on cells adhering to a biomaterial
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Proceedings Paper
CT XXVth Congress of the Societe-de-Biomecanique and XIth Congress of the
   Societe-Canadienne-de-Biomecanique
CY AUG 23-26, 2000
CL MONTREAL, CANADA
SP Soc Biomecan, Soc Canadienne Biomecan
ID CUPROPHAN; AN69
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
RP Chotard-Ghodsnia, R (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
CR ARTMANN GM, 1995, BIORHEOLOGY, V32, P553, DOI 10.1016/0006-355X(95)00032-5
   CHOTARDGHODSNIA R, 2000, MECANOTRANSDUCTION
   Faucheux N, 1999, BIOMATERIALS, V20, P159, DOI 10.1016/S0142-9612(98)00156-2
   Faucheux N, 1998, J BIOMED MATER RES, V39, P506, DOI 10.1002/(SICI)1097-4636(19980305)39:3<506::AID-JBM23>3.0.CO;2-6
NR 4
TC 0
Z9 0
U1 0
U2 1
PU SWETS ZEITLINGER PUBLISHERS
PI LISSE
PA P O BOX 825, 2160 SZ LISSE, NETHERLANDS
SN 1381-3455
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD APR
PY 2000
VL 108
IS 1-2
BP 164
EP 164
PG 1
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA 364FX
UT WOS:000089882600164
DA 2018-10-19
ER

PT J
AU Colthurst, MJ
   Williams, RL
   Hiscott, PS
   Grierson, I
AF Colthurst, MJ
   Williams, RL
   Hiscott, PS
   Grierson, I
TI Biomaterials used in the posterior segment of the eye
SO BIOMATERIALS
LA English
DT Review
DE retinal detachment; vitreous tamponade; sustained drug release; scleral
   buckle
ID INTRAVITREAL SUSTAINED-RELEASE; EXPERIMENTAL PROLIFERATIVE
   VITREORETINOPATHY; CROSS-LINKED POLY(1-VINYL-2-PYRROLIDINONE);
   RHEGMATOGENOUS RETINAL-DETACHMENT; BIODEGRADABLE POLYMERIC DEVICE;
   FLUOROSILICONE COPOLYMER OIL; DRUG-DELIVERY SYSTEMS; SUBFOVEAL CHOROIDAL
   NEOVASCULARIZATION; POTENTIAL VITREOUS SUBSTITUTES; SILICONE OIL
AB The treatment of posterior segment eye disease and related conditions has improved greatly in recent years with the advent of new therapies, materials and devices. Vitreoretinal conditions, however, remain significant causes of blindness in the developed world. Biomaterials play a major role in the treatment of many of these disorders and the success rate of vitreoretinal surgery, especially in the repair of retinal detachment and related conditions, would increase with the introduction of new and improved materials. This review, which focuses on disorders that feature retinal detachment, briefly describes the anatomy of the eye and the nature and treatment of posterior segment eye disorders. The roles, required properties and suitability of the materials used in vitreoretinal surgery as scleral buckles, tamponade agents or drug delivery devices, are reviewed. Experimental approaches are discussed, along with the methods used for their evaluation, and future directions for biomaterial research in the posterior segment of the eye are considered. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Liverpool, Dept Med, Unit Ophthalmol, Liverpool L69 3BX, Merseyside, England.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3BX, Merseyside, England.
RP Colthurst, MJ (reprint author), Univ Liverpool, Dept Med, Unit Ophthalmol, POB 147, Liverpool L69 3BX, Merseyside, England.
OI Williams, Rachel/0000-0002-1954-0256
CR ALGVERE PV, 1992, ACTA OPHTHALMOL, V70, P632
   American Academy of Ophthalmology, 1996, OPHTHALMOLOGY, V103, P1313
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   ARAIZ JJ, 1993, INVEST OPHTH VIS SCI, V34, P522
   ARROYO MH, 1993, RETINA-J RET VIT DIS, V13, P245, DOI 10.1097/00006982-199313030-00011
   Azen SP, 1998, OPHTHALMOLOGY, V105, P1587, DOI 10.1016/S0161-6420(98)99023-6
   AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780
   Berger AS, 1996, INVEST OPHTH VIS SCI, V37, P2318
   BORISLAV D, 1993, DOC OPHTHALMOL, V83, P79, DOI 10.1007/BF01203573
   BRYAN JS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1098, DOI 10.1001/archopht.1994.01090200104030
   Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014
   CHAN IM, 1984, RETINA-J RET VIT DIS, V4, P51, DOI 10.1097/00006982-198400410-00009
   CHANG S, 1984, AM J OPHTHALMOL, V98, P180, DOI 10.1016/0002-9394(87)90353-9
   Chirila T V, 1994, J Biomater Appl, V9, P121
   CHIRILA TV, 1995, CELL MATER, V5, P83
   Chirila TV, 1998, POLYM INT, V46, P183, DOI 10.1002/(SICI)1097-0126(199807)46:3<183::AID-PI941>3.3.CO;2-0
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   CHUNG H, 1988, CURR EYE RES, V7, P1199, DOI 10.3109/02713688809033224
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   COLTHURST M, 1997, OPHTHALMIC RES, V29, P80
   Cunha-Vaz JG, 1997, DOC OPHTHALMOL, V93, P149, DOI 10.1007/BF02569055
   DALTON PD, 1995, BIO-MED MATER ENG, V5, P185
   Dalton PD, 1995, POLYM GELS NETW, V3, P429, DOI 10.1016/0966-7822(94)00011-5
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   de Juan E, 1998, AM J OPHTHALMOL, V125, P635, DOI 10.1016/S0002-9394(98)00018-X
   DEJUAN E, 1985, SURV OPHTHALMOL, V30, P47, DOI 10.1016/0039-6257(85)90088-8
   DHERMIES F, 1995, RETINA-J RET VIT DIS, V15, P62, DOI 10.1097/00006982-199515010-00012
   DOI M, 1994, EXP EYE RES, V59, P737, DOI 10.1006/exer.1994.1160
   DOI M, 1995, EXP EYE RES, V61, P469, DOI 10.1016/S0014-4835(05)80142-3
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Enyedi LB, 1996, CURR EYE RES, V15, P549, DOI 10.3109/02713689609000766
   ENYEDI LB, 1994, INVEST OPHTH VIS SCI, V35, P1906
   FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870
   FERNANDEZVIGO J, 1990, RETINA-J RET VIT DIS, V10, P148, DOI 10.1097/00006982-199004000-00012
   GIORDANO GG, 1993, INVEST OPHTH VIS SCI, V34, P2743
   Giordano GG, 1998, PROG POLYM SCI, V23, P509, DOI 10.1016/S0079-6700(97)00046-4
   GIUNCHEDI P, 1995, STP PHARMA SCI, V5, P276
   Grierson I, 1996, EYE, V10, P671, DOI 10.1038/eye.1996.160
   Grierson I, 1997, P ROY MICROSC SOC, V32, P161
   HASHIZOE M, 1994, ARCH OPHTHALMOL-CHIC, V112, P1380, DOI 10.1001/archopht.1994.01090220130035
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   HASHIZOE M, 1995, CURR EYE RES, V14, P473, DOI 10.3109/02713689509003758
   HAUT J, 1993, J FR OPHTALMOL, V16, P153
   HEIDENKUMMER HP, 1992, RETINA, V12, P28
   Herrero-Vanrell R, 1998, STP PHARMA SCI, V8, P237
   HILTON G, 1983, OPHTHALMOLOGY, V90, P121
   Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X
   HO PC, 1984, OPHTHALMIC SURG LAS, V15, P511
   HO T, 1992, SURV OPHTHALMOL, V37, P190, DOI 10.1016/0039-6257(92)90137-I
   Hoerauf H, 1999, INVEST OPHTH VIS SCI, V40, pS944
   HOFFMAN AS, 1991, POLYMER GELS, P289
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Honavar SG, 1999, OPHTHALMOLOGY, V106, P169, DOI 10.1016/S0161-6420(99)90017-9
   Hong Y, 1998, J BIOMED MATER RES, V39, P650, DOI 10.1002/(SICI)1097-4636(19980315)39:4<650::AID-JBM21>3.0.CO;2-9
   Hong Y, 1997, BIO-MED MATER ENG, V7, P35
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   Hong Y, 1996, J BIOMATER APPL, V11, P135, DOI 10.1177/088532829601100202
   Hui YN, 1998, GRAEF ARCH CLIN EXP, V236, P709, DOI 10.1007/s004170050145
   HUTTON WL, 1994, ARCH OPHTHALMOL-CHIC, V112, P778, DOI 10.1001/archopht.1994.01090180076038
   Hwang KI, 1997, ARCH OPHTHALMOL-CHIC, V115, P1205, DOI 10.1001/archopht.1997.01100160375024
   Imai K, 1998, AM J OPHTHALMOL, V125, P627, DOI 10.1016/S0002-9394(98)00023-3
   JABS DA, 1992, ARCH OPHTHALMOL-CHIC, V110, P185, DOI 10.1001/archopht.1992.01080140041022
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Juzoji H, 1997, JPN J OPHTHALMOL, V41, P278, DOI 10.1016/S0021-5155(97)00070-1
   KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175
   KIMURA H, 1994, INVEST OPHTH VIS SCI, V35, P2815
   Kimura H, 1999, INVEST OPHTH VIS SCI, V40, P524
   KIMURA H, 1995, INVEST OPHTH VIS SCI, V36, P2110
   KRAUSS JM, 1995, LASER SURG MED, V17, P102, DOI 10.1002/lsm.1900170203
   KUCKELKORN R, 1997, OPHTHAL RES, V29, P125
   LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V
   Langefeld S, 1999, GRAEF ARCH CLIN EXP, V237, P201, DOI 10.1007/s004170050219
   Larrosa JM, 1997, CURR EYE RES, V16, P1030, DOI 10.1076/ceyr.16.10.1030.9022
   Lean JS, 1989, OPHTHALMOLOGY, V96, P756
   LEBOURLAIS CA, 1995, DRUG DEV IND PHARM, V21, P19, DOI 10.3109/03639049509048095
   Liang CP, 1998, INT OPHTHALMOL, V22, P13, DOI 10.1023/A:1006016809070
   MADREPERLA SA, 1995, RETINA-J RET VIT DIS, V15, P87, DOI 10.1097/00006982-199515020-00001
   MARCUS DM, 1994, INT OPHTHALMOL CLIN, V34, P97, DOI 10.1097/00004397-199403430-00011
   MARIN JF, 1992, ARCH OPHTHALMOL-CHIC, V110, P86, DOI 10.1001/archopht.1992.01080130088031
   MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023
   Marx JL, 1996, ARCH OPHTHALMOL-CHIC, V114, P815, DOI 10.1001/archopht.1996.01100140029003
   MCALLISTER IL, 1988, OPHTHALMOLOGY, V95, P877
   MEINERT H, 1996, Patent No. 0003542
   MEISNER D, 1995, ADV DRUG DELIVER REV, V16, P75, DOI 10.1016/0169-409X(95)00016-Z
   Metrikin D C, 1994, Curr Opin Ophthalmol, V5, P21, DOI 10.1097/00055735-199406000-00005
   MICHELS RG, 1986, RETINA-J RET VIT DIS, V6, P1, DOI 10.1097/00006982-198600610-00002
   MORITERA T, 1991, INVEST OPHTH VIS SCI, V32, P1785
   Musch DC, 1997, NEW ENGL J MED, V337, P83, DOI 10.1056/NEJM199707103370203
   Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4
   NAKAGAWA M, 1995, INVEST OPHTH VIS SCI, V36, P2388
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   NAKAMURA K, 1991, INVEST OPHTH VIS SCI, V32, P3007
   OHIRA A, 1991, RETINA-J RET VIT DIS, V11, P259, DOI 10.1097/00006982-199111020-00012
   Orzalesi N, 1998, CURR EYE RES, V17, P828, DOI 10.1076/ceyr.17.8.828.5157
   Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239
   Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X
   Pastor JC, 1998, EUR J OPHTHALMOL, V8, P179
   PEYMAN GA, 1995, ADV DRUG DELIVER REV, V16, P107, DOI 10.1016/0169-409X(95)00018-3
   PEYMAN GA, 1995, SURV OPHTHALMOL, V39, P375
   PEYMAN GA, 1992, OPHTHALMIC SURG LAS, V23, P811
   PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P657
   PEYMAN GA, 1985, SURV OPHTHALMOL, V29, P434, DOI 10.1016/0039-6257(85)90208-5
   Peyman GA, 1995, VITREOUS SUBSTITUTES
   Putnam D, 1995, ADV POLYM SCI, V122, P55
   Refojo M. F., 1995, Proceedings of the 1995 Fourteenth Southern Biomedical Engineering Conference (Cat. No.95TH0703-9), P143, DOI 10.1109/SBEC.1995.514462
   REFOJO MF, 1983, RETINA-J RET VIT DIS, V3, P45, DOI 10.1097/00006982-198300310-00011
   REFOJO MF, 1996, INVEST OPHTH VIS SCI, V37, P18
   Roldan-Pallares M, 1999, ARCH OPHTHALMOL-CHIC, V117, P197
   SAETTONE MF, 1995, ADV DRUG DELIVER REV, V16, P95, DOI 10.1016/0169-409X(95)00014-X
   SANBORN GE, 1992, ARCH OPHTHALMOL-CHIC, V110, P188, DOI 10.1001/archopht.1992.01080140044023
   SCHEPENS CL, 1991, SURV OPHTHALMOL, V35, P447, DOI 10.1016/0039-6257(91)90108-R
   Scholda CD, 1998, ACTA OPHTHALMOL SCAN, V76, P192, DOI 10.1034/j.1600-0420.1998.760214.x
   Schulman JA, 1993, OPHTHALMIC DRUG DELI, P383
   SEBAG J, 1993, RETINA-J RET VIT DIS, V13, P8, DOI 10.1097/00006982-199313010-00003
   Sintzel MB, 1996, EUR J PHARM BIOPHARM, V42, P358
   SMIDDY WE, 1995, OPHTHALMOLOGY, V102, P1688
   SMITH TJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P255, DOI 10.1001/archopht.1992.01080140111037
   Steffansen B, 1996, INT J PHARM, V132, P243, DOI 10.1016/0378-5173(95)04376-4
   Stolba U, 1997, RETINA-J RET VIT DIS, V17, P146, DOI 10.1097/00006982-199703000-00011
   SUZUKI M, 1991, JPN J OPHTHALMOL, V35, P282
   Thumann G, 1997, RETINA-J RET VIT DIS, V17, P330, DOI 10.1097/00006982-199707000-00009
   VELIKAY M, 1993, AM J OPHTHALMOL, V116, P565, DOI 10.1016/S0002-9394(14)73197-6
   VELIKAY M, 1995, GRAEF ARCH CLIN EXP, V233, P26, DOI 10.1007/BF00177782
   Veloso AAS, 1997, EXP EYE RES, V65, P425
   WIEDEMANN P, 1988, OPHTHALMIC RES, V20, P74
   WILKES SR, 1993, J NATL MED ASSOC, V85, P841
   Wolf S, 1999, GRAEF ARCH CLIN EXP, V237, P51, DOI 10.1007/s004170050194
   Wong D, 1998, GRAEF ARCH CLIN EXP, V236, P234, DOI 10.1007/s004170050070
   YAMAUCHI A, 1991, POLYMER GELS, P127
   Yang CS, 1998, ARCH OPHTHALMOL-CHIC, V116, P69, DOI 10.1001/archopht.116.1.69
   ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2
   Zinutti C, 1996, INT J PHARM, V133, P97, DOI 10.1016/0378-5173(95)04423-X
NR 132
TC 99
Z9 106
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2000
VL 21
IS 7
BP 649
EP 665
DI 10.1016/S0142-9612(99)00220-3
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288TZ
UT WOS:000085581700001
PM 10711963
DA 2018-10-19
ER

PT J
AU Anselme, K
AF Anselme, K
TI Osteoblast adhesion on biomaterials
SO BIOMATERIALS
LA English
DT Review
DE osteoblast; adhesion; biomaterial; tissue engineering
ID HUMAN BONE-CELLS; GAP-JUNCTIONAL COMMUNICATION; FIBRONECTIN-MEDIATED
   ADHESION; PATTERNED SURFACE-CHEMISTRY; MECHANICAL STRAIN; IN-VITRO;
   SIGNAL-TRANSDUCTION; INTEGRIN RECEPTORS; MARROW-CELLS;
   HORMONAL-REGULATION
AB The development of tissue engineering in the held of orthopaedic surgery is now booming. Two fields of research in particular are emerging: the association of osteo-inductive factors with implantable materials; and the association of osteogenic stem cells with these materials (hybrid materials). In both cases, an understanding of the phenomena of cell adhesion and, in particular, understanding of the proteins involved in osteoblast adhesion on contact with the materials is of crucial importance. The proteins involved in osteoblast adhesion are described in this review (extracellular matrix proteins, cytoskeletal proteins, integrins, cadherins, etc.). During osteoblast/material interactions, their expression is modified according to the surface characteristics of materials. Their involvement in osteoblastic response to mechanical stimulation highlights the significance of taking them into consideration during development of future biomaterials. Finally, an understanding of the proteins involved in osteoblast adhesion opens up new possibilities for the grafting of these proteins (or synthesized peptide) onto vector materials, to increase their in vivo bioactivity or to promote cell integration within the vector material during the development of hybrid materials. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Inst Rech Malad Squelette, Inst Calot, F-62600 Berck Sur Mer, France.
RP Anselme, K (reprint author), Inst Rech Malad Squelette, Inst Calot, Rue Dr Calot, F-62600 Berck Sur Mer, France.
OI Anselme, Karine/0000-0002-6669-205X
CR Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   ANSELME K, 1994, CELL MATER, V4, P113
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ASK M, 1988, APPL SURF SCI, V35, P283
   BAB I, 1984, CLIN ORTHOP RELAT R, P243
   BAB I, 1988, BONE MINER, V4, P373
   Babich Michael, 1994, Life Sciences, V54, P201
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043
   Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   BOWERS VM, 1989, J BIOMED MATER RES, V23, P1453, DOI 10.1002/jbm.820231208
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brighton CT, 1996, J BONE JOINT SURG AM, V78A, P1337, DOI 10.2106/00004623-199609000-00007
   BUCKLEY MJ, 1988, BONE MINER, V4, P225
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Burmeister JS, 1998, BIOMATERIALS, V19, P307, DOI 10.1016/S0142-9612(97)00109-9
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   CALLEN BW, 1993, J BIOMED MATER RES, V27, P851, DOI 10.1002/jbm.820270703
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F
   CARVALHO RS, 1994, J BONE MINER RES, V9, P999
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   CASSERBETTE M, 1990, CALCIFIED TISSUE INT, V46, P46, DOI 10.1007/BF02555824
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CHIBA H, 1994, CELL STRUCT FUNCT, V19, P173, DOI 10.1247/csf.19.173
   CHIQUETEHRISMANN R, 1995, CURR OPIN CELL BIOL, V7, P715, DOI 10.1016/0955-0674(95)80114-6
   CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406
   CIVITELLI R, 1995, CALCIFIED TISSUE INT, V56, pS29, DOI 10.1007/BF03354649
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   CORRY WD, 1981, J BIOCHEM BIOPH METH, V4, P29, DOI 10.1016/0165-022X(81)90003-8
   Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2
   Davidson RM, 1996, CALCIFIED TISSUE INT, V59, P500, DOI 10.1007/s002239900165
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   FAUCHEUX C, 1994, J MATER SCI-MATER M, V5, P635, DOI 10.1007/BF00120345
   Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7
   FRAYSSINET P, 1993, REV RHUM, V60, P342
   FRAYSSINET P, 1991, J MATER SCI-MATER M, V2, P217, DOI 10.1007/BF00703374
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093
   GOMMER RS, 1998, CALCIFIED TISSUE INT, V62, P532
   Goomer RS, 1998, CALCIFIED TISSUE INT, V62, P532, DOI 10.1007/s002239900474
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   GUIGNANDON A, 1995, CELL STRUCT FUNCT, V20, P369, DOI 10.1247/csf.20.369
   Guignandon A, 1997, EXP CELL RES, V236, P66, DOI 10.1006/excr.1997.3703
   Gundle R, 1997, J MATER SCI-MATER M, V8, P519, DOI 10.1023/A:1018538529108
   HARTER LV, 1995, ENDOCRINOLOGY, V136, P528, DOI 10.1210/en.136.2.528
   HAYESWORTH SE, 1992, BONE, V13, P81
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hillsley MV, 1997, CALCIFIED TISSUE INT, V60, P48, DOI 10.1007/s002239900185
   HOCHMUTH RM, 1993, J BIOMECH ENG-T ASME, V115, P515, DOI 10.1115/1.2895533
   HOLDEN C M, 1990, Journal of Oral Implantology, V16, P86
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HUNG CT, 1995, CLIN ORTHOP RELAT R, P256
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Johnson EE, 1998, CLIN ORTHOP RELAT R, P105
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   Jorgensen NR, 1997, J CELL BIOL, V139, P497, DOI 10.1083/jcb.139.2.497
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KEILA S, 1994, J BONE MINER RES, V9, P321
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lo CM, 1998, EUR BIOPHYS J BIOPHY, V27, P9, DOI 10.1007/s002490050105
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Lu J. X., 1997, BIOCERAMICS, V10, P583
   MAEZZINI MC, 1998, J ORTHOPAED RES, V16, P170
   MALAVAL L, 1996, PROTEINES MALADIES M, P17
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MCDAVID PT, 1979, J DENT RES, V58, P1478, DOI 10.1177/00220345790580050901
   MEGE JL, 1986, CELL BIOPHYS, V8, P141
   MEYER U, 1993, CELL MATER, V3, P129
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MikuniTakagaki Y, 1996, ENDOCRINOLOGY, V137, P2028, DOI 10.1210/en.137.5.2028
   Miyajima K, 1990, Nihon Kyosei Shika Gakkai Zasshi, V49, P226
   MULAVAL L, 1996, MALADIES METABILOQUE, P17
   NADE S, 1983, CLIN ORTHOP RELAT R, P255
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   NGAN P, 1990, ARCH ORAL BIOL, V35, P717, DOI 10.1016/0003-9969(90)90094-Q
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   OKASAKI M, 1994, J BIOL CHEM, V269, P12092
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Owen M, 1988, J Cell Sci Suppl, V10, P63
   OZAWA H, 1990, J CELL PHYSIOL, V142, P177, DOI 10.1002/jcp.1041420122
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   Pommerenke H, 1996, EUR J CELL BIOL, V70, P157
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133
   Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0
   SCHILLER PC, 1992, MOL ENDOCRINOL, V6, P1433, DOI 10.1210/me.6.9.1433
   Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081
   SCHOETERS G, 1992, CELL PROLIFERAT, V25, P587, DOI 10.1111/j.1365-2184.1992.tb01462.x
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SINHA RK, 1996, BONE, V18, P4151
   Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   STANFORD CM, 1995, J ORTHOPAED RES, V13, P664, DOI 10.1002/jor.1100130505
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STEINBERG TH, 1994, EMBO J, V13, P744, DOI 10.1002/j.1460-2075.1994.tb06316.x
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Thoumine O, 1996, CELL MOTIL CYTOSKEL, V33, P276
   Thoumine O, 1997, J CELL SCI, V110, P2109
   Thoumine O, 1997, BIORHEOLOGY, V34, P309, DOI 10.1016/S0006-355X(98)00007-9
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   UCHIDA A, 1987, J BIOMED MATER RES, V21, P1, DOI 10.1002/jbm.820210106
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VERRIER S, 1998, J BONE MINER RES, V23, pS535
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   Werntz JR, 1996, J ORTHOP RES, V14, P85, DOI 10.1002/jor.1100140115
   WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163
   WITTBJER J, 1983, CLIN ORTHOP RELAT R, P229
   WU CY, 1995, J CELL SCI, V108, P821
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Zhuang HM, 1996, BIOCHEM BIOPH RES CO, V229, P449, DOI 10.1006/bbrc.1996.1824
   Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218
   Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 170
TC 1634
Z9 1721
U1 19
U2 524
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2000
VL 21
IS 7
BP 667
EP 681
DI 10.1016/S0142-9612(99)00242-2
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288TZ
UT WOS:000085581700002
PM 10711964
DA 2018-10-19
ER

PT J
AU Fini, M
   Pierini, G
   Giavaresi, G
   Biagini, G
   Belmonte, MM
   Aldini, NN
   Rocca, M
   Martini, L
   Giardino, R
AF Fini, M
   Pierini, G
   Giavaresi, G
   Biagini, G
   Belmonte, MM
   Aldini, NN
   Rocca, M
   Martini, L
   Giardino, R
TI The ovariectomised sheep as a model for testing biomaterials and
   prosthetic devices in osteopenic bone: a preliminary study on iliac
   crest biopsies
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE sheep; ovariectomy; osteoporosis; biomaterials; implants
ID MINERAL DENSITY; INTIMAL HYPERPLASIA; TITANIUM IMPLANTS; GROWTH-FACTOR;
   OSTEOPOROSIS; EWES; OSSEOINTEGRATION; COMPLICATIONS; ACCUMULATION;
   REPLACEMENT
AB A histomorphometric and ultrastructural evaluation on sheep iliac bone was performed. Six sheep were ovariectomised (OVX Group) and 6 were left intact (Sham-aged, Control Group). An iliac crest biopsy was performed randomly in 6 animals at the beginning of the study then, in all the animals, after 12 and 24 months. A significant decrease in trabecular bone volume, trabecular thickness (p<0.0005) and cell volume (p<0.005) was observed in OVX animals. A modest decrease in trabecular number and osteoid thickness together with an increase in trabecular separation were observed in OVX animals at 12 and 24 months. The osteoid volume showed a significant difference (p<0.05) between the groups. In OVX animals, at 12 months, Scanning Electron Microscopy revealed an enlargement of the trabecular space and a progressive replacement of bone matrix with adipose tissue. These signs were accentuated at 24 months.
   In conclusion, OVX sheep showed a loss of trabecular bone starting at 12 months after ovariectomy The developed osteopenic state may be considered as a useful tool when doing research on biomaterial osteointegration.
C1 Rizzoli Orthopaed Inst, Dept Expt Surg, Bologna, Italy.
   Univ Bologna, Dept Forens Med, Fac Med, I-40126 Bologna, Italy.
   Univ Ancona, Inst Human Normal Morphol, Fac Med, I-60128 Ancona, Italy.
   Univ Bologna, Fac Med, Chair Surg Pathophysiol, I-40126 Bologna, Italy.
RP Fini, M (reprint author), IOR, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Via di Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016; Mattioli-Belmonte, Monica/J-5861-2012
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR ALFAROADRIAN J, 1998, HIP INT, V8, P62
   Aroldi A, 1998, INT J ARTIF ORGANS, V21, P251
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Baxter J C, 1993, J Prosthodont, V2, P120, DOI 10.1111/j.1532-849X.1993.tb00393.x
   Belmonte MM, 1998, J MATER SCI-MATER M, V9, P485, DOI 10.1023/A:1008827619290
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   CEDER L, 1998, HIP INT, V8, P99
   CHAVASSIEUX P, 1991, BONE, V12, P421, DOI 10.1016/8756-3282(91)90031-D
   CHAVASSIEUX P, 1993, OSTEOPOROSIS INT, V3, P97, DOI 10.1007/BF01623380
   De Benedittis A, 1999, INT J ARTIF ORGANS, V22, P516
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   FINI M, 2000, IN PRESS J MAT SCI M, V11
   FINI M, IN PRESS J BONE JOIN
   Fujimoto T, 1998, INT J ORAL MAX IMPL, V13, P183
   Gennari C, 1998, AGING-CLIN EXP RES, V10, P214, DOI 10.1007/BF03339655
   Geusens P, 1996, CALCIFIED TISSUE INT, V59, P315
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   HAYASHI K, 1989, J ARTHROPLASTY, V4, P256
   HOMBY SB, 1995, BONE, V17, pS389
   Johnson RB, 1997, J PERIODONTOL, V68, P864, DOI 10.1902/jop.1997.68.9.864
   Khosla Sundeep, 1995, P183
   KLEEREKOPER M, 1998, METABOLIC BONE DIS, P387
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Marotti G., 1990, ULTRASTRUCTURE SKELE, P19
   MARTIN RB, 1988, J BONE JOINT SURG AM, V70A, P540, DOI 10.2106/00004623-198870040-00010
   Meunier Pierre J., 1995, P299
   Monier-Faugere M, 1998, METABOLIC BONE DIS C, P237
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Parker M J, 1998, HIP INT, V8, P10
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   Selzman CH, 1998, J SURG RES, V80, P380, DOI 10.1006/jsre.1998.5487
   Selzman CH, 1998, CIRCULATION, V98, P2049, DOI 10.1161/01.CIR.98.19.2049
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   TORRICELLI P, IN PRESS ART CELLS B
   Turner AS, 1997, OSTEOARTHR CARTILAGE, V5, P63, DOI 10.1016/S1063-4584(97)80032-5
   TURNER AS, 1995, BONE, V17, pS395, DOI 10.1016/8756-3282(95)00317-7
   TURNER AS, 1995, BONE, V17, pS421, DOI 10.1016/8756-3282(95)00321-4
   Weinhold PS, 1999, ANN BIOMED ENG, V27, P103, DOI 10.1114/1.153
NR 41
TC 31
Z9 32
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 2000
VL 23
IS 4
BP 275
EP 281
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 317NN
UT WOS:000087231600011
PM 10832663
DA 2018-10-19
ER

PT J
AU Kanno, T
   Tanaka, H
   Miyoshi, N
   Kawai, T
AF Kanno, T
   Tanaka, H
   Miyoshi, N
   Kawai, T
TI A new self-fabrication of large-scale deoxyribonucleic acid network on
   mica surfaces
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS
LA English
DT Article
DE deoxyribonucleic acid (DNA); poly(dA-dT) poly(dA-dT); mica; surface
   atomic force microscopy (AFM); DNA network; DNA film
ID ATOMIC-FORCE MICROSCOPY; DNA
AB We have successfully fabricated large-scale deoxyribonucleic acid (DNA) networks on mica surfaces using a simple and easy fabrication method for the first time. Sample drops of poly(dA-dT). poly(dA-dT) which is a synthetic linear DNA were spotted on freshly cleaved mica and blown off with air. At low DNA concentrations, clusters of DNA molecules were separated from each other. However at high concentrations, substrates were covered with a two-dimensional DNA network measuring more than 12 mm laterally. The DNA network discovered in our study seems highly practical due to its simple and easy fabrication method and its length. We believe this DNA network has the potential to serve as a biomaterial for medical, engineering and environmental applications.
C1 Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.
   Fukui Med Univ, Dept Pathol, Fukui 9101193, Japan.
RP Kanno, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P273
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P145
   Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496
   Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398
   Nakamura T, 1999, J VAC SCI TECHNOL B, V17, P288, DOI 10.1116/1.590552
   RABKE CE, 1994, SCANNING MICROSCOPY, V8, P471
   SCHAPER A, 1993, NUCLEIC ACIDS RES, V21, P6004, DOI 10.1093/nar/21.25.6004
   THUNDAT T, 1994, NUCLEIC ACIDS RES, V22, P4224, DOI 10.1093/nar/22.20.4224
   Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998
   Yamada M., 1999, NUCL ACIDS S SER, V42, P103
NR 13
TC 46
Z9 46
U1 0
U2 4
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 2
JI Jpn. J. Appl. Phys. Part 2 - Lett.
PD APR 1
PY 2000
VL 39
IS 4A
BP L269
EP L270
DI 10.1143/JJAP.39.L269
PG 2
WC Physics, Applied
SC Physics
GA 347CX
UT WOS:000088910800002
DA 2018-10-19
ER

PT J
AU Daculsi, G
   Rohanizadeh, R
   Weiss, P
   Bouler, JM
AF Daculsi, G
   Rohanizadeh, R
   Weiss, P
   Bouler, JM
TI Crystal polymer interaction with new injectable bone substitute; SEM and
   Hr TEM study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE ultrastructural study; calcium phosphate; polymer crystal interaction;
   biomaterial; bone substitute
ID CALCIUM-PHOSPHATE CERAMICS; COMPOSITE; SURGERY; IMPLANTATION; DEFECTS
AB A composite constituted of calcium phosphate (CaP) granules and a hydrophilic polymer as a carrier (hydroxy-propyl-methyl cellulose, HPMC) was developed to be an injectable bone substitute (IBS, CNRS patent). IBS is a composite and not an ionic cement. The composite obtained is ready to use and sterile. Chemical interactions between organic and inorganic components appeared during the association of the two. The interactions of the CaP and the polymer have been studied using scanning electron microscopy (SEM), electron microprobe (EDX), and high-resolution transmission electron microscopy (HrTEM) SEM revealed a degradation of the granules into smaller particles while EDX was unable to show significant changes in the Ca/P ratio during aging of the composite. With Hr TEM, however, we observed hydrolysis (process of dissolution and precipitation) from the surface to about 13 nm into the HA crystals and occasional dissolution with precipitation of beta-TCP crystals. In HA, the first zone of interaction consisted of a single layer of small globular crystals of 2 to 3 nm in diameter. Numerous lattice patterns in all three axes could be observed. Under the globular crystals zone, the inter-reticular distances of the single crystals appeared enlarged by 1.2% (from 0.817 to 0.827 nm). The enlargement seems to correspond to diffusion of HPO4 into the crystal lattice. In beta-TCP crystals, dissolution was observed to be several nanometers deep, but globular surface precipitation rarely was observed. With time or after steam sterilization, no changes were observed. These data demonstrate the strong interactions of the hydrophylic polymer with calcium phosphate, but only in the first several nanometers of thickness. (C) 2000 John Wiley & Sons, inc.
C1 Fac Chirurg Dent, UPRES EA 2159, F-44042 Nantes, France.
RP Daculsi, G (reprint author), Fac Chirurg Dent, UPRES EA 2159, Pl A Ricordeau, F-44042 Nantes, France.
RI Daculsi, Guy/P-1320-2014; Weiss, Pierre/P-1372-2014; Rohanizadeh,
   Ramin/J-5719-2016
OI Daculsi, Guy/0000-0003-1030-3446; Weiss, Pierre/0000-0002-6159-8590;
   Rohanizadeh, Ramin/0000-0002-7967-5515; BOULER,
   Jean-Michel/0000-0001-9784-5584
CR BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   BROWN WE, 1985, Patent No. 4518430
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1996, J BIOMED MATER RES, V31, P495, DOI 10.1002/(SICI)1097-4636(199608)31:4<495::AID-JBM9>3.0.CO;2-G
   DACULSI G, 1991, J APPL BIOMATER, V2, P147, DOI 10.1002/jab.770020302
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   DACULSI G, 1994, Patent No. 01414
   DACULSI G, 1989, CLIN ORTHOP RELAT R, V248, P169
   DACULSI G, 1999, IN PRESS BONE, P25
   DEGROOT K, 1987, HIGH TECH CERAMICS, P381
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P93
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GRIMANDI G, 1997, THESIS U NANTES FRAN
   GROSS UM, 1991, BONE-BIOMATERIAL INTERFACE, P308
   Hirth J. P., 1968, THEORY DISLOCATIONS
   Ito M, 1996, J BIOMED MATER RES, V32, P95, DOI 10.1002/(SICI)1097-4636(199609)32:1<95::AID-JBM11>3.3.CO;2-L
   JARCHO M, 1992, Dental Clinics of North America, V36, P19
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, V15, P169
   LEGEROS RZ, 1992, BONE BONDING BIOMATE, P201
   MILLOT F, IN PRESS CELL MAT
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   ROHANIZADEH R, IN PRESS CALCIF TISS
   ROHANIZADEH R, IN PRESS J BIOMED MA
   SHIRKAHANZADEH M, 1994, J MATER SCI LETT, V10, P1415
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   Weiss P, 1998, J BIOMED MATER RES, V41, P167, DOI 10.1002/(SICI)1097-4636(199807)41:1<167::AID-JBM20>3.0.CO;2-J
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   WEISS P, 1999, IN PRESS BONE, P25
NR 39
TC 19
Z9 22
U1 2
U2 17
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2000
VL 50
IS 1
BP 1
EP 7
DI 10.1002/(SICI)1097-4636(200004)50:1<1::AID-JBM1>3.0.CO;2-W
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274NP
UT WOS:000084772200001
PM 10644956
DA 2018-10-19
ER

PT J
AU Nonami, T
   Tsutsumi, S
AF Nonami, T
   Tsutsumi, S
TI Press-formable CaO-MgO-SiO2-TiO2-Ag2O glass as a biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE glass-ceramics; biomaterial; diopside; crystallization; viscosity;
   artificial bone
ID CERAMIC DIOPSIDE
AB Glass-ceramics were investigated to obtain a glass with a composition of CaO . MgO . 2SiO(2) . 0.375TiO(2) . 0.007Ag(2)O. The glass melted at 1500 degrees C and could be cast. Crystallization of diopside of this glass is controlled by volume nucleation and growth processes. In a crystallization treatment at 850 degrees-870 degrees C, this glass presented a milky white, semitransparent color. The crystals formed were diopside, their crystal grain diameter was 1-2 mu m, and crystallization was 15-25%. The bending strength of the glass produced by a crystallization treatment of 25 min at 850 degrees C was 400 MPa, which is suitable for artificial bones. This crystallized glass also was extremely stable, with no weight loss after stability testing in artificial saliva. The softening point, as determined fron the viscosity curve, was 830 degrees C, and the crystallization temperature was 895 degrees C. Thus this glass can be press-formed at a temperature of 830 degrees-880 degrees C. Actual press-forming at a pressure of 0.64 MPa was carried out for 40 min at 850 degrees C and resulted in the formation of desired shapes. Given its ready formation into desired shapes and its great strength after crystallization, such glass is applicable for use as artificial bones and as dental roots and crowns. (C) 2000 John Wiley & Sons, Inc.
C1 Natl Ind Res Inst Nagoya, Kita Ku, Nagoya, Aichi 4628510, Japan.
   Kyoto Univ, Sakyo Ku, Kyoto 606, Japan.
RP Nonami, T (reprint author), Natl Ind Res Inst Nagoya, Kita Ku, 1-1 Hirate, Nagoya, Aichi 4628510, Japan.
CR ABE Y, 1979, NATURE, V282, P55, DOI 10.1038/282055a0
   BEALL GH, 1969, J MATER SCI, V4, P340, DOI 10.1007/BF00550404
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kobayashi T, 1997, J BIOMED MATER RES, V37, P100, DOI 10.1002/(SICI)1097-4636(199710)37:1<100::AID-JBM12>3.0.CO;2-K
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Miake Y, 1995, J DENT RES, V74, P1756, DOI 10.1177/00220345950740110701
   NAKAJIMA M, 1990, SHIKWA GAKUHO, V90, P525
   NONAMI T, 1992, MATER RES SOC SYMP P, V252, P87
   Nonami T, 1996, J CERAM SOC JPN, V104, P201, DOI 10.2109/jcersj.104.201
   Nonami T., 1994, J JPN SOC BIOMATER, V12, P274
   NONAMI T, 1983, INT C DENT MAT P, P309
   NONAMI T, IN PRESS J MAT SCI M
   NONAMI T, 1994, P ANN M CER SOC JPN, P75
   PRIZIBRAM K, 1956, IRRADIATION COLORS L, P85
NR 15
TC 2
Z9 2
U1 2
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2000
VL 50
IS 1
BP 8
EP 15
DI 10.1002/(SICI)1097-4636(200004)50:1<8::AID-JBM2>3.0.CO;2-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274NP
UT WOS:000084772200002
PM 10644957
DA 2018-10-19
ER

PT J
AU Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
AF Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
TI Biomaterial-associated persistence of Streptococcus epidermidis in
   pericatheter macrophages
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 39th Interscience Conference on Antimicrobial Agents and Chemotherapy
CY SEP 26-29, 1998
CL SAN FRANCISCO, CALIFORNIA
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS;
   TUMOR-NECROSIS-FACTOR; BIOMEDICAL POLYMERS; INTERFERON-GAMMA;
   INTERLEUKIN-10; ADHESION; MODEL; PATHOGENESIS; NEUTROPHILS
AB Biomaterial surfaces may be modified to reduce bacterial adhesion. The susceptibility in mice to Staphylococcus epidermidis infection in tissue surrounding the commonly used catheter materials-silicon elastomer (SE), polyamide (PA), and their surface-modified polyvinylpyrrolidone (PVP)-grafted derivatives, SE-PVP and PA-PVP, respectively-was assessed. Abscesses developed around SE-PVP Around SE, PA, and PA-PVP catheters, no signs of infection were observed, although mice carrying PA-PVP developed septicemia after 14-21 days. S. epidermidis was cultured from the tissue surrounding PA-PVP segments. Cells around PA-PVP segments containing large numbers of bacteria were identified as macrophages by use of immunohistochemistry and electron microscopy. This persistence of intracellular bacteria was also observed around SE-PVP, SE, and PA, catheters, although to a lesser extent. The cytokine profiles around the 4 materials were different. Implanted biomaterial induces an inflammatory response favorable to the persistence of S. epidermidis. Intracellular persistence of bacteria inside macrophages may be a pivotal process in the pathogenesis of biomaterial-associated infection.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   Maastricht Ctr Biomat Res, Maastricht, Netherlands.
   Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, J6-S-208,POB 9600, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BADDOUR LM, 1984, J INFECT DIS, V150, P721, DOI 10.1093/infdis/150.5.721
   Bisno AL, 1994, INFECT ASS INDWELLIN
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   BOELENS J, 1998, 38 INT C ANT AG CHEM
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   COSTERTON J, 1975, J ANTIMICROB CHEMOTH, V4, P363
   COSTERTON JW, 1981, CRC CR REV MICROBIOL, V8, P303, DOI 10.3109/10408418109085082
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DUQUID I, 1992, J ANTIMICROB CHEMOTH, V30, P803
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   EMILIE D, 1995, REV RHUM, V62, P229
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   GRAY ED, 1987, ZBL BAKT S, V16, P45
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   JOHNSON GM, 1987, ZENTRALBLATT BAKTE S, V16, P33
   Kanangat S, 1999, INFECT IMMUN, V67, P2834
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAUFMANN S, 1993, LEPROSY, P57
   Kaufmann SHE, 1995, CIBA F SYMP, V195, P123
   KLOCK JC, 1976, BLOOD, V48, P149
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9
   LAMAN J, 1998, J NEUROIMMUNOL, V86, P303
   LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NOBLE WC, 1965, BRIT J EXP PATHOL, V46, P254
   OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676
   PAUL WE, 1993, FUNDAMENTAL IMMUNOLO
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Seifert H., 1997, CATHETER RELATED INF
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   TAUBLER JH, 1966, J INFECT DIS, V116, P257, DOI 10.1093/infdis/116.3.257
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 56
TC 72
Z9 73
U1 2
U2 10
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR
PY 2000
VL 181
IS 4
BP 1337
EP 1349
DI 10.1086/315369
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 311KT
UT WOS:000086883900014
PM 10762565
OA Bronze
DA 2018-10-19
ER

PT J
AU Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
AF Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
TI An experimental approach to spinal fusion using sintered bovine bone in
   a pig model
SO JOURNAL OF SPINAL DISORDERS
LA English
DT Article
DE animal model; biomaterials; biomechanics; sintered bovine bone; spinal
   fusion
ID INTERNAL-FIXATION; OSTEOPOROSIS; FRACTURE; ANTERIOR; INSTRUMENTATION;
   DEVICES; GRAFT
AB Sintered bovine bone is a biomaterial based on calcium phosphate, an organized crystal of bone mineral that possesses a natural trabecular structure. The authors considered whether sintered bovine bone can integrate with recipient bone and adjust to the strength of recipient bone for anterior spinal fusion in an animal model. Either autologous iliac bone or sintered bovine bone was implanted for a spinal body fusion. Some pigs underwent exposure of the spinal bodies without implantation. Based on radiographic evaluation, manual palpation, biomechanical testing, and histologic examination, spinal fusion with sintered bovine bone resulted in a composition and structure similar to that of the autograft (or of no implantation). The sintered bovine bone with its moderate strength tended to adjust to the bone stiffness of the host bone in the specimens as new bone grew.
C1 Wakayama Med Coll, Dept Orthopaed Surg, Wakayama 6410012, Japan.
RP Minamide, A (reprint author), Wakayama Med Coll, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6410012, Japan.
EM minamide@wakayama-med.ac.jp
CR ABUMI K, 1989, SPINE, V14, P1249, DOI 10.1097/00007632-198911000-00019
   ABUMI K, 1998, RINSHO SEIKEIGEKA, V33, P495
   ARCIERO RA, 1989, SPINE, V14, P114, DOI 10.1097/00007632-198901000-00024
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Biggerman M, 1995, VERTEBRAL FRACTURE O, P21
   BOHLMAN HH, 1985, J BONE JOINT SURG AM, V67A, P360, DOI 10.2106/00004623-198567030-00002
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   COOKE FW, 1990, CLIN ORTHOPAEDICS, V276, P135
   EISMONT FJ, 1983, J BONE JOINT SURG AM, V65, P19, DOI 10.2106/00004623-198365010-00004
   FRIEDLAENDER GE, 1982, J BONE JOINT SURG AM, V64, P307, DOI 10.2106/00004623-198264020-00031
   GAINES RW, 1991, SPINE, V16, P902, DOI 10.1097/00007632-199108000-00007
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003
   HOPP SG, 1989, J ORTHOPAED RES, V7, P579, DOI 10.1002/jor.1100070416
   Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008
   KANEDA K, 1992, SPINE, V17, pS295, DOI 10.1097/00007632-199208001-00015
   KANEDA K, 1988, SPINE, V13, P286
   KATOH T, 1993, CLIN ORTHOP RELAT R, V287, P266
   KEMPINSKY WH, 1958, NEUROLOGY, V8, P181, DOI 10.1212/WNL.8.3.181
   KOSTUIK JP, 1988, SPINE, V13, P286, DOI 10.1097/00007632-198803000-00011
   KURIHARA N, 1987, QUINTESSENCE, V6, P104
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LEONG JCY, 1994, CLIN ORTHOP RELAT R, P52
   Matsumoto T, 1999, J ORTHOP RES, V17, P586, DOI 10.1002/jor.1100170419
   Minamide A, 1999, SPINE, V24, P1863, DOI 10.1097/00007632-199909150-00002
   MINAMIDE A, 1999, RINSHO SEIKEIGEKA, V48, P973
   Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005
   Nibu K, 1997, J SPINAL DISORD, V10, P357
   PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   RYAN MD, 1986, CLIN ORTHOP RELAT R, P196
   SALOMON C, 1988, SPINE, V13, P222, DOI 10.1097/00007632-198802000-00019
   SHIKATA J, 1990, SPINE, V15, P485, DOI 10.1097/00007632-199006000-00010
   SHIRADO O, 1992, SPINE, V17, P795, DOI 10.1097/00007632-199207000-00012
   SHONO Y, 1994, SPINE, V19, P1711, DOI 10.1097/00007632-199408000-00010
   SIEGAL T, 1985, J BONE JOINT SURG AM, V67A, P375, DOI 10.2106/00004623-198567030-00004
   STEFFEE AD, 1986, CLIN ORTHOP RELAT R, P45
   TAMAKI T, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P235
   TANEICHI H, 1998, SPINE SPINAL CORD, V11, P829
   Taniguchi Y, 1999, J HAND SURG-BRIT EUR, V24B, P109, DOI 10.1016/S0266-7681(99)90055-4
   TORIBATAKE Y, 1997, SEIKEIGEKA, V48, P973
   UENO Y, 1985, BESSATSU SEIKEIGEKA, V8, P85
   Whitecloud TS, 1998, J SPINAL DISORD, V11, P479
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889
NR 45
TC 2
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0895-0385
J9 J SPINAL DISORD
JI J. Spinal Disord.
PD APR
PY 2000
VL 13
IS 2
BP 156
EP 164
DI 10.1097/00002517-200004000-00011
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 302YR
UT WOS:000086394500011
PM 10780692
DA 2018-10-19
ER

PT J
AU Lu, YP
   Zhu, RF
   Lei, TQ
   Li, ST
   Ma, QS
   Li, MS
   Chao, ZQ
AF Lu, YP
   Zhu, RF
   Lei, TQ
   Li, ST
   Ma, QS
   Li, MS
   Chao, ZQ
TI Electron theory analysis on Ti-6Al-4V and Au-8Pd-10Pt alloys
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE alloy; electron theory; biology
ID HYDROXYAPATITE; PHOSPHATE; IMPLANTS; BONE
AB The valence electron structures and electron densities on some lattice planes of biomaterials Ti-6Al-4V and Au-Pd-Pt were calculated by using bond length difference method of the empirical electron theory of solids and molecules. The results show that there exist the planes with continuous densities in the three crystal cells involved, which verified to some extent the validity of "Atomic Boundary Condition" applying in biomaterials research. It was proposed that the sufficient understanding and reasonable modeling on microstructure of living body are necessary to evaluate directly the electron density continuity between biomaterial and living tissue.
C1 Harbin Inst Technol, Harbin 150001, Peoples R China.
   Shandong Univ Technol, Coll Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Provincial Hosp, Qingrui Oral Implant Ctr, Jinan 250021, Peoples R China.
CR CHENG KJ, 1993, PROGR NATURAL SCI, V3, P417
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   INDOME T, 1995, J BIOMED MATER RES, V29, P19
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Muller RT, 1997, ARCH ORTHOP TRAUM SU, V116, P334
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   SUN ZG, 1995, CHINESE SCI BULL, V40, P2219
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   ZHANG FC, 1991, CHINESE SCI BULL, V36, P382
   Zhang R L, 1993, EMPIRICAL ELECT THEO, P83
NR 12
TC 0
Z9 0
U1 0
U2 3
PU ALLERTON PRESS INC
PI NEW YORK
PA 150 FIFTH AVE, NEW YORK, NY 10011 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD APR
PY 2000
VL 10
IS 2
BP 232
EP 234
PG 3
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 310PC
UT WOS:000086835700022
DA 2018-10-19
ER

PT J
AU Udhardt, URE
   Klemm, DO
   Marsch, SE
   Schumann, DA
AF Udhardt, URE
   Klemm, DO
   Marsch, SE
   Schumann, DA
TI Structural design of bacterial cellulose as biomaterial in microsurgery.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Jena, Inst Organ Chem & Macromol, D-6900 Jena, Germany.
   Univ Jena, Clin Maxillofacial & Plast Surg, D-07740 Jena, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 26
PY 2000
VL 219
MA 12-CELL
BP U258
EP U258
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 317UV
UT WOS:000087246101229
DA 2018-10-19
ER

PT J
AU Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Lopes, A
   Pereira, L
   Castro, M
AF Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Lopes, A
   Pereira, L
   Castro, M
TI In vitro release studies of methylmethacrylate liberation from acrylic
   cement powder
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE poly(methylmethacrylate); methylmethacrylate; biomaterial; bone cement;
   release model
ID FREE-RADICALS; BONE-CEMENT; POLYMERIZATION; MONOMER
AB Bone cement or polymethylmethacrylate (PMMA) is commonly used for anchoring cemented prosthesis to the bone. Cytotoxic effect of culture media exposed to PMMA powder may be related with long term problems associated with acrylic cement application, being the monomer (methylmethacrylate) one of the cement's component partly responsible for the cytotoxic effect. The present work reports the studies of monomer release from acrylic bone cement powder under different experimental conditions: setting time of PMMA (in solution and air) and different culture media composition. High-performance liquid chromatography was used for the determination of residual monomer. Mathematical models were applied to experimental dissolution data revealing that monomer release is lightly affected by the studied variables. The monomer release seems to be a surface phenomena, suggesting that the possible actions of monomer will mainly be due to the initial loss of non polymerized monomer rather than to further depolymerization of the already polymerized cement. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Lisbon, Fac Farm, P-1600083 Lisbon, Portugal.
   Univ Lisbon, Ctr Electroquim & Cinet, P-1600083 Lisbon, Portugal.
   Univ Lisbon, Ctr Farmacol Expt & Clin, P-1600083 Lisbon, Portugal.
   Hosp Sta Maria, Serv Ortoped, Lisbon, Portugal.
RP Bettencourt, A (reprint author), Univ Lisbon, Fac Farm, Av Forcas Armadas, P-1600083 Lisbon, Portugal.
RI Calado, Antonio/M-4647-2014; iMed.ULisboa, iMed.ULisboa/C-6292-2014;
   Bettencourt, Ana/M-4219-2013; iMed.ULisboa, CBT/B-4215-2014; Castro,
   Matilde/A-9468-2014
OI Calado, Antonio/0000-0003-4110-0182; Bettencourt,
   Ana/0000-0002-8498-5892; Castro, Matilde/0000-0002-6314-8251; Monteiro,
   Jacinto Manuel de Melo Oliveira/0000-0002-4067-200X
CR BRAUER GM, 1977, J BIOMED MATER RES, V11, P577, DOI 10.1002/jbm.820110412
   Brossard C., 1990, STP PHARM, V6, P728
   DAVY KWM, 1991, BIOMATERIALS, V12, P540, DOI 10.1016/0142-9612(91)90047-E
   DONBROW M, 1992, MICROCAPSULES NANOPA, P193
   KNEPP MV, 1987, CONTROLLED RELEASE T, P267
   LINDER LG, 1976, CLIN ORTHOP RELAT R, P242
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   *NAT FORM US, 1995, US PHARM CONV, V18, P2265
   PETTY W, 1980, J BIOMED MATER RES, V14, P427, DOI 10.1002/jbm.820140409
   SCHOENFELD CM, 1979, J BIOMED MATER RES, V13, P135, DOI 10.1002/jbm.820130114
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   WILLERT HG, 1973, CHROMATOGRAPHIA, V6, P226
NR 12
TC 22
Z9 23
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD MAR 20
PY 2000
VL 197
IS 1-2
BP 161
EP 168
DI 10.1016/S0378-5173(99)00468-8
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 293JA
UT WOS:000085847300016
PM 10704803
DA 2018-10-19
ER

PT J
AU Yang, ZP
   Chilkoti, A
AF Yang, ZP
   Chilkoti, A
TI Microstamping of a biological ligand onto an activated polymer surface
SO ADVANCED MATERIALS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; MAMMALIAN-CELLS; ADHESION; STREPTAVIDIN;
   BIOTIN; PATTERNS; PROTEINS; ORIGINS
AB Communication: Patterning of bioligands and proteins onto surfaces has important applications in tissue engineering and biosensor fabrication, but until now the best results have utilized organic films on gold. These authors present a new method (MAPS), and demonstrate its use by micropatterning a biotin ligand onto the widely used biomaterial poly(ethylene terephthalate), shown in the Figure.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Chilkoti, A (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
CR Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BRAYBROOK JH, 1990, PROG POLYM SCI, V15, P715, DOI 10.1016/0079-6700(90)90009-P
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chen W, 1998, MACROMOLECULES, V31, P3648, DOI 10.1021/ma9710601
   CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   GREEN NM, 1966, BIOCHEM J, V101, P774, DOI 10.1042/bj1010774
   HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190
   Hengsakul M, 1996, BIOCONJUGATE CHEM, V7, P249, DOI 10.1021/bc960007z
   Hidber PC, 1996, LANGMUIR, V12, P1375, DOI 10.1021/la9507500
   KIRKPATRICK CJ, 1991, CELL MATER, V1, P93
   KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   LISTON EM, 1993, J ADHES SCI TECHNOL, V7, P1091, DOI 10.1163/156856193X00600
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mooney JF, 1996, P NATL ACAD SCI USA, V93, P12287, DOI 10.1073/pnas.93.22.12287
   MRKSICH M, 1995, TRENDS BIOTECHNOL, V13, P228, DOI 10.1016/S0167-7799(00)88950-7
   RANBY B, 1988, ACS SYM SER, V364, P168
   Ratner BD, 1990, PLASMA DEPOSITION TR
   Sabbatini L., 1993, SURFACE CHARACTERIZA, P221
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722
   Wilchek M., 1990, AVIDIN BIOTIN TECHNO, V184
   Wybourne MN, 1996, NANOTECHNOLOGY, V7, P302, DOI 10.1088/0957-4484/7/3/021
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 28
TC 56
Z9 56
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAR 16
PY 2000
VL 12
IS 6
BP 413
EP +
DI 10.1002/(SICI)1521-4095(200003)12:6<413::AID-ADMA413>3.0.CO;2-#
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 295YP
UT WOS:000085996500010
DA 2018-10-19
ER

PT J
AU Chen, GP
   Ushida, T
   Tateishi, T
AF Chen, GP
   Ushida, T
   Tateishi, T
TI Hybrid biomaterials for tissue engineering: A preparative method for PLA
   or PLGA-collagen hybrid sponges
SO ADVANCED MATERIALS
LA English
DT Article
ID BIODEGRADABLE POLYMER SCAFFOLDS; MATRICES; CULTURE; ACID); FOAMS
AB Research News: A novel hybrid biomaterial for tissue engineering has been developed by forming collagen microsponges in the pores of poly(alpha ester) sponge. Poly(alpha ester) sponge provides the skeleton with a high degree of mechanical strength, while the collagen provides cell compatibility. The Figure shows mouse fibroblast cells and bovine articular chondrocytes adhered to a PLGA-collagen hybrid sponge.
C1 Natl Inst Adv Interdisciplinary Res, 3D Tissue Engn Grp, Tsukuba, Ibaraki 3058562, Japan.
   Univ Tsukuba, Grad Sch Med, Med Res Inst, Tsukuba, Ibaraki 3058575, Japan.
RP Chen, GP (reprint author), Natl Inst Adv Interdisciplinary Res, 3D Tissue Engn Grp, 1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.
CR CHEN G, IN PRESS T MAT RES S
   CHEN G, IN PRESS J BIOMED MA
   Chen GP, 1999, CHEM LETT, P561, DOI 10.1246/cl.1999.561
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
NR 16
TC 114
Z9 119
U1 2
U2 48
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 16
PY 2000
VL 12
IS 6
BP 455
EP +
DI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 295YP
UT WOS:000085996500021
DA 2018-10-19
ER

PT J
AU Martino, M
   Coviello, A
   Tamburro, AM
AF Martino, M
   Coviello, A
   Tamburro, AM
TI Synthesis and structural characterization of poly(LGGVG), an
   elastin-like polypeptide
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE elastin; elasticity; conformational studies
ID GLY-GLY-NME; MOLECULAR-DYNAMICS; TETRAPEPTIDE; PROTEIN; FRAGMENTS;
   SEQUENCE; BEHAVIOR; ANALOGS
AB Poly(LGGVG) a potential elastin-like biomaterial has been synthesized and studied both in solution (by circular dicroism and nuclear magnetic resonance) and in the aggregated state (by transmission electron microscopy). For sake of comparison, also the conformation of the protected (Boc-LGGVG-OEt) and free (H-2(+)-LGGVG-OH) 'monomers' has been investigated. While in the latter ones the presence has been evidenced of more or less stable type LI beta-turns, the polymer showed a conformational ensemble, possibly comprising type II beta-turns, type I beta-turns and open (unordered) structures. At supramolecular level, twisted-rope aggregates were observed by transmission electron microscopy for the polymer. Thus, the title compound has shown to possess, at both molecular and supramolecular level, physico-chemical properties very similar to those of elastin, so to give some confidence that it could really constitute the precursor of an artificial substitute of elastin itself. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basilicata, Dipartimento Chim, I-85100 Potenza, Italy.
RP Tamburro, AM (reprint author), Univ Basilicata, Dipartimento Chim, Via N Sauro 85, I-85100 Potenza, Italy.
CR Cao QP, 1997, CURR BIOL, V7, pR677, DOI 10.1016/S0960-9822(06)00353-8
   COHENADDAD JP, 1993, PROGR NUCLEAR MAGNET, V25, P1
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   GOTTE L, 1976, MICRON, V7, P95, DOI 10.1016/0047-7206(76)90052-2
   GUANTIERI V, 1990, BIOPOLYMERS, V29, P845, DOI 10.1002/bip.360290418
   Martino M, 1998, J BIOMOL STRUCT DYN, V15, P861, DOI 10.1080/07391102.1998.10508208
   NISHI N, 1987, INT J PEPT PROT RES, V30, P275
   PERCZEL A, 1993, INT J PEPT PROT RES, V41, P223
   ROBSON P, 1993, J BIOL CHEM, V268, P1440
   SERAFINIFRACASSINI A, 1978, J ULTRA MOL STRUCT R, V65, P190, DOI 10.1016/S0022-5320(78)90056-4
   TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419
   TAMBURRO AM, 1995, J BIOMOL STRUCT DYN, V12, P1161, DOI 10.1080/07391102.1995.10508805
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   VILLANI V, 1993, J CHEM SOC PERK T 2, P1951, DOI 10.1039/p29930001951
   Villani V, 1998, THEOCHEM-J MOL STRUC, V431, P205, DOI 10.1016/S0166-1280(97)00345-X
   Villani V, 1997, J CHEM SOC PERK T 2, P2375, DOI 10.1039/a702217d
   VILLANI V, 1995, J BIOMOL STRUCT DYN, V12, P1173, DOI 10.1080/07391102.1995.10508806
   VILLANI V, 1994, J MOL STRUCT THEOCHE, V308, P141
   VILLANI V, 1997, ELASTIN ELASTIC TISS, P31
   WALKER GH, 1969, PHYS REV, V188, P416, DOI 10.1103/PhysRev.188.416
NR 21
TC 40
Z9 40
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR 16
PY 2000
VL 27
IS 1
BP 59
EP 64
DI 10.1016/S0141-8130(99)00118-X
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 294EL
UT WOS:000085898300008
PM 10704987
DA 2018-10-19
ER

PT J
AU Sechriest, VF
   Miao, YJ
   Niyibizi, C
   Westerhausen-Larson, A
   Matthew, HW
   Evans, CH
   Fu, FH
   Suh, JK
AF Sechriest, VF
   Miao, YJ
   Niyibizi, C
   Westerhausen-Larson, A
   Matthew, HW
   Evans, CH
   Fu, FH
   Suh, JK
TI GAG-augmented polysaccharide hydrogel: A novel biocompatible and
   biodegradable material to support chondrogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; biomaterial; articular chondrocyte; chitosan; cell
   biomaterial interaction
ID ARTICULAR-CARTILAGE DEFECTS; IN-VITRO; OSTEOCHONDRAL DEFECTS; CANINE
   CHONDROCYTES; COLLAGEN TYPE; REPAIR; MATRIX; CHITOSAN; CULTURE; IMPLANTS
AB The quality of articular cartilage engineered using a cell-polymer construct depends, in part, on the chemical composition of the biomaterial and whether that biomaterial can support the chondrocytic phenotype. Acknowledging the supportive influence of tissue-specific matrix molecules on the chondrocytic phenotype, we have combined chondroitin sulfate-A (CSA) and chitosan, a glycosaminoglycan (GAG) analog, to develop a novel biomaterial to support chondrogenesis. Chitosan is a polycationic repeating monosaccharide of beta-1,4-linked glucosamine monomers with randomly located N-acetyl glucosamine units. Chitosan may be combined with the polyanionic CSA such that ionic crosslinking results in hydrogel formation. Bovine primary articular chondrocytes, when seeded onto a thin layer of CSA-chitosan, form discrete, focal adhesions to the material and maintain many characteristics of the differentiated chondrocytic phenotype, including round morphology, limited mitosis, collagen type II, and proteoglycan production. Our findings suggest CSA-chitosan may be well suited as a carrier material for the transplant of autologous chondrocytes or as a scaffold for the tissue engineering of cartilage-like tissue. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Pittsburgh, Dept Orthopaed Surg, Musculoskeletal Res Ctr, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.
   Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Suh, JK (reprint author), Tulane Univ, Dept Biomed Engn, Lindy Boggs Ctr, Suite 500, New Orleans, LA 70118 USA.
EM fsuh@mailhost.tcs.tulane.edu
OI Matthew, Howard/0000-0001-6033-9258
CR AYDELOTTE MB, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P237
   BASSLEER C, 1992, INT J TISSUE REACT, V14, P231
   BATOLUCCI C, 1991, INT J TISSUE REACT, V13, P311
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   DAHLBERG L, 1991, J ORTHOPAED RES, V9, P11, DOI 10.1002/jor.1100090103
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREEN WT, 1977, CLIN ORTHOP RELAT R, P237
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   ITAY S, 1987, CLIN ORTHOP RELAT R, P284
   IZUME M, 1989, CHITIN CHITOSAN, P653
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   KOSHER RA, 1973, DEV BIOL, V35, P210, DOI 10.1016/0012-1606(73)90018-3
   MADIHALLY SV, 1997, ASME P BIOENG C, P417
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   Minas T, 1997, ORTHOPEDICS, V20, P525
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   ROBINSON D, 1990, METHODS CARTILAGE RE, P327
   SANFORD PA, 1989, CHITIN CHITOSAN SOUR, P51
   Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   VACANTI CA, 1994, AM J SPORT MED, V22, P485, DOI 10.1177/036354659402200408
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 41
TC 216
Z9 240
U1 1
U2 52
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 15
PY 2000
VL 49
IS 4
BP 534
EP 541
DI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270AE
UT WOS:000084512500012
PM 10602087
DA 2018-10-19
ER

PT J
AU Yuan, ML
   Wang, YH
   Li, XH
   Xiong, CD
   Deng, XM
AF Yuan, ML
   Wang, YH
   Li, XH
   Xiong, CD
   Deng, XM
TI Polymerization of lactides and lactones. 10. Synthesis,
   characterization, and application of amino-terminated poly(ethylene
   glycol)-co-poly(epsilon-caprolactone) block copolymer
SO MACROMOLECULES
LA English
DT Article
ID POLYLACTONES; GLYCOL)
AB The synthesis of hydroxy-terminated poly(ethylene glycol)-co-poly(epsilon-caprolactone) (MPEG-PCL was investigated by the reaction of poly(ethylene glycol) and epsilon-caprolactone in the presence of stannous octoate. The polymerization was proved to be carried out in a controllable way. Bromo-terminated MPEG-PCL copolymer has been synthesized by macromolecular reaction as a possible method to prepare primary amino-terminated MPEG-PCL. The conversion of hydroxy-terminated MPEG-PCL to amino-terminated MPEG-PCL was detected quantitatively. The primary amino-terminated MPEG-PCL was an effective macroinitiator for the ring-opening polymerization of beta-benzyl L-aspartate-N-carboxy anhydride. The A-B-C triblock copolymer of MPEG-PCL-PBLA thus synthesized may be used as a new potential biomaterial, which contains both a hydrophilic unit and a hydrophobic unit as well as functional groups.
C1 Acad Sinica, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Yuan, ML (reprint author), Acad Sinica, Chengdu Inst Organ Chem, POB 415, Chengdu 610041, Peoples R China.
CR BERGER A, 1951, J AM CHEM SOC, V73, P4084, DOI 10.1021/ja01153a009
   BLOUT ER, 1956, J AM CHEM SOC, V78, P941, DOI 10.1021/ja01586a020
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   DEGEE P, 1992, MACROMOLECULES, V25, P4242, DOI 10.1021/ma00043a002
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   Dunn RL, 1988, POLYM MED, VIII, P149
   Gan ZH, 1996, J APPL POLYM SCI, V59, P961, DOI 10.1002/(SICI)1097-4628(19960207)59:6<961::AID-APP8>3.0.CO;2-N
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   KIM SH, 1992, MAKROMOL CHEM, V193, P1623
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   Kricheldorf HR, 1990, MODELS BIOPOLYMERS R
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   SASAKI T, 1982, J CHEM SOC PERK T 1, P1953, DOI 10.1039/p19820001953
   Youxin L., 1993, J CONTROL RELEASE, V27, P247
NR 19
TC 78
Z9 82
U1 2
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 7
PY 2000
VL 33
IS 5
BP 1613
EP 1617
DI 10.1021/ma991388p
PG 5
WC Polymer Science
SC Polymer Science
GA 293BY
UT WOS:000085832700026
DA 2018-10-19
ER

PT J
AU Khouw, IMSL
   van Wachem, PB
   van der Worp, RJ
   van den Berg, TK
   de Leij, LFMH
   van Luyn, MJA
AF Khouw, IMSL
   van Wachem, PB
   van der Worp, RJ
   van den Berg, TK
   de Leij, LFMH
   van Luyn, MJA
TI Systemic anti-IFN-gamma treatment and role of macrophage subsets in the
   foreign body reaction to dermal sheep collagen in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE foreign body reaction; interferon-gamma; macrophages; major
   histocompatibility complex class II
ID MONOCLONAL-ANTIBODY; INTERFERON-GAMMA; TISSUE REACTION; INFLAMMATORY
   RESPONSES; MONOCYTES MACROPHAGES; CONSTANT DETERMINANT; LYMPHOID ORGANS;
   IMMUNE-RESPONSE; CROSS-LINKING; HETEROGENEITY
AB The application of a biomaterial induces a foreign body reaction. By controlling this reaction,biocompatibility could be improved. We previously demonstrated that impregnation of a biodegradable biomaterial with antibodies against interferon-gamma (IFN-gamma) inhibits the foreign body reaction. In this study we investigate whether systemic administration of the antibody can induce similar reactions. Several parameters are compared between control and anti-IFN-gamma-treated rats: cellular ingrowth; degradation of the biomaterial; ingrowth of macrophage (MO) subsets, T cells, B cells, NK cells, and granulocytes; and expression of the major histocompatibility complex class II (MHC class II) molecule on antigen presenting cells. Treatment with anti-IFN-gamma results in increased cellular ingrowth and biomaterial degradation and a decreased expression of MHC class II. Overall, systemic treatment with anti-IFN-gamma is insufficient to modulate the foreign body reaction. This suggests an alternative mechanism for MO activation besides IFN-gamma. The role of T cells and MO subsets in the foreign body reaction is discussed. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, NL-9712 KZ Groningen, Netherlands.
   Free Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands.
   Univ Groningen Hosp, NL-9713 GZ Groningen, Netherlands.
RP Khouw, IMSL (reprint author), Univ Groningen, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR Abumiya T, 1996, LAB INVEST, V75, P125
   Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563
   BARBE E, 1990, IMMUNOBIOLOGY, V182, P88, DOI 10.1016/S0171-2985(11)80586-3
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BILLIAU A, 1990, BIOCHEM PHARMACOL, V40, P1433, DOI 10.1016/0006-2952(90)90437-P
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   DAMOISEAUX JGMC, 1989, J LEUKOCYTE BIOL, V46, P556
   Dianzani F, 1990, Ann Ist Super Sanita, V26, P255
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1992, CURR EYE RES, V11, P75, DOI 10.3109/02713689208999514
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   GARSIDE P, 1995, IMMUNOL TODAY, V16, P220, DOI 10.1016/0167-5699(95)80162-6
   Gessani S, 1998, CYTOKINE GROWTH F R, V9, P117, DOI 10.1016/S1359-6101(98)00007-0
   HARTUNG HP, 1990, ANN NEUROL, V27, P247, DOI 10.1002/ana.410270306
   HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   KNOP J, 1990, J INVEST DERMATOL, V95, pS72, DOI 10.1111/1523-1747.ep12874780
   KUHNLEIN P, 1994, J IMMUNOL, V153, P979
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Nadarajah V, 1996, J TOXICOL ENV HEALTH, V49, P113
   PAINEAU J, 1991, J HEART LUNG TRANSPL, V10, P424
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   ROZEMA FR, 1992, ADV BIOMAT, V10, P349
   SCHOEN FJ, 1995, CARDIOVASC PATHOL, V4, P241, DOI 10.1016/1054-8807(95)00051-6
   SHARKNESS CM, 1993, PUBLIC HEALTH REP, V108, P70
   STET RJM, 1985, TRANSPLANT P, V17, P1829
   STRIGARD K, 1989, ACTA NEUROL SCAND, V80, P201, DOI 10.1111/j.1600-0404.1989.tb03863.x
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANLUYN MJA, 1994, J MATER SCI-MATER M, V5, P671, DOI 10.1007/BF00120354
   VANLUYN MJA, IN PRESS REPETITIVE
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VERSCHURE PJ, 1989, SCAND J IMMUNOL, V29, P371, DOI 10.1111/j.1365-3083.1989.tb01136.x
   WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5
   WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211
   YOUNG WW, 1980, J IMMUNOL, V124, P199
NR 43
TC 13
Z9 13
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2000
VL 49
IS 3
BP 297
EP 304
DI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266WQ
UT WOS:000084323600001
PM 10602061
DA 2018-10-19
ER

PT J
AU Webb, K
   Hlady, V
   Tresco, PA
AF Webb, K
   Hlady, V
   Tresco, PA
TI Relationships among cell attachment, spreading, cytoskeletal
   organization, and migration rate for anchorage-dependent cells on model
   surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cell attachment; cell spreading; migration rate; model surfaces;
   MC3T3-E1 osteoblasts
ID SUBSTRATUM ADHESIVENESS; SIGNAL-TRANSDUCTION; GRADIENT SURFACES;
   FREE-ENERGY; ADHESION; FIBRONECTIN; FIBROBLASTS; ADSORPTION; INTEGRINS;
   GROWTH
AB Many research and commercial applications use a synthetic substrate which is seeded with cells in a serum-containing medium. The surface properties of the material influence the composition of the adsorbed protein layer, which subsequently regulates a variety of cell behaviors such as attachment, spreading, proliferation, migration, and differentiation. In this study, we examined the relationships among cell attachment, spreading, cytoskeletal organization, and migration rate for MC3T3-E1. osteoblasts on glass surfaces modified with SOx, -NH2, -N+(CH3)(3), -SH, and -CH3 terminal silanes, We also studied the relationship between cell spread area and migration rate for a variety of anchorage-dependent cell types on a model polymeric biomaterial, poly(acrylonitrile-vinylchloride). Our results indicated that MC3T3-E1 osteoblast behavior was surface chemistry dependent, and varied with individual functional groups rather than general surface properties such as wettability. In addition, cell migration rate was inversely related to cell spread area for MC3T3-E1 osteoblasts on a variety of silane-modified surfaces as well as for different anchorage-dependent cell types on a model polymeric biomaterial. Furthermore, the data revealed significant differences in migration rate among different cell types on a common polymeric substrate, suggesting that cell type-specific differences must be considered when using, selecting, or designing a substrate for research and therapeutic applications. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Utah, Dept Bioengn, WM Keck Ctr Tissue Engn, Ctr Biopolymers Interfaces, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, WM Keck Ctr Tissue Engn, Ctr Biopolymers Interfaces, Salt Lake City, UT 84112 USA.
FU NHLBI NIH HHS [R01 HL044538, R01 HL044538-09]
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161
   COLTON CK, 1991, T ASME, V113, P152
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206
   GENTILE FT, 1995, REACT POLYM, V25, P207, DOI 10.1016/0923-1137(94)00097-O
   GEORGER JH, 1992, THIN SOLID FILMS, V210, P716, DOI 10.1016/0040-6090(92)90383-M
   GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lin Y S, 1995, Colloids Surf B Biointerfaces, V4, P65, DOI 10.1016/0927-7765(94)01150-4
   Liu J, 1996, COLLOID SURFACE B, V8, P25, DOI 10.1016/S0927-7765(96)01298-2
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   NOBLE M, 1984, J NEUROSCI, V4, P1892
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   SANKAR S, 1995, AM J PATHOL, V147, P601
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHOTCHFORD CA, 1997, T 23 ANN M SOC BIOM, P202
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   TAWIL NJ, 1994, J NEUROSCI RES, V39, P436, DOI 10.1002/jnr.490390411
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
NR 34
TC 160
Z9 166
U1 2
U2 35
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2000
VL 49
IS 3
BP 362
EP 368
DI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266WQ
UT WOS:000084323600009
PM 10602069
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Malmonge, SM
   Arruda, AC
AF Malmonge, SM
   Arruda, AC
TI Artificial articular cartilage: Mechanoelectrical transduction under
   dynamic compressive loading
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1st Latin American Congress for Artificial Organs and Biomaterials
CY DEC 10-13, 1998
CL BELO HORIZONT, BRAZIL
SP Int Soc Artificial Organs, Financier Studies & Projects, Fdn Res Support St Minas Gerais, Fed Univ Minas Gerais, Brizilian Inst Biomat
DE articular cartilage; hydrogel; mechanoelectrical transduction; fixed
   negative charge
ID MECHANICAL-PROPERTIES; FLUID TRANSPORT; PLUGS
AB The search for biomaterials to be used as an artificial articular cartilage in joint restoration is a challenging research area. Because the articular cartilage plays a fundamental role in joint function, the biomaterial has to be able to mimic the behavior of the natural healthy surface. Articular cartilage is a biphasic material composed by a solid extracellular matrix and a fluid phase, the synovial fluid. When the tissue is pressed, there is a mechanoelectrical transduction that is believed to modulate the cellular activity of chondrocytes, being fundamental for tissue repair. This work aimed at the development of hydrogels for use as an artificial articular cartilage. Hydrogels with negative groups fixed in the macromolecular network were obtained by copolymerizing 2-hydroxyethyl methacrylate with acrylic acid. The obtained hydrogels showed a mechanoelectrical transduction under dynamic compressive loading with potential amplitude increasing with fixed charge density values.
C1 State Univ Campinas, Ctr Technol, Biomech Engn Lab, BR-13083970 Campinas, SP, Brazil.
RP Malmonge, SM (reprint author), State Univ Campinas, Ctr Technol, Biomech Engn Lab, POB 6131, BR-13083970 Campinas, SP, Brazil.
RI Malmonge, Sonia/I-4610-2012
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   BENTLEY G, 1992, ANN RHEUM DIS, V51, P292, DOI 10.1136/ard.51.3.292
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602
   HOLMES MH, 1985, J BIOMECH ENG-T ASME, V107, P206
   KIM YJ, 1995, J BIOMECH, V28, P1055, DOI 10.1016/0021-9290(94)00159-2
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   LEE RC, 1981, J BIOMECH ENG-T ASME, V103, P280, DOI 10.1115/1.3138294
   LIM FC, 1965, ARTHRITS RHEUM, V8, P481
   LOTKE PA, 1974, J BONE JOINT SURG AM, VA 56, P1040, DOI 10.2106/00004623-197456050-00015
   MAROUDAS A, 1975, BIORHEOLOGY, V12, P233
   MAROUDAS A, 1979, ADUT ARTICULAR CARTI, P214
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MESSNER K, 1993, J BIOMED MATER RES, V27, P1527, DOI 10.1002/jbm.820271209
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1991, J BIOMECHANICAL ENG, V113, P193
   MUIR H, 1983, BIOCHEM SOC T, V11, P613, DOI 10.1042/bst0110613
   PALMOSKI MJ, 1984, ARTHRITIS RHEUM, V27, P675, DOI 10.1002/art.1780270611
   Reissis N, 1995, J MATER SCI-MATER M, V6, P768, DOI 10.1007/BF00134315
   SAH RLY, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P373
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
NR 23
TC 5
Z9 7
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2000
VL 24
IS 3
BP 174
EP 178
DI 10.1046/j.1525-1594.2000.06538.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 300GL
UT WOS:000086244500003
PM 10759634
DA 2018-10-19
ER

PT J
AU dos Santos, LA
   de Oliveira, LC
   Rigo, ECD
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
AF dos Santos, LA
   de Oliveira, LC
   Rigo, ECD
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
TI Fiber reinforced calcium phosphate cement
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1st Latin American Congress for Artificial Organs and Biomaterials
CY DEC 10-13, 1998
CL BELO HORIZONT, BRAZIL
SP Int Soc Artificial Organs, Financier Studies & Projects, Fdn Res Support St Minas Gerais, Fed Univ Minas Gerais, Brizilian Inst Biomat
DE calcium phosphate cement; calcium phosphate; alpha-tricalcium phosphate;
   bioceramic; biomaterial; medical devices
ID BONE CEMENTS; SETTING REACTION
AB The term calcium phosphate cement was introduced by Gruninger et al. (1). This type of cement can be prepared by reacting a calcium phosphate salt with an aqueous solution, which causes it to set by the crossing of the precipitated crystals. These cements offer a series of advantages that allow their use as grafts and substitutes of damaged parts of the bone system. However, these cements have low mechanical strength compared to human bones. This work studied the influence of the use of polyamide fibers in the mechanical properties of a calcium phosphate cement based on alpha-tricalcium phosphate as well as the mechanisms involved in the increase of mechanical strength. The results demonstrate the feasibility of the use of polymeric fibers to increase mechanical strength and the need for coupling agents for the effective performance of the fibers as reinforcement in these materials.
C1 Univ Estadual Campinas, Fac Engn Mecan, BR-13081970 Campinas, SP, Brazil.
   Univ Fed Sao Carlos, Dept Mat Engn, Sao Paulo, Brazil.
   Univ La Habana, Ctr Biomat, Havana, Cuba.
RP dos Santos, LA (reprint author), Univ Estadual Campinas, Fac Engn Mecan, Caixa Postal 6136, BR-13081970 Campinas, SP, Brazil.
RI Vercik, Luci/H-8579-2012; Rigo, Eliana/H-4926-2012; Garcia Carrodeguas,
   Raul/E-5087-2012
OI Rigo, Eliana/0000-0003-3368-5707; Garcia Carrodeguas,
   Raul/0000-0002-4379-4598
CR Beaudoin J. J., 1990, HDB FIBER REINFORCED
   BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P144, DOI 10.1007/BF00053334
   CARRODEGUAS RG, 1997, 1 C IB BIOM BIOMAT 9
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   GRUNINGER SE, 1984, J DENT RES, V63, P200
   Monma H, 1984, GYPSUM LIME, V188, P11
   OYABU M, 1973, Patent No. 4819489
   RIGO ECS, 1996, 3 ENC NAC BIOM SAO P, P9
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 15
TC 46
Z9 46
U1 1
U2 16
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2000
VL 24
IS 3
BP 212
EP 216
DI 10.1046/j.1525-1594.2000.06541.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 300GL
UT WOS:000086244500013
PM 10759644
DA 2018-10-19
ER

PT J
AU Temenoff, JS
   Mikos, AG
AF Temenoff, JS
   Mikos, AG
TI Review: tissue engineering for regeneration of articular cartilage
SO BIOMATERIALS
LA English
DT Review
DE cartilage repair; cartilage regeneration; cartilage tissue engineering;
   cell transplantation; bioreactors; chondrogenesis
ID BIODEGRADABLE POLYMER SCAFFOLDS; IN-VITRO; OSTEOCHONDRAL DEFECTS;
   INJECTABLE CARTILAGE; HUMAN CHONDROCYTES; PERFUSION CULTURE; CALCIUM
   ALGINATE; MATRIX; REPAIR; GROWTH
AB Joint pain due to cartilage degeneration is a serious problem, affecting people of all ages. Although many techniques, often surgical, are currently employed to treat this affliction, none have had complete success. Recent advances in biology and materials science have pushed tissue engineering to the forefront of new cartilage repair techniques. This review seeks to condense information for the biomaterialist interested in developing materials for this application. Articular cartilage anatomy, types of injury, and current repair methods are explained. The need for biomaterials, current commonly used materials for tissue-engineered cartilage, and considerations in scale-up of cell-biomaterial constructs are summarized. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   Rice Univ, Dept Chem Engn, Houston, TX 77005 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, 6100 Main,MS 142, Houston, TX 77005 USA.
RI Sano, Michael/E-1715-2011
FU NIAMS NIH HHS [R01-AR44381, R29-AR42639]; NIDCR NIH HHS [R01-DE13031]
CR ASTON JE, 1986, J BONE JOINT SURG BR, V68, P29
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   Breinan HA, 1998, TISSUE ENG, V4, P101, DOI 10.1089/ten.1998.4.101
   Brittberg M, 1993, Agents Actions Suppl, V39, P237
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   BUCKWALTER JA, 1983, AAOS I COURSE LECT, V32, P349
   BUJIA J, 1995, ACTA OTO-LARYNGOL, V115, P307, DOI 10.3109/00016489509139316
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CAPLAN AI, 1994, ENDOCHONDRAL BONE FO, P1
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   CHU CR, 1995, BIOMATERIALS, V16, P1381, DOI 10.1016/0142-9612(95)96873-X
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Coutts RD, 1997, AAOS I COURSE LECT, V46, P487
   DAVISSON TH, 1999, 45 ANN M AN ORTH RES
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   DUKE PJ, 1993, J CELL BIOCHEM, V51, P274, DOI 10.1002/jcb.240510306
   Fedewa MM, 1998, J ORTHOPAED RES, V16, P227, DOI 10.1002/jor.1100160210
   Freed L.E., 1997, PRINCIPLES TISSUE EN, P151
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Gillogly SD, 1998, J ORTHOP SPORT PHYS, V28, P241, DOI 10.2519/jospt.1998.28.4.241
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   GOLDBERG VM, 1999, AAOS I COURSE LECT, V48, P623
   Grande D A, 1995, Tissue Eng, V1, P345, DOI 10.1089/ten.1995.1.345
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   HARTY M, 1978, HUMAN JOINT HLTH DIS, P3
   Heath CA, 1996, BIOTECHNOL BIOENG, V50, P430, DOI 10.1002/(SICI)1097-0290(19960520)50:4<430::AID-BIT10>3.0.CO;2-N
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   McPherson JM, 1997, ARTHROSCOPY, V13, P541, DOI 10.1016/S0749-8063(97)90141-9
   Minas T., 1999, AAOS INSTR COURSE LE, V48, P629
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Obradovic B, 1999, BIOTECHNOL BIOENG, V63, P197, DOI 10.1002/(SICI)1097-0290(19990420)63:2<197::AID-BIT8>3.0.CO;2-2
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   RODRIGUEZ AM, 1998, FRONTIERS TISSUE ENG, P400
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Ting V, 1998, ANN PLAS SURG, V40, P413, DOI 10.1097/00000637-199804000-00016
   VACANTI CA, 1994, AM J SPORT MED, V22, P485, DOI 10.1177/036354659402200408
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VACANTI CA, 1997, PRINCIPLES TISSUE EN, P619
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wirth CJ, 1996, ARTHROSCOPY, V12, P300, DOI 10.1016/S0749-8063(96)90062-6
   Wong M, 1996, J ORTHOPAED RES, V14, P424, DOI 10.1002/jor.1100140313
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 75
TC 670
Z9 720
U1 16
U2 268
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2000
VL 21
IS 5
BP 431
EP 440
DI 10.1016/S0142-9612(99)00213-6
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 280YN
UT WOS:000085131500001
PM 10674807
DA 2018-10-19
ER

PT J
AU Malmonge, SM
   Zavaglia, CAC
   Belangero, WD
AF Malmonge, SM
   Zavaglia, CAC
   Belangero, WD
TI Biomechanical and histological evaluation of hydrogel implants in
   articular cartilage
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE biomaterial; cartilage repair; hydrogel; biomechanical evaluation
ID BIPHASIC INDENTATION; POLYMER SYSTEM; REGENERATION; GRAFTS
AB We evaluated the mechanical behavior of the repaired surfaces of defective articular cartilage in the intercondylar region of the rat femur after a hydrogel graft implant. The results were compared to those for the adjacent normal articular cartilage and for control surfaces where the defects remained empty. Hydrogel synthesized by blending poly(2-hydroxyethyl methacrylate) and poly(methyl methacrylate-co-acrylic acid) was implanted in male Wistar rats. The animals were divided into five groups with postoperative follow-up periods of 3, 5, 8, 12 and 16 weeks. Indentation tests were performed on the neoformed surfaces in the knee joint (with or without a hydrogel implant) and on adjacent articular cartilage in order to assess the mechanical properties of the newly formed surface. Kruskal-Wallis analysis indicated that the mechanical behavior of the neoformed surfaces was significantly different from that of normal cartilage. Histological analysis of the repaired defects showed that the hydrogel implant filled the defect with no signs of inflammation as it was well anchored to the surrounding tissues, resulting in a newly formed articular surface. In the case of empty control defects, osseous tissue grew inside the defects and fibrous tissue formed on the articular surface of the defects. The repaired surface of the hydrogel implant was more compliant than normal articular cartilage throughout the 16 weeks following the operation, whereas the fibrous tissue that formed postoperatively over the empty defect was stiffer than normal articular cartilage after 5 weeks. This stiffness started to decrease 16 weeks after the operation, probably due to tissue degeneration. Thus, from the biomechanical and histological point of view, the hydrogel implant improved the articular surface repair.
C1 Univ Estadual Campinas, Ctr Tecnol, Lab Engn Biomecan, BR-13083970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Fac Engn Mecan, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Fac Med, Dept Ortopedia & Traumatol, BR-13083970 Campinas, SP, Brazil.
RP Malmonge, SM (reprint author), Univ Estadual Campinas, Ctr Tecnol, Lab Engn Biomecan, Caixa Postal 6131, BR-13083970 Campinas, SP, Brazil.
RI Malmonge, Sonia/I-4610-2012
CR BENTLEY G, 1992, ANN RHEUM DIS, V51, P292, DOI 10.1136/ard.51.3.292
   CHIRILA TV, 1994, J BIOMED MATER RES, V28, P745, DOI 10.1002/jbm.820280612
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Haider MA, 1997, J BIOMECH, V30, P747, DOI 10.1016/S0021-9290(97)00024-9
   KEMPSON GE, 1971, J BIOMECH, V4, P239, DOI 10.1016/0021-9290(71)90030-3
   KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288
   KUDELA V, 1990, ENCY POLYM SCI ENG
   MAK AF, 1987, J BIOMECH, V20, P703, DOI 10.1016/0021-9290(87)90036-4
   MALMONGE SM, 1997, ANN 13 EUR C BIOM 4
   MORAN ME, 1992, J BONE JOINT SURG BR, V74, P659
   MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1991, J BIOMECHANICAL ENG, V113, P193
   RATNER BD, 1981, BIOCOMPATIBILITY CLI
   Reissis N, 1995, J MATER SCI-MATER M, V6, P768, DOI 10.1007/BF00134315
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Solchaga L, 1996, REV CHIR ORTHOP, V82, P101
   Swann A C, 1989, Proc Inst Mech Eng H, V203, P143, DOI 10.1243/PIME_PROC_1989_203_026_01
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
NR 21
TC 15
Z9 15
U1 0
U2 6
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAR
PY 2000
VL 33
IS 3
BP 307
EP 312
DI 10.1590/S0100-879X2000000300008
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 298GM
UT WOS:000086131000008
PM 10719382
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Nemet, B
   Zagar, Z
AF Nemet, B
   Zagar, Z
TI Fibronectin concentrations in catheter sepsis
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE fibronectin; catheter sepsis; coagulase-negative staphylococci
ID BINDING-SITES; GLYCOPROTEINS; STAPHYLOCOCCI; STREPTOCOCCI; FIBRINOGEN;
   ADHERENCE
AB Objective To investigate the role of fibronectin in the pathogenesis of biomaterial-related infections and the influence of catheter sepsis on the concentration of plasma fibronectin during Various stages of bacteremia.
   Methods Plasma fibronectin concentrations were determined by the simple radial immunodiffusion method. Four groups of subjects were used: one group comprised patients with catheter sepsis, the second patients with local inflammation of the catheter insertion site caused by slime-positive, coagulase-negative staphylococci, the third patients with slime-negative, coagulase-negative staphylococci isolated from the catheter, and the fourth demonstrably healthy persons.
   Results In patients with catheter sepsis, fibronectin concentrations were found after the disappearance of catheter sepsis and 3-5 days after the removal of the catheter. A statistically significant decrease in fibronectin concentration was detected in the plasma of patients with catheter sepsis compared with other groups of patients and control subjects.
   Conclusions The above results indicate a pathogenic role for fibronectin in biomaterial-related infections.
C1 Inst Publ Hlth, Microbiol Lab, Varazdin 42000, Croatia.
RP Nemet, B (reprint author), Inst Publ Hlth, Microbiol Lab, 1 Mestrovica BB, Varazdin 42000, Croatia.
CR BOZZINI S, 1992, EUR J BIOCHEM, V207, P327, DOI 10.1111/j.1432-1033.1992.tb17054.x
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369
   HYNES RO, 1986, SCI AM, V254, P32
   JULKUNEN I, 1983, INFECT IMMUN, V40, P876
   KIRK RE, 1995, EXPT DESIGN PROCEDUR
   KUUSELA P, 1984, INFECT IMMUN, V45, P433
   KUUSELA P, 1985, INFECT IMMUN, V50, P77
   LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P124
   Petz B., 1985, OSNOVNE STATISTICKE
   PROCTOR RA, 1987, REV INFECT DIS, V9, pS317
   RUSSELL PB, 1987, J CLIN MICROBIOL, V25, P1083
   SALGO L, 1988, LABOR AKTUELL, V7, P12
   SWITALSKI LM, 1983, INFECT IMMUN, V42, P628
   VALENTINWEIGAND P, 1993, J MED MICROBIOL, V38, P90, DOI 10.1099/00222615-38-2-90
   VISAI L, 1991, FEBS LETT, V290, P111, DOI 10.1016/0014-5793(91)81238-4
   WADSTROM T, 1987, PATHOGENICITY CLIN S, P83
NR 17
TC 4
Z9 4
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1198-743X
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2000
VL 6
IS 3
BP 121
EP 124
DI 10.1046/j.1469-0691.2000.00029.x
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 311YU
UT WOS:000086915000002
PM 11168086
OA Bronze
DA 2018-10-19
ER

PT J
AU Lekskul, M
   Burrows, R
   Kublin, CL
   Cintron, C
AF Lekskul, M
   Burrows, R
   Kublin, CL
   Cintron, C
TI CxGELSIX: A novel preparation of type VI collagen with possible use as a
   biomaterial
SO CORNEA
LA English
DT Article
DE type VI collagen; beta ig; cornea; stroma; biomaterial; Gelsix; CxGelsix
ID GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; RABBIT CORNEA;
   MOLECULAR-CLONING; II COLLAGEN; FASCICLIN-I; PROTEIN; PROTEOGLYCAN;
   BETA-IG-H3; ADHESION
AB Purpose. This study was initiated to evaluate tissue acceptance and stability of a novel type VI collagen preparation (CxGelsix) as a biomaterial in the rabbit corneal stroma. We hypothesized that CxGelsix, embedded intrastromally, does nor have any adverse affect on surrounding corneal tissues, and remains intact in the presence of an acute inflammatory reaction during corneal wound healing. Methods. Type VI collagen was extracted and purified from rabbit corneal stroma under nondenaturing conditions. This preparation, Gelsix, was concentrated and cross-linked with polyethylene glycol to produce a transparent film (CxGelsix). Discs of CxGelsix, 4.0-mm diameter, 9- to 35-mu m thick were implanted intrastromally and clinically examined periodically for 4 months. In another experiment. implantation of CxGelsix. 2.0-mm-diameter. was followed by corneal wounding adjacent to the implant and examined clinically for 30 weeks. At the end of these periods, the tissues from these experiments were processed for light and transmission electron microscopy. Results. An intralamellar 4.0-mm-diameter disc of CxGelsix does not alter the structure of corneal epithelium above the implant, suggesting normal transport of nutrients through CxGelsix. Moreover, no structural abnormalities were seen in the rest of the cornea, and the cornea remains transparent. Although the cornea accepts the presence of CxGelsix disc as judged by clinical criteria, gradual degradation of the implant is seen ultrastructurally. CxGelsix is remarkably stable despite its exposure to endogenous enzymes during inflammation and wound healing. Partial degradation of the implant occurs only after many months, and it is gradually replaced with bundles of fine collagen fibrils reminiscent of normal cornea. Conclusion. The results of this study suggest that CxGelsix is potentially useful as a biomaterial.
C1 Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA.
   Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA.
RP Cintron, C (reprint author), POB 210, E Randolph, VT 05041 USA.
FU NEI NIH HHS [R01-EYO1199]
CR BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250
   BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021
   Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110
   Chiou AGY, 1998, OPHTHALMOLOGY, V105, P746, DOI 10.1016/S0161-6420(98)94033-7
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   CINTRON C, 1973, EXP EYE RES, V17, P251, DOI 10.1016/0014-4835(73)90176-0
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P760
   DESGRANGES P, 1992, INT J ARTIF ORGANS, V15, P722
   DOANE KJ, 1992, EXP CELL RES, V200, P490, DOI 10.1016/0014-4827(92)90200-R
   Doane KJ, 1998, INVEST OPHTH VIS SCI, V39, P263
   Everts V., 1994, MATRIX BIOL, V14, P665
   Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817
   Fitton JH, 1998, CORNEA, V17, P108, DOI 10.1097/00003226-199801000-00016
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   Gibson MA, 1997, J HISTOCHEM CYTOCHEM, V45, P1683, DOI 10.1177/002215549704501212
   Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096
   Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4
   HERZLINGER GA, 1981, BLOOD, V57, P764
   Hoylaerts MF, 1997, BIOCHEM J, V324, P185, DOI 10.1042/bj3240185
   Ito HO, 1997, CLIN EXP IMMUNOL, V108, P213, DOI 10.1046/j.1365-2249.1997.3721269.x
   KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995
   KELMAN CD, 1994, Patent No. 5354336
   KELMAN CD, 1993, Patent No. 5219895
   KIELTY CM, 1992, J CELL BIOL, V118, P979, DOI 10.1083/jcb.118.4.979
   KOCHOUNIAN HH, 1991, J CATARACT REFR SURG, V17, P139, DOI 10.1016/S0886-3350(13)80243-X
   KOLLER E, 1989, EMBO J, V8, P1073, DOI 10.1002/j.1460-2075.1989.tb03475.x
   KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x
   LEBARON RG, 1995, J INVEST DERMATOL, V104, P844, DOI 10.1111/1523-1747.ep12607024
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Mast BA, 1992, FETAL WOUND HEALING, P227
   MCDEVITT CA, 1991, FEBS LETT, V294, P167, DOI 10.1016/0014-5793(91)80660-U
   Orgill DP, 1998, J BIOMED MATER RES, V39, P358, DOI 10.1002/(SICI)1097-4636(19980305)39:3<358::AID-JBM3>3.0.CO;2-I
   Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893
   RHEE W, 1992, Patent No. 5162430
   SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571
   SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511
   TAKAHASHI T, 1993, J HISTOCHEM CYTOCHEM, V41, P1447, DOI 10.1177/41.10.8245404
   TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   THOMPSON KP, 1993, CORNEA, V12, P35, DOI 10.1097/00003226-199301000-00007
   Tillet E, 1997, J BIOL CHEM, V272, P10769
   TRUEB B, 1987, EUR J BIOCHEM, V166, P699, DOI 10.1111/j.1432-1033.1987.tb13568.x
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VERHAGEN C, 1992, INVEST OPHTH VIS SCI, V33, P273
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   Werkmeister JA, 1998, J BIOMED MATER RES, V39, P429, DOI 10.1002/(SICI)1097-4636(19980305)39:3<429::AID-JBM12>3.0.CO;2-5
   ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6
   ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0
NR 49
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-3740
J9 CORNEA
JI Cornea
PD MAR
PY 2000
VL 19
IS 2
BP 194
EP 203
DI 10.1097/00003226-200003000-00013
PG 10
WC Ophthalmology
SC Ophthalmology
GA 292VH
UT WOS:000085815400013
PM 10746452
DA 2018-10-19
ER

PT J
AU Yang, R
   Ng, S
   Nichol, M
   Laine, L
AF Yang, R
   Ng, S
   Nichol, M
   Laine, L
TI A cost and performance evaluation of disposable and reusable biopsy
   forceps in GI endoscopy
SO GASTROINTESTINAL ENDOSCOPY
LA English
DT Article
ID CAMPYLOBACTER-PYLORI INFECTION; GASTROINTESTINAL ENDOSCOPY; TRANSMISSION
AB Background: Biopsy forceps are widely used in gastrointestinal endoscopy, and yet few data exist on the usage and costs associated with disposable versus reusable forceps.
   Methods: We prospectively measured the costs and operational performance of disposable and reusable forceps in 200 biopsy sessions; 100 sessions were performed using disposable forceps and 100 sessions were performed using reusable forceps. Total cost per use of the reusable forceps, including acquisition costs plus the costs of reprocessing per established guidelines, was determined. At the end of the study, the reusable forceps were disassembled to determine the cause of mechanical failures.
   Results: The total cost per use of the disposable forceps was $38. For the reusable forceps, the acquisition cost per forceps was $415 and the total reprocessing cost was $16.56 +/- 0.07 per forceps. For 10, 15 and 20 uses, reusable forceps costs were $58.06, $44.23, and $37.31, respectively. Reusable forceps malfunction at 11 to 15 uses was 5%; at 16 to 20 uses was 25%; and at 21 to 25 uses reached 80% (p < 0.001). Dismantling of the reusable forceps at the end of the study demonstrated coiled sheath kinking, rust in the forceps closure mechanism, bent spikes, and biomaterial contamination.
   Conclusions: Up to 15 to 20 uses, disposable and reusable forceps costs were similar. If reusable forceps are used more than 20 times, then they are less expensive. However, in this range of uses, reusable biopsy forceps performance diminishes. With disposable biopsy forceps costing less than $40, cost differences between reusable and disposable forceps are minimal.
C1 Univ So Calif, Los Angeles Cty Med Ctr, Div Gastroenterol & Liver Dis, Sch Med, Los Angeles, CA 90033 USA.
   Univ So Calif, Sch Med, Dept Pharmacoecon, Los Angeles, CA 90033 USA.
RP Yang, R (reprint author), Univ So Calif, Los Angeles Cty Med Ctr, Div Gastroenterol & Liver Dis, Sch Med, Bldg 1,Room 12-100,1200 N State St, Los Angeles, CA 90033 USA.
CR Bronowicki JP, 1997, NEW ENGL J MED, V337, P237, DOI 10.1056/NEJM199707243370404
   DWYER DM, 1987, GASTROINTEST ENDOSC, V33, P84, DOI 10.1016/S0016-5107(87)71515-6
   GRAHAM DY, 1988, AM J GASTROENTEROL, V83, P974
   KARIM QN, 1989, J HOSP INFECT, V13, P87, DOI 10.1016/0195-6701(89)90099-6
   Kozarek RA, 1996, GASTROINTEST ENDOSC, V43, P10, DOI 10.1016/S0016-5107(06)80073-8
   LANGENBERG W, 1990, J INFECT DIS, V161, P507, DOI 10.1093/infdis/161.3.507
   MISTUNE NP, 1993, J CLIN PATHOL, V46, P540
   *SOC GASTR NURS AS, 1990, REC GUID INF CONTR G
   SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008
   TYTGAT GNJ, 1995, ALIMENT PHARM THERAP, V9, P105
   Weatherly K S, 1994, AORN J, V59, P489
   YANG R, 1994, GASTROINTEST ENDOSC, V40, P671
   YANG R, 1990, GASTROINTEST ENDOSC, V36, P379, DOI 10.1016/S0016-5107(90)71069-3
   YANG R, 1996, AM J GASTROENTEROL, V91, pA456
NR 14
TC 29
Z9 29
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0016-5107
J9 GASTROINTEST ENDOSC
JI Gastrointest. Endosc.
PD MAR
PY 2000
VL 51
IS 3
BP 266
EP 270
DI 10.1016/S0016-5107(00)70353-1
PG 5
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 293LY
UT WOS:000085854400004
PM 10699769
DA 2018-10-19
ER

PT J
AU Boelens, JJ
   Zaat, SAJ
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dankert, J
AF Boelens, JJ
   Zaat, SAJ
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dankert, J
TI Enhanced susceptibility to subcutaneous abscess formation and persistent
   infection around catheters is associated with sustained interleukin-1
   beta levels
SO INFECTION AND IMMUNITY
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; COMPLICATIONS; MODEL
AB A persistent Staphylococcus epidermidis infection in mice around a subcutaneous polyvinypyrrolidone-grafted silicon elastomer catheter (SEpvp) but not around a conventional silicon elastomer catheter was observed. With SEpvp pericatheter tissue, protracted and exaggerated interleukin-1 beta (IL-1 beta) production was found. Apparently, sustained levels of IL-1 beta are associated with enhanced susceptibility to biomaterial-associated S. epidermidis infection.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, J6-S-208, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Bisno AL, 1994, INFECT ASS INDWELLIN
   BOELENS JJ, IN PRESS J ANTIMICRO
   BOELENS JJ, IN PRESS J BIOMED MA
   Cameron D, 1996, J CARDIOVASC PHARM, V27, pS1
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448
   EDLICH RF, 1973, ANN SURG, V177, P679, DOI 10.1097/00000658-197306000-00006
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306
   HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120
   Kanangat S, 1999, INFECT IMMUN, V67, P2834
   LONG JP, 1993, J MED MICROBIOL, V39, P191, DOI 10.1099/00222615-39-3-191
   MARTIN LF, 1991, ARCH SURG-CHICAGO, V126, P1087
   Meduri GU, 1996, EUR RESPIR J, V9, P2650, DOI 10.1183/09031936.96.09122650
   PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820
   SCHINDLER R, 1990, KIDNEY INT, V37, P85, DOI 10.1038/ki.1990.12
   Seifert H., 1997, CATHETER RELATED INF
   TOMFORD JW, 1984, ARCH INTERN MED, V144, P1191, DOI 10.1001/archinte.144.6.1191
NR 19
TC 13
Z9 13
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAR
PY 2000
VL 68
IS 3
BP 1692
EP 1695
DI 10.1128/IAI.68.3.1692-1695.2000
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 285UW
UT WOS:000085407400091
PM 10678990
OA Bronze
DA 2018-10-19
ER

PT J
AU Calvano, CJ
   Moran, ME
   Parekh, A
   Desai, PJ
   Cisek, LJ
AF Calvano, CJ
   Moran, ME
   Parekh, A
   Desai, PJ
   Cisek, LJ
TI Laparoscopic augmentation cystoplasty using the novel biomaterial
   Surgisis (TM): Small-intestinal submucosa
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID ACELLULAR MATRIX GRAFT; BLADDER AUGMENTATION; REGENERATION; DETRUSOR
AB Background and Purpose: Urinary bladder augmentation is indicated for diverse conditions, including neurogenic bladder, cancer resection, spinal cord injury, and congenital anomalies. The ideal cystoplasty material is yet to be described, Native gastrointestinal segments commonly used are limited by leakage and small-bowel obstruction, metabolic/nutritional abnormalities, calculi, and malignancy, This study assessed laparoscopic bladder augmentation with porcine small intestinal submucosa (SIS),
   Materials and Methods: Five female pigs (<25 kg) were prepared for surgery under general anesthesia. After Veress needle insufflation, a main 10-mm trocar was placed in the midline for the laparoscope, with two lateral 10-mm ports added for operative instruments. The bladder dome was incised, and a patch of SIS was sewn into the bladder using running 2-0 Vicryl, Three animals served as technical studies. Two additional sows underwent long-term survival surgery: one undiverted and one diverted via a Stamey suprapubic: catheter,
   Results: There were no operative losses, The mean operative time was 140 minutes, The SIS graft held the sutures without tearing. Laparoscopic survey revealed no urine leaks-at bladder closure, All five animals voided postoperatively, Urinary extravasation was evident in the three undiverted technique animals, In the other two sows, cystoscopy at 7 days showed intact suture lines without evidence of urinary extravasation and with normal vesicular volumes. Tissue growth was evident, but the graft margins were still discernible.
   Conclusions: Laparoscopic bladder augmentation was possible using SIS but at minimal volumes, There were no operative complications; however, the material was difficult to deploy and may benefit from application of an absorbable scaffold. Postoperative urinary drainage is necessary, Further studies will optimize the graft configuration for maximal augmentation.
C1 Albany Med Coll, Div Urol, Albany, NY 12208 USA.
   George Washington Univ, Childrens Natl Med Ctr, Washington, DC USA.
   Harvard Univ, Sch Med, Ctr Minimally Invas Surg, Cambridge, MA 02138 USA.
RP Calvano, CJ (reprint author), 319 S Manning Blvd,Suite 106, Albany, NY 12208 USA.
CR CHOPRA A, 1995, ATLAS UROL CLIN N AM, V3, P81
   DOCIMO SG, 1995, UROLOGY, V46, P565, DOI 10.1016/S0090-4295(99)80275-1
   Duel BP, 1998, J UROLOGY, V159, P998, DOI 10.1016/S0022-5347(01)63820-5
   Fauza DO, 1998, J PEDIATR SURG, V33, P7, DOI 10.1016/S0022-3468(98)90350-5
   FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3
   Frey P, 1996, J UROLOGY, V156, P608, DOI 10.1016/S0022-5347(01)65762-8
   Ikeguchi EF, 1998, J UROLOGY, V159, P1665, DOI 10.1097/00005392-199805000-00086
   KERBL K, 1993, J UROLOGY, V149, P1437, DOI 10.1016/S0022-5347(17)36408-X
   Kirsch AJ, 1996, J UROLOGY, V156, P614, DOI 10.1016/S0022-5347(01)65763-X
   Kronner KM, 1998, J UROLOGY, V160, P1096, DOI 10.1016/S0022-5347(01)62707-1
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Piechota HJ, 1998, BRIT J UROL, V81, P548
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   RINK RC, 1998, CAMPBELLS UROLOGY, P3167
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
NR 19
TC 16
Z9 17
U1 0
U2 4
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD MAR
PY 2000
VL 14
IS 2
BP 213
EP 217
DI 10.1089/end.2000.14.213
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 299YG
UT WOS:000086225600017
PM 10772517
DA 2018-10-19
ER

PT J
AU Boelens, JJ
   van der Poll, T
   Dankert, J
   Zaat, SAJ
AF Boelens, JJ
   van der Poll, T
   Dankert, J
   Zaat, SAJ
TI Interferon-gamma protects against biomaterial-associated Staphylococcus
   epidermidis infection in mice
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID RECEPTOR; GENE
AB Survival of Staphylococcus epidermidis inside macrophages has been recognized as a pivotal process in the pathogenesis of biomaterial-associated infection (BAI). Interferon (IFN)-gamma is a potent activator of macrophages. This study examined whether subcutaneous injections of IFN-gamma can reverse macrophage deactivation induced by implanted biomaterials, Mice received subcutaneous implants combined with an injection of 10(6) S, epidermidis to induce an experimental BAI, Subsequently, 3 groups of mice received subcutaneous injections of 25,000 IU IFN-gamma 3 times weekly, 10,000 IU IFN-gamma 3 times in 2 weeks, or saline 3 times weekly (saline control), respectively. A fourth group received no injections (control), Segments and tissues of the IFN-gamma-treated mice were significantly less (P < .05) culture positive than those of the control groups. Histologically, the high numbers of intracellularly persisting gram-positive cocci observed in the control mice were absent in the IFN-gamma-treated mice. These data indicate that IFN-gamma protects against experimental BAI.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, POB 9600, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Bisno AL, 1994, INFECT ASS INDWELLIN
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   BOELENS JJ, IN PRESS J INFECT DI
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243
   Dellacasagrande J, 1999, J IMMUNOL, V162, P2259
   Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   Kaufmann Stefan H. E., 1993, P1251
   Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602
   Rozalska B, 1998, ZBL BAKT-INT J MED M, V288, P237
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 15
TC 25
Z9 27
U1 0
U2 5
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR
PY 2000
VL 181
IS 3
BP 1167
EP 1171
DI 10.1086/315344
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 302BE
UT WOS:000086344400050
PM 10720548
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, DQ
   Lundberg, F
   Ljungh, A
AF Li, DQ
   Lundberg, F
   Ljungh, A
TI Binding of von Willebrand factor by coagulase-negative staphylococci
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID VONWILLEBRAND-FACTOR; PLASMA-PROTEINS; AUREUS; FIBRONECTIN; VITRONECTIN;
   SURFACE; EXPRESSION; INFECTION; IDENTIFICATION; EPIDERMIDIS
AB Coagulase-negative staphylococci (CNS) are the most common infectious microorganisms isolated from prosthetic devices. To determine whether von Willebrand factor (vWF) acts as an adhesin in bacterial recognition, bacterial binding of recombinant vWF (rvWF) was studied. Eleven CNS strains, belonging to S. epidermidis, S. haemolyticus and S. hominis species, bound soluble rvWF, but to a lesser extent than S. aureus. S. epidermidis strain H2-W bound I-125-labelled rvWF in a dose-dependent manner. The binding could be inhibited by unlabelled rvWF and thrombospondin, but not by fibrinogen, vitronectin or the carbohydrates N-acetylgalactoseamine, D-galactose, D-glucose, and D-fucose. Pre-incubation of rvWF with type I collagen and Arg-Gly-Asp-Ser (RGDS) peptides did not inhibit binding, whereas pre-incubation of rvWF with heparin decreased binding significantly. The interaction between CNS and rvWF was sensitive to proteinase treatment of bacterial cells. CNS strains bound to immobilised rvWF an extent greater or equal to the positive control strain S. aureus Cowan I. rvWF binding structures from bacterial cell wall were detected by immunoblot. Cowan I strain had 140-, 90- and 38-kDa binding molecules. S. haemolyticus strain SM131 and S. epidermidis strain H2-W had two (120 and 60 kDa) and five (120, 90, 60, 52 and 38 kDa) binding molecules, respectively. Similar binding structures were formed when cell wall extracts from these strains were incubated with thrombospondin. These results indicate that specific ligand-receptor interaction between CNS and rvWF may contribute to bacterial adhesion and colonisation on biomaterial surfaces. Heparin-binding domains of rvWF might be the crucial regions for bacterial attachment. rvWF and thrombospondin may recognise similar molecules in staphylococcal cell wall extracts.
C1 Univ Lund, Dept Infect Dis & Med Microbiol, Lund, Sweden.
RP Ljungh, A (reprint author), Univ Lund, Dept Infect Dis & Med Microbiol, Lund, Sweden.
CR BODEN MK, 1989, INFECT IMMUN, V57, P2358
   CHEUNG AL, 1988, INFECT IMMUN, V56, P1061
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   Fischer BE, 1998, BIOCHEM J, V331, P483, DOI 10.1042/bj3310483
   Fischer BE, 1997, CELL MOL LIFE SCI, V53, P943, DOI 10.1007/s000180050115
   FROMAN G, 1987, J BIOL CHEM, V262, P6564
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hell W, 1998, MOL MICROBIOL, V29, P871, DOI 10.1046/j.1365-2958.1998.00983.x
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Herrmann M, 1997, J INFECT DIS, V176, P984, DOI 10.1086/516502
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIANG OD, 1992, INFECT IMMUN, V60, P899
   LIANG OD, 1994, J BIOCHEM-TOKYO, V116, P457, DOI 10.1093/oxfordjournals.jbchem.a124546
   LIANG OD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P57, DOI 10.1016/0925-4439(93)90122-H
   LJUNGH A, 1995, MICROBIOL IMMUNOL, V39, P753, DOI 10.1111/j.1348-0421.1995.tb03267.x
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Ni Eidhin Deirdre, 1998, Molecular Microbiology, V30, P245, DOI 10.1046/j.1365-2958.1998.01050.x
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   Paulsson M, 1990, FEMS Microbiol Immunol, V2, P55
   PAULSSON M, 1992, J CLIN MICROBIOL, V30, P2006
   Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080
   ROALD HE, 1994, BLOOD COAGUL FIBRIN, V5, P355
   RUCHETON M, 1992, CR ACAD SCI III-VIE, V314, P533
   RUGGERI ZM, 1992, THROMB HAEMOSTASIS, V67, P594
   RYDEN C, 1990, J INFECT DIS, V161, P814, DOI 10.1093/infdis/161.4.814
   SADLER JE, 1991, J BIOL CHEM, V266, P22777
   SPEZIALE P, 1985, ZENTRALBL BAKTERIO S, V14, P191
   SWITALSKI LM, 1983, INFECT IMMUN, V42, P628
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TUDDENHAM EGD, 1982, BRIT J HAEMATOL, V52, P259, DOI 10.1111/j.1365-2141.1982.tb03888.x
   Wade D, 1998, BIOCHEM BIOPH RES CO, V248, P690, DOI 10.1006/bbrc.1998.9028
   Wadstrom T., 1990, MICROBIAL CELL SURFA, P315
   WEISS HJ, 1991, ANN NY ACAD SCI, V614, P125, DOI 10.1111/j.1749-6632.1991.tb43698.x
   YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281
   ZARDI L, 1980, J IMMUNOL METHODS, V34, P155, DOI 10.1016/0022-1759(80)90169-6
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 37
TC 8
Z9 8
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD MAR
PY 2000
VL 49
IS 3
BP 217
EP 225
DI 10.1099/0022-1317-49-3-217
PG 9
WC Microbiology
SC Microbiology
GA 287EX
UT WOS:000085494500003
PM 10707941
OA Bronze
DA 2018-10-19
ER

PT J
AU Kwon, SY
   Takei, H
   Pioletti, DP
   Lin, T
   Ma, QJ
   Akeson, WH
   Wood, DJ
   Sung, KLP
AF Kwon, SY
   Takei, H
   Pioletti, DP
   Lin, T
   Ma, QJ
   Akeson, WH
   Wood, DJ
   Sung, KLP
TI Titanium particles inhibit osteoblast adhesion to fibronectin-coated
   substrates
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID POROUS POLYESTERURETHANE FOAM; DEGRADATION PRODUCTS; LIGAMENT
   FIBROBLASTS; MACROPHAGES; POLYETHYLENE; ADHESIVENESS; BIOMATERIAL; BONE;
   CELL; WEAR
AB To illuminate the effect of titanium particles on osteoblast function, we compared the adhesion force of neonatal rat calvarial osteoblasts on fibronectin-coated glass after incubation with titanium particles (80% had diameters of less than 5 mu m). The cells were incubated with the particles for 1.5-72 hours. Using a micropipette single-cell manipulation system, we showed that the adhesion force of the osteoblasts to fibronectin-coated glass (1.0 mu g/ml) was significantly affected by the presence of particulate debris. The adhesion force of the cells incubated with titanium particles for less than 3 hours was not significantly affected by exposure to the particles; after 4 hours, however, it was significantly reduced relative to that of controls. Aspiration of particle-challenged osteoblasts into the micropipette demonstrated that the particles were not stripped from the cell surface and therefore confirmed that the osteoblasts had ingested them. During aspiration, the particles traveled through the cytoplasm rather than on the cell surface. When the osteoblasts were exposed to the particles and cytochalasin D, they exhibited much lower adhesion forces than did the controls or the cells exposed to titanium particles only; this indicates an important role of actin filaments in the osteoblastic response to particles. Staining for F-actin also indicated an influence of internalized titanium particulate on cytoskeletal arrangement and cell spreading. Furthermore, with standard Northern blotting techniques, levels of mRNA for collagen type I and fibronectin were significantly reduced as early as 4 hours after exposure to particles compared with levels in controls, and this effect continued to 72 hours. These data indicate that direct exposure of osteoblasts to titanium particles, which we propose to be ingested by the osteoblasts, can significantly decrease osteoblast adhesion force; this may lead to decreased cellular activity and gene expression of fibronectin and collagen type I in the presence of titanium wear debris.
C1 Univ Calif San Diego, Dept Orthopaed, La Jolla, CA 92093 USA.
   Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   Univ Calif San Diego, Inst Biomed Engn, La Jolla, CA 92093 USA.
RP Sung, KLP (reprint author), Univ Calif San Diego, Dept Orthopaed, 0412,9500 Gilman Dr, La Jolla, CA 92093 USA.
RI Pioletti, Dominique/C-5697-2008
OI Pioletti, Dominique/0000-0001-5535-5296
FU NIAMS NIH HHS [AR14915]
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   ESCALAS F, 1976, J BIOMED MATER RES, V10, P175, DOI 10.1002/jbm.820100203
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P517, DOI 10.1002/jbm.820240408
   Goodman SB, 1996, BIOMATERIALS, V17, P1943, DOI 10.1016/0142-9612(96)00013-0
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   JACOBS EJ, 1998, T SOC BIOMATER, V24, P56
   JASTY M, 1992, Current Opinion in Rheumatology, V4, P204, DOI 10.1097/00002281-199204000-00012
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MCKELLOP HA, 1990, J BONE JOINT SURG AM, V72A, P512, DOI 10.2106/00004623-199072040-00007
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, P175
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   POLLICE PF, 1995, J ORTHOPAED RES, V13, P325, DOI 10.1002/jor.1100130305
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Sabokbar A, 1998, ARCH ORTHOP TRAUM SU, V117, P136, DOI 10.1007/s004020050213
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426
   Sung KLP, 1996, J ORTHOP RES, V14, P729, DOI 10.1002/jor.1100140508
   SUNG KLP, 1995, J ORTHOP RES, V13, P166, DOI 10.1002/jor.1100130204
   Sung KLP, 1996, P NATL ACAD SCI USA, V93, P9182, DOI 10.1073/pnas.93.17.9182
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Wirganowicz PZ, 1997, CLIN ORTHOP RELAT R, P100
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
NR 38
TC 19
Z9 22
U1 0
U2 2
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD MAR
PY 2000
VL 18
IS 2
BP 203
EP 211
DI 10.1002/jor.1100180207
PG 9
WC Orthopedics
SC Orthopedics
GA 312NK
UT WOS:000086949200006
PM 10815820
DA 2018-10-19
ER

PT J
AU Pan, J
   Karlen, C
   Ulfvin, C
AF Pan, J
   Karlen, C
   Ulfvin, C
TI Electrochemical study of resistance to localized corrosion of stainless
   steels for biomaterial applications
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID OSTEOSYNTHESIS DEVICES; CREVICE CORROSION; NITROGEN; PASSIVATION; FILMS
AB Sandvik Bioline High-N and 316 LVM are two austenitic stainless steels especially developed for biomaterial applications. Their resistance to localized corrosion was investigated by electrochemical methods including cyclic potentiodynamic polarization and potentiostatic polarization measurements in a phosphate-buffered saline solution and in a simulated crevice solution, i.e., designed for crevice corrosion testing. Sandvik SAF 2507 (a high-performance super duplex stainless steel) was included in the tests as a reference material. High-N, higher alloyed than 316 LVM, demonstrated excellent resistance to pitting initiation and a strong tendency to repassivation. High-N proved to have an equivalent or even higher resistance to localized corrosion than SAF 2507. The latter is known for its impressive corrosion properties, particularly in chloride containing environments. While 316 LVM may run the risk of crevice corrosion in implant applications, the risk seems negligible for High-N. In view of the fact that also the mechanical properties are superior to those of 316 LVM, High-N is a very attractive implant material. (C) 2000 The Electrochemical Society. S0013-4651(99)105-087-9. All rights reserved.
C1 Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.
   AB Sandvik Steel, Prot Res, SE-81181 Sandviken, Sweden.
RP Pan, J (reprint author), Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.
CR Andrews K., 1968, INTERPRETATION ELECT
   Baroux Bernard, 1995, CORROSION MECH THEOR, P265
   BLACK J, 1994, COMPATIBILITY BIOMED, P35
   CIGADA A, 1989, J BIOMED MATER RES, V23, P1087, DOI 10.1002/jbm.820230908
   CLAYTON CR, 1995, MAT SCI ENG A-STRUCT, V198, P135, DOI 10.1016/0921-5093(95)80068-6
   CLAYTON CR, 1995, CORROSION MECH THEOR, P175
   Fraker A. C., 1987, METALS HDB, V13, P1324
   GREENE ND, 1985, CORROSION DEGRADATIO, V859, P5
   Halada GP, 1996, CORROSION, V52, P36, DOI 10.5006/1.3292093
   *INT ORG STAND, 1992, 58329 ISO
   *INT ORG STAND, 1992, 58321 ISO
   JONES DA, 1992, PRINCIPLES PREVENTIO, P198
   KOHN DH, 1992, MAT SCI TECHNOLOGY, V14, P29
   Kruger J., 1979, ASTM SPEC TECH PUBL, P107
   MATTSSON E, 1978, BRIT CORROS J, V13, P5, DOI 10.1179/000705978798358626
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   NILSSON JO, 1992, MATER SCI TECH SER, V8, P685, DOI 10.1179/mst.1992.8.8.685
   OLDFIELD JW, 1978, BRIT CORROS J, V13, P104, DOI 10.1179/000705978798276258
   OLDFIELD JW, 1978, BRIT CORROS J, V13, P13, DOI 10.1179/000705978798358671
   Olefjord I, 1996, CORROS SCI, V38, P1203, DOI 10.1016/0010-938X(96)00018-2
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Shreir L.L., 1994, CORROSION, V1, P2
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   Wegrelius L, 1995, MATER SCI FORUM, V185-, P347, DOI 10.4028/www.scientific.net/MSF.185-188.347
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
NR 25
TC 45
Z9 46
U1 0
U2 24
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PD MAR
PY 2000
VL 147
IS 3
BP 1021
EP 1025
DI 10.1149/1.1393307
PG 5
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 294LL
UT WOS:000085912700032
DA 2018-10-19
ER

PT J
AU Ryhanen, J
AF Ryhanen, J
TI Biocompatibility of Nitinol
SO MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
LA English
DT Article
DE Nitinol; NiTi; biocompatibility; toxicity; cancer
ID SHAPE-MEMORY ALLOY; NICKEL SENSITIVITY; IN-VITRO; TITANIUM; IMPLANTS;
   TISSUE; STENTS; METAL; PLACEMENT; RESPONSES
AB This review links together recent information on the biocompatibility of Nitinol. Fundamental aspects of biological responses to Nitinol and its alloy components are clarified. The clinical advantages of using this functional biomaterial are evident. Although most studies support the good biocompatibility of Nitinol, there are still a lot of unanswered questions. The long-term in vivo performance of this material has not been well demonstrated, and host-Nitinol interactions at cell and molecular level are mostly unknown. However, the experimental and clinical data strongly support Nitinol as a safe biomaterial, at least as good as stainless steel or titanium alloys.
C1 Univ Oulu, Cent Hosp, Dept Surg, FIN-90220 Oulu, Finland.
RP Ryhanen, J (reprint author), Univ Oulu, Cent Hosp, Dept Surg, Kajaanintie 52 A, FIN-90220 Oulu, Finland.
CR Andreasen G.F., 1987, ENCY MED DEVICES INS, P15
   Anke M., 1984, IARC SCI PUBL, V53, P339
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   BARNETSON R, 1993, IMMUNOLOGY
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BJURHOLM A, 1990, ACTA ORTHOP SCAND, V61, P248, DOI 10.3109/17453679008993510
   Blum U, 1997, J ENDOVASC SURG, V4, P137, DOI 10.1583/1074-6218(1997)004<0137:TCGEWA>2.0.CO;2
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CHRISTENSEN OB, 1990, DERMATOL CLIN, V8, P37, DOI 10.1016/S0733-8635(18)30518-7
   CRAGG A, 1983, RADIOLOGY, V147, P261, DOI 10.1148/radiology.147.1.6828742
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   Dai KR, 1996, BIO-MED MATER ENG, V6, P233
   DRUGACZ J, 1995, J ORAL MAXIL SURG, V53, P665, DOI 10.1016/0278-2391(95)90166-3
   Endo K, 1994, Dent Mater J, V13, P228
   GAWKRODGER DJ, 1993, CONTACT DERMATITIS, V28, P257, DOI 10.1111/j.1600-0536.1993.tb03427.x
   Gerber H, 1980, EVALUATION BIOMATERI, P307
   GRENADIER E, 1994, AM HEART J, V128, P870, DOI 10.1016/0002-8703(94)90582-7
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HARTWIG A, 1994, TOXICOL LETT, V72, P353, DOI 10.1016/0378-4274(94)90048-5
   Hayoz D, 1997, J ENDOVASC SURG, V4, P354, DOI 10.1583/1074-6218(1997)004<0354:AIRAWE>2.0.CO;2
   Ishii Norihisa, 1993, Journal of Dermatological Science, V6, P159, DOI 10.1016/0923-1811(93)90007-C
   Itro A, 1997, Minerva Stomatol, V46, P381
   KASEMO B, 1991, BONE BIOMATERIAL INT, V2, P19
   Kellner W, 1997, RADIOLOGY, V202, P327, DOI 10.1148/radiology.202.2.9015051
   KLEIN CB, 1991, SCIENCE, V251, P796, DOI 10.1126/science.1990442
   KLEIN CB, 1991, CHEM RES TOXICOL, V4, P592, DOI 10.1021/tx00024a001
   KRUGER J, 1983, BIOMATERIALS RECONST, P145
   Kuo P P, 1989, Orthopedics, V12, P111
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   MATSUMOTO K, 1993, J JPN ORTHOP ASSOC, V67, P267
   Milavec-Puretic V, 1998, ARCH ORTHOP TRAUM SU, V117, P383, DOI 10.1007/s004020050272
   Musialek J, 1998, ARCH ORTHOP TRAUM SU, V117, P341, DOI 10.1007/s004020050262
   Oller AR, 1997, TOXICOL APPL PHARM, V143, P152, DOI 10.1006/taap.1996.8075
   OSHIDA Y, 1992, Bio-Medical Materials and Engineering, V2, P51
   PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x
   PFEIFFER KM, 1994, INJURY, V25, P87, DOI 10.1016/0020-1383(94)90108-2
   POEHLER OEM, 1983, BIOMATERIALS RECONST, P158
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   RABKIN D I, 1986, Meditsinskaya Radiologiya, V31, P55
   Rechavia E, 1998, CATHETER CARDIO DIAG, V45, P202, DOI 10.1002/(SICI)1097-0304(199810)45:2<202::AID-CCD20>3.0.CO;2-L
   ROCK M, 1998, HDB BIOMATERIAL PROP, V5, P529
   RYAHANEN J, 1999, J BIOMED MATER RES, V47, P472
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   RYHANEN J, 1998, 7 INT C SURG SHOULD, P292
   SALISSOGLIO G, 1989, Z ORTHOP, V127, P191
   Schurmann K, 1997, RADIOLOGY, V204, P757, DOI 10.1148/radiology.204.3.9280255
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Sheth S, 1996, CIRCULATION, V94, P1733, DOI 10.1161/01.CIR.94.7.1733
   Silberstein B., 1997, SHAPE MEMORY SUPEREL, P617
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   SUTTON CS, 1988, AM J ROENTGENOL, V151, P597, DOI 10.2214/ajr.151.3.597
   Sysolyatin P. G., 1994, SHAPE MEMORY SUPEREL, P470
   SZILAGYI M, 1991, ACTA VET HUNG, V39, P231
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   TOTH RW, 1985, J PROSTHET DENT, V54, P564, DOI 10.1016/0022-3913(85)90435-4
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   TRIGWELL S, 1997, SHAPE MEMORY SUPEREL, P383
   VANHOOGSTRATEN IMW, 1992, J INVEST DERMATOL, V99, P608, DOI 10.1111/1523-1747.ep12668010
   WAKHLOO AK, 1994, AM J NEURORADIOL, V15, P493
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
   WEAVER DJ, 1997, BIOMATERIALS, V18, P1115
   WILLIAMS DF, 1992, 2 C DEF BIOM, P525
   YANG PJ, 1987, CHINESE MED J-PEKING, V100, P712
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 73
TC 32
Z9 35
U1 0
U2 14
PU ISIS MEDICAL MEDIA LTD
PI OXFORD
PA 59 ST ALDATES, OXFORD OX1 1ST, ENGLAND
SN 1364-5706
J9 MINIM INVASIV THER
JI Minim. Invasive Ther. Allied Technol.
PD MAR
PY 2000
VL 9
IS 2
BP 99
EP 105
DI 10.3109/13645700009063056
PG 7
WC Surgery
SC Surgery
GA 319RJ
UT WOS:000087355400008
DA 2018-10-19
ER

PT J
AU Cho, YW
   Han, SS
   Ko, SW
AF Cho, YW
   Han, SS
   Ko, SW
TI PVA containing chito-oligosaccharide side chain
SO POLYMER
LA English
DT Article
DE poly(vinyl alcohol); chito-oligosaccharide; N-methylolacrylamide
ID N-ACETYLATED CHITOSAN; POLY(VINYL ALCOHOL); CROSS-LINKING; NITROUS-ACID;
   CELLULOSE; BLEND; PERMEABILITY; SOLUBILITY; MEMBRANES; HYDROGEL
AB A chito-oligosaccharide (COS) with the number average degree of polymerization (DPn) of 9 was immobilized on poly(vinyl alcohol) (PVA) by crosslinking with a bifunctional compound, N-methylolacrylamide (NMA). The reaction was composed of two successive steps, the reaction of COS with NMA in an acidic medium in the first step and the reaction of the COS-NMA with PVA in an alkaline medium in the second step. The reaction products were characterized by H-1 NMR, differential scanning calorimetry (DSC), and X-ray diffractometry. The relative crystallinity of PVA containing COS side chain (PC) was found to be lower than that of PVA due to the bulky and rigid COS backbones. The tensile modulus of PC film was lower than that of PVA him, but its tensile strength was higher. The antimicrobial activity of PC was excellent in spite of its low COS content. The PC is considered to be a good candidate for a new biomaterial having various functional properties of chitosan coupled with good mechanical properties of PVA. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Seoul Natl Univ, Dept Fiber & Polymer Sci, Seoul 151742, South Korea.
   Yeungnam Univ, Sch Text, Kyongsan 712749, South Korea.
RP Ko, SW (reprint author), Seoul Natl Univ, Dept Fiber & Polymer Sci, Seoul 151742, South Korea.
CR ALLAN CR, 1979, EXP MYCOL, V3, P285, DOI 10.1016/S0147-5975(79)80054-7
   CHANDY T, 1992, J APPL POLYM SCI, V44, P2145, DOI 10.1002/app.1992.070441210
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   FEIT BA, 1963, J ORG CHEM, V28, P406, DOI 10.1021/jo01037a031
   FESSENDEN RJ, 1990, ORGANIC CHEM, V4, P719
   GARDON JL, 1961, J APPL POLYM SCI, V5, P734
   Guibal E, 1999, INT J BIOL MACROMOL, V24, P49, DOI 10.1016/S0141-8130(98)00067-1
   HASEGAWA M, 1992, J APPL POLYM SCI, V45, P1857, DOI 10.1002/app.1992.070451020
   HASEGAWA M, 1994, POLYMER, V35, P983, DOI 10.1016/0032-3861(94)90942-3
   HASEGAWA M, 1992, J APPL POLYM SCI, V45, P1873, DOI 10.1002/app.1992.070451101
   HASHEM MM, 1995, ANGEW MAKROMOL CHEM, V230, P189, DOI 10.1002/apmc.1995.052300114
   HIRANO S, 1985, CARBOHYD RES, V144, P338, DOI 10.1016/S0008-6215(00)90682-7
   HORIIKE S, 1995, J APPL POLYM SCI, V58, P1335, DOI 10.1002/app.1995.070580815
   HORTON D, 1973, CARBOHYD RES, V30, P367, DOI 10.1016/S0008-6215(00)81823-6
   IBRAHIM NA, 1993, J APPL POLYM SCI, V49, P291, DOI 10.1002/app.1993.070490210
   KAMEL M, 1973, J APPL POLYM SCI, V17, P2725, DOI 10.1002/app.1973.070170909
   KAMEL M, 1975, TEXT RES J, V45, P131, DOI 10.1177/004051757504500208
   KENDRA DF, 1984, EXP MYCOL, V8, P276, DOI 10.1016/0147-5975(84)90013-6
   Kubota N, 1997, POLYM J, V29, P123, DOI 10.1295/polymj.29.123
   Lee YM, 1996, POLYMER, V37, P5897, DOI 10.1016/S0032-3861(96)00449-1
   LIM HH, 1997, J KOREAN FIBER SOC, V34, P444
   LLANOS GR, 1991, MACROMOLECULES, V24, P6065, DOI 10.1021/ma00023a003
   Martinou A, 1998, CARBOHYD RES, V311, P71, DOI 10.1016/S0008-6215(98)00183-9
   MASUDA M, 1991, POLYVINYL ALCOHOL DE, P403
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   MIYA M, 1984, J POLYM SCI POL PHYS, V22, P1149, DOI 10.1002/pol.1984.180220615
   NAKATSUKA S, 1992, J APPL POLYM SCI, V44, P17, DOI 10.1002/app.1992.070440103
   NISHIO Y, 1988, MACROMOLECULES, V21, P1270, DOI 10.1021/ma00183a016
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   PETER MG, 1995, J MACROMOL SCI PURE, VA32, P629, DOI 10.1080/10601329508010276
   PETERSEN H, 1971, CHEM AFTERTREATMENT, P174
   QUCHI T, 1989, MAKROMOL CHEM, V190, P1817
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SAKURADA I, 1985, POLYVINYL ALCOHOL FI, P3
   SANNAN T, 1976, MAKROMOL CHEM, V177, P3589
   SEO H, 1992, ADVANCES IN CHITIN AND CHITOSAN, P34
   YANG NC, 1997, J KOREAN FIBER SOC, V34, P10
NR 37
TC 33
Z9 36
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD MAR
PY 2000
VL 41
IS 6
BP 2033
EP 2039
DI 10.1016/S0032-3861(99)00351-1
PG 7
WC Polymer Science
SC Polymer Science
GA 271TB
UT WOS:000084608600008
DA 2018-10-19
ER

PT J
AU Lheureux, D
   Saied, A
   Werner, L
   Legeais, JM
   Berger, G
AF Lheureux, D
   Saied, A
   Werner, L
   Legeais, JM
   Berger, G
TI High-frequency ultrasound characterization of microporous biointegrable
   polymers in cornea using acoustic parameters
SO ULTRASONICS
LA English
DT Article; Proceedings Paper
CT 1st Joint Meeting Ultrasonics International Conference/World Congress on
   Ultrasonics (UI 99/WCU 99)
CY JUN 29-JUL 01, 1999
CL TECH UNIV DENMARK, LYNGBY, DENMARK
SP Tech Univ Denmark
HO TECH UNIV DENMARK
DE artificial cornea; attenuation coefficient; cells; collagen;
   high-frequency ultrasound; histology; integrated backscatter;
   keratoprosthesis; polymer
ID ATTENUATION; TISSUE
AB The current work deals with the use of high-frequency quantitative backscatter acoustic microscopy for the evaluation of the biointegration of microporous polymer implants used as support of artificial cornea. A three-dimensional (3-D) 80 MHz ultrasound microscope (25 mu m axial resolution at focus) was used for the imaging and characterization of the progressive biointegration of polymers implanted in rabbit cornea. In-vitro and in-vivo studies were performed. Quantitative assessment of the structural changes in the biomaterial was performed using the spectral analysis of the radio frequency signal and the estimation of acoustic parameters in the 10-65 MHz frequency bandwidth. Correlation of in-vitro ultrasound data with histologic findings has shown that attenuation and backscatter coefficients are sensitive to the changes in the polymer pore content with time. Our results obtained in vivo demonstrated that 3-D 80 MHz echography coupled with quantitative characterization provide a unique tool for the non-invasive and objective follow-up of the implant biointegration and should contribute to clinical management of artificial cornea. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Paris 06, CNRS UMR 7623, Lab Imagerie Paramet, F-75006 Paris, France.
   Hop Hotel Dieu, Dept Ophthalmol, F-75004 Paris, France.
RP Saied, A (reprint author), Univ Paris 06, CNRS UMR 7623, Lab Imagerie Paramet, 15 Rue Ecole Med, F-75006 Paris, France.
CR ALLEMANN N, 1993, OPHTHALMOLOGY, V100, P1351
   Aslanides Ioannis M., 1995, CLAO Journal, V21, P268
   KUK R, 1984, IEEE T ACOUST SPEECH, V32, P2
   LEGEAIS JM, 1994, EXP EYE RES, V58, P41, DOI 10.1006/exer.1994.1193
   MORAN CM, 1995, ULTRASOUND MED BIOL, V21, P1177, DOI 10.1016/0301-5629(95)00049-6
   ODONNELL M, 1979, J ACOUST SOC AM, V65, P512, DOI 10.1121/1.382352
   PAVLIN CJ, 1991, OPHTHALMOLOGY, V98, P287
   ROONEY JA, 1982, J ACOUST SOC AM, V71, P462, DOI 10.1121/1.387468
   SAIED A, 1995, IEEE ULTRASONICS S, P1299
   SAIED A, 1997, IEEE ULTRASONICS S P, P1093
   SILVERMAN RH, 1995, OPHTHALMOLOGY, V102, P837, DOI 10.1016/S0161-6420(95)30948-7
   URSEA R, 1998, OPHTHALMOLOGY, V105, P908
   YE SG, 1995, IEEE T ULTRASON FERR, V42, P8, DOI 10.1109/58.368319
NR 13
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0041-624X
J9 ULTRASONICS
JI Ultrasonics
PD MAR
PY 2000
VL 38
IS 1-8
BP 391
EP 395
DI 10.1016/S0041-624X(99)00136-5
PG 5
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 307PQ
UT WOS:000086662100078
PM 10829694
DA 2018-10-19
ER

PT J
AU Wan, YZ
   Wang, YL
   Yao, KD
   Cheng, GX
AF Wan, YZ
   Wang, YL
   Yao, KD
   Cheng, GX
TI Carbon fiber-reinforced gelatin composites. II. Swelling behavior
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE gelatin; carbon fiber; composite; swelling behavior
ID CROSS-LINKED GELATIN; TRANSITION-TEMPERATURES; MECHANICAL-PROPERTIES;
   ORIENTED GELATIN; GELS; FILMS
AB Carbon fiber-reinforced gelatin composites have been prepared in our laboratory to obtain a navel biomaterial of improved mechanical properties. The swelling behavior (swelling rate, swelling kinetics, maximum solvent uptake, etc.) for both continuous carbon fiber-reinforced gelatin composite (C-L/Gel) and short carbon fiber-reinforced gelatin composite (C-S/Gel) are investigated. Experimental data show that the swelling process of the original gelatin and gelatin matrixes in both composites follows a second-order kinetics. The swelling of the gelatin matrixes in both composites proceeds slower than that of the pristine gelatin, and depends on fiber form and fiber volume fraction (Vf). Results indicate that the presence of carbon fibers suppresses the swelling of the gelatin matrixes in both composites. It is found that the gelatin matrix in C-S/Gel possesses a smaller swelling rate and maximum solvent uptake than that in C-L/Gel. A mechanism governing these phenomena is discussed in this article. (C) 2000 John Wiley & Sons, Inc.
C1 Tianjin Univ, Coll Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Wan, YZ (reprint author), Tianjin Univ, Coll Mat Sci & Engn, Tianjin 300072, Peoples R China.
CR Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Fakirov S, 1997, COLLOID POLYM SCI, V275, P307, DOI 10.1007/s003960050087
   Fakirov S, 1996, COLLOID POLYM SCI, V274, P334, DOI 10.1007/BF00654053
   FISCHER KLK, 1998, J APPL POLYM SCI, V68, P281
   JOPLING DW, 1956, J APPL CHEM-USSR, V6, P79
   Katime I, 1996, POLYM INT, V40, P281
   Klepko VV, 1995, POLYMER, V36, P5057, DOI 10.1016/0032-3861(96)81636-3
   KOUR H, 1990, MACROMOLECULES, V23, P4868
   Lin FH, 1998, BIOMATERIALS, V19, P905, DOI 10.1016/S0142-9612(97)00202-0
   Maeda T, 1996, KOBUNSHI RONBUNSHU, V53, P155, DOI 10.1295/koron.53.155
   OFNER CM, 1986, J PHARM SCI, V75, P790, DOI 10.1002/jps.2600750814
   ROBINSON ID, 1964, PHOTOGR SCI ENG, V8, P220
   SHAH CB, 1992, J APPL POLYM SCI, V45, P293, DOI 10.1002/app.1992.070450211
   WAN YZ, IN PRESS J APPL POLY
   XIE WB, 1991, J MEMBRANE SCI, V64, P113, DOI 10.1016/0376-7388(91)80082-H
   Zhao WY, 1996, CHEMTECH, V26, P32
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
NR 17
TC 18
Z9 18
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 22
PY 2000
VL 75
IS 8
BP 994
EP 998
DI 10.1002/(SICI)1097-4628(20000222)75:8<994::AID-APP3>3.0.CO;2-7
PG 5
WC Polymer Science
SC Polymer Science
GA 270UD
UT WOS:000084554700003
DA 2018-10-19
ER

PT J
AU Martin, MA
   Miguens, FC
   Rieumont, J
   Sanchez, R
AF Martin, MA
   Miguens, FC
   Rieumont, J
   Sanchez, R
TI Tailoring of the external and internal morphology of poly-3-hydroxy
   butyrate microparticles
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE follicle stimulating hormone; microcapsules; microparticles; morphology;
   poly-3-hydroxybutyrate
ID BIODEGRADABLE MEDICAL DEVICES; DOUBLE EMULSION-EVAPORATION;
   MICROCAPSULES; MICROSPHERES; STABILITY; RELEASE;
   POLY(HYDROXYBUTYRATE-HYDROXYVALERATE); MICROENCAPSULATION; PROGESTERONE;
   POLYMERS
AB Some microencapsulation procedures such as oil-in-water (o/w) and water-in-oil-in-water (w/o/w) emulsions were selected in an attempt to produce tailored poly-3-hydroxybutyrate (PHB) microparticles. The effects of several processing parameters such as polymer precipitation, surfactant, solvent, stirring and solvent evaporation rates were also considered. As a rule, low stirring rates at 500 rpm yielded particles ranging between 100 to 250 mu m and at rates over 8000 rpm, diameters around 5-10 mu m. The surfaces of the bigger particles, observed by scanning electron microscopy (SEM), were rough and the smaller ones were even rougher, irregular, cauliflower like. The extraction of the chloroform under low pressure or to the open atmosphere did not produce any appreciable change in the morphology for either type of particle. Transmission electron microscopy (TEM) micrographs suggest that microparticles obtained by o/w emulsions are monolithics but those obtained by w/o/w emulsions are of capsule-like structure. Microencapsulation of a peptide material such as follicle stimulating hormone was carried out with success using a double emulsion technique. This biomaterial, dissolved in the inner aqueous phase, was able to stabilize the primary emulsion without using a surfactant. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 State Univ N Fluminense, Ctr Sci & Technol, BR-2000 Horto, Brazil.
   Fed Univ Rio de Janeiro, Biophys Inst Carlos Chagas, Rio De Janeiro, Brazil.
   Univ Havana, Fac Chem, Havana, Cuba.
RI Sanchez Rodriguez, Ruben Jesus/F-5999-2010
OI Sanchez Rodriguez, Ruben Jesus/0000-0002-1434-5144
CR Atkins TW, 1997, BIOMATERIALS, V18, P173, DOI 10.1016/S0142-9612(96)00111-1
   COURTEILLE F, 1994, J CONTROL RELEASE, V30, P17, DOI 10.1016/0168-3659(94)90040-X
   Doi Y., 1990, MICROBIAL POLYESTERS
   EMBLETON JK, 1993, J MICROENCAPSUL, V10, P341, DOI 10.3109/02652049309031524
   EMBLETON JK, 1992, J MICROENCAPSUL, V9, P73, DOI 10.3109/02652049209021225
   GANGRADE N, 1991, J MICROENCAPSUL, V8, P185, DOI 10.3109/02652049109071487
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   NIHANT N, 1994, PHARMACEUT RES, V11, P1479, DOI 10.1023/A:1018912426983
   NIHANT N, 1995, J COLLOID INTERF SCI, V173, P55, DOI 10.1006/jcis.1995.1296
   Ottenbrite RM, 1996, MACROMOL SYMP, V101, P379, DOI 10.1002/masy.19961010143
   Richards JH, 1986, POLYM PERMEABILITY, P217
   SCHUGENS C, 1994, J CONTROL RELEASE, V32, P161, DOI 10.1016/0168-3659(94)90055-8
   TICE T R, 1985, Journal of Controlled Release, V2, P343, DOI 10.1016/0168-3659(85)90056-2
   VACHON MG, 1995, J MICROENCAPSUL, V12, P287, DOI 10.3109/02652049509010297
NR 15
TC 15
Z9 16
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 15
PY 2000
VL 17
IS 2
BP 111
EP 116
DI 10.1016/S0927-7765(99)00087-9
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 271ZH
UT WOS:000084625200005
DA 2018-10-19
ER

PT J
AU Poelstra, KA
   Barekzi, NA
   Grainger, DW
   Gristina, AG
   Schuler, TC
AF Poelstra, KA
   Barekzi, NA
   Grainger, DW
   Gristina, AG
   Schuler, TC
TI A novel spinal implant infection model in rabbits
SO SPINE
LA English
DT Article
DE animal model; biofilm; biomaterial; infection; methicillin resistant
   Staphylococcus aureus; orthopedic; rabbit
ID POSTOPERATIVE INFECTIONS; INSTRUMENTATION; SURGERY
AB Study Design. A new spinal implant model was designed to study device-centered infection with methicillin- resistant Staphylococcus aureus in multiple noncontiguous surgical sites in the lumbar spine region of a rabbit.
   Objective. To develop a multiple-site spinal implant device-centered infection model in rabbits.
   Summary of Background Data. Results in many recent studies show that postoperative wound infection after spinal implant surgery and the increase in antibiotic-resistant bacteria are a concern. Anti-infection strategies must be tested in relevant animal models that will lead to appropriate clinical studies.
   Methods. Eight anesthetized New Zealand White rab bits underwent completely isolated partial laminectomy and subsequent stainless steel Kirschner wire implantation directly into the transverse processes of vertebrae T13, L3, and L6. The middle sites (L3) were used as sterile; control sites, and the outer sites (T13, L6) were challenged with different amounts of methicillin-resistant Staphylococcus aureus, Rabbits were killed after 7 days, and biopsies were performed to provide evidence for device-centrered-infection. Bacterial growth on the implant surfaces and in surrounding tissues and bone was assayed.
   Results. Overall device-centered infection was established after 7 days in 100% of the sites challenged with 10(3) colony-forming units methicillin-resistant Staphylococcus aureus or higher. No infection was seen in any of the control sites located between infected vertebrae. Multiple blood and liver samples showed that the separate localized infections did not become systemic after 7 days.
   Conclusions. This new animal model demonstrates that multiple biomaterial implants can be evaluated in the same animal and provides a technique for investigating postoperative device-centered infection of the spine. In infection was demonstrated in noncontiguous lumbar sites of the spine, whereas adjacent control sites remained sterile. Because there was no cross contamination or systemic spread of the infection, multiple anti-infection strategies or implant materials can now be tested for efficacy in a single animal to combat dramatic and costly postoperative implant infections.
C1 Anthony G Gristina Inst Biomed Res, Herndon, VA USA.
   Virginia Spine Inst, Reston, VA USA.
   Gamma A Technol, Herndon, VA USA.
RP Poelstra, KA (reprint author), Univ Virginia, Hlth Sci Ctr, Dept Orthoped, Box 159, Charlottesville, VA 22908 USA.
CR Andreshak TG, 1997, J SPINAL DISORD, V10, P376
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Belmatoug N, 1996, J INFECT DIS, V174, P414, DOI 10.1093/infdis/174.2.414
   Calderone RR, 1996, ORTHOP CLIN N AM, V27, P171
   Eerenberg J P, 1994, J Invest Surg, V7, P453, DOI 10.3109/08941939409016511
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   Glassman SD, 1996, SPINE, V21, P2163, DOI 10.1097/00007632-199609150-00021
   Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907
   GRIFFITHS HJ, 1995, RADIOL CLIN N AM, V33, P401
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HEGGENESS MH, 1993, SPINE, V18, P492
   KAYVANFAR JF, 1995, AAAOS, V388, P253
   Keller R B, 1972, Orthop Clin North Am, V3, P99
   Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975
   LONSTEIN J, 1973, CLIN ORTHOP RELAT R, P222
   MASSIE JB, 1992, CLIN ORTHOP RELAT R, P99
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   SCHWAB FJ, 1995, SPINE, V20, P2023, DOI 10.1097/00007632-199509150-00014
   Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895
   Sheridan R L, 1994, Adv Surg, V27, P43
   TAMBORNINO JM, 1964, J BONE JOINT SURG AM, V46, P313, DOI 10.2106/00004623-196446020-00007
   Tenover FC, 1996, JAMA-J AM MED ASSOC, V275, P300, DOI 10.1001/jama.275.4.300
   THALGOTT JS, 1991, SPINE, V16, P981, DOI 10.1097/00007632-199108000-00020
   Theiss SM, 1996, ORTHOP CLIN N AM, V27, P105
NR 25
TC 28
Z9 29
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD FEB 15
PY 2000
VL 25
IS 4
BP 406
EP 410
DI 10.1097/00007632-200002150-00003
PG 5
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 286ZD
UT WOS:000085478000002
PM 10707383
DA 2018-10-19
ER

PT J
AU Seidel, A
   Liivak, O
   Calve, S
   Adaska, J
   Ji, GD
   Yang, ZT
   Grubb, D
   Zax, DB
   Jelinski, LW
AF Seidel, A
   Liivak, O
   Calve, S
   Adaska, J
   Ji, GD
   Yang, ZT
   Grubb, D
   Zax, DB
   Jelinski, LW
TI Regenerated spider silk: Processing, properties, and structure
SO MACROMOLECULES
LA English
DT Article
ID CLAVIPES DRAGLINE SILK; C-13 CHEMICAL-SHIFTS; BOMBYX-MORI FIBROIN;
   NEPHILA-CLAVIPES; SOLID-STATE; CONFORMATIONAL CHARACTERIZATION;
   ESCHERICHIA-COLI; PROTEINS; NMR; FIBERS
AB Spider dragline silk is Nature's high-performance protein fiber. This biomaterial has attracted much interest from scientists in various disciplines since it has become feasible to produce spider silk proteins by means of biotechnology. This article reports on research directed toward the regeneration of spider silk. A procedure is described - including spinning and postspinning processing - that produces fibers with promising mechanical properties from dissolved natural spider dragline silk. Tensile tests and structural characterization of the regenerated fibers illustrate correlations between the macroscopic and microscopic properties of the final material and between these properties and the fiber's processing history. Results point to the importance of an aqueous environment in the annealing of structure. The revealed structure-property relationships are expected to be of fundamental importance for the future design of man-made protein products.
C1 Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
   Cornell Univ, Ctr Adv Technol Biotechnol, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.
   Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.
RP Jelinski, LW (reprint author), Louisiana State Univ, Dept Chem, 240 T Boyd Hall, Baton Rouge, LA 70803 USA.
CR Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   BAMFORD CH, 1954, NATURE, V173, P27, DOI 10.1038/173027a0
   BUNNING TJ, 1994, ACS S SERIES, V544, pCH29
   Byrom D., 1991, BIOMATERIALS NOVEL M
   CAPPELLO J, 1994, ACS S SERIES, V544, pCH26
   Cohen P, 1998, NEW SCI, V160, P11
   Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAHNESTOCK SR, 1994, Patent No. 06689
   GRUBB DP, UNPUB
   Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jelinski LW, 1998, CURR OPIN SOLID ST M, V3, P237, DOI 10.1016/S1359-0286(98)80097-1
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Lock RL, 1993, Patent, Patent No. 5252285
   Michal CA, 1998, J BIOMOL NMR, V12, P231, DOI 10.1023/A:1008286004222
   O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.3.CO;2-K
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018
   SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Z. F., UNPUB
   ZACHARIADES AE, 1983, STRENGTH STIFFNESS P
   ZEMLIN JC, 1968, TR6929CM USA NAT LAB
NR 34
TC 130
Z9 137
U1 1
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 8
PY 2000
VL 33
IS 3
BP 775
EP 780
DI 10.1021/ma990893j
PG 6
WC Polymer Science
SC Polymer Science
GA 282YC
UT WOS:000085248500021
DA 2018-10-19
ER

PT J
AU Matsuda, T
   Mizutani, M
AF Matsuda, T
   Mizutani, M
TI Molecular design of photocurable liquid biodegradable copolymers. 2.
   Synthesis of coumarin-derivatized oligo(methacrylate)s and photocuring
SO MACROMOLECULES
LA English
DT Article
ID POLYMERS
AB Photocurable, biodegradable liquid copolymers, which undergo liquid-to-gel transformation upon ultraviolet (UV) light irradiation, may find versatile biomaterial applications. A multifunctionally derivatized liquid prepolymer that is oligo(2-hydroxyl methacrylate) grafted with oligo(epsilon-caprolactone) and subsequently end-capped with a photodimerizable group, coumarin, at the terminal ends of the side chains, was prepared. UV irradiation produced a cross-linked solid.
C1 Natl Cardiovasc Ctr, Res Inst, Dept Bioengn, Suita, Osaka 5658565, Japan.
RP Matsuda, T (reprint author), Kyushu Univ, Dept Biomed Engn, Grad Sch Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
CR ALBERTSSON AC, 1995, ACTA POLYM, V46, P114, DOI 10.1002/actp.1995.010460203
   BEZWADA RS, 1995, Patent No. 5653992
   Kito H, 1993, ASAIO J, V39, pM506
   MATSUDA T, IN PRESS MACROMOLECU
   Moghaddam M J, 1991, ASAIO Trans, V37, pM437
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   Piskin E., 1994, J BIOMAT SCI-POLYM E, V6, P775
   SCOPELIANOS AG, 1994, Patent No. 5599852
   SCOPELIANOS AG, 1996, Patent No. 5728752
   SCOPELIANOS AG, 1996, Patent No. 5824333
   SCOPELIANOS AG, 1993, Patent No. 5411554
NR 11
TC 34
Z9 34
U1 4
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 8
PY 2000
VL 33
IS 3
BP 791
EP 794
DI 10.1021/ma991405a
PG 4
WC Polymer Science
SC Polymer Science
GA 282YC
UT WOS:000085248500023
DA 2018-10-19
ER

PT J
AU Xia, HY
   Rayson, GD
AF Xia, HY
   Rayson, GD
TI Solid-state Cd-113 NMR studies of metal-binding to a Datura innoxia
   biomaterial
SO ADVANCES IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE NMR; biomaterials; Datum innoxia; cadmium; binding
ID ION-BINDING; CHEMICAL MODIFICATION; SITES; SPECTROSCOPY; LUMINESCENCE;
   BIOMASS; IMPACT; PROBE; CD
AB The use of both slurry and solid-state Cd-113 NMR has been applied to the investigation of the chemical moieties involved in cadmium ion binding to a biosorbent. This material was derived from fragments of cell walls cultured from the plant Datura innoxia. Comparison of the -14-ppm chemical shift of the bound metal ion with that of model ligands directly demonstrated the involvement of carboxylate-containing binding sites. The application of solid-state cross-polarization magic angle spinning techniques to the metal-bound material yielded a broad resonance. This was interpreted as indicative of the presence of a distribution of chemically similar sites. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, Box 30001 MSC 3C, Las Cruces, NM 88003 USA.
CR Akitt J. W., 1992, NMR CHEM INTRO MODER
   Armitage I. M., 1983, NMR NEWLY ACCESSIBLE, V2, P337
   CHEUNG TTP, 1980, J MAGN RESON, V41, P158, DOI 10.1016/0022-2364(80)90213-9
   Chung KH, 1996, CAN J CHEM, V74, P1360, DOI 10.1139/v96-152
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL D W, 1986, P1
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Drake LR, 1996, ANAL CHEM, V68, pA22, DOI 10.1021/ac9618029
   Drake LR, 1997, APPL SPECTROSC, V51, P1476, DOI 10.1366/0003702971939253
   Ellis P. D., 1983, Multinuclear Approach to NMR Spectroscopy. Proceedings of the NATO Advanced Study Institute, P457
   Gardea-Torresdey J.L, 1999, ADV ENVIRON RES, V3, P83
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   HARTMANN SR, 1962, PHYS REV, V128, P2042, DOI 10.1103/PhysRev.128.2042
   JAMESON CJ, 1986, MULTINUCLEAR NMR, P39
   KE HYD, 1993, ENVIRON SCI TECHNOL, V27, P2466, DOI 10.1021/es00048a024
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   Larive CK, 1996, ENVIRON SCI TECHNOL, V30, P2828, DOI 10.1021/es9600845
   Lin S, 1998, ENVIRON SCI TECHNOL, V32, P1488, DOI 10.1021/es970843z
   Lin S, 1996, ANAL CHEM, V68, P4087, DOI 10.1021/ac960569b
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   MONCRIEF RM, 1995, SEPAR SCI TECHNOL, V30, P2421, DOI 10.1080/01496399508013120
   PINES A, 1973, J CHEM PHYS, V59, P569, DOI 10.1063/1.1680061
   Sanders J. K. M., 1987, MODERN NMR SPECTROSC
   SUMMERS MF, 1988, COORDIN CHEM REV, V86, P43, DOI 10.1016/0010-8545(88)85012-4
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   Xia HY, 1998, ENVIRON SCI TECHNOL, V32, P2688, DOI 10.1021/es980171s
   ZHANG WX, 1993, APPL SPECTROSC, V47, P2151, DOI 10.1366/0003702934066406
NR 31
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1093-0191
J9 ADV ENVIRON RES
JI Adv. Environ. Res.
PD FEB
PY 2000
VL 4
IS 1
BP 69
EP 77
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 383VZ
UT WOS:000165906200007
DA 2018-10-19
ER

PT J
AU Wyre, RM
   Downes, S
AF Wyre, RM
   Downes, S
TI An in vitro investigation of the PEMA/THFMA polymer system as a
   biomaterial for cartilage repair
SO BIOMATERIALS
LA English
DT Article
DE chondrocytes; cartilage repair; polymer; biomaterials; methacrylate;
   cell culture
ID MAMMALIAN CHONDROCYTES INVITRO; BOVINE ARTICULAR CHONDROCYTES;
   HETEROCYCLIC METHACRYLATES; CLINICAL-APPLICATIONS; SUB-POPULATIONS;
   IN-VITRO; CULTURE; COLLAGEN; MATRIX; PHENOTYPE
AB A polymer system consisting of poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate (PEMA/THFMA) was investigated as a biomaterial for cartilage repair using chondrocyte culture. The PEMA/THFMA system and Thermanox control were shown to support chondrocytes seeded directly onto the surface for up to 28 days in culture. Differences were seen between the PEMA/TKFMA system and Thermanox in DNA content, proliferation and glycosaminoglycon (GAG) synthesis. There was a significantly greater medium : cell GAG ratio for the PEMA/THFMA system compared to Thermanox. A greater number of chondrocytes isolated from the superficial zone of bovine cartilage attached to the PEMA/THFMA system compared to cells isolated from the deep zone, whereas the converse was seen for Thermanox. Matrix constituents including collagen type II were synthesised indicating that the differentiated phenotype was maintained for some of the chondrocytes, although the production of type I collagen indicated that dedifferentiation of some of the chondrocytes had occurred. In conclusion, this study has shown that the PEMA/THFMA system can support chondrocytes in vitro and together with further investigations could lead to the development of the polymer as an ideal candidate for articular cartilage repair. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.
RP Wyre, RM (reprint author), Royal S Hants Hosp, Steve Mills Transplant Lab, Brintons Terrace,Off St Marys Rd, Southampton SO1 OYG, Hants, England.
CR ADOLPHE M, 1992, BIOL REGULATION CHON, P105
   ARCHER CW, 1990, J CELL SCI, V97, P361
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808
   AYDELOTTE MB, 1990, METHODS CARTILAGE RE, P90
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   CHACKO S, 1969, J EXP MED, V130, P417, DOI 10.1084/jem.130.2.417
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   GHADIALLY FN, 1983, FINE STRUCTURE SYNOV, P42
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   HANDLEY CJ, 1979, BIOCHIM BIOPHYS ACTA, V582, P234, DOI 10.1016/0304-4165(79)90387-8
   HORWITZ AL, 1970, J CELL BIOL, V45, P434, DOI 10.1083/jcb.45.2.434
   HUNZIKER EB, 1982, J ULTRA MOL STRUCT R, V81, P1, DOI 10.1016/S0022-5320(82)90036-3
   HUNZIKER EB, 1983, J HISTOCHEM CYTOCHEM, V31, P717, DOI 10.1177/31.6.6341460
   KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4
   KUETTNER KE, 1982, J CELL BIOL, V93, P751, DOI 10.1083/jcb.93.3.751
   KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743
   LAYMAN DL, 1972, EXP CELL RES, V73, P107, DOI 10.1016/0014-4827(72)90107-3
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   MESSNER K, 1993, J BIOMED MATER RES, V27, P949, DOI 10.1002/jbm.820270714
   PAGE B, 1993, INT J ONCOL, V3, P473
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   PATEL MP, 1991, BIOMATERIALS, V12, P645, DOI 10.1016/0142-9612(91)90110-V
   PATEL MP, 1991, BIOMATERIALS, V12, P649, DOI 10.1016/0142-9612(91)90111-M
   PATEL MP, 1989, BIOMATERIALS, V10, P277, DOI 10.1016/0142-9612(89)90106-3
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P402, DOI 10.1007/BF00058973
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P793, DOI 10.1007/BF00213137
   ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007
   Sawtell RM, 1995, J MATER SCI-MATER M, V6, P676, DOI 10.1007/BF00134299
   SAWTELL RM, 1995, CELL MATER, V5, P63
   SAWTELL RM, 1997, THESIS NOTTINGHAM UK
   SICZKOWSKI M, 1990, J CELL SCI, V97, P349
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WATT FM, 1988, J CELL SCI, V89, P373
   ZANETTI M, 1985, J CELL BIOL, V101, P53, DOI 10.1083/jcb.101.1.53
NR 37
TC 30
Z9 31
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2000
VL 21
IS 4
BP 335
EP 343
DI 10.1016/S0142-9612(99)00185-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275RG
UT WOS:000084833500002
PM 10656314
DA 2018-10-19
ER

PT J
AU Moreau, MF
   Gallois, Y
   Basle, MF
   Chappard, D
AF Moreau, MF
   Gallois, Y
   Basle, MF
   Chappard, D
TI Gamma irradiation of human bone allografts alters medullary lipids and
   releases toxic compounds for osteoblast-like cells
SO BIOMATERIALS
LA English
DT Article
DE bone allograft; lipids; peroxidated lipids; lipofuschine; osteoblast;
   bone bank; biomaterial; bone substitute
ID FREE-RADICALS; TRABECULAR BONE; RABBITS; BANK; ACID; RESORPTION;
   PRODUCTS; BIOLOGY; DISEASE; GRAFTS
AB The uncertainties about the transmission of prion proteins from xenogenic grafts prepared from bovine bone has led to the reconsideration of allogenic bone as a grafting material. Allografting is a complementary technique to autografting nowadays when large bone volumes are necessary. Several preparation techniques have been proposed. Fresh-frozen, freeze-dried and gamma irradiation are the most common. However, a large amount of lipids is present in the medullary spaces (near 70% in weight for a human femoral head). They are known to strongly influence the biocompatibility of the bone graft. The exact changes of lipids upon the sterilization and storage processes are poorly known. The aims of the present study were to appreciate the effects of gamma irradiation on medullary lipids and to identify the cytotoxicity of gamma-irradiated bank bone with/without lipid on cultures of osteoblast-like cells. Bone cores from 8 femoral heads retrieved during prosthesis surgery for arthritis were prepared with a drilling trephine. Cores were either sterilized by gamma radiations (25000 gray) or kept frozen until lipid extraction and lipofuschine-like dosage by Folch's method and fluorometric study. Peroxidated lipids appeared 2 to 3-fold higher in the gamma-irradiated cores than in frozen ones; Slices were prepared from bone cores and were transferred on confluent osteoblast-like cell layers (Saos-2). The raw slices (containing lipids) did not induce cell death. On the other hand, cell death was dramatically increased around the gamma-irradiated slices. Defatted slices which had been sterilized by gamma radiations or UV did not induce cell death. Defatting procedures should be added when preparing bone allografts in human bone banks. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 CHU Angers, Lab Histol Embryol, F-49045 Angers, France.
   Fac Med, Lab Biochim, F-49045 Angers, France.
RP Chappard, D (reprint author), CHU Angers, Lab Histol Embryol, F-49045 Angers, France.
CR ALBEE FH, 1915, BONE GRAFT SURG, P13
   ARO HT, 1993, ANN MED, V25, P402
   ASPENBERG P, 1990, ACTA ORTHOP SCAND, V61, P546, DOI 10.3109/17453679008993579
   Bettin D, 1998, ACTA ORTHOP SCAND, V69, P311, DOI 10.3109/17453679809000937
   BOUSQUET J, 1991, CLIN REV ALLERG, V9, P357
   BUCK BE, 1994, CLIN ORTHOP RELAT R, P8
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Butler D, 1998, NATURE, V391, P320
   CHAPMAN PG, 1992, J BONE JOINT SURG BR, V74, P398
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   CLOWARD RB, 1980, SPINE, V5, P4, DOI 10.1097/00007632-198001000-00002
   CONWAY B, 1991, AIDS, V5, P608, DOI 10.1097/00002030-199105000-00029
   DEJIKERS RLM, 1997, J BONE JT SURG B, V79, P161
   DZIEDZICGOCLAWSKA A, 1991, CLIN ORTHOP RELAT R, P30
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   FOLCH J, 1961, METHOD BIOCHEM ANAL, P106
   FRIEDLAENDER GE, 1976, J BONE JOINT SURG AM, V58, P854, DOI 10.2106/00004623-197658060-00018
   FRIEDLAENDER GE, 1981, AAOS INSTR COURSE LE, V30, P36
   *GESTO, 1994, GUID PREL SEL CONS A, P1
   Girotti AW, 1998, J LIPID RES, V39, P1529
   Gouin F, 1996, J BONE JOINT SURG BR, V78B, P38
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Hogg N, 1999, BBA-BIOENERGETICS, V1411, P378, DOI 10.1016/S0005-2728(99)00027-4
   KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lefevre G, 1998, ANN BIOL CLIN-PARIS, V56, P305
   Levai JP, 1996, CLIN ORTHOP RELAT R, P108
   LEXER E, 1908, ARCH KLIN CHIR, V86, P939
   LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M
   LOTY B, 1990, INT ORTHOP, V14, P237
   MEGHJI S, 1988, PROSTAG OTH LIPID M, V36, P139, DOI 10.1016/0090-6980(88)90301-2
   Mejdahl S, 1998, ACTA ORTHOP SCAND, V69, P63, DOI 10.3109/17453679809002359
   Mellonig JT, 1996, CLIN ORTHOP RELAT R, P116
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   MULARCHUK P, 1990, CALCIFIED TISSUE INT, V46, P57, DOI 10.1007/BF02555825
   NEMZEK JA, 1994, J BONE JOINT SURG AM, V76A, P1036, DOI 10.2106/00004623-199407000-00012
   OLDER MWJ, 1992, BONE IMPLANT GRAFTIN, P15
   Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680
   PROLO DJ, 1982, CLIN ORTHOP RELAT R, P230
   RAISZ LG, 1993, J BONE MINER RES, V8, pS457
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   SALZMAN NP, 1993, CLIN ORTHOP RELAT R, P384
   THOREN K, 1993, ACTA ORTHOP SCAND, V64, P44, DOI 10.3109/17453679308994526
   THOREN K, 1995, CLIN ORTHOP RELAT R, P232
   TOMFORD WW, 1983, CLIN ORTHOP RELAT R, P15
   Voggenreiter G, 1996, ACTA ORTHOP SCAND, V67, P583, DOI 10.3109/17453679608997761
   Watkins BA, 1998, WORLD REV NUTR DIET, V83, P38
   XU H, 1995, CALCIFIED TISSUE INT, V57, P293, DOI 10.1007/BF00298885
   YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1
NR 50
TC 106
Z9 114
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2000
VL 21
IS 4
BP 369
EP 376
DI 10.1016/S0142-9612(99)00193-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275RG
UT WOS:000084833500006
PM 10656318
DA 2018-10-19
ER

PT J
AU Yung, LYL
   Lim, F
   Khan, MMH
   Kunapuli, SP
   Rick, L
   Colman, RW
   Cooper, SL
AF Yung, LYL
   Lim, F
   Khan, MMH
   Kunapuli, SP
   Rick, L
   Colman, RW
   Cooper, SL
TI High-molecular-weight kininogen preadsorbed to glass surface markedly
   reduces neutrophil adhesion
SO BIOMATERIALS
LA English
DT Article
DE leukocyte adhesion; high molecular weight kininogen; protein adsorption;
   anionic surfaces
ID LIGHT-CHAIN; ANIONIC SURFACE; HEAVY-CHAIN; FIBRINOGEN; BINDING; PROTEIN;
   PURIFICATION; FIBRONECTIN; ADSORPTION; INTEGRINS
AB Adsorbed proteins on biomaterial surfaces determine whether cells adhere, but rheological variables are also critical. Neutrophil adhesion under well-defined radial flow conditions was studied on glass preadsorbed with plasma proteins or plasma protein domain fragments. Fibrinogen, low-molecular-weight kininogen (LK), high-molecular-weight kininogen (HK), cleaved HK (HKa), and recombinant HK domains 3 and 5 (D-3 and D-5H) were used. The number of adherent cells on the HK and HKa surfaces was less than 10% that found on the fibrinogen absorbed surface. The degree of spreading was minimal and detachment of adherent neutrophils was observed. HK and HKa contain binding sites for both anionic surfaces and neutrophils in the same domain (D-5H). When adsorbed to surfaces, HK and HKa did not have the neutrophil binding sites available and therefore exhibited an anti-adhesive effect. Although D-5H contains anionic surface binding sites, its small molecular size required a higher number of adsorbed molecules to cover the surface before a significant decrease in cell adhesion was observed. Since LK and D-3 do not possess specific anionic surface binding sites, the adsorption of these proteins on glass was very low compared to HK and HKa. Thus, extensive cell adhesion and spreading were observed on the surfaces partially covered with preadsorbed LK and D-3. (C) 2000 Elsevier Science Ltd. Ail rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.
RP Yung, LYL (reprint author), Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
RI Yung, Lanry/B-6515-2009
OI Yung, Lanry/0000-0001-7579-6347
FU NHLBI NIH HHS [HL-56914, HL-47197]
CR BOHNSACK JF, 1992, J IMMUNOL, V149, P1340
   BRASH JL, 1988, BLOOD, V71, P932
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   COLLINS WE, 1990, THESIS U WISCONSIN M
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DELACADENA RA, 1992, PROTEIN SCI, V1, P151
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   FALLMAN M, 1993, J IMMUNOL, V151, P330
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377
   JACOBSEN S, 1967, BRIT J PHARM CHEMOTH, V29, P25, DOI 10.1111/j.1476-5381.1967.tb01935.x
   Khan M., 1995, Blood, V86, p33A
   Khan MMH, 1998, AM J PHYSIOL-HEART C, V275, pH145, DOI 10.1152/ajpheart.1998.275.1.H145
   KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028
   KUNAPULI SP, 1993, J BIOL CHEM, V268, P2486
   Kunapuli SP, 1996, J BIOL CHEM, V271, P11228, DOI 10.1074/jbc.271.19.11228
   LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D
   MARCHANT RE, 1984, J ADHESION, V20, P211
   MULLERESTERL W, 1982, BIOCHIM BIOPHYS ACTA, V706, P145, DOI 10.1016/0167-4838(82)90480-0
   Rosenoer VM, 1977, ALBUMIN STRUCTURE FU
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SCHMAIER AH, 1984, THROMB RES, V33, P51, DOI 10.1016/0049-3848(84)90154-3
   SCHMAIER AH, 1983, J CLIN INVEST, V71, P1477, DOI 10.1172/JCI110901
   SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319
   TAYEH MA, 1994, J BIOL CHEM, V269, P16318
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WACHTFOGEL YT, 1994, J BIOL CHEM, V269, P19307
   WEISEL JW, 1994, J BIOL CHEM, V269, P10100
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
NR 30
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2000
VL 21
IS 4
BP 405
EP 414
DI 10.1016/S0142-9612(99)00203-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 275RG
UT WOS:000084833500011
PM 10656323
DA 2018-10-19
ER

PT J
AU Lupton, JR
   Alster, TS
AF Lupton, JR
   Alster, TS
TI Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel
SO DERMATOLOGIC SURGERY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; COLLAGEN
AB BACKGROUND. Injectable hyaluronic acid gel is a nonanimal biomaterial used for soft tissue augmentation.
   OBJECTIVE. The dermal implantation of this naturally occuring polysaccharide is reported to be well tolerated by patients, with a longer duration in tissue than bovine collagen without any major local or systemic side effects. We report a case of an acute hypersensitivity reaction in a woman after her third injection for improvement of melolabial fold wrinkles.
   METHODS. An adverse granulomatous-like response to the intradermal injection of a modified hyaluronic acid gel is described.
   RESULTS. The patient developed indurated and erythematous papulocystic nodules in the melolabial folds bilaterally at the sites of injection.
   CONCLUSION. Injectable hyaluronic acid gel can be associated with severe allergic reactions and patients should be warned of this possible treatment side effect.
C1 Washington Inst Dermatol Laser Surg, Washington, DC 20037 USA.
RP Alster, TS (reprint author), Washington Inst Dermatol Laser Surg, 2311 M St NW,Suite 200, Washington, DC 20037 USA.
CR Duranti F, 1998, DERMATOL SURG, V24, P1317, DOI 10.1111/j.1524-4725.1998.tb00007.x
   ELSON ML, 1995, DERMATOL SURG, V21, P491, DOI 10.1111/j.1524-4725.1995.tb00252.x
   GALLO RL, 1999, FITZPATRICKS DERMATO, P283
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   KLEIN AW, 1989, J DERMATOL SURG ONC, V15, P263, DOI 10.1111/j.1524-4725.1989.tb03157.x
   MCCOY JP, 1985, ARCH DERMATOL, V121, P990, DOI 10.1001/archderm.121.8.990
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   POLLACK SV, 1990, J DERMATOL SURG ONC, V16, P957, DOI 10.1111/j.1524-4725.1990.tb01560.x
   *Q MED AB, 1996, REST INV BROCH
   Stegman S, 1988, J DERMATOL SURG O S1, V14, P39
   WEST TB, 1999, IN PRESS PLAST RECON
NR 11
TC 128
Z9 128
U1 1
U2 12
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1076-0512
J9 DERMATOL SURG
JI Dermatol. Surg.
PD FEB
PY 2000
VL 26
IS 2
BP 135
EP 137
DI 10.1046/j.1524-4725.2000.99202.x
PG 3
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 284FX
UT WOS:000085321200010
PM 10691942
DA 2018-10-19
ER

PT J
AU Duskova, M
   Kozak, J
   Mazanek, J
   Smahel, Z
   Vohradnik, M
AF Duskova, M
   Kozak, J
   Mazanek, J
   Smahel, Z
   Vohradnik, M
TI Augmentation of facial skeleton with ceramics in congenital disorders
   and in post-traumatic or postoperative deformities: a preliminary report
SO EUROPEAN JOURNAL OF PLASTIC SURGERY
LA English
DT Article
DE bioactive glass ceramics; bone substitutes; facial skeleton
   augmentation; congenital and acquired deformities
ID ALGINATE-CHONDROCYTE CONSTRUCTS; BONE-GRAFTS; BIODEGRADABLE POLYMERS;
   POROUS HYDROXYAPATITE; PLASTIC-SURGERY; CRANIOPLASTY; REPLACEMENT;
   SUBSTITUTES; IMPLANTS; CONTOUR
AB The reconstruction of defects of the facial skeleton resulting from congenital faults, tumor removal, or trauma should provide function and form. Synthetic bone substitutes can be used in patients in which autologous bone graft or other operative techniques are contraindicated by the patient's condition or would not achieve the expected result. The advantages of synthetic substances are obvious: there is no secondary defect due to harvest, and surgery and healing time are therefore reduced. This, together with the shortening of operating and hospital times, reduces costs. A satisfactory result can be achieved in one surgical intervention. Implants are available in the size, volume, and shape required by the anatomical defect; in addition, they are easy to insert, can be stored for long periods, and can be resterilized if necessary. Biocompatible nonresorbable glass ceramics based on oxyfluoroapatite and wollastonite (BAS-0) have been used successfully as a filler or a bone substitute in orthopedics or in maxillofacial surgery since 1991. Surface-active inorganic polycrystalline, nonmetal biomaterial with osteoconductivity, permits osseointegration, i.e., a direct physicochemical bond between live bone tissue and the implant without formation of a fibrous capsule. Compared with hydroxyapatite, it has significantly higher durability to mechanical strain in simulated body fluid and a chemical bond with live bone tissue that is ten- to 100-fold stronger. Due to these features, this material was chosen for restoration of the facial skeletal framework in ten patients in whom other previous solutions had been unsuccessful (contour bone defect with chronic frontal sinusitis developed after open penetrating injury, bone defect after surgery associated with irradiation, significant congenital malformations of the facial skeleton, post-traumatic defects, and postsurgical deformities). The mean time of observation was 6 months. Healing occurred without any adverse reaction or side effect. Two extrusions were solved by secondary surgery. Carefully indicated application of a bone substitute can increase the patient's quality of life and reduce surgery time and treatment costs.
C1 Charles Univ, Dept Stomat, Dept Plast Surg, Prague 10034 10, Czech Republic.
RP Duskova, M (reprint author), Charles Univ, Dept Stomat, Dept Plast Surg, Srobarova 50, Prague 10034 10, Czech Republic.
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Andreani J. F., 1993, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V94, P21
   BLAKE DP, 1994, MIL MED, V159, P466
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V91, P80, DOI 10.1097/00006534-199301000-00011
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V91, P89
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   CHEN B, 1994, CHUNG HUA CHENG HSIN, V10, P368
   Chen X, 1993, Hua Xi Yi Ke Da Xue Xue Bao, V24, P45
   CHEN X, 1995, CHUNG HUA CHENG HSIN, V11, P419
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   COULDWELL WT, 1994, J NEUROSURG, V81, P483, DOI 10.3171/jns.1994.81.3.0483
   DUSKOVA M, 1997, CZECH NAT ANN S INT
   EPPLEY BL, 1995, PLAST RECONSTR SURG, V96, P316, DOI 10.1097/00006534-199508000-00009
   EPPLEY BL, 1995, AESTHET PLAST SURG, V19, P445, DOI 10.1007/BF00453878
   Filip M, 1995, Acta Chir Orthop Traumatol Cech, V62, P226
   FRIEDMAN CD, 1994, OTOLARYNG CLIN N AM, V27, P847
   Habal MB, 1996, CLIN PLAST SURG, V23, P1
   HABAL MB, 1994, CLIN PLAST SURG, V21, P525
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KNORINGER P, 1989, NEUROSURG REV, V12, P31, DOI 10.1007/BF01787124
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Kozak J, 1995, Acta Chir Plast, V37, P71
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Lin CC, 1996, BIOMATERIALS, V17, P1133, DOI 10.1016/0142-9612(96)85916-3
   Lodde J P, 1995, Ann Chir Plast Esthet, V40, P676
   MAUGARS Y, 1995, REV CHIR ORTHOP, V81, P326
   MCCARTHY JG, 1990, PLASTIC SURG, V2
   MOMMAERTS MY, 1995, J CRANIO MAXILL SURG, V23, P12, DOI 10.1016/S1010-5182(05)80248-3
   MU X, 1995, CHUNG HUA YEN KO TSA, V31, P447
   Ousterhout DK, 1996, CLIN PLAST SURG, V23, P183
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P179
   PALCHUN VT, 1994, VESTN OTORINOLARYNG, V3, P25
   PAPACHARALAMBOUS SK, 1993, INT J ORAL MAX SURG, V22, P260, DOI 10.1016/S0901-5027(05)80511-9
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   ROHANOVA D, 1992, SKLAR KERAMIK, V42, P398
   Satoh K, 1996, PLAST RECONSTR SURG, V97, P338, DOI 10.1097/00006534-199602000-00010
   STAFFEL G, 1995, OTOLARYNG CLIN N AM, V28, P295
   STAINDL O, 1979, ARCH OTO-RHINO-LARYN, V222, P241, DOI 10.1007/BF01261169
   STRICKER M, 1986, MAXIOFACIAL DENT SUR, V4, P93
   STRNAD Z, 1992, BIOMATERIALS, V13, P317, DOI 10.1016/0142-9612(92)90056-T
   Thaller S R, 1993, J Craniofac Surg, V4, P228
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   TOTH JM, 1993, BIOCERAMICS, V6
   Urban K, 1996, Acta Chir Orthop Traumatol Cech, V63, P16
   Urban K, 1993, Acta Chir Orthop Traumatol Cech, V60, P40
   URBAN K, 1989, SKLAR KERAMIK, V38, P292
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   WANG JS, 1994, CLIN ORTHOP RELAT R, P272
   YAREMCHUK MJ, 1996, J CRANIOFAC SURG, V6, P473
NR 54
TC 4
Z9 4
U1 1
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0930-343X
J9 EUR J PLAST SURG
JI Eur. J. Plast. Surg.
PD FEB
PY 2000
VL 23
IS 2
BP 57
EP 63
PG 7
WC Surgery
SC Surgery
GA 289GY
UT WOS:000085613200001
DA 2018-10-19
ER

PT J
AU Hollister, SJ
   Levy, RA
   Chu, TM
   Halloran, JW
   Feinberg, SE
AF Hollister, SJ
   Levy, RA
   Chu, TM
   Halloran, JW
   Feinberg, SE
TI An image-based approach for designing and manufacturing craniofacial
   scaffolds
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE craniofacial reconstruction; biomaterial scaffolds; imaging; tissue
   engineering
AB Bone tissue engineering (BTE), which combines biomaterial scaffolds with biologically active factors, holds tremendous promise for reconstructing craniofacial defects. A significant challenge in craniofacial reconstructive BTE applications is the complex patient-specific geometry that must be reconstructed. In this paper, we present an image-based approach for designing and manufacturing patient-specific craniofacial biomaterial scaffolds directly from CT or MRI data. In this approach, voxel density distribution is used to define scaffold topology. The scaffold design topology is created using image processing techniques, This voxel density distribution is then converted to data that can be used to drive a Solid Free-Form Fabrication machine to either directly build the scaffold or build a mold for the scaffold. Several preliminary applications for craniofacial surgery including a mandibular condyle scaffold, an orbital floor scaffold, and a general mandibular defect scaffold, are illustrated. Finally, we show applications to in vivo models.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mech Engn & Appl Mech, Ann Arbor, MI 48109 USA.
   Diagnost Radiol Associates, Saginaw, MI USA.
   Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Oral & Maxillofacial Surg, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Rm 3304 GG Brown Bldg,2350 Hayward, Ann Arbor, MI 48109 USA.
RI Halloran, John/G-9210-2011
OI Chu, Tien-Min Gabriel/0000-0002-7190-837X; Halloran,
   John/0000-0002-1913-6886
CR Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   CHU TM, UNPUB J MAT SCI MAT
   CHU TM, 1997, CASE STUDIES CERAMIC, V75, P119
   CHU TM, 1995, CERAMIC T, V65, P57
   Levy RA, 1997, AM J NEURORADIOL, V18, P1522
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 7
TC 131
Z9 137
U1 2
U2 36
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD FEB
PY 2000
VL 29
IS 1
BP 67
EP 71
DI 10.1034/j.1399-0020.2000.290115.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 283FN
UT WOS:000085265900015
PM 10691148
DA 2018-10-19
ER

PT J
AU Loke, WK
   Lau, SK
   Yong, LL
   Khor, E
   Sum, CK
AF Loke, WK
   Lau, SK
   Yong, LL
   Khor, E
   Sum, CK
TI Wound dressing with sustained anti-microbial capability
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE wounds; infection; chitin-chitosan based dual-layer wound dressing;
   chlorhexidine gluconate; Bauer-Kirby Disk Diffusion Test
ID POVIDONE-IODINE; CHLORHEXIDINE; TOXICITY
AB To overcome current limitations in wound dressings for treating mustard-burn induced septic wound injuries, a nonadherent wound dressing with sustained anti-microbial capability has been developed. The wound dressing consists of two layers: the upper layer is a carboxymethyl-chitin hydrogel material, while the lower layer is an anti-microbial impregnated biomaterial, The hydrogel layer acts as a mechanical and microbial barrier, and is capable of absorbing wound exudate. In physiological fluid, the carboxymethylated-chitin hydrogel swells considerably, imbibing up to 4 times its own weight of water and is also highly porous to water vapor. The moisture permeability of the dressing prevents the accumulation of fluid in heavily exudating wounds seen in second-degree burns. The lower layer, fabricated from chitosan acetate foam, is impregnated with chlorhexidine gluconate. From the in vitro release studies, the loading concentration was optimized to deliver sufficient anti-microbial drug into the wound area to sustain the anti-microbial activity for 24 h. The anti-microbial activity of the dressing against Pseudomonas aeruginosa and Staphylococcus aureus was tested using the Bauer-Kirby Disk Diffusion Test. (C) 2000 John Wiley & Sons, Inc.
C1 DSO Natl Labs, Singapore, Singapore.
   Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.
   Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore.
RP Loke, WK (reprint author), DSO Natl Labs, 20 Sci Pk Dr,POB 118230, Singapore, Singapore.
EM lwengkeo@dso.org.sg
RI Lim, Lee Yong/C-6144-2013
OI Lim, Lee Yong/0000-0002-7307-0742
CR ALLEN GG, 1984, CHITIN CHITOSAN RELA, P119
   DENTON GW, DISINFECTION STERILI, P274
   Ikeda H, 1995, CHEM PHARM BULL, V43, P2211
   Khor E, 1997, J POLYM SCI POL CHEM, V35, P2049
   LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267
   MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9
   MARTINDALE, 1996, ENCY DRUG INFORMATIO, P1124
   MCCAULEY RL, 1989, J SURG RES, V46, P267, DOI 10.1016/0022-4804(89)90069-3
   MONAFO WW, 1990, DRUGS, V40, P364, DOI 10.2165/00003495-199040030-00004
   MUZZARELLI R, 1992, ADVANCES IN CHITIN AND CHITOSAN, P25
   Papirmeister B, 1991, MED DEFENSE MUSTARD
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   SANCHEZ IR, 1988, VET SURG, V17, P291, DOI 10.1111/j.1532-950X.1988.tb01019.x
   SIDELL FR, 1992, CHEM WARFARE AGENTS, P52
   SOHRABPOUR MD, 1987, MED J ISLAM REPUB IR, V1, P32
   THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M
   THOMAS S, 1990, WOUND MANAGEMENT DRE
   Wan ACA, 1997, J BIOACT COMPAT POL, V12, P208, DOI 10.1177/088391159701200304
NR 18
TC 111
Z9 118
U1 2
U2 52
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 53
IS 1
BP 8
EP 17
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 276CC
UT WOS:000084857200002
PM 10634947
DA 2018-10-19
ER

PT J
AU van Wachem, PB
   Brouwer, LA
   Zeeman, R
   Dijkstra, PJ
   Feijen, J
   Hendriks, M
   Cahalan, PT
   van Luyn, MJA
AF van Wachem, PB
   Brouwer, LA
   Zeeman, R
   Dijkstra, PJ
   Feijen, J
   Hendriks, M
   Cahalan, PT
   van Luyn, MJA
TI In vivo behavior of epoxy-crosslinked porcine heart valve cusps and
   walls
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE prosthesis; heart valve; crosslinking; epoxy; calcification
ID DERMAL SHEEP COLLAGEN; CROSS-LINKING; BIOPROSTHETIC VALVES;
   CALCIFICATION; GLUTARALDEHYDE; CYTOTOXICITY; BIOMATERIAL; PREVENTION;
   PROSTHESES
AB Calcification limits the long-term durability of xenograft glutaraldehyde-crosslinked heart valves. In this study, epoxy-crosslinked porcine aortic valve tissue was evaluated after subcutaneous implantation in weanling rats, Non-crosslinked valves and valves crosslinked with glutaraldehyde or carbodiimide functioned as control. Epoxy-crosslinked valves had somewhat lower shrinkage temperatures than the crosslinked controls, and within the series also some macroscopic and microscopic differences were obvious. After 8 weeks implantation, cusps from non-crosslinked valves were not retrieved. The matching walls were more degraded than the epoxy- and control-crosslinked walls. This was observed from the higher cellular ingrowth with fibroblasts, macrophages, and giant cells. Furthermore, non-crosslinked malls showed highest numbers of lymphocytes, which were most obvious in the capsules. Epoxy- and control-crosslinked cusps and walls induced lower reactions, Calcification, measured by von Kossa-staining and by Ca-analysis, was always observed. Crosslinked cusps calcified more than walls, Of all mall samples, the non-crosslinked walls showed the highest calcification. It is concluded that epoxy-crosslinked valve tissue induced a foreign body and calcification reaction similar to the two crosslinked controls, Therefore, epoxy-crosslinking does not represent a solution for the calcification problem of heart valve bioprostheses, (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Fac Med Sci, NL-9712 KZ Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
   Medtron Bakken Res Ctr, NL-6201 MP Maastricht, Netherlands.
RP van Wachem, PB (reprint author), Univ Groningen, Fac Med Sci, Bloemsingel 10-B2, NL-9712 KZ Groningen, Netherlands.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1985, BIOCOMPATIBILITY TIS, V1
   Biedrzycki LM, 1997, J BIOMED MATER RES, V34, P411, DOI 10.1002/(SICI)1097-4636(19970315)34:4<411::AID-JBM2>3.3.CO;2-F
   CHANDA J, 1994, ARTIF ORGANS, V18, P752, DOI 10.1111/j.1525-1594.1994.tb03314.x
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DELRIZZO DF, 1995, CAN J CARDIOL, V11, P597
   GIRARDOT MN, 1994, INT J ARTIF ORGANS, V17, P76
   GOLDMAN BS, 1994, J CARDIOVASC SURG, V35, P105
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Gratzer PF, 1997, J BIOMED MATER RES, V37, P497, DOI 10.1002/(SICI)1097-4636(19971215)37:4<497::AID-JBM8>3.0.CO;2-G
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Imamura E, 1989, J Card Surg, V4, P50, DOI 10.1111/j.1540-8191.1989.tb00256.x
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   LEVY RJ, 1995, J BIOMED MATER RES, V29, P217, DOI 10.1002/jbm.820290212
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   Noishiki Y., 1988, Patent, Patent No. [EP 0 306 256 A2, 0306256]
   OLIVER RF, 1985, BIOCOMPATIBILITY TIS, V1
   Ricou F, 1996, CARDIOLOGY, V87, P212, DOI 10.1159/000177089
   ROSS D, 1995, STENTLESS BIOPROSTHE
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   SCHOEN FJ, 1994, J THORAC CARDIOV SUR, V108, P880
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, J BIOMED MATER RES-A, V21, P91
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   VANLUYN MJA, 1995, J MATER SCI-MATER M, V6, P288, DOI 10.1007/BF00120273
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Vyavahare NR, 1997, CARDIOVASC PATHOL, V6, P219, DOI 10.1016/S1054-8807(97)00017-3
   WEBB CL, 1992, AM J PATHOL, V141, P487
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   ZEEMAN R, IN PRESS CHARACTERIZ
   ZEEMAN R, IN PRESS IN VITRO DE
NR 33
TC 15
Z9 15
U1 2
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 53
IS 1
BP 18
EP 27
DI 10.1002/(SICI)1097-4636(2000)53:1<18::AID-JBM3>3.3.CO;2-A
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 276CC
UT WOS:000084857200003
PM 10634948
DA 2018-10-19
ER

PT J
AU Anselme, K
   Bigerelle, M
   Noel, B
   Dufresne, E
   Judas, D
   Iost, A
   Hardouin, P
AF Anselme, K
   Bigerelle, M
   Noel, B
   Dufresne, E
   Judas, D
   Iost, A
   Hardouin, P
TI Qualitative and quantitative study of human osteoblast adhesion on
   materials with various surface roughnesses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cell adhesion; vinculin; beta 1 integrin; roughness characterization;
   fractal dimension; human osteoblasts
ID HUMAN BONE-CELLS; BIOMATERIAL SURFACES; INTEGRIN EXPRESSION; MORPHOLOGIC
   ASPECTS; CELLULAR-RESPONSES; IMPLANT MATERIALS; FOCAL CONTACTS;
   IN-VITRO; ATTACHMENT; TITANIUM
AB We quantitatively evaluated the adhesion of human osteoblasts on orthopedic metallic substrates (Ti6Al4V alloy) with various surface roughnesses at several times after inoculation and studied its correlation with qualitative changes in the expression of adhesion proteins and with parameters extensively describing the surface topographies. Cells were orientated in a parallel order on polished surfaces. This orientation was not affected by residual grooves after polishing. On sandblasted surfaces the cells never attained confluence and had a stellate shape, and the cell layer had no particular organization. Extracellular matrix (fibronectin, type I collagen, osteopontin) and cytoskeletal protein (actin, vinculin) orientation reflected the cell layer organization. In our experiment human osteoblasts expressed alpha 3 beta 1 integrin but not alpha 2 beta 1 integrin. In addition to currently analyzed roughness magnitude parameters, we calculated roughness organization parameters (fractal dimension parameters) of the substrates. We observed lower adhesion and proliferation on less organized surfaces (i.e., sand-blasted ones). The significant statistical correlation observed between fractal dimension parameters (describing surface roughness organization) and cell parameters adds a new concept to the studies of substratum roughness influence on cell behavior. An attempt at modelization of the cell-surface interaction was made that includes the influence of fractal dimensions parameters. (C) 2000 John Wiley & Sons, Inc.
C1 Inst Calot, IRMS, F-62608 Berck Sur Mer, France.
   ENSAM, CNRS, UMR 8517, F-59046 Lille, France.
   CRITT Ceram Fines, F-59600 Maubeuge, France.
RP Anselme, K (reprint author), Inst Calot, IRMS, Rue Dr Calot, F-62608 Berck Sur Mer, France.
RI IOST, alain/D-8909-2011
OI IOST, alain/0000-0003-2185-4673; Maxence, Bigerelle/0000-0002-4144-245X;
   Anselme, Karine/0000-0002-6669-205X
CR ANSELME K, 1994, CELL MATER, V4, P113
   Bigerelle M, 1996, CR ACAD SCI II B, V323, P669
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLOVER J, 1992, J CELL SCI, V103, P267
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HORTON MA, 1989, J BONE MINER RES, V4, P803
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LOPEZ J, 1994, J PHYS III, V4, P2501, DOI 10.1051/jp3:1994294
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MEYER U, 1993, CELL MATER, V3, P129
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MOLLER K, 1994, CELL MATER, V4, P263
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SOBEY PG, 1993, J BONE MINER RES, V8, pS483
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
NR 41
TC 376
Z9 387
U1 9
U2 119
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 49
IS 2
BP 155
EP 166
DI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259DY
UT WOS:000083880300002
PM 10571901
DA 2018-10-19
ER

PT J
AU Barralet, J
   Akao, M
   Aoki, H
   Aoki, H
AF Barralet, J
   Akao, M
   Aoki, H
   Aoki, H
TI Dissolution of dense carbonate apatite subcutaneously implanted in
   Wistar rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE carbonate hydroxyapatite; dissolution; in vivo; tricalcium phosphate;
   hydroxyapatite
ID POROUS HYDROXYAPATITE; TRICALCIUM PHOSPHATE; PROSTHETIC APPLICATIONS;
   MECHANICAL-PROPERTIES; BONE; SUBSTITUTE; INTERFACE; TITANIUM; CERAMICS;
   TISSUE
AB Hydroxyapatite (HA) is used as a biomaterial in orthopedic applications because it is similar in composition to bone mineral; however, carbonate apatite (CHA) is closer in chemical composition to bone mineral because bone mineral contains significant amounts of carbonate, yet there have been few reports comparing biological responses to HA and CHA. It is generally agreed that bone forms a bond of some kind to HA, and there is conflicting evidence as to whether HA is resorbed in vivo or not. However, comparative reports generally agree that beta-tricalcium phosphate (beta-TCP) is removed faster than HA from an implant site by an undetermined combination of resorption and/or dissolution. The work reported here attempts to provide the first directly comparable subcutaneous dissolution data for dense sintered HA, beta-TCP, and CHA in rats. The weight losses of HA, beta-TCP, and 3.2 wt % CHA were approximately 60, 520, and 320 mg m(-2) day(-1), respectively. Histological sections did not show any evidence of giant cells, and all of the samples were encapsulated with fibrous tissue. beta-TCP and (to a lesser degree) CHA were found to be resistant to dissolution around the edges of the sample. An X-ray analysis did not indicate that any phase transformation had occurred in the dissolution resistant region. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Birmingham, Sch Dent, Birmingham B4 6NN, W Midlands, England.
   Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Tokyo 1010062, Japan.
   Int Apatite Inst, Chiyoda Ku, Tokyo 1010062, Japan.
RP Barralet, J (reprint author), Univ Birmingham, Sch Dent, Birmingham B4 6NN, W Midlands, England.
RI barralet, jake/A-5820-2008
OI barralet, jake/0000-0003-3543-6042
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   AKAO M, 1982, J MATER SCI, V17, P343, DOI 10.1007/BF00591468
   AOKI H, 1991, SCI MED APPL HYDROXA
   BARRALET J, 1995, Patent No. 5470803
   BARRALET J, 1995, THESIS U LONDON
   BARRALET JE, 1993, BIOCERAMICS, V6, P179
   BARRALET JE, 1996, BIOMED MAT ENG, V9, P1
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   DREISSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   ELLIES LG, 1988, J BIOMED MATER RES, V22, P137, DOI 10.1002/jbm.820220206
   Elliott JC, 1964, THESIS U LONDON
   FUSHIMI M, 1986, ORTHOP CERAM IMPLANT, V6, P27
   FUSHIMI M, 1995, BIOMATERIALS, V13, P16
   HARDY DCR, 1994, ACTA ORTHOP SCAND, V65, P253, DOI 10.3109/17453679408995449
   HAYASHI K, 1994, BIOMATERIALS, V15, P1187, DOI 10.1016/0142-9612(94)90241-0
   HOLMES R, 1988, J CRANIO MAXILL SURG, V16, P199, DOI 10.1016/S1010-5182(88)80047-7
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   KUROYAMA Y, 1993, J JPN SOC DENT MAT D, V12, P528
   LEGEROS RZ, 1969, EXPERIENTIA, V25, P5, DOI 10.1007/BF01903856
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, V15, P114
   LEGEROS RZ, 1983, CARVES RES, V17, P19
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   LUKLINSKA ZB, 1992, BONE BONDING MAT, P73
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   METSGER DS, 1993, CLIN ORTHOP RELAT R, P283
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   MORS WA, 1975, ARCH ORAL BIOL, V20, P365, DOI 10.1016/0003-9969(75)90028-X
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   NELSON DGA, 1983, CARIES RES, V17, P200, DOI 10.1159/000260668
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, P569
   Nordstrom E. G., 1992, Bio-Medical Materials and Engineering, V2, P115
   POLLICK S, 1995, J ORAL MAXIL SURG, V53, P915, DOI 10.1016/0278-2391(95)90281-3
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, P272
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173
NR 41
TC 71
Z9 76
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 49
IS 2
BP 176
EP 182
DI 10.1002/(SICI)1097-4636(200002)49:2<176::AID-JBM4>3.3.CO;2-#
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259DY
UT WOS:000083880300004
PM 10571903
DA 2018-10-19
ER

PT J
AU Kraft, CN
   Hansis, M
   Arens, S
   Menger, MD
   Vollmar, B
AF Kraft, CN
   Hansis, M
   Arens, S
   Menger, MD
   Vollmar, B
TI Striated muscle microvascular response to silver implants: A comparative
   in vivo study with titanium and stainless steel
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE silver implants; osteosynthesis materials; microcirculation;
   biocompatibility; skinfold chamber model
ID ISCHEMIA-REPERFUSION INJURY; IN-VITRO; BIOCOMPATIBILITY; ELECTRODES;
   BACTERIAL; TOXICITY; REFLOW; IONS
AB Local microvascular perfusion is the primary line of defense of tissue against microorganisms and plays a considerable role in reparative processes. The impairment of the microcirculation by a biomaterial may therefore have profound consequences. Silver is known to have excellent antimicrobial activity and, although regional and systemic toxic effects have been described, silver is regularly discussed as an implant material in bone surgery. Because little is known about the influence of silver implants on the adjacent host tissue microvasculature, we studied in vivo nutritive perfusion and leukocytic response, and compared these results with those of the conventionally used materials titanium and stainless steel. Using the hamster dorsal skinfold chamber preparation and intravital microscopy, the implantation of a commercially pure silver sample led to a distinct and persistent activation of leukocytes combined with a marked disruption of the microvascular endothelial integrity, massive leukocyte extravasation, and considerable venular dilation. Whereas animals with stainless-steel implants showed a moderate increase in these parameters with a tendency to recuperate, titanium implants caused only a transient increase of leukocyte-endothelial cell interaction within the first 120 min and no significant change in macromolecular leakage, leukocyte extravasation and venular diameter. After 3 days, five of six preparations with silver samples showed severe inflammation and massive edema. Thus, the use of silver as an implant material should be critically judged despite its bactericidal properties. The implant material titanium seems to be well tolerated by the local vascular system and currently represents the golden standard. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Bonn, Dept Orthoped, D-53105 Bonn, Germany.
   Univ Bonn, Dept Traumatol, D-53105 Bonn, Germany.
   Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthoped, D-53105 Bonn, Germany.
CR ARENS S, IN PRESS ARCH ORTHOP
   BABB TL, 1984, EXP NEUROL, V86, P171, DOI 10.1016/0014-4886(84)90179-1
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357
   CANNAS M, 1996, 5 WORLD BIOM C TOR C
   CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701
   CLARKE SD, 1981, MED J AUSTRALIA, V2, P208
   COLLINGE CA, 1994, ORTHOPEDICS, V17, P445
   DEITCH EA, 1987, J TRAUMA, V27, P301
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FALCONE AE, 1986, PLAST RECONSTR SURG, V77, P455, DOI 10.1097/00006534-198603000-00022
   FISCHER G, 1957, P STAFF M MAYO CLIN, V32, P14
   FRASER GL, 1979, JAMA-J AM MED ASSOC, V241, P1928, DOI 10.1001/jama.241.18.1928
   GAMELLI RL, 1993, SURG GYNECOL OBSTET, V177, P115
   HULTMAN P, 1994, CLIN EXP IMMUNOL, V96, P285
   *ISO, 1997, ISO7405, P1
   *ISO, 1995, IMPL SURG MET MAT 2, P1
   JACKSON WF, 1983, CIRC RES, V53, P105, DOI 10.1161/01.RES.53.1.105
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   JANSSON G, 1993, FREE RADICAL RES COM, V18, P87, DOI 10.3109/10715769309147345
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   LIU J, 1991, TOXICOL APPL PHARM, V107, P27, DOI 10.1016/0041-008X(91)90327-B
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1901
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1892
   Nand S, 1996, J Indian Med Assoc, V94, P91
   NORDMAN H, 1986, HDB TOXICOLOGY METAL, P594
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   SPADARO JA, 1986, J BIOMED MATER RES, V20, P565, DOI 10.1002/jbm.820200504
   STEFFENSEN IL, 1994, GEN PHARMACOL, V25, P1621, DOI 10.1016/0306-3623(94)90364-6
   WILLIAMS DF, 1994, J BONE JOINT SURG BR, V76B, P348
   Williams DF, 1981, SYSTEMIC ASPECTS BIO, P169
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Zapata-Sirvent Ramon L., 1993, Journal of Burn Care and Rehabilitation, V14, P132, DOI 10.1097/00004630-199303000-00002
NR 35
TC 81
Z9 82
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 49
IS 2
BP 192
EP 199
DI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259DY
UT WOS:000083880300006
PM 10571905
DA 2018-10-19
ER

PT J
AU Ono, K
   Saito, Y
   Yura, H
   Ishikawa, K
   Kurita, A
   Akaike, T
   Ishihara, M
AF Ono, K
   Saito, Y
   Yura, H
   Ishikawa, K
   Kurita, A
   Akaike, T
   Ishihara, M
TI Photocrosslinkable chitosan as a biological adhesive
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE chitosan; chitin; biological adhesive; photocrosslink
ID BIOMATERIAL; DERIVATIVES; CHITIN
AB A photocrosslinkable chitosan to which both azide and lactose moieties were introduced (Az-CH-LA) was prepared as a biological adhesive for soft tissues and its effectiveness was compared with that of fibrin glue. Introduction of the lactose moieties resulted in a much more water-soluble chitosan at neutral pH. Application of ultraviolet light (UV) irradiation to photocrosslinkable Az-CH-LA produced an insoluble hydrogel within 60 s. This hydrogel firmly adhered two pieces of sliced ham with each other, depending upon the Az-CH-LA concentration. The binding strength of the chitosan hydrogel prepared from 30-50 mg/mL of Az-CH-LA was similar to that of fibrin glue. Compared to the fibrin glue, the chitosan hydrogel more effectively sealed air leakage from pinholes on isolated small intestine and aorta and from incisions on isolated trachea. Neither Az-CH-LA nor its hydrogel showed any cytotoxicity in cell culture tests of human skin fibroblasts, coronary endothelial cells, and smooth muscle cells. Furthermore, all mice studied survived for at least 1 month after implantation of 200 mu L of photocrosslinked chitosan gel and intraperitoneal administration of up to 1 mt of 30 mg/mL of Az-CH-LA solution. These results suggest that the photocrosslinkable chitosan developed here has the potential of serving as a new tissue adhesive in medical use. (C) 2000 John Wiley & Sons, Inc.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan.
   NeTech Inc, Kawasaki, Kanagawa 2130012, Japan.
   Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 226, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
CR BORST HG, 1982, J THORAC CARDIOV SUR, V84, P548
   BRAUNWALD NS, 1966, SURGERY, V59, P1024
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   JOHN A, 1984, ANN THORAC SURG, V38, P409
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   KOEHNLEIN HE, 1969, SURGERY, V66, P377
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   MINAMI S, 1992, ADVANCES IN CHITIN AND CHITOSAN, P61
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MOY OJ, 1988, J HAND SURG-AM, V13A, P273, DOI 10.1016/S0363-5023(88)80063-7
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   THETTER O, 1981, THORAC CARDIOV SURG, V29, P290, DOI 10.1055/s-2007-1023498
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
   YURA H, 1995, J BIOMED MATER RES, V29, P1557, DOI 10.1002/jbm.820291212
NR 22
TC 231
Z9 242
U1 9
U2 114
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2000
VL 49
IS 2
BP 289
EP 295
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 259DY
UT WOS:000083880300018
PM 10571917
DA 2018-10-19
ER

PT J
AU Yoshida, Y
   Van Meerbeek, B
   Nakayama, Y
   Snauwaert, J
   Hellemans, L
   Lambrechts, P
   Vanherle, G
   Wakasa, K
AF Yoshida, Y
   Van Meerbeek, B
   Nakayama, Y
   Snauwaert, J
   Hellemans, L
   Lambrechts, P
   Vanherle, G
   Wakasa, K
TI Evidence of chemical bonding at biomaterial-hard tissue interfaces
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE polyalkenoic acid; enamel; hydroxyapatite; chemical bonding; interface
ID GLASS-IONOMER; CEMENT; ADHESION; DENTIN; FILMS
AB For many years, glass-polyalkenoate cements have been described as possessing the unique properties of self-adherence to human hard tissues, such as bones or teeth. However, direct experimental evidence to prove the existence of chemical bonding has not been advanced. X-ray Photoelectron Spectroscopy (XPS) was used to analyze the chemical interaction of a synthesized polyalkenoic acid with enamel and synthetic hydroxyapatite. For both enamel and hydroxyapatite, the peak representing the carboxyl groups of the polyalkenoic acid was detected to have significantly shifted to a lower binding energy. De-convolution of this shifted peak disclosed two components with a peak representing unreacted carboxyl groups and a peak suggesting chemical bonding to hydroxyapatite. On average, 67.5% of the carboxyl groups of the polyalkenoic acid were measured to have bonded to hydroxyapatite. XPS of hydroxyapatite also disclosed its surface to be enriched in calcium and decreased in phosphorus, indicating that phosphorus was extracted at a relatively higher rate than calcium. Analysis of these data supports the mechanism in which carboxylic groups replace phosphate ions (PO(4)(3-)) Of the substrate and make ionic bonds with calcium ions of hydroxyapatite. It is concluded that an ultrathin layer of a polyalkenoic acid can be prepared on a hydroxyapatite-based substrate by careful removal of non-bonded molecules. With this specimen-processing method, XPS not only provided direct evidence of chemical bonding, but also enabled us to quantify the percentages of functional groups of the polyalkenoic acids that bonded to calcium of hydroxyapatite.
C1 Katholieke Univ Leuven, Sch Dent Oral Pathol & Maxillofacial Surg, Dept Operat Dent & Dent Mat, BIOMAT, B-3000 Louvain, Belgium.
   Hiroshima Univ, Fac Dent, Dept Biomat Sci, Minami Ku, Hiroshima 7348553, Japan.
   Natl Space Dev Agcy Japan, NASDA, Tsukuba, Ibaraki 3058505, Japan.
   Katholieke Univ Leuven, Dept Chem, Lab Chem & Biol Dynam, B-3001 Heverlee, Belgium.
RP Van Meerbeek, B (reprint author), Katholieke Univ Leuven, Sch Dent Oral Pathol & Maxillofacial Surg, Dept Operat Dent & Dent Mat, BIOMAT, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.ac.be
RI YOSHIDA, Yasuhiro/B-2472-2011
CR AKINMADE AO, 1993, J MATER SCI-MATER M, V4, P93
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   Degrange M, 1997, MINIMALLY INVASIVE R
   Esker AR, 1998, SCIENCE, V280, P892, DOI 10.1126/science.280.5365.892
   Gladys S, 1997, J DENT RES, V76, P883, DOI 10.1177/00220345970760041001
   KENT BE, 1979, J DENT RES, V58, P1607, DOI 10.1177/00220345790580061001
   Knight J, 1998, NEW SCI, V158, P15
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   Nakabayashi N, 1998, HYBRIDIZATION DENT H
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Smith D C, 1968, Br Dent J, V124, P381
   Titley KC, 1996, J DENT, V24, P411, DOI 10.1016/0300-5712(95)00097-6
   VAIDYANATHAN J, 1984, J BIOMED MATER RES, V18, P871, DOI 10.1002/jbm.820180803
   WILSON AD, 1972, BRIT DENT J, V132, P133, DOI 10.1038/sj.bdj.4802810
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
NR 17
TC 257
Z9 264
U1 5
U2 41
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD FEB
PY 2000
VL 79
IS 2
BP 709
EP 714
DI 10.1177/00220345000790020301
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 287FF
UT WOS:000085495300003
PM 10728971
DA 2018-10-19
ER

PT J
AU Karlsson, JO
   Henriksson, A
   Michalek, J
   Gatenholm, P
AF Karlsson, JO
   Henriksson, A
   Michalek, J
   Gatenholm, P
TI Control of cellulose-supported hydrogel microstructures by
   three-dimensional graft polymerization of glycol methacrylates
SO POLYMER
LA English
DT Article
DE cellulose-supported hydrogel; microstructures; graft polymerization
ID BIOMATERIAL APPLICATIONS; POLYMERS; COPOLYMER; BEHAVIOR; SURFACES; FILMS
AB This article describes a method for controlled surface coating of cellulose fibers with micro-size hydrogel particles. The addition of ethyleneglycol dimethacrylate (EDMA) to the diethylene glycol methacrylate (DEGMA) monomer mixture used for grafting resulted in a dramatic enhancement of the grafting amount onto ozone-activated fibers and subsequent formation of particles on the fiber surfaces, as observed with AFM and SEM. The enhancement of the amount of grafting was explained by an initiation of the pendent double bonds and autoacceleration of graft polymerization as indicated by differential scanning calorimetry (DSC). Such 3-dimensional growth had a maximum at 4% of crosslinker and was significantly reduced when longer crosslinkers were used. This was explained by a cyclization reaction of the pendant double bonds. The surface structures were controlled by selecting the graft polymerization time. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Chalmers Univ Technol, Dept Polymer Technol, S-41296 Gothenburg, Sweden.
   Acad Sci Czech Republ, Inst Macromol Chem, Prague 16206, Czech Republic.
RP Gatenholm, P (reprint author), Chalmers Univ Technol, Dept Polymer Technol, S-41296 Gothenburg, Sweden.
RI Michalek, Jiri/D-7251-2013
CR Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   GINESTE JL, 1994, J APPL POLYM SCI, V51, P63, DOI 10.1002/app.1994.070510108
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Karlsson JO, 1999, POLYMER, V40, P379, DOI 10.1016/S0032-3861(98)00243-2
   Karlsson JO, 1998, POLYMER, V39, P3589, DOI 10.1016/S0032-3861(97)10353-6
   Karlsson JO, 1996, POLYMER, V37, P4251, DOI 10.1016/0032-3861(96)00277-7
   KARLSSON JO, 1996, SURFACE MODIFICATION
   KOPECEK J, 1971, COLLECT CZECH CHEM C, V36, P2703, DOI 10.1135/cccc19712703
   KOPECEK J, 1971, COLLECT CZECH CHEM C, V36, P3394, DOI 10.1135/cccc19713394
   KOPECEK J, 1971, J POLYM SCI A1, V9, P147, DOI 10.1002/pol.1971.150090113
   KOPECEK J, 1968, J POLYM SCI POL SYM, P3877
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   MALAVASIC T, 1988, J MACROMOL SCI CHEM, VA25, P55, DOI 10.1080/00222338808053365
   MIYAZAKI K, 1988, J BIOMED MATER RES, V22, P1011, DOI 10.1002/jbm.820221105
   MORRA M, 1993, COLLOID POLYM SCI, V271, P696, DOI 10.1007/BF00652832
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   PRITCHARD DJ, 1995, ANAL CHEM, V67, P3605, DOI 10.1021/ac00115a034
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   Ratner B. D., 1996, SURFACE MODIFICATION
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   SCRANTON AB, 1992, POLYMER, V33, P1683, DOI 10.1016/0032-3861(92)91067-C
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
NR 28
TC 19
Z9 19
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD FEB
PY 2000
VL 41
IS 4
BP 1551
EP 1559
DI 10.1016/S0032-3861(99)00277-3
PG 9
WC Polymer Science
SC Polymer Science
GA 260BT
UT WOS:000083929000034
DA 2018-10-19
ER

PT J
AU Gupta, KC
   Kumar, MNVR
AF Gupta, KC
   Kumar, MNVR
TI Preparation, characterization and release profiles of pH-sensitive
   chitosan beads
SO POLYMER INTERNATIONAL
LA English
DT Article
DE beads; biomaterial; chitosan; controlled release; swelling behaviour
ID INTERPENETRATING POLYMER NETWORKS; POLY(ETHYLENE OXIDE); DRUG-RELEASE;
   GELS; MORPHOLOGY; HYDROGELS; MEMBRANE; EPOXY; WATER
AB Spherical crosslinked beads using chitosan, glycine and glutaraldehyde were prepared for controlled release formulations. Structural investigation of the beads was made with IR analysis. Morphological study of the beads was carried out by scanning electron microscopy. The swelling behaviour of the beads was monitored as a function of time in solutions of different pH. The release experiments were performed using thiamine hydrochloride (Thi-HCl) as a model drug. These preliminary results suggest the possibility of modifying the formulations to obtain the desired controlled release of drug in an oral sustained delivery system. (C) 2000 Society of Chemical Industry.
C1 Univ Roorkee, Dept Chem, Polymer Res Lab, Roorkee 247667, Uttar Pradesh, India.
RP Gupta, KC (reprint author), Univ Roorkee, Dept Chem, Polymer Res Lab, Roorkee 247667, Uttar Pradesh, India.
RI Kumar, M N V R/D-6286-2011
OI Kumar, M N V R/0000-0001-5606-401X
CR Ashford M., 1992, Journal of Pharmacy and Pharmacology, V44, P1049
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   BELLAMY LJ, 1980, INFRARED SPECTRA COM, P52
   BLAIR HS, 1980, J CHEM TECH BIOTECHN, V31, P6
   Chang H, 1985, J PHARM SCI, V74, P399
   DAS B, 1994, J APPL POLYM SCI, V53, P1491, DOI 10.1002/app.1994.070531111
   Davidson H. I., 1990, J GASTROINTEST MOTIL, V2, P31
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   DONG LC, 1990, P INT S CONTROL REL, V17, P325
   EISENBERG SR, 1984, J MEMBRANE SCI, V19, P173, DOI 10.1016/S0376-7388(00)80207-0
   GRAHAM NB, 1990, POLYMER, V31, P909, DOI 10.1016/0032-3861(90)90055-4
   GUPTA N, 1994, POLYMER, V35, P3769, DOI 10.1016/0032-3861(94)90560-6
   HOFFMAN AS, 1986, J CONTROL RELEASE, V4, P212
   ISHIHARA K, 1984, J POLYM SCI POL CHEM, V22, P881, DOI 10.1002/pol.1984.170220341
   ISHIHARA K, 1984, J APPL POLYM SCI, V29, P211, DOI 10.1002/app.1984.070290119
   KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R
   KUKUFATA E, 1991, NATURE, V351, P302
   KUMAR MNV, IN PRESS PROG POLYM
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   KWON IC, 1990, MAKROMOL CHEM-M SYMP, V33, P265, DOI 10.1002/masy.19900330123
   LANCASTER CM, 1989, POLYM PREPRINTS, V30, P480, DOI DOI 10.1016/0032-3861(89)90018-9
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   LIN MS, 1993, J POLYM SCI POL CHEM, V31, P3317, DOI 10.1002/pola.1993.080311320
   MAKINO K, 1990, J CONTROL RELEASE, V112, P235
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   ROBERTS GFA, 1982, INT J BIOL MACROMOL, V4, P373
   SANNAN T, 1978, POLYMER, V19, P458, DOI 10.1016/0032-3861(78)90256-2
   SANNAN T, 1976, POLYM COMMUN, V19, P458
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P179, DOI 10.1016/0168-3659(88)90044-2
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   YAO KD, 1994, POLYM INT, V34, P213, DOI 10.1002/pi.1994.210340213
   YASHIDA R, 1991, JPN J ARTIF ORGANS, V2, P465
NR 35
TC 70
Z9 73
U1 0
U2 9
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD FEB
PY 2000
VL 49
IS 2
BP 141
EP 146
DI 10.1002/(SICI)1097-0126(200002)49:2<141::AID-PI303>3.0.CO;2-0
PG 6
WC Polymer Science
SC Polymer Science
GA 282KH
UT WOS:000085216900001
DA 2018-10-19
ER

PT J
AU Nogata, F
AF Nogata, Fumio
TI Biological strain/stress sensing power in plants and modelling
   mechanisms
SO STRAIN
LA English
DT Article
DE Biomaterial; smart material; cell based mechanosensor;
   self-organisation; photoelasticity; biological signal; adaptive
   modelling mechanism; ion channel
AB This paper describes a cell based mechanosensing power and adapting modelling mechanisms found in plants. Biological structures consist of mechanical load carriers, which are strongly optimised in terms of mechanical strength and minimum mass. It is shown that bamboo structures are designed to have uniform stresses at all positions, applying various sizes of bamboo fibre at the optimal locations. As a significant biological design system, a biological sensing power for detecting the strain/stress induced by external loads can be accepted. The mechanosensing system can be regarded as that in which live cells detect the external mechanical strain/stress as biological electric signals generated by the motions of various ions throughout and/or into the channels of the cell membrane. The modelling mechanism is a cell based mechanosensor that depends on the kind of plant. Three types for detecting the mechanical strain/stress (tension sensitive, compression sensitive, and tension and compression sensitive types) are investigated. Changes in electrical signals at the local portion of a plant body due to the mechanical deformation of cell membranes, affect the modelling of a plant S tissue to fit external mechanical environments.
C1 Gifo Univ, Fac Engn, Dept Mech & Syst Engn, Yanagido Gifu 5011193, Japan.
RP Nogata, F (reprint author), Gifo Univ, Fac Engn, Dept Mech & Syst Engn, Yanagido Gifu 5011193, Japan.
CR Ding J. P., 1989, BIOPHYS J, V55, p224a
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317
   HAYES WC, 1982, FINITE ELEMENTS BIOM, P223
   Koch JC, 1917, AM J ANAT, V21, P177, DOI 10.1002/aja.1000210202
   MATTHECK C, 1990, INT J FATIGUE, V12, P185, DOI 10.1016/0142-1123(90)90094-U
   MATTHECK C, 1990, MATERIALWISS WERKST, V21, P143, DOI 10.1002/mawe.19900210403
   Nishihara K., 1997, P INT C MAT MECH ICM, P66
   NOGATA F, 1995, COMPOS ENG, V5, P743, DOI 10.1016/0961-9526(95)00037-N
   Nogata F., 1997, P INT C ADV TECHN EX, P215
   Nogata F., 1997, MATER TECHNOL, V12, P104
   POLLACK SR, 1984, CALCIFIED TISSUE INT, V36, pS77, DOI 10.1007/BF02406138
   POLLACK SR, 1984, J BIOMECH, V17, P627, DOI 10.1016/0021-9290(84)90094-0
   SIGURDSON WJ, 1987, J EXP BIOL, V127, P191
   Sokabe J., 1991, BIOPHYS J, V59, P722
   Stockbridge L. L., 1988, BIOPHYS J, V54, P17
   The Japan Wood Research Society, 1995, WOND WORLD WOOD JAP, P25
   WILLIAMS WS, 1975, J BIOMECH, V8, P407, DOI 10.1016/0021-9290(75)90076-7
   Wolff J, 1870, ARCH PATHOLOGISCHE A, V50, P389
NR 19
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0039-2103
J9 STRAIN
JI Strain
PD FEB
PY 2000
VL 36
IS 1
BP 3
EP 8
DI 10.1111/j.1475-1305.2000.tb01162.x
PG 6
WC Materials Science, Characterization & Testing
SC Materials Science
GA V22DJ
UT WOS:000208255600001
DA 2018-10-19
ER

PT J
AU Cheng, EY
   Kropp, BP
AF Cheng, EY
   Kropp, BP
TI Urologic tissue engineering with small-intestinal submucosa: potential
   clinical applications
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE tissue engineering; bladder; regeneration
ID BLADDER AUGMENTATION; GRAFT; REGENERATION; MEMBRANE; DETRUSOR; SURGERY;
   RABBIT; INVIVO; DOG
AB Small-intestinal submucosa (SIS) is a unique biomaterial that has been shown to induce tissue-specific regeneration in numerous organ systems. In the urinary tract, animal studies have demonstrated that SIS promotes functional bladder regeneration. Other preliminary studies have suggested that SIS may also be extremely useful for several other types of urologic surgery application where new tissue is needed or reinforcement of native structures is desired. This article reviews past and current work with SIS in the urinary tract and focuses on applications that will likely have future clinical utility.
C1 Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA.
RP Cheng, EY (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, 920 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.
CR AGISHI T, 1975, J BIOMED MATER RES, V9, P119, DOI 10.1002/jbm.820090416
   ASHKAR L, 1967, J UROLOGY, V98, P679, DOI 10.1016/S0022-5347(17)62956-2
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1996, 1 SIS S ORL FLOR 11
   BOHNE AW, 1955, SURG GYNECOL OBSTET, V100, P259
   BOHNE AW, 1957, J UROLOGY, V77, P725, DOI 10.1016/S0022-5347(17)66624-2
   FISHMAN IJ, 1987, J UROLOGY, V138, P1291, DOI 10.1016/S0022-5347(17)43586-5
   FURNESS PD, 1998, 2 SIS S ORL FLOR 2 3
   GORHAM S, 1984, UROL RES, V12, P295, DOI 10.1007/BF00258039
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   KOLLIGIAN MK, 1997, AM AC PED SECT UR NE
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   KROPP BP, 1995, ADV EXP MED BIOL, V385, P229
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   KUDISH HG, 1957, J UROLOGY, V78, P232, DOI 10.1016/S0022-5347(17)66428-0
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Metzger DW, 1996, 1 SIS S ORL FLOR 11
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SAFIR MH, 1997, J UROLOGY, V157, pA139
   SCOTT R, 1988, BRIT J UROL, V62, P26, DOI 10.1111/j.1464-410X.1988.tb04259.x
   SWINNEY J, 1961, BR J UROL, V33, P414
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Weigel Noel D., 1996, Journal of Urology, V155, p546A
   ZHANG YY, 1999, AM AC PED SECT UR WA
NR 34
TC 73
Z9 77
U1 0
U2 4
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD FEB
PY 2000
VL 18
IS 1
BP 26
EP 30
DI 10.1007/PL00007071
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 298WD
UT WOS:000086161700005
PM 10766040
DA 2018-10-19
ER

PT J
AU Rojas, IA
   Slunt, JB
   Grainger, DW
AF Rojas, IA
   Slunt, JB
   Grainger, DW
TI Polyurethane coatings release bioactive antibodies to reduce bacterial
   adhesion
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE immunoglobulins; hydrogel coating; antibodies; controlled release;
   bacteria; infection; adhesion
ID INTRAVENOUS IMMUNE GLOBULIN; CENTRAL VENOUS CATHETER;
   PSEUDOMONAS-AERUGINOSA; IN-VITRO; STAPHYLOCOCCUS-EPIDERMIDIS;
   MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; ANTIPEPTIDE ANTIBODIES;
   INFECTIOUS-DISEASES; CONTROLLED TRIAL
AB This study describes the formulation of a biomedical grade polyurethane hydrogel coating containing solid dispersed bioactive antibodies cast from an organic solvent onto a model polymer biomaterial substrate. A prepolymer dispersion in anhydrous isopropanol containing a uniformly distributed slurry of 22 mu m sieved commercial lyophilized polyclonal pooled human immunoglobulin G (IgG) solids was coated onto polymer substrates by simple immersion. Maximum antibody release was approximately 50 mu g/cm(2) from a 15% w/w IgG polymer coating. In vitro antimicrobial studies utilized Escherichia coli to compare performance of bare uncoated tubing, hydrogel-coated tubing with added aqueous phase antibodies, and antibody-dispersed hydrogel-coated tubing. Bacterial adhesion was reduced significantly (p<0.05) in the presence of antibodies with the greatest reduction seen with the antibody releasing coating. The presence of antibody also significantly enhanced the killing of the bacteria in an in vitro opsonophagocytic assay using freshly isolated blood neutrophils over 2 h indicating that antibody bioactivity is maintained. This controlled release polyurethane hydrogel coating imparts infection resistance by exploiting the low adhesive properties of the biomedical grade hydrogel and the intrinsic bioactive role of the antibodies to reduce bacterial adhesion and promote clearance via natural immune mechanisms. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Gamma A Technol, Herndon, VA 20170 USA.
   Anthony G Cristina Inst Biomed Res, Herndon, VA 20170 USA.
RP Slunt, JB (reprint author), Gamma A Technol, 520 Huntmar Pk Dr,Suite 101, Herndon, VA 20170 USA.
FU NIAMS NIH HHS [2R01AR26957-11A1]
CR Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Braatz J A, 1994, J Biomater Appl, V9, P71, DOI 10.1177/088532829400900104
   BRAATZ JA, 1992, J BIOMAT SCI-POLYM E, V3, P451, DOI 10.1163/156856292X00439
   CASADEVALL A, 1995, CLIN INFECT DIS, V21, P150, DOI 10.1093/clinids/21.1.150
   Casadevall A, 1996, EMERG INFECT DIS, V2, P200, DOI 10.3201/eid0203.960306
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   Darouiche RO, 1997, NUTRITION, V13, pS26, DOI 10.1016/S0899-9007(97)00219-0
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   DAVIS CP, 1995, J UROLOGY, V154, P1948, DOI 10.1016/S0022-5347(01)66832-0
   Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678
   El-Zaim HS, 1998, INFECT IMMUN, V66, P5551
   Ellis ME, 1996, SCAND J INFECT DIS, V28, P91, DOI 10.3109/00365549609027157
   Elzaim HS, 1998, INFECT IMMUN, V66, P2170
   FISCHER GW, 1994, J INFECT DIS, V169, P324, DOI 10.1093/infdis/169.2.324
   Gabriel MM, 1996, CURR MICROBIOL, V33, P1, DOI 10.1007/s002849900064
   Garrison JR, 1997, ASAIO J, V43, P8, DOI 10.1097/00002480-199701000-00003
   Gemmell CG, 1996, DRUG EXP CLIN RES, V22, P51
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gristina Anthony G., 1994, Clinical Microbiology Newsletter, V16, P171, DOI 10.1016/0196-4399(94)90037-X
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   HAMMARSTROM L, 1990, INFECTION, V18, P314, DOI 10.1007/BF01647018
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HIEMSTRA PS, 1994, J LAB CLIN MED, V123, P241
   John SF, 1996, FEMS MICROBIOL LETT, V144, P241, DOI 10.1016/0378-1097(96)00352-7
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   KOU JH, 1990, J CONTROL RELEASE, V12, P241, DOI 10.1016/0168-3659(90)90105-3
   KRISHNAMURTHY R, 1998, BIOPHARM         JAN, P32
   Kuo PY, 1998, NAT BIOTECHNOL, V16, P163, DOI 10.1038/nbt0298-163
   Lamp KC, 1996, ANTIMICROB AGENTS CH, V40, P247, DOI 10.1128/AAC.40.1.247
   LAMPERI S, 1987, ARTIF CELLS ARTIF OR, V15, P151
   LANDSPERGER WJ, 1994, INFECT IMMUN, V62, P4825
   Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607
   Larsen T, 1997, J CLIN PERIODONTOL, V24, P254, DOI 10.1111/j.1600-051X.1997.tb01839.x
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   LOPEZLOPEZ G, 1991, J MED MICROBIOL, V34, P349, DOI 10.1099/00222615-34-6-349
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   Markowitz MA, 1997, APPL BIOCHEM BIOTECH, V68, P57, DOI 10.1007/BF02785980
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   OCHI H, 1991, INFECT IMMUN, V59, P550
   PARANAVITANA CM, 1996, IMMUNOTHER INFECT DI, V8, P25
   PFEIFER RW, 1994, AM J HOSP PHARM, V51, P1676
   REID G, 1994, J BIOMED MATER RES, V28, P731, DOI 10.1002/jbm.820280610
   ROJAS IA, 1999, UNPUB INFECT IMMUN
   ROSOK MJ, 1990, INFECT IMMUN, V58, P3819
   Schierholz JM, 1997, ZBL BAKT-INT J MED M, V286, P107
   SHERERTZ RJ, 1983, J CLIN MICROBIOL, V18, P160
   Sherertz RJ, 1997, J CLIN MICROBIOL, V35, P641
   TAKIGUCHI K, 1992, ARCH VIROL, V122, P1, DOI 10.1007/BF01321113
   Trautmann M, 1998, J ANTIMICROB CHEMOTH, V41, P163, DOI 10.1093/jac/41.2.163
   Tzianabos AO, 1998, J INFECT DIS, V178, P200, DOI 10.1086/515594
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   van Oss CJ, 1997, J MOL RECOGNIT, V10, P203, DOI 10.1002/(SICI)1099-1352(199709/10)10:5<203::AID-JMR366>3.0.CO;2-Z
   Vogel P, 1996, LAB ANIM SCI, V46, P516
   Wizemann TM, 1999, EMERG INFECT DIS, V5, P395, DOI 10.3201/eid0503.990310
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
NR 60
TC 66
Z9 67
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 3
PY 2000
VL 63
IS 1-2
BP 175
EP 189
DI 10.1016/S0168-3659(99)00195-9
PG 15
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 274AB
UT WOS:000084740600017
PM 10640591
DA 2018-10-19
ER

PT B
AU Canham, L
AF Canham, L
BE Dittmar, A
   Beebe, D
TI Porous silicon as a therapeutic biomaterial
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
ID SURFACE
AB Silicon, the dominant semiconductor, has not been actively developed as a biomaterial,despite the attractiveness of chip-based microsystems for therapeutic applications. There is now both in-vitro and in-vivo evidence that silicon surfaces can be engineered to have bone-bonding potential, and that highly porous silicon can be biodegradable in the human body.
C1 DERA, Sensors & Elect Div, Malvern WR14 3PS, Worcs, England.
RP Canham, L (reprint author), DERA, Sensors & Elect Div, St Andrews Rd, Malvern WR14 3PS, Worcs, England.
CR Bowditch AP, 1999, MATER RES SOC SYMP P, V536, P149
   Buriak J.M., 1999, J CHEM SOC CHEM COMM, P1051
   CANHAM L, 1997, PROPERTIES POROUS SI, P405
   Canham LT, 1996, ADV MATER, V8, P850, DOI 10.1002/adma.19960081020
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   CANHAM LT, 2000, IN PRESS PHYSICA STA
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   DESAI T, 1995, T ASME PD, V71, P97
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   EVERED D, 1986, SILICON BIOCH, P264
   HETKE JF, 1994, IEEE T BIO-MED ENG, V41, P314, DOI 10.1109/10.284959
   JAY T, 2000, IN PRESS PHYSICA STA
   KANDA Y, 1981, ELECTRON LETT, V17, P558, DOI 10.1049/el:19810391
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Williams DF, 1999, WILLIAMS DICT BIOMAT, P343
NR 19
TC 5
Z9 5
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 109
EP 112
DI 10.1109/MMB.2000.893752
PG 4
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000024
DA 2018-10-19
ER

PT B
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
BE Dittmar, A
   Beebe, D
TI Laser microfabricated polymer surfaces: Effect of microtopography on
   cell growth
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
ID EXCIMER-LASER; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS
AB The relatively recent introduction of microelectronics technology into the area of biological sciences has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate new methods combining microphotolithographical techniques with high energy KrF excimer laser beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic topographical surface features that are relevant in governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells plated onto the laser modified surfaces showed preferential cell deposition on surfaces presenting "smooth" microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field of biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients).
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, F-33076 Bordeaux, France.
RP Duncan, AC (reprint author), Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
CR CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 542
EP 544
DI 10.1109/MMB.2000.893843
PG 3
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000115
DA 2018-10-19
ER

PT J
AU Kozek-Langenecker, SA
   Mohammad, SF
   Masaki, T
   Green, W
   Kamerath, C
   Cheung, AK
AF Kozek-Langenecker, SA
   Mohammad, SF
   Masaki, T
   Green, W
   Kamerath, C
   Cheung, AK
TI The effects of aprotinin on platelets in vitro using whole blood flow
   cytometry
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID CARDIOPULMONARY BYPASS; ACTIVATED PLATELETS; MECHANISMS; NEUTROPHIL;
   ADHESION; SURGERY
AB We sought to evaluate the effects of aprotinin on the number and function of the platelet glycoprotein (GP) IIb-IIIa receptor and on the expression of P-selectin in vitro in order to gain insight into the potential mechanisms involved in the platelet-protective action of aprotinin during cardiopulmonary bypass. Aprotinin at 50 to 200 kallikrein inhibiting units/mL decreased the expression of activated GP IIb-IIIa complex in response to adenosine diphosphate or thrombin receptor activator peptide 6 in a dose-dependent manner in both citrated and heparinized whole blood experiments. Aprotinin inhibited adenosine diphosphate-induced platelet aggregation, but it exhibited no effect on the expression of GP IIIa and P-selectin. These results indicate that aprotinin interferes with the platelet fibrinogen receptor function during pharmacological activation. Reduced aggregability and platelet adhesion to fibrinogen adsorbed to synthetic surfaces in the presence of aprotinin may prevent platelet consumption during clinical cardiopulmonary bypass. This in vitro study demonstrates that aprotinin decreases the agonist-induced expression of activated GP IIb-IIIa receptors that play a major role in platelet aggregation and adhesion to biomaterial surfaces. Implications: This in vitro study demonstrates that aprotinin decreases the agonist-induced expression of activated glycoprotein IIb-IIIa receptors that play a major role in platelet aggregation and adhesion to biomaterial surfaces.
C1 Univ Vienna, Sch Med, Dept Anesthesiol, Vienna, Austria.
   Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA.
   Univ Utah, Sch Med, Artificial Heart Lab, Salt Lake City, UT USA.
   Univ Utah, Sch Med, Dept Med, Div Nephrol & Hypertens, Salt Lake City, UT USA.
   Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA.
   Vet Affairs Med Ctr, Med & Res Serv, Salt Lake City, UT 84148 USA.
RP Kozek-Langenecker, SA (reprint author), Univ Vienna, Dept Anesthesiol & Gen Intens Care, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
CR BOISCLAIR MD, 1993, BLOOD, V82, P3350
   Campbell F W, 1991, J Cardiothorac Vasc Anesth, V5, P8, DOI 10.1016/1053-0770(91)90080-D
   COUGHLIN S, 1992, J CLIN INVEST, V89, P353
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Golanski J, 1996, THROMB RES, V83, P199, DOI 10.1016/0049-3848(96)00129-6
   KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P315, DOI 10.1016/S1010-7940(05)80092-2
   KETTERL R, 1980, MED WELT, V31, P1239
   Kozek-Langenecker SA, 1999, KIDNEY INT, V56, P299, DOI 10.1046/j.1523-1755.1999.00518.x
   LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4
   LAVEE J, 1993, ANN THORAC SURG, V55, P114, DOI 10.1016/0003-4975(93)90484-Y
   MATZDORFF AC, 1993, HAEMOSTASIS, V23, P293
   MOHAMMAD SF, 1981, AM J PATHOL, V104, P132
   Parolari A, 1999, ANESTH ANALG, V89, P26, DOI 10.1097/00000539-199907000-00005
   Primack C, 1996, ANN THORAC SURG, V61, P1188, DOI 10.1016/0003-4975(96)00016-1
   Ray MJ, 1997, ANN THORAC SURG, V63, P57
   Salzman E. W., 1994, HEMOSTASIS THROMBOSI, P1469
   Schmitz G, 1998, THROMB HAEMOSTASIS, V79, P885
   SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107
   SHATTIL SJ, 1987, BLOOD, V70, P307
   TANGEN O, 1971, THROMB DIATH HAEMOST, V25, P268
   VANOEVEREN W, 1990, J THORAC CARDIOV SUR, V99, P788
   VANOEVEREN W, 1987, ANN THORAC SURG, V44, P640, DOI 10.1016/S0003-4975(10)62153-4
   WACHTFOGEL YT, 1993, J THORAC CARDIOV SUR, V106, P1
   Wahba A, 1996, THROMB HAEMOSTASIS, V75, P844
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
NR 25
TC 18
Z9 18
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD JAN
PY 2000
VL 90
IS 1
BP 12
EP 16
DI 10.1097/00000539-200001000-00004
PG 5
WC Anesthesiology
SC Anesthesiology
GA 270WF
UT WOS:000084559600004
PM 10624968
DA 2018-10-19
ER

PT J
AU Edds, EM
   Bergamini, TM
   Brittian, KR
AF Edds, EM
   Bergamini, TM
   Brittian, KR
TI Bacterial components inhibit fibroblast proliferation in vitro
SO ASAIO JOURNAL
LA English
DT Article
ID STREPTOCOCCAL LIPOTEICHOIC ACID; ENTEROCOCCUS-HIRAE ATCC-9790; VASCULAR
   GRAFT INFECTION; NECROSIS-FACTOR-ALPHA; IN-SITU REPLACEMENT;
   STAPHYLOCOCCUS-EPIDERMIDIS; SURGICAL-MANAGEMENT; CYTOKINE PRODUCTION;
   ARTERIAL GRAFTS; HUMAN MONOCYTES
AB Perigraft fluid from Staphylococcus epidermidis infected grafts in a mouse model significantly inhibits fibroblast proliferation (60-98% at 7 and 28 days), compared with perigraft fluid from sterile grafts. The fibroblast inhibitor was trypsin-heat resistant and dependent primarily upon the bacteria, not the host proinflammatory mediators or the vascular graft biomaterial. We tested the inhibitory properties of S. epidermidis strains RP62A (slime producer) and RP62NA (nonslime producer) and Staphylococcus aureus strain 502a, using an in vitro tritiated thymidine murine fibroblast (ATCC CCL-12) proliferation assay. Whole killed bacteria, disrupted bacteria (live and killed), bacterial supernatants, and purified cell wall products (peptidoglycan, teichoic acid, and lipoteichoic acid from disrupted bacteria) were studied. Significant fibroblast inhibition occurred for all three bacterial strains with disrupted bacteria (live or killed) and cell free bacteria derived supernatants. The fibroblast inhibitor from disrupted slime producing S. epidermidis was trypsin-heat resistant. The fibroblast inhibitor from disrupted S. aureus and supernatants for all three bacterial strains at 1 x 10(7) were trypsin-heat sensitive. Fibroblast inhibition was not dependent upon bacterial viability and not mediated by bacterial cell wall products. In conclusion, components of slime and nonslime producing S. epidermidis and S. aoreus inhibit fibroblast proliferation.
C1 Univ Louisville, Dept Surg, Sch Med, Louisville, KY 40202 USA.
   Vet Adm Med Ctr, Louisville, KY USA.
RP Bergamini, TM (reprint author), Univ Louisville, Dept Surg, Sch Med, 550 S Jackson St, Louisville, KY 40202 USA.
CR BANDYK DF, 1991, J VASC SURG, V13, P575
   BANDYK DF, 1993, J VASC SURG, V18, P398, DOI 10.1016/0741-5214(93)90257-M
   BOUHOUTSOS J, 1974, BRIT J SURG, V61, P108, DOI 10.1002/bjs.1800610208
   Brant MD, 1996, J UROLOGY, V155, P155, DOI 10.1016/S0022-5347(01)66580-7
   Bunt T J, 1993, Cardiovasc Surg, V1, P489
   BUNT TJ, 1983, SURGERY, V93, P733
   CALLE PP, 1990, ZOO BIOL, V9, P11, DOI 10.1002/zoo.1430090103
   CALLIGARO KD, 1994, ANN SURG, V220, P461, DOI 10.1097/00000658-199410000-00005
   Concannon M. J., 1993, Journal of Burn Care and Rehabilitation, V14, P141, DOI 10.1097/00004630-199303000-00003
   Earnshaw J J, 1996, Cardiovasc Surg, V4, P570, DOI 10.1016/0967-2109(96)88095-1
   Elgavish A, 1996, J CELL PHYSIOL, V169, P52, DOI 10.1002/(SICI)1097-4652(199610)169:1<52::AID-JCP6>3.0.CO;2-D
   FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x
   FRY WJ, 1972, SURG CLIN N AM, V52, P1419
   Garrison JR, 1997, ASAIO J, V43, P8, DOI 10.1097/00002480-199701000-00003
   GRECO RS, 1991, J VASC SURG, V5, P753
   Henke PK, 1998, J SURG RES, V74, P17, DOI 10.1006/jsre.1997.5210
   HEUMANN D, 1994, INFECT IMMUN, V62, P2715
   HYZY J, 1992, MICROB PATHOGENESIS, V13, P123, DOI 10.1016/0882-4010(92)90072-V
   Jacobs M J, 1991, Eur J Vasc Surg, V5, P83, DOI 10.1016/S0950-821X(05)80932-6
   JENSEN B, 1993, J ANTIMICROB CHEM SA, V32, P69
   Lambert PA, 1996, J MED MICROBIOL, V44, P355, DOI 10.1099/00222615-44-5-355
   LIEKWEG WG, 1977, SURGERY, V81, P335
   LORENTZEN JE, 1985, SURGERY, V98, P81
   MANCUSO G, 1994, INFECT IMMUN, V62, P1470
   MARTINEZMARTINEZ L, 1993, J MED MICROBIOL, V39, P196, DOI 10.1099/00222615-39-3-196
   MATTSSON E, 1993, FEMS IMMUNOL MED MIC, V7, P281, DOI 10.1111/j.1574-695X.1993.tb00409.x
   MERTENS RA, 1995, J VASC SURG, V21, P782, DOI 10.1016/S0741-5214(05)80009-6
   MONEFELDT K, 1994, ORAL MICROBIOL IMMUN, V9, P70, DOI 10.1111/j.1399-302X.1994.tb00037.x
   OHSHIMA Y, 1992, ZBL BAKT-INT J MED M, V277, P357
   ONTA T, 1993, MICROBIOL IMMUNOL, V37, P573, DOI 10.1111/j.1348-0421.1993.tb01679.x
   PADBERG FT, 1992, J SURG RES, V53, P384, DOI 10.1016/0022-4804(92)90065-8
   PADBERG FT, 1995, ARCH SURG-CHICAGO, V130, P183
   PETERSON PK, 1978, J CLIN INVEST, V61, P597, DOI 10.1172/JCI108971
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   SEABROOK GR, 1990, J VASC SURG, V11, P625
   SUDA Y, 1995, FEMS IMMUNOL MED MIC, V12, P97, DOI 10.1016/0928-8244(95)00055-C
   TABBARA MR, 1995, ANN VASC SURG, V9, P378, DOI 10.1007/BF02139410
   TAKADA H, 1995, INFECT IMMUN, V63, P57
   TOWNE JB, 1994, J VASC SURG, V19, P226, DOI 10.1016/S0741-5214(94)70098-2
   TSUKAYAMA DT, 1991, ORTHOPEDICS, V14, P841
   VIJTIUK N, 1993, IMMUNOBIOLOGY, V188, P274, DOI 10.1016/S0171-2985(11)80235-4
   VonHunolstein C, 1997, INFECT IMMUN, V65, P4017
   Wagstaff S A, 1996, Cardiovasc Surg, V4, P796, DOI 10.1016/S0967-2109(95)00143-3
   WILLE JJ, 1992, J CELL PHYSIOL, V150, P52, DOI 10.1002/jcp.1041500108
NR 44
TC 5
Z9 7
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JAN-FEB
PY 2000
VL 46
IS 1
BP 33
EP 37
DI 10.1097/00002480-200001000-00011
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 392UK
UT WOS:000166430800011
PM 10667713
DA 2018-10-19
ER

PT S
AU Leroux, L
   Freche, M
   Lacout, JL
AF Leroux, L
   Freche, M
   Lacout, JL
BE Giannini, S
   Moroni, A
TI Calcium phosphate cement to prepare Sr-containing biomaterials
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE apatite; calcium phosphate cement; ceramic; release tests; strontium
ID STRONTIUM; DISSOLUTION
AB A new route, based on the use of ionic calcium phosphate cements, has been developed to synthesize calcium strontium hydroxyapatite. Cements were prepared from tetracalcium phosphate, a-tricalcium phosphate, phosphoric acid, strontium nitrate and water and were then mixed and shaped. Cements with various amounts of strontium (0 to 4.3wt%) were prepared. All the materials obtained were coherent and solid. Mixed hydroxyapatite was obtained at low temperatures. Mixed calcium strontium apatite was obtained after heating. This original method can be of interest for the preparation of biomaterials because strontium plays a part in the mineralisation of bone. The steady release of strontium was studied and can lead to a better osteointegartion of the biomaterial.
C1 Ecole Natl Super Chim, CIRIMAT, INPT ENSCT, CNRS UMR 5085,Equipe Physicochim Phosphates, FR-31400 Toulouse, France.
RP Leroux, L (reprint author), Ecole Natl Super Chim, CIRIMAT, INPT ENSCT, CNRS UMR 5085,Equipe Physicochim Phosphates, 38 Rue 36 Ponts, FR-31400 Toulouse, France.
CR ANDERSON P, 1992, J DENT RES, V71, P1473, DOI 10.1177/00220345920710080301
   BRANDI ML, 1993, AM J MED, V95, pS69, DOI 10.1016/0002-9343(93)90386-4
   Bronner Felix, 1996, P295
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   HATIM Z, 1997, BIOCERAMICS, V10, P375
   HATIM Z, 1998, THESIS U CHOUAIB DOU
   HERBISON RJ, 1975, J DENT RES, V54, P1107, DOI 10.1177/00220345750540060201
   KREFTING ER, 1993, SCANNING MICROSCOPY, V7, P203
   LACOUT JL, 1998, Patent No. 9803459
   LEROUX L, 2000, THESIS INP TOULOUSE
NR 11
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 235
EP 238
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700059
DA 2018-10-19
ER

PT S
AU Ignjatovic, N
   Delijic, K
   Vukcevic, M
   Uskokovic, D
AF Ignjatovic, N
   Delijic, K
   Vukcevic, M
   Uskokovic, D
BE Giannini, S
   Moroni, A
TI Microstructure and mechanical properties of hot-pressed
   hydroxyapatite/poly-L-lactide biomaterials
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE composite biomaterial; compressive strength; density; designing;
   elasticity modulus; hot pressing
ID COMPOSITES; POLYLACTIDE; DEVICES
AB Effects of the hot pressing parameters on the designing of structures and propel-ties of hydroxyapatite/poly-L-lactide (HAD/PLLA) biocomposite blocks have been studied. Interdependences of temperature, pressure and time of hot pressing and the density, compressive strength, elasticity modulus were defined. Microstructures of the fracture surfaces were observed by scanning electron microscopy (SEM), A wide spectrum of block properties such as relative density of 86.2-99.6%, compressive strength of 38.2-139.0 MPa and elasticity modulus of 1.9-10.0 Cpa was obtained by varying the hot pressing parameters.
C1 Serbian Acad Sci & Arts, Inst Tech Serv, Belgrade, Yugoslavia.
   Univ Podgorica, Fac Technol & Met, Podgorica, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Sci & Arts, Inst Tech Serv, K Mihajlova 35-5, Belgrade, Yugoslavia.
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X
CR CHO S, 1997, KEY ENG MATER, V132, P802
   Gogolewski S, 1996, J BIOMED MATER RES, V32, P227
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, MATER SCI FORUM, V352, P143, DOI 10.4028/www.scientific.net/MSF.352.143
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   KATZ JL, 1986, ENCY MAT SCI ENG, P475
   LAURENCIN C, 1998, POLYM PREPRINTS, V2, P122
   Lu LC, 1996, MRS BULL, V21, P28
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P267, DOI 10.1016/0141-3910(85)90050-3
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Wang M., 1996, P 7 EUR C COMP MAT L, P455
NR 14
TC 5
Z9 5
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 737
EP 740
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700176
DA 2018-10-19
ER

PT J
AU Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
AF Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
TI Preparation and characterization of hydrophobic polymeric films that are
   thromboresistant via nitric oxide release
SO BIOMATERIALS
LA English
DT Article
DE nitric oxide; polymer materials; blood compatibility; biomaterial
   surfaces
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PLATELET-AGGREGATION; IN-VIVO;
   9-FLUORENYLMETHYL CHLOROFORMATE; PRECOLUMN DERIVATIZATION; VASCULAR
   ENDOTHELIUM; MEMBRANE-ELECTRODE; HEPARIN; SENSORS; BIOCOMPATIBILITY
AB The preparation of hydrophobic polymer films (polyurethane and poly(vinyl chloride)) containing nitric oxide (NO)-releasing diazeniumdiolate functions is reported as a basis for improving the thromboresistivity of such polymeric materials for biomedical applications. Several different approaches for preparing NO-releasing polymer films are presented, including: (1) dispersion of diazeniumdiolate molecules within the polymer matrix; (2) covalent attachment of the diazeniumdiolate to the polymer backbone; and (3) ion-pairing of a diazeniumdiolated heparin species to form an organic soluble complex that can be blended into the polymer. Each approach is characterized in terms of NO release rates and in vitro biocompatibility. Results presented indicate that the polymer films prepared by each approach release NO for variable periods of time (10-72 h), although they differ in the mechanism, location and amount of NO released. In vitro platelet adhesion studies demonstrate that the localized NO release may prove to be an effective strategy for improving blood compatibility of polymer materials for a wide range of medical devices. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA.
   NCI, Frederick Canc Res & Dev Ctr, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.
RI Keefer, Larry/N-3247-2014
OI Keefer, Larry/0000-0001-7489-9555
FU NCI NIH HHS [N01-CO-56000]; NIGMS NIH HHS [GM 56991]
CR ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANNICH GM, 1999, IN PRESS CRIT CARE M
   Banerjee R, 1997, J BIOMATER APPL, V12, P57, DOI 10.1177/088532829701200104
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   DAVIDSON GWR, 1984, BIOMATERIALS, V5, P227, DOI 10.1016/0142-9612(84)90020-6
   DAVSON H, 1952, PERMEABILITY NATURAL, P38
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   FU B, 1995, MACROMOLECULES, V28, P5834, DOI 10.1021/ma00121a021
   FU B, 1994, ANAL CHEM, V66, P2250, DOI 10.1021/ac00086a009
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   Hrabie JA, 1999, ORG PREP PROCED INT, V31, P189, DOI 10.1080/00304949909355709
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   HULANICKI A, 1987, ANAL CHIM ACTA, V194, P119, DOI 10.1016/S0003-2670(00)84765-0
   IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103
   Keefer LK, 1996, METHOD ENZYMOL, V268, P281
   KELM M, 1996, METHODS NITRIC OXIDE, P47
   KUSY RP, 1994, POLYMER, V35, P2141, DOI 10.1016/0032-3861(94)90241-0
   KYROLAINEN M, 1995, ACTA ANAESTH SCAND, V39, P55, DOI 10.1111/j.1399-6576.1995.tb04255.x
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   Li Z, 1996, ANAL CHEM, V68, P1717, DOI 10.1021/ac950557a
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LOEPPKY RN, 1994, ACS SYM SER, V553, P1
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Merchant K, 1996, CHEM RES TOXICOL, V9, P891, DOI 10.1021/tx950102g
   MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6
   MIWA H, 1994, J VASC SURG, V19, P658, DOI 10.1016/S0741-5214(94)70039-7
   MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955
   MONROE JM, 1980, BIOMATER ARTIF CELL, V8, P103, DOI 10.3109/10731198009118976
   Mowery KA, 1999, POLYMER, V40, P6203, DOI 10.1016/S0032-3861(99)00187-1
   MOWERY KA, 1999, IN PRESS ELECTROANAL
   Pasic M, 1996, EUR J CARDIO-THORAC, V10, P372, DOI 10.1016/S1010-7940(96)80097-2
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x
   RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Ramamurthy N, 1998, CLIN CHEM, V44, P606
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   SAAVEDRA JE, 1992, J ORG CHEM, V57, P6134, DOI 10.1021/jo00049a017
   SAAVEDRA JE, 1999, IN PRESS J ORG CHEM
   SABRI MI, 1989, J NEUROSCI METH, V29, P27, DOI 10.1016/0165-0270(89)90105-2
   SALVEMINI D, 1990, BRIT J PHARMACOL, V101, P991, DOI 10.1111/j.1476-5381.1990.tb14194.x
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SCHMIDT HHH, 1996, METHODS NITRIC OXIDE, P491
   SCHOENFISCH MH, 1998, 216 ACS NAT M BOST M
   SCHOENFISCH MH, UNPUB IMPROVING THRO
   SCHWAKE A, 1997, P EUROSENSORS 11, V1, P243
   SINEY L, 1992, EUR J PHARMACOL, V229, P223, DOI 10.1016/0014-2999(92)90559-M
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Stead DA, 1996, J CHROMATOGR B, V675, P295, DOI 10.1016/0378-4347(95)00355-X
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   THOMSON C, 1973, CLIN SCI MOL MED, V45, P485, DOI 10.1042/cs0450485
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Weerwind PW, 1998, INT J ARTIF ORGANS, V21, P291
   YANG VC, 1993, CHEMTECH, V23, P25
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   YUN JH, 1993, ELECTROANAL, V5, P719, DOI 10.1002/elan.1140050903
NR 58
TC 151
Z9 157
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2000
VL 21
IS 1
BP 9
EP 21
DI 10.1016/S0142-9612(99)00127-1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266FW
UT WOS:000084290800003
PM 10619674
DA 2018-10-19
ER

PT J
AU Caplan, MR
   Schwartzfarb, EM
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Schwartzfarb, EM
   Kamm, RD
   Lauffenburger, DA
TI Controlling the properties of a self-assembling, oligopeptide
   biomaterial via amino acid sequence
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 MIT, Cambridge, MA 02139 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2000
VL 78
IS 1
MA 77Plat
BP 14A
EP 14A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 274RR
UT WOS:000084779300077
DA 2018-10-19
ER

PT J
AU Arenas, MA
   Tate, TJ
   Conde, A
   De Damborenea, J
AF Arenas, MA
   Tate, TJ
   Conde, A
   De Damborenea, J
TI Corrosion behaviour of nitrogen implanted titanium in simulated body
   fluid
SO BRITISH CORROSION JOURNAL
LA English
DT Article
ID HYDROGEN-PEROXIDE; BIOMATERIAL APPLICATIONS; SURFACE MODIFICATIONS;
   ION-IMPLANTATION; STAINLESS-STEEL; RESISTANCE; FILMS
AB Titanium is one of the most important materials for medical applications, as a result of its uniquely high biocompatibility. The effect of nitrogen implantation on the biocompatibility and the corrosion resistance of cp titanium are reported. Grazing incidence X-ray diffraction studies showed that implantation formed a delta -TiN(x) phase. Electrochemical tests in NBSS showed an optimal decrease in corrosion current density for specimens implanted with 3 x 10(17) ions cm(-2) at 25 keV, compared with unimplanted titanium Following implantation and immersion in a commercial physiological solution, phases are precipitated which are rich in calcium and phosphorus, and these hydroxyapatite precursors indicate that this implantation regime confers optimal properties of corrosion resistance and biocompatibility.
C1 CSIC, CENIM, Dept Corros & Protect, Madrid 28040, Spain.
   Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London SW7 2BT, England.
RI de Damborenea, Juan/B-1018-2008; Conde, Ana/G-1530-2018
OI de Damborenea, Juan/0000-0002-8053-594X; Conde, Ana/0000-0001-7889-8664;
   Arenas, Maria Angeles/0000-0002-7807-8209
CR Badawy W. A., 1993, British Corrosion Journal, V28, P133
   De Groot Klaas, 1993, P49
   DEARNALEY G, 1991, SURFACE ENG HEAT TRE, P285
   DEDAMBORENEA JJ, 1997, B SOC ESPAN CERAM VI, V36, P202
   Ensinger W., 1997, PROTECTIVE COATINGS, P585
   Garcia I, 1998, CORROS SCI, V40, P1411, DOI 10.1016/S0010-938X(98)00046-8
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HEIDE N, 1992, SURF INTERFACE ANAL, V19, P423, DOI 10.1002/sia.740190179
   HOHMUTH K, 1985, MATER SCI ENG, V69, P489, DOI 10.1016/0025-5416(85)90351-9
   JimenezMorales A, 1997, J APPL ELECTROCHEM, V27, P550, DOI 10.1023/A:1018446628256
   Krupa D, 1996, SURF COAT TECH, V79, P240, DOI 10.1016/0257-8972(95)02457-3
   Leitao E, 1997, CORROS SCI, V39, P377, DOI 10.1016/S0010-938X(97)83352-5
   LEITAO E, 1995, CORROS SCI, V37, P1861, DOI 10.1016/0010-938X(95)00091-W
   Leitao E, 1997, J MATER SCI-MATER M, V8, P365, DOI 10.1023/A:1018532900458
   MAZZOLDI P, 1992, EURO MECH M, V1, P83
   MERGET M, 1984, P 5 INT C TIT SEPT, V2, P1393
   MIRANDA R, 1984, VACUUM, V34, P1069, DOI 10.1016/0042-207X(84)90227-6
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PESCH HJ, 1984, P 5 INT C TIT MUN 10, V2, P1387
   RODRIGUEZ AS, 1994, AVANCE PERSPECTIVA, V13, P49
   RODRIGUEZ R, 1996, SEGUNDO CURSO CIENCI, P203
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   Wolf GK, 1996, SURF COAT TECH, V83, P1, DOI 10.1016/0257-8972(95)02810-2
   YILBAS BS, 1995, CORROS SCI, V37, P1627, DOI 10.1016/0010-938X(95)00065-R
NR 28
TC 35
Z9 35
U1 0
U2 4
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0007-0599
J9 BRIT CORROS J
JI Br. Corros. J.
PY 2000
VL 35
IS 3
BP 232
EP 236
DI 10.1179/000705900101501308
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 396CL
UT WOS:000166618700009
DA 2018-10-19
ER

PT J
AU Jackson, IT
   Yavuzer, R
AF Jackson, IT
   Yavuzer, R
TI Hydroxyapatite cement: an alternative for craniofacial skeletal contour
   refinements
SO BRITISH JOURNAL OF PLASTIC SURGERY
LA English
DT Article
DE hydroxyapatite cement; craniofacial surgery; biomaterials
ID RECONSTRUCTION; CRANIOPLASTY; AUGMENTATION; IMPLANT
AB Hydroxyapatite cement is a calcium phosphate preparation composed of tetracalcium phosphate and dicalcium phosphate anhydrous powders. When mixed with water it isothermically forms a paste which can easily be shaped intraoperatively. This mixture sets in approximately 15-20 min and converts into water insoluble, nonceramic, microporous hydroxyapatite in 4 h. This biomaterial tvas used to correct either congenital or traumatic craniofacial contour irregularities or deficiencies in 20 patients. On follow-up there was only one patient who required repeat surgery for further correction, there were no other complications. The good cosmetic results, the ease of operation, the pliability of the cement paste allowing precise moulding during application, the short operation time and the avoidance of a donor site makes hydroxyapatite cement an attractive material for treating craniofacial contour defects. Careful long term follow-up is necessary to establish its safety and reliability. (C) 2000 The British Association of Plastic Surgeons.
C1 Providence Hosp, Inst Craniofacial & Reconstruct Surg, Southfield, MI 48037 USA.
RP Jackson, IT (reprint author), Inst Craniofacial & Reconstruct Surg, Fisher Ctr, 16001 W 9 Mile Rd,3rd Floor, Southfield, MI 48075 USA.
CR Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAMERER DB, 1994, AM J OTOL, V15, P47
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Maniker A, 1998, NEUROSURGERY, V43, P953, DOI 10.1097/00006123-199810000-00134
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   Smith AW, 1999, EUR J PLAST SURG, V22, P17, DOI 10.1007/s002380050137
   Stelnicki EJ, 1997, J CRANIOFAC SURG, V8, P367, DOI 10.1097/00001665-199708050-00007
NR 17
TC 47
Z9 51
U1 0
U2 9
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0007-1226
J9 BRIT J PLAST SURG
JI Br. J. Plast. Surg.
PD JAN
PY 2000
VL 53
IS 1
BP 24
EP 29
DI 10.1054/bjps.1999.3236
PG 6
WC Surgery
SC Surgery
GA 279EL
UT WOS:000085031400005
PM 10657445
DA 2018-10-19
ER

PT B
AU Barbucci, R
   Lamponi, S
   Magnani, A
AF Barbucci, R
   Lamponi, S
   Magnani, A
BE Fabbrizzi, L
   Poggi, A
TI Biological performance of materials
SO CHEMISTRY AT THE BEGINNING OF THE THIRD MILLENNIUM: MOLECULAR DESIGN,
   SUPRAMOLECULES, NANOTECHNOLOGY AND BEYOND
LA English
DT Proceedings Paper
CT German-Italian Meeting of Coimbra Group Universities Meeting on
   Chemistry at the Beginning of the 3rd Millennium
CY OCT 07-10, 1999
CL PAVIA, ITALY
SP Coimbra Grp Univ
ID BLOOD COMPATIBILITY; POLYMER SURFACES; HYDROGELS; SCIENCE; BIOMATERIALS;
   PRECURSORS; MONOLAYERS; TOPOGRAPHY; ACTIVATION; CHEMISTRY
AB The biomaterial science, the study of the application of materials to biological and biomedical problems is a field characterised by medical needs, basic research, advanced technological development, industrial involvement, ethical considerations and regulations. The biological performance of materials largely depends on their bulk and surface properties.
   Some general concepts necessary to define the biological performance of materials are discussed. Current approaches of surface modification of materials and methods of synthesis for creating surfaces with specific biofuncionality are reviewed.
C1 Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, Via E Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   BRANKER JH, 1995, J BIOMED MATER RES, V29, P1517
   CHAMILTON D, UNPUB IMPLICATIONS C
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   Curtis A, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P158
   CURTIS ASG, 1988, TOPOGRAPHY CONTROL C, V7, P141
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FOWKES FM, 1988, ENCY POLYM SCI ENG S, P1
   GARBASSI F, 1989, SURF INTERFACE ANAL, V14, P585, DOI 10.1002/sia.740141004
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1985, POLYM MED, V2, P157
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LAURENT TC, 1998, CHEM BIOL HYALURONAN
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MAGNANI A, 1995, J MATER CHEM, V5, P1321, DOI 10.1039/jm9950501321
   MAGNANI A, 1993, TEST PROCEDURES BLOO, P171
   MAGNANI A, UNPUB IN VITRO STUDY
   MAGNANI A, IN PRESS NOVEL POLYS
   MALLIK S, 1994, NEW J CHEM, V18, P299
   NOCENTINI M, 1993, TEST PROCEDURES BLOO, P151
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PLATE NA, 1986, ADV POLYM SCI, V79, P95
   PRITCHARD DJ, 1995, ANAL CHEM, V67, P3605, DOI 10.1021/ac00115a034
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1993, CARDIOVASC PATHOL S, V2, P875
   RATNER BD, 1993, ACS POLYM PREPR, V34, P643
   RATNER BD, 1988, POLYM SURFACE DYNAMI, P137
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SOMORJAI GA, 1990, J PHYS CHEM-US, V94, P1013, DOI 10.1021/j100366a001
   SOMORJAI GA, 1991, LANGMUIR, V7, P3176, DOI 10.1021/la00060a043
   SUM F, 1994, J VAC SCI TECHNOL A, V12, P2499
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Williams D, 1988, ADV BIOMATER, V8, P11
   WOICIAKSTOTHARD B, 1997, DEV BIOL ANIMAL, V33, P110
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu S., 1982, POLYM INTERFACE ADHE
NR 58
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-67460-8
PY 2000
BP 161
EP 183
PG 23
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic; Chemistry, Physical
SC Chemistry
GA BQ71C
UT WOS:000089239800008
DA 2018-10-19
ER

PT J
AU Webb, K
   Caldwell, K
   Tresco, PA
AF Webb, K
   Caldwell, K
   Tresco, PA
TI Fibronectin immobilized by a novel surface treatment regulates
   fibroblast attachment and spreading
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 18th Southern Biomedical Engineering Conference/2nd International
   Conference on Ethical Issues in Biomedical Engineering
CY MAY 21-23, 1999
CL CLEMSON UNIV, CLEMSON, SOUTH CAROLINA
HO CLEMSON UNIV
DE tissue engineering; covalent immobilization; ECM proteins
ID EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; PROTEIN ADSORPTION; INTEGRINS
AB In order to understand the influence of cell-adhesive molecules on anchorage-dependent cell behavior on biomaterial surfaces, a model system is required where these molecules can be applied to surfaces with controlled surface ligand density and resistance to the adsorption of additional proteins present in the medium. This study asked whether fibronectin could be immobilized in a controlled manner to a hydrophobic surface with a chemically modified triblock surfactant. ELISA studies indicated that variation of the soluble fibronitctin concentration used for immobilization could be used to control the amount of fibronectin immobilized to the surface. Furthermore, fibroblasts seeded on these surfaces in 10% serum-containing medium atttched and spread as a function of the amount of immobilized fibronectin. Surfaces treated with unmodified surfactant did not support cell attachment, suggesting that cell attachment and spreading were primarily regulated by the immobilized fibronectin with minimal interference from adsorption of serum proteins. Together, these results suggest that covalent immobilization to Pluronic(TM) F108 provides a method for studying cellular responses to cell adhesive proteins with little interference from competing adsorbates, even in the presence of complex biological fluids such as serum. This technique may be applicable to a variety of existing hydrophobic biomedical polymers as a basic scence tool as well as for influencing cell behavior at implant interfaces.
C1 WM Keck Ctr Tissue Engn, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Webb, K (reprint author), WM Keck Ctr Tissue Engn, Dept Bioengn, 20 S 2030 E,Room 506,Biopolymers Bldg, Salt Lake City, UT 84112 USA.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Li JT, 1996, COLLOID SURFACE B, V7, P9, DOI 10.1016/0927-7765(96)01269-6
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
NR 13
TC 13
Z9 13
U1 0
U2 2
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892 USA
SN 0278-940X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 2000
VL 28
IS 1-2
BP 203
EP 208
DI 10.1615/CritRevBiomedEng.v28.i12.350
PG 6
WC Engineering, Biomedical
SC Engineering
GA 352ZA
UT WOS:000089248200036
PM 10999388
DA 2018-10-19
ER

PT J
AU Lombello, CB
   Malmonge, SM
   Wade, MLF
AF Lombello, CB
   Malmonge, SM
   Wade, MLF
TI Morphology of fibroblastic cells cultured on poly(HEMA-co-AA) substrates
SO CYTOBIOS
LA English
DT Article
DE biomaterial; poly(2-hydroxyethylmethacrylate); acrylic acid; Vero cell;
   cell culture
ID ARTICULAR-CARTILAGE; CHONDROCYTES; GROWTH; SHAPE; EXPRESSION; SURFACES
AB Fibroblastic cells in culture are characteristically elongated and grow in monolayers. This growth pattern can be modified by different factors, such as substrate interaction. It is characteristic of hydrogels made of poly(2-hydroxyethylmethacrylate) (polyHEMA) that they inhibit cellular attachment and spreading. Vero cells were cultured on porous samples of polyHEMA and the copolymer poly(HEMA-co-AA) with 7.5% (w/w) and 15% (w/w) acrylic acid. Cultures were maintained for 2 and 10 days in HAM F10 medium with 10% foetal calf serum. Hydrogel samples were processed for light microscopy and scanning electron microscopy. The round Vero cells proliferated on the hydrogels and were principally located inside the pores. Some cells were aggregated, but no extracellular matrix was found. The copolymer with 15% (w/w) acrylic acid was the most suitable substrate and should be used in future tests of morphological differentiation and induction of cellular function.
C1 UNICAMP, Inst Biol, Dept Cellular Biol, BR-13083970 Campinas, SP, Brazil.
   UNICAMP, Ctr Technol, Biomech Engn Lab, BR-13083970 Campinas, SP, Brazil.
RP Lombello, CB (reprint author), UNICAMP, Inst Biol, Dept Cellular Biol, CxP 6109, BR-13083970 Campinas, SP, Brazil.
RI Lombello, Christiane/G-4128-2014; Malmonge, Sonia/I-4610-2012
OI Lombello, Christiane Bertachini/0000-0002-4927-7292
CR ADAMS RLP, 1990, CELL CULTURE BIOCHEM
   Bujia J, 1996, IN VITRO CELL DEV-AN, V32, P116
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KLEBE RJ, 1981, J CELL PHYSIOL, V109, P481, DOI 10.1002/jcp.1041090314
   LEARY K, 1980, J ULTRA MOL STRUCT R, V72, P123, DOI 10.1016/S0022-5320(80)90050-7
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7
   LYNDON MJ, 1985, BIOMAT, V6, P396
   MALMONGE SM, 1999, IN PRESS REV BRASIL
   MALMONGE SM, 1997, WORLD C MED PHYS BIO
   MALMONGE SM, 1997, REV POL CIENC TECNOL, V2, P22
   NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7
   PATRONE LM, 1992, J TISS CULT METHODS, V14, P225
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   Peppas NA, 1987, HYDROGELS MED PHARM
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   Reissis N, 1995, J MATER SCI-MATER M, V6, P768, DOI 10.1007/BF00134315
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   WADA MLF, 1991, CYTOBIOS, V67, P101
NR 24
TC 14
Z9 15
U1 0
U2 7
PU FACULTY PRESS
PI CAMBRIDGE
PA 88 REGENT ST, CAMBRIDGE, CAMBS, ENGLAND CB2 1DP
SN 0011-4529
J9 CYTOBIOS
JI Cytobios
PY 2000
VL 101
IS 397
BP 115
EP 122
PG 8
WC Cell Biology
SC Cell Biology
GA 291AP
UT WOS:000085710800006
PM 10756984
DA 2018-10-19
ER

PT J
AU Ouchi, T
   Seike, H
   Miyazaki, H
   Tasaka, F
   Ohya, Y
AF Ouchi, T
   Seike, H
   Miyazaki, H
   Tasaka, F
   Ohya, Y
TI Synthesis of a block copolymer of L-lactide and depsipeptide with
   pendant thiol groups
SO DESIGNED MONOMERS AND POLYMERS
LA English
DT Article
DE polylactide; polydepsipeptide; block copolymer; thiol group;
   macro-initiator
AB In order to develop a new type of lactic acid copolymer having pendant reactive groups as a biodegradable biomaterial, the synthesis of an AB-type diblock copolymer of L-lactide (L-LA) and depsipeptide with pendant thiol groups was investigated. Cyclodepsipeptide consisting of glycolic acid (Glc) and beta -methoxybenzyl L-cystine (Cys), cyclo[Glc-Cys(MBzl)], was polymerized in tetrahydrofuran (THF) solution using potassium ethoxide as an initiator. The terminal hydroxyl group of the poly[Glc-Cys(MBzl)] obtained was converted to potassium alkoxide by K/naphthalene. L-LA was polymerized in THF using the polymer alkoxide as a macro-initiator to obtain poly[Glc-Cys(MBzl)]- block-polyLA showing two melting temperatures (T(m)8). Through subsequent deprotection of the methoxybenzyl groups, the objective biodegradable amphiphilic AB-type block copolymer, poly(Glc Cys)-block-polyLA, was obtained. The accumulation ability of thiol groups located on the surface of the block copolymer film was evaluated to be higher than that of the random copolymer film.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
CR ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   KOHN FE, 1984, J APPL POLYM SCI, V29, P4265, DOI 10.1002/app.1984.070291255
   OHYA Y, UNPUB MACROMOLECULES
   Ouchi T, 1996, MACROMOL CHEM PHYSIC, V197, P1823, DOI 10.1002/macp.1996.021970604
   Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
NR 7
TC 12
Z9 13
U1 0
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 1385-772X
J9 DES MONOMERS POLYM
JI Des. Monomers Polym.
PY 2000
VL 3
IS 3
BP 279
EP 287
DI 10.1163/156855500300160230
PG 9
WC Polymer Science
SC Polymer Science
GA 379LQ
UT WOS:000165643900004
DA 2018-10-19
ER

PT J
AU Pardo-Yissar, V
   Katz, E
   Willner, I
   Kotlyar, AB
   Sanders, C
   Lill, H
AF Pardo-Yissar, V
   Katz, E
   Willner, I
   Kotlyar, AB
   Sanders, C
   Lill, H
TI Biomaterial engineered electrodes for bioelectronics
SO FARADAY DISCUSSIONS
LA English
DT Article
ID GLUCOSE-OXIDASE; KINETIC SEPARATION; GOLD ELECTRODE; ELECTROCHEMICAL
   REDUCTION; 4-ELECTRON REDUCTION; ENZYME ELECTRODES; AU-ELECTRODES;
   CYTOCHROME-C; MONOLAYERS; DIOXYGEN
AB A series of single-cysteine-containing cytochrome c, Cyt c, heme proteins including the wild-type Cyt c (from Saccharomyces cerevisiae) and the mutants (V33C, Q21C, R18C, G1C, K9C and K4C) exhibit direct electrical contact with Au-electrodes upon covalent attachment to a maleimide monolayer associated with the electrode. With the G1C-Cyt c mutant, which includes the cysteine residue in the polypeptide chain at position 1, the potential-induced switchable control of the interfacial electron transfer was observed. This heme protein includes a positively charged protein periphery that surrounds the attachment site and faces the electrode surface. Biasing of the electrode at a negative potential (-0.3 V vs. SCE) attracts the reduced Fe(ii)-Cyt c heme protein to the electrode surface. Upon the application of a double-potential-step chronoamperometric signal onto the electrode, where the electrode potential is switched to +0.3 V and back to -0.3 V, the kinetics of the transient cathodic current, corresponding to the re-reduction of the Fe(iii)-Cyt c, is controlled by the time interval between the oxidative and reductive potential steps. While a short time interval results in a rapid interfacial electron-transfer, k(et)(1)=20 s(-1), long time intervals lead to a slow interfacial electron transfer to the Fe(iii)-Cyt c, k(et)(2)=1.5 s(-1). The fast interfacial electron-transfer rate-constant is attributed to the reduction of the surface-attracted Fe(iii)-Cyt c. The slow interfacial electron-transfer rate constant is attributed to the electrostatic repulsion of the positively charged Cyt c from the electrode surface, resulting in long-range electron transfer exhibiting a lower rate constant. At intermediate time intervals between the oxidative and reductive steps, two populations of Cyt c, consisting of surface-attracted and surface-repelled heme proteins, are observed. Crosslinking of a layered affinity complex between the Cyt c and cytochrome oxidase, COx, on an Au-electrode yields an electrically-contacted, integrated, electrode for the four-electron reduction of O-2 to water. Kinetic analysis reveals that the rate-limiting step in the bioelectrocatalytic reduction of O-2 by the integrated Cyt c/COx electrode is the primary electron transfer from the electrode support to the Cyt c units.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
   Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.
   Univ Osnabruck, Biophys Abt, D-49069 Osnabruck, Germany.
RP Pardo-Yissar, V (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il
RI Kotlyar, Alexander/H-7314-2016
OI Kotlyar, Alexander/0000-0003-0713-6499
CR Armstrong F.A., 1986, Q REV BIOPHYS, V18, P261
   ARMSTRONG FA, 1988, ACCOUNTS CHEM RES, V21, P407, DOI 10.1021/ar00155a004
   Bard A. J., 1980, ELECTROCHEMICAL METH
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BARTLETT P N, 1991, Progress in Reaction Kinetics, V16, P55
   CASS AEG, 1985, BIOCHIM BIOPHYS ACTA, V828, P51, DOI 10.1016/0167-4838(85)90008-1
   COLLMAN JP, 1983, J AM CHEM SOC, V105, P2699, DOI 10.1021/ja00347a030
   COLLMAN JP, 1980, J AM CHEM SOC, V102, P6027, DOI 10.1021/ja00539a009
   COLLMAN JP, 1983, J AM CHEM SOC, V105, P2694, DOI 10.1021/ja00347a029
   COLLMAN JP, 1986, J AM CHEM SOC, V108, P7847, DOI 10.1021/ja00284a067
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   DURAND RR, 1983, J AM CHEM SOC, V105, P2710, DOI 10.1021/ja00347a032
   Forster RJ, 1996, ANALYST, V121, P733, DOI 10.1039/an9962100733
   FORSTER RJ, 1995, LANGMUIR, V11, P2247, DOI 10.1021/la00006a064
   FORSTER RJ, 1995, ANAL CHEM, V67, P1232, DOI 10.1021/ac00103a014
   GOODSELL DS, 1993, TRENDS BIOCHEM SCI, V18, P65, DOI 10.1016/0968-0004(93)90153-E
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   HILL HAO, 1981, FEBS LETT, V126, P282, DOI 10.1016/0014-5793(81)80261-X
   HILL HAO, 1982, J AM CHEM SOC, V104, P6515, DOI 10.1021/ja00388a006
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   KATZ E, 1994, J ELECTROANAL CHEM, V367, P59, DOI 10.1016/0022-0728(93)03010-M
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   Katz E, 1998, BIOSENS BIOELECTRON, V13, P741, DOI 10.1016/S0956-5663(98)00038-4
   KATZ E, 1994, J ELECTROANAL CHEM, V368, P87, DOI 10.1016/0022-0728(93)03039-R
   Katz E, 1997, LANGMUIR, V13, P3364, DOI 10.1021/la961095e
   KAWANO M, 1993, J AM CHEM SOC, V115, P2068, DOI 10.1021/ja00058a080
   KHARITONOV AP, UNPUB
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   MURPHY MEP, 1992, J MOL BIOL, V227, P160, DOI 10.1016/0022-2836(92)90689-H
   Patolsky F, 1998, CHEM-EUR J, V4, P1068, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1068::AID-CHEM1068>3.3.CO;2-H
   SANDERS C, IN PRESS BIOCH BIOPH
   Willner I, 1999, J AM CHEM SOC, V121, P6455, DOI 10.1021/ja983182u
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031
   WOOD F, 1980, BRAIN LANG, V9, P1, DOI 10.1016/0093-934X(80)90068-1
   YONETANI T, 1961, J BIOL CHEM, V236, P1680
NR 37
TC 62
Z9 63
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-6640
EI 1364-5498
J9 FARADAY DISCUSS
JI Faraday Discuss.
PY 2000
VL 116
BP 119
EP 134
DI 10.1039/b001508n
PG 16
WC Chemistry, Physical
SC Chemistry
GA 372RZ
UT WOS:000165249000010
PM 11197474
DA 2018-10-19
ER

PT J
AU Pardo-Yissar, V
   Katz, E
   Willner, I
   Kotlyar, AB
   Sanders, C
   Lill, H
AF Pardo-Yissar, V
   Katz, E
   Willner, I
   Kotlyar, AB
   Sanders, C
   Lill, H
TI Biomaterial engineered electrodes for bioelectronics (vol 116, pg 119,
   2000)
SO FARADAY DISCUSSIONS
LA English
DT Correction
RI Kotlyar, Alexander/H-7314-2016
CR Pardo-Yissar V, 2000, FARADAY DISCUSS, V116, P119, DOI 10.1039/b001508n
NR 1
TC 1
Z9 1
U1 0
U2 1
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0301-7249
J9 FARADAY DISCUSS
JI Faraday Discuss.
PY 2000
VL 116
BP 356
EP 356
PG 1
WC Chemistry, Physical
SC Chemistry
GA 372RZ
UT WOS:000165249000028
DA 2018-10-19
ER

PT B
AU Schwager, K
AF Schwager, K
BE Rosowski, JJ
   Merchant, SN
TI Titanium in ossicular chain reconstruction - Morphological results in
   animal experiments and after implantation in the human middle ear
SO FUNCTION AND MECHANICS OF NORMAL, DISEASED AND RECONSTRUCTED MIDDLE EARS
LA English
DT Proceedings Paper
CT 2nd International Symposium on Middle Ear Mechanics in Research and
   Otosurgery
CY OCT 21-24, 1999
CL BOSTON, MA
SP Harvard Med Sch, Dept Continuing Educ, Massachusetts Eye & Ear Infirmary, Dept Otolaryngol
DE titanium; middle ear; ossicular replacement
ID OTOLOGIC SURGERY; HYDROXYLAPATITE; OSSICULOPLASTY; PROSTHESES
AB Titanium ossicular replacement prostheses were studied using light and scanning electron microscopy. An animal study was performed in the middle ear of the rabbit: titanium pins were used as middle ear prostheses, and morphological studies were performed up to 504 days after implantation. In a subsequent clinical study, a total of 536 ears were implanted and 23 prostheses removed at revision surgery were studied morphologically. Tissue reactions in animal and in human middle ears looked similar. An inflammatory reaction was seen in the early postoperative stage in the animal study and in chronic ear disease. The material's surface was covered with regular mucosa and submucosal connective tissue. In cases of chronic ear disease, high cylindrical epithelium with ciliated and goblet cells was detected. From the experimental standpoint and clinical experience so far, titanium seems to be a favorable biomaterial for ossicular replacement.
C1 Univ Wurzburg, Klin & Poliklin Hals Nasen & Ohrenkranke, D-97080 Wurzburg, Germany.
RP Schwager, K (reprint author), Univ Wurzburg, Klin & Poliklin Hals Nasen & Ohrenkranke, Josef Schneider Str 11, D-97080 Wurzburg, Germany.
EM K.Schwager@mail.uni-wuerzburg.de
CR ALBREKTSSON T, 1982, CLIN APPL BIOMATERIA, P167
   ARNOLD W, 1977, ARCH OTO-RHINO-LARYN, V216, P537, DOI 10.1007/BF00458962
   COLETTI V, 1984, ACTA OTORHINOL ITAL, V4, P689
   COUSINS VC, 1987, CLIN OTOLARYNGOL, V12, P183, DOI 10.1111/j.1365-2273.1987.tb00185.x
   DARC MB, 1996, KNOCHENERSATZ MITTEL, V1, P47
   Geyer G, 1997, HNO, V45, P222, DOI 10.1007/s001060050108
   GEYER G, 1993, EUR ARCH OTO-RHINO-L, V250, P253
   GEYER G, 1990, THESIS WURZBURG
   GJURIC M, 1987, LARYNGO RHINO OTOL, V66, P522, DOI 10.1055/s-2007-998723
   GROTE JJ, 1981, ORL J OTO-RHINO-LARY, V43, P248, DOI 10.1159/000275544
   GROTE JJ, 1985, AM J OTOL, V6, P269
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   HOMSY CA, 1984, BIOMATERIALS OTOLOGY, P9
   HOPPE F, 1996, KNOCHENERSATZ MITTEL, V1, P104
   JAEHNE M, 1996, KNOCHENERSATZ MITTEL, V1, P63
   JAHNKE K, 1980, ARCH OTO-RHINO-LARYN, V227, P624, DOI 10.1007/BF00467629
   JAHNKE K, 1979, ARCH OTO-RHINO-LARYN, V223, P373, DOI 10.1007/BF01109587
   KERR AIG, 1984, CLIN OTOLARYNGOL, V9, P361, DOI 10.1111/j.1365-2273.1984.tb01522.x
   KUIJPERS W, 1984, BIOMATERIALS OTOLOGY, P18
   MCELVEEN JT, 1994, OTOLARYNG CLIN N AM, V27, P777
   MCELVEEN JT, 1995, OTOLARYNG HEAD NECK, V113, P420, DOI 10.1016/S0194-5998(95)70079-X
   PLESTER D, 1981, AM J OTOL, V3, P104
   PUSALKAR A, 1996, KNOCHENERSATZ MITTEL, V1, P55
   RECK R, 1981, CLIN OTOLARYNGOL, V6, P63, DOI 10.1111/j.1365-2273.1981.tb01786.x
   SCHWAGER K, IN PRESS BIOMATERIAL
   SPECTOR M, 1984, BIOMATERIALS OTOLOGY, P29
   STEINBACH E, 1996, KNOCHENERSATZ MITTEL, V1, P58
   Stupp CH, 1996, LARYNGO RHINO OTOL, V75, P335, DOI 10.1055/s-2007-997590
   TEICHGRAEBER JF, 1983, AM J OTOL, V5, P127
   WEHRS RE, 1989, AM J OTOL, V10, P181
NR 30
TC 1
Z9 1
U1 0
U2 1
PU KUGLER PUBLICATIONS BV
PI THE HAGUE
PA PO BOX 97747, 2509 GC THE HAGUE, NETHERLANDS
BN 90-6299-181-5
PY 2000
BP 243
EP 254
PG 12
WC Acoustics; Engineering, Biomedical; Otorhinolaryngology
SC Acoustics; Engineering; Otorhinolaryngology
GA BS14B
UT WOS:000168820700021
DA 2018-10-19
ER

PT J
AU Farrar, DJ
AF Farrar, DJ
TI Development of a prosthetic coronary artery bypass graft
SO HEART SURGERY FORUM
LA English
DT Article; Proceedings Paper
CT 3rd Annual NewEra Cardiac Care Conference
CY JAN 13-16, 2000
CL SAN DIEGO, CA
ID VENTRICULAR ASSIST DEVICES; EXPERIENCE; CONDUIT; SURGERY
AB Background: The patient population undergoing repeat coronary revascularization is increasing, with estimates of approximately 15% of these patients in need of alternative conduits. Pre-existing conditions may limit the availability of suitable autogenous vessels for complete coronary revascularization. As an alternative, previous investigators have attempted to develop prosthetic conduits for coronary artery bypass grafting (CABG), but as yet without clinical success. To be of clinical benefit, a prosthetic graft would require demonstrated patency at least as good as a marginal quality autogenous vessel used in the same position, without unexpected adverse effects. The use of a prosthetic graft may also reduce surgical complications associated with conduit harvesting and thereby enhance the speed of patient recovery.
   Methods: Our group has investigated the potential of a novel synthetic small diameter vascular graft (2.5- to 3.5-mm diameter), as an alternative conduit for CABG. The graft is designed with three distinct layers composed of Thoralon(R), a proprietary polyetherurethaneurea with a silicone-based surface modifying additive. This biomaterial is the same material successfully used for the thromboresistant blood-contacting surfaces of an FDA approved and clinically successfull ventricular assist device.
   Results: Aria(TM) grafts underwent extensive preclinical testing in sheep with results to over one year that demonstrate the graft's biocompatibility, biodurability, and ability to maintain patency in both peripheral access graft and coronary applications. Compassionate use human coronary implants have been performed in 27 patients in the coronary position in Canada and Europe. Although incomplete, the data demonstrate no device related serious injury and all surviving patients have remained symptom free.
   Conclusions: A prosthetic coronary artery bypass graft has been developed and has undergone extensive pre-clinical testing and preliminary clinical use. Based upon the results, a prospective, randomized, controlled clinical study, the AEGIS/Canada (AlternativE Graft Investigational Study) trial using the Aria(TM) graft in the coronary position in human patients is underway. Additionally, an IDE submission has been submitted to the FDA to expand the AEGIS clinical trial device to the United States.
C1 Thoratec Labs Corp, Pleasanton, CA 94588 USA.
RP Farrar, DJ (reprint author), Thoratec Labs Corp, 6035 Stoneridge Dr, Pleasanton, CA 94588 USA.
EM djfarrar@thoratec.com
CR Allen RDM, 1996, AUST NZ J SURG, V66, P738, DOI 10.1111/j.1445-2197.1996.tb00733.x
   AMANO I, 1996, JIN TO TOSEKI, V41
   Barner HB, 1998, ANN THORAC SURG, V66, pS2, DOI 10.1016/S0003-4975(98)00966-7
   BROCKBANK KGM, 1992, J CARDIAC SURG, V7, P170, DOI 10.1111/j.1540-8191.1992.tb00793.x
   CANVER CC, 1995, CHEST, V108, P1150, DOI 10.1378/chest.108.4.1150
   Eagle KA, 1999, CIRCULATION, V100, P1464, DOI 10.1161/01.CIR.100.13.1464
   Emery RW, 1996, ANN THORAC SURG, V62, P691, DOI 10.1016/S0003-4975(96)00506-1
   FARRAR DJ, 1988, J THORAC CARDIOV SUR, V95, P191
   Farrar DJ, 1997, J THORAC CARDIOV SUR, V113, P202, DOI 10.1016/S0022-5223(97)70416-1
   GLICKMAN MH, 1999, 2 INT S ANG HEM TOUR
   Korfer R, 1999, ANN THORAC SURG, V68, P678, DOI 10.1016/S0003-4975(99)00541-X
   Love C, 1998, ASAIO J, V44, pM648, DOI 10.1097/00002480-199809000-00070
   McBride LR, 1999, ANN THORAC SURG, V67, P1233, DOI 10.1016/S0003-4975(99)00246-5
   McLarty AJ, 1998, ANN THORAC SURG, V65, P1442, DOI 10.1016/S0003-4975(98)00031-9
   MITCHELL IM, 1993, ANN THORAC SURG, V55, P120, DOI 10.1016/0003-4975(93)90485-Z
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 16
TC 25
Z9 25
U1 0
U2 4
PU FORUM MULTIMEDIA PUBLISHING, LLC
PI CHARLOTTESVILLE
PA 375 GREENBRIER DR, CHARLOTTESVILLE, VA 22901 USA
SN 1098-3511
J9 HEART SURG FORUM
JI Heart Surg. Forum
PY 2000
VL 3
IS 1
BP 36
EP 40
AR 2000-3141
PG 5
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 334WV
UT WOS:000088209400007
PM 11064545
DA 2018-10-19
ER

PT J
AU Hardouin, P
   Anselme, K
   Flautre, B
   Bianchi, F
   Bascoulenguet, G
   Bouxin, B
AF Hardouin, P
   Anselme, K
   Flautre, B
   Bianchi, F
   Bascoulenguet, G
   Bouxin, B
TI Tissue engineering and skeletal diseases
SO JOINT BONE SPINE
LA English
DT Review
DE bone marrow stroma cells; cell therapy; gene therapy; hybrid
   biomaterial; tissue engineering; tissue regeneration
ID BIOACTIVE GLASS; MARROW-CELLS; GENE-THERAPY; BONE; HYDROXYAPATITE;
   ADHESION; RABBIT; MODEL
AB Tissue engineering, a cross between the science of the living organism and that of engineering, aims to replace, maintain or improve human tissue functions, by means of tissue substitutes containing living elements. Thus, it is about production of artificial tissue, using (alone or in combination) cells, matrix or bioactive factors. Their association gives rise to a hybrid biomaterial combining biological components (cells, growth factors or adhesion proteins) and materials (polymers, ceramics). The applications are wide-ranging, from the skin, to the liver, or to the cornea as well as to the locomotor system. Bone tissue engineering has advanced the most in this field, partly because of the progress made by research into bone substitutes, although cartilage and tendons are also concerned. This technology requires cell culture (committed cells or more often bone marrow stem cells), biomaterials (porous materials with controlled architecture and cements), growth factors (such as 'Bone Morphogenetic Proteins'), the proteins implicated in cell adhesion (such as fibronectin or the aminoacid sequences specifically recognised by integrin subunits) or gene therapy (notably using transfected stem cells). Tissue engineering and regenerative stimulation of tissue are now booming on experimental and industrial levels and clinical applications are increasingly numerous. Considering the potential of these technologies, they should continue to develop widely. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
C1 Inst Rech Biomat & Biotechnol, F-62608 Berck Sur Mer, France.
   Inst Calot, Serv Rhumatol, Grp Hopale, F-62608 Berck Sur Mer, France.
   Inst Calot, Grp Hopale, Lab Anal Med, F-62608 Berck Sur Mer, France.
   Inst Calot, Grp Hopale, Dept Chirurg Orthoped & Traumatol Sport, F-62608 Berck Sur Mer, France.
RP Hardouin, P (reprint author), Inst Rech Biomat & Biotechnol, IR2B,52 Rue Dr Calot, F-62608 Berck Sur Mer, France.
OI Anselme, Karine/0000-0002-6669-205X
CR Anselme K, 1999, BONE, V25, P51
   ARNOCZKY SP, 1999, CLIN ORTHOP S, V367, P244
   BODEN SD, 1998, BONE S, V23, P242
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CAPLAN AI, 1999, CLIN ORTHOP S, V367, P1
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   CUI Q, 1999, J BONE MINER RES S, V14, P160
   Dennis J E, 1992, Cell Transplant, V1, P23
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Flautre B, 1999, J MATER SCI-MATER M, V10, P811, DOI 10.1023/A:1008923625599
   Flautre B, 1996, J MATER SCI-MATER M, V7, P63, DOI 10.1007/BF00058716
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Grande DA, 1999, CLIN ORTHOP S, V367s, P176
   Hardouin P, 1996, PRESSE MED, V25, P1860
   HARDOUIN P, 1997, SEMIN MUSCULOSKELETA, V1, P319
   HARDOUIN P, 1999, IN VIVO EVALUATION B
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hernigou P, 1997, REV CHIR ORTHOP, V83, P495
   HERNIGOU P, 1998, REV RHUM, V2, P79
   Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294
   Hubbell JA, 1996, MRS BULL, V21, P33
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mehara B, 1999, J BONE MINER RES, V14, P1290
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   OHURA K, 1997, BIOCERAMICS, V9, P247
   Oyama M, 1999, GENE THER, V6, P321, DOI 10.1038/sj.gt.3300839
   PASSUTI N, 1999, 14015B10
   PASSUTI N, 1999, SOFCOT
   Riew KD, 1998, CALCIFIED TISSUE INT, V63, P357, DOI 10.1007/s002239900540
   *SOFCOT, 1999, MON GESTO
   Vacanti C.A., 1995, TISSUE ENG
   VERRIER S, 1998, J BONE MINER RES S, V23, P535
   WOO SL, 1999, CLIN ORTHOP S, V367, P312
NR 37
TC 23
Z9 26
U1 2
U2 4
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1297-319X
J9 JOINT BONE SPINE
JI Joint Bone Spine
PY 2000
VL 67
IS 5
BP 419
EP 424
PG 6
WC Rheumatology
SC Rheumatology
GA 376LV
UT WOS:000165459800008
PM 11143908
DA 2018-10-19
ER

PT J
AU Banerjee, R
   Puniyani, RR
AF Banerjee, R
   Puniyani, RR
TI Exogenous surfactant therapy and mucus rheology in chronic obstructive
   airway diseases
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Review
DE biomaterial; surfactant; mucus viscosity; asthma; chronic bronchitis;
   cystic fibrosis
ID RESPIRATORY-DISTRESS SYNDROME; PEPTIDE-CONTAINING SURFACTANT; PULMONARY
   SURFACTANT; CYSTIC-FIBROSIS; CHRONIC-BRONCHITIS; GUINEA-PIGS;
   TRACHEOBRONCHIAL SECRETIONS; MUCOCILIARY CLEARANCE; ASTHMATIC-PATIENTS;
   NARROW TUBE
AB Exogenous surfactant is a specialized biomaterial used for substitution of the lipoprotein mixture normally present in the lungs-pulmonary surfactant. Respiratory Distress Syndrome is a disease of preterm infants mainly caused by pulmonary immaturity as evidenced by a deficiency of mature lung surfactant. Pulmonary surfactant is known to stabilize small alveoli and prevent them from collapsing during expiration. However, apart from alveoli, surfactant also lines the narrow conducting airways of the tracheobronchial tree. This paper reviews the role of this surfactant in the airways and its effect on mucus rheology and mucociliary clearance. Its potential role as a therapeutic biomaterial in chronic obstructive airway diseases, namely asthma, chronic bronchitis, and respiratory manifestations of cystic fibrosis, are discussed. This paper also attempts to elucidate the exact steps in the pathogenic pathway of these diseases which could be reversed by supplementation of exogenous surfactant formulations. It is shown that there is great potential for the use of present day surfactants (which are actually formulated for use in Respiratory Disease Syndrome) as therapy in the aforementioned diseases of altered mucus viscoelasticity and mucociliary clearance. However, for improved effectiveness, specific surfactant formulations satisfying certain specific criteria should be tailor-made for the clinical condition for which they are intended. The properties required to be fulfilled by the optimal exogenous surfactant in each of the above clinical conditions are enumerated in this paper.
C1 Indian Inst Technol, Sch Biomed Engn, Bombay 400076, Maharashtra, India.
CR ALLEGRA L, 1985, EUR J RESPIR DIS, V67, P71
   Anzueto A, 1997, JAMA-J AM MED ASSOC, V278, P1426
   BECHER G, 1985, BIOMED BIOCHIM ACTA, V44, pK57
   BENSON BJ, 1984, BIOCHIM BIOPHYS ACTA, V793, P18, DOI 10.1016/0005-2760(84)90048-1
   BROWN DL, 1993, CLIN PERINATOL, V20, P761
   CAMNER P, 1979, SCAND J RESPIR DIS, V60, P56
   Chinet T., 1995, Revue de Pneumologie Clinique, V51, P122
   CLEMENTS JA, 1981, PROG RESPIR RES, V15, P20
   COLACICCO G, 1976, RESP PHYSIOL, V27, P169, DOI 10.1016/0034-5687(76)90072-4
   CRAWFORD ABH, 1995, P ANN SCI MFG ANZ TH, P277
   DAVIS S S, 1969, Biorheology, V6, P11
   DESANCTIS GT, 1994, EUR RESPIR J, V7, P1616, DOI 10.1183/09031936.94.07091616
   Dhanireddy R, 1990, Indian J Pediatr, V57, P743, DOI 10.1007/BF02722267
   DOBBS LG, 1989, ANNU REV MED, V40, P431
   EBERT RV, 1978, ANN INTERN MED, V88, P98, DOI 10.7326/0003-4819-88-1-98
   ENHORNING G, 1989, FERNS FOUND SERIES, V12, P273
   ENHORNING G, 1995, AM J RESP CRIT CARE, V151, P554, DOI 10.1164/ajrccm.151.2.7842219
   ENHORNING G, 1993, J APPL PHYSIOL, V74, P2922
   FARIDY EE, 1976, RESP PHYSIOL, V27, P323, DOI 10.1016/0034-5687(76)90061-X
   FOLDESFILEP E, 1994, J LEUKOCYTE BIOL, V56, P475
   GALABERT C, 1987, CLIN CHIM ACTA, V164, P139, DOI 10.1016/0009-8981(87)90065-9
   GALABERT C, 1989, Biorheology, V26, P521
   Galabert C, 1981, Bull Eur Physiopathol Respir, V17, P197
   GELMAN RA, 1979, AM REV RESPIR DIS, V120, P553
   GIL J, 1971, ANAT REC, V169, P185, DOI 10.1002/ar.1091690205
   GIORDANO AM, 1978, AM REV RESPIR DIS, V118, P245
   GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107
   GIROD S, 1992, AM REV RESPIR DIS, V145, pA689
   GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205
   Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983
   Griese M, 1997, EUR RESPIR J, V10, P1989, DOI 10.1183/09031936.97.10091989
   HALLER CJ, 1994, MICRON, V25, P527, DOI 10.1016/0968-4328(94)90015-9
   Hills BA, 1996, THORAX, V51, P773, DOI 10.1136/thx.51.8.773
   HOFFMAN DR, 1986, BIOCHIM BIOPHYS ACTA, V879, P88, DOI 10.1016/0005-2760(86)90270-5
   Hohlfeld J, 1997, EUR RESPIR J, V10, P482, DOI 10.1183/09031936.97.10020482
   HOLGATE ST, 1993, EUR RESPIR J, V6, P1507
   IRAVANI J, 1972, J PATHOL, V106, P81, DOI 10.1002/path.1711060204
   JOBE A, 1988, NEONATAL CARDIOPULMO, P297
   Johansson J, 1998, BIOL NEONATE, V74, P9, DOI 10.1159/000047029
   KAKUTA Y, 1991, RESP PHYSIOL, V83, P313, DOI 10.1016/0034-5687(91)90050-S
   KAMM RD, 1989, RESP PHYSIOL, V75, P141, DOI 10.1016/0034-5687(89)90059-5
   KILBURN KH, 1968, AM REV RESPIR DIS, V98, P449
   KIM CS, 1983, J APPL PHYSIOL, V55, P154
   KING M, 1979, BIORHEOLOGY, V16, P57
   KING M, 1989, BIORHEOLOGY, V26, P737
   Kristova V, 1992, Bratisl Lek Listy, V93, P41
   Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1254, DOI 10.1164/ajrccm.155.4.9105063
   KURASHIMA K, 1991, Japanese Journal of Allergology, V40, P160
   Kurashima K, 1997, CLIN EXP ALLERGY, V27, P337
   LACHMANN B, 1985, EUR J RESPIR DIS, V67, P49
   Liu M, 1997, CLIN EXP ALLERGY, V27, P802, DOI 10.1111/j.1365-2222.1997.tb01215.x
   LIU MY, 1991, J APPL PHYSIOL, V71, P742
   LORENZI G, 1992, BIORHEOLOGY, V29, P433
   LOW RB, 1978, AM REV RESPIR DIS, V118, P863
   Lusuardi M, 1995, Monaldi Arch Chest Dis, V50, P346
   MACKLEM PT, 1970, RESP PHYSIOL, V8, P191, DOI 10.1016/0034-5687(70)90015-0
   Manalo E, 1996, PEDIATR RES, V39, P947, DOI 10.1203/00006450-199606000-00004
   MATALON S, 1987, J APPL PHYSIOL, V62, P756
   MATTHYS H, 1983, RESPIRATION, V44, P329
   MENDENHA.RM, 1972, RESP PHYSIOL, V16, P175, DOI 10.1016/0034-5687(72)90049-7
   MEYER K, 1992, CHEST S, V102, pS85
   MITCHELL RS, 1968, AM REV RESPIR DIS, V97, P54
   MORGENROTH K, 1985, RESPIRATION, V47, P225
   MORGENROTH K, 1985, EUR J RESPIR DIS, V67, P7
   MOTTA C, 1984, CYSTIC FIBROSIS, P337
   Notter RH, 1997, REV CHEM ENG, V13, P1
   Oetomo SB, 1996, AM J RESP CRIT CARE, V153, P1148, DOI 10.1164/ajrccm.153.3.8630559
   Palmblad M, 1999, BIOCHEM J, V339, P381, DOI 10.1042/0264-6021:3390381
   Posselt H G, 1997, Z Arztl Fortbild Qualitatssich, V91, P243
   Pryhuber GS, 1998, MOL GENET METAB, V64, P217, DOI 10.1006/mgme.1998.2722
   PUCHELLE E, 1995, RESPIRATION, V62, P2
   PUCHELLE E, 1985, EUR J CLIN INVEST, V15, P389, DOI 10.1111/j.1365-2362.1985.tb00290.x
   PUCHELLE E, 1980, EUR J RESPIR DIS, V61, P254
   REID L, 1959, BRIT J RADIOL, V32, P291, DOI 10.1259/0007-1285-32-377-291
   REIFENRATH R, 1978, B EUR PHYSIOPATH RES, V14, pP79
   REIFENRATH R, 1983, PULMONARY SURFACTANT, P339
   Resnikoff J R, 1998, Curr Opin Pulm Med, V4, P130
   Revak SD, 1996, PEDIATR RES, V39, P715, DOI 10.1203/00006450-199604000-00025
   RICHMAN PS, 1990, J LAB CLIN MED, V116, P18
   ROTH MD, 1993, AM J RESP CELL MOL, V9, P652, DOI 10.1165/ajrcmb/9.6.652
   RUBIN BK, 1992, CHEST, V101, P1080, DOI 10.1378/chest.101.4.1080
   RUBIN BK, 1992, PEDIATR PULM, V13, P4, DOI 10.1002/ppul.1950130103
   RUBIN BK, 1990, BIORHEOLOGY, V32, P213
   SADE J, 1970, AM REV RESPIR DIS, V102, P48
   SCHLIMMER P, 1983, EUR J RESPIR DIS, V64, P318
   SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726
   SLOMIANY A, 1982, BIOCHIM BIOPHYS ACTA, V710, P106, DOI 10.1016/0005-2760(82)90196-5
   SLOMIANY BL, 1988, CELLULAR MOL BASIS C, P263
   Smith A, 1997, PEDIATR INFECT DIS J, V16, P91, DOI 10.1097/00006454-199701000-00030
   SNIDER GL, 1988, TXB RESPIRATORY MED, P1070
   STARK AR, 1986, PEDIATR CLIN N AM, V33, P533
   TABOR BL, 1992, AM J OBSTET GYNECOL, V167, P810, DOI 10.1016/S0002-9378(11)91594-4
   TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0
   THOMASSEN MJ, 1994, AM J RESP CELL MOL, V10, P399, DOI 10.1165/ajrcmb.10.4.8136155
   THURLBECK W. M., 1964, THORAX, V19, P436, DOI 10.1136/thx.19.5.436
   TOMASHEFSKI JF, 1985, PULMONARY DEV TRANSI, P387
   TOMKIEWICZ RP, 1990, BIORHEOLOGY, V32, P364
   UCHIDA M, 1992, FOLIA PHARMACOL JPN, V100, P293, DOI 10.1254/fpj.100.293
   VACHIER I, 1994, EUR RESPIR J, V7, P1585, DOI 10.1183/09031936.94.07091585
   VANGOLDE LMG, 1995, BIOL NEONATE, V67, P2
   Wang JY, 1998, AM J RESP CRIT CARE, V158, P510, DOI 10.1164/ajrccm.158.2.9709111
   WANNER A, 1990, CHEST, V97, pS11
   WIDDICOMBE JG, 1985, EUR J RESPIR DIS, V67, P1
   WILKINSON AR, 1993, RECENT ADV PEDIAT, V11, P53
   WOLFF F, 1990, GEBURTSH FRAUENHEILK, V50, P171, DOI 10.1055/s-2007-1026458
   WOODWARD H, 1982, BIOCHEMISTRY-US, V21, P694, DOI 10.1021/bi00533a017
   YAGER D, 1989, J APPL PHYSIOL, V66, P2873
NR 107
TC 9
Z9 9
U1 1
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2000
VL 14
IS 3
BP 243
EP 272
DI 10.1106/9D4B-L6PP-7CTF-BY8G
PG 30
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 276CH
UT WOS:000084857700004
PM 10656543
DA 2018-10-19
ER

PT J
AU Vasudev, SC
   Chandy, T
   Sharma, CP
   Mohanty, M
   Umasankar, PR
AF Vasudev, SC
   Chandy, T
   Sharma, CP
   Mohanty, M
   Umasankar, PR
TI Effects of double cross-linking technique on the enzymatic degradation
   and calcification of bovine pericardia
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE cross-linking; biodegradation; collagenase; glutaraldehyde;
   carbodiimide; hexamethylene diisocyanate; calcification; polyethylene
   glycol
ID MINERALIZATION; POLYURETHANE; COLLAGEN; BIOPROSTHESES; BIOMATERIAL;
   INHIBITION; POROSITY
AB The strength, resorption rates, and biocompatibility of collagenous biomaterials are profoundly influenced by the method of cross-linking. The in vitro and in viuo calcification and enzymatic degradation of bovine pericardia (BP) after a series of surface modifications were studied as a function of exposure time. Collagenase degradations of modified BP were monitored by scanning electron microscopy and tensile strength measurements. Bovine pericardium was modified by a combination of different tissue fixatives such as glutaraldehyde (GA), carbodiimide (EDC), diisocyanate (HMDIC), and polyethylene glycol (PEG). GA-PEG-EDC-PEG and GA-PEG-HMDIC-PEG combination treated BP retained maximum stability in collagenase digestion compared to GATBP. In vitro calcification studies and in vivo rat subcutaneous implantations of modified pericardium have shown substantial reduction in the calcification of double cross-linked BP with PEG modification. Further, the biocompatibility aspects of pericardial tissues were established by platelet adhesion and octane contact angle. It seems that cross-links involving amino and carboxyl residues may provide new ways of controlling biodegradation and calcification.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 605012, Kerala, India.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR Aravind S, 1998, J BIOMATER APPL, V13, P158
   *ASTM, 1982, 63880 ASTM, P250
   BAGNALL RD, 1980, J BIOMED MATER RES, V14, P1, DOI 10.1002/jbm.820140102
   CHANDY T, 1994, J APPL BIOMATER, V5, P245, DOI 10.1002/jab.770050310
   Chandy T, 1996, BIOMATERIALS, V17, P577, DOI 10.1016/0142-9612(96)88708-4
   CHANDY T, 1983, J COLLOID INTERF SCI, V92, P102, DOI 10.1016/0021-9797(83)90120-0
   CHANDY T, 1991, BIOMATERIALS, V12, P677, DOI 10.1016/0142-9612(91)90116-R
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   DOILLON CJ, 1994, J BIOMAT SCI-POLYM E, V6, P715
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1992, J MATER SCI-MATER M, V3, P272, DOI 10.1007/BF00705292
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1989, CRC CRITICAL REV BIO, V2, P147
   PASQUINO E, 1992, J MATER SCI-MATER M, V3, P272
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730
   Tang Z, 1995, ASAIO J, V41, P72, DOI 10.1097/00002480-199501000-00012
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   Vasudev SC, 1997, J BIOMED MATER RES, V35, P357, DOI 10.1002/(SICI)1097-4636(19970605)35:3<357::AID-JBM10>3.0.CO;2-C
   Vasudev SC, 1997, J BIOMATER APPL, V11, P430, DOI 10.1177/088532829701100403
   WEADOCK K, 1983, BIOMAT MED DEV ARTIF, V411, P293
NR 25
TC 5
Z9 6
U1 1
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2000
VL 14
IS 3
BP 273
EP 295
DI 10.1106/HV9G-JEBF-Q7WU-P5XL
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 276CH
UT WOS:000084857700005
PM 10656544
DA 2018-10-19
ER

PT J
AU Myles, JL
   Burgess, BT
   Dickinson, RB
AF Myles, JL
   Burgess, BT
   Dickinson, RB
TI Modification of the adhesive properties of collagen by covalent grafting
   with RGD peptides
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Type I collagen; RGD peptides; K1735 M4 murine melanoma; cell adhesion;
   cell migration
ID MELANOMA CELL-ADHESION; IV COLLAGEN; HETEROBIFUNCTIONAL REAGENT;
   EXTRACELLULAR-MATRIX; BIOARTIFICIAL LIVER; MIGRATION; FIBRONECTIN;
   INVITRO; IDENTIFICATION; IMMUNOASSAYS
AB Collagen, either alone or in combination with other materials, is an important natural biomaterial that is used in a variety of tissue-engineering applications. Cell adhesion and migration of cells within collagen-based biomaterials may be controlled by modifying the adhesive properties of collagen. Furthermore, spatially controlling the adhesiveness of the collagen may allow controlled localization or redistribution of cells. A method is presented for covalently coupling peptides that contain the well-characterized arginine-glycine-aspartic acid adhesion sequence directly to type I collagen monomers prior to fibrillogenesis. A heterobifunctional coupling agent was used to create stable amide and disulfide bonds with the lysine residues of the collagen monomers and the cysteine termini of the peptide molecules, respectively. The degree of conjugation could be controlled by changing the reaction conditions (ratios of reactants added and the length of incubation). The microstructure and gelation times of gels composed of covalently modified collagen were similar to those of unmodified gels. Cell adhesion on adsorbed monolayers of modified collagen was quantified using a well-established clonal cell line (K1735 murine melanoma). Cell adhesion was found to increase with both increasing degree of conjugation and increasing ratio of modified to unmodified collagen.
C1 Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   Univ Florida, Biomed Engn Program, Gainesville, FL 32611 USA.
RP Dickinson, RB (reprint author), Univ Florida, Dept Chem Engn, POB 116005, Gainesville, FL 32611 USA.
RI Dickinson, Richard/A-4435-2012
OI Dickinson, Richard/0000-0002-7415-2889
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   BARD JBL, 1975, J CELL BIOL, V67, P400, DOI 10.1083/jcb.67.2.400
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BONZON N, 1995, BIOMATERIALS, V16, P747, DOI 10.1016/0142-9612(95)99636-Z
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, V282, P250
   BURGESS BT, 1999, IN PRESS ANN BIOMED
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHELBERG MK, 1989, CANCER RES, V49, P4796
   CHELBERG MK, 1990, J CELL BIOL, V111, P261, DOI 10.1083/jcb.111.1.261
   CUMBER AJ, 1985, METHOD ENZYMOL, V112, P207
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   EHRMANN RL, 1956, J NATL CANCER I, V16, P1375
   GEHLSEN KR, 1988, J CELL BIOL, V106, P925, DOI 10.1083/jcb.106.3.925
   GEY GO, 1974, EXP CELL RES, V84, P63, DOI 10.1016/0014-4827(74)90380-2
   GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799
   GRINNELL F, 1982, J CELL SCI, V58, P95
   GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x
   GULLBERG D, 1990, EXP CELL RES, V190, P254, DOI 10.1016/0014-4827(90)90194-F
   HABEEB AFSA, 1981, BIOCHEM BIOPH RES CO, V100, P1154, DOI 10.1016/0006-291X(81)91945-8
   HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kong LB, 1996, INT J ARTIF ORGANS, V19, P72
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   MEIER S, 1974, DEV BIOL, V38, P249, DOI 10.1016/0012-1606(74)90005-0
   NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x
   NEURATH AR, 1981, J VIROL METHODS, V3, P155, DOI 10.1016/0166-0934(81)90050-1
   PAIN D, 1981, J IMMUNOL METHODS, V40, P219, DOI 10.1016/0022-1759(81)90068-5
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   SAITO Y, 1980, THROMB RES, V17, P809, DOI 10.1016/0049-3848(80)90246-7
   SCHOR SL, 1980, J CELL SCI, V41, P159
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   STUCHBURY T, 1975, Biochemical Journal, V151, P417
   Taguchi K, 1996, ARTIF ORGANS, V20, P178
   TAKAGI J, 1992, BIOCHEMISTRY-US, V31, P8530, DOI 10.1021/bi00151a021
   Takatsuka M, 1992, ASAIO J, V38, pM275, DOI 10.1097/00002480-199207000-00036
   WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873
NR 43
TC 31
Z9 37
U1 3
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 1
BP 69
EP 86
DI 10.1163/156856200743508
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 281UQ
UT WOS:000085179500006
PM 10680609
DA 2018-10-19
ER

PT J
AU Turczyn, R
   Weiss, P
   Lapkowski, M
   Daculsi, G
AF Turczyn, R
   Weiss, P
   Lapkowski, M
   Daculsi, G
TI In situ self hardening bioactive composite for bone and dental surgery
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; hydroxyethylcellulose; silanised functional groups;
   hydrophilic gel
ID PHOSPHATE
AB A new biomaterial is presented which consists of a cellulose derivative - silanised hydroxyethylcellulose (HEC-SIL) and biphasic calcium phosphate (BCP). Rheological properties of the polymer itself and its mixture with BCP are pH-dependent. At pH 10-12 HEC-SIL. is liquid and undergoes quick gellation at pH < 9. Similarly, the paste of HEC-SIL and BCP is fluid and injectable at higher pH and solidifies in biological solutions. The rate of this solidification can be easily controlled by the degree of substitution of hydroxyethylcellulose with silicoalkoxy groups.
C1 Fac Chirurg Dent, INSERM 99 03, Equipe Rech Mat Interet Biol, UPRES EA 2159, F-44042 Nantes 01, France.
   Silesian Tech Univ, Dept Chem, PL-44100 Gliwice, Poland.
   Lodz Tech Univ, Dept Text Engn & Environm Sci, PL-43300 Bielsko Biala, Poland.
RP Weiss, P (reprint author), Fac Chirurg Dent, INSERM 99 03, Equipe Rech Mat Interet Biol, UPRES EA 2159, 1 Pl A Ricordeau, F-44042 Nantes 01, France.
RI Weiss, Pierre/P-1372-2014; turczyn, roman/C-1678-2017; Lapkowski,
   Mieczyslaw/D-5242-2014; Daculsi, Guy/P-1320-2014
OI Weiss, Pierre/0000-0002-6159-8590; turczyn, roman/0000-0001-6221-634X;
   Lapkowski, Mieczyslaw/0000-0001-7099-3982; Daculsi,
   Guy/0000-0003-1030-3446
CR CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1998, BIOMATERIALS, V191, P473
   DACULSI G, Patent No. 9521634
   de Groot K, 1983, BIOCERAMICS CALCIUM
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P257
   LAPKOWSKI M, Patent No. 9705911
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LEMAITRE J, 1995, INNOV TECH BIOL MED, V16, P109
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   SAU AC, 1992, ACS SYM SER, V476, P265
   SAU AC, 1990, POLYM PREPRINTS, V31, P636
   WIERUCKAMLYNARC.B, 1998, THESIS SILESIAN MED
NR 12
TC 32
Z9 32
U1 1
U2 8
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 2
BP 217
EP 223
DI 10.1163/156856200743661
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 290KM
UT WOS:000085675500006
PM 10718480
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Patel, N
   Bhandari, R
   Shakesheff, KM
   Cannizzaro, SM
   Davies, MC
   Langer, R
   Roberts, CJ
   Tendler, SJB
   Williams, PM
AF Patel, N
   Bhandari, R
   Shakesheff, KM
   Cannizzaro, SM
   Davies, MC
   Langer, R
   Roberts, CJ
   Tendler, SJB
   Williams, PM
TI Printing patterns of biospecifically-adsorbed protein
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE patterning; microcontact printing; atomic force microscopy; tissue
   engineering; biodegradable; polylactic acid; poly(ethylene glycol); RGD
ID SELF-ASSEMBLED MONOLAYERS; BIODEGRADABLE POLYMER; MICROFLUIDIC NETWORKS;
   SURFACES; MICROSCOPY
AB The advancement of elastomeric patterning techniques in recent years has significantly enhanced our ability to spatially control biomaterial surface chemistry at the micrometre level. The application of this technology to the patterning of biomolecules onto solid surfaces has created many potential applications including the development of advanced biosensors, combinatorial library screening and the formation of tissue engineering templates. Tn this paper, we describe the direct patterning of protein by microcontact printing. An important consideration for the fabrication of protein micropatterns intended For these applications is the nature of the protein immobilization to a substrate. To date, the patterning of proteins by direct microcontact printing (mu CP) has relied on the non-covalent adsorption to a substrate. Ideally, the proteins need to be firmly anchored onto a surface without adversely effecting their activity. Here, the high affinity avidin-biotin receptor-ligand interaction has been exploited to form arrays of avidin molecules onto a polymeric substrate expressing biotin moieties. This: has created a generic technique by which any biotinylated species can be subsequently immobilized into defined patterns. Utilizing atomic force microscopy (AFM), the patterned surfaces have been characterized to molecular resolution. The micropatterned sample supported cell adhesion when biotin-(G)(11)-GRGDS was bound to the avidin bearing arrays.
C1 Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Patel, N (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RI Roberts, Clive/C-6970-2009; Williams, Philip/C-6947-2009
OI Roberts, Clive/0000-0001-9443-3445; Williams,
   Philip/0000-0002-1822-2133; Davies, Martyn/0000-0001-7695-0596;
   Shakesheff, Kevin/0000-0003-3236-2439
CR Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   EKINS RP, 1994, TRENDS BIOTECHNOL, V12, P89, DOI 10.1016/0167-7799(94)90111-2
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   Jones VW, 1998, ANAL CHEM, V70, P1233, DOI 10.1021/ac971125y
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Patel N, 1998, FASEB J, V12, P1447
   PRITCHARD DJ, 1995, ANGEW CHEM INT EDIT, V34, P91, DOI 10.1002/anie.199500911
   Qin D, 1998, TOP CURR CHEM, V194, P1
   Schultz JS, 1996, BIOTECHNOL PROGR, V12, P729, DOI 10.1021/bp960081w
   XIA YN, 1995, J AM CHEM SOC, V117, P3274, DOI 10.1021/ja00116a033
   You HX, 1996, J COLLOID INTERF SCI, V182, P586, DOI 10.1006/jcis.1996.0504
   Zhong Q, 1993, SURF SCI LETT, V290, P688
NR 21
TC 50
Z9 56
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 3
BP 319
EP 331
DI 10.1163/156856200743724
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 313LQ
UT WOS:000087001500006
PM 10841282
DA 2018-10-19
ER

PT J
AU Minuth, WW
   Schumacher, K
   Strehl, R
   Kloth, S
AF Minuth, WW
   Schumacher, K
   Strehl, R
   Kloth, S
TI Physiological and cell biological aspects of perfusion culture technique
   employed to generate differentiated tissues for long term biomaterial
   testing and tissue engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE biomaterial testing; tissue engineering; differentiation;
   dedifferentiation; tissue carrier; perfusion culture container;
   electrolyte environment
ID COLLECTING DUCT EPITHELIA; FIBROBLAST GROWTH-FACTOR; IN-VITRO;
   STEM-CELL; ELECTROLYTE ENVIRONMENT; CLINICAL-APPLICATIONS;
   EXTRACELLULAR-MATRIX; INTERCALATED CELLS; ARTIFICIAL TISSUES; POLYMER
   SCAFFOLDS
AB Optimal results in biomaterial testing and tissue engineering under in vitro conditions can only be expected when the tissue generated resembles the original tissue as closely as possible. However, most of the presently used stagnant cell culture models do not produce the necessary degree of cellular differentiation, since important morphological, physiological, and biochemical characteristics disappear. while atypical features arise. To reach a high degree of cellular differentiation and to optimize the cellular environment, an advanced culture technology allowing the regulation of differentiation on different cellular levels was developed. By the use of tissue carriers, a variety of biomaterials or individually selected scaffolds could be tested for optimal tissue development. The tissue carriers are to be placed in perfusion culture containers, which are constantly supplied with fresh medium to avoid an accumulation of harmful metabolic products. The perfusion of medium creates a constant microenvironment with serum-containing or serum-free media. By this technique, tissues could be used for biomaterial or scaffold testing either in a proliferative or in a postmitotic phase, as is observed during natural development. The present paper summarizes technical developments, physiological parameters, cell biological reactions, and theoretical considerations for an optimal tissue development in the field of perfusion culture.
C1 Univ Regensburg, Dept Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Anat, Univ Str 31, D-93053 Regensburg, Germany.
CR Abe Y, 1996, J IMMUNOL, V157, P5061
   ABRASS CK, 1995, J AM SOC NEPHROL, V5, P1591
   Aigner J, 1995, EPITHELIAL CELL BIOL, V4, P121
   ALLEN MD, 1993, CIRCULATION, V88, P243
   Arsenijevic Y, 1998, J NEUROSCI, V18, P2118
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Benardeau A, 1997, J MOL CELL CARDIOL, V29, P1307, DOI 10.1006/jmcc.1996.0366
   BILBO PR, 1993, J TOXICOL-CUTAN OCUL, V12, P183, DOI 10.3109/15569529309036259
   BLUNK T, 1997, KEYSTONE S BONE CART, P19
   Bohnke M, 1998, GRAEF ARCH CLIN EXP, V236, P522, DOI 10.1007/s004170050115
   BOUKAMP P, 1993, J CELL BIOL, V120, P981, DOI 10.1083/jcb.120.4.981
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   BUJIA J, 1995, ACTA OTO-LARYNGOL, V115, P307, DOI 10.3109/00016489509139316
   CHAILLER P, 1991, ANAT EMBRYOL, V184, P319, DOI 10.1007/BF00957893
   Chapekar MS, 1996, J BIOMED MATER RES, V33, P199, DOI 10.1002/(SICI)1097-4636(199623)33:3<199::AID-JBM10>3.0.CO;2-C
   Chen SC, 1996, INT J ARTIF ORGANS, V19, P664
   Couvelard A, 1998, HEPATOLOGY, V27, P839, DOI 10.1002/hep.510270328
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135
   DAVIES JA, 1995, DEV BIOL, V167, P50, DOI 10.1006/dbio.1995.1006
   Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997
   Dharmavaram RM, 1997, J BIOL CHEM, V272, P26918, DOI 10.1074/jbc.272.43.26918
   Doyle A., 1996, CELL TISSUE CULTURE, P11
   DURSO EM, 1994, J BIOACT COMPAT POL, V9, P367, DOI 10.1177/088391159400900402
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   GERDES J, 1991, AM J PATHOL, V138, P867
   GERLACH JC, 1996, TRANSPLANTATION, V62, P546
   Globus RK, 1998, J CELL SCI, V111, P1385
   Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Haas I, 1996, EUR ARCH OTO-RHINO-L, V253, P405
   Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393
   Hagiwara H, 1996, J BIOCHEM-TOKYO, V119, P264
   Hay ED, 1991, CELL BIOL EXTRACELLU
   Hayashi H, 1998, TRANSPLANT P, V30, P83, DOI 10.1016/S0041-1345(97)01187-1
   HELLMAN KB, 1994, J CELL BIOCHEM, V56, P210, DOI 10.1002/jcb.240560216
   HELLMAN KB, 1998, ANN NY ACAD SCI, V831, P1
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.3.CO;2-3
   Hirsch MS, 1998, BIOTECHNIQUES, V24, P632, DOI 10.2144/98244st04
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HORTON WA, 1993, PROG CLIN BIOL RES, V383, P533
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Humes HD, 1996, AM J PHYSIOL-RENAL, V271, pF42
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   JAKOBY WB, 1993, METHODS ENZYMOLOGY, V58
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kedinger M, 1998, PHILOS T R SOC B, V353, P847, DOI 10.1098/rstb.1998.0249
   KIM SS, 1998, ANN SURG, V228, P14
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Kloth S, 1998, IN VITRO CELL DEV-AN, V34, P515
   KLOTH S, 1994, EUR J CELL BIOL, V63, P84
   KLOTH S, 1995, FASEB J, V9, P963
   Kloth S, 1998, KIDNEY INT, V53, P970, DOI 10.1111/j.1523-1755.1998.00854.x
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   KOLETTAS E, 1995, J CELL SCI, V108, P1991
   Koller MR, 1998, BIOMATERIALS, V19, P1963, DOI 10.1016/S0142-9612(98)00101-X
   Lafrenie RM, 1998, ANN NY ACAD SCI, V842, P42, DOI 10.1111/j.1749-6632.1998.tb09630.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180
   MacKay SM, 1998, ASAIO J, V44, P179, DOI 10.1097/00002480-199805000-00011
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Marx U, 1998, INT J ARTIF ORGANS, V21, P119
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Minuth WW, 1997, EXP NEPHROL, V5, P10
   Minuth WW, 1997, EXP NEPHROL, V5, P414
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   Minuth WW, 1996, BIOTECHNIQUES, V20, P498
   Mundel P, 1997, J AM SOC NEPHROL, V8, P697
   Naughton G, 1997, ARTIF ORGANS, V21, P1203
   Naumann A, 1998, AM J RHINOL, V12, P59, DOI 10.2500/105065898782102972
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Noishiki Y, 1998, ARTIF ORGANS, V22, P50, DOI 10.1046/j.1525-1594.1998.06068.x
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Pennati G, 1998, INT J ARTIF ORGANS, V21, P97
   Powell RJ, 1996, ANN VASC SURG, V10, P4, DOI 10.1007/BF02002334
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   Ramasubbu K, 1998, J AM SOC NEPHROL, V9, P937
   RAMDI H, 1993, EXP CELL RES, V207, P449, DOI 10.1006/excr.1993.1214
   RISEAU W, 1997, NATURE, V386, P671
   ROJKIND M, 1980, J CELL BIOL, V87, P225
   Ronziere MC, 1997, OSTEOARTHR CARTILAGE, V5, P205, DOI 10.1016/S1063-4584(97)80015-5
   Rosales C, 1996, CANCER RES, V56, P2302
   ROSALES C, 1995, BBA-REV CANCER, V1242, P77, DOI 10.1016/0304-419X(95)00005-Z
   SATO M, 1994, ASAIO J, V40, P389
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schmalz G, 1996, J ENDODONT, V22, P249, DOI 10.1016/S0099-2399(06)80142-1
   Schultz O, 1997, ARTHRITIS RHEUM, V40, P1420, DOI 10.1002/art.1780400809
   SCHUMACHER K, 1999, CELL DEV BIOL ANIMAL, V35, P465
   Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074
   SEGAL R, 1989, KIDNEY INT, V36, P2
   SHABIBAEI M, 1998, EXP CELL RES, V240, P95
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   SMITH RM, 1975, CRITICAL STABILITY C, V2, P105
   Srebrow A, 1998, J CELL BIOCHEM, V69, P377, DOI 10.1002/(SICI)1097-4644(19980615)69:4<377::AID-JCB1>3.0.CO;2-K
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Sun A M, 1992, ASAIO J, V38, P125, DOI 10.1097/00002480-199204000-00012
   TAIT IS, 1995, AM J SURG, V169, P120, DOI 10.1016/S0002-9610(99)80119-6
   Tang MJ, 1996, BIOCHEM BIOPH RES CO, V218, P658, DOI 10.1006/bbrc.1996.0118
   TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Tomakidi P, 1998, CELL TISSUE RES, V292, P355, DOI 10.1007/s004410051066
   Tremblay E, 1997, GASTROENTEROLOGY, V112, P1188, DOI 10.1016/S0016-5085(97)70130-6
   Tresco P A, 1992, ASAIO J, V38, P17, DOI 10.1097/00002480-199201000-00006
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VERT M, 1994, J BIOMAT SCI-POLYM E, V6, P639, DOI 10.1163/156856294X00581
   Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   VUKICEVIC S, 1995, EUR J CLIN CHEM CLIN, V33, P661
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Walter I, 1996, HISTOCHEM J, V28, P671, DOI 10.1007/BF02409004
   WANG Z, 1998, ONCOL REP, V5, P1991
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WEISS L, 1977, HISTOLOGY, P66
   WELLER A, 1991, DEV BIOL, V144, P248, DOI 10.1016/0012-1606(91)90419-4
   WILKINS LM, 1994, BIOTECHNOL BIOENG, V43, P747, DOI 10.1002/bit.260430809
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WINTERMANTEL E, 1998, BIOKOMPATIBLE WERKST, P87
   Wookey PJ, 1998, KIDNEY INT, V53, P25, DOI 10.1046/j.1523-1755.1998.00722.x
   YAMADA KM, 1991, CELL BIOL EXTRACELLU, P111
   YEH LA, 1995, J RHEUMATOL, V22, P1740
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
   ZHANG XC, 1993, J MACROMOL SCI PURE, VA30, P933, DOI 10.1080/10601329308009437
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
NR 133
TC 44
Z9 44
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 5
BP 495
EP 522
DI 10.1163/156856200743832
PG 28
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 335FZ
UT WOS:000088234600004
PM 10896044
DA 2018-10-19
ER

PT J
AU Morra, M
AF Morra, M
TI On the molecular basis of fouling resistance
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE fouling; bioadhesion; interfacial interactions; acid-base interactions;
   wettability; poly-ethyleneoxide; polysaccharides
ID PROTEIN SURFACE INTERACTIONS; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE
   MICROSCOPE; STATISTICAL THERMODYNAMICS; BIOMATERIAL SURFACES; TENSION
   COMPONENTS; POLYETHYLENE OXIDE; POLYMER LAYERS; WATER; ADSORPTION
AB This paper presents a review of models used to describe the properties of fouling resistant surfaces, i.e. the relationship between molecular structure and resistance to adsorption/adhesion of biological moieties. In particular, the well established 'physical' school of thought, mostly based on ideas stemming from the Alexander-De Gennes theory of polymer interfaces, which appears especially suitable for the modeling of resistance to bio-adhesion in terms of entropic effects, is compared to approaches that call into play the role of interfacial forces based on hydrogen bonding and molecular conformations. It is underlined that the presently prevailing view based on 'steric' stabilization effects is based on models that do not take into account some of the most fundamental aspects of water-soluble polymers and that, within this approximation, repulsive forces resulting from the 'compression' of tethered layers is the only possible explanation. When effects typical of water, such as hydrogen bonding, are considered, different pictures arise, even if their quantification poses several analytical challenges and new theoretical problems.
C1 Nobil Bio Ric, I-14018 Villafranca Dasti, Italy.
RP Morra, M (reprint author), Nobil Bio Ric, Str S Rocco 32, I-14018 Villafranca Dasti, Italy.
EM mmorra@tin.it
CR ALBERTS B, 1984, MOL BIOL CELL, P44
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700
   Azegami S, 1999, LANGMUIR, V15, P940, DOI 10.1021/la9809269
   BESSELING NAM, 1994, J PHYS CHEM-US, V98, P11597, DOI 10.1021/j100095a048
   BESSELING NAM, 1994, J PHYS CHEM-US, V98, P11610, DOI 10.1021/j100095a049
   BESSELING NAM, 1995, PURE APPL CHEM, V67, P881, DOI 10.1351/pac199567060881
   BESSELING NAM, 1997, LANGMUIR, V13, P2109
   Bohanon TM, 1999, LANGMUIR, V15, P174, DOI 10.1021/la980348w
   BUDIAMAN ER, 1987, J DAIRY SCI, V70, P534, DOI 10.3168/jds.S0022-0302(87)80038-3
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4
   Cowman MK, 1998, WENN GR INT, V72, P17
   DEGENNES PG, 1987, ANN CHIM-ROME, V77, P389
   deGennes PG, 1979, SCALING CONCEPTS POL
   Dellerba R, 1997, POLYM NETWORK BLEND, V7, P1
   Douillard JM, 1997, J COLLOID INTERF SCI, V188, P511, DOI 10.1006/jcis.1997.4768
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Esumi K, 1999, POLYMER INTERFACES AND EMULSIONS, P467
   FOWKES FM, 1985, SURFACE INTERFACIAL, V1, pCH9
   GARBASSI F, 1998, POLYM SURFACES PHYSI, pCH1
   GOLDSTEIN RE, 1984, J CHEM PHYS, V80, P5340, DOI 10.1063/1.446567
   GOOD RJ, 1991, MODERN APPROACH WETT, pCH1
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   HURRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819
   IKAWA T, 1975, J POLYM SCI POL CHEM, V13, P1505, DOI 10.1002/pol.1975.170130703
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Janczuk B, 1999, J COLLOID INTERF SCI, V211, P96, DOI 10.1006/jcis.1998.5990
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   LAURENT TC, 1957, ARK KEMI, V11, P487
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   MACKOR EL, 1951, J COLL SCI IMP U TOK, V6, P492, DOI 10.1016/0095-8522(51)90019-0
   MACKOR EL, 1952, J COLL SCI IMP U TOK, V7, P535, DOI 10.1016/0095-8522(52)90035-4
   MARCELJA S, 1976, CHEM PHYS LETT, V42, P129, DOI 10.1016/0009-2614(76)80567-2
   McGurk SL, 1999, LANGMUIR, V15, P5136, DOI 10.1021/la981788q
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 1996, J COLLOID INTERF SCI, V182, P312, DOI 10.1006/jcis.1996.0469
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   MORRA M, UNPUB
   MORRA M, IN PRESS COLLOIDS B
   NAGAOKA S, 1991, HIGH PERFORMANCE BIO
   NAGAOKA S, 1987, ASAIO, V10, P76
   Napper DH, 1983, POLYM STABILIZATION
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Padday J. F., 1969, SURFACE COLLOID SCI
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RAND RP, 1992, SCIENCE, V256, P618, DOI 10.1126/science.256.5057.618
   SCOTT JE, 1978, BIOCHEM J, V173, P103, DOI 10.1042/bj1730103
   Scott JE, 1998, WENN GR INT, V72, P7
   SCOTT JE, 1989, CIBA F SYMP, V143, P6
   Shi HQ, 1999, NATURE, V398, P593
   SMITH KL, 1959, IND ENG CHEM, V51, P1361, DOI 10.1021/ie50599a029
   Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8
   Szleifer I, 1996, CURR OPIN COLLOID IN, V1, P416, DOI 10.1016/S1359-0294(96)80142-7
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1986, J PROTEIN CHEM, V5, P385, DOI 10.1007/BF01025572
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
NR 64
TC 198
Z9 199
U1 4
U2 75
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 6
BP 547
EP 569
DI 10.1163/156856200743869
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 347VJ
UT WOS:000088949600001
PM 10981673
DA 2018-10-19
ER

PT J
AU Lin, JC
   Tiong, SL
   Chen, CY
AF Lin, JC
   Tiong, SL
   Chen, CY
TI Surface characterization and platelet adhesion studies on fluorocarbons
   prepared by plasma-induced graft polymerization
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE plasma-induced grafting polymerization; surface modification;
   fluorocarbon; blood compatibility; platelet adhesion
ID BLOOD COMPATIBILITY; POLYETHYLENE; ADSORPTION; PROTEINS; ACID
AB It is believed that the interactions between the biological environment and biomaterial surface are the key factors influencing its biocompatibility. Therefore, plasma processing, which can vary the surface properties without altering the bulk properties, has been considered as one of the important techniques for improving a materials' biocompatibility. In this investigation, plasma-induced grafting polymerization of vinylidene fluoride (VDF) and chlorotrifluoroethylene (CTFE), instead of direct plasma polymerization, was attempted with an aim to improve the substrate blood compatibility. Contact angle measurement indicated both fluorocarbon-grafted Pdyethylenes (PEs) are hydrophobic. Due to the additional fluorine and chlorine atoms on the CTFE chain, the PCTFE-grafted PE exhibited a higher hydrophobicity than the PVDF-grafted one. ESCA analysis has revealed that these two plasma-induced fluorocarbon deposits contain almost no CFx (x > 2) binding on the surface layer, indicating the grafting polymerization mainly follows the free radical mechanism instead of the molecule-highly-fragmented reaction steps commonly seen in the direct plasma polymerization treatment. In addition, ATR-FTIR has shown the surface chemical configuration of these PVDF- and PCTFE-grafted PEs to be very similar to those of the bulk samples of PVDF and PCTFE. The surface toughness decreased after oxygen plasma treatment and was further reduced by VDF and CTFE grafting polymerization. III vitro platelet adhesion testing indicated these two fluorocarbon grafted PEs are less platelet-activating than the nontreated PE control and oxygen plasma activated one.
C1 Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RI Lin, Jui-Che/C-8230-2012
OI Lin, Jui-Che/0000-0003-4436-655X
CR ANDRADE JD, 1985, SURFACE INTERFAC ASP, V1, pCH5
   BEE TG, 1992, MACROMOLECULES, V25, P2093, DOI 10.1021/ma00034a006
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   DAGOSTINO R, 1990, PLASMA DEPOSITION TR, pCH2
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, pR9, DOI 10.1002/jbm.820200903
   KAWANO Y, 1992, POLYM DEGRAD STABIL, V35, P99, DOI 10.1016/0141-3910(92)90099-Q
   KO TM, 1993, BIOMATERIALS, V14, P657
   KO TM, 1993, J COLLOID INTERF SCI, V156, P207, DOI 10.1006/jcis.1993.1101
   Lee SD, 1996, J POLYM SCI POL CHEM, V34, P141, DOI 10.1002/(SICI)1099-0518(19960115)34:1<141::AID-POLA15>3.0.CO;2-L
   Lin JC, 1999, BIOMATERIALS, V20, P1613, DOI 10.1016/S0142-9612(99)00068-X
   LIN JC, 1995, BIOMATERIALS, V16, P1017
   Lin JC, 1999, BIOMATERIALS, V20, P1439, DOI 10.1016/S0142-9612(98)00200-2
   Lin Y, 1996, J POLYM SCI POL CHEM, V34, P1843
   LIN YS, 1992, BIOMATERIALS, V13, P497
   MILLARD MM, 1976, J MACROMOL SCI CHEM, VA 10, P579, DOI 10.1080/00222337608061201
   *SADTL RES LAB, 1986, SADTL COMM INFR GRAT
   SAFRANJ A, 1990, T 16 ANN M SOC BIOM, P201
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   TIAN J, 1995, EUR POLYM J, V31, P755, DOI 10.1016/0014-3057(95)00021-6
   Visser SA, 1997, J APPL POLYM SCI, V66, P409
   WOJCIECHOWSKI PW, 1993, COLLOID SURFACE B, V1, P107, DOI 10.1016/0927-7765(93)80041-V
   Yamaguchi T, 1996, J POLYM SCI POL CHEM, V34, P1203, DOI 10.1002/(SICI)1099-0518(199605)34:7<1203::AID-POLA6>3.0.CO;2-3
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   Yasuda H., 1985, PLASMA POLYM
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
NR 28
TC 35
Z9 35
U1 0
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 7
BP 701
EP 714
DI 10.1163/156856200743968
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 357CG
UT WOS:000089480500003
PM 11011768
DA 2018-10-19
ER

PT J
AU Filmon, R
   Basle, MF
   Barbier, A
   Chappard, D
AF Filmon, R
   Basle, MF
   Barbier, A
   Chappard, D
TI Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: A composite
   biomaterial allowing in vitro studies of bisphosphonates on the
   mineralization process
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE alkaline phosphatase; poly(2-hydroxy ethyl methacrylate); pHEMA;
   methacrylate; mineralization; bone biology; biomaterials; bone
   substitute; polymer; bisphosphonate; etidronate; alendronate;
   tiludronate
ID ALKALINE-PHOSPHATASE; LOW-TEMPERATURE; IN-VITRO; BETA-GLYCEROPHOSPHATE;
   CALCIFICATION; POLYMERIZATION; MECHANISMS; DEPOSITION; RESORPTION;
   IMPLANTS
AB We have immobilized the mineralizing agent alkaline phosphatase (AlkP) in a hydrophilic polymer: poly(2-hydroxy ethyl methacrylate) - (pHEMA)- in a copolymerization technique. Histochemical study on polymer sections revealed that AlkP has retained its enzymic activity. The image analysis of sections using a tessellation method showed a lognormal distribution of the area of the tiles surrounding AlkP particles, thus confirming a homogeneous distribution of the enzyme in the polymer. Pellets of pHEMA-AlkP were incubated with a synthetic body fluid containing organic phosphates (beta -glycerophosphate). Mineral deposits with a rounded shape (calcospherites) were obtained in about 17 days. We have investigated the effects of three bisphosphonic pharmacological compounds (etidronate, alendronate and tiludronate) on this system which mimics the mineralization process of cartilage and woven bone. Bisphosphonates at a concentration of 10(-2) M totally inhibited AlkP in solution at a concentration of 10(-4) mg/ml. Inhibition has been reported being due to the chelation of a metal cofactor (Zn2+). Etidronate and alendronate appeared to similarly inhibit the calcospherite deposition onto the pHEMA-AlkP material. Both bisphosphonates possess three sites for the mineral complexion by Ca chemisorbtion. On the other hand, tiludronate having only two sites, was associated with a reduced inhibitory effect on mineralization but larger crystals were obtained. The pHEMA-AlkP material contains an immobilized enzyme in a hydrogel and mimics the physiological conditions of matrix vesicles entrapped within the cartilage (or bone) matrix. It provides an interesting method to study the effects of pharmacological compounds on the mineralization process in bone and cartilage in a non cellular and protein-free model.
C1 Fac Med & CHU Angers, LHEA, Lab Histol Embryol, F-49045 Angers, France.
   Fac Med, Serv Commun Microscopie Elect, F-49045 Angers, France.
   Sanofi Rech, F-34082 Montpellier, France.
RP Chappard, D (reprint author), Fac Med & CHU Angers, LHEA, Lab Histol Embryol, F-49045 Angers, France.
CR Anagnostou F, 1996, J CELL BIOCHEM, V62, P262, DOI 10.1002/(SICI)1097-4644(199608)62:2<262::AID-JCB14>3.0.CO;2-N
   ARSENAULT AL, 1984, J CELL BIOL, V98, P911, DOI 10.1083/jcb.98.3.911
   BAHR GF, 1987, ANAL QUANT CYTOL, V9, P341
   BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805
   BONUCCI E, 1987, SCANNING MICROSCOPY, V1, P1089
   CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862
   CHAPPARD D, 1983, STAIN TECHNOL, V58, P299, DOI 10.3109/10520298309066802
   CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0
   CHAPPARD D, 1989, J HISTOTECHNOL, V12, P89
   CHAPPARD D, 1985, MIKROSKOPIE, V42, P148
   CHAPPARD D, 1992, INNOV TECH BIOL MED, V13, P527
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   Denissen H, 1997, J BONE MINER RES, V12, P290, DOI 10.1359/jbmr.1997.12.2.290
   Ebetino FH, 1998, REV CONTEMP PHARMACO, V9, P233
   Ebetino Frank H., 1995, P139
   FELIX R, 1976, BIOCHIM BIOPHYS ACTA, V429, P429, DOI 10.1016/0005-2744(76)90291-6
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R., 1996, Cells and Materials, V6, P11
   FISHMAN WH, 1990, CLIN BIOCHEM, V23, P99, DOI 10.1016/0009-9120(90)80019-F
   FLEISCH H, 1997, BISPHOSPHONATE BONE
   Gehron-Robey P, 1996, OSTEOPOROSIS, P95
   GOLUB EE, 1992, BONE MINER, V17, P272
   HARRIS H, 1990, CLIN CHIM ACTA, V186, P133, DOI 10.1016/0009-8981(90)90031-M
   HARRISON G, 1995, J BONE MINER RES, V10, P568, DOI 10.1002/jbmr.5650100409
   Hui M, 1997, CALCIFIED TISSUE INT, V60, P467, DOI 10.1007/s002239900264
   Kato K, 1996, J BIOMED MATER RES, V32, P687, DOI 10.1002/(SICI)1097-4636(199612)32:4<687::AID-JBM23>3.0.CO;2-9
   KIM SH, 1988, JPN J EXP MED, V56, P251
   KOK DJ, 1988, KIDNEY INT, V34, P346, DOI 10.1038/ki.1988.187
   KUMAKURA M, 1984, J MOL CATAL, V23, P1, DOI 10.1016/0304-5102(84)85048-8
   LARSSON A, 1979, J HISTOCHEM CYTOCHEM, V27, P982, DOI 10.1177/27.5.225377
   LEONE FA, 1997, TRENDS COMP BIOCH PH, V3, P57
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P699
   ORNOY A, 1979, ISRAEL J MED SCI, V15, P928
   ORNOY A, 1978, ISRAEL J MED SCI, V14, P745
   PEAKE MJ, 1988, J CLIN PATHOL, V41, P202, DOI 10.1136/jcp.41.2.202
   Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   ROGERS MJ, 1995, MOL PHARMACOL, V47, P398
   Serra J, 1982, IMAGE ANAL MATH MORP
   Skrtic D, 1996, CALCIFIED TISSUE INT, V58, P347, DOI 10.1007/BF02509384
   SPRINCL L, 1981, J BIOMED MATER RES, V15, P437, DOI 10.1002/jbm.820150314
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   TENENBAUM HC, 1992, BONE, V13, P129, DOI 10.1016/8756-3282(92)90002-E
   vanBeek E, 1996, J BONE MINER RES, V11, P1492
   VANDENBOS T, 1994, J BIOMED MATER RES, V28, P1295, DOI 10.1002/jbm.820281107
   WOLTGENS JH, 1973, CALC TISS RES, V13, P151, DOI 10.1007/BF02015405
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, P219
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
NR 49
TC 44
Z9 45
U1 0
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 8
BP 849
EP 868
DI 10.1163/156856200744057
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 393VL
UT WOS:000166490300005
PM 11211096
DA 2018-10-19
ER

PT J
AU Cassinelli, C
   Morra, M
   Pavesio, A
   Renier, D
AF Cassinelli, C
   Morra, M
   Pavesio, A
   Renier, D
TI Evaluation of interfacial properties of hyaluronan coated
   poly(methylmethacrylate) intraocular lenses
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE intraocular lenses; hyaluronan; surface modification; surface analysis;
   atomic force microscopy
ID ATOMIC-FORCE MICROSCOPE; POLY(METHYL METHACRYLATE); BIOMATERIAL
   SURFACES; ENDOTHELIAL DAMAGE; HEPARIN; IMPLANTATION; MODEL;
   BIOCOMPATIBILITY; ADHESION; INVITRO
AB Polymethylmethacrylate intraocular lenses (IOLs) were surface-modified by the linking of a overlayer of hyaluronan. In vitro experiments show that the hydrophilic HA overlayer prevents fibroblasts adhesion and greatly reduces Staphyloccous epidermidis adhesion to the IOL surface. To gain insights into the interfacial properties of untreated and hyaluronan-coated PMMA IOLs, force-distance curves were obtained by atomic force microscopy, using standard and modified tips. These measurements allow clear appreciation of the marked difference between the mechanical and chemico-physical properties at the aqueous interface of the uncoated and hyaluronan-coated lenses.
C1 Nobil Bio Ric, Villafranca Dasti, Italy.
   Fidia Adv Biopolymers, Abano Terme, Pd, Italy.
RP Morra, M (reprint author), Nobil Bio Ric, Str S Rocco 32, Villafranca Dasti, Italy.
CR ARCIOLA CR, 1993, J APPL BIOMATER, V4, P249, DOI 10.1002/jab.770040306
   BALAZS EA, 1978, BIOL FIBROBLAST
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   BOURNE WM, 1976, AM J OPHTHALMOL, V81, P482, DOI 10.1016/0002-9394(76)90305-6
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   EVERED D, 1989, BIOL HYALURONAN
   Fagerholm P., 1987, ACTA OPHTHALMOL, V65, P110
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   KAUFMAN HE, 1976, INVEST OPHTH VISUAL, V15, P996
   Knight P M, 1979, J Am Intraocul Implant Soc, V5, P123
   KRAFF C, 1980, AM INTRAOCULAR IMPAL, V6, P129
   LARSSON R, 1989, BIOMATERIALS, V10, P511, DOI 10.1016/0142-9612(89)90055-0
   LARSSON R, 1992, J CATARACT REFR SURG, V18, P247, DOI 10.1016/S0886-3350(13)80901-7
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X
   LUNDGREN B, 1992, J CATARACT REFR SURG, V18, P65, DOI 10.1016/S0886-3350(13)80385-9
   LUNDGREN B, 1992, J CATARACT REFR SURG, V18, P602, DOI 10.1016/S0886-3350(13)80452-X
   MONDINO BJ, 1985, INVEST OPHTH VIS SCI, V26, P905
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Pavesio A, 1997, Med Device Technol, V8, P20
   PEKNA M, 1993, BIOMATERIALS, V14, P189, DOI 10.1016/0142-9612(93)90022-T
   PHILIPSON B, 1992, J CATARACT REFR SURG, V18, P71, DOI 10.1016/S0886-3350(13)80386-0
   RATNER BD, 1988, SURFACE CHARACTERIZA
   RIEDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   SCOTT JE, 1989, CIBA F SYMP, V143, P6
   SPANGBERG M, 1990, J CATARACT REFR SURG, V16, P170, DOI 10.1016/S0886-3350(13)80726-2
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   WEIGEL PH, 1989, CIBA F SYMP, V143, P248
   Werner L, 1999, J BIOMED MATER RES, V46, P347
   WOLTER JR, 1985, OPHTHALMOLOGY, V92, P135
NR 41
TC 38
Z9 38
U1 0
U2 13
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 9
BP 961
EP 977
DI 10.1163/156856200744138
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 379HW
UT WOS:000165637500005
PM 11211089
DA 2018-10-19
ER

PT J
AU Ho, JY
   Matsuura, T
   Santerre, JP
AF Ho, JY
   Matsuura, T
   Santerre, JP
TI The effect of fluorinated surface modifying macromolecules on the
   surface morphology of polyethersulfone membranes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE membranes; surface modification; additives; dialysis; polyethersulfone
ID SEGMENTED POLYURETHANES; POLYMER; TEMPERATURE; ADDITIVES; ENERGY; REDUCE
AB Polyethersulfone (PES) has been recently adopted for membrane materials in applications such as ultrafiltration and haemodialysis. As a biomaterial, the factors which affect the blood compatibility of PES membranes include surface energetics, hydrophobicity, and surface morphology. Surface fluorination of materials has been found to create surfaces with improved blood compatibility and chemical stability. One never approach to generating fluorinated polymer surfaces has included the use of fluorinated surface modifying macromolecules (SMMs). These macromolecules have been reported to establish fluorinated functional groups at surfaces of polymeric materials without significantly affecting the physical properties of the base polymer. However, to date there has been relatively little information published on the nature of the surface structure for PES materials containing these SMMs. In this study, synthesized SMMs with varying chemical compositions were characterized and blended with PES, and fabricated into flat sheet membranes. The bulk thermal transitions of PES materials were not significantly altered by the addition of 4 wt% SMMs. Contact angle data showed that the addition of SMMs in PES created more hydrophobic surfaces, accompanied by an increase in surface heterogeneity. X-ray photoelectron spectroscopy studies confirmed the presence of elemental fluorine at the surface. Through microscopy studies, it was shown that surface modification was achieved by the migration of SMM concentrated microdomains to the air-membrane interface. The generated microdomains (approximately 1-2 mum in diameter) are dispersed within the top 8 mum of the surface. The concentration of microdomains was gradually depleted from the surface to the bulk of the membrane. A schematic of the morphology for SMMs within the PES membrane surface was proposed.
C1 Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON, Canada.
   Univ Toronto, Dept Chem Engn, Toronto, ON, Canada.
   Univ Ottawa, Dept Chem Engn, Ind Membrane Res Inst, Ottawa, ON, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St, Toronto, ON, Canada.
CR AUBIN M, 1988, MACROMOLECULES, V21, P2945, DOI 10.1021/ma00188a010
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   CHEUNG AK, 1990, CLIN DIJALYSIS
   CLAROTTI G, 1992, BIOMATERIALS, V13, P832, DOI 10.1016/0142-9612(92)90176-O
   COUCHMAN PR, 1978, MACROMOLECULES, V11, P117, DOI 10.1021/ma60061a021
   FANG Y, 1994, J APPL POLYM SCI, V54, P1937, DOI 10.1002/app.1994.070541216
   GARBASSI F, 1994, POLYM SURFACE PHYSIC
   Hamza A, 1997, J MEMBRANE SCI, V131, P217, DOI 10.1016/S0376-7388(97)00050-1
   Herman B, 1993, OPTICAL MICROSCOPY E
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   HWANG SS, 1995, POLYMER, V36, P1321, DOI 10.1016/0032-3861(95)93937-H
   KAKU M, 1994, J POLYM SCI POL CHEM, V32, P2187, DOI 10.1002/pola.1994.080321122
   MAHER J, 1995, ADV MATER PROCESS, V147, P47
   MOHR JM, 1991, J MEMBRANE SCI, V55, P149, DOI 10.1016/S0376-7388(00)82332-7
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PETROVIC ZS, 1985, RUBBER CHEM TECHNOL, V58, P685, DOI 10.5254/1.3536086
   Pham VA, 1999, J APPL POLYM SCI, V73, P1363
   Piirma I., 1992, POLYM SURFACTANTS
   PIZZOFERRATO A, 1995, BIOMATERIALS, V16, P361, DOI 10.1016/0142-9612(95)93853-6
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tang YW, 1997, BIOMATERIALS, V18, P37, DOI 10.1016/S0142-9612(96)00101-9
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   WARD RS, 1989, IEEE ENG MED BIOL, V8, P22
   WEILER L, 1997, THESIS U TORONTO CAN
NR 24
TC 61
Z9 62
U1 2
U2 20
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 10
BP 1085
EP 1104
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 393VN
UT WOS:000166490500006
PM 11211159
DA 2018-10-19
ER

PT J
AU Park, K
   Shim, HS
   Dewanjee, MK
   Eigler, NL
AF Park, K
   Shim, HS
   Dewanjee, MK
   Eigler, NL
TI In vitro and in vivo studies of PEO-grafted blood-contacting
   cardiovascular prostheses
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Devices and Diagnostics in Contact with Blood: Issue in
   Blood Compatibility at the Close of the 20th Century
CY AUG 04-06, 1999
CL SEATTLE, WASHINGTON
SP Univ Washington, Engineered Biomaterials, Univ Washington, Engn Res Ctr
DE PEO; block copolymer; surface grafting; stent; biomaterial; blood;
   cardiovascular; platelet
ID DIMETHYLDICHLOROSILANE-COATED GLASS; GAMMA-IRRADIATION; SURFACE
   MODIFICATION; PLATELET ACTIVATION; PROTEIN ADSORPTION; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; POLYMER SURFACES; STENT THROMBOSIS;
   EX-VIVO
AB The initial step of thrombus formation on blood-contacting biomaterials is known to be adsorption of blood proteins followed by platelet adhesion. Poly(ethylene oxide) (PEO) has been frequently used to modify biomaterial surfaces to minimize or prevent protein adsorption and cell adhesion. PEG was grafted onto a number of biomaterials in our laboratory. Nitinol stents and glass tubes were grafted with PEG by priming the metal surface with trichlorovinylsilane (TCVS) followed by adsorption of Pluronic and gamma -irradiation. Nitinol stents were also coated with Carbothane(R) for PEO grafting. Chemically inert polymeric biomaterials, such as Carbothane, polyethylene, silicone rubber, and expanded polytetrafluoroethylene (e-PTFE), were first adsorbed with PEO-polybutadiene- PEO (PEO-PB-PEO) triblock copolymers and then exposed to gamma -irradiation for covalent grafting. For PEO grafting to Dacron(R) (polyethylene terephthalate), the surface was sequentially treated with PEO-PB-PEO and Pluronics(R) followed by gamma -irradiation.
   In vitro studies showed substantial reduction in fibrinogen adsorption and platelet adhesion to the PEG-grafted surfaces compared with control surfaces. Fibrinogen adsorption was reduced by 70-95% by PEO grafting on all surfaces, except for e-PTFE. The platelet adhesion corresponded to the fibrinogen adsorption. When the PEG-grafted surfaces were tested ex vivo/in vivo, however, the expected beneficial effect of PEO grafting was inconsistent. The beneficial effect of the PEO grafting was most pronounced on the PEG-grafted nitinol stents. Thrombus formation was reduced by more than 85% by PEO grafting on metallic stents. Only moderate improvement (i.e. 35% decrease in platelet deposition) was observed with PEG-grafted tubes of polyethylene, silicone rubber, and glass. For PEG-grafted heart valves made of Dacron, however, no effect of PEO grafting was observed at all. It appears that the extent of thrombus formation on PEO-grafted biomaterials was directly related to the extent of tissue damage during implantation surgery. Platelets: can be activated and form aggregates in the bulk blood, and the formed platelet aggregates may be able to deposit on the PEO monolayer overcoming its repulsive property. Our studies indicate that the testing of in vitro platelet adhesion should include adhesion of large platelet aggregates, in addition to adhesion of individual platelets. Furthermore, the surface modification methods should be improved over the current monolayer grafting concept so that the repulsive force by the grafted PEO layers is large enough to prevent adhesion of platelet aggregates formed in the bulk blood before arriving at the biomaterial surface.
C1 Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Medtron Inc, Heart Valve Div, Irvine, CA 92714 USA.
   Univ Illinois, Dept Vet Biosci, Urbana, IL 61801 USA.
   Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Los Angeles, CA 90048 USA.
RP Park, K (reprint author), Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
CR AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BADIMON L, 1987, J LAB CLIN MED, V110, P706
   Byun Y, 1996, BIOTECHNOL PROGR, V12, P217, DOI 10.1021/bp950076c
   CATTANEO M, 1991, THROMB HAEMOSTASIS, V66, P694
   Dewanjee MK, 1999, J HEART VALVE DIS, V8, P324
   Gross DR, 1997, ASAIO J, V43, pM382
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Kamat SG, 1997, J CARDIOVASC PHARM, V29, P156, DOI 10.1097/00005344-199702000-00002
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   Kamath KR, 1996, J BIOMAT SCI-POLYM E, V7, P977, DOI 10.1163/156856296X00381
   KAMATH KR, 1994, COLLOID SURFACE B, V2, P471
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   KIDANE A, 2000, COLLOIDS SURFACES B
   Kim SW, 1996, BLOOD PURIFICAT, V14, P357
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KONSTANTOPOULOS K, 1995, CIRCULATION, V91, P1427, DOI 10.1161/01.CIR.91.5.1427
   LAKI K, 1951, ARCH BIOCHEM BIOPHYS, V32, P317, DOI 10.1016/0003-9861(51)90277-9
   LI T, IN PRESS COMP THEOR
   Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1
   Makkar RR, 1997, CIRCULATION, V95, P1015
   MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590
   MAKKAR RR, 1995, CIRCULATION S1, V92, P86
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MCPHERSON T, 1996, 22 ANN M SOC BIOM 5, V2, P111
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   Park K, 1985, Trans Am Soc Artif Intern Organs, V31, P483
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311
   PARK K, 1988, J COLLOID INTERF SCI, V125, P702, DOI 10.1016/0021-9797(88)90037-9
   Park K, 1989, Scanning Microsc Suppl, V3, P137
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   ROGERS C, 1993, CIRCULATION, V88, P1215, DOI 10.1161/01.CIR.88.3.1215
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   ScottBurden T, 1996, CIRCULATION, V94, P235
   Serruys PW, 1996, CIRCULATION, V93, P412, DOI 10.1161/01.CIR.93.3.412
   SHETH S, 1996, CIRCULATION, V93, P423
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   SHOENFELD NA, 1987, J VASC SURG, V5, P76, DOI 10.1067/mva.1987.avs0050076
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   Tseng Y C, 1993, J Biomater Appl, V7, P233, DOI 10.1177/088532829300700303
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   TSENG YC, 1993, BIOMATERIALS, V14, P392, DOI 10.1016/0142-9612(93)90060-F
   Willerson JT, 1997, CIRCULATION, V96, P383
NR 46
TC 68
Z9 69
U1 0
U2 30
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 11
BP 1121
EP 1134
DI 10.1163/156856200744228
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 409WM
UT WOS:000167408700003
PM 11263803
DA 2018-10-19
ER

PT J
AU Sefton, MV
   Gemmell, CH
   Gorbet, MB
AF Sefton, MV
   Gemmell, CH
   Gorbet, MB
TI What really is blood compatibility?
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Devices and Diagnostics in Contact with Blood - Issues in
   Blood Compatibility at the Close of the 20th Century
CY AUG 04-06, 1999
CL Seattle, WA
SP Univ Washington, Engineered Biomat, Univ Washington, Engn Res Ctr
DE thrombogenicity; biomaterial; complement; platelets; leukocytes
ID PLATELET-DERIVED MICROPARTICLES; TISSUE FACTOR EXPRESSION;
   CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; PROCOAGULANT ACTIVITY;
   ARTIFICIAL SURFACES; NEUTROPHIL ACTIVATION; THROMBIN GENERATION;
   LEUKOCYTE ADHESION; ALCOHOL) HYDROGEL
AB The criteria for nonthrombogenicity are classically defined as long clotting times and minimal platelet deposition. The inability to point to unequivocal progress in the development of truly nonthrombogenic materials, highlights the inadequacy if not actually invalidity of these criteria. Our approach is to define nonthrombogenicity in terms of: (1) a thrombin production rate constant, k(p) < 10(-4) cm s(-1); (2) low platelet consumption and low degree of platelet activation (e.g., microparticle formation), (3) perhaps some platelet spreading; and (4) low complement and leukocyte activation. Only when the target becomes clear, will it be possible to identify clear strategies for producing the materials we need.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
FU NHLBI NIH HHS [HL24020]
CR ARNAOUT MA, 1990, BLOOD, V75, P1037
   Barstad RM, 1998, THROMB HAEMOSTASIS, V79, P302
   BASMADJIAN D, 1990, ANN BIOMED ENG, V18, P685, DOI 10.1007/BF02368455
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Beutler E, 1995, WILLIAMS HEMATOLOGY
   BLACK JP, IN PRESS BIOMATERIAL
   BLAJCHMAN MA, 1986, PROG HEMATOL, V14, P149
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BURMAN JF, 1994, LANCET, V344, P1192, DOI 10.1016/S0140-6736(94)90509-6
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P399, DOI 10.1002/jbm.820230403
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   Duncan AC, 1997, BIOMATERIALS, V18, P1585, DOI 10.1016/S0142-9612(97)00100-2
   ECKSTEIN EC, 1991, BIOPHYS J, V60, P53, DOI 10.1016/S0006-3495(91)82030-6
   Ernofsson M, 1997, J THORAC CARDIOV SUR, V113, P576, DOI 10.1016/S0022-5223(97)70373-8
   Gawaz MP, 1999, ARTIF ORGANS, V23, P29, DOI 10.1046/j.1525-1594.1999.06289.x
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   GEMMELL CH, 1993, J BIOL CHEM, V268, P14586
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 2000, J BIOMAT SCI-POLYM E, V11, P1197, DOI 10.1163/156856200744273
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P176, DOI 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.3.CO;2-Z
   Gemmell CH, 1998, J LAB CLIN MED, V131, P84, DOI 10.1016/S0022-2143(98)90081-6
   Gemmell CH, 1998, J BIOMED MATER RES, V42, P611, DOI 10.1002/(SICI)1097-4636(19981215)42:4<611::AID-JBM18>3.0.CO;2-D
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0
   GILLINOV AM, 1994, ANN THORAC SURG, V57, P345, DOI 10.1016/0003-4975(94)90995-4
   GOOSEN MFA, 1983, J BIOMED MATER RES, V17, P359, DOI 10.1002/jbm.820170212
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   GORBET MB, UNPUB J LAB CLIN MED
   Goto S, 1996, THROMB RES, V84, P351, DOI 10.1016/S0049-3848(96)00199-5
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1985, J CLIN INVEST, V75, P1591, DOI 10.1172/JCI111865
   HARKER LA, 1979, J CLIN INVEST, V64, P559, DOI 10.1172/JCI109494
   HARKER LA, 1980, BLOOD, V56, P824
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOHNSON PC, 1992, PLAST RECONSTR SURG, V90, P650, DOI 10.1097/00006534-199210000-00015
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   LLANOS GR, 1993, J BIOMED MATER RES, V27, P1383, DOI 10.1002/jbm.820271105
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   MONROE DM, 1991, THROMB HAEMOST, V65
   Parratt R, 1998, BRIT J HAEMATOL, V101, P40, DOI 10.1046/j.1365-2141.1998.00674.x
   POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224
   RATNER B, 1996, BIOMATERIALS SCI
   RINDER CS, 1992, BLOOD, V79, P1201
   ROLLASON G, 1992, J BIOMED MATER RES, V26, P675, DOI 10.1002/jbm.820260509
   Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6
   SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   SIMON P, 1987, NEPHRON, V45, P172, DOI 10.1159/000184109
   SIMS PJ, 1989, J BIOL CHEM, V264, P17049
   SIMS PJ, 1988, J BIOL CHEM, V263, P18205
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   STRZINAR I, 1992, J BIOMED MATER RES, V26, P577, DOI 10.1002/jbm.820260503
   Stuard S, 1998, INT J ARTIF ORGANS, V21, P75
   SUNDARAM S, 1994, INT J ARTIF ORGANS, V17, P118
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Taylor AD, 1996, BIOPHYS J, V71, P3488, DOI 10.1016/S0006-3495(96)79544-9
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   TURITTO VT, 1974, THROMB DIATH HAEMOST, P17
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   WABERS HD, 1992, J BIOMAT SCI-POLYM E, V4, P107
   WACHTFOGEL YT, 1994, THROMB HAEMOSTASIS, V72, P843
   WEILY HS, 1974, NEW ENGL J MED, V290, P534, DOI 10.1056/NEJM197403072901002
   WEISS HJ, 1987, ANN NY ACAD SCI, V516, P380, DOI 10.1111/j.1749-6632.1987.tb33057.x
   Wilhelm CR, 1998, ANN THORAC SURG, V65, P1071, DOI 10.1016/S0003-4975(98)00111-8
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   YEO E, 1993, MINIMAL P SELECTIN C
NR 78
TC 41
Z9 44
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 11
BP 1165
EP 1182
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 409WM
UT WOS:000167408700006
PM 11263806
DA 2018-10-19
ER

PT J
AU Ishihara, K
   Fujita, H
   Yoneyama, T
   Iwasaki, Y
AF Ishihara, K
   Fujita, H
   Yoneyama, T
   Iwasaki, Y
TI Antithrombogenic polymer alloy composed of 2-methacryloyloxyethyl
   phosphorylcholine polymer and segmented polyurethane
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Devices and Diagnostics in Contact with Blood: Issue in
   Blood Compatibility at the Close of the 20th Century
CY AUG 04-06, 1999
CL SEATTLE, WASHINGTON
SP Univ Washington, Engineered Biomaterials, Univ Washington, Engn Res Ctr
DE polymer alloy; phospholipid polymer; segmented polyurethane;
   antithrombogenicity; in vivo evaluation
ID PHOSPHOLIPID POLAR GROUPS; BLOOD COMPATIBILITY; PROTEIN ADSORPTION;
   SURFACE MODIFICATION; PLATELET-ADHESION; MEMBRANES; HEMOCOMPATIBILITY;
   BIOMATERIALS; IMPROVEMENT; ACTIVATION
AB To evaluate the antithrombogenicity of a new polymeric biomaterial in vivo, a polymer alloy tube composed of poly[2-methacryloyloxyethyl phosphorylcholine(MPC)-co-2-ethylhexyl methacrylate](PMEH) polymer and a segmented polyurethane (SPU) was prepared by a solvent evaporation method on a Teflon rod from a homogeneous solution containing both the PMHE and SPU. The composition of the PMEH vs the SPU was 10 wt%. The inner and outer surfaces of the polymer alloy tubing were characterized by X-ray electron spectroscopic (XPS) measurements. The MPC units were located on the inner surface of the polymer alloy tubing rather than the outer surface. After immersion in aqueous media, a higher concentration of the MPC units was observed on both surfaces. Selective staining of the MPC units with osmium tetraoxide was carried out to observe the morphology of the PMEH domain on the surface of the polymer alloy. There were large-sized PMEH domains on the inner surface of the tubing but small-sized domains were found on the outer surface. This result was in good agreement with the XPS results. Blood compatibility of the polymer alloy was evaluated by observation of fibrinogen adsorption and platelet adhesion from human plasma. A lot of fibrinogen was adsorbed and many platelets adhered to the inner surface of the original SPU tubing. On the other hand, the PHEH/SPU polymer alloy tubing suppressed these adsorptions and adhesions. When the PMEH/SPU polymer alloy tubing was implanted into a rabbit's artery, thrombus could not be observed even after a 7-day implantation but the original SPU tubing was almost totally occluded only after a 90-min implantation due to serious thrombus deposition on the surface. These results clearly indicated that the PMEH in the SPU matrix acted as an antithrombus reagent by suppression of protein adsorption and platelet adhesion and activation. Particularly, the MPC units played a significant role in this function.
C1 Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
   Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1100062, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Brash JL, 1987, ACS S SERIES, V343
   Campbell E., 1994, ASAIO J, V4, P853
   Chang PCT, 1998, J BIOMED MATER RES, V39, P380
   Horbett TA, 1995, ACS S SERIES, V602
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P271, DOI 10.1163/156856299X00342
   ISHIHARA K, 2000, IN PRESS COLLOID S B
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   Kohler AS, 1996, J BIOMED MATER RES, V32, P237, DOI 10.1002/(SICI)1097-4636(199610)32:2<237::AID-JBM13>3.0.CO;2-G
   Lelah M. D., 1986, POLYURETHANES MED
   Liu JH, 1999, J APPL POLYM SCI, V74, P2947, DOI 10.1002/1097-4628(19991213)74:12<2947::AID-APP21>3.0.CO;2-1
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Murphy EF, 1999, LANGMUIR, V15, P1313, DOI 10.1021/la9813580
   Nakabayashi N, 1996, MACROMOL SYMP, V101, P405, DOI 10.1002/masy.19961010146
   Oishi T, 1998, POLYM J, V30, P17, DOI 10.1295/polymj.30.17
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   SUGIYAMA K, 1994, POLYM J, V26, P561, DOI 10.1295/polymj.26.561
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
   YUI N, 1995, J BIOMAT SCI-POLYM E, V7, P253
NR 29
TC 22
Z9 25
U1 1
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 11
BP 1183
EP 1195
DI 10.1163/156856200744264
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 409WM
UT WOS:000167408700007
PM 11263807
DA 2018-10-19
ER

PT J
AU Lamba, NMK
   Baumgartner, JN
   Cooper, SL
AF Lamba, NMK
   Baumgartner, JN
   Cooper, SL
TI The influence of thrombus components in mediating bacterial adhesion to
   biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Devices and Diagnostics in Contact with Blood: Issue in
   Blood Compatibility at the Close of the 20th Century
CY AUG 04-06, 1999
CL SEATTLE, WASHINGTON
SP Univ Washington, Engineered Biomaterials, Univ Washington, Engn Res Ctr
DE bacteria; polyurethane; protein; thrombus; platelet
ID MOLECULAR-WEIGHT KININOGEN; POLYMERIC BIOMATERIALS; POLYURETHANE
   SURFACES; PROTEIN ADSORPTION; REDUCED THROMBOGENICITY;
   STAPHYLOCOCCUS-AUREUS; POLAR GROUPS; FIBRINOGEN; CATHETERS; ALBUMIN
AB Thrombosis and infection represent the two largest limiting factors determining the long term success of implanted biomaterials. Infections associated with biomaterials are difficult to treat, and appear to evade the host defense systems. Mechanisms relating infection to thrombosis are described. Investigations into the role of receptors in mediating adhesion to thrombi are also discussed, in addition to strategies to reduce bacterial adhesion to biomaterial surfaces.
C1 IIT, Chicago, IL 60616 USA.
   Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   Cerus Corp, Concord, CA USA.
RP Cooper, SL (reprint author), IIT, Chicago, IL 60616 USA.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Andersson R., 1995, INT J CONSUMER SAFET, V2, P61
   ANDERTON A, 1991, J HOSP INFECT, V18, P131, DOI 10.1016/0195-6701(91)90157-4
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1611
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BALTIMORE RS, 1980, J INFECT DIS, V141, P238, DOI 10.1093/infdis/141.2.238
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   CHAN BMC, 1981, J COLLOID INTERF SCI, V84, P263, DOI 10.1016/0021-9797(81)90283-6
   CHAPMAN D, 1993, BIOCHEM SOC T, V21, P258, DOI 10.1042/bst0210258
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P303
   COLLINS WE, 1987, SCANNING MICROSCOPY, V1, P1669
   DEITCH EA, 1983, ANTIMICROB AGENTS CH, V23, P356, DOI 10.1128/AAC.23.3.356
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   DINEEN P, 1977, VASCULAR SURG, V11, P29, DOI 10.1177/153857447701100106
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   ENDO Y, 1987, APPL ENVIRON MICROB, V53, P2050
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FARRAH SR, 1991, CAN J MICROBIOL, V37, P445, DOI 10.1139/m91-073
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   HABAL MB, 1980, J BIOMED MATER RES, V14, P455, DOI 10.1002/jbm.820140412
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   JOHNSTON EE, 1997, POLYM PREPRINTS AM S
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Lamba N. M. K., 1998, POLYURETHANES BIOMED, P277
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   MCLEAN RJC, 1993, CAN J MICROBIOL, V39, P895, DOI 10.1139/m93-134
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   MOHAMMAD SF, 1988, T AM SOC ART INT ORG, V34, P573
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203
   Nickel J C, 1992, Can J Infect Dis, V3, P261
   NOSE Y, 1992, ARTIF ORGANS, V16, P19
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P3, DOI 10.1016/0142-9612(91)90123-R
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PARK KD, 1996, 5 BIOM WORLD C
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Petrocci A.N., 1983, DISINFECTION STERILI
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   RODRIGUEZ J L, 1986, Current Surgery, V43, P423
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SANTERRE JP, 1989, T SOC BIOMATER, V15, P113
   SHETH NK, 1983, J CLIN MICROBIOL, V18, P1061
   SILVER JH, 1992, BIOMATERIALS, V13, P339, DOI 10.1016/0142-9612(92)90037-O
   SLACK SM, 1988, 3 WORLD BIOM C KYOT, P95
   TROOSKIN SZ, 1985, SURGERY, V97, P547
   van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202
   WADSTROM T, 1990, PATHOGENESIS WOUND B
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
   Yung LYL, 1996, IMMUNOPHARMACOLOGY, V32, P19, DOI 10.1016/0162-3109(96)00003-3
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 62
TC 16
Z9 16
U1 1
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 11
BP 1227
EP 1237
DI 10.1163/156856200744174
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 409WM
UT WOS:000167408700010
PM 11263810
DA 2018-10-19
ER

PT J
AU Tassiopoulos, AK
   Greisler, HP
AF Tassiopoulos, AK
   Greisler, HP
TI Angiogenic mechanisms of endothelialization of cardiovascular implants:
   a review of recent investigative strategies
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE cardiovascular implants; angiogenesis; growth factors
ID EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS; GROWTH-FACTOR TYPE-1; FIBRIN
   GLUE; SMOOTH-MUSCLE; PLATELET DEPOSITION; VASCULAR GRAFTS; EPTFE GRAFTS;
   FACTOR-I; HEPARIN; CELLS
AB Both cardiovascular implants and therapeutic interventions on native arteries fail due to biologic responses occurring at the blood/prosthesis/arterial wall and tissue/prosthesis/arterial wall interfaces, resulting in the failure modes of thrombosis and myointimal hyperplasia. Systemic pharmacologic approaches including use of anti-coagulant and anti-platelet agents have significant untoward side effects and have not resulted in a dramatic impact on failure modes in many applications, including small diameter vascular grafts. Local delivery of therapeutic agents via surface attachment with defined release kinetics may alter thrombogenicity and/or myointimal hyperplasia. Therapeutic agents may include a spectrum of biologic agents from peptides to endothelial cells. Efficient attachment and release of these agents in biologically active form is dependent upon improved methods of surface modification. The intended action of the biologic agent may similarly be impacted by the surface and bulk characteristics of the underlying biomaterial.
   It is often assumed, without concrete data, that surface re-endothelialization may have a beneficial impact on both thrombogenicity acid myointimal hyperplasia. New clinical data on endothelial cell seeding has been supportive. Spontaneous re-endothelialization may be stimulated via an induced directed angiogenesis resulting in trans-interstitial capillarization and surface endothelialization. Recent advances in therapeutic angiogenesis have suggested the power of angiogenic factors to induce neovascularization of ischemic tissue beds. These concepts have been used to surface modify prosthetic devices with either VEGF or FGF and both in vitro and animal data suggest a potent stimulation of surface re-endothelialization. Neither of these growth factors is likely to be ideal. VEGF is relatively endothelial cell specific but is a relatively weak endothelial cell mitogen. FGF-I and FGF-2 are more potent mitogens but are less cell specific. Recent work has led to the generation of mutant growth Factors via site-induced mutagenesis and results of several such FGF mutants on endothelial cell and smooth muscle cell proliferative response have been studied. The use of 'designer growth factors' on cardiovascular implants and on manipulated native vessels may have a significant positive impact on re-endothelialization and thereby on the failure modes of thrombosis and myointimal hyperplasia.
C1 Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA.
   Loyola Univ, Med Ctr, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA.
RP Tassiopoulos, AK (reprint author), Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA.
EM hgreisl@lumc.edu
FU NHLBI NIH HHS [R01 HL41272]
CR BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOWLIN GL, 1996, THESIS U AKRON OH
   BURGESS WH, 1985, J BIOL CHEM, V260, P1389
   CALLOW AD, 1982, SURG CLIN N AM, V62, P501
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   GALLUS A S, 1976, Seminars in Thrombosis and Hemostasis, V2, P291
   Gosselin C, 1996, J SURG RES, V60, P327, DOI 10.1006/jsre.1996.0052
   GOSSELIN C, 1995, AM J SURG, V170, P126, DOI 10.1016/S0002-9610(99)80270-0
   Gray J. L., 1993, Surgical Forum, V44, P394
   GREISLER HP, 1992, SURGERY, V112, P244
   GREISLER HP, 1988, CIRCULATION, V78, P6
   Greisler HP, 1996, J CONTROL RELEASE, V39, P267, DOI 10.1016/0168-3659(95)00159-X
   GREISLER HP, 1991, NEW BIOL SYNTHETIC V, P20
   HAMPTON BS, 1992, MOL BIOL CELL, V3, P85
   HERRING M, 1984, SURGERY, V84, P848
   HIRKO MK, 1995, ASAIO J, V41, pM630, DOI 10.1097/00002480-199507000-00087
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   KOHLER TR, 1992, SURGERY, V112, P901
   KRETSCHMER G, 1987, SURGERY, V102, P453
   Lin PH, 1998, ATHEROSCLEROSIS, V137, P277, DOI 10.1016/S0021-9150(97)00284-0
   Pepper MS, 1997, ARTERIOSCL THROM VAS, V17, P605, DOI 10.1161/01.ATV.17.4.605
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   RUPNICK MA, 1989, J VASC SURG, V9, P788, DOI 10.1067/mva.1989.vs0090788
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SHIREMAN PK, IN PRESS J VASC SURG
   Stanley J. C., 1986, VASCULAR GRAFT UPDAT, P33
   VEITH FJ, 1986, J VASC SURG, V3, P104
   VOHRA R, 1991, BRIT J SURG, V78, P417, DOI 10.1002/bjs.1800780411
   WONG P, 1995, J BIOL CHEM, V270, P25805, DOI 10.1074/jbc.270.43.25805
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
   Zarge JI, 1997, J VASC SURG, V25, P840, DOI 10.1016/S0741-5214(97)70213-1
   Zarge JI, 1997, J SURG RES, V67, P4, DOI 10.1006/jsre.1996.4903
   ZILLA P, 1994, VASCULAR SURG, V25, P540
NR 36
TC 34
Z9 34
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 11
BP 1275
EP 1284
DI 10.1163/156856200744200
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 409WM
UT WOS:000167408700013
PM 11263813
DA 2018-10-19
ER

PT J
AU Kingshott, P
   St John, HAW
   Chatelier, RC
   Griesser, HJ
AF Kingshott, P
   St John, HAW
   Chatelier, RC
   Griesser, HJ
TI Matrix-assisted laser desorption ionization mass spectrometry detection
   of proteins adsorbed in vivo onto contact lenses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE matrix-assisted laser desorption ionization mass; spectrometry; protein
   adsorption; contact lenses; lysozyme; biofouling
ID ADSORPTION; BIOFILMS; SURFACES
AB Identification of the biomolecules that form the first adsorbed monolayer, which thus effect "interface conversion", in competitive adsorption from multicomponent biological solutions can be challenging because of limitations in mass resolution and sensitivity of established techniques. In this study matrix-assisted laser desorption ionization (MALDI) time of flight mass spectrometry is developed and applied as a novel surface analytical method to enable analysis of adsorbed multicomponent biomolecule layers directly on the biomaterial surfaces. We show that proteins adsorbed in vivo (on human eyes) an contact lenses can be detected rapidly and conveniently by the diagnostic highly resolved mass signals recorded by MALDI mass spectrometry This new approach allows detection of minor (and major) proteinaceous constituents of biofouled layers at levels substantially below monolayer coverage. Identification is done by comparison with molecular masses of known proteins. Specifically, it is shown that in addition to lysozyme, other low molecular weight proteins adsorb from human tear fluid onto contact lenses; these proteins had not been detected in earlier studies using other techniques. (C) 2000 John Wiley & Sons, Inc.
C1 CSIRO, Mol Sci, Clayton, Vic 3169, Australia.
RP Griesser, HJ (reprint author), CSIRO, Mol Sci, Private Bag 10,Clayton S MDC, Clayton, Vic 3169, Australia.
EM h.griesser@molsci.csiro.au
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863; Kingshott, Peter/0000-0001-5882-5804
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   FRANKLIN VJ, 1993, TRENDS POLYM SCI, V1, P9
   GOLDENBERG MS, 1991, BIOMATERIALS, V12, P267, DOI 10.1016/0142-9612(91)90033-7
   HLADY V, 1993, CLIN MATER, V13, P85, DOI 10.1016/0267-6605(93)90094-N
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   Horbett TA, 1995, ACS S SERIES, V602
   JESPERSEN S, 1994, RAPID COMMUN MASS SP, V8, P581, DOI 10.1002/rcm.1290080802
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KINGSHOTT P, 1998, THESIS U NEW S WALES
   KINGSHOTT P, 1997, AM CHEM SOC POLYM PR, V38, P1008
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   WEDLER FC, 1982, BIOCOMPATIBILITY CLI, V11, P1
   YAN GY, 1993, INVEST OPHTH VIS SCI, V34, P1804
NR 17
TC 44
Z9 44
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2000
VL 49
IS 1
BP 36
EP 42
DI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260ND
UT WOS:000083956000005
PM 10559744
DA 2018-10-19
ER

PT J
AU Raisanen, L
   Kononen, M
   Juhanoja, J
   Varpavaara, P
   Hautaniemi, J
   Kivilahti, J
   Hormia, M
AF Raisanen, L
   Kononen, M
   Juhanoja, J
   Varpavaara, P
   Hautaniemi, J
   Kivilahti, J
   Hormia, M
TI Expression of cell adhesion complexes in epithelial cells seeded on
   biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE epithelial cells; vinculin; integrin; cell adhesion; biomaterials
ID HUMAN GINGIVAL FIBROBLASTS; CRYSTAL SAPPHIRE IMPLANTS; LONG-TERM
   EVALUATION; HEMIDESMOSOME FORMATION; TITANIUM SURFACES; ATTACHMENT;
   INVITRO; IMMUNOLOCALIZATION; INTEGRIN-ALPHA-6-BETA-4; ALPHA-6-BETA-4
AB Clinical studies indicate that soft tissue responses around dental implants vary, depending on the material used. It is therefore also possible that there are differences in how epithelial cells attach to various biomaterial surfaces. We studied the adhesion of cultured epithelial cells to five different dental material surfaces and to glass. The efficacy of adhesion was evaluated by using scanning electron microscopy (SEM) and immunofluorescence microscopy (IF) with antibodies to vinculin and alpha(6)beta(4) integrin, two cell surface molecules that are functional in epithelial cell adhesion. Our results indicate that epithelial cells adhere and spread more avidly on metallic surfaces (titanium, Ti6Al4V titanium alloy, dental gold alloy) than on ceramic surfaces (dental porcelain, aluminum oxide). As revealed by SEM, cells on metallic surfaces had a flattened morphology and formed multicellular islands. On porcelain and aluminum oxide most cells were round and adhesion occurred as single cells. Surface coverage was over twofold on metallic surfaces as compared to ceramic surfaces. IF of cells grown on metallic surfaces revealed vinculin in well-organized focal contacts and alpha(6)beta(4) integrin in punctate patterns typical of prehemidesmosomes. On porcelain and aluminum oxide surfaces the cells were mostly round and showed less well-organized adhesion complexes. Our results indicate that smooth metallic biomaterial surfaces are optimal for epithelial cell adhesion and spreading. These findings may have clinical implications in the design of transgingival implant structures. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Turku, Inst Dent, Dept Periodontol, FIN-20520 Turku, Finland.
   Helsinki Univ Technol, Dept Mat Sci & Engn, FIN-02150 Espoo, Finland.
   Univ Turku, Dept Appl Phys, FIN-20014 Turku, Finland.
   Univ Helsinki, Inst Biotechnol Electron Microscopy, Bioctr 1, FIN-00014 Helsinki, Finland.
   Aarhus Univ, Royal Dent Coll, Dept Prosthet Dent & Stomatognath Physiol, DK-8000 Aarhus C, Denmark.
   Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland.
RP Hormia, M (reprint author), Univ Turku, Inst Dent, Dept Periodontol, Lemminkaisenkatu 2, FIN-20520 Turku, Finland.
CR ALBREKTSSON T, 1988, J PROSTHET DENT, V60, P75, DOI 10.1016/0022-3913(88)90355-1
   Arvidson K, 1996, CLIN ORAL IMPLAN RES, V7, P1, DOI 10.1034/j.1600-0501.1996.070101.x
   Arvidson K, 1991, CLIN ORAL IMPLAN RES, V2, P47, DOI 10.1034/j.1600-0501.1991.020201.x
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Cranin A N, 1993, J Oral Implantol, V19, P221
   Fartash B, 1997, CLIN ORAL IMPLAN RES, V8, P58, DOI 10.1111/j.1600-0501.1997.tb00008.x
   Fartash B, 1990, CLIN ORAL IMPLAN RES, V1, P13, DOI 10.1034/j.1600-0501.1990.010103.x
   Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5
   GIPSON IK, 1983, J CELL BIOL, V97, P849, DOI 10.1083/jcb.97.3.849
   GOULD TRL, 1981, J PERIODONTAL RES, V16, P611, DOI 10.1111/j.1600-0765.1981.tb00999.x
   GOULD TRL, 1984, J PROSTHET DENT, V52, P418, DOI 10.1016/0022-3913(84)90459-1
   HORMIA M, 1995, J INVEST DERMATOL, V105, P557, DOI 10.1111/1523-1747.ep12323451
   HORMIA M, 1992, J DENT RES, V71, P1503, DOI 10.1177/00220345920710080801
   HORMIA M, 1994, J PERIODONTAL RES, V29, P146, DOI 10.1111/j.1600-0765.1994.tb01103.x
   HORMIA M, 1991, J PERIODONTAL RES, V26, P491, DOI 10.1111/j.1600-0765.1991.tb01800.x
   HORMIA M, 1994, J DENT RES, V73, P255
   JANSEN JA, 1985, J DENT RES, V64, P891, DOI 10.1177/00220345850640060601
   JONES JCR, 1991, CELL REGUL, V2, P427
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   Kasten FH, 1990, INT J PERIODONT REST, V10, P69
   KLAWITTER JJ, 1977, J DENT RES, V56, P768, DOI 10.1177/00220345770560071101
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737
   LANGHOFER M, 1993, J CELL SCI, V105, P753
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   Lodish H., 1995, MOL CELL BIOL
   Maxson B B, 1992, Oral Surg Oral Diagn, V3, P31
   MCKINNEY RV, 1985, J PERIODONTOL, V56, P579, DOI 10.1902/jop.1985.56.10.579
   NIEDERAUER GG, 1994, BIOMATERIALS, V15, P342, DOI 10.1016/0142-9612(94)90246-1
   Persson LG, 1996, CLIN ORAL IMPLAN RES, V7, P366, DOI 10.1034/j.1600-0501.1996.070410.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   RATY R, 1966, J SCI INSTRUM, V43, P367, DOI 10.1088/0950-7671/43/6/304
   RIDDELLE KS, 1991, J CELL BIOL, V112, P159, DOI 10.1083/jcb.112.1.159
   RUSS JC, 1995, IMAGE PROCESSING HDB
   SCHROEDER HE, 1977, MONOGRAPHS DEV BIOL, V2
   SCHUPBACH P, 1994, CLIN ORAL IMPLAN RES, V5, P55, DOI 10.1034/j.1600-0501.1994.050201.x
   SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cellbio.6.1.461
   SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907
   SPINARDI L, 1995, J CELL BIOL, V129, P473, DOI 10.1083/jcb.129.2.473
   Steflik D E, 1988, Ann N Y Acad Sci, V523, P4, DOI 10.1111/j.1749-6632.1988.tb38497.x
   STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970
   TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593
NR 46
TC 32
Z9 33
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2000
VL 49
IS 1
BP 79
EP 87
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 260ND
UT WOS:000083956000010
PM 10559749
DA 2018-10-19
ER

PT J
AU Schoof, H
   Bruns, L
   Fischer, A
   Heschel, I
   Rau, G
AF Schoof, H
   Bruns, L
   Fischer, A
   Heschel, I
   Rau, G
TI Dendritic ice morphology in unidirectionally solidified collagen
   suspensions
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE collagen sponges; unidirectional solidification; Bridgman technique;
   collagen suspensions; acetic acid solutions; dendritic ice morphology
AB Collagen is a fibrillar protein which is commonly used as a biodegradable biomaterial. A typical application of such a biomaterial is a freeze-dried collagen sponge which is primarily used as a permanent skin replacement for the treatment of deep dermal burns. Especially to diminish scar formation caused by a severe loss of skin, it is necessary to induce a cell migration into the sponges and the regeneration of endogenous tissue within the sponges. Thereby, the three-dimensional structure and the pore sizes of the collagen sponges strongly influence the wound healing. In order to study this influence, the development of a process to manufacture collagen sponges with an adjustable and homogeneous three-dimensional structure is necessary. The porous structure of freeze-dried sponges corresponds to the ice crystal morphology after freezing. In order to form an adjustable and homogeneous ice morphology, the unidirectional solidification of collagen suspensions was investigated. All experiments were performed in a cryomicroscope according to the Bridgman technique. To induce a constitutional supercooling leading to the breakdown of the planar ice front and the formation of a stable dendritic ice crystal morphology (without side branches), the addition of solutes to the basic collagen suspension is required. We used acetic acid and ethanol as soluble additives, because they are suitable for medical application. The effects of the temperature gradient, the ice front velocity, and the solute concentration on the primary spacing and the dendrite sizes were examined. In order to find a simplified experimental system, acetic acid solutions without collagen were solidified under the same freezing conditions. Although the primary spacings and the dendrite sizes almost varied in the same range for solutions and suspensions, they were influenced in a different manner by the freezing parameters and the solute concentrations. Varying the aforementioned parameters the primary spacing could be adjusted in the range from 40 to 60 mu m. Furthermore, the ice crystal sizes, which correspond to the pore size after freeze-drying, could be varied between 30 and 50 mu m. (C) 2000 Elsevier Science B.V, All rights reserved.
C1 Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
RP Schoof, H (reprint author), Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Pauwelsstr 20, D-52074 Aachen, Germany.
CR AUBOURG P, 1978, THESIS MIT CAMBRIDGE
   BECKMANN J, 1990, CRYOBIOLOGY, V27, P279, DOI 10.1016/0011-2240(90)90027-2
   BRONSTEIN VL, 1981, J CRYST GROWTH, V52, P345, DOI 10.1016/0022-0248(81)90216-5
   BROWER WE, 1981, CRYOBIOLOGY, V18, P277, DOI 10.1016/0011-2240(81)90099-7
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   HOBBS PV, 1974, ICE PHYSICS, P584
   KORBER C, 1988, Q REV BIOPHYS, V21, P229
   KURZ W, 1989, FUNDAMENTALS SOLIDIF, P7
   LIPP G, 1991, THESIS RWTH AACHEN G
   MULLINS WW, 1963, J APPL PHYS, V34, P328
   POTSCHKE J, 1986, NATURWISSENSCHAFTEN, V73, P381, DOI 10.1007/BF00367273
   RUBINSKY B, 1985, CRYOBIOLOGY, V22, P55, DOI 10.1016/0011-2240(85)90008-2
   RUTTER JW, 1953, CAN J PHYS, V31, P15, DOI 10.1139/p53-003
   SILVERSTEIN ME, 1980, J TRAUMA, V20, P688, DOI 10.1097/00005373-198008000-00010
   TILLER WA, 1953, ACTA METALL MATER, V1, P428, DOI 10.1016/0001-6160(53)90126-6
   WINTER G, 1973, BIOL FIBROBLAST, P104
   YANNAS I, 1989, Patent No. 10728
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1988, COLLAGEN, V3, P87
NR 20
TC 64
Z9 64
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JAN
PY 2000
VL 209
IS 1
BP 122
EP 129
DI 10.1016/S0022-0248(99)00519-9
PG 8
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 273GT
UT WOS:000084700100016
DA 2018-10-19
ER

PT J
AU Al-Abdullat, Y
   Kuwahara, H
   Peng, C
   Tsutsumi, S
AF Al-Abdullat, Y
   Kuwahara, H
   Peng, C
   Tsutsumi, S
TI Possibilities of magnesium as a new dental biomaterial
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.
   Inst Appl Sci, Kyoto, Japan.
NR 0
TC 1
Z9 1
U1 0
U2 4
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PY 2000
VL 79
SI SI
MA 3794
BP 618
EP 618
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 277MH
UT WOS:000084937003789
DA 2018-10-19
ER

PT J
AU Beatty, MF
AF Beatty, MF
TI The Mullins effect in a pure shear
SO JOURNAL OF ELASTICITY
LA English
DT Article
ID CONSTITUTIVE EQUATION; UNIAXIAL EXTENSION; PERMANENT SET; STRESS;
   DEFORMATION; INFLATION; SOLIDS
AB The Mullins effect in a rubberlike material subjected to a pure shear deformation is studied in the context of a recent theory of stress-softening for incompressible materials proposed by Beatty and Krishnaswamy. Some general technical results characterizing the mechanical response are presented. These show that the theory delivers results consistent with the overall behavior expected of a Mullins material, but usually exhibited in uniaxial extension or equibiaxial stretch experiments. The extent of stress-softening in a pure shear is shown to be much less than that due to an equibiaxial deformation, and only slightly greater than the degree of stress-softening induced by an uniaxial deformation, all to the same stretch. The Mullins effect in an equivalent simple shear deformation, even one having a rather large angle of shear, is small. The simple shear is the least damaging deformation among all of those mentioned here. Some graphical results, based on a special class of stress-softening materials applied to two parent material models - the familiar Mooney-Rivlin and a certain biotype material model, illustrate the general conclusions obtained for arbitrary Mullins materials. The inflation of a biomaterial membrane preconditioned in a pure shear deformation demonstrates the familiar stress-softening phenomenon observed in the inflation of a balloon.
C1 Univ Nebraska, Dept Engn Mech, Lincoln, NE 68588 USA.
RP Beatty, MF (reprint author), Univ Nebraska, Dept Engn Mech, Lincoln, NE 68588 USA.
CR BEATTY M. F., 1996, NONLINEAR EFFECTS FL, P13
   Beatty MF, 2000, J MECH PHYS SOLIDS, V48, P1931, DOI 10.1016/S0022-5096(99)00085-X
   BEATTY MF, IN PRESS Z ANGEW MAT
   Emery JL, 1997, J BIOMECH ENG-T ASME, V119, P6, DOI 10.1115/1.2796067
   Huntley HE, 1996, MATH MECH SOLIDS, V1, P267, DOI 10.1177/108128659600100301
   Huntley HE, 1997, IMA J APPL MATH, V59, P309, DOI 10.1093/imamat/59.3.309
   JOHNSON MA, 1995, INT J ENG SCI, V33, P223, DOI 10.1016/0020-7225(94)E0052-K
   JOHNSON MA, 1993, CONTINUUM MECH THERM, V5, P83, DOI 10.1007/BF01141446
   JOHNSON MA, 1993, CONTINUUM MECH THERM, V5, P301, DOI 10.1007/BF01135817
   Krishnaswamy S, 2000, INT J ENG SCI, V38, P1397, DOI 10.1016/S0020-7225(99)00125-1
   KRISHNASWAMY S, IN PRESS Q J MECH AP
   Mullins L., 1957, RUBBER CHEM TECHNOL, V30, P551
   MULLINS L, 1947, J RUBBER RES, V16, P275, DOI DOI 10.5254/1.3546914
   RAJAGOPAL KR, 1992, INT J PLASTICITY, V8, P385, DOI 10.1016/0749-6419(92)90056-I
   RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004
   TRUESDELL C, 1965, FLUGGES HDB PHYSIK, V3
   Wineman A. S., 1990, Archives of Mechanics, V42, P53
   WINEMAN AS, 1994, INT J SOLIDS STRUCT, V31, P3295, DOI 10.1016/0020-7683(94)90101-5
NR 18
TC 13
Z9 13
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0374-3535
J9 J ELASTICITY
JI J. Elast.
PY 2000
VL 59
IS 1-3
BP 369
EP 392
DI 10.1023/A:1011007522361
PG 24
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary;
   Mechanics
SC Engineering; Materials Science; Mechanics
GA 417UC
UT WOS:000167851700019
DA 2018-10-19
ER

PT J
AU Grabenwoger, M
   Fitzal, F
   Gross, C
   Simon, P
   Hutschala, D
   Bock, P
   Brucke, P
   Wolner, E
AF Grabenwoger, M
   Fitzal, F
   Gross, C
   Simon, P
   Hutschala, D
   Bock, P
   Brucke, P
   Wolner, E
TI Different modes of degeneration in autologous and heterologous heart
   valve prostheses
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT World Symposium on Heart Valve Disease
CY JUN 11-14, 1999
CL LONDON, ENGLAND
ID GLUTARALDEHYDE; CALCIFICATION; TISSUE; COLLAGEN; ACID
AB Background and aim of the study: This study was performed to elucidate the mechanism of primary tissue failure of bioprosthetic heart valves, which were fabricated from autologous pericardium (Autogenics(R)). Results were compared with the degeneration pattern of heterologous pericardial bioprostheses.
   Methods: Between March 1994 and December 1996, 87 Autogenics heart valves were implanted in the aortic position. Since then, 15 valves had to be explanted due to structural deterioration. The average implant period was 33 +/- 8 months. All explants were examined by gross morphological evaluation and X-ray analysis to identify the failure mode of these devices. In eight explanted autologous tissue valves and six explanted heterologous pericardial bioprostheses, exact morphological evaluation was performed by scanning electron microscopy, microscopic and immunohistochemical techniques.
   Results: All autologous tissue valves failed due to cuspal tears localized at the commissures. Nocalcification could be detected by X-ray analysis and microscopic methods. Endothelial cell coverage was evident at the outflow surface of all autologous bioprostheses. Histological examination showed severe disintegration of the collagen fibers by insudated plasma proteins and erythrocytes, and the absence of the original fibroblasts. Collagen fibers were vigorously altered between the inner and outer stent of the Autogenics valve. In contrast, heterologous pericardial valves failed due to severe calcification of the cusps. Histological evaluation displayed invasion of macrophages and calcific deposits. The collagenous texture of the pericardial tissue was significantly better preserved compared with autologous tissue.
   Conclusion: High biocompatibility of autologous tissue valves is indicated by the absence of calcium deposits, macrophages and foreign body giant cells, and the presence of endothelial cell ingrowth. Severe disintegration of autologous tissue suggests that brief immersion in glutaraldehyde generates inadequate mechanical stability of bioprosthetic heart valve material. Heterologous valves exhibit low biocompatibility but superior preservation of the collagenous biomaterial.
C1 Univ Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria.
   Gen Hosp, Dept Surg 1, Linz, Austria.
   Vet Univ Vienna, Inst Histol & Embryol, A-1030 Vienna, Austria.
RP Grabenwoger, M (reprint author), Univ Vienna, Dept Cardiothorac Surg, Wahringer Gurtel 18-20,Leitstelle 20, A-1090 Vienna, Austria.
CR BOCK P, 1989, ROMEIS MIKROSKOPISCH, P559
   CARPENTIER A, 1968, J THORAC CARDIOV SUR, V56, P388
   CHAUVAUD S, 1991, J THORAC CARDIOV SUR, V102, P171
   CHEN WL, 1994, CIRCULATION, V90, P323, DOI 10.1161/01.CIR.90.1.323
   CHRISTIE GW, 1992, EUR J CARDIO-THORAC, V6, P95
   GRABENWOGER M, 1992, J THORAC CARDIOV SUR, V104, P14
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   IONESCU MI, 1969, LANCET, V2, P335
   Liao Kangxiong, 1995, Annals of Thoracic Surgery, V60, P343
   Love J W, 1992, J Heart Valve Dis, V1, P232
   LOVE JW, 1993, AUTOLOGOUS TISSUE HE
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   PETCH M, 1974, BRIT HEART J, V36, P177
   Schoen F J, 1984, Cardiol Clin, V2, P717
   SENNING A, 1967, J THORAC CARDIOV SUR, V54, P465
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   ZUHDI N, 1973, J CARDIOVASC SURG, V8, P425
NR 20
TC 18
Z9 20
U1 0
U2 1
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD, ENGLAND HA6
   2ET
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JAN
PY 2000
VL 9
IS 1
BP 104
EP 109
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 276YH
UT WOS:000084905600020
PM 10678382
DA 2018-10-19
ER

PT J
AU Proctor, RA
AF Proctor, RA
TI Toward an understanding of biomaterial infections: A complex interplay
   between the host and bacteria
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Editorial Material
ID STAPHYLOCOCCUS-AUREUS; ENDOCARDITIS; ADHESION
C1 Univ Wisconsin, Sch Med, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.
RP Proctor, RA (reprint author), Univ Wisconsin, Sch Med, Dept Med Microbiol & Immunol, 407 SMI, Madison, WI 53706 USA.
CR Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   BISNO AL, 1994, INFECT ASSOCIATED IN, pR11
   CHEUNG AL, 1994, INFECT IMMUN, V62, P1719
   COOPER SL, 1987, ANN NY ACAD SCI, V516, P572, DOI 10.1111/j.1749-6632.1987.tb33074.x
   Foster T. J., 1994, P31
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   Maki Dennis G., 1994, P155
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PROCTOR RA, 1984, J LAB CLIN MED, V104, P455
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VAUDAUX P, IN PRESS INFECT ASSO, pCH2
   WU T, 1994, ANTIMICROB AGENTS CH, V38, P729, DOI 10.1128/AAC.38.4.729
   Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1111, DOI 10.1128/AAC.43.5.1111
NR 15
TC 14
Z9 15
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD JAN
PY 2000
VL 135
IS 1
BP 14
EP 15
DI 10.1016/S0022-2143(00)70015-1
PG 2
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 300EP
UT WOS:000086240100003
PM 10638689
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Contreras, LA
   Pascual, G
   Bujan, J
AF Bellon, JM
   Contreras, LA
   Pascual, G
   Bujan, J
TI Evaluation of the acute scarring response to the implant of different
   types of biomaterial in the abdominal wall
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYTETRAFLUOROETHYLENE PROSTHESIS; MACROPHAGE RESPONSE; MYCRO-MESH;
   DEFECTS; REPAIR; POLYPROPYLENE; MARLEX; PATCH
AB Since the short-term, acute scarring process induced by a biomaterial may condition the evolution of the repair process, the present investigation evaluates the behavior of polytetrafluoroethylene (PTFE) and polypropylene (PL) biomaterials in the initial stages of repair. Three PTFE biomaterials (Mycro Mesh(R), Dual Mesh(R) and Soft Tissue Patch(R)) and one PL biomaterial (Marlex(R)) were employed to repair defects created in the abdominal wall of New Zealand rabbits. Animals were sacrificed at 3 or 7 days. Specimens were obtained for light and scanning electron microscopy, and immunohistochemical analysis using the RAM-11 monoclonal antibody for rabbit macrophages. The PL implants showed substantial adhesion formation with viscera. Lower adhesion formation was detected in the PTFE implants. The evolution of the acute phase of the repair process was similar for each PTFE biomaterial. At 3 days post implant, an incipient neoperitoneum was detected which was fully established after 7 days. The behavior of the PL implant was similar, although a greater amount of reticular granulation was detected. The neoformed peritoneum was irregular. Few RAM-11-labeled macrophages were detected in all cases. The acute phase of the tissue repair process induced by the implant of PTFE and PL biomaterials generally proceeds along similar lines to a normal repair process. However, the use of microporous, laminar materials seems to favor the early establishment of a well-defined neoperitoneal layer. (C) 2000 Kluwer Academic Publishers.
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Madrid 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Crta Madrid Barcelona Km 33,600, Madrid 28871, Spain.
OI BELLON, JUAN M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476;
   PASCUAL, GEMMA/0000-0002-1623-4384
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 1996, BIOMATERIALS, V17, P2367, DOI 10.1016/S0142-9612(96)00080-4
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellon JM, 1996, J MATER SCI-MATER M, V7, P331, DOI 10.1007/BF00154544
   Bellon JM, 1996, J MATER SCI-MATER M, V7, P475, DOI 10.1007/BF00705428
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   LAMB JP, 1983, SURGERY, V93, P643
   Law NW, 1988, CLIN MATER, V3, P95
   MURPHY JL, 1989, CAN J SURG, V32, P244
   PANS A, 1992, EUR SURG RES, V24, P54, DOI 10.1159/000129188
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
NR 15
TC 19
Z9 21
U1 2
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2000
VL 11
IS 1
BP 25
EP 29
DI 10.1023/A:1008981517743
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 265PR
UT WOS:000084253000004
PM 15348095
DA 2018-10-19
ER

PT J
AU Kimber, CP
   Dunkley, MP
   Haddock, G
   Robertson, L
   Carey, FA
   Cuschieri, A
AF Kimber, CP
   Dunkley, MP
   Haddock, G
   Robertson, L
   Carey, FA
   Cuschieri, A
TI Patch incorporation in diaphragmatic hernia
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article; Proceedings Paper
CT 46th Annual International Congress of the
   British-Association-of-Paediatric-Surgeons
CY JUL 21-24, 1999
CL LIVERPOOL, ENGLAND
SP British Assoc Paediat Surgeons
DE congenital diaphragmatic hernia; diaphragmatic patches; biomaterial
   insertion; fluorinated polyester; polytetrafluoro-ethylene
ID ABDOMINAL-WALL DEFECTS; PARENTERAL-NUTRITION; PROSTHESES; INFANTS;
   REPAIR
AB Background/Purpose: Biomaterial insertion often is required for closure of congenital diaphragmatic hernia (CDH). The optimal biomaterial remains uncertain. This study was designed to compare a commonly used patch (polytetrafluoroethylene) with a recently available fabric, fluorinated polyester. The aim of this study was to determine the clinical performance, histological tissue-polymer interaction, bacterial adhesion, and shrinkage rates of biomaterial inserted endoscopically into a CDH lamb model.
   Methods: Polytetrafluoro-ethylene (PTFE) and fluorinated polyester (FP) were randomised for laparoscopic patch insertion into 12 lambs. All lambs (age <4 weeks) underwent 3-port laparoscopy, surgical creation of diaphragmatic hernia, and sutured patch placement. Two PTFE and 2 FP lambs were killed at 1-, 3-, and 6-month intervals postoperatively. Postmortem examination histopathology, electron microscopy, and specific bacterial broth immersion (Escherichia coli Staphlococcus aurens, and epidermidis) were performed.
   Results: All 12 lambs completed the study with intact patches that were fully peritonised. One abdominal adhesion was noted in a FP lamb at 6 months. FP was comparatively easier to insert, manipulate, and suture endoscopically. Histopathology findings showed that PTFE patches created a strong peripheral foreign body reaction with dystrophic calcification, whereas FP was well incorporated with intrapatch fibroblastic activity and neovascularsation. No significant difference in resistance to bacterial adhesion of relevant organisms was noted between the materials. Graft shrinkage for FP was 7% in one direction only, evident by 3 months.
   Conclusions: Fluorinated polyester has advantages in this laparoscopic lamb model. It shows rapid and sustained incorporation with intrapatch neovascularisation when compared with polytetrafluoro-ethylene's significant foreign body reaction. It was preferred for its endoscopic handling and suturing properties. The laparoscopic techniques used may contribute to the general lack of adhesions, and insufficient data are available to comment on the comparative effect of the materials on adhesion formation. No difference was demonstrated in resistance to bacterial adherence in the harvested materials.
C1 Univ Dundee, Dept Surg, Dundee DD1 9SY, Scotland.
   Univ Dundee, Dept Pathol, Dundee DD1 4HN, Scotland.
   Univ Glasgow, Dept Vet Anat & Paediat Surg, Glasgow, Lanark, Scotland.
RP Kimber, CP (reprint author), Royal Childrens Hosp, Dept Surg, Flemington Rd, Parkville, Vic 3052, Australia.
RI Cuschieri, Alfred/A-7634-2013
CR BORZI P, 1999, INT PAED END GROUP M
   deKort LMO, 1996, EUR J PEDIATR SURG, V6, P136, DOI 10.1055/s-2008-1066490
   GUIDOIN G, 1994, ASAIO T, V40, P870
   Langer J C, 1996, Semin Pediatr Surg, V5, P124
   Lloyd DA, 1997, J PEDIATR SURG, V32, P943, DOI 10.1016/S0022-3468(97)90374-2
   NEWMAN BM, 1985, J PEDIATR SURG, V20, P362, DOI 10.1016/S0022-3468(85)80220-7
   Pierro A, 1996, ARCH SURG-CHICAGO, V131, P176
   Soares BM, 1996, J BIOMED MATER RES, V32, P259, DOI 10.1002/(SICI)1097-4636(199610)32:2<259::AID-JBM16>3.0.CO;2-E
   Tan KH, 1996, BRIT MED J, V313, P903
   TUNELL WP, 1995, ANN SURG, V221, P525, DOI 10.1097/00000658-199505000-00010
   ZDANOWSKI Z, 1993, EUR J VASCULAR SURG, V7, P277, DOI 10.1016/S0950-821X(05)80009-X
   ZHANG Z, 1995, BIOMATERIALS, V16, P369, DOI 10.1016/0142-9612(95)93854-7
NR 12
TC 25
Z9 25
U1 1
U2 3
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0022-3468
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PD JAN
PY 2000
VL 35
IS 1
BP 120
EP 123
DI 10.1016/S0022-3468(00)80027-5
PG 4
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 278UJ
UT WOS:000085007100045
PM 10646788
DA 2018-10-19
ER

PT J
AU Walker, AK
   Land, CM
   Kinsel, GR
   Nelson, KD
AF Walker, AK
   Land, CM
   Kinsel, GR
   Nelson, KD
TI Quantitative determination of the peptide retention of polymeric
   substrates using matrix-assisted laser desorption/ionization mass
   spectrometry
SO JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
LA English
DT Article
ID PROTEIN ADSORPTION; SOLID-SURFACES; DESORPTION; CRYSTALS; CHARGE; ACID
AB Polymer surface-peptide binding interactions have been shown previously to lead to reductions in peptide matrix assisted laser desorption/ionization (MALDI) ion signals. In previous studies, increases in surface-peptide binding were characterized by the increases in both the initially adsorbed and retained quantities of I-125-radiolabeled peptides. The present studies establish a specific correlation between the peptide retention properties of the polymer surface and the reduction in the peptide MALDI ion signal. This correlation is demonstrated by obtaining MALDI mass spectra of angiotensin I applied to various polymer surfaces having a range of peptide adsorption and retention properties. In addition, the use of a MALDI based method of standard additions is shown to allow the quantitation of the polymer surface-peptide retention affinity for angiotensin I and porcine insulin. The MALDI standard additions method for measurement of surface-peptide retention affinities offers a number of significant advantages over conventional radiolabeled peptide binding methods and promises to be a valuable tool for the determination of this important biomaterial characteristic. (J Am Soc Mass Spectrom 2000, 11, 62-68) (C) 2000 American Society for Mass Spectrometry.
C1 Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
   Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Kinsel, GR (reprint author), Univ Texas, Dept Chem & Biochem, Box 19065, Arlington, TX 76019 USA.
CR ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   BEAVIS RC, 1993, J PHYS D APPL PHYS, V26, P442, DOI 10.1088/0022-3727/26/3/015
   CHEN K, IN PRESS J MASS SPEC
   Fournier I, 1997, INT J MASS SPECTROM, V169, P19, DOI 10.1016/S0168-1176(97)00212-7
   Gao JM, 1997, ANAL CHEM, V69, P575, DOI 10.1021/ac9608073
   HARRIS DC, 1998, QUANTITATIVE CHEM AN, P104
   Horbett TA, 1995, ACS S SERIES, V602
   Horneffer V, 1999, INT J MASS SPECTROM, V185, P859, DOI 10.1016/S1387-3806(98)14218-5
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   Sarkar D, 1996, J COLLOID INTERF SCI, V178, P606, DOI 10.1006/jcis.1996.0157
   SCHMITT A, 1983, J COLLOID INTERF SCI, V92, P25, DOI 10.1016/0021-9797(83)90113-3
   Schreiner M, 1996, ELECTROPHORESIS, V17, P954, DOI 10.1002/elps.1150170518
   STRUPAT K, 1991, INT J MASS SPECTROM, V111, P89, DOI 10.1016/0168-1176(91)85050-V
   VanDelden CJ, 1996, J BIOMAT SCI-POLYM E, V8, P251
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Walker AK, 1999, ANAL CHEM, V71, P268, DOI 10.1021/ac980750f
   XIANG F, 1993, ORG MASS SPECTROM, V28, P1424, DOI DOI 10.1002/OMS.1210281211
NR 17
TC 23
Z9 23
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 1044-0305
J9 J AM SOC MASS SPECTR
JI J. Am. Soc. Mass Spectrom.
PD JAN
PY 2000
VL 11
IS 1
BP 62
EP 68
DI 10.1016/S1044-0305(99)00117-8
PG 7
WC Biochemical Research Methods; Chemistry, Analytical; Chemistry,
   Physical; Spectroscopy
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA 266XM
UT WOS:000084325600008
PM 10631665
DA 2018-10-19
ER

PT J
AU Irigaray, JL
   Barbotteau, Y
   Chassot, E
   Oudadesse, H
AF Irigaray, JL
   Barbotteau, Y
   Chassot, E
   Oudadesse, H
TI Trace elements cartography by the PIXE method at the interfaces of an
   implant coated with bioglass
SO JOURNAL OF TRACE AND MICROPROBE TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on Trace Elements in Humans: New
   Perspectives
CY OCT 07-09, 1999
CL UNIV ATHENS, ATHENS, GREECE
HO UNIV ATHENS
DE implant; bioactive glass; PIXE; scanning; neoformed bone
AB Osteointegration of an implant is related to migrations of atomic elements between the implant, the coating biomaterial and the bone site. In our experiments, a metallic alloy, Ti 6Al 4V, was coated with a bioactive glass and implanted in thighbone of ovine. The analytical method consists of irradiating a section of the sample by scanning small areas of the interfaces with a 3 MeV proton beam. The emitted X-rays are detected by a Si semiconductor. The scanning reveals the presence of traces of Fe, Zn and Sr in addition to major elements such as Ca, P and Si. After 3 months of implantation, a gel appears between metallic implant and bone. The trace element signals in the gel are more intense than in mature bone. Osteoconduction leads to neoformed bone founding in which the signals of these elements are however less intense than in mature bone. Using the PIXE method, we can distinguish and evaluate the degree of bone remodeling around the implant. We detect also Ti and Al contamination in the surrounding region: the presence of these elements delay the new bone formation around the implant.
C1 Univ Blaise Pascal, CNRS, IN2P3, Phys Corpusculaire Lab, F-63177 Clermont Ferrand, France.
RP Irigaray, JL (reprint author), Univ Blaise Pascal, CNRS, IN2P3, Phys Corpusculaire Lab, F-63177 Clermont Ferrand, France.
CR LLABADOR Y, 1993, NUCL INSTRUM METH B, V77, P123, DOI 10.1016/0168-583X(93)95533-B
   OUDADESSE H, 1999, ADV SCI TECHNOLOGY M, V28, P321
   1999, EUR C BIOM
NR 3
TC 4
Z9 4
U1 0
U2 3
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0733-4680
J9 J TRACE MICROPROBE T
JI J. Trace Microprobe Tech.
PY 2000
VL 18
IS 4
BP 499
EP 503
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 375HD
UT WOS:000165392700003
DA 2018-10-19
ER

PT S
AU Jacques, SL
AF Jacques, SL
BE Duncan, DD
   Hollinger, JO
   Jacques, SL
TI Optical assessment of tissue heterogeneity in biomaterials and implants
SO LASER-TISSUE INTERACTION XI: PHOTOCHEMICAL, PHOTOTHERMAL, AND
   PHOTOMECHANICAL
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Laser-Tissue Interaction XI - Photochemical, Photothermal,
   and Photomechanical
CY JAN 22-27, 2000
CL SAN JOSE, CA
SP USAF Off Sci Res, SPIE, Int Biomed Opt Soc
DE optical diagnostics; imaging; tissue engineering; biomaterials
AB Optical techniques can assess the heterogeneity and structural layers of biomaterials and implants. Such assessment can assist engineering of tissue patches and implants by assessing implant structure, monitoring the implant fabrication process, controlling the machining of the implant, and monitoring in vivo the body's host response to the implant. Optical scattering can quantify the granularity of a biomaterial on the scale of 0.1-10 mu m. Optical coherence tomography can map heterogeneity on the scale of 2-20 mu m Optoacoustic imaging can image absorbing heterogeneities on the scale of 20 mu m - 10 mm (or more). Diffusion optical tomography can image absorbing and scattering heterogeneities on the scale of 5 mm - 5 cm (or more). The opportunities for optical techniques in preparing biomaterials and implants are discussed.
C1 Oregon Med Laser Ctr, Portland, OR 97225 USA.
RP Jacques, SL (reprint author), Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3530-9
J9 PROC SPIE
PY 2000
VL 3914
BP 576
EP 580
DI 10.1117/12.388080
PG 5
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BQ53Q
UT WOS:000088674300065
DA 2018-10-19
ER

PT S
AU Kuwahara, H
   Al-Abdullat, Y
   Ohta, M
   Tsutsumi, S
   Ikeuchi, K
   Mazaki, N
   Aizawa, T
AF Kuwahara, H
   Al-Abdullat, Y
   Ohta, M
   Tsutsumi, S
   Ikeuchi, K
   Mazaki, N
   Aizawa, T
BE Kojima, Y
   Aizawa, T
   Kamado, S
TI Surface reaction of magnesium in Hank's solutions
SO MAGNESIUM ALLOYS 2000
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 1st Nagaoka International Workshop on Magnesium Platform Science and
   Technology 2000
CY JUL 27-29, 2000
CL NAGAOKA CITY, JAPAN
SP Minist Educ, Sci, Sports & Culture
DE implant; magnesium apatite like; self-protection from corrosion; surface
   modification
AB As magnesium is an essential element, magnesium implants can be expected to be safety though its corrosion resistance is low. To understand its corrosion behavior in, vitro circumstance, for example Hank's solution and to improve its corrosion resistance, the present study was carried out.
   Specimens of 10 X 20 X (2 - 4) mm(3) were dipped in two kinds of Hank's solutions (without Ca and Mg ions - HBSS(-) and with Ca and Mg ions - HBSS(+)) for various periods (25 - 625 hours or to 1080 hours). Ratio of change of mass of each specimen was measured the surface microstructure was observed by a scanning electron microscope, identification of corrosion product was examined by both techniques of an x-ray diffraction and a grazing incident x-ray diffraction. Chemical composition of reacted products was also analyzed by an energy dispersion x-ray technique.
   AZ91 alloy maintains a good corrosion resistance in both of HBSS(-) and HBSS(+) though AZ31 was completely melted within 4 days. Oxidized commercial pure Mg (3N-Mg) behaved stably good corrosion resistance in HBSS(+) though 3N-Mg did unstably corrosion resistance in HBSS(+). Magnesium reacted with HBSS(+) or (-) and then a certain substance was formed on the specimen surface. The substance consisted of Mg and P in HBSS(-), or of Mg, P, and Ca in HBSS(+). However, x-ray diffraction couldn't unfortunately identify many peaks, which showed the substance in content of Mg, P, or Ca. It can be succeeded to prepare crown and denture for dental use.
   The present study can conclude that magnesium is possible to apply to a biomaterial in the near future.
C1 Res Inst Appl Sci, Sakyo Ku, Kyoto 6068202, Japan.
   Kyoto Univ, Grad Sch Engn, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
   Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan.
RP Kuwahara, H (reprint author), Res Inst Appl Sci, Sakyo Ku, Tanaka Ohicho, Kyoto 6068202, Japan.
RI Ohta, Makoto/I-7104-2018
OI Ohta, Makoto/0000-0001-8571-6400
CR KUROKAWA M, 1994, J JPN PLASTIC RECONS, V16, P75
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V14, P238
   KUWAHARA H, 1994, JPN I MET 114 M, P86
   KUWAHARA H, 1996, REPORTS TATEISI SCI, V5, P80
   TAKAYA M, 1998, J JPN I LIGHT METALS, V48, P352
NR 5
TC 60
Z9 68
U1 3
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-862-1
J9 MATER SCI FORUM
PY 2000
VL 350-3
BP 349
EP 358
DI 10.4028/www.scientific.net/MSF.350-351.349
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BS04T
UT WOS:000168447200044
DA 2018-10-19
ER

PT S
AU Giannoulis, CS
   Desai, TA
AF Giannoulis, CS
   Desai, TA
BE Mariella, RP
TI Characterization of fibroblasts and proteins on thin films
SO MICRO- AND NANOTECHNOLOGY FOR BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Micro- and Nanotechnology for Biomedical and Environmental
   Applications
CY JAN 26-27, 2000
CL SAN JOSE, CA
SP USAF, Off Sci Res, SPIE, Int Biomed Opt Sci
DE silicon; fibroblasts; albumin; fibrinogen; RGD peptide; ellipsometry;
   AFM; XPS
ID AFFINITY LIGANDS; SILICON SURFACES; IMMOBILIZATION; CELLS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and microstructure. One of the greatest challenges with silicon biomedical microdevices is to improve biocompatibility, which may be achieved by modifying the exposed silicon surface with thin or adsorbed films. In this study, films of silicon nitride, doped polysilicon, undoped polysilicon, as well as RGD peptide adsorbed surfaces were incubated with fibroblasts for a period of four days. Results demonstrate that RGD adsorbed surfaces encourage the greatest cell proliferation, followed by undoped polysilicon and unmodified (control) surfaces. Protein adsorption studies using fibrinogen and albumin, two proteins implicated in cellular adhesion and surface activity, reveal greatest protein adsorption on low stress silicon nitride surfaces, followed by undoped polysilicon and unmodified surfaces. This finding may compliment the differential cellular binding found on modified and unmodified silicon surfaces. The thickness of adsorbed albumin and fibrinogen was measured by ellipsometry and compared to contact angle measurements of non-adsorbed surfaces. Moreover, silicon surfaces coupled with a synthetic RGD peptide, as characterized with XPS and atomic force microscopy, display enhanced cell proliferation and bioactivity. Understanding the biological response to thin films will allow us to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices.
C1 Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RP Giannoulis, CS (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   HANSFORD DJ, 1999, THESIS U CALIF, P68
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAEGER RC, 1988, INTRO MICROELECTRONI, V5
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   NILSSON K, 1980, EUR J BIOCHEM, V112, P397, DOI 10.1111/j.1432-1033.1980.tb07218.x
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B. D., 1997, SURFACE MODIFICATION
   Zhang MQ, 1998, PROG BIOM O, V3258, P15, DOI 10.1117/12.304384
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 16
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-3528-7
J9 PROG BIOM O
PY 2000
VL 1
BP 122
EP 129
PG 8
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BP95B
UT WOS:000086711200014
DA 2018-10-19
ER

PT S
AU Chow, LC
AF Chow, LC
BE Li, PJ
   Calvert, P
   Kokubo, T
   Levy, R
   Scheid, C
TI Calcium phosphate cements: Chemistry, properties, and applications
SO MINERALIZATION IN NATURAL AND SYNTHETIC BIOMATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Mineralization in Natural and Synthetic Biomaterials
CY NOV 29-DEC 01, 1999
CL BOSTON, MA
SP Mat Res Soc
ID ROOT-CANAL SEALER; HYDROXYAPATITE CEMENT; SOLUBILITY; RECONSTRUCTION;
   DEFECTS; OBLITERATION; SURGERY; REPAIR; SYSTEM
AB This paper reviews recent studies on self-setting calcium phosphate cements (CPC). Discussions are focused on the cement setting reactions, the products formed, those properties of the cements that contribute to their clinical efficacy, and areas of future improvements that could make CPC useful in a wider range of applications. The strengths of CPC are considerably lower than ceramic calcium phosphate biomaterials and are also lower than some of the dental cements. On the other hand, the combination of self-setting capability and high biocompatibility makes CPC a unique biomaterial. Near perfect adaptation of the cement to the tissue surfaces in a defect, and a gradual resorption followed by new bone formation are some of the distinctive advantages of CPC. In its present state CPC appears to be suitable for a number of applications. Much remains to be done to further improve its properties to meet the requirements for different applications.
C1 NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
RP Chow, LC (reprint author), NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
CR *AM DENT ASS, 1974, 9 AM DENT ASS, P194
   BAUER G, 1985, BIOAKTIVE WERKSTOFFE, V6, P103
   BROWN WE, 1965, J RES NBS A PHYS CH, VA 69, P547, DOI 10.6028/jres.069A.059
   Brown WE, 1987, CEMENTS RES PROGR 19, P352
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chow LC, 1998, CEMENTS RESEARCH PROGRESS 1996, P215
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1997, INNOV TECH BIOL MED, V18, P11
   CHOW LC, UNPUB J BIOMED MAT R
   CHOW LC, 1996, CEMENTS RES PROGR 19, P189
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   FOWLER BO, 1986, CALCIFIED TISSUE INT, V38, P197, DOI 10.1007/BF02556711
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GREGORY TM, 1974, J RES NBS A PHYS CH, VA 78, P667, DOI 10.6028/jres.078A.042
   GREGORY TM, 1968, J RES NAT BUR STAND, V74, P773
   HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406
   ISHKAWA K, 1995, J MATL SCI MATL MED, V6, P528
   KAMERER DB, 1994, AM J OTOL, V15, P47
   KRELL KF, 1984, J ENDODONT, V10, P571, DOI 10.1016/S0099-2399(84)80103-X
   Kveton JF, 1996, LARYNGOSCOPE, V106, P1241, DOI 10.1097/00005537-199610000-00014
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   KVETON JF, 1995, AM J OTOL, V16, P465
   LEGEROS RZ, 1994, CALCIUM PHOSPHATES O, P162
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   Markovic M, 1998, J DENT RES, V77, P789
   Matsuya S, 1996, J MATER SCI, V31, P3263, DOI 10.1007/BF00354678
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   MCDOWELL H, 1971, INORG CHEM, V10, P1638
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Monma H, 1984, GYPSUM LIME, V188, P11
   MORENO EC, 1977, CARIES RES, V11, P142, DOI 10.1159/000260299
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SUGAWARA A, 1990, J ENDODONT, V16, P162, DOI 10.1016/S0099-2399(06)81963-1
   Sugawara A, 1992, Dent Mater J, V11, P11
   Sugawara A, 1990, TOKYO SHIKA ISHIKAI, V38, P348
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   TAKAGI S, IN PRESS J MAT SCI M
   TAKEZAWA Y, 1988, J JAPAN SOC DENT MAT, V7, P641
   TUNG MS, 1988, J RES NAT BUR STAND, V93, P613, DOI 10.6028/jres.093.153
   Weissman JL, 1996, AM J NEURORADIOL, V17, P1569
NR 42
TC 65
Z9 66
U1 0
U2 21
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-507-2
J9 MATER RES SOC SYMP P
PY 2000
VL 599
BP 27
EP 37
PG 11
WC Materials Science, Biomaterials; Materials Science, Coatings & Films
SC Materials Science
GA BQ82B
UT WOS:000089704700003
DA 2018-10-19
ER

PT J
AU Pietrucha, K
   Polis, L
   Bidzinski, J
AF Pietrucha, K
   Polis, L
   Bidzinski, J
TI Long-term clinical experiences with a new dural substitute
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Frontiers of Polymers and Advanced
   Materials
CY JUN 21-25, 1999
CL POZNAN, POLAND
DE collagen coated polyester mesh; dural substitute; radiation crosslinking
ID MATER GRAFT; COLLAGEN; VICRYL
AB We have studied the application of irradiation crosslinked collagen-coated polyester mesh as a dural substitute. Earlier, the bioprostheses were characterized by in vitro measuring of physicochemical and biological properties as well as by in vivo testing on experimental animals. Further. very satisfactory effect was obtained in results on application of these bioprostheses in patients, Consequently, this work concerns mainly a delayed observation of the patients after implantation of biomaterial in repairing cerebral and spinal dura. It was found among others, that application of the bioprosthesis in the surgical treatment of dysraphic defect on central nervous system in children such as: meningocele. meningoencephalocele. meningomyelocele makes it possible to approach large hernias, disqualified for operation so far. Neither allergy nor inflammation after operation of patients with intracranial rumor in early and delayed observation was noticed. The authors suggest that the bioprosthesis could be used not only as a very satisfactory dural substitute but also as a substitute of other connective tissues.
C1 Lodz Tech Univ, Inst Appl Radiat Chem, Lodz, Poland.
   Polish Mothers Memor Inst, Dept Pediat Neurosurg, Lodz, Poland.
   Dept Neurosurg AM, Warsaw, Poland.
RP Pietrucha, K (reprint author), Lodz Tech Univ, Inst Appl Radiat Chem, Lodz, Poland.
RI Polis, Lech/M-9729-2014
CR AWWAD EE, 1991, J COMPUT ASSIST TOMO, V15, P618, DOI 10.1097/00004728-199107000-00017
   Bidzinski J, 1993, Neurol Neurochir Pol, V27, P717
   COHEN AR, 1989, J NEUROSURG, V70, P633, DOI 10.3171/jns.1989.70.4.0633
   Harat M, 1989, Zentralbl Neurochir, V50, P145
   HEIMING E, 1986, Z KINDERCHIR, V44, P67
   LAQUERRIERE A, 1993, J NEUROSURG, V78, P487, DOI 10.3171/jns.1993.78.3.0487
   MEDDINGS N, 1992, ACTA NEUROCHIR, V117, P53, DOI 10.1007/BF01400636
   ONEILL P, 1984, J NEUROSURG, V61, P351, DOI 10.3171/jns.1984.61.2.0351
   Park YK, 1998, NEUROSURGERY, V42, P813, DOI 10.1097/00006123-199804000-00076
   PIETRUCHA K, 1991, BIOMATERIALS, V12, P320, DOI 10.1016/0142-9612(91)90041-8
   POLIS L, 1993, NEUR NEUROCHIR POL, V27, P323
   POLIS L, 1997, ANN ACAD MED LODZENS, V38, P5
   POLIS L, 1994, NEUR NEUROCHIR POL, V28, P331
   SANGALLI F, 1992, NEUROSURGERY, V30, P396, DOI 10.1227/00006123-199203000-00014
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   YAMADA S, 1994, NEUROSURGERY, V34, P740, DOI 10.1227/00006123-199404000-00027
NR 16
TC 0
Z9 0
U1 0
U2 0
PU GORDON BREACH PUBLISHING, TAYLOR & FRANCIS GROUP
PI PHILADELPHIA
PA 325 CHESTNUT ST, 8TH FL, PHILADELPHIA, PA 19106 USA
SN 1058-725X
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2000
VL 354
BP 831
EP 836
PG 6
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 422QY
UT WOS:000168131800023
DA 2018-10-19
ER

PT J
AU Willner, I
   Willner, B
AF Willner, I
   Willner, B
TI Molecular and biomolecular assemblies based on photochromic compounds
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Organic Photochromism (ISOP99)
CY NOV 14-18, 1999
CL FUKUOKA, JAPAN
SP Chem Soc Japan, Soc Polymer Sci, Japanese Photochem Assoc, Japan Sci & Technol Corp, Fukuoka Ind Sci & Technol Fdn, Nagase Sci & Technol Fdn, Tokyo Ohka Fdn Promot Sci & Technol, Casio Sci Promot Fdn, Asahi Glass Fdn, Gordon & Breach Sci Publishers, Mitsubishi Chem Corp, Toppan Printing Co Ltd, Toda Kogyo Corp
DE molecular switches; photoswitch; biomaterial photoswitches;
   optobioelectronics; monolayers; immunosensors
ID ANTIGEN-ANTIBODY INTERACTIONS; RECORDED OPTICAL SIGNALS; AMPEROMETRIC
   TRANSDUCTION; MONOLAYER ELECTRODES; GLUCOSE-OXIDASE; GOLD ELECTRODES;
   NITROSPIROPYRAN; BIOMATERIALS
AB Photoswitchable redox-activated monolayers on electrode supports act as molecular electronic systems for the electronic transduction of recorded photonic information. Photoisomerizable monolayers assembled on electrodes may act as command interfaces far controlling interfacial electron transfer and thus act as interfaces for the amperometric transduction of photonic signals recorded by the monolayer. Photoswitchable biomaterials assembled on electronic transducers represent novel optobioelectronic systems. This is exemplified by the organization of a photoswitchable enzyme for the amplified amperometric transduction of photonic signals, and by the tailoring of reversible immunosensor systems.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR Blonder R, 1998, J AM CHEM SOC, V120, P9335, DOI 10.1021/ja981126n
   Blonder R, 1997, J AM CHEM SOC, V119, P10467, DOI 10.1021/ja971980z
   Blonder R, 1997, J AM CHEM SOC, V119, P11747, DOI 10.1021/ja972663v
   Doron A, 1997, LANGMUIR, V13, P1783, DOI 10.1021/la960729e
   Doron A, 1996, J AM CHEM SOC, V118, P8937, DOI 10.1021/ja961814b
   Kaganer E, 1999, LANGMUIR, V15, P3920, DOI 10.1021/la981147v
   Patolsky F, 1998, J PHYS CHEM B, V102, P10359, DOI 10.1021/jp983700n
   Willner I, 1998, J MATER CHEM, V8, P2543, DOI 10.1039/a804135k
   WILLNER I, 1993, J AM CHEM SOC, V115, P4937, DOI 10.1021/ja00064a084
   WILLNER I, 1995, J AM CHEM SOC, V117, P6581, DOI 10.1021/ja00129a023
   Willner I, 1996, ANGEW CHEM INT EDIT, V35, P367, DOI 10.1002/anie.199603671
   Willner I, 1997, ACCOUNTS CHEM RES, V30, P347, DOI 10.1021/ar9700062
NR 12
TC 1
Z9 1
U1 0
U2 5
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND
SN 1058-725X
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2000
VL 344
BP 15
EP 22
DI 10.1080/10587250008023809
PG 8
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 352CE
UT WOS:000089196300004
DA 2018-10-19
ER

PT S
AU Solchaga, LA
   Goldberg, VM
   Caplan, AI
AF Solchaga, LA
   Goldberg, VM
   Caplan, AI
BE Abatangelo, G
   Weigel, PH
TI Hyaluronic acid-based biomaterials in tissue engineered cartilage repair
SO NEW FRONTIERS IN MEDICAL SCIENCES: REDEFINING HYALURONAN
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT Symposium on New Frontiers in Medical Sciences: Redefining Hyaluronan
CY JUN 17-19, 1999
CL PRAGLIA, ITALY
SP Consorzio Tissuetech, Italian Govt, European Community
DE biomaterial; cartilage; cartilage repair; hyaluronic acid; tissue
   engineering
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; RABBIT ARTICULAR-CARTILAGE;
   MESENCHYMAL STEM-CELLS; OSTEOCHONDRAL DEFECTS; SURFACES; CULTURE; JOINT;
   KNEE; BONE; LIMB
AB Articular cartilage in adults has limited ability for self-repair. Some methods devised to augment the natural healing response stimulate some regeneration, but the repair is often incomplete and lacks durability. Hyaluronic acid (HA)-based polymers were tested for their ability to enhance the natural healing response. Our hypothesis is that HA-based polymers recreate an embryonic-like milieu, in which host progenitor cells can regenerate the damaged articular surface and underlying bone. Osteochondral defects were made on the femoral condyles of 4-month-old rabbits and were left empty or filled with HA-based polymers that were loaded or not with either autologous bone marrow (BM) or autologous mesenchymal progenitor cells (MPCs). The polymers tested were ACP(TM) and HYAFF(R) -11 (provided by Fidia Advanced Biopolymers: Abano Terme. Italy). Rabbits were sacrificed at various time points after surgery and the condyles processed for histology. Untreated defects filled with bony tissue up to or beyond the tidemark, and the noncalcified surface layer varied from fibrous to hyaline-like tissue. Four weeks after surgery, defects treated with ACP(TM) exhibited bony filling to the level of the tidemark, and the surface layer was composed of hyaline-like cartilage that was well-integrated with the adjacent cartilage. The 12-week specimens presented bone beyond the tidemark that was covered with a thin layer of hyaline cartilage. Four weeks after surgery, defects treated with HYAFF(R) -11 contained a rim of chondrogenic cells at the interface with host tissue. In general, by 12 weeks the defects exhibited good bony fill, and the surface was mainly hyaline cartilage. We conclude that the introduction of these HA-based polymers into defects provides an appropriate scaffolding and favorable microenvironment for the reparative process. Further work is required to fully assess the long-term outcome of defects treated with these polymers.
C1 Case Western Reserve Univ, Sch Med, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Sch Med, Dept Orthopaed, Cleveland, OH USA.
RP Caplan, AI (reprint author), Case Western Reserve Univ, Sch Med, Skeletal Res Ctr, Dept Biol, 2080 Adelbert Rd, Cleveland, OH 44106 USA.
CR AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   BENTLEY G, 1971, NATURE, V230, P385, DOI 10.1038/230385a0
   BERNARD M, 1998, CELL TISSUE RES, P1
   Bobic V, 1996, Knee Surg Sports Traumatol Arthrosc, V3, P262, DOI 10.1007/BF01466630
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRITTBERG M, 1994, CLIN ORTHOP RELAT R, P155
   BRITTBERG M, 1996, CLIN ORTHOP RELAT R, V326, P270
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   BRUDER SP, 1990, BONE, V11, P189, DOI 10.1016/8756-3282(90)90213-I
   Buckwalter J A, 1997, Iowa Orthop J, V17, P1
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   BUCKWALTER JA, 1995, DEGENERATIVE JOINT D, P2
   Buckwalter JA, 1994, J AM ACAD ORTHOP SUR, V2, P192
   BUCKWALTER JA, 1992, OSTEOARTHRITIS DIAGN, P71
   Campbell C J, 1969, Clin Orthop Relat Res, V64, P45
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caplan A.I.B.B., 1994, BONE, V8, P1
   CAPLAN AI, 1990, J CONTROL RELEASE, V11, P157, DOI 10.1016/0168-3659(90)90129-H
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CAPLAN AI, 1990, CLIN ORTHOP RELAT R, P257
   CAPLAN AI, 1997, CLIN ORTHOP RELAT R, V342, P254
   Caplan AI, 1998, FRONTIERS TISSUE ENG, P471
   CAPLAN AI, 1992, BIOL MECH TOOTH MOVE, P433
   Dennis J E, 1992, Cell Transplant, V1, P23
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Goldberg V M, 1997, Ryumachi, V37, P148
   GOLDBERG VM, 1994, ORTHOPEDICS, V17, P819
   Goldberg VM, 1998, J SPORT TRAUMATOL, V20, P81
   GOLDBERG VM, 1999, SEMIN ARTHROPLASTY, V10, P30
   GOLDBERG VM, 1995, OSTEOARTHRITIC DISOR, pCH25
   GOLDBERG VM, IN PRESS INSTR VET C
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   GROSS AE, 1997, OPER TECH ORTHOP, V7, P334
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   HUNZIKER EB, 1998, OSTEOARTHRITIS CART
   HUNZIKER EB, 1992, T ORTHOP RES SOC, V17, P231
   HUNZIKER EB, 1994, T ORTHOP RES SOC, V19, P236
   ITAY S, 1987, CLIN ORTHOP RELAT R, V220, P284
   JOHNSTONE B, IN PRESS CLIN ORTHOP
   KUJAWA MJ, 1986, DEV BIOL, V113, P10, DOI 10.1016/0012-1606(86)90103-X
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   KUJAWA MJ, 1986, DEV BIOL, V114, P519, DOI 10.1016/0012-1606(86)90215-0
   KWAN MK, 1989, J BIOMECH, V22, P921, DOI 10.1016/0021-9290(89)90076-6
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406
   Mankin HJ, 1996, J BONE JOINT SURG AM, V78A, P1
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   OUTERBRIDGE HK, 1995, J BONE JOINT SURG AM, V77A, P65, DOI 10.2106/00004623-199501000-00009
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   RODRIGO JJ, 1978, CLIN ORTHOP RELAT R, P342
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SOLCHAGA L, 1999, T ORTHOP RES SOC, V24, P801
   SOLCHAGA L, 1999, T ORTHOP RES SOC, V24, P56
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SOLCHAGA LA, 1999, T ORTHOP RES SOC, V24, P791
   SOLCHAGA LA, 1998, T ORTHOP RES SOC, V23, P800
   SOLCHAGA LA, IN PRESS CELL TRANSP
   TONA A, 1996, 5 WORLD BIOM C TOR, V2, P849
   Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O
   TOOLE BP, 1972, DEV BIOL, V29, P321, DOI 10.1016/0012-1606(72)90071-1
   TOOLE BP, 1972, P NATL ACAD SCI USA, V69, P1384, DOI 10.1073/pnas.69.6.1384
   TRIPPEL SB, 1995, J RHEUMATOL, V22, P129
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   ZWILLING E, 1968, DEV BIOL S, V2, P198
NR 75
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-50357-9
J9 INT CONGR SER
JI Int. Congr. Ser.
PY 2000
VL 1196
BP 233
EP 246
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BR39R
UT WOS:000166298900022
DA 2018-10-19
ER

PT S
AU Aigner, J
   Staudenmaier, R
   Rotter, N
   Kloppel, M
   Radice, M
   Pavesio, A
   Naumann, A
AF Aigner, J
   Staudenmaier, R
   Rotter, N
   Kloppel, M
   Radice, M
   Pavesio, A
   Naumann, A
BE Abatangelo, G
   Weigel, PH
TI Cartilage tissue engineering using scaffolds of hyaluronan benzyl esters
   for reconstructive head and neck surgery
SO NEW FRONTIERS IN MEDICAL SCIENCES: REDEFINING HYALURONAN
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT Symposium on New Frontiers in Medical Sciences: Redefining Hyaluronan
CY JUN 17-19, 1999
CL PRAGLIA, ITALY
SP Consorzio Tissuetech, Italian Govt, European Community
DE bioresorbable materials; cartilage-engineering; dedifferentiation;
   redifferentiation; tissue-engineering
ID ARTICULAR-CARTILAGE; CHONDROCYTES; COLLAGEN; GELS; ALGINATE; CULTURE;
   BIOCOMPATIBILITY; PROLIFERATION; EXPRESSION; PHENOTYPE
AB Background Tissue engineering techniques may offer the means to generate hyaline cartilage for reconstructive surgery and to repair articular defects. Our approach is based on the use of isolated auricular or nasoseptal chondrocytes, which are first expanded and then seeded on bioresorbable cell carriers allowing a three-dimensional (3-D) cell arrangement. While traditional cell culture techniques lead to the dedifferentiation of cells, cells cultured on 3-D scaffolds should reexpress their cartilage-specific phenotype.
   Methods. Since HA plays an essential role in cartilage matrix organization, our investigations focused on the redifferentiation capability of human and rabbit chondrocytes cultured on HYAFF(R)-11, a nonwoven benzyl esterified hyaluronic acid derivative.
   Results. Following xenogen implantation of human cells in nude mice, as well as autologous implantation of rabbit cells, chondrocytes regained their phenotype as demonstrated by re-expression of collagen type II.
   Conclusion. The data show that previously dedifferentiated chondrocytes regain their ability to express cartilage specific molecules when cultured in a 3-D structure on special cell carriers. Longterm studies should clarify the biological effects of the cultured cells with respect to the degradation properties of the nonwoven scaffold. The biomaterial, HYAFF(R)-11, available in versatile forms and structures, provides promising opportunities for the production of custom-designed scaffolds in tissue engineering procedures.
C1 Univ Munich, Dept Otorhinolaryngol, D-81377 Munich, Germany.
   Tech Univ Munich, Dept Plast & Reconstruct Surg, D-8000 Munich, Germany.
   Univ Padua, Fac Med, Inst Histol & Embryol, Padua, Italy.
   Fidia Adv Biopolymers Srl, Abano Terme, PD, Italy.
RP Aigner, J (reprint author), Univ Munich, Dept Otorhinolaryngol, Marchioninistr 15,Grosshadern, D-81377 Munich, Germany.
EM Joachim.Aigner@hno.med.uni-muenchen.de
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Aigner J, 1997, IN VITRO CELL DEV-AN, V33, P407, DOI 10.1007/s11626-997-0054-x
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRUNNER FS, 1993, EUR ARCH OTO-RHINO-L, P311
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Fukuda K, 1996, J PHARMACOL EXP THER, V277, P1672
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDOLFO M, 1993, CALCIFIED TISSUE INT, V52, P42, DOI 10.1007/BF00675625
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   KUIAWA MJ, 1986, DEV BIOL, V114, P519
   MOW VC, 1991, J BIOMECH ENG-T ASME, V113, P198, DOI 10.1115/1.2891235
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   TOOLE BP, 1989, CIBA F SYMP, V143, P138
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 32
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-50357-9
J9 INT CONGR SER
JI Int. Congr. Ser.
PY 2000
VL 1196
BP 255
EP 265
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BR39R
UT WOS:000166298900024
DA 2018-10-19
ER

PT S
AU Metzler, V
   Lehmann, T
   Aach, T
AF Metzler, V
   Lehmann, T
   Aach, T
BE Dougherty, ER
   Astola, JT
TI Morphological multiscale shape analysis of light micrographs
SO NONLINEAR IMAGE PROCESSING XI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Nonlinear Image Processing XI
CY JAN 24-25, 2000
CL SAN JOSE, CA
SP SPIE, Soc Imaging Sci & Technol
DE shape analysis; mathematical morphology; scale-space; light micrograph;
   logarithmic image model; quantitative cytology; biomaterials;
   cytotoxicity; pattern spectrum
ID FILTERS
AB Shape analysis of light-micrographs of cell populations is important for cytotoxicity evaluation. This paper presents a morphological method for quantitative analysis of shape deformations of cells in contact to a biomaterial. After illumination normalization, a morphological multiscale segmentation yields separated cells. Shape deformation, and hence, toxicity of the substance under scrutiny, is quantified by means of compactness distribution and pattern spectrum of the population. Since the logarithmic image model is applicable to transmitted light, illumination normalization is achieved by removing the illumination component from the log-image by a tophat transform utilizing a large reconstruction filter. Subsequent thresholding and noise filtering yields connected binary cells, which are segmented by a marker-based, multiscale approach. For this, size-specific marker scales are generated removing noise and false markers. Each cell is now represented by an isolated marker. Converse integration of marker scales is performed by successive reconstruction of the original cell shapes, preventing merging of markers. Our method yields reasonable cell segmentations that go along with cell morphology even for differently sized and very distinct shapes. The obtained quantitative data is significantly correlated to the toxicity of the substance to be evaluated. Currently, the method is used for extensive biocompatibility tests.
C1 Med Univ Lubeck, Inst Signalverarbeitung, D-23538 Lubeck, Germany.
RP Metzler, V (reprint author), Med Univ Lubeck, Inst Signalverarbeitung, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
CR BORGEFORS G, 1986, COMPUTER VISION GRAP, V34, P679
   Dougherty E.R., 1992, INTRO MORPHOLOGICAL
   Elmoataz A, 1998, SIGNAL PROCESS, V71, P215, DOI 10.1016/S0165-1684(98)00146-7
   GOUTSIAS J, 1999, PNAR9810 CWI
   HEIJMANS H, 1994, SHAPE PICTURE MATH D, P147
   JOURLIN M, 1988, J MICROSC-OXFORD, V149, P21, DOI 10.1111/j.1365-2818.1988.tb04559.x
   Lehmann T, 1997, COMPUT BIOL MED, V27, P151, DOI 10.1016/S0010-4825(97)83769-9
   MARAGOS P, 1989, IEEE T PATTERN ANAL, V11, P701, DOI 10.1109/34.192465
   MARAGOS P, 1987, IEEE T ACOUST SPEECH, V35, P1170, DOI 10.1109/TASSP.1987.1165254
   Metzler V, 1998, P SOC PHOTO-OPT INS, V3338, P1246, DOI 10.1117/12.310852
   Metzler V, 1999, ASAIO J, V45, P264, DOI 10.1097/00002480-199907000-00004
   METZLER V, 2000, P SPIE, V3961
   METZLER V, 2000, IN PRESS COMPUTERS B
   Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, P21, DOI 10.1016/1047-3203(90)90014-M
   MOLONEY CR, 1991, IEEE PACIF, P811, DOI 10.1109/PACRIM.1991.160864
   NIEDERAUER GG, 1994, BIOMATERIALS, V15, P342, DOI 10.1016/0142-9612(94)90246-1
   OPPENHEI.AV, 1968, PR INST ELECTR ELECT, V56, P1264, DOI 10.1109/PROC.1968.6570
   ORBERT C, 1992, P SOC PHOTO-OPT INS, V1902, P159
   Portet S, 1999, CYTOMETRY, V35, P203, DOI 10.1002/(SICI)1097-0320(19990301)35:3<203::AID-CYTO3>3.0.CO;2-K
   REINHARDT J, 1996, IEEE T PATTERN ANAL, V18
   RUSS JC, 1990, COMPUTER ASSISTED MI
   SALEMBIER P, 1992, SIGNAL PROCESS, V27, P205, DOI 10.1016/0165-1684(92)90008-K
   Serra J, 1982, IMAGE ANAL MATH MORP
   SKIFSTAD K, 1989, COMPUT VISION GRAPH, V46, P387, DOI 10.1016/0734-189X(89)90039-X
   Soille P, 1999, MORPHOLOGICAL IMAGE
   TOTH D, 2000, IN PRESS IEEE SW S I
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   WEI Q, 1993, P SOC PHOTO-OPT INS, V1905, P175, DOI 10.1117/12.148632
   Young IT, 1996, IEEE ENG MED BIOL, V15, P59, DOI 10.1109/51.482844
NR 29
TC 3
Z9 4
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3579-1
J9 P SOC PHOTO-OPT INS
PY 2000
VL 3961
BP 227
EP 238
DI 10.1117/12.379396
PG 12
WC Optics; Imaging Science & Photographic Technology
SC Optics; Imaging Science & Photographic Technology
GA BP87Y
UT WOS:000086473300022
DA 2018-10-19
ER

PT J
AU Jones, DS
   Djokic, J
   McCoy, CP
   Gorman, SP
AF Jones, DS
   Djokic, J
   McCoy, CP
   Gorman, SP
TI Effects of storage on thermomechanical properties of
   poly(epsilon-caprolactone) blends containing poly(vinyl
   pyrrolidone/iodine)
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Article
ID URETERAL STENT BIOMATERIAL; MECHANICAL-PROPERTIES; POLYMERS;
   ENCRUSTATION; DEGRADATION; POLYURETHANE; RESISTANCE; SILICONE; BIOFILM;
   DEVICES
AB This study reports the effects of: the molecular weight ratio of poly(epsilon -caprolactone) (PCL) in blends containing polymer of high (50 000 g mol(-1)) and low (4000 g mol(-1)) molecular weight; the concentration (0, 1, and 5 wt-%) of poly(vinyl pyrrolidone/iodine) (PVP/I); and storage at 30 degreesC and 75% relative humidity; on the thermomechanical properties of films prepared by solvent evaporation from solutions containing both PCL and PVP/I. The tensile properties were found to be statistically dependent on the molecular weight ratio of PCL but not on the concentration of PVP/I. The reductions in tensile strength and elongation at break associated with increasing amounts of low molecular weight PCL were attributed to a reduction in the concentration of chain entanglements. No changes were observed in viscoelastic properties or the glass transition temperature. Following storage there were no changes in the tensile strength, glass transition temperature, or viscoelastic properties of the films; however, significant reductions in elongation at break were observed. It is suggested that this is due to hydrolytic chain scission of amorphous PCL. Inclusion of 5 wt-% PVP/I increased this process in films containing 100:0 and 80:20 high/low molecular weight PCL (but not 60.40), but the extent of this was small. This study highlighted significant aging properties of PCL in a moist atmosphere. Consequently, it is recommended that suitable packaging materials should be employed to control the exposure of PCL films to water during storage.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
OI McCoy, Colin/0000-0002-6468-2018
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Bonner MC, 1997, INT J PHARM, V151, P201, DOI 10.1016/S0378-5173(97)04903-X
   BRINSON LC, 1995, INT J SOLIDS STRUCT, V32, P827, DOI 10.1016/0020-7683(94)00163-Q
   BULL E, 1991, BRIT J UROL, V68, P394, DOI 10.1111/j.1464-410X.1991.tb15359.x
   CALLISTER WD, 1997, MAT SCI ENG INTRO, P437
   Clavreul R, 1999, NUCL INSTRUM METH B, V151, P449, DOI 10.1016/S0168-583X(99)00100-7
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   DJOKIC J, 1997, J PHARM PHARM S, V49, P124
   Elves AWS, 1997, BRIT J UROL, V80, P1, DOI 10.1046/j.1464-410X.1997.00208.x
   GEBELEIN CG, 1987, POLYM MAT SCI ENG, V57, P413
   GENT AN, 1972, J POLYM SCI A2, V10, P571, DOI 10.1002/pol.1972.160100314
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Gorman SP, 1997, J MATER SCI-MATER M, V8, P631, DOI 10.1023/A:1018571403609
   Grosvenor MP, 1996, INT J PHARM, V135, P103, DOI 10.1016/0378-5173(95)04404-3
   GUO JH, 1991, PHARMACEUT RES, V8, P1500, DOI 10.1023/A:1015890232106
   Hatada K, 1996, PURE APPL CHEM, V68, P2313, DOI 10.1351/pac199668122313
   Jones David S., 1998, Journal of Pharmacy and Pharmacology, V50, P1
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   KANDIL SH, 1989, BIOMATERIALS, V10, P540, DOI 10.1016/0142-9612(89)90059-8
   KASUYA K, 1998, POLYM DEGRAD STABIL, V59, P307
   LEVITA G, 1983, POLYMER, V24, P1071, DOI 10.1016/0032-3861(83)90162-3
   LIN WJ, 1994, PHARMACEUT RES, V11, P1030, DOI 10.1023/A:1018943622498
   MARDIS HK, 1987, SEMIN INTERVENT RAD, V4, P36, DOI 10.1055/s-2008-1075982
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Medlicott NJ, 1996, INT J PHARM, V143, P25, DOI 10.1016/S0378-5173(96)04675-3
   Medlicott NJ, 1999, J CONTROL RELEASE, V61, P337, DOI 10.1016/S0168-3659(99)00152-2
   PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   STRUIK LCE, 1987, POLYMER, V28, P1521, DOI 10.1016/0032-3861(87)90353-3
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   TUNNEY MM, METHODS ENZYMOLOGY B, V310, P558
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VERDU J, 1994, M MACROMOL SCI A, V31, P1383
   Wironen J, 1997, J LONG-TERM EFF MED, V7, P1
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
NR 39
TC 4
Z9 5
U1 0
U2 6
PU I O M COMMUNICATIONS LTD INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PY 2000
VL 29
IS 7
BP 371
EP 377
DI 10.1179/146580100101541175
PG 7
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 376WA
UT WOS:000165478700008
DA 2018-10-19
ER

PT J
AU Patil, RD
   Mark, JE
   Dalev, PG
   Vassileva, ED
   Fakirov, SC
AF Patil, RD
   Mark, JE
   Dalev, PG
   Vassileva, ED
   Fakirov, SC
TI Solubilization and biodegradation of cross-linked gelatins by alkaline
   proteinase
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE gelatin; cross-linking; solubilization; hydrolysis; biodegradation;
   enzymes; proteinases; subtilisin
ID POLYMERS; WATER
AB This investigation involves the chemical modification of gelatin, a biomaterial which has been widely studied because of its environmental friendliness, its ready availability from waste products, and its biodegradability. The focus was on cross-linking because it has been shown that the mechanical properties of gelatin can be improved by a sequence of processing steps involving cross-linking, swelling, orientation, and, finally, drying in the oriented state. Because cross-linking is required in this technique, the present study characterizes its possible effects on gelatin biodegradability, as gauged by the time required to solubilize the material. A series of cross-linking agents having various alkylene sequence lengths was used. The resulting cross-linked gelatins were relatively insoluble in phosphate buffer (pH = 8.2) at room temperature, but at higher temperatures, they became partially soluble. Full solubilization of cross-linked gelatins was successfully obtained, however, by the action of an alkaline proteinase, specifically subtilisin. Both the rate of the partial solubilization in buffer and the full solubilization with alkaline proteinase showed dependences on the type, concentration, and chain lengths of the cross-linking agent.
C1 Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.
   Univ Cincinnati, Polymer Res Ctr, Cincinnati, OH 45221 USA.
   Univ Sofia, Fac Biol, Sofia 1421, Bulgaria.
   Univ Sofia, Struct & Properties Polymers Lab, BU-1126 Sofia, Bulgaria.
RP Mark, JE (reprint author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.
RI Vassileva, Elena/A-7324-2015
OI Vassileva, Elena/0000-0002-0566-5883
CR Adler-Nissen J, 1986, ENZYMATIC HYDROLYSIS
   Apostolov AA, 1999, J APPL POLYM SCI, V71, P465, DOI 10.1002/(SICI)1097-4628(19990118)71:3<465::AID-APP13>3.0.CO;2-1
   BUTCHER C, 1990, CHEM ENG, V474, P15
   COGHLAN A, 1990, NEW SCI, V125, P12
   DAVIS P, 1963, J POLYM SCI PART A, V1, P799, DOI 10.1002/pol.1963.100010217
   FRENCH D, 1945, ADV PROTEIN CHEM, V2, P277, DOI 10.1016/S0065-3233(08)60627-0
   LEWIS MS, 1964, BIOCHEMISTRY-US, V3, P1126, DOI 10.1021/bi00896a020
   LIGHT ND, 1982, METHOD ENZYMOL, V82, P360
   LO F, 1993, CHEM ENG PROG, V89, P55
   MARK JE, 1998, P NSF DES MAN GRANT, P735
   MCCARTHYBATES L, 1993, PLAST WORLD, V25, P22
   MYERS J, 1994, MOD PLAST, V71, P33
   PATIL RD, 1999, EUR POLYM J, V9, P63
   POOL R, 1989, SCIENCE, V245, P1187, DOI 10.1126/science.245.4923.1187
   Ramachandran G.N., 1967, TREATISE COLLAGEN
   ROSS PL, 1988, ENCY POLYM SCI ENG, V7, P488
   Tomihata K, 1992, POLYM PREPRINTS, V33, P534
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   UEHLING M, 1993, NEW SCI, V139, P12
   Zhao WY, 1996, CHEMTECH, V26, P32
NR 20
TC 7
Z9 7
U1 0
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2000
VL 39
IS 4
BP 683
EP 697
DI 10.1081/PPT-100100051
PG 15
WC Polymer Science
SC Polymer Science
GA 345XW
UT WOS:000088841400003
DA 2018-10-19
ER

PT S
AU Nawrat, Z
   Kostka, P
   Malota, Z
   Wszolek, J
   Nozynski, J
   Lachecka, L
   Cwalina, B
   Religa, Z
AF Nawrat, Z
   Kostka, P
   Malota, Z
   Wszolek, J
   Nozynski, J
   Lachecka, L
   Cwalina, B
   Religa, Z
BE Enderle, JD
TI Biomaterials dedicated for valve prostheses testing system.
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE biomaterials; valves prostheses
AB The physico-chemical modificated biomaterials dedicated for valve prostheses have been tested in varius methods for optymalisation the process of its treatment, Theres were tested fresh, cryopreservated, glutardehyded (GA) and photoxidated material, The data includes results of the qualification test and computer simulation of valve Work, stress-strain and shrinkaige temperature and calcification tin vitro and in vivo). As a conclusion was stated that our system consist of constructed ourself devices passed successfully all tests and is able for testing different types of biomaterial and heart valves prostheses, The treatment by GA Is simpler and shows better repeatability of measurements than photoxidation. Because the results of tests of the photooxidated tissue are promising we work on automatisation and better controlling the proces.
RI Nozynski, Jerzy/C-3922-2013
CR Glass KC, 1997, INT J LAW PSYCHIAT, V20, P5, DOI 10.1016/S0160-2527(96)00020-9
NR 1
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 3226
EP 3229
PN 1-4
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300902
DA 2018-10-19
ER

PT S
AU Kirkpatrick, CJ
AF Kirkpatrick, CJ
BE Balls, M
   VanZeller, AM
   Halder, ME
TI Designing biofunctionality assays to test biomaterials in vitro
SO PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL
   EXPERIMENTATION
SE DEVELOPMENTS IN ANIMAL AND VETERINARY SCIENCES
LA English
DT Proceedings Paper
CT 3rd World Congress on Alternatives and Animal Use in the Life Science
CY AUG 29-SEP 02, 1999
CL BOLOGNA, ITALY
SP Colgate Palmolive Co, European Commiss, Environm DIrector Gen, European Commiss, Joint Res Ctr, Toiletry & Perfumery Assoc, European Cosmet, Gillette Co, Glaxo Wellcome, Int Fdn Eth Res, Kimberly Clark Corp, L Oreal, Procter & Gamble Co, Unilever Res, Utrecht Congress
ID HUMAN ENDOTHELIAL-CELLS; SMOOTH-MUSCLE CELLS; HEAVY-METAL IONS;
   IN-VITRO; TISSUE; EXPRESSION; ACTIVATION; ADHESION; STRESS; CYTOTOXICITY
AB The increasing use of biomaterials in clinical medicine to augment or replace failing organ function has heightened the need to apply relevant test systems to study the safety and efficacy of new medical devices. This becomes all the more important as the field of "tissue engineering" develops, in which the aim is to reconstruct tissue and organ function by using the patient's own cells seeded onto a three-dimensional (3-D) scaffold structure, In the biomaterial research field, there has been a necessary expansion of the concept of biocompatibility to address not only the biosafety issue, that is the exclusion of cytotoxic and other deleterious effects of biomaterials, but also the biofunctionality component, which concerns the fulfilment of the intended function of the applied biomaterial. Careful scrutiny of this concept leads to the conclusion that relevant test systems for biofunctionality must centre on human cells, studied under conditions relevant to the situation in the living organism for which the medical device has been constructed. Thus, progress in biocompatibility and tissue engineering would today be inconceivable without the aid of in vitro techniques. In designing such biofunctionality assays, there are certain fundamental principles which must be adhered to. A constant difficulty is the availability of sterile human tissue for such test systems. Also of paramount importance is proving the maintenance of the cell phenotype in vitro. Loss of essential characteristic functions of the cultivated cells makes extrapolatory interpretations meaningless for the clinical situation. This presentation gives an overview of the basic design principles for suitable assays, and various examples covering a spectrum of applications. Relevant functional parameters will be emphasised, as well as the use of modern methods of cell and molecular biology, with measurement of these parameters at both the gene product and transcription levels. These parameters include the expression of cytokines, growth factors and cell adhesion molecules. In addition, assays can be constructed to study inflammation and the wound healing response, which includes the angiogenic reaction. Tissue remodelling around biomaterials can be studied in vitro by using cells such as fibroblasts, endothelial cells and various inflammatory cells, important parameters reflecting control of this remodelling being the matrix metalloproteinases and their inhibitors. The need for more co-culture and 3-D models is stressed and data from the author's own laboratory are presented to illustrate these principles. Finally, the importance of signal transduction within those cells in contact with, or in the vicinity of, biomaterials is emphasised, as this knowledge offers the scientific basis for rational therapeutic intervention to suppress negative effects and enhance positive biological responses (use of drug delivery systems). Well-designed in vitro assays have a central role to play in this endeavour.
C1 Univ Mainz, Univ Clin, Inst Pathol, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Univ Clin, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
CR Assoian Richard K., 1997, Cytokine and Growth Factor Reviews, V8, P165, DOI 10.1016/S1359-6101(97)00011-7
   Bittinger F, 1996, J MATER SCI-MATER M, V7, P543, DOI 10.1007/BF00122177
   Buchner J, 1996, FASEB J, V10, P10
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   DARTSCH PC, 1986, EUR J CELL BIOL, V41, P339
   DEKKER A, 1994, CELL MATER, V4, P101
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   GERDES J, 1984, J IMMUNOL, V133, P1710
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   HEMBRY RM, 1995, HISTOPATHOLOGY, V27, P149, DOI 10.1111/j.1365-2559.1995.tb00023.x
   Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x
   Hu YH, 1998, FASEB J, V12, P1135
   Ilan N, 1998, J CELL SCI, V111, P3621
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KIRKPATRICK CJ, 1992, CELL MATER, V2, P169
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   KLEIN CL, 1995, PATHOBIOLOGY, V63, P83, DOI 10.1159/000163938
   Kreitz MR, 1997, BIOMATERIALS, V18, P597, DOI 10.1016/S0142-9612(96)00153-6
   L'Heureux N, 1998, FASEB J, V12, P47
   Lawrence WT, 1998, CLIN PLAST SURG, V25, P321
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Nicosia RF, 1999, INT REV CYTOL, V185, P1
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   RAGHOW R, 1994, FASEB J, V8, P823
   Remy M, 1999, BIOMATERIALS, V20, P241, DOI 10.1016/S0142-9612(98)00167-7
   van Kooten TG, 1999, J BIOMED MATER RES, V46, P33, DOI 10.1002/(SICI)1097-4636(199907)46:1<33::AID-JBM4>3.0.CO;2-K
   Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
NR 31
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5168
BN 0-444-50529-6
J9 DEV AN VET
PY 2000
VL 31
BP 329
EP 337
PN A & B
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BS42Q
UT WOS:000169797500031
DA 2018-10-19
ER

PT S
AU Ignjatovic, N
   Plavsic, M
   Najman, S
   Savic, V
   Uskokovic, D
AF Ignjatovic, N
   Plavsic, M
   Najman, S
   Savic, V
   Uskokovic, D
BE Uskokovic, DP
   Battiston, GA
   Nedeljkovic, JM
   Milonjic, SK
   Rakovic, DI
TI Analysis of in vivo substitution of bone tissue by HAp/PLLA composite
   biomaterial with PLLA of different molecular weights using FTIR
   spectroscopy
SO TRENDS IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd Yugoslov-Materials-Research-Society Conference
CY SEP 20-24, 1999
CL HERCEG-NOVI, YUGOSLAVIA
SP Fed Republic Yugoslavia, Minist Dev, Sci & Environm, Republic Serbia, Minist Sci & Technol, ZAMTES, Inst Inorgan Chem, Inorgan Technol & Adv Mat, Yugoslav Mat Res Soc
DE absorption band; autologous bone; collagen; FTIR spectroscopy;
   hydroxyapatite/poly-L-lactide composite biomaterial; in vivo
ID INFRARED-SPECTROSCOPY; IN-VIVO; POLYLACTIDES; DEGRADATION
AB Hydroxyapatite/poly-L-lactide (HAp/PLLA) composite biomaterial with PLLA of 50,000 and 430,000 g/mole molecular weight was studied in vivo. The biocomposite with PLLA of both molecular weights was implanted into mice and after 1 and 3 weeks removed from their organisms and analyzed by the FT-IR spectroscopy. After one week of testing in vivo, the implanted samples gave spectra in which absorption bands arising from new-formed functional groups of amine and peptide can be seen. Analysis of the spectra revealed faster formation of peptide compounds when the biocomposite with PLLA of lower molecular weight was used. After 3 weeks, the spectra of the biocomposite of both compositions were registered with pronounced absorption bands at about 3420 and 1650 cm(-1) assigned to new-generated collagen, a component of the extracellular connective-tissue matrix. Also, in the case of the biocomposite sample with PLLA of lower molecular weight, disappearance of the previously present absorption band at about 1760 cm(-1) originating from the C=O group of PLLA indicates complete bioresorption of the PLLA used. Analysis of the microstructures of the sample surfaces by scanning electron microscopy before and after implantation revealed bioresorption of the PLLA polymer phase in the system with PLLA of lower molecular weight and generation of collagen fibers at the sites of implanted bioresorptive PLLA. A mixture of autologous bone powder and HAp/PLLA biocomposite was also examined. After implantation, the same final products as in the case of HAp/PLLA composite biomaterial alone were found.
C1 SASA, Inst Tech Sci, Belgrade, Yugoslavia.
   Fac Technol & Met Belgrade, YU-11000 Belgrade, Yugoslavia.
   Fac Med, Nis, Yugoslavia.
RP Ignjatovic, N (reprint author), SASA, Inst Tech Sci, Belgrade, Yugoslavia.
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Najman, Stevo/0000-0002-2411-9802
CR AGRAWAL M, 1998, JOM             0131
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, P247
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CHO S, 1997, KEY ENG MATER, V132, P802
   Francioso O, 1998, APPL SPECTROSC, V52, P270, DOI 10.1366/0003702981943347
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fujii T, 1997, APPL SPECTROSC, V51, P1682, DOI 10.1366/0003702971939352
   HARAKE E, 1998, AM J PHYSL
   HUMMEL O, 1984, ATLAS POLYM PLASTICS, P373
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   IGNJATOVIC N, 1999, UNPUB BIOMATERIALS
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   KOLARUSSO P, 1998, APPL SPECTROSC, V52, P106
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   LINGER J, 1977, CLIN PLAST SURG, V4, P425
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   MainilVarlet P, 1996, J MATER SCI-MATER M, V7, P713, DOI 10.1007/BF00121406
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   MANTSCH H, 1995, J MOL STRUCT, V347, P187, DOI 10.1016/0022-2860(95)08545-7
   MANTSCH HH, 1990, J MOL STRUCT, V217, P347, DOI 10.1016/0022-2860(90)80374-S
   Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591
   Ripamonti U, 1996, MRS BULL, V21, P36
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   SCHRADER B, 1996, 23 EUR C MOL SPECTR
   STRYER L, 1981, BIOCHEMISTRY, V186
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 26
TC 10
Z9 10
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-859-1
J9 MATER SCI FORUM
PY 2000
VL 352
BP 143
EP 150
DI 10.4028/www.scientific.net/MSF.352.143
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BS04U
UT WOS:000168448800021
DA 2018-10-19
ER

PT S
AU Accoroni, M
   Battiston, GA
   Gerbasi, R
   Tiziani, A
AF Accoroni, M
   Battiston, GA
   Gerbasi, R
   Tiziani, A
BE Uskokovic, DP
   Battiston, GA
   Nedeljkovic, JM
   Milonjic, SK
   Rakovic, DI
TI MOCVD engineering and economic analysis for biomaterial coatings
SO TRENDS IN ADVANCED MATERIALS AND PROCESSES
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd Yugoslov-Materials-Research-Society Conference
CY SEP 20-24, 1999
CL HERCEG-NOVI, YUGOSLAVIA
SP Fed Republic Yugoslavia, Minist Dev, Sci & Environm, Republic Serbia, Minist Sci & Technol, ZAMTES, Inst Inorgan Chem, Inorgan Technol & Adv Mat, Yugoslav Mat Res Soc
DE biomaterials; dental implant; MOCVD economic analysis; titanium dioxide
AB A better comprehension of the different roles of the phenomena involved in a deposition process can be achieved by modelling studies. We have so developed a model for the analysis of the technical and economic aspects of a Low-Pressure Metal-Organic Chemical Vapour Deposition (LP-MOCVD) system for the deposition of titanium dioxide to be used as biomaterial coating. Good-quality, polycrystalline, extremely uniform TiO2 thin films were deposited on dental implants by employing a hot wall reactor in the temperature range 350-430 degreesC and titanium tetraisopropoxide Ti(i-OPr)(4) as precursor in non oxidising environments. The preliminary study consisted in the development of a deposition kinetic model. The economic analysis considers all the various process steps, including cost of investment, installation, labour, reactants, energy and consumables. This model-based procedure related the running operating conditions (pressure, temperature, number and size of substrates and concentration of reactants) to costs and the optimum conditions were obtained. Automation and labour costs resulted as cost determining parameters.
C1 ICTIMA, CNR, IT-35127 Padua, Italy.
   Univ Padua, DTGSI, IT-36100 Vicenza, Italy.
RP Accoroni, M (reprint author), ICTIMA, CNR, Corso Stati Uniti 4, IT-35127 Padua, Italy.
OI gerbasi, rosalba/0000-0002-9583-9364
CR TAMANI T, 1995, J PHYSIQUE, V4, P323
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-859-1
J9 MATER SCI FORUM
PY 2000
VL 352
BP 159
EP 164
DI 10.4028/www.scientific.net/MSF.352.159
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BS04U
UT WOS:000168448800023
DA 2018-10-19
ER

PT J
AU Cautenet, S
   Poulet, D
   Delon, C
   Delmas, R
   Gregoire, JM
   Pereira, JM
   Cherchali, S
   Amram, O
   Flouzat, G
AF Cautenet, S
   Poulet, D
   Delon, C
   Delmas, R
   Gregoire, JM
   Pereira, JM
   Cherchali, S
   Amram, O
   Flouzat, G
TI Simulation of carbon monoxide redistribution over central Africa during
   biomass burning events (Experiment for Regional Sources and Sinks of
   Oxidants (EXPRESSO))
SO JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES
LA English
DT Article
ID KRUGER-NATIONAL-PARK; SOUTHERN AFRICA; SAVANNA FIRES; TROPOSPHERIC
   OZONE; TRACE-A; MODELING SYSTEM; IVORY-COAST; EMISSIONS; CHEMISTRY;
   SATELLITE
AB The Regional Atmospheric Modeling System (RAMS) is used to assess a realistic estimate of emissions by savanna fires from NOAA advanced very high resolution radiometer (AVHRR) satellite imagery during the Experiment for Regional Sources and Sinks of Oxidants (EXPRESSO) campaign. The daily amounts of gases released by biomass burning depend on burnt biomaterial, the mass of which is estimated from two independent methods: classification of vegetation formations (CV) or net primary productivity (NPP). The area of the burnt zone is derived from satellite imagery. The percent of burnt biomass or combustion factor (alpha) is determined by an adjustment procedure using two model runs and assumed to be 40%, a value consistent with the biomass wetness. The simulated CO redistribution is compared with aircraft measurements (tracks and profiles). Two events of 4 and 5 days are examined, where flights above forest and savanna zones have been performed. In this study we show that the main mechanisms of the chemical species spatial redistribution originates from mesoscale features. The RAMS results are in rather good agreement with the aircraft measurements (vertical profiles or horizontal legs) over forest and savanna. The difference between the CO simulated fields obtained from CV or NPP is weak (about 20% or 30%), and it is difficult to discriminate the best method because this difference is generally inferior to the gap between model and observations. One may consider this study as a preliminary approach to improve the estimate of released gases by biomass burning with the help of mesoscale modeling and the knowledge of the real sources.
C1 Lab Meteorol Phys, F-63177 Aubiere, France.
   Univ Toulouse 3, CNRS, Ctr Natl Etud Spatiales, UMR,CESBIO, F-31062 Toulouse, France.
   Univ Toulouse 3, CNRS, OMM, LA, F-31062 Toulouse, France.
   Commiss European Communities, Joint Res Ctr, Space Applicat Inst, Global Vegetat Monitoring Unit, I-21020 Ispra, Italy.
   Univ Tecn Lisboa, Inst Super Agron, P-1300 Lisbon, Portugal.
RP Cautenet, S (reprint author), Lab Meteorol Phys, 24 Ave Landais, F-63177 Aubiere, France.
EM cautenet@opgc.univ-bpclermont.fr; JPereira@pinus.isa.utl.pt
CR Andreae M. O., 1996, BIOMASS BURNING GLOB, P278
   ANDREAE MO, 1991, GLOBAL BIOMASS BURNING, P3
   Andreae MO, 1996, J GEOPHYS RES-ATMOS, V101, P23603, DOI 10.1029/95JD01733
   AVISSAR R, 1989, MON WEATHER REV, V117, P2113, DOI 10.1175/1520-0493(1989)117<2113:APOHLS>2.0.CO;2
   Browell EV, 1996, J GEOPHYS RES-ATMOS, V101, P24043, DOI 10.1029/95JD02536
   Brown S, 1996, BIOMASS BURNING GLOB, V1, P133
   Chatfield RB, 1996, J GEOPHYS RES-ATMOS, V101, P24279, DOI 10.1029/96JD01871
   CHEN S, 1988, J ATMOS SCI, V45, P3897, DOI 10.1175/1520-0469(1988)045<3897:TSOASE>2.0.CO;2
   CLARK TL, 1984, J ATMOS SCI, V41, P329, DOI 10.1175/1520-0469(1984)041<0329:SDWCIT>2.0.CO;2
   Cofer WR, 1996, J GEOPHYS RES-ATMOS, V101, P23597, DOI 10.1029/95JD02048
   COFER WR, 1990, ATMOS ENVIRON A-GEN, V24, P1653, DOI 10.1016/0960-1686(90)90499-D
   CROS B, 1992, J GEOPHYS RES-ATMOS, V97, P12869, DOI 10.1029/92JD01219
   CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669
   DAVIES HC, 1976, Q J ROY METEOR SOC, V102, P405, DOI 10.1002/qj.49710243210
   DELMAS R, 1995, J ATMOS CHEM, V22, P175, DOI 10.1007/BF00708188
   DELMAS RA, 1991, GLOBAL BIOMASS BURNING, P126
   Edy J, 1998, NATO CHAL M, V22, P63
   FISHMAN J, 1992, J ATMOS TERR PHYS, V54, P589, DOI 10.1016/0021-9169(92)90099-7
   Fishman J, 1996, J GEOPHYS RES-ATMOS, V101, P24069, DOI 10.1029/95JD03576
   FISHMAN J, 1990, J GEOPHYS RES-ATMOS, V95, P3599, DOI 10.1029/JD095iD04p03599
   Flasse SP, 1996, INT J REMOTE SENS, V17, P419, DOI 10.1080/01431169608949018
   Garstang M, 1996, J GEOPHYS RES-ATMOS, V101, P23721, DOI 10.1029/95JD00844
   Heimann M., 1989, GEOPHYS MONOGR SER, V55, P237
   HURST DF, 1994, J ATMOS CHEM, V18, P33, DOI 10.1007/BF00694373
   HURST DF, 1994, J GEOPHYS RES-ATMOS, V99, P16441, DOI 10.1029/94JD00670
   JANODET E, 1996, I96245 JRC
   KOPPMANN R, 1996, BIOMASS BURNING GLOB, V1, P309
   Krishnamurti TN, 1996, J GEOPHYS RES-ATMOS, V101, P23889, DOI 10.1029/95JD02419
   Kumar M., 1982, PLANTS DAYLIGHT SPEC, P133
   Lacaux J. P., 1993, FIRE ENV ECOLOGICAL, P159
   LACAUX JP, 1995, J ATMOS CHEM, V22, P195, DOI 10.1007/BF00708189
   LeCanut P, 1996, J GEOPHYS RES-ATMOS, V101, P23615, DOI 10.1029/95JD02610
   Levine J. S., 1991, GLOBAL BIOMASS BURNI, P25
   LOBERT JM, 1991, GLOBAL BIOMASS BURNING, P289
   LYONS WA, 1995, J APPL METEOROL, V34, P1762, DOI 10.1175/1520-0450(1995)034<1762:AOTRAM>2.0.CO;2
   MENAUT JC, 1991, GLOBAL BIOMASS BURNING, P133
   MENZEL WP, 1991, GLOBAL BIOMASS BURNING, P41
   Millan MM, 1997, J GEOPHYS RES-ATMOS, V102, P8811, DOI 10.1029/96JD03610
   Moula M, 1996, J ATMOS CHEM, V25, P1, DOI 10.1007/BF00053283
   Pereira JMC, 1999, IEEE T GEOSCI REMOTE, V37, P217, DOI 10.1109/36.739156
   Pickering KE, 1996, J GEOPHYS RES-ATMOS, V101, P23993, DOI 10.1029/96JD00346
   PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401
   PINTY B, 1992, VEGETATIO, V101, P15, DOI 10.1007/BF00031911
   RAMANATHAN V, 1985, J GEOPHYS RES-ATMOS, V90, P5547, DOI 10.1029/JD090iD03p05547
   Ruimy A, 1994, J GEOPHYS RES-ATMOS, V99, P5263, DOI 10.1029/93JD03221
   Rutherford M. C., 1978, Biogeography and ecology of Southern Africa. Vol.1., P621
   Scholes RJ, 1996, J GEOPHYS RES-ATMOS, V101, P23667, DOI 10.1029/96JD01623
   Shea RW, 1996, J GEOPHYS RES-ATMOS, V101, P23551, DOI 10.1029/95JD02047
   Stocks BJ, 1996, J GEOPHYS RES-ATMOS, V101, P23541, DOI 10.1029/95JD01734
   Thompson AM, 1996, J GEOPHYS RES-ATMOS, V101, P23793, DOI 10.1029/95JD02459
   TREMBACK CJ, 1987, MON WEATHER REV, V115, P540, DOI 10.1175/1520-0493(1987)115<0540:TFTUAS>2.0.CO;2
   TREMBACK CJ, 1985, 7 AMS C NUM WEATH PR
   Tripoli G. J., 1982, Journal de Recherches Atmospheriques, V16, P185
   Trollope WSW, 1996, J GEOPHYS RES-ATMOS, V101, P23531, DOI 10.1029/96JD00691
   WANG Y, 1996, J GEOPHYS RES, V101, P23993
NR 55
TC 23
Z9 23
U1 1
U2 5
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 2169-897X
J9 J GEOPHYS RES-ATMOS
JI J. Geophys. Res.-Atmos.
PD DEC 20
PY 1999
VL 104
IS D23
BP 30641
EP 30657
DI 10.1029/1999JD900393
PG 17
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA 268DR
UT WOS:000084399500036
OA Bronze
DA 2018-10-19
ER

PT J
AU Kao, JM
   Rose, R
   Yousef, M
   Hunter, SK
   Rodgers, VGJ
AF Kao, JM
   Rose, R
   Yousef, M
   Hunter, SK
   Rodgers, VGJ
TI In vivo biocompatibility evaluation of Cibacron blue-agarose
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE Cibacron blue; agarose; albumin; biomaterial; biocompatibility;
   transplantation
ID ALBUMIN-BINDING SURFACES; MICROBEADS
AB This study investigated the biocompatibility of Cibacron blue-agarose as a biomaterial for microencapsulation. Cibacron blue-agarose is known to have an affinity for albumin under certain pH conditions and in the proper steric environment. Thus it was postulated that the material's high affinity for host albumin might reduce a secondary immune response and reduce the fibrotic overgrowth that often accompanies transplanted foreign materials. In vivo tests were performed using the Lewis rat model. Both Cibacron blue-agarose and plain agarose disks were prepared, with some disks from each group being pre-exposed to sera from Lewis rats. The disks were transplanted into the peritoneal cavities of Lewis rats. After 115 days the disks were excised. Fibrotic overgrowth was analyzed using light microscopy, and a blind study was used to measure the average growth thickness on each disk. The results demonstrated that all disks developed some fibrotic encapsulation and that the presence of Cibacron blue was not significant in reducing fibrotic overgrowth (p = 0.62). Agarose disks preexposed to sera had significantly less average overgrowth than any other group (p = 0.06). (C) 1999 John Wiley & Sons, Inc.
C1 Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA.
   Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.
RP Rodgers, VGJ (reprint author), Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA.
RI Rodgers, Victor/G-3652-2016
OI Rodgers, Victor/0000-0002-1857-8025
CR DEAN PDG, 1979, J CHROMATOGR, V165, P310
   Denizli A, 1997, J BIOMAT SCI-POLYM E, V8, P411, DOI 10.1163/156856297X00353
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   IWATA H, 1994, J BIOMED MATER RES, V28, P1201, DOI 10.1002/jbm.820281010
   KELLEHER PC, 1979, J CHROMATOGR, V173, P415, DOI 10.1016/S0021-9673(00)92314-8
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   KUNG IM, 1995, BIOMATERIALS, V16, P649, DOI 10.1016/0142-9612(95)93863-9
   LAGERCRANTZ C, 1983, BIOCHEM J, V213, P387, DOI 10.1042/bj2130387
   LASCU I, 1984, J CHROMATOGR, V283, P199, DOI 10.1016/S0021-9673(00)96255-1
   LEATHERBARROW RJ, 1980, BIOCHEM J, V189, P27, DOI 10.1042/bj1890027
   MASAKI K, 1986, TOHOKU J EXP MED, V150, P249, DOI 10.1620/tjem.150.249
   WAYPOLE RE, 1989, PROBABILITY STAT ENG
   YANG H, 1994, BIOMATERIALS, V15, P113, DOI 10.1016/0142-9612(94)90259-3
NR 14
TC 8
Z9 8
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 1999
VL 47
IS 4
BP 537
EP 542
DI 10.1002/(SICI)1097-4636(19991215)47:4<537::AID-JBM10>3.0.CO;2-I
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 241YD
UT WOS:000082910700010
PM 10497289
DA 2018-10-19
ER

PT J
AU Craig, RG
   LeGeros, RZ
AF Craig, RG
   LeGeros, RZ
TI Early events associated with periodontal connective tissue attachment
   formation on titanium and hydroxyapatite surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cementum; collagen synthesis; hydroxyapatite; periodontal connective
   tissues; titanium
ID ALKALINE-PHOSPHATASE ACTIVITY; HUMAN GINGIVAL FIBROBLASTS; IN-VITRO;
   ENAMEL MATRIX; LIGAMENT; CELLS; PROLIFERATION; EXPRESSION; IMPLANTS;
   REGENERATION
AB Endosseous dental implants can support at least three types of biomaterial/connective tissue interfaces: osseointegration, fibro-osseous integration, and periodontal connective tissue attachment. Although a periodontal connective tissue attachment offers distinct advantages, only osseointegration and fibro-osseous integration are at present clinically achievable. Recent studies indicate a periodontal regeneration-competent cell population and an appropriate biomaterial substrate both are required for periodontal connective attachment formation on biomaterial surfaces. We therefore have developed an in vitro model to characterize the effects of various biomaterial substrates on the early events of periodontal connective tissue attachment formation. Primary cultures of periodontal ligament and gingival connective tissue cells were cultured on uncoated (control) and coated (titanium- and hydroxyapatite-coated) tissue culture plastic, and the level of cell proliferation, collagen, and noncollagen protein synthesis, alkaline phosphatase activity, and expression of a 42 kD cementum extracellular matrix protein were measured over 5, 7, and 9 days in culture. While all three substrates supported cell attachment, proliferation, and protein synthesis, only uncoated and titanium-coated tissue culture plastic supported expression of the cementum extracellular matrix protein after 9 days of culture. In addition, the levels of cell proliferation and collagen and noncollagen protein synthesis for cells grown on hydroxyapatite-coated surfaces lagged behind cells cultured on the control or titanium-coated surfaces at each of the three time points. These data suggest that biomaterial substrates markedly can influence the temporal sequence of extracellular matrix proteins associated with periodontal connective tissue attachment formation. In addition to surface composition (titanium versus hydroxyapatite), surface properties (e.g., topography) also may have an effect on periodontal connective tissue attachment formation. This model may be of use in designing biomaterials to support the formation of periodontal connective tissue attachment in vivo. (C) 1999 John Wiley & Sons, Inc.
C1 NYU, Coll Dent, Div Basic Sci, New York, NY 10010 USA.
   NYU, Coll Dent, Div Restorat Sci, New York, NY 10010 USA.
   NYU, Coll Dent, Div Surg Sci, New York, NY 10010 USA.
RP Craig, RG (reprint author), NYU, Coll Dent, Div Basic Sci, Mail Code 9401,345 E 24th St, New York, NY 10010 USA.
FU NIDCR NIH HHS [DE 12388, DE10094]
CR AlliotLicht B, 1997, J PERIODONTOL, V68, P158, DOI 10.1902/jop.1997.68.2.158
   AUKHIL I, 1988, J CLIN PERIODONTOL, V15, P374, DOI 10.1111/j.1600-051X.1988.tb01015.x
   BARTOLD PM, 1998, BIOL PERIODONTAL CON, P241
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P601, DOI 10.1016/0278-2391(87)90270-9
   BOYKO GA, 1981, J PERIODONTAL RES, V16, P73, DOI 10.1111/j.1600-0765.1981.tb00951.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRANEMARK PI, 1977, SCAND J PLAST RECONS, V11, pS16
   BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUSER D, 1990, J PERIODONTOL, V61, P597, DOI 10.1902/jop.1990.61.9.597
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CRAIG RG, 1989, ENDOCRINOLOGY, V125, P1430, DOI 10.1210/endo-125-3-1430
   Craig RG, 1997, J ENDODONT, V23, P494, DOI 10.1016/S0099-2399(97)80308-1
   CRAIG RG, 1997, ORAL MAXILLOFAC SURG, V9, P581
   DErrico JA, 1997, BONE, V20, P117, DOI 10.1016/S8756-3282(96)00348-1
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   Groeneveld MC, 1996, J PERIODONTAL RES, V31, P73, DOI 10.1111/j.1600-0765.1996.tb00466.x
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   HAMMARSTROM L, 1997, J CLIN PERIODONTOL, V24, P666
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P693, DOI 10.1111/j.1600-051X.1997.tb00251.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Kurachi T, 1997, ARCH ORAL BIOL, V42, P465, DOI 10.1016/S0003-9969(97)00019-8
   LANG H, 1995, J DENT RES, V74, P1219, DOI 10.1177/00220345950740051201
   Lang H, 1998, J DENT RES, V77, P393, DOI 10.1177/00220345980770020801
   LeGeros R.Z., 1993, J BONE MINER RES, V8, P583
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   Locci P, 1996, J PERIODONTOL, V67, P1260, DOI 10.1902/jop.1996.67.12.1260
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   MCCULLOCH CA, 1988, ANAT REC, V219, P233
   MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009
   PITARU S, 1994, J PERIODONTAL RES, V29, P81, DOI 10.1111/j.1600-0765.1994.tb01095.x
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SLAVKIN HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P12, DOI 10.1016/0304-4165(89)90021-4
   Takata T, 1994, Int J Oral Maxillofac Implants, V9, P77
   TAKATA T, 1995, J PERIODONTOL, V66, P125, DOI 10.1902/jop.1995.66.2.125
   Tenorio D, 1996, ARCH ORAL BIOL, V41, P299, DOI 10.1016/0003-9969(95)00113-1
   TENORIO D, 1993, J PERIODONTAL RES, V28, P411
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WARRER K, 1993, J PERIODONTOL, V64, P29, DOI 10.1902/jop.1993.64.1.29
   WEISS C M, 1986, Journal of Oral Implantology, V12, P169
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
NR 49
TC 23
Z9 28
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 1999
VL 47
IS 4
BP 585
EP 594
DI 10.1002/(SICI)1097-4636(19991215)47:4<585::AID-JBM16>3.0.CO;2-O
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 241YD
UT WOS:000082910700016
PM 10497295
DA 2018-10-19
ER

PT J
AU Hanssen, HHL
   Wetzels, GMR
   Benzina, A
   van der Veen, FH
   Lindhout, T
   Koole, LH
AF Hanssen, HHL
   Wetzels, GMR
   Benzina, A
   van der Veen, FH
   Lindhout, T
   Koole, LH
TI Metallic wires with an adherent lubricious and blood-compatible
   polymeric coating and their use in the manufacture of novel
   slippery-when-wet guidewires: Possible applications related to
   controlled local drug delivery
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
AB A new procedure was developed for the controlled application of adherent hydrophilic and biocompatible coatings onto the surface of "endless" metallic wires. Use of copolymers of 1-vinyl-2-pyrrolidinone and alkylmethacrylates provided coatings with excellent adherence and lubricity, and markedly low thrombogenicity. Coated wires could be spiralized without damaging the coating; the resulting coils are potentially useful as lubricious guidewires for use in, for example, interventional cardiology or urology. This study demonstrates that the lubricity of the coating is dependent on the composition (hydrophilicity) of the coating biomaterial, as wed as on the thickness of the coating. Furthermore, the results imply that the adherence of the hydrophilic coating is essentially due to entanglement of the binder polymer chains and the hydrophilic copolymer chains. Moreover, the idea to use the hydrophilic coating on the wire as a temporary depot for controlled local drug delivery was explored, The coating was loaded with the dye rhodamine, and release of the dye upon immersion of the coated wire in water was studied. This work revealed that release of the drug is dependent on the composition of the coating. The potential utility of such wires with a drug-charged coating for controlled local drug delivery is discussed briefly. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   MC Tec, NL-5900 AA Venlo, Netherlands.
   Univ Limburg, Acad Hosp Maastricht, Dept Cardiothorac Surg, Maastricht, Netherlands.
   Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
CR Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   Blezer R, 1998, THROMB HAEMOSTASIS, V79, P296
   Blezer R, 1998, BLOOD COAGUL FIBRIN, V9, P435, DOI 10.1097/00001721-199807000-00006
   HANSSEN JHL, 1995, Patent No. 1001746
   Hem ker HC, 1983, HDB SYNTHETIC SUBSTR
   Ikada Y, 1993, LUBRICATING POLYM SU
   KUTRYK M, 1999, CORONARY STENTING CU
   ODIAN G, 1991, PRINCIPLES POLYM
   SAFIAN RD, 1996, NEW MANUAL INTERVENT, P1
   Silver F.H., 1993, BIOMATERIALS MED DEV
   TOPOL EJ, 1994, TXB INTERVENTIONAL C, V1
NR 11
TC 20
Z9 20
U1 2
U2 11
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 1999
VL 48
IS 6
BP 820
EP 828
DI 10.1002/(SICI)1097-4636(1999)48:6<820::AID-JBM9>3.0.CO;2-K
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 257FQ
UT WOS:000083772200009
PM 10556846
DA 2018-10-19
ER

PT J
AU Kam, HM
   Khor, E
   Lim, LY
AF Kam, HM
   Khor, E
   Lim, LY
TI Storage of partially deacetylated chitosan films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE chitosan; chitosan acetate; partial deacetylation; films; storage
ID DERIVATIVES; CHITIN; ACID
AB Chitosan has wide-ranging applications as a biomaterial, but its stability in storage is not widely known. The objective of this study was to evaluate the storage stability of films prepared from chitosan of 77% deacetylation, Both the neutralized and acetate films were evaluated, as chitosan salts offer the advantage of being soluble in water at the neutral-to-basic pH range. Aqueous solutions containing 0.5-5% acetic acid were used as solvents. The X-ray diffraction pattern, the IR spectrum, water uptake, and solubility of the films were influenced by the presence of the N-acetyl functionality, the acetate ions, and storage of the films. The anhydrous chitosan crystal in the neutralized films was unstable to storage at 4 degrees C and 28 degrees C, Its formation, as well as that of the hydrated crystal, were further hindered by the presence of even small quantities of the acetate ions. The resultant amorphous nature of the acetate films, coupled with the acidifying action of the acetic acid, led to greater water uptake and solubility compared to the neutralized films, Storage reduced the differences between the neutralized and acetate films. It also minimized the influence of the initial acetic acid content on the IR absorption and water uptake of the acetate films, exerting its leveling effects mainly within the first meek of storage. Using a lower storage temperature of 4 degrees C or heating the films for 2 h at 120 degrees C prior to storage did not significantly modify the results. A pertinent factor appears to be the degree of deacetylation of the chitosan that was used to prepare the films. (C) 1999 John Wiley & Sons, Inc.
C1 Natl Univ Singapore, Dept Pharm, Singapore 119260, Singapore.
   Natl Univ Singapore, Dept Chem, Singapore 119260, Singapore.
RP Lim, LY (reprint author), Natl Univ Singapore, Dept Pharm, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM phalimly@nus.edu.sg
RI Lim, Lee Yong/C-6144-2013
OI Lim, Lee Yong/0000-0002-7307-0742
CR AMIJI MM, 1995, CARBOHYD POLYM, V26, P211, DOI 10.1016/0144-8617(94)00095-B
   ANTHONSEN MW, 1994, CARBOHYD POLYM, V25, P13, DOI 10.1016/0144-8617(94)90157-0
   ARGUELLESMONAL W, 1993, MAKROMOL CHEM-RAPID, V14, P735
   ERRINGTON N, 1993, INT J BIOL MACROMOL, V15, P113, DOI 10.1016/0141-8130(93)90008-A
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Ito A, 1997, ANGEW MAKROMOL CHEM, V248, P85, DOI 10.1002/apmc.1997.052480105
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   LIM LY, IN PRESS J BIOMED MA
   LIM LY, 1998, C DRUG DEL PHARM TEC, P196
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   OGAWA K, 1991, AGR BIOL CHEM TOKYO, V55, P2375, DOI 10.1080/00021369.1991.10870939
   Peniche C, 1998, POLYMER, V39, P6549, DOI 10.1016/S0032-3861(98)00059-7
   ROBERTS GAF, 1982, INT J BIOL MACROMOL, V4, P374, DOI 10.1016/0141-8130(82)90074-5
   Toffey A, 1996, J APPL POLYM SCI, V60, P75, DOI 10.1002/(SICI)1097-4628(19960404)60:1<75::AID-APP9>3.0.CO;2-S
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Yamamoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1230, DOI 10.1271/bbb.61.1230
NR 18
TC 23
Z9 25
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 1999
VL 48
IS 6
BP 881
EP 888
DI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 257FQ
UT WOS:000083772200018
PM 10556855
DA 2018-10-19
ER

PT J
AU Oudadesse, H
   Irigaray, JL
   Brun, V
   Terver, S
   Vanneuville, G
AF Oudadesse, H
   Irigaray, JL
   Brun, V
   Terver, S
   Vanneuville, G
TI Determination of metallic ion transfer from an implanted prosthesis by
   the PIXE method
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article; Proceedings Paper
CT 1998 International Conference on Nuclear Methods in the Life Sciences
   (NAMLS)
CY OCT 26-30, 1998
CL BEIJING, PEOPLES R CHINA
SP China Inst Atomic Energy, Int Atom Energy Agcy, Natl Nat Sci Fdn China, China Natl Nucl Corp, Chinese Academy Sci, Inst High Energy Phys, Chinese Nucl Soc
DE prosthesis; PIXE method; contaminations by transfer
AB Prostheses can release some metallic elements to the surrounding tissues, particularly when they are not covered with a biomaterial layer and when an unsealing process happens. We try to measure major and trace elements in these tissues with an experimentally sensitive method. Proton-induced X-ray emission is used to detect about 10 elements in tissue. Tissues are calcinated and deposited in a thin layer before irradiation. Results are obtained in a standard and samples from three patients. We observe contamination by Ti, Cr, Ni, and ZI I in the tissues. Correlations are to be studied between these atomic transfers and prosthesis in the patient.
C1 Univ Blaise Pascal, Lab Phys Corpusculaire Clermont Ferrand, F-63177 Clermont Ferrand, France.
   Fac Med, F-63000 Clermont Ferrand, France.
RP Irigaray, JL (reprint author), Univ Blaise Pascal, Lab Phys Corpusculaire Clermont Ferrand, F-63177 Clermont Ferrand, France.
CR AZAHRA M, 1993, THESIS U CLERMONT FE
   Campbell JL, 1996, NUCL INSTRUM METH B, V109, P71, DOI 10.1016/0168-583X(95)01221-4
   CHOI CG, 1996, THESIS U ORLEANS FRA
   Johanson S. A. E., 1988, PIXE NOVEL TECHNIQUE
   LINDH U, 1990, NUCL INSTRUM METH B, V49, P451, DOI 10.1016/0168-583X(90)90292-3
   ZINE E, 1990, NUCL INSTRUM METH B, V49, P446, DOI 10.1016/0168-583X(90)90291-2
   ZINE M, 1989, THESIS U CLERMONT FE
NR 7
TC 0
Z9 0
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD WIN
PY 1999
VL 71-2
BP 595
EP 601
DI 10.1007/BF02784248
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 271TT
UT WOS:000084610100065
PM 10676536
DA 2018-10-19
ER

PT J
AU Irigaray, JL
   Oudadesse, H
   Brun, V
   Labarre, P
   Rapp, M
   Madelmont, JC
   Bonafous, J
AF Irigaray, JL
   Oudadesse, H
   Brun, V
   Labarre, P
   Rapp, M
   Madelmont, JC
   Bonafous, J
TI Study of implanted biomaterial functionality by diphosphonate molecules
   labeled with radioactive Tc-99m
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article; Proceedings Paper
CT 1998 International Conference on Nuclear Methods in the Life Sciences
   (NAMLS)
CY OCT 26-30, 1998
CL BEIJING, PEOPLES R CHINA
SP China Inst Atomic Energy, Int Atom Energy Agcy, Natl Nat Sci Fdn China, China Natl Nucl Corp, Chinese Academy Sci, Inst High Energy Phys, Chinese Nucl Soc
DE coral; biofunctionality; diphosphonates; technetium
ID BONE METASTASES; CORAL
AB An implanted biomaterial can be transformed into young bone after some months, but it has not necessary reached full biofunctionality. Mineral concentration kinetics and crystal-structure studies, still being carried out in our group, are completed here by biofunctionality determinations. A natural coral is implanted in vivo at the cortical level of the femoral diaphyse in rabbits.
   Diphosphonates molecules labeled with radioactive Tc-99m are then injected in rabbits and the fixation of the radioactivity is analyzed in several sites for 8 mo after the implantation. Nuclear instruments and methods are used for the measurements.
   Four successive cycles of osseous remodeling are determined before reaching a biofunctional phase.
C1 Univ Blaise Pascal, IN2P3 CNRS, Lab Phys Corpusculaire Clermont Ferrand, F-63177 Clermont Ferrand, France.
   INSERM, U484, F-63005 Clermont Ferrand, France.
   Ctr Jean Perrin, F-63011 Clermont Ferrand, France.
RP Irigaray, JL (reprint author), Univ Blaise Pascal, IN2P3 CNRS, Lab Phys Corpusculaire Clermont Ferrand, F-63177 Clermont Ferrand, France.
CR FRANCIS MD, 1969, SCIENCE, V165, P1264, DOI 10.1126/science.165.3899.1264
   IRIGARAY JL, 1990, BIOMATERIALS, V11, P73
   IRIGARAY JL, 1995, J MATER SCI-MATER M, V6, P230, DOI 10.1007/BF00146861
   LUMBROSO J, 1993, MED NUCL, V17, P359
   SILBERSTEIN EB, 1973, RADIOLOGY, V107, P551, DOI 10.1148/107.3.551
   SUBRAMANIAN G, 1972, SOC NUCL MED NY, V34, P319
NR 6
TC 0
Z9 0
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD WIN
PY 1999
VL 71-2
BP 629
EP 633
DI 10.1007/BF02784253
PG 5
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 271TT
UT WOS:000084610100070
PM 10676541
DA 2018-10-19
ER

PT J
AU Puleo, D
   Dee, KC
   Bizios, R
AF Puleo, D
   Dee, KC
   Bizios, R
TI Current challenges in cell-biomaterial interactions - Preface
SO BIOMATERIALS
LA English
DT Editorial Material
C1 Univ Kentucky, Lexington, KY 40506 USA.
   Tulane Univ, New Orleans, LA 70118 USA.
   Rensselaer Polytech Inst, Troy, NY 12181 USA.
RP Puleo, D (reprint author), Univ Kentucky, Lexington, KY 40506 USA.
RI Gentleman, Molly/A-7137-2010
NR 0
TC 1
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1999
VL 20
IS 23-24
BP 2201
EP 2201
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266BQ
UT WOS:000084281100001
DA 2018-10-19
ER

PT J
AU James, K
   Levene, H
   Parsons, JR
   Kohn, J
AF James, K
   Levene, H
   Parsons, JR
   Kohn, J
TI Small changes in polymer chemistry have a large effect on the
   bone-implant interface: evaluation of a series of degradable
   tyrosine-derived polycarbonates in bone defects
SO BIOMATERIALS
LA English
DT Article
DE tyrosine-based polycarbonate; biomaterial; prosthesis-bone interface;
   bone-material interactions; degradable polymer; poly(DTE carbonate);
   structure-property relationships; calcium ion chelation; bone
   apposition; bone bonding
ID POLY(L-LACTIC ACID); APATITE FORMATION; BIOMATERIALS
AB In a series of homologous, tyrosine-based polycarbonates, small changes in the chemical structure of the polymer pendent chain were found to affect the bone response in a long-term (1280 d) implantation study. Identically sized pins, prepared from poly(DTE carbonate), poly(DTB carbonate), poly(DTH carbonate), and poly(DTO carbonate) were implanted transcortically in the proximal tibia and the distal femur of skeletally mature New Zealand White Rabbits. The tissue response at the bone-implant interface was characterized in terms of the absence of a fibrous capsule (direct bone apposition, indicative of a bone bonding response) or the presence of a fibrous capsule (referred to as the encapsulation response). The relative frequency of direct bone apposition versus encapsulation was recorded for each polymer throughout the entire period of the study. While all four polymers were tissue compatible, there was a correlation between the chemical structure of the pendent chain and the type of bone response observed, with poly(DTE carbonate) having the highest tendency to elicit direct bone apposition. Based on in vivo degradation data and the ability of moder polymers with carboxylate groups at their surface to chelate calcium ions, it is proposed that the ability of poly(DTE carbonate) to bond to bone is caused by the facile hydrolysis of the pendent ethyl eater groups which creates calcium ion chelation sites on the polymer surface. The incorporation of calcium chelation sites into the chemical structure of an implant material appears to be a key requirement if direct bone apposition/bone bonding is desired. This study demonstrates that very subtle changes in the chemical composition of an implant material can have significant effects on the long-term tissue response in a clinically relevant model. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA.
   Univ Med & Dent New Jersey, Sch Med, Dept Orthopaed, Newark, NJ 07103 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd, Piscataway, NJ 08854 USA.
FU NIGMS NIH HHS [GM39455]
CR ALBREKTSSON T, 1998, HDB BIOMATERIAL PROP, P504
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   Hooper KA, 1998, J BIOMED MATER RES, V41, P443, DOI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   James H, 1996, NEURAL COMPUT APPL, V4, P1, DOI 10.1007/BF01413863
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   JAMES K, 1997, CONTROLLED DRUG DELI, P389
   JAMES KS, 1997, 23 ANN M SOC BIOM NE, P120
   JAMES KS, 1999, METHODS MOL MED TISS, P121
   JAMES KS, 1998, 24 ANN M SOC BIOM SA, P146
   LeGeros R.Z., 1993, J BONE MINER RES, V8, P583
   Li P, 1997, J BIOMED MATER RES, V34, P79, DOI 10.1002/(SICI)1097-4636(199701)34:1<79::AID-JBM11>3.0.CO;2-K
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Plenk H, 1998, J BIOMED MATER RES, V43, P350
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
NR 24
TC 71
Z9 74
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1999
VL 20
IS 23-24
BP 2203
EP 2212
DI 10.1016/S0142-9612(99)00151-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266BQ
UT WOS:000084281100002
PM 10614927
DA 2018-10-19
ER

PT J
AU Puleo, DA
   Nanci, A
AF Puleo, DA
   Nanci, A
TI Understanding and controlling the bone-implant interface
SO BIOMATERIALS
LA English
DT Review
DE orthopedic implants; dental implants; ultrastructure cell-biomaterial
   interactions; surface modification
ID CELL-GROWTH FACTOR; CO-CR-MO; SELF-ASSEMBLED MONOLAYERS; IN-VITRO;
   TITANIUM INTERFACE; STAINLESS-STEEL; FIBROBLAST CELLS; ULTRASTRUCTURAL
   CHARACTERIZATION; CHEMICAL MODIFICATION; MATRIX PROTEINS
AB A goal of current implantology research is to design devices that induce controlled, guided, and rapid healing. In addition to acceleration of normal wound healing phenomena, endosseous implants should result in formation of a characteristic interfacial layer and bone matrix with adequate biomechanical properties. To achieve these goals, however, a better understanding of events at the interface and of the effects biomaterials have on bone and bone cells is needed. Such knowledge is essential for developing strategies to optimally control osseointegration. This paper reviews current knowledge of the bone-biomaterial interface and methods being investigated for controlling it. Morphological studies have revealed the heterogeneity of the bone-implant interface. One feature often reported, regardless of implant material, is an afibrillar interfacial zone, comparable to cement lines and laminae limitantes at natural bone interfaces. These electron-dense interfacial layers are rich in noncollagenous proteins, such as osteopontin and bone sialoprotein. Several approaches, involving alteration of surface physicochemical, morphological, and/or biochemical properties, are being investigated in an effort to obtain a desirable bone-implant interface. Of particular interest are biochemical methods of surface modification, which immobilize molecules on biomaterials for the purpose of inducing specific cell and tissue responses or, in other words, to control the tissue-implant interface with biomolecules delivered directly to the interface. Although still in its infancy, early studies indicate the value of this methodology for controlling cell and matrix events at the bone-implant interface. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Kentucky, Wenner Gren Lab, Ctr Biomed Engn, Lexington, KY 40506 USA.
   Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada.
RP Puleo, DA (reprint author), Univ Kentucky, Wenner Gren Lab, Ctr Biomed Engn, Lexington, KY 40506 USA.
EM puleo@pop.uky.edu
CR Agrawal CM, 1997, J BIOMED MATER RES, V36, P516, DOI 10.1002/(SICI)1097-4636(19970915)36:4<516::AID-JBM9>3.0.CO;2-H
   ALBELDA SM, 1990, FASEB J, V4, P2868
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAIER RE, 1970, ADHESION BIOL SYSTEM, P14
   BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   BAUER TW, 1994, CLIN ORTHOP RELAT R, V298, P11
   Black J., 1992, BIOL PERFORMANCE MAT
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   BRUNSKI JB, 1999, IN PRESS ADV DENT RE
   BUTLER WT, 1995, INT J DEV BIOL, V39, P169
   CARTER DR, 1977, CLIN ORTHOP RELAT R, P265
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   COOK SD, 1988, CLIN ORTHOP RELAT R, P90
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   COWIN SC, 1987, HDB BIOENGINEERING
   CURREY JD, 1984, MECHANICAL ADAPTATIO
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DHERT WJA, 1994, MED PROG TECHNOL, V20, P143
   DORR LD, 1990, CLIN ORTHOP RELAT R, V261, P82
   Dunlap J, 1988, Dent Econ, V78, P101
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Endo K, 1995, Dent Mater J, V14, P185
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Friberg L., 1979, HDB TOXICOLOGY METAL
   GALANTE JO, 1992, CLIN ORTHOP RELAT R, V276, P41
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401
   GRAVES E, 1995, VITAL HLTH STAT DETA
   HAMAMOTO N, 1995, ARCH ORAL BIOL, V40, P97, DOI 10.1016/0003-9969(94)00153-3
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   Irie K, 1998, ANAT RECORD, V252, P554
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KATZ RW, 1988, BIOCHEM BIOPH RES CO, V157, P1253, DOI 10.1016/S0006-291X(88)81009-X
   KISSLING RA, 1999, T SOC BIOMATER, V27, P338
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   Lind M, 1996, J BONE JOINT SURG BR, V78B, P377
   Lind M, 1998, ACTA ORTHOP SCAND, V69, P2
   LINDER L, 1985, ACTA ORTHOP SCAND, V56, P269, DOI 10.3109/17453678508993011
   LIU SQ, 1992, J BIOCHEM BIOPH METH, V25, P139
   LIU SQ, 1993, INT J BIOL MACROMOL, V15, P221, DOI 10.1016/0141-8130(93)90041-J
   LIU SQ, 1992, BIOMATERIALS, V13, P50, DOI 10.1016/0142-9612(92)90095-6
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   LYNCH SE, 1991, J PERIODONTOL, V62, P710, DOI 10.1902/jop.1991.62.11.710
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   Merritt K, 1996, CLIN ORTHOP RELAT R, pS233
   MICHEL R, 1991, ARCH ORTHOP TRAUM SU, V110, P61, DOI 10.1007/BF00393876
   Miles RR, 1998, J CELL BIOCHEM, V68, P355, DOI 10.1002/(SICI)1097-4644(19980301)68:3<355::AID-JCB6>3.0.CO;2-T
   MOHAN S, 1991, CLIN ORTHOP RELAT R, V263, P30
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Murai K, 1996, J BIOMED MATER RES, V30, P523, DOI 10.1002/(SICI)1097-4636(199604)30:4<523::AID-JBM11>3.3.CO;2-6
   MUTHUKUMARAN N, 1988, COLLAGEN REL RES, V8, P433
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   NANCI A, 1994, CELL MATER, V4, P1
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nanci A, 1998, BIOL MECH TOOTH ERUP, P487
   Nichols KG, 1997, J BIOMED MATER RES, V35, P265
   Piattelli A, 1996, BIOMATERIALS, V17, P1443, DOI 10.1016/0142-9612(96)87288-7
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PILLIAR RM, 1991, BONE-BIOMATERIAL INTERFACE, P380
   Pimentel E, 1994, HDB GROWTH FACTORS
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   Puleo DA, 1999, ARTIF CELL BLOOD SUB, V27, P65, DOI 10.3109/10731199909117484
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   SODEK J, 1992, INT CONGR SER, V1002, P297
   STANFORD CM, 1995, J ORTHOPAED RES, V13, P664, DOI 10.1002/jor.1100130505
   Steinemann SG, 1986, BIOL BIOMECHANICAL P, P409
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   SUNDGREN JE, 1985, J BIOMED MATER RES, V19, P663, DOI 10.1002/jbm.820190606
   Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   WALSH WR, 1995, BIOMATERIALS, V16, P1319
   WENNERBERG A, 1991, SWED DENT J, V15, P95
   WILLIAMS DF, 1982, BIOCOMPATIBILITY ORT, P231
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
NR 107
TC 818
Z9 866
U1 18
U2 330
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1999
VL 20
IS 23-24
BP 2311
EP 2321
DI 10.1016/S0142-9612(99)00160-X
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266BQ
UT WOS:000084281100012
PM 10614937
DA 2018-10-19
ER

PT J
AU Chistolini, P
   Ruspantini, I
   Bianco, P
   Corsi, A
   Cancedda, R
   Quarto, R
AF Chistolini, P
   Ruspantini, I
   Bianco, P
   Corsi, A
   Cancedda, R
   Quarto, R
TI Biomechanical evaluation of cell-loaded and cell-free hydroxyapatite
   implants for the reconstruction of segmental bone defects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; COMPRESSIVE STRENGTH; CANCELLOUS BONE;
   RESISTANCE; INGROWTH; BOVINE; MARROW
AB Porous hydroxyapatite (HA) scaffoldings are currently used in tissue engineering for bone reconstruction. When this osteoconductive biomaterial is combined with osteoprogenitor cells, it acquires osteoinductive features which accelerate and improve bone formation in vivo. The aim of our study was to assess the mechanical properties of HA-bone complexes undergoing indentation tests, and relate stiffness to composition and structure as examined by micro X-ray. To this purpose, 35-mm tibia diaphyseal resections were performed in sheep. Gaps were filled using porous HA cylinders. Implants were loaded with autologous bone marrow stromal cells (BMSC); cell-free cylinders were used as control. After 8 weeks, bone tissue was found within the internal macropores of cell-loaded HA carriers, and in control implants, bone formation was mostly limited to the outer surface. As assessed by indentation testing the stiffness values of bone-HA composites were halfway between those of HA scaffoldings and tibia bone. Cell-loaded implants were stiffer than cell-free ones. In a cell-loaded implant we also analyzed the variation of stiffness along the main axis of the tibia. (C) 1999 Kluwer Academic Publishers.
C1 Ist Super Sanita, Biomed Engn Lab, I-00161 Rome, Italy.
   Univ Aquila, Dept Expt Med, Rome, Italy.
   Univ Rome La Sapienza, Rome, Italy.
   Natl Inst Canc Res, Adv Biotechnol Ctr, Genoa, Italy.
RP Chistolini, P (reprint author), Ist Super Sanita, Biomed Engn Lab, Rome 299, I-00161 Rome, Italy.
RI RUSPANTINI, IRENE/E-6670-2015
OI RUSPANTINI, IRENE/0000-0002-9780-0682; Quarto,
   Rodolfo/0000-0002-1146-894X
CR BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   BRUDER SP, 1997, T ORTHOP RES SOC, V22, P250
   Gao TJ, 1996, J BIOMED MATER RES, V32, P505, DOI 10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   HOUDE J, 1995, CALCIFIED TISSUE INT, V57, P201, DOI 10.1007/BF00310259
   Kang Q, 1997, AM J VET RES, V58, P1171
   KON E, IN PRESS J BIOMED MA
   Lang H, 1991, Dtsch Z Mund Kiefer Gesichtschir, V15, P64
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   MARTIN RB, 1989, BIOMATERIALS, V10, P491
   Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5
   SUMNER DR, 1994, J BIOMECH, V27, P1095, DOI 10.1016/0021-9290(94)90226-7
   Timoshenko SP, 1970, THEORY ELASTICITY, P380
   TRECANT M, 1994, CLIN MATER, V15, P233, DOI 10.1016/0267-6605(94)90051-5
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
NR 22
TC 42
Z9 44
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1999
VL 10
IS 12
BP 739
EP 742
DI 10.1023/A:1008939524807
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256GC
UT WOS:000083716700010
PM 15347943
DA 2018-10-19
ER

PT J
AU Bordenave, L
   Chaudet, B
   Bareille, R
   Fernandez, P
   Amedee, J
AF Bordenave, L
   Chaudet, B
   Bareille, R
   Fernandez, P
   Amedee, J
TI In vitro assessment of endothelial cell adhesion mechanism on vascular
   patches
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ATTACHMENT; GRAFTS
AB Endothelial cell (EC) seeding of small caliber vascular grafts prior to their implantation has proved to significantly improve long-term patency in humans. We have previously demonstrated that a monolayer of EC could be obtained on type I collagen-coated knitted ultrathin polyster grafts (InterVascular, La Ciotat, France). Thus, the aim of the present work was to understand the nature of cell adhesion mechanisms involved in the cell /biomaterial interface, using HemaCarotid(R) (InterVascular) patches made of type I collagen-coated knitted ultrathin polyster (type I collagen is used to coat patches to attain low permeability). By means of quantitative attachment tests, adhesion blocking assays, RT-PCR for the expression of beta(1) integrin mRNA, indirect immunofluorescence with antivinculin antibody, we were able to show that EC are able to adhere to such surfaces by the means (non-unique) of cell surface receptors of the beta(1) integrin group. However, the latter are probably downregulated at the cell/biomaterial interface. (C) 1999 Kluwer Academic Publishers.
C1 Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
RP Bordenave, L (reprint author), Univ Bordeaux 2, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
CR Akiyama S K, 1996, Hum Cell, V9, P181
   AMEDEE J, 1994, BIOMATERIALS, V15, P1029, DOI 10.1016/0142-9612(94)90086-8
   ANDERSON JS, 1987, SURGERY, V101, P577
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   De Filippi P., 1997, SIGNAL TRANSDUCTION
   Fernandez P, 1999, J NUCL MED, V40, P1756
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   L'Heureux N, 1998, FASEB J, V12, P47
   Meinhart J, 1997, ASAIO J, V43, P515
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OToole TE, 1997, MATRIX BIOL, V16, P165, DOI 10.1016/S0945-053X(97)90004-4
   SAUVAGE LR, 1975, ANN SURG, V182, P759
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   WU MHD, 1995, J VASC SURG, V21, P862, DOI 10.1016/S0741-5214(05)80019-9
   Yamada KM, 1997, MATRIX BIOL, V16, P137, DOI 10.1016/S0945-053X(97)90001-9
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
NR 20
TC 2
Z9 2
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1999
VL 10
IS 12
BP 807
EP 810
DI 10.1023/A:1008971505127
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256GC
UT WOS:000083716700023
PM 15347956
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   Van der Mei, HC
   Busscher, HJ
   Grijpma, DW
   Feijen, J
AF Gottenbos, B
   Van der Mei, HC
   Busscher, HJ
   Grijpma, DW
   Feijen, J
TI Initial adhesion and surface growth of Pseudomonas aeruginosa on
   negatively and positively charged poly(methacrylates)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID METHACRYLATE POLYMERS; MICROBIAL ADHESION; ESCHERICHIA-COLI;
   IMAGE-ANALYSIS; FLOW CHAMBER; STAPHYLOCOCCI; COPOLYMERS; SERIES
AB The infection risk of biomaterial implants is determined by an interplay of bacterial adhesion and surface growth of the adhering organisms. In this study, we compared initial adhesion and surface growth of Pseudomonas aeruginosa AK1 (zeta potential -7 mV) on negatively charged (PMMA/MAA, zeta potential -18 mV) and positively charged (PMMA/TMAEMA-Cl, zeta potential +12 mV) methacrylate copolymers in situ in a parallel plate flow chamber. Initial adhesion was measured using phosphate-buffered saline and subsequent surface growth of the adhering bacteria using nutrient broth as growth medium. Initial adhesion was twice as fast on the positively charged methacrylate than on the negatively charged copolymer. Surface growth, however, was absent on the positively charged copolymer, while on the negatively charged methacrylate the number of bacteria increased exponentially during surface growth with a generation time of 32 min. From the results of this study it can be concluded that positively charged biomaterial surfaces might show reduced risks of biomaterials-centered infections, despite being more adhesive. (C) 1999 Kluwer Academic Publishers.
C1 Univ Groningen, Dept Biomed Engn, Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Groningen, Netherlands.
CR Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   GOTTENBOS B, 1999, UNPUB
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   NOORDMANS J, 1993, J COLLOID INTERF SCI, V156, P394, DOI 10.1006/jcis.1993.1128
   SPEIER JL, 1982, J COLLOID INTERF SCI, V89, P68, DOI 10.1016/0021-9797(82)90121-7
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
NR 15
TC 35
Z9 36
U1 1
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1999
VL 10
IS 12
BP 853
EP 855
DI 10.1023/A:1008989416939
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256GC
UT WOS:000083716700031
PM 15347964
DA 2018-10-19
ER

PT J
AU Thompson, JI
   Gregson, PJ
   Revell, PA
AF Thompson, JI
   Gregson, PJ
   Revell, PA
TI Analysis of push-out test data based on interfacial fracture energy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SHEAR-STRENGTH; BONE
AB Push-out testing is frequently used to assess the interfacial shear strength developed at a bone-biomaterial interface during in vivo experiments. The aim of the present research was to assess the in vivo performance of a novel substrate/coating combination and to introduce a more rigorous fracture mechanics analysis of the push-out test data. An adhesively bonded hydroxyapatite (HA), and a Ti-6Al-4V alloy plasma sprayed with HA, were implanted in female New Zealand white rabbits for up to 6 months in duration. After death, push-out tests were carried out and the shear strength was calculated in the conventional way, together with microscopical examination of crack paths. A finite element model was drawn up representing four potential failure mechanisms. The measured "failure shear strengths" in conventional analysis were approximately equal for the two coatings. However, J(C) at failure calculated from the model was 210 J m(-2) at the novel adhesively bonded HA/bone interface and 5 J m(-2) at a conventional titanium/plasma-sprayed HA interface. The conventional shear strength approach is strongly test dependent, and we believe that the fracture energy approach represents a more rigorous analysis of the real failure criterion in the implant/host tissue structure. (C) 1999 Kluwer Academic Publishers.
C1 Univ Southampton, Dept Mat Engn, Southampton, Hants, England.
   Royal Free Hosp, Sch Med, Dept Histopathol, London, England.
RP Thompson, JI (reprint author), Univ Southampton, Dept Mat Engn, Southampton, Hants, England.
CR ALBUSTANEY KR, 1997, P 13 EUR C BIOM SEPT, P37
   BOONE PS, 1989, J BIOMED MATER RES-A, V23, P183
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   EVANS SL, 1994, J MATER SCI-MATER M, V5, P507, DOI 10.1007/BF00124881
   EVANS SL, 1994, THESIS U SOUTHAMPTON
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   HING KA, 1997, P 13 EUR C BIOM SEPT, P44
   INADOME T, 1995, J BIOMED MATER RES, V29, P19, DOI 10.1002/jbm.820290104
   Norman TL, 1996, J BIOMECH, V29, P1023, DOI 10.1016/0021-9290(96)00009-7
   THOMPSON JI, 1998, THESIS U SOUTHAMPTON
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   ZHANG X, 1997, LINK PROGRAMME STAGE
NR 13
TC 18
Z9 19
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1999
VL 10
IS 12
BP 863
EP 868
DI 10.1023/A:1008929201918
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 256GC
UT WOS:000083716700033
PM 15347966
DA 2018-10-19
ER

PT J
AU Herzberg, O
   Epple, M
AF Herzberg, O
   Epple, M
TI Thermally induced polymerization in m- and p-halogenomethyl-benzoates to
   poly(hydroxymethylbenzoic acid)
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID CHLOROACETATE; POLYGLYCOLIDE; BIOMATERIAL
AB Heating alkali sails of m- and p-halogenomethylbenzoic acid above ca. 100 degrees C leads to elimination of alkali halide and formation of the corresponding poly(hydroxymethylbenzoic acid). The salt is precipitated as small cubes (ca. 0.3 mu m) in a matrix of the polyester and can be washed out with water to leave a porous material (pore size <1 mu m) The degree of polymerisation of the polymers is between 30 and 100, depending on the benzoate salt and the reaction conditions. The reaction appears to occur at least partially in the solid state.
C1 Univ Hamburg, Inst Inorgan & Appl Chem, D-20146 Hamburg, Germany.
RP Epple, M (reprint author), Univ Hamburg, Inst Inorgan & Appl Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany.
CR ANSCHUTZ R, 1892, CHEM BER, V25, P3506
   BISCHOFF CA, 1893, CHEM BER, V26, P262
   BRINDELL GD, 1976, IND ENG CHEM PROD RD, V15, P83, DOI 10.1021/i360057a017
   Cammenga H.K., 1995, ANGEW CHEM, V34, P1171
   CARAZZOLO G, 1963, MAKROMOLEKUL CHEM, V60, P171
   Ehrenberg H, 1999, ACTA CRYSTALLOGR B, V55, P517, DOI 10.1107/S0108768199003614
   Elizabe L, 1997, J PHYS CHEM B, V101, P8827, DOI 10.1021/jp9712563
   ENKELMANN V, 1994, CHEM MATER, V6, P1337, DOI 10.1021/cm00044a035
   Epple M, 1997, CHEM BER-RECL, V130, P291, DOI 10.1002/cber.19971300224
   Epple M, 1997, J MATER CHEM, V7, P1037, DOI 10.1039/a700275k
   Epple M, 1997, LIEBIGS ANN-RECL, P81
   HASEGAWA M, 1983, CHEM REV, V83, P507, DOI 10.1021/cr00057a001
   JAKABHAZY SZ, 1963, J POLYM SCI C, V4, P805
   Kohlschutter HW, 1932, Z PHYS CHEM B-CHEM E, V16, P284
   PINKUS AG, 1992, J MACROMOL SCI PURE, V29, P1031, DOI 10.1080/10601329208054139
   PINKUS AG, 1993, J MACROMOL SCI R M C, VC33, P259, DOI 10.1080/15321799308021437
   SARGE SM, 1994, THERMOCHIM ACTA, V247, P129, DOI 10.1016/0040-6031(94)80118-5
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   SWEENY W, 1963, J APPL POLYM SCI, V7, P1983
   WEGNER G, 1977, PURE APPL CHEM, V49, P443, DOI 10.1351/pac197749040443
NR 20
TC 5
Z9 5
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD DEC
PY 1999
VL 200
IS 12
BP 2662
EP 2666
DI 10.1002/(SICI)1521-3935(19991201)200:12<2662::AID-MACP2662>3.3.CO;2-8
PG 5
WC Polymer Science
SC Polymer Science
GA 266PZ
UT WOS:000084309500012
DA 2018-10-19
ER

PT J
AU Klages, CP
AF Klages, CP
TI Modification and coating of biomaterial surfaces by glow-discharge
   processes. A review
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
ID CELL-ADHESION; PROTEIN ADSORPTION; PLASMA DEPOSITION; BIOMEDICAL
   APPLICATIONS; POLYMER SURFACES; ACRYLIC-ACID; FILMS; IMMOBILIZATION;
   MECHANISMS; ATTACHMENT
AB Glow-discharge treatment processes offer a range of specific advantages for the modification of biomaterial surfaces: Versatility with respect to the substrates, geometric conformality, adherence and impermeability of coatings and a wide range of compositions available, to name the most important. After a concise introduction into the generation, properties and uses of glow-discharges, the presentation will give an overview of several reports on glow-discharge-based processes applied to biomaterial surfaces. Examples to be covered include the reduction of platelet reactivity of surfaces, enhancement of cell growth and the reduction of protein adsorption.
C1 Fraunhofer Inst Schicht & Oberflachentech, D-38108 Braunschweig, Germany.
RP Klages, CP (reprint author), Fraunhofer Inst Schicht & Oberflachentech, Bienroder Weg 54 E, D-38108 Braunschweig, Germany.
CR AMON M, 1995, P IEEE EMBC CMBEC CA, P107
   Angus J. C., 1986, PLASMA DEPOSITED THI, P89
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BOLZ A, 1992, BIOMED TECH, V37, P244, DOI 10.1515/bmte.1992.37.11.244
   Bolz A., 1991, ARTIF ORGANS, V14, P151
   CAHPMAN B, 1980, GLOW DISCHARGE PROCE
   CLAROTTI G, 1992, BIOMATERIALS, V13, P832, DOI 10.1016/0142-9612(92)90176-O
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Hsiue GH, 1996, J BIOMAT SCI-POLYM E, V7, P839, DOI 10.1163/156856296X00020
   IKADA Y, 1984, POLYM MED, P104
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   KOGELSCHATZ U, 1992, 10TH P INT C GAS DIS, V2, P972
   Lampe F, 1998, BIOMED TECH, V43, P58, DOI 10.1515/bmte.1998.43.3.58
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1989, KOREA SOC MED BIOL E, V10, P43
   LEE JH, 1989, J KOREA SOC MED BIOL, V10, P195
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lens JP, 1997, J BIOMAT SCI-POLYM E, V8, P963, DOI 10.1163/156856297X00128
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MARCHANT RE, 1990, J BIOMED MATER RES, V24, P1521, DOI 10.1002/jbm.820241108
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   MORRA M, 1995, J BIOMED MATER RES, V29, P39, DOI 10.1002/jbm.820290107
   OEHR C, 1992, J BIOMAT SCI-POLYM E, V4, P13
   PANCHALINGAM V, 1993, J BIOMAT SCI-POLYM E, V5, P131
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RATNER BD, 1990, POLYM MAT SCI ENG, V62, P250
   SASS N, 1998, BIOMATERIALS FUNDAME
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P455, DOI 10.3109/10731199309117651
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Thyen R, 1997, SURF COAT TECH, V97, P426, DOI 10.1016/S0257-8972(97)00158-8
   vanDelden CJ, 1997, BIOMATERIALS, V18, P845, DOI 10.1016/S0142-9612(96)00209-8
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   Vasilets VN, 1997, BIOMATERIALS, V18, P1139, DOI 10.1016/S0142-9612(97)00045-8
   Wu WJ, 1997, J BIOMED MATER RES, V35, P93, DOI 10.1002/(SICI)1097-4636(199704)35:1<93::AID-JBM9>3.0.CO;2-H
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
NR 43
TC 13
Z9 14
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 1999
VL 30
IS 12
BP 767
EP 774
DI 10.1002/(SICI)1521-4052(199912)30:12<767::AID-MAWE767>3.0.CO;2-S
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 289XJ
UT WOS:000085647000005
DA 2018-10-19
ER

PT J
AU Feng, Y
   Klee, D
   Hocker, H
AF Feng, Y
   Klee, D
   Hocker, H
TI New biomaterial: triblock copolymers of poly
   [3(S)-isobutyl-morpholine-2,5-dione]-poly(ethylene oxide)
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
ID POLY(ETHYLENE GLYCOL); LACTIDE; POLYDEPSIPEPTIDES; POLYMERIZATION; ACID)
AB ABA-type block copolymers with poly[3(S)-isobutyl-morpholine-2,5-dione](PIBMD, A) and poly(ethylene oxide) ((M) over bar(n) = 6000, PEO, B) blocks, PIBMD-b-PEO-b-PIBMD, were synthesised via ring-opening polymerization of 3(S)-isobutyl-morpholine-2,5-dione in the presence of hydroxytelechelic poly(ethylene oxide) with stannous octoate as a catalyst. These block copolymers may find applications in cell encapsulation and in drug delivery. (M) over bar(n) of the resulting copolymers increases with increasing 3(S)-isobutyl-morpholine-2,5-dione content in the feed at constant molar ratio of monomer (M) to catalyst (C) (M/C = 125). No racemization of the leucine residue takes place during both homopolymerization of IBMD and polymerization of IBMD in the presence of PEO and Sn(Oct)(2). The melting temperature of the PIBMD segments in the block copolymers depends on the length of the PIBMD blocks. The melting temperature of the PEO blocks is lower than that of the homopolymer, and the crystallinity of the PEO block decreases with increasing length of the PIBMD blocks. The PIBMD block crystallizes first upon cooling from the melt. This leads to only imperfect crystallization or no crystallization of the PEO blocks.
C1 Rhein Westfal TH Aachen, Dept Text Chem & Makromol Chem, D-52062 Aachen, Germany.
RP Hocker, H (reprint author), Rhein Westfal TH Aachen, Dept Text Chem & Makromol Chem, Veltmanpl 8, D-52062 Aachen, Germany.
CR ASANO M, 1992, Membrane, V17, P216
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   DU YJ, 1995, MACROMOLECULES, V28, P2124, DOI 10.1021/ma00111a004
   Feng YK, 1999, MACROMOL CHEM PHYSIC, V200, P2276, DOI 10.1002/(SICI)1521-3935(19991001)200:10<2276::AID-MACP2276>3.0.CO;2-N
   Feng YK, 1999, MACROMOL CHEM PHYSIC, V200, P1506, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1506::AID-MACP1506>3.0.CO;2-T
   Feng YK, 1999, MACROMOL RAPID COMM, V20, P88, DOI 10.1002/(SICI)1521-3927(19990201)20:2<88::AID-MARC88>3.0.CO;2-B
   FUNG FN, 1989, Patent No. 322154
   Gan ZH, 1996, J APPL POLYM SCI, V59, P961, DOI 10.1002/(SICI)1097-4628(19960207)59:6<961::AID-APP8>3.0.CO;2-N
   GRIJPMA DW, 1993, POLYMER, V34, P1496, DOI 10.1016/0032-3861(93)90868-B
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   HELDER J, 1985, MAKROMOL CHEM-RAPID, V6, P9
   HELDER J, 1986, MAKROMOL CHEM-RAPID, V7, P193
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P1927
   Jorres V, 1998, MACROMOL CHEM PHYSIC, V199, P835
   Jorres V, 1998, MACROMOL CHEM PHYSIC, V199, P825
   JORRES V, 1997, THESIS RWTH AACHEN G
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   Ouchi T, 1999, MACROMOL CHEM PHYSIC, V200, P436, DOI 10.1002/(SICI)1521-3935(19990201)200:2<436::AID-MACP436>3.0.CO;2-6
   Ouchi T, 1996, MACROMOL CHEM PHYSIC, V197, P1823, DOI 10.1002/macp.1996.021970604
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   STEVELS WM, 1995, MACROMOL CHEM PHYSIC, V196, P3687, DOI 10.1002/macp.1995.021961121
   Wang H, 1998, J POLYM SCI POL CHEM, V36, P695, DOI 10.1002/(SICI)1099-0518(19980415)36:5<695::AID-POLA3>3.0.CO;2-L
   YOSHIDA M, 1990, J BIOMED MATER RES, V24, P1173, DOI 10.1002/jbm.820240904
   125733
NR 26
TC 9
Z9 9
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 1999
VL 30
IS 12
BP 862
EP 868
DI 10.1002/(SICI)1521-4052(199912)30:12<862::AID-MAWE862>3.3.CO;2-Z
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 289XJ
UT WOS:000085647000019
DA 2018-10-19
ER

PT J
AU Angele, P
   Kujat, R
   Nerlich, M
   Yoo, J
   Goldberg, V
   Johnstone, B
AF Angele, P
   Kujat, R
   Nerlich, M
   Yoo, J
   Goldberg, V
   Johnstone, B
TI Engineering of osteochondral tissue with bone marrow mesenchymal
   progenitor: Cells in a derivatized hyaluronan-gelatin composite sponge
SO TISSUE ENGINEERING
LA English
DT Article
ID COLLAGEN; BIOMATERIAL; SCAFFOLDS; GRAFTS; FILMS
AB The aim of this study was to investigate the-potential Of a composite matrix, containing esterified hyaluronic acid and gelatin, to facilitate the-osteochondral differentiation of culture-expanded, bone marrow-derived mesenchymal progenitor cells. The cell loading characteristics and the effects of the matrix on cell differentiation were examined in vitro and in vivo. Empty and cell-loaded composites were cultivated for up to 28 days in a chemically defined medium with or without transforming growth factor-beta 1 (TGF-beta 1). A type II collagen-rich extracellular matrix was produced by cells-loaded:ih the matrix and cultured in the presence of TGF-beta 1. Empty and cell-loaded matrices were:also implanted subcutaneously in immunodeficient mice. Three types of implant,were: used: empty (group I), cell-loaded matrices (Group II), and cell-loaded matrices cultured for 14 days in vitro in defined medium with TGF-beta 1 (group III). No osteochondral differentiation was found in implanted empty matrices; however, the matrix supported osteochondrogenic cell differentiation in the cell-loaded implants. Preculture in vitro in a chondrogenic medium increased the percentage of osteochondral tissue found in the constructs after 3 weeks. These results indicate the potential use of this composite matrix for delivery of bone marrow-derived mesenchymal progenitor cells for the repair of chondral and osseous defects. The results also indicate that this composite matrix is useful for in vitro tissue engineering.
C1 Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA.
   Univ Regensburg, Dept Trauma Surg, D-8400 Regensburg, Germany.
FU NIAMS NIH HHS [AR-37726, AR-44390]
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294
   BALAZS EA, 1991, BLOOD COAGUL FIBRIN, V2, P173, DOI 10.1097/00001721-199102000-00026
   BARRY FP, 1998, 44 ANN M ORS NEW ORL
   BENEDETTI LM, 1990, J CONTROL RELEASE, V13, P33, DOI 10.1016/0168-3659(90)90072-2
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Campoccia D, 1996, BIOMATERIALS, V17, P963, DOI 10.1016/0142-9612(96)84670-9
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   HANSEN AL, 1990, CLIN ORTHOP RELAT R, P286
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253
   NIXON AJ, 1993, AM J VET RES, V54, P349
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P47, DOI 10.1016/S1063-4584(05)80037-8
   SOLCHAGA LA, 1998, 44 ANN M ORS NEW ORL
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P155, DOI 10.1016/0142-9612(90)90148-J
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
NR 23
TC 131
Z9 139
U1 2
U2 12
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 1999
VL 5
IS 6
BP 545
EP 553
DI 10.1089/ten.1999.5.545
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 271LL
UT WOS:000084595000005
PM 10611546
DA 2018-10-19
ER

PT J
AU Toman, PD
   Pieper, F
   Sakai, N
   Karatzas, C
   Platenburg, E
   de Wit, I
   Samuel, C
   Dekker, A
   Daniels, GA
   Berg, RA
   Platenburg, GJ
AF Toman, PD
   Pieper, F
   Sakai, N
   Karatzas, C
   Platenburg, E
   de Wit, I
   Samuel, C
   Dekker, A
   Daniels, GA
   Berg, RA
   Platenburg, GJ
TI Production of recombinant human type I procollagen homotrimer in the
   mammary gland of transgenic mice
SO TRANSGENIC RESEARCH
LA English
DT Article
DE collagen; transgenic mice; expression; mammary gland; biomaterial
ID HIGH-LEVEL EXPRESSION; TISSUE-PLASMINOGEN-ACTIVATOR; HUMAN PROTEIN-C;
   HUMAN SERUM-ALBUMIN; OSTEOGENESIS IMPERFECTA; COLLAGEN GENE; PROLYL
   4-HYDROXYLASE; TRIPLE-HELIX; PHARMACEUTICAL PROTEINS; REQUIRES
   COEXPRESSION
AB The large scale production of recombinant collagen for use in biomaterials requires an efficient expression system capable of processing a large (> 400 Kd) multisubunit protein requiring post-translational modifications. To investigate whether the mammary gland of transgenic animals fulfills these requirements, transgenic mice were generated containing the alpha S1-casein mammary gland-specific promoter operatively linked to 37 Kb of the human alpha 1(I) procollagen structural gene and 3' flanking region. The frequency of transgenic lines established was 12%. High levels of soluble triple helical homotrimeric [(alpha 1)(3)] type I procollagen were detected (up to 8 mg/ml) exclusively in the milk of six out of 9 lines of lactating transgenic mice. The transgene-derived human procollagen chains underwent efficient assembly into a triple helical structure. Although proline or lysine hydroxylation has never been described for any milk protein, procollagen was detected with these post-translational modifications. The procollagen was stable in mil; minimal degradation was observed. These results show that the mammary gland is capable of expressing a large procollagen gene construct, efficiently assembling the individual polypeptide chains into a stable triple helix, and secreting the intact molecule into the milk.
C1 Cohes Technol, Palo Alto, CA 94303 USA.
   Pharming BV, NL-2333 CA Leiden, Netherlands.
RP Toman, PD (reprint author), Cohes Technol, 2500 Faber Pl, Palo Alto, CA 94303 USA.
CR BARASH I, 1994, TRANSGENIC RES, V3, P141, DOI 10.1007/BF01973981
   BARSH GS, 1984, J BIOL CHEM, V259, P4906
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005
   BREM G, 1994, GENE, V149, P351, DOI 10.1016/0378-1119(94)90175-9
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   BUHLER TA, 1990, BIO-TECHNOL, V8, P140, DOI 10.1038/nbt0290-140
   BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X
   CHO M, 1981, ANAT RECORD, V199, P309, DOI 10.1002/ar.1091990302
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CHU ML, 1985, J BIOL CHEM, V260, P2315
   CROUCH E, 1978, BIOCHEM, V17, P3499
   DALESSIO M, 1988, GENE, V67, P110
   DEAK SB, 1985, COLLAGEN REL RES, V5, P305
   DEAK SB, 1983, J BIOL CHEM, V258, P5192
   DICKSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P4524, DOI 10.1073/pnas.81.14.4524
   DREWS R, 1995, P NATL ACAD SCI USA, V92, P10462, DOI 10.1073/pnas.92.23.10462
   DROHAN WN, 1994, TRANSGENIC RES, V3, P355, DOI 10.1007/BF01976767
   EBERT KM, 1994, BIO-TECHNOL, V12, P699, DOI 10.1038/nbt0794-699
   EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835
   Echelard Y, 1996, CURR OPIN BIOTECH, V7, P536, DOI 10.1016/S0958-1669(96)80058-9
   ELSON ML, 1993, DERMATOL CLIN, V11, P361, DOI 10.1016/S0733-8635(18)30274-2
   FEICK RG, 1990, ANAL BIOCHEM, V187, P205, DOI 10.1016/0003-2697(90)90445-F
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Fisher L W, 1989, Connect Tissue Res, V21, P43, DOI 10.3109/03008208909049994
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GHERSI G, 1989, EUR J CELL BIOL, V50, P279
   GORDON K, 1987, BIO-TECHNOL, V5, P1183, DOI 10.1038/nbt1187-1183
   Gorham S. D., 1991, BIOMATERIALS, P55
   GREENBERG NM, 1991, P NATL ACAD SCI USA, V88, P8327, DOI 10.1073/pnas.88.19.8327
   HANSSON L, 1994, J BIOL CHEM, V269, P5358
   HARALSON MA, 1987, LAB INVEST, V57, P513
   HENNIGHAUSEN L, 1990, Protein Expression and Purification, V1, P3, DOI 10.1016/1046-5928(90)90037-Y
   HOLMES DF, 1992, P NATL ACAD SCI USA, V89, P9855, DOI 10.1073/pnas.89.20.9855
   Houdebine LM, 1995, REPROD NUTR DEV, V35, P609, DOI 10.1051/rnd:19950601
   HOUDEBINE LM, 1994, J BIOTECHNOL, V34, P269, DOI 10.1016/0168-1656(94)90062-0
   HULMES DJS, 1983, P NATL ACAD SCI-BIOL, V80, P388, DOI 10.1073/pnas.80.2.388
   JAMES DC, 1995, BIO-TECHNOL, V13, P592, DOI 10.1038/nbt0695-592
   JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1
   JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3
   JOHN CA, 1999, NAT BIOTECHNOL, V17, P385
   KADLER K, 1994, PROTEIN PROFILE, V1, P519
   KADLER KE, 1987, J BIOL CHEM, V262, P15696
   KAO WWY, 1979, J BIOL CHEM, V254, P2234
   KAY EP, 1986, INVEST OPHTH VIS SCI, V27, P891
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   KIVIRIKKO KI, 1990, ANN NY ACAD SCI, V580, P132, DOI 10.1111/j.1749-6632.1990.tb17925.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   LEHEUP BP, 1989, LAB INVEST, V60, P791
   Lubon H, 1996, TRANSFUS MED REV, V10, P131, DOI 10.1016/S0887-7963(96)80089-7
   Massoud M, 1996, REPROD NUTR DEV, V36, P555, DOI 10.1051/rnd:19960511
   MEADE H, 1990, BIO-TECHNOL, V8, P443, DOI 10.1038/nbt0590-443
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   MINAFRA S, 1989, BRIT J CANCER, V60, P185, DOI 10.1038/bjc.1989.248
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MUNKSGAARD EC, 1978, EUR J BIOCHEM, V82, P609, DOI 10.1111/j.1432-1033.1978.tb12057.x
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   NARAYANAN AS, 1976, J BIOL CHEM, V251, P5464
   NICHOLLS AC, 1979, LANCET, V1, P1193
   Niemann H, 1996, J ANIM BREED GENET, V113, P437, DOI 10.1111/j.1439-0388.1996.tb00634.x
   PALEYANDA RK, 1994, TRANSGENIC RES, V3, P335, DOI 10.1007/BF01976765
   Paleyanda RK, 1997, NAT BIOTECHNOL, V15, P971, DOI 10.1038/nbt1097-971
   PARKER MI, 1989, J BIOL CHEM, V264, P7147
   PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941
   PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874
   PLATENBURG GJ, 1994, TRANSGENIC RES, V3, P99, DOI 10.1007/BF01974087
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prunkard D, 1996, NAT BIOTECHNOL, V14, P867, DOI 10.1038/nbt0796-867
   ROKKONES E, 1995, J CELL BIOCHEM, V59, P168, DOI 10.1002/jcb.240590206
   RUPARD JH, 1988, AM J PATHOL, V133, P316
   SANDELL LJ, 1990, EXTRACELLULAR MATRIX, P1
   SASKI T, 1987, ARCH DERMATOL, V123, P76
   Shani Moshe, 1992, Transgenic Research, V1, P195, DOI 10.1007/BF02524750
   Stromqvist M, 1996, TRANSGENIC RES, V5, P475
   Subramanian A, 1996, ANN NY ACAD SCI, V782, P87, DOI 10.1111/j.1749-6632.1996.tb40550.x
   THEPOT D, 1995, MOL REPROD DEV, V42, P261, DOI 10.1002/mrd.1080420302
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   TROMP G, 1988, BIOCHEM J, V253, P919, DOI 10.1042/bj2530919
   UITTO J, 1979, ARCH BIOCHEM BIOPHYS, V192, P371, DOI 10.1016/0003-9861(79)90105-X
   UusiOukari M, 1997, TRANSGENIC RES, V6, P75, DOI 10.1023/A:1018461201385
   VANDERREST M, 1993, CURR OPIN STRUC BIOL, V3, P430, DOI 10.1016/S0959-440X(05)80117-4
   VELANDER WH, 1992, P NATL ACAD SCI USA, V89, P12003, DOI 10.1073/pnas.89.24.12003
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201
   WALL RJ, 1991, P NATL ACAD SCI USA, V88, P1696, DOI 10.1073/pnas.88.5.1696
   WALLACE DG, 1983, BIOPOLYMERS, V25, P1793
   WEI YL, 1995, TRANSGENIC RES, V4, P232, DOI 10.1007/BF01969116
   WEN JY, 1995, MOL REPROD DEV, V41, P399, DOI 10.1002/mrd.1080410402
   WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830
   Yarus S, 1997, TRANSGENIC RES, V6, P51, DOI 10.1023/A:1018405116406
NR 95
TC 38
Z9 47
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0962-8819
J9 TRANSGENIC RES
JI Transgenic Res.
PD DEC
PY 1999
VL 8
IS 6
BP 415
EP 427
DI 10.1023/A:1008959924856
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 288TG
UT WOS:000085580100002
PM 10767986
DA 2018-10-19
ER

PT J
AU Burrows, LL
   Khoury, AE
AF Burrows, LL
   Khoury, AE
TI Issues surrounding the prevention and management of device-related
   infections
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
ID CATHETER-ASSOCIATED BACTERIURIA; PSEUDOMONAS-AERUGINOSA BIOFILMS;
   INDWELLING URETHRAL CATHETERS; URINARY-TRACT INFECTIONS;
   PROTEUS-MIRABILIS BIOFILMS; DAILY MEATAL CARE; IN-VITRO; RISK-FACTORS;
   SILVER; ENCRUSTATION
AB The use of biomaterial devices in all aspects of modern medicine has increased exponentially in the past three decades. Device-related infections constitute one of the main impediments to their long-term use. We discuss the pathogenesis, prevention. and management of catheter-associated urinary tract infection (CAUTI). The recent innovations in biomaterial design and surface coatings intended to prevent colonization of the device surface are presented. Despite these significant advances, the ability to protect these surfaces beyond the short term presents a continued challenge to investigators.
C1 Univ Toronto, Hosp Sick Children, Dept Surg, Div Urol, Toronto, ON M5G 1X8, Canada.
   Toronto Gen Hosp, Ctr Infect & Biomat Res, Toronto, ON, Canada.
RP Khoury, AE (reprint author), Univ Toronto, Hosp Sick Children, Dept Surg, Div Urol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
RI Burrows, Lori/D-1142-2010
OI Burrows, Lori/0000-0003-0838-5040
CR ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647
   ARONSON M, 1988, INFECT IMMUN, V56, P1615
   BURKE JP, 1981, AM J MED, V70, P655, DOI 10.1016/0002-9343(81)90591-X
   CLASSEN DC, 1991, INFECT CONT HOSP EP, V12, P157
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1993, INT J ARTIF ORGANS, V16, P765
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   GABRIEL MM, 1995, CURR MICROBIOL, V30, P17, DOI 10.1007/BF00294518
   Gabriel MM, 1996, CURR MICROBIOL, V33, P1, DOI 10.1007/s002849900064
   Goto T, 1999, UROLOGY, V53, P1058, DOI 10.1016/S0090-4295(98)00649-9
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   HUTH TS, 1992, J INFECT DIS, V165, P14, DOI 10.1093/infdis/165.1.14
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   Johnson LL, 1998, J BIOMAT SCI-POLYM E, V9, P1177, DOI 10.1163/156856298X00712
   Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013
   KING JB, 1992, UROL RES, V20, P403, DOI 10.1007/BF00294496
   LARSEN RA, 1986, INFECT CONT HOSP EP, V7, P212, DOI 10.1017/S019594170008396X
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   MAIZELS M, 1980, J UROLOGY, V123, P841, DOI 10.1016/S0022-5347(17)56156-X
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   Morris NS, 1997, BRIT J UROL, V80, P58, DOI 10.1046/j.1464-410X.1997.00185.x
   Morris NS, 1998, UROL RES, V26, P275, DOI 10.1007/s002400050057
   MUNCIE HL, 1989, ARCH INTERN MED, V149, P441, DOI 10.1001/archinte.149.2.441
   Nakano Y, 1999, J UROLOGY, V162, P243, DOI 10.1097/00005392-199907000-00075
   Nickel J C, 1991, Can J Infect Control, V6, P38
   NICKEL JC, 1985, UROLOGY, V26, P369, DOI 10.1016/0090-4295(85)90185-2
   OLSON ME, 1989, J INFECT DIS, V159, P1065, DOI 10.1093/infdis/159.6.1065
   POURDJABBAR F, 1979, MICROBIOS, V26, P73
   PUGACH JL, 1999, IN PRESS J UROL
   Qian Z, 1997, ANN BIOMED ENG, V25, P69, DOI 10.1007/BF02738539
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   Saint S, 1999, ARCH INTERN MED, V159, P800, DOI 10.1001/archinte.159.8.800
   SCHAEFFER AJ, 1986, UROL CLIN N AM, V13, P735
   SCHAEFFER AJ, 1983, J UROLOGY, V130, P1096, DOI 10.1016/S0022-5347(17)51701-2
   Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587
   SOBOH F, 1995, ANTIMICROB AGENTS CH, V39, P1281, DOI 10.1128/AAC.39.6.1281
   Stamm WE, 1991, AM J MED S3B, V91, P65
   Stewart PS, 1999, ANTIMICROB AGENTS CH, V43, P292, DOI 10.1128/AAC.43.2.292
   Stickler D, 1999, EUR J CLIN MICROBIOL, V18, P206, DOI 10.1007/s100960050260
   Stickler DJ, 1998, APPL ENVIRON MICROB, V64, P3486
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   Tambyah PA, 1999, MAYO CLIN PROC, V74, P131, DOI 10.4065/74.2.131
   Tanaka G, 1999, CHEMOTHERAPY, V45, P28, DOI 10.1159/000007162
   TRILLA A, 1991, INFECT CONT HOSP EP, V12, P150
   WARREN JW, 1994, INFECT CONT HOSP EP, V15, P557
   Warren JW, 1997, INFECT DIS CLIN N AM, V11, P609, DOI 10.1016/S0891-5520(05)70376-7
   Wellman N, 1996, ANTIMICROB AGENTS CH, V40, P2012, DOI 10.1128/AAC.40.9.2012
   Whalen RL, 1997, ASAIO J, V43, pM842
   WOO GL, 1999, P 25 ANN M SOC BIOM, P320
NR 56
TC 5
Z9 6
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD DEC
PY 1999
VL 17
IS 6
BP 402
EP 409
DI 10.1007/s003450050166
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 273HV
UT WOS:000084702600011
PM 10654371
DA 2018-10-19
ER

PT J
AU Park, JC
   Lee, DH
   Suh, H
AF Park, JC
   Lee, DH
   Suh, H
TI Preclinical evaluation of prototype products
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE preclinical evaluation; medical device; biomaterial; safety;
   biocompatibility
ID GENE-TOX PROGRAM; BIOMATERIALS
AB Preclinical evaluation of medical devices (prototype produces) offers the opportunity co investigate and study the intended use of device materials. Preclinical evaluation programs are designed to determine the efficacy, safety, and biocompatibility of biomaterials, prostheses, and medical devices. The purpose of safety testing is to determine ii a material presents potential harm to the human; it evaluates the interaction of the material with the in vivo environment and determines the effect of the host on the implant. Preclinical evaluation is the determination of the ability of the prototype product to perform with appropriate host response in a specific application, considered from the perspective of human clinical use. Therefore, preclinical data should include materials science and engineering, biology, biochemistry, medicine, host reactions and their evaluation, the resting of biomaterials, and the degradation of materials in a biological environment.
C1 Yonsei Univ, Dept Med Engn, Coll Med, Seoul 120752, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Dept Med Engn, Coll Med, CPO Box 8044, Seoul 120752, South Korea.
CR Ames B. N., 1975, MUTAT RES, V31, P237
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   *ASTM, 1993, F756 ASTM
   *ASTM, 1991, F619 ASTM
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BICK PH, 1985, IMMUNOTOXICOLOGY IMM, P1
   BUDINSKI K, 1995, ENG MAT PROPERTIES S
   CLIVE D, 1975, MUTAT RES, V31, P17, DOI 10.1016/0165-1161(75)90059-X
   Cooper J.F., 1975, B PARENT DRUG ASSOC, V3, P122
   ECANOW B, 1977, BRIT J CANCER, V36, P397, DOI 10.1038/bjc.1977.207
   FARRAR DB, 1988, FUND APPL TOXICOL, V11, P652, DOI 10.1016/0272-0590(88)90128-5
   Hajian G, 1983, Toxicol Pathol, V11, P83
   HEIDELBERGER C, 1983, MUTAT RES, V114, P283, DOI 10.1016/0165-1110(83)90036-2
   HSIE AW, 1979, STRATEGIES SHORT TER, P39
   JOHN VB, 1983, INTRO ENG MAT
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   LEININGER RI, 1964, T AM SOC ART INT ORG, V10, P320
   LEVINSON IJ, 1971, STAT STRENGTH MAT
   LUSTER MI, 1992, TOXICOL LETT, V64, P717
   MITCHELL AD, 1983, MUTAT RES, V123, P363, DOI 10.1016/0165-1110(83)90029-5
   PIZZOFERRATO A, 1988, BIOMATERIALS, V9, P314, DOI 10.1016/0142-9612(88)90025-7
   SHAYNE CG, 1997, SAFETY EVALUATION ME, P97
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   *US PHARM, 1990, US PHARM CONV, P1515
   Weary M., 1977, B PARENT DRUG ASSOC, V31, P1127
NR 25
TC 4
Z9 5
U1 0
U2 1
PU YONSEI UNIV COLLEGE MEDICINE
PI SEOUL
PA C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL
   120-752, SOUTH KOREA
SN 0513-5796
J9 YONSEI MED J
JI Yonsei Med. J.
PD DEC
PY 1999
VL 40
IS 6
BP 530
EP 535
DI 10.3349/ymj.1999.40.6.530
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 276RC
UT WOS:000084890300002
PM 10661028
OA Bronze
DA 2018-10-19
ER

PT J
AU Hincke, MT
   Gautron, J
   Tsang, CPW
   McKee, MD
   Nys, Y
AF Hincke, MT
   Gautron, J
   Tsang, CPW
   McKee, MD
   Nys, Y
TI Molecular cloning and ultrastructural localization of the core protein
   of an eggshell matrix proteoglycan, ovocleidin-116
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CHONDROITIN SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; MINERALIZED
   TISSUES; SOLUBLE MATRIX; HENS; BIOMINERALIZATION; PEPTIDES; CLEAVAGE;
   MODEL; CELLS
AB The role of avian eggshell matrix proteins in shell formation is poorly understood. This calcitic biomaterial forms in a uterine fluid where the protein composition varies during the initial, calcification, and terminal phases of eggshell deposition, A specific antibody was raised to a 116-kDa protein, which is most abundant in uterine fluid during active eggshell calcification. This antiserum was used to expression screen a bacteriophage cDNA library prepared using mRNA extracted from pooled uterine tissue harvested at the midpoint of eggshell calcification. Plasmids containing inserts of differing 5'-lengths were isolated with a maximum cDNA sequence of 2.4 kilobases, Northern blotting and reverse transcriptase-polymerase chain reaction demonstrated that the 2,35-kilobase message was expressed in a uterine-specific manner,. The hypothetical translational product from the open reading frame corresponded to a novel 80-kDa protein, which we have named ovocleidin-116, After removal of the predicted signal peptide, its N-terminal sequence corresponded almost exactly with that determined from direct microsequencing of the 116-kDa uterine protein (this work) and with that previously determined for the core protein of a 120-kDa egg shell dermatan sulfate proteoglycan (Corrino, D. A., Rodriguez, J, P,, and Caplan, A. I. (1997) Connect. Tissue Res. 36, 175-193), Ultrastructural colloidal gold immunocytochemistry of ovocleidin-116 demonstrated its presence in the organic matrix, in small vesicles found throughout the mineralized palisade layer, and the calcium reserve assembly of the mammillary layer. Ovocleidin-116 thus is a candidate molecule for the regulation of calcite growth during eggshell calcification.
C1 Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   INRA, Rech Avicoles Stn, F-37380 Nouzilly, France.
   McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
   Agr Canada, Ctr Food & Anim Res, Cent Expt Farm, Ottawa, ON K1A 0C6, Canada.
RP Hincke, MT (reprint author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.
EM mhincke@uottawa.ca
RI Gautron, Joel/A-1753-2017
OI Gautron, Joel/0000-0001-7800-0578
CR ADAIR WS, 1990, P NATL ACAD SCI USA, V87, P7355, DOI 10.1073/pnas.87.19.7355
   Addadi L., 1989, Connective Tissue Research, V21, P127, DOI 10.3109/03008208909050003
   ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732
   ARIAS JL, 1992, ARCH BIOCHEM BIOPHYS, V298, P293, DOI 10.1016/0003-9861(92)90126-H
   ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brinkmann T, 1997, J BIOL CHEM, V272, P11171
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CORRINO DA, 1997, CONNECT TISSUE RES, V36, P175
   Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8
   Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x
   FUREDIMILHOFER H, 1994, CONNECT TISSUE RES, V30, P251, DOI 10.3109/03008209409015041
   Gautron J, 1996, BRIT POULTRY SCI, V37, P853, DOI 10.1080/00071669608417914
   Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220
   GAUTRON J, 1999, IN PRESS P 6 INT C C
   HAMES BD, 1981, GEL ELECTROPHORESIS
   HAMILTON RMG, 1986, FOOD MICROSTRUCT, V5, P99
   Hincke M. T., 1999, Egg nutrition and biotechnology., P447
   HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593
   Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814
   HINCKE MT, 1992, BRIT POULTRY SCI, V33, P505, DOI NO_DOI
   HUNTER GK, 1992, MATRIX, V12, P362, DOI 10.1016/S0934-8832(11)80032-6
   HUNTER GK, 1991, CLIN ORTHOP RELAT R, P256
   KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229
   KRUEGER RC, 1990, J BIOL CHEM, V265, P12075
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   NYS Y, 1999, IN PRESS POULT AVIAN
   OLDBERG A, 1987, BIOCHEM J, V243, P255, DOI 10.1042/bj2430255
   Panheleux M, 1999, BRIT POULTRY SCI, V40, P240, DOI 10.1080/00071669987665
   PARSONS AH, 1982, POULTRY SCI, V61, P2013, DOI 10.3382/ps.0612013
   PINES M, 1996, MATRIX BIOL, V14, P765
   Sambrook J, 1989, MOL CLONING LAB MANU
   Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101
   TERMINE JD, 1984, METHODS CALCIFIED TI, P547
   Watanabe H, 1998, J BIOCHEM-TOKYO, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166
   WU TM, 1992, INT CONGR SER, V1002, P133
   WU TM, 1994, MATRIX BIOL, V14, P507
   ZHANG LJ, 1994, J BIOL CHEM, V269, P19295
NR 43
TC 104
Z9 110
U1 2
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 12
PY 1999
VL 274
IS 46
BP 32915
EP 32923
DI 10.1074/jbc.274.46.32915
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 254QE
UT WOS:000083623000057
PM 10551857
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhou, CR
   Yi, ZJ
AF Zhou, CR
   Yi, ZJ
TI Blood-compatibility of polyurethane/liquid crystal composite membranes
SO BIOMATERIALS
LA English
DT Article
DE polyurethane; liquid crystal; composite membrane; haemocompatibility
AB Polyurethane/liquid crystal composite membranes were first suggested to be used as biomaterials. In our work, three series of polyurethane/liquid crystal composite membranes based on three different kinds of liquid crystal compounds [N-(-4-methyoxybenzylidene)-4'-heptylaniline, 4-pentyl-4'-nitrile-biphenyl and cholesteryl oleyl carbonate] were prepared by casting on glass plates from a tetrahydrofuran (THF) solution of polymer and liquid crystal at room temperature. In our opinion, the formation of liquid crystal phase on the composite membrane surface is the basic requirement for getting better biomaterial. The result of this work is in accordance with our opinion. The effect of liquid crystal content on the formation of liquid crystal phase was identified by the observation of optical polarization microscopy (OPM). The results showed that the content of liquid crystal in composite membrane must be more than 30% (wt) in order to form liquid crystal phase on the composite membrane surface. The blood-compatibility of the composite membranes was assessed from SEM observation of the platelet's adhesion to membrane's surface, blood clotting time and haemolysis ratio. The observation of platelet's adhesion showed that the platelets gathered together on the pure polyurethane films, but the amount of platelets which were adherent on the surface covered by the liquid crystal phase was fewer than that of pure polyurethane film when platelet-rich plasma was allowed to be in contact with the membranes for Ih at room temperature. The determination of blood clotting time and haemolysis ratio showed that these polyurethane/liquid crystal composite membranes, in which the content of liquid crystal was more than 30% (wt), appear to be beneficial in improving the blood compatibility and reducing the thrombogenicity. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Jinan Univ, Inst Biomed Engn, Guangzhou 510632, Peoples R China.
RP Zhou, CR (reprint author), Jinan Univ, Inst Biomed Engn, Guangzhou 510632, Peoples R China.
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   Amundson K, 1996, MATER RES SOC SYMP P, V425, P269, DOI 10.1557/PROC-425-269
   Bouteiller L, 1996, LIQ CRYST, V21, P157, DOI 10.1080/02678299608032820
   CHAIKOF EL, 1996, CHEMTECH, P17
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   Lelah MD, 1996, POLYURETHANE MED
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   *MIN PUBL HLTH PR, 1994, EV STAN BIOL MAT PRO
   TU X, 1995, J FUNCTIONAL POLYM, V8, P209
   WALSH PN, 1981, HEMOSTASIS THROMBOSI, P404
   XIE Y, 1995, PROGR NATURAL SCI, V5, P63
   ZHOU C, 1997, POLYM MAT SCI ENG S, V13, P110
   Zhou CR, 1998, EUR POLYM J, V34, P1663, DOI 10.1016/S0014-3057(98)00017-2
   Zhou JH, 1998, WORLD J GASTROENTERO, V4, P238, DOI 10.3748/wjg.v4.i3.238
NR 14
TC 67
Z9 86
U1 3
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 22
BP 2093
EP 2099
DI 10.1016/S0142-9612(99)00080-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247UH
UT WOS:000083238000001
PM 10555076
DA 2018-10-19
ER

PT J
AU Lamghari, M
   Huet, H
   Laurent, A
   Berland, S
   Lopez, E
AF Lamghari, M
   Huet, H
   Laurent, A
   Berland, S
   Lopez, E
TI A model for evaluating injectable bone replacements in the vertebrae of
   sheep: radiological and histological study
SO BIOMATERIALS
LA English
DT Article
DE experimental bone defect; trabecular bone; lumbar vertebrae;
   interventional radiology; percutaneous injection; biomaterial
ID OSTEOBLASTS MAINTAINED INVITRO; NACRE; POLYMETHYLMETHACRYLATE;
   VERTEBROPLASTY; CERAMICS
AB We developed a bone-defect model in the vertebrae of sheep. Forty four cavities were prepared in the upper lumbar vertebrae of 11 sheep using a biopsy trocar via a posterior-lateral extracanal percutaneous route and the location was monitored by radiology with a brilliance amplifier. The cavities were 3 mm in diameter. The histological study was performed on 15 cavities which were left empty to give reference data for the model. Histological and histomorphometry results showed that 67% of the surface area of the empty cavities was still empty 3 months after their preparation. Thus, the natural regenerative capacity of vertebral trabecular bone is limited. We performed preliminary percutaneous injections of polymethylmethacrylate (PMMA) and nacre powder to assess whether this bone-defect model would be suitable for further studies on bone repair. Cavities were successfully filled with nacre powder (21 cavities) or PMMA (8 cavities) while monitoring the process by interventional radiology. The experimental sheep vertebrae defect system is reproducible and appears to be a suitable model for testing injectable biomaterials for treating bone loss. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Museum Natl Hist Nat, URA CNRS 90, Lab Physiol Gen & Comparee, F-75231 Paris 05, France.
   CHU Caen, Serv Neuroradiol, F-14000 Caen, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Interventionnelle, F-75475 Paris, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, URA CNRS 90, Lab Physiol Gen & Comparee, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR ANDERS H, 1989, CLIN ORTHOP RELAT R, V249, P265
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   CERASI P, 1997, ITBM, V16, P15
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   Chiras J, 1997, J NEURORADIOLOGY, V24, P45
   CHOW LC, 1997, INNOV TECH BIOL MED, V18, P11
   Cotten A, 1998, RADIOGRAPHICS, V18, P311, DOI 10.1148/radiographics.18.2.9536480
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEBUSSCHEDEPRIE.C, 1991, NEURORADIOLOGY, V33, P149
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   DERAMOND H, 1990, RADIOLOGY, V117, P352
   DERAMOND H, 1989, RACHIS, V1, P143
   GOBIN P, 1989, J NEURORADIOLOGY, V16, P203
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   KAEMMERLEN P, 1989, Journal de Radiologie (Paris), V70, P557
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1994, RECHERCHE, V262, P208
   Murai K, 1996, J BIOMED MATER RES, V30, P523, DOI 10.1002/(SICI)1097-4636(199604)30:4<523::AID-JBM11>3.3.CO;2-6
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   WEILAND AJ, 1981, J BONE JOINT SURG AM, V63, P166, DOI 10.2106/00004623-198163010-00025
   Weill A, 1996, RADIOLOGY, V199, P241, DOI 10.1148/radiology.199.1.8633152
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 25
TC 18
Z9 23
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 22
BP 2107
EP 2114
DI 10.1016/S0142-9612(99)00113-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247UH
UT WOS:000083238000003
PM 10555078
DA 2018-10-19
ER

PT J
AU Pereira, MC
   Pereira, ML
   Sousa, JP
AF Pereira, MC
   Pereira, ML
   Sousa, JP
TI Histological effects of iron accumulation on mice liver and spleen after
   administration of a metallic solution
SO BIOMATERIALS
LA English
DT Article
DE iron; biomaterial; liver; spleen; histology; adsorptive stripping
   voltammetry
ID MICROELECTRODES; KIDNEY; ION
AB Special attention has been focused on the toxicity of some metallic species released from implanted materials, which accumulate in vital organs over long periods of time. A set of experiments with mice was designed to investigate the individual effects caused by iron in the liver and spleen. Histological features of these organs were evaluated and slight morphological changes were observed during the treatment time suggesting a negative correlation with the duration of the iron treatment. In addition, to associate the histological changes in the organs with iron accumulation an electrochemical method, adsorptive stripping voltammetry, was chosen to quantify the iron levels in these mentioned organs. The accuracy of the proposed method was checked by atomic absorption spectrometry. Both organs showed elevated concentrations of iron, nearly twofold, 7 days after iron administration compared to control organs. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Porto, Fac Engn, Dept Engn Quim, P-4050123 Porto, Portugal.
   Univ Aveiro, Dept Biol, P-3810 Aveiro, Portugal.
   Inst Biomed Engn, INEB, P-4050 Porto, Portugal.
RP Pereira, MC (reprint author), Univ Porto, Fac Engn, Dept Engn Quim, Rua dos Bragos, P-4050123 Porto, Portugal.
RI Pereira, Maria/S-6624-2016
OI Pereira, Maria/0000-0001-8505-3432; Sousa, Joao/0000-0002-8269-9390;
   Pereira, Maria de Lourdes/0000-0001-6703-7869
CR BLACK J, 1981, BIOL PERFORMANCE MAT, V8, P158
   BRITTON SR, 1994, PROGR IRON RES, P239
   CRICHTON RR, 1992, IRON HUMAN DIS, P23
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   GOSZTONYI E, 1983, IRON METABOLISM, P339
   LUX F, 1974, J RADIOANAL CHEM, V19, P289, DOI 10.1007/BF02518564
   LYNCH SR, 1974, IRON BIOCH MED, P563
   Pereira M. L., 1995, Biomedical Letters, V52, P235
   Pereira MC, 1997, ELECTROANAL, V9, P150, DOI 10.1002/elan.1140090212
   Pereira MC, 1998, J TRACE ELEM MED BIO, V12, P50, DOI 10.1016/S0946-672X(98)80021-7
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   POHLER OEM, 1983, BIOMATERIALS RECONST, P196
   RHEINOLD JB, 1975, CLIN CHEM, V21, P476
   Smith G. K., 1983, BIOMATERIALS RECONST, P229
   SMITH GK, 1985, CORROSION DEGRADATIO, P223
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, P77
   TRAISNEL M, 1990, Clinical Materials, V5, P309, DOI 10.1016/0267-6605(90)90030-Y
   VAN DEN BERG CMG, 1984, J ELECTROANAL CHEM, V177, P269, DOI 10.1016/0022-0728(84)80228-4
   WEINBERG ED, 1992, IRON HUMAN DIS, P179
   WINTER GD, 1976, BIOCOMPATIBILITY IMP, P28
   Winter GD, 1974, J BIOMED MATER RES S, V5, P11
NR 22
TC 21
Z9 21
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 22
BP 2193
EP 2198
DI 10.1016/S0142-9612(99)00124-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247UH
UT WOS:000083238000013
PM 10555088
DA 2018-10-19
ER

PT J
AU Kocak, I
   Unlu, C
   Akcan, Y
   Yakin, K
AF Kocak, I
   Unlu, C
   Akcan, Y
   Yakin, K
TI Reduction of adhesion formation with cross-linked hyaluronic acid after
   peritoneal surgery in rats
SO FERTILITY AND STERILITY
LA English
DT Article
DE adhesion; animal; cross-linked hyaluronan
ID POSTOPERATIVE ADHESIONS; PREVENTION; MODELS
AB Objective: To examine the effectiveness of a cross-linked hyaluronan solution (auto-cross-linked polysaccharide [ACP] gel) for the prevention of postsurgical adhesions.
   Design: A randomized blinded study using a rat model of laparotomy.
   Setting: Surgical Research Laboratory in a university medical school.
   Animal(s): Sixty-seven sexually mature rats.
   Intervention(s): Standardized surgical trauma was induced in the rat uterine horn to induce adhesion formation. After trauma, group-1 animals (n = 23) received no treatment, group 2 (n = 21) received noncross-linked hyaluronic acid (HA), and group 3 (n = 23) received cross-linked HA applied on the lesion.
   Main Outcome Measure(s): Six weeks after laparotomy, repeat laparotomy was performed and the adhesions were scored according to Blauer's scoring system.
   Result(s): Overall, 84% of the untreated animals and 65% of the animals treated with noncross-linked KA presented with severe adhesions. The mean (+/-SEM) increase in the adhesion score was 2.46 +/- 0.23 in the untreated group, 2.23 +/- 0.29 in the group receiving noncross-linked HA, and 1.27 +/- 0.12 in the ACP gel group.
   Conclusion(s): ACP gel holds promise as a novel resorbable biomaterial for the reduction of postoperative adhesions after laparotomy. (Fertil Steril(R) 1999;72:873-8. (C)1999 by American Society for Reproductive Medicine.).
C1 Ondokuz Mayis Univ, Sch Med, Dept Obstet & Gynecol, Samsun, Turkey.
   Ankara Univ, Sch Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey.
   Samsun Hosp, Samsun, Turkey.
RP Kocak, I (reprint author), Adalet Mah 100 yd,Bul CaykaraApt 242, Samsun, Turkey.
CR BALAZS EA, 1989, P NISSH INT C CELL U, P233
   BENEDETTI L, 1994, NOVEL BIOMATERIALS B, P20
   Burns JW, 1996, FERTIL STERIL, V66, P814, DOI 10.1016/S0015-0282(16)58642-7
   DEIACO P, 1994, FERTIL STERIL, V62, P400
   DIAMOND MP, 1990, TREATMENT POSTSURGIC, P27
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   DOUGLAS BJ, 1997, FERTIL STERIL, V68, P37
   GRAINGER DA, 1991, J GYNECOL SURG, V7, P97, DOI 10.1089/gyn.1991.7.97
   HAGBERG L, 1992, J HAND SURG-AM, V17A, P935, DOI 10.1016/0363-5023(92)90474-4
   HOLTZ G, 1985, FERTIL STERIL, V44, P174
   KING SR, 1991, SURGERY, V109, P76
   LUCIANO AA, 1983, AM J OBSTET GYNECOL, V146, P88, DOI 10.1016/0002-9378(83)90932-8
   Mensitieri M, 1996, J MATER SCI-MATER M, V7, P695, DOI 10.1007/BF00123409
   MILLIGAN DW, 1974, BRIT J SURG, V61, P274, DOI 10.1002/bjs.1800610406
   PIER AD, 1998, FERTIL STERIL, V69, P318
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SRAVELOS HG, 1996, J REPROD MED, V41, P42
   THOMPSON JN, 1989, BRIT J SURG, V76, P382, DOI 10.1002/bjs.1800760422
   URMAN B, 1991, FERTIL STERIL, V56, P563
   Ustun C, 1998, GYNECOL OBSTET INVES, V46, P202, DOI 10.1159/000010034
   WRIGHT JA, 1995, FERTIL STERIL, V63, P1094, DOI 10.1016/S0015-0282(16)57554-2
NR 22
TC 32
Z9 32
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD NOV
PY 1999
VL 72
IS 5
BP 873
EP 878
DI 10.1016/S0015-0282(99)00368-4
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 251QH
UT WOS:000083456000018
PM 10560992
DA 2018-10-19
ER

PT J
AU Piattelli, M
   Favero, GA
   Scarano, A
   Orsini, G
   Piattelli, A
AF Piattelli, M
   Favero, GA
   Scarano, A
   Orsini, G
   Piattelli, A
TI Bone reactions to anorganic bovine bone (Bio-Oss) used in sinus
   augmentation procedures: A histologic long-term report of 20 cases in
   humans
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE anorganic bovine bone; biomaterials; sinus augmentation
ID DIFFERENT GRAFTING MATERIALS; MAXILLARY SINUS; DENTAL IMPLANTS;
   AUTOGENOUS BONE; FLOOR; DEFECTS; REGENERATION; HYDROXYAPATITE;
   BIO-OSS(R); MEMBRANES
AB Many materials are used for sinus augmentation procedures. Anorganic bovine bone (Bio-Oss) has been reported to be osteoconductive, and no inflammatory responses have been observed with the use of this biomaterial. One of the main questions pertaining to Bio-Oss concerns its biodegradation and substitution by host bone. Some investigators have observed rapid replacement by host bone, while other researchers observed slow resorptive activity or no resorption at all. The aim of the present study was to conduct a long-term histologic analysis of retrieved specimens in humans where Bio-Oss was used in sinus augmentation procedures. Specimens were retrieved from 20 patients after varying peri ods from 6 months to 4 years and were processed to obtain thin ground sections. Bio-Oss particles were surrounded for the most part by mature, compact bone. In some Haversian canals it was possible to observe small capillaries, mesenchymal cells, and osteoblasts in conjunction with new bone. No gaps were present at the interface between the Bio-Oss particles and newly formed bone, in specimens retrieved after 18 months and 4 years, it was also possible to observe the presence of osteoclasts in the process of resorbing the Bio-Oss particles and neighboring newly formed bone. Bio-Oss appears to be highly biocompatible and osteoconductive, is slowly resorbed in humans, and can be used with success as a bone substitute in maxillary sinus augmentation procedures.
C1 Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   Univ Padua, Sch Dent, Padua, Italy.
   UCL Eastman Dent Inst Oral Hlth Care Sci, London, England.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Orsini, Giovanna/B-5470-2016; Scarano, Antonio/F-6961-2017
OI Orsini, Giovanna/0000-0002-2641-0695; Scarano,
   Antonio/0000-0003-1374-6146; favero, gian antonio/0000-0002-9126-2393
CR Avera SP, 1997, INT J ORAL MAX IMPL, V12, P88
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CLERGEAU LP, 1996, J PERIODONTOL, V67, P1140
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P52
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   HISLOP WS, 1993, BRIT J ORAL MAX SURG, V31, P149, DOI 10.1016/0266-4356(93)90113-B
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   JENSEN J, 1990, J ORAL MAXIL SURG, V48, P27, DOI 10.1016/0278-2391(90)90175-2
   KENT JN, 1989, J ORAL MAXIL SURG, V47, P238, DOI 10.1016/0278-2391(89)90225-5
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Lorenzetti M, 1998, INT J ORAL MAX IMPL, V13, P69
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   MOY PK, 1993, J ORAL MAXIL SURG, V51, P857, DOI 10.1016/S0278-2391(10)80103-X
   PIATTELLI A, 1995, BIOMATERIALS, V16, P1333, DOI 10.1016/0142-9612(95)91049-5
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Pinholt EM, 1991, SCAND J DENT RES, V99, P1
   RAGHOEBAR GM, 1993, J ORAL MAXIL SURG, V51, P1198, DOI 10.1016/S0278-2391(10)80288-5
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   Small S A, 1993, Int J Oral Maxillofac Implants, V8, P523
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   SMILER D G, 1987, Journal of Oral Implantology, V13, P239
   Storgard-Jensen S, 1996, INT J ORAL MAXILLOF, V11, P55
   TIDWELL JK, 1992, INT J ORAL MAX SURG, V21, P204, DOI 10.1016/S0901-5027(05)80219-X
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 34
TC 297
Z9 310
U1 1
U2 30
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD NOV-DEC
PY 1999
VL 14
IS 6
BP 835
EP 840
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 264XX
UT WOS:000084210000007
PM 10612920
DA 2018-10-19
ER

PT J
AU Bruining, MJ
   Edelbroek-Hoogendoorn, PS
   Blaauwgeers, HGT
   Mooy, CM
   Hendrikse, FH
   Koole, LH
AF Bruining, MJ
   Edelbroek-Hoogendoorn, PS
   Blaauwgeers, HGT
   Mooy, CM
   Hendrikse, FH
   Koole, LH
TI New biodegradable networks of poly(N-vinylpyrrolidinone) designed for
   controlled nonburst degradation in the vitreous body
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biodegradable biomaterials; intraocular drug delivery; crosslinked
   hydrogels; photopolymerization
ID CYTOMEGALO-VIRUS RETINITIS; DRUG-DELIVERY SYSTEM; INTRAVITREAL
   GANCICLOVIR; SUSTAINED-RELEASE; POLYMERIC DEVICE; MICROSPHERES;
   SUBSTITUTES; POLY(1-VINYL-2-PYRROLIDINONE); HYDROGELS; CLEARANCE
AB Polymers of N-vinylpyrrolidinone (NVP) are known to have excellent biocompatibility when implanted in the vitreous body or used as a vitreous substitute. Al though poly(NVP) is capable of absorbing relatively large amounts of water, it is not prone to hydrolysis. Yet intraocular degradation of several crosslinked poly(NVP) hydrogels has been reported recently, but some ambiguity remains about the exact mechanism of degradation of these materials. To date there is no biomaterial that combines the excellent intraocular biocompatibility on the one hand and controlled kinetics of degradation on the other hand. We attempted to design and prepare such materials through the chemical synthesis of a novel dimethacrylate crosslinker molecule. The essential feature of this molecule is that its core contains two carbonate groups, which are evidently susceptible to hydrolytic scission. We studied a series of 3-dimensional networks of poly(NVP), which were crosslinked by this molecule. This approach offers several advantages: the hydrolysis of the carbonate groups in the crosslinks leads to liberation of poly(NVP) and/or oligo(NVP) chains that can probably be cleared from the eye via phagocytosis; hydrolysis generates two alcohols and CO2 (i.e., there is no catalytic burst effect); when these materials are implanted in dry form, swelling and degradation will progress from the exterior of the material toward its interior. Therefore, these materials can be designed such that surface degradation rather than bulk degradation occurs; the hydrolysis rate can be controlled via the crosslink density or through synthesis of other crosslink molecules with either more (>2) or less (1) carbonate groups or alternatively with one or more other labile groups. We report on the chemical synthesis of the crosslinker molecule, as well, as the preparation and degradation of a series of poly(NVP)-based hydrogels in vitro and in vivo (rabbit eyes). We found that these materials indeed displayed excellent biocompatibility in the rabbit eye. Further, the experiments confirmed that degradation occurs without the burst effect. The results are in line with the idea that the rate of intraocular swelling and degradation depends on the crosslink density, but this is only a preliminary conclusion that must be strengthened by much more experimental work. Nonetheless, we foresee several applications of these or related materials in ophthalmology, for example, as biodegradable matrix materials for controlled drug delivery of ganciclovir in the vitreous body. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Univ Limburg, Acad Hosp Maastricht, Dept Ophthalmol, Maastricht, Netherlands.
   Acad Hosp Dijkzigt, Dept Clin Pathol, NL-3000 DR Rotterdam, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
CR ANAND R, 1993, ARCH OPHTHALMOL-CHIC, V111, P223, DOI 10.1001/archopht.1993.01090020077027
   CANTRILL HL, 1989, OPHTHALMOLOGY, V96, P367, DOI 10.1016/S0161-6420(89)32900-9
   CHIRILA TV, 1995, CELL MATER, V5, P83
   COCHEREAUMASSIN I, 1991, OPHTHALMOLOGY, V98, P1348
   GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   HENRY K, 1987, AM J OPHTHALMOL, V103, P17, DOI 10.1016/S0002-9394(14)74163-7
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   Hong Y, 1996, J BIOMATER APPL, V11, P135, DOI 10.1177/088532829601100202
   HONG Y, 1998, J BIOMED MATER RES, V41, P650
   Hong Ye, 1996, In Vitro Toxicology, V9, P73
   KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175
   KIMURA H, 1994, INVEST OPHTH VIS SCI, V35, P2815
   KUNOU N, 1995, J CONTROL RELEASE, V37, P143, DOI 10.1016/0168-3659(95)00074-I
   MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023
   MORITERA T, 1991, INVEST OPHTH VIS SCI, V32, P1785
   PEYMAN GA, 1992, INT OPHTHALMOL, V16, P109, DOI 10.1007/BF00918942
   TERANISHI K, 1995, SYNTHESIS-STUTTGART, P176
   Veloso AAS, 1997, INVEST OPHTH VIS SCI, V38, P665
   Vijayasekaran S, 1996, J BIOMAT SCI-POLYM E, V7, P685, DOI 10.1163/156856296X00453
NR 20
TC 22
Z9 23
U1 2
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1999
VL 47
IS 2
BP 189
EP 197
DI 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 230KW
UT WOS:000082251200008
PM 10449629
DA 2018-10-19
ER

PT J
AU Habal, MB
   Pietrzak, WS
AF Habal, MB
   Pietrzak, WS
TI Key points in the fixation of the craniofacial skeleton with absorbable
   biomaterial
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
ID FRACTURES; STRENGTH; DEVICES; SURGEON; SCREWS
C1 Tampa Bay Craniofacial Ctr, Tampa, FL 33603 USA.
   Biomet Inc, Warsaw, IN USA.
RP Habal, MB (reprint author), Tampa Bay Craniofacial Ctr, 801 W ML King Blvd, Tampa, FL 33603 USA.
CR An YHH, 1998, CLIN ORTHOP RELAT R, P300
   BARBER FA, 1995, ARTHROSCOPY, V11, P21, DOI 10.1016/0749-8063(95)90084-5
   Barber FA, 1998, ORTHOPEDICS, V4, P11
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BOSTMAN O, 1993, J PEDIATR ORTHOPED, V13, P242
   BOSTMAN OM, 1995, CLIN ORTHOP RELAT R, P101
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   Edwards RC, 1999, J CRANIOFAC SURG, V10, P230, DOI 10.1097/00001665-199905000-00011
   EITENMULLER J, 1990, 53 JAHR DTSCH GES UN, V64
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P103, DOI 10.1097/00001665-199703000-00008
   Habal MB, 1997, J CRANIOFAC SURG, V8, P121, DOI 10.1097/00001665-199703000-00011
   Johnson LL, 1996, ARTHROSCOPY, V12, P452, DOI 10.1016/S0749-8063(96)90039-0
   Pietrzak WS, 1997, J BIOMED MATER RES, V38, P17
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P92, DOI 10.1097/00001665-199703000-00005
   Pietrzak WS, 1996, BONE, V19, pS109, DOI 10.1016/S8756-3282(96)00139-1
   PIETRZAK WS, 1999, PRACTICAL GUIDE MECH
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   SIMON JA, 1999, AM J ORTHOPSYCHIAT, V28, P754
   SIMON JA, 1996, AM J ORTHOPSYCHIAT, V25, P665
NR 21
TC 33
Z9 36
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD NOV
PY 1999
VL 10
IS 6
BP 491
EP 499
DI 10.1097/00001665-199911000-00008
PG 9
WC Surgery
SC Surgery
GA 258NG
UT WOS:000083844800009
PM 10726502
DA 2018-10-19
ER

PT J
AU Wilson, JF
   Liu, JR
   Romero-Borja, F
   Chu, WK
AF Wilson, JF
   Liu, JR
   Romero-Borja, F
   Chu, WK
TI Study of hydrogen annealing of ultrahigh molecular weight polyethylene
   irradiated with high-energy protons
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID WEAR PROPERTIES; POLYMER-FILMS; PROSTHESES
AB Ultrahigh molecular weight polyethylene, an important biomaterial for orthopedic implants, was irradiated with 2.6- and 3-MeV H+ ions at low doses from 5.7 x 10(11) to 2.3 x 10(14) ions/cm(2). Fourier transform infrared spectroscopy showed that irradiation resulted in increased free radicals, carbon double bonds, and increased methyl and vinyl end groups. The free radicals resulted in poor polymer oxidative stability, as measured by increased carbonyl concentration. Hydrogen annealing after ion irradiation reacted with the free radicals generated during proton irradiation resulted in a 40-50% decrease in infrared absorption associated with carbonyl and prevented further oxidation.
C1 Univ Houston, Texas Ctr Superconduct, Houston, TX 77204 USA.
RP Wilson, JF (reprint author), Univ Houston, Texas Ctr Superconduct, Houston, TX 77204 USA.
CR Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   BELLAMY LJ, 1980, INFRARES SPECTRA COM, V2
   BLUNN GW, 1992, ACTA ORTHOP SCAND, V63, P247, DOI 10.3109/17453679209154776
   Bohr N., 1948, MAT FYS MEDD DAN VID, V18
   BRUGEL W, 1992, INTRO INFRARED SPECT
   BULLOUGH PG, 1991, ULTRA HIGH MOL WEIGH, P104
   CALCAGNO L, 1992, NUCL INSTRUM METH B, V65, P413, DOI 10.1016/0168-583X(92)95077-5
   DUPLESSIS TA, 1977, RADIAT PHYS CHEM, V9, P647, DOI 10.1016/0146-5724(77)90178-9
   FRANCK A, 1991, ULTRA HIGH MOL WEIGH, P15
   Henniker JC, 1967, INFRARED SPECTROSCOP
   ISHITANI A, 1989, NUCL INSTRUM METH B, V39, P783, DOI 10.1016/0168-583X(89)90896-3
   JAHAN MS, 1991, J BIOMED MATER RES, V25, P1005, DOI 10.1002/jbm.820250807
   KELLERSOHN DIR, 1991, ULTRA HIGH MOL WEIGH, P6
   KOENIG JL, 1992, SPECTROSCOPY POLYM
   KURTH M, 1991, ULTRAHIGH MOL WEIGHT, P82
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   Lindhard J., 1963, MAT FYS MEDD DAN VID, V33, P14
   PUGLISI O, 1987, NUCL INSTRUM METH B, V19-20, P865, DOI 10.1016/S0168-583X(87)80173-8
   RAO GR, 1994, WEAR, V174, P103, DOI 10.1016/0043-1648(94)90091-4
   RAO GR, 1995, J MATER RES, V10, P190, DOI 10.1557/JMR.1995.0190
   Saunders K. J., 1973, ORGANIC POLYM CHEM
   SEYMOR RB, 1987, ADV POLYOLEFINS
   Siesler H.W., 1980, INFRARED RAMAN SPECT
   Socrates G., 1994, INFRARED CHARACTERIS
   STREICHER RM, 1991, ULTRA HIGH MOL WEIGH, P66
   Thomson JJ, 1912, PHILOS MAG, V23, P449, DOI 10.1080/14786440408637241
   TOPCHIEV AV, 1962, POLYOLEFINES
   VENKATESAN T, 1985, NUCL INSTRUM METH B, V7-8, P461, DOI 10.1016/0168-583X(85)90413-6
   WILLERT HG, 1991, ULTRA HIGH MOL WEIGH, P1
   WILSON JF, 1997, THESIS U HOUSTON HOU
   ZIEGLER JF, 1985, STOPPING RAGE IONS S
NR 31
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD NOV
PY 1999
VL 14
IS 11
BP 4431
EP 4436
DI 10.1557/JMR.1999.0600
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 257FC
UT WOS:000083771000045
DA 2018-10-19
ER

PT J
AU Chu, CL
   Zhu, JC
   Yin, ZD
   Wang, SD
AF Chu, CL
   Zhu, JC
   Yin, ZD
   Wang, SD
TI Hydroxyapatite-Ti functionally graded biomaterial fabricated by powder
   metallurgy
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally-graded material; biomaterial; titanium; hydroxyapatite
ID MECHANICAL-PROPERTIES; SINTERING BEHAVIOR; MICROSTRUCTURE
AB A functionally-graded biomaterial (FGM) in a hydroxyapatite (HA)-Ti system was developed by an optimized powder metallurgical process and investigated by microstructural analysis and mechanical tests. The constituents in sintered HA-Ti FGM distribute gradually with the variation in chemical composition, eliminating the macroscopic interfaces, such as that in HA-Ti direct joint. Partial decomposition of HA phase was found in interlayers of the FGM due to the co-existence of Ti during sintering. Mechanical properties in HA-Ti FGM also exhibit gradient distributions. Vickers hardness and Young's modulus are strongly affected by the porosity. However, bending strength and fracture toughness increase remarkably with the rise of Ti content, especially in the Ti-rich region. Maximum strength and toughness (971.96 Mpa and 29.691 MPam(1/2) respectively) were reached in the pure Ti layer, which are far higher than those of human bone. In addition, the strengthening and toughening mechanism was discussed. In summary, HA-TI FGM is a promising biomaterial for use as a hard-tissue replacement implant, considering its mechanical behaviors. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
   SE Univ, Anal & Testing Ctr, Nanjing 210018, Peoples R China.
RP Chu, CL (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, Box 433, Harbin 150001, Peoples R China.
CR AOKI H, 1991, SCI MED APPL HYDROXY
   Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   BROSSA F, 1994, J MATER SCI-MATER M, V5, P855, DOI 10.1007/BF01172024
   CHAKI TK, 1994, J MATER SCI-MATER M, V5, P533, DOI 10.1007/BF00124886
   DEWITH G, 1981, J MATER SCI, V16, P1592
   HALOUANI R, 1994, J MATER SCI-MATER M, V5, P563, DOI 10.1007/BF00124890
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JI HX, 1993, J MATER SCI, V28, P1941, DOI 10.1007/BF00595767
   KAWAHARA H, 1982, CERAMICS SURG, P49
   Kimura H, 1996, POWDER METALL, V39, P59, DOI 10.1179/pom.1996.39.1.59
   Kirihara S, 1997, MATER T JIM, V38, P650, DOI 10.2320/matertrans1989.38.650
   MUNZ D, 1989, MECH VERHALTEN KERAM
   SABER KT, 1983, ACTA METALL, V31, P565
   Sonoda T, 1997, MATER RES BULL, V32, P899, DOI 10.1016/S0025-5408(97)00035-4
   Tanihata K., 1997, Journal of the Society of Materials Science, Japan, V46, P775
   WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
NR 20
TC 70
Z9 75
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD NOV 1
PY 1999
VL 271
IS 1-2
BP 95
EP 100
DI 10.1016/S0921-5093(99)00152-5
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 255AR
UT WOS:000083647800013
DA 2018-10-19
ER

PT J
AU Huynh, T
   Abraham, G
   Murray, J
   Brockbank, K
   Hagen, PO
   Sullivan, S
AF Huynh, T
   Abraham, G
   Murray, J
   Brockbank, K
   Hagen, PO
   Sullivan, S
TI Remodeling of an acellular collagen graft into a physiologically
   responsive neovessel
SO NATURE BIOTECHNOLOGY
LA English
DT Article
DE collagen; biomaterials; tissue engineering; vascular prostheses
ID INTESTINAL SUBMUCOSA; BLOOD-VESSEL; CELLS; MODEL; EQUIVALENT; CULTURE;
   WALL
AB Surgical treatment of vascular disease has become common, creating the need for a readily available, small-diameter vascular graft. However, the use of synthetic materials is limited to grafts larger than 5-6 mm because of the frequency of occlusion observed with smaller-diameter prosthetics. An alternative to synthetic materials would be a biomaterial that could be used in the design of a tissue-engineered graft. We demonstrate that a small-diameter (4 mm) graft constructed from a collagen biomaterial derived from the submucosa of the small intestine and type I bovine collagen has the potential to integrate into the host tissue and provide a scaffold for remodeling into a functional blood vessel. The results obtained using a rabbit arterial bypass model have shown excellent hemostasis and patency. Furthermore, within three months after implantation, the collagen grafts were remodeled into cellularized vessels that exhibited physiological activity in response to vasoactive agents.
C1 Organogenesis Inc, Canton, MA 02021 USA.
   Duke Univ, Med Ctr, Durham, NC 27710 USA.
   KGB Associates Inc, Charleston, SC 29401 USA.
RP Sullivan, S (reprint author), Organogenesis Inc, Canton, MA 02021 USA.
CR ABRAHAM GA, 1998, Patent No. 49969
   *AM HEART ASS, 1995, HEART STROK FACTS S
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P623, DOI 10.1016/S0963-6897(97)00096-1
   BREWSTER DC, 1995, VASCULAR SURG, P492
   CALLOW AD, 1986, BIOL SYNTHETIC VASCU, P11
   CRAMER R, 1973, RADIOLOGY, V109, P585, DOI 10.1148/109.3.585
   DAVIDS L, 1999, TISSUE ENG PROSTHETI, P3
   DAVIES MG, 1994, J CLIN INVEST, V94, P1680, DOI 10.1172/JCI117513
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   EDWARDS WS, 1966, SURG GYNECOL OBSTETR, V122, P37
   EGUSA S, 1968, ACTA MED OKAYAMA, V22, P153
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   GUNDRY SR, 1987, J SURG RES, V43, P75, DOI 10.1016/0022-4804(87)90049-7
   HardinYoung J, 1996, BIOTECHNOL BIOENG, V49, P675, DOI 10.1002/(SICI)1097-0290(19960320)49:6<675::AID-BIT9>3.0.CO;2-L
   HERRING MB, 1987, SURGERY, V84, P498
   KEMP PD, 1993, Patent No. 5256418
   KIM KM, 1999, AM J PATHOL, V154, P671
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P14
   L'Heureux N, 1998, FASEB J, V12, P47
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LAWLER MR, 1971, AM J SURG, V122, P517, DOI 10.1016/0002-9610(71)90478-8
   LEVESQUE MJ, 1989, BIORHEOLOGY, V26, P345
   MATSUDA T, 1995, J THORAC CARDIOV SUR, V110, P988, DOI 10.1016/S0022-5223(05)80166-7
   MATSUMOTO T, 1966, SURGERY, V60, P739
   MILLS I, 1999, TISSUE ENG PROSTHETI, P425
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   ODONNELL TF, 1984, J VASC SURG, V1, P136
   OMALLEY MK, 1986, SURGERY, V99, P36
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PASIC M, 1994, ANN THORAC SURG, V58, P677, DOI 10.1016/0003-4975(94)90726-9
   SOWTON E, 1991, BRIT HEART J, V66, P325
   STEPHEN M, 1977, SURGERY, V81, P314
   TERMIN PL, 1993, AAMI CARD SCI TECHN
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Williams S K, 1994, J Invest Surg, V7, P503, DOI 10.3109/08941939409015367
   ZARGE JI, 1997, PRINCIPLES TISSUE EN, P349
   ZIEGLER T, 1995, CELL MATER, V5, P115
NR 39
TC 208
Z9 225
U1 2
U2 32
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1087-0156
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV
PY 1999
VL 17
IS 11
BP 1083
EP 1086
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 251CX
UT WOS:000083428000024
PM 10545913
DA 2018-10-19
ER

PT J
AU Aguilar, MD
   Espinosa, S
   Rodriguez, L
   Pina, C
AF Aguilar, MD
   Espinosa, S
   Rodriguez, L
   Pina, C
TI Biocompatibility in vitro tests of Zinalco (TM)
SO MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
LA English
DT Article
DE Zinalco (TM); biomaterials; biocompatibility
ID DNA-DAMAGE; HUMAN-LYMPHOCYTES; INDIVIDUAL CELLS; ORGANISMS; ASSAY
AB In this study, cultures of human lymphocytes were exposed for 48 h to aqueous suspensions of Zinalco(TM), with different times of corrosion, to test the biocompatibility of this alloy and support its use in medical implants. The results show that the Zinalco(TM) concentrations assessed affect the mitotic index (MI) and some also increase the length of DNA migration measured in the comet assay in a significant manner; none of them showed clastogenic nor aneugenic effects. The authors conclude that Zinalco(TM) may be considered as an alternative biomaterial and suggest its use for short-term implants. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Mexico City 09340, DF, Mexico.
   Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
RP Aguilar, MD (reprint author), Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Apartado Postal 55-535, Mexico City 09340, DF, Mexico.
RI Pina, Cristina/K-2026-2012
CR AGARWAL K, 1989, CHEM-BIOL INTERACT, V69, P1, DOI 10.1016/0009-2797(89)90094-X
   AGUILAR MA, 1994, P REC ADV SCI TECHN
   ALVARADOLOPEZ F, 1995, THESIS UNAM MEXICO
   ARAKAKI D. T., 1963, CYTOGENETICS [BASEL], V2, P57, DOI 10.1159/000129767
   BETANCOURT M, 1995, MUTAT RES-FUND MOL M, V331, P65, DOI 10.1016/0027-5107(95)00052-K
   COHEN M, 1974, CHEM MUTAGENS PRINCI, V2
   DEKNUDT G, 1978, TOXICOLOGY, V10, P67, DOI 10.1016/0300-483X(78)90056-2
   GIRI AK, 1988, TOXICOL LETT, V44, P253, DOI 10.1016/0378-4274(88)90164-6
   HEINKE G, 1990, CRITERIA BIOINERTNES, V1
   HOFFMAN G, 1996, TOXICOLOGY
   Nacci DE, 1996, AQUAT TOXICOL, V35, P197, DOI 10.1016/0166-445X(96)00016-1
   Ostrosky W.P., 1994, GACETA MED MEXICO, V130, P432
   Perez G. N. S., 1996, Veterinaria Mexico, V27, P325
   PILLIAR R, 1984, P REC ADV SCI TECHN
   PINA C, 1994, P REC ADV SCI TECHN
   Pina Cristina, 1995, Ciencia (Mexico City), V46, P524
   RAMIREZVICTORIA P, 1995, THESIS UNAM MEXICO
   SHARMA A, 1987, ENVIRON MOL MUTAGEN, V9, P191, DOI 10.1002/em.2860090210
   SINGH NP, 1991, MUTAT RES, V256, P1, DOI 10.1016/0921-8734(91)90026-8
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   SUTOW E, 1981, BIOCOMPATIBILITY CLI, V1
   TORRESVILLASENO.G, 1988, CIENCIA, V39, P103
   VAZQUEZCURIEL E, 1993, THESIS UNAM MEXICO
   VEGA L, 1995, MUTAT RES-ENVIR MUTA, V334, P365, DOI 10.1016/0165-1161(95)90074-8
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V1
NR 25
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1383-5718
J9 MUTAT RES-GEN TOX EN
JI Mutat. Res. Genet. Toxicol. Environ. Mutagen.
PD OCT 29
PY 1999
VL 446
IS 1
BP 129
EP 134
DI 10.1016/S1383-5718(99)00158-8
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 255AW
UT WOS:000083648200013
PM 10613193
DA 2018-10-19
ER

PT J
AU Yung, LYL
   Colman, RW
   Cooper, SL
AF Yung, LYL
   Colman, RW
   Cooper, SL
TI Neutrophil adhesion on polyurethanes preadsorbed with high molecular
   weight kininogen
SO BLOOD
LA English
DT Article
ID BACTERIAL ADHESION; LIGHT-CHAIN; SULFONATE INCORPORATION; PHOSPHOLIPID
   POLYMERS; MONOCLONAL-ANTIBODIES; PROTEIN ADSORPTION; LEUKOCYTE COUNTS;
   ANIONIC SURFACE; HEAVY-CHAIN; BINDING
AB Interaction of biomaterials with blood components including neutrophils is responsible for some of the clinical complications that have occurred in cardiopulmonary bypass, hemodialysis, and ventricular assist procedures. The possibility of inhibiting the initial adhesion of neutrophils to biomaterials has been studied extensively, but the problem remains unsolved. In this study, we investigated the effect of HK adsorption on polyurethane, a widely used component of extracorporeal and intracorporeal devices. HK and HKa were allowed to adsorb on 4 different charged polyurethanes: noncharged (PU), cationic (NR4), anionic (SO3), and zwitterionic (GPC) polyurethanes. The effect of kininogen adsorption on neutrophil adhesion, the surface density of the adsorbed kininogen, and the exposure of HK domains 3 and 5 (D-3 and D-5H) which are responsible for the binding of HK to the neutrophil integrin alpha(m)beta(2) or Mac-1, were examined. On PU, NR4, and SO3, kininogen adsorption reached 80% of monolayer coverage when 100 pmol/mL or higher concentration of protein solutions were used. The NR4 surface adsorbed the most kininogen along with a high exposure of D-3 and D-5H. The availability of D-3 and D5H allowed neutrophils to bind to the surface via the Mac-1 receptor; thus, on the NR4 surface, adsorbed kininogens lost their antiadhesive property, which resulted in a high degree of neutrophil adhesion. Increasing Mac-1 expression by exposure to fMLP increased the neutrophil adhesion on this surface. In contrast, exposure of D-3 and D-5H on SO3 was significantly less, because HK binds to anionic surfaces with similar protein sequences used for cell binding. This low binding site exposure preserved the antiadhesive property of HK. GPC was resistant to neutrophil adhesion even in the absence of adsorbed kininogens because of its phosphorylcholine moiety. Thus, both SO3 coupled with kininogen (or kininogen peptides) and GPC have the potential to markedly reduce neutrophil adhesion to biomaterial devices. (C) 1999 by The American Society of Hematology.
C1 Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.
   Univ Delaware, Dept Chem Engn, Newark, DE USA.
RP Colman, RW (reprint author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.
RI Yung, Lanry/B-6515-2009
OI Yung, Lanry/0000-0001-7579-6347
FU NHLBI NIH HHS [HL-56914, HL-47179]
CR Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   BOHLER J, 1983, CONTRIB NEPHROL, V36, P15
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DELACADENA RA, 1992, PROTEIN SCI, V1, P151
   DELACADENA RA, 1994, HEMOSTASIS THROMBOSI, P219
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P1347, DOI 10.1002/jbm.820281113
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   JACOBSEN S, 1967, BRIT J PHARM CHEMOTH, V29, P25, DOI 10.1111/j.1476-5381.1967.tb01935.x
   JIANG YP, 1992, THROMB HAEMOSTASIS, V68, P143
   Khan MMH, 1998, AM J PHYSIOL-HEART C, V275, pH145, DOI 10.1152/ajpheart.1998.275.1.H145
   KLOCK JC, 1976, BLOOD, V48, P149
   KUNAPULI SP, 1993, J BIOL CHEM, V268, P2486
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   LIM F, 1995, BIOMATERIALS, V16, P457, DOI 10.1016/0142-9612(95)98818-Y
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P3, DOI 10.1016/0142-9612(91)90123-R
   RYHANEN P, 1979, J THORAC CARDIOV SUR, V77, P259
   SCHMAIER AH, 1984, THROMB RES, V33, P51, DOI 10.1016/0049-3848(84)90154-3
   SCHMAIER AH, 1987, J BIOL CHEM, V262, P1405
   SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319
   Sheng N, 1997, FASEB J, V11, pA920
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WACHTFOGEL YT, 1994, J BIOL CHEM, V269, P19307
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   YUNG LL, IN PRESS BIOMATERIAL
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 36
TC 15
Z9 16
U1 0
U2 5
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD OCT 15
PY 1999
VL 94
IS 8
BP 2716
EP 2724
PG 9
WC Hematology
SC Hematology
GA 244PM
UT WOS:000083060000021
PM 10515875
DA 2018-10-19
ER

PT J
AU Katti, D
   Krishnamurti, N
AF Katti, D
   Krishnamurti, N
TI Anionic polymerization of alkyl cyanoacrylates: In vitro model studies
   for in vivo applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE anionic polymerization; alkyl cyanoacrylate; bioadhesive; biomaterial
ID TISSUE ADHESIVE; POLYALKYLCYANOACRYLATE NANOPARTICLES; CORNEAL
   PERFORATIONS; DRUG CARRIER; SKIN; NANOCAPSULES; TOXICITY; REPAIR
AB Alkyl cyanoacrylates were polymerized anionically in water medium at different levels of pH. The effect of pH on the molecular weight and softening points of the polymers was studied. Alkyl cyanoacrylates were also polymerized in suspension by using the combination of methanol-water, and also by using different catalysts such as triethylamine, diazabicyclooctane, and diazabicycloundecane. The poly(cyanoacrylates) thus obtained were characterised by infrared and nuclear magnetic resonance spectroscopy. The molecular weight, molecular weight distribution, and the softening points of the polymers were determined. These studies would help in more effective usage of cyanoacrylates as bioadhesives under varied physiological conditions. (C) 1999 John Wiley & Sons, Inc.
C1 Indian Inst Chem Technol, Organ Coatings & Polymers Div, Hyderabad 500007, Andhra Pradesh, India.
RP Krishnamurti, N (reprint author), Indian Inst Chem Technol, Organ Coatings & Polymers Div, Hyderabad 500007, Andhra Pradesh, India.
CR AGARWAL V, 1996, INDIAN J OPHTHALMOL, V44, P23
   Ayton J M, 1993, Arctic Med Res, V52, P127
   Celik H, 1991, J Neurosurg Sci, V35, P83
   COOVER HW, 1977, HDB ADHESIVES
   COUVREUR P, 1991, J CONTROL RELEASE, V17, P187, DOI 10.1016/0168-3659(91)90058-L
   COUVREUR P, 1982, J PHARM SCI, V71, P790, DOI 10.1002/jps.2600710717
   Couvreur P, 1986, POLYM NANOPARTICLES
   DAMGE C, 1990, J CONTROL RELEASE, V13, P233, DOI 10.1016/0168-3659(90)90013-J
   DAMGE C, 1988, DIABETES, V37, P246, DOI 10.2337/diabetes.37.2.246
   DOUGLAS SG, 1987, POLYM CONTROLLED DRU
   DUNCAN R, 1984, ADV POLYM SCI POLYM
   ERDEY RA, 1991, OPHTHALMIC SURG LAS, V22, P352
   FERETIS C, 1990, ENDOSCOPY, V22, P282, DOI 10.1055/s-2007-1012872
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   GAU GS, 1991, J CLIN PATHOL, V44, P759, DOI 10.1136/jcp.44.9.759
   GOLDBERG EP, 1980, BIOMEDICAL POLYM POL
   Gomori G., 1955, METHODS ENZYMOLOGY, V1
   HALPERN BD, 1985, ENCY POLYM SCI ENG
   KANTE B, 1982, J PHARM SCI, V71, P786, DOI 10.1002/jps.2600710716
   LEAHEY AB, 1993, OPHTHALMOLOGY, V100, P173
   LEONARD F, 1966, J APPL POLYM SCI, V10, P259, DOI 10.1002/app.1966.070100208
   LIPATOVA TE, 1986, ADV POLYM SCI BIOPOL
   MESSI G, 1992, PANMINERVA MED, V34, P77
   MILLET GH, 1986, STRUCTURAL ADHESIVES
   Noordzij J. Pieter, 1994, Journal of Emergency Medicine, V12, P645
   Park JB, 1979, BIOMATERIALS INTRO
   QUINN JV, 1993, ANN EMERG MED, V22, P1130, DOI 10.1016/S0196-0644(05)80977-1
   RAYMOND MJ, 1989, HEPATOLOGY, V10, P493
   SAINI JS, 1992, OPHTHALMIC SURG LAS, V23, P399
   SHANTHA KL, 1989, J ADHES SCI TECHNOL, V3, P237, DOI 10.1163/156856189X00191
   SOCHENDRA N, 1986, ENDOSCOPY, V18, P25
   SREENIVAS DV, 1996, CLIN P NIMS, V11, P40
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
   VIJAYALAKSHMI V, 1990, J ADHES SCI TECHNOL, V4, P733, DOI 10.1163/156856190X00630
   VIJAYALAKSHMI V, 1991, POLYM PAINT COL J, V181, P506
   WEISS JL, 1983, OPHTHALMOLOGY, V90, P610
   ZAKI I, 1994, J DERMATOL SURG ONC, V20, P827, DOI 10.1111/j.1524-4725.1994.tb03713.x
NR 37
TC 15
Z9 15
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 10
PY 1999
VL 74
IS 2
BP 336
EP 344
DI 10.1002/(SICI)1097-4628(19991010)74:2<336::AID-APP15>3.0.CO;2-S
PG 9
WC Polymer Science
SC Polymer Science
GA 226UC
UT WOS:000082039600015
DA 2018-10-19
ER

PT J
AU Shehata, WA
   Nasr, FN
   Tadros, AW
AF Shehata, WA
   Nasr, FN
   Tadros, AW
TI Application of some bacterial varieties of Bacillus thuringiensis and
   its bioproduct Delfin on Synanthedon myopaeformis Borkh. (Lep.
   Aegeriidae) in apple orchards
SO ANZEIGER FUR SCHADLINGSKUNDE-JOURNAL OF PEST SCIENCE
LA English
DT Article
AB Field experiments were conducted using the biological agent Bacillus thuringiensis to control the clearwing moth, Synanthedon myopaeformis (Lep. Aegeriidae) in apple orchards at Alexandria governorate during 1995, 1996 and 1997., Three bacterial varieties of B. thuringiensis showed significant influence on the reduction of borer infestation. Four applications with the sporic concentration 12 x 10(7) spores/ml of each of B. th. var. kurstaki, B. th. var, alesti and B. th. var. thuringiensis induced 82.5, 51.1 and 42.1% reduction of infestation, respectively. Methods of application showed highly significant effect on infestation level. Spraying after scraping was the best method (80.0%, reduction) followed by painting after scraping (71.5%, reduction) then spraying alone (59.7%, reduction) or painting alone (43.0%, reduction). A control programme was carried out using three applications of the biomaterial, Delfin at the rate of 200 g/100 I.w during mid-March, early June and mid-August resulted in 88.5-91.4% reduction of infestation.
C1 MOA, ARC, Plant Protect Res Inst, Giza, Egypt.
RP Nasr, FN (reprint author), Agr Res Ctr, 536 Horreia St, Alexandria, Egypt.
CR CAMPBELL RW, 1971, J INVERTEBR PATHOL, V18, P1
   DESEOEKOVACS KV, 1987, SCHR REIHE BUNDESMIN, V344, P211
   KAHOUNOVA L, 1991, ACTA ENTOMOL BOHEMOS, V88, P205
   KIRALY Z., 1970, METHODS PLANT PATHOL
   MORTIGNONI ME, 1961, LAB EXERCISES INSECT
   Nachtigall G., 1992, Acta Phytopathologica et Entomologica Hungarica, V27, P485
   Ozkan A., 1984, Bitki Koruma Bulteni, V24, P213
   SHEHATA WA, 1995, MANSOURA U J AGR SC, V20, P2545
   SHEHATA WA, 1995, COMMUN SCI DEV RES, V51, P1
   Snedecor G. W., 1961, STAT METHODS
   Sontgen J.M., 1988, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V6, P262
   TADROS AW, 1977, THESIS CAIRO U
NR 12
TC 3
Z9 4
U1 0
U2 3
PU BLACKWELL WISSENSCHAFTS-VERLAG GMBH
PI BERLIN
PA KURFURSTENDAMM 57, D-10707 BERLIN, GERMANY
SN 1436-5693
J9 ANZ SCHADL-J PEST SC
JI Anz. Schadlingskd.-J. Pest Sci.
PD OCT
PY 1999
VL 72
IS 5
BP 129
EP 132
DI 10.1007/BF02770710
PG 4
WC Entomology
SC Entomology
GA 258LL
UT WOS:000083840600004
DA 2018-10-19
ER

PT J
AU Yuan, HP
   Kurashina, K
   de Bruijn, JD
   Li, YB
   de Groot, K
   Zhang, XD
AF Yuan, HP
   Kurashina, K
   de Bruijn, JD
   Li, YB
   de Groot, K
   Zhang, XD
TI A preliminary study on osteoinduction of two kinds of calcium phosphate
   ceramics
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate biomaterials; micropores; biomaterials with intrinsic
   osteoinductive property; material dependent
ID BONE MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE; OSTEOBLASTIC
   PHENOTYPE; GRAFT SUBSTITUTES; BIOACTIVE GLASS; IN-VITRO;
   TRANSPLANTATION; OSTEOGENESIS; EXPRESSION; CARBONATE
AB With respect to the effect of material factors on calcium phosphate biomaterial-induced osteogenesis, the osteoinductive property of two kinds of porous hydroxyapatite ceramics, which were made by different producers, was investigated in dorsal muscles of dogs. One hydroxyapatite ceramic (S-HA), macroporous implants with rough pore walls containing abundant micropores, was made by Sichuan Union University (Chengdu, China); the other hydroxyapatite ceramic (J-HA), porous implants with smooth macropore walls composed of regularly aligned crystal grains, was provided by Mitsubishi Ceramic Int. (Japan). Different tissue response was detected histologically and microradiographically after the ceramic samples had been implanted in dorsal muscles of dogs for 3 and 6 months. Bone formation was found in S-HA at 3 months, which increased at 6 months. In contrast, no bone formation was detected in J-HA at both 3 and 6 months. These results indicate that with the special architecture, calcium phosphate ceramic can induce bone formation in soft tissue. As both materials were very similar in their chemical and crystallographic structures, but varied in their microstructures, the latter seem to be an important factor affecting the osteoinductive capacity of calcium phosphate ceramics. These data suggest that, by controlling the preparation of calcium phosphate ceramic, bone substitutes with intrinsic osteoinductive property can be developed from calcium phosphates. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 IsoTis BV, NL-3723 MB Bilthoven, Netherlands.
   Sichuan Union Univ, Inst Mat Sci & Technol, Chengdu 610064, Peoples R China.
   Leiden Univ, Biomat Res Grp, NL-3723 MB Bilthoven, Netherlands.
   Shinshu Univ, Dept Dent & Oral Surg, Matsumoto, Nagano 390, Japan.
RP Yuan, HP (reprint author), IsoTis BV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
CR DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Daculsi G, 1989, BIOCERAMICS, V2, P3
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn JD, 1994, BIOCERAMICS, V7, P293
   DEBRUIJN JD, 1998, COMMUNICATION
   DUCHEYNE P, 1996, BIOCERAMICS, V9, P19
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   El-Ghannam A., 1996, BIOCERAMICS, V9, P53
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5
   INOUE O., 1992, BIOCERAMICS, V5, P411
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   ISHIDA H, 1996, BIOCERAMICS, V9, P73
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, P281
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   KLEIN CPAT, 1994, J APPL BIOMATER, V5, P369, DOI 10.1002/jab.770050413
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lin TC, 1997, J BIOMED MATER RES, V36, P91, DOI 10.1002/(SICI)1097-4636(199707)36:1<91::AID-JBM11>3.0.CO;2-M
   NAKAMURA T, 1996, BIOCERAMICS, V9, P31
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ohgushi H., 1996, BIOCERAMICS, V9, P49
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1993, BIOCHEM BIOPH RES CO, V193, P509, DOI 10.1006/bbrc.1993.1653
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   Vacanti C A, 1995, Tissue Eng, V1, P301, DOI 10.1089/ten.1995.1.301
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   Vidal B de C, 1996, Tissue Eng, V2, P151, DOI 10.1089/ten.1996.2.151
   VolekSmith H, 1996, P SOC EXP BIOL MED, V211, P265
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   YUAN H, 1997, BIOMEDICAL MAT RES F, P228
   YUAN H, 1997, BIOMED ENG-APP BAS C, V9, P268
   YUAN H, 1997, BIOMEDICAL MAT RES F, V3, P116
   Yuan H., 1997, BIOMEDICAL MAT RES F, V3, P188
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
NR 55
TC 387
Z9 411
U1 4
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1999
VL 20
IS 19
BP 1799
EP 1806
DI 10.1016/S0142-9612(99)00075-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 237MP
UT WOS:000082660400006
PM 10509190
DA 2018-10-19
ER

PT J
AU Khouw, IMSL
   van Wachem, PB
   Plantinga, JA
   Vujaskovic, Z
   Wissink, MJB
   de Leij, LFMH
   van Luyn, MJA
AF Khouw, IMSL
   van Wachem, PB
   Plantinga, JA
   Vujaskovic, Z
   Wissink, MJB
   de Leij, LFMH
   van Luyn, MJA
TI TGF-beta and bFGF affect the differentiation of proliferating porcine
   fibroblasts into myofibroblasts in vitro
SO BIOMATERIALS
LA English
DT Article
DE porcine (myo)fibroblast; TGF-beta; bFGF; proliferation; differentiation
ID SMOOTH MUSCLE-ACTIN; GROWTH-FACTOR-BETA; TRANSFORMING
   GROWTH-FACTOR-BETA-1; IN-VITRO; WOUND CONTRACTION; CULTURED HUMAN;
   ALPHA; EXPRESSION; CELLS; INDUCTION
AB Fibroblasts and myofibroblasts are involved in the foreign body reaction to biomaterials, especially in capsule formation. However, contraction or detachment of the capsule can lead to complications. Biocompatibility of biomaterials may be improved by the application of proteins regulating the differentiation or activation of(myo)fibroblasts. Myofibroblasts, differentiating from fibroblasts can be identified by the expression of alpha-smooth muscle actin (alpha-SM actin). We investigated the influence of proliferation and quiescence on the differentiation of porcine dermal cells and whether transforming growth factor-beta (TGF-beta) and basic fibroblast growth factor (bFGF) are involved in the differentiation of proliferating cells. Porcine cells were used because pigs increasingly function as in vivo models while little is known of the characteristics of their cells. Serum-free cultured, quiescent fibroblasts differentiated into myofibroblasts, while proliferating fibroblasts cultured in the presence of serum containing TGF-beta, formed alpha-SM actin-negative cell clusters. After reaching confluency, these clusters started to expressing alpha-SM actin. Moreover, these proliferating cells produced TGF-beta from day 4 onwards while bFGF did not. Differentiation into myofibroblasts was inhibited by bFGF and to an even greater extent by antibodies to TGF-beta. Further, two theories concerning the role of the myofibroblast in tissue contraction in view of two biomaterial application will be discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Cell Biol & Biomat, NL-9712 KZ Groningen, Netherlands.
   Univ Groningen, Dept Radiobiol, Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, Inst Biomed Technol, Polymer Chem & Biomat Grp, NL-7500 AE Enschede, Netherlands.
   Univ Groningen Hosp, Dept Clin Immunol, NL-9713 EZ Groningen, Netherlands.
RP Khouw, IMSL (reprint author), Univ Groningen, Dept Cell Biol & Biomat, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR Andresen JL, 1998, CURR EYE RES, V17, P79
   DARBY I, 1990, LAB INVEST, V63, P21
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   Dugina V, 1998, EXP CELL RES, V238, P481, DOI 10.1006/excr.1997.3868
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   Fafeur V, 1990, Growth Factors, V3, P237, DOI 10.3109/08977199009043908
   FRIEDMAN RJ, 1994, SEMIN ARTHRITIS RHEU, V24, P8, DOI 10.1016/0049-0172(94)90103-1
   GABBIANI G, 1992, J EXP MED, V135, P819
   Garner Warren L., 1995, Wound Repair and Regeneration, V3, P185, DOI 10.1046/j.1524-475X.1995.30210.x
   GRIERSON I, 1988, EYE, V2, P135, DOI 10.1038/eye.1988.27
   Grierson I, 1996, EYE, V10, P671, DOI 10.1038/eye.1996.160
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   JANSEN JA, 1994, J BIOMED MATER RES, V28, P1047, DOI 10.1002/jbm.820280909
   Jester JV, 1996, CORNEA, V15, P505
   KUROSAKA D, 1995, INVEST OPHTH VIS SCI, V36, P1701
   Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426
   MITCHELL JJ, 1993, AM J RESP CELL MOL, V9, P10, DOI 10.1165/ajrcmb/9.1.10
   Moulin V, 1996, BURNS, V22, P359, DOI 10.1016/0305-4179(95)00167-0
   OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343
   Peehl DM, 1997, EXP CELL RES, V232, P208, DOI 10.1006/excr.1997.3525
   POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251
   RONNOVJESSEN L, 1993, LAB INVEST, V68, P696
   RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67
   SANGER JW, 1974, P NATL ACAD SCI USA, V71, P3621, DOI 10.1073/pnas.71.9.3621
   SAPPINO AP, 1990, AM J PATHOL, V137, P585
   Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044
   VANROOZENDAAL CEP, 1995, MOL CELL ENDOCRINOL, V111, P1, DOI 10.1016/0303-7207(95)03539-J
   VanWaarde MAWH, 1997, ANAL BIOCHEM, V247, P45, DOI 10.1006/abio.1997.2026
   Yokozeki M, 1997, EXP CELL RES, V231, P328, DOI 10.1006/excr.1997.3473
NR 29
TC 43
Z9 45
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1999
VL 20
IS 19
BP 1815
EP 1822
DI 10.1016/S0142-9612(99)00077-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 237MP
UT WOS:000082660400008
PM 10509192
DA 2018-10-19
ER

PT J
AU Wetzels, GMR
   Koole, LH
AF Wetzels, GMR
   Koole, LH
TI Photoimmobilisation of poly(N-vinylpyrrolidinone) as a means to improve
   haemocompatibility of polyurethane biomaterials
SO BIOMATERIALS
LA English
DT Article
DE surface modification; photo-immobilisation; haemocompatibility; platelet
   adhesion
ID VASCULAR GRAFTS; SAPHENOUS-VEIN; SURFACES; ACTIVATION; ADHESION
AB A novel method to improve the haemocompatibility of polymeric biomaterials (in particular: polyurethane elastomers) is reported. The new approach essentially rests upon photochemical immobilisation of the highly biocompatible polymer poly(N-vinylpyrrolidinone) (poly(NVP)) onto the biomaterial's surface. One of the key steps in the surface modification procedure is the preparation of a copolymer of NVP and the photoreactive building block 4-[4'-azidobenzoyl]-oxo-n-butylmethacrylate (1). This copolymer is first dissolved in a volatile solvent, then sprayed onto the biomaterial's surface, and subsequently immobilised via irradiation with ultraviolet light. The paper describes: (i) preparation of 1, (ii) preparation of the copolymer (NVP + 1), (iii) physico-chemical characterisation of the modified surfaces, and (iv) results of two in vitro haemocompatibility assays (i.e. thrombin generation and adhesion of blood platelets from recalcified human platelet-rich plasma). Furthermore, the surface modification was performed with a microporous polyurethane vascular graft (Chronoflex (R)), which is already in clinical use. The in vitro experiments revealed that significant improvement of the haemocompatibility of polyurethanes can be achieved through this method. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
CR Aldenhoff YBJ, 1997, BIOCONJUGATE CHEM, V8, P296, DOI 10.1021/bc970020z
   ALFREY T, 1947, J POLYM SCI, V2, P101, DOI 10.1002/pol.1947.120020112
   ANDRADE JD, 1985, SURFACE INTERFACIAL
   BULAN J, 1998, J BIOMED MATER RES, V39, P32
   Conte MS, 1998, FASEB J, V12, P43
   Edwards A, 1995, J BIOMATER APPL, V10, P171, DOI 10.1177/088532829501000207
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   HANSEN CM, 1992, Patent No. 591091
   HEMKER HC, 1986, THROMB HAEMOSTASIS, V56, P9
   KO TM, 1993, BIOMATERIALS, V14, P657
   KUIJPENS JMH, 1995, J AM CHEM SOC, V117, P8691, DOI 10.1021/ja00139a001
   L'Heureux N, 1998, FASEB J, V12, P47
   Lelah M. D., 1986, POLYURETHANES MED
   MAZZUCOTELLI JP, 1991, INT J ARTIF ORGANS, V14, P482
   MERRIL EW, 1997, Patent No. 18904
   ODIAN G, 1991, PRINCIPLES POLYM, P452
   PooleWarren LA, 1996, J BIOMED MATER RES, V30, P221, DOI 10.1002/(SICI)1097-4636(199602)30:2<221::AID-JBM12>3.0.CO;2-P
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Reed A M, 1994, J Biomater Appl, V8, P210, DOI 10.1177/088532829400800303
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   SCHOEN FJ, 1993, CARDIOVASC PATHOL, V2, P209
   Scriven E. F. V., 1984, AZIDES NITRENES
   SERVICE RF, 1995, SCIENCE, V270, P230, DOI 10.1126/science.270.5234.230
   Shangraw RF, 1981, PHARM TECHNOL, V5, P44
   Swanson MJ, 1997, POLYMER SURFACES AND INTERFACES: CHARACTERIZATION, MODIFICATION AND APPLICATION, P19
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   vanderHeiden AP, 1996, MACROMOLECULES, V29, P7012, DOI 10.1021/ma960279x
   VEITH FJ, 1986, J VASC SURG, V3, P104
NR 29
TC 59
Z9 64
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1999
VL 20
IS 20
BP 1879
EP 1887
DI 10.1016/S0142-9612(99)00067-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239GD
UT WOS:000082759700002
PM 10514064
DA 2018-10-19
ER

PT J
AU Montanaro, L
   Arciola, CR
   Baldassarri, L
   Borsetti, E
AF Montanaro, L
   Arciola, CR
   Baldassarri, L
   Borsetti, E
TI Presence and expression of collagen adhesin gene (cna) and slime
   production in Staphylococcus aureus strains from orthopaedic prosthesis
   infections
SO BIOMATERIALS
LA English
DT Article
DE collagen adhesin gene (cna); polymerase chain reaction (PCR); bacterial
   adhesion; slime; biomaterial-associated infection; Staphylococcus aureus
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SEPTIC ARTHRITIS; FIBRONECTIN;
   ADHERENCE; POLYMERS; DEVICES
AB Prosthesis-associated infections still represent one of the most serious complications in the clinical use of biomaterials. The most frequent causes are Staphylococcus aureus and Staphylococcus epidermidis. Several studies have been devoted to identify adhesion mechanisms for these bacteria. Slime in particular has been extensively investigated. Recently, in Staphylococcus aureus species, considerable attention has been given to the host protein receptors that have been shown in in vitro assays to serve as substrates for bacterial adhesion. Collagen-rich tissues, as bone and cartilage, that are the preferential sites of staphylococcal infections, are also the tissues that harbour orthopaedic implants. These can be easily coated in vivo by collagen and thus become prone to adhesion of Staphylococci strains which carry the collagen adhesin gene (cna). In this study the frequency of cna was determined within a collection of 35 Staphylococcus aureus strains from orthopaedic prosthesis infections by a PCR method. Also the collagen-binding ability and slime forming capacity was evaluated. 29% of the strains were cna-positive and also able to bind collagen in vitro. 83% of the strains were slime forming. The results indicate that in the examined bacterial population slime-positive strains predominate over the cna-positive strains, with a striking association of the two adhesion mechanisms in cna-positive strains. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Lab Biocompatibil Mat Impianto, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy.
   Ist Super Sanita, Ultrastrutture Lab, I-00161 Rome, Italy.
RP Arciola, CR (reprint author), Ist Ortoped Rizzoli, Lab Biocompatibil Mat Impianto, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Baldassarri, Lucilla/B-1042-2013
CR ARCIOLA CR, UNPUB COLONY VARIANT
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V3, P195
   Baldassarri L, 1997, INFECT IMMUN, V65, P1522
   Baldassarri L, 1995, MICROECOL T, V25, P103
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   GATERMANN S, 1994, INFECT IMMUN, V62, P4556
   Gillaspy AF, 1997, GENE, V196, P239, DOI 10.1016/S0378-1119(97)00256-4
   LECH MS, 1989, J BIOL CHEM, V264, P21080
   Montanaro L, 1998, MICROBIOLOGICA, V21, P359
   Nomura S, 1997, J BIOMED MATER RES, V38, P35
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   PATTI JM, 1994, J BIOL CHEM, V269, P11672
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   Smeltzer MS, 1997, GENE, V196, P249, DOI 10.1016/S0378-1119(97)00237-0
   SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
NR 21
TC 59
Z9 62
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1999
VL 20
IS 20
BP 1945
EP 1949
DI 10.1016/S0142-9612(99)00099-X
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 239GD
UT WOS:000082759700010
PM 10514072
DA 2018-10-19
ER

PT J
AU Jackson, DW
   Simon, TM
AF Jackson, DW
   Simon, TM
TI Tissue engineering principles in orthopaedic surgery
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT Workshop of the Association-of-Bone-and-Joint-Surgeons
CY NOV 12-15, 1998
CL TAMPA, FLORIDA
SP Assoc Bone & Joint Surgeons
ID CRUCIATE LIGAMENT RECONSTRUCTION; RABBIT KNEE; GOAT MODEL; OSTEOCHONDRAL
   DEFECTS; CARTILAGE; REPAIR; MATRIX
AB Advances in the fields of biotechnology and biomaterials offer the orthopaedic surgeon the exciting possibility of repair or regeneration of tissue lost to injury, disease, or aging. The promising area of tissue engineering represents a multidisciplinary approach aimed at solving some of the most perplexing biologic problems, namely, the creation of new tissues and organs similar to the original tissues and organs. In addition, strategies using new synthetic polymer formulations can facilitate tissue replacement and represent alternatives to tissue regeneration in certain conditions. Although biotechnology has broad application over many medical specialties, orthopaedics is receiving a large focus of the research effort devoted to techniques for developing bone, articular cartilage, ligaments, and tendons. Because bioengineered tissue and/or techniques to stimulate tissue regeneration soon may be used clinically, orthopaedic surgeons should have a working knowledge of the basic concepts involved. Terms, such as biomaterial, biotechnology, matrices of synthetic or biologic polymers or both, adhesion, cohesion, porosity, induction, conduction, stem cell, progenitor cell, mesenchymal cell, tissue growth factor, bone morphogenetic protein, mitogenic and chemotactic factors, and numerous other terms will become part of the working language of clinicians of the twenty-first century.
C1 So Calif Ctr Sports Med, Long Beach, CA USA.
RP Jackson, DW (reprint author), 2760 Atlantic Ave, Long Beach, CA 90806 USA.
CR ARCHER CW, 1999, INT CARTILAGE RESP S, V1, P14
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BROWN TD, 1991, J ORTHOPAED RES, V9, P559, DOI 10.1002/jor.1100090412
   CAMPBELL CJ, 1969, CLIN ORTHOP RELAT R, P45
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CONVERY FR, 1972, CLIN ORTHOP RELAT R, P253
   FRANK C, 1987, INJURY REPAIR MUSCUL, P45
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Grande D A, 1995, Tissue Eng, V1, P345, DOI 10.1089/ten.1995.1.345
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531
   JACKSON DW, 1987, AM J SPORT MED, V15, P295, DOI 10.1177/036354658701500401
   Jackson DW, 1996, AM J SPORT MED, V24, P405, DOI 10.1177/036354659602400403
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   JACKSON DW, 1991, J BONE JOINT SURG AM, V73A, P201, DOI 10.2106/00004623-199173020-00008
   JACKSON DW, 1992, J BONE JOINT SURG AM, V74A, P112, DOI 10.2106/00004623-199274010-00014
   JACKSON DW, 1991, T ORTHOP RES SOC, V16, P184
   Katsumi A, 1999, J Orthop Sci, V4, P127, DOI 10.1007/s007760050084
   KOSEK JC, 1969, SURGERY, V66, P269
   LOCKSHIN M, 1995, HOUSE APPROPRIATIONS
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MOHRI H, 1967, J THORAC CARDIOV SUR, V54, P622
   MOHRI H, 1968, J THORAC CARDIOV SUR, V56, P767
   MOW VC, 1991, J BIOMECH ENG-T ASME, V113, P198, DOI 10.1115/1.2891235
   Murphy Patricia G., 1993, P165
   O'Brien M F, 1987, J Card Surg, V2, P153
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   SMITH A, 1991, WEALTH NATIONS, P9
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   *US BUR CENS, 1998, STAT ABSTR US, V164
   VENTER JC, 1998, PFIZER, V2, P13
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
NR 35
TC 14
Z9 14
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 1999
IS 367
SU S
BP S31
EP S45
PG 15
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 247RR
UT WOS:000083234200005
DA 2018-10-19
ER

PT J
AU Hudson, TW
   Evans, GRD
   Schmidt, CE
AF Hudson, TW
   Evans, GRD
   Schmidt, CE
TI Engineering strategies for peripheral nerve repair
SO CLINICS IN PLASTIC SURGERY
LA English
DT Article
ID RAT SCIATIC-NERVE; SEMIPERMEABLE GUIDANCE CHANNELS; CULTURED
   SCHWANN-CELLS; LAMININ-CONTAINING GEL; GROWTH-FACTOR;
   EXTRACELLULAR-MATRIX; REGENERATION INVIVO; ENTUBULATION REPAIR;
   COLLAGEN; GRAFTS
AB Tissue engineering in the peripheral nervous system unites efforts by physicians, engineers, and biologists toward a common goal to create either natural or synthetic tubular nerve guidance channels as alternatives to nerve autografts for the repair of peripheral nerve defects. Guidance channels help direct axons sprouting from the regenerating nerve end, provide a conduit for diffusion of neurotropic and neurotrophic factors secreted by the damaged nerve stumps, and minimize infiltration of fibrous tissue. In addition to efforts to control these physical characteristics of nerve guidance channels, researchers are optimizing the incorporation of biologic factors and engineering interactive biomaterial that can specifically stimulate the regeneration process. It is believed that current and future research will ultimately result in biologically active and interactive nerve guidance channels that can support and enhance peripheral nerve regeneration over longer, more clinically relevant defect lengths.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR AEBISCHER P, 1989, J NEUROSCI, V9, P3590
   AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Albert E., 1885, WIEN MED PRESSE, V26, P1285
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Brown RE, 1996, J RECONSTR MICROSURG, V12, P149, DOI 10.1055/s-2007-1006468
   CAJAL SRR, 1905, TRAB LAB INBEST BIOL, V4, P119
   CAMARATA PJ, 1992, NEUROSURGERY, V30, P313, DOI 10.1227/00006123-199203000-00001
   CAMPBELL JJ, 1993, BRAIN RES, V603, P264, DOI 10.1016/0006-8993(93)91246-O
   Cheng ET, 1998, MICROSURG, V18, P35, DOI 10.1002/(SICI)1098-2752(1998)18:1<35::AID-MICR9>3.0.CO;2-T
   CHIU DTW, 1990, PLAST RECONSTR SURG, V86, P928, DOI 10.1097/00006534-199011000-00015
   CORDEIRO PG, 1989, PLAST RECONSTR SURG, V83, P1013, DOI 10.1097/00006534-198906000-00014
   DANIELSEN N, 1995, BRAIN RES, V681, P105, DOI 10.1016/0006-8993(95)00300-F
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   DUBEY N, 1996, 1996 AM I CHEM ENG A
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W
   FERRARA G, 1608, NUOVA SELVA CIRURGIA
   FIELDS RD, 1986, EXP NEUROL, V92, P48, DOI 10.1016/0014-4886(86)90124-X
   Friedman W A, 1991, Neurosurg Clin N Am, V2, P43
   FURNISH EJ, 1998, FRONTIERS TISSUE ENG
   Genden EM, 1998, SURGERY, V124, P448, DOI 10.1016/S0039-6060(98)70152-7
   GLUCK T, 1880, ARCH KLIN CHIR, V25, P606
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Gulati AK, 1995, BRAIN RES, V705, P118, DOI 10.1016/0006-8993(95)01144-7
   GULATI AK, 1994, ACTA NEUROCHIR, V126, P158, DOI 10.1007/BF01476427
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   HALL SM, 1986, NEUROPATH APPL NEURO, V12, P27, DOI 10.1111/j.1365-2990.1986.tb00679.x
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Ho PR, 1998, ARCH OTOLARYNGOL, V124, P761, DOI 10.1001/archotol.124.7.761
   HUBER GC, 1895, J MORPHOL, V11, P629
   Ide C, 1996, NEUROSCI RES, V25, P101
   JOHNSON PC, 1982, MUSCLE NERVE, V5, P335, DOI 10.1002/mus.880050410
   Kakinoki R, 1997, INT ORTHOP, V21, P332, DOI 10.1007/s002640050179
   KEELEY R, 1993, RESTOR NEUROL NEUROS, V5, P353, DOI 10.3233/RNN-1993-55606
   Kirk EG, 1915, J AMER MED ASSOC, V65, P486
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   Letievant JJE, 1873, TRAITE SECTIONS NERV
   LEVI ADO, 1994, J NEUROSCI, V14, P1309
   LIONS WR, 1949, ATLAS PERIPHERAL NER
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   LUNDBORG G, 1986, SCAND J PLAST RECONS, V20, P279, DOI 10.3109/02844318609004486
   Lundborg G, 1988, NERVE INJURY REPAIR
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   MACKENZIE JAJ, 1909, SURG GYNECOL OBSTET, V9, P30
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MACKINNON SE, 1986, J HAND SURG-AM, V11A, P888, DOI 10.1016/S0363-5023(86)80244-1
   MACKINNON SE, 1988, SURG PERIPHERAL NERV
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1988, BRAIN RES, V447, P325, DOI 10.1016/0006-8993(88)91135-3
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Medinaceli L, 1982, EXP NEUROL, V77, P634
   MILLESI H, 1967, CHIR PLAST RECONSTR, V3, P47
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Munro CA, 1998, MUSCLE NERVE, V21, P1095, DOI 10.1002/(SICI)1097-4598(199808)21:8<1095::AID-MUS20>3.0.CO;2-S
   Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4
   Payr E, 1900, ARCH KLIN CHIR, V62, P67
   POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9
   RAIVICH G, 1993, INT J DEV NEUROSCI, V11, P311, DOI 10.1016/0736-5748(93)90003-V
   ROBINSON PH, 1991, MICROSURG, V12, P412, DOI 10.1002/micr.1920120608
   ROSEN JM, 1990, ANN PLAS SURG, V25, P375, DOI 10.1097/00000637-199011000-00006
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SEDDON HJ, 1947, BRIT J SURG, V35, P15
   SEDDON HJ, 1947, LANCET, V1, P418
   Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   TAKAHASHI M, 1988, ACTA PATHOL JAPON, V38, P1489
   TONG XJ, 1994, BRAIN RES, V663, P155, DOI 10.1016/0006-8993(94)90473-1
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   VALENTINI RF, 1995, BIOMEDICAL ENG HDB
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   WANG KK, 1993, J RECONSTR MICROSURG, V9, P39, DOI 10.1055/s-2007-1006637
   WANG KK, 1993, MICROSURG, V14, P608, DOI 10.1002/micr.1920140914
   Weiss P, 1944, J EXP ZOOL, V95, P233, DOI 10.1002/jez.1400950205
   WEISS P, 1946, J NEUROSURG, V3, P375, DOI 10.3171/jns.1946.3.5.0375
   WILLIAMS LR, 1985, J COMP NEUROL, V231, P209, DOI 10.1002/cne.902310208
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WILLIAMS LR, 1987, EXP NEUROL, V97, P555, DOI 10.1016/0014-4886(87)90113-0
NR 87
TC 98
Z9 112
U1 0
U2 8
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0094-1298
J9 CLIN PLAST SURG
JI Clin. Plast. Surg.
PD OCT
PY 1999
VL 26
IS 4
BP 617
EP +
PG 13
WC Surgery
SC Surgery
GA 247HC
UT WOS:000083214500009
PM 10553217
DA 2018-10-19
ER

PT J
AU Radhika, M
   Babu, M
   Sehgal, PK
AF Radhika, M
   Babu, M
   Sehgal, PK
TI Cellular proliferation on desamidated collagen matrices
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY &
   ENDOCRINOLOGY
LA English
DT Article
DE Achilles tendon; biocompatibility; biomaterial; cell viability;
   collagen; collagen substrata; desamidation; fibroblasts; hide trimmings;
   keratinocytes
ID CHEMICALLY MODIFIED COLLAGEN; EXTRACELLULAR-MATRIX; HUMAN-FIBROBLASTS;
   GROWTH; ATTACHMENT; LATTICES; INVITRO; CULTURE; CELLS
AB The attachment and growth of human skin keratinocytes (KR) and fibroblasts (FB) on collagen modified by desamidation were investigated. Unlike type I native collagen, desamidated collagen has a sharp iso-ionic pH (5.1) thereby making available either negative or positively charged biomolecules as and when required for a specific bio-application. The cytocompatibility of desamidated collagen prepared from bovine achilles tendons (DCA) and hide trimmings (DCH) was compared with the bovine type I collagen CNC). KR or FB were seeded onto the wells of tissue culture plates coated with the collagen preparations (DCA, DCH and NC). Cellular proliferation on each of these substrates was monitored by reduction of MITT ([3-(4,5-dimethyl-2-thiazolyl)-2,5-dimethyltelrazolium bromide] and by determining the DNA synthesis with [H-3]thymidine. In both cases cells proliferated well indicating that DCA. and DCH serve as good substrata and are biocompatible. Cell growth occurred without any morphological changes in cell appearance as observed from the phase-contrast microscopy of the cultures: indicating no toxicity of the material during the period studied. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Cent Leather Res Inst, Adyar 600020, Chennai, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, Adyar 600020, Chennai, India.
CR Alpaslan C, 1997, BRIT J ORAL MAX SURG, V35, P129, DOI 10.1016/S0266-4356(97)90689-6
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Berthod F, 1996, J BIOMED MATER RES, V32, P87, DOI 10.1002/(SICI)1097-4636(199609)32:1<87::AID-JBM10>3.0.CO;2-F
   COULOMB B, 1989, J INVEST DERMATOL, V92, P122, DOI 10.1111/1523-1747.ep13071335
   DOILLON CJ, 1988, BIOMATERIALS, V9, P91, DOI 10.1016/0142-9612(88)90077-4
   ELAD A, 1987, BURNS, V13, P173
   Elliott AT, 1996, NUCL MED COMMUN, V17, P3, DOI 10.1097/00006231-199601000-00002
   *EUR COMM STAND, 1994, 30993 EN
   GUSTAVSON KH, 1956, CHEM REACTIVITY COLL, P99
   KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0
   KNAPP TR, 1983, BIOMATERIALS RECONST, P882
   KONO T, 1990, Journal of Dermatology (Tokyo), V17, P2
   LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W
   MANIMALHA B, 1997, IN VITRO CELL DEV, V33, P233
   RADHIKA M, 1997, J BIOMED MATER RES, V35, P4
   RAO KP, 1989, COLLAGEN GRAFT COPOL, V3, P63
   REID GG, 1993, J MATER SCI-MATER M, V4, P201, DOI 10.1007/BF00120393
   RHUDY RW, 1988, J CELL PHYSIOL, V137, P185, DOI 10.1002/jcp.1041370123
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUCKER I, 1972, P SOC EXP BIOL MED, V139, P749
   SENGEL P, 1983, BIOCH PHYSL SKIN, P102
   SLATTER DH, 1982, AUST VET J, V59, P4, DOI 10.1111/j.1751-0813.1982.tb02700.x
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P162, DOI 10.1016/0142-9612(90)90149-K
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   TURLEY EA, 1985, DEV BIOL, V109, P347, DOI 10.1016/0012-1606(85)90461-0
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YOSHIZATO K, 1985, BIOMED RES-TOKYO, V6, P61
   Ziats Nicholas P., 1988, BIOMATERIALS, V9, P5
NR 28
TC 22
Z9 23
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0742-8413
J9 COMP BIOCHEM PHYS C
JI Comp. Biochem. Physiol. C-Pharmacol. Toxicol. Endocrinol.
PD OCT
PY 1999
VL 124
IS 2
BP 131
EP 139
DI 10.1016/S0742-8413(99)00042-0
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
GA 250NZ
UT WOS:000083395600003
PM 10622428
DA 2018-10-19
ER

PT J
AU Ono, I
   Tateshita, T
   Inoue, M
AF Ono, I
   Tateshita, T
   Inoue, M
TI Effects of a collagen matrix containing basic fibroblast growth factor
   on wound contraction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE wound healing; wound contraction; rabbit model; dermal substitute;
   collagen matrix; fibroblast growth factor; collagen gel contraction
ID ARTIFICIAL DERMIS; CYTOKINES; SKIN; BIOMATERIAL; SPONGE; REPAIR; MODEL;
   CELLS; FLUID
AB We evaluated the effectiveness of basic fibroblast growth factor (bFGF) in inhibiting wound contraction, both alone and in combination with collagen matrix, using a simulated in vivo delayed healing type model. We also studied the mechanisms involved in this inhibition in in vitro experiments using fibroblast populated collagen gels. As a result, we were able to demonstrate that both collagen matrix and bFGF significantly inhibited mound contraction; especially, bFGF acted in a dose-dependent fashion. Interestingly, their combination was much more effective than either collagen matrix or bFGF alone, a finding that was supported by the histopathological data. Wounds treated with collagen matrix, but not control wounds, showed horizontal rearrangement of collagen fibers in dermis as well as evidence of fibroblast proliferation, which was not observed in scar regions surrounded by normal dermis, Using fibroblast-populated collagen gel contraction as an in vitro model, we found that bFGF significantly inhibited contraction. Taking all these results together, it was concluded that collagen matrix is useful not only as a carrier of cytokines such as bFGF, but also for the quick closure of chronic wounds, thereby preventing contracture, which remains one of the most challenging problems in treating this type of wound. Application of bFGF-treated collagen matrix to chronic wounds such as decubitus, and diabetic and leg ulcers may prove to be highly beneficial in clinical practice. (C) 1999 John Wiley & Sons, Inc.
C1 Fukushima Med Univ, Sch Med, Dept Dermatol, Div Plast & Reconstruct Surg, Fukushima 9601295, Japan.
RP Ono, I (reprint author), Fukushima Med Univ, Sch Med, Dept Dermatol, Div Plast & Reconstruct Surg, Hikarigaoka 1, Fukushima 9601295, Japan.
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   Alaish Samuel M., 1996, Wound Repair and Regeneration, V4, P477, DOI 10.1046/j.1524-475X.1996.40412.x
   BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   BREW EC, 1995, J AM COLL SURGEONS, V180, P499
   COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012
   DAVIDSON JM, 1991, ANN NY ACAD SCI, V638, P306, DOI 10.1111/j.1749-6632.1991.tb49041.x
   DOILLON CJ, 1988, SCANNING MICROSCOPY, V2, P985
   FIDDES JC, 1991, ANN NY ACAD SCI, V638, P316
   FORD HR, 1989, ARCH SURG-CHICAGO, V124, P1422
   GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036
   GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95
   GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0
   Greiling D, 1996, J INVEST DERMATOL, V106, P1236, DOI 10.1111/1523-1747.ep12348928
   Grotendorst G, 1992, WOUND HEALING BIOCH, P237
   HAYWARD P, 1992, AM J SURG, V163, P288, DOI 10.1016/0002-9610(92)90004-B
   Imaizumi T, 1996, J DERMATOL SCI, V11, P134, DOI 10.1016/0923-1811(95)00431-9
   INOUE M, 1996, WOUND REPAIR REGEN, V6, P213
   Inoue Masayuki, 1996, Wound Repair and Regeneration, V4, P426, DOI 10.1046/j.1524-475X.1996.40406.x
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   KUROSAKA D, 1995, INVEST OPHTH VIS SCI, V36, P1701
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   Matsui R, 1996, BIOMATERIALS, V17, P995, DOI 10.1016/0142-9612(96)84674-6
   Ono I, 1996, J CRANIOFAC SURG, V7, P418, DOI 10.1097/00001665-199611000-00006
   ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z
   ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4
   PIERCE GF, 1992, AM J PATHOL, V140, P1375
   Robson M. C., 1994, Wound Repair and Regeneration, V2, P177, DOI 10.1046/j.1524-475X.1994.20307.x
   Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x
   ROBSON MC, 1992, ANN SURG, V216, P401, DOI 10.1097/00000658-199210000-00002
   ROBSON MC, 1992, WOUND HEALING BIOCH, P292
   SAKSELA O, 1987, J CELL BIOL, V105, P957, DOI 10.1083/jcb.105.2.957
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003
   Tarnuzzer Roy W., 1996, Wound Repair and Regeneration, V4, P321, DOI 10.1046/j.1524-475X.1996.40307.x
NR 38
TC 70
Z9 71
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 48
IS 5
BP 621
EP 630
DI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 238JV
UT WOS:000082707900005
PM 10490675
DA 2018-10-19
ER

PT J
AU Choi, YS
   Hong, SR
   Lee, YM
   Song, KW
   Park, MH
   Nam, YS
AF Choi, YS
   Hong, SR
   Lee, YM
   Song, KW
   Park, MH
   Nam, YS
TI Studies on gelatin-containing artificial skin: II. Preparation and
   characterization of cross-linked gelatin-hyaluronate sponge
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE gelatin; hyaluronic acid; sponge; cross-linking; wound dressing
ID LINKING; ACID; BIOMATERIALS
AB This study was conducted to develop a new sponge type of biomaterial to be used for either wound dressing or scaffold for tissue engineering. We were able to prepare an insoluble matrix composed of gelatin and sodium hyaluronate (HA) by dipping the soluble sponge into 90% (w/v) acetone/water mixture containing a small amount of cross-linking agent, 1-ethyl-3-3-dimethylaminoproplycarbodiimide hydrochloride, EDC, To characterize the sponge, Fourier-transformed infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and Instron analysis were performed. The obtained results indicate that the chemically cross-linked sponge shows a cross-linking degree of 10-35%, a mean pore size of 40-160 mu m, porosity of 35-67%, and a tensile strength of 10-30 gf/cm(2). Especially, the porosity measured by image analysis showed a tendency to increase with HA content, resulting in an increased water uptake. The resistance to collagenase degradation in vitro increased for up to 2 days. Silver sulfadiazine (AgSD)-impregnated gelatin-Hi sponge was also prepared and compared with conventional vaseline gauze by applying it onto a dorsal skin defect of wistar rat for 5, 12, and 21 days, Histological results showed an enhancement of wound healing in AgSD-impregnated gelatin-HA sponge. (C) 1999 John Wiley & Sons, Inc.
C1 Hanyang Univ, Coll Engn, Dept Ind Chem, Seoul 133791, South Korea.
   Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea.
   Hanyang Univ, Coll Med, Dept Gen Surg, Seoul 133791, South Korea.
RP Lee, YM (reprint author), Hanyang Univ, Coll Engn, Dept Ind Chem, Seoul 133791, South Korea.
EM ymlee@email.hanyang.ac.kr
RI Lee, Young Moo/G-5920-2015
OI Lee, Young Moo/0000-0002-5047-3143
CR BALAZS EA, 1986, Patent No. 4605691
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   Fakirov S, 1996, COLLOID POLYM SCI, V274, P334, DOI 10.1007/BF00654053
   HARPER E, 1972, BIOPOLYMERS, V11, P1607, DOI 10.1002/bip.1972.360110807
   Hazel B, 1980, BIOCHIM BIOPHYS ACTA, V632, P589
   KUROYANAGI Y, 1991, Journal of Burn Care and Rehabilitation, V12, P106, DOI 10.1097/00004630-199103000-00004
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   MALSON T, 1987, BIOMATERIALS CLIN AP, P345
   NEUMANN PM, 1981, J BIOMED MATER RES, V15, P9, DOI 10.1002/jbm.820150105
   OKAMOTO Y, 1992, ADVANCES IN CHITIN AND CHITOSAN, P70
   PETERSEN JK, 1984, INT J ORAL MAXILLOF, V13, P406
   Schacht E., 1993, Polymer Gels and Networks, V1, P213, DOI 10.1016/0966-7822(93)90001-X
   Sung HW, 1996, BIOMATERIALS, V17, P1405, DOI 10.1016/0142-9612(96)87282-6
   Takahashi Hitoshi, 1993, Tokushima Journal of Experimental Medicine, V40, P169
   TOMAS M, 1990, Patent No. 9401
   TOMAS M, 1986, Patent No. 79
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   TOMIHATA K, 1994, ACS S SERIES, V540
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Yao CH, 1996, MATER CHEM PHYS, V45, P6, DOI 10.1016/0254-0584(96)80040-X
   YUI N, 1992, J CONTROL RELEASE, V22, P105
NR 26
TC 170
Z9 176
U1 3
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 48
IS 5
BP 631
EP 639
DI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 238JV
UT WOS:000082707900006
PM 10490676
DA 2018-10-19
ER

PT J
AU Kidane, A
   Park, K
AF Kidane, A
   Park, K
TI Complement activation by PEO-grafted glass surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE complement activation; poly (ethylene oxide) grafting; glass surfaces;
   pluronic surfactants; single-hit mechanism; gamma-irradiation; plasma
ID PLASMA-PROTEIN ADSORPTION; POLY(ETHYLENE OXIDE); TRIBLOCK COPOLYMERS;
   PLATELET-ADHESION; BLOOD COMPATIBILITY; GAMMA-IRRADIATION; POLYMER
   SURFACES; HUMAN-SERUM; POLYURETHANE; PREVENTION
AB Activation of the complement system is one way in which the human body reacts to foreign materials that come in contact with blood, Poly(ethylene oxide) (PEO) has been used quite frequently to modify biomaterial surfaces to prevent protein adsorption and cell adhesion. Despite extensive use of PEG, however, PEG-induced complement activation has not been examined before. We examined the complement activation by PEO chains grafted to glass surfaces. PEO was grafted to trichlorovinylsilane-treated glass (TCVS-glass) by gamma-irradiation using PEO homopolymer, Pluronic(R) F108 (PF108), and PEO-polybutadiene-PEO triblock copolymer (COP5000), Complement activation was assessed by measuring the plasma C3a level. Of the three polymers grafted (PEO, PF108, and COP5000), only PF108 showed significant increases in complement activation over controls. Complement C3a production on PF108-grafted glass was linearly dependent on surface concentration of grafted PF108, The C3a concentration increased from 46 ng/mL to 316 ng/mL as the surface PF108 concentration increased from 0-0.25 mu g/cm(2), Kinetics of C3a generation by PF108-grafted surfaces show that 60% of the steady state C3a concentration was generated during the first hour of plasma exposure, When the same PF108-grafted glass surface was repeatedly exposed to fresh plasma, the amount of C3a generated decreased by 70% after the first exposure. This supports the "single-hit" mechanism in complement activation. PEO homopolymer did not activate complement in bulk solution, and, thus, it appears that C3a complement activation by PF108-grafted surfaces is due to the presence of poly(propylene oxide) units. Grafting of PEO using PEG-containing block copolymers requires examination of complement activating properties of the non-PEG segment. (C) 1999 John Wiley & Sons, Inc.
C1 Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA.
RP Park, K (reprint author), Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA.
FU NHLBI NIH HHS [HL-39081]
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   ATKINSON JP, 1987, IMMUNOL TODAY, V8, P212, DOI 10.1016/0167-5699(87)90167-8
   BACKER WA, 1983, KIDNEY INT, V23, P738
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   CARRENO MP, 1988, BIOMATERIALS, V9, P514, DOI 10.1016/0142-9612(88)90047-6
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1988, ARTIF ORGANS, V12, P508, DOI 10.1111/j.1525-1594.1988.tb02815.x
   CHENOWETH DE, 1984, ASAIO J, V7, P44
   COOPER NR, 1980, IMMUNOASSAYS CLIN LA, P393
   CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GYONGYOSSYISSA MIC, 1994, J LAB CLIN MED, V123, P859
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   HARPER GR, 1995, BIOMATERIALS, V16, P427, DOI 10.1016/0142-9612(95)98815-V
   Harris J. M. E., 1992, POLYETHYLENE GLYCOL, P385
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   Ho CH, 1998, LANGMUIR, V14, P3889, DOI 10.1021/la980148k
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   HUGLI TE, 1980, IMMUNOASSAYS CLIN LA, P443
   IKEDA Y, 1988, POLYM J, V20, P273, DOI 10.1295/polymj.20.273
   KAMP KW, 1993, INT J ART ORG, V16, P836
   KIDANE A, 1998, THESIS PURDUE U
   LABARRE DJ, 1990, INT J ARTIF ORGANS, V13, P651
   LARSSON R, 1989, BIOMATERIALS, V10, P511, DOI 10.1016/0142-9612(89)90055-0
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LIM F, 1993, BIOMATERIALS, V14, P537, DOI 10.1016/0142-9612(93)90243-U
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1157
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
NR 43
TC 26
Z9 26
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 48
IS 5
BP 640
EP 647
DI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 238JV
UT WOS:000082707900007
PM 10490677
DA 2018-10-19
ER

PT J
AU Yang, MJ
   Zhang, Z
   Hahn, C
   King, MW
   Guidoin, R
AF Yang, MJ
   Zhang, Z
   Hahn, C
   King, MW
   Guidoin, R
TI Assessing the resistance to calcification of polyurethane membranes used
   in the manufacture of ventricles for a totally implantable artificial
   heart
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyurethane; calcification; surface analysis; ventricle; artificial
   heart
ID BIOSTABILITY; BLOOD; MINERALIZATION; ELASTOMER
AB Ventricles made from segmented polyurethane membranes and used in the fabrication of a totally implantable artificial heart are known to undergo biomaterial-associated calcification. As there is no effective method currently available to prevent such biomaterials from calcifying, a practical solution is to use only materials with a relatively high resistance to calcification, to extend ventricular durability and ensure a longer functional life for the manufactured device. In the present study, an in vitro calcification protocol was used to determine the relative resistance to calcification of six different polyurethanes, namely, Carbothane(R) PC3570A, Chronoflex(R) AR, Corethane(R) 80A, Corethane(R) 55D, Tecoflex(R) EG80A, and Tecothane(R) TT1074A, The results demonstrated that all sis polyurethanes did become calcified during the 60-day incubation period in the calcification solution, The degree of calcification was found to be associated,vith the surface chemistry of the particular polyurethane, with the Tecothane TT1074A exhibiting the highest level. The Corethane 80A and 55D polymers showed a relatively low propensity to calcify. These two membranes can, therefore, be considered as the most appropriate materials for the fabrication of ventricles for a totally implantable artificial heart. In addition, since the calcification occurred primarily at the surface of the membranes, without affecting the bulk microphase structure, the issue of modifying the surface chemistry to reduce the incidence of calcification is discussed. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Laval, Dept Surg, Expt Surg Lab, Ste Foy, PQ G1K 7P4, Canada.
   CHUQ, Quebec Biomat Inst, Quebec City, PQ, Canada.
   Cardiovasc Res Ctr, CH-1423 Arzier, Switzerland.
RP Guidoin, R (reprint author), Univ Laval, Dept Surg, Expt Surg Lab, Room 1701,Serv Bldg, Ste Foy, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ABOUZAHR S, 1982, POLYMER, V23, P1077, DOI 10.1016/0032-3861(82)90411-6
   BEHMAN I, 1997, J MATER SCI-MATER M, V8, P1
   BRIGGS D, 1992, ANAL CHEM, V64, P1729, DOI 10.1021/ac00039a018
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COURY AJ, 1990, T SOC BIOMATER, V13, P158
   CUMMING RD, 1985, MECH ETIOLOGY CALCIF, P104
   Dillon J., 1989, INFRARED SPECTROSCOP
   DILLON JG, 1992, BIOMATERIALS, V13, P240, DOI 10.1016/0142-9612(92)90191-P
   FISHER AC, 1992, INT J ARTIF ORGANS, V15, P284
   Gadsden J.A., 1975, INFRARED SPECTRA MIN
   GIBBONS DF, 1992, CARDIOVASCULAR BIOMA, P185
   GLASMACHERSEILER B, 1990, ADV BIOMAT, V9, P105
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   HARASAKI H, 1979, T AM SOC ART INT ORG, V25, P305
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   IMACHI K, 1981, T AM SOC ART INT ORG, V27, P118
   KAPOLOS J, 1997, J BIOMED MATER RES, V38, P83
   LIU Q, 1996, P 5 WORLD BIOM C TOR, pR2
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   NOSE Y, 1981, T AM SOC ART INT ORG, V27, P714
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   PHILLIPS WM, 1980, SYNTHETIC BIOMEDICAL, P39
   PIERCE WS, 1980, SCIENCE, V208, P601, DOI 10.1126/science.7367883
   PIERCE WS, 1975, POLYM MED SURGERY, P263
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   PINCHUK L, 1994, T SOC BIOMATER, V17, P47
   POIRIER V, 1980, SYNTHETIC BIOMEDICAL, P73
   Reed A M, 1994, J Biomater Appl, V8, P210, DOI 10.1177/088532829400800303
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SINGH PI, 1983, MECH ETIOLOGY CALCIF, P158
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   SZYCHER M, 1977, ASAIO T, V23, P116
   Thoma R J, 1987, J Biomater Appl, V1, P449
   THOMA RJ, 1986, T SOC BIOMATER, V9, P47
   Wickelgren I, 1996, SCIENCE, V272, P668
   Yang MJ, 1999, J BIOMED MATER RES, V48, P13
   YEH JT, 1994, T SOC BIOMATER, V17, P47
   ZHANG Z, 1994, BIOMATERIALS, V15, P483
NR 41
TC 22
Z9 22
U1 1
U2 18
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 48
IS 5
BP 648
EP 659
DI 10.1002/(SICI)1097-4636(1999)48:5<648::AID-JBM8>3.0.CO;2-6
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 238JV
UT WOS:000082707900008
PM 10490678
DA 2018-10-19
ER

PT J
AU Balmain, J
   Hannoyer, B
   Lopez, E
AF Balmain, J
   Hannoyer, B
   Lopez, E
TI Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction
   analyses of mineral and organic matrix during heating of mother of pearl
   (nacre) from the shell of the mollusc Pinctada maxima
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE mother of pearl (nacre); FT-IR spectroscopy; X-ray diffraction; thermal
   behavior
ID OSTEOBLASTS MAINTAINED INVITRO; CALCIUM-PHOSPHATE; BONE; CARBONATE;
   HYDROXYAPATITE; ENVIRONMENT; PHASE; AGE
AB Fourier transform infrared spectroscopy (FT-IR) and X-ray diffraction patterns were used to analyze the mineral structure and organic matrix composition and thermal behavior of the internal nacreous layer (mother of pearl or nacre) of the shell of the giant oyster Pinctada maxima. Nacre is a natural biomaterial with osteogenic properties. The mineral of nacre is calcium carbonate crystallized as aragonite and it is highly crystallized. The FT-IR spectra showed amide, amine, and carboxylic acid groups in the organic matrix of the whole (organic and mineral) nacreous layer, with the HCO3- groups possibly at the organic-mineral interface. The insoluble organic matrix remaining after decalcification contained amide, amine, and carboxylic groups. The heated aragonite mineral structure of nacre underwent two transformations (X-ray diffraction), aragonite to calcite at 300-400 degrees C, and calcite to calcium oxide (CaO) at 500-600 degrees C, The organic matrix of nacre was destroyed around 550-600 degrees C, the same temperature as the calcite to CaO transformation, revealing the great thermal stability of the organic matrix and the organic-mineral bonding. This could be an useful feature for the in vivo use of this natural biomaterial as an implant. (C) 1999 John Wiley & Sons. Inc.
C1 Univ Rouen, IUT, LASTSM, F-76821 Mont St Aignan, France.
   Museum Natl Hist Nat, CNRS, URA 90, F-75231 Paris 05, France.
RP Balmain, J (reprint author), Univ La Rochelle, LEMMA, Pole Sci & Technol,Ave Marillac, F-17042 La Rochelle, France.
EM jbalmain@univ-lr.fr; lopez@mnhn.fr
CR ATLAN G, 1997, CR HEBD ACAD SCI, V320, P13
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   BILTZ RM, 1977, CLIN ORTHOP RELAT R, P279
   Bobbio A, 1972, Bull Hist Dent, V20, P1
   Boskey AL, 1997, J DENT RES, V76, P1433, DOI 10.1177/00220345970760080501
   Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022
   DAUPHIN Y, 1995, EXPERIENTIA, V51, P278, DOI 10.1007/BF01931112
   DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P1
   FRICAIN JC, 1997, BIOCERAMICS, V10, P383
   Fujita T, 1996, CALCIFIED TISSUE INT, V58, P226
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   Irigaray JL, 1996, J BIOMAT SCI-POLYM E, V7, P741, DOI 10.1163/156856296X00507
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   LEGROS R, 1987, CALCIFIED TISSUE INT, V41, P137, DOI 10.1007/BF02563793
   LEGROS R, 1986, J CHEM RES-S, P8
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1995, B I OCEANO MONACO, V3, P49
   MANNE S, 1994, P ROY SOC B-BIOL SCI, V256, P17, DOI 10.1098/rspb.1994.0043
   Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657
   MUTVEI H, 1977, CALC TISS RES, V24, P11, DOI 10.1007/BF02223291
   MUTVEI H, 1978, ZOOL SCR, V7, P287, DOI 10.1111/j.1463-6409.1978.tb00612.x
   NIARD R, 1996, ENCY MED CHIR TECHNI, P20
   NYQUIST RA, 1971, HDB INFRARED RAMAN S
   Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371
   PATAT JL, 1990, ACTUALITES BIOMATERI, P161
   POSNER AS, 1975, J DENT RES, V54, pB88, DOI 10.1177/00220345750540023301
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   Ross S. D., 1972, INORGANIC INFRARED R
   SABBIDES TG, 1993, J CRYST GROWTH, V133, P13, DOI 10.1016/0022-0248(93)90098-H
   SEDEL L, 1997, BIOCERAMICS, V10
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P4
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
NR 37
TC 88
Z9 99
U1 1
U2 48
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 48
IS 5
BP 749
EP 754
DI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 238JV
UT WOS:000082707900022
PM 10490692
DA 2018-10-19
ER

PT J
AU Kimakhe, S
   Bohic, S
   Larrose, C
   Reynaud, A
   Pilet, P
   Giumelli, B
   Heymann, D
   Daculsi, G
AF Kimakhe, S
   Bohic, S
   Larrose, C
   Reynaud, A
   Pilet, P
   Giumelli, B
   Heymann, D
   Daculsi, G
TI Biological activities of sustained polymyxin B release from calcium
   phosphate biomaterial prepared by dynamic compaction: An in vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polymyxin B; drug delivery system; capillary electrophoresis;
   monocytes/macrophages; lipopolysaccharides; calcium phosphate
   biomaterials; dynamic compaction
ID TETRACYCLINE FIBER THERAPY; PERIODONTAL-DISEASE; DELIVERY SYSTEM;
   GROWTH-HORMONE; ANTIBIOTICS
AB Calcium phosphate ceramics (CaP) have recently been proposed as a potential matrix for a bioactive drug delivery system (DDS) in which the effect in situ of a released therapeutic agent is favored by the biocompatibility, osteoconductivity, and bioresorption of the ceramic material. Polymyxin B (PMB) is a polypeptidic antibiotic which undergoes thermodamage above 60 degrees C. The dynamic compaction method was developed to consolidate the drug load on CaP powder without external heating. Two projectile velocities (50 and 25 m/s) were used here to achieve powder consolidation. Among the different techniques used to associate therapeutic agents with CaP, wet adsorption was performed before the dynamic compaction process. The PMB release profile was measured by a capillary electrophoresis technique, CaP crystallography was studied by x-ray diffraction, and Cap physicochemical analysis was performed by infrared spectroscopy. The biological activities of PMB-loaded compacted CaP were determined by the effect of the antibiotic and monocyte/macroyhage degradation on compact surfaces. PMB release began after 2-3 days of incubation for blocks compacted at 25 m/s velocity and on day 5 for those compacted at 50 m/s velocity, a discrepancy was noted between the amounts of PMB released (0.5-2.1 mg) and the amounts initially compacted (2-8 mg) with CaP powder. The biological activities (antibacterial activity and inhibited lipopolysaccharide effects on monocyte/ macrophage CaP degradation) of PMB released from compacted calcium-deficient apatite were unaltered. Thus, dynamic compaction allows PMB to be used with Cap ceramics without any loss in its integrity and biological effects. (C) 1999 John Wiley & Sons, Inc.
C1 Fac Chirurg Dent, UPRES 2159, F-44042 Nantes 01, France.
   CHU Nantes, Inst Biol, Lab Biochim Gen, F-44093 Nantes, France.
   CHU Nantes, Inst Biol, Bacteriol Lab, F-44093 Nantes 01, France.
   Fac Med, Lab Histol Embryol, F-44093 Nantes 01, France.
RP Kimakhe, S (reprint author), Fac Chirurg Dent, UPRES 2159, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes 01, France.
RI Daculsi, Guy/P-1320-2014; BOHIC, Sylvain/F-6464-2013; Paul,
   Pilet/A-3755-2015
OI Daculsi, Guy/0000-0003-1030-3446; BOHIC, Sylvain/0000-0001-6355-7592; 
CR *ASS FRANC NORM, 1993, 94066 AFNOR S
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   BARNEY VC, 1986, J PERIODONTOL, V57, P764, DOI 10.1902/jop.1986.57.12.764
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   BRAUN RE, 1992, J PERIODONTOL, V63, P469, DOI 10.1902/jop.1992.63.5.469
   Ciancio SG, 1995, PERIODONTOL 2000, V9, P27, DOI 10.1111/j.1600-0757.1995.tb00054.x
   CIANCIO SG, 1992, J PERIODONTOL, V63, P849, DOI 10.1902/jop.1992.63.10.849
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DALY CG, 1980, J ORAL PATHOL MED, V9, P1, DOI 10.1111/j.1600-0714.1980.tb01383.x
   DIJKMANS R, 1990, INFECT IMMUN, V58, P32
   GAUTIER H, IN PRESS J BIOMED MA
   GOODSON JM, 1991, J PERIODONTAL RES, V26, P361, DOI 10.1111/j.1600-0765.1991.tb02075.x
   GUCHIEUX J, 1998, J BONE MINER RES, V13, P739
   Guicheux J, 1997, J BIOMED MATER RES, V34, P165, DOI 10.1002/(SICI)1097-4636(199702)34:2<165::AID-JBM4>3.0.CO;2-O
   Guicheux J, 1997, J BIOMED MATER RES, V36, P258, DOI 10.1002/(SICI)1097-4636(199708)36:2<258::AID-JBM15>3.0.CO;2-C
   HARVEY W, 1986, BRIT J EXP PATHOL, V67, P699
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   Kimakhe S, 1998, J BIOMED MATER RES, V40, P336, DOI 10.1002/(SICI)1097-4636(199805)40:2<336::AID-JBM19>3.3.CO;2-5
   KORKUSUZ F, 1993, J BONE JOINT SURG BR, V75, P111
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LINDEMANN RA, 1988, J DENT RES, V67, P1131, DOI 10.1177/00220345880670081401
   Maze GI, 1996, J CLIN PERIODONTOL, V23, P1133, DOI 10.1111/j.1600-051X.1996.tb01815.x
   NEWMAN M, 1994, J PERIODONTOL, V7, P685
   OTSUKA M, 1994, J PHARM SCI, V83, P6411
   PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, V248, P12
   PEDRAZZOLI V, 1992, J CLIN PERIODONTOL, V19, P715, DOI 10.1111/j.1600-051X.1992.tb02534.x
   POTHIER A, 1979, PHARM CLIN BASES THE
   REY C, 1990, Biomaterials, V11, P13
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   TONETTI MS, 1996, P 2 EUR WORKSH PER C
   Trecant M, 1997, BIOMATERIALS, V18, P141, DOI 10.1016/S0142-9612(96)00108-1
   TRECANT M, 1995, J MATER SCI-MATER M, V6, P545, DOI 10.1007/BF00151037
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Yu D, 1991, J Formos Med Assoc, V90, P953
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 37
TC 36
Z9 37
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 47
IS 1
BP 18
EP 27
DI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 219GP
UT WOS:000081599800003
PM 10400876
DA 2018-10-19
ER

PT J
AU Hu, M
   Sabelman, EE
   Lai, S
   Timek, EK
   Zhang, F
   Hentz, VR
   Lineaweaver, WC
AF Hu, M
   Sabelman, EE
   Lai, S
   Timek, EK
   Zhang, F
   Hentz, VR
   Lineaweaver, WC
TI Polypeptide resurfacing method improves fibroblast's adhesion to
   hyaluronan strands
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hyaluronic acid; polypeptide; glutaraldehyde; fibroblast; cell adhesion
ID FETAL WOUND FLUID; CROSS-LINKING; BINDING PROTEINS; COLLAGEN; ACID;
   GLUTARALDEHYDE; IDENTIFICATION; PROLIFERATION; PEPTIDES; RECEPTOR
AB Hyaluronic acid (hyaluronan, HyA) is a matrix component that takes part in cell adhesion and growth in normal and repaired tissues. Since it is soluble in water, HyA has been of limited use in tissue engineering of artificial matrices. Recent studies demonstrate that polypeptides hale the twin advantages of reducing solubility of HyA and improving cellular attachment via cell surface adhesion molecule receptors. This paper describes a new approach of using a polypeptide resurfacing method to enhance the attachment of cells to HyA strands. HyA strands were crosslinked by glutaraldehyde and then resurfaced with poly-D-lysine, poly-L-lysine, glycine, or glutamine. After inoculation with fibroblasts in vitro, modified HyA was evaluated with histological and immunohistochemical staining methods for cell adhesion and proliferation. Modified HyA with fibroblast cells also were implanted in vivo. The results show that (1) both polylysines enhanced fibroblast adhesion to crosslinked HyA strands; (2) HyA strands were able to be crosslinked well by 3 days of treatment in glutaraldehyde, and as a biomaterial they could resist biodegradation; (3) modified HS A has good biocompatibility, both in vitro and in vivo. The results demonstrate that HyA material resurfaced by polypeptides has positive advantages for cellular adhesion. Resurfaced HyA has much potential as an improved biomaterial for clinical usage. (C) 1999 John Wiley & Sons, Inc.
C1 Stanford Univ, Dept Funct Restorat, Stanford, CA 94305 USA.
   VA Hosp, RR&D Ctr, Palo Alto, CA 94306 USA.
RP Hu, M (reprint author), 4483 Macbeth Circle, Fremont, CA 94555 USA.
CR ANMARKRUD N, 1992, ACTA OPHTHALMOL, V70, P96
   BOENSCH C, 1995, J BIOL CHEM, V270, P1807, DOI 10.1074/jbc.270.4.1807
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   Hellstrom S, 1987, Acta Otolaryngol Suppl, V442, P54
   Huang LLH, 1998, J BIOMED MATER RES, V39, P630, DOI 10.1002/(SICI)1097-4636(19980315)39:4<630::AID-JBM18>3.3.CO;2-U
   ISDALE A H, 1991, Journal of Drug Development, V4, P93
   IWATA H, 1993, CLIN ORTHOP RELAT R, P285
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   LARSEN NE, 1993, J BIOMED MATER RES, V42, P716
   LIAO KX, 1995, ANN THORAC SURG, V60, pS343, DOI 10.1016/0003-4975(95)00286-T
   Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853
   LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003
   LONGAKER MT, 1989, ANN SURG, V210, P667, DOI 10.1097/00000658-198911000-00016
   Loomans EEMG, 1997, ANAL BIOCHEM, V248, P117, DOI 10.1006/abio.1997.2119
   LOVE CS, 1991, J CARDIAC SURG, V6, P499, DOI 10.1111/j.1540-8191.1991.tb00351.x
   Love J W, 1992, J Heart Valve Dis, V1, P232
   MAKOHLISO SA, 1993, J BIOMED MATER RES, V27, P1075, DOI 10.1002/jbm.820270813
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   Melrose J, 1996, ELECTROPHORESIS, V17, P205, DOI 10.1002/elps.1150170134
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Miller D, 1980, J Am Intraocul Implant Soc, V6, P13
   Nothias F, 1997, EUR J NEUROSCI, V9, P1553, DOI 10.1111/j.1460-9568.1997.tb01513.x
   Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198
   Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395
   SWANN DA, 1978, JOINTS SYNOVIAL FLUI, P407
   SZYMANSKI PT, 1993, AM J PHYSIOL, V265, pC379
   THOMAS SC, 1986, CLIN ORTHOP RELAT R, P281
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   WIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447
   YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15
NR 36
TC 22
Z9 24
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 47
IS 1
BP 79
EP 84
DI 10.1002/(SICI)1097-4636(199910)47:1<79::AID-JBM11>3.0.CO;2-J
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 219GP
UT WOS:000081599800011
PM 10400884
DA 2018-10-19
ER

PT J
AU Yoshida, Y
   Van Meerbeek, B
   Snauwaert, J
   Hellemans, L
   Lambrechts, P
   Vanherle, G
   Wakasa, K
   Pashley, DH
AF Yoshida, Y
   Van Meerbeek, B
   Snauwaert, J
   Hellemans, L
   Lambrechts, P
   Vanherle, G
   Wakasa, K
   Pashley, DH
TI A novel approach to AFM characterization of adhesive tooth-biomaterial
   interfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE adhesive interface; atomic force microscopy; collagen; dentin;
   ultra-morphology
ID ATOMIC-FORCE MICROSCOPE; GLASS-IONOMER; DENTIN ADHESIVE; CEMENTS;
   SYSTEMS
AB A novel approach is proposed for studying tooth-biomaterial interactions with high resolution. Thus far,: polished interfaces examined by AFM have not disclosed much detail, mainly due to the destruction of soft surface texture and the smearing of polishing debris across the interface that obscures the actual ultra-structure. Therefore the practical utility of diamond-knife microtomy as a sample preparation technique for imaging tooth-biomaterial interfaces by AFM with high resolution was tested in this study and compared to that of ultra-fine mechanical polishing-techniques. The AFM images clearly demonstrated the enhanced potential of diamond-knife microtomy for nondestructively producing clean cross-sections through interfaces that allow the interfacial ultra-structure to be imaged by AFM:with a resolution equaling that of TEM. This novel approach opens the field to the full range of scanning probe microscopy, including physical and chemical surface characterization of interfaces with a mix of soft and hard substrates. (C) 1999 John Wiley & Sons, Inc.
C1 Catholic Univ Louvain, Sch Dent Oral Pathol & Maxillofacial Surg, BIOMAT, B-3000 Louvain, Belgium.
   Hiroshima Univ, Sch Dent, Dept Biomat Sci, Minami Ku, Hiroshima 7348553, Japan.
   Katholieke Univ Leuven, Dept Chem, Lab Chem & Biol Dynam, B-3001 Heverlee, Belgium.
   Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Sch Dent Oral Pathol & Maxillofacial Surg, BIOMAT, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
RI YOSHIDA, Yasuhiro/B-2472-2011
CR ANUSAVICE KJ, 1989, QUALITY EVLAUATION D
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   DAVIES JP, 1994, ORTHOPEDICS, V17, P171
   Degrange M, 1997, MINIMALLY INVASIVE R
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   Gladys S, 1997, J DENT RES, V76, P883, DOI 10.1177/00220345970760041001
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   MARSHALL S, 1997, J DENT RES, V76, P315
   Sidhu SK, 1998, J DENT RES, V77, P1749, DOI 10.1177/00220345980770091101
   Soballe K., 1993, ACTA ORTHOP SCAND S, V64, P1
   Steflik D E, 1993, J Oral Implantol, V19, P90
   Tay FR, 1998, J DENT, V26, P147, DOI 10.1016/S0300-5712(96)00090-5
   Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501
   VanMeerbeek B, 1996, J DENT RES, V75, P879, DOI 10.1177/00220345960750030401
   VANMEERBEEK B, 1998, T ACAD DENT MATER, V11, P33
   WATSON TF, 1989, J DENT RES, V68, P1124, DOI 10.1177/00220345890680061301
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   YOSHIDA Y, 1999, J DENT RES, V78, P530
   YOSHIDA Y, IN PRESS EVIDENCE CH
NR 20
TC 38
Z9 39
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1999
VL 47
IS 1
BP 85
EP 90
DI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 219GP
UT WOS:000081599800012
PM 10400885
DA 2018-10-19
ER

PT J
AU Winn, SR
   Randolph, G
   Uludag, H
   Wong, SC
   Hair, GA
   Hollinger, JO
AF Winn, SR
   Randolph, G
   Uludag, H
   Wong, SC
   Hair, GA
   Hollinger, JO
TI Establishing an immortalized human osteoprecursor cell line: OPC1
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST-LIKE CELLS; LARGE
   TUMOR-ANTIGEN; STROMAL CELLS; DIFFERENTIATION; GROWTH; MARROW;
   SIMIAN-VIRUS-40; REGENERATION; RECEPTORS
AB The present studies evaluated the feasibility of establishing a conditionally immortalized osteoprecursor cell line derived from human fetal bone tissue. Primary cultures were transfected with a plasmid in which the Mx-l promoter drives the expression of SV40 T-antigen when activated by human AID interferon, Several neomycin (G418)-resistant colonies were characterized for cell growth and alkaline phosphatase (ALP) enzyme activity. The clone, designated OPC1 (osteoblastic precursor cell line 1), which exhibited the highest ALP enzyme activity at passage 10 (P10), was selected for additional osteogenic phenotypic characterization. Reverse transcription-polymerase chain reaction (RT-PCR) phenotyping revealed abundant mRNA for osteocalcin (OC), osteonectin (ON), osteopontin (OP), parathyroid hormone receptor (PTHr), ALP, and procollagen type I (ProI). In addition, the levels of quantitative RT-PCR product of ON, OF, PTHr, and ProI mRNAs exhibited a marked up-regulation when maintained in medium containing an osteogenic supplement (OS), The ability to stimulate osteogenic differentiation was characterized in postconfluent OPC1 cells maintained in tissue culture medium supplemented with recombinant human bone morphogenetic protein-2 (rhBMP-2) either with or without an OS, All treatment groups exhibited a striking up-regulation of ALP enzyme activity that coincided with ALP histochemical observations. Postconfluent cells also exhibited the ability to form mineralized nodules under all treatments (confirmed by von Kossa histochemical staining and calcium deposition). An enzyme immunosorbent assay (EIA) was utilized to measure intact human OC from the OPC1 line under the various treatments. Abundant OC was evident in the tissue culture medium indicating de novo sythesis and release from the OPC1 line under appropriate conditions. The clonal human-derived OPC1 line represents a homogeneous osteogenic cell line that not only has maintained a consistent bone phenotype from P10 to at least P30, but has also exhibited the capacity to generate programmed differentiation in the presence of tow dose rhBMP-2 (10 ng/ml), Thus, the OPC1 line is a human-derived osteoprecursor that provides a sensitive in vitro cell culture system to evaluate bone development, cell/biomaterial interactions, and may be a useful screen for putative bone differentiating factors.
C1 Oregon Hlth & Sci Univ, Div Plast & Reconstruct Surg, Portland, OR 97201 USA.
   Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.
   Modex Therapeut SA, Dept Mol Biol, Lausanne, Switzerland.
   Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA USA.
RP Winn, SR (reprint author), Oregon Hlth & Sci Univ, Div Plast & Reconstruct Surg, L352A,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
CR Bilbe G, 1996, BONE, V19, P437, DOI 10.1016/S8756-3282(96)00254-2
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   EVANS CE, 1995, J ORTHOPAED RES, V13, P317, DOI 10.1002/jor.1100130304
   FANNING E, 1992, ANNU REV BIOCHEM, V61, P55
   GALLAGHER JA, 1996, HUMAN CELL CULTURE P, P233
   HAMMANG JP, 1995, SOC NEUR ABS, V21, P1075
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Hollinger J, 1996, J CONTROL RELEASE, V39, P287, DOI 10.1016/0168-3659(95)00183-2
   Hollinger JO, 1999, TISSUE ENGINEERING, P17
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6
   Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014
   KEETING PE, 1992, J BONE MINER RES, V7, P127
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   KRIEGLER M, 1990, GENE TRANSFER EXPRES, P103
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   MANFREDI JJ, 1994, BBA-REV CANCER, V1198, P65, DOI 10.1016/0304-419X(94)90006-X
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   RODAN SB, 1987, CANCER RES, V47, P4961
   ROSEN V, 1994, J BONE MINER RES, V9, P1759
   ROULEAU MF, 1988, ENDOCRINOLOGY, V123, P187, DOI 10.1210/endo-123-1-187
   SCHINSTINE M, 1995, CELL TRANSPLANT, V4, P93, DOI 10.1016/0963-6897(94)00047-N
   SMITH JL, 1995, J CONTROL RELEASE, V36, P183, DOI 10.1016/0168-3659(95)00046-B
   STEINER AL, 1972, J BIOL CHEM, V247, P1114
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   VACANTI CA, 1997, PRINCIPLES TISSUE EN, P619
   VUKICEVIC S, 1993, ADV MOL CELL BIOL, V6, P207
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 42
TC 66
Z9 68
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD OCT
PY 1999
VL 14
IS 10
BP 1721
EP 1733
DI 10.1359/jbmr.1999.14.10.1721
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 238VA
UT WOS:000082732700012
PM 10491220
OA Bronze
DA 2018-10-19
ER

PT J
AU Ornberg, RL
   Woerner, BM
   Edwards, DA
AF Ornberg, RL
   Woerner, BM
   Edwards, DA
TI Analysis of stained objects in histological sections by spectral imaging
   and differential absorption
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE digital image analysis; color image analysis; spectral analysis; image
   segmentation; differential absorption; morphometry
ID MICROSCOPY; MARKERS; CANCER; IMAGES; CELLS
AB We describe a new light microscopic imaging system and method to perform high through put color image analysis on histological tissue sections. The system features a computer-controlled, random-access liquid crystal tunable filter and high-resolution digital camera on a conventional brightfield microscope. For any combination of stains, the method determines the spectral transmittance of each stain on the slide and selects two or more wavelengths at which the differential absorption between stain and counterstain is greatest and the exposure time is reasonably short. Flatfield corrected digital images at these wavelengths are acquired and divided to produce a gray scale ratio image. The ratio image is calculated such that the stained features of interest are highlighted above a uniform background and the counterstained features are highlighted below background. Image threshold procedures using either visual inspection or a threshold value determined by the image mean intensity and standard deviation are used to segment the stained features of interest for subsequent morphometry. Results are presented for peroxidase-AEC-labeled tumor tissue and trichrome-stained biomaterial implant tissues. In principle, the method should work for any combination of colored stains.
C1 Monsanto Co, St Louis, MO 63198 USA.
RP Ornberg, RL (reprint author), Monsanto Co, 700 Chesterfield Pkwy N,GG3G, St Louis, MO 63198 USA.
CR BACUS SS, 1989, AM J PATHOL, V135, P783
   Carron CP, 1998, CANCER RES, V58, P1930
   Castleman KR, 1998, BIOL BULL, V194, P100, DOI 10.2307/1543039
   EM P, 1996, COMPUT MED IMAG GRAP, V20, P357
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661
   Kohlberger PD, 1997, GYNECOL ONCOL, V64, P404, DOI 10.1006/gyno.1996.4565
   Morris HR, 1996, APPL SPECTROSC, V50, P805, DOI 10.1366/0003702963905655
   MORRIS HR, 1994, APPL SPECTROSC, V48, P857, DOI 10.1366/0003702944029820
   PRATT WK, 1991, DIGITAL IMAGING PROC
   Ruifrok AC, 1997, ANAL QUANT CYTOL, V19, P107
   RUSS JC, 1990, COMPUTER ASSISTED MI
   Smolle J, 1996, ANAL QUANT CYTOL, V18, P323
   Tomatis S, 1998, TUMORI, V84, P29
   Weaver JR, 1997, CYTOMETRY, V29, P128, DOI 10.1002/(SICI)1097-0320(19971001)29:2<128::AID-CYTO5>3.0.CO;2-9
   WILLEMSE F, 1994, ANAL QUANT CYTOL HIS, V16, P366
   Zhou RX, 1996, MED PHYS, V23, P1977, DOI 10.1118/1.597841
NR 16
TC 44
Z9 48
U1 0
U2 4
PU HISTOCHEMICAL SOC INC
PI SEATTLE
PA UNIV WASHINGTON, DEPT BIOSTRUCTURE, BOX 357420, SEATTLE, WA 98195 USA
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD OCT
PY 1999
VL 47
IS 10
BP 1307
EP 1313
DI 10.1177/002215549904701010
PG 7
WC Cell Biology
SC Cell Biology
GA 240QW
UT WOS:000082837500010
PM 10490459
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Otto, M
   Kooten, TV
   Krump, V
   Kriegsmann, J
   Bittinger, F
AF Kirkpatrick, CJ
   Otto, M
   Kooten, TV
   Krump, V
   Kriegsmann, J
   Bittinger, F
TI Endothelial cell cultures as a tool in biomaterial research
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN UMBILICAL VEIN; FLOW CHAMBER SYSTEM; HEAVY-METAL IONS; NF-KAPPA-B;
   ADHESION MOLECULES; IN-VITRO; SURFACE; GROWTH; COMMUNICATION;
   ANGIOGENESIS
AB Progress in biocompatibility and tissue engineering would today be inconceivable without the aid of in vitro techniques. Endothelial cell cultures represent a valuable tool not just in haemocompatibility testing, but also in the concept of designing hybrid organs. In the past endothelial cells (EC) have frequently been used in cytotoxicity testing of materials, especially polymers, used in blood-contacting implants, as well as for investigating seeding technologies for vascular prostheses. At present the exponential development both in theory and practice of cell and molecular biology of the endothelium offers great promise in the biomaterial field. Up until now this EC research field has mostly been non-biomaterial orientated. Nevertheless, the relevance for biomaterial research is apparent. Four aspects will be concisely reviewed under the headings inflammation, with special reference to cell adhesion molecules (CAMs) and cytokines, angiogenesis, focusing on the healing response, signal transduction, presenting examples from cytokine- and metal ion-induced up-regulation of genes coding for CAMs, and, finally, endothelial functionality, with emphasis on the principal characteristics of the physiological endothelial phenotype. Finally, the application of these fields to three foci of biomaterial research will be discussed, emphasizing the role of EC culture techniques in controlling the host response to biomaterials (microvascular EC), controlling EC functionality (promoting positive effects and down-regulating negative effects), and tissue engineering (integration of EC into hybrid organs/biosensors). The need for more co-culture and three-dimensional models will be stressed and data from the authors' laboratory presented to illustrate these principles. (C) 1999 Kluwer Academic Publishers.
C1 Univ Mainz, Inst Pathol, D-6500 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, D-6500 Mainz, Germany.
CR BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   CARMELIET P, 1997, AM J PHYSL, V273
   Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162
   Cicala C, 1998, LIFE SCI, V62, P1817, DOI 10.1016/S0024-3205(97)01167-3
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DEKKER A, 1994, CELL MATER, V4, P101
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hill SM, 1998, ANAT REC, V253, P42, DOI 10.1002/(SICI)1097-0185(199804)253:2<42::AID-AR7>3.0.CO;2-G
   Isomaki P, 1997, ANN MED, V29, P499, DOI 10.3109/07853899709007474
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KADER K, 1998, P 24 ANN M SOC BIOM
   Kirkpatrick CJ, 1996, VIRCHOWS ARCH, V427, P461
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KIRKPATRICK CJ, 1992, CELL MATER, V2, P169
   KIRKPATRICK CJ, 1991, CELL MATER, V1, P93
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P199, DOI 10.1159/000163911
   KLEIN CL, 1994, COLLOID SURFACE B, V3, P229
   Onishi M, 1998, Int Rev Immunol, V16, P617, DOI 10.3109/08830189809043011
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   REDMOND EM, 1995, IN VITRO CELL DEV-AN, V31, P601
   Schweitzer KM, 1997, LAB INVEST, V76, P25
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135
NR 33
TC 39
Z9 39
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 589
EP 594
DI 10.1023/A:1008946615663
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000002
PM 15347971
DA 2018-10-19
ER

PT J
AU Kao, WJ
   Hubbell, JA
   Anderson, JM
AF Kao, WJ
   Hubbell, JA
   Anderson, JM
TI Protein-mediated macrophage adhesion and activation on biomaterials: a
   model for modulating cell behavior
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIO-MEDICAL POLYMERS; IN-VIVO; THEORETICAL-ANALYSIS; FIBRONECTIN;
   COMPLEMENT; PEPTIDE; NETWORKS; RECEPTOR
AB The elucidation of proteins involved in biomaterial-modulated macrophage behavior is critical for the improvement of material performance and the initial exploration of material design capable of manipulating macrophage function for tissue engineering. In this paper, several in vitro and in vivo techniques are presented to demonstrate means of delineating a part of the complex molecular mechanisms involved in the interaction between biomaterial and macrophage adhesion and phenotypic development. The following conclusions were reached: (1) using radioimmunoassay, complement component C3 was found to be critical in mediating human macrophage adhesion on polyurethanes. (2) The presence of a diphenolic antioxidant additive in polyurethanes increased the propensity for complement upregulation but did not affect adherent macrophage density. (3) The subcutaneous cage-implant system was utilized to delineate interleukin-4 participation in the fusion of adherent macrophages to form foreign body giant cells in vivo in mice. The injection of purified interleukin-4 neutralizing antibody into the implanted cages significantly decreased the giant cell density; conversely, the giant cell density was significantly increased by the injection of recombinant interleukin-4 when compared with the controls. (4) The RGD and PHSRN amino acid sequences of the central cell binding domain and the PRRARV sequence of the C-terminal heparin binding domain of human plasma fibronectin were utilized to study the structure-functional relationship of protein in mediating macrophage behavior. Polyethyleneglycol-based networks grafted with the RGD-containing peptide supported higher adherent human macrophage density than surfaces grafted with other peptides. The formation of foreign body giant cell was highly dependent on the relative orientation between PHSRN and RGD domains located in a single peptide. (C) 1999 Kluwer Academic Publishers.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland.
   Univ Zurich, Zurich, Switzerland.
   Case Western Reserve Univ, Dept Biomed Engn, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR AKERSTROM B, 1985, J IMMUNOL, V135, P2589
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   AURIAULT C, 1983, FEBS LETT, V153, P11, DOI 10.1016/0014-5793(83)80109-4
   CHENOWETH DE, 1991, ARTIF ORGANS, V12, P502
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003
   FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   KAO J, 1994, J BIOL CHEM, V269, P9774
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   LIU HL, 1992, J BIOL CHEM, V267, P20811
   MARDER SR, 1985, J IMMUNOL, V134, P3325
   McNally AK, 1996, AM J PATHOL, V149, P975
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   WEWERS MD, 1992, CYTOKINES HLTH DIS, P235
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 31
TC 47
Z9 49
U1 0
U2 12
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 601
EP 605
DI 10.1023/A:1008971222932
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000004
PM 15347973
DA 2018-10-19
ER

PT J
AU Oreffo, ROC
   Triffitt, JT
AF Oreffo, ROC
   Triffitt, JT
TI In vitro and in vivo methods to determine the interactions of osteogenic
   cells with biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN-BONE CELLS; POROUS HYDROXYAPATITE; PARATHYROID-HORMONE;
   MONOCLONAL-ANTIBODIES; OSTEOBLAST CULTURES; STROMAL CELLS;
   DIFFERENTIATION; PHENOTYPE; INVITRO; SARCOMA
AB To assess new biomaterials for possible use as bone graft substitutes, a number of techniques allow interactions with osteoblastic cells to be studied, with respect to effects on proliferation and differentiation of osteoprogenitors. In vitro models include the use of bone explant cultures, fetal rat calvarial-derived osteoblast cells, primary stromal populations, transformed and non-transformed cell lines and immortalized osteoblast cell lines. However, these assessments are limited by the extent of osteogenic differentiation and bone formation that can be observed in vitro, species differences and phenotypic drift of cells cultured in vitro. The use of in vivo experimental systems such as the segmental/calvarial bone defect model, the subcutaneous implant model and the diffusion chamber implantation model circumvent some of these issues and, in the appropriate model, provide data on efficacy, biocompatibility and osteointegration of a biomaterial. The combination of in vitro and in vivo approaches together with the development of new cell labeling techniques, in particular the ability to genetically mark and select specific human bone cell populations provides new avenues for their potential evaluation in combination with appropriate biomaterials for clinical use. These in vitro and in vivo techniques are reviewed and those recently developed for assessment of human osteogenic cells should be applicable to many other cell systems where knowledge of specific human tissue or cell interactions with biomaterials is required. (C) 1999 Kluwer Academic Publishers.
C1 Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, MRC,Bone Res Lab, Oxford OX3 7LD, England.
RP Triffitt, JT (reprint author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, MRC,Bone Res Lab, Oxford OX3 7LD, England.
EM James.Triffitt@ndos.ox.ac.uk
RI Oreffo, Richard/A-4615-2011
OI Oreffo, Richard/0000-0001-5995-6726
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Aubin Jane E., 1996, P51
   Aubin Jane E., 1993, P1
   AUFMKOLK B, 1985, CALCIFIED TISSUE INT, V37, P228, DOI 10.1007/BF02554868
   BARD DR, 1972, NATURE, V236, P314, DOI 10.1038/236314a0
   BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X
   BRUDER SP, 1990, BONE MINER, V11, P141, DOI 10.1016/0169-6009(90)90054-J
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   CHEUNG HS, 1980, P SOC EXP BIOL MED, V163, P547
   ECAROTCHARRIER B, 1988, BONE, V9, P147, DOI 10.1016/8756-3282(88)90004-X
   Gallagher James A., 1996, P233
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   GRANTHOS S, 1998, MARROW STROMAL CELL, P26
   GUNDLE R, 1995, BONE, V16, P597, DOI 10.1016/8756-3282(95)00112-Q
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, P303
   Houghton A, 1998, BONE, V22, P7, DOI 10.1016/S8756-3282(97)00229-9
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, P229
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   KASUGAI S, 1995, BONE, V17, P1, DOI 10.1016/8756-3282(95)00134-Y
   KEETING PE, 1992, J BONE MINER RES, V7, P127
   Kodama H., 1981, JPN J ORAL BIOL, V23, P899
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494
   MAJESKA RJ, 1978, EXP CELL RES, V111, P465, DOI 10.1016/0014-4827(78)90193-3
   MAURIZI M, 1983, CELL TISSUE RES, V229, P505
   MUNDY GR, 1991, METHODS ENZYMOL, V198, P502
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   OHGUSHI H, 1989, J ORTHOP RES, V7, P578
   Oreffo ROC, 1997, EUR J CELL BIOL, V74, P251
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   OREFFO ROC, 1997, P 13 EUR SOC BIOM, pS38
   Owen ME, 1998, MARROW STROMAL CELL, P1
   OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496
   PARTRIDGE NC, 1980, FEBS LETT, V115, P139, DOI 10.1016/0014-5793(80)80744-7
   PARTRIDGE NC, 1983, CANCER RES, V43, P4308
   POCKWINSE S, 1990, J CELL PHYSL, V143, P420
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V89, P731, DOI 10.1097/00006534-199204000-00025
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   Smith L. F., 1997, Bone (New York), V20, p78S
   STEIN GS, 1995, ENDOCRINE REV MONOGR, V4, P290
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Takaoka T, 1996, BIOMATERIALS, V17, P1499, DOI 10.1016/0142-9612(96)89774-2
   Triffitt James T., 1996, P39
   TRIFFITT JT, 1998, MOL CELLULAR BIOL BO, P475
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 49
TC 15
Z9 15
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 607
EP 611
DI 10.1023/A:1008931607002
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000005
PM 15347974
DA 2018-10-19
ER

PT J
AU Brun, P
   Cortivo, R
   Zavan, B
   Vecchiato, N
   Abatangelo, G
AF Brun, P
   Cortivo, R
   Zavan, B
   Vecchiato, N
   Abatangelo, G
TI In vitro reconstructed tissues on hyaluronan-based temporary scaffolding
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; CULTURED SKIN; ARTICULAR-CARTILAGE; ACID; KERATINOCYTES;
   FIBROBLASTS; BIOCOMPATIBILITY; EXPRESSION; DERMIS; DIFFERENTIATION
AB Tissue engineering offers the possibility to reconstruct tissue substitutes in order to replace lost or damaged tissues. The availability of appropriate biomaterial devices is essential to allow in vitro cultured cells to behave as in the original tissues in vivo. In our studies we utilized a seminatural biomaterial made up by the benzyl ester of hyaluronan to grow keratinocytes, fibroblasts and chondrocytes. Keratinocytes and fibroblasts were isolated from human foreskin. Cells were separately cultured on two different hyaluronan based biomaterial devices for the first 15 days and then co-cultured for an additional period of 2 weeks. Keratinocytes gave rise to a well-differentiated epithelial layer, while fibroblasts were able to synthesize all the main extracellular molecules inside the biomaterial spaces, forming dermal-like tissues. When these two tissues were co-cultured, a skin equivalent was formed with a dermal-epidermal junction. Chondrocytes were obtained from chick-embryo sterna and cultured for 21 days inside a non-woven scaffolding made up of a hyaluronan-based biomaterial. Cells were able to organize themselves into nodules embedded in a dense metachromatic substance in which type II collagen was present. Data from this study suggest that this novel class of hyaluronan derived biomaterials is suitable for different cell culture and in vitro tissue reconstruction. (C) 1999 Kluwer Academic Publishers.
C1 Univ Padua, Fac Med, Inst Histol & Embryol, I-35121 Padua, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Fac Med, Inst Histol & Embryol, Viale G Colombo 3, I-35121 Padua, Italy.
EM abatange@civ.bio.unipd.it
CR ABATANGELO G, 1994, P WORKSH ANN M EUR S, P8
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   BLAYNEY AW, 1992, ACTA OTO-LARYNGOL, V112, P322, DOI 10.1080/00016489.1992.11665426
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BROWN JJG, 1993, DEVELOPMENT, V117, P483
   Bush RB, 1996, J BIOMED MATER RES, V33, P107, DOI 10.1002/(SICI)1097-4636(199622)33:2<107::AID-JBM7>3.0.CO;2-V
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   COOPER ML, 1990, J CELL BIOCH E, V14, P251
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   COULOMB B, 1989, J INVEST DERMATOL, V92, P122, DOI 10.1111/1523-1747.ep13071335
   CUONO CB, 1987, PLAST RECONSTR SURG, V80, P626, DOI 10.1097/00006534-198710000-00029
   Della V.F., 1987, European Patent, Patent No. 216453
   DELLAVALLE F, 1995, Patent No. 5466461
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DUBERTRET L, 1995, B ACAD NAT MED PARIS, V179, P1121
   Fusenig N. E., 1994, KERATINOCYTE HDB, P71
   GIUSTI P, 1994, Patent No. 01468
   GOTZ W, 1995, J ANAT, V186, P111
   HANSBROUGH JF, 1993, WOUNDS, V5, P174
   HECK EL, 1985, J TRAUMA, V25, P106, DOI 10.1097/00005373-198502000-00002
   KNUDSON CB, 1990, CANCER LETT, V52, P113, DOI 10.1016/0304-3835(90)90253-T
   KREJCI NC, 1991, J INVEST DERMATOL, V97, P843, DOI 10.1111/1523-1747.ep12491522
   KRENN V, 1991, AM J ANAT, V192, P400, DOI 10.1002/aja.1001920407
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MACKENZIE IC, 1994, KERATINOCYTE HDB, P243
   Maleski MP, 1996, CONNECT TISSUE RES, V34, P75, DOI 10.3109/03008209609028895
   MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1
   MATOUSKOVA E, 1993, BURNS, V19, P118, DOI 10.1016/0305-4179(93)90032-4
   Medalie DA, 1996, J INVEST DERMATOL, V107, P121, DOI 10.1111/1523-1747.ep12298363
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682
   Metsaranta M, 1996, MATRIX BIOL, V15, P39, DOI 10.1016/S0945-053X(96)90125-0
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Moriarty Kevin P., 1996, Wound Repair and Regeneration, V4, P346, DOI 10.1046/j.1524-475X.1996.40311.x
   OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785
   PETERSON PE, 1993, ACTA ANAT, V146, P13
   Pistoor FHM, 1996, AM J PATHOL, V149, P337
   PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856
   RASTRELLI A, 1990, ADV BIOMAT, V9, P199
   Rennekampff HO, 1996, J SURG RES, V62, P288, DOI 10.1006/jsre.1996.0210
   Rennekampff HO, 1996, SURGERY, V120, P16, DOI 10.1016/S0039-6060(96)80235-2
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X
   ROONEY P, 1993, DIFFERENTIATION, V54, P1
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   SANDER TW, 1994, Patent No. 5356629
   Shepard S, 1996, ANN PLAS SURG, V36, P65, DOI 10.1097/00000637-199601000-00013
   SIEBERT JW, 1990, PLAST RECONSTR SURG, V85, P495, DOI 10.1097/00006534-199004000-00001
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P155, DOI 10.1016/0142-9612(90)90148-J
   SUNG KC, 1994, J MEMBRANE SCI, V92, P157, DOI 10.1016/0376-7388(94)00062-X
   TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7
   TOOLE BP, 1989, CIBA F SYMP, V143, P138
   WHEATLEY SC, 1993, DEVELOPMENT, V119, P295
   YANNAS IV, 1994, J CELL BIOCHEM, V56, P188, DOI 10.1002/jcb.240560212
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 60
TC 34
Z9 36
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 683
EP 688
DI 10.1023/A:1008960413362
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000017
PM 15347986
DA 2018-10-19
ER

PT J
AU Fernandez, P
   Bordenave, L
   Celerier, C
   Bareille, R
   Brouillaud, B
   Basse-Cathalinat, B
AF Fernandez, P
   Bordenave, L
   Celerier, C
   Bareille, R
   Brouillaud, B
   Basse-Cathalinat, B
TI A novel potential application for Tc-99m-HMPAO: Endothelial cell
   labeling for in vitro investigation of cell-biomaterial interactions
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article
DE Tc-99m-hexamethyl propyleneamine oxime; in vitro labeling; endothelial
   cells; vascular graft; shear stress
ID PROSTHETIC GRAFTS; IN-VITRO; LYMPHOCYTES; RETENTION; MECHANISM; FLOW
AB Good adherence of endothelial cells (ECs) seeded on vascular prostheses and cell retention under flow conditions are important factors to consider in the use of functionalized prostheses in vascular surgery. Because (111)ln-oxine radiolabeling presents disadvantages, we wondered whether, because of its well-known physical properties, Tc-99m-hexamethyl propyleneamine oxime (HMPAO or exametazime) could be used. Methods: The cytotoxicity of unlabeled HMPAO and Tc-99m-HMPAO at increasing concentrations and activities was tested on monolayers of the EC line EA-hy-926. The influence of temperature and time on tracer incorporation into cells was also tested. The optimal labeling conditions were applied to evaluate the retention of ECs seeded on polyester grafts under flow conditions by gamma camera detection. Results: The activity of 10 MBq/10(6) cells corresponding to 4.5 mu g/10(6) cells of unlabeled HMPAO, applied for 3 h at 37 degrees C (cellular uptake = 18%), was the best compromise between the maintenance of cell viability and metabolic activity and efficient detection by the gamma camera. Spontaneous leakage was observed and analyzed by high-performance liquid chromatography. A cell loss of 13% after 180-min exposure to shear stress was obtained. Conclusion: Our data thus indicate the feasibility of using such a radiolabeling technique to investigate EC-biomaterial interactions.
C1 Univ Bordeaux 2, Lab Biophys, F-33076 Bordeaux, France.
   INSERM, U443, Bordeaux, France.
RP Fernandez, P (reprint author), Univ Bordeaux 2, Lab Biophys, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
CR Abbott W M, 1995, Semin Vasc Surg, V8, P236
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   CARR HMH, 1995, CELL TRANSPLANT, V4, P291, DOI 10.1016/0963-6897(94)00057-Q
   Carr HMH, 1996, ANN VASC SURG, V10, P469, DOI 10.1007/BF02000595
   Datz FL, 1997, J NUCL MED, V38, P987
   de Labriolle-Vaylet C, 1998, EUR J NUCL MED, V25, P1423, DOI 10.1007/s002590050318
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Giudiceandrea A, 1998, EUR J VASC ENDOVASC, V15, P147, DOI 10.1016/S1078-5884(98)80136-6
   GOUREVITCH D, 1988, BIOMATERIALS, V9, P97, DOI 10.1016/0142-9612(88)90078-6
   Herring M B, 1991, Ann Vasc Surg, V5, P424, DOI 10.1007/BF02133046
   JacquierSarlin MR, 1996, J NUCL MED, V37, P1413
   MARSFIED PB, 1970, REV SURG, V27, P291
   Meinhart J, 1997, ASAIO J, V43, pM515
   MERZ T, 1986, J NUCL MED, V27, P105
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   NEIRINCKX RD, 1988, J CEREBR BLOOD F MET, V8, pS4, DOI 10.1038/jcbfm.1988.27
   PATTERSON RB, 1989, J VASC SURG, V117, P650
   PUNCHER MRB, 1994, EUR J NUCL MED, V21, P1175
   SENTISSI JM, 1986, SURGERY, V99, P337
   SHAREFKIN JB, 1983, J BIOMED MATER RES, V17, P345, DOI 10.1002/jbm.820170211
   STANSBY G, 1994, INT J ANGIOLOGY, V3, P86
   SUESS E, 1992, J NUCL MED, V33, P108
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
NR 23
TC 8
Z9 8
U1 0
U2 1
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD OCT
PY 1999
VL 40
IS 10
BP 1756
EP 1763
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 242TD
UT WOS:000082957000029
PM 10520719
DA 2018-10-19
ER

PT J
AU di Gioia, L
   Cuq, B
   Guilbert, S
AF di Gioia, L
   Cuq, B
   Guilbert, S
TI Plasticization of corn gluten meal and characterization of the blends
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article
DE plasticization; DMTA; corn gluten meal; biomaterial
ID GLASS-TRANSITION; PROTEINS
AB Corn gluten meal has thermoplastic properties enhanced by it's high zein content. The addition of an efficient plasticizer is necessary to lower the glass transition temperature. Homogeneous blends of plasticizer and corn gluten meal can be obtained either by a wet mixing technique or by compounding the two substances in an heated batch mixer. The resulting raw material is suitable for "thermoplastic forming" of low cost biomaterials.
C1 INRA, ENSAM, UFR Technol Cereales & Agropolymeres, F-34080 Montpellier 01, France.
RP Guilbert, S (reprint author), INRA, ENSAM, UFR Technol Cereales & Agropolymeres, 2 Pl Viala, F-34080 Montpellier 01, France.
OI GUILBERT, Stephane/0000-0002-8964-670X
CR Cuq B, 1998, CEREAL CHEM, V75, P1, DOI 10.1094/CCHEM.1998.75.1.1
   DERKSEN JTP, 1998, CROPS GREEN IND, P155
   di Gioia L, 1998, CEREAL CHEM, V75, P514, DOI 10.1094/CCHEM.1998.75.4.514
   DIGIOIA L, 1998, IN PRESS INT J BIOL
   DIGIOIA L, 1998, IN PRESS J AGR FOOD
   Gontard N, 1996, J AGR FOOD CHEM, V44, P3474, DOI 10.1021/jf960230q
   KALICHEVSKY MT, 1993, GLASSY STATE IN FOODS, P133
   Madeka H, 1996, CEREAL CHEM, V73, P433
   NEUMANN PE, 1984, CEREAL CHEM, V61, P353
   Swallen LC, 1941, IND ENG CHEM, V33, P394, DOI 10.1021/ie50375a026
NR 10
TC 7
Z9 7
U1 2
U2 6
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 1999
VL 144
BP 365
EP 369
DI 10.1002/masy.19991440133
PG 5
WC Polymer Science
SC Polymer Science
GA 283TD
UT WOS:000085291100032
DA 2018-10-19
ER

PT J
AU Montanaro, L
   Arciola, CR
   Borsetti, E
   Collamati, S
   Baldassarri, L
   Montanaro, L
AF Montanaro, L
   Arciola, CR
   Borsetti, E
   Collamati, S
   Baldassarri, L
   Montanaro, L
TI Detection of fibronectin-binding protein genes in staphylococcal strains
   from peri-prosthesis infections
SO MICROBIOLOGICA
LA English
DT Article
DE fibronectin-binding protein gene (fnbA, fbnB); polymerase chain reaction
   (PCR); bacterial adhesion; biomaterial-associated infection;
   Staphylococcus aureus; Staphylococcus epidermidis
ID AUREUS COLLAGEN ADHESIN; POLYMERS
AB Several studies have been devoted to identify the adhesion mechanisms of Staphylococcus aureus and Staphylococcus epidermidis, which are the most frequent causes of prosthesis-associated infections. Recently, in particular for Staphylococcus aureus, considerable attention has been given to the host protein receptors as mediators for bacterial adherence. Fibronectin, an important matrix protein, seems to be a major ligand for bacterial adherence in the early stages of infection. To determine the importance of the fibronectin adhesin as virulence factor in Staphylococcus-induced prosthesis infection, a simple and reliable method using a polymerase chain reaction (PCR) was devised to identify fibronectin adhesin genes (fnbA and fnbB).
   Results obtained by this method were in accordance with those obtained by the in vitro phenotypic characterization of binding ability to fibronectin of Staphylococcus strains.
C1 Ist Ortoped Rizzoli, Lab Biocompatibilita Mat Impainto, I-40136 Bologna, Italy.
RP Montanaro, L (reprint author), Ist Ortoped Rizzoli, Lab Biocompatibilita Mat Impainto, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Baldassarri, Lucilla/B-1042-2013
CR ARCIOLA CR, 1994, J CATARACT REFR SURG, V3, P195
   Baldassarri L, 1995, MICROECOL T, V25, P103
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GATERMANN S, 1994, INFECT IMMUN, V62, P4556
   Gillaspy AF, 1997, GENE, V196, P239, DOI 10.1016/S0378-1119(97)00256-4
   HUFF S, 1994, J BIOL CHEM, V269, P15663
   KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647
   LECH MS, 1989, J BIOL CHEM, V264, P21080
   LEE CY, 1995, GENE, V167, P227
   Nomura S, 1997, J BIOMED MATER RES, V38, P35
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   PATTI JM, 1994, J BIOL CHEM, V269, P11672
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   ROZEN S, 1997, PRIMER3
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
NR 17
TC 19
Z9 19
U1 0
U2 3
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-7138
J9 MICROBIOLOGICA
JI Microbiologica
PD OCT
PY 1999
VL 22
IS 4
BP 331
EP 336
PG 6
WC Microbiology
SC Microbiology
GA 249UT
UT WOS:000083352200007
DA 2018-10-19
ER

PT J
AU Burstein, FD
   Cohen, SR
   Hudgins, R
   Boydston, W
   Simms, C
AF Burstein, FD
   Cohen, SR
   Hudgins, R
   Boydston, W
   Simms, C
TI The use of hydroxyapatite cement in secondary craniofacial
   reconstruction
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENTS; SURGERY; CRANIOPLASTY; ANTIBIOTICS; SKELETON
AB Sixty-one patients underwent secondary craniofacial reconstruction for contour defects using hydroxyapatite cement over a 3-year period (20-month mean follow-up). There were 56 children, aged 2.2 to 18 years (mean, 10.7 years), 21 boys and 35 girls. This is the first series of pediatric patients in whom the use of hydroxyapatite cement has been reported. There were five adults aged 21 to 46 years (mean, 32 years), 3 men and 2 women. Thirty-one patients underwent reconstruction for secondary orbitocranial defects after surgery for synostosis, 7 after surgery for hypertelorism, 10 for posttraumatic skull defects, and 13 for a variety of other facial skeletal defects. There were seven complications (11 percent), ranging from a retained drain to postoperative seromas, all of which required reoperation without loss of the contour correction. All of the complications occurred in the first 18 months of our study. There has been excellent retention of im plant volume with no recurrence of contour defects to date. We have not found any visible evidence of interference with craniofacial growth over the study period. We conclude that hydroxyapatite cement is a versatile and safe biomaterial when used for the correction of secondary craniofacial contour defects in children and adults. The coupling of antibiotics with this biomaterial may have applications in the treatment of osteomyelitis.
C1 Scottish Rite Childrens Med Ctr, Ctr Craniofacial Disorders, Atlanta, GA 30342 USA.
   Scottish Rite Childrens Med Ctr, Div Neurosurg, Atlanta, GA 30342 USA.
RP Burstein, FD (reprint author), Scottish Rite Childrens Med Ctr, Ctr Craniofacial Disorders, 5455 Meridian Mark Rd,Suite 200, Atlanta, GA 30342 USA.
CR BURSTEIN F, 1995, 6 INT C INT SOC CRAN
   Burstein FD, 1997, PLAST RECONSTR SURG, V100, P869, DOI 10.1097/00006534-199709001-00007
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   COSTANTINO PD, 1991, P MAT RES SOC S, V179, P3
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KAMERER DB, 1994, AM J OTOL, V15, P47
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   KVETON JF, 1995, AM J OTOL, V16, P465
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   NELLHAUS G, 1968, PEDIATRICS, V41, P106
   ROSEN HM, 1989, PLAST RECONSTR SURG, V83, P985, DOI 10.1097/00006534-198906000-00009
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   TUNG IC, 1995, ARTIF CELL BLOOD SUB, V23, P81, DOI 10.3109/10731199509117669
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 22
TC 63
Z9 64
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD OCT
PY 1999
VL 104
IS 5
BP 1270
EP 1275
DI 10.1097/00006534-199910000-00005
PG 6
WC Surgery
SC Surgery
GA 241FF
UT WOS:000082871500005
PM 10513905
DA 2018-10-19
ER

PT J
AU Oyane, A
   Onuma, K
   Kokubo, T
   Ito, A
AF Oyane, A
   Onuma, K
   Kokubo, T
   Ito, A
TI Clustering of calcium phosphate in the system CaCl2-H3PO4-KCl-H2O
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID PHASE-SHIFT INTERFEROMETRY; ATOMIC-FORCE MICROSCOPY; HYDROXYAPATITE
   CRYSTALS; OCTACALCIUM PHOSPHATE; SOLUBILITY PRODUCT; GROWTH-KINETICS;
   CALCIFICATION; 25-DEGREES-C; DISSOLUTION; BIOMATERIAL
AB The stability of calcium phosphate clusters approximately 0.8 nm in diameter, which were found in a simulated body fluid in a previous work, was investigated in the system CaCl2-H3PO4-KCl-H2O using an intensity-enhanced dynamic light-scattering technique at 25 degrees C. It was shown that tris(hydroxymethyl)aminomethane, which was used as a buffer in the previous study, had no effect on the formation of the clusters. The amount of clusters decreased with decreasing supersaturation of the solution with respect to hydroxyapatite. Under constant supersaturation with respect to hydroxyapatite, the amount of the clusters reached a maximum in solutions with Ca/P molar ratios ranging from 1 to 8.
C1 Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6068501, Japan.
RP Onuma, K (reprint author), Natl Inst Adv Interdisciplinary Res, 1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.
RI Oyane, Ayako/M-1671-2018; Ito, Atsuo/M-6785-2018
OI Ito, Atsuo/0000-0003-3318-040X
CR BELL LC, 1978, ARCH ORAL BIOL, V23, P329, DOI 10.1016/0003-9969(78)90089-4
   Brown W., 1993, DYNAMIC LIGHT SCATTE
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   Christoffersen J, 1996, J CRYST GROWTH, V163, P304, DOI 10.1016/0022-0248(95)00963-9
   CHRISTOFFERSEN MR, 1990, J CRYST GROWTH, V106, P349, DOI 10.1016/0022-0248(90)90079-Z
   CHRISTOFFERSEN MR, 1992, J CRYST GROWTH, V121, P617, DOI 10.1016/0022-0248(92)90569-5
   Chu B, 1974, LASER LIGHT SCATTERI
   DOHERTY TM, 1994, CALCIFIED TISSUE INT, V54, P224, DOI 10.1007/BF00301683
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fujiwara T., 1982, J CRYST SOC JPN, V24, P54
   HENCH LL, 1993, INTRO BIOCERAMICS, P8
   HEUGHEBAERT JC, 1985, J CHEM ENG DATA, V30, P279, DOI 10.1021/je00041a013
   HOHL H, 1982, J CRYST GROWTH, V57, P325, DOI 10.1016/0022-0248(82)90487-0
   Ito A, 1997, J BIOMED MATER RES, V36, P522, DOI 10.1002/(SICI)1097-4636(19970915)36:4<522::AID-JBM10>3.0.CO;2-C
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   MANN S, 1989, BIOMINERALIZATION
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   MEYER JL, 1978, CALC TISS RES, V25, P59, DOI 10.1007/BF02010752
   MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910
   MORENO EDGARD C., 1960, SOIL SCI SOC AMER PROC, V24, P99
   MURPHY B T, 1962, Br J Urol, V34, P129, DOI 10.1111/j.1464-410X.1962.tb06505.x
   Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]
   NANCOLLAS GH, 1974, J PHYS CHEM-US, V78, P2218, DOI 10.1021/j100615a007
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   NANCOLLAS GH, 1989, ANAT RECORD, V224, P234, DOI 10.1002/ar.1092240213
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 1996, J CRYST GROWTH, V167, P773, DOI 10.1016/0022-0248(96)00421-6
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   Onuma K, 1998, J PHYS CHEM B, V102, P7833, DOI 10.1021/jp981617u
   PALACHE C, 1951, DANAS SYSTEM MINERAL, V2, P887
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SONEL O, 1988, J CRYST GROWTH, V89, P202
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
NR 33
TC 57
Z9 57
U1 2
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD SEP 30
PY 1999
VL 103
IS 39
BP 8230
EP 8235
DI 10.1021/jp9910340
PG 6
WC Chemistry, Physical
SC Chemistry
GA 243RR
UT WOS:000083011500006
DA 2018-10-19
ER

PT J
AU Chen, WL
   Shull, KR
AF Chen, WL
   Shull, KR
TI Hydrophilic surface coatings from acrylic block copolymers
SO MACROMOLECULES
LA English
DT Article
ID POLY(TERT-BUTYL ACRYLATE) DIBLOCK; POLY(ETHYLENE OXIDE); TRIBLOCK
   COPOLYMERS; POLYETHYLENE OXIDE; ANIONIC-POLYMERIZATION; BIOMATERIAL
   SURFACES; ADHESION; POLYMERS; BLENDS; POLYSTYRENE
AB A variety of hydrophilic acrylic copolymers have been synthesized and evaluated for their use as hydrophilic surface coatings. The polymers are based on an acrylic backbone onto which oligomeric analogues (degrees of polymerization of 1, 2, or 3) of monomethoxy poly(ethylene glycol) (PEG) have been grafted. The polymers are formed by transesterification of anionically polymerized poly(tert-butyl acrylate). Because acrylic acid groups are introduced during the conversion process, these polymers are actually random copolymers of a PEG-acrylate and acrylic acid. These random copolymers are hydrophilic and water-soluble. Triblock copolymers with these random copolymers as the midblock and poly(methyl methacrylate) (PMMA) end blocks have also been synthesized. The hydrophilic polymers corresponding to the midblocks are immiscible with PMMA and have surface energies which are comparable to PMMA. Spun-cast films of the triblock copolymers do not dissolve in water and are quite hydrophilic, as determined by contact angle measurements with water. Direct measurements of adhesive interactions in water show that the block copolymer coatings are able to completely eliminate adhesive interactions in an aqueous environment. Studies of the gelation process of the triblock copolymers in water/ethanol mixtures have also been performed in order to characterize the self-assembly of these materials into physically cross-linked gels.
C1 Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Shull, KR (reprint author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RI Shull, Kenneth/B-7536-2009
CR Ahn D, 1996, MACROMOLECULES, V29, P4381, DOI 10.1021/ma9518924
   AHN D, 1997, THESIS NW U
   Blainey BL, 1991, BIOFOULING, V4, P309
   Chen WL, 1999, MACROMOLECULES, V32, P136, DOI 10.1021/ma981331n
   CLARE AS, 1992, INVERTEBR REPROD DEV, V22, P67, DOI 10.1080/07924259.1992.9672258
   CLOETE TE, 1992, INT BIODETER BIODEGR, V29, P299, DOI 10.1016/0964-8305(92)90050-X
   Dee GT, 1998, ADV PHYS, V47, P161, DOI 10.1080/000187398243546
   Deguchi S, 1996, MACROMOL SYMP, V109, P1, DOI 10.1002/masy.19961090102
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DRUMHELLER PD, 1994, BIOTECHNOL BIOENG, V43, P772, DOI 10.1002/bit.260430812
   EVANS LV, 1993, J APPL BACTERIOL, V74, pS119, DOI 10.1111/j.1365-2672.1993.tb04348.x
   FRERE Y, 1992, NEW POLYM MAT, V3, P175
   GEHLSEN MD, 1992, MACROMOLECULES, V25, P939, DOI 10.1021/ma00028a066
   GLASS JE, 1996, HYDROPHILIC POLYM PE
   HAUTEKEER JP, 1990, MACROMOLECULES, V23, P3893, DOI 10.1021/ma00219a005
   HELFAND E, 1971, J POLYM SCI POL LETT, V9, P741, DOI 10.1002/pol.1971.110091006
   HELLWEGE KH, 1962, KOLLOID Z Z POLYM, V183, P110, DOI 10.1007/BF02657207
   HOPKINSON I, 1995, POLYMER, V36, P3523, DOI 10.1016/0032-3861(95)92024-9
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   KLEIN JW, 1990, POLYM BULL, V24, P39, DOI 10.1007/BF00298319
   Kulik E, 1996, J BIOMED MATER RES, V30, P295, DOI 10.1002/(SICI)1097-4636(199603)30:3<295::AID-JBM4>3.0.CO;2-L
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047
   LEIBLER L, 1988, MAKROMOL CHEM-M SYMP, V16, P1, DOI 10.1002/masy.19880160103
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   LI X, 1984, J POLYM SCI POL PHYS, V22, P1331, DOI 10.1002/pol.1984.180220715
   LITAUSZKI L, 1995, POLYM PREPR AM CHEM, V36, P65
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MAUGIS D, 1978, J PHYS D APPL PHYS, V11, P1989, DOI 10.1088/0022-3727/11/14/011
   MEYER AE, 1988, CAN J CHEM ENG, V66, P55, DOI 10.1002/cjce.5450660108
   MORTENSEN K, 1994, MACROMOLECULES, V27, P5654, DOI 10.1021/ma00098a020
   Mowery CL, 1997, LANGMUIR, V13, P6101, DOI 10.1021/la9705672
   Russel W.B, 1989, COLLOIDAL DISPERSION
   Sauer BB, 1998, J COLLOID INTERF SCI, V199, P28, DOI 10.1006/jcis.1997.5319
   SEMENOV AN, 1985, ZH EKSP TEOR FIZ, V61, P733
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shull KR, 1997, LANGMUIR, V13, P1799, DOI 10.1021/la960845h
   SHULL KR, 1993, MACROMOLECULES, V26, P2346, DOI 10.1021/ma00061a030
   SHULL KR, 1990, MACROMOLECULES, V23, P4780, DOI 10.1021/ma00224a006
   TANGARI C, 1982, MACROMOLECULES, V15, P132, DOI 10.1021/ma00229a027
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   VARSHNEY SK, 1991, MACROMOLECULES, V24, P4997, DOI 10.1021/ma00018a003
   VITT E, 1995, MACROMOLECULES, V28, P6349, DOI 10.1021/ma00122a049
   Yan F., 1990, MAKROMOL CHEM, V191, P1197
NR 47
TC 13
Z9 13
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 21
PY 1999
VL 32
IS 19
BP 6298
EP 6306
DI 10.1021/ma9818836
PG 9
WC Polymer Science
SC Polymer Science
GA 239JX
UT WOS:000082765900040
DA 2018-10-19
ER

PT J
AU Casas, J
   Zhao, Q
   Donovan, M
   Schroeder, P
   Stokes, K
   Untereker, D
AF Casas, J
   Zhao, Q
   Donovan, M
   Schroeder, P
   Stokes, K
   Untereker, D
TI In vitro modulation of macrophage phenotype and inhibition of polymer
   degradation by dexamethasone in a human macrophage/Fe/stress system
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biodegradation; dexamethasone; ESC; macrophages; oxidation; polyurethane
ID FREE-RADICALS; HUMAN-DISEASE; POLYURETHANES; BIODEGRADATION;
   BIOSTABILITY; BIOCOMPATIBILITY; ANTIOXIDANTS; GENERATION; MECHANISMS;
   ELASTOMERS
AB A new in vitro accelerated biological model, the macrophage-FeCl2-stress system was used for the evaluation of dexamethasone (DEX)-polymer formulations. This model combines the effects of cells (macrophages), transition metal ions (Fe2+), and polymer stress to promote material biodegradation. The cell and material effects of DEX, either in solution or incorporated into a polyetherurethane matrix (DEX/PEU), were monitored. Cell morphology and hydroperoxide formation in the polymer during cell culturing were characterized. After a subsequent treatment with FeCl2 the development of environmental stress cracking in the polymer was evaluated. We attempted to duplicate the biodegradation of PEU in terms of environmental stress cracking (ESC). Our results support the direct involvement of macrophages in polyetherurethane oxidation, probably by inducing hydroperoxide formation in the polymer structure. Under the influence of stress or strain, polymers with sufficient hydroperoxides degrade in the presence of Fe2+ metal ions in a manner that closely resembles the stress cracking that is observed in vivo. By contrast, polymers treated with either agents that inhibit cell activation and/or the oxidative burst, or with cells with no oxidative burst did not show signs of the biodegradative process. We demonstrated a reduction in hydroperoxide formation and no later ESC development in macrophage-cultured PEU in the presence of DEX in solution or in DEX-loaded PEU. We believe the prevention of initial polymer oxidation by reducing the cell's potential to produce oxidative stress at the tissue-biomaterial interface can directly inhibit the ESC degradation of chronically implanted polymers. The in vitro macrophage-Fe-stress system is a valuable tool for reliable assessment and cost-effective evaluation of biomaterials. (C) 1999 John Wiley & Sons, Inc.
C1 Medtron Inc, Biosci Lab, Mat & Biosci Ctr, Minneapolis, MN 55430 USA.
   Medtron Inc, Brady Leads Res, Minneapolis, MN 55432 USA.
RP Casas, J (reprint author), Medtron Inc, Biosci Lab, Mat & Biosci Ctr, Minneapolis, MN 55430 USA.
CR ALDERSON E, 1976, J IMMUNOL METHODS, V11, P297, DOI 10.1016/0022-1759(76)90123-X
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BOYUM A, 1991, BLOOD SEPARATION PLA, P217
   Byrd CL, 1995, CLIN CARDIAC PACING, P491
   CASAS J, 1998, T AM CHEM SOC POLYM, V79, P512
   CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0
   Collier T, 1998, J BIOMED MATER RES, V41, P192, DOI 10.1002/(SICI)1097-4636(199808)41:2<192::AID-JBM3>3.0.CO;2-D
   Edelman ER, 1998, CIRCULATION, V97, P416
   ELHAG A, 1984, J IMMUNOL, V132, P569
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   GRECH ED, 1993, LANCET, V341, P990, DOI 10.1016/0140-6736(93)91074-V
   GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2
   GRISHAM MB, 1992, REACTIVE OXYGEN META
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HENSON PM, 1980, AM J PATHOL, V101, P494
   JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7
   KIM KB, 1994, ANN THORAC SURG, V58, P170, DOI 10.1016/0003-4975(94)91094-4
   Labow RS, 1997, J BIOMAT SCI-POLYM E, V8, P779, DOI 10.1163/156856297X00317
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   SIES H, 1991, OXIDATIVE STRESS, V2
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1993, CARDIOVASC PATHOL, V2, pS111
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   WITSTUM JL, 1994, LANCET, V344, P793
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
NR 33
TC 15
Z9 15
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1999
VL 46
IS 4
BP 475
EP 484
DI 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213WE
UT WOS:000081295600005
PM 10398008
DA 2018-10-19
ER

PT J
AU Ishikawa, K
   Takagi, S
   Chow, LC
   Suzuki, K
AF Ishikawa, K
   Takagi, S
   Chow, LC
   Suzuki, K
TI Reaction of calcium phosphate cements with different amounts of
   tetracalcium phosphate and dicalcium phosphate anhydrous
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE calcium phosphate cement; hydroxyapatite; hydroxyapatite cement;
   self-setting cement; biomaterial; tetracalcium phosphate; dicalcium
   phosphate anhydrous
ID HYDROXYAPATITE CEMENT; SETTING BEHAVIOR; TISSUE-RESPONSE
AB Calcium phosphate cements (CPCs) with different amounts of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) (TTCP/DCPA molar ratio from 0.25 to 2.00) were prepared to further understand the setting reaction and the factors that could influence the properties of CPCs. Quantitative X-ray diffraction patterns, Fourier transform IR spectra, and diametral tensile strength of the set mass were measured along with pH measurements of the CPC suspension. Calcium-deficient hydroxyapatite (d-HAP) with a calcium to phosphate molar ratio of approximately 1.5 was formed initially in the CPC setting consisting of an equimolar mixture of TTCP and DCPA. This gradually transformed into stoichiometric KA (s-HA) with increasing incubation time. The s-HA was formed in the initial stage when the CPC contained an excess amount of TTCP. In contrast, maturation to s-HAP was slow when the CPC contained excess amounts of DCPA. The highest mechanical strength of set CPC was associated with an equimolar mixture of TTCP and DCPA, and the mechanical strength decreased as the TTCP/DCPA molar ratio deviated from 1.00. We concluded, therefore, that the setting reaction and the nature of the resulting set mass are dependent on the molar ratios of TTCP and DCPA. (C) 1999 John Wiley & Sons, Inc.*.
C1 Okayama Univ, Sch Dent, Dept Biomat, Okayama 7008525, Japan.
   NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
RP Ishikawa, K (reprint author), Okayama Univ, Sch Dent, Dept Biomat, 2-5-1 Shikata, Okayama 7008525, Japan.
FU NIDCR NIH HHS [DE11789]
CR BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BROWN PW, 1991, J AM CERAM SOC, V74, P934, DOI 10.1111/j.1151-2916.1991.tb04324.x
   BROWN WE, 1987, CEMENTS RES PROGR, P351
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   CHOHAYEB AA, 1987, J ENDODONT, V13, P384, DOI 10.1016/S0099-2399(87)80198-X
   Chow L., 1994, HYDROXYAPATITE RELAT
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   Constantino PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FULMER MT, 1992, J BIOMED MATER RES, V27, P1095
   HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   JORIS SJ, 1971, J PHYS CHEM-US, V75, P3167, DOI 10.1021/j100689a024
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   Miyamato Y, 1996, BIOMATERIALS, V17, P1429, DOI 10.1016/0142-9612(96)87286-3
   Miyamoto Y, 1997, J BIOMED MATER RES, V37, P457
   MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   STRUSBURG R, 1991, J DENT RES, V70, P567
   Sugawara A, 1992, Dent Mater J, V11, P11
   Takechi M, 1996, J MATER SCI-MATER M, V7, P317, DOI 10.1007/BF00154542
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
NR 27
TC 60
Z9 62
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1999
VL 46
IS 4
BP 504
EP 510
DI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213WE
UT WOS:000081295600008
PM 10398011
DA 2018-10-19
ER

PT J
AU Shive, MS
   Hasan, SM
   Anderson, JM
AF Shive, MS
   Hasan, SM
   Anderson, JM
TI Shear stress effects on bacterial adhesion, leukocyte adhesion, and
   leukocyte oxidative capacity on a polyetherurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE infection; polymorphonuclear leukocytes; polyurethane; sheer stress;
   superoxide anion
ID BIOMATERIAL-INDUCED ALTERATIONS; FOREIGN-BODY INFECTION;
   STAPHYLOCOCCUS-EPIDERMIDIS; HUMAN NEUTROPHILS; NITRIC-OXIDE;
   POLYMORPHONUCLEAR LEUKOCYTES; IN-VITRO; PATHOGENESIS; SURFACES; AUREUS
AB Infection of implanted cardiovascular biomaterials still occurs despite inherent host defense mechanisms. Using a rotating disk system, we investigated Staphylococcus epidermidis and polymorphonuclear leukocyte (PMN) adhesion to a polyetherurethane urea (PEUU-A') under shear stress (0-17.5 dynes/cm(2)) for time periods up to 6 h. In addition, the superoxide (SO) release capacity of PMNs after transient exposure to PEUU-A' under shear stress was determined. Bacterial adhesion in phosphate-buffered saline (PBS) showed a linear shear dependence, decreasing with increasing shear stress. Overall adhesion in PBS decreased with time. However, bacterial adhesion in 25% human serum was similar for all time points up to 360 min. Adhesion was observed at all shear levels, displaying no shear dependence. In contrast, PMN adhesion demonstrated a strong shear dependence similarly for times up to 240 min, decreasing sharply with increasing shear stress. Although PMNs preexposed to shear stress showed a slightly diminished SO release response compared to fresh cells for all stimuli, it was not statistically significant regardless of the stimulus. We conclude that circulating leukocytes are unable to adhere in regions of high shear which may contain adherent bacteria. In addition, exposure to PEUU-A' and shear stress (in the range 0-18 dynes/cm(2)) is insufficient to cause a depression in the oxidative response of PMNs. (C) 1999 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL47300]
CR AN HA, 1996, HUMAN BIOMATERIALS A, P19
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Daher AH, 1997, AM J RESP CELL MOL, V16, P407, DOI 10.1165/ajrcmb.16.4.9115751
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553
   GENIS I, 1990, BLOOD, V76, P1233
   GIRIDHAR G, 1995, J BIOMED MATER RES, V29, P1179, DOI 10.1002/jbm.820291004
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1996, BIOMATERIALS SCI INT, P205
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   HENSON PM, 1992, INFLAMMATION BASIC P, P511
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   HOLMES CJ, 1995, ARTIF ORGANS, V19, P1126, DOI 10.1111/j.1525-1594.1995.tb02274.x
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Larfars G, 1998, J LAB CLIN MED, V132, P54, DOI 10.1016/S0022-2143(98)90025-7
   LAURENT F, 1991, J LEUKOCYTE BIOL, V49, P217
   LEWIS SL, 1987, AM J KIDNEY DIS, V9, P381, DOI 10.1016/S0272-6386(87)80141-5
   Merritt K, 1999, J BIOMED MATER RES, V44, P261, DOI 10.1002/(SICI)1097-4636(19990305)44:3<261::AID-JBM4>3.0.CO;2-M
   Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   OBRIEN T, 1992, BRIT J SURG, V79, P1262, DOI 10.1002/bjs.1800791205
   Okuyama M, 1996, J CELL BIOCHEM, V63, P432
   RIBER U, 1993, APMIS, V101, P55, DOI 10.1111/j.1699-0463.1993.tb00081.x
   Rodenas J, 1998, AM J PHYSIOL-CELL PH, V274, pC827, DOI 10.1152/ajpcell.1998.274.3.C827
   Rosenson-Schloss RS, 1999, MED BIOL ENG COMPUT, V37, P257, DOI 10.1007/BF02513296
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   SHETH NK, 1985, LANCET, V2, P1266
   SLACK SM, 1993, CARDIOVASC PATHOL, V2, pS11
   STICKLER DJ, 1995, CELL MATER, V5, P167
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   Tomczok J, 1996, BIOMATERIALS, V17, P1359, DOI 10.1016/0142-9612(96)87275-9
   VACHEETHASANEE K, IN PRESS J BIOMED MA
   Vaudaux Pierre E., 1994, P1
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WEBSTER RO, 1986, AM J PATHOL, V125, P369
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 47
TC 35
Z9 35
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1999
VL 46
IS 4
BP 511
EP 519
DI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213WE
UT WOS:000081295600009
PM 10398012
DA 2018-10-19
ER

PT J
AU Minamide, A
   Tamaki, T
   Kawakami, M
   Hashizume, H
   Yoshida, M
   Sakata, R
AF Minamide, A
   Tamaki, T
   Kawakami, M
   Hashizume, H
   Yoshida, M
   Sakata, R
TI Experimental spinal fusion using sintered bovine bone coated with type I
   collagen and recombinant human bone morphogenetic protein-2
SO SPINE
LA English
DT Article
DE animal model; biomaterials; bone morphogenetic protein; spinal fusion;
   Type I collagen
ID GRAFT SUBSTITUTE; VIVO EVALUATION; DIFFERENTIATION; MODEL
AB Study Design. Posterolateral lumbar transverse process fusion using recombinant human bone morphogenetic protein (rhBMP)-2 carried by sintered bovine bone and Type I collagen complex was compared with fusion achieved using autogenous bone graft or sintered bovine bone alone.
   Objectives. This study examined the efficacy of sintered bovine bone coated with Type I collagen as a carrier of rhBMP-2 for lumbar intertransverse process arthrodesis.
   Summary of Background Data. Posterolateral intertransverse process arthrodesis using osteoinductive growth factors is performed experimentally in the lumbar spine. The previous studies revealed the efficacy of osteoinductive factors applied to carriers having no bony structures, such as collagen sheet or polylactic acid polymer, for the spinal fusion. However, in their studies, a large amount of osteoinductive proteins have been applied for the spinal fusion. We used the sintered bovine bone "True Bone Ceramics" (TBC; Koken Co., Tokyo, Japan) coated with type I collagen as the carrier. True Bone Ceramics is the only biomaterial possessing a natural trabecular structure and an organized crystal of bone minerals.
   Methods. Twenty-two adult rabbits underwent bilateral lumbar intertransverse process arthrodesis at L4-L5. The animals were divided into four groups and had materials implanted as follows: autologous bone group, grafted autologous corticocancellous bone harvested from the posterior iliac crest; implanted TBC group; TBC collagen group, implanted TBC coated with Type I collagen infiltrating into the porous space; and BMP group, implanted sintered bovine bone coated with Type I collagen infiltrated with 100 mu g of rhBMP-2. Spinal fusion was evaluated by radiographic analysis, manual palpation, biomechanical testing, and histologic examination 6 weeks after surgery.
   Results. Two rabbits were killed because of infection and lumbar plexus palsy. Radiographs of the BMP group showed a homogeneous fusion mass at the intertransverse area, and stability was confirmed by dynamic radiographs at 3 and 6 weeks after surgery. In the BMP group, a bony mass in the intertransverse a rea was more prominent than in the other groups. The BMP group had a higher fusion rate based on manual palpation than the-other groups, and BMP fusions showed significantly higher tensile strength and stiffer fusion. The histologic findings in the BMP group demonstrated membranous bone and endochondral bone formations between the transverse process and the fusion mass. In the other groups, continuous trabecular bone formation was observed in the:area surrounding the transverse process, but gaps between grafted fragments and less mature bone formation were present in the intertransverse area.
   Conclusions. Sintered bovine bone coated with Type-1 collagen and rhBMP-2 resulted in a higher fusion rate than the autograft and can be used as a carrier for rh-BMP-2 in spinal fusion.
C1 Wakayama Med Coll, Dept Orthoped Surg, Wakayama 6410012, Japan.
RP Minamide, A (reprint author), Wakayama Med Coll, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama 6410012, Japan.
EM minamide@wakayama-med.ac.jp
CR ALDINGER G, 1991, INT ORTHOP, V15, P169
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1997, J SPINAL DISORD, V10, P1
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   COOKE FW, 1990, CLIN ORTHOPAEDICS, V276, P135
   DAVISON PF, 1967, J EXP MED, V126, P331, DOI 10.1084/jem.126.2.331
   DePalma A F, 1968, Clin Orthop Relat Res, V59, P113
   ENNEKING WF, 1975, J BONE JOINT SURG AM, VA 57, P237, DOI 10.2106/00004623-197557020-00018
   FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006
   FRIEDLAENDER GE, 1991, BONE AND CARTILAGE ALLOGRAFTS : BIOLOGY AND CLINICAL APPLICATIONS, P185
   FRIEDLAENDER GE, 1982, J BONE JOINT SURG AM, V64, P307, DOI 10.2106/00004623-198264020-00031
   HANAMURA H, 1980, CLIN ORTHOP RELAT R, V148, P281
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   HECKMAN JD, 1991, J BONE JOINT SURG AM, V73A, P750, DOI 10.2106/00004623-199173050-00015
   HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003
   HOPP SG, 1989, J ORTHOPAED RES, V7, P579, DOI 10.1002/jor.1100070416
   KATOH T, 1993, CLIN ORTHOP RELAT R, V287, P266
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, V217, P281
   KURIHARA N, 1987, QUINTESSENCE, V6, P104
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LOVELL TP, 1989, CLIN ORTHOP RELAT R, V243, P266
   MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213
   Morone MA, 1998, SPINE, V23, P159, DOI 10.1097/00007632-199801150-00003
   MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   ROSEN V, 1989, CONNECT TISSUE RES, V20, P313, DOI 10.3109/03008208909023902
   RUBIN AL, 1965, BIOCHEMISTRY-US, V4, P181, DOI 10.1021/bi00878a001
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   SAUK JJ, 1991, BONE-BIOMATERIAL INTERFACE, P111
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   STEINMANN JC, 1992, CLIN ORTHOPAEDICS, V284, P80
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, V234, P250
   TAMAKI T, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P235
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WATKINS MB, 1959, J BONE JOINT SURG AM, V41, P388, DOI 10.2106/00004623-195941030-00002
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   WILTSE LL, 1968, J BONE JOINT SURG AM, VA 50, P919, DOI 10.2106/00004623-196850050-00004
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 46
TC 35
Z9 50
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD SEP 15
PY 1999
VL 24
IS 18
BP 1863
EP 1870
DI 10.1097/00007632-199909150-00002
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 238BV
UT WOS:000082691800001
PM 10515009
DA 2018-10-19
ER

PT J
AU Bense, CA
   Woodhouse, KA
AF Bense, CA
   Woodhouse, KA
TI Plasmin degradation of fibrin coatings on synthetic polymer substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE fibrin coating; crosslinking; fibrinolysis; fibrin degradation products;
   enzymatic activity
ID COATED POLYETHYLENE; ANTITHROMBIN-III; ACTIVATION; INHIBITORS; THROMBIN;
   SEALANT; LINKING; HEPARIN
AB The goal of this research was to evaluate the in vitro stability of fibrin coatings on polymeric materials in the presence of plasmin. Factor XIIIa-crosslinked and non-crosslinked fibrin layers were coated on three different polyurethane substrates: Corethane(TM), Tegaderm(R), and a biodegradable polyurethane, PCL/HDI/Phe. Degradation assays indicated that crosslinking the fibrin coatings enhanced the stability of the coatings on both Tegaderm(R) and PCL/HDI/ Phe; however, the persistence of the coating on the woven Corethane(TM) was not influenced by crosslinking. Degradation assay results also showed that the fibrin coating on the Corethane(TM) was significantly less stable than the fibrin coatings on the Tegaderm(R) and PCL/HDI/Phe films. The chromogenic substrate assay data showed crosslinking did not affect the specific plasmin activity on the coatings; therefore, the increased stability resulting from crosslinking was not achieved through a reduction of fibrinolysis. The plasmin activity on the coated Corethane(TM) samples was much greater than that on either of the coated flat wound dressing materials. The large surface area of Corethane(TM), a porous woven vascular graft material, may have had a direct influence on the fibrinolysis of its coatings by providing a large number of tissue-type plasminogen activator (tPA) binding sites. A thin, crosslinked, fibrin-coated polyurethane provides a theoretically attractive biomaterial for use in a wound dressing application and should be subject to ongoing research. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 305-314, 1999.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON MS5 3E5, Canada.
RP Woodhouse, KA (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON MS5 3E5, Canada.
CR AZOURY R, 1989, BIOCHIM BIOPHYS ACTA, V295, P295
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   DINGES HP, 1986, PATHOL RES PRACT, V181, P746, DOI 10.1016/S0344-0338(86)80051-6
   EAGELSTEIN WH, 1991, PROG CLIN BIOL RES, V365, P257
   FEARS R, 1989, BIOCHEM J, V261, P313, DOI 10.1042/bj2610313
   FISCHER B, 1990, BIOL CHEM H-S, V371, P1067, DOI 10.1515/bchm3.1990.371.2.1067
   FRANCIS CW, 1979, BLOOD, V54, P1282
   FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150
   Friberger P., 1982, SCAND J CLIN LA S162, V42, P15
   GABRIEL DA, 1992, J BIOL CHEM, V267, P24259
   HABER E, 1989, SCIENCE, V243, P51, DOI 10.1126/science.2492113
   HOYALERTZ M, 1982, J BIOL CHEM, V257, P2920
   Jackson MR, 1996, NAT MED, V2, P637, DOI 10.1038/nm0696-637
   KUDINOV SA, 1990, BIOCHEMISTRY-US, V54, P1538
   MARDER VJ, 1983, ANN NY ACAD SCI, P397
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P
   Mosesson MW, 1996, J CLIN INVEST, V97, P2342, DOI 10.1172/JCI118677
   NORRMAN B, 1985, EUR J BIOCHEM, V149, P193, DOI 10.1111/j.1432-1033.1985.tb08911.x
   PEACOCK EE, 1984, WOUND REPAIR, P1
   Ratner Buddy D., 1996, P1, DOI 10.1016/B978-012582460-6/50002-5
   REDL H, 1986, FIBRIN SEALANT OPERA, V1, P13
   REILLY CF, 1992, J BIOL CHEM, V267, P17128
   RUBENS F, 1992, J BIOMED MATER RES, V26, P1651, DOI 10.1002/jbm.820261209
   RUBENS FD, 1993, THROMB HAEMOSTASIS, V69, P130
   RUBENS FD, 1995, THROMB HAEMOSTASIS, V73, P850
   SCHLAG G, 1986, FIBRIN SEALANT OPERA, V1, P1
   SERRANO SMT, 1993, TOXICON, V31, P483, DOI 10.1016/0041-0101(93)90183-J
   SHAINOFF JR, 1991, J BIOL CHEM, V266, P6429
   SIEBENLIST KR, 1994, J BIOL CHEM, V269, P28414
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SKARJA GA, UNPUB BIOMATERIALS
   URANO S, 1989, P NATL ACAD SCI USA, V86, P2568, DOI 10.1073/pnas.86.8.2568
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   WILLIAMS DF, P CONS C EUR SOC BIO, P7
   WOODS DR, 1990, SURFACES COLLOIDS 2
   WU S, 1982, POLYM INTERFACE ADHE, P171
NR 38
TC 13
Z9 15
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1999
VL 46
IS 3
BP 305
EP 314
DI 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 209QY
UT WOS:000081061000001
PM 10397986
DA 2018-10-19
ER

PT J
AU Brun, P
   Abatangelo, G
   Radice, M
   Zacchi, V
   Guidolin, D
   Gordini, DD
   Cortivo, R
AF Brun, P
   Abatangelo, G
   Radice, M
   Zacchi, V
   Guidolin, D
   Gordini, DD
   Cortivo, R
TI Chondrocyte aggregation and reorganization into three-dimensional
   scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE chondrocyte; biomaterial; hyaluronic acid derivative; extracellular
   matrix
ID ARTICULAR-CARTILAGE; IN-VITRO; HUMAN SKIN; REPAIR; BIOCOMPATIBILITY;
   FIBROBLAST; DEFECTS; GROWTH; TISSUE; GRAFTS
AB Articular cartilage has a very limited self-repairing capacity; thus, chondral lesions normally result in chronic degeneration and, eventually, osteoarthritis development. Currently, tissue engineering offers a new tool for the clinical treatment of osteochondral defects. The present investigation aimed to develop an in vitro engineered cartilage using a new class of semisynthetic scaffolds. Two nonwoven meshes of hyaluronan esters (Hyaff(R) derivatives) were seeded with sternal chick embryo chondrocytes cultured for up to 21 days, after which time they were assessed for both the cellular growth profile and histological features. Avian chondrocytes easily adhered and proliferated onto hyaluronan-based scaffolds, demonstrating a significant preference for the fully esterified benzylic form. Histochemical staining revealed the presence of a neosynthesized glycosaminoglycan-rich extracellular matrix, and immunohistochemistry confirmed the deposition of collagen type II. Moreover, ultrastructural observations supported evidence that chondrocytes grown onto a hyaluronan-derived three-dimensional scaffold maintained their unique phenotype and organization in a cartilage-like extracellular matrix. These findings support the further pursuit of a transplantable engineered cartilage using human chondrocytes for the regeneration of chondral lesions. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 337-346, 1999.
C1 Univ Padua, Fac Med, Inst Histol & Embryol, I-35121 Padua, Italy.
   Fidia Res Labs, I-35031 Abano Terme, Italy.
RP Abatangelo, G (reprint author), Univ Padua, Fac Med, Inst Histol & Embryol, Viale G Colombo 3, I-35121 Padua, Italy.
OI Guidolin, Diego/0000-0003-2133-3552
CR BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FLEISCHMAJER R, 1993, J HISTOCHEM CYTOCHEM, V41, P1359, DOI 10.1177/41.9.7689083
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   GHADIALLY FN, 1978, EXPERIENTIA, V34, P1212, DOI 10.1007/BF01922963
   GHADIALLY FN, 1982, ULTRASTRUCT PATHOL, P90
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREEN WT, 1971, CLIN ORTHOP RELAT R, P248
   HANSBROUGH JF, 1993, WOUNDS, V5, P174
   LIMOVA M, 1995, WOUNDS, V7, P170
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682
   Metsaranta M, 1996, MATRIX BIOL, V15, P39, DOI 10.1016/S0945-053X(96)90125-0
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Paige K T, 1995, Tissue Eng, V1, P97, DOI 10.1089/ten.1995.1.97
   PALFREY AJ, 1966, J ANAT, V100, P213
   PHILLIPS TJ, 1994, WOUNDS, V6, P113
   POOLE CA, 1990, CONNECT TISSUE RES, V24, P319, DOI 10.3109/03008209009152158
   POOLE CA, 1988, J ORTHOPAED RES, V6, P408, DOI 10.1002/jor.1100060312
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 29
TC 121
Z9 126
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1999
VL 46
IS 3
BP 337
EP 346
DI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 209QY
UT WOS:000081061000005
PM 10397990
DA 2018-10-19
ER

PT J
AU Santin, M
   Motta, A
   Freddi, G
   Cannas, M
AF Santin, M
   Motta, A
   Freddi, G
   Cannas, M
TI In vitro evaluation of the inflammatory potential of the silk fibroin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE silk fibroin; inflammation; protein adsorption; macrophage adhesion;
   monocyte activation
ID COMPLEMENT ACTIVATION; FIBROBLAST CELLS; SOLID-SURFACES; HUMAN MONOCYTE;
   IN-VITRO; ADSORPTION; MEMBRANES; POLYMER; ALPHA-1-MICROGLOBULIN;
   BIOMATERIAL
AB Silk fibroin membranes recently have been suggested as matrices for biomedical applications,,such as guided tissue regeneration and burn wound dressings. The aim of this study was to evaluate the inflammatory potential of fibroin films and to compare the fibroin films with two model materials with completely different physico-chemical properties: poly(styrene) and poly(2-hydroxyethyl methacrylate). Fibroin bound lower levels of fibrinogen than did the two synthetic polymers while the same amounts of adsorbed human plasma complement fragment C3 and IgG were detected. Studies of the binding strength of C3 to fibroin, evaluated by a novel experimental procedure, indicated the occurrence of strong hydrophobic interactions at the interface. The activation of the mononuclear cells by fibroin, measured as interleukin 1 beta production,was lower than the reference materials. Adhesion experiments showed the ability of the macrophages to adhere to fibroin by filopodia without a complete spreading of the cells. The results achieved in this study demonstrate that the interactions of fibroin with the humoral components of the inflammatory system were comparable with those of the two model surfaces while the degree of activatiorr and adhesion of the immunocompetent cells appeared more limited. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 382-389, 1999.
C1 Univ E Peidmont A Avogadro, Dept Med Sci, I-28100 Novara, Italy.
   Univ Brighton, Sch Pharm & Biomol sci, Brighton BN2 4GJ, E Sussex, England.
   Expt Silk Stn, I-20133 Milan, Italy.
RP Cannas, M (reprint author), Univ E Peidmont A Avogadro, Dept Med Sci, Via Solaroli 17, I-28100 Novara, Italy.
OI Motta, Antonella/0000-0003-4893-6863
CR ANDERSON JM, 1988, ASAIO, V11, P101
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Mahiout A, 1997, J MATER SCI-MATER M, V8, P287, DOI 10.1023/A:1018560211844
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
NR 24
TC 319
Z9 332
U1 3
U2 57
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1999
VL 46
IS 3
BP 382
EP 389
DI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 209QY
UT WOS:000081061000011
PM 10397996
DA 2018-10-19
ER

PT J
AU Cook, JL
   Tomlinson, JL
   Kreeger, JM
   Cook, CR
AF Cook, JL
   Tomlinson, JL
   Kreeger, JM
   Cook, CR
TI Induction of meniscal regeneration in dogs using a novel biomaterial
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; GLYCOSAMINOGLYCANS; INJURIES; REPAIR
AB A unique biomaterial, porcine small intestinal submucosa, was used to construct grafts for implantation into surgically created medial meniscal defects in dogs. Five dogs received grafts and two were left untreated as controls. All dogs were evaluated at 4, 8, and 12 weeks by means of lameness scoring, force plate analysis, and ultrasonography. Twelve weeks after implantation the dogs were sacrificed and the replacement tissue was evaluated for gross and histologic appearance, amount, glycosaminoglycan content, and type II collagen immunoreactivity. Four weeks after instrumentation, both groups had lameness scores that were significantly higher than preoperative scores, but at the 8- and 12-week evaluations, scores for the grafted dogs were not different from preoperative values. The ultrasonographic appearance of replacement tissue in grafted defects resembled normal meniscus. In the untreated defects, only unorganized tissue was present. In control dogs, replacement tissue resembled fibrous tissue and cartilage erosions were visible on the medial femoral condyles. In four of the five grafted dogs, replacement tissue was grossly indistinguishable from normal meniscus. The amount of tissue in the defect was significantly greater for the grafted dogs. Histologically, replacement tissue in control dogs was composed of vascularized connective tissue with no evidence of chondroid differentiation. Replacement tissue in grafted dogs closely resembled normal meniscal tissue with respect to chondroid differentiation, collagen content, and zonal architecture. Porcine small intestinal submucosa appeared to have beneficial effects on meniscal regeneration.
C1 Univ Missouri, Vet Med Teaching Hosp, Columbia, MO 65211 USA.
   Vet Med Diagnost Lab, Columbia, MO USA.
RP Cook, JL (reprint author), Univ Missouri, Vet Med Teaching Hosp, 379 E Campus Dr, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR ADAMS ME, 1987, CONNECT TISSUE RES, V16, P269, DOI 10.3109/03008208709006981
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   Arnoczky SP, 1988, INJURY REPAIR MUSCUL, P487
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1996, P SIS S W LAF IN PUR, P90
   BURR DB, 1982, CLIN ORTHOP RELAT R, P121
   Collier S, 1996, VET COMP ORTHOPAED, V9, P60
   COOK CR, 1998, VET RADIOL ULTRASOUN, V39, P247
   COOK JL, 1996, P SIS S W LAF IN PUR, P28
   COX JS, 1975, CLIN ORTHOP RELAT R, P178
   DEYOUNG DJ, 1980, AM J ANIM HOSP ASS, V16, P639
   DIMENT MT, 1993, ORTHOPEDICS, V16, P973
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FLO GL, 1978, J AM ANIM HOSP ASSOC, V14, P683
   GALLOWAY MT, 1994, B RHEUM DIS, V43, P3
   Hardin G T, 1992, Orthop Rev, V21, P1311
   HAZEL WA, 1993, CLIN ORTHOP RELAT R, P232
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MESSNER K, 1994, BIOMATERIALS, V15, P243, DOI 10.1016/0142-9612(94)90046-9
   METELMAN LA, 1995, VET COMP ORTHOPAED, V8, P118
   NEWMAN AP, 1993, ARTHROSCOPY, V9, P33, DOI 10.1016/S0749-8063(05)80342-1
   O'Meara P M, 1993, Orthop Rev, V22, P681
   Pearson P T, 1971, Vet Clin North Am, V1, P489
   SIEGEL MG, 1993, CLIN SPORT MED, V12, P59
   Smillie IS, 1944, BRIT J SURG, V31, P398, DOI 10.1002/bjs.18003112412
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Takeuchi N, 1997, CLIN ORTHOP RELAT R, P253
   VELTRI DM, 1994, CLIN ORTHOP RELAT R, P44
   WILLIAMS J, 1994, VET MED-US, V89, P42
NR 30
TC 91
Z9 95
U1 0
U2 3
PU AMER ORTHOPAEDIC SOC SPORT MED
PI WALTHAM
PA 230 CALVARY STREET, WALTHAM, MA 02154 USA
SN 0363-5465
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD SEP-OCT
PY 1999
VL 27
IS 5
BP 658
EP 665
DI 10.1177/03635465990270051901
PG 8
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 236ML
UT WOS:000082603300019
PM 10496586
DA 2018-10-19
ER

PT J
AU Eligio, T
   Rieumont, J
   Sanchez, R
   Silva, JFS
AF Eligio, T
   Rieumont, J
   Sanchez, R
   Silva, JFS
TI Characterization of chemically modified poly(3-hydroxyalkanoates) and
   their performance as matrix for hormone release
SO ANGEWANDTE MAKROMOLEKULARE CHEMIE
LA English
DT Article
ID DOUBLE EMULSION-EVAPORATION; STABILITY; POROSITY
AB Partially degraded and trans-esterified poly(3-hydroxybutyrate) and its copolymer with hydroxyvalerate (22 mol-%) were prepared and characterized by GPC, DSC, X-ray diffraction and scanning electron microscopy with the purpose to improve them as release matrix in comparison with the original nonmodified polymer.
   Microencapsulation by double emulsion (water-oil-water) of peptide hormones in these modified polymers was carried out with the aim to study the release properties of follicle stimulating hormone and leuthicine hormone. However, in spite of the stability attained for the primary emulsion, by using surfactant in the oil phase and other additives such as palmitic acid, it is unavoidable to lose a fraction of the initial amount of biomaterial.
   Release drug profiles obeyed the Fickian-type t(1/2) dependence, indicating that diffusion is the controlling step. Two release patterns were observed. Release profiles for low drug loading microparticles attained a plateau after about 100 h. However, higher drug loading microparticles did not show such a plateau at that time indicating a slower release rate. Furthermore, a two-step profile was observed, exhibiting an initial slower and a second faster step. These observations lead to consider that a portion of the biomaterial is dispersed near the particle surface and the remaining in the core.
C1 State Univ N Fluminense, Ctr Sci & Technol, Rio De Janeiro, Brazil.
RP Sanchez, R (reprint author), State Univ N Fluminense, Ctr Sci & Technol, Av Alberto Lamego 2000, Rio De Janeiro, Brazil.
RI Sanchez Rodriguez, Ruben Jesus/F-5999-2010
OI Sanchez Rodriguez, Ruben Jesus/0000-0002-1434-5144
CR Atkins TW, 1997, BIOMATERIALS, V18, P173, DOI 10.1016/S0142-9612(96)00111-1
   Doi Y., 1990, MICROBIAL POLYESTERS
   EMBLETON JK, 1993, J MICROENCAPSUL, V10, P341, DOI 10.3109/02652049309031524
   EMBLETON JK, 1992, MICROENCAPSULATION, V9, P73
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   JUNI K, 1986, Journal of Controlled Release, V4, P25
   LAUZIER C, 1994, POLYMER, V35, P4156, DOI 10.1016/0032-3861(94)90590-8
   MARTIN MA, IN PRESS COLLOIDS B
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   NIHANT N, 1994, PHARMACEUT RES, V11, P1479, DOI 10.1023/A:1018912426983
   NIHANT N, 1995, J COLLOID INTERF SCI, V173, P55, DOI 10.1006/jcis.1995.1296
   Ottenbrite RM, 1996, MACROMOL SYMP, V101, P379, DOI 10.1002/masy.19961010143
   PAUL DR, 1976, ACS SYM SER, V33, P1
   Richards JH, 1986, POLYM PERMEABILITY, P217
   SCHUGENS C, 1994, J CONTROL RELEASE, V32, P161, DOI 10.1016/0168-3659(94)90055-8
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
NR 16
TC 8
Z9 9
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0003-3146
J9 ANGEW MAKROMOL CHEM
JI Angew. Makromol. Chem.
PD SEP
PY 1999
VL 270
BP 69
EP 75
PG 7
WC Polymer Science
SC Polymer Science
GA 252YF
UT WOS:000083529300012
DA 2018-10-19
ER

PT J
AU Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Cavalli, M
   Gnappi, G
   Montenero, A
AF Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Cavalli, M
   Gnappi, G
   Montenero, A
TI XPS study of apatite-based coatings prepared by sol-gel technique
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE biomaterial; apatite; XPS; sol-gel
ID SURFACE SPECTROSCOPIC CHARACTERIZATION; TITANIUM IMPLANT MATERIALS
AB Biocompatible layers of hydroxyapatite and fluorhydroxyapatite were grown on Ti substrates by means of dip-coating into sol-gel. In order to improve the adhesion of apatite-based coatings, the substrates were a priori covered with calcium titanate. Therefore, the hydroxyapatite, fluorhydroxyapatite and CaTiO3 coatings were produced and analysed. The chemical composition of the coatings (CaTiO3, CaTiO3 + hydroxyapatite, and CaTiO3 + fluorhydroxyapatite) was studied by using X-ray photoelectron spectroscopy (XPS). The data of quantitative XPS analysis displayed the different features (cleanness, homogeneity, etc.) of CaTiO3, hydroxyapatite, and fluorhydroxyapatite films after the growth and after the treatment in vitro. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo Scalo, Italy.
   Univ Parma, Dept Chem, I-43100 Parma, Italy.
RP Mattogno, G (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo Scalo, Italy.
RI Kaciulis, Saulius/G-5252-2010
OI Kaciulis, Saulius/0000-0002-9868-7626
CR Brinker C. J., 1990, SOL GEL SCI
   CAVALLI M, 1998, THESIS U PARMA
   CIRILLI F, 1997, P ECASIA 97, P1063
   Demri B, 1997, APPL SURF SCI, V108, P245, DOI 10.1016/S0169-4332(96)00576-4
   Gardella JA, 1996, J ELECTRON SPECTROSC, V81, P227, DOI 10.1016/0368-2048(96)03054-X
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   MENG LJ, 1995, P ECASIA 95, P815
   MONTENERO A, IN P0RESS
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   PIVETEAU LD, IN PRESS J MAT SCI M
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   WILSON J, 1994, BIOCERAMICS, V8
NR 21
TC 86
Z9 89
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD SEP
PY 1999
VL 151
IS 1-2
BP 1
EP 5
DI 10.1016/S0169-4332(99)00267-6
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 238KZ
UT WOS:000082710600001
DA 2018-10-19
ER

PT J
AU Kurtz, SM
   Muratoglu, OK
   Evans, M
   Edidin, AA
AF Kurtz, SM
   Muratoglu, OK
   Evans, M
   Edidin, AA
TI Advances in the processing, sterilization, and crosslinking of
   ultra-high molecular weight polyethylene for total joint arthroplasty
SO BIOMATERIALS
LA English
DT Review
DE UHMWPE; ultra-high molecular weight polyethylene; resin; processing;
   manufacturing; morphology; conversion; sterilization; degradation;
   oxidation; wear; mechanical behavior; crosslinking; carbon-fiber
   reinforced UHMWPE; poly II (TM); Hylamer (TM); total joint;
   arthroplasty; replacement
ID CROSS-LINKED POLYETHYLENE; GAS PLASMA STERILIZATION;
   MECHANICAL-PROPERTIES; ACETABULAR COMPONENTS; INFRARED SPECTROMETRY;
   LINEAR POLYETHYLENE; GAMMA-RADIATION; WEAR; BEHAVIOR; UHMWPE
AB Despite the recognized success and worldwide acceptance of total joint arthroplasty, wear is a major obstacle limiting the longevity of implanted UHMWPE components. Efforts to solve the wear problem in UHMWPE have spurred numerous detailed studies into the structure, morphology, and mechanical properties of the polymer at every stage of its production from original resin into stock material and final fabricated form. Scientific developments in this field are occurring at an accelerating rate, and periodic review of UHMWPE technology is therefore increasingly necessary. The present article provides a four-part comprehensive review of technological advancements in the processing, manufacture, sterilization, and crosslinking of UHMWPE for total joint replacements. The first part of this article describes the recently updated nomenclature of UHMWPE, including the process of resin production and conversion to stock material. The second part outlines the methods of manufacturing UHMWPE into joint replacement components and provides overviews of alternate forms of UHMWPE, namely carbon-fiber reinforced UHMWPE (Poly II(TM)) and UHMWPE recrystallized under high temperature and pressure (Hylamer(TM)). The third part summarizes the sterilization and degradation of UHMWPE. Newly developed methods for accelerating the oxidation of UHMWPE after sterilization (for preconditioning of test specimens), as well as methods for quantifying the oxidation of UHMWPE, are also discussed. Finally, the fourth part reviews the development and properties of crosslinked UHMWPE, a promising alternate biomaterial for total joint replacements. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Exponent Failure Anal Associates, Philadelphia, PA 19103 USA.
   Harvard Univ, Sch Med, Orthopaed Biomech Lab, Massachusetts Gen Hosp, Boston, MA 02114 USA.
   Poly Hi Solidur MediTech, Ft Wayne, IN 46809 USA.
   Stryker Howmedica Osteon, Allendale, NJ 07401 USA.
RP Kurtz, SM (reprint author), Exponent Failure Anal Associates, 2300 Chestnut St,Suite 150, Philadelphia, PA 19103 USA.
EM skurtz@exponent.com
CR Ainsworth R, 1977, T 3 SOC BIOMATER, P119
   Amstutz H.C., 1991, HIP ARTHROPLASTY
   ATKINSON JR, 1984, BIOMATERIALS, V5, P326, DOI 10.1016/0142-9612(84)90030-9
   ATKINSON JR, 1983, BIOMATERIALS, V4, P267, DOI 10.1016/0142-9612(83)90026-1
   ATKINSON JR, 1980, BIOMATERIALS, V1, P89, DOI 10.1016/0142-9612(80)90005-8
   BAKER D, 1998, T 24 ANN M SOC BIOM, V21, P122
   BALDINI TH, 1997, T 43 ORTHOP RES SOC, V43, P780
   BARLOW A, 1977, PLAST ENG, V33, P41
   BARNETSON A, 1995, J MATER SCI LETT, V14, P80, DOI 10.1007/BF00456553
   BASTIAANSEN CWM, 1990, POLYMER, V31, P1435, DOI 10.1016/0032-3861(90)90147-Q
   Bellare A, 1996, BIOMATERIALS, V17, P2325, DOI 10.1016/S0142-9612(96)00086-5
   BELLARE A, 1995, MACROMOLECULES, V17, P2325
   BELLARE A, 1996, T 5 WORLD BIOM C, V2, P982
   Besong AA, 1997, BIO-MED MATER ENG, V7, P59
   Beveridge C, 1987, MATER DESIGN, V8, P263
   *BIOM INC, 1997, YBMT503 BIOM INC
   *BIOM INC, 1995, YBEM069 BIOM INC
   BIRNKRAUT HW, 1991, ULTRAHIGH MOL WEIGHT
   BIRNKRAUT WH, 1981, J APPL POLYM SCI, P79
   Bower DI, 1989, VIBRATIONAL SPECTROS
   BRAGDON CR, 1998, T SOC BIOMATER, V21, P2
   BREMNER T, 1993, J APPL POLYM SCI, V49, P785, DOI 10.1002/app.1993.070490504
   BROWN E, 1998, COMMUNICATION    FEB
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   Busanelli L, 1996, Chir Organi Mov, V81, P263
   Butler MF, 1998, POLYMER, V39, P39, DOI 10.1016/S0032-3861(97)00226-7
   CHAMPION AR, 1994, T ORTHOP RES SOC, V19, P585
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1963, LANCET, V2, P1379
   CHARNLEY J, 1961, LANCET, V1, P1129
   Charnley J, 1968, Triangle, V8, P211
   CHARNLEY J, 1979, LOW FRICTION ARTHROP
   CHEN KC, 1981, ANTEC 81, V39, P270
   Chmell MJ, 1996, J ARTHROPLASTY, V11, P351, DOI 10.1016/S0883-5403(96)80093-3
   Choudhury M, 1997, WEAR, V203, P335, DOI 10.1016/S0043-1648(96)07364-4
   CHUBBERLEY AH, 1965, ULTRAHIGH MOL WEIGHT
   CLARKE IC, 1991, HIP ARTHROPLASTY
   Collier JP, 1998, ORTHOPEDICS, V21, P865
   COLLIER JP, 1996, CLIN ORTHOP RELAT R, V333, P76
   COLLIER JP, 1990, CLIN ORTHOP RELAT R, V261, P107
   CONNELLY G M, 1984, Journal of Orthopaedic Research, V2, P119, DOI 10.1002/jor.1100020202
   COOPER JR, 1993, WEAR, V162, P378, DOI 10.1016/0043-1648(93)90521-M
   COUGHLAN JJ, 1986, ENCY POLYM SCI ENG
   CRANE D, 1998, T 24 SOC BIOMATER, V21, P503
   CURRIER BH, 1997, CLIN ORTHOP RELAT R, V342, P111
   DAVE B, 1988, HDB ELASTOMERS
   DEBOER J, 1981, MAKROMOL CHEM-RAPID, V2, P749
   DEBOER J, 1984, POLYMER, V25, P513, DOI 10.1016/0032-3861(84)90213-1
   DEBOER J, 1982, POLYMER, V23, P1944
   DEBOER J, 1976, J POLYM SCI POL PHYS, V14, P187
   DEVANATHAN D, 1995, T 21 SOC BIOMATER, V18, P113
   DIMAIO WG, 1998, T ORTHOP RES SOC, V23, P363
   EDIDIN AA, 1999, T 45 ORTHOP RES SOC, V24, P74
   EDIDIN AA, 1998, T SOC BIOMATER, V21, P220
   EDIDIN AA, 1999, IN PRESS J ARTHROPLA
   EDIDIN AA, 1999, T 45 ORTHOP RES SOC, V24, P856
   ESSNER A, 1998, T SOC BIOMATER, V21, P4
   ESSNER A, 1997, T 43 ORTHOP RES SOC, V22, P784
   EYERER P, 1985, PLASTVERARBEITER, V36, P46
   EYERER P, 1990, CONSISE ENCY MED DEN
   FELDMAN LA, 1997, MED DEVICE DIAGN IND, V19, P57
   Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02
   FISHER J, 1998, COMMUNICATION    OCT
   FURMAN BD, 1998, T ORTHOP RES SOC, V23, P102
   Goldman M, 1996, POLYMER, V37, P2909, DOI 10.1016/0032-3861(96)89386-4
   Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J
   Goldman M, 1998, POLYM DEGRAD STABIL, V62, P97, DOI 10.1016/S0141-3910(97)00265-6
   Goldman M, 1998, J BIOMED MATER RES, V40, P378, DOI 10.1002/(SICI)1097-4636(19980605)40:3<378::AID-JBM6>3.0.CO;2-C
   GREER KW, 1998, T 44 ORTHOP RES SOC, V23, P52
   GREGG J, 1998, COMMUNICATION    FEB
   GRIFFITH MJ, 1978, CLIN ORTHOP RELAT R, V137, P37
   GROBBELAAR CJ, 1978, J BONE JOINT SURG BR, V60, P370
   GSELL C, 1979, J MATER SCI, V14, P583
   GSELL C, 1997, DEFORMATION YIELD FR, V10, P57
   GSELL R, 1997, QUALITY INDICATORS H
   GUL R, 1997, THESIS MIT BOSTON
   GUL RM, 1998, T 44 ORTHOP RES SOC, V23, P99
   Hall RM, 1997, MED ENG PHYS, V19, P711, DOI 10.1016/S1350-4533(97)00032-5
   HALLDIN GW, 1977, POLYM ENG SCI, V17, P21, DOI 10.1002/pen.760170104
   HALLDIN GW, 1977, ANTEC 77, V35, P298
   HAMILTON JV, 1996, T 5 WORLD BIOM C, V2, P511
   HAN KS, 1981, J MACROMOL SCI PHYS, VB19, P313, DOI 10.1080/00222348108015307
   Han SS, 1997, J APPL POLYM SCI, V66, P1583, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1583::AID-APP20>3.0.CO;2-3
   *HOECHST AG, 1988, 70701 WN HOECHST AG
   *HOECHST AG OB, 1988, 00701 WN HOECHST AG
   JASTY M, 1997, T 43 ORTH RES SOC, V43, P785
   JOHNSON T, 1996, T 5 WORLD BIOM C, V2, P514
   JOYCE TJ, 1998, T BRIT ORTHOP RES SO, P19
   KING R, 1995, T 41 ORTHOP RES SOC, V20, P759
   KING R, 1996, T 5 WORLD BIOM C, V2, P196
   KLEIN PG, 1991, POLYMER, V32, P1732, DOI 10.1016/0032-3861(91)90355-M
   Kurtz SM, 1998, BIOMATERIALS, V19, P1989, DOI 10.1016/S0142-9612(98)00112-4
   Kurtz SM, 1996, J ORTHOPAED RES, V14, P755, DOI 10.1002/jor.1100140512
   Kurtz SM, 1997, J ORTHOPAED RES, V15, P57, DOI 10.1002/jor.1100150109
   Kurtz SM, 1997, BIOMATERIALS, V18, P1659, DOI 10.1016/S0142-9612(97)00124-5
   Kurtz SM, 1999, J BIOMED MATER RES, V48, P75, DOI 10.1002/(SICI)1097-4636(1999)48:1<75::AID-JBM13>3.0.CO;2-H
   Kurtz SM, 1998, J BIOMED MATER RES, V43, P241, DOI 10.1002/(SICI)1097-4636(199823)43:3<241::AID-JBM4>3.3.CO;2-I
   KURTZ SM, 1999, T 45 ORTHOP RES SOC, V24, P842
   KURTZ SM, 1998, T 44 ORTHOP RES OSC, V23, P361
   KURTZ SM, 1999, T 45 ORTHOP RES SOC, V24, P98
   KUSY RP, 1986, J APPL POLYM SCI, V32, P4263, DOI 10.1002/app.1986.070320337
   Kyi MS, 1995, J HOSP INFECT, V31, P275, DOI 10.1016/0195-6701(95)90206-6
   Lancaster JG, 1997, P I MECH ENG H, V211, P17, DOI 10.1243/0954411971534647
   Lewis G, 1997, J BIOMED MATER RES, V38, P55, DOI 10.1002/(SICI)1097-4636(199721)38:1<55::AID-JBM8>3.0.CO;2-G
   LI S, 1994, J BONE JOINT SURG AM, V76A, P1080, DOI 10.2106/00004623-199407000-00020
   Livingston BJ, 1997, J BONE JOINT SURG AM, V79A, P1529, DOI 10.2106/00004623-199710000-00010
   LYKINS MD, 1995, T 21 SOC BIOMATER, V18, P385
   MATSUO M, 1987, MACROMOLECULES, V20, P1745, DOI 10.1021/ma00174a004
   MATSUO M, 1986, MACROMOLECULES, V19, P2028, DOI 10.1021/ma00161a041
   MCCORD JM, 1983, SURGERY, V94, P412
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503
   MCKELLOP H, 1997, T 23 ANN M SOC BIOM, V20, P45
   MCKELLOP H, 1992, T ORTHOP RES SOC, V17, P356
   MCKELLOP H, 1996, T ORTHOP RES SOC, V21, P483
   MCKELLOP H, 1998, T ORTHOP RES SOC, V23, P98
   MCKELLOP H, 1997, T 43 SOC BIOMATER, V20, P43
   MCKELLOP HA, 1981, ENG MED, V10, P123
   MCKELLOP HA, 1998, ADULT HIP
   MCKELLOP HA, 1997, T ORTHOP RES SOC, V22, P94
   MCKENNA GB, 1981, ANTEC 81, V39, P82
   MURATOGLU OK, 1997, T 43 ORTHOP RES SOC, V22, P852
   MURATOGLU OK, 1997, T 23 SOC BIOMATER, V20, P49
   MURATOGLU OK, 1997, T ORTHOP RES SOC, V22, P773
   MURATOGLU OK, 1997, T SOC BIOMATER, V20, P74
   MURATOGLU OK, 1998, T 44 ORTHOP RES SOC, V23, P782
   NARKIS M, 1987, J MACROMOL SCI PHYS, VB26, P37, DOI 10.1080/00222348708248057
   OONISHI H, 1992, RADIAT PHYS CHEM, V39, P495
   OONISHI H, 1995, ENCY HDB BIOMATERI A
   Oonishi H, 1995, ORTHOP SURG TRAUMATO, V38, P1255
   PAGE BF, 1998, MED DEVICE DIAGN IND, V20, P73
   PASCAUD RS, 1995, T 21 SOC BIOMATER, V18, P809
   PAYER W, 1988, INTEGRATION FUNDAMEN, V2
   PENNING JP, 1994, COLLOID POLYM SCI, V272, P664, DOI 10.1007/BF00659280
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Phillips R, 1996, SOC PLAST E, V42, P2062
   PHILLIPS RA, 1997, J POLYM SCI B, V36, P495
   PIENKOWSKI D, 1995, J BIOMED MATER RES, V29, P1167, DOI 10.1002/jbm.820291002
   *POL HIS GREAT BRI, 1994, BRIEF HIST
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   PREMNATH V, 1997, T 43 ORTH RES SOC, V22, P91
   Pruitt L, 1998, POLYMER, V39, P1545, DOI 10.1016/S0032-3861(97)00448-5
   RAMANI K, 1998, CHARACTERIZATION PRO
   Ries MD, 1996, J ARTHROPLASTY, V11, P974, DOI 10.1016/S0883-5403(96)80143-4
   Ries MD, 1996, CLIN ORTHOP RELAT R, P87
   RIES MD, 1996, CLIN ORTHOP RELAT R, V331, P159
   RIMNAC CM, 1994, J APPL BIOMATER, V5, P17, DOI 10.1002/jab.770050104
   RIMNAC CM, 1996, T ORS, V21, P481
   ROSE R M, 1984, Journal of Orthopaedic Research, V2, P393, DOI 10.1002/jor.1100020412
   SANFORD WM, 1997, T 43 ORTHOP RES SOC, V22, P95
   SANFORD WM, 1995, T ORTHOP RES SOC, V20, P119
   SANFORD WM, 1996, T ORTHOP RES SOC, V21, P23
   SAUER WL, 1998, ALTERNATIVE BEARING
   SCHMALZREID TP, 1997, T 43 ORTHOP RES SOC, V22, P787
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1998, T SOC BIOMATER, V21, P216
   SCHMIDT MB, 1996, T ORTHOP RES SOC, V21, P22
   Shen FW, 1998, J BIOMED MATER RES, V41, P71, DOI 10.1002/(SICI)1097-4636(199807)41:1<71::AID-JBM9>3.0.CO;2-N
   Shen FW, 1996, J POLYM SCI POL PHYS, V34, P1063, DOI 10.1002/(SICI)1099-0488(19960430)34:6<1063::AID-POLB4>3.0.CO;2-Z
   SHEN FW, 1998, T SOC BIOMATER, V21, P3
   SHENOY AV, 1985, PLAST RUB PROC APPL, V5, P313
   SMITH RC, 1995, ORTHOPEDIC PRODUCT 1
   SMITH RC, 1996, MED HEALTHCARE MARKE
   SMITHPETERSEN MN, 1948, J BONE JOINT SURG BR, V30, P59
   SOLTI A, 1986, MAKROMOL CHEM-M SYMP, V5, P105, DOI 10.1002/masy.19860050112
   Speed JS, 1940, SURG GYNECOL OBSTET, V70, P224
   STEIN H, 1997, COMMUNICATION   0708
   Sun D. C., 1994, POLYM REPRINTS, V35, P969
   Sun DC, 1996, T 5 WORLD BIOM C, P195
   SUN DC, 1996, T ORTHOP RES SOC, V21, P493
   SUTULA LC, 1995, CLIN ORTHOP RELAT R, P28
   SWARTS D, 1996, T 5 WORLD BIOM C, V2, P196
   Sychterz CJ, 1998, J ARTHROPLASTY, V13, P508, DOI 10.1016/S0883-5403(98)90049-3
   TANNER MG, 1995, CLIN ORTHOP RELAT R, V317, P83
   TAYLOR G, 1997, T 43 ANN M ORTH RES, V22, P776
   TAYLOR S, 1999, T 45 ORTH RES SOC, V24, P252
   Thomas Y, 1997, ANTEC'97 - PLASTICS SAVING PLANET EARTH, CONFERENCE PROCEEDINGS, VOLS 1 - 3, P1551
   TRUSS RW, 1980, POLYM ENG SCI, V20, P747, DOI 10.1002/pen.760201109
   VOIGTMARTIN IG, 1980, J POLYM SCI POL PHYS, V18, P2347, DOI 10.1002/pol.1980.180181204
   WAGNER HL, 1988, J APPL POLYM SCI, V36, P567, DOI 10.1002/app.1988.070360310
   WAGNER HL, 1979, J BIOMED MATER RES, V13, P821, DOI 10.1002/jbm.820130512
   Walker PS, 1996, J BIOMED MATER RES, V33, P159
   Wang A, 1997, WEAR, V203, P230, DOI 10.1016/S0043-1648(96)07362-0
   Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X
   WANG A, 1997, T SOC BIOMATER, V20, P394
   WANG XY, 1988, J APPL POLYM SCI, V35, P2165, DOI 10.1002/app.1988.070350816
   WEIGHTMAN B, 1985, BIOMATERIALS, V6, P177, DOI 10.1016/0142-9612(85)90006-7
   WHITE SE, 1996, CLIN ORTHOPAEDICS, V331, P164
   WRIGHT T, 1991, T ORTHOP RES SOC, V16, P248
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P1312, DOI 10.2106/00004623-198870090-00006
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P926, DOI 10.2106/00004623-198870060-00019
   WRIGHT TM, 1986, CLIN ORTHOP RELAT R, V205, P67
   Wroblewski BM, 1996, J BONE JOINT SURG BR, V78B, P280
   WRONA M, 1994, CLIN ORTHOP RELAT R, V299, P92
   XENOS JS, 1995, CLIN ORTHOP RELAT R, V317, P29
   ZACHARIADES AE, 1985, POLYM ENG SCI, V25, P747, DOI 10.1002/pen.760251204
   1966, MODERN PLASTICS ENCY
   1961, MODERN PLASTICS ENCY
   1997, ORTHOP TODAY, V17, P35
   1988, 00704 WN HOECHST AG
   1997, ORTHOP TODAY, V17, P31
NR 201
TC 540
Z9 549
U1 11
U2 194
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1999
VL 20
IS 18
BP 1659
EP 1688
DI 10.1016/S0142-9612(99)00053-8
PG 30
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232AP
UT WOS:000082343800003
PM 10503968
DA 2018-10-19
ER

PT J
AU Pianigiani, E
   Andreassi, A
   Taddeucci, P
   Alessandrini, C
   Fimiani, M
   Andreassi, L
AF Pianigiani, E
   Andreassi, A
   Taddeucci, P
   Alessandrini, C
   Fimiani, M
   Andreassi, L
TI A new model for studying differentiation and growth of epidermal
   cultures on hyaluronan-based carrier
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; hyaluronic acid; cell carrier; cell culture
ID HUMAN KERATINOCYTES; CELLS; DERMIS
AB Here, a three-dimensional model based on fragments of human de-epidermized dermis (DED) is prepared in order to study the performance of a microperforated, hyaluronan-based membrane as a carrier of cultured epidermal cells. Hyaluronic acid is, in fact, considered to be an optimal biomaterial allowing proliferation of both keratinocytes and melanocytes, and it is already used for clinical aims. The carrier with subconfluent human epidermal cultures is positioned onto the DED and kept in culture until a new epidermis is formed. This model system allowed to study the migration and growth of human epidermal cells from the carrier, resembling 'in vivo' re-epithelization. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Siena, Dept Dermatol, Policlin Scotte, I-53100 Siena, Italy.
   Univ Siena, Dept Histol, I-53100 Siena, Italy.
RP Pianigiani, E (reprint author), Univ Siena, Dept Dermatol, Policlin Scotte, Viale Bracci, I-53100 Siena, Italy.
CR Andreassi L, 1998, INT J DERMATOL, V37, P595, DOI 10.1046/j.1365-4362.1998.00411.x
   ANDREASSI L, 1991, WOUNDS, V3, P116
   ASSELINEAU D, 1986, J INVEST DERMATOL, V86, P181, DOI 10.1111/1523-1747.ep12284237
   BECTHEL MJ, 1998, BRIT J DERMATOL, V138, P22
   Berthod F, 1997, BRIT J DERMATOL, V136, P809, DOI 10.1111/j.1365-2133.1997.tb03917.x
   BOYCE S, 1990, Skin Pharmacology, V3, P136
   Chung JH, 1997, ARCH DERMATOL RES, V289, P677, DOI 10.1007/s004030050261
   DELUCA M, 1988, EUR J CELL BIOL, V46, P176
   FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807
   Hollander D, 1996, Unfallchirurgie, V22, P268
   Limat A, 1996, J INVEST DERMATOL, V107, P128, DOI 10.1111/1523-1747.ep12298415
   MAST BA, 1993, MATRIX, V13, P144
   Myers S. R., 1997, Journal of Burn Care and Rehabilitation, V18, P214, DOI 10.1097/00004630-199705000-00007
   PRUNEIRAS M, 1983, J INVEST DERMATOL, V81, P28
   PRUNIERAS M, 1979, ANN CHIR PLAST ESTH, V24, P357
   REGNIER M, 1990, Skin Pharmacology, V3, P70
   REGNIER M, 1986, EXP CELL RES, V165, P63, DOI 10.1016/0014-4827(86)90533-1
   Rennekampff HO, 1996, J SURG RES, V62, P288, DOI 10.1006/jsre.1996.0210
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 21
TC 26
Z9 28
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1999
VL 20
IS 18
BP 1689
EP 1694
DI 10.1016/S0142-9612(99)00056-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232AP
UT WOS:000082343800004
PM 10503969
DA 2018-10-19
ER

PT J
AU Langstaff, S
   Sayer, M
   Smith, TJN
   Pugh, SM
   Hesp, SAM
   Thompson, WT
AF Langstaff, S
   Sayer, M
   Smith, TJN
   Pugh, SM
   Hesp, SAM
   Thompson, WT
TI Resorbable bioceramics based on stabilized calcium phosphates. Part I:
   rational design, sample preparation and material characterization
SO BIOMATERIALS
LA English
DT Article
DE bioceramic; orthopedics; hydroxyapatite; tricalcium phosphate;
   osteoclast; resorbable
ID CRYSTAL-STRUCTURE; THIN-FILMS; TRICALCIUM PHOSPHATE; LIGHT-SCATTERING;
   BROWNIAN-MOTION; LOW-TEMPERATURE; HYDROXYAPATITE; BETA-CA3(PO4)2;
   RESORPTION; CHEMISTRY
AB It has long been the goal of biomaterials research in the field of orthopedics to develop synthetic structures exhibiting comprehensive bioactivity. In particular, an ideal bone-biomaterial would support the activity of osteoblasts in the development of new bone, while simultaneously being resorbed by osteoclasts as part of the lifelong orderly process of bone remodelling. Such resorbable calcium phosphate-based thin films and bulk ceramics have now been created by the high-temperature processing of a fine precipitate, formed from a colloidal sol and stabilized using an additive such as silicon. The materials have two characteristic features: a phase composition which is a mixture of calcium hydroxyapatite and a silicon stabilized tricalcium phosphate, and a microporous morphology based on inter-connected particles (0.2-1 mu m in diameter). X-ray diffraction, infrared spectroscopy, nuclear magnetic resonance spectroscopy, and light scattering experiments indicate that the characteristic phase composition arises during sintering through substitution reactions where silicon enters the calcium phosphate lattice under conditions of high chemical reactivity. The crystallographic features are linked through the glaserite form of the apatite structure. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada.
   Millenium Biologix Inc, Kingston, ON, Canada.
   Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada.
   Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.
RP Langstaff, S (reprint author), Queens Univ, Dept Phys, Stirling Hall,Rm 206A, Kingston, ON K7L 3N6, Canada.
CR *ASTM JCPDS INT CT, 1991, POWD DIFFR FIL IN OR
   BALE CW, 1997, FACT DATABASE COMPUT
   BROWN PW, 1991, J AM CERAM SOC, V74, P934, DOI 10.1111/j.1151-2916.1991.tb04324.x
   BROWN PW, 1991, J AM CERAM SOC, V74, P1848, DOI 10.1111/j.1151-2916.1991.tb07798.x
   BROWN WE, 1981, PROG CRYST GROWTH CH, V4, P59, DOI 10.1016/0146-3535(81)90048-4
   CALVO C, 1975, AM MINERAL, V60, P120
   CLARK NA, 1970, AM J PHYS, V38, P575, DOI 10.1119/1.1976408
   Cotell CM, 1996, MATER RES SOC SYMP P, V414, P171
   DAVIES C, UNPUB TITANIUM DOPIN
   DAVIES JE, 1993, CELL MATER, V3, P245
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   DICKENS B, 1972, ACTA CRYSTALL B-STRU, VB 28, P3056, DOI 10.1107/S0567740872007411
   Driessens FCM, 1990, BIOMINERALS
   ELLIOTT JC, 1971, NATURE-PHYS SCI, V230, P72, DOI 10.1038/physci230072a0
   Elliott JC, 1994, STRUCTURE CHEM APATI
   GERHART TN, 1988, J BIOMED MATER RES, V22, P1071, DOI 10.1002/jbm.820221110
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GRISWOLD E, UNPUB TRANSMISSION E
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   LABARTHE JC, 1973, ANN CHIM FRANCE, V8, P289
   Langstaff S, 1996, MATER RES SOC SYMP P, V414, P87
   LANGSTAFF S, 1998, MAT RES SOC S P
   LANGSTAFF S, UNPUB RESORBABLE B 2
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   MATHEW M, 1977, ACTA CRYSTALLOGR B, V33, P1325, DOI 10.1107/S0567740877006037
   MEYER J, 1997, INORG CHEM, V21, P3029
   NURSE RW, 1959, J CHEM SOC, P1077, DOI 10.1039/jr9590001077
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   QIU Q, 1993, CELL MATER, V3, P351
   QIU Q, 1992, THESIS QUEENS U
   SANTOS RV, 1995, AM MINERAL, V80, P336
   SCHROEDER LW, 1977, J SOLID STATE CHEM, V22, P253, DOI 10.1016/0022-4596(77)90002-0
   SCHUMACHER RT, 1986, AM J PHYS, V54, P137, DOI 10.1119/1.14709
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   SHURVELL H, 1997, COMMUNICATION
   TOLMAN DE, 1993, MAYO CLIN PROC, V68, P323, DOI 10.1016/S0025-6196(12)60125-6
   WELCH JH, 1961, J CHEM SOC, P4442, DOI 10.1039/jr9610004442
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   1994, Patent No. 26872
NR 39
TC 126
Z9 129
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1999
VL 20
IS 18
BP 1727
EP 1741
DI 10.1016/S0142-9612(99)00086-1
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232AP
UT WOS:000082343800009
PM 10503974
DA 2018-10-19
ER

PT J
AU Kreklau, B
   Sittinger, M
   Mensing, MB
   Voigt, C
   Berger, G
   Burmester, GR
   Rahmanzadeh, R
   Gross, U
AF Kreklau, B
   Sittinger, M
   Mensing, MB
   Voigt, C
   Berger, G
   Burmester, GR
   Rahmanzadeh, R
   Gross, U
TI Tissue engineering of biphasic joint cartilage transplants
SO BIOMATERIALS
LA English
DT Article
DE calcium carbonate; resorbable polymers; cartilage; tissue engineering
ID ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; NATURAL CORAL; CORTICAL BONE;
   RAT FEMUR; CHONDROCYTES; CULTURE; CELLS; SUBSTITUTION; INVITRO
AB In isolated posttraumatic or idiopathic joint defects the chondral layers and adjacent subchondral spongy bone are usually destructed. For regeneration we suggest the in vitro formation of a cartilage-coated biomaterial carriers (biphases) in order to fill the corresponding joint defects. In this study Biocoral(R), a natural coralline material made of calcium carbonate, and calcite, a synthetic calcium carbonate, were used as supports for the cultivation of bovine chondrocytes in a three-dimensional polymer fleece. The cell-polymer-structure was affixed to the biomaterial with a fibrin-cell-solution. The artificial cartilage formed a new matrix and fused with the underlying biomaterial. The results indicate a promising technical approach to anchor tissue engineered cartilage in joint defects. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Free Univ Berlin, Inst Pathol, Med Ctr Benjamin Franklin, D-12200 Berlin, Germany.
   Free Univ Berlin, Dept Traumatol & Reconstruct Surg, Med Ctr Benjamin Franklin, D-12200 Berlin, Germany.
   Humboldt Univ, Dept Rheumatol, Charite, D-10117 Berlin, Germany.
   German Rheumatism Res Ctr, D-10117 Berlin, Germany.
   Fed Inst Mat Res & Testing BAM, Berlin, Germany.
RP Gross, U (reprint author), Free Univ Berlin, Inst Pathol, Med Ctr Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany.
CR ASTON JE, 1986, J BONE JOINT SURG BR, V68, P29
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BUCHOLZ RW, 1981, ORTHOP T, V21, P353
   BURMESTER GR, 1983, ARTHRITIS RHEUM, V26, P1187, DOI 10.1002/art.1780261003
   CHEUNG HS, 1985, IN VITRO CELL DEV, V10, P63
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Haisch A, 1996, HNO, V44, P624, DOI 10.1007/s001060050067
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Minuth WW, 1996, BIOTECHNIQUES, V20, P498
   MullerMai C, 1996, J MATER SCI-MATER M, V7, P479, DOI 10.1007/BF00705429
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   VOIGT C, 1994, J MATER SCI-MATER M, V5, P688, DOI 10.1007/BF00120357
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
NR 18
TC 81
Z9 88
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1999
VL 20
IS 18
BP 1743
EP 1749
DI 10.1016/S0142-9612(99)00061-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232AP
UT WOS:000082343800010
PM 10503975
DA 2018-10-19
ER

PT J
AU Pereira, MD
   Pereira, MD
   Sousa, JP
AF Pereira, MD
   Pereira, MD
   Sousa, JP
TI Individual study of chromium in the stainless steel implants
   degradation: An experimental study in mice
SO BIOMETALS
LA English
DT Article
DE biomaterial; chromium; histology; mice organs
ID TOTAL HIP-REPLACEMENT; METAL-ION RELEASE; CORROSION PRODUCTS; NICKEL;
   COBALT; MICROELECTRODES; SERUM; ACCUMULATION; PROTEINS; INVITRO
AB To study the accumulation and the histological effects in mice organs caused by hexavalent chromium, one of the corrosion products released from AISI 316L stainless steel implants, mice groups were subcutaneously injected with a metallic solution of chromium during a certain period of time. Similar injections were made with HBSS (Hank's Balanced Salt Solution) in other groups to be used as controls. The levels of chromium found in the liver, kidney and spleen of the control and the treated animals were obtained by atomic absorption spectrometry (AAS) and were compared to those obtained by AdSV (adsorptive stripping voltammetry) to test the accuracy of the results. During the experimental period, the liver and spleen showed a progressive and significant accumulation of chromium whereas in the kidney the significant accumulation found after the first week practically remained unchanged during the four weeks. Apparently, the histological analysis of these tissues did not evidence any relevant morphological alteration induced by the chromium accumulations during the four weeks of treatment.
C1 FEUP, Dept Engn Quim, P-4050123 Porto, Portugal.
   Univ Aveiro, Dept Biol, P-3810 Aveiro, Portugal.
   Univ Porto, Fac Engn, Inst Biomed Engn, P-4050 Porto, Portugal.
RP Pereira, MD (reprint author), FEUP, Dept Engn Quim, Rua Bragas, P-4050123 Porto, Portugal.
EM mcsp@fe.up.pt; mcsp@fe.up.pt
OI Pereira, Maria do Carmo/0000-0001-8505-3432; Pereira, Maria de
   Lourdes/0000-0001-6703-7869; Sousa, Joao/0000-0002-8269-9390
CR BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   BLACK J, 1983, BIOMATERIALS, V4, P160, DOI 10.1016/0142-9612(83)90003-0
   BRIEN WW, 1990, J BONE JOINT SURG AM, V72A, P1097, DOI 10.2106/00004623-199072070-00023
   BROWN SA, 1993, J BIOMED MATER RES, V27, P1007, DOI 10.1002/jbm.820270806
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   BURROWS D, 1983, CHROMIUM METABOLISM
   DOBBS HS, 1980, BIOMATERIALS, V1, P193, DOI 10.1016/0142-9612(80)90016-2
   KARGACIN B, 1993, BIOL TRACE ELEM RES, V36, P307, DOI 10.1007/BF02783964
   Katz S. A., 1994, BIOL ENV CHEM CHROMI
   KATZ SA, 1993, J APPL TOXICOL, V13, P217, DOI 10.1002/jat.2550130314
   LANGARD S, 1981, SYSTEMIC ASPECTS BIO, P143
   MARTIN A, 1988, J BONE JOINT SURG AM, V70A, P1561, DOI 10.2106/00004623-198870100-00017
   MERRITT K, 1989, J BIOMED MATER RES, V23, P845, DOI 10.1002/jbm.820230804
   MERRITT K, 1995, J BIOMED MATER RES, V29, P627, DOI 10.1002/jbm.820290510
   MERRITT K, 1992, ADV BIOMAT, V10, P49
   MERRITT K, 1984, J BIOMED MATER RES, V18, P991, DOI 10.1002/jbm.820180904
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   MERRITT K, 1985, CORROSION DEGRADATIO, P195
   Pereira MC, 1997, ELECTROANAL, V9, P941, DOI 10.1002/elan.1140091215
   Pereira MC, 1997, ELECTROANAL, V9, P150, DOI 10.1002/elan.1140090212
   Pereira MC, 1998, J TRACE ELEM MED BIO, V12, P50, DOI 10.1016/S0946-672X(98)80021-7
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   Pohler O, 1983, BIOMATERIALS RECONST, P158
   Ross MH, 1985, HISTOLOGY TEXT ATLAS, pxvi
   SMITH GK, 1985, CORROSION DEGRADATIO, P233
   SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302
   YANG J, 1994, BIOMATERIALS, V15, P262, DOI 10.1016/0142-9612(94)90049-3
   YOUNG E, 1987, CONTACT DERMATITIS, V17, P104, DOI 10.1111/j.1600-0536.1987.tb02670.x
NR 28
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0966-0844
J9 BIOMETALS
JI Biometals
PD SEP
PY 1999
VL 12
IS 3
BP 275
EP 280
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 239NU
UT WOS:000082775900012
DA 2018-10-19
ER

PT J
AU Yung, LYL
   Colman, RW
   Cooper, SL
AF Yung, LYL
   Colman, RW
   Cooper, SL
TI The effect of high molecular weight kininogen on neutrophil adhesion to
   polymer surfaces
SO IMMUNOPHARMACOLOGY
LA English
DT Article; Proceedings Paper
CT 15th International Conference on Kinins (Kinin 98)
CY OCT 19-24, 1998
CL NARA, JAPAN
DE neutrophils; high molecular weight kininogen; mac-1 receptors; cell
   adhesion
ID LIGHT-CHAIN; BACTERIAL ADHESION; LEUKOCYTE COUNTS; ANIONIC SURFACE;
   BINDING; INVITRO
AB The adhesion of neutrophils on a biomaterial surface depends on the surface chemistry of the material and the cell, as well as the composition and conformation of adsorbed protein and the adherence of other cells when the biomaterial is exposed to circulating blood. In this study, HK and HKa were allowed to adsorb on three different polyurethanes: underivatized (PU-base), quatemized (PU-NR4), sulfonated (PU-SO3). The effect of kininogen adsorption on the degree of neutrophil adhesion was examined. The surface density of the adsorbed protein was also investigated. The PU-NR4 surface adsorbed the most HK and HKa and had the high degree of neutrophil adhesion. Although the surface density of adsorbed HK and HKa on the PU-SO3 surface, the degree of neutrophil on adhesion was significantly lower when compared to the PLT-NR4 and PU-base surfaces. HK and HKa contain binding sites for both anionic surfaces and neutrophils in the same domain (D-5H). When adsorbed to the anionic PU-SO3 surfaces, HK and HKa did not have the neutrophil binding sites available and therefore, exhibited an anti-adhesive effect. In contrast, the neutrophil binding domains D-3 and D-5H of adsorbed kininogens were available on the PU-NR4 and PU-base surfaces. Thus, adsorbed kininogens on these two surfaces lost their anti-adhesive property and this led to a high degree of neutrophil adhesion. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.
RP Yung, LYL (reprint author), Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
RI Yung, Lanry/B-6515-2009
OI Yung, Lanry/0000-0001-7579-6347
CR BOHLER J, 1983, CONTRIB NEPHROL, V36, P15
   DELACADENA RA, 1992, PROTEIN SCI, V1, P151
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   JACOBSEN S, 1967, BRIT J PHARM CHEMOTH, V29, P25, DOI 10.1111/j.1476-5381.1967.tb01935.x
   KLOCK JC, 1976, BLOOD, V48, P149
   KUNAPULI SP, 1993, J BIOL CHEM, V268, P2486
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   RYHANEN P, 1979, J THORAC CARDIOV SUR, V77, P259
   SCHMAIER AH, 1984, THROMB RES, V33, P51, DOI 10.1016/0049-3848(84)90154-3
   SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WACHTFOGEL YT, 1994, J BIOL CHEM, V269, P19307
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   Yung LYL, 1996, IMMUNOPHARMACOLOGY, V32, P19, DOI 10.1016/0162-3109(96)00003-3
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 19
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0162-3109
J9 IMMUNOPHARMACOLOGY
JI Immunopharmacology
PD SEP
PY 1999
VL 43
IS 2-3
BP 281
EP 286
DI 10.1016/S0162-3109(99)00134-4
PG 6
WC Immunology; Pharmacology & Pharmacy
SC Immunology; Pharmacology & Pharmacy
GA 258PQ
UT WOS:000083847900028
PM 10596864
DA 2018-10-19
ER

PT J
AU Bobyn, JD
   Stackpool, GJ
   Hacking, SA
   Tanzer, M
   Krygier, JJ
AF Bobyn, JD
   Stackpool, GJ
   Hacking, SA
   Tanzer, M
   Krygier, JJ
TI Characteristics of bone ingrowth and interface mechanics of a new porous
   tantalum biomaterial
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID MARKERS; GROWTH
AB We have studied the characteristics of bone ingrowth of a new porous tantalum biomaterial in a simple transcortical canine model using cylindrical implants 5x10 mm in size. The material was 75% to 80% porous by volume and had a repeating arrangement of slender interconnecting struts which formed a regular array of dodecahedron-shaped pores. We performed histological studies on two types of material, one with a smaller pore size averaging 430 pm at 4, 16 and 52 weeks and the other with a larger pore size averaging 650 mu m at 2, 3, 4, 16 and 52 weeks, Mechanical push-out tests at 4 and 16 weeks were used to assess the shear strength of the bone-implant interface on implants of the smaller pore size.
   The extent of filling of the pores of the tantalum material with new bone increased from 13% at two weeks to between 42% and 53% at four weeks. By 16 and 52 weeks the average extent of bone ingrowth ranged from 63% to 80%, The tissue response to the small and large pore sizes was similar, with regions of contact between bone and implant increasing with time and with evidence of Haversian remodelling within the pores at later periods. Mechanical tests at four weeks indicated a minimum shear fixation strength of 18.5 MPa, substantially higher than has been obtained with other porous materials with less volumetric porosity. This porous tantalum biomaterial has desirable characteristics for bone ingrowth; further studies are warranted to ascertain its potential for clinical reconstructive orthopaedics.
C1 Montreal Gen Hosp, Dept Surg, Montreal, PQ H3G 1A4, Canada.
   Montreal Gen Hosp, Dept Biomed Engn, Montreal, PQ H3G 1A4, Canada.
   Montreal Gen Hosp, Res Inst, Jo Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
   Montreal Gen Hosp, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada.
   McGill Univ, Montreal, PQ H3A 2T5, Canada.
RP Bobyn, JD (reprint author), Montreal Gen Hosp, Dept Surg, Rm A2-156,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.
RI Hacking, Adam/F-3645-2010
CR ALBERIUS P, 1983, ACTA ANAT, V115, P310
   ARONSON AS, 1985, SKELETAL RADIOL, V14, P207, DOI 10.1007/BF00355566
   *ASTM, 1998, ANN BOOK ASTM STAND, P63
   BAILEY OT, 1952, J NEUROSURG, V9, P83, DOI 10.3171/jns.1952.9.1.0083
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn J. Dennis, 1996, P75
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Carney HM, 1942, P SOC EXP BIOL MED, V51, P147
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, P173
   Cook S D, 1988, J Arthroplasty, V3, P249
   COOK SD, 1991, J ARTHROPLASTY S, V6, P37
   DUCHEYNE P, 1979, T ANN M SOC BIOMATER, P30
   ENGH CA, 1995, J BONE JOINT SURG AM, V77A, P903, DOI 10.2106/00004623-199506000-00011
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GOLDBERG VM, 1995, CLIN ORTHOP RELAT R, P122
   Grundschober F, 1982, BIOMATERIALS 1980, P365
   Hacking SA, 1999, CLIN ORTHOP RELAT R, P240
   HAMMAN G, 1987, ASTM STP, V953, P77
   JOHNSON PF, 1977, J BIOMED MATER RES, V11, P637, DOI 10.1002/jbm.820110502
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KRYGIER JJ, 1999, MECH CHARACTERISATIO
   Pfluger G., 1980, BIOMATERIALS 1980, P161
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   Plenk Jr H, 1984, CEMENTLESS FIXATION, P174
   Plenk Jr H, 1982, P WORLD C MED PHYS B, P3
   Pudenz RH, 1943, J AMER MED ASSOC, V121, P478
   ROBERTSON RCL, 1945, J NEUROSURG, V2, P281, DOI 10.3171/jns.1945.2.4.0281
   SPECTOR M, 1982, BIOCOMPATIBILITY ORT, P89
   SPURLING RG, 1943, SURG CLIN N AM, V23, P1491
   STACKPOOL GJ, 1995, T COMBINED ORS, V45
   STEIN T, 1991, ORTHOP T, V15, P178
   Tanzer M, 1996, J ORTHOPAED RES, V14, P901, DOI 10.1002/jor.1100140609
   Tegtmeyer C J, 1975, Can J Otolaryngol, V4, P81
NR 42
TC 515
Z9 558
U1 6
U2 78
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON, ENGLAND WC2N 6ET
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD SEP
PY 1999
VL 81B
IS 5
BP 907
EP 914
DI 10.1302/0301-620X.81B5.9283
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 243BF
UT WOS:000082976700032
PM 10530861
DA 2018-10-19
ER

PT J
AU Arevalo, JM
   Lorente, JA
AF Arevalo, JM
   Lorente, JA
TI Skin coverage with Biobrane* biomaterial for the treatment of patients
   with toxic epidermal necrolysis
SO JOURNAL OF BURN CARE & REHABILITATION
LA English
DT Article
ID STEVENS-JOHNSON SYNDROME; EARLY WOUND COVERAGE
AB Toxic epidermal necrolysis (TEN) is an exfoliative skin disorder that may involve a large body surface area and mucosal surfaces, The microscopic changes that occur with this condition are similar to those that occur with superficial dermal burns, such as dermal detachment from the underlying dermis. Complications of TEN are related to the loss of the the epithelial skin barrier and include pain, fluid and electrolyte loss, and an increased risk of sepsis. The treatment of a patient with TEN is best accomplished in a burn unit, where expert treatment of these complications can be provided. Medical treatment includes the administration of immunosuppressive therapy and the discontinuation of any previous corticosteroid treatment. Surgical management includes the debridement of necrotic areas. In this article, the surgical management of 8 consecutive patients with TEN who were admitted to the intensive care burn unit at the Hospital Universitario de Getafe in Madrid, Spain, from 1996 to 1998 is described. These patients were treated with extensive early debridement of necrotic skin areas followed by wound coverage with Biobrane (Dow B. Hickam, Inc, Sugarland, Tex), a temporary semisynthetic skin substitute. Skin coverage with this material decreases pain and fluid loss, and it possibly facilitates epithelization and decreases the risk of sepsis, without adverse side effects. This semisynthetic material meets some standards of an ideal skin substitute: it is easy to use, provides several beneficial physiologic effects, and improves patients' comfort. In the 8 cases of patients with TEN that were studied, the use of Biobrane skin substitute for the coverage of massive areas of detached skin was found to be an important aspect of treatment.
C1 Hosp Univ Getafe, Serv Cirugia Plast, Getafe 28905, Madrid, Spain.
   Hosp Univ Getafe, Unidad Grandes Quemados, Getafe 28905, Madrid, Spain.
   Hosp Univ Getafe, Unidad Ciudados Intens, Getafe 28905, Madrid, Spain.
RP Arevalo, JM (reprint author), Hosp Univ Getafe, Serv Cirugia Plast, Carretera Toledo,Km 12500, Getafe 28905, Madrid, Spain.
CR AlQattan MM, 1996, ANN PLAS SURG, V36, P224, DOI 10.1097/00000637-199602000-00025
   AMON RB, 1975, ARCH DERMATOL, V111, P1433, DOI 10.1001/archderm.111.11.1433
   Arevalo JM, 1998, MED CLIN-BARCELONA, V111, P27
   Bishop JF, 1995, J BURN CARE REHABIL, V16, P341
   BRADLEY T, 1995, ANN PLAS SURG, V35, P124, DOI 10.1097/00000637-199508000-00002
   BROEKHUIZEN TH, 1983, LANCET, V2, P1023
   CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43
   CORREIA O, 1993, ARCH DERMATOL, V129, P466, DOI 10.1001/archderm.129.4.466
   EZPELETA A, 1994, MED INTENSIVA BARCEL, V18, P478
   HALEBIAN PH, 1986, ANN SURG, V204, P503, DOI 10.1097/00000658-198611000-00001
   HEIMBACH DM, 1987, JAMA-J AM MED ASSOC, V257, P2171
   KELEMEN JJ, 1995, J AM COLL SURGEONS, V180, P273
   Khoo AKM, 1996, BURNS, V22, P275, DOI 10.1016/0305-4179(95)00140-9
   Kucan John O., 1995, Journal of Burn Care and Rehabilitation, V16, P324, DOI 10.1097/00004630-199505000-00020
   LORENTE JA, 1994, ENTERAL NUTRITION CR, P45
   LYELL A, 1956, BRIT J DERMATOL, V68, P355, DOI 10.1111/j.1365-2133.1956.tb12766.x
   MARSHALL JC, 1997, SEPSIS MULTIORGAN FA, P286
   NALDI L, 1990, ARCH DERMATOL, V126, P1103, DOI 10.1001/archderm.1990.01670320127028
   PRASAD JK, 1986, J TRAUMA, V26, P945, DOI 10.1097/00005373-198610000-00016
   PRUITT BA, 1984, ARCH SURG-CHICAGO, V119, P312
   REFINDO B, 1994, PIEL, V9, P423
   Rodeheaver George T., 1995, Journal of Burn Care and Rehabilitation, V16, P321, DOI 10.1097/00004630-199505000-00019
   ROJEAU JC, 1994, NEW ENGL J MED, V331, P1272
   ROJEAU JC, 1995, NEW ENGL J MED, V333, P1600
   SOWDER L L, 1990, Journal of Burn Care and Rehabilitation, V11, P237, DOI 10.1097/00004630-199005000-00010
   Yarbrough Dabney R. Iii, 1996, Journal of Burn Care and Rehabilitation, V17, P30, DOI 10.1097/00004630-199601000-00008
   ZOLTIE N, 1994, BURNS, V20, P368, DOI 10.1016/0305-4179(94)90072-8
NR 27
TC 34
Z9 34
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0273-8481
J9 J BURN CARE REHABIL
JI J. Burn Care Rehabil.
PD SEP-OCT
PY 1999
VL 20
IS 5
BP 406
EP 410
DI 10.1097/00004630-199909000-00013
PG 5
WC Emergency Medicine; Rehabilitation; Surgery
SC Emergency Medicine; Rehabilitation; Surgery
GA 237DM
UT WOS:000082640100012
PM 10501329
DA 2018-10-19
ER

PT J
AU Nakamachi, E
   Yamada, T
AF Nakamachi, E
   Yamada, T
TI Molecular structural analysis of actomyosin to characterize the motor
   protein system
SO JSME INTERNATIONAL JOURNAL SERIES C-MECHANICAL SYSTEMS MACHINE ELEMENTS
   AND MANUFACTURING
LA English
DT Article
DE muscle and skeleton; biomaterial; biomechanics; computer-aided analysis;
   molecular dynamics; actomyosin; ATP; ADP; minimum-energy conformation;
   fluctuation
ID NUCLEIC-ACIDS; FORCE-FIELD
AB Muscle contraction results from the relative sliding motion between thick myosin and thin actin filaments. Actomyosin is a molecular machine that converts chemical energy produced by the hydrolysis of ATP into kinetic energy. The investigation of the contractile mechanism of muscles at the atomic/molecular level was motivated by the determination of the structures of actin and myosin head S1 monomers by X-ray diffraction analyses. In order to clarify microscopic kinetic function and material heterogeneity, the molecular structural analysis of actomyosin was carried out using the molecular mechanics simulation code "AMBER". The 3-D molecular structures of actomyosin employ three models which consist of three kinds of myosin head S1 (with ATP, with ADP, and without nucleotide) and F-actin itself to reveal the fundamental micromechanism of activation in the motility assay. The minimum-energy conformations of actomyosin in the three models were determined from molecular mechanics analyses. The differences in atomic coordinates and potential energy distributions show the existence of local packing and microstructural heterogeneity. Then, molecular fluctuations were studied by molecular dynamics analysis. The fluctuations reveal the dynamic properties at the atomic level and the possibility of change in the mesoscale structure as well as the emergence of the sliding motion of the entire molecule.
C1 Osaka Inst Technol, Dept Mech Engn, Asahi Ku, Osaka 5358585, Japan.
   Howa Kogyo Co Ltd, Arakawa, Aichi 4528601, Japan.
RP Nakamachi, E (reprint author), Osaka Inst Technol, Dept Mech Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.
CR EGUCHI Y, 1991, PHYSICAL CHEM FDN PR
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0
   NAKAMACHI E, 1997, T JPN SOC MECH ENG, V63, P225
   NAKAMACHI E, 1994, T JPN SOC MECH ENG, V60, P233
   NAKAMACHI E, 1997, T JPN SOC MECH ENG, V63, P214
   NAKAMACHI E, 1995, T JPN SOC MECH ENG, V61, P277
   RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858
   RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   YOUNT RG, 1995, BIOPHYS J, V68, pS44
NR 12
TC 0
Z9 0
U1 0
U2 0
PU JAPAN SOC MECHANICAL ENGINEERS
PI TOKYO
PA SHINANOMACHI-RENGAKAN BLDG, SHINANOMACHI 35, SHINJUKU-KU, TOKYO, 160,
   JAPAN
SN 1340-8062
J9 JSME INT J C-MECH SY
JI JSME Int. J. Ser. C-Mech. Syst. Mach. Elem. Manuf.
PD SEP
PY 1999
VL 42
IS 3
BP 746
EP 752
DI 10.1299/jsmec.42.746
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 247MR
UT WOS:000083225000038
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ohl, A
   Schroder, K
AF Ohl, A
   Schroder, K
TI Plasma-induced chemical micropatterning for cell culturing applications:
   a brief review
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Plasma Surface Engineering (PSE 98)
CY SEP 14-18, 1998
CL GARMISCH PARTENKI, GERMANY
SP European Joint Comm Plasma & Ion Surface Engn
DE biomaterials; cell culturing; low-temperature plasma; micropatterning;
   polymer scaffold; surface modification
ID COPLANAR MOLECULAR ASSEMBLIES; ETHYLENE-PROPYLENE FILMS; GLOW-DISCHARGE
   TREATMENT; VEIN ENDOTHELIAL-CELLS; BIOMEDICAL APPLICATIONS; SURFACE
   IMMOBILIZATION; RADIOFREQUENCY PLASMAS; BIOMATERIAL SURFACES;
   INTRAOCULAR LENSES; INITIAL ATTACHMENT
AB Plasma-induced chemical micropatterning for cell culturing is a new field of plasma surface modification of biomaterials. It is based on a trend to miniaturization of detailed structures of tissue culture scaffolds. In the present paper plasma methods are discussed with respect to other techniques which also induce micropatterned cell growth. Plasma-based methods might have certain advantages regarding modification of various biocompatible materials. Examples are given to demonstrate this. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Inst Low Temp Plasma Phys, D-17489 Greifswald, Germany.
RP Ohl, A (reprint author), Inst Low Temp Plasma Phys, FL Jahn Str 19, D-17489 Greifswald, Germany.
EM ohl@inp.greifswald.de
CR Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2
   CHESMEL K, 1989, T ANN M SOC BIOMATER, V12, P1
   Chinn J. A., 1994, Journal of Tissue Culture Methods, V16, P155, DOI 10.1007/BF01540643
   CLARK P, 1992, J CELL SCI, V103, P287
   CLARK P, 1993, J CELL SCI, V105, P203
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   CONNOLLY P, 1994, TRENDS BIOTECHNOL, V12, P123, DOI 10.1016/0167-7799(94)90089-2
   CURTIS A, 1994, ENABLING TECHNOLOGIE, P99
   CURTIS ASG, 1992, J CELL SCI, V101, P427
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   DUNN GA, 1995, BIOMEDICAL ENG, P1679
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Flounders AW, 1997, BIOSENS BIOELECTRON, V12, P447, DOI 10.1016/S0956-5663(96)00064-4
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Fortsch M, 1993, Ophthalmologe, V90, P754
   FROMHERZ P, 1991, NEUROSCI LETT, V129, P77, DOI 10.1016/0304-3940(91)90724-8
   Fuhr G., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P47
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HOLLER C, 1993, ZBL HYG UMWELTMED, V194, P380
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JANSEN J, 1997, VACUUM SOLUTIONS, P25
   KAMEL I, 1994, Patent No. 5326584
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KESSLER L, 1995, BIOMATERIALS, V16, P185, DOI 10.1016/0142-9612(95)92116-N
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Kiss E, 1987, PROG COLLOID POLYM S, V74, P113
   KLEE D, 1995, SPEKT WISS, V9, P90
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   KOHNEN W, 1994, BIOTECHNOLOGY AND BIOACTIVE POLYMERS, P317
   LaRocca P, 1996, CELL LINE, V6, P1
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MAN N K, 1990, Artificial Organs, V14, P44
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Matsuda T, 1992, ASAIO J, V38, pM243, DOI 10.1097/00002480-199207000-00029
   MOY E, 1994, COLLOID POLYM SCI, V272, P1245, DOI 10.1007/BF00657777
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   OHL A, 1997, P 13 INT S PLASM CHE, V3, P1259
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROZSNYAI LF, 1992, ANGEW CHEM INT EDIT, V31, P759, DOI 10.1002/anie.199207591
   Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1
   Schnelle T, 1996, LANGMUIR, V12, P801, DOI 10.1021/la950065t
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SHAY JW, 1977, EXP CELL RES, V105, P1, DOI 10.1016/0014-4827(77)90146-X
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Steele JG, 1995, ACS SYM SER, V602, P436
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   THELEN H, 1995, FRESEN J ANAL CHEM, V353, P290, DOI 10.1007/BF00322054
   TIDWELL CD, 1997, LANGMUIR, V13, P4304
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   YUAN S, 1993, J BIOMED MATER RES, V27, P811, DOI 10.1002/jbm.820270614
NR 85
TC 84
Z9 85
U1 1
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1999
VL 116
BP 820
EP 830
DI 10.1016/S0257-8972(99)00150-4
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 259VG
UT WOS:000083914200130
DA 2018-10-19
ER

PT J
AU Chen, F
   Yoo, JJ
   Atala, A
AF Chen, F
   Yoo, JJ
   Atala, A
TI Acellular collagen matrix as a possible "off the shelf" biomaterial for
   urethral repair
SO UROLOGY
LA English
DT Article
ID BLADDER MUCOSAL GRAFT; RECONSTRUCTION
AB Objectives. To determine whether a naturally derived collagen-based tissue substitute developed for urethral reconstruction would be suitable for urethral repair in an animal model. Several urethral conditions often require nongenital tissues for reconstruction, such as skin grafts or mucosal grafts from the bladder or buccal regions. However, the use of these tissues for urethroplasty may be associated with additional procedures for graft retrieval, prolonged hospitalization, and morbidity.
   Methods. A ventral urethral defect was created in 10 male rabbits. The acellular collagen matrix, obtained and processed from porcine bladder submucosa, was trimmed and used to replace the urethral defect in an onlay fashion. Serial urethrography was performed pre- and postoperatively at 0.5, 1, 2, 3, and 6 months. The animals were sacrificed 0.5, 1, 2, 3, and 6 months after surgery. The retrieved implants were analyzed grossly, histologically, and with immunocytochemistry.
   Results. All animals survived until being sacrificed without any noticeable voiding dysfunction. Serial urethrograms confirmed the maintenance of a wide urethral caliber without any signs of strictures. Cross examination at retrieval showed normally appearing tissue without any evidence of fibrosis. Histologically, the implanted matrices contained host cell infiltration and generous angiogenesis by 2 weeks after surgery. The presence of a confluent transitional cell layer was confirmed by immunocytochemical analyses using pancytokeratin antibodies. Anti-alpha actin antibodies demonstrated the migration of unorganized muscle fiber bundles 2 months after implantation and organized muscle bundles 6 months after implantation.
   Conclusions. The acellular collagen matrix appears to be a useful material for urethral repair in the rabbit. The matrix can be processed easily, has good characteristics for tissue handling and urethral function, and has the advantage of being an "off the shelf" material. (C) 1999, Elsevier Science Inc.
C1 Childrens Hosp, Dept Urol, Boston, MA 02115 USA.
   Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Atala, A (reprint author), Childrens Hosp, Dept Urol, 300 Longwood Ave, Boston, MA 02115 USA.
RI Sano, Michael/E-1715-2011
OI Atala, Anthony/0000-0001-8186-2160
CR ALBERT HM, 1977, ANN SURG, V185, P717, DOI 10.1097/00000658-197706000-00015
   Caldamone AA, 1998, UROLOGY, V51, P15, DOI 10.1016/S0090-4295(98)00088-0
   DESSANTI A, 1992, J UROLOGY, V147, P1081, DOI 10.1016/S0022-5347(17)37478-5
   EHRLICH RM, 1989, J UROLOGY, V142, P626, DOI 10.1016/S0022-5347(17)38837-7
   Humby G, 1941, BRIT J SURG, V29, P84, DOI 10.1002/bjs.18002911312
   KOYLE MA, 1987, J UROLOGY, V138, P1093, DOI 10.1016/S0022-5347(17)43511-7
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   TSUJI I, 1967, J UROLOGY, V98, P91, DOI 10.1016/S0022-5347(17)62828-3
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 9
TC 223
Z9 249
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD SEP
PY 1999
VL 54
IS 3
BP 407
EP 410
DI 10.1016/S0090-4295(99)00179-X
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 230LC
UT WOS:000082251800004
PM 10475343
DA 2018-10-19
ER

PT J
AU Hansen, GP
AF Hansen, GP
TI Understanding dressing composition: A biomaterial point of view.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Johnson & Johnson Med, Arlington, TX 76004 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 1999
VL 218
MA 23-CELL
BP U218
EP U218
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 226QZ
UT WOS:000082033900596
DA 2018-10-19
ER

PT J
AU Luginbuhl, R
   Buenviaje, C
   Pan, VY
   Ratner, BD
   Overney, RM
AF Luginbuhl, R
   Buenviaje, C
   Pan, VY
   Ratner, BD
   Overney, RM
TI Molecular confinement at biomaterial interfaces.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Washington, Dept Bioengn & Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 1999
VL 218
MA 169-COLL
BP U448
EP U448
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 226QZ
UT WOS:000082033901362
DA 2018-10-19
ER

PT J
AU Whitlock, PW
   Clarson, SJ
   Retzinger, GS
AF Whitlock, PW
   Clarson, SJ
   Retzinger, GS
TI Functionality of fibrinogen bound to pdms biomaterial.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Cincinnati, Coll Engn, Polymer Res Grp, Cincinnati, OH 45221 USA.
   Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 1999
VL 218
MA 153-POLY
BP U442
EP U442
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 226RA
UT WOS:000082034001294
DA 2018-10-19
ER

PT J
AU Houel, R
   Moczar, M
   Clerin, V
   Loisance, DY
AF Houel, R
   Moczar, M
   Clerin, V
   Loisance, DY
TI Pseudointima in inflow conduits of left ventricular assist devices
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Circulatory Support Devices for Severe
   Cardiac Failure
CY OCT 03-05, 1997
CL HOUSTON, TEXAS
ID ARTERIAL PROSTHESES; CELLS
AB Background. Explant analysis of left ventricular assist systems (LVAS) should permit a better evaluation of long-term evolution of materials and tissue healing in patients supported by mechanical devices and a precise understanding of embolic phenomena, observed clinically.
   Methods. Five Novacor LVAS and their conduits have been explanted after 156 days (range 61-226 days) of mechanical support. The pseudo-intima (PI) developed in the inflow and outflow conduits was characterized microscopically, using monoclonal antibodies.
   Results. The morphological aspects of PI were quite different in the inflow and outflow conduits. Blood coagulation between the basal surface of the PI and the Dacron tube, irregular collagen type I matrix with plasma infiltration, macrophages, and neutrophil granulocyte elastase characterized the nonadherent, loose, and potentially thrombogenic PI growth in the inflow conduit. The PI from collagen types I and IV with circumferentially oriented alpha-smooth muscle cell actin-positive cells was anchored to the outflow conduits.
   Conclusions. The observations, which have to be confirmed by a more extensive study on a larger number of specimens, suggest the role of the biomaterial itself, as well as the configuration, physical characteristics, and rheology in the conduit. They also suggest that thromboembolic complications of LVAS may eventually be related to this host tissue response. (C) 1999 by The Society of Thoracic Surgeons.
C1 Hop Henri Mondor, Fac Med, Ctr Rech Chirurg Henri Mondor, Dept Cardiothorac & Cardiovasc Surg, F-94010 Creteil, France.
RP Loisance, DY (reprint author), Hop Henri Mondor, Fac Med, Ctr Rech Chirurg Henri Mondor, Dept Cardiothorac & Cardiovasc Surg, 8 Rue Gen Sarrail, F-94010 Creteil, France.
CR AGARWAL KC, 1982, J THORAC CARDIOV SUR, V83, P584
   ANDERSON JM, 1984, BIOMATERIALS, V54, P5
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   CALLOW AD, 1982, ARCH SURG-CHICAGO, V117, P1447
   Chengshi H, 1989, P NATL ACAD SCI USA, V86, P2632
   CLOWES AW, 1986, LAB INVEST, V54, P295
   Despotis GJ, 1996, J THORAC CARDIOV SUR, V112, P538, DOI 10.1016/S0022-5223(96)70284-2
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   KOHLER TR, 1992, SURGERY, V112, P901
   LEVINSON MM, 1986, ARTIF ORGANS, V10, P236, DOI 10.1111/j.1525-1594.1986.tb02552.x
   LOISANCE D, 1995, EUR J CARDIO-THORAC, V9, P95, DOI 10.1016/S1010-7940(05)80026-0
   LOISANCE D, 1995, ASSISTED CIRCULATION, P55
   MATHISEN SR, 1986, J VASC SURG, V4, P33
   PORTNER PM, 1995, MECH CIRCULATORY SUP, P217
   Rafii S, 1995, ANN THORAC SURG, V60, P1627, DOI 10.1016/0003-4975(95)00807-1
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   SHAH PK, 1995, CIRCULATION, V92, P1565
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Spanier T, 1996, J THORAC CARDIOV SUR, V112, P1090, DOI 10.1016/S0022-5223(96)70111-3
   SUMPIO BE, 1988, J SURG RES, V44, P696, DOI 10.1016/0022-4804(88)90103-5
NR 20
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 1999
VL 68
IS 2
BP 717
EP 723
DI 10.1016/S0003-4975(99)00527-5
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 230LT
UT WOS:000082253200111
PM 10475477
DA 2018-10-19
ER

PT J
AU Rinkevich, B
   Ben-Yakir, S
   Ben-Yakir, R
AF Rinkevich, B
   Ben-Yakir, S
   Ben-Yakir, R
TI Regeneration of amputated avian bone by a coral skeletal implant
SO BIOLOGICAL BULLETIN
LA English
DT Article
ID FRACTURES; BIRDS
AB Bone fractures are common in both wild and captive birds (1, 2). Avian bones are thin and brittle and tend to break into fragments or shatter upon a variety of natural events (midair collisions, fights with other animals; ref 2) or anthropogenic experiences (wounding by gunfire, collisions with cars or fences, encounters with traps, attacks by dogs or cats, etc.; ref I). The prospect of full recovery following repair of avian bone fracture is often pool; and the complication rate is high (3). For wild birds, anything less than complete normal function cannot be regarded as successful, and slight malunion or a change in a few degrees of rotation can produce a severe loss of flight function (4). Furthermore, in nomadic species, time is critical because long periods of rehabilitation may prevent the birds from reuniting with their flocks. lit experiments with implantation of fragments of skeleton from the coral Stylophora pistillata, we found the implants to be avian osteo-conductive biomaterial, acting as a scaffold for a direct osteoblastic deposition. In the case study presented here, the bird regained complete flight activity within 2 weeks after surgery, with full regeneration of the amputated ulna.
C1 Natl Inst Oceanog, IL-31080 Haifa, Israel.
   Hod Hasharon Vet Clin, Hod Hasharon, Israel.
RP Rinkevich, B (reprint author), Natl Inst Oceanog, POB 8030, IL-31080 Haifa, Israel.
CR BENNETT RA, 1992, J ZOO WILDLIFE MED, V23, P5
   FIX AS, 1990, J WILDLIFE DIS, V26, P18, DOI 10.7589/0090-3558-26.1.18
   Guillemin G., 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P67
   HOUSTON DC, 1993, IBIS, V135, P468, DOI 10.1111/j.1474-919X.1993.tb02122.x
   KEHR PH, 1993, ORTHOP TRAUMATOL, V3, P287
   LOYA Y, 1976, NATURE, V259, P478, DOI 10.1038/259478a0
   MACCOY DM, 1992, VET CLIN N AM-SMALL, V22, P225, DOI 10.1016/S0195-5616(92)50016-X
   MATHEWS KG, 1994, VET COMP ORTHOPAED, V7, P158
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
NR 9
TC 2
Z9 2
U1 0
U2 2
PU MARINE BIOLOGICAL LABORATORY
PI WOODS HOLE
PA 7 MBL ST, WOODS HOLE, MA 02543 USA
SN 0006-3185
J9 BIOL BULL
JI Biol. Bull.
PD AUG
PY 1999
VL 197
IS 1
BP 11
EP 13
DI 10.2307/1542992
PG 3
WC Biology; Marine & Freshwater Biology
SC Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology
GA 233AM
UT WOS:000082403400003
PM 28296497
DA 2018-10-19
ER

PT J
AU Tang, LP
   Sheu, MS
   Chu, TM
   Huang, YH
AF Tang, LP
   Sheu, MS
   Chu, TM
   Huang, YH
TI Anti-inflammatory properties of triblock siloxane copolymer-blended
   materials
SO BIOMATERIALS
LA English
DT Article
DE polycaprolactone-polydimethyl siloxane-polycaprolactone; polyvinyl
   chloride; fibrinogen; inflammatory responses
ID COMPLEMENT ACTIVATION; INVIVO BIOCOMPATIBILITY; POLYMER SURFACES;
   FIBRINOGEN ADSORPTION; ARTERIAL PROSTHESES; PROTEIN ADSORPTION;
   PLATELET-ADHESION; FUNCTIONAL-GROUPS; POLYETHYLENE; BIOMATERIALS
AB Implantable biomaterials often trigger a variety of adverse responses. Because polydimethyl siloxane surfaces have good hemo- and bio-compatibility, it is generally believed that surface biocompatibility may be improved by modifying biomaterial surfaces with silicone-like properties. For this, we developed a series of polycaprolactone-polydimethylsiloxane-polycaprolactone (PDMS-PCL) copolymers. By mixing the substrate material-polyvinyl chloride-with law concentrations (1.2 and 2.4%) of the PDMS-PCL copolymer, we generated materials with silicone-like surface properties as reflected by increased surface silicon content and surface contact angles. We assessed the biocompatibility of these surfaces in vitro and found that the addition of PDMS-PCL significantly reduced the percentages of surface-'denatured' fibrinogen, a critical element of genesis of many adverse responses to implanted biomaterials. Indeed, using an animal implantation model, we find that PDMS-PCL-blended materials triggered significantly weaker inflammatory responses than did polyvinyl chloride, the substrate control. The results from these experiments suggest that the use of PDMS-PCL additives (2.4%) in polymer blends is a useful means of camouflaging the substrate surface properties and improving the biocompatibility of biomaterials. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   Adv Surface Technol Inc, Billerica, MA 01821 USA.
   New Jersey Inst Technol, Dept Mech Engn, Newark, NJ 07102 USA.
   Datascope Corp, Fairfield, NJ 07004 USA.
RP Tang, LP (reprint author), Baylor Coll Med, Dept Pediat, 1 Baylor Plaza, Houston, TX 77030 USA.
FU NHLBI NIH HHS [R01-HL53637, R01-HL56187]
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRASH JL, 1977, ANN NY ACAD SCI, V283, P356, DOI 10.1111/j.1749-6632.1977.tb41781.x
   CAPPELLI G, 1989, BLOOD PURIFICAT, V7, P293, DOI 10.1159/000169604
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLEMAN RW, 1984, J CLIN INVEST, V73, P1249
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DEALY JM, 1982, RHEOMETERS MOLTEN PL
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HORBETT TA, 1986, J BIOMED MATER RES, V20, P739, DOI 10.1002/jbm.820200608
   Jansen B, 1988, J Biomater Appl, V2, P520
   KAWAKAMI Y, 1985, ACS SYM SER, V286, pCH19
   KO TM, 1993, BIOMATERIALS, V14, P657
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KUMAKI T, 1985, J BIOMED MATER RES, V19, P785, DOI 10.1002/jbm.820190706
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Leininger R I, 1968, Ann N Y Acad Sci, V146, P11, DOI 10.1111/j.1749-6632.1968.tb20267.x
   LELAH MD, 1986, POLYURETHANE MED
   LEW DP, 1989, EUR J CANCER CLIN ON, V25, P1379, DOI 10.1016/0277-5379(89)90091-6
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MERHI Y, 1989, BIOMATERIALS, V10, P56, DOI 10.1016/0142-9612(89)90010-0
   Noll W., 1968, CHEM TECHNOLOGY SILI
   NOSHAY A, 1977, BLOCK COPOLYMER OVER
   NUSBACHER J, 1978, BLOOD, V51, P359
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   Rauwendaal C., 1986, POLYM EXTRUSION
   ROOHK HV, 1977, T AM SOC ART INT ORG, V23, P152
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SHEU MS, 1996, MATERIALS, P865
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   UENOYAMA K, 1988, J CATARACT REFR SURG, V14, P187, DOI 10.1016/S0886-3350(88)80094-4
   Van Wazer J.R., 1963, VISCOSITY FLOW MEASU
   Voronkov M. G., 1978, SILOXANE BOND
   Walters K., 1980, RHEOMETRY IND APPL
   WHICHER SJ, 1978, J BIOMED MATER RES, V12, P181, DOI 10.1002/jbm.820120205
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   YILGOR I, 1989, J POLYM SCI POL CHEM, V27, P3673, DOI 10.1002/pola.1989.080271110
   YILGOR I, 1988, ADV POLYM SCI POLYSI, P1
   ZISMAN WA, 1967, Patent No. 3356632
NR 54
TC 34
Z9 36
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1999
VL 20
IS 15
BP 1365
EP 1370
DI 10.1016/S0142-9612(99)00034-4
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213PX
UT WOS:000081283400002
PM 10454007
DA 2018-10-19
ER

PT J
AU Chuang, WY
   Young, TH
   Yao, CH
   Chiu, WY
AF Chuang, WY
   Young, TH
   Yao, CH
   Chiu, WY
TI Properties of the poly(vinyl alcohol)/chitosan blend and its effect on
   the culture of fibroblast in vitro
SO BIOMATERIALS
LA English
DT Article
DE poly(vinyl alcohol); chitosan; cell culture
ID GROWTH; PERFORMANCE; MEMBRANES; PROLIFERATION; BIOMATERIAL; CHITOSAN;
   INVITRO; CHITIN; ISLETS
AB In this work, the properties of poly(vinyl alcohol) (PVA) and PVA/chitosan blended membranes were investigated by scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and electron spectroscopy for chemical analysis (ESCA). The SEM photographs show the PVA/chitosan blended membrane undergoes dramatic changes on the surface and bulk structure during the membrane formation. The DSC analysis shows that PVA and chitosan are not very compatible in the PVA/chitosan blended membrane, whereas the combination of two polymer chains of constitutionally different features is revealed. In addition, the surface of the PVA/chitosan blended membrane is enriched with nitrogen atoms at the ESCA analysis. These reflect the PVA membrane can be modified by blending with chitosan that in turn may affect the biocompatibility of the blended membrane. Therefore, adhesion and growth of fibroblasts on the PVA as well as PVA/chitosan blended membranes were investigated. Cell morphologies on the membranes were examined by SEM and cell viability was studied using MTT assay. It was observed that the PVA/chitosan blended membrane was more favorable for the cell culture than the pure PVA membrane. Cells cultured on the PVA/chitosan blended membrane had good spreading, cytoplasm webbing and flattening and were more compacting than on the pure PVA membrane. Consequently, the PVA/chitosan blended membrane may spatially mediate cellular response that can promote cell attachment and growth, indicating the PVA/chitosan blended membrane should be useful as a biomaterial for cell culture. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Coll Engn, Inst Mat Sci & Engn, Taipei 10016, Taiwan.
   Chungtai Inst Hlth Sci & Technol, Dept Radiol Technol, Taichung, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
OI CHIU, WEN-YEN/0000-0001-5110-0392
CR APICELLA A, 1982, POLYM ENG SCI, V22, P382, DOI 10.1002/pen.760220610
   Beatrice S., 1995, BIOMATERIALS, V16, P785
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang SJ, 1996, PLANT MOL BIOL, V31, P693, DOI 10.1007/BF00042242
   Hara Y, 1979, Nippon Ganka Gakkai Zasshi, V83, P1478
   IIO K, 1994, J BIOMED MATER RES, V28, P459, DOI 10.1002/jbm.820280408
   INOUE K, 1992, PANCREAS, V7, P562, DOI 10.1097/00006676-199209000-00009
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Loeb S., 1963, ADV CHEM SER, V38, P117, DOI DOI 10.1021/ADVANCES
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   Paul W, 1997, J BIOMAT SCI-POLYM E, V8, P755, DOI 10.1163/156856297X00290
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Sakurada I., 1985, POLYVINYL ALCOHOL FI
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   WU LG, 1994, J MEMBRANE SCI, V90, P207, DOI 10.1016/0376-7388(94)80072-3
   Young TH, 1998, J BIOMED MATER RES, V40, P385, DOI 10.1002/(SICI)1097-4636(19980605)40:3<385::AID-JBM7>3.0.CO;2-B
   Young TH, 1996, BIOMATERIALS, V17, P2139, DOI 10.1016/0142-9612(96)00043-9
   Yunlin G., 1998, J APPL POLYM SCI, V67, P1965
NR 23
TC 200
Z9 219
U1 3
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1999
VL 20
IS 16
BP 1479
EP 1487
DI 10.1016/S0142-9612(99)00054-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232EB
UT WOS:000082355500005
PM 10458561
DA 2018-10-19
ER

PT J
AU Laffargue, P
   Hildebrand, HF
   Rtaimate, M
   Frayssinet, P
   Amoureux, JP
   Marchandise, X
AF Laffargue, P
   Hildebrand, HF
   Rtaimate, M
   Frayssinet, P
   Amoureux, JP
   Marchandise, X
TI Evaluation of human recombinant bone morphogenetic protein-2-loaded
   tricalcium phosphate implants in rabbits' bone defects
SO BONE
LA English
DT Article; Proceedings Paper
CT 9th European Meeting on Injectable Bone and Joint Substitution Materials
CY MAR 01-02, 1999
CL LAUSANNE, SWITZERLAND
DE bone substitute; osteoinduction; bone morphogenetic protein; tricalcium
   phosphate; dual-energy X-ray absorptiometry; 31-phosphorus NMR
   spectroscopy
ID NMR-SPECTROSCOPY; CERAMICS
AB Porous beta-tricalcium phosphate (beta TCP) has osteoconductive properties. The adsorption of human recombinant bone morphogenetic protein-2 (rhBMP-2) onto TCP could realize an osteoinductive bone substitute. We evaluated it on an animal model using dual-energy X-ray absorptiometry (DEXA) and solid-state P-31 nuclear magnetic resonance (NMR) spectroscopy. beta TCP cylinders loaded with rhBMP-2 were implanted into rabbits' femoral condyle bone defects, and beta TCP alone as control into the controlateral femur. We studied two different doses of rhBMP-2 (10 and 40 mu g) on two groups of four animals, Evaluation consisted in radiography, histology, and histomorphometry, DEXA, and NMR spectroscopy using an original method of quantification, With both doses of rhBMP-2, we observed on radiographs an increase of trabecular hone around implants. Histology showed resorption of the ceramic, trabecular bone with osteoblasts and osteoid substance around the implants, and colonization inside the porous beta TCP by new bone formed. Histomorphometry showed that the osteoid surface (OS/BS was greatest with the high dose of rhBMP-2. The difference was slight between the low dose of rhBMP-2 and control. DEXA showed a dose-dependent increase of bone mineral density of rhBMP-2-loaded beta TCP vs. control. NMR spectroscopy confirmed that the amount of new bone formed in beta TCP was greater when beta TCP carried rhBMP-2, and increased with the dose of rhBMP-2 used. We showed that beta TCP was a good matrix for rhBMP-2, which gave it osteoinductive properties in an orthotopic site, in a dose-dependent manner. Thus, such composite biomaterial seems to be of great interest in reconstructive bone surgery. Further studies are needed in clinical practice to determine optimal doses. (Bone 25:55S-58S; 1999) (C) 1999 by Elsevier Science Inc. All rights reserved.
C1 Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Clin Orthoped & Traumatol, F-59037 Lille, France.
   Fac Med, Biophys Lab, Unite Programmee Rech & Enseignement Sci, Equipe Accueil UPRES EA 1049, Lille, France.
   Lab Bioland, Toulouse, France.
   Univ Lille 1, Lab Dynam & Struct Mat Mol, F-59655 Villeneuve Dascq, France.
   Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Serv Cent Med Nucl & Imagerie Fonct, Villeneuve Dascq, France.
RP Laffargue, P (reprint author), Ctr Hosp Reg & Univ Lille, Hop Roger Salengro, Clin Orthoped & Traumatol, Pl Verdun, F-59037 Lille, France.
OI Amoureux, jean paul/0000-0003-3772-6801
CR FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   MARCHANDISE X, 1992, MAGNET RESON MED, V28, P1, DOI 10.1002/mrm.1910280102
   MARCHANDISE X, 1995, INNOV TECH BIOL MED, V16, P49
   MOSHEIFF R, 1992, BIOMATERIALS, V13, P462, DOI 10.1016/0142-9612(92)90167-M
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Rodgers JB, 1998, J CRANIOFAC SURG, V9, P147, DOI 10.1097/00001665-199803000-00012
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 9
TC 44
Z9 46
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 1999
VL 25
IS 2
SU S
BP 55S
EP 58S
DI 10.1016/S8756-3282(99)00134-9
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 225CA
UT WOS:000081937400011
PM 10458276
DA 2018-10-19
ER

PT J
AU Zahraoui, C
   Sharrock, P
AF Zahraoui, C
   Sharrock, P
TI Influence of sterilization on injectable bone biomaterials
SO BONE
LA English
DT Article; Proceedings Paper
CT 9th European Meeting on Injectable Bone and Joint Substitution Materials
CY MAR 01-02, 1999
CL LAUSANNE, SWITZERLAND
DE calcium phosphate cement; lactic acid copolymer; resorbable polyester;
   implant recolonization
ID BLOCK-COPOLYMERS
AB Injectable biomaterials used in bone surgery include acrylic bone cements, calcium phosphate cements, and new composite-type biomaterials with a mineral content and an organic phase dispersed or dissolved in water. Cellulose derivatives, chitosan solutions, alginates, and other polymers are studied as useful modifiers and binding agents in calcium phosphate cements. We have developed proprietary polyester copolymers including lactic acid moieties and present here results concerning the effect of sterilization on the physico-chemical properties of derived bone biomaterials, Chitosan solutions show a dramatic decrease in viscosity after 25-kGy gamma sterilization, Aqueous copolylactic solutions also show, by capillary electrophoresis, that hydrolysis occurs to liberate monomers after 25-kGy gamma sterilization, Heat sterilization also degrades chitosan solutions, and ultrafiltration is difficult because of high viscosity. However, apatite-copolylactic solids can he steam sterilized without deterioration. Gelatin has been used as a natural polymer to bind apatite particles. Gel exclusion chromatography reveals crosslinking of the chains by irradiation. Standard acrylic cements contain monomers sterilized by ultrafiltration because they do not tolerate irradiation. We have used ultrafiltration to prepare aqueous copolylactic solutions without polymer hydrolysis, Implantation of calcium phosphate cement modified by; copolylactic acid in a rabbit metaphyseal model defect shows progressive substitution of the biomaterial by new bone tissue. At 3 months, a mild inflammatory reaction still remains associated with the continuing resorption of the biomaterial. These results show that interesting biological properties can be obtained with products not sterilized by irradiation. Undoubtedly, many biopolymers are fragile and, like reactive monomers, need to be sterilized by special methods if they are to he used in injectable, liquid form, (Bone 25:63S-65S; 1999) (C) 1999 by Elsevier Science Inc, All rights reserved.
C1 Univ Toulouse 3, Chim Inorgan Lab, F-31062 Toulouse, France.
   Inst Univ Technol, Dept Chim Castres, Castres, France.
RP Sharrock, P (reprint author), Univ Toulouse 3, Chim Inorgan Lab, 118 Route Narbonne, F-31062 Toulouse, France.
CR BRES E, 1998, CALCIUM PHOSPHATE MA
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Harper EJ, 1997, J MATER SCI-MATER M, V8, P849, DOI 10.1023/A:1018545519964
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   RAILHAC JJ, 1997, BIOMATERIALS, V10, P507
   SAITOH H, 1994, J MATER SCI-MATER M, V5, P194, DOI 10.1007/BF00121088
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wilson J. E., 1974, RAD CHEM MONOMERS PO
   YOUSSEF SK, 1994, J MATER SCI, V29, P5417, DOI 10.1007/BF01171555
NR 10
TC 27
Z9 29
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 1999
VL 25
IS 2
SU S
BP 63S
EP 65S
DI 10.1016/S8756-3282(99)00136-2
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 225CA
UT WOS:000081937400013
PM 10458278
DA 2018-10-19
ER

PT J
AU Weiss, P
   Gauthier, O
   Bouler, JM
   Grimandi, G
   Daculsi, G
AF Weiss, P
   Gauthier, O
   Bouler, JM
   Grimandi, G
   Daculsi, G
TI Injectable bone substitute using a hydrophilic polymer
SO BONE
LA English
DT Article; Proceedings Paper
CT 9th European Meeting on Injectable Bone and Joint Substitution Materials
CY MAR 01-02, 1999
CL LAUSANNE, SWITZERLAND
DE biomaterial; calcium phosphate; injection; bone substitute
ID COMPOSITE
AB We studied a new injectable biomaterial for bone and dental surgery consisting of a hydrophilic polymer as matrix and bioactive calcium phosphate (CaP ceramics as fillers. This material is composed of complex fluids whose flow is determined by the laws of rheology. We investigated the macromolecular effects on this composite in a tube, The stability of the polymer and the mixture is essential to the production of a ready-to-use injectable biomaterial, These flow properties are necessary to obtain Cap bioactivity in a dental canal or bone defect during percutaneous surgery. Macromolecules provide spaces between CaP ceramic granules and facilitate the role of the biological agents of bone substitution. (Bone 25:67S-70S; 1999) (C) 1999 by Elsevier Science Inc. All rights reserved.
C1 Fac Chirurg Dent, UFR Odontol, Equipe INSERM Mat Interet Biol, UPRES EA 2159, F-44042 Nantes 01, France.
RP Weiss, P (reprint author), Fac Chirurg Dent, UFR Odontol, Equipe INSERM Mat Interet Biol, UPRES EA 2159, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes 01, France.
RI Daculsi, Guy/P-1320-2014; Gauthier, Olivier/A-4639-2015; Weiss,
   Pierre/P-1372-2014
OI Daculsi, Guy/0000-0003-1030-3446; Weiss, Pierre/0000-0002-6159-8590;
   BOULER, Jean-Michel/0000-0001-9784-5584
CR CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1998, BIOMATERIALS, V191, P473
   DACULSI G, 1995, Patent No. 21634
   de Groot K, 1983, BIOCERAMICS CALCIUM
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GAUTHIER O, 1999, J PERIODONTOL, V70, P359
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   LAHDENPAA E, 1996, EUR J PHARM BIOPHARM, V3, P177
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   MILLOT F, IN PRESS J BIOMED MA
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Trecant M, 1996, J MATER SCI-MATER M, V7, P227, DOI 10.1007/BF00119735
   Weiss P, 1998, J BIOMED MATER RES, V41, P167, DOI 10.1002/(SICI)1097-4636(199807)41:1<167::AID-JBM20>3.0.CO;2-J
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
NR 18
TC 40
Z9 43
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 1999
VL 25
IS 2
SU S
BP 67S
EP 70S
DI 10.1016/S8756-3282(99)00146-5
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 225CA
UT WOS:000081937400014
PM 10458279
DA 2018-10-19
ER

PT J
AU Lamghari, M
   Almeida, MJ
   Berland, S
   Huet, H
   Laurent, A
   Milet, C
   Lopez, E
AF Lamghari, M
   Almeida, MJ
   Berland, S
   Huet, H
   Laurent, A
   Milet, C
   Lopez, E
TI Stimulation of bone marrow cells and bone formation by nacre: In vivo
   and in vitro studies
SO BONE
LA English
DT Article; Proceedings Paper
CT 9th European Meeting on Injectable Bone and Joint Substitution Materials
CY MAR 01-02, 1999
CL LAUSANNE, SWITZERLAND
DE bone marrow cells; nacre; phosphatase alkaline; lumbar vertebrae
ID OSTEOBLASTS MAINTAINED INVITRO; BETA
AB There is frequently a loss of vertebral bone due to disease or aging, Nacre (mother of pearl from the oyster Pinctada maxima) stimulates bone cell differentiation and bone formation in vitro and in vivo. Experimental bone defects were prepared in the vertebrae of sheep and used to test the suitability of nacre as an injectable osteogenic biomaterial for treating vertebral bone loss, Twenty-one cavities were prepared in the first four upper lumbar vertebrae of II sheep and filled with nacre powder. The lumbar vertebrae were removed after 1 to 12 weeks, embedded undecalcified in methacrylate, and processed for histological studies. The nacre slowly dissolved and the experimental cavities contained a large active cell population. By 12 weeks, the experimental cavity,vas occupied by newly matured bone trabeculae in contact with or adjacent to the dissolving nacre. The functional new bone trabeculae were covered with osteoid lined with osteoblasts, indicating continuing bone formation. The in vitro study on rat bone marrow explants cultured with a water-soluble extract of the nacre organic matrix also resulted in the stimulation of osteogenic bone marrow cells with enhanced alkaline phosphatase activity. Thus, both the in vivo and in vitro findings suggest that nacre contains one or more signal molecules capable of activating osteogenic bone marrow cells. (Bone 25:91S-94S; 1999) (C) 1999 by Elsevier Science Inc. All rights reserved.
C1 Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, URA 90, F-75231 Paris 05, France.
   CHU Cote de Nacre, Serv Neuroradiol, Caen, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Intervent, F-75475 Paris, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, URA 90, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR ALMEIDA MJ, UNPUB EFFECT WATER S
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   HARADA K, 1988, BONE, V9, P177, DOI 10.1016/8756-3282(88)90007-5
   HUET H, 1995, INNOV TECH BIOL MED, V16, P27
   LAMGHARI M, 1997, INNOV BIOL MED, V18, P65
   Le Faou A., 1995, Calcified Tissue International, V56, P461
   Liao H, 1997, J MATER SCI-MATER M, V8, P823, DOI 10.1023/A:1018537318147
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, Patent No. [9515650, FR9515650]
   LOPEZ E, 1991, IMPLANTODONNE, V2, P13
   LOPEZ E, 1994, RECHERCHE, V262, P208
   LOPEZ E, 1995, Patent No. 24133
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   NODA M, 1986, BIOCHEM BIOPH RES CO, V140, P56, DOI 10.1016/0006-291X(86)91057-0
   PFEILSCHIFTER J, 1987, ENDOCRINOLOGY, V121, P212, DOI 10.1210/endo-121-1-212
   RIPAMONTI U, 1991, CLIN ORTHOP RELAT R, P284
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
NR 17
TC 61
Z9 69
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD AUG
PY 1999
VL 25
IS 2
SU S
BP 91S
EP 94S
DI 10.1016/S8756-3282(99)00141-6
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 225CA
UT WOS:000081937400019
PM 10458284
DA 2018-10-19
ER

PT J
AU Zhang, FR
   Kabeya, H
   Kitagawa, R
   Hirotsu, T
   Yamashita, M
   Otsuki, T
AF Zhang, FR
   Kabeya, H
   Kitagawa, R
   Hirotsu, T
   Yamashita, M
   Otsuki, T
TI Preparation and characterization of a novel polyethylene-Chlorella
   composite
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MECHANICAL-PROPERTIES; MALEIC-ANHYDRIDE; POLYPROPYLENE COMPOSITES;
   FIBERS; CELLULOSE; ADHESION
AB Preparation and Characterization of a Novel Polyethylene-Chlorella Composite A composite of polyethylene (PF,) and chlorella, a kind of microalga produced from biological CO2 fixation, was prepared by chemical modification of polyethylene with maleic anhydride. This novel biomaterial has an interesting structure characterized by cellular and foamy grains of chlorella, which are well inlaid in the PE matrix. Strong adhesion between a modified PE matrix and chlorella grains can be successfully achieved probably due to chemical bonding which results in a high-chlorella filling rate of 40% with no sharp drop in tensile strength.
C1 Shikoku Natl Ind Res Inst, Biol Mat Div, Takamatsu, Kagawa 7610395, Japan.
   Project Ctr CO2 Fixat & Utilizat, Res Inst Innovat Technol Earth, Minato Ku, Tokyo 105, Japan.
RP Hirotsu, T (reprint author), Shikoku Natl Ind Res Inst, Biol Mat Div, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.
CR *ALDR CHEM CO, 1998, PROD CAT ALDR, P1368
   BESHAY A, 1992, SCI ENG COMPOS MATER, V2, P85
   Coutinho FMB, 1997, J APPL POLYM SCI, V65, P1227, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1227::AID-APP18>3.0.CO;2-Q
   Devi LU, 1997, J APPL POLYM SCI, V64, P1739
   FELIX JM, 1993, POLYM COMPOSITE, V14, P449, DOI 10.1002/pc.750140602
   FELIX JM, 1991, J APPL POLYM SCI, V42, P609, DOI 10.1002/app.1991.070420307
   GAO SL, 1993, J APPL POLYM SCI, V47, P2065, DOI 10.1002/app.1993.070471116
   GAYLORD NG, 1989, J MACROMOL SCI CHEM, VA26, P1211, DOI 10.1080/00222338908052043
   GAYLORD NG, 1983, J POLYM SCI POL LETT, V21, P23, DOI 10.1002/pol.1983.130210104
   GAYLORD NG, 1989, J APPL POLYM SCI, V38, P359, DOI 10.1002/app.1989.070380217
   Heinen W, 1996, MACROMOLECULES, V29, P1151, DOI 10.1021/ma951015y
   Hornsby PR, 1997, J MATER SCI, V32, P1009, DOI 10.1023/A:1018578322498
   *JAP STAND SOC, 1995, JIS K7113 1995 TEST
   Karnani R, 1997, POLYM ENG SCI, V37, P476, DOI 10.1002/pen.11691
   KHANOLKAR A, 1995, P SOC PLAST ENG ANN, V53, P2120
   LIU NC, 1990, J APPL POLYM SCI, V41, P2285, DOI 10.1002/app.1990.070410931
   MALDAS D, 1988, POLYMER, V29, P1255, DOI 10.1016/0032-3861(88)90053-5
   MANSOUR OY, 1983, J POLYM SCI POL CHEM, V21, P715, DOI 10.1002/pol.1983.170210307
   Price GJ, 1996, MACROMOLECULES, V29, P5664, DOI 10.1021/ma951812w
   ROOVER BD, 1995, J POLYM SCI A, V33, P829
   TAKECHI Y, 1973, FUNDAMENTALS APPL CH, P28
   VIJAYALAKSHMI NS, 1992, J APPL POLYM SCI, V44, P1377, DOI 10.1002/app.1992.070440809
   YAMADA B, 1995, RES REPORT  UK001 CH
NR 23
TC 16
Z9 16
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD AUG
PY 1999
VL 11
IS 8
BP 1952
EP +
DI 10.1021/cm990041y
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 227YZ
UT WOS:000082108800002
DA 2018-10-19
ER

PT J
AU Latour, RA
AF Latour, RA
TI Molecular modeling of biomaterial surfaces
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; DYNAMICS SIMULATION;
   WATER; CONFORMATION; CHEMISTRY; MEMBRANE; DESIGN; WEAR
AB Molecular modeling has become widely recognized and accepted as an extremely valuable research tool for understanding and predicting molecular behavior. Recently reported papers utilizing molecular modeling to address biomaterial surface issues have centered upon the design of surfaces that are either resistant to protein adsorption or that specifically bind targeted biomolecules. Other applications include investigations of biomaterials and biological materials surface structure, surface hydrolysis and tribological behavior. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Clemson Univ, Rhodes Engn Res Ctr 501, Dept Bioengn, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Rhodes Engn Res Ctr 501, Dept Bioengn, Clemson, SC 29634 USA.
CR Blau PJ, 1997, TRIBOL INT, V30, P321, DOI 10.1016/S0301-679X(96)00062-X
   Bujnowski AM, 1998, J COLLOID INTERF SCI, V203, P47, DOI 10.1006/jcis.1998.5477
   HARBERS RGM, 1998, T SOC BIOMATER, V21, P170
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hass KC, 1998, SCIENCE, V282, P265, DOI 10.1126/science.282.5387.265
   KEOGH JR, 1998, T SOC BIOMATER, V21, P166
   LATOUR RA, 1998, T SOC BIOMATER, V21, P169
   LATOUR RA, 1999, T SOC BIOMATER, V22, P202
   Li RX, 1998, NAT BIOTECHNOL, V16, P190, DOI 10.1038/nbt0298-190
   Li TL, 1998, J BIOMAT SCI-POLYM E, V9, P327, DOI 10.1080/09205063.1998.9753059
   Li TW, 1998, J PHYS CHEM B, V102, P2935, DOI 10.1021/jp980049f
   Papisov MI, 1998, ADV DRUG DELIVER REV, V32, P119, DOI 10.1016/S0169-409X(97)00135-X
   PasenkiewiczGierula M, 1997, J PHYS CHEM A, V101, P3677, DOI 10.1021/jp962099v
   Pitt WG, 1997, J COLLOID INTERF SCI, V185, P258, DOI 10.1006/jcis.1996.4607
   Sham TL, 1997, WEAR, V207, P100, DOI 10.1016/S0043-1648(96)07471-6
   Smith C, 1998, SCIENTIST, V12, P17
   Spohr E, 1998, J ELECTROANAL CHEM, V450, P327, DOI 10.1016/S0022-0728(97)00651-7
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Takaoka Y, 1998, FLUID PHASE EQUILIBR, V144, P387, DOI 10.1016/S0378-3812(97)00283-5
   Trioni MI, 1997, J NON-CRYST SOLIDS, V220, P164, DOI 10.1016/S0022-3093(97)00302-5
   van Eijk MCP, 1998, EUR PHYS J B, V1, P233, DOI 10.1007/s100510050177
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   West JK, 1997, J BIOMED MATER RES, V37, P585
   West JK, 1997, J BIOMED MATER RES, V35, P505, DOI 10.1002/(SICI)1097-4636(19970615)35:4<505::AID-JBM10>3.0.CO;2-A
   Zhang LC, 1997, WEAR, V211, P44, DOI 10.1016/S0043-1648(97)00073-2
NR 25
TC 17
Z9 17
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD AUG
PY 1999
VL 4
IS 4
BP 413
EP 417
DI 10.1016/S1359-0286(99)00022-4
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 270MD
UT WOS:000084538800015
DA 2018-10-19
ER

PT J
AU Cetta, F
   Rappuoli, R
   Montalto, G
   Baldi, C
   Gori, M
   Cetta, D
   Zuckermann, M
   Magnani, A
   Barbucci, R
AF Cetta, F
   Rappuoli, R
   Montalto, G
   Baldi, C
   Gori, M
   Cetta, D
   Zuckermann, M
   Magnani, A
   Barbucci, R
TI New biliary endoprosthesis less liable to block in biliary infections:
   Description and in vitro studies
SO EUROPEAN JOURNAL OF SURGERY
LA English
DT Article
DE biliary endoprostheses; bacterial overgrowth; new biomaterial pupa;
   brown stones
ID ENDOSCOPIC SPHINCTEROTOMY; AQUEOUS-SOLUTION; DUCT; PATHOGENESIS;
   OBSTRUCTION; PALLIATION; BEHAVIOR; BACTERIA; HEPARIN; STONES
AB Objective: To rest in vitro stents made from a new biomaterial that is less liable to encourage adhesion of bacteria that may lead to blockage of the stent.
   Design: Laboratory experiment.
   Setting: University hospital, Italy.
   Material: 15 polyethylene biliary endoprostheses that had been removed endoscopically a mean of 151 days (range 55-416) after insertion. PUPA, a biomaterial that contains polyamidoamine cross-linked to polyurethane chains. This can bind large quantities of heparin and HyaIS(x) (hyaluronic acid at a different stage of sulphation) in a stable fashion.
   Main outcome measures: Incidence of blockage and growth of pathogens in the polyethylene biliary prostheses. Adhesion of pathogens to PUPA in vitro on electron microscopy.
   Results: 12 of 15 polyethylene prostheses were blocked by brown concretions composed of calcium bilirubinate, palmitate, and little cholesterol. All concretions grew more than one pathogen, and the growth always included Escherichia coli. Of the 5 PUPA stents rested, only 1 had bacteria sticking to their surfaces.
   Conclusion: These results confirm previous studies that showed that HyalS(x) appreciably inhibited the adhesion of bacteria and is therefore a suitable material for the manufacture of biliary stents.
C1 Univ Siena, Inst Surg Clin, Nuovo Policlin, Interuniv Ctr Res Hepatobiliary Dis, IT-53100 Siena, Italy.
   Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Cetta, F (reprint author), Univ Siena, Inst Surg Clin, Nuovo Policlin, Interuniv Ctr Res Hepatobiliary Dis, Viale Bracci, IT-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   BARBUCCI R, 1991, POLYMER, V32, P897, DOI 10.1016/0032-3861(91)90517-M
   BARBUCCI R, 1995, GAZZ CHIM ITAL, V125, P169
   BARBUCCI R, 1991, Clinical Materials, V8, P17, DOI 10.1016/0267-6605(91)90005-Z
   BARBUCCI R, 1991, INT J ARTIF ORGANS, V14, P499
   CETTA F, 1995, GASTROENTEROLOGY, V109, P2050, DOI 10.1016/0016-5085(95)90787-4
   CETTA F, 1991, ANN SURG, V213, P315, DOI 10.1097/00000658-199104000-00006
   CETTA F, 1993, ARCH SURG-CHICAGO, V128, P329
   Cetta F, 1997, DIGEST DIS SCI, V42, P2052, DOI 10.1023/A:1018862300064
   Cetta F, 1998, AM J GASTROENTEROL, V93, P493, DOI 10.1111/j.1572-0241.1998.493a_b.x
   Cetta F, 1997, AM J GASTROENTEROL, V92, P542
   CETTA F, 1996, P 2 WORLD C IHPBA BO, P595
   CETTA FM, 1986, HEPATOLOGY, V6, P482, DOI 10.1002/hep.1840060327
   DOWIDAR N, 1991, SCAND J GASTROENTERO, V26, P1137, DOI 10.3109/00365529108998605
   Geoghegan J, 1991, GASTROINTEST ENDOSC, V37, P257
   GREGG JA, 1985, AM J SURG, V149, P668, DOI 10.1016/S0002-9610(85)80152-5
   LEUNG JWC, 1992, GASTROINTEST ENDOSC, V38, P338, DOI 10.1016/S0016-5107(92)70428-3
   MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010
   MOESCH C, 1991, HEPATOLOGY, V14, P1142, DOI 10.1002/hep.1840140631
   SEITZ U, 1994, ENDOSCOPY, V26, P478, DOI 10.1055/s-2007-1009008
   SPEER A, 1988, ANN INTERN MED, V34, P19
   SUNG JJY, 1995, DIGEST DIS SCI, V40, P1167, DOI 10.1007/BF02065519
   SUNG JY, 1991, DIGEST DIS SCI, V36, P943, DOI 10.1007/BF01297145
NR 23
TC 8
Z9 8
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 1102-4151
J9 EUR J SURG
JI Eur. J. Surg.
PD AUG
PY 1999
VL 165
IS 8
BP 782
EP 785
PG 4
WC Surgery
SC Surgery
GA 229RT
UT WOS:000082208900012
PM 10494646
DA 2018-10-19
ER

PT J
AU Esposito, M
   Lausmaa, J
   Hirsch, JM
   Thomsen, P
AF Esposito, M
   Lausmaa, J
   Hirsch, JM
   Thomsen, P
TI Surface analysis of failed oval titanium implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE dental implants; surface spectroscopy; medical device failure;
   osseointegration; titanium
ID OSSEOINTEGRATED ORAL IMPLANTS; SPECTROSCOPIC CHARACTERIZATION;
   HYDROGEN-PEROXIDE; CONTAMINATION; FAILURES; TISSUE; CLEANLINESS;
   BIOMATERIAL; GROWTH
AB The aim of the present study was to investigate the surface topography, composition, and oxide thickness of consecutively failed, oral Branemark implants in order to determine possible causes for failure. The failure criterion was lack of osseointegration manifested as implant mobility. Ten implants were retrieved before loading (early failures) and 12 during a period of function up to 8 years (late failures). At retrieval, early losses did not display any clinical sign of infection. All late failures were radiographically characterized by peri-implant radiolucency and did not show infectious signs with one exception. No implant seemed to be lost due to peri-implantitis (plaque-induced progressive marginal bone loss). Twelve implants were analyzed by scanning electron microscopy (SEM), Auger electron spectroscopy (AES), and depth profiling using a blind protocol. Two pristine fixtures, which underwent the same preparation as the failed implants, were used as controls. In the SEM, control samples were essentially free from macroscopic contamination, whereas failed implants contained varying amounts of tissue residues. AES showed that all surfaces consisted of Ti oxide and varying amounts of additional elements, with C dominating in most cases, Nitrogen and sometimes Na, Ca, P, Cl, S, and Si were detected. The Si contamination was most likely due to ion leaching from the glass vials used for storage. Depth profiles showed a typical oxide thickness of 5-8 nm for all samples, In conclusion, no significant changes in the oxide layer composition or thickness as a result of implantation were observed. The results do not indicate any material-related cause for the failures of these implants. Possible reasons for these failures were impaired healing, asymptomatic infection, and overload. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Gothenburg, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
   Univ Uppsala Hosp, Dept Oral & Maxillofacial Surg, Uppsala, Sweden.
   Swedish Natl Testing & Res Inst SP, Dept Chem & Mat Technol, Boras, Sweden.
   Univ Gothenburg, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden.
RP Esposito, M (reprint author), Univ Gothenburg, Inst Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Adell R., 1985, TISSUE INTEGRATED PR, P211
   AMEEN AP, 1993, CLIN ORAL IMPLAN RES, V4, P144, DOI 10.1034/j.1600-0501.1993.040305.x
   APARICIO C, 1992, International Journal of Oral and Maxillofacial Implants, V7, P94
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Binon P P, 1992, Int J Oral Maxillofac Implants, V7, P168
   BJURSTEN LM, 1986, TISSUE INTEGRATION O, P511
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BRANEMARK PI, 1995, RECONSTRUCTIVE PREPR, P165
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   EDWARDS BN, 1992, BIOMATERIALS, V13, P775, DOI 10.1016/0142-9612(92)90017-I
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   Ericsson I, 1996, CLIN ORAL IMPLAN RES, V7, P320, DOI 10.1034/j.1600-0501.1996.070404.x
   Esposito M, 1997, CLIN ORAL IMPLAN RES, V8, P352, DOI 10.1034/j.1600-0501.1997.080502.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   ESPOSITO M, IN PRESS INT J ORAL
   Friberg B, 1996, J ORAL MAXIL SURG, V54, P1334, DOI 10.1016/S0278-2391(96)90493-0
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Henry P J, 1996, Int J Oral Maxillofac Implants, V11, P450
   Isidor F, 1997, CLIN ORAL IMPLAN RES, V8, P1, DOI 10.1111/j.1600-0501.1997.tb00001.x
   Ivanoff CJ, 1996, CLIN ORAL IMPLAN RES, V7, P128, DOI 10.1034/j.1600-0501.1996.070206.x
   Jemt T, 1996, Int J Oral Maxillofac Implants, V11, P291
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Kuliralo M, 1991, J Biol Buccale, V19, P247
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1988, BIOMATERIALS, V9, P277, DOI 10.1016/0142-9612(88)90098-1
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   Lekholm U, 1994, INT J ORAL MAXILLOF, V9, P627
   McQueen D, 1982, CLIN APPL BIOMATERIA, P179
   Mouhyi J, 1998, CLIN ORAL IMPLAN RES, V9, P185, DOI 10.1034/j.1600-0501.1998.090306.x
   Olefjord I, 1993, Int J Oral Maxillofac Implants, V8, P32
   OSBORN JF, 1990, ADV BIOMAT, V9, P75
   Smith D C, 1993, Int J Prosthodont, V6, P106
   SMITH DC, 1991, BONE-BIOMATERIAL INTERFACE, P3
   STRID KG, 1985, TISSUE INTEGRATED PR, P317
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V10, P9
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Zoller GO, 1996, CLIN ORAL IMPLAN RES, V7, P311, DOI 10.1034/j.1600-0501.1996.070402.x
NR 51
TC 63
Z9 65
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1999
VL 48
IS 4
BP 559
EP 568
DI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 216KG
UT WOS:000081440800023
PM 10421701
DA 2018-10-19
ER

PT J
AU Barbucci, R
   Lamponi, S
   Aloisi, AM
AF Barbucci, R
   Lamponi, S
   Aloisi, AM
TI The role of plasma proteins and stress in the assessment of
   hemocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE platelets; proteins; fibrinogen; stress condition; polyethylene
ID GLYCOPROTEIN-IIB-IIIA; PLATELET ACTIVATION; ANTIBODY-BINDING;
   FIBRINOGEN; RECOGNITION; ADHESION; DISEASE; COMPLEX
AB The physiological and psychological conditions of subjects supplying blood for hemocompatibility tests significantly affect the behavior of platelets in terms of both adhesion and activation. The responses of platelets to a standard biomaterial, polyethylene (PE), were examined with blood collected from male rabbits both in basal conditions and after stress, Different media were utilized. First, platelet-rich plasma (PRP) was used to obtain a PE response to contact with platelets. Then platelets drawn from PRP were isolated and washed with Krebs-Ringer solution. One aliquot was suspended in serum (Pw-S) where fibrinogen was absent, another aliquot in Krebs-Ringer solution (Pw-KR) tin order to avoid the influence of the plasma proteins on platelets), and a third aliquot in the original plasma from which the platelets were drawn (Pw-PPP) tin order to restore the initial condition of the plasma but with washed platelets). The analysis of platelet adhesion and morphology was performed by Scanning Electron Microscopy (SEM). Differences in platelet adhesion and morphology were observed with four different media in nonstressed animals, with Pw-PPP showing a higher number and Pw-S and PW-KR lower numbers. Platelet morphology indicated low levels of activation. The platelets drawn from stressed subjects could not be counted in either PRP or PPP medium because they were fully aggregated and adhered; in contrast, in Pw-KR and Pw-S, no significant differences were found with respect to nonstressed conditions, and there was little difference in platelet morphology. All of these factors underline the role of plasma proteins, in particular fibrinogen, in the stress-induced activation of platelets. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
   Univ Siena, Inst Human Physiol, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, Dept Chem & Biosyst Sci & Technol, Pian Mantellini 44, I-53100 Siena, Italy.
RI Aloisi, Anna Maria/E-7183-2013
CR Aloisi AM, 1996, NEUROSCIENCE, V74, P1019, DOI 10.1016/S0306-4522(96)00232-1
   ALOISI AM, 1998, INT J ARTIF ORGANS, V21, P592
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   Barbucci R, 1999, J BIOMED MATER RES, V48, P9
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0
   FISCHER LA, 1993, CIBA FDN S, V172, P243
   Frimerman A, 1997, AM J CARDIOL, V79, P72, DOI 10.1016/S0002-9149(96)00680-7
   GAEBEL K, 1991, BIOMATERIALS, V12, P597, DOI 10.1016/0142-9612(91)90058-I
   HJEMDAHL P, 1987, LIFE SCI, V41, P841, DOI 10.1016/0024-3205(87)90176-7
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIEFFER N, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P15
   KO TM, 1993, BIOMATERIALS, V14, P657
   MALKOFF SB, 1993, PSYCHOSOM MED, V55, P477, DOI 10.1097/00006842-199311000-00001
   Markovitz JH, 1996, PSYCHOSOM MED, V58, P143, DOI 10.1097/00006842-199603000-00008
   PATTERSON SM, 1995, PSYCHOSOM MED, V57, P592, DOI 10.1097/00006842-199511000-00012
   PICKERING TG, 1993, PSYCHOSOM MED, V55, P483, DOI 10.1097/00006842-199311000-00002
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SIMS PJ, 1991, J BIOL CHEM, V266, P7345
   ZAMARRON C, 1991, J BIOL CHEM, V266, P16193
NR 22
TC 11
Z9 11
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1999
VL 46
IS 2
BP 186
EP 192
DI 10.1002/(SICI)1097-4636(199908)46:2<186::AID-JBM7>3.0.CO;2-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 200QM
UT WOS:000080551600007
PM 10379996
DA 2018-10-19
ER

PT J
AU Uludag, H
   D'Augusta, D
   Palmer, R
   Timony, G
   Wozney, J
AF Uludag, H
   D'Augusta, D
   Palmer, R
   Timony, G
   Wozney, J
TI Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial
   carriers in the rat ectopic model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE rhBMP-2; pharmacokinetics; biomaterial; osteoinduction; protein delivery
ID BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; DIFFERENTIATION; CELLS
AB Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a member of the bone morphogenetic protein family involved in de novo bone induction. Successful use of rhBMP-2 requires implantation with a biomaterial which can act as a scaffold for cell invasion for osteoinduction and retains rhBMP-2 at a site of implantation. This study was carried out to characterize rhBMP-2 pharmacokinetics from a variety of biomaterial carriers in a rat ectopic model. Retention of rhBMP-2 within carriers after 3 h was variable among the carriers (range, 75-10%), with collagenous sponges retaining the highest fraction of implanted dose. A gradual loss of rhBMP-2 was subsequently observed, the kinetics of which was strongly dependent on the implanted carrier. Collagenous carriers were observed to lose rhBMP-2 gradually from the implant site, whereas some of the mineral-based carriers retained a fraction of implanted rhBMP-2 within the implants. These differences in protein pharmacokinetics among carriers, in addition to their physicochemical nature, are expected to affect the biological activity of implanted rhBMP-2. (C) 1999 John Wiley & Sons, Inc.
C1 Inst Genet, Andover, MA 01810 USA.
RP Uludag, H (reprint author), Univ Alberta, Dept Biomed Engn, 10-102 Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.
CR Cheung HS, 1993, STP PHARMA SCI, V3, P51
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   FAGES J, 1994, BIOMATERIALS, V15, P650, DOI 10.1016/0142-9612(94)90162-7
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312
   GLOWACKI J, 1991, BONE GRAFTS BONE SUB, P84
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476
   KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6
   KINLEY RA, 1993, PHARMACEUT RES, V10, P1393
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   LINDHOLM TS, 1993, ANN CHIR GYNAECOL FE, V82, P3
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229
   Nevins M, 1996, INT J PERIODONT REST, V16, P9
   Ongpipattanakul B, 1997, J BIOMED MATER RES, V36, P295, DOI 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   RATHORE S, 1995, PROTEIN SCI, V4, P140
   Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   RIPAMONTI U, 1993, ANN CHIR GYNAECOL, V82, P13
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   SIGURDSSON TJ, IN PRESS J PERIODONT
   Steinijans V. W., 1993, Clinical Research and Regulatory Affairs, V10, P203, DOI 10.3109/10601339309079568
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   ULUDAG H, 1998, T SOC BIOM M APR 199, P140
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 33
TC 194
Z9 194
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1999
VL 46
IS 2
BP 193
EP 202
DI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 200QM
UT WOS:000080551600008
PM 10379997
DA 2018-10-19
ER

PT J
AU Zhang, XS
   Revell, PA
   Evans, SL
   Tuke, MA
   Gregson, PJ
AF Zhang, XS
   Revell, PA
   Evans, SL
   Tuke, MA
   Gregson, PJ
TI In vivo biocompatibility and mechanical study of novel bone-bioactive
   materials for prosthetic implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE composite material; rabbit; implantation; biocompatibility; mechanical
   strength
ID COMPOSITE STRUCTURAL BIOMATERIALS; CALCIUM-PHOSPHATE COATINGS;
   PLASMA-SPRAYED COATINGS; MATRIX INTERFACIAL BOND; COATED IMPLANTS;
   HYDROXYLAPATITE COATINGS; HISTOLOGICAL-EVALUATION; ORTHOPEDIC IMPLANTS;
   DENTAL IMPLANTS; HYDROXYAPATITE
AB Two epoxy materials with or without adhesively bonded hydroxyapatite (HA) coatings were studied for their biocompatibility and mechanical pushout strength using in vivo implantation in the rabbit lower femur for a duration of 10 days to 6 months. Both were two-part epoxies cured at room temperature for 24 h, with material 1 (Ampreg 26; SP Systems Limited, Cowes, UK) postcured at 110 degrees C (T-g similar to 80 degrees C) and Material 2 (CG5052; Ciba Geigy Limited, Cambridge, UK) at 125 degrees C (T-g similar to 120 degrees C). Implantation in dead rabbit bone was performed to provide mechanical baseline levels. Polymethylmethacrylate (PMMA) and conventionally HA-coated titanium alloy (Ti-6Al-4V) were used as control materials. In the biological study, different fluorescent dyes were used to label newly formed bone. After 6 weeks of implantation, results from mechanical pushout tests showed that the interfacial shear strength (ISS) values were significantly higher than for dead bones with each of the different implants (p < .01-.001). HA-coated material 2 showed a significantly higher ISS value than the uncoated material (p <.05) after 6 weeks' implantation. However, the ISS value for the uncoated material 2 was significantly higher than for PMMA controls (p <.05). No significant differences in the TSS values were shown between HA-coated materials 1 and 2 and Ti-6Al-4V on in vivo implantation for 6 weeks. Failure points of the pushout test from the three HA-coated materials were defined by scanning electron microscopy. Specimens implanted with both HA-coated epoxies were fractured within the HA-coatings or the bone, while with HA-coated Ti-6Al-4V cracked between the coating and metal implant. The percentage of bone in contact with the implant surface was obtained by image analysis which showed that there were no significant differences between different materials after short time implantation (up to 6 week). Longterm implantation of the HA-coated material 2 showed that the percentage of bone contact had increased from 52.8 +/- 1.1% (6 week) to 80.0 +/- 0.3% (3 months) (p <.01) and remained at 81.0 +/- 0.8% (6 months). Measurements of bone mineralization rate (BMR) showed that after 3 weeks of implantation, there were no significant differences between PMMA and uncoated materials 1 and 2. After 6 weeks, the BMRs in animals implanted with either HA-coated material 1 or 2 were significantly higher than with HA-coated Ti-6Al-4V (p <.05-.0001 in both cases), but with HA-coated material 2 was lower than with this material uncoated (p <.05-.001). No significant differences were found between the two HA-coated epoxy materials. In addition, there were always lower BMRs during the third week of implantation than other periods regardless of biomaterial implanted. The study indicated that the adhesively bonded HA-coated novel epoxy materials were superior to conventional plasma-sprayed Ti-6Al-4V implants with respect to both BMR and bone integration with the implant surfaces. Adhesively bonded HA-coated epoxy materials had similar ISS values to HA-coated Ti-6Al-4V, but the former failed within the bone and coating, while the latter showed splitting between coating and metal. (C) 1999 John Wiley & Sons, Inc.
C1 Royal Free Hosp, Sch Med, Dept Histopathol, Osteoarticular Res Grp, London NW3 2PF, England.
   Cardiff Sch Engn, Med Engn Res Unit, Cardiff CF2 3TE, S Glam, Wales.
   Finsbury Instruments Ltd, Leatherhead KT22 0BA, Surrey, England.
   Univ Southampton, Dept Mat Engn, Southampton SO17 1BJ, Hants, England.
RP Revell, PA (reprint author), Royal Free Hosp, Sch Med, Dept Histopathol, Osteoarticular Res Grp, Rowland Hill St, London NW3 2PF, England.
OI Evans, Sam/0000-0003-3664-2569
CR ALBERT K, 1994, BIO-MED MATER ENG, V4, P199
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P601, DOI 10.1016/0278-2391(87)90270-9
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   Brossa F., 1993, Bio-Medical Materials and Engineering, V3, P127
   BUMA P, 1995, J ARTHROPLASTY, V10, P389, DOI 10.1016/S0883-5403(05)80190-1
   Cook S D, 1992, J Oral Implantol, V18, P359
   Cooke F W, 1992, Clin Orthop Relat Res, P135
   DALTON JE, 1995, J BIOMED MATER RES, V29, P239, DOI 10.1002/jbm.820290215
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   DHERT WJA, 1994, MED PROG TECHNOL, V20, P143
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   DUCHEYNE P, 1992, BIOMATERIALS, V13, P617, DOI 10.1016/0142-9612(92)90030-R
   Ducheyne P, 1993, BONE BIOACTIVE BIOMA, P1
   EVANS SL, 1994, J MATER SCI-MATER M, V5, P495, DOI 10.1007/BF00058990
   EVANS SL, 1994, Patent No. 00085
   KIESWETTER K, 1994, J BIOMED MATER RES, V28, P281, DOI 10.1002/jbm.820280302
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   KRAUSER T, 1989, DENT TODAY, V8, P34
   LATOUR RA, 1992, J BIOMED MATER RES, V26, P593, DOI 10.1002/jbm.820260504
   LATOUR RA, 1993, J BIOMED MATER RES, V27, P1281, DOI 10.1002/jbm.820271008
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   Overgaard S, 1997, ACTA ORTHOP SCAND, V68, P337, DOI 10.3109/17453679708996173
   Overgaard S, 1997, CLIN ORTHOP RELAT R, P286
   Schreurs BW, 1996, BIOMATERIALS, V17, P1177, DOI 10.1016/0142-9612(96)84938-6
   Takeshita F, 1997, BIOMATERIALS, V18, P317, DOI 10.1016/S0142-9612(96)00143-3
   THOMPSON JL, 1997, 13 EUR C BIOM GOTH S, P55
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
NR 30
TC 10
Z9 12
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1999
VL 46
IS 2
BP 279
EP 286
DI 10.1002/(SICI)1097-4636(199908)46:2<279::AID-JBM18>3.0.CO;2-M
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 200QM
UT WOS:000080551600018
PM 10380007
DA 2018-10-19
ER

PT J
AU Shinzato, S
   Kobayashi, M
   Choju, K
   Kokubo, T
   Nakamura, T
AF Shinzato, S
   Kobayashi, M
   Choju, K
   Kokubo, T
   Nakamura, T
TI Bone-bonding behavior of alumina bead composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE alumina; amorphous, Bis-GMA; composite; bone-bonding strength
ID LOAD-BEARING CONDITIONS; GLASS-CERAMIC POWDER; BIOLOGICAL PROPERTIES;
   MECHANICAL-PROPERTIES; CEMENT; APATITE; HYDROXYAPATITE; BIOMATERIALS;
   INTERFACE; INVIVO
AB Previously we developed an alumina bead composite (ABC) consisting of alumina bead powder (AL-P) and bisphenol-alpha-glycidyl methacrylate (Bis-GMA)-based resin and reported its excellent osteoconductivity in rat tibiae. In the present study, are evaluated histologically and mechanically the effect of alumina crystallinity on the osteoconductivity and bone-bonding strength of the composite. AL-P was manufactured by fusing crushed alpha-alumina powder and quenching it. The AL-P was composed mainly of amorphous and delta-crystal phases of alumina. Its average particle size was 3.5 mu m, and it took a spherical form. Another composite (alpha ALC), filled with pure alpha-alumina powder (alpha AL-P), was used as a referential material. The proportion of powder added to each composite was 70% w/w. Mechanical testing of ABC and alpha ALC indicated that they would be strong enough for use under weight-bearing conditions. The affinity indices for ABC, determined using male Wistar rat tibiae, were significantly higher than those for alpha ALC (p < 0.0001) up to 8 weeks. Composite plates (15 x 10 x 2 mm) that had an uncured surface layer on one side were made in situ in a rectangular mold. One of the plates was implanted into the proximal metaphysis of the tibia of a male Japanese white rabbit, and the failure load was measured by a detaching test 10 weeks after implantation. The failure loads for ABC on its uncured surface [1.91 +/- 1.23 kgf (n = 8)] were significantly higher than those for alpha ALC on its uncured surface [0.35 +/- 0.33 kgf (n = 8); (p < 0.0001)], and they also were significantly higher than those for ABC on the other (cured surface) side (p < 0.0001). Histological examinations using rabbit tibiae revealed bone ingrowth into the composite only on the uncured surface of ABC. This study revealed that the amorphous phase of alumina and formation of an uncured surface layer are needed for the osteoconductive and bone-bonding ability of ABC. ABC shows promise as a basis for the development of a highly osteoconductive and mechanically strong biomaterial. (C) 1999 John Wiley & Sons, Inc.
C1 Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Otsu Red Cross Hosp, Dept Orthopaed Surg, Otsu, Shiga 5200046, Japan.
   Nippon Elect Glass Co Ltd, Otsu, Shiga 5208639, Japan.
   Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto 6068317, Japan.
RP Shinzato, S (reprint author), Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
CR ACKLEY MA, 1980, BIOMATERIALS, V1, P217, DOI 10.1016/0142-9612(80)90021-6
   BIGGS JT, 1995, J ENDODONT, V21, P521, DOI 10.1016/S0099-2399(06)80526-1
   BRAUER GM, 1984, J DENT RES, V63, P1315, DOI 10.1177/00220345840630111301
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   Fujita H, 1998, J BIOMED MATER RES, V40, P145, DOI 10.1002/(SICI)1097-4636(199804)40:1<145::AID-JBM17>3.3.CO;2-F
   FUJITA H, 1997, BIOCERAMICS, V10, P497
   GREENBERG AR, 1976, J BIOMED MATER RES, V10, P777, DOI 10.1002/jbm.820100510
   HAYASHI K, 1992, BIOMATERIALS, V13, P195, DOI 10.1016/0142-9612(92)90184-P
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1986, SILICON BIOCH, P231
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   KAKUTANI Y, 1989, J BIOMED MATER RES, V23, P781, DOI 10.1002/jbm.820230709
   KAWANABE K, 1993, J APPL BIOMATER, V4, P135, DOI 10.1002/jab.770040204
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   Kobayashi M, 1998, J BIOMED MATER RES, V43, P140, DOI 10.1002/(SICI)1097-4636(199822)43:2<140::AID-JBM8>3.0.CO;2-O
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P68, DOI 10.1002/(SICI)1097-4636(199710)37:1<68::AID-JBM9>3.0.CO;2-H
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P554
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P301, DOI 10.1002/(SICI)1097-4636(19971205)37:3<301::AID-JBM1>3.0.CO;2-P
   KOBAYASHI M, IN PRESS J BIOMED MA
   KOBAYASHI M, 1997, BIOCERAMICS, V10, P313
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1995, BIOCERAMICS, V8, P213
   LI ZL, 1995, J BIOMED MATER RES, V29, P1081, DOI 10.1002/jbm.820290908
   MACDONALD A, 1994, J ENDODONT, V20, P598, DOI 10.1016/S0099-2399(06)80085-3
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   Matsuda Y, 1997, CLIN ORTHOP RELAT R, P263
   MOLONEY LG, 1993, J ENDODONT, V19, P59, DOI 10.1016/S0099-2399(06)81195-7
   NAJI A, 1991, BIOMATERIALS, V12, P690, DOI 10.1016/0142-9612(91)90118-T
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Senaha Y, 1996, J BONE JOINT SURG BR, V78B, P26
   TAKAGI H, 1989, J BIOMED MATER RES-A, V23, P161
   Tamura J, 1997, CLIN ORTHOP RELAT R, P183
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   TAMURA J, 1995, J BIOMED MATER RES, V29, P551, DOI 10.1002/jbm.820290502
   YUHTA T, 1994, J BIOMED MATER RES, V28, P217, DOI 10.1002/jbm.820280212
NR 37
TC 23
Z9 23
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1999
VL 46
IS 2
BP 287
EP 300
DI 10.1002/(SICI)1097-4636(199908)46:2<287::AID-JBM19>3.0.CO;2-I
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 200QM
UT WOS:000080551600019
PM 10380008
DA 2018-10-19
ER

PT J
AU Suzuki, T
   Mizushima, Y
   Umeda, T
   Ohashi, R
AF Suzuki, T
   Mizushima, Y
   Umeda, T
   Ohashi, R
TI Further biocompatibility testing of silica-chitosan complex membrane in
   the production of tissue plasminogen activator by epithelial and
   fibroblast cells
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE silica; chitosan; wet contact angle; zeta potential; plasminogen
   activator; epithelial cells; fibroblasts
ID WOUND MANAGEMENT PRODUCTS; PLATELET-ADHESION; STAPHYLOCOCCUS-AUREUS;
   POLYURETHANE SURFACES; GRADIENT SURFACES; GROWTH; PROLIFERATION;
   BINDING; CULTURE
AB The effects of the physicochemical characteristics of a silica-chitosan complex membrane (SiCM) on the expression of tissue plasminogen activator (tPA) by contacting cells were investigated with the aim of improving the biocompatibility of the novel implant biomaterial. Expression of fPA is considered to be effective in wound healing by preventing thrombus formation, which causes inflammatory responses and rejection of implant materials. Inducing the epithelial cells surrounding implant materials to secrete tPA, which serves as an early signaling system to proliferate cells underlying connective tissues, would be further effective in accelerating mound healing. An epithelial 293 cell line derived From human embryonic kidney and a fibroblast IMR-90 cell line from human lung possessing the ability to secrete tPA were cultured on SiCMs, whose composition was stepwise controlled by adjusting the mixing ratio between silica and chitosan to give silica contents of 20, 33, 43, and 50wt%. Both strains showed strong adhesion on chitosan (0%-SiCM) and 50%-SiCM, The cell proliferation rates were also accelerated in a manner that was dependent on the increase in the adhesion strength of the cells cultured on the SiCMs. Furthermore, the tPA activity in the culture medium increased in accordance with the cell density, while the cellular specific activity of IMR-90 cells to secrete tPA was synergistically enhanced by strong adhesion and a high cell density on the surface of chitosan and 50%-SiCM. Analysis of the physicochemical effects of the SiCMs revealed that the cells were dominantly affected by the surface hydrophobicity rather than by the zeta potential, as well as by the mixing ratio between chitosan and silica. The met contact angles of 50%-SiCM and chitosan, which were 68 degrees and 65 degrees, respectively, were found to be suitable for adhesion and growth of Both the epithelial 293 cells and fibroblast IMR-90 cells. A hydrophobic surface at 65 degrees-68 degrees was also effective for the production of tPA by IMR-90 cells, whereas the tPA activity of 293 cells reached its highest level on the SiCM with a wet contact angle of 63 degrees. These results suggest that a suitable adhesion strength is a significant factor in the expression of tPA by cells contacting an implant biomaterial.
C1 Sci Univ Tokyo, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan.
   NGK Spark Plug Co Ltd, Aichi 4858510, Japan.
RP Suzuki, T (reprint author), Sci Univ Tokyo, Dept Biol Sci & Technol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
CR Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Chen HM, 1998, ARTIF CELL BLOOD SUB, V26, P431, DOI 10.3109/10731199809117683
   CHUNG LY, 1994, J BIOMED MATER RES, V28, P463, DOI 10.1002/jbm.820280409
   Deible CR, 1998, J BIOMED MATER RES, V41, P251
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   INUI H, 1995, BIOSCI BIOTECH BIOCH, V59, P2111, DOI 10.1271/bbb.59.2111
   ITAGAKI Y, 1991, AGR BIOL CHEM TOKYO, V55, P1225, DOI 10.1080/00021369.1991.10870756
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   MARTIN P, 1992, Progress in Growth Factor Research, V4, P25, DOI 10.1016/0955-2235(92)90003-Z
   MATSUSHITA T, 1991, MEMOIRS FAC ENG KYUS, V51, P313
   Menouny M, 1998, INT J CANCER, V77, P874, DOI 10.1002/(SICI)1097-0215(19980911)77:6<874::AID-IJC13>3.0.CO;2-1
   MIZUSHIMA Y, 1992, J NON-CRYST SOLIDS, V144, P305, DOI 10.1016/S0022-3093(05)80414-4
   Pearson ML, 1998, J BIOMED MATER RES, V40, P419, DOI 10.1002/(SICI)1097-4636(19980605)40:3<419::AID-JBM12>3.0.CO;2-E
   PLOUG J, 1957, BIOCHIM BIOPHYS ACTA, V24, P278, DOI 10.1016/0006-3002(57)90194-4
   Sacomen D, 1998, J BIOMED MATER RES, V43, P123, DOI 10.1002/(SICI)1097-4636(199822)43:2<123::AID-JBM6>3.3.CO;2-F
   SCHMIDT RJ, 1993, J PHARM PHARMACOL, V45, P508, DOI 10.1111/j.2042-7158.1993.tb05589.x
   STATHOPOULOS NA, 1985, BIOTECHNOL BIOENG, V27, P1021, DOI 10.1002/bit.260270713
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   Vogler EA, 1998, J BIOMED MATER RES, V40, P92, DOI 10.1002/(SICI)1097-4636(199804)40:1<92::AID-JBM11>3.3.CO;2-W
   Yumoto H, 1999, INFECT IMMUN, V67, P384
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 30
TC 24
Z9 25
U1 0
U2 6
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD AUG
PY 1999
VL 88
IS 2
BP 194
EP 199
DI 10.1016/S1389-1723(99)80201-1
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 249NG
UT WOS:000083338700013
PM 16232597
DA 2018-10-19
ER

PT J
AU Saiki, M
   Rogero, SO
   Costa, I
   Correa, OV
   Higa, OZ
AF Saiki, M
   Rogero, SO
   Costa, I
   Correa, OV
   Higa, OZ
TI Neutron activation analysis of corrosion products from gold coated ear
   piercing studs
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th Tihany Symposium on Radiation Chemistry
CY AUG 29-SEP 03, 1998
CL TATABANYA, HUNGARY
DE neutron activation analysis; cytotoxicity assay; biomaterial corrosion;
   gold coated ear piercing studs
AB Neutron activation analysis was applied to the determination of elements Au, Cr, Fe, Ni and Zn released in NaCl solution and in a culture medium in which gold coated studs were immersed for corrosion tests. The coating defects and corrosion effects on the stud surfaces were studied by scanning electron microscopy and energy dispersive spectroscopy analysis. The cytotoxicity assay of culture medium from corrosion test showed toxicity in a culture of mammalian cells, (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 IPEN, CNEN SP, BR-05422970 Sao Paulo, Brazil.
RP Saiki, M (reprint author), IPEN, CNEN SP, Caixa Postal 11 049, BR-05422970 Sao Paulo, Brazil.
RI Saiki, Mitiko/B-7975-2012; Costa, Isolda/E-8506-2012
OI Saiki, Mitiko/0000-0003-2197-3592; Costa, Isolda/0000-0002-4987-3334
CR [Anonymous], 1992, 10993 ISO 5
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   MEIJER C, 1995, CONTACT DERMATITIS, V32, P147, DOI 10.1111/j.1600-0536.1995.tb00804.x
   NAKAMURA A, 1989, P JAP AT RES I JAERI, P79
NR 4
TC 5
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1999
VL 55
IS 5-6
BP 753
EP 756
DI 10.1016/S0969-806X(99)00224-8
PG 4
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 221YN
UT WOS:000081755600054
DA 2018-10-19
ER

PT J
AU Stocum, DL
AF Stocum, DL
TI Regenerative biology: A millenial revolution
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE cell transplants; bioartificial tissues; regeneration in vivo
ID MESENCHYMAL STEM-CELLS; SPINAL-CORD; DENTATE GYRUS; GERM-CELLS; MARROW;
   BONE; REPAIR; RATS; FETAL; TRANSPLANTATION
AB Regenerative biology promises to be one of the biomedical revolutions of the 21st century. It encompasses three research approaches: cell transplantation, implantation of bioartificial tissues, and stimulation of regeneration from residual tissues in vivo. Multipotent and pluripotent stern cells are promising for use in cell transplantation and bioartificial tissue construction. The regeneration of some tissues has been stimulated by implanted biomaterial scaffolds. Critical research issues in regenerative biology are: (1) hour to direct the differentiation of stern or progenitor cells in specific directions (2) negating immunorejection of transplants and implants; (3) the ubiquity of regeneration competent cells; (4) the identification and roles of factors that distinguish wound repair from regeneration; and (5) bioethical considerations.
C1 Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA.
RP Stocum, DL (reprint author), Indiana Univ Purdue Univ, Dept Biol, 402 N Blackford St, Indianapolis, IN 46202 USA.
CR Boyce S T, 1996, Tissue Eng, V2, P255, DOI 10.1089/ten.1996.2.255
   Bracy JL, 1998, SCIENCE, V281, P1845, DOI 10.1126/science.281.5384.1845
   Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81
   Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709
   Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481
   Caplan Arnold I., 1993, P405
   Carlson Bruce M., 1998, Wound Repair and Regeneration, V6, P425, DOI 10.1046/j.1524-475X.1998.60504.x
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Chernoff EAG, 1996, INT J DEV BIOL, V40, P823
   Chiang YH, 1996, CELL TRANSPLANT, V5, P179, DOI 10.1016/0963-6897(95)02043-8
   Christenson L, 1998, GENET ENG NEWS, V18, P11
   Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519
   EFRAT S, 1995, P NATL ACAD SCI USA, V92, P6947, DOI 10.1073/pnas.92.15.6947
   FAUSTO N, 1995, LIVER BIOL PATHOBIOL, P1501
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473
   Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   JU BG, 1994, DEV DYNAM, V199, P253, DOI 10.1002/aja.1001990402
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kim HD, 1998, TISSUE ENG, V4, P35, DOI 10.1089/ten.1998.4.35
   KLUG MG, 1996, J CLIN INVEST, V98, P1
   LANDEEN LK, 1992, WOUNDS, V4, P167
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lau HT, 1996, SCIENCE, V273, P109, DOI 10.1126/science.273.5271.109
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   McCallion RL, 1996, MOL CELLULAR BIOL WO, P561
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Miyazaki K, 1996, P NATL ACAD SCI USA, V93, P6819, DOI 10.1073/pnas.93.13.6819
   Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X
   Morshead CM, 1998, DEVELOPMENT, V125, P2251
   Neff AW, 1996, INT J DEV BIOL, V40, P719
   Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Pain B, 1996, DEVELOPMENT, V122, P2339
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   REYNOLDS BA, 1996, DEV BIOL, V175, P11
   Saito T, 1995, Tissue Eng, V1, P327, DOI 10.1089/ten.1995.1.327
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Stocum David L., 1998, Wound Repair and Regeneration, V6, P276, DOI 10.1046/j.1524-475X.1998.60404.x
   Stocum DL, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P411
   Studer L, 1998, NAT NEUROSCI, V1, P290
   Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510
   TANAKA E, 1997, J CELL BIOL, V136, P11
   Tanaka E M, 1998, Wound Repair Regen, V6, P371, DOI 10.1046/j.1524-475X.1998.60413.x
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   YANG EV, 1994, DEV BIOL, V166, P696, DOI 10.1006/dbio.1994.1348
   YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205
   Young Henry E., 1998, Wound Repair and Regeneration, V6, P65, DOI 10.1046/j.1524-475X.1998.60110.x
NR 61
TC 7
Z9 7
U1 0
U2 1
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD AUG
PY 1999
VL 10
IS 4
BP 433
EP 440
DI 10.1006/scdb.1999.0330
PG 8
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 244EN
UT WOS:000083039000009
PM 10497100
DA 2018-10-19
ER

PT J
AU Cenni, E
   Ciapetti, G
   Granchi, D
   Arciola, CR
   Savarino, L
   Stea, S
   Montanaro, L
   Pizzoferrato, A
AF Cenni, E
   Ciapetti, G
   Granchi, D
   Arciola, CR
   Savarino, L
   Stea, S
   Montanaro, L
   Pizzoferrato, A
TI Established cell lines and primary cultures in testing medical devices
   in vitro
SO TOXICOLOGY IN VITRO
LA English
DT Article; Proceedings Paper
CT 10th International Workshop on In Vitro Toxicology (INVITOX 98)
CY SEP 14-18, 1998
CL SPARSHOLT, ENGLAND
SP AgrEvo Ltd, BAT Int, European Ctr Validat Alternat Methods, Glaxo Wellcome R&D, Johnson & Johnson, Minist Agr Fisheries & Food, Procter & Gamble Co, Roche Prod, Sanofi Res, Unilever Res, Zeneca Pharmaceut
DE cell culture; cell function; biomaterial; device
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO; PROTEIN EXPRESSION; DACRON; GRAFTS;
   BONE; BIOCOMPATIBILITY; CYTOTOXICITY; RELEASE; ASSAY
AB In testing for the cytotoxicity of medical devices, crucial parameters are the type of cells, the duration of the exposure, the physical form of the device and the method of evaluation. Using cell cultures the changes of cell functions induced by artificial materials may be evaluated. In screening rests the effect of biomaterials on functions common to all cell types is investigated through both continuous lines and primary cultures. In supplementary tests the effect of biomaterials on specific functions is studied, employing cells of the same type of those which will be in contact with the device in vivo. Osteoblasts, either From primary culture or an established line, are used to study the interaction with materials for bone implants. We evaluated whether dental cements affect the replication cycle of osteoblast-like cells MG63. The S phase was inhibited by the cements with a phenolic group, even though to a different extent. Mononuclear cell cultures are used to investigate the immune response, which is important in the host reaction to implant. We investigated whether the chromium ions released in a biological fluid may induce PBMC to produce cytokines involved in bone resorption. Chromium extract did not impair TNF alpha release significantly, but inhibited IL-6 release significantly in stimulated PBMC. Endothelial cell cultures are useful to the evaluation of materials for vascular grafts. We studied the influence of some types of Dacron on endothelial functions. Collagen-coated Dacron decreased significantly the production of 6-keto-prostaglandin F-1 alpha. Knitted Dacron caused a significant increase of tissue factor, a significant reduction in PECAM-1 and a significant increase in ELAM-1. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Lab Biocompatibil Res Implant Mat, Bologna, Italy.
RP Cenni, E (reprint author), Ist Ortoped Rizzoli, Lab Biocompatibil Res Implant Mat, Via di Barbiano 1-10, Bologna, Italy.
RI Granchi, Donatella/J-3647-2016
OI Granchi, Donatella/0000-0001-7225-0023; savarino,
   lucia/0000-0002-3177-3546; Ciapetti, Gabriela/0000-0001-6740-0357
CR AKARASEREENONT P, 1995, BRIT J PHARMACOL, V115, P401, DOI 10.1111/j.1476-5381.1995.tb16347.x
   *ASTM, 1992, ANN BOOK ASTM STAND, P172
   CAUSEY AL, 1994, J IMMUNOL METHODS, V175, P115, DOI 10.1016/0022-1759(94)90337-9
   Cenni E, 1996, Minerva Cardioangiol, V44, P49
   Cenni E, 1997, Minerva Cardioangiol, V45, P167
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   CIAPETTI G, 1994, J MATER SCI-MATER M, V5, P640, DOI 10.1007/BF00120346
   DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573
   FEDARKO NS, 1990, J CELL PHYSIOL, V144, P115, DOI 10.1002/jcp.1041440115
   Gosselin C, 1996, J SURG RES, V60, P327, DOI 10.1006/jsre.1996.0052
   GRANCHI D, 1995, ORAL SURG ORAL MED O, V79, P359, DOI 10.1016/S1079-2104(05)80230-6
   Granchi D, 1998, BIOMATERIALS, V19, P93, DOI 10.1016/S0142-9612(97)00161-0
   Granchi D, 1998, BIOMATERIALS, V19, P283, DOI 10.1016/S0142-9612(97)00148-8
   GREISLER HP, 1992, SURGERY, V112, P244
   GREISLER HP, 1993, J BIOMAT SCI-POLYM E, V4, P415, DOI 10.1163/156856293X00672
   GRUBER HE, 1991, P SOC EXP BIOL MED, V197, P219
   HARMAND M-F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P67, DOI 10.1163/156856291X00070
   HARMAND MF, 1997, BIOCOMPATIBILITY ASS, P119
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   *ISO, 1992, 109935 ISO 5
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KU PT, 1995, J CELL BIOCHEM, V58, P328, DOI 10.1002/jcb.240580307
   NAIJ A, 1990, J BIOMEDICAL MAT RES, V24, P861
   PASIC M, 1995, CIRCULATION, V92, P2605, DOI 10.1161/01.CIR.92.9.2605
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SOYOMBO AA, 1993, EUR HEART J, V14, P201
   Sun XL, 1997, J BIOMED MATER RES, V34, P9
   Svendsen O, 1996, ATLA-ALTERN LAB ANIM, V24, P659
   WALLACH S, 1992, CALCIFIED TISSUE INT, V50, P1, DOI 10.1007/BF00297287
   WILLIAMS DF, 1987, DEFINITIONS BIOMATER, P67
   YANG J, 1994, J BIOMED MATER RES, V28, P1249, DOI 10.1002/jbm.820281102
NR 36
TC 16
Z9 17
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD AUG-OCT
PY 1999
VL 13
IS 4-5
BP 801
EP 810
DI 10.1016/S0887-2333(99)00058-2
PG 10
WC Toxicology
SC Toxicology
GA 228PD
UT WOS:000082144100046
PM 20654553
DA 2018-10-19
ER

PT J
AU Hanawa, T
AF Hanawa, T
TI In vivo metallic biomaterials and surface modification
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Electrochemical/Chemical Reactivity of
   Novel Materials
CY OCT 04-07, 1998
CL SENDAI, JAPAN
DE metallic biomaterial; surface oxide layer; metallic ion release;
   titanium; surface modification
ID ION-IMPLANTED TITANIUM; CALCIUM-PHOSPHATE COATINGS; OXIDE-FILMS;
   CORROSION; ALLOYS; ELECTROLYTE; DISSOLUTION; DEPOSITION; RESISTANCE;
   ADSORPTION
AB The chemical properties of metallic biomaterials used for artificial joints, bone plates, and dental implants in vivo are discussed based on empirical data. focusing on the maturation of surface oxide film on titanium and the film's destruction and regeneration in body fluids. It is reviewed the behavior of metallic materials in vivo and how to modify the surface of biomaterials to improve corrosion and wear resistance and bone conductivity. Effect of calcium ion implantation into titanium for improvement of its bone conductivity is given as an example. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Natl Res Inst Met, Biomat Res Team, Tsukuba, Ibaraki 3050047, Japan.
RP Hanawa, T (reprint author), Natl Res Inst Met, Biomat Res Team, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
CR [Anonymous], 1989, ILLUSTRATED ENCY DIC, P1800
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   BUCHANAN RA, 1990, J BIOMED MATER RES, V24, P309, DOI 10.1002/jbm.820240304
   Doi H, 1998, J JPN SOC DENT MAT D, V17, P247
   EKTESSABI AM, 1994, SURF COAT TECH, V68, P208, DOI 10.1016/0257-8972(94)90162-7
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   Endo K, 1995, Dent Mater J, V14, P185
   GOLD JM, 1989, HELV PHYS ACTA, V62, P246
   Halliwell B., 1989, FREE RADICAL BIO MED, P22
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   HANAWA T, 1994, AM SOC TEST MATER, V1196, P170, DOI 10.1520/STP25192S
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   HANAWA T, 1992, J JPN SOC DENT MATER, V11, P777
   HANAWA T, 1997, J JPN SOC BIOMATER, V15, P249
   HANAWA T, 1997, J JPN SOC DENT MATER, V16, P134
   HANAWA T, 1992, J SURF FINISH SOC JP, V43, P739
   HANAWA T, 1994, J JPN SOC BIOMATER, V12, P209
   HAYASHI K, 1991, J BIOMED MATER RES, V25, P515, DOI 10.1002/jbm.820250408
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1111, DOI 10.1002/jbm.820240813
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   HISAMATSU Y, 1981, B JPN I MET, V3, P20
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ITAKURA Y, 1989, BIOMATERIALS, V10, P489, DOI 10.1016/0142-9612(89)90091-4
   *JAP SOC CHEM, 1995, BIOL ACT TRAC MET
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kimura H, 1988, JPN J DENT MAT, V7, P106
   LEE IS, 1991, J BIOMED MATER RES, V25, P1039, DOI 10.1002/jbm.820250810
   Lundstrom I, 1986, J COLLOID INTERF SCI, V11, P9
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   MERRITT K, 1988, J BIOMED MATER RES, V22, P111, DOI 10.1002/jbm.820220204
   MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4
   MU Y, 1996, J JPN SOC ORTHOP, V70, pS148
   MURAKAMI K, 1997, P 19 ANN M JPN SOC B, P36
   MY Y, 1997, P 19 ANN M JPN SOC B, P76
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SUGIMOTO T, 1995, INTERNAL MED VER 6, P2004
   TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Williams D.F, 1981, BIOCOMPATIBILITY CLI, V1, P9
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P181, DOI 10.1016/0142-9612(88)90119-6
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   Yoshinari M, 1997, J BIOMED MATER RES, V37, P60, DOI 10.1002/(SICI)1097-4636(199710)37:1<60::AID-JBM8>3.0.CO;2-H
NR 64
TC 163
Z9 169
U1 4
U2 38
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 31
PY 1999
VL 267
IS 2
BP 260
EP 266
DI 10.1016/S0921-5093(99)00101-X
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 216ME
UT WOS:000081445800014
DA 2018-10-19
ER

PT J
AU Lohman, M
   Partio, EK
   Vehmas, T
   Kivisaari, A
   Kivisaari, L
AF Lohman, M
   Partio, EK
   Vehmas, T
   Kivisaari, A
   Kivisaari, L
TI MR imaging in biofix-osteosynthesis
SO ACTA RADIOLOGICA
LA English
DT Article
DE ankle, fractures; injuries, implants; MR imaging
ID SCREWS; ANKLE
AB Purpose: Osteosynthesis by means of bioresorbable implants, mostly of self-reinforced poly-L-lactide (SR-PLLA), has been used in humans for about 10 years. The aim of this study was to examine the controversy between histological studies confirming fragmentation of the biomaterial and radiological studies showing no breaking of the material.
   Material and Methods. Six patients with displaced malleolar fractures operatively treated with biodegradable SR-PLLA screws underwent MR examinations at 1.5 T, immediately postoperatively and after one to two years.
   Results: The biodegradable osteosynthetic screws were clearly seen on all MR images. Of 12 screws, 6 were broken at the final examination (5 syndesmotic transfixation screws and 1 screw through the growth cartilage).
   Conclusion: The breaking of a biodegradable osteosynthesis is possible to document on MR images.
C1 Univ Helsinki, Cent Hosp, Dept Radiol, FIN-00290 Helsinki, Finland.
   Univ Helsinki Hosp, Dept Radiol, Helsinki, Finland.
   Dextra Hosp, Dept Orthoped & Traumatol, Helsinki, Finland.
RP Lohman, M (reprint author), Univ Helsinki, Cent Hosp, Dept Radiol, Stenbackinkatu 9, FIN-00290 Helsinki, Finland.
CR ALANEN A, 1995, ACTA RADIOL, V36, P92
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BOSTMAN OM, 1995, CLIN ORTHOP RELAT R, P101
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   KAYE RA, 1989, FOOT ANKLE, V9, P290, DOI 10.1177/107110078900900606
   MAJOLA A, 1991, CLIN ORTHOP RELAT R, P260
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   Pihlajamaki HK, 1997, J ORTHOP TRAUMA, V11, P559, DOI 10.1097/00005131-199711000-00003
   VILJANEN J, 1995, BIOMATERIALS, V16, P1353, DOI 10.1016/0142-9612(95)91052-Z
NR 10
TC 4
Z9 4
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0284-1851
J9 ACTA RADIOL
JI Acta Radiol.
PD JUL
PY 1999
VL 40
IS 4
BP 415
EP 417
DI 10.3109/02841859909177756
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 227BQ
UT WOS:000082058600010
PM 10394870
DA 2018-10-19
ER

PT J
AU Metzler, V
   Bienert, H
   Lehmann, T
   Mottaghy, K
   Spitzer, K
AF Metzler, V
   Bienert, H
   Lehmann, T
   Mottaghy, K
   Spitzer, K
TI A novel method for quantifying shape deformation applied to
   biocompatibility testing
SO ASAIO JOURNAL
LA English
DT Article
ID IN-VITRO; GM1 GANGLIOSIDE; CELL-CULTURE; ETHANOL; TOXICITY
AB Cytotoxicity tests are important for the screening and evaluation of biocompatibility of artificial organs. Morphologic changes of cells that were contacted biomaterials or biomaterial extracts indicate their toxicity. However, information on cytotoxic effects is still obtained by subjective visual inspection of microscopic samples. In this article, a novel computer assisted method is introduced. The automatic analysis of digitized micrographs is achieved in several stages: segmentation, separation, classification, and measurement The segmentation of the image is provided by a new local adaptive thresholding technique, which adapts the threshold window sizes onto local gray level distribution and yields optimal window sizes. The actual threshold is obtained by maximizing interclass variances and minimizing intraclass variance. For the separation of connected cells, the binarized samples are cleaned from "false" markers by morphologic filtering. The subsequent separation is a two phase approach. Information levels are generated top-down by successively applying an enhanced erosion operator, which yields markers and filters noise usually evolving from multiple erosions. The converse bottom-up integration of the eroded markers is performed by successively applying an enhanced dilation operator, which reconstructs the cells and prevents merging of already separated objects. The subsequent measuring provides quantitative parameters of the distribution of size and compactness of the cells contained within the sample. The method was evaluated by L-929 fibroblasts that were in contact with 0%, 5%, and 10% concentrations of ethanol. For each concentration, 268 images of the cell populations were captured. The obtained quantitative parameters are highly correlated to the common verbal description of morphologic changes. Therefore, the proposed automatic method has several advantages compared with subjective examinations. The re suits allow an objective comparison of the quantification of phenomena; the subjective influence of the observer is eliminated; and the laboratory staff is relieved of time consuming routine work.
C1 Rhein Westfal TH Aachen, Inst Med Informat, D-5100 Aachen, Germany.
   Rhein Westfal TH Aachen, Inst Physiol, D-5100 Aachen, Germany.
   Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res Biomat, D-5100 Aachen, Germany.
RP Metzler, V (reprint author), Univ Lubeck, TZL, Inst Signalverarbeitung & Proze, Seelandstr 1A, D-23569 Lubeck, Germany.
CR BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   BORGEFORS G, 1986, COMPUTER VISION GRAP, V34, P679
   Chen SY, 1996, ALCOHOL, V13, P589
   CIAPETTI G, 1992, INT J ARTIF ORGANS, V15, P62
   *DIN EN, 1994, 309935 DIN EN
   DOILLON CJ, 1990, INT J ARTIF ORGANS, V13, P517
   Dougherty E.R., 1992, INTRO MORPHOLOGICAL
   Glasbery C.A., 1995, IMAGE ANAL BIOL SCI
   Godbole S., 1995, Real-Time Imaging, V1, P191, DOI 10.1006/rtim.1995.1019
   GURLAND HJ, 1994, NEPHROL DIAL TRANSPL, V9, P4
   Higashi K, 1996, ALCOHOL CLIN EXP RES, V20, pA320, DOI 10.1111/j.1530-0277.1996.tb01800.x
   Klein RF, 1996, ALCOHOL CLIN EXP RES, V20, P572, DOI 10.1111/j.1530-0277.1996.tb01095.x
   KOVALEV VA, 1996, SPIE P, V2434, P754
   Laev H, 1996, ALCOHOL, V13, P187, DOI 10.1016/0741-8329(95)02045-4
   Leung CK, 1996, PATTERN RECOGN, V29, P1523, DOI 10.1016/0031-3203(96)00009-X
   MACAULAY C, 1988, ANAL QUANT CYTOL, V10, P134
   Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, P21, DOI 10.1016/1047-3203(90)90014-M
   MURRAY C, 1993, IMAGE VISION COMPUT, V11, P155, DOI 10.1016/0262-8856(93)90054-K
   NI Y, 1992, CELL BIOL TOXICOL, V8, P1, DOI 10.1007/BF00119291
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   PAYNE CM, 1989, ANAL QUANT CYTOL, V11, P341
   Pei SC, 1997, GRAPH MODEL IM PROC, V59, P109, DOI 10.1006/gmip.1996.0416
   RUSS JC, 1990, COMPUTER ASSISTED MI
   Serra J, 1982, IMAGE ANAL MATH MORP
   SMITH MD, 1992, INT J ARTIF ORGANS, V15, P191
   Tapani E, 1996, ACTA RADIOL, V37, P923, DOI 10.3109/02841859609175470
   Young IT, 1996, IEEE ENG MED BIOL, V15, P59, DOI 10.1109/51.482844
NR 27
TC 17
Z9 28
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 1999
VL 45
IS 4
BP 264
EP 271
DI 10.1097/00002480-199907000-00004
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 220RQ
UT WOS:000081681600004
PM 10445730
OA Bronze
DA 2018-10-19
ER

PT J
AU Clubb, FJ
   Clapper, DL
   Deferrari, DA
   Hu, SP
   Seare, WJ
   Capek, PP
   Armstrong, J
   McGee, MG
   Billings, LA
   Fuqua, JM
   Parnis, SM
AF Clubb, FJ
   Clapper, DL
   Deferrari, DA
   Hu, SP
   Seare, WJ
   Capek, PP
   Armstrong, J
   McGee, MG
   Billings, LA
   Fuqua, JM
   Parnis, SM
TI Surface texturing and coating of biomaterial implants: Effects on tissue
   integration and fibrosis
SO ASAIO JOURNAL
LA English
DT Article
ID POLYETHYLENE; SILICONE; SMOOTH
AB To determine whether texturing and coating have additive effects in promoting tissue integration and inhibiting fibrosis, we evaluated smooth silicone rubber (SSR), textured silicone rubber (TSR), porous silicone rubber (PSR), expanded polytetrafluoroethylene (ePTFE), and porous polyurethane (PPU) subcutaneous implants in eight minipigs. Some of the implants were coated with type IV collagen (Col) and/or fibronectin (Fn). At 6 months, we removed the implants and examined them microscopically. Texturing was more important than Col and Fn in reducing fibrosis and inflammation. The PSR yielded the best response, including reduced fibrosis and inflammation, satisfactory adherence, and no dystrophic mineralization.
C1 Texas Heart Inst, Dept Comparat Cardiovasc Serv, Houston, TX 77225 USA.
   SurMod Inc, Eden Prairie, MN USA.
   Seare Biomatrix Syst, Salt Lake City, UT USA.
RP Clubb, FJ (reprint author), Texas Heart Inst, Dept Comparat Cardiovasc Serv, POB 20345,MC 1-283, Houston, TX 77225 USA.
FU NIDDK NIH HHS [R44DK38271]
CR Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   BARONE FE, 1992, PLAST RECONSTR SURG, V90, P77, DOI 10.1097/00006534-199207000-00012
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   HAKELIUS L, 1992, PLAST RECONSTR SURG, V90, P247, DOI 10.1097/00006534-199290020-00012
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P209, DOI 10.1016/0142-9612(93)90025-W
   KIRKHAM SM, 1991, OPHTHALMIC SURG LAS, V22, P455
   KUHN K, 1994, MATRIX BIOL, V14, P439
   OKADA T, 1993, J BIOMED MATER RES, V27, P1509, DOI 10.1002/jbm.820271207
   Seare W J Jr, 1993, ASAIO J, V39, pM668
   Yamada KM, 1989, CURR OPIN CELL BIOL, V1, P956, DOI 10.1016/0955-0674(89)90065-3
NR 14
TC 8
Z9 8
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 1999
VL 45
IS 4
BP 281
EP 287
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 220RQ
UT WOS:000081681600006
PM 10445732
DA 2018-10-19
ER

PT J
AU Hofman, S
   Sidqui, M
   Abensur, D
   Valentini, P
   Missika, P
AF Hofman, S
   Sidqui, M
   Abensur, D
   Valentini, P
   Missika, P
TI Effects of Laddec (R) on the formation of calcified bone matrix in rat
   calvariae cells culture
SO BIOMATERIALS
LA English
DT Article
DE osteoblasts; in vitro; xenografts; alkaline phosphatase mineralization;
   image analysis
ID INVITRO; COLLAGEN; HYDROXYAPATITE; OSTEOBLASTS; INTERFACE; TISSUE;
   IMPLANTS; DEFECTS; MINERALIZATION; BIOMATERIALS
AB Osteoblasts from 21 day-old fetal rats calvaria were isolated using a collagenase digestion procedure. Cells were cultured in the presence of Laddec(R) (a highly purified bovine xenograft) and Bio-Oss(R) (natural bone mineral). Optical microscopic observations showed that osteoblasts attached on the plastic culture dishes and formed close contact with biomaterial particles. By day 5, the osteoblasts formed a confluent monolayer. A cytozymatic method showed intense alkaline phosphatase (ALP) staining around and between the substrate granules of the two materials. By day 14, inverted phase microscopic observations showed that osteoblasts formed bone nodules around and between substrate particles, In addition, at this time, the Von Kossa staining was positive. Using a conventional assay, ALP specific activity was higher in the presence of Laddec(R) than in the presence of Bio-Oss(R). A quantitative morphological method using image analysis showed that the proportion of mineralized bone formed around biomaterial particles in relation to total bone was increased with Laddec(R) (15% more than with Bio-Oss(R)). Ultrastructural observations by TEM showed the presence of an electron dense collagen-free layer at the biomaterial/bone interface and a collagenous matrix deposited at the periphery, indicating the bioactivity of the biomaterials. These results indicated that Laddec(R) increased the expression of ALP in osteoblast cultures and facilitated the formation of multiple cell layers, providing a culture environment suitable for mineralization. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Inst Biomed Cordeliers, Lab Biol Odontol, F-75270 Paris 06, France.
RP Hofman, S (reprint author), Inst Biomed Cordeliers, Lab Biol Odontol, 15-21 Rue Ecole Med, F-75270 Paris 06, France.
CR ADAM M, 1992, P C COLL NAT BIOM BO, P1
   ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   AMUNDESWARI S, 1986, J BIOMED MATER RES, V29, P1103
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   BLUMENTHAL N, 1989, J PERONDONTAL, V59, P18
   BOSKEY AL, 1989, BONE MINER, V6, P11
   BOYNE PJ, 1989, MATER RES SOC S P, V110, P219
   BOYNE PJ, 1988, BONE GRAFTS BONE SUB, P291
   BURKE KE, 1983, J DERMATOL SURG ONC, V9, P889, DOI 10.1111/j.1524-4725.1983.tb01036.x
   Chappard D, 1993, Bull Assoc Anat (Nancy), V77, P59
   CHAPPARD D, 1993, BIOMATERIALS, V14, P379
   COBB CM, 1976, ORAL SURG ORAL MED O, V41, P24, DOI 10.1016/0030-4220(76)90248-6
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   Davies JE, 1996, ANAT REC, V245, P426
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DEPORTER DA, 1988, CALCIFIED TISSUE INT, V42, P321, DOI 10.1007/BF02556367
   DEVORE DT, 1997, ORAL SURG, V38, P677
   GILBERT DL, 1987, J BIOMED MATER RES, V21, P643, DOI 10.1002/jbm.820210509
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Isaksson S, 1992, Swed Dent J Suppl, V84, P1
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P209, DOI 10.1016/0142-9612(93)90025-W
   LOMRI A, 1988, BONE, V9, P165, DOI 10.1016/8756-3282(88)90006-3
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LUBBEN RA, 1976, ENDOCRINOLOGY, V99, P526
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   McComb RB, 1979, ALKALINE PHOSPHATASE
   MCCULLOCH CAG, 1990, DEV BIOL, V140, P352, DOI 10.1016/0012-1606(90)90085-W
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   MINABE M, 1988, J PERIODONTOL, V59, P671, DOI 10.1902/jop.1988.59.10.671
   MISSIKA P, 1993, ACTA ODONTO STOMATO, V184, P491
   Morax S, 1993, Ann Chir Plast Esthet, V38, P445
   NANCI A, 1994, CELL MATER, V4, P1
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   Nefussi JR, 1997, BONE, V20, P5, DOI 10.1016/S8756-3282(96)00319-5
   OLLIVIER A, 1993, QUANTIMETRIE ANAL IM
   OSDOBY P, 1981, DEV BIOL, V86, P147, DOI 10.1016/0012-1606(81)90325-0
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P154
   POHUNKOVA H, 1995, BIOMATERIALS, V16, P67, DOI 10.1016/0142-9612(95)91098-J
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   SAUIER JM, 1992, BIOMATERIALS, V6, P400
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAUTIER JM, 1992, CALCIFIED TISSUE INT, V50, P527, DOI 10.1007/BF00582168
   SAUTIER JM, 1990, IN VITRO CELL DEV B, V26, P1079
   SAUTIER JM, 1994, CELL MATER, V4, P357
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   SETH R, 1990, ANN PLAST SURG, V25, P435
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   STASSEN LFA, 1994, BRIT J ORAL MAX SURG, V32, P83, DOI 10.1016/0266-4356(94)90133-3
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
NR 59
TC 17
Z9 26
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1999
VL 20
IS 13
BP 1155
EP 1166
DI 10.1016/S0142-9612(97)00082-3
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204ZE
UT WOS:000080795600001
PM 10395384
DA 2018-10-19
ER

PT J
AU Kue, R
   Sohrabi, A
   Nagle, D
   Frondoza, C
   Hungerford, D
AF Kue, R
   Sohrabi, A
   Nagle, D
   Frondoza, C
   Hungerford, D
TI Enhanced proliferation and osteocalcin production by human
   osteoblast-like MG63 cells on silicon nitride ceramic discs
SO BIOMATERIALS
LA English
DT Article
DE ceramic; osteoblast; osteocalcin; in vitro
ID LINE MG-63; SECRETION; TOXICITY
AB The biocompatibility of silicon nitride (Si3N4) was assessed in an in vitro model using the human osteoblast-like MG-63 cell line. Cells were propagated on the surface of: reaction-bonded silicon nitride discs, sintered after reaction-bonded silicon nitride discs or control polystyrene surface for 48 h. Compared to cells propagated on polystyrene surface, cells grown on the surface of unpolished silicon nitride discs had significantly lower cell yield and decreased osteocalcin production. In contrast, cells on the surface of polished silicon nitride discs showed similar proliferative capacity to control cells propagated on polystyrene surface. Cells propagated on polished discs also produced higher levels of osteocalcin than cells on unpolished discs. SEM analysis showed cells with well-delineated morphology and cytoplasmic extensions when propagated on polished sintered after reaction-bonded discs. Cells appeared more spherical, when grown on polished reaction-bonded discs. The results of this study suggest that silicon nitride is a non-toxic, biocompatible ceramic surface for the propagation of functional human bone cells in vitro. Its high wear resistance and ability to support bone cell growth and metabolism make silicone nitride an attractive candidate for clinical application. Further studies are needed to explore the feasibility of using silicon nitride clinically as an orthopedic biomaterial. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21239 USA.
   Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RP Frondoza, C (reprint author), Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, 5601 Loch Raven Blvd G-1, Baltimore, MD 21239 USA.
RI Nagle, Dennis/A-3310-2010
CR BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   CALLAWAY G, 1995, J ARTHRO, V6, P855
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   DELMAS PD, 1995, BIOCH MARKERS ASSESS, P319
   DOBBS HS, 1983, TITANIUM ALLOYS SURG, P174
   EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0
   Fritsch EW, 1996, CLIN ORTHOP RELAT R, P129
   FRONDOZA CG, 1988, HYBRIDOMA, V7, P397, DOI 10.1089/hyb.1988.7.397
   GANGOPADHYAY A, 1994, FRICTION WEAR CERAMI, P329
   GUALTIERI G, 1992, CLIN ORTHOP RELAT R, P81
   HAUMS J, 1979, J BIOMED MATER RES, V13, P67
   Higuchi F, 1995, J ARTHROPLASTY, V10, P851, DOI 10.1016/S0883-5403(05)80086-5
   Howlett C., 1989, CLIN ORTHOP RELAT R, V244, P296
   KATZ N, 1993, MATER RES SOC S P, V287, P199
   LAJEUNESSE D, 1990, J BONE MINER RES, V5, P915
   LAJEUNESSE D, 1991, BONE MINER, V14, P237, DOI 10.1016/0169-6009(91)90025-U
   Lin TW, 1997, J BIOMED MATER RES, V36, P137, DOI 10.1002/(SICI)1097-4636(199708)36:2<137::AID-JBM1>3.0.CO;2-L
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MICHAUD R, 1995, J ARTHRO, V6, P863
   MITTELMEIER H, 1992, CLIN ORTHOP RELAT R, P64
   PLENK H, 1982, BIOCOMPATIBILITY ORT, V1, P270
   Price N., 1997, J BIOMED MAT SCI, V37, P397
   RICHERSON DW, 1989, MATER SCI FORUM, V47, P282
   SEDEL L, 1994, CLIN ORTHOP RELAT R, P175
   SEDEL L, 1990, J BONE JOINT SURG BR, V72, P658
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   WALTER IA, 1992, CLIN ORTHOP RELAT R, V282, P31
   WEIGHTMAN B, 1986, BIOMATERIALS, V7, P20
   WILLIAMS DF, 1982, BIOCOMPATIBILITY ORT, V1, P231
   WROBLESKI B, 1989, REVISION SURGERY TOT, P63
   ZICHNER LP, 1992, CLIN ORTHOP RELAT R, P86
NR 34
TC 85
Z9 90
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1999
VL 20
IS 13
BP 1195
EP 1201
DI 10.1016/S0142-9612(99)00007-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204ZE
UT WOS:000080795600005
PM 10395388
DA 2018-10-19
ER

PT J
AU Viator, JA
   Jacques, SL
   Prahl, SA
AF Viator, JA
   Jacques, SL
   Prahl, SA
TI Depth profiling of absorbing soft materials using photoacoustic methods
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE absorption coefficient; algorithm; elastin; Nd : YAG; photoacoustic;
   Q-switched
ID LASER; WAVES
AB A Q-switched, frequency doubled, Nd:YAG laser coupled to an optical parametric oscillator generated 4.75-ns laser pulses at 726 nm to create subsurface acoustic waves in India ink solutions, India ink acrylamide gels, and in flat segments of elastin biomaterial stained with India ink. The acoustic waves traveled through the target and were detected by a piezoelectric transducer. The waveforms were converted to measurements of initial laser induced pressure and temperature as functions of depth in the material. An algorithm based on Beer's Law was developed and applied to the acoustic signals to extract information about the absorption coefficient as a function of depth in the samples.
C1 Oregon Grad Inst Sci & Technol, Beaverton, OR USA.
   Oregon Med Laser Ctr, Portland, OR 97225 USA.
   Oregon Hlth Sci Univ, Portland, OR 97201 USA.
RP Viator, JA (reprint author), Oregon Grad Inst Sci & Technol, Beaverton, OR USA.
CR Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CRISSMAN RS, 1987, J ELECTRON MICR TECH, V6, P335, DOI 10.1002/jemt.1060060404
   Kruger J., 1994, FOLIA GEOGRAPHICA DA, V21, P1
   ORAEVSKY AA, 1995, J APPL PHYS, V78, P1281, DOI 10.1063/1.360370
   ORAEVSKY AA, 1994, P SOC PHOTO-OPT INS, V2134, P122
   ORAEVSKY AA, 1993, SPIE, V1882, P86
   Paltauf G, 1996, APPL PHYS LETT, V69, P1526, DOI 10.1063/1.117993
   Sathyam U S, 1997, J Biomed Opt, V2, P251, DOI 10.1117/12.275218
   SIGRIST MW, 1986, J APPL PHYS, V60, P83
   Viator JA, 1998, P SOC PHOTO-OPT INS, V3254, P104, DOI 10.1117/12.308154
NR 10
TC 46
Z9 46
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD JUL-AUG
PY 1999
VL 5
IS 4
BP 989
EP 996
DI 10.1109/2944.796321
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 248CM
UT WOS:000083257800017
DA 2018-10-19
ER

PT J
AU Suggs, LJ
   Shive, MS
   Garcia, CA
   Anderson, JM
   Mikos, AG
AF Suggs, LJ
   Shive, MS
   Garcia, CA
   Anderson, JM
   Mikos, AG
TI In vitro cytotoxicity and in vivo biocompatibility of poly(propylene
   fumarate-co-ethylene glycol) hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cytotoxicity; biocompatibility; hydrogel; poly(ethylene glycol);
   poly(propylene fumarate); cardiovascular stent; tissue engineering
ID INVIVO BIOCOMPATIBILITY; RESTENOSIS; ANGIOPLASTY; DEGRADATION;
   COPOLYMER; CELLS
AB The in vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol)[P(PF-co-EG)] hydrogels were assessed in order to investigate the influence of poly(ethylene glycol) molecular weight and copolymer composition. These materials have application as injectable cardiovascular implants;cytotoxicity due to leachable products, as well as inflammation caused by the biomaterial itself, may ultimately affect the biocompatibility of the implant. We utilized a 7-day in vitro cytotoxicity assay to quantify cell density and cellular proliferation in the presence of copolymer films. The copolymer films exhibited slight to moderate cytotoxicity toward cultured endothelial cells, showing 20-86% viability relative to controls. Cell viability increased with an increasing weight percent of PEG or, to a lesser extent, the molecular weight of PEG. In vivo biocompatibility was assessed using a cage implantation model over a 21-day time period. This system was used to characterize the local cellular and humoral inflammatory response in the surrounding exudate, as well as the size and density of macrophages adherent to the material itself. All copolymer formulations exhibited excellent biocompatibility relative to controls with no significant differences in total leukocyte count among the different formulations. The in vivo inflammatory reaction displayed normal wound healing over 21 days as shown by a progressive decrease in both leukocyte concentration and enzymatic activity. The surface coverage of the copolymer films remained relatively constant from 7 to 21 days; There were no cells larger than 0.003 mm(2),which was previously shown to be the threshold value for foreign-body giant cells.,These data suggest that P(PF-co-EG) hydrogels have potential for use as injectable biomaterials. (C) 1999 John Wiley & Sons, Inc.
C1 Rice Univ, Inst Biosci & Bioengn, Cox Lab Biomed Engn, Houston, TX 77251 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Mikos, AG (reprint author), Rice Univ, Inst Biosci & Bioengn, Cox Lab Biomed Engn, 6100 S Main St, Houston, TX 77251 USA.
FU NIAMS NIH HHS [R01-AR44381]; NIGMS NIH HHS [5T32GM08362]
CR CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   FRANKLIN SM, 1993, CORONARY ARTERY DIS, V4, P232, DOI 10.1097/00019501-199303000-00003
   GILDING DK, 1979, POLYMER, V20, P1454, DOI 10.1016/0032-3861(79)90008-9
   GottsaunerWolf M, 1996, CLIN CARDIOL, V19, P347, DOI 10.1002/clc.4960190505
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Holmes Jr DR, 1984, AM J CARDIOL SC, V53, p77C
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   Nikolaychik VV, 1996, J BIOMAT SCI-POLYM E, V7, P881, DOI 10.1163/156856296X00057
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   PETER SJ, IN PRESS J BIOMATER
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Suggs LJ, 1997, MACROMOLECULES, V30, P4318, DOI 10.1021/ma970312v
   SUGGS LJ, IN PRESS BIOMATERIAL
   VILLARETE LH, 1995, BIOCHEM BIOPH RES CO, V211, P671, DOI 10.1006/bbrc.1995.1864
   Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   ZHU KJ, 1986, J POLYM SCI POL LETT, V24, P331, DOI 10.1002/pol.1986.140240706
NR 23
TC 100
Z9 104
U1 2
U2 28
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1999
VL 46
IS 1
BP 22
EP 32
DI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197LH
UT WOS:000080365900003
PM 10357132
DA 2018-10-19
ER

PT J
AU van Kooten, TG
   Klein, CL
   Wagner, M
   Kirkpatrick, CJ
AF van Kooten, TG
   Klein, CL
   Wagner, M
   Kirkpatrick, CJ
TI Focal adhesions and assessment of cytotoxicity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE focal adhesion; vinculin; fibronectin; biomaterial; cytotoxicity
ID HUMAN ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS;
   PROLIFERATION; ATTACHMENT; BIOMATERIALS; OSTEOBLASTS; FIBROBLASTS;
   KINASE; QUANTIFICATION
AB Focal adhesions are highly ordered assemblies of transmembrane receptors, extracellular matrix proteins, and a large number of cytoplasmic proteins, including structural proteins, as well as tyrosine kinases, phosphatases, and their substrates. They are now accepted as a prime component of signal transduction. Because focal adhesions also play an important role in cell morphology and migration, it can be argued that their presence is indicative of healthy cells. This has been the reason for several research groups to conclude that biomaterials sustaining focal adhesion assembly are biocompatible. In this study we demonstrate that cells under cytotoxic stress may still be able to retain their focal adhesions. Human umbilical vein endothelial cells at passage 2 were exposed to nickel and zinc ion solutions ranging from 1 to 0.01 mM for 4 and 24 h. Cells were seeded on fibronectin precoated glass slides or in tissue culture quality 96-well plates. MTT conversion with 1 and 0.5 mM nickel and zinc was strongly depressed, indicating that these concentrations are cytotoxic. Proliferative activity was also affected by these concentrations. Cells exposed to zinc typically retracted and detached from the surface, whereas cells exposed to nickel remained on the surface without signs of retraction. Nevertheless, cells exposed to nickel were impaired to reach con fluency, which was determined by cadherin-5 expression. All these data indicate that nickel ions at a sufficient concentration influence cells in a cytotoxic way. Despite this apparent cytotoxicity, focal adhesion distribution as visualized by immunofluorescence staining of vinculin was not affected. With zinc the morphological changes were accompanied by apparent fusion of focal adhesions during retraction and finally dissolution. These data indicate that the mere presence of focal adhesions does not allow a reliable statement about the functional status of a fell. On the other hand, when focal adhesions are affected it is an excellent monitor of disturbed cell function. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP van Kooten, TG (reprint author), Univ Groningen, Cell Biol & Biomat Grp, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   DESAI N P, 1989, Journal of Biomaterials Science Polymer Edition, V1, P123, DOI 10.1163/156856289X00118
   GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121
   GOEBELER M, 1995, J IMMUNOL, V155, P2459
   GRANDO SA, 1993, SKIN PHARMACOL, V6, P135
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KANESHIRO ES, 1993, J MICROBIOL METH, V17, P1, DOI 10.1016/S0167-7012(93)80010-4
   KEY G, 1994, J IMMUNOL METHODS, V177, P113, DOI 10.1016/0022-1759(94)90148-1
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KROESEN BJ, 1992, J IMMUNOL METHODS, V156, P47, DOI 10.1016/0022-1759(92)90009-I
   LAMPUGNANI MG, 1993, BAILLIERE CLIN HAEM, V6, P539, DOI 10.1016/S0950-3536(05)80187-8
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   LO SH, 1994, CANCER METAST REV, V13, P9, DOI 10.1007/BF00690415
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   OPAS M, 1989, DEV BIOL, V131, P281, DOI 10.1016/S0012-1606(89)80001-6
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   SCRAGG MA, 1991, ANAL BIOCHEM, V198, P80, DOI 10.1016/0003-2697(91)90509-R
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Starborg M, 1996, J CELL SCI, V109, P143
   THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   WAGNER M, 1996, THESIS MAINZ U MAINZ
   WANG JYJ, 1994, TRENDS CARDIOVAS MED, V4, P264, DOI 10.1016/1050-1738(94)90030-2
   WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319
   Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x
NR 36
TC 21
Z9 21
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1999
VL 46
IS 1
BP 33
EP 43
DI 10.1002/(SICI)1097-4636(199907)46:1<33::AID-JBM4>3.0.CO;2-K
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197LH
UT WOS:000080365900004
PM 10357133
DA 2018-10-19
ER

PT J
AU Furukawa, K
   Ushida, T
   Sugano, H
   Ohshima, N
   Tateishi, T
AF Furukawa, K
   Ushida, T
   Sugano, H
   Ohshima, N
   Tateishi, T
TI Real time observation of platelet adhesion to opaque biomaterial
   surfaces under shear flow conditions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cone and plate-type rheometer; upright microscope; platelets; materials;
   shear stress
ID ENDOTHELIAL-CELLS; BLOOD; ANTICOAGULABILITY; COAGULATION; POLYMER;
   STRESS; CONE
AB We developed a new system which enables direct observation of platelet adhesion on opaque biomaterials under shear flow conditions, by combining a thin quartz cone which produces laminar shear flows, with an upright epifluorescence microscope which visualizes stained platelets through the rotating cone. This is the first report on the observation of platelets adhered to opaque biomaterials in real time under shear flow conditions. The direct observation of platelet adhesion to expanded polytetrafluoroethylene (ePTFE) as an opaque biomaterial revealed that the kinetics of platelet adhesion to ePTFE depended greatly on shear stresses, showing that the shear stress of 5.0 dyne/cm(2) induced higher adhesiveness of platelets to ePTFE than that of either 0.1 or 15 dyne/cm(2). The observation also showed a difference in platelet adhesiveness among ePTFEs with different fibril lengths-0, 3.2, 18, and 35 mu m-indicating that ePTFEs with shorter fibril length had lower adhesiveness of platelets under a shear stress of 5.0 dyne/cm(2). It is indispensable for analyzing the phenomena of platelet adhesion to opaque biomaterials to observe in real-time rolling, adhesion, and detachment of platelets under shear stresses without disturbing shear flow conditions. The results showed that the mechanical and optical design of the system could serve this purpose. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Tsukuba, Grad Sch Med, Med Res Inst, Tsukuba, Ibaraki, Japan.
   Natl Inst Interdisciplinary Res, Bion Design Grp, Tsukuba, Ibaraki 3058562, Japan.
   Nippon Inst Technol, Fac Engn, Dept Mech Engn, Minamisaitama, Saitama 3450826, Japan.
   Univ Tsukuba, Inst Basic Med Sci, Dept Biomed Engn, Tsukuba, Ibaraki 3050006, Japan.
RP Furukawa, K (reprint author), Univ Tsukuba, Grad Sch Med, Med Res Inst, Tsukuba, Ibaraki, Japan.
CR BRONNERFRASER M, 1982, J CELL BIOCHEM, V18, P221
   DESAI N P, 1989, Journal of Biomaterials Science Polymer Edition, V1, P123, DOI 10.1163/156856289X00118
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   FEUERSTEIN IA, 1975, T AM SOC ART INT ORG, V11, P427
   GIORGIO TD, 1988, BIORHEOLOGY, V25, P605
   GRABOWSKI EF, 1972, IND ENG CHEM FUND, V11, P224, DOI 10.1021/i160042a013
   GROTH T, 1992, J BIOMAT SCI-POLYM E, V3, P285, DOI 10.1163/156856292X00385
   Jen CJ, 1996, AM J PHYSIOL-HEART C, V270, pH160
   JEN CJ, 1991, AM J PHYSIOL, V261, pH1457
   KAIBARA M, 1985, BIORHEOLOGY, V22, P197
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KAWAGOISHI N, 1994, ARTIF ORGANS, V18, P588, DOI 10.1111/j.1525-1594.1994.tb03383.x
   KAWAMOTO Y, 1988, BIORHEOLOGY, V25, P289
   LEE JS, 1992, BIOMATERIALS, V13, P1025, DOI 10.1016/0142-9612(92)90154-G
   Lee RI, 1913, AM J MED SCI, V145, P495, DOI 10.1097/00000441-191304000-00004
   OHSHIMA N, 1989, T AM SOC ART INT ORG, V35, P379
   SATO M, 1992, BIORHEOLOGY, V29, P489
   SCHMIDSCHONBEIN H, 1969, J APPL PHYSIOL, V26, P674
   SCHMIDSCHONBEIN H, 1968, J CLIN INVEST, V47, P1447, DOI 10.1172/JCI105836
   SCHNITTLER HJ, 1993, AM J PHYSIOL, V265, pC289
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   ZINGG W, 1982, CAN J SURG, V25, P16
NR 23
TC 14
Z9 14
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1999
VL 46
IS 1
BP 93
EP 102
DI 10.1002/(SICI)1097-4636(199907)46:1<93::AID-JBM11>3.0.CO;2-I
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197LH
UT WOS:000080365900011
PM 10357140
DA 2018-10-19
ER

PT J
AU Griffet, J
   Chevallier, A
   El Hayek, T
   Odin, G
   Pebeyre, B
   Accorsi, E
AF Griffet, J
   Chevallier, A
   El Hayek, T
   Odin, G
   Pebeyre, B
   Accorsi, E
TI Diaphyseal fractures treated by polylactide and hydroxyapatite pins.
   Experimental study in rat
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-GRAFT SUBSTITUTES; GROWING DOGS; RESORBABLE MATERIALS; FIXATION;
   SCREWS; POLY(L-LACTIDE); OSTEOTOMIES; POLYGLYCOLIDE; DEGRADATION;
   IMPLANTS
AB In order to develop a biodegradable interlocking nail for fracture fixation, polylactic acid (PLA) pins and hydoxyapatite pins were implanted in the femoral bone in rats. A distal fracture was performed. The union and the tissue reaction to PLA and hydroxyapatite versus stainless steel rods were studied after 15 days, 1, 2 and 6 months implantation. Metal and PLA pins induced a union. Hydroxyapatite pins (Ossatite(R)) did not prevent callus formation, but did not lead to consolidation in all cases because of weakness of the gelatin matrix binding the apatite particles together. PLA and stainless steel pins induced the same union and a similar tissue reaction during the studied implantation of 6 months. The biocompatility of Ossatite(R) is satisfactory and the osteo-inductive properties of hydroxyapatite was confirmed. With injectable Ossatite(R), we could not obtain rat femoral fracture consolidation. We can confirm good biomaterial tolerance in bone which contrasts with important soft tissue reactions. Use of such material should be carefully limited to filling intra-osseous cavities. (C) 1999 Kluwer Academic Publishers.
C1 Univ Nice, Fac Med, Dept Paediat Orthopaed Surg, Hosp Archet, F-06202 Nice 3, France.
   Univ Nice, Fac Med, Dept Expt Surg Lab, Hosp Archet, F-06202 Nice, France.
   Univ Nice, Fac Med, Dept Pathol Lab, Hosp Archet, F-06202 Nice 3, France.
   Inst Infancy Burlo Garofolo, Trieste, Italy.
RP Griffet, J (reprint author), Univ Nice, Fac Med, Dept Paediat Orthopaed Surg, Hosp Archet, BP 3079, F-06202 Nice 3, France.
RI Griffet, Jacques/M-5958-2014
CR BAUER TW, 1995, ORTHOPEDICS, V18, P885
   BENZ G, 1994, EUR J PEDIATR SURG, V4, P103, DOI 10.1055/s-2008-1066078
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P193
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Burstein FD, 1997, PLAST RECONSTR SURG, V100, P869, DOI 10.1097/00006534-199709001-00007
   DARD M, 1995, CHIR DENT FR, V739, P33
   DARD M, 1997, CELL ENG, V2, P84
   Davies JE, 1996, ANAT REC, V245, P426
   DONIGIAN AM, 1993, J PEDIATR ORTHOPED, V13, P349, DOI 10.1097/01241398-199305000-00014
   GETTER L, 1972, J ORAL SURG, V30, P344
   GROSS UM, 1991, BONE-BIOMATERIAL INTERFACE, P308
   Juutilainen T, 1997, ARCH ORTHOP TRAUM SU, V116, P204, DOI 10.1007/s004020050099
   Kankare J, 1997, ARCH ORTHOP TRAUM SU, V116, P133, DOI 10.1007/s004020050087
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   MAJOLA A, 1992, INT ORTHOP, V16, P101
   MAJOLA A, 1991, CLIN ORTHOP RELAT R, P260
   METAIZEAU JP, 1983, REV CHIR ORTHOP, V69, P495
   MIETTINEN H, 1992, J BIOMAT SCI-POLYM E, V3, P435, DOI 10.1163/156856292X00411
   MIETTINEN H, 1992, J BIOMAT SCI-POLYM E, V4, P135
   MIETTINEN H, 1992, Clinical Materials, V9, P31, DOI 10.1016/0267-6605(92)90007-G
   MIETTINEN H, 1992, J BIOMAT SCI-POLYM E, V3, P443, DOI 10.1163/156856292X00420
   NACHIN P, 1995, REV CHIR ORTHOP S2, V81, P200
   Overgaard S, 1997, J BONE JOINT SURG BR, V79B, P654, DOI 10.1302/0301-620X.79B4.7670
   PAIVARINTA U, 1993, ARCH ORTHOP TRAUM SU, V112, P71, DOI 10.1007/BF00420258
   Partio EK, 1997, ARCH ORTHOP TRAUM SU, V116, P213, DOI 10.1007/BF00393712
   PAVAN A, 1979, J BIOMED MATER RES, V13, P477, DOI 10.1002/jbm.820130312
   PIHLAJAMAKI H, 1994, CLIN ORTHOP RELAT R, P277
   RATKAKRUGER P, 1997, J PARODONTOL, V16, P289
   SARTORIS DJ, 1986, RADIOLOGY, V159, P133, DOI 10.1148/radiology.159.1.3513246
   SEDEL L, 1978, REV CHIR ORTHOP, V64, P92
   SHARROCK P, 1995, INNOV TECH BIOL MED, V16, P160
   SHARROCK P, Patent No. 9108107
   SHARROCK P, 1994, BIOCERAMICS, V6, P333
   TUNC DC, 1986, P 12 ANN M SOC BIOM, P168
   TUNC DC, 1995, J BIOMAT SCI-POLYM E, V7, P370
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   VIHTONEN K, 1987, CLIN ORTHOP RELAT R, P297
   VILJANEN J, 1995, BIOMATERIALS, V16, P1353, DOI 10.1016/0142-9612(95)91052-Z
   Viljanen J, 1997, ANN CHIR GYNAECOL FE, V86, P66
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Williams D.F., 1979, ASTM SPECIAL TECHNIC, P61
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
NR 46
TC 3
Z9 3
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1999
VL 10
IS 7
BP 411
EP 418
DI 10.1023/A:1008975014015
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 217WE
UT WOS:000081521300005
PM 15348126
DA 2018-10-19
ER

PT J
AU Hanarp, P
   Sutherland, D
   Gold, J
   Kasemo, B
AF Hanarp, P
   Sutherland, D
   Gold, J
   Kasemo, B
TI Nanostructured model biomaterial surfaces prepared by colloidal
   lithography
SO NANOSTRUCTURED MATERIALS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Nanostructured Materials (NANO 98)
CY JUN 14-19, 1998
CL STOCKHOLM, SWEDEN
SP Royal Inst Technol, Sweden, Swedish Consortium Clusters & Ultrafine Particles, Sweden, Royal Inst Technol, Brinell Ctr, Sweden, European Consortium Nanophase Mat, Switzerland, Acta Met Inc, USA, Alps Elect Co, Japan, Canon Ctr City, Sweden, Carl Tryggers Stiftelse, Sweden, Elsevier Sci Inc, Switzerland, Finnair, Finland, Off Naval Res ONR, USA, European Res Off US Army, USARDSD-UK, Swedish Nat Sci Res Council, NFR, Sweden, Swedish Res Council Engn Sci, TFR, Sweden, Swedish Nat Board Ind & Tech Dev (NUTEK), Swedish Royal Acad Sci, Nobel Comm Phys, Sweden, Swedish Royal Acad Sci, Nobel comm Chem, Sweden
ID PARTICLES; ADSORPTION
AB Adsorption of 110 nm negatively charged polystyrene particles on positively charged titanium surfaces was studied for the purpose of making surfaces with controlled nanotopography. Surfaces with 9-26 % saturation coverages of evenly spaced particles were produced by varying the salt concentration in the particle solution (0.01-1 mM NaCl). This is a quick and relatively simple method to make uniform nanostructures over large surface areas (similar to cm(2)). The produced surfaces are used for in vitro cell studies of how sub-micrometre topography influences cell adhesion and function. (C) 1999 Acta Metallurgica Inc.
C1 Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
RP Hanarp, P (reprint author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
RI Sutherland, Duncan/E-4385-2010
OI Sutherland, Duncan/0000-0002-5045-9915
CR ADAMCZYK Z, 1990, J COLLOID INTERF SCI, V140, P123, DOI 10.1016/0021-9797(90)90329-M
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Johnson CA, 1996, J COLLOID INTERF SCI, V179, P587, DOI 10.1006/jcis.1996.0253
   Krozer A, 1995, J COLLOID INTERF SCI, V176, P479, DOI 10.1006/jcis.1995.9943
NR 4
TC 58
Z9 58
U1 1
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-9773
J9 NANOSTRUCT MATER
JI Nanostruct. Mater.
PD JUL
PY 1999
VL 12
IS 1-4
SI SI
BP 429
EP 432
DI 10.1016/S0965-9773(99)00151-8
PN A
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 224RM
UT WOS:000081912100098
DA 2018-10-19
ER

PT J
AU Prive, GG
   Anderson, DH
   Wesson, L
   Cascio, D
   Eisenberg, D
AF Prive, GG
   Anderson, DH
   Wesson, L
   Cascio, D
   Eisenberg, D
TI Packed protein bilayers in the 0.90 angstrom resolution structure of a
   designed alpha helical bundle
SO PROTEIN SCIENCE
LA English
DT Article
DE atomic resolution; biomaterial; crystal engineering; peptide design;
   peptide physics
ID CRYSTAL-STRUCTURE DETERMINATION; EUPLOTES-RAIKOVI; PHEROMONE ER-1;
   PEPTIDE; REFINEMENT
AB A 12-residue peptide designed to form an ct-helix and self-associate into an antiparallel 4-alpha-helical bundle yields a 0.9 Angstrom crystal structure revealing unanticipated features. The structure was determined by direct phasing with the "Shake-and-Bake" program, and contains four crystallographically distinct 12-mer peptide molecules plus solvent for a total of 479 atoms. The crystal is formed from nearly ideal alpha-helices hydrogen bonded head-to-tail into columns, which in turn pack side-by-side into sheets spanning the width of the crystal. Within each sheet, the cr-helices run antiparallel and are closely spaced (9-10 Angstrom center-to-center). The sheets are more loosely packed against each other (13-14 Angstrom between helix centers). Each sheet is amphiphilic: apolar leucine side chains project from one face, charged lysine and glutamate side chains from the other face. The sheets are stacked with two polar faces opposing and two apolar faces opposing. The result is a periodic biomaterial composed of packed protein bilayers, with alternating polar and apolar interfaces. All of the 30 water molecules in the unit cell lie in the polar interface or between the stacked termini of helices. A section through the sheet reveals that the helices packed at the apolar interface resemble the four-ct-helical bundle of the design, but the helices overhang parts of the adjacent bundles, and the helix crossing angles are less steep than intended (7-11 degrees rather than 18 degrees).
C1 Univ Calif Los Angeles, DOE, Inst Mol Biol, Lab Struct Biol & Mol Med, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.
RP Eisenberg, D (reprint author), Univ Calif Los Angeles, DOE, Inst Mol Biol, Lab Struct Biol & Mol Med, Box 951570, Los Angeles, CA 90095 USA.
CR Anderson DH, 1996, ACTA CRYSTALLOGR D, V52, P469, DOI 10.1107/S0907444995014235
   Betz SF, 1996, FOLD DES, V1, P57, DOI 10.1016/S1359-0278(96)00012-0
   Blessing RH, 1996, ACTA CRYSTALLOGR D, V52, P257, DOI 10.1107/S0907444995014053
   Blessing RH, 1998, NATO ADV SCI I C-MAT, V507, P47
   Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6
   *CCP4, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   DICKERSON RE, 1990, STRUCTURE METHODS, V3
   EISENBERG D, 1986, Proteins Structure Function and Genetics, V1, P16, DOI 10.1002/prot.340010105
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   HILL CP, 1990, SCIENCE, V249, P543, DOI 10.1126/science.2382133
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   JONES TA, 1993, O COMPUTR GRAPHICS P
   KARLE IL, 1990, P NATL ACAD SCI USA, V87, P7921, DOI 10.1073/pnas.87.20.7921
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MCREE DE, 1993, PRACTICAL PROTEIN CR
   Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9
   MILLER R, 1993, SCIENCE, V259, P1430, DOI 10.1126/science.8451639
   MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191
   Ogihara NL, 1997, PROTEIN SCI, V6, P80
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Patterson WR, 1999, PROTEIN SCI, V8, P1410, DOI 10.1110/ps.8.7.1410
   SCHAFMEISTER CE, 1993, SCIENCE, V262, P734, DOI 10.1126/science.8235592
   Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6
   SMITH JL, 1986, BIOCHEMISTRY-US, V25, P5018, DOI 10.1021/bi00366a008
   Taylor KS, 1996, PROTEIN SCI, V5, P414
   WEISS MS, 1995, P NATL ACAD SCI USA, V92, P10172, DOI 10.1073/pnas.92.22.10172
   WEN DY, 1992, J BIOL CHEM, V267, P14102
NR 29
TC 29
Z9 29
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD JUL
PY 1999
VL 8
IS 7
BP 1400
EP 1409
DI 10.1110/ps.8.7.1400
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 213KL
UT WOS:000081271700003
PM 10422828
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Jallot, E
   Irigaray, JL
   Weber, G
   Frayssinet, P
AF Jallot, E
   Irigaray, JL
   Weber, G
   Frayssinet, P
TI In vivo characterization of the interface between cortical bone and
   biphasic calcium phosphate by the PIXE method
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE interface; biphasic calcium phosphate; bone; PIXE; bioceramic
ID ALPHA-PARAMETER METHOD; THICK TARGETS TTPIXE; IN-VIVO; BIOMATERIALS;
   DEGRADATION; SUBSTITUTE
AB The aim of this study is to evaluate the resorption of a calcium phosphate ceramic composed of 75% hydroxyapatite and 25% beta-tricalcium phosphate (HTCP) used as a biomaterial, The animal implantation has been made in the cortical femur of sheep. Delays of 2, 4, 8, 12, 16, 20, 28, 36 and 48 weeks between graft and analysis were used. The samples were a section of cortical bone containing the implant, The mechanism of bioceramic degradation was studied by the particle-induced x-ray emission (PIXE) method, The bone/implant interface was analysed and Ca, P, Zn, Fe and Sr were measured for the nine delay periods. We found a discontinuity of elemental concentration at the interface. Thus, we observed evolution of the concentration of each element in HTCP according to time after implantation. Then we determined the kinetics of resorption. Copyright (C) 1999 John Wiley & Sons, Ltd.
C1 INSERM, U314, Lab Microscopie Elect, F-51685 Reims 2, France.
   Lab PHys Corpusculaire Clermont Ferrand, IN2P3, CNRS, F-63177 Clermont Ferrand, France.
   Inst Phys Nucl Expt, B-4000 Liege, Belgium.
   Soc Ind Bioland, F-31100 Toulouse, France.
RP Jallot, E (reprint author), INSERM, U314, Lab Microscopie Elect, 21 Rue Clement Ader, F-51685 Reims 2, France.
EM edouard.jallot@univ-reims.fr
CR Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DELBROUCKHABARU JM, 1993, NUCL INSTRUM METH B, V73, P71, DOI 10.1016/0168-583X(93)96055-H
   FINNEGAN M, 1989, CRIT REV BIOCOMPAT, V5, P1
   FRAYSSINET P, 1993, BIOTECH HISTOCHEM, V68, P333, DOI 10.3109/10520299309105639
   Fujishiro Y, 1997, J MATER SCI-MATER M, V8, P649, DOI 10.1023/A:1018527621356
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Jallot E, 1998, NUCL INSTRUM METH B, V142, P156, DOI 10.1016/S0168-583X(98)00269-9
   Mengucci P, 1998, BIOMATERIALS, V19, P1447, DOI 10.1016/S0142-9612(98)00056-8
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   SMIH DC, 1991, BONE BIOMATERIAL INT, V18, P3
   Weber G, 1996, NUCL INSTRUM METH B, V109, P186, DOI 10.1016/0168-583X(95)00903-5
   WEBER G, 1994, NUCL INSTRUM METH B, V89, P200, DOI 10.1016/0168-583X(94)95172-1
NR 15
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUL
PY 1999
VL 27
IS 7
BP 648
EP 652
DI 10.1002/(SICI)1096-9918(199907)27:7<648::AID-SIA555>3.0.CO;2-Q
PG 5
WC Chemistry, Physical
SC Chemistry
GA 216BK
UT WOS:000081420500006
DA 2018-10-19
ER

PT J
AU Hong, J
   Andersson, J
   Ekdahl, KN
   Elgue, G
   Axen, N
   Larsson, R
   Nilsson, B
AF Hong, J
   Andersson, J
   Ekdahl, KN
   Elgue, G
   Axen, N
   Larsson, R
   Nilsson, B
TI Titanium is a highly thrombogenic biomaterial: Possible implications for
   osteogenesis
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
ID COMPLEMENT ACTIVATION; WHOLE-BLOOD; ARTIFICIAL SURFACES; PROTEIN
   ADSORPTION; GROWTH-FACTOR; IN-VITRO; PLATELET; HEMOCOMPATIBILITY;
   IMPLANTS; BONE
AB Titanium has superior osteointegrating properties compared to other biomaterials. The mechanism for this is unknown. During the initial phase of bone implantation the biomaterial comes into direct contact with whole blood. In this study we use a newly developed in vitro chamber model to compare different commonly used biomaterials in contact with whole blood. These materials were selected with respect to their different osteointegrating properties in order to correlate these properties with the response to whole blood. In the presence of 3 IU/ml of heparin only titanium induced macroscopic clotting. This was reflected by the generation of thrombin-antithrombin which was much increased in blood in contact with titanium compared with steel and PVC. The coagulation activation caused by titanium was triggered by the intrinsic pathway because the generation of FXIIa-AT/C1 esterase inhibitor paralleled that of thrombin-antithrombin, and both thrombin-antithrombin complex and FXIIa-AT/C1 esterase inhibitor generation were abrogated by corn trypsin inhibitor, which is a specific inhibitor of FXIIa. The binding of platelets was increased on the titanium surface compared to the other biomaterial surfaces and the state of platelet activation was much more pronounced as reflected by the levels of beta-thromboglobulin and PDGF. This study indicates that titanium is unsuitable as a biomaterial in devices which are in direct contact with blood for a prolonged period. Furthermore, PDGF and other alpha-granule proteins e. g. TGF-beta, are known to be potent promoters of osteogenesis which suggests that the pronounced thrombogenic properties of titanium might contribute to the good osteointegrating properties.
C1 Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
   Uppsala Univ, Dept Mat Sci, Angstrom Lab, Uppsala, Sweden.
   Univ Kalmar, Dept Nat Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Andersson, Joakim/A-3017-2009;
   Nilsson, Bo/B-3102-2012
OI Andersson, Joakim/0000-0003-2991-1927; Nilsson, Bo/0000-0003-0057-2730
CR Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   ANTONIADES HN, 1991, BAILLIERE CLIN ENDOC, V5, P595, DOI 10.1016/S0950-351X(10)80005-9
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   DION I, 1992, INT J ARTIF ORGANS, V15, P617
   DION I, 1993, BIOMATERIALS, V14, P169, DOI 10.1016/0142-9612(93)90019-X
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   EKVALL P, 1998, TRIBOLOGIA, V17, P20
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Kaplan K L, 1978, Adv Exp Med Biol, V102, P105
   Larsson M, 1995, SURF COAT TECH, V76, P202
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   LARSSON R, 1977, THROMB RES, V11, P51730
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Monties JR, 1997, ARTIF ORGANS, V21, P730, DOI 10.1111/j.1525-1594.1997.tb03731.x
   Nilsson B, 1998, BLOOD, V92, P1661
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Sherris DA, 1998, LARYNGOSCOPE, V108, P368, DOI 10.1097/00005537-199803000-00011
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SPYCHER MO, 1995, INFUSIONSTHERAPIE, V22, P36
   Sun Y, 1996, Chin Med Sci J, V11, P209
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   WROBLEWSKI J, 1992, CELL BIOL INT REP, V16, P133, DOI 10.1016/S0309-1651(06)80107-4
   Yang YQ, 1996, J HEART VALVE DIS, V5, P532
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
NR 42
TC 128
Z9 131
U1 0
U2 6
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0340-6245
EI 2567-689X
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUL
PY 1999
VL 82
IS 1
BP 58
EP 64
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 220XR
UT WOS:000081694200013
PM 10456455
DA 2018-10-19
ER

PT J
AU Konig, DP
   Perdreau-Remington, F
   Rutt, J
   Hilgers, RD
   Schierholz, JM
AF Konig, DP
   Perdreau-Remington, F
   Rutt, J
   Hilgers, RD
   Schierholz, JM
TI Adherence to and accumulation of S. epidermidis on different
   biomaterials due to extracellular slime production - In vitro comparison
   of a slime-producing strain (Rp 62 A) and its isogenic slime negative
   mutant (M7)
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; AUREUS; COLONIZATION; ADHESION; INVITRO;
   INVIVO
AB In an in vitro study, the bacterial adherence of a slime-producing strain (RP 62 A) was compared with its isogenic slime-negative mutant (M7). Standardized biomaterial discs were incubated under growth conditions in tryptic soy broth containing either strain RP 62 A or M7. After 24 h of incubation, the attached bacteria were removed by sonication and the colony-forming units were counted after plating of serial dilutions. We observed a significantly increased adherence and accumulation of the slime-producing strain (RP 62 A). In contrast to the slime negative mutant (M7) (p=0.0001). The highest colony counts were found for the slime-producing strain on polyethylene and polymethylmethacrylate. The slime-negative mutant lacked the ability of accumulation. Our in-vitro results show the relevance of slime production by S. epidermidis for in-vitro colonisation of biomaterials, with a preference for polyethylene and polymethylmethacrylate.
C1 Univ Cologne, Dept Orthopaed Surg, D-50924 Cologne, Germany.
   Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA 94110 USA.
   Univ Cologne, Dept Med Stat, D-50924 Cologne, Germany.
   Univ Cologne, Inst Med Mikrobiol & Hyg, D-5000 Cologne, Germany.
RP Konig, DP (reprint author), Univ Cologne, Dept Orthopaed Surg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.
RI Hilgers, Ralf-Dieter/C-7090-2013
OI Hilgers, Ralf-Dieter/0000-0002-5945-1119
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Brause BD, 1989, INFECT ASS INDWELLIN, P111
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   DELMI M, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P349
   GALLIANI S, 1994, J LAB CLIN MED, V123, P685
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   Gristina A. G., 1987, ZENTRALBL BAKTERIO S, V16, P143
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Konig DP, 1998, ACTA ORTHOP SCAND, V69, P523, DOI 10.3109/17453679808997791
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   PETERS G, 1988, J ANTIMICROB CHEMOTH, V21, P139, DOI 10.1093/jac/21.suppl_C.139
   PETERS G, 1991, ZBL BAKT S, V21, P329
   PETERS G, 1986, CHEMOTHERAPY, V5, P1341
   PETERS G, 1987, PATHOGENICITY CLIN S, P15
   RUTT J, 1990, ORTHOP PRAX, V9, P587
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
NR 21
TC 3
Z9 4
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD JUL
PY 1999
VL 289
IS 3
BP 355
EP 364
PG 10
WC Microbiology; Virology
SC Microbiology; Virology
GA 224TR
UT WOS:000081915700010
PM 10467666
DA 2018-10-19
ER

PT J
AU Sun, JS
   Lin, FH
   Hung, TY
   Tsuang, YH
   Chang, WHS
   Liu, HC
AF Sun, JS
   Lin, FH
   Hung, TY
   Tsuang, YH
   Chang, WHS
   Liu, HC
TI The influence of hydroxyapatite particles on osteoclast cell activities
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; osteoclasts; cytokines; prostaglandin; lactate
   dehydrogenase
ID CEMENTLESS HIP-ARTHROPLASTY; BONE-RESORPTION; FEMORAL COMPONENTS;
   INVITRO; IMPLANTS; GROWTH; BIOCOMPATIBILITY; OSTEOBLASTS; OSTEOLYSIS;
   CULTURES
AB Aseptic loosening after total joint arthroplasty is a major problem in orthopedic surgery. Small particles from material wear have been reported as the main cause of implant failure. For this reason, investigation into possible wear particles from the materials used in the implant may lead to longevity after arthroplasty. Hydroxyapatite (HA) has been extensively investigated and reported as an excellent biomaterial with excellent biocompatibility. In this study, we used an in vitro osteoblast/osteoclast model to test the biocompatibility of various-sized HA particles. Primary osteoclasts/osteoblasts were co-cultured with different-sized HA particles (0.5-3.0 mu m, 37-53 mu m, 177-205 mu m, and 420-841 mu m) for 3 h, 1 day, 3 days, and 7 days. Cellular responses to the HA particles were evaluated by changes in cell counts and the secretion of transforming growth factor (TGF-beta 1), alkaline phosphatase (ALP), tumor necrosis factor (TNF-alpha), prostaglandin (PGE,), and lactate dehydrogenase (LDH) in the supernatant of the culture media. The results showed that osteoblasts/osteoclasts co-cultured with HA particles smaller than 53 mu m undergo the most significant changes. Cellular counts significantly decreased, and the changes were more obvious in the osteoblast population. There also was a significant decrease in TGF-beta 1 concentration and a significant increase in PGE, and LDH concentration, but there were no changes in the TNF-alpha or ALP titer. It can be concluded that larger HA particles may be quite compatible with bone cells while smaller-sized HA particles can both activate the osteoclasts and decrease the cell population of the osteoblasts. Justification for the additional expense incurred with the use of hydroxyapatite in primary total hip arthroplasty should be further evaluated. (C) 1999 John Wiley & Sons, Inc.
C1 Natl Taiwan Univ Hosp, Coll Med, Dept Orthoped Surg, Taipei, Taiwan.
   Natl Taiwan Univ, Coll Med, Ctr Biomed Engn, Taipei, Taiwan.
   Chung Yuan Christian Univ, Inst Biomed Engn, Tao Yuan, Taiwan.
   China Med Coll Hosp, Dept Orthoped Surg, Taichung, Taiwan.
RP Sun, JS (reprint author), Natl Taiwan Univ Hosp, Coll Med, Dept Orthoped Surg, 7 Chung Shan S Rd, Taipei, Taiwan.
OI SUN, JUI-SHENG/0000-0001-5142-8777
CR BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Bloebaum RD, 1997, CLIN ORTHOP RELAT R, P109
   BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261
   CHAMBERS TJ, 1979, J PATHOL, V127, P55, DOI 10.1002/path.1711270202
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Ciccotti M G, 1991, Semin Arthroplasty, V2, P280
   Collier J P, 1993, J Arthroplasty, V8, P389, DOI 10.1016/S0883-5403(06)80037-9
   COLLINS DA, 1992, J BONE MINER RES, V7, P555
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DESIMONE DP, 1993, J BONE MINER RES, V8, P625
   EVANS JJ, 1991, CLIN MATER, V7, P241
   FRIEDMAN RJ, 1991, T ORTHOP RES SOC, V16, P538
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GOODMAN S, 1992, ACTA ORTHOP SCAND, V63, P358, DOI 10.3109/17453679209154804
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   KAHN AJ, 1978, SCIENCE, V199, P988, DOI 10.1126/science.622581
   KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436
   KROON PO, 1992, J BONE JOINT SURG BR, V74, P518
   KURIHARA N, 1989, BLOOD, V74, P1295
   LEARMONTH ID, 1995, J ARTHROPLASTY, V10, P257, DOI 10.1016/S0883-5403(05)80171-8
   Learmonth ID, 1996, ACTA ORTHOP SCAND, V67, P245, DOI 10.3109/17453679608994681
   Learmonth ID, 1997, J ARTHROPLASTY, V12, P305, DOI 10.1016/S0883-5403(97)90027-9
   LERNER UH, 1987, CALCIFIED TISSUE INT, V40, P323, DOI 10.1007/BF02556694
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   MACDONALD BR, 1987, ENDOCRINOLOGY, V120, P2326, DOI 10.1210/endo-120-6-2326
   MAGUIRE JK, 1987, CLIN ORTHOP RELAT R, P213
   Massari Leo, 1996, Bulletin Hospital for Joint Diseases, V54, P206
   Munting E, 1996, INT ORTHOP, V20, P1, DOI 10.1007/PL00006691
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   Rothman RH, 1996, J BONE JOINT SURG AM, V78A, P319, DOI 10.2106/00004623-199603000-00001
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   SANTORO MG, 1977, P SOC EXP BIOL MED, V156, P373
   SCHELLING SH, 1980, LAB INVEST, V42, P290
   Scott DF, 1996, J ARTHROPLASTY, V11, P429, DOI 10.1016/S0883-5403(96)80033-7
   SGONC R, 1994, TRENDS GENET, V10, P41, DOI 10.1016/0168-9525(94)90140-6
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600
   TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179
   TEITELBAUM SL, 1979, CALCIFIED TISSUE INT, V27, P255, DOI 10.1007/BF02441194
   VENDANTAM R, 1996, J ARTHROPLASTY, V11, P534
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P108
NR 48
TC 58
Z9 61
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 1999
VL 45
IS 4
BP 311
EP 321
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 189JD
UT WOS:000079900600005
PM 10321703
DA 2018-10-19
ER

PT J
AU Kubo, T
   Sawada, K
   Hirakawa, K
   Shimizu, C
   Takamatsu, T
   Hirasawa, Y
AF Kubo, T
   Sawada, K
   Hirakawa, K
   Shimizu, C
   Takamatsu, T
   Hirasawa, Y
TI Histiocyte reaction in rabbit femurs to UHMWPE, metal, and ceramic
   particles in different sizes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; particle; size; surface area; histological reaction
ID BONE-CEMENT INTERFACE; TOTAL HIP ARTHROPLASTIES; SYNOVIAL-LIKE MEMBRANE;
   WEAR DEBRIS; REPLACEMENT; RESORPTION; PROSTHESES; KNEE
AB To assess the histologic reaction caused by biomaterial particles in different sizes around the bone-implant interface, we examined ultra-high molecular weight polyethylene (UHMWPE, average diameter of 11 mu m), UHMWPE (99 mu m), cobalt-chromium alloy (Co-Cr, 3.9 mu m), stainless steel (SUS316L, 3.9 mu m), alumina ceramics (3.9 mu m), titanium alloy (Ti, 3.5 mu m), Co-Cr (0.03 mu m), and Ti (0.03 mu m) After the longitudinal groove on a polymethylmethacrylate plug was filled with one type of the particles, the plug was inserted into the medullar canal of the distal end of rabbit femurs, and tissue block was resected 4 and 12 weeks after the insertion. Histiocytes were markedly accumulated around the particles of UHMWPE (11 mu m), Co-Cr (3.9 mu m), SUS316L (3.9 mu m), Co-Cr (0.03 mu m), and titanium alloy (0.03 mu m). Around the UHMWPE particles (99 mu m), a slight histiocytic reaction and bone formation were observed. Particles of alumina ceramics (3.9 mu m) and titanium alloy (3.5 mu m) which were in phagocytosable sizes also had few histiocytic reactions. Statistically, the material difference was more strongly related to the histiocyte reaction than to the particle size and calculated total surface area of particles. Our findings demonstrate that particles of different biomaterials and in different sizes induce different foreign-body histological reactions. (C) 1999 John Wiley & Sons, Inc.
C1 Kyoto Prefectural Univ Med, Dept Orthopaed Surg, Kamigyo Ku, Kyoto 6020841, Japan.
   Yokohama City Univ, Sch Med, Dept Orthopaed Surg, Yokohama, Kanagawa 232, Japan.
   Kyoto Prefectural Univ Med, Dept Pathol & Cell Regulat, Kyoto, Japan.
RP Kubo, T (reprint author), Kyoto Prefectural Univ Med, Dept Orthopaed Surg, Kamigyo Ku, Kyoto 6020841, Japan.
CR BAUER TW, 1995, ORTHOPEDICS, V18, P791
   BROWN IW, 1985, J BONE JOINT SURG BR, V67, P218
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   Hirakawa K, 1996, J BIOMED MATER RES, V31, P257, DOI 10.1002/(SICI)1097-4636(199606)31:2<257::AID-JBM13>3.0.CO;2-I
   Hirakawa K, 1996, J BONE JOINT SURG AM, V78A, P1235, DOI 10.2106/00004623-199608000-00014
   HIRAKAWA K, 1996, SEMIN ARTHROPLASTY, V7, P285
   Howie D W, 1990, J Arthroplasty, V5, P337, DOI 10.1016/S0883-5403(08)80093-9
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, V218, P123
   JONES LC, 1987, CLIN ORTHOP RELAT R, V225, P192
   KOZZIN SC, 1986, J ARTHROPLASTY, V1, P249
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   Lerouge S, 1996, J BIOMED MATER RES, V32, P627, DOI 10.1002/(SICI)1097-4636(199612)32:4<627::AID-JBM16>3.0.CO;2-A
   Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621
   MAGUIRE JK, 1987, CLIN ORTHOP RELAT R, V216, P213
   MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P1627, DOI 10.2106/00004623-199311000-00007
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PAZZAGLIA UE, 1985, ARCH ORTHOP TRAUM SU, V104, P164, DOI 10.1007/BF00454694
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   SCHMALZRIED TP, 1994, J APPL BIOMATER, V5, P185, DOI 10.1002/jab.770050302
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J ARTHROPLASTY, V8, P179
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   TANZER M, 1992, J BONE JOINT SURG AM, V74A, P404, DOI 10.2106/00004623-199274030-00012
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WIRGANOWICZ PZ, 1997, CLIN ORTHOP RELAT R, V338, P100
NR 38
TC 41
Z9 43
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 1999
VL 45
IS 4
BP 363
EP 369
DI 10.1002/(SICI)1097-4636(19990615)45:4<363::AID-JBM11>3.0.CO;2-3
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 189JD
UT WOS:000079900600011
PM 10321709
DA 2018-10-19
ER

PT J
AU Lopes, MA
   Monteiro, FJ
   Santos, JD
   Serro, AP
   Saramago, B
AF Lopes, MA
   Monteiro, FJ
   Santos, JD
   Serro, AP
   Saramago, B
TI Hydrophobicity, surface tension, and zeta potential measurements of
   glass-reinforced hydroxyapatite composites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite-glass composites; tricalcium phosphate; hydrophobicity;
   surface tension; zeta potential
ID DROP SHAPE-ANALYSIS; TIME-DEPENDENT VARIATION; PROTEIN; VITRONECTIN;
   ADHESION; TISSUE; CELLS
AB Wettability and zeta potential studies were performed to characterize the hydrophobicity, surface tension, and surface charge of P2O5-glass-reinforced hydroxyapatite composites. Quantitative phase analysis was performed by the Rietveld method using GSAS software applied to X-ray diffractograms. Surface charge was assessed by zeta potential measurements. Protein adsorption studies were performed using vitronectin. Contact angles and surface tensions variation with time were determined by the sessile and pendent drop techniques, respectively, using ADSA-P software. The highest (-18.1 mV) and lowest (-28.7 mV) values of zeta potential were found for hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), respectively, with composite materials presenting values in between. All studied bioceramic materials showed similar solid surface tension. For HA and beta-TCP, solid surface tensions of 46.7 and 45.3 mJ/m(2), respectively, were obtained, while composites presented intermediate surface tension values. The dispersive component of surface tension was the predominant one for all materials studied. Adhesion work values between the vitronectin solution and HA and beta-TCP were found to be 79.8 and 88.0 mJ/m(2), respectively, while the 4.0 wt % glass composites showed slightly lower values than the 2.5 wt % ones. The presence of P-TCP influenced surface charge, hydrophobicity, and protein adsorption of the glass-reinforced HA composites, and therefore indirectly affected cell-biomaterial interactions. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Porto, Inst Biomed Engn, INEB, P-4150 Oporto, Portugal.
   Univ Porto, FEUP, Dept Mat & Met Engn, P-4099 Oporto, Portugal.
   Inst Super Tecn, Ctr Quim Estrutural, P-1096 Lisbon, Portugal.
RP Santos, JD (reprint author), Univ Porto, Inst Biomed Engn, INEB, Rua Campo Alegre 823, P-4150 Oporto, Portugal.
RI Serro, Ana/H-7797-2012; Lopes, Cristina/A-4241-2010; Lopes, Maria
   A./P-4442-2014; Saramago, Benilde/A-4882-2012
OI Serro, Ana/0000-0002-6179-9296; Lopes, Maria A./0000-0003-4105-8148;
   Saramago, Benilde/0000-0002-8968-4781; Monteiro,
   Fernando/0000-0002-1361-4605; Santos, Jose Domingos/0000-0002-6871-9850
CR ADAMSON W, 1990, PHYSICAL CHEM SURFAC, P4
   AGATHOPOULOS S, 1995, 4 EUROCERAMICS, V8, P319
   AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   AOKI H, 1991, SCI MED APPL HYDROXY, P1
   CHANG SK, 1997, MED PROGR TECHNOL, V5, P57
   CHENG P, 1992, COLLOID SURFACE, V62, P297, DOI 10.1016/0166-6622(92)80055-7
   CHENG P, 1990, COLLOID SURFACE, V43, P151, DOI 10.1016/0166-6622(90)80286-D
   Correia NT, 1997, J COLLOID INTERF SCI, V189, P361, DOI 10.1006/jcis.1997.4857
   Davies J., 1988, SURFACE CHARACTERIZA, P219
   DIMITROV AS, 1991, J COLLOID INTERF SCI, V145, P279, DOI 10.1016/0021-9797(91)90120-W
   DUCHEYNE P, 1992, J BIOMED MATER RES, V26, P147, DOI 10.1002/jbm.820260203
   FORMIGLI L, 1992, ANN NY ACAD SCI, V673, P120, DOI 10.1111/j.1749-6632.1992.tb27443.x
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   HAY H, 1991, CELL BIOL EXTRACELLU, P127
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HORBERT TA, 1994, ACS SYM SER, V602, P92
   KOWALCHUK RM, 1993, J BIOMED MATER RES, V27, P783, DOI 10.1002/jbm.820270611
   LAPIN M, 1997, J BIOMED MATER RES, V36, P99
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   MANSON SR, 1980, J LAB CLIN MED, V95, P289
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RODAN GA, 1992, BONE, V12, P53
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SARAMAGO B, 1996, A ADHES SCI TECHNOL, V10, P1111
   SCHRADER ME, 1995, LANGMUIR, V11, P3585, DOI 10.1021/la00009a049
   Seiffert D, 1996, J HISTOCHEM CYTOCHEM, V44, P275, DOI 10.1177/44.3.8648088
   SUSUKI T, 1997, J BIOMED MATER RES, V34, P507
   Suzuki T, 1996, J FERMENT BIOENG, V81, P226, DOI 10.1016/0922-338X(96)82213-6
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VOGLER EA, 1993, WETTABILITY, V49, P183
   VOIGT A, 1991, COLLOID SURFACE, V58, P315, DOI 10.1016/0166-6622(91)80231-C
   WILLIAMS DF, 1998, FUNDAMENTAL ASPECTS, V2, P113
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
   YAMAMURO Y, 1990, CRC HDB BIOACTIVE CE
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Young T., 1855, MISCELLANEOUS WORKS, V1, P418
NR 40
TC 85
Z9 87
U1 2
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 1999
VL 45
IS 4
BP 370
EP 375
DI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 189JD
UT WOS:000079900600012
PM 10321710
DA 2018-10-19
ER

PT J
AU Dalton, BA
   Evans, MDM
   McFarland, GA
   Steele, JG
AF Dalton, BA
   Evans, MDM
   McFarland, GA
   Steele, JG
TI Modulation of corneal epithelial stratification by polymer surface
   topography
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE stratification; ECM deposition; corneal epithelium; surface topography
ID BASEMENT-MEMBRANE; CELL OUTGROWTH; ORGAN-CULTURE; DIFFERENTIATION;
   MIGRATION; INVITRO; SUBSTRATUM; IMPLANTS; BEHAVIOR; GROWTH
AB The topography and porosity of a polymer may affect the epithelialization of a corneal implant. We used: an in vitro model to examine the effect of polymer surface topography on corneal epithelial tissue stratification and the deposition of proteins associated with epithelial adhesion. A range of topographies was provided by polycarbonate membranes with nominal pore diameters of 0.1, 0.4, 0.8, 1.0, 2.0, or 3.0 mu m and a nonporous surface. Stratification of epithelial tissue outgrowth on-these surfaces was evaluated using light and electron microscopy. Deposition of proteins associated with basement membrane and adhesion complex formation at the tissue-polymer interface was assessed using immunohistochemistry. Surfaces with pores in the 0.1-0.8-mu m-diameter range supported superior stratification and protein deposition compared with those containing pores of greater than or equal to 1.0 mu m Cytoplasmic processes penetrated single pores 2.0 and 3.0 mu m in diameter and fused pores 1.0 mu m in diameter. Tissue on the nonporous surface had a lower level of stratification compared with surfaces with pores 0.1-0.8 mu m in diameter. These results point to the significance of surface topography in biomaterial applications that require persistent epithelialization. (C) 1999 John Wiley & Sons, Inc.
C1 CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, N Ryde, NSW 1670, Australia.
RP Dalton, BA (reprint author), CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, Riverside Corp Pk,POB 184, N Ryde, NSW 1670, Australia.
RI Evans, Margaret/B-3261-2011
OI Evans, Margaret/0000-0003-3078-1576
CR BUTOR C, 1992, EXP CELL RES, V203, P115, DOI 10.1016/0014-4827(92)90046-B
   CAMERON JD, 1989, INVEST OPHTH VIS SCI, V30, P2407
   CAMERON JD, 1988, CURR EYE RES, V7, P293, DOI 10.3109/02713688809047035
   CHEHROUDI B, 1995, J BIOMED MATER RES, V29, P371, DOI 10.1002/jbm.820290312
   CHLAPOWSKI F, 1976, DEV BIOL, V51, P49
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   COOK JR, 1989, IN VITRO CELL DEV B, V25, P914
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   DUA HS, 1994, BRIT J OPHTHALMOL, V78, P401, DOI 10.1136/bjo.78.5.401
   DUNN GA, 1991, BIOESSAYS, V13, P541, DOI 10.1002/bies.950131008
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Fitton H. J., 1998, J BIOMED MATER RES, V42, P245
   HOGAN MJ, 1971, HISTOLOGY HUMAN EYE, P55
   Kim KJ, 1997, J MEMBRANE SCI, V123, P303, DOI 10.1016/S0376-7388(96)00232-3
   KONIG A, 1994, LAB INVEST, V70, P203
   KRUSE FE, 1992, J CELL PHYSIOL, V151, P347, DOI 10.1002/jcp.1041510216
   LANE SS, 1991, INT OPHTHALMOL CLIN, V31, P37, DOI 10.1097/00004397-199103110-00007
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   MARINKOVICH MP, 1993, DEV DYNAM, V197, P255, DOI 10.1002/aja.1001970404
   McCarey B E, 1990, Refract Corneal Surg, V6, P40
   MCCAREY BE, 1991, INT OPHTHALMOL CLIN, V31, P87, DOI 10.1097/00004397-199103110-00012
   MCDONALD MB, 1993, J CATARACT REFR SURG, V19, P213, DOI 10.1016/S0886-3350(13)80945-5
   MCDONALD MB, 1988, CORNEA, P697
   PETTIT DK, 1990, INVEST OPHTH VIS SCI, V31, P2269
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   RICHARD NR, 1991, CURR EYE RES, V10, P739, DOI 10.3109/02713689109013868
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   STEELE JG, 1987, J NEUROSCI RES, V17, P119, DOI 10.1002/jnr.490170205
   Sweeney DF, 1998, INVEST OPHTH VIS SCI, V39, P284
   TrinkausRandall V, 1997, ARTIF ORGANS, V21, P1185
   TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P1800
   TURSS R, 1970, EXP EYE RES, V9, P254, DOI 10.1016/S0014-4835(70)80082-3
   Xie RZ, 1997, AUST NZ J OPHTHALMOL, V25, pS46
   XIE RZ, 1997, AUST NZ J OPHTHALMOL, V23, P3
   ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300
NR 37
TC 61
Z9 61
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 1999
VL 45
IS 4
BP 384
EP 394
DI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 189JD
UT WOS:000079900600014
PM 10321712
DA 2018-10-19
ER

PT J
AU Stanislawski, L
   Daniau, X
   Lautie, A
   Goldberg, M
AF Stanislawski, L
   Daniau, X
   Lautie, A
   Goldberg, M
TI Factors responsible for pulp cell cytotoxicity induced by resin-modified
   glass ionomer cements
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE resin-modified glass ionomer; cytotoxicity; cell culture; resin monomers
ID RESTORATIVE MATERIALS; IN-VITRO; RELEASE; DENTIN; HEMA
AB Resin-modified glass ionomer cements (RM-GICs) are the last generation of GICs commonly used in restorative dentistry. They contain various resins that improve their mechanical properties. These modifications, however, may also affect their biocompatibility, We compared the cytotoxicity of seven biomaterials (five RM-GICs, one metal-reinforced GIC (M-GIC), and a zinc-oxyphosphate cement) using an assay of pulp cell viability in vitro (MTT assay). The most toxic materials appeared to be the M-GIC Hi-Dense and the RM-GIC Vitremer, The less toxic ones appeared to be the RM-GICs Compoglass and Photac-Fil, Attempts made to identify the factors responsible for their cytotoxicity indicated that in vitro cytotoxicity did not seem to be caused by any change in pH of the biomaterial eluates. Adsorption of biomaterial eluates on dentin powder significantly reduced the cytotoxicity of all biomaterials. The concentration of F-, Sr2+, and Al3+ (major ionic elements present in GICs) in the eluate of six glass ionomer containing biomaterials was too low to be cytotoxic, However, Cu2+ and Ag+ (present in alloys of M-GIC) were present in toxic concentrations in Hi-Dense eluates, Unpolymerized monomers leached from resins were identified by Fourier transform IR spectroscopy in biomaterial eluates, The monomers hydroxyethyl methacrylate (HEMA), triethylene glycol dimethacrylate (TEGDMA), and poly(acrylic) acid were identified in eluates of Vitremer, Compoglass, and Hi-Dense, respectively, After ethanol elution of HEMA and TEGDMA from Vitremer and Compoglass, respectively, the cytotoxicity of these two RM-GICs was drastically reduced. Our results suggest that the principal compounds responsible for cytotoxicity are unpolymerized resin monomers in the two RM-GICs and Cu2+ and Ag+ in the M-GIC, (C) 1999 John Wiley & Sons, Inc.
C1 Fac Chirurg Dentaire, Lab Biol & Physiopathol Craniofaciale, F-92120 Montrouge, France.
   Univ Paris 06, LASIR, CNRS, Thiais, France.
RP Stanislawski, L (reprint author), Fac Chirurg Dentaire, Lab Biol & Physiopathol Craniofaciale, 1 Rue Maurice Arnoux, F-92120 Montrouge, France.
CR BARTON TF, 1997, ANAL LEACHABLES DENT, V73, P73
   Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X
   DAVIDSON CL, 1991, REAL CLIN, V2, P325
   deGee AJ, 1996, J DENT RES, V75, P1613, DOI 10.1177/00220345960750081401
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   GERZINA TM, 1994, J ORAL REHABIL, V21, P463, DOI 10.1111/j.1365-2842.1994.tb01160.x
   HUME W R, 1986, Journal of Dental Research, V65, P726
   HUME WR, 1994, J ORAL REHABIL, V21, P469, DOI 10.1111/j.1365-2842.1994.tb01161.x
   MCLEAN JW, 1984, BRIT DENT J, V157, P432, DOI 10.1038/sj.bdj.4805511
   MULLER J, 1990, DENT MATER, V6, P172, DOI 10.1016/0109-5641(90)90024-9
   SIDHU SK, 1995, AM J DENT, V8, P59
   SMITH DC, 1986, J AM DENT ASSOC, V112, P654, DOI 10.14219/jada.archive.1986.0069
   STANLEY HR, 1985, TOXICITY TESTING DEN, P91
   WATAHA JC, 1994, J ORAL REHABIL, V21, P453, DOI 10.1111/j.1365-2842.1994.tb01159.x
   Wilson A D, 1990, Int J Prosthodont, V3, P425
   WILSON AD, 1972, BRIT DENT J, V132, P133, DOI 10.1038/sj.bdj.4802810
   YOSHIKAWA T, 1994, J DENT RES, V73, P133
NR 17
TC 59
Z9 63
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 1999
VL 48
IS 3
BP 277
EP 288
DI 10.1002/(SICI)1097-4636(1999)48:3<277::AID-JBM11>3.0.CO;2-T
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 199KT
UT WOS:000080480900011
PM 10398031
DA 2018-10-19
ER

PT J
AU Holland, NB
   Siedlecki, CA
   Marchant, RE
AF Holland, NB
   Siedlecki, CA
   Marchant, RE
TI Intermolecular force mapping of platelet surfaces on collagen substrata
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE atomic force microscopy; adhesion
ID ADHESION FORCE; MICROSCOPE; RECEPTOR; LIGAND; RECOGNITION; FIBRINOGEN;
   INTEGRINS; MOLECULES; PROTEINS; CELLS
AB The interactions between plasma proteins and platelets are responsible for surface adsorption and activation of platelets, which leads to initiation of platelet-mediated thrombotic events at biomaterial surfaces. We are seeking to gain a fundamental understanding of these interactions. The atomic force microscope (AFM) has been used to create force maps across platelets adsorbed onto collagen substrata using peptide-modified probes. Combining the imaging and force-measuring capabilities of AFM, the force-mapping mode has been used to measure interactions of peptide-modified AFM probes with the surface. Observed differences in the force of adhesion are clearly evident in the platelet samples fixed in air, proving the ability of the AFM system to map adhesion. When this system is changed to a fluid environment we are no longer able to see such evident adhesion because of the membrane flexibility; instead the deformability of the surface is mapped. The specific interaction between the peptide sequence RGD and platelets was measured in a non-mapping mode of the AFM. Although this does not provide a force map, we can see significant differences between the forces measured on the substrate and those measured with a control hexapeptide. (C) 1999 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Marchant, RE (reprint author), Case Western Reserve Univ, Dept Macromol Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
RI Holland, Nolan/F-6933-2011
OI Holland, Nolan/0000-0002-0752-6887
FU NHLBI NIH HHS [HL40047]
CR ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258
   BALTZ JM, 1990, J THEOR BIOL, V142, P163, DOI 10.1016/S0022-5193(05)80219-X
   CALVETE JJ, 1995, P SOC EXP BIOL MED, V208, P346
   CHANG L, 1993, BIOPHYS J, V64, P1282, DOI 10.1016/S0006-3495(93)81493-0
   DANILICH MJ, 1992, J BIOMAT SCI-POLYM E, V3, P195, DOI 10.1163/156856292X00123
   DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   Finlay BB, 1990, CURR OPIN CELL BIOL, V2, P815, DOI 10.1016/0955-0674(90)90078-S
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   KOHN J, 1983, FEBS LETT, V154, P209, DOI 10.1016/0014-5793(83)80905-3
   LAL R, 1994, AM J PHYSIOL, V266, pC1
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   Ludwig M, 1997, BIOPHYS J, V72, P445, DOI 10.1016/S0006-3495(97)78685-5
   LUDWIG M, 1994, MICROSC MICROANAL M, V5, P321, DOI 10.1051/mmm:0199400504-6032100
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   NAKAGAWA T, 1994, J VAC SCI TECHNOL B, V12, P2215, DOI 10.1116/1.587744
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505
   RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2
   RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   RosaZeiser A, 1997, MEAS SCI TECHNOL, V8, P1333, DOI 10.1088/0957-0233/8/11/020
   Siedlecki CA, 1996, BLOOD, V88, P2939
   SUNG KLP, 1993, BLOOD, V81, P419
   TEDDER TF, 1995, FASEB J, V9, P866
   TOMIYAMA Y, 1992, BLOOD, V79, P2303
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   VANDERWERF KO, 1994, APPL PHYS LETT, V65, P1195, DOI 10.1063/1.112106
   Veis A., 1994, EXTRACELLULAR MATRIX, P15
NR 34
TC 20
Z9 20
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 1999
VL 45
IS 3
BP 167
EP 174
DI 10.1002/(SICI)1097-4636(19990605)45:3<167::AID-JBM2>3.0.CO;2-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 183QX
UT WOS:000079565900002
PM 10397972
DA 2018-10-19
ER

PT J
AU Goodman, SL
AF Goodman, SL
TI Sheep, pig, and human platelet-material interactions with model
   cardiovascular biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE platelets; in vitro; pyrolytic carbon; mechanical heart valves;
   thrombosis
ID TEMPERATURE ISOTROPIC CARBON; PROTEIN ADSORPTION; PYROLYTIC CARBON;
   CYTOSKELETAL REORGANIZATION; BLOOD COMPATIBILITY; VALVE PROSTHESIS;
   ADHESION; AGGREGATION; MICROSCOPY; FIBRINOGEN
AB The relationship between cardiovascular device performance in animals and humans is not straightforward. As the principal formed element in a thrombus, platelets play a major role in determining the hemocompatibility of mechanical heart valves and other high-shear-rate cardiovascular devices. Since larger animals are required to test many such devices, sheep and porcine platelet responses were compared to humans. Adhesion, spreading, and the formation of thrombilike structures were examined in vitro on pyrolytic carbon mechanical heart valve leaflets, National Institutes of Health-reference polyethylene and silicone rubber, and Formvar. Principal findings were that platelet responses are strongly dependent upon the biomaterial and the species: Porcine and human platelets spread extensively on pyrolytic carbon, formed thrombuslike structures on Formvar, and were least active on silicone rubber. Human and porcine platelets responded differently to polyethylene: Human platelets spread extensively, while porcine platelets remained pseudopodial. In contrast sheep platelets attached much less, never reached fully spread shapes, and were far less active overall. Since porcine responses were generally similar to humans, pigs may be a useful predictor of in vivo platelet-biomaterial interaction in humans. Conversely, as ovine platelets were much less active, this must be accounted for in the evaluation of cardiovascular devices tested in sheep. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Connecticut, Ctr Hlth, Ctr Biomat, Farmington, CT 06030 USA.
RP Goodman, SL (reprint author), Univ Connecticut, Ctr Hlth, Ctr Biomat, 263 Farmington Ave, Farmington, CT 06030 USA.
FU NCRR NIH HHS [RR-570]
CR ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   BAIER RE, 1970, T AM SOC ART INT ORG, V24, P19
   Bhuvaneshwar GS, 1996, J HEART VALVE DIS, V5, P448
   CENNI E, 1995, BIOMATERIALS, V16, P973, DOI 10.1016/0142-9612(95)94903-X
   CHIN JA, 1994, T SOC BIOMAT, V17, P250
   Chinn JA, 1996, J COLLOID INTERF SCI, V184, P11, DOI 10.1006/jcis.1996.0592
   DIDISHEIM P, 1986, BLOOD MAT INTERACTIO
   DODDS WJ, 1987, BLOOD CONTACT NATURA, P631
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FENG L, 1993, J BIOMED MATER RES, V27, P177, DOI 10.1002/jbm.820270206
   FENG L, 1994, BIOMATERIALS, V15, P323
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1995, CELL MATER, V5, P15
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   GOODMAN SL, 1994, T SOC BIOMATER, V17, P251
   GOODMAN SL, 1998, MICROSC MICROANAL, P180
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GOODMAN SL, 1996, INTERFACIAL BEHAV BI, P485
   GOODMAN SL, 1996, T 5 WORLD BIOM C, V1, P248
   GOODMAN SL, 1998, T SOC BIOMAT, V21, P209
   GOODMAN SL, 1997, CELLS MAT, V6, P303
   GOODMAN SL, 1985, PROGR ARTIFICIAL ORG, P1050
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   GREHAN JF, 1998, WORKSH PROSTH HEART, P7
   Gross DR, 1997, ASAIO J, V43, pM382
   HANSON SR, 1987, BLOOD COMPATIBILITY, P37
   Hasenkam JM, 1996, J HEART VALVE DIS, V5, P574
   Haubold A, 1983, ASAIO J, V29, P88
   HENNEMAN OD, 1998, WORKSH PROSTH HEART, P9
   LEWIS JC, 1985, CELL MOTIL, V3, P589
   LOFTUS JC, 1984, J CELL BIOL, V98, P2019, DOI 10.1083/jcb.98.6.2019
   MCCOY TJ, 1989, BIOMATERIALS, V10, P243, DOI 10.1016/0142-9612(89)90100-2
   MCINTIRE LV, 1985, GUIDELINES BLOOD MAT, P219
   MCINTIRE LV, 1985, GUIDELINES BLOOD MAT, P203
   More R. B., 1996, Cells and Materials, V6, P273
   OKASAKI Y, 1996, ASAIO J, V42, pM750
   OROURKE ST, 1986, J LAB CLIN MED, V108, P206
   OROURKE ST, 1984, SCAN ELECT MICROSC, V3, P1337
   PELZER H, 1986, J BIOMED MATER RES, V20, P1401, DOI 10.1002/jbm.820200913
   PHILP RB, 1992, CAN J PHYSIOL PHARM, V70, P1161, DOI 10.1139/y92-161
   Schreck S, 1995, J Heart Valve Dis, V4 Suppl 1, pS21
   TANGEN O, 1971, THROMB DIATH HAEMOST, V25, P268
   Tweden Katherine S., 1996, Cells and Materials, V6, P319
   VanRijkZwikker GL, 1996, EUR J CARDIO-THORAC, V10, P513, DOI 10.1016/S1010-7940(96)80417-9
   WILSON RS, 1986, POLYM BIOMATERIALS, P15
   WILSON RS, 1988, TECHNIQUES BIOCOMPAT, P151
   Yang YQ, 1996, J HEART VALVE DIS, V5, P526
NR 49
TC 117
Z9 121
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 1999
VL 45
IS 3
BP 240
EP 250
DI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 183QX
UT WOS:000079565900012
PM 10397982
DA 2018-10-19
ER

PT J
AU Godo, MN
   Sefton, MV
AF Godo, MN
   Sefton, MV
TI Characterization of transient platelet contacts on a polyvinyl alcohol
   hydrogel by video microscopy
SO BIOMATERIALS
LA English
DT Article
DE video microscopy; transient platelet contacts
ID BIOMATERIAL SURFACES; MURAL THROMBOGENESIS; FLOW; DETACHMENT;
   FIBRINOGEN; ADHERENCE; VISUALIZATION; FLUORESCENT; ADHESION; INVITRO
AB Acridine orange labelled, washed human platelets were counted and tracked on polyvinyl alcohol (PVA), heparin-PVA and polyethylene (PE)-coated coverslips with a view to understand why transient contact on the PVA hydrogels lead to elevated platelet activation and consumption relative to polyethylene. Over the 4 min of initial contact that was studied, platelet adhesion was higher on PE than on PVA or heparin-PVA at both 40 and 200 s(-1), as expected, regardless of whether the surfaces were pre-treated with albumin or fibrinogen. Not all platelets appearing to make contact with the surface, actually attached. For example, less than 2% of the platelets contacting albumin pre-treated PVA (at 40 s(-1)) remained adherent at the end of the initial 60 s observation time, while the corresponding number for PE was greater than 9%. A greater fraction of the platelets remained adherent at the higher shear rate or with fibrinogen pre-treatment, but the difference between PVA and PE remained similar: for example, with fibrinogen pretreatment at 200 s(-1), similar to 25% of the platelet contacts resulted in adhesion on PVA while 66% did so on PE. While net platelet adhesion was less for the hydrogels, than for PE, the total number of contacts (adherents + non-adherents) were more comparable and unexpectedly higher for albumin pre-treatment than for fibrinogen. Net platelet adhesion is but one component of the total platelet interaction with a material surface. Fluorescent video microscopy has been shown to be a useful, albeit not unequivocal, method for assessing the platelets that make contact with but do not adhere to a surface. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   Univ Toronto, Ctr Biomat, Toronto, ON M5S 3E5, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
FU NHLBI NIH HHS [HL 24020]
CR ADAMS GA, 1980, T AM SOC ART INT ORG, V26, P17
   CAPSON DW, 1989, IEEE T BIO-MED ENG, V36, P860, DOI 10.1109/10.30814
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P399, DOI 10.1002/jbm.820230403
   CONOVER WJ, 1980, PRACTICAL NONPARAMET
   DABROS T, 1982, J COLLOID INTERF SCI, V89, P232, DOI 10.1016/0021-9797(82)90137-0
   DESAI N P, 1989, Journal of Biomaterials Science Polymer Edition, V1, P123, DOI 10.1163/156856289X00118
   Duncan AC, 1997, BIOMATERIALS, V18, P1585, DOI 10.1016/S0142-9612(97)00100-2
   FEUERSTEIN IA, 1986, THROMB HAEMOSTASIS, V55, P184
   FEUERSTEIN IA, 1991, J BIOMED MATER RES, V25, P185, DOI 10.1002/jbm.820250206
   FEUERSTEIN IA, 1992, J BIOMED MATER RES, V26, P221, DOI 10.1002/jbm.820260208
   FEUERSTEIN IA, 1986, J BIOMECH ENG-T ASME, V108, P49, DOI 10.1115/1.3138579
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P176, DOI 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.3.CO;2-Z
   GEMMELL CH, 1994, J LAB CLIN MED, V125, P276
   GODO MN, 1992, THESIS U TORONTO
   GRABOWSKI EF, 1978, MICROVASC RES, V16, P159, DOI 10.1016/0026-2862(78)90053-5
   GRABOWSKI EF, 1974, THROMB DIATH HAEMO, V60, P127
   HARKER LA, 1979, J CLIN INVEST, V64, P559, DOI 10.1172/JCI109494
   HAYCOX CL, 1991, J BIOMED MATER RES, V25, P1317, DOI 10.1002/jbm.820251011
   HORBETT TA, UNPUB
   HUBBELL JA, 1986, BIOMATERIALS, V7, P354, DOI 10.1016/0142-9612(86)90006-2
   HUBBELL JA, 1986, REV SCI INSTRUM, V57, P892, DOI 10.1063/1.1138830
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   LLANOS GR, 1991, MACROMOLECULES, V24, P6065, DOI 10.1021/ma00023a003
   LOREZ HP, 1977, J LAB CLIN MED, V89, P200
   MALUDZINSKI RA, 1988, THESIS MCMASTER U HA
   MALYSA K, 1988, MATER SCI FORUM, V25, P405
   RICHARDSON PD, 1979, T AM SOC ART INT ORG, V25, P147
   RICHARDSON PD, 1977, P EUR SOC ARTIF ORGA, V4, P175
   SMITH BAH, 1992, J BIOMED MATER RES, V26, P421
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   ZINGG W, 1982, CAN J SURG, V25, P16
NR 32
TC 18
Z9 19
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1999
VL 20
IS 12
BP 1117
EP 1126
DI 10.1016/S0142-9612(99)00012-5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197VD
UT WOS:000080385600006
PM 10382827
DA 2018-10-19
ER

PT J
AU Murata, M
   Huang, BZ
   Shibata, T
   Imai, S
   Nagai, N
   Arisue, M
AF Murata, M
   Huang, BZ
   Shibata, T
   Imai, S
   Nagai, N
   Arisue, M
TI Bone augmentation by recombinant human BMP-2 and collagen on adult rat
   parietal bone
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE bone morphogenetic protein; collagen; onlay graft; augmentation;
   biomaterial
ID MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE; GRAFT SUBSTITUTE; ECTOPIC
   SITES; CARRIER; DIFFERENTIATION; HYDROXYLAPATITE; OSTEOGENIN; FIBRILLAR;
   INDUCTION
AB A composite of recombinant human bone morphogenetic protein-2 (rhBMP-2) and collagen was implanted beneath the cranial periosteum of 10-month-old rats to observe bone development and absorbent change of carrier collagen. The rhBMP-2/collagen onlay implant resulted in active bone formation and the augmented bone was connected directly with the original bone, whereas the collagen alone resulted in neither bone nor cartilage. The ossification process in the rhBMP-2/collagen occurred directly through bone formation, similar to intramembranous ossification. The carrier collagen fibers were found in the woven bone and were completely absorbed at 8 weeks in the presence of rhBMP-2, while the collagen alone implant remained encapsulated by a thin, fibrous connective tissue. Our results indicate that rhBMP-2/collagen is an effective material as a biological onlay implant, showing osteoinductive properties and being completely replaced by new bone. Carrier collagen not only plays a role in rhBMP-2 delivery, but also provides a cell anchorage for cell differentiation and remains as an artificial matrix in woven bone.
C1 Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Surg 2, Tobetsu, Hokkaido 0610293, Japan.
   Okayama Univ, Sch Dent, Dept Oral Pathol, Okayama 700, Japan.
RP Murata, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Surg 2, Tobetsu, Hokkaido 0610293, Japan.
CR BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   ELDEEB M, 1989, J ORAL MAXIL SURG, V47, P480, DOI 10.1016/0278-2391(89)90281-4
   GONGLOFF RK, 1986, INT J ORAL MAX SURG, V15, P263, DOI 10.1016/S0300-9785(86)80083-7
   Gordh M, 1998, INT J ORAL MAX SURG, V27, P67, DOI 10.1016/S0901-5027(98)80102-1
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113
   KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P37, DOI 10.1016/0278-2391(86)90012-1
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   KUBOKI Y, 1995, CONNECT TISSUE RES, V31, P1
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Omura S, 1998, INT J ORAL MAX SURG, V27, P129, DOI 10.1016/S0901-5027(98)80312-3
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   ONO I, 1995, J CRANIOFAC SURG, V6, P238, DOI 10.1097/00001665-199505000-00011
   QIN CL, 1997, JPN J ORAL BIOL, V38, P572
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   Satow S, 1997, INT J ORAL MAX SURG, V26, P358, DOI 10.1016/S0901-5027(97)80797-7
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Viljanen VV, 1996, INT J ORAL MAX SURG, V25, P217, DOI 10.1016/S0901-5027(96)80034-8
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 34
TC 53
Z9 62
U1 0
U2 6
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUN
PY 1999
VL 28
IS 3
BP 232
EP 237
DI 10.1034/j.1399-0020.1999.283280316.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 197NH
UT WOS:000080371000016
PM 10355948
DA 2018-10-19
ER

PT J
AU Vandenberg, EJ
   Tian, D
AF Vandenberg, EJ
   Tian, D
TI A new, crystalline high melting bis(hydroxymethyl)polycarbonate and its
   acetone ketal for biomaterial applications
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; WEIGHT POLY(TRIMETHYLENE CARBONATE);
   2,2-DIMETHYLTRIMETHYLENE CARBONATE; EPSILON-CAPROLACTONE; TRIMETHYLENE
   CARBONATE; COPOLYMERIZATION; INITIATORS; POLYCARBONATE;
   1,3-DIOXAN-2-ONE; POLYMERS
AB Hydroxypolycarbonates (HPC) offer to the biomedical area hydroxyl functional polymers not now readily available to bind drugs, proteins, or carbohydrate polymers chemically or via hydrogen bonding to facilitate drug delivery and utility with subsequent biodegradibility to acceptable byproducts. The cyclic carbonate (CC) from the monoketal diol of pentaerythritol polymerized in CHCl3 at 60 degrees C with Et2Zn catalyst in CHCl3 at 60 degrees C in 4 h to a quantitative yield of high molecular weight, crystalline polymer (PCC), melt peak 199 degrees C and T-g of 99 degrees C. PCC is readily hydrolyzed with 80% acetic acid to the water-insoluble but water-swollen HPC, poly[5,5-bis(hydroxymethyl)-1,3-dioxan-2-one], with M-w = 3.1 x 10(4). HPC degrades completely in vitro in <16 h in PBS-1X buffer (pH 7.4, 37 degrees C) to pentaerythritol and presumably CO2. This rapid degradation rate is decreased with random copolymers of HPC with CC, epsilon-caprolactone, or L-lactide. HPC and PCC may have important biomaterial applications as is and as the copolymers noted above or with ethylene oxide or other desirable comonomers. PCC and CC copolymers have properties attractive to the biomedical area as is or by conversion to the HPC product provided by hydrolysis or by in vivo enzymatic attack.
C1 Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.
RP Vandenberg, EJ (reprint author), Arizona State Univ, Dept Chem & Biochem, Main Campus,POB 871604, Tempe, AZ 85287 USA.
CR ACEMOGLU M, 1993, Patent No. 20126
   ALBERTSSON AC, 1992, J MACROMOL SCI PURE, V29, P43, DOI 10.1080/10101329208054106
   ARIGA T, 1993, J POLYM SCI POL CHEM, V31, P581, DOI 10.1002/pola.1993.080310232
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858
   BRUNELLE DJ, 1996, KIRKOTHMER ENCY CHEM, V19, P584
   Chen XH, 1997, MACROMOLECULES, V30, P3470, DOI 10.1021/ma961821k
   FIETIER I, 1990, POLYM BULL, V24, P349, DOI 10.1007/BF00294086
   GELBIN ME, 1992, J AM CHEM SOC, V114, P3962, DOI 10.1021/ja00036a051
   GRIJPMA DW, 1994, POLYM ENG SCI, V34, P1674, DOI 10.1002/pen.760342205
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   HOCKER H, 1992, MAKROMOL CHEM-M SYMP, V54-5, P9, DOI 10.1002/masy.19920540104
   HOCKER H, 1995, MACROMOL SYMP, V98, P825, DOI 10.1002/masy.19950980169
   HOCKER H, 1991, MAKROMOL CHEM-M SYMP, V42-3, P145, DOI 10.1002/masy.19910420111
   HOCKER H, 1993, PURE APPL CHEM A, V30, P595
   Hori Y, 1996, MACROMOLECULES, V29, P804, DOI 10.1021/ma951345i
   Hostettler F., 1966, [Heterocyclic spiro carbonats, US Patent], Patent No. 3251857
   HOVESTADT W, 1992, POLYMER, V33, P1941, DOI 10.1016/0032-3861(92)90497-K
   Inoue S., 1975, APPL POLYM S, V26, P257
   KAWAGUCHI T, 1983, CHEM PHARM BULL, V31, P4157
   KAWAGUCHI T, 1983, CHEM PHARM BULL, V31, P1400
   KEUL H, 1995, MACROMOL SYMP, V95, P243, DOI 10.1002/masy.19950950121
   KEUL H, 1986, MAKROMOL CHEM, V187, P2579
   KOJIMA T, 1984, CHEM PHARM BULL, V32, P2795
   KRICHELDORF HR, 1989, J MACROMOL SCI CHEM, VA26, P631, DOI 10.1080/00222338908051999
   KRICHELDORF HR, 1995, J POLYM SCI POL CHEM, V33, P2193, DOI 10.1002/pola.1995.080331313
   KUHLING S, 1992, MAKROMOL CHEM, V193, P1207
   KUHLING S, 1991, MAKROMOL CHEM, V192, P1193
   Matsumura S, 1997, MACROMOLECULES, V30, P3122, DOI 10.1021/ma961862g
   MULLER AJ, 1991, EUR POLYM J, V27, P1323, DOI 10.1016/0014-3057(91)90229-H
   NAKANO M, 1984, YUKI GOSEI KAGAKU KY, V42, P665
   NISHIDA H, 1994, CHEM LETT, P421, DOI 10.1246/cl.1994.421
   RODEHEAVER GT, 1987, AM J SURG, V154, P544, DOI 10.1016/0002-9610(87)90275-3
   Schmidt P, 1996, MACROMOLECULES, V29, P3674, DOI 10.1021/ma951489x
   Shen YQ, 1997, J POLYM SCI POL CHEM, V35, P1339, DOI 10.1002/(SICI)1099-0518(199706)35:8<1339::AID-POLA1>3.0.CO;2-V
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   VANDENBERG EJ, 1983, CHEMTECH, V13, P474
   WURM B, 1992, MAKROMOL CHEM-RAPID, V13, P9
   WURM B, 1992, MACROMOLECULES, V25, P2977, DOI 10.1021/ma00037a029
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   1989, J POLYM SCI A, V27, P3083
NR 41
TC 67
Z9 72
U1 5
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUN 1
PY 1999
VL 32
IS 11
BP 3613
EP 3619
DI 10.1021/ma9816822
PG 7
WC Polymer Science
SC Polymer Science
GA 203DA
UT WOS:000080691300009
DA 2018-10-19
ER

PT J
AU Ramanathan, C
   Ackerman, JL
AF Ramanathan, C
   Ackerman, JL
TI Quantitative solid-state NMR imaging of synthetic calcium phosphate
   implants
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE biomaterial; bioceramic; MRI; quantitation
ID NUCLEAR MAGNETIC-RESONANCE; BONE-MINERAL DENSITY; TRABECULAR BONE;
   IN-VIVO; SPECTROSCOPY; INVIVO; OSTEOPOROSIS; PHASES; MODELS
AB It is shown that solid-state phosphorus-31 nuclear magnetic resonance imaging can be used to measure quantitatively the mass of hydroxyapatite (HA), a synthetic calcium phosphate used as an orthopedic implant material, in the presence of bone. A three-dimensional projection reconstruction technique was used to produce solid-state images from 998 free induction decays sampled in the presence of a fixed amplitude field gradient whose direction was varied uniformly over the unit sphere. Chemical selection is achieved using T-1 contrast, as the synthetic calcium phosphate has a shorter T-1 (1.8 sec at 4.7 T) compared with the bone (approximately 15 sec at 4.7 T in vivo, 42 sec ex vivo). Experimental results demonstrating the linear relationship between image intensity and HA density in phantoms containing HA and silicon (IV) oxide, and HA and bone are shown. Chemically pure images of bone mineral and synthetic HA have been computed from images of New Zealand White rabbits acquired in vivo at two different recycle times. The technique can be used to follow noninvasively the resorption and remodeling of calcium phosphate implants in vivo. (C) 1999 Wiley-Liss, Inc.
C1 Massachusetts Gen Hosp, Dept Radiol, Biomat Lab, NMR Ctr, Charlestown, MA 02129 USA.
   Harvard Univ, Sch Med, Charlestown, MA USA.
RP Ackerman, JL (reprint author), Massachusetts Gen Hosp, Dept Radiol, Biomat Lab, NMR Ctr, Rm 2301,149 13th St, Charlestown, MA 02129 USA.
RI Ramanathan, Chandrasekhar/C-5207-2008
OI Ramanathan, Chandrasekhar/0000-0002-7457-3608; Ackerman,
   Jerome/0000-0001-5176-7496
FU NIAMS NIH HHS [AR42258]
CR ACKERMAN JL, 1992, MAGNET RESON MED, V25, P1, DOI 10.1002/mrm.1910250102
   ACKERMAN JL, 1992, MAGNETIC RESONANCE M, P237
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   BROWN CE, 1988, CLIN CHEM, V34, P1431
   BUSSE LJ, 1986, MED PHYS, V13, P518, DOI 10.1118/1.595960
   CHESLER D, 1992, P SMRM 11 ANN M BERL, P665
   CODE RF, 1990, MAGNET RESON MED, V13, P358, DOI 10.1002/mrm.1910130303
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DOLECKI M, 1990, 9TH ANN M SOC MAGN R, P1229
   GHOSH P, 1995, IEEE T MED IMAGING, V14, P616, DOI 10.1109/42.414627
   JARA H, 1993, MAGNET RESON MED, V29, P528, DOI 10.1002/mrm.1910290415
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   LI L, 1990, PHYS MED BIOL, V35, P1153, DOI 10.1088/0031-9155/35/8/011
   LI LM, 1991, PHYS MED BIOL, V36, P199, DOI 10.1088/0031-9155/36/2/005
   Majumdar S, 1997, J BONE MINER RES, V12, P111, DOI 10.1359/jbmr.1997.12.1.111
   MARCHANDISE X, 1992, MAGNET RESON MED, V28, P1, DOI 10.1002/mrm.1910280102
   MOORE JR, 1995, MAGNET RESON MED, V33, P293, DOI 10.1002/mrm.1910330303
   MOSHEIFF R, 1992, BIOMATERIALS, V13, P462, DOI 10.1016/0142-9612(92)90167-M
   Press WH, 1992, NUMERICAL RECIPES C
   Ramanathan C, 1996, J MAGN RESON SER A, V121, P127, DOI 10.1006/jmra.1996.0152
   Ramanathan C, 1997, J MAGN RESON, V127, P26, DOI 10.1006/jmre.1997.1173
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, P272
   ROUFOSSE AH, 1984, BIOCHEMISTRY-US, V23, P6115, DOI 10.1021/bi00320a033
   SCHEIDLER PA, 1992, BIOMED SCI INSTRUM, V28, P183
   Selby K, 1996, JMRI-J MAGN RESON IM, V6, P549, DOI 10.1002/jmri.1880060319
   WEHRLI FW, 1995, RADIOLOGY, V196, P631, DOI 10.1148/radiology.196.3.7644622
   Wu Y, 1998, CALCIFIED TISSUE INT, V62, P512
   WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740
   Wu YT, 1999, P NATL ACAD SCI USA, V96, P1574, DOI 10.1073/pnas.96.4.1574
   Yablonskiy DA, 1997, MAGN RESON MED, V37, P214, DOI 10.1002/mrm.1910370213
NR 31
TC 14
Z9 15
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0740-3194
J9 MAGNET RESON MED
JI Magn. Reson. Med.
PD JUN
PY 1999
VL 41
IS 6
BP 1214
EP 1220
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 216CG
UT WOS:000081422500018
PM 10371454
DA 2018-10-19
ER

PT J
AU Pan, FX
   Beatty, MF
AF Pan, FX
   Beatty, MF
TI Instability of a bell constrained cylindrical tube under end thrust -
   Part 2: Examples, thin tube analysis
SO MATHEMATICS AND MECHANICS OF SOLIDS
LA English
DT Article
AB This paper is a continuation of an earlier work that analyzed the elastic stability of a homogeneous, isotropic, Bell constrained cylindrical tube of uniform cross section subjected to axial end thrust. Here, the focus is on some applications. Four kinds of material models are considered: a simple hyperelastic Bell material model, Bell's empirical material model, and two new theoretical models, one being similar to a well-known biomaterial model. Numerical results for a thick-walled tube and a solid bar are illustrated graphically. The thin-walled tube problem, however, is studied analytically for a general class of Bell constrained materials, and the critical stretch and corresponding critical load are derived. The load result is shown to be consistent with the classical solution obtained by Southwell and Dean.
C1 Univ Nebraska, Dept Engn Mech, Lincoln, NE 68588 USA.
RP Pan, FX (reprint author), Univ Nebraska, Dept Engn Mech, Lincoln, NE 68588 USA.
CR BEATTY M. F., 1996, NONLINEAR EFFECTS FL, P13
   BEATTY MF, 1986, J APPL MECH-T ASME, V53, P807, DOI 10.1115/1.3171862
   BEATTY MF, 1992, J ELASTICITY, V29, P1, DOI 10.1007/BF00043445
   BEATTY MF, IN PRESS INT J NONLI
   Bell J. F., 1985, International Journal of Plasticity, V1, P3, DOI 10.1016/0749-6419(85)90011-7
   Dean WR, 1925, P R SOC LOND A-CONTA, V107, P734, DOI 10.1098/rspa.1925.0053
   MCLACHLAN NW, 1953, BESSEL FUNCTIONS ENG
   Pan FX, 1997, J ELASTICITY, V48, P217
   Pan FX, 1997, MATH MECH SOLIDS, V2, P243, DOI 10.1177/108128659700200301
   Relton F.E., 1946, APPL BESSEL FUNCTION
   Southwell RV, 1914, PHILOS T R SOC LOND, V213, P187, DOI 10.1098/rsta.1914.0005
   Timoshenko SP, 1961, THEORY ELASTICITY ST
   Wilkes EW, 1955, Q J MECH APPL MATH, V8, P89
NR 13
TC 3
Z9 3
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1081-2865
J9 MATH MECH SOLIDS
JI Math. Mech. Solids
PD JUN
PY 1999
VL 4
IS 2
BP 227
EP 250
DI 10.1177/108128659900400205
PG 24
WC Materials Science, Multidisciplinary; Mathematics, Interdisciplinary
   Applications; Mechanics
SC Materials Science; Mathematics; Mechanics
GA 199JC
UT WOS:000080476600005
DA 2018-10-19
ER

PT J
AU Perkins, GD
   Hulme, J
   Shore, HR
   Bion, JF
AF Perkins, GD
   Hulme, J
   Shore, HR
   Bion, JF
TI Basic life support training for health care students
SO RESUSCITATION
LA English
DT Article
DE basic life support; training; cardiopulmonary resuscitation
ID CARDIOPULMONARY-RESUSCITATION; EFFICACY
AB This paper describes a novel method for delivering basic life support training to undergraduate healthcare students. A comprehensive 8 h programme is organised and delivered by undergraduate students to their peers. These students have undergone training as basic life support instructors validated by the Royal Life Saving Society UK. The course is delivered to multiprofessional groups of medical, dental, physiotherapy, biomaterial and nursing undergraduates. It has been well received by students and academic staff and provides a solution to reduce the workload of over burdened clinical staff while at the same time enhancing quality. It forms part of an overall strategy for improving resuscitation training for undergraduates from all disciplines. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Birmingham, Queen Elizabeth Hosp, Dept Anaesthet & Intens Care Med N5, Birmingham B15 2TH, W Midlands, England.
   Birmingham Heartlands Hosp, Dept Med, Birmingham B9 5SS, W Midlands, England.
   City Hosp, Dept Paediat, Birmingham B18 7QH, W Midlands, England.
RP Bion, JF (reprint author), Univ Birmingham, Queen Elizabeth Hosp, Dept Anaesthet & Intens Care Med N5, Birmingham B15 2TH, W Midlands, England.
CR ARESKOG NH, 1988, MED EDUC, V22, P251
   BASKETT PJF, 1985, BRIT MED J, V290, P31
   DALEN JE, 1980, NEW ENGL J MED, V303, P455, DOI 10.1056/NEJM198008213030810
   GRAHAM CA, 1994, J ACCID EMERG MED, V11, P162
   Graham CA, 1996, RESUSCITATION, V32, P105, DOI 10.1016/0300-9572(96)01012-X
   Handley AJ, 1998, RESUSCITATION, V37, P67, DOI 10.1016/S0300-9572(98)00036-7
   HANDLEY AJ, 1998, LIFE SUPPORT
   Leah V, 1998, RESUSCITATION, V39, P87, DOI 10.1016/S0300-9572(98)00126-9
   Maibach EW, 1996, PEDIATRICS, V97, P94
   MARTEAU TM, 1990, BRIT MED J, V300, P849, DOI 10.1136/bmj.300.6728.849
   MOWBRAY A, 1987, MED EDUC, V21, P285, DOI 10.1111/j.1365-2923.1987.tb00364.x
   NELSON M, 1982, MED EDUC, V16, P7, DOI 10.1111/j.1365-2923.1982.tb01211.x
   Parsell G, 1998, POSTGRAD MED J, V74, P89, DOI 10.1136/pgmj.74.868.89
   RAMIREZ AG, 1977, AM J PUBLIC HEALTH, V67, P1093, DOI 10.2105/AJPH.67.11.1093
   *ROYAL COLL PHYS, 1987, J R COL PHYS LOND, V21, P176
   SAFAR P, 1988, CARDIOPULMONARY CERE, P339
   TWWED WA, 1980, CRIT CARE MED, V8, P651
   WYNNE G, 1987, BRIT MED J, V294, P1198, DOI 10.1136/bmj.294.6581.1198
   WYNNE G, 1992, J ROY COLL PHYS LOND, V26, P372
   YAKEL ME, 1989, HEART LUNG, V18, P520
NR 20
TC 31
Z9 32
U1 0
U2 5
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0300-9572
J9 RESUSCITATION
JI Resuscitation
PD JUN
PY 1999
VL 41
IS 1
BP 19
EP 23
DI 10.1016/S0300-9572(99)00037-4
PG 5
WC Critical Care Medicine; Emergency Medicine
SC General & Internal Medicine; Emergency Medicine
GA 223CZ
UT WOS:000081823800002
PM 10459588
DA 2018-10-19
ER

PT J
AU van Kooten, TG
   von Recum, AF
AF van Kooten, TG
   von Recum, AF
TI Cell adhesion to textured silicone surfaces: The influence of time of
   adhesion and texture on focal contact and fibronectin fibril formation
SO TISSUE ENGINEERING
LA English
DT Article
ID HUMAN-ENDOTHELIAL CELLS; EXTRACELLULAR-MATRIX; MICROGROOVED SURFACES;
   MICROTEXTURED SILICONE; TOPOGRAPHICAL CONTROL; HUMAN FIBROBLASTS;
   POLYMER SURFACES; IN-VITRO; VITRONECTIN; SUBSTRATUM
AB Cell adhesion and spreading on biomaterials is a key issue in the study of cell-biomaterial interactions. With the development of new disciplines within biomaterials research such as tissue engineering and cellular therapy, information at molecular and structural levels is needed in order to conceive and design biomaterials that elicit specific, functional cell responses. In this study we determined the formation of focal adhesions and fibronectin fibrillar structures by human fibroblasts and human umbilical vein endothelial cells adhered to fibronectin-precoated, smooth, and textured silicones as a function of time. Textures consisted of parallel ridges and 0.5 mu m deep grooves with a width of 2, 5, and 10 mu m. In addition, pillar and well constructs were used. Cells assembled focal adhesions within the first 24 h of adhesion. Fibronectin production and assembly resulted in a dense fibrillar network at day 6. Initial focal adhesion density and size were dictated by the presence of the texture. Topography also influenced initial fibronectin deposition, although the differences did not result in apparent differences in fibronectin networks after 6 days of incubation. Without fibronectin preadsorption, cells did not proliferate on the silicone surfaces. Cells adhered to glass removed all the preadsorbed fibronectin, whereas on silicone they did not. The present study shows that different textures initially give rise to differences in focal contact and fibronectin fibril assembly. The effects of the small, initial in vitro differences on in vivo tissue biocompatibility remains to be studied.
C1 Univ Groningen, Dept Biomed Engn, Groningen, Netherlands.
   Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CAHALON L, 1994, CELL ADHES COMMUN, V2, P269, DOI 10.3109/15419069409004447
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X
   GRANCHI D, 1995, J BIOMED MATER RES, V29, P197, DOI 10.1002/jbm.820290209
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Ireland G W, 1987, J Cell Sci Suppl, V8, P19
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JAUREGUI HO, 1987, T AM SOC ART INT ORG, V33, P66
   KASPER CS, 1994, AM J CLIN PATHOL, V102, P655, DOI 10.1093/ajcp/102.5.655
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MATSUZAWA M, 1993, J NEUROSCI METH, V50, P253, DOI 10.1016/0165-0270(93)90014-I
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0
   ONEILL C, 1990, J CELL SCI, V95, P577
   OPAS M, 1991, IN VITRO CELL DEV B, V27, P878
   OPAS M, 1989, DEV BIOL, V131, P281, DOI 10.1016/S0012-1606(89)80001-6
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   QUADE BJ, 1988, J BIOL CHEM, V263, P19602
   RAGHOW R, 1994, FASEB J, V8, P823
   SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SHELTON RM, 1991, BONE-BIOMATERIAL INTERFACE, P181
   SIMPSON DG, 1994, J CELL PHYSIOL, V161, P89, DOI 10.1002/jcp.1041610112
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   TOYOIZUMI R, 1991, J EXP ZOOL, V260, P345, DOI 10.1002/jez.1402600309
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   VanKooten TG, 1997, J MATER SCI-MATER M, V8, P835
   VANKOOTEN TG, 1994, COLLOID SURFACE B, V3, P147
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VAUGHAN FL, 1983, BIOCOMPATIBLE POLYM, P621
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   VONRECUM AF, 1992, MUSCULOSKELETAL INFE, P191
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   WU CY, 1993, J BIOL CHEM, V268, P21883
   WU E, 1991, THESIS CLEMSON U CLE
NR 70
TC 50
Z9 50
U1 0
U2 13
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 1999
VL 5
IS 3
BP 223
EP 240
PG 18
WC Cell & Tissue Engineering
SC Cell Biology
GA 211UC
UT WOS:000081179400004
PM 10434070
DA 2018-10-19
ER

PT J
AU Sittinger, M
   Perka, C
   Schultz, O
   Haupl, T
   Burmester, GR
AF Sittinger, M
   Perka, C
   Schultz, O
   Haupl, T
   Burmester, GR
TI Joint cartilage regeneration by tissue engineering
SO ZEITSCHRIFT FUR RHEUMATOLOGIE
LA English
DT Article
DE cartilage repair; tissue engineering; biomaterials; bone morphogenetic
   proteins
ID HUMAN CHONDROCYTES; IN-VITRO; CULTURE; PROTEOGLYCAN; DISEASE; SURGERY
AB The research field of tissue engineering combines cells biology, biomaterial science, and surgery. Major long-term goals are tissue and organ replacement therapies using the patients' own cells. Our work is focused on the treatment of severe joint defects and on plastic surgery using in vitro engineered cartilage tissues. The practical approaches in cartilage engineering face problems with three-dimensional cell distribution or cell immobilization raising biocompatibility problems. The tissue engineering of cartilage is based on combining biocompatible cell embedding substances such as fibrin, agarose, alginate, hyaluronic acid and fiber fleece scaffolds of poly a-hydroxy acids (PLLA/PGLA). Different technical approaches were established: a) three-dimensional in vitro cultures of chondrocytes for the development of vital tissue transplants and b) interacting three-dimensional cultures consisting of different cell populations, such as BMP-transfected mesenchymal cells. The pre shaped artificial tissue constructs were cultured in perfusion chambers to maintain a stable diffusion of nutrients during the in vitro pre-formation step. Subsequently, pre-formed tissues were implanted into nude mice and into 4 mm, articular joint defects of rabbits. Transplants were found to produce cartilage typic morphological patterns and matrix. 80% of the transplants remained stable in vivo. However, 20% of the tissues are resorbed or replaced by a fibrous tissue. These results demonstrate that current artificial cartilage transplants are already feasible for plastic reconstruction. The treatment of severe joint defects, however, faces additional problems which are addressed in ongoing studies: (a) the fixation of engineered cartilage in joints, (b) the protection against chronic inflammatory degradation, and (c) the required enormous mechanical stability.
C1 Dept Rheumatol Charite, D-10117 Berlin, Germany.
   German Rheumatism Res Ctr, D-10117 Berlin, Germany.
   German Rheumatism Res Ctr, D-10115 Berlin, Germany.
   Humboldt Univ, Dept Orthoped Charite, D-10098 Berlin, Germany.
RP Sittinger, M (reprint author), Dept Rheumatol Charite, Tucholskystr 2, D-10117 Berlin, Germany.
CR BASSLEER C, 1986, IN VITRO CELL DEV B, V22, P113
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BURKHARDT H, 1989, RHEUMATOLOGIE URBAN
   CAMPBELL IK, 1988, BIOCHIM BIOPHYS ACTA, V967, P183, DOI 10.1016/0304-4165(88)90008-6
   GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823
   Gruber R, 1996, LARYNGO RHINO OTOL, V75, P105, DOI 10.1055/s-2007-997545
   Haisch A, 1996, HNO, V44, P624, DOI 10.1007/s001060050067
   HAISCH A, 1997, 16 WORLD C OT HEAD N, P145
   HAISCH A, 1998, FACE, V6, P107
   HARDINGHAM TE, 1987, J ORTHOP RES, V5, P36, DOI 10.1002/jor.1100050107
   HAUPL T, 1997, 2 INT C BMPS SACR
   KNUDSON W, 1991, J CELL SCI, V99, P227
   KREKLAU B, 1999, IN PRESS BIOMATERIAL
   LOHMANDER S, 1988, BAILLIERE CLIN RHEUM, V2, P37, DOI 10.1016/S0950-3579(88)80004-9
   LUYTEN FP, 1994, EXP CELL RES, V210, P224, DOI 10.1006/excr.1994.1033
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P1049, DOI 10.1016/0142-9612(96)84682-5
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   VERBRUGGEN G, 1990, CLIN EXP RHEUMATOL, V8, P371
   VERBRUGGEN G, 13 EUR C RHEUM AMST
NR 21
TC 52
Z9 59
U1 0
U2 11
PU DR DIETRICH STEINKOPFF VERLAG
PI DARMSTADT
PA PLATZ DER DEUTSCHEN EINHEIT 25, D-64293 DARMSTADT, GERMANY
SN 0340-1855
J9 Z RHEUMATOL
JI Z. Rheumatol.
PD JUN
PY 1999
VL 58
IS 3
BP 130
EP 135
DI 10.1007/s003930050162
PG 8
WC Rheumatology
SC Rheumatology
GA 217KV
UT WOS:000081499200012
PM 10441839
DA 2018-10-19
ER

PT J
AU Blazewicz, M
   Gajewska, MC
   Paluszkiewicz, C
AF Blazewicz, M
   Gajewska, MC
   Paluszkiewicz, C
TI Application of vibrational spectroscopy in the in vitro studies of
   carbon fiber-polylactic acid composite degradation.
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 24th European Congress on Molecular Spectroscopy
CY AUG 23-28, 1998
CL CZECH TECH UNIV, PRAGUE, CZECH REPUBLIC
SP Ioannes Marcus Marci Spectroscopic Soc, Inst Chem Technol, Czech Tech Univ, Charles Univ
HO CZECH TECH UNIV
DE biomaterial; GTR technique; composite material; vibrational
   spectroscopy; polylactic acid
ID BIOMATERIALS
AB Vibrational spectroscopy was used for assessment of new material for stomatology, for guided tissue regeneration (GTR) technique. Implants applied in the healing of periodontal defects using GTR technique have to meet stringent requirements concerning their chemical as well physical properties. At present the implants prepared from two layers membranes differing in porosity in their outer and inner layers are studied clinically. Composite plates prepared by us consist of three layers: polylactic acid film, carbon fibres coated with polylactic acid and carbon fabric. Vibrational spectroscopic studies of the material; polylactic acid- carbon fiber have made it possible to analyse chemical reactions occurring between the polymer and carbon surface. Analysis of the IR spectra of samples treated in Ringer solution allowed to describe the phenomena resulting from the composite degradation. It was shown that material biostability is related to the presence of carbon fibers. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Min & Met, Dept Adv Ceram, PL-30059 Krakow, Poland.
   Jagiellonian Univ, Coll Med, PL-31108 Krakow, Poland.
   Jagiellonian Univ, Reg Lab, PL-30060 Krakow, Poland.
RP Blazewicz, M (reprint author), Univ Min & Met, Dept Adv Ceram, 30 Mickiewicz Ave, PL-30059 Krakow, Poland.
CR ANDRADE J D, 1992, Clinical Materials, V11, P19, DOI 10.1016/0267-6605(92)90026-P
   CIESLIK T, 1998, ENG BIOMATERIALS, V2, P16
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   LUNDGREN D, 1994, J SDA, V86, P13
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
NR 7
TC 8
Z9 8
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 25
PY 1999
VL 482
SI SI
BP 519
EP 524
DI 10.1016/S0022-2860(98)00695-4
PG 6
WC Chemistry, Physical
SC Chemistry
GA 209FT
UT WOS:000081038100096
DA 2018-10-19
ER

PT J
AU Rudenja, S
   Leygraf, C
   Pan, J
   Kulu, P
   Talimets, E
   Mikli, V
AF Rudenja, S
   Leygraf, C
   Pan, J
   Kulu, P
   Talimets, E
   Mikli, V
TI Duplex TiN coatings deposited by arc plating for increased corrosion
   resistance of stainless steel substrates
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT ICMCTF 98 Conference
CY APR 25-MAY 01, 1998
CL SAN DIEGO, CA
DE AISI 304; arc plating; corrosion resistance; duplex coatings; EIS;
   Mott-Schottky plot; stainless steel
ID BIOMATERIAL APPLICATIONS; ION-IMPLANTATION; TITANIUM; ALUMINUM; ENERGY;
   XPS
AB The corrosion performance of coatings depends on both the substrate and coating properties. In this work, duplex TiN coatings were deposited on AISI 304 stainless steel with are-ion plating. Before deposition, nitriding of the substrate was done with a N-2(+) ion energy of 500 eV or 700 eV in the same physical vapor deposition plant. The corrosion performance of the duplex TiN coatings was evaluated in an acidic chloride solution by using electrochemical techniques such as potentiodynamic polarization and electrochemical impedance spectroscopy (EIS). The measurements were also performed on the uncoated substrates for comparison.
   It was observed that the nitriding pretreatment leads to a high corrosion resistance of the substrate due to the formation of a highly protective passive film on the surface. For the coated system, the electrochemical behavior seemed to be dominated by the TiN coating. However, the formation of a thin oxide film on the surface of the TiN coating was also evident from Mott-Schottky plot measurements that indicate a n-type semiconducting behavior. The high donor density obtained suggests that the oxide film is very thin and probably amorphous. The oxide film formed on the TiN coating may be an important factor influencing the corrosion performance of the coated substrate. A model was proposed for the interaction between the duplex coating and aqueous solution which leads to the formation of a passive oxide film on the surface. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Royal Inst Technol, Dept Mat Sci & Engn, Div Corros Sci, S-10044 Stockholm, Sweden.
   Tallinn Univ Technol, Dept Mat Technol, EE-19086 Tallinn, Estonia.
   Tallinn Univ Technol, Dept Basic & Appl Chem, EE-19086 Tallinn, Estonia.
   Tallinn Univ Technol, Ctr Mat Res, EE-19086 Tallinn, Estonia.
RP Rudenja, S (reprint author), Royal Inst Technol, Dept Mat Sci & Engn, Div Corros Sci, Drotning Kristinas Vag 51, S-10044 Stockholm, Sweden.
EM sergei@corrosci.kth.se
CR BELL T, 1990, SCAND J METALL, V19, P218
   BELL T, 1990, SURF ENG, V6, P31
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P1505, DOI 10.1016/0013-4686(89)87033-1
   Buchler M, 1998, J ELECTROCHEM SOC, V145, P378, DOI 10.1149/1.1838272
   Dingremont N, 1995, SURF COAT TECH, V76, P218
   Dong H, 1997, SURF COAT TECH, V90, P91, DOI 10.1016/S0257-8972(96)03099-X
   Elsener B., 1991, MATER SCI FORUM, V44, P29
   FORSEN O, 1993, NEW MAT TECHNOLOGIES, P13
   GORBACHEV AK, 1983, PROT MET+, V19, P212
   HEIDE N, 1993, NUCL INSTRUM METH B, V80-1, P467, DOI 10.1016/0168-583X(93)96162-6
   Hock K., 1996, SURF COAT TECH, P44
   JULIAO JF, 1980, J ELECTROCHEM SOC, V129, P2246
   KUHN AT, 1997, TECHNIQUES ELECTROCH, P96
   Lide D. R., 1994, CRC HDB CHEM PHYSICS, P12
   MUNZ WD, 1992, SURF COAT TECH, V50, P169, DOI 10.1016/0257-8972(92)90058-I
   Musil J, 1995, SURF COAT TECH, V76, P341
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PENTTINEN IM, 1992, SURF COAT TECH, V50, P161, DOI 10.1016/0257-8972(92)90057-H
   Rie KT, 1996, MRS BULL, V21, P46
   ROTA A, 1990, SURFACE ENG PRACTICE, P587
   RUDENJA S, 1997, SOC VAC COAT 40 ANN, P58
   RUDENJA S, 1996, P EST ACAD SCI, V2, P43
   RUDJENA S, 1998, SURF COAT TECH, V100, P247
   SAMSONOV GV, 1982, OXIDE HDB
   SIEMENSMEYER B, 1991, BER BUNSEN PHYS CHEM, V95, P1461, DOI 10.1002/bbpc.19910951128
   Silva R., 1990, British Corrosion Journal, V25, P136
   SUN Y, 1991, MAT SCI ENG A-STRUCT, V140, P419, DOI 10.1016/0921-5093(91)90458-Y
   Wei R, 1996, SURF COAT TECH, V83, P218, DOI 10.1016/0257-8972(95)02828-5
   Wei R, 1996, SURF COAT TECH, V83, P235, DOI 10.1016/0257-8972(95)02825-0
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
   ZLATANOVIC M, 1990, SURF COAT TECH, V41, P17, DOI 10.1016/0257-8972(90)90127-X
NR 32
TC 71
Z9 75
U1 0
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 12
PY 1999
VL 114
IS 2-3
BP 129
EP 136
DI 10.1016/S0257-8972(99)00033-X
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 205EN
UT WOS:000080808500003
DA 2018-10-19
ER

PT J
AU Yin, GF
   Luo, JM
   Zheng, CQ
   Tong, HH
   Huo, YF
   Mu, LL
AF Yin, GF
   Luo, JM
   Zheng, CQ
   Tong, HH
   Huo, YF
   Mu, LL
TI Preparation of DLC gradient biomaterials by means of plasma source ion
   implant-ion beam enhanced deposition
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT Joint Symposium of the 4th Asia-Pacific Conference on Plasma Science and
   Technology (APCPST-4) / 11th Symposium of Plasma Science for Materials
   (SPSM-11)
CY JUL 26-29, 1998
CL SYDNEY, AUSTRALIA
DE diamond-like carbon; gradient material; plasma source ion implant-ion
   beam enhanced deposition
AB In this study, a new kind of Ti-TiC-C gradient biomaterial has been prepared by means of plasma source ion implant-ion beam enhanced deposition (PSII-IBED). The experimental results showed that the involved components could be controlled to distribute gradually along the depth through changing ion implantation and deposition conditions. As the result, the intrinsic stress and thermal stress would be remarkably relaxed, and the adhesive strength could be greatly increased. This gradient biomaterial made with PSII-IBED can meet the needs of artificial mechanical heart valves. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Sichuan Union Univ, Chengdu 610065, Peoples R China.
   SW Inst Phys, Chengdu 610041, Peoples R China.
RP Yin, GF (reprint author), Sichuan Union Univ, Chengdu 610065, Peoples R China.
CR CHANGQIONG Z, 1987, P 1987 INT C PHYS VA, P133
   HINO M, 1987, J JPN COMPOSITE MAT, V13, P257
   WANG HW, 1996, THESIS SICHUAN UNION
   YIN GF, 1996, PREPARATION DLC SI S, P91
   YIN GF, 1992, P 1 AS PAC C PLASM S, V1, P179
   YOSHINO N, 1991, SURF COAT TECH, V47, P84, DOI 10.1016/0257-8972(91)90270-7
   ZHENG CQ, 1991, MATER SCI MONOG, V73, P711
   ZHENGKUIS, 1997, PLASMA SOURCE ION IM
NR 8
TC 36
Z9 43
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD MAY 7
PY 1999
VL 345
IS 1
BP 67
EP 70
DI 10.1016/S0040-6090(99)00076-0
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 207RN
UT WOS:000080949700015
DA 2018-10-19
ER

PT J
AU Schrader, B
   Dippel, B
   Erb, I
   Keller, S
   Lochte, T
   Schulz, H
   Tatsch, E
   Wessel, S
AF Schrader, B
   Dippel, B
   Erb, I
   Keller, S
   Lochte, T
   Schulz, H
   Tatsch, E
   Wessel, S
TI NIR Raman spectroscopy in medicine and biology: results and aspects
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 24th European Congress on Molecular Spectroscopy
CY AUG 23-28, 1998
CL CZECH TECH UNIV, PRAGUE, CZECH REPUBLIC
SP Ioannes Marcus Marci Spectroscopic Soc, Inst Chem Technol, Czech Tech Univ, Charles Univ
HO CZECH TECH UNIV
DE fluorescence-free Raman spectroscopy; Raman diagnostics; identification
   of microorganisms; natural products of plants; control of food
ID DIAGNOSIS
AB Analyses of biomaterial by 'classical' Raman spectroscopy with excitation in the visible range has not been possible since the fluorescence of many essential constituents of all animal and plant cells and tissues overlays the Raman spectra completely. Fluorescence, however, is virtually avoided, when Raman spectra are excited with the Nd : YAG laser line at 1064 nm. Within seven dissertations we explored different fields of potential applications to medical diagnostics. Identification and qualification of tissues and cells is possible. Tumors show small but significant differences to normal tissues; in order to develop a reliable tool for tumor diagnostics more research is necessary, especially a collection of reference spectra in a data bank is needed. Raman spectra of biomineralization structures in teeth and bones show pathological tissues as well as the development of new mineralized structures. NIR Raman spectra of flowers, leaves, and fruit show, without special preparation, their constituents: alkaloids, the essential oils, natural dyes, flavors, spices and drugs. They allow application to taxonomy, optimizing plant breeding and control of food. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Essen Gesamthsch, Inst Phys & Theoret Chem, D-45117 Essen, Germany.
   Bundesanstalt Zuchtungsforsch Kulturpflanzen, D-06484 Quedlinburg, Germany.
RP Schrader, B (reprint author), Soniusweg 20, D-45259 Essen, Germany.
CR CAREY P, 1998, FACSS C AUST
   CARTER EA, 1998, SPIE, V3257, P72
   DIPPEL B, 1997, THESIS U ESSEN
   DIPPEL B, IN PRESS BIOSPECTROS
   DONG J, IN PRESS APPL SPECTR
   EDWARDS HGM, 1997, J RAMAN SPECTROSC, V28
   Fendel S, 1998, FRESEN J ANAL CHEM, V360, P609, DOI 10.1007/s002160050767
   FENDEL S, 1997, THESIS U ESSEN
   FRANK CJ, 1995, ANAL CHEM, V67, P777, DOI 10.1021/ac00101a001
   FREIS R, 1997, THESIS U ESSEN
   Gniadecka M, 1997, J RAMAN SPECTROSC, V28, P125
   GNIADECKA M, 1998, J INVEST DERMATOL, V110, P101
   HIRSCHFELD T, 1986, APPL SPECTROSC, V40, P133, DOI 10.1366/0003702864509538
   Jackson M, 1997, J MOL STRUCT, V408, P105, DOI 10.1016/S0022-2860(96)09461-6
   KELLER S, 1993, FRESEN J ANAL CHEM, V346, P863, DOI 10.1007/BF00321306
   KELLER S, 1994, J RAMAN SPECTROSC, V25, P663, DOI 10.1002/jrs.1250250729
   KELLER S, 1995, THESIS U ESSEN
   LOCHTE T, 1997, THESIS U ESEN
   LUCASSEN GW, 1998, SPIE, V3257, P52
   LUTZ M, 1991, CHLOROPHYLLS
   MANTSCH HH, 1998, SPIE, V3257
   MATTIOLI TA, 1990, CR ACAD SCI III-VIE, V310, P441
   NAUMANN D, 1995, J MOL STRUCT, V347, P399, DOI 10.1016/0022-2860(95)08562-A
   NAUMANN D, 1998, SPIE, V3257, P235
   Schrader B, 1997, CHEM UNSERER ZEIT, V31, P229, DOI 10.1002/ciuz.19970310504
   Schrader B, 1997, J MOL STRUCT, V408, P23, DOI 10.1016/S0022-2860(96)09491-4
   Schrader B, 1996, FRESEN J ANAL CHEM, V355, P233
   SCHRADER B, 1995, J MOL STRUCT, V348, P293, DOI 10.1016/0022-2860(95)08646-D
   SCHRADER B, IN PRESS
   SCHRADER B, 1998, SPIE, V3257, P66
   SCHRADER B, IN PRESS ASIAN J PHY
   Schrader B, 1995, INFRARED RAMAN SPECT
   SCHULZ H, IN PRESS
   TATSCH E, 1997, THESIS U ESSEN
   Urlaub E, 1998, BIOSPECTROSCOPY, V4, P113
   WESSEL S, 1998, IN PRESS BRIT J DERM
NR 36
TC 51
Z9 53
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 4
PY 1999
VL 481
SI SI
BP 21
EP 32
DI 10.1016/S0022-2860(98)00650-4
PG 12
WC Chemistry, Physical
SC Chemistry
GA 206XT
UT WOS:000080906300004
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Tomic, S
   Dakic, M
   Miljkovic, M
   Plavsic, M
   Uskokovic, D
AF Ignjatovic, N
   Tomic, S
   Dakic, M
   Miljkovic, M
   Plavsic, M
   Uskokovic, D
TI Synthesis and properties of hydroxyapatite/poly-L-lactide composite
   biomaterials
SO BIOMATERIALS
LA English
DT Article
DE calcium hydroxyapatite; poly-L-lactide; biocomposite; designing;
   microstructure
ID BONE
AB Calcium hydroxyapatite (HAp) and poly-L-lactide (PLLA) were synthesized chemically. The obtained HAp was of high purity and, after special thermal treatment, of high crystallinity as well. Synthesis of PLLA was performed using L-lactide as a monomer and nontoxic initiator. In this way a polymer of large molar weight (about 400 000) was obtained. The HAp and PLLA obtained were used as constituents of the HAp/PLLA composite biomaterial, a potential material for implants. The composite was obtained by mixing completely dissolved PLLA with granules of HAp. The composite was compacted by cold and hot pressing at pressures of 49.0-490.5 MPa and temperatures of 20-184 degrees C. The material obtained at optimum process parameters had a density of 99.6% and compressive strength of 93.2 MPa. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Serbian Acad Sci & Arts, Inst Tech Sci, YU-11000 Belgrade, Yugoslavia.
   Fac Technol & Met Belgrade, YU-11000 Belgrade, Yugoslavia.
   Univ Nis, Univ Ctr Electron Microscopy, YU-18000 Nish, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Sci & Arts, Inst Tech Sci, K Mihajlova 35-IV, YU-11000 Belgrade, Yugoslavia.
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Tomic, Simonida/0000-0002-9013-682X
CR German R.M., 1996, SINTERING THEORY PRA, P225
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIENDERAUER G, 1991, CERAMIC B, V70, P1010
   IGNJATOVIC N, 1998, MAT C 98 U OXF OXF, P214
   KATZ JL, 1986, ENCY MAT SCI ENG, P475
   LABELLA R, 1994, BIOMATERIALS, V15, P1197, DOI 10.1016/0142-9612(94)90269-0
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Lu LC, 1996, MRS BULL, V21, P28
   MCINTYRE JP, 1991, AM CERAM SOC BULL, V70, P1499
   OKUBO T, 1991, J AM CERAM SOC, V7, P1739
   Ripamonti U, 1996, MRS BULL, V21, P36
   Ristich Ch., 1996, J SERB CHEM SOC, V61, P311
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   SCHINDER A, 1979, J POLYM SCI POL CHEM, V17, P293
   TORMALA P, 1992, ADV MATER, V4, P589, DOI 10.1002/adma.19920040915
   USKOKOVIC D, 1989, SCI SINTERING NEW DI, P644
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Wang M., 1996, P 7 EUR C COMP MAT L, P455
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
   ZANG X, 1992, POLYM B, V27, P623
NR 23
TC 179
Z9 194
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1999
VL 20
IS 9
BP 809
EP 816
DI 10.1016/S0142-9612(98)00234-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 186ZQ
UT WOS:000079761800002
PM 10226707
DA 2018-10-19
ER

PT J
AU Park, JH
   Park, KD
   Bae, YH
AF Park, JH
   Park, KD
   Bae, YH
TI PDMS-based polyurethanes with MPEG grafts: synthesis, characterization
   and platelet adhesion study
SO BIOMATERIALS
LA English
DT Article
DE polymer grafting; poly(dimethyl siloxane); poly(ethylene glycol);
   polyurethane; platelet adhesion
ID BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLY(ETHYLENE GLYCOL);
   BACTERIAL ADHESION; VIVO EVALUATION; EX-VIVO; SURFACES; URETHANES;
   OXIDE; ZWITTERIONOMERS
AB Polyurethane (PU), based on poly(dimethyl siloxane) (PDMS) as a soft segment, with monomethoxy poly(ethylene glycol) (MPEG) grafted onto it, was synthesized as a new polymeric biomaterial for coating PDMS-based biomedical devices. Two different chain extenders, ethylene glycol (EG) and diethyl bis(hydroxymethyl) malonate (DBM), were used for the synthesis of PDMS-based PUs and then MPEG was grafted onto them by allophanate and esterification reactions, respectively. Their molecular structures were confirmed qualitatively and quantitatively using FT-IR and H-1-NMR measurements. PDMS-based PU was more hydrophobic than Pellethane(R), which is a commercial biomedical-grade poly(ether urethane), due to the PDMS-rich phase at the polymeric surface. However, the incorporation of MPEG in PDMS-based PU induced an increase in hydrophilicity. Analyses of their morphology using dynamic mechanical analysis and differential scanning calorimetry showed that the degree of phase separation increased with the content of hard segments. It also showed that MPEG is compatible with a hard segment consisting of 4,4'-diphenylmethane diisocyanate (MDI) and DBM, while being incompatible with one consisting of MDI and EG. Platelet adhesions with PDMS-based PUs were significantly reduced when compared with Pellethane(R). It was also observed from a platelet adhesion experiment that the incorportion of MPEG further reduced platelet adhesion. PDMS-based PUs with MPEG grafts, which have few hard segments and a distinct PEG phase, exhibited the least platelet adhesion among the polymer samples tested. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Kwangju 506712, South Korea.
   Korea Inst Sci & Technol, Polymer Chem Lab, Seoul 130650, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, 572 Sangam Dong, Kwangju 506712, South Korea.
RI Park, Jae Hyung/B-5967-2018; byun, jaehyun/G-5584-2014
CR ARKLES B, 1983, BIOCOMPATIBLE POLYM, P749
   Baumgartner JN, 1996, ASAIO J, V42, pM476, DOI 10.1097/00002480-199609000-00033
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   Chandy T, 1996, ARTIF ORGANS, V20, P752, DOI 10.1111/j.1525-1594.1996.tb04536.x
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   HERMAN S, 1995, J BIOACT COMPAT POL, V10, P145, DOI 10.1177/088391159501000205
   Inoue H, 1997, J BIOMED MATER RES, V35, P255
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   KOBER M, 1992, J POLYM SCI POL CHEM, V30, P1061, DOI 10.1002/pola.1992.080300611
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LI C, 1988, J POLYM SCI POL PHYS, V26, P315, DOI 10.1002/polb.1988.090260209
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   Nojiri C, 1996, ASAIO J, V42, pM468, DOI 10.1097/00002480-199609000-00032
   Park KD, 1996, ASAIO J, V42, pM876, DOI 10.1097/00002480-199609000-00117
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   RICHARDS TM, 1987, T ASAIO, V33, P643
   SIGGIA S, 1948, ANAL CHEM, V20, P1084, DOI 10.1021/ac60023a029
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   TSURUTA T, 1993, BIOMEDICAL APPL POLY, P89
   VOS RD, 1986, POLYM B, V15, P547
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   YANG CZ, 1991, J POLYM SCI POL PHYS, V29, P75, DOI 10.1002/polb.1991.090290110
   YU XH, 1985, J POLYM SCI POL PHYS, V23, P2319, DOI 10.1002/pol.1985.180231106
NR 34
TC 122
Z9 128
U1 7
U2 84
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1999
VL 20
IS 10
BP 943
EP 953
DI 10.1016/S0142-9612(98)00250-6
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 188EG
UT WOS:000079833000005
PM 10353648
DA 2018-10-19
ER

PT J
AU Shah, AK
   Sinha, RK
   Hickok, NJ
   Tuan, RS
AF Shah, AK
   Sinha, RK
   Hickok, NJ
   Tuan, RS
TI High-resolution morphometric analysis of human osteoblastic cell
   adhesion on clinically relevant orthopedic alloys
SO BONE
LA English
DT Article
DE human osteoblasts; cell adhesion; focal adhesion contacts; cytoskeletal
   organization; cell morphology; confocal laser scanning microscopy;
   bioimplants; titanium alloy; chrome-cobalt alloy
ID EXTRACELLULAR-MATRIX; IMPLANT MATERIALS; INTEGRIN EXPRESSION; SIGNAL
   TRANSDUCTION; FOCAL ADHESIONS; IN-VITRO; SURFACE; BONE; SUBSTRATA;
   GROWTH
AB Understanding the cellular basis of osteoblastic cell-biomaterial interaction is crucial to the analysis of the mechanism of osseointegration, a requirement of long-term orthopedic implant stability. Clinically, the amount of bone ingrowth is variable, and cellular parameters that influence ingrowth have yet to be clearly determined. In this study, two clinically relevant orthopedic alloys, titanium Ti6A14V (Ti) and cobalt-chrome-molybdenum (CC), were used for a comparative analysis of primary human osteoblastic cell adhesion and spreading, where cell adhesion represents the initial interaction between cellular elements and the biomaterial surface. The kinetic profile of adhesion revealed enhanced cell attachment upon rough Ti surfaces relative to rough Cc. Using confocal laser scanning microscopy (CLSM), we observed that, during the first 12 h of contact with the substratum, osteoblastic cells were relatively less spread on rough Ti, whereas cells appeared elongated with multiple cellular extensions on rough CC. Focal adhesion contacts, as indicated by vinculin immunostaining, were distributed throughout the cells adhering to Ti, but were relatively sparse and localized to cellular processes on CC. Furthermore, three;dimensional CLSM reconstruction analysis indicated the presence of vinculin at all membrane-to-surface contact points on both Ti and CC. On Ti, these contact points closely followed the surface contour, whereas, on CC, they were restricted to relative topographic peaks only. Actin cytoskeletal reorganization was prominent in cells cultured on Ti, with stress fibers arranged throughout the cell body, whereas, on CC, actin filaments were sparse and localized primarily to cellular extensions. Because cell attachment mechanisms are likely to influence signal transduction and regulation of gene expression, these early differential responses of osteoblastic cells on Ti and CC may have functional implications on subsequent extracellular matrix mineralization and bone ingrowth at the cell-biomaterial interface. (C) 1999 by Elsevier Science Inc. All rights reserved.
C1 Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA.
   Thomas Jefferson Univ, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA.
RP Tuan, RS (reprint author), Thomas Jefferson Univ, Dept Orthoped Surg, 1015 Walnut St,Curtis 501, Philadelphia, PA 19107 USA.
FU NICHD NIH HHS [HD29937, HD15822]; NIAMS NIH HHS [AR01877]
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   ALBREKTSSON T, 1987, ACTA ORTHOP SCAND, V58, P567, DOI 10.3109/17453678709146401
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CANNAS M, 1988, J ORTHOPAED RES, V6, P58, DOI 10.1002/jor.1100060108
   Castoldi M, 1997, CELL BIOL INT, V21, P7, DOI 10.1006/cbir.1996.0110
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CURTIS A, 1987, J CELL SCI, V87, P609
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HORTON MA, 1989, J BONE MINER RES, V4, P803
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1994, BIOESSAYS, V16, P663, DOI 10.1002/bies.950160912
   Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   KUMAR NM, 1995, EXP CELL RES, V221, P385, DOI 10.1006/excr.1995.1389
   LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601
   Lian J B, 1995, Iowa Orthop J, V15, P118
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MCCANN T, 1995, BIOCHEM SOC T, V23, pS404, DOI 10.1042/bst023404s
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   MUNDY GR, 1995, CLIN ORTHOP RELAT R, P19
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   Price N, 1997, J BIOMED MATER RES, V37, P394, DOI 10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C
   R Chang, 1998, T ORTHOP RES SOC, V44, P517
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   SINHA R K, 1991, Journal of Cell Biology, V115, p448A
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SINHA RK, 1992, MOL BIOL CELL, V3, pA1332
   SPECTOR M, 1981, BIOCOMPATIBILITY CLI
   THOMAS KA, 1987, T ORTHOP RES SOC, V33, P432
   UYEN HMW, 1990, J BIOMED MATER RES, V24, P1599, DOI 10.1002/jbm.820241205
NR 51
TC 73
Z9 74
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 1999
VL 24
IS 5
BP 499
EP 506
DI 10.1016/S8756-3282(99)00077-0
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 190GN
UT WOS:000079954600008
PM 10321910
DA 2018-10-19
ER

PT J
AU Rao, GHR
   Chandy, T
AF Rao, GHR
   Chandy, T
TI Role of platelets in blood-biomaterial interactions
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE platelet adhesion; protein adsorption; biomaterials; surface induced
   platelet activation; fibrinogen; platelet-surface receptors;
   antiplatelet drugs
ID FIBRINOGEN BINDING; SURFACE PROPERTIES; PLASMA-PROTEINS; FACTOR-XII;
   ADHESION; ATHEROSCLEROSIS; AGGREGATION; CATHETERS; RECEPTORS; RELEASE
AB Over 2 million cardiovascular procedures are performed annually in the United States. Every one of these procedures requires some period of contact with blood with several different biomaterials used in the manufacture of assist devices or implant devices. In view of the increasing importance of the biomaterials in clinical practice, it would be timely to review briefly physicochemical characterization as well as biological evaluations. Blood compatibility encompasses a variety of events associated with blood interaction with the biomaterials used in various procedures. Two separate coagulation mechanisms are involved (arterial and venous) depending upon the flow characteristics. At least three Interacting factors modulate normal hemostasis and the pathogenesis of thromboembolic events. They are the state of activation of coagulation cascade, circulating levels of thrombin and fibrinogen and relative activity of platelets. In this overview we discuss the current concepts on the role of platelets in blood-biomaterial interactions.
   When blood contacts a biomaterial surface a variety of blood components interact with the surface. Some of the key players in platelet activation on biomaterial surface include fibrinogen and von Willebrand factor. Currently available antiplatelet drugs effectively block aggregation and secretion induced by physiological agonists such as epinephrine, adenosine diphosphate and thromboxane in suspension. However, they do not prevent platelet interaction on biomaterial surfaces. Mechanisms involved in platelet activation In suspension and on surfaces as well as the pharmacology of newer antiplatelet drugs will be discussed.
C1 Univ Minnesota, Acad Hlth Ctr, Inst Biomed Engn, Minneapolis, MN 55455 USA.
RP Rao, GHR (reprint author), Univ Minnesota, Acad Hlth Ctr, Inst Biomed Engn, PB 609 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.
OI Rao, Gundu H.R./0000-0002-2692-7950
CR ABSOLOM DR, 1984, BIOMATER ARTIF CELL, V12, P235, DOI 10.3109/10731198409118834
   ANDREWS RK, 1991, CURR OPIN CELL BIOL, V2, P894
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   CHANDY T, 1987, POLYM-PLAST TECHNOL, V26, P143, DOI 10.1080/03602558708071937
   Chandy T, 1998, J BIOMATER APPL, V13, P46, DOI 10.1177/088532829801300103
   CHANDY T, 1988, ARTIF ORGANS, V12, P143, DOI 10.1111/j.1525-1594.1988.tb02747.x
   CHESNEY CM, 1982, BLOOD, V59, P582
   CHESTERMAN CN, 1986, CLIN HAEMATOL, V15, P323
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   DIFAZIO LT, 1994, J SURG RES, V57, P133, DOI 10.1006/jsre.1994.1120
   FEUERSTEIN IA, 1993, BIOMATERIALS, V14, P137, DOI 10.1016/0142-9612(93)90228-T
   FRESSINAUD E, 1988, J LAB CLIN MED, V112, P58
   FRIEDMAN LI, 1970, T AM SOC ART INT ORG, V16, P63
   Goldsmith H L, 1972, Prog Hemost Thromb, V1, P97
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001
   KLOCZEWIAK M, 1989, BIOCHEMISTRY-US, V28, P2915, DOI 10.1021/bi00433a025
   LINDON JN, 1986, BLOOD, V68, P355
   MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357
   MOHAMMAD SF, 1974, HAEMOSTASIS, V3, P257
   MUSTARD JF, 1975, THROMB DIATH HAEMOST, V33, P444, DOI 10.1055/s-0038-1647838
   PACKHAM MA, 1984, BLOOD PLATELET FUNCT, P61
   Park K, 1989, Scanning Microsc Suppl, V3, P137
   PEERSCHKE EI, 1980, BLOOD, V55, P841
   Rao Gundu H. R., 1994, Indian Journal of Physiology and Pharmacology, V38, P69
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SHARMA CP, 1984, BIOMATER ARTIF CELL, V12, P215, DOI 10.3109/10731198409118833
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1982, ADV CHEM SER, V199, P266
   WHITE AM, 1978, BRIT MED BULL, V34, P123, DOI 10.1093/oxfordjournals.bmb.a071481
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 35
TC 11
Z9 12
U1 0
U2 12
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD MAY
PY 1999
VL 22
IS 3
BP 633
EP 639
DI 10.1007/BF02749979
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 214EV
UT WOS:000081316400068
DA 2018-10-19
ER

PT J
AU Kelley, C
   Mielke, RE
   Dimaquibo, D
   Curtis, AJ
   Dewitt, JG
AF Kelley, C
   Mielke, RE
   Dimaquibo, D
   Curtis, AJ
   Dewitt, JG
TI Adsorption of Eu(III) onto roots of water hyacinth
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID DATURA-INNOXIA BIOMATERIAL; ION-BINDING-SITES; INDIAN MUSTARD; CADMIUM
   UPTAKE; LUMINESCENCE; EUROPIUM(III); COMPLEXES; COPPER; SPECTROSCOPY;
   ACCUMULATION
AB The water hyacinth (Eichhornia crassipes) has drawn attention as a plant capable of removing pollutants, including toxic metals, from water. We are interested in the capacity of the water hyacinth to remediate aquatic environments that have been contaminated with the lanthanide metal, europium (Eu(III)). Using scanning electron microscopy (SEM) we have been able to determine that Eu(III) is adsorbed onto the surface of the roots from water and that the highest concentration of Eu(III) is on the root hairs. X-ray absorption spectroscopy (XAS) techniques were used to speciate the Eu(III) adsorbed onto the surface of the roots. The XAS data for Eu-contaminated water hyacinth roots provides evidence of a Eu-oxygen environment and establishes that Eu(III) is coordinated to 10-11 oxygen atoms at a distance of 2.44 parallel to. This likely involves binding of Eu(III) to the root via carboxylate groups and hydration of Eu(III) at the root surface.
C1 No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA.
   San Francisco State Univ, San Francisco, CA 94132 USA.
RP Kelley, C (reprint author), No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA.
CR BOMBIERI G, 1989, POLYHEDRON, V8, P2157
   BOMBIERI G, 1991, POLYHEDRON, V10, P1385, DOI 10.1016/S0277-5387(00)81273-5
   CHIGBO FE, 1982, ENVIRON POLLUT A, V27, P31, DOI 10.1016/0143-1471(82)90060-5
   Cotton FA, 1988, ADV INORGANIC CHEM
   CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4
   DELGADO M, 1993, WATER RES, V27, P269, DOI 10.1016/0043-1354(93)90085-V
   Denecke MA, 1997, RADIOCHIM ACTA, V79, P151
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Drake LR, 1997, APPL SPECTROSC, V51, P1476, DOI 10.1366/0003702971939253
   EPHRAIM JH, 1991, SCI TOTAL ENVIRON, V108, P261, DOI 10.1016/0048-9697(91)90363-J
   Forstner U., 1979, METAL POLLUTION AQUA
   GONZALEZ H, 1989, B ENVIRON CONTAM TOX, V43, P910, DOI 10.1007/BF01702064
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   HAO YY, 1993, J ENVIRON SCI HEAL A, V28, P2333, DOI 10.1080/10934529309376013
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1993, ENVIRON SCI TECHNOL, V27, P2466, DOI 10.1021/es00048a024
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KELLEY C, IN PRESS WATER AIR S
   Koningsberger D., 1988, XRAY ABSORPTION PRIN
   Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0
   LEE TA, 1987, J ENVIRON SCI HEAL A, V22, P141, DOI 10.1080/10934528709375340
   Lin S, 1998, ENVIRON SCI TECHNOL, V32, P1488, DOI 10.1021/es970843z
   Liu SY, 1996, INORG CHEM, V35, P76, DOI 10.1021/ic941469w
   LOW K S, 1990, Pertanika, V13, P129
   LOW KS, 1994, J ENVIRON SCI HEAL A, V29, P171, DOI 10.1080/10934529409376028
   LOW KS, 1995, BIORESOURCE TECHNOL, V52, P79, DOI 10.1016/0960-8524(95)00007-2
   MCKALE AG, 1988, J AM CHEM SOC, V110, P3763, DOI 10.1021/ja00220a008
   MORET E, 1990, INORG CHIM ACTA, V178, P83, DOI 10.1016/S0020-1693(00)88138-4
   MURAMOTO S, 1983, B ENVIRON CONTAM TOX, V30, P170, DOI 10.1007/BF01610117
   NAKAMURA K, 1995, ACTA CRYSTALLOGR C, V51, P1559, DOI 10.1107/S0108270195001843
   NIR R, 1990, B ENVIRON CONTAM TOX, V44, P149, DOI 10.1007/BF01702375
   Norton MV, 1997, WATER ENVIRON RES, V69, P244, DOI 10.2175/106143097X125416
   OKEEFFE DH, 1984, ENVIRON POLLUT A, V34, P133, DOI 10.1016/0143-1471(84)90054-0
   Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643
   SALT DE, 1995, PLANT PHYSIOL, V109, P1427, DOI 10.1104/pp.109.4.1427
   Salt DE, 1997, ENVIRON SCI TECHNOL, V31, P1636, DOI 10.1021/es960802n
   SCOTT RA, 1982, J AM CHEM SOC, V104, P5364, DOI 10.1021/ja00384a020
   SCOTT RA, 1985, METHOD ENZYMOL, V117, P414
   WATANABE M, 1907, ENVIRON SCI TECHNOL, V31, P182
   WOLVERTON BC, 1975, TMX72721 NASA
   ZHURAVLEV MG, 1989, DOKL AKAD NAUK SSSR+, V306, P878
NR 42
TC 55
Z9 59
U1 2
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD MAY 1
PY 1999
VL 33
IS 9
BP 1439
EP 1443
DI 10.1021/es9807789
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 192YH
UT WOS:000080107000033
DA 2018-10-19
ER

PT J
AU Jallot, E
   Irigaray, JL
   Oudadesse, H
   Brun, V
   Weber, G
   Frayssinet, P
AF Jallot, E
   Irigaray, JL
   Oudadesse, H
   Brun, V
   Weber, G
   Frayssinet, P
TI Resorption kinetics of four hydroxyapatite-based ceramics by particle
   induced X-ray emission and neutron activation analysis
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID ALPHA-PARAMETER METHOD; THICK TARGETS TTPIXE; CALCIUM-PHOSPHATE; NATURAL
   CORAL; PIXE; OSSIFICATION; DEGRADATION
AB From the viewpoint of hard tissue response to implant materials, calcium phosphates are probably the most compatible materials presently known. During the last few years, much attention has been paid to hydroxyapatite and beta-tricalcium phosphate as potential biomaterials for bone substitute. A good implantation of biomaterials in the skeleton is to reach full integration of non-living implant with living bone. The aim of this study is to compare the resorption kinetics of four kinds of calcium phosphate ceramics: hydroxyapatite (Ca-10(PO4)(6)(OH)(2)), hydroxyapatite doped with manganese or zinc and a composite material of 75% hydroxyapatite and 25% beta-tricalcium phosphate (Ca-3(PO4)(2)) Cylinders (5-6 mm in diameter) of these ceramics were packed into holes made in the femur diaphysis of mature ovine. At 2, 4, 8, 12, 16, 20, 28, 36 and 48 weeks after the operation, bone/implant interface was embedded in polymethylmethacrylate. We used the PIXE method (particle induced X-ray emission) to measure the distribution of mineral elements (Ca, P, Sr, Zn, Mn and Fe) at the bone/implant interface. At 4, 8; 16, 28 and 48 weeks after implantation we studied a biopsy of the ceramics by neutron activation method. Then, we have a global measurement of mineral elements in the biomaterial. The results showed that the resorption kinetics of hydroxyapatite doped with zinc was faster than that of the three other bioceramics.
C1 Lab Microscopie Elect, F-51685 Reims 2, France.
   Lab Phys Corpusculaire Clermont Ferrand, CNRS, IN2P3, F-63177 Aubiere, France.
   Inst Phys Nucl Expt, B-4000 Liege, Belgium.
   Soc Ind Bioland, F-31100 Toulouse, France.
RP Jallot, E (reprint author), Lab Microscopie Elect, 21 Rue Clement Ader, F-51685 Reims 2, France.
CR Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DARDENNE C, 1993, J RADIOAN NUCL CH AR, V168, P417, DOI 10.1007/BF02040522
   DELBROUCKHABARU JM, 1993, NUCL INSTRUM METH B, V73, P71, DOI 10.1016/0168-583X(93)96055-H
   DZHELEPOV BS, 1961, DECAY SCHEMES RADIOA
   FRAYSSINET P, 1993, BIOTECH HISTOCHEM, V68, P333, DOI 10.3109/10520299309105639
   *INT AT EN AG, 1974, TECHN REP SER INT AT, V156
   Irigaray JL, 1996, J BIOMAT SCI-POLYM E, V7, P741, DOI 10.1163/156856296X00507
   IRIGARAY JL, 1995, J MATER SCI-MATER M, V6, P230, DOI 10.1007/BF00146861
   IWAMI K, 1992, J ENVIRON SCI HEAL A, VA27, P771, DOI 10.1080/10934529209375760
   Jallot E, 1998, NUCL INSTRUM METH B, V142, P156, DOI 10.1016/S0168-583X(98)00269-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KIENHOLZ EW, 1961, J NUTR, V15, P211
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LI CY, 1993, P NATL ACAD SCI USA, V90, P8264, DOI 10.1073/pnas.90.17.8264
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Weber G, 1996, NUCL INSTRUM METH B, V109, P186, DOI 10.1016/0168-583X(95)00903-5
   WEBER G, 1994, NUCL INSTRUM METH B, V89, P200, DOI 10.1016/0168-583X(94)95172-1
   ZAZO JF, 1993, MED HYG, V51, P2304
NR 21
TC 26
Z9 26
U1 0
U2 6
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD MAY
PY 1999
VL 6
IS 2
BP 205
EP 215
DI 10.1051/epjap:1999172
PG 11
WC Physics, Applied
SC Physics
GA 213NV
UT WOS:000081280900014
DA 2018-10-19
ER

PT J
AU Tuan, DQ
   Zollweg, JA
   Harriott, P
   Rizvi, SSH
AF Tuan, DQ
   Zollweg, JA
   Harriott, P
   Rizvi, SSH
TI Measurement and modeling of viscosity of supercritical carbon
   dioxide/biomaterial(s) mixtures
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID CORRESPONDING STATES; FATTY-ACIDS; DIOXIDE; FLUIDS; PREDICTION; OILS
AB The viscosities of a binary, supercritical carbon dioxide/methyl oleate (SC-CO2/MO, and a multicomponent, SC-CO2/anhydrous milkfat (AMF) system at 40 degrees C and over a pressure range of 10.6-25.0 MPa were measured in a high-pressure capillary viscometer. The experimental data, and data from the literature, were utilized in viscosity modeling with fly and Hanley's corresponding states model for SC-CO2/biomaterial(s) systems. The modified Benedict-Webb-Rubin equation of state and a viscosity correlation with propane as the reference material were used. An adjustable parameter was added to the energy shape factor equation. This approach worked well for both the fluid and liquid phases of the SC-CO2/biomaterial(s) systems with an average absolute deviation of 3-6%. Compared to the purely correlative Grunberg and Nissan model, this method has better predictive capability, while maintaining comparable accuracy.
C1 Cornell Univ, Inst Food Sci, Ithaca, NY 14853 USA.
   Cornell Univ, Sch Chem Engn, Ithaca, NY 14853 USA.
RP Rizvi, SSH (reprint author), Cornell Univ, Inst Food Sci, Stocking Hall, Ithaca, NY 14853 USA.
OI Rizvi, Syed/0000-0001-9518-1243
CR ANGUS S, 1992, IUPAC CARBON DIOXIDE, V3
   BHASKAR AR, 1993, J FOOD SCI, V58, P748, DOI 10.1111/j.1365-2621.1993.tb09350.x
   BRUNO JT, 1991, REV MODERN THEORY AP, P245
   CHEN LJ, 1988, AICHE J, V34, P1743, DOI 10.1002/aic.690341023
   DAUBERT TE, 1989, PHYSICAL THERMODYNAM
   Ely J.F., 1981, 1039 NBS
   Ely J. F., 1984, P 63 ANN CONV, P9
   ELY JF, 1981, IND ENG CHEM FUND, V20, P323, DOI 10.1021/i100004a004
   HANLEY HJM, 1976, CRYOGENICS, V16, P643, DOI 10.1016/0011-2275(76)90035-7
   Huber M, 1996, TRANSPORT PROPERTIES, P283
   HWANG MJ, 1987, IND ENG CHEM RES, V26, P1758, DOI 10.1021/ie00069a008
   KASHULINES P, 1991, J AM OIL CHEM SOC, V68, P912, DOI 10.1007/BF02657535
   KASHULINES PT, 1992, THESIS CORNELL U ITH
   LLAVE FM, 1990, SPE RESERVOIR EN FEB, P47
   Mehrotra AK, 1996, FLUID PHASE EQUILIBR, V117, P344, DOI 10.1016/0378-3812(95)02971-0
   MONNERY WD, 1991, CAN J CHEM ENG, V69, P1213, DOI 10.1002/cjce.5450690523
   MONNERY WD, 1995, CAN J CHEM ENG, V93, P3
   PEDERSEN KS, 1984, CHEM ENG SCI, V39, P1011, DOI 10.1016/0009-2509(84)87009-8
   Peter S., 1991, J SUPERCRIT FLUID, V4, P166
   PETER S, 1988, P INT S SUPERCRITICA, P303
   REID RC, 1987, PROPERTIES GASES LIQ, P577
   RIZVI SSH, 1986, FOOD TECHNOL-CHICAGO, V40, P57
   Stephan K., 1979, VISCOSITY DENSE FLUI
   TILLY KD, 1994, IND ENG CHEM RES, V33, P681, DOI 10.1021/ie00027a028
   YENER ME, 1996, THESIS CORNELL U ITH
   Yu Z. R., 1992, THESIS CORNELL U ITH
   YU ZR, 1994, J SUPERCRIT FLUID, V7, P51, DOI 10.1016/0896-8446(94)90006-X
NR 27
TC 18
Z9 18
U1 1
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAY
PY 1999
VL 38
IS 5
BP 2129
EP 2136
DI 10.1021/ie980363w
PG 8
WC Engineering, Chemical
SC Engineering
GA 194LL
UT WOS:000080195000045
DA 2018-10-19
ER

PT J
AU Rupp, ME
   Ulphani, JS
   Fey, PD
   Bartscht, K
   Mack, D
AF Rupp, ME
   Ulphani, JS
   Fey, PD
   Bartscht, K
   Mack, D
TI Characterization of the importance of polysaccharide intercellular
   adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis
   of biomaterial-based infection in a mouse foreign body infection model
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE/ADHESIN;
   TRANSPOSON MUTANTS; BIOFILM PRODUCTION; ADHERENCE; SLIME; ADHESIN;
   CATHETERS; ENDOCARDITIS; ASSOCIATION
AB The production of biofilm is thought to be crucial in the pathogenesis of prosthetic-device infections caused by Staphylococcus epidermidis, An experimental animal model was used to assess the importance of biofilm production, which is mediated by polysaccharide intercellular adhesin/hemagglutinin (PIA/HA), in the pathogenesis of a biomaterial-based infection. Mice were inoculated along the length of a subcutaneously implanted intravenous catheter with either wild-type S, epidermidis 1457 or its isogenic PIA/HA-negative mutant. The wild-type strain was significantly more likely to cause a subcutaneous abscess than the mutant strain (P < 0.01) and was significantly less likely to be eradicated from the inoculation site by host defense (P < 0.05). In addition, the wild-type strain was found to adhere to the implanted catheters more abundantly than the PIG/HA-negative mutant (P < 0.05), The reliability of the adherence assay was assessed by scanning electron microscopy, To exclude contamination or spontaneous infection, bacterial strains recovered from the experimental animals were compared to inoculation strains by analysis of restriction fragment length polymorphism patterns by pulsed-field gel electrophoresis. In vitro binding of the wild-type strain and its isogenic mutant to a fibronectin-coated surface was similar. These results confirm the importance of biofilm production, mediated by PIA/HA, in the pathogenesis of S, epidermidis experimental foreign body infection.
C1 Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.
   Univ Hamburg, Inst Med Microbiol & Immunol, Hamburg, Germany.
RP Rupp, ME (reprint author), 985400 Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.
CR Baldassarri L, 1997, INFECT IMMUN, V65, P1522
   BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
   CANO M, 1993, SCANNING MICROSCOPY, V7, P363
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   DIAZMITOMA F, 1987, J INFECT DIS, V156, P555
   DREWRY DT, 1990, J CLIN MICROBIOL, V28, P1292
   Favero MS, 1996, AM J INFECT CONTROL, V24, P380
   FEY P, 1998, 98 GEN M AM SOC MICR, P241
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hussain M, 1997, INFECT IMMUN, V65, P519
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   KRISTINSSON KG, 1988, J MED MICROBIOL, V27, P207, DOI 10.1099/00222615-27-3-207
   LIMOGES J, 1995, 95 GEN M AM SOC MICR, P241
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, IN PRESS J HOSP INFE
   MacKay DJC, 1996, NEURAL COMPUT, V8, P178, DOI 10.1162/neco.1996.8.1.178
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PATRICK CC, 1992, INFECT IMMUN, V60, P1363
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Rupp M E, 1995, Infect Dis Obstet Gynecol, V2, P218, DOI 10.1155/S1064744995000056
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042
   TAKEDA S, 1991, CIRCULATION, V84, P2539, DOI 10.1161/01.CIR.84.6.2539
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
NR 38
TC 200
Z9 206
U1 1
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAY
PY 1999
VL 67
IS 5
BP 2627
EP 2632
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 189MQ
UT WOS:000079909300079
PM 10225932
DA 2018-10-19
ER

PT J
AU Rupp, ME
   Ulphani, JS
   Fey, PD
   Mack, D
AF Rupp, ME
   Ulphani, JS
   Fey, PD
   Mack, D
TI Characterization of Staphylococcus epidermidis polysaccharide
   intercellular adhesin/hemagglutinin in the pathogenesis of intravascular
   catheter-associated infection in a rat model
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE/ADHESIN;
   TRANSPOSON MUTANTS; BIOFILM PRODUCTION; ADHESIN; SLIME; ADHERENCE;
   STRAINS; ACCUMULATION; ENDOCARDITIS
AB Biofilm production is thought to be a crucial factor in the ability of Staphylococcus epidermidis to produce a biomaterial-based infection. A rat central venous catheter (CVC)-associated infection model was used to assess the importance of biofilm production, mediated by polysaccharide intercellular adhesin/hemagglutinin (PIA/HA), in the pathogenesis of intravascular catheter-associated infection, PIA/HA-positive S. epidermidis 1457 was significantly more likely to cause a CVC-associated infection (71 versus 14%, P < 0.03) resulting in bacteremia and metastatic disease than its isogenic PIA/HA-negative mutant. These results confirm the importance of biofilm production, mediated by PIA/HA in the pathogenesis of S. epidermidis experimental CVC-associated infection.
C1 Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.
   Univ Hamburg, Inst Med Microbiol & Immunol, Hamburg, Germany.
RP Rupp, ME (reprint author), Univ Nebraska, Med Ctr, Dept Internal Med, 600 S 42nd St, Omaha, NE 68198 USA.
CR BANERJEE JSN, 1991, AM J MED S3B, V91
   BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   Christensen Gordon D., 1994, P45
   DREWRY DT, 1990, J CLIN MICROBIOL, V28, P1292
   FEY PD, 1998, 98 GEN M AM SOC MICR, P62
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Jarvis WR, 1997, AM J INFECT CONTROL, V25, P477
   KOJIMA Y, 1990, J INFECT DIS, V162, P435, DOI 10.1093/infdis/162.2.435
   LIMOGES J, 1995, 95 GEN M AM SOC MICR, P241
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, IN PRESS J HOSP INFE
   MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   PATRICK CC, 1992, INFECT IMMUN, V60, P1363
   Perdreau-Remington F, 1998, INFECT IMMUN, V66, P2778
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   RUPP ME, 1997, 97 GEN M AM SOC MICR, P98
   RUPP ME, 1998, Patent No. 5839393
   RUPP ME, 1997, 35 ANN M INF DIS SOC, P143
   RUPP ME, 1993, CLIN INFECT DIS, V17, P554
   RUPP ME, 1998, Patent No. 5762636
   SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   ULPHANI JS, IN PRESS LAB ANIM SC
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 40
TC 161
Z9 166
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAY
PY 1999
VL 67
IS 5
BP 2656
EP 2659
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 189MQ
UT WOS:000079909300085
PM 10225938
DA 2018-10-19
ER

PT J
AU Mottu, F
   Rufenacht, DA
   Doelker, E
AF Mottu, F
   Rufenacht, DA
   Doelker, E
TI Radiopaque polymeric materials for medical applications - Current
   aspects of biomaterial research
SO INVESTIGATIVE RADIOLOGY
LA English
DT Review
DE biomaterials; radiopacity; x-ray imaging; radiopaque polymers; polymers;
   implants; inserts; review
ID CEREBRAL ARTERIOVENOUS-MALFORMATIONS; CELLULOSE-ACETATE POLYMER;
   ISOBUTYL 2-CYANOACRYLATE BUCRYLATE; ENDOVASCULAR EMBOLIZATION; DIRECT
   THROMBOSIS; EXPERIMENTAL ANEURYSMS; CLINICAL-EXPERIENCE;
   SPHERICAL-PARTICLES; FOLLOW-UP; POLY(2-HYDROXYETHYL METHACRYLATE)
AB The aim of this review is to give an overview and some insight into different radiopaque polymeric materials that are currently used as medical implants or inserts. The advantages and limitations of each radiopaque polymeric material are summarized. The main method used to make medical implants radiologically visible is based on blending polymers with conventional radiopaque agents, blends which usually are a physical mixture of acrylic derivatives and inorganic salts, Other methods reported involve either the formation of single-phase radiopaque polymer salt complexes somehow preventing the release of the radiopacifying element by entrapment of the complex in a crosslinked network, or radiopaque polymerized monomers characterized by a radiopacifying element associated with the monomer unit prior to polymerization,
   In the near future, research will certainly concentrate on biocompatible radiopaque polymers,vith covalently bound opaque elements leading to stable polymers with properties equivalent to the nonopaque, parent polymer.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut Technol, CH-1211 Geneva 4, Switzerland.
   Univ Geneva, Div Diagnost & Intervent Radiol, Geneva, Switzerland.
RP Doelker, E (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut Technol, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.
CR ABOUTABL ZM, 1979, BRIT DENT J, V147, P187, DOI 10.1038/sj.bdj.4804318
   ACKERMAN JR, 1982, ENCY CHEM TECHNOLOGY, P786
   AKIMOVA AY, 1988, Patent No. 2610828
   ALVARES LC, 1966, ORAL SURG ORAL MED O, V22, P318, DOI 10.1016/0030-4220(66)90301-X
   BANK WO, 1981, RADIOLOGY, V139, P609, DOI 10.1148/radiology.139.3.6165036
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   BERENSTEIN A, 1979, RADIOLOGY, V132, P631, DOI 10.1148/132.3.631
   BOENIG HV, 1973, STRUCTURE PROPERTIES
   Bovey F, 1979, MACROMOLECULES INTRO
   BOWEN RL, 1969, J DENT RES, V48, P79, DOI 10.1177/00220345690480013101
   BOWEN RL, 1972, J DENT RES, V51, P177, DOI 10.1177/00220345720510011301
   BRAUER GM, 1981, J AM DENT ASSOC, V102, P347
   BROTHERS MF, 1989, AM J NEURORADIOL, V10, P177
   CASASCO A, 1994, AM J NEURORADIOL, V15, P1233
   CAUSTON BE, 1982, Patent No. 8201006
   Cekirge S, 1996, CARDIOVASC INTER RAD, V19, P56, DOI 10.1007/BF02560151
   CHALOUPKA JC, 1993, J NEUROSURG, V78, P1006
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Chandler H H, 1971, J Biomed Mater Res, V5, P335, DOI 10.1002/jbm.820050406
   Chandler H H, 1971, J Biomed Mater Res, V5, P359, DOI 10.1002/jbm.820050407
   CHANDLER H H, 1971, Journal of Biomedical Materials Research, V5, P253, DOI 10.1002/jbm.820050312
   CHANDLER H H, 1971, Journal of Biomedical Materials Research, V5, P245, DOI 10.1002/jbm.820050311
   CHANDLER HH, 1973, J DENT RES, V52, P1128, DOI 10.1177/00220345730520052201
   CHANDLER HH, 1970, J AM DENT ASSOC, V81, P935, DOI 10.14219/jada.archive.1970.0349
   CHANG PI, 1981, BIOMATERIALS, V2, P151, DOI 10.1016/0142-9612(81)90041-7
   CIFKOVA I, 1988, BIOMATERIALS, V9, P372, DOI 10.1016/0142-9612(88)90036-1
   Cognard C, 1996, NEURORADIOLOGY, V38, P603, DOI 10.1007/s002340050317
   COHEN Z, 1981, J COMPUT ASSIST TOMO, V5, P843, DOI 10.1097/00004728-198112000-00010
   Combe E C, 1971, Dent Pract Dent Rec, V22, P51
   Combe E C, 1969, Br Dent J, V127, P355
   Combe E C, 1972, J Dent, V1, P93, DOI 10.1016/0300-5712(72)90010-3
   COMBE EC, 1971, J DENT RES, V50, P668
   Cotten A, 1998, RADIOGRAPHICS, V18, P311, DOI 10.1148/radiographics.18.2.9536480
   CROMWELL LD, 1979, AM J ROENTGENOL, V132, P799, DOI 10.2214/ajr.132.5.799
   CROMWELL LD, 1980, J NEUROSURG, V52, P705, DOI 10.3171/jns.1980.52.5.0705
   CROMWELL LD, 1986, AM J ROENTGENOL, V147, P627, DOI 10.2214/ajr.147.3.627
   DAVY KWM, 1982, J DENT, V10, P254, DOI 10.1016/0300-5712(82)90058-6
   DEBRUN G, 1982, J NEUROSURG, V56, P615, DOI 10.3171/jns.1982.56.5.0615
   DEBRUN GM, 1984, J NEUROSURG, V61, P37, DOI 10.3171/jns.1984.61.1.0037
   DELAVIZ Y, 1990, J APPL POLYM SCI, V40, P835, DOI 10.1002/app.1990.070400519
   DELAVIZ Y, 1989, POLYM PREPR AM CHEM, V30, P215
   DELAVIZ Y, 1989, POLYM PREPR AM CHEM, V30, P185
   DOPPMAN JL, 1971, INVEST RADIOL, V6, P304, DOI 10.1097/00004424-197109000-00002
   DOTTER CT, 1975, RADIOLOGY, V114, P227, DOI 10.1148/114.1.227
   ELIAS H, 1984, MACROMOLECULES, V2
   ELZAY RP, 1971, J PROSTHET DENT, V25, P251, DOI 10.1016/0022-3913(71)90185-5
   ESPELID I, 1991, DENT MATER, V7, P114, DOI 10.1016/0109-5641(91)90056-5
   FREENY PC, 1979, AM J ROENTGENOL, V133, P647, DOI 10.2214/ajr.133.4.647
   FREENY PC, 1979, RADIOLOGY, V132, P51, DOI 10.1148/132.1.51
   GOLDIN AR, 1976, BRIT J RADIOL, V49, P583, DOI 10.1259/0007-1285-49-583-583
   Gruber A, 1996, AM J NEURORADIOL, V17, P1323
   GUNTHER R, 1978, CARDIOVASC RADIOL, V1, P101, DOI 10.1007/BF02552003
   HALBACH VV, 1989, AM J NEURORADIOL, V10, P143
   Heller J., 1987, CONTROLLED DRUG DELI, P139
   Horak D, 1997, BIOMATERIALS, V18, P1355, DOI 10.1016/S0142-9612(97)00059-8
   HORAK D, 1987, BIOMATERIALS, V8, P142, DOI 10.1016/0142-9612(87)90104-9
   HORAK D, 1986, BIOMATERIALS, V7, P467, DOI 10.1016/0142-9612(86)90037-2
   HORAK D, 1986, BIOMATERIALS, V7, P188, DOI 10.1016/0142-9612(86)90100-6
   HORAK D, 1988, BIOMATERIALS, V9, P367, DOI 10.1016/0142-9612(88)90035-X
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   IGNATIOUS F, 1992, MAKROMOL CHEM-M SYMP, V60, P247, DOI 10.1002/masy.19920600122
   IGNATIOUS F, 1991, INTEGR FUNDAM POLYM, V5, P400
   JAY MJ, 1991, Patent No. 5019370
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   Kalachandra S., 1995, P1545
   Kazekawa K, 1997, J BIOMED MATER RES, V38, P79, DOI 10.1002/(SICI)1097-4636(199722)38:2<79::AID-JBM1>3.0.CO;2-D
   KERBER C, 1975, INVEST RADIOL, V10, P10, DOI 10.1097/00004424-197501000-00002
   KERBER C, 1975, INVEST RADIOL, V10, P536, DOI 10.1097/00004424-197509000-00011
   KERBER C, 1976, RADIOLOGY, V120, P547, DOI 10.1148/120.3.547
   KERBER CW, 1985, NEUROSURGERY, V16, P13, DOI 10.1227/00006123-198501000-00004
   KINUGASA K, 1993, J NEUROSURG, V78, P1007
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1994, NEUROSURGERY, V35, P755, DOI 10.1227/00006123-199410000-00027
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   KINUGASA K, 1995, NEUROSURGERY, V36, P661, DOI 10.1227/00006123-199504000-00004
   KINUGASA K, 1995, J NEUROSURG, V83, P34, DOI 10.3171/jns.1995.83.1.0034
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   LARSEN NE, 1991, J BIOMED MATER RES, V25, P699, DOI 10.1002/jbm.820250602
   LASJAUNIAS P, 1987, SURG NEUROANGIOGRAPH, V2, P1
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   McCabe J F, 1976, J Dent, V4, P211, DOI 10.1016/0300-5712(76)90050-6
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Murray V K, 1991, N Y State Dent J, V57, P25
   OMER OE, 1986, J DENT, V14, P178, DOI 10.1016/0300-5712(86)90022-9
   PAVCNIK D, 1992, RADIOLOGY, V183, P151, DOI 10.1148/radiology.183.1.1549662
   PELZ DM, 1995, AM J NEURORADIOL, V16, P19
   PEREGRIN JH, 1984, CARDIOVASC INTER RAD, V7, P97, DOI 10.1007/BF02552689
   PRIMACK JE, 1972, J PROSTHET DENT, V28, P363, DOI 10.1016/0022-3913(72)90236-3
   RAWLS HR, 1990, J DENT RES, V69, P342
   RAWLS HR, 1990, DENT MATER, V6, P250, DOI 10.1016/S0109-5641(05)80006-5
   Rawls HR, 1996, J BIOMED MATER RES, V31, P339, DOI 10.1002/(SICI)1097-4636(199607)31:3<339::AID-JBM7>3.0.CO;2-N
   RAWLS HR, 1992, DENT MATER, V8, P54, DOI 10.1016/0109-5641(92)90054-G
   RODESCH G, 1992, NEUROCHIRURGIE, V38, P282
   Rodriguez F., 1982, PRINCIPLES POLYM SYS
   SADATO A, 1994, NEURORADIOLOGY, V36, P634, DOI 10.1007/BF00600429
   Sarpeshkar A. M., 1993, U. S. Patent, Patent No. [5177170, 5177170-A]
   SHEY Z, 1979, J AM DENT ASSOC, V98, P569, DOI 10.14219/jada.archive.1979.0093
   SILBERMANHAZONY R, 1988, ENCY POLYM SCI ENG R, P1
   SMID J, 1987, MAKROMOL CHEM-RAPID, V8, P543
   Smid J., 1989, U. S. patent, Patent No. 4882392
   SMID J, 1987, POLYM PREPR AM CHEM, V28, P133
   SMID J, 1990, Patent No. 9003036
   Smid J., 1993, U.S. Patent, Patent No. [5,256,334, 5256334]
   SOLODOVNIK VD, 1985, Patent No. 214432M
   SPIEGEL SM, 1986, AM J NEURORADIOL, V7, P109
   STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   SZMIGIELSKI W, 1981, INVEST RADIOL, V16, P65, DOI 10.1097/00004424-198101000-00012
   TAIRA M, 1993, DENT MATER, V9, P167, DOI 10.1016/0109-5641(93)90115-7
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TANAKA M, 1993, ADV URETHANE SCI TEC, V12, P1
   TENG MMH, 1994, NEURORADIOLOGY, V36, P144, DOI 10.1007/BF00588084
   THANOO BC, 1989, J MICROENCAPSUL, V6, P233, DOI 10.3109/02652048909098026
   THANOO BC, 1990, BIOMATERIALS, V11, P477, DOI 10.1016/0142-9612(90)90061-T
   THANOO BC, 1991, BIOMATERIALS, V12, P525, DOI 10.1016/0142-9612(91)90154-3
   THANOO BC, 1991, J MICROENCAPSUL, V8, P95, DOI 10.3109/02652049109021863
   TVEIT AB, 1986, DENT MATER, V2, P159, DOI 10.1016/S0109-5641(86)80027-6
   VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559
   VINTERS HV, 1986, NEW ENGL J MED, V314, P477, DOI 10.1056/NEJM198602203140804
   VINTERS HV, 1981, J NEUROSURG, V55, P819, DOI 10.3171/jns.1981.55.5.0819
   VLAHOS L, 1980, BRIT J RADIOL, V53, P289, DOI 10.1259/0007-1285-53-628-289
   WATTS DC, 1987, J DENT, V15, P175, DOI 10.1016/0300-5712(87)90148-5
   WATTS DC, 1987, J DENT, V15, P38, DOI 10.1016/0300-5712(87)90096-0
   WILLEMS G, 1991, J DENT, V19, P362, DOI 10.1016/0300-5712(91)90056-5
   XIA DW, 1985, POLYM PREPR-ACS, V26, P72
   YAMASHITA K, 1994, AM J NEURORADIOL, V15, P1103
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
   ZANETTI PH, 1972, J NEUROSURG, V36, P72, DOI 10.3171/jns.1972.36.1.0072
NR 134
TC 37
Z9 37
U1 1
U2 29
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0020-9996
J9 INVEST RADIOL
JI Invest. Radiol.
PD MAY
PY 1999
VL 34
IS 5
BP 323
EP 335
DI 10.1097/00004424-199905000-00001
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 189FY
UT WOS:000079895000001
PM 10226844
DA 2018-10-19
ER

PT J
AU Yang, JM
   Huang, MJ
   Yeh, TS
AF Yang, JM
   Huang, MJ
   Yeh, TS
TI Preparation of poly(acrylic acid) modified polyurethane membrane for
   biomaterial by UV radiation without degassing
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyurethane; poly(acrylic acid); surface free energy; toxicity; cell
   culture; biocompatibility
ID VP COPOLYMER MEMBRANE; PROTEIN ADSORPTION; PLATELET-ADHESION;
   IMMOBILIZATION; SURFACES; FILMS
AB Poly(acrylic acid) modified polyurethane (AA/PU) membranes were prepared by UV radiation without degassing. The chemical composition of the AA/PU membrane was studied by IR spectroscopy. In addition to those absorption peaks associated with pure PU, the absorption peak at 2400 cm(-1) of poly(AA) was also found. The morphology of AA/PU membrane was studied by optical polarizing microscopy. We also measured the glass transition temperature and the decomposition temperature of the AA/PU membrane by differential scanning calorimetry and thermogravimetric analysis. A significant domain was found in the AA/PU membrane, which resulted in different glass transition temperature and decomposition temperature between AA/PU and pure PU membrane. The effect of AA content on the contact angle and water absorption of the AA/PU membrane was determined. It was found that the water content of AA/PU membrane increased with increasing AA content, whereas the contact angle decreased. By using Kaeble's equation and the contact angle data, the surface free energy of AA/PU membrane was determined. The increase of surface free energy resulted from the increase of the dispersion (gamma(d)) term and polar (gamma(p)) term. In order to evaluate the biocompatibility of these membranes, a cytotoxicity test and a cell adhesion and proliferation assay were conducted in cell culture. Immortal cells and primary lymphocytes were both used in this study. The results showed that these AA/PU membranes exhibited very low cytotoxicity and could support cell adhesion and growth. An animal primary test was also done in this study. It was found that the AA/PU membrane could possibly be employed in the treatment of bowel defect. (C) 1999 John Wiley & Sons, Inc.
C1 Chang Gung Univ, Dept Chem Engn, Tao Yuan 333, Taiwan.
   Chang Gung Mem Hosp, Dept Surg, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem Engn, Tao Yuan 333, Taiwan.
CR CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GINESTE JL, 1994, J APPL POLYM SCI, V51, P63, DOI 10.1002/app.1994.070510108
   GUIDOIN R, 1992, BIOMATERIALS, V13, P281, DOI 10.1016/0142-9612(92)90051-O
   Hari P R, 1993, J Biomater Appl, V8, P174, DOI 10.1177/088532829300800205
   Hari P R, 1991, J Biomater Appl, V6, P170, DOI 10.1177/088532829100600205
   JANSEN B, 1984, J BIOMED MATER RES, V18, P655, DOI 10.1002/jbm.820180607
   KAEBLE DH, 1977, POLYMER, V18, P475
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KISHIDA A, 1994, BIOMATERIALS, V15, P1170, DOI 10.1016/0142-9612(94)90238-0
   MINOURA N, 1993, BIOMEDICAL APPL POLY, P118
   OKONIEWSKI M, 1988, J APPL POLYM SCI, V35, P1241, DOI 10.1002/app.1988.070350510
   PARK JB, 1992, BIOMATERIALS INTRO, P255
   REMBAUM S, 1997, J BIOMED MAT RES S, V8, P101
   ROMAN JS, 1994, BIOMATERIALS, V15, P759
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
NR 20
TC 27
Z9 27
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1999
VL 45
IS 2
BP 133
EP 139
DI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 173BT
UT WOS:000078961600008
PM 10397967
DA 2018-10-19
ER

PT J
AU Redey, SA
   Razzouk, S
   Rey, C
   Bernache-Assollant, D
   Leroy, G
   Nardin, M
   Cournot, G
AF Redey, SA
   Razzouk, S
   Rey, C
   Bernache-Assollant, D
   Leroy, G
   Nardin, M
   Cournot, G
TI Osteoclast adhesion and activity synthetic hydroxyapatite, carbonated
   hydroxyapatite, and natural calcium carbonate: Relationship to surface
   energies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE osteoclast; adhesion; spreading; surface energies; biomaterials
ID SUBSTRATE COMPOSITION; RESORPTION
AB This study investigates the adhesion, cytoskeletal changes, and resorptive activity of disaggregated rat osteoclasts cultured on polished slices of three biomaterials: crystalline synthetic hydroxyapatite (HA), carbonated hydroxyapatite (C-HA), and natural calcium carbonate (C). The surface chemistry of each substrate was defined by X-ray diffraction and IR spectroscopy, surface wettability by the dispersive, and the polar components of the surface energies. Osteoclast adhesion was modulated by the polar component of the surface energy: fewer (p < 0.01) osteoclasts adhered to C-HA (97 +/- 20/slice, surface energy 9 +/- 5 mJ/m(2)) than to HA (234 +/- 16/slice, surface energy 44 +/- 2 mJ/m(2)) or to C (268 +/- 37/slice, surface energy 58 +/- 0.5 mJ/m(2)). Actin rings, which are the cytoskeletal structure essential for re-sorption, developed on all three materials. The area of the actin ring, which is resorbed by local acidification, and the osteoclast area, which reflects osteoclast spreading, were both greater in osteoclasts cultured on IIA and C-HA than in those cultured on C. C was resorbed, hut HA and C-HA were not. Thus, we surface energy plays an Essential role in osteoclast adhesion, whereas osteoclast spreading may depend on the surface chemistry, especially on protein adsorption and/or on newly formed apatite layers. Resorption may be limited to the solubility of the biomaterial. (C) 1999 John Wiley & Sons, Inc.
C1 INRA, LNSA, CNRS, UPR 1524, F-78350 Jouy En Josas, France.
   CNRS, ICSI, F-68057 Mulhouse, France.
   CNRS, UPRESA 5071, F-31400 Toulouse, France.
   CNRS, UPRESA 6012, F-87060 Limoges, France.
   LBM, F-59000 Lille, France.
RP Cournot, G (reprint author), INRA, LNSA, CNRS, UPR 1524, F-78350 Jouy En Josas, France.
EM cournot@jouy.inra.fr
CR ABSOLOM DR, 1985, J COLLOID INTERF SCI, V104, P51, DOI 10.1016/0021-9797(85)90008-6
   BALMAIN N, 1982, CALCIFIED TISSUE INT, V34, P380
   BENHAMED M, 1997, J BIOMED MATER RES, V34, P115
   Bonel G, 1988, Ann N Y Acad Sci, V523, P115, DOI 10.1111/j.1749-6632.1988.tb38506.x
   CHAMBERS TJ, 1984, J CELL SCI, V70, P61
   CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104
   DALCUSI G, 1990, CALCIFIED TISSUE INT, V46, P20
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   DEBRUIJN JD, 1996, INT LIAISON COMITY B, P929
   Elliott JC, 1994, STRUCTURE CHEM APATI
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   GUILLEMIN G, 1995, CELL MATER, V5, P157
   HEYMANN D, 1996, INT LIAISON COMITY B, P421
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   JONES SJ, 1984, ANAT EMBRYOL, V170, P247, DOI 10.1007/BF00318728
   Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448
   LELIEVRE F, 1992, THESIS U LIMOGES FRA
   LELIEVRE F, 1992, T 4 WORLD BIOM C BER, P330
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   Nakamura I, 1996, J BONE MINER RES, V11, P1873
   Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364
   PENEL G, 1997, BIOCERAMICS, V10, P571
   RADDER AM, 1994, THESIS U LEIDEN NETH
   REDEY SA, IN PRESS J BIOMED MA
   REY C, 1995, 4 EUROCERAMICS, V8, P301
   Rodan SB, 1997, J ENDOCRINOL, V154, pS47
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHULTZ J, 1981, 27 INT S MACR, P289
   SHIMIZU H, 1989, BONE MINER, V6, P261, DOI 10.1016/0169-6009(89)90033-0
   Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869
   Trombe JC, 1972, THESIS UPS TOULOUSE
   Vaananen HK, 1996, PRINCIPLES BONE BIOL, P103
   VANBLITTERSWIJK CA, 1991, BONE-BIOMATERIAL INTERFACE, P295
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
NR 36
TC 139
Z9 146
U1 4
U2 36
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1999
VL 45
IS 2
BP 140
EP 147
DI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 173BT
UT WOS:000078961600009
PM 10397968
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Contreras, LA
   Bujan, J
   Pascual, G
   Carrera-San Martin, A
AF Bellon, JM
   Contreras, LA
   Bujan, J
   Pascual, G
   Carrera-San Martin, A
TI Effect of relaparotomy through previously integrated polypropylene and
   polytetrafluoroethylene experimental implants in the abdominal wall
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article
ID REPAIR; DEFECTS; MESH; PROSTHESIS; MARLEX; BIOMATERIALS; PATCH
AB Background: The appearance of new pathologies affecting abdominal organs after implant of a prosthesis to repair an abdominal wall defect may necessitate reintervention. The aim of this study was to compare the behavior of two types of biomaterial widely used in clinical practice, polypropylene (PL) and polytetrafluoroethylene (ePTFE), after a second laparotomy involving the implant, The behavior, in terms of tensile resistance and integration with tissues, of intact prostheses was compared to that of prostheses subjected to opening and repair.
   Methods: A defect (7 x 5 cm) involving all tissue layers was created in the anterior abdominal wall of 24 male New Zealand rabbits. These defects were repaired with a reticular, macroporous PL mesh (Marlex, Bard Card., Madrid, Spain) or a laminar, micro/macroporous ePTFE prosthesis (Mycro Mesh, W.L, Gore, Flagstaff, AZ) of similar size to the defect. Four study groups were established: Intact PL/Intact ePTFE (n=6 each): animals implanted with a PL or ePTFE prosthesis and sacrificed 90 days after implant; Repaired PL/Repaired ePTFE (n=6 each): animals implanted with a PL or ePTFE prosthesis subjected to midlongitudinal relaparotomy through the center of the prosthesis 90 days postimplant, followed by repair with continuous polypropylene 4/0 suture. Animals in repaired groups were sacrificed 90 days after the second intervention. Specimens comprised of prosthesis and neoformed tissue were subjected to light and scanning electron microscopy. In addition, 2 cm-wide strips, consisting of the prosthesis and anchorage tissue, were subjected to biomechanical analysis using an Instron tensiometer (Instron, Canton, MA). The results obtained were statistically compared using the Mann-Whitney U-test.
   Results: The intact PL implants were fully infiltrated by dense,disorganized, well-vascularized scar tissue with fibers concentric to the mesh monofilaments. The appearance of the repaired FL prostheses was similar, with establishment of neoformed tissue in repaired areas of the prosthesis such that both cut edges of the prosthesis were joined together. In contrast, intact ePTFE prostheses were encapsulated by organized tissue with fibers running parallel to the surface of the biomaterial. Repaired ePTFE prostheses including sutured areas were similarly encapsulated. But the edges of the sutured middle area did not fuse. Tensile resistance values of intact and repaired PL prostheses were similar (intact, mean, 34.78 Newtons; repaired, mean, 34.74N, p > 0.001). Tensile resistance values of intact ePTFE implants were significantly different to those of the repaired ePTFE prostheses (intact, mean, 22.64N; repaired, mean, 17.21N, p < 0.001), Breakage of both types of PL specimen strips was restricted to recipient tissue while breakage of intact ePTFE specimens occurred in the areas of anchorage to the abdominal wall. Rupture of repaired ePTFE specimens took place in the sutured central areas of the prostheses.
   Conclusions: We conclude that relaparotomy through an existing PL prosthesis previously integrated with the abdominal wall does not affect the tissue integration process or the tensile resistance of the implant. When the relaparotomy involves an ePTFE prosthesis, however, although the repair process itself is unaffected, significant loss in tensile strength is incurred. In addition, relaparotomy through both types of biomaterial is likely to result in the neoformation of adhesions in the areas of the prosthesis subjected to opening and repair but, in general, the number of adhesions formed in the presence of intact or repaired polypropylene implants was larger than that observed with the use of ePTFE. (J Am Coll Surg 1999;188:466-472. (C) 1999 by the American College of Surgeons).
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Madrid 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Crta Mardrid Barcelona Km 33600, Madrid 28871, Spain.
OI PASCUAL, GEMMA/0000-0002-1623-4384; bujan, Julia/0000-0003-2419-2476;
   BELLON, JUAN M./0000-0002-6071-5011
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 1996, BIOMATERIALS, V17, P2367, DOI 10.1016/S0142-9612(96)00080-4
   Bellon JM, 1996, BIOMATERIALS, V17, P1265, DOI 10.1016/0142-9612(96)88671-6
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   LAW NW, 1991, SURGERY, V109, P652
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   MURPHY JL, 1989, CAN J SURG, V32, P244
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
NR 14
TC 15
Z9 16
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 1072-7515
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD MAY
PY 1999
VL 188
IS 5
BP 466
EP 472
DI 10.1016/S1072-7515(99)00029-0
PG 7
WC Surgery
SC Surgery
GA 191TP
UT WOS:000080037900002
PM 10235573
DA 2018-10-19
ER

PT J
AU Black, FE
   Hartshorne, M
   Davies, MC
   Roberts, CJ
   Tendler, SJB
   Williams, PM
   Shakesheff, KM
AF Black, FE
   Hartshorne, M
   Davies, MC
   Roberts, CJ
   Tendler, SJB
   Williams, PM
   Shakesheff, KM
TI Surface engineering and surface analysis of a biodegradable polymer with
   biotinylated end groups
SO LANGMUIR
LA English
DT Article
ID POLY(LACTIC ACID-CO-LYSINE); DRUG-DELIVERY; RGD; MICROPARTICLES;
   BIOMATERIALS; RECOGNITION; XPS
AB In the design of advanced polymeric biomaterials there is a need to tailor the surface chemistry of the biomaterial to elicit beneficial interactions with cells and biomolecules. To facilitate the fabrication of complex biomaterial surfaces, we have previously described the synthesis and application of a poly(lactic acid)-poly(ethylene glycol) block copolymer (PLA-PEG) with the biotinylated PEG end groups (final polymer termed PLA-PEG-biotin). This polymer is biodegradable and resistant to nonspecific protein adsorption, and the biotin moiety allows surface chemical engineering to be achieved using avidin-biotin interactions. Here, we describe a detailed surface analysis of this polymer using X-ray photoelectron spectroscopy and surface plasmon resonance analysis. This analysis has revealed that the avidin-biotin surface engineering strategy is a rapid method of immobilizing biomolecules at biomaterial surfaces under aqueous conditions. The surface engineering generates a specific and high-density change in surface structure. The effect of PLA segment molecular weight and the influence of the surfactant on the nature of the surface engineering has been determined with the objective of proving that the extent of specific ligand immobilization is controllable and resilient to surface stabilization by surfactants.
C1 Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RI Williams, Philip/C-6947-2009; Roberts, Clive/C-6970-2009
OI Williams, Philip/0000-0002-1822-2133; Roberts,
   Clive/0000-0001-9443-3445; Shakesheff, Kevin/0000-0003-3236-2439;
   Davies, Martyn/0000-0001-7695-0596
CR BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BEAMSON G, 1992, HIGH RESOLUTION XPS, P84
   BRINDLEY A, 1995, J COLLIOD INTERFACE, V23, P101
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   DAVIES MC, 1989, SURF INTERFACE ANAL, V14, P115, DOI 10.1002/sia.740140304
   DIAMANDIS EP, 1991, CLIN CHEM, V37, P625
   DRUMHELLER PD, 1995, BIOMEDICAL ENG HDB, P1583
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   HEATON R, UNPUB
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEA AS, 1994, COLLOID SURFACE A, V93, P349, DOI 10.1016/0927-7757(94)02878-8
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Marshall D, 1996, BRIT J CANCER, V73, P565, DOI 10.1038/bjc.1996.99
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1997, J COLLOID INTERF SCI, V185, P538, DOI 10.1006/jcis.1996.4637
NR 24
TC 74
Z9 76
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 27
PY 1999
VL 15
IS 9
BP 3157
EP 3161
DI 10.1021/la9803575
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 192YG
UT WOS:000080106900023
DA 2018-10-19
ER

PT J
AU Oerther, S
   Le Gall, H
   Payan, E
   Lapicque, F
   Presle, N
   Hubert, P
   Dexheimer, J
   Netter, P
   Lapicque, F
AF Oerther, S
   Le Gall, H
   Payan, E
   Lapicque, F
   Presle, N
   Hubert, P
   Dexheimer, J
   Netter, P
   Lapicque, F
TI Hyaluronate-alginate gel as a novel biomaterial: Mechanical properties
   and formation mechanism
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE sodium alginate; sodium hyaluronate; rheological measurements; diffusion
   phenomena
ID ACID; BEADS; RELEASE; CARRIER
AB With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL, The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate. (C) 1999 John Wiley & Sons, Inc.
C1 UHP Nancy 1, UMR 7561 CNRS, F-54505 Vandoeuvre Nancy, France.
   Fac Med, FR CNRS W0070, F-54505 Vandoeuvre Nancy, France.
   Ecole Natl Super Ind Chim, Inst Natl Polytech Lorraine, Lab Sci Genie Chim, F-54001 Nancy, France.
   INPL, UMR 7568, F-54001 Nancy, France.
   UHP, Fac Sci, Lab Biol Forestiere, F-54506 Vandoeuvre Nancy, France.
RP Netter, P (reprint author), UHP Nancy 1, UMR 7561 CNRS, BP 184, F-54505 Vandoeuvre Nancy, France.
EM lapicque@facmed.u-nancy.fr
CR BALAZS EA, 1993, J RHEUMATOL, V20, P3
   BALAZS EA, 1958, FED PROC, V17, P1086
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   Brandrup J., 1989, POLYM HDB
   BURD DAR, 1991, BRIT J PLAST SURG, V44, P579, DOI 10.1016/0007-1226(91)90093-Y
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CHAKRABARTI B, 1977, ARCH BIOCHEM BIOPHYS, V180, P146, DOI 10.1016/0003-9861(77)90018-2
   CLAYTON HA, 1991, J MICROENCAPSUL, V8, P211
   Couarraze G., 1991, INITIATION RHEOLOGIE
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Garcia AM, 1996, J CONTROL RELEASE, V40, P179, DOI 10.1016/0168-3659(95)00179-4
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   HUME LR, 1990, PHARMACEUT RES, pS174
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Murata Y, 1996, J CONTROL RELEASE, V38, P101, DOI 10.1016/0168-3659(95)00098-4
   OERTHER S, 1998, ACTUALITES BIOMATERI, P413
   OERTHER S, 1998, THESIS U POINCARE NA
   OSTBERG T, 1994, INT J PHARM, V112, P241, DOI 10.1016/0378-5173(94)90360-3
   PAYAN E, 1991, J CHROMATOGR-BIOMED, V566, P9, DOI 10.1016/0378-4347(91)80106-M
   RAJAONARIVONY M, 1993, J PHARM SCI, V82, P912, DOI 10.1002/jps.2600820909
   SCHMUT O, 1982, GRAEF ARCH CLIN EXP, V218, P311, DOI 10.1007/BF02150446
   SKJAKBRAEK G, 1989, CARBOHYD POLYM, V10, P31, DOI 10.1016/0144-8617(89)90030-1
   SMIDSROD O, 1974, FARADAY DISCUSS, V57, P263
   TOMAS M, 1986, Patent No. 79
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WANG JH, 1954, J PHYS CHEM-US, V58, P686, DOI 10.1021/j150519a003
   WEAST RC, 1986, HDB CHEM PHYSICS
   WINTER WT, 1975, J MOL BIOL, V99, P219, DOI 10.1016/S0022-2836(75)80142-2
   WINTER WT, 1977, J MOL BIOL, V117, P761, DOI 10.1016/0022-2836(77)90068-7
   YOTSUYANAGI T, 1987, CHEM PHARM BULL, V35, P1555
   YOTSUYANAGI T, 1990, CHEM PHARM BULL, V38, P3124, DOI 10.1248/cpb.38.3124
   Young R. J, 1981, INTRO POLYM
NR 33
TC 42
Z9 43
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD APR 20
PY 1999
VL 63
IS 2
BP 206
EP 215
DI 10.1002/(SICI)1097-0290(19990420)63:2<206::AID-BIT9>3.0.CO;2-8
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 169AK
UT WOS:000078725200009
PM 10099597
DA 2018-10-19
ER

PT J
AU Hudson, MC
   Ramp, WK
   Frankenburg, KP
AF Hudson, MC
   Ramp, WK
   Frankenburg, KP
TI Staphylococcus aureus adhesion to bone matrix and bone-associated
   biomaterials
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE Staphylococcus aureus; microbial surface component recognizing adhesive
   matrix molecules; bone matrix; biomaterial
ID FIBRONECTIN-BINDING-PROTEINS; COLLAGEN ADHESIN; CLUMPING FACTOR;
   LIGAND-BINDING; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE;
   FIBRINOGEN RECEPTOR; SEPTIC ARTHRITIS; GENE; SIALOPROTEIN
AB Staphylococcus aureus is a frequent cause of orthopedic infections in humans. The bacterium expresses several adhesins that facilitate bacterial binding to the bone matrix and to bone implant biomaterials coated with host plasma constituents. The relevant S. aureus adhesins are termed microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) and specific MSCRAMMs are involved in bone and joint infections. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.
   Carolinas Med Ctr, Baxter Orthopaed Res Lab, Dept Orthopaed Surg, Charlotte, NC 28232 USA.
RP Hudson, MC (reprint author), Univ N Carolina, Dept Biol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
CR BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x
   Casolini F, 1998, INFECT IMMUN, V66, P5433
   Darouiche RO, 1997, J MED MICROBIOL, V46, P75, DOI 10.1099/00222615-46-1-75
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   Eidhin DN, 1998, MOL MICROBIOL, V30, P245
   FISHER LW, 1983, J BIOL CHEM, V258, P2723
   FRANZEN A, 1984, BIOCHEM J, V224, P59, DOI 10.1042/bj2240059
   Gillaspy AF, 1997, INFECT IMMUN, V65, P1536
   Gillaspy AF, 1998, INFECT IMMUN, V66, P3170
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379
   HUFF S, 1994, J BIOL CHEM, V269, P15563
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   Koontz CS, 1998, J BIOMED MATER RES, V42, P238, DOI 10.1002/(SICI)1097-4636(199811)42:2<238::AID-JBM8>3.3.CO;2-Y
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   LINDE A, 1983, J BIOL CHEM, V258, P1698
   LJUNGH A, 1996, ANTIADHESION THERAPY, P129
   MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479
   NORDEN C, 1992, CLIN INFECT DIS, V15, pS177, DOI 10.1093/clind/15.Supplement_1.S177
   PAN LC, 1985, P NATL ACAD SCI USA, V82, P6109, DOI 10.1073/pnas.82.18.6109
   Park PW, 1996, J BIOL CHEM, V271, P15803, DOI 10.1074/jbc.271.26.15803
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   RYDEN C, 1989, EUR J BIOCHEM, V184, P331, DOI 10.1111/j.1432-1033.1989.tb15023.x
   RYDEN C, 1987, LANCET, V2, P515
   SAKAKURA T, 1994, PERSPECT DEV NEUROBI, V2, P111
   SCOTTILE J, 1991, J BIOL CHEM, V266, P12840
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   Smeltzer MS, 1997, GENE, V196, P249, DOI 10.1016/S0378-1119(97)00237-0
   SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x
   Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   VAUDAUX PE, 1995, INFECT IMMUN, V63, P585
   YACOUB A, 1994, EUR J BIOCHEM, V222, P919, DOI 10.1111/j.1432-1033.1994.tb18940.x
NR 39
TC 63
Z9 65
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD APR 15
PY 1999
VL 173
IS 2
BP 279
EP 284
DI 10.1111/j.1574-6968.1999.tb13514.x
PG 6
WC Microbiology
SC Microbiology
GA 184YF
UT WOS:000079640800001
PM 10227156
OA Bronze
DA 2018-10-19
ER

PT J
AU Millsap, KW
   Bos, R
   Busscher, HJ
   van der Mei, HC
AF Millsap, KW
   Bos, R
   Busscher, HJ
   van der Mei, HC
TI Surface aggregation of Candida albicans on glass in the absence and
   presence of adhering Streptococcus gordonii in a parallel-plate flow
   chamber: A surface thermodynamical analysis based on acid-base
   interactions
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE C-albicans; S-gordonii; adhesion; surface aggregation; acid-base
   interactions
ID ORAL CANDIDA; SACCHAROMYCES-CEREVISIAE; TENSION FORCES; CONTACT ANGLES;
   HIV-INFECTION; HYDROPHOBICITY; ADHESION; BACTERIA; COAGGREGATION;
   ADHERENCE
AB Adhesive interactions between yeasts and bacteria are important in the maintenance of infectious mixed biofilms on natural and biomaterial surfaces in the human body. In this study, the extended DLVO (Derjaguin-Landau-Verwey-Overbeek) approach has been applied to explain adhesive interactions between C. albicans ATCC 10261 and S. gordonii NCTC 7869 adhering on glass. Contact angles with different liquids and the zeta potentials of both the yeasts and bacteria were determined and their adhesive interactions were measured in a parallel-plate flow chamber. Streptococci were first allowed to adhere to the bottom glass plate of the flow chamber to different seeding densities, and subsequently deposition of yeasts was monitored with an image analysis system, yielding the degree of initial surface aggregation of the adhering yeasts and their spatial arrangement in a stationary end point. Irrespective of growth temperature, the yeast cells appeared uncharged in TNMC buffer, but yeasts grown at 37 degrees C were intrinsically more hydrophilic and had an increased electron-donating character than cells grown at 30 degrees C. All yeasts showed surface aggregation due to attractive Lifshitz-van der Waals forces. In addition, acid-base interactions between yeasts, yeasts and the glass substratum, and yeasts and the streptococci were attractive for yeasts grown at 30 degrees C, but yeasts grown at 37 degrees C only had favorable acid-base interactions with the bacteria, explaining the positive relationship between the surface coverage of the glass by streptococci and the surface aggregation of the yeasts. (C) 1999 Academic Press.
C1 Univ Groningen, Mat Tech Lab, NL-9712 KZ Groningen, Netherlands.
RP Millsap, KW (reprint author), Univ Groningen, Mat Tech Lab, Bloemsngel 10, NL-9712 KZ Groningen, Netherlands.
CR ARENDORF TM, 1980, ARCH ORAL BIOL, V25, P1, DOI 10.1016/0003-9969(80)90147-8
   BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1
   BOS R, IN PRESS COLLOIDS B
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   COLEMAN DC, 1993, CRIT REV MICROBIOL, V19, P61, DOI 10.3109/10408419309113523
   FERNANDES PA, 1993, YEAST, V9, P859, DOI 10.1002/yea.320090806
   GOLDACRE MJ, 1979, BMJ-BRIT MED J, V1, P1450, DOI 10.1136/bmj.1.6176.1450
   Grimaudo NJ, 1996, ORAL MICROBIOL IMMUN, V11, P59, DOI 10.1111/j.1399-302X.1996.tb00337.x
   HAZEN KC, 1986, INFECT IMMUN, V54, P269
   HAZEN KC, 1992, INFECT IMMUN, V60, P1499
   HAZEN KC, 1990, APPL ENVIRON MICROB, V56, P1974
   HAZEN KC, 1994, CAN J MICROBIOL, V40, P266, DOI 10.1139/m94-043
   Hazen KC, 1990, MICROBIAL CELL SURFA, P249
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   Holmes AR, 1996, INFECT IMMUN, V64, P4680
   HSU LY, 1990, J CLIN MICROBIOL, V28, P2621
   JAMES AM, 1991, MICROBIAL CELL SURFA, P221
   JENKINSON HF, 1990, INFECT IMMUN, V58, P1429
   LEENAARS AFM, 1989, PHILIPS J RES, V44, P183
   Li Z, 1997, J DISPER SCI TECHNOL, V18, P223, DOI 10.1080/01932699708943732
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   Marples M J, 1974, Soc Appl Bacteriol Symp Ser, V3, P7
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   Meinders JM, 1995, J COLLOID INTERF SCI, V176, P329, DOI 10.1006/jcis.1995.9960
   MILLSAP KW, 1997, BIOFILMS COMMUNITY I, P87
   MIYAKE Y, 1986, MICROBIOS, V46, P7
   NIKAWA H, 1993, ARCH ORAL BIOL, V38, P631, DOI 10.1016/0003-9969(93)90132-6
   Noordmans J, 1997, J ADHES SCI TECHNOL, V11, P957, DOI 10.1163/156856197X00525
   ODDS FC, 1988, CANDIDA CANDIDOSIS R
   Priestley CJF, 1997, GENITOURIN MED, V73, P23
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   Rutter P.R., 1980, ADHESION MICROORGANI, P79
   SHANKAR CS, 1994, MICROBIOL-SGM, V140, P1097, DOI 10.1099/13500872-140-5-1097
   SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263
   SMIT G, 1992, APPL ENVIRON MICROB, V58, P3709
   TORSSANDER J, 1987, SCAND J INFECT DIS, V19, P291, DOI 10.3109/00365548709018473
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANOSS CJ, 1990, J DISPER SCI TECHNOL, V11, P75, DOI 10.1080/01932699008943237
   VANOSS CJ, 1991, J DISPER SCI TECHNOL, V12, P201, DOI 10.1080/01932699108913120
   VANOSS CJ, 1972, J RETICULOENDOTH SOC, V12, P283
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   VERRAN J, 1987, J DENT, V15, P73, DOI 10.1016/0300-5712(87)90003-0
   VISSINK A, 1984, J ORAL PATHOL MED, V13, P22, DOI 10.1111/j.1600-0714.1984.tb01397.x
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
NR 47
TC 20
Z9 20
U1 0
U2 4
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 1999
VL 212
IS 2
BP 495
EP 502
DI 10.1006/jcis.1998.6054
PG 8
WC Chemistry, Physical
SC Chemistry
GA 182LM
UT WOS:000079500500035
DA 2018-10-19
ER

PT J
AU Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
AF Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
TI Adhesion forces between E-coli bacteria and biomaterial surfaces
SO LANGMUIR
LA English
DT Article
ID SOLID-SURFACES; HYDROPHOBIC INTERACTIONS; FREE-ENERGY; MICROSCOPY;
   ATTACHMENT; PARTICLES; CELLS; SUBSTRATA; POLYMERS; DLVO
AB Bacterial infection of biomaterial surfaces is an important problem in the biomedical and health industries. The design of materials resistant to infections necessitates an understanding of the forces driving bacterial adhesion. Escherichia coli cells were immobilized onto the tip of a standard atomic force microscope (AFM) cantilever, and force measurements were performed by approaching the modified cantilever onto mica, hydrophilic glass, hydrophobic glass, polystyrene, and Teflon. Consistent with prior qualitative observations, we show that bacterial adhesion is indeed enhanced by the surface hydrophobicity of the substrate. The forces of interaction measured with the AFM are compared to those of model predictions based on an extended-DLVO approach. In this model, short-range acid-base and steric interactions are included with the conventional van der Waals attraction and electrostatic components. The theoretical predictions agree well with experimental data for E. coli D21f2, a strain whose outer surface consists of lipopolysaccharide molecules with severely truncated carbohydrate chains. However, the adhesive behavior off. coli strains with more complex cell surface structures was found to be more difficult to model because of the possible involvement of steric and bridging effects or specific receptor-ligand interactions that remain to be resolved.
C1 Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cell Biol, Austin, TX 78712 USA.
RP Sharma, MM (reprint author), Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
CR BOMAN HG, 1975, J BACTERIOL, V121, P455
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUTT HJ, 1991, BIOPHYS J, V60, P777, DOI 10.1016/S0006-3495(91)82112-9
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   DUCKER WA, 1994, LANGMUIR, V10, P3279, DOI 10.1021/la00021a061
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   Freeman A, 1996, BIOTECHNOL BIOENG, V52, P625, DOI 10.1002/(SICI)1097-0290(19961205)52:5<625::AID-BIT10>3.3.CO;2-O
   FRIETAS AM, UNPUB
   Good R.J., 1991, FUNDAMENTALS ADHESIO
   GREGORY J, 1981, J COLLOID INTERF SCI, V83, P138, DOI 10.1016/0021-9797(81)90018-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOH JH, 1994, J CELL SCI, V107, P1105
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   ISRAELACHVILI JN, 1974, Q REV BIOPHYS, V6, P341
   KLOTZ SA, 1990, MICROBIAL CELL SURFA
   MCELDOWNEY S, 1986, J GEN MICROBIOL, V132, P513
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   MOZES N, 1987, BIOTECHNOL BIOENG, V30, P439, DOI 10.1002/bit.260300315
   NEIDHARDT FC, 1990, ESCHERICHIA COLI SAL
   OFEK I, 1994, BACTERIAL ADHESION C
   PASHLEY RM, 1984, J COLLOID INTERF SCI, V97, P446, DOI 10.1016/0021-9797(84)90316-3
   RAZATOS AP, IN PRESS J BIOMATER
   RAZATOS AP, UNPUB
   RUCKENSTEIN E, 1976, AICHE J, V22, P276, DOI 10.1002/aic.690220209
   SCHOENENBERGER CA, 1994, BIOPHYS J, V67, P929, DOI 10.1016/S0006-3495(94)80556-9
   SEEBERGH JE, 1995, COLLOID SURFACE A, V100, P139, DOI 10.1016/0927-7757(95)03155-7
   STICKLER DJ, 1995, CELL MATER, V5, P167
   UYEN HM, 1988, APPL ENVIRON MICROB, V54, P837
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
   Zita A, 1997, FEMS MICROBIOL LETT, V152, P299, DOI 10.1111/j.1574-6968.1997.tb10443.x
NR 37
TC 324
Z9 327
U1 12
U2 170
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 13
PY 1999
VL 15
IS 8
BP 2719
EP 2725
DI 10.1021/la981104e
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 187FF
UT WOS:000079775700018
DA 2018-10-19
ER

PT J
AU Hong, J
   Ekdahl, KN
   Reynolds, H
   Larsson, R
   Nilsson, B
AF Hong, J
   Ekdahl, KN
   Reynolds, H
   Larsson, R
   Nilsson, B
TI A new in vitro model to study interaction between whole blood and
   biomaterials. Studies of platelet and coagulation activation acid the
   effect of aspirin
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; aspirin
ID CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; GENERATION
AB We have developed a versatile in vitro chamber model with a double purpose: first, to be able to study mechanisms of bioincompatibility, and, second, to test biomaterials at all levels of interactions, in whole blood. The use of biomaterials in the form of microscope slides as walls in the chamber makes it possible to analyse both the biomaterial surface with regard to protein and cell binding, as well as the molecular events taking place in the fluid. Incubation of blood in the chamber, for 60 min at 37 degrees C resulted in the rapid binding of complement and coagulation proteins and of leukocytes and platelets to polyvinylchloride (PVC) slides. The cells formed a layer which more or less covered the underlying surface. Unlike complement activation, as reflected by soluble C3a and C5b-9, the thrombin-antithrombin formation was completely nullified in cell-depleted plasma Despite the fact that thrombin-antithrombin generation was also negligible in platelet-rich plasma, inhibition of platelet aggregation on the material surface with aspirin resulted in suppressed generation of thrombin-antithrombin complexes. Taken together, the coagulation activation in the chamber was dependent on the presence of blood cells which suggests that bound/aggregated platelets initiate a sequence of events involving leukocytes that results in coagulation activation. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Nat Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   GILLINOV AM, 1993, ANN THORAC SURG, V55, P619, DOI 10.1016/0003-4975(93)90264-I
   GONG J, 1996, J CLIN IMMUNOL, V16, P223
   GREELEY WJ, 1991, ANN THORAC SURG, V52, P417, DOI 10.1016/0003-4975(91)90900-B
   HAKIM RM, 1986, CLIN NEPHROL, V26, pS9
   HAKIM RM, 1984, KIDNEY INT, V26, P194, DOI 10.1038/ki.1984.155
   Johnson R J, 1990, Prog Clin Biol Res, V337, P507
   KARLSSONPARRA A, 1983, J IMMUNOL METHODS, V64, P85, DOI 10.1016/0022-1759(83)90386-1
   Kirklin JK, 1989, CARDIOPULMONARY BYPA, P131
   LARSSON R, 1977, THROMB RES, V11, P517, DOI 10.1016/0049-3848(77)90205-5
   MOLLNES T, 1985, SCAND J IMMUNOL, V22, P703
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   PEKNA M, 1993, BIOMATERIALS, V14, P189, DOI 10.1016/0142-9612(93)90022-T
   POPLI S, 1982, ARTIF ORGANS, V6, P312
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   SUNDARAM S, 1991, INT J ARTIF ORGANS, V14, P729
   VONOEVEREN W, 1995, J THORAC CARDIOVASC, V89, P888
   WESTABY S, 1987, INTENS CARE MED, V13, P89
NR 22
TC 83
Z9 83
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1999
VL 20
IS 7
BP 603
EP 611
DI 10.1016/S0142-9612(98)00210-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176XR
UT WOS:000079177900001
PM 10208402
DA 2018-10-19
ER

PT J
AU Conrad, V
   Dupouy, M
   Bordenave, L
   Lacombe, F
   Baquey, C
   Reiffers, J
   Ripoche, J
AF Conrad, V
   Dupouy, M
   Bordenave, L
   Lacombe, F
   Baquey, C
   Reiffers, J
   Ripoche, J
TI Expansion and differentiation of haemopoietic progenitor cells on
   endothelialized hydroxyapatite under static conditions
SO BRITISH JOURNAL OF HAEMATOLOGY
LA English
DT Article
DE haemopoietic progenitors; endothelial cells; hydroxyapatite; biomaterial
ID EX-VIVO EXPANSION; HUMAN BONE-MARROW; CULTURE-INITIATING CELLS;
   COLONY-STIMULATING ACTIVITY; HEMATOPOIETIC STEM-CELLS; MESSENGER-RNA
   EXPRESSION; UMBILICAL-CORD BLOOD; HIGH-DOSE CHEMOTHERAPY; IN-VITRO
   EXPANSION; GROWTH-FACTORS
AB We have analysed the potential of an endothelialized hydroxyapatite matrix (HAP), a synthetic bone substitute, as a cellularized support for the expansion of haemopoietic progenitor cells. Scanning electron microscopy (SEM) showed that the endothelial cells (EC) tended to form a monolayer fitting closely to the matrix, and that the progenitors adhered to the EC layer. Endothelialized HAP supported the proliferation and differentiation of the progenitors with the addition of the exogenous cytokines IL-1, and IL-3. The expanded cell population essentially belonged to the myeloid and monocytic lineages, with a smaller percentage of the megakaryocyte lineage, In comparative experiments CD34(+) progenitors were expanded on endothelialized tissue culture flasks, and a significant higher viability of the expanded cells was found with the endothelialized HAP. A high percentage (approx. 40%) of mature granulocytes was generated in accordance with the presence of differentiating cytokines such as G-CSF and GM-CSF at high concentrations in the coculture medium. Other cytokines that could be detected were IL-6, M-CSF, SCF, flt3-ligand. More than 50% of the expanded cell population was able to phagocytose bacteria and to generate an oxydative burst. These data indicate that cellularized HAP may be a useful matrix for stromal cell-based expansion systems.
C1 Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
   Univ Bordeaux 2, Lab Greffe de Moelle IFR 60, F-33076 Bordeaux, France.
RP Conrad, V (reprint author), Univ Bordeaux 2, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
CR ABBOUD M, 1992, EXP HEMATOL, V20, P1043
   Alcorn MJ, 1996, J CLIN ONCOL, V14, P1839, DOI 10.1200/JCO.1996.14.6.1839
   AMEDEE J, 1994, BIOMATERIALS, V15, P1029, DOI 10.1016/0142-9612(94)90086-8
   BAGBY GC, 1986, J CLIN INVEST, V78, P1316, DOI 10.1172/JCI112717
   BAGBY GC, 1983, BLOOD, V62, P663
   Bhatia R, 1997, EXP HEMATOL, V25, P980
   Breems DA, 1997, LEUKEMIA, V11, P142, DOI 10.1038/sj.leu.2400530
   BREEMS DA, 1994, LEUKEMIA, V8, P1095
   Breems DA, 1998, BLOOD, V91, P111
   BROUDY VC, 1986, P NATL ACAD SCI USA, V83, P7467, DOI 10.1073/pnas.83.19.7467
   BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109
   BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503
   BUZBY JS, 1994, EXP HEMATOL, V22, P122
   Conrad PD, 1998, J LEUKOCYTE BIOL, V64, P147
   Conrad V, 1997, J MATER SCI-MATER M, V8, P819, DOI 10.1023/A:1018585201309
   DAVIS TA, 1995, BLOOD, V85, P1751
   Denning-Kendall PA, 1998, BONE MARROW TRANSPL, V21, P225, DOI 10.1038/sj.bmt.1701078
   Dooley DC, 1997, BLOOD, V90, P3903
   FAUCHEUX C, 1994, J MATER SCI-MATER M, V5, P635, DOI 10.1007/BF00120345
   FENNIE C, 1995, BLOOD, V86, P4454
   Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602
   GROSSET C, 1995, BLOOD, V86, P3763
   Gupta P, 1996, BLOOD, V87, P3229
   HASUI M, 1989, J IMMUNOL METHODS, V117, P53, DOI 10.1016/0022-1759(89)90118-X
   HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665
   HAYLOCK DN, 1992, BLOOD, V80, P1405
   Herman P, 1998, LEUKEMIA, V12, P735, DOI 10.1038/sj.leu.2400924
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jazwiec B, 1998, LEUKEMIA, V12, P1210, DOI 10.1038/sj.leu.2401086
   KNUDTZON S, 1975, BLOOD, V46, P937
   KOENIG A, 1994, BLOOD, V83, P2836
   Kogler G, 1998, BONE MARROW TRANSPL, V21, pS48
   KOLLER MR, 1993, BIO-TECHNOL, V11, P358, DOI 10.1038/nbt0393-358
   KOLLER MR, 1995, BLOOD, V86, P1784
   Koller MR, 1996, EXP HEMATOL, V24, P1484
   Lenhoff S, 1996, CYTOKINE, V8, P702, DOI 10.1006/cyto.1996.0093
   Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470
   Piacibello W, 1998, VOX SANG, V74, P457, DOI 10.1111/j.1423-0410.1998.tb05456.x
   Piacibello W, 1997, BLOOD, V89, P2644
   Poloni A, 1995, NOUV REV FR HEMATOL, V37, P367
   Querol S, 1998, BONE MARROW TRANSPL, V21, pS77
   QUESENBERRY PJ, 1980, BLOOD, V56, P1060
   RAFII S, 1995, BLOOD, V86, P3353
   Shapiro F, 1996, J Hematother, V5, P655, DOI 10.1089/scd.1.1996.5.655
   SHPALL EJ, 1994, J CLIN ONCOL, V12, P28, DOI 10.1200/JCO.1994.12.1.28
   SIEFF CA, 1987, J CLIN INVEST, V79, P48, DOI 10.1172/JCI112806
   SUEN Y, 1994, BLOOD, V84, P4125
   SUTHERLAND HJ, 1991, BLOOD, V78, P666
   TURHAN AG, 1989, NEW ENGL J MED, V320, P1655, DOI 10.1056/NEJM198906223202504
   VERFAILLIE CM, 1995, BLOOD, V86, P2137
   VERFAILLIE CM, 1994, J EXP MED, V179, P643, DOI 10.1084/jem.179.2.643
   VERFAILLIE CM, 1993, BLOOD, V82, P2045
   Verfaillie CM, 1996, LEUKEMIA, V10, P498
   WILLIAMS DA, 1993, BLOOD, V81, P3169
   Williams SF, 1996, BLOOD, V87, P1687
   ZUCKERMAN KS, 1985, J CLIN INVEST, V75, P722, DOI 10.1172/JCI111752
NR 56
TC 3
Z9 3
U1 0
U2 2
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0007-1048
J9 BRIT J HAEMATOL
JI Br. J. Haematol.
PD APR
PY 1999
VL 105
IS 1
BP 40
EP 49
PG 10
WC Hematology
SC Hematology
GA 192CP
UT WOS:000080060900006
PM 10233361
DA 2018-10-19
ER

PT J
AU Kaplan, SS
   Heine, RP
   Simmons, RL
AF Kaplan, SS
   Heine, RP
   Simmons, RL
TI Defensins impair phagocytic killing by neutrophils in
   biomaterial-related infection
SO INFECTION AND IMMUNITY
LA English
DT Article
ID HUMAN POLYMORPHONUCLEAR LEUKOCYTES; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   NATURAL PEPTIDE ANTIBIOTICS; FOREIGN-BODY INFECTION; SURFACE
   THERMODYNAMICS; DIRECT INACTIVATION; SECRETORY VESICLES; MICROBIAL
   ADHESION; TISSUE INTEGRATION; CYTO-TOXICITY
AB The implantation of foreign material carries a risk of infection which frequently is resistant to all treatment short of removing the implant. We have previously shown that these materials activate neutrophils by contact, leading to production of oxygen free radicals accompanied by release of granule products. Such activation further results in depletion of local host defenses, including the capacity of biomaterial-activated neutrophils to kill bacteria. Among the granule products released from neutrophils are small cationic antibacterial peptides (human neutrophil peptides [HNP]) known as defensins. Here we tested the hypothesis that defensins, released from activated neutrophils onto the surface of biomaterials, might play a role in the deactivation of subsequent neutrophil populations. Incubation of neutrophils with purified HNP resulted in a dose-related impairment of stimulus-induced oxygen radical production and of phagocytic killing. Furthermore, fresh neutrophils added to biomaterial-associated neutrophils exhibited impaired phagocytic killing. This impairment could be abrogated by antibody to HNP but not by an irrelevant antibody Taken together, these observations support the idea that neutrophils activated at a material surface can create, by means of HNP release, an environment hostile to their microbicidal function and that of their infiltrating brethren.
C1 Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA.
   Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.
RP Kaplan, SS (reprint author), Univ Pittsburgh, Med Ctr, Room 5930 MT CHP,200 Lothrop St, Pittsburgh, PA 15213 USA.
FU NIGMS NIH HHS [R01-GM-41734]
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BABIOR BM, 1984, BLOOD, V64, P959
   BADDOUR LM, 1984, J INFECT DIS, V150, P721, DOI 10.1093/infdis/150.5.721
   BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BRUNSTEDT MR, 1995, J BIOMED MATER RES, V29, P455, DOI 10.1002/jbm.820290405
   CHARP PA, 1988, BIOCHEM PHARMACOL, V37, P951, DOI 10.1016/0006-2952(88)90187-6
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   DAHER KA, 1986, J VIROL, V60, P1068
   Dougherty S H, 1989, Infect Dis Clin North Am, V3, P199
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   Friedman David W., 1994, P1
   GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120
   GANZ T, 1987, INFECT IMMUN, V55, P568
   GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F
   GERA JF, 1991, CELL IMMUNOL, V138, P108, DOI 10.1016/0008-8749(91)90136-Y
   GORMLEY IP, 1985, BRIT J EXP PATHOL, V66, P409
   Greco RS, 1997, J BIOMED MATER RES, V34, P409, DOI 10.1002/(SICI)1097-4636(19970315)34:4<409::AID-JBM1>3.0.CO;2-O
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   GUO W, 1993, B DEP SURG LUND U, V92, P9
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   KAGAN BL, 1994, TOXICOLOGY, V87, P131, DOI 10.1016/0300-483X(94)90158-9
   KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAPLAN SS, 1977, J RETICULOENDOTH SOC, V22, P499
   KAPLAN SS, 1987, ANN ALLERGY, V59, P213
   Karlsson C, 1996, J LAB CLIN MED, V128, P496, DOI 10.1016/S0022-2143(96)90047-5
   KATZ DA, 1994, SURGERY, V116, P446
   KATZ DA, 1994, GEN SURG, P209
   KLOCK JC, 1976, BLOOD, V48, P149
   KUHNS DB, 1986, BLOOD, V68, P535
   LEHRER RI, 1990, BLOOD, V76, P2169
   LEHRER RI, 1985, J VIROL, V54, P467
   LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198
   LICHTENSTEIN A, 1986, BLOOD, V68, P1407
   LICHTENSTEIN A, 1991, J CLIN INVEST, V88, P93, DOI 10.1172/JCI115310
   LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686
   LICHTENSTEIN AK, 1988, CELL IMMUNOL, V114, P104, DOI 10.1016/0008-8749(88)90258-4
   MALANGONI MA, 1993, J SURG RES, V54, P168, DOI 10.1006/jsre.1993.1027
   MARCHANT R, 1983, J BIOMED MATER RES, V2, P283
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MILLER RA, 1995, J INVEST MED, V43, P39
   PANYUTICH AV, 1991, J IMMUNOL METHODS, V141, P149, DOI 10.1016/0022-1759(91)90141-2
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P752, DOI 10.2106/00004623-197860060-00004
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SCHWARZMANN S, 1971, INFECT IMMUN, V3, P762
   SELSTED ME, 1985, INFECT IMMUN, V49, P202
   SENGELOV H, 1995, J IMMUNOL, V154, P4157
   SENGELOV H, 1993, J IMMUNOL, V150, P1535
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHEU MJT, 1985, ANTIMICROB AGENTS CH, V28, P626, DOI 10.1128/AAC.28.5.626
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   Tal T, 1998, J LEUKOCYTE BIOL, V63, P305
   TAL T, 1993, BIOCHEM BIOPH RES CO, V196, P636, DOI 10.1006/bbrc.1993.2297
   WADE BH, 1983, AM J MED, V74, P686, DOI 10.1016/0002-9343(83)91028-8
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WRIGHT DG, 1977, AM J PATHOL, V87, P273
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562
   Yomogida S, 1996, INFLAMM RES, V45, P62, DOI 10.1007/BF02265117
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 79
TC 24
Z9 25
U1 1
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD APR
PY 1999
VL 67
IS 4
BP 1640
EP 1645
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 178QZ
UT WOS:000079278700014
PM 10084997
DA 2018-10-19
ER

PT J
AU Bobyn, JD
   Toh, KK
   Hacking, SA
   Tanzer, M
   Krygier, JJ
AF Bobyn, JD
   Toh, KK
   Hacking, SA
   Tanzer, M
   Krygier, JJ
TI Tissue response to porous tantalum acetabular cups - A canine model
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE porous tantalum; acetabular cup; bone ingrowth; total hip arthroplasty;
   canine
ID BONE INGROWTH; COMPONENTS; IMPLANTS; TITANIUM
AB This study evaluated the osseous tissue response to a noncemented metal-backed acetabular component made of a new porous tantalum biomaterial. Eleven dogs with bilateral total hip arthroplasties (22 acetabular implants) were studied for a period of 6 months. Thin section histology, high-resolution radiography, and backscattered scanning electron microscopy revealed that all 22 implants had stable bone-implant interfaces. Regions of bone ingrowth were present in all histologic sections. The depth of bone ingrowth varied from 0.2 mm to the maximal limit of 2 mm. Analyzing contiguous regions of interest across the full bone-implant interface, the mean bone ingrowth for all sections was 16.8% +/- 5.7%. In the peripheral regions of the cup where bone-implant contact was most consistent, bone ingrowth averaged 25.1% +/- 10.1%. The data indicate that the porous tantalum material is effective for biologic fixation in the dog and may provide a suitable alternative to other porous materials used in acetabular cup design.
C1 McGill Univ, Montreal Gen Hosp, Div Orthopaed, Jo Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
RP Bobyn, JD (reprint author), McGill Univ, Montreal Gen Hosp, Div Orthopaed, Jo Miller Orthopaed Res Lab, Room A2-156,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.
RI Hacking, Adam/F-3645-2010
CR ARONSON AS, 1985, SKELETAL RADIOL, V14, P207, DOI 10.1007/BF00355566
   BOBYN JD, 1994, CLIN ORTHOP RELAT R, P27
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOBYN JD, 1981, ACTA ORTHOP SCAND, V52, P145, DOI 10.3109/17453678108991775
   BOBYN JD, 1999, IN PRESS J BONE JOIN
   Cook S D, 1988, J Arthroplasty, V3, P249
   ENGH CA, 1994, CLIN ORTHOP RELAT R, P89
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   FITZPATRICK D, 1997, 21 ANN AM SOC BIOM C
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Goldberg VM, 1996, CLIN ORTHOP RELAT R, P147
   HAMMAN G, 1987, ASTM STP, V953, P77
   HOFMANN AA, 1993, J ARTHROPLASTY, V8, P157, DOI 10.1016/S0883-5403(06)80056-2
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   JASTY M, 1988, NONCEMENTED TOTAL HI, P175
   JOHNSON PF, 1977, J BIOMED MATER RES, V11, P637, DOI 10.1002/jbm.820110502
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   Plenk Jr H, 1984, CEMENTLESS FIXATION, P174
   ROBERTSON RCL, 1945, J NEUROSURG, V2, P281, DOI 10.3171/jns.1945.2.4.0281
   SCHMALZRIED TP, 1993, J BONE JOINT SURG BR, V75, P608
   SPECTOR M, 1982, BIOCOMPATIBILITY ORT, P89
   SPURLING RG, 1943, SURG CLIN N AM, V23, P1491
   SUMNER DR, 1990, J ORTHOPAED RES, V8, P448, DOI 10.1002/jor.1100080316
NR 24
TC 182
Z9 187
U1 1
U2 17
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 1999
VL 14
IS 3
BP 347
EP 354
DI 10.1016/S0883-5403(99)90062-1
PG 8
WC Orthopedics
SC Orthopedics
GA 184WA
UT WOS:000079635700013
PM 10220190
DA 2018-10-19
ER

PT J
AU Kienapfel, H
   Sprey, C
   Wilke, A
   Griss, P
AF Kienapfel, H
   Sprey, C
   Wilke, A
   Griss, P
TI Implant fixation by bone ingrowth
SO JOURNAL OF ARTHROPLASTY
LA English
DT Review
DE bone ingrowth; osseointegration; implant fixation; porous coating; bone
   morphogenetic proteins; factor XIII; calcium phosphate coatings
ID POROUS TITANIUM IMPLANTS; ROENTGEN STEREOPHOTOGRAMMETRIC ANALYSIS;
   HYDROXYAPATITE-COATED IMPLANTS; ELECTRICAL-STIMULATION; TIBIAL
   COMPONENT; SURFACE TEXTURE; CANINE MODEL; TOTAL KNEE; INTERFACE; GROWTH
AB The term osseointegration referred originally to an intimate contact of bone tissue with the surface of a titanium implant; the term bone ingrowth refers to bone formation within an irregular (beads, wire mesh, casting voids, cut grooves) surface of an implant. The section dealing with the historical background describes the development of macroporous, microporous, and textured surfaces with an emphasis on the evolution of porous and textured metal surfaces. The principal requirements for osseointegration and bone ingrowth are systematically reviewed as follows: i) the physiology of osseointegration and bone ingrowth, including biomaterial biocompatibility with respect to cellular and matrix response at the interface; ii) the implant surface geometry characteristics; iii) implant micromotion and fixation modes; and iv) the implant-bone interface distances. Based on current methods of bone ingrowth assessment, this article comparatively reviews and discusses the results of experimental studies with the objective of determining local and systemic factors that enhance bone ingrowth fixation.
C1 Univ Marburg, Dept Orthopaed Surg, D-35033 Marburg, Germany.
RP Kienapfel, H (reprint author), Univ Marburg, Dept Orthopaed Surg, D-35033 Marburg, Germany.
FU PHS HHS [39827, 16485]
CR ANDRIACCHI TP, 1993, CLIN ORTHOP RELAT R, P40
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   BERRY JL, 1986, J BIOMED MATER RES, V20, P65, DOI 10.1002/jbm.820200107
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOBYN JD, 1981, ACTA ORTHOP SCAND, V52, P145, DOI 10.3109/17453678108991775
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   Branson P J, 1989, J Arthroplasty, V4, P21, DOI 10.1016/S0883-5403(89)80049-X
   BROWN SD, 1980, MECH PROPERTIES BIOM, P19
   BRYAN RS, 1958, MAYO CLIN P, V33, P453
   Burke D.W., 1993, T 39 ANN ORS, V18, P470
   BURKE DW, 1991, 37TH T ANN M ORTH RE, V16, P103
   CALLAHAN BC, 1995, J BONE JOINT SURG AM, V77A, P225, DOI 10.2106/00004623-199502000-00008
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   CARREROT H, 1989, BIOCERAMICS, P211
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Chae J C, 1988, Ann N Y Acad Sci, V523, P81, DOI 10.1111/j.1749-6632.1988.tb38502.x
   CHESMEL KD, 1993, BIOCERAMICS, V6, P211
   CHIN HC, 1993, CLIN ORTHOP RELAT R, P254
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COLELLA SM, 1981, J BIOMED MATER RES, V15, P37, DOI 10.1002/jbm.820150108
   COLLIER JP, 1992, CLIN ORTHOP RELAT R, P97
   COOK SD, 1995, J ARTHROPLASTY, V10, P351, DOI 10.1016/S0883-5403(05)80184-6
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1985, CLIN ORTHOP RELAT R, P271
   COOK SD, 1992, CLIN ORTHOP RELAT R, P163
   DALTON JE, 1995, J BONE JOINT SURG AM, V77A, P97, DOI 10.2106/00004623-199501000-00012
   DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P, 1974, Acta Orthop Belg, V40, P799
   ENGH CA, 1985, BIOL FIXATION TOTAL
   FRIEDENBERG ZB, 1963, SURG GYNECOL OBSTET, V116, P588
   Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GILMER WS, 1961, SURG GYNECOL OBSTET, V113, P143
   GOLDBERG VM, 1995, CLIN ORTHOP RELAT R, P122
   GREENFIELD EJ, 1909, Patent No. 478360
   GREIS PE, 1992, CLIN ORTHOP RELAT R, P47
   GUYTON JL, 1991, T ORTHOP RES SOC, V16, P32
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   HEIMKE G, 1990, OSSEOINTEGRATED IMPL
   HERMENS KA, 1986, T ORTHOP RES SOC, V11, P343
   HIRSCHHORN JS, 1969, RES DENTAL MED MAT
   HOFMANN AA, 1992, INT ORTHOP, V16, P349
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   HUNGERFORD DS, 1982, ORTHOP CLIN N AM, V13, P103
   HUNGERFORD DS, 1984, TOTAL HIP ARTHROPLAS
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   JASTY M, 1989, SCANNING MICROSCOPY, V3, P1051
   JASTY M, 1991, J BONE JOINT SURG AM, V73A, P1331, DOI 10.2106/00004623-199173090-00007
   Jasty M, 1993, J Arthroplasty, V8, P33, DOI 10.1016/S0883-5403(06)80105-1
   JASTY M, 1992, CLIN ORTHOP RELAT R, P300
   JUDET R, 1978, REV CHIR ORTHOP, V64, P14
   KANG JD, 1991, J BONE JOINT SURG AM, V73A, P93, DOI 10.2106/00004623-199173010-00012
   KARRHOLM J, 1994, J BONE JOINT SURG AM, V76A, P1692, DOI 10.2106/00004623-199411000-00013
   KARRHOLM J, 1992, J ORTHOPAED RES, V10, P826, DOI 10.1002/jor.1100100612
   Kienapfel H, 1997, ARCH ORTHOP TRAUM SU, V116, P239, DOI 10.1007/BF00393720
   KIENAPFEL H, 1992, J ORTHOPAED RES, V10, P423, DOI 10.1002/jor.1100100315
   KIENAPFEL H, 1991, ARCH ORTHOP TRAUM SU, V110, P179, DOI 10.1007/BF00571055
   KIENAPFEL H, 1996, RECONSTRUCTION KNEE
   KIENAPFEL H, 1990, T ORTHOP RES SOC, V15, P432
   KIENAPFEL H, 1996, CERAMIC IMPLANT MAT, P22
   KIENAPFEL H, 1994, GRUNDLAGEN ZEMENTFRE
   KITSUGI T, 1995, J ARTHROPLASTY, V10, P245, DOI 10.1016/S0883-5403(05)80134-2
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOZINN SC, 1981, T ORTHOP RES SOC, V7, P181
   LEMBERT E, 1972, CLIN ORTHOP RELAT R, P303
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Lewis CG, 1997, J ARTHROPLASTY, V12, P451, DOI 10.1016/S0883-5403(97)90202-3
   LEWIS CG, 1987, T ORTHOP RES SOC, V12, P319
   LISECKI EJ, 1992, T ORTHOP RES SOC, V17, P368
   LUECK R A, 1969, Surgical Forum (Chicago), V20, P456
   MANDARINO M P, 1958, Surg Forum, V9, P762
   MCDONALD DJ, 1988, J BONE JOINT SURG AM, V70A, P728, DOI 10.2106/00004623-198870050-00014
   MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150
   MCLAUGHLIN RE, 1984, CLIN ORTHOP RELAT R, P255
   Morberg PH, 1997, ACTA ORTHOP SCAND, V68, P344, DOI 10.3109/17453679708996174
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   NILLES JL, 1973, J BIOMED MATER RES, V7, P63, DOI 10.1002/jbm.820070306
   Nilsson K G, 1991, J Arthroplasty, V6, P265, DOI 10.1016/S0883-5403(06)80174-9
   ORTH J, 1990, ADV BIOMAT, V9, P283
   Osborn J F, 1979, SSO Schweiz Monatsschr Zahnheilkd, V89, P1138
   Overgaard S, 1997, ACTA ORTHOP SCAND, V68, P337, DOI 10.3109/17453679708996173
   Overgaard S, 1997, CLIN ORTHOP RELAT R, P286
   PARK JB, 1980, ANN BIOMED ENG, V8, P93, DOI 10.1007/BF02363173
   PFLUGER G, 1979, WIEN KLIN WOCHENSCHR, V91, P482
   PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   POPOVICI A F, 1954, Bull Georgetown Univ Med Cent, V7, P177
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   RIVERO DP, 1986, T ORTHOP RES SOC, V11, P492
   RIVERO DP, 1985, T ORTHOP RES SOC, V10, P191
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   ROY RG, 1993, AM J VET RES, V54, P1188
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUSOTTI GM, 1987, HIP, P120
   RYD L, 1992, ARCH ORTHOP TRAUM SU, V111, P148, DOI 10.1007/BF00388089
   SADR B, 1977, INJURY, V8, P234, DOI 10.1016/0020-1383(77)90137-1
   Sandborn P M, 1988, J Arthroplasty, V3, P337, DOI 10.1016/S0883-5403(88)80034-2
   SCHUTZER SF, 1990, CLIN ORTHOP RELAT R, P297
   SHAW JA, 1994, J ORTHOPAED RES, V12, P268, DOI 10.1002/jor.1100120217
   SHEN WJ, 1993, CLIN ORTHOP RELAT R, P346
   SHIMAGAKI H, 1990, J ORTHOPAED RES, V8, P64, DOI 10.1002/jor.1100080108
   SKINNER HB, 1979, BIOMATER ARTIF CELL, V7, P141, DOI 10.3109/10731197909119381
   SMITH L, 1963, ARCH SURG-CHICAGO, V87, P137
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   SOBALLE K, 1992, CLIN ORTHOP RELAT R, P282
   SPECTOR M, 1976, J BIOMED MATER RES, V10, P595, DOI 10.1002/jbm.820100416
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   SPIVAK JM, 1990, J BIOMED MATER RES, V24, P1121, DOI 10.1002/jbm.820240902
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   Strickland AB, 1988, T ORTHOP RES SOC, V13, P476
   STRUTHERS A M, 1955, Plast Reconstr Surg (1946), V15, P274, DOI 10.1097/00006534-195504000-00003
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   SUMNER DR, 1990, J BONE JOINT SURG AM, V72A, P1527, DOI 10.2106/00004623-199072100-00015
   SUMNER DR, 1990, J ORTHOPAED RES, V8, P448, DOI 10.1002/jor.1100080316
   SUMNER DR, 1993, ACTA ORTHOP SCAND, V64, P619, DOI 10.3109/17453679308994584
   SUMNER DR, 1995, J ARTHROPLASTY, V10, P157, DOI 10.1016/S0883-5403(05)80122-6
   SUMNER DR, 1990, SURGERY MUSCULOSKELE, P151
   SUMNER DR, 1992, BONE GRAFTS BONE SUB, P252
   Tanzer M, 1996, J ORTHOPAED RES, V14, P901, DOI 10.1002/jor.1100140609
   TENSI HM, 1989, BIOMED TECH, V34, P308, DOI 10.1515/bmte.1989.34.12.308
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   TULLOS HS, 1984, J BONE JOINT SURG AM, V66A, P888, DOI 10.2106/00004623-198466060-00009
   TURNER TM, 1993, J BONE JOINT SURG AM, V75A, P845, DOI 10.2106/00004623-199306000-00006
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1980, FUNDAMENTAL CLIN BON, P331
   VOLZ RG, 1988, CLIN ORTHOP RELAT R, P38
   WEINSTEIN AM, 1976, J BIOMED MATER RES, V10, P23
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Young DR, 1997, J ORTHOPAED RES, V15, P773, DOI 10.1002/jor.1100150521
   1984, Patent No. 31016917
   1976, Patent No. 23456465
NR 146
TC 215
Z9 220
U1 1
U2 43
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 1999
VL 14
IS 3
BP 355
EP 368
DI 10.1016/S0883-5403(99)90063-3
PG 14
WC Orthopedics
SC Orthopedics
GA 184WA
UT WOS:000079635700014
PM 10220191
DA 2018-10-19
ER

PT J
AU Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
AF Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
TI Mechanical properties of medical grade expanded polytetrafluoroethylene:
   The effects of internodal distance, density, and displacement rate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE expanded polytetrafluoroethylene (e-PTFE); implants; structure;
   mechanical properties
ID SURGERY; GRAFTS
AB Expanded polytetrafluoroethylene (e-PTFE) is used successfully in a multitude of biomedical and clinical applications, The success of this biomaterial is due to its microporous structure that allows biointegration for fixation, as well as overall mechanical integrity. The mechanical properties and degree of tissue ingrowth depend on the microstructure of the expanded polymer foam, yet little is known about the correlation of the internodal distance and other microstructural features with the monotonic tensile properties. Complete structure-property correlation can be used to provide invaluable knowledge for the design of biomedical devices, The purpose of this study was to investigate the monotonic tensile properties of e-PTFE over a range of medically relevant microstructural features and manufacturing parameters. The microstructural and manufacturing parameters considered were internodal distance, linear density, volumetric density, and reduction ratio. Additionally, the effect of displacement rate on mechanical properties was studied. We found that the ultimate stress and strain increased linearly with linear density (R-2 = 0.88 and 0.67, respectively). Surprisingly, elastic modulus did not correlate with any parameter measured and only weak correlations were found between all properties and internodal distance. The yield and ultimate stresses increased with increasing displacement rate (R-2 = 0.88 and 0.57, respectively), The findings from this study indicate that linear density is a better predictor of mechanical properties than internodal distance and may be the preferred parameter to control when specifying a material for implantation in load bearing situations. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA.
RP Pruitt, L (reprint author), Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
EM lpruitt@euler.berkeley.edu
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bolton W, 1983, Aktuelle Probl Chir Orthop, V26, P40
   Bolton W, 1983, Aktuelle Probl Chir Orthop, V25, P42
   BOYCE B, 1983, CONCISE ENCY MED DEN, pCH33
   Brun J. L., 1992, Bio-Medical Materials and Engineering, V2, P203
   CAMPBELL CD, 1975, ANN SURG, V182, P138, DOI 10.1097/00000658-197508000-00010
   COCHRAN RP, 1991, J CARDIAC SURG, V6, P508, DOI 10.1111/j.1540-8191.1991.tb00352.x
   Greene D, 1997, LARYNGOSCOPE, V107, P957, DOI 10.1097/00005537-199707000-00024
   KONIOR RJ, 1992, ARCH OTOLARYNGOL, V118, P1188
   MAAS CS, 1993, ARCH OTOLARYNGOL, V119, P1008
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   PAAVOLAINEN P, 1993, ACTA ORTHOP SCAND, V64, P323, DOI 10.3109/17453679308993636
   RITTGERS SE, 1985, J MED ENG TECHNOL, V9, P1, DOI 10.3109/03091908509018197
   SANTIAGO EJ, 1981, ANN ROY COLL SURG, V63, P253
   WATANABE T, 1984, J JPN SURG SOC, V85, P580
NR 16
TC 41
Z9 42
U1 4
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1999
VL 48
IS 2
BP 187
EP 192
DI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 181HW
UT WOS:000079436800013
PM 10331912
DA 2018-10-19
ER

PT J
AU Acero, J
   Calderon, J
   Salmeron, JI
   Verdaguer, JJ
   Concejo, C
   Somacarrera, ML
AF Acero, J
   Calderon, J
   Salmeron, JI
   Verdaguer, JJ
   Concejo, C
   Somacarrera, ML
TI The behaviour of titanium as a biomaterial: microscopy study of plates
   and surrounding tissues in facial osteosynthesis
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
ID MANDIBULAR FRACTURES; DENTAL IMPLANTS; RESPONSES; INTERFACE; FIXATION;
   ADJACENT; BONE
AB Titanium has become the biomaterial of choice for facial osteosynthesis, Titanium is considered a highly biocompatible and corrosion resistant material, although the ultrastructural behaviour of titanium in human tissues after bone fixation is not well documented,
   A prospective scanning electron microscopy study was carried out on 37 commercially pure titanium miniplates which were removed from 23 patients who had undergone surgery for maxillofacial trauma or deformity. Twenty two cases were used as a control group. Implant-bone specimens were excised using tungsten burs and studied with a scanning electron microscope (Jeol JSM-T-300). Findings at the bone-titanium interface were analyzed, as well as the presence of contaminating bodies on the specimen surface, Biopsies were also obtained from the soft tissues adjacent to 20 miniplates, then sectioned and stained with Haematoxilin-Eosin for histological evaluation by light microscopy:
   The results showed good ultrastructural osseointegration of the osteosynthesis material in most cases (81.8%). Mobility was found upon removal in 80% of plates which showed clinical complications, A significant correlation was found between the degree of microscopical osseointegration and macroscopic fixation of the plate. Microscopical contamination was found in 100% of the nine plates with intraoral exposure, while only 36% of the 22 miniplates of the control group had contaminating elements (P<0.001). Thirty-five point one percent of the plates showed hole-like substance loss images, whose size ranged from 10-25 mu. Light microscopy showed granular deposits in soft tissues surrounding the plates in 80% of the 20 specimens investigated. Our findings suggest a higher development of corrosion in titanium than previously reported. These findings are not correlated, however with the clinical complications.
C1 Gregorio Maranon Univ Hosp, Dept Maxillofacial Surg, Madrid 28007, Spain.
   Univ Complutense, Dept Stomatol, Sch Dent, E-28040 Madrid, Spain.
RP Acero, J (reprint author), C-Velazquez 27,2 Izq, Madrid 28001, Spain.
CR ARRANZ JL, 1980, REV EUROPEA ODONTOES, V5, P319
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BOS R, 1990, ORAL MAXILLOFACIAL C, V2, P745
   BREME J, 1988, BIOMATERIALS, V9, P310, DOI 10.1016/0142-9612(88)90024-5
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285, DOI 10.3109/17453678608994393
   DENG ZL, 1988, REV INFECT DIS, V10, P640
   DISEGI JA, 1989, ORTHOPEDICS, V12, P75
   GORES RJ, 1989, J ORAL MAXIL SURG, V47, P302, DOI 10.1016/0278-2391(89)90237-1
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HECK DA, 1986, J BONE JOINT SURG AM, V68A, P118, DOI 10.2106/00004623-198668010-00015
   Jorgenson DS, 1997, PLAST RECONSTR SURG, V99, P976, DOI 10.1097/00006534-199704000-00006
   KALEBO P, 1988, BIOMATERIALS, V9, P295, DOI 10.1016/0142-9612(88)90022-1
   Katou F, 1996, J CRANIO MAXILL SURG, V24, P155, DOI 10.1016/S1010-5182(96)80049-7
   KATSIKERIS N, 1987, INT J ORAL MAX SURG, V16, P473, DOI 10.1016/S0901-5027(87)80087-5
   Kim YK, 1997, J ORAL MAXIL SURG, V55, P322, DOI 10.1016/S0278-2391(97)90115-4
   KREKELER G, 1985, INT J ORAL MAXILLOF, V14, P447, DOI 10.1016/S0300-9785(85)80078-8
   KROON FHM, 1991, J CRANIO MAXILL SURG, V19, P199, DOI 10.1016/S1010-5182(05)80547-5
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   MARRIE TJ, 1983, AM J OBSTET GYNECOL, V146, P384, DOI 10.1016/0002-9378(83)90818-9
   MARSH JL, 1989, CLIN PLAST SURG, V16, P49
   MORAN CA, 1991, HUM PATHOL, V22, P450, DOI 10.1016/0046-8177(91)90130-H
   MUSTER F, 1987, ENCY MED CHIRURG PAR, P12
   NISHIOKA GJ, 1988, J ORAL MAXIL SURG, V46, P19, DOI 10.1016/0278-2391(88)90295-9
   RAVEH Y, 1983, J ORAL MAXIL SURG, V41, P3, DOI 10.1016/S0278-2391(83)80024-X
   SCHLIEPHAKE H, 1993, INT J ORAL MAX SURG, V22, P20, DOI 10.1016/S0901-5027(05)80350-9
   STEFLIK DE, 1990, SCANNING MICROSCOPY, V4, P1039
   STEFLIK DE, 1990, SCANNING MICROSCOPY, V4, P1021
   Weber W, 1990, Dtsch Z Mund Kiefer Gesichtschir, V14, P46
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 29
TC 46
Z9 48
U1 0
U2 7
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD APR
PY 1999
VL 27
IS 2
BP 117
EP 123
DI 10.1016/S1010-5182(99)80025-0
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 192RN
UT WOS:000080092900010
PM 10342150
DA 2018-10-19
ER

PT J
AU Gauthier, O
   Boix, D
   Grimandi, G
   Aguado, E
   Bouler, JM
   Weiss, P
   Daculsi, G
AF Gauthier, O
   Boix, D
   Grimandi, G
   Aguado, E
   Bouler, JM
   Weiss, P
   Daculsi, G
TI A new injectable calcium phosphate biomaterial for immediate bone
   filling of extraction sockets: A preliminary study in dogs
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone regeneration; calcium phosphates; bone substitutes; tooth
   extraction
ID FREEZE-DRIED BONE; PERIODONTAL OSSEOUS DEFECTS; ALVEOLAR RIDGE
   AUGMENTATION; MANDIBULAR AUGMENTATION; POROUS HYDROXYAPATITE;
   HYDROXYLAPATITE; CERAMICS; PLACEMENT; IMPLANTS; SITES
AB Background: Many different bone substitutes, such as autografts, allografts or synthetic biomaterials have been proposed to restore alveolar bone loss and support efficient placement of dental implants. This experimental study evaluated the osteoconductive properties of an injectable bone substitute (IBS) composed of a polymeric carrier and a calcium phosphate mineral phase, used to fill mandibular and maxillary canine extraction sockets.
   Methods: The polymer was a cellulose derivative (methyl-hydroxy-propyl-cellulose, MHPC), and the mineral phase consisted of granules of biphasic calcium phosphate (BCP) ceramics 200 to 500 mu m in diameter, Mandibular and maxillary premolars extracted from 3 dogs (a total of 60 extraction sites) were immediately treated with the IBS or left unfilled as control sites. Animals were sacrificed 3 months after implantation and all extraction sockets were prepared for histological evaluation.
   Results: Qualitative histological studies showed that the IBS was able to support the extensive apposition of well-mineralized newly formed lamellar bone over the entire socket surface and appeared to prevent alveolar ridge bone loss in treated extraction sites. Quantitative evaluation showed that the amount of newly formed bone was significantly higher in mandibular than maxillary extraction sockets for both treated and control sites.
   Conclusions: An injectable bone substitute composed of a polymeric carrier and calcium phosphate was effective in enhancing the bone fill of extraction sockets. This approach may prove promising for periodontal lesions. The material expressed osteoconductive capacities, and the biological properties of the mineral phase were conserved.
C1 Ecole Natl Vet, Lab Chirurg, F-44307 Nantes 3, France.
   Fac Chirurg Dent, Equipe INSERM, Lab Rech Mat Interet Biol, Nantes, France.
RP Gauthier, O (reprint author), Ecole Natl Vet, Lab Chirurg, Route Gachet,BP 40706, F-44307 Nantes 3, France.
RI Daculsi, Guy/P-1320-2014; Weiss, Pierre/P-1372-2014; Gauthier,
   Olivier/A-4639-2015
OI Daculsi, Guy/0000-0003-1030-3446; Weiss, Pierre/0000-0002-6159-8590;
   BOULER, Jean-Michel/0000-0001-9784-5584
CR BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   BEIME OR, 1985, J DENT RES, V64, P1152
   BEIRNE OR, 1986, J PROSTHET DENT, V55, P362, DOI 10.1016/0022-3913(86)90121-6
   BELL DH, 1986, J PROSTHET DENT, V56, P322, DOI 10.1016/0022-3913(86)90013-2
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   BLOCK MS, 1991, J ORAL MAXIL SURG, V49, P1269, DOI 10.1016/0278-2391(91)90302-3
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   BOWEN JA, 1989, J PERIODONTOL, V60, P647, DOI 10.1902/jop.1989.60.12.647
   BOYNE PJ, 1984, J ORAL MAXIL SURG, V42, P589, DOI 10.1016/0278-2391(84)90089-2
   Brugnami F, 1996, J PERIODONTOL, V67, P821, DOI 10.1902/jop.1996.67.8.821
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   Cook S D, 1994, J Oral Implantol, V20, P292
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   FERMIN OT, 1987, J ORAL MAXILLOFAC SU, V45, P188
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Ishikawa I, 1995, INT J PERIODONT REST, V15, P204
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JEAN AH, 1993, CELL MATER, V3, P193
   Jovanovic S A, 1995, Int J Oral Maxillofac Implants, V10, P23
   KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2
   Kraut R A, 1989, Int J Oral Maxillofac Implants, V4, P153
   MEHLISCH DR, 1987, J ORAL MAXIL SURG, V45, P408, DOI 10.1016/0278-2391(87)90008-5
   MENTAG P J, 1989, Journal of Oral Implantology, V15, P114
   MOY PK, 1993, J ORAL MAXIL SURG, V51, P857, DOI 10.1016/S0278-2391(10)80103-X
   NERY EB, 1990, J PERIODONTOL, V61, P166, DOI 10.1902/jop.1990.61.3.166
   NERY EB, 1978, J PROSTHET DENT, V40, P668, DOI 10.1016/0022-3913(78)90067-7
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   NEVINS M, 1994, INT J PERIODONT REST, V14, P97
   OREAMUNO S, 1990, J PERIODONTOL, V61, P399, DOI 10.1902/jop.1990.61.7.399
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P64
   REY C, 1990, Biomaterials, V11, P13
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   SHERER AD, 1987, J PROSTHET DENT, V57, P331, DOI 10.1016/0022-3913(87)90308-8
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   Takeshita F, 1997, J PERIODONTOL, V68, P924, DOI 10.1902/jop.1997.68.10.924
NR 44
TC 72
Z9 80
U1 1
U2 12
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 1999
VL 70
IS 4
BP 375
EP 383
DI 10.1902/jop.1999.70.4.375
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 192RU
UT WOS:000080093400004
PM 10328648
DA 2018-10-19
ER

PT J
AU Shi, X
   Datta, AK
   Mukherjee, S
AF Shi, X
   Datta, AK
   Mukherjee, S
TI Thermal fracture in a biomaterial during rapid freezing
SO JOURNAL OF THERMAL STRESSES
LA English
DT Article
ID ELEMENT METHOD; FAILURE; TEMPERATURE; STRESSES
AB Thermal stresses leading to fracture during rapid freezing of a biomaterial are studied using potato tissues as an example. The thermal model includes the gradual freezing of the tissue, that is, the presence of a mushy zone. Water in the biomaterial expands almost 9% during freezing and develops transient stresses when the material is frozen from all sides. A viscoelastic model for the tissue is used with mechanical properties changing continuously during freezing. A comparison of stresses developed during freezing, with experimentally measured failure strength, is used as a criterion for initiation of a crack. The strain energy release rate G is calculated using the J integral. Experimental evidence of a catastrophic fracture during very rapid freezing (boundary temperature of -200 degrees C) suggests that the G value is likely to exceed the critical rate (G,) at this temperature but not so for slow freezing at a boundary temperature of -40 degrees C, for which no experimental fractures are observed. A multistep freezing process consisting of initial slow freezing followed by fast freezing to reach the final temperature of -200 degrees C reduces the strain energy release rate, and experiments show that catastrophic failure can be avoided with this protocol.
C1 Cornell Univ, Dept Agr & Biol Engn, Ithaca, NY 14853 USA.
   Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA.
RP Datta, AK (reprint author), Cornell Univ, Dept Agr & Biol Engn, Riley Robb Hall, Ithaca, NY 14853 USA.
EM akdl@cornell.edu
RI Datta, Ashim/K-2294-2012
OI Datta, Ashim/0000-0002-1397-6892
CR Aklonis J. J., 1983, INTRO POLYM VISCOELA
   Anderson T. -L., 1995, FRACTURE MECH FUNDAM
   [Anonymous], 1995, ANN BOOK ASTM STAND
   Begley J.A, 1972, ASTM STP, V514, P1
   Christensen R. M., 1971, THEORY VISCOELASTICI
   CHUMA Y, 1983, T ASAE, V26, P1258
   DIEHL KC, 1980, J TEXTURE STUD, V10, P371, DOI 10.1111/j.1745-4603.1980.tb00866.x
   DILLER KR, 1992, ADV HEAT TRANSFER, V22, P177
   FAHY GM, 1990, CRYOBIOLOGY, V27, P492, DOI 10.1016/0011-2240(90)90038-6
   GAO D, 1991, THESIS CONCORDIA U M
   HAGHIGHI K, 1988, T ASAE, V31, P930
   HAMZA H, 1984, COLD REG SCI TECHNOL, V9, P249, DOI 10.1016/0165-232X(84)90071-5
   HEINLEIN M, 1986, ACTA MECH, V59, P59, DOI 10.1007/BF01177060
   HUNT CJ, 1994, CRYOBIOLOGY, V31, P506, DOI 10.1006/cryo.1994.1061
   JACOBSEN A, 1987, BIOPHYSICS ORGAN PRE
   KIM NK, 1994, J FOOD SCI, V59, P669, DOI 10.1111/j.1365-2621.1994.tb05590.x
   KROENER C, 1966, BIODYNAMICA, V10, P48
   Levitt J, 1980, RESPONSES PLANTS ENV
   MELLOR M, 1982, COLD REG SCI TECHNOL, V5, P201, DOI 10.1016/0165-232X(82)90015-5
   MILES JA, 1973, T ASAE, V16, P1148
   Pitt R. E., 1992, VISCOELASTIC PROPERT
   REEVE RM, 1968, J FOOD SCI, V33, P326, DOI 10.1111/j.1365-2621.1968.tb01379.x
   RICE JR, 1968, J APPL MECH, V35, P379, DOI 10.1115/1.3601206
   RUBINSKY B, 1980, CRYOBIOLOGY, V17, P66, DOI 10.1016/0011-2240(80)90009-7
   SEGERLIND LJ, 1978, 783556 ASAE
   Shi X, 1998, J BIOMECH ENG-T ASME, V120, P720, DOI 10.1115/1.2834885
   Shi X, 1998, T ASAE, V41, P1407
   Sih G. H., 1986, HYGROTHERMOELASTICIT
NR 28
TC 14
Z9 17
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0149-5739
EI 1521-074X
J9 J THERM STRESSES
JI J. Therm. Stresses
PD APR
PY 1999
VL 22
IS 3
BP 275
EP 292
DI 10.1080/014957399280878
PG 18
WC Thermodynamics; Mechanics
SC Thermodynamics; Mechanics
GA 192FW
UT WOS:000080068700002
DA 2018-10-19
ER

PT J
AU Meena, C
   Mengi, SA
   Deshpande, SG
AF Meena, C
   Mengi, SA
   Deshpande, SG
TI Biomedical and industrial applications of collagen
SO PROCEEDINGS OF THE INDIAN ACADEMY OF SCIENCES-CHEMICAL SCIENCES
LA English
DT Article
DE collagen; gelatin; composites; templates; dressings; shields
ID SKIN
AB Collagen is the principal structural protein present in the skin, tendon and bone of the vertebrate body. Ten different vertebrate collagens have been identified, of which the dominant collagen is type I. Interest in collagen as a biomaterial is due to its low immunogenicity and high biocompatibility. Collagen has diverse general and biomedical applications and is also a common constituent of many cosmetic and food products in the form of gelatin. This paper discusses the use of collagen in the fields of medicine and biotechnology, as well as in the cosmetic and pharmaceutical industry.
C1 SNDT Womens Univ, CU Shah Coll Pharm, Bombay 400049, Maharashtra, India.
RP Meena, C (reprint author), SNDT Womens Univ, CU Shah Coll Pharm, Bombay 400049, Maharashtra, India.
CR BAUMGARTNER L, 1982, CHEM ABSTR 40969, V96
   BERG, 1984, PARFUEM KOSMET, V65, P391
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   BOWEN RL, 1968, J PROSTHET DENT, V20, P426, DOI 10.1016/S0022-3913(68)80020-4
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   CIOCA G, 1982, CHEM ABSTR 44306, V97
   CONRADT HS, 1989, J BIOL CHEM, V264, P17368
   COWAN D, 1983, PROTEINS IND ENZYMOL, P353
   COY HD, 1953, J AM DENT ASSOC, V47, P352
   FEKETE K, 1982, CHEM ABSTR 148445B, V96
   FREDBIRDS S, 1985, CHEM ABSTR 213303D, V103
   GETTELMAN L, 1983, J DENT RES 61 GEN SE, V62, P725
   JAMES MH, 1993, CORNEAL SHIELDS OCUL, V58, P262
   LEE DW, HIGH DENSITY BHK CUL
   Miller EJ, 1984, COLLAGEN EXTRACELLUL, P41
   *MOCH PHARM CO LTD, 1983, CHEM ABSTR 27825D
   OKAZAKI S, 1983, CHEM ABSTR 110772E, V99
   PIEZ KA, 1960, J BIOL CHEM, V235, P995
   RIES P, 1982, CHEM ABSTR 110202G, V96
   RING W, 1985, PURE APPL CHEM, V57, P1427, DOI 10.1351/pac198557101427
   ROELS H, 1981, SKIN REGENERATION TE, P243
   RUNSTADLER PW, 1990, OPTIMIZATION MICROEN, pCH12
   SABELMAN EE, 1985, BIOCOMPATIBILITY TIS, P171
   SHINJIRO M, 1984, J DERMATOL, V11, P253
   *SHIS CO LTD, 1982, CHEM ABSTR 161681W, V96
   SILVER FH, 1994, BIOMATERIALS MED DEV, P44
   STEFFAN W, 1983, CHEM ABSTR, V99
   STEULA B, 1982, CHEM ABSTR 44306M, V97
   TAKEDA U, 1983, Journal of Dermatology (Tokyo), V10, P475
   VOROBEV VS, 1984, CHEM ABSTR, V101, P19120
   VOROBEV VS, 1984, CHEM ABSTR 191201, V101
   WIDRA A, 1989, SUTURES POLYM BIOMAT, P431
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 33
TC 27
Z9 28
U1 1
U2 14
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0253-4134
J9 P INDIAN AS-CHEM SCI
JI Proc. Indian Acad. Sci.-Chem. Sci.
PD APR
PY 1999
VL 111
IS 2
BP 319
EP 329
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 203RR
UT WOS:000080721100002
DA 2018-10-19
ER

PT J
AU Lafrance, ML
   Armstrong, DW
AF Lafrance, ML
   Armstrong, DW
TI Novel living skin replacement biotherapy approach for wounded skin
   tissues
SO TISSUE ENGINEERING
LA English
DT Article
ID CULTURED EPITHELIAL AUTOGRAFTS; THICKNESS BURN WOUNDS; FULL-THICKNESS;
   CLINICAL-APPLICATIONS; DERMAL FIBROBLASTS; KERATINOCYTES; GRAFTS;
   SUBSTITUTE; EPIDERMIS; INVITRO
AB A novel living skin replacement (LSR) biotherapy concept, addressing the challenging problems related to tissue regeneration and wound healing, is presented for the treatment of skin burns, traumatic injuries and ulcerations. LSR combines elements of cell therapy along with those of tissue engineering to allow for the regeneration of wounded skin. It takes advantage of biodegradable microspheres onto which donor skin epidermal and dermal cells can be attached and expanded in vitro for subsequent direct application down to the deepest recesses of the wound bed. The key element of the biotherapy is the ability of the skin cells to migrate freely from the microspheres into the wound for regeneration of the tissues. The large surface to volume ratio of the microspheres allows for the delivery of appropriate cell numbers while minimizing the amount of biomaterial to be resorbed. This novel approach presents a number of advantages over existing therapies including facilitated cell manipulations, ease of storage and transportation, rapid clinical intervention due to the elimination of any surgical suturing or stapling, and a more natural three-dimensional tissue remodeling and anatomical compliance. Preliminary in vitro and in vivo evidence of the LSR functionality and its potential benefits is presented.
C1 Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.
CR ARMSTRONG DW, 1998, Patent No. 5830507
   BARROWS TH, 1991, HIGH PERFORMANCE BIO, P243
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BLIGHT A, 1991, BURNS, V17, P495, DOI 10.1016/0305-4179(91)90079-V
   BRADY JM, 1973, J BIOMED MATER RES, V7, P155, DOI 10.1002/jbm.820070204
   BUTLER M, 1987, ANIMAL CELL TECHNOLO
   CAIRNS BA, 1993, ARCH SURG-CHICAGO, V128, P1246
   CLARK RAF, 1993, J DERMATOL SURG ONC, V19, P693, DOI 10.1111/j.1524-4725.1993.tb00413.x
   CLUGSTON P A, 1991, Journal of Burn Care and Rehabilitation, V12, P533, DOI 10.1097/00004630-199111000-00008
   COMPTON CC, 1989, LAB INVEST, V60, P600
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   COOPER ML, 1994, CLIN DERMATOL, V12, P183, DOI 10.1016/0738-081X(94)90268-2
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   CUONO CB, 1987, PLAST RECONSTR SURG, V80, P626, DOI 10.1097/00006534-198710000-00029
   DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7
   EDGINGTON SM, 1992, BIO-TECHNOL, V10, P855
   FOGH K, 1993, ACTA DERM-VENEREOL, V73, P191
   FONG JW, 1986, J CONTROL RELEASE, V3, P103
   GALLICO GG, 1985, CLIN PLAST SURG, V12, P149
   GRANDFILS C, 1992, J BIOMED MATER RES, V26, P467, DOI 10.1002/jbm.820260405
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   HAWLEYNELSON P, 1980, J INVEST DERMATOL, V75, P176, DOI 10.1111/1523-1747.ep12522602
   HECHT J, 1996, 2 JOINT M WOUND HEAL
   HECK EL, 1985, J TRAUMA, V25, P106, DOI 10.1097/00005373-198502000-00002
   LAUFMAN H, 1977, SURG GYNECOL OBSTET, V145, P597
   Lerner-Tung M B, 1989, J Burn Care Rehabil, V10, P151, DOI 10.1097/00004630-198903000-00009
   LIMAT A, 1989, J INVEST DERMATOL, V92, P758, DOI 10.1111/1523-1747.ep12722530
   MacCoubrey IC, 1990, J CELL BIOL, V111, P303
   MCAREE KG, 1993, J PEDIATR SURG, V28, P166, DOI 10.1016/S0022-3468(05)80266-0
   Meyer W, 1978, Curr Probl Dermatol, V7, P39
   MOL MAE, 1991, TOXICOL APPL PHARM, V107, P439, DOI 10.1016/0041-008X(91)90307-Z
   MOORE PL, 1990, J CELL BIOL, V111, P304
   MUHLBAUER W, 1995, CHIRURG, V66, P271
   OCONNOR NE, 1981, LANCET, V1, P75
   OLIVE PL, 1994, CANCER METAST REV, V13, P121, DOI 10.1007/BF00689632
   PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744
   PHILLIPS TJ, 1993, J DERMATOL SURG ONC, V19, P794, DOI 10.1111/j.1524-4725.1993.tb00426.x
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHIOZER WA, 1994, BURNS, V20, P503, DOI 10.1016/0305-4179(94)90006-X
   SLEZAK SE, 1989, BLOOD, V74, P2171
   SLIVKA SR, 1993, J INVEST DERMATOL, V100, P40, DOI 10.1111/1523-1747.ep12354098
   SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417
   WILKINS LM, 1994, BIOTECHNOL BIOENG, V43, P747, DOI 10.1002/bit.260430809
   WOLLINA U, 1991, ACTA HISTOCHEM, V90, P87, DOI 10.1016/S0065-1281(11)80166-2
   WOODLEY DT, 1988, JAMA-J AM MED ASSOC, V259, P2566, DOI 10.1001/jama.259.17.2566
   WOODLEY DT, 1990, J INVEST DERMATOL, V95, P20, DOI 10.1111/1523-1747.ep12872722
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 49
TC 22
Z9 27
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 1999
VL 5
IS 2
BP 153
EP 170
DI 10.1089/ten.1999.5.153
PG 18
WC Cell & Tissue Engineering
SC Cell Biology
GA 188EW
UT WOS:000079834700007
PM 10358222
DA 2018-10-19
ER

PT J
AU Schierholz, JM
   Beuth, J
   Konig, D
   Nurnberger, A
   Pulverer, G
AF Schierholz, JM
   Beuth, J
   Konig, D
   Nurnberger, A
   Pulverer, G
TI Antimicrobial substances and effects on sessile bacteria
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA BIOFILMS; FOREIGN-BODY INFECTIONS;
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IN-VITRO; ANTIBACTERIAL AGENTS;
   CSF-SHUNT; CIPROFLOXACIN; ANTIBIOTICS; RIFAMPIN
AB Biofilms occur in natural aquatic ecosystems and on surfaces of biomaterials. They are generally associated with clinical infections predominantly of prothetic hip joints, heart valves and catheters.
   Sessile microorganisms may be intimately associated with each other and to solid substratum through binding to and inclusion into exopolymer matrices an biofilms. The establishment of functional colonies within the exopolymeric matrices generate physico-chemical gradients within biofilms, that modify the metabolism and cell-wall properties of the microorganism. A consequence of biofilm growth is enhanced microbial resistance to chemical antimicrobial agents and antibiotics. Investigations on the antimicrobial efficacy of antibiotics, antiseptics and antimicrobial heavy ions, however, gave controversial results. No single antimicrobial substance has been developed for the efficient eradication of adherent bacteria.
   This review elucidates the mechanisms of microbial resistance in biofilms and strategies for the prevention of biofilm development. Pharmacokinetical and pharmacodynamical issues for the screening of biofilm-active drugs are presented. Combinations of antistaphylococcal antibiotics with rifampin may be advantageous for preventing and curing biomaterial infections.
C1 Univ Cologne, Inst Med Microbiol & Hyg, D-50935 Cologne, Germany.
   Univ Cologne, Clin Orthoped, Cologne, Germany.
   Univ Cologne, Clin Prothet Dent, D-50935 Cologne, Germany.
RP Schierholz, JM (reprint author), Univ Cologne, Inst Med Microbiol & Hyg, Goldenfelsstr 19-21, D-50935 Cologne, Germany.
CR Berthaud N, 1997, J ANTIMICROB CHEMOTH, V39, P99, DOI 10.1093/jac/39.suppl_1.99
   BROWN ML, 1995, APPL ENVIRON MICROB, V61, P187
   BUTTS JD, 1994, CLIN PHARMACOKINET, V27, P63, DOI 10.2165/00003088-199427010-00006
   CALDWELL DE, 1997, ADV DENT RES, V1, P4
   CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331
   COPPER M, 1995, LIFE DEATH BIOFILM, P93
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   DEARELLANO ER, 1994, J MED MICROBIOL, V40, P43
   DEARELLANO ER, 1995, ENFERM INFEC MICROBI, V13, P581
   ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   FARBER BF, 1990, J INFECT DIS, V161, P37, DOI 10.1093/infdis/161.1.37
   Fujiwara Seiji, 1998, Hiroshima Journal of Medical Sciences, V47, P1
   Gagnon R F, 1994, Adv Perit Dial, V10, P189
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Gilbert P, 1998, J ANTIMICROB CHEMOTH, V41, P571, DOI 10.1093/jac/41.5.571
   HACKBARTH CJ, 1986, ANTIMICROB AGENTS CH, V29, P611, DOI 10.1128/AAC.29.4.611
   HAMPL J, 1995, ACTA NEUROCHIR, V133, P147, DOI 10.1007/BF01420065
   HAMPL J, 1992, INT C ANT AG CHEM, V32, P196
   HARAOKA M, 1995, UROL RES, V22, P383, DOI 10.1007/BF00296880
   HUSSAIN M, 1993, FEMS MICROBIOL REV, V10, P91
   Hyde JAJ, 1998, J HEART VALVE DIS, V7, P316
   Jarvis WR, 1991, AM J MED, V91, P1855
   KHARDORI N, 1995, J IND MICROBIOL, V15, P141, DOI 10.1007/BF01569817
   KHARDORI N, 1995, J IND MICROBIOL, V15, P148, DOI 10.1007/BF01569818
   KUMON H, 1994, MICROBIOL IMMUNOL, V38, P615, DOI 10.1111/j.1348-0421.1994.tb01831.x
   Landa A S, 1997, Adv Dent Res, V11, P528
   Larsen T, 1996, APMIS, V104, P280, DOI 10.1111/j.1699-0463.1996.tb00718.x
   Livermore D M, 1990, Scand J Infect Dis Suppl, V74, P15
   MARSH PD, 1996, J MED MICROBIOL, V44, P79
   Martone WJ, 1992, HOSP INFECT, P577
   Miyanaga Y, 1997, OPHTHALMOLOGICA, V211, P9, DOI 10.1159/000310879
   NYSTROM B, 1983, J HOSP INFECT, V4, P338, DOI 10.1016/0195-6701(83)90004-X
   OBST G, 1989, AM J NEPHROL, V9, P414, DOI 10.1159/000168004
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   REID G, 1994, J UROLOGY, V152, P865, DOI 10.1016/S0022-5347(17)32592-2
   Richards G K, 1994, Adv Perit Dial, V10, P183
   SCHIERHOLZ J, 1994, BIOMATERIALS, V15, P996, DOI 10.1016/0142-9612(94)90080-9
   Schierholz JM, 1997, BIOMATERIALS, V18, P635, DOI 10.1016/S0142-9612(96)00071-3
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   Schierholz JM, 1997, ZBL BAKT-INT J MED M, V286, P107
   Schierholz JM, 1996, ZBL BAKT-INT J MED M, V284, P390
   Schierholz JM, 1997, ARZNEIMITTEL-FORSCH, V47, P70
   SCHIERHOLZ JM, 1997, IN PRESS J HOSP INF
   SCHIERHOLZ JM, 1998, ZBL BAKT, V288, P441
   Shigeta M, 1997, CHEMOTHERAPY, V43, P137, DOI 10.1159/000239548
   Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587
   Souli M, 1998, ANTIMICROB AGENTS CH, V42, P939, DOI 10.1128/AAC.42.4.939
   SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125
   SUNG JJY, 1995, J IND MICROBIOL, V15, P152, DOI 10.1007/BF01569819
   Thrower Y, 1997, J MED MICROBIOL, V46, P425, DOI 10.1099/00222615-46-5-425
   Tresse O, 1997, J ANTIMICROB CHEMOTH, V40, P419, DOI 10.1093/jac/40.3.419
   WAGMAN GH, 1975, J ANTIMICROBIAL AGEN, V7, P316
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   Wilson M, 1996, ORAL MICROBIOL IMMUN, V11, P188, DOI 10.1111/j.1399-302X.1996.tb00356.x
   WILSON M, 1995, ADV DENT RES, V9, P244
   ZEILER HJ, 1984, EUR J CLIN MICROBIOL, V3, P339, DOI 10.1007/BF01977490
   ZEILER HJ, 1985, ANTIMICROB AGENTS CH, V28, P524, DOI 10.1128/AAC.28.4.524
   Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537
NR 60
TC 29
Z9 31
U1 0
U2 2
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD APR
PY 1999
VL 289
IS 2
BP 165
EP 177
PG 13
WC Microbiology; Virology
SC Microbiology; Virology
GA 195ZF
UT WOS:000080282500007
PM 10360317
DA 2018-10-19
ER

PT J
AU John, G
   Morita, M
AF John, G
   Morita, M
TI Synthesis and characterization of photo-cross-linked networks based on
   L-lactide/serine copolymers
SO MACROMOLECULES
LA English
DT Article
ID L-ASPARTIC ACID); BIOMATERIALS
AB New lactide-based polydepsipeptide polymer networks and cross-linked beads have been prepared by UV photopolymerization of acrylated poly(L-lactic acid-co-glycolic acid-co-L-serine) [PLA(Glc-Ser)]. These materials have been developed for use as polymer scaffolds in tissue engineering, cell encapsulation, and injectable drug delivery, which have ligand-immobilizable and biodegradable characteristics. The acrylated PLA(Glc-Ser) cross-linked polymer networks obtained were-glassy and transparent, and the gel content was approximately 90%. The networks showed relatively low swelling in water, due to their cross-linked nature, but are easily swelling in chloroform and in dimethyl sulfoxide. The acrylate polymers on copolymerization with 2-hydroxyethyl methacrylate (HEMA) resulted in crosslinked networks [PLA(Glc-Ser)/HEMA], which were swelling in water and in DMSO showing the potential of the polymer in hydrogel applications. The modified PLA(Glc-Ser) beads prepared by UV-initiated suspension polymerization were characterized by optical microscopy and FTIR. These degradable networks and beads should be useful as polymer scaffolds for biomaterial applications.
C1 Hokkaido Natl Ind Res Inst, Biosci & Chem Div, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan.
   Japan Small Business Corp, Minato Ku, Tokyo 1058453, Japan.
RP Morita, M (reprint author), Hokkaido Natl Ind Res Inst, Biosci & Chem Div, Toyohira Ku, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BELL CL, 1995, ADV POLYM SCI, V122, P128
   BRANNONPEPPAS L, 1994, ACS S SERIES, V573
   BRAUD C, 1985, POLYM PREPR AM CHEM, V24, P71
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hrkach JS, 1996, ACS SYM SER, V627, P93
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P2713
   John G, 1997, J POLYM SCI POL CHEM, V35, P1901, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1901::AID-POLA4>3.0.CO;2-Q
   Jorres V, 1998, MACROMOL CHEM PHYSIC, V199, P835
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEWIS DH, 1990, BIODEGRADABLE POLYM, V1
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1523
   REMBAUM ZA, 1988, BEADS MED BIOL APPL
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Wang D, 1997, MACROMOLECULES, V30, P5688, DOI 10.1021/ma9701752
NR 21
TC 40
Z9 42
U1 1
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 23
PY 1999
VL 32
IS 6
BP 1853
EP 1858
DI 10.1021/ma981729j
PG 6
WC Polymer Science
SC Polymer Science
GA 180MH
UT WOS:000079389400019
DA 2018-10-19
ER

PT J
AU Vandenberg, EJ
   Tian, D
AF Vandenberg, EJ
   Tian, D
TI New crystalline hydroxypolycarbonates for drug delivery and other
   biomaterial applications.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 21
PY 1999
VL 217
MA 222-POLY
BP U601
EP U601
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 176JP
UT WOS:000079148201804
DA 2018-10-19
ER

PT J
AU Zreiqat, H
   Evans, P
   Howlett, CR
AF Zreiqat, H
   Evans, P
   Howlett, CR
TI Effect of surface chemical modification of bioceramic on phenotype of
   human bone-derived cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE surface chemistry modification; magnesium; human bone-derived cells;
   mRNA; protein
ID MESSENGER-RNA EXPRESSION; HYDROXYAPATITE CERAMICS; ION-IMPLANTATION; RAT
   BONE; OSTEOBLASTS; ADHESION; INVITRO; MATRIX; TITANIUM; TISSUE
AB In the search for methods to improve the biocompatibility of prosthetic materials, attention has recently been directed toward the potential use of surface chemical modification and its influence on cellular behavior. This in vitro study investigates the effect of surface chemistry modification of bioceramics on human bone-derived cells (HBDCs) grown on biomaterial surfaces for 2 weeks. Cells were cultured on either alumina (Al2O3), alumina doped with magnesium ions ([Mg]-Al2O3), or hydroxyapatite (HAP), as well as tissue culture polystyrene (TCPS). Expression of alkaline phosphatase (ALP), thrombospondin (Tsp), osteopontin (OP), osteocalcin (OC), osteonectin (ON/SPARC), type I collagen (Col I), and bone sialoprotein (BSP) were determined in terms of mRNAs and proteins, Protein levels for ALP, OF, OC, and BSP were significantly (p < 0.05) greater at day 5 in HBDCs cultured on [Mg]-Al2O3 compared to those cells grown on Al2O3. At day 14 the levels of ALP, Tsp, Col I, OF, ON/SPARC, and BSP rose significantly (p < 0.09) above those occurring in HBDCs grown on Al2O3, HAP, and TCPS. This suggests that HBDCs from the same patient respond to differences in the surface chemical groups. This study confirms that the chemistry of a substratum, which facilitates cellular adhesion, will enhance cellular differentiation. (C) 1999 John Wiley & Sons, Inc.
C1 Univ New S Wales, Sch Pathol, Bone Biomat Unit, Sydney, NSW 2052, Australia.
   Australian Nucl Sci & Technol Org, Div Phys, Sydney, NSW, Australia.
RP Zreiqat, H (reprint author), Univ New S Wales, Sch Pathol, Bone Biomat Unit, Sydney, NSW 2052, Australia.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   ANAST CS, 1977, DISORDERS MINERAL ME, P423
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BOSKEY AL, 1992, J ORTHOP RES, V10, P774, DOI 10.1002/jor.1100100605
   BROWN IG, 1986, REV SCI INSTRUM, V57, P1069, DOI 10.1063/1.1138660
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CARPENTER TO, 1992, AM J PHYSIOL, V263, pE107
   CURTIS ASG, 1973, P BIOPHYS MOL BIOL, V28, P317
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   Dee K C, 1995, Tissue Eng, V1, P135, DOI 10.1089/ten.1995.1.135
   DESAUTELS M, 1982, J BIOL CHEM, V257, P1673
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   GERSTENFELD LC, 1990, ANAT REC, V228, P93, DOI 10.1002/ar.1092280113
   GRABOWSKI KS, 1987, MATER RES SOC S P, V110, P697
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1975, ADV BIOMED ENG, V5, P135
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   IBARAKI K, 1992, J BONE MINER RES, V7, P743
   LEE JS, 1993, BIOMATERIALS, V14, P958, DOI 10.1016/0142-9612(93)90139-S
   MARKOVIC B, 1994, J IMMUNOL METHODS, V172, P105, DOI 10.1016/0022-1759(94)90383-2
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   NAKAI T, 1994, J BIOCHEM-TOKYO, V116, P752, DOI 10.1093/oxfordjournals.jbchem.a124592
   RABINOVITCH M, 1973, J CELL BIOL, V59, P165, DOI 10.1083/jcb.59.1.165
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   SHELTON RM, 1991, BONE-BIOMATERIAL INTERFACE, P181
   STANDARD OC, 1993, J AUSTROLASIA CERAM, V29, P103
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   YAO KL, 1994, J BONE MINER RES, V9, P231
   Zreiqat H., 1996, Cells and Materials, V6, P45
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 36
TC 80
Z9 81
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 15
PY 1999
VL 44
IS 4
BP 389
EP 396
DI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154DV
UT WOS:000077874100004
PM 10397942
DA 2018-10-19
ER

PT J
AU Lausmaa, J
   Lofgren, P
   Kasemo, B
AF Lausmaa, J
   Lofgren, P
   Kasemo, B
TI Adsorption and coadsorption of water and glycine on TiO2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE adsorption; water; TiO2; thermal desorption spectroscopy
ID INFRARED REFLECTION ABSORPTION; SECONDARY ION EMISSION; AMINO-ACID
   OVERLAYERS; X-RAY PHOTOELECTRON; TIO2(110) SURFACE; MOLECULAR-BEAM;
   METAL-SURFACES; SOLID-SURFACES; L-CYSTEINE; SPECTROSCOPY
AB Adsorption of water, ions, and biomolecules constitutes the first events occurring at biomaterial biosystem interfaces. In this work, the adsorption and coadsorption of water and glycine on TiO2 were studied by thermal desorption spectroscopy (TDS). The first water monolayer desorbs in three peaks around 180K, 300K, and 400K, which are assigned to water molecularly adsorbed at oxygen sites, at Ti4+ sites, and to recombination of dissociated water, respectively. A fourth desorption peak (160K), appearing at coverages > 0.8 monolayer, is attributed to water clusters and multilayers. The water-TiO2 interaction is changed if the surface is annealed in vacuum, which leads to increased hydroxylation. Desorption spectra from glycine overlayers evaporated on TiO2 in situ show that around 40% of the first monolayer desorbs as intact molecules (-300-450 K) and the remainder as dissociation fragments and surface reaction products around 600 K. At coverages > 0.6 monolayers, intact molecules desorbing from cluster multilayers at 310 K are detected. The glycine desorption spectra are unaffected by coadsorbed water. In contrast, coadsorption of glycine displaces water from more strongly bound states in the monolayer to more weakly bound states and clusters, making the surface more hydrophobic. The study shows that TDS is a powerful method for characterizing biomaterial surfaces with regard to their interaction with biologically relevant molecules. (C) 1999 John Wiley & Sons, Inc.
C1 Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   Gothenburg Univ, S-41296 Gothenburg, Sweden.
   Swedish Natl Testing & Res Inst, Dept Chem & Mat Technol, S-50115 Boras, Sweden.
RP Lausmaa, J (reprint author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
EM Jukka.Lausmaa@sp.se
CR ANDRADE J D, 1992, Clinical Materials, V11, P67, DOI 10.1016/0267-6605(92)90031-N
   ATANASOSKA LL, 1978, SURF SCI, V72, P189, DOI 10.1016/0039-6028(78)90388-6
   Barteau MA, 1996, CHEM REV, V96, P1413, DOI 10.1021/cr950222t
   BRASH JL, 1996, INTERFACIAL PHENOMEN
   CARRIZOSA I, 1977, J CATAL, V49, P174, DOI 10.1016/0021-9517(77)90253-6
   CHAKAROV DV, 1995, LANGMUIR, V11, P1201, DOI 10.1021/la00004a028
   COLTON RJ, 1979, SURF SCI, V84, P235, DOI 10.1016/0039-6028(79)90135-3
   COOPER E, 1993, J ELECTRON SPECTROSC, V64-5, P469, DOI 10.1016/0368-2048(93)80111-X
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   ENGQUIST I, 1995, J PHYS CHEM-US, V99, P12257, DOI 10.1021/j100032a031
   ERNST KH, 1989, SURF SCI, V224, P277, DOI 10.1016/0039-6028(89)90916-3
   FERRANTE J, 1989, SURF INTERFACE ANAL, V14, P809, DOI 10.1002/sia.740141203
   GAMBLE L, 1995, LANGMUIR, V11, P4505, DOI 10.1021/la00011a054
   GOLD JM, 1989, HELV PHYS ACTA, V62, P246
   GROENEWEGEN JA, 1972, J CATAL, V27, P369, DOI 10.1016/0021-9517(72)90172-8
   Henderson MA, 1996, SURF SCI, V355, P151, DOI 10.1016/0039-6028(95)01357-1
   Henrich V. E., 1994, SURFACE SCI METAL OX
   HENRICH VE, 1977, SOLID STATE COMMUN, V24, P623, DOI 10.1016/0038-1098(77)90376-3
   HOLTKAMP D, 1985, J VAC SCI TECHNOL A, V3, P1394, DOI 10.1116/1.572787
   HOLTKAMP D, 1987, J VAC SCI TECHNOL A, V5, P2912, DOI 10.1116/1.574264
   HOLTKAMP D, 1984, APPL SURF SCI, V17, P296, DOI 10.1016/0378-5963(84)90018-7
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   Horbett TA, 1995, ACS S SERIES, V602
   HUGENSCHMIDT MB, 1994, SURF SCI, V302, P329, DOI 10.1016/0039-6028(94)90837-0
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   IHS A, 1991, J COLLOID INTERF SCI, V144, P282, DOI 10.1016/0021-9797(91)90259-B
   JIRIKOWSKY M, 1987, SURF SCI, V182, P576, DOI 10.1016/0039-6028(87)90022-7
   JUNK G, 1963, J AM CHEM SOC, V85, P839
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   KING DA, 1975, SURF SCI, V47, P384, DOI 10.1016/0039-6028(75)90302-7
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2
   LANGE W, 1984, SURF SCI, V136, P419, DOI 10.1016/0039-6028(84)90621-6
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LEE H, 1991, J RAMAN SPECTROSC, V22, P91, DOI 10.1002/jrs.1250220208
   LEWIS KE, 1966, T FARADAY SOC, V62, P204, DOI 10.1039/tf9666200204
   LIEDBERG B, 1987, J COLLOID INTERF SCI, V120, P64, DOI 10.1016/0021-9797(87)90323-7
   LIEDBERG B, 1985, J COLLOID INTERF SCI, V108, P123, DOI 10.1016/0021-9797(85)90242-5
   LIEDBERG B, 1986, THESIS U LINKPING
   Lofgren P, 1997, SURF SCI, V370, P277, DOI 10.1016/S0039-6028(96)00961-2
   LOFGREN P, 1996, THESIS GOTEBORG U
   MUNUERA G, 1971, DISCUSS FARADAY SOC, P205
   OKUDE S, 1987, JPN J APPL PHYS 1, V26, P627, DOI 10.1143/JJAP.26.627
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   SALANECK WR, 1985, PROG COLL POL SCI S, V70, P83
   SMITH PB, 1987, SURF SCI, V188, P241, DOI 10.1016/S0039-6028(87)80155-3
   SORIAGA MP, 1988, MOL PHENOMENA ELECTR, V378
   STERN DA, 1988, LANGMUIR, V4, P711, DOI 10.1021/la00081a037
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   UVDAL K, 1992, J COLLOID INTERF SCI, V149, P162, DOI 10.1016/0021-9797(92)90401-7
   UVDAL K, 1990, J COLLOID INTERF SCI, V140, P207, DOI 10.1016/0021-9797(90)90336-M
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   WU CR, 1987, PHYS SCRIPTA, V35, P586, DOI 10.1088/0031-8949/35/4/034
   YATES DJ, 1961, J PHYS CHEM-US, V65, P746, DOI 10.1021/j100823a011
NR 59
TC 45
Z9 45
U1 1
U2 33
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 227
EP 242
DI 10.1002/(SICI)1097-4636(19990305)44:3<227::AID-JBM1>3.0.CO;2-H
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500001
PM 10397925
DA 2018-10-19
ER

PT J
AU Merritt, K
   Hitchins, VM
   Neale, AR
AF Merritt, K
   Hitchins, VM
   Neale, AR
TI Tissue colonization from implantable biomaterials with low numbers of
   bacteria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE infection; Staphylococcus aureus; Staphylococcus epidermidis;
   multifilament; monofilament
ID INFECTION
AB This study was undertaken to evaluate the risk of infection (defined as the recovery of the relevant organism from the implant site) in a mouse model when low numbers of bacteria were present on an implanted biomaterial. Segments of different types of suture with adherent bacteria were implanted subcutaneously into mice. The infection risk with Staphylococcus aureus was greater than with Staphylococcus epidermidis RP62A or Candida albicans. The infection risk with the implantation of multifilament sutures was significantly greater than with monofilament sutures. When <10 colony forming units (cfu) of S. aureus were present on monofilament suture material, the infection rate was 3%. When <10 cfu of S. aureus were present on multifilament suture material, the infection rate was 7%. An infection rate of 15% occurred with <10 cfu of S. aureus on multifilament nylon sutures. When >10 but <20 cfu of S. aureus were present, the infection rates were 4 and 51%, respectively. These data confirm that the infection rate with multifilament sutures (or porous materials) is greater than with monofilament sutures (or solid materials) when the organisms are encountered at implantation (acute model) and indicate that a significant risk of infection may occur when only a few organisms are on a device at implantation. (C) 1999 John Wiley & Sons, Inc.
C1 US FDA, CDRH, OST, Div Life Sci, Rockville, MD 20852 USA.
RP Merritt, K (reprint author), 17704 Stoneridge Dr, Gaithersburg, MD 20878 USA.
CR ALEXANDER JW, 1967, ANN SURG, V165, P192, DOI 10.1097/00000658-196702000-00005
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   EDLICH RF, 1974, J BIOMED MATER RES, V8, P15
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   KIECHEL SF, 1977, SURG GYNECOL OBSTET, V144, P59
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MOORE W S, 1974, Surgical Forum (Chicago), V25, P250
   ROON AJ, 1979, J SURG RES, V22, P489
   Russell A. D., 1992, PRINCIPLES PRACTICE
   Saladino RA, 1997, INFECT IMMUN, V65, P4701
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   SMELTZER MS, 1996, T ORS, V21, P256
   WILSON SE, 1975, J SURG RES, V18, P221, DOI 10.1016/0022-4804(75)90145-6
NR 13
TC 49
Z9 50
U1 1
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 261
EP 265
DI 10.1002/(SICI)1097-4636(19990305)44:3<261::AID-JBM4>3.0.CO;2-M
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500004
PM 10397928
DA 2018-10-19
ER

PT J
AU DeFife, KM
   Shive, MS
   Hagen, KM
   Clapper, DL
   Anderson, JM
AF DeFife, KM
   Shive, MS
   Hagen, KM
   Clapper, DL
   Anderson, JM
TI Effects of photochemically immobilized polymer coatings on protein
   adsorption, cell adhesion, and the foreign body reaction to silicone
   rubber
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE photochemical immobilization; silicone rubber; protein adsorption;
   fibroblast and leukocyte adhesion; fibrous encapsulation
ID MODIFIED POLYETHYLENE TEREPHTHALATE; HYALURONIC-ACID; IN-VIVO; SURFACES;
   CD44; OXIDE; GLYCOSYLATION; COMPLICATIONS; BIOMATERIAL; ATTACHMENT
AB Photochemical immobilization technology was utilized to covalently couple polymers to silicone rubber either at multiple points along a polymer backbone or at the endpoint of an amphiphilic chain. The coating variants then were tested in vitro and in vivo for improvement of desired responses compared to uncoated silicone rubber. All coating variants suppressed the adsorption of fibrinogen and immunoglobulin G, and most also inhibited fibroblast growth by 90-99%. None of the coating variants inhibited monocyte or neutrophil adhesion in vitro. However, the surfaces that supported the highest levels of monocyte adhesion also elicited the lowest secretion of pro-inflammatory cytokines. None of the materials elicited a strong inflammatory response or significantly (p< 0.05) reduced the thickness of the fibrous capsule when implanted subcutaneously in rats. Overall, the most passivating coating variant was an endpoint immobilized polypeptide that reduced protein adsorption, inhibited fibroblast growth by 90%, elicited low cytokine secretion from monocytes, and reduced fibrous encapsulation by 33%. In general, although some coating variants modified the adsorption of proteins and the behavior of leukocytes or fibroblasts in vitro, none abolished the development of a fibrous capsule in vivo. (C) 1999 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   SurMod Inc, Eden Prairie, MN 55344 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL33849, HL55714]; NICHD NIH HHS [HD34318]
CR Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   AREND WT, 1996, CLIN IMMUNOLOGY PRIN, V2, P2046
   BARENBERG SA, 1986, TECHNIQUES BIOCOMPAT, V2, P1
   BARRETT SP, 1988, EPIDEMIOL INFECT, V100, P91, DOI 10.1017/S0950268800065596
   Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x
   GLOOR HJ, 1983, AM J MED, V74, P593, DOI 10.1016/0002-9343(83)91016-1
   GOWER DJ, 1992, NEUROSURGERY, V31, P1132, DOI 10.1227/00006123-199212000-00024
   GRANT GH, 1982, FUNDAMENTALS CLIN CH, P298
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HECKER J, 1993, LANCET, V342, P242, DOI 10.1016/0140-6736(93)92334-P
   HOBAN LD, 1994, J SURG RES, V56, P179, DOI 10.1006/jsre.1994.1029
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431
   LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O
   Levesque MC, 1996, J IMMUNOL, V156, P1557
   Levesque MC, 1997, J IMMUNOL, V159, P6184
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   Matsuda T, 1996, J BIOMED MATER RES, V32, P165
   Matsuda T, 1993, ASAIO J, V39, pM327
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MELLMAN I, 1992, MONONUCLEAR PHAGOCYTES, P169
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NAGAOKA S, 1995, ASAIO J, V41, pM365, DOI 10.1097/00002480-199507000-00032
   NAGAOKA S, 1987, T AM SOC ART INT ORG, V33, P76
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   OKADA T, 1993, J BIOMED MATER RES, V27, P1509, DOI 10.1002/jbm.820271207
   OLSEN CL, 1995, DIABETES CARE, V18, P70, DOI 10.2337/diacare.18.1.70
   PATARROYO M, 1992, MONONUCLEAR PHAGOCYTES, P92
   Pericle F, 1996, J IMMUNOL, V157, P4657
   PICCIOLO GL, 1993, P 19 ANN M SOC BIOM, P130
   RENARD E, 1995, DIABETES CARE, V18, P300, DOI 10.2337/diacare.18.3.300
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
   1995, BIORAD LAB B, V1202
NR 49
TC 53
Z9 55
U1 0
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 298
EP 307
DI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500008
PM 10397932
DA 2018-10-19
ER

PT J
AU Peter, SJ
   Kim, P
   Yasko, AW
   Yaszemski, MJ
   Mikos, AG
AF Peter, SJ
   Kim, P
   Yasko, AW
   Yaszemski, MJ
   Mikos, AG
TI Crosslinking characteristics of an injectable poly(propylene
   fumarate)/beta-tricalcium phosphate paste and mechanical properties of
   the crosslinked composite for use as a biodegradable bone cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone tissue engineering; poly(propylene fumarate); orthopedic
   biomaterial; unsaturated linear polyester; in situ polymerizable
AB We investigated the crosslinking characteristics of an injectable composite paste of poly(propylene fumarate) (PPF), N-vinyl pyrrolidinone (N-VP), benzoyl peroxide (BP), sodium chloride (NaCl), and beta-tricalcium phosphate (beta-TCP). We examined the effects of PPF molecular weight, N-VP/PPF ratio, BP/PPF ratio, and NaCl weight percent on the crosslinking temperature, heat release upon crosslinking, gel point, and the composite compressive strength and modulus. The maximum crosslinking temperature did not vary widely among formulations, with the absolute values falling between 38 degrees and 48 degrees C, which was much lower than that of 94 degrees C for poly(methyl methacrylate) bone cement controls tested under the same conditions. The total heat released upon crosslinking was decreased by an increase in PPF molecular weight and a decrease in N-VP/PPF ratio. The gel point was affected strongly by the PPF molecular weight, with a decrease in PPF molecular weight more rapidly leading to a gel point. An increase in initiator concentration had the same effect to a lesser degree. The time frame for curing was varied from 1-121 min, allowing the composite to be tailored to specific applications. The compressive strength and compressive modulus values increased with decreasing N-VP/PPF, increasing NaCl content, and increasing BP/PPF ratio. For all formulations, the compressive strength values fell between I and 12 MPa, and the compressive modulus values fell between 23 and 265 MPa. These data suggest that injectable PPF/beta-TCP pastes can be prepared with handling characteristics appropriate for clinical orthopedic applications and that the mechanical properties of the cured composites are suitable for trabecular bone replacement. (C) 1999 John Wiley & Sons, Inc.
C1 Rice Univ, Cox Lab Biomed Engn, Inst Biosci & Bioengn, Houston, TX 77251 USA.
   Rice Univ, Dept Chem Engn, Houston, TX 77251 USA.
   Univ Texas, Md Anderson Canc Ctr, Dept Orthoped Surg, Houston, TX 77030 USA.
   Mayo Clin, Dept Orthopaed Surg, Rochester, MN 55901 USA.
RP Mikos, AG (reprint author), Rice Univ, Cox Lab Biomed Engn, Inst Biosci & Bioengn, 6100 S Main, Houston, TX 77251 USA.
EM mikos@rice.edu
FU NIGMS NIH HHS [5T32GM08362]; NIAMS NIH HHS [R01-AR44381]
CR BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Box G.E.P., 1978, STAT EXPT
   BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Frazier DD, 1995, MATER RES SOC SYMP P, V394, P15, DOI 10.1557/PROC-394-15
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   GOLDSTEIN SA, 1983, J BIOMECH, V16, P965, DOI 10.1016/0021-9290(83)90097-0
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   HAAS SS, 1975, J BONE JOINT SURG AM, VA 57, P380, DOI 10.2106/00004623-197557030-00017
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   LIGHT M, 1991, Journal of Foot Surgery, V30, P472
   MIGLIARESI C, 1994, BIOMATERIALS, V15, P875, DOI 10.1016/0142-9612(94)90110-4
   ODIAN G, 1991, PRINCIPLES POLYM
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   PETER SJ, IN PRESS J BIOMATER
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
NR 18
TC 150
Z9 160
U1 1
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 314
EP 321
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500010
PM 10397934
DA 2018-10-19
ER

PT J
AU Lewandowska-Szumiel, M
AF Lewandowska-Szumiel, M
TI Alternative methods for assessing biocompatibility and function of
   implant materials
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE biomaterials; biocompatibility; cell culture; implants; in vitro
ID IN-VITRO BIOCOMPATIBILITY; CELL-BIOMATERIAL INTERACTION;
   NECROSIS-FACTOR-ALPHA; BIOACTIVE GLASS; SURFACE-ROUGHNESS; MEDICAL
   DEVICES; TITANIUM-ALLOY; HUMAN BONE; INVITRO; OSTEOBLASTS
AB Biocompatibility testing is used to evaluate the host response to implantable materials and to assess their ability to perform in applications in which they are intended to interact with biological systems. In compliance with international and/or national standards, such assessment is based mainly on the results of experimental implantation into animal tissues. However, the development of in vitro experimental techniques creates new opportunities to observe and to understand the interaction of biomaterials with host tissue. The state-of-the-art application of alternative methods in biocompatibility testing is presented in this review article. It is discussed with respect to the Three Rs concept (reduction, refinement, replacement) of Russell & Burch. Perspectives on alternative methods in biocompatibility studies are discussed with regard to the possible role of biomaterials in tissue engineering.
C1 Med Univ Warsaw, Inst Biostruct, Dept Transplantol, PL-02004 Warsaw, Poland.
   Med Univ Warsaw, Cent Tissue Bank, PL-02004 Warsaw, Poland.
RP Lewandowska-Szumiel, M (reprint author), Med Univ Warsaw, Inst Biostruct, Dept Transplantol, Ul Chalubinskiego 5, PL-02004 Warsaw, Poland.
OI Lewandowska-Szumiel, Malgorzata/0000-0002-7140-0541
CR Algan SM, 1996, J ORTHOPAED RES, V14, P30, DOI 10.1002/jor.1100140107
   ALLEN M, 1995, BIO-MED MATER ENG, V5, P151
   AMMAR A, 1984, ACTA NEUROCHIR, V72, P45, DOI 10.1007/BF01406813
   Anderson J., 1986, J MATH BEHAVIOR, V5, P5
   Barth E, 1988, J Invest Surg, V1, P291, DOI 10.3109/08941938809141095
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Boyan B D, 1993, J Oral Implantol, V19, P116
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyce DE, 1997, BRIT J PLAST SURG, V50, P362, DOI 10.1016/S0007-1226(97)90546-4
   CASCONE MG, 1993, CYTOTECHNOLOGY, V11, P137, DOI 10.1007/BF00746079
   *CEN, 1997, 309931 EN CEN
   CENNI E, 1992, ATLA-ALTERN LAB ANIM, V20, P61
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CIAPETTI G, 1992, ATLA-ALTERN LAB ANIM, V20, P52
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   COURTENEYHARRIS RG, 1995, BIOMATERIALS, V16, P489, DOI 10.1016/0142-9612(95)98823-W
   ELAGLI K, 1995, BIOMATERIALS, V16, P1345, DOI 10.1016/0142-9612(95)91051-Y
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fukuchi N, 1995, BIO-MED MATER ENG, V5, P219
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   HARMAND M-F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P67, DOI 10.1163/156856291X00070
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HONIGER J, 1995, BIOMATERIALS, V16, P753, DOI 10.1016/0142-9612(95)99637-2
   HONIGER J, 1994, INT J ARTIF ORGANS, V17, P46
   HUNT JA, 1992, J BIOMED MATER RES, V26, P819, DOI 10.1002/jbm.820260610
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   ITAKURA Y, 1988, J BIOMED MATER RES, V22, P613, DOI 10.1002/jbm.820220703
   KUBO K, 1993, J BIOMED MATER RES, V27, P1175, DOI 10.1002/jbm.820270908
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   MAURER AM, 1994, J BIOMED MATER RES, V28, P241, DOI 10.1002/jbm.820280215
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   NEEDLEMAN IG, 1995, BIOMATERIALS, V16, P617, DOI 10.1016/0142-9612(95)93859-C
   NIEDERAUER GG, 1994, BIOMATERIALS, V15, P342, DOI 10.1016/0142-9612(94)90246-1
   *NIH, 1994, NIH CONSENSUS STATE, V12, P1
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   RADDER AM, 1994, J BIOMED MATER RES, V28, P269, DOI 10.1002/jbm.820280218
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMES A, 1991, BIOMATERIALS, V12, P661, DOI 10.1016/0142-9612(91)90114-P
   RICCIO V, 1994, CLIN ORTHOP RELAT R, P73
   Richards RG, 1996, INJURY, V27, P38
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SAMMONS RL, 1994, BIOMATERIALS, V15, P536, DOI 10.1016/0142-9612(94)90020-5
   SCHMALZ G, 1995, ATLA-ALTERN LAB ANIM, V23, P469
   SCHMIDT RJ, 1993, J PHARM PHARMACOL, V45, P508, DOI 10.1111/j.2042-7158.1993.tb05589.x
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   Svendsen O, 1996, ATLA-ALTERN LAB ANIM, V24, P659
   SYRJANEN S, 1986, J BIOMED MATER RES, V20, P1111, DOI 10.1002/jbm.820200805
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   THOMSON LA, 1992, BIOMATERIALS, V13, P811, DOI 10.1016/0142-9612(92)90173-L
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   VROUWENVELDER WCA, 1994, BIOMATERIALS, V15, P97, DOI 10.1016/0142-9612(94)90257-7
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
NR 82
TC 1
Z9 1
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM, NOTTS,
   ENGLAND NG1 4EE
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD MAR-APR
PY 1999
VL 27
IS 2
BP 271
EP 281
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 189BR
UT WOS:000079884700011
PM 25426591
DA 2018-10-19
ER

PT J
AU Griffet, J
   Chevallier, A
   Accorsi, E
   El Hayek, T
   Odin, G
   Pebeyre, B
AF Griffet, J
   Chevallier, A
   Accorsi, E
   El Hayek, T
   Odin, G
   Pebeyre, B
TI Osteosynthesis of diaphyseal fracture by Ossatite (R) - Experimental
   study in rat
SO BIOMATERIALS
LA English
DT Article
DE apatite; fracture healing; union; tissue reaction
ID BONE-GRAFT SUBSTITUTES; HYDROXYAPATITE
AB In order to develop a biodegradable interlocking nail for fracture fixation, hydoxylapatite pins and paste were implanted in the femoral bone of rats. A distal fracture was performed. The union and the tissue reaction to hydroxylapatite versus stainless-steel rods were studied after 15 days, 1, 2 and 6 months implantation. Metal pins induced a union. Hydroxylapatite pins (Ossatite(R)) did not prevent callus formation, but did not lead to consolidation in all cases due to weakness of gelatin matrix binding the apatite particles together. The biocompatility of material is satisfactory and the osteo-inductive properties of hydroxylapatite was confirmed. With injectable Ossatite(R), we could not obtain rat femoral fracture consolidation. We can confirm good biomaterial tolerance in bone which contrasts with important soft tissue reactions. Use of such material should be carefully limited to filling intra-osseous cavities. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Nice, Hop Archet, Fac Med, Dept Pediat Orthoped Surg, F-06202 Nice 3, France.
   Univ Nice, Hop Archet, Fac Med, Expt Surg Lab, F-06202 Nice 3, France.
   Univ Nice, Hop Archet, Fac Med, Pathol Lab, F-06202 Nice 3, France.
   Inst Infancy Burlo Garofolo, Trieste, Italy.
RP Griffet, J (reprint author), Univ Nice, Hop Archet, Fac Med, Dept Pediat Orthoped Surg, BP 3079, F-06202 Nice 3, France.
RI Griffet, Jacques/M-5958-2014
CR BAUER TW, 1995, ORTHOPEDICS, V18, P885
   Burstein FD, 1997, PLAST RECONSTR SURG, V100, P869, DOI 10.1097/00006534-199709001-00007
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DARD M, 1995, CHIR DENT FR, V739, P33
   Juutilainen T, 1997, ARCH ORTHOP TRAUM SU, V116, P204, DOI 10.1007/s004020050099
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   METAIZEAU JP, 1983, REV CHIR ORTHOP, V69, P495
   Overgaard S, 1997, J BONE JOINT SURG BR, V79B, P654, DOI 10.1302/0301-620X.79B4.7670
   RATKAKRUGER P, 1997, J PARODONTOL, V16, P289
   SARTORIS DJ, 1986, RADIOLOGY, V159, P133, DOI 10.1148/radiology.159.1.3513246
   SHARROCK P, 1995, INNOV TECH BIOL MED, V16, P160
   SHARROCK P, Patent No. 9108107
   SHARROCK P, 1994, BIOCERAMICS, V6, P333
NR 13
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1999
VL 20
IS 6
BP 511
EP 515
DI 10.1016/S0142-9612(98)00196-3
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176XQ
UT WOS:000079177800002
PM 10213353
DA 2018-10-19
ER

PT J
AU Salzmann, DL
   Kleinert, LB
   Berman, SS
   Williams, SK
AF Salzmann, DL
   Kleinert, LB
   Berman, SS
   Williams, SK
TI Inflammation and neovascularization associated with clinically used
   vascular prosthetic materials
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID PTFE PROSTHESES; ARTERIAL GRAFTS; ADIPOSE-TISSUE; POROSITY; IMPLANTS;
   PROLIFERATION; ANGIOGENESIS; MECHANISMS
AB This study was designed to evaluate and compare healing characteristics, specifically neovascularization and inflammation, of polymeric vascular graft materials commonly used in clinical applications. Our hypotheses were (i) polymeric materials used in vascular graft manufacture stimulate chronic inflammation and (ii) inflammation and neovascularization of polymeric materials are related. Impra and Gore-Tex ePTFE, Meadox weavenit and woven Dacron, Hemashield microvel and woven Dacron, and Golaski microknit Dacron were implanted as 6-mm diameter disks within rat subcutaneous and adipose tissue. Following 5 weeks of implantation samples were evaluated by histological and immunocytochemical analysis. Sections were stained using hematoxylin and eosin or reacted with ED1 antibody and GSI lectin to quantify inflammation and neovascularization, respectively. The extent of inflammation and neovascularization were influenced by both tissue site of implantation and polymer characteristics. For subcutaneous implants, inflammation was graded as follows: Meadox weavenit > Hemashield woven > Meadox woven > Gore-Tex ePTFE > Hemashield microvel > Impra ePTFE > Golaski microknit, while only the Golaski microknit neovascularized. Inflammation was graded as follows for adipose implants: Hemashield woven > Hemashield microvel > Meadox weavenit > Meadox woven > Gore-Ter ePTFE > Golaski microknit > Impra ePTFE, while the following order of neovascularization was observed: Impra ePTFE > Gore-Tex ePTFE > Golaski microknit. The degree of inflammation following biomaterial implantation has a profound effect on implant neovascularization. These data suggest an inverse relationship exists between inflammation and neovascularization. (C) 1999 by Elsevier Science Inc.
C1 Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Surg Res, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Surg Res, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
CR ANDERMANN G, 1988, APPL SURF SCI, V31, P1, DOI 10.1016/0169-4332(88)90022-0
   Andrade J D, 1973, Med Instrum, V7, P110
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   CLOWES AW, 1985, AM J PATHOL, V118, P43
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   JANSEN JA, 1994, J BIOMED MATER RES, V28, P1047, DOI 10.1002/jbm.820280909
   KOHLER TR, 1992, SURGERY, V112, P901
   LEONARD EF, 1991, J BIOMAT SCI-POLYM E, V3, P95, DOI 10.1163/156856292X00105
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   REKHTER M, 1993, ARTERIOSCLER THROMB, V13, P609, DOI 10.1161/01.ATV.13.4.609
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   STRACHAN CJL, 1995, J HOSP INFECT, V30, P54, DOI 10.1016/0195-6701(95)90006-3
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
   ZENNI GC, 1993, J INVEST SURG, V7, P135
NR 21
TC 33
Z9 33
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 1054-8807
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD MAR-APR
PY 1999
VL 8
IS 2
BP 63
EP 71
DI 10.1016/S1054-8807(98)00003-9
PG 9
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA 180QY
UT WOS:000079397700001
PM 10724503
DA 2018-10-19
ER

PT J
AU Rubens, FD
   Ruel, M
   Lavallee, G
   Watson, M
   Robblee, J
   Wozny, D
   Nathan, H
AF Rubens, FD
   Ruel, M
   Lavallee, G
   Watson, M
   Robblee, J
   Wozny, D
   Nathan, H
TI Circuits with surface modifying additive alter the haemodynamic response
   to cardiopulmonary bypass
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE cardiopulmonary bypass; complement activation; blood pressure response;
   biocompatibility
ID P-SELECTIN; MECHANISMS
AB Objective: Blood contact with synthetic surfaces during cardiopulmonary bypass (CPB), inevitably results in the activation of a variety of interrelated pathways of inflammation and coagulation that may contribute to postoperative complications in cardiac surgery patients. The objective of this trial was to evaluate clinical events and complement activation related to the use of a novel biomaterial, into which a surface modifying additive had been incorporated into the polymer used to prepare the bypass circuit. Methods: A prospective, double-blind trial was carried out with 34 patients randomized to surgery, with either a standard circuit or a circuit treated ('tip to tip') with the surface modifying additive. Variables recorded included perioperative haemodynamics, volume replacement, ai-agonist and inotrope use. Terminal complement complex (SC5b-9) was measured using an ELISA. Results: Upon initiation of bypass, there was a decrease in mean arterial pressure (MAP) in the control group, not seen in the test group (P = 0.0005, ANOVA). There was a decrease in the total volume of replacement fluid given intraoperatively in the test group as compared with the control group (total plus prime; control 5.3 +/- 1.2 L, test 4.4 +/- 1.9 L, P = 0.03, Mann-Whitney test). There was a trend to decreased need for inotrope infusion in the test group after CPB (test 1/17, control 6/17, Fisher exact test; P = 0.085). No difference was seen in the generation of terminal complement complex between the groups either during or after CPB. Conclusions: The decrease in blood pressure in the control group, upon the initiation of CPB, did not occur in patients undergoing CPB with the circuit prepared with the surface modifying additive. The decrease in blood pressure was likely associated with the increase in total administered fluids intraoperatively (approximately 1 1/patient) and perhaps the trend towards higher use of inotropes in the control patients as opposed to the test patients. These haemodynamic changes did not appear to be related to complement activation early in CPB. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
RP Rubens, FD (reprint author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
OI RUEL, MARC/0000-0002-0487-1319
CR BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   *CHEM RUBB CO, 1969, CRC STAND MATH TABL, P625
   DEPPISCH RM, 1994, BLOOD PURIFICAT, V12, P115
   Dore M, 1996, BLOOD, V87, P2029
   Edmunds L H Jr, 1995, Adv Card Surg, V6, P131
   Gu YJ, 1998, ANN THORAC SURG, V65, P1342, DOI 10.1016/S0003-4975(98)00223-9
   JESSEN M, 1996, ASAIO J, V25, P21
   LOVINGER AJ, 1993, J POLYM SCI POL PHYS, V31, P115, DOI 10.1002/polb.1993.090310201
   MAUGERI N, 1994, THROMB HAEMOSTASIS, V72, P450
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   RUBANYI GM, 1991, FASEB J, V5, P2713
   RUBENS FD, 1999, IN PRESS ANN THORAC, P67
   TSAI CC, 1994, ASAIO J, V40, P7619
   WARD RS, 1987, Patent No. 4663413
NR 15
TC 7
Z9 8
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD MAR
PY 1999
VL 15
IS 3
BP 353
EP 358
DI 10.1016/S1010-7940(99)00015-9
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 188MR
UT WOS:000079851300035
PM 10333035
OA Bronze
DA 2018-10-19
ER

PT J
AU Bagley, J
   Rosenzweig, M
   Marks, DF
   Pykett, MJ
AF Bagley, J
   Rosenzweig, M
   Marks, DF
   Pykett, MJ
TI Extended culture of multipotent hematopoietic progenitors without
   cytokine augmentation in a novel three-dimensional device
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Article
DE hematopoietic progenitor cell (HPC); culture; cytokine-free;
   three-dimensional; matrix
ID CELLS IN-VITRO; NYLON MESH TEMPLATES; LONG-TERM CULTURE; GROWTH-FACTORS;
   EXPANSION; PROLIFERATION; QUIESCENT; VIVO
AB The ability to culture multipotent hematopoietic progenitor cells for extended periods is of practical importance to both clinical and research efforts involving these cells. Conventional techniques for the extended culture of hematopoietic progenitor cells (HPCs) have proven largely ineffective in sustaining these cells and preserving their multipotency over protracted periods. To overcome barriers to extended HPC culture, numerous alternative approaches, including cytokine augmentation and co-culture with bone marrow stroma, have been explored to enhance HPC maintenance but have generally yielded mixed results, The present study examined the ability of a novel, three-dimensional, tantalum-coated porous biomaterial (TCPB) to support HPC maintenance and multipotency in long-term cultures to which no exogenous cytokines have been added. As a follow-up to previously published short-term HPC cultures in TCPB, we examined the maintenance, phenotype and multipotency of HPCs cultured for up to 6 weeks in the TCPB matrix compared to control systems, including fibronectin-coated plastic, bone marrow stroma cocultures and other three-dimensional materials. These studies indicated that TCPB supports the maintenance of immature progenitors for up to 6 weeks in the absence of supplemented cytokines, Further, the results demonstrate that the TCPB matrix facilitates and enhances HPC maintenance and leads to a 1.5-fold expansion of HPC numbers following 1 week in culture and a 6.7-fold increase in colony-forming ability following 6 weeks in culture in the absence of exogenous cytokines, Under the same conditions, control systems were less able to support progenitor viability and multipotency, These findings point to new approaches that may improve the in vitro preservation of progenitors and may have important implications in clinical areas such as progenitor expansion, bone marrow transplantation and gene therapy. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
C1 Cytomatrix, Cambridge, MA 02139 USA.
   Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Immunol, Southborough, MA 01772 USA.
RP Pykett, MJ (reprint author), Cytomatrix, 100 Inman St,Suite 104, Cambridge, MA 02139 USA.
EM cytomat@msn.com
CR Alcorn MJ, 1996, BLOOD REV, V10, P167, DOI 10.1016/S0268-960X(96)90023-5
   BIDDLE W, 1994, J PROG CLIN BIOL RES, V389, P351
   Dexter T M, 1984, Kroc Found Ser, V18, P57
   GORE SD, 1995, EXP HEMATOL, V23, P413
   Hao QL, 1996, BLOOD, V88, P3306
   JACOBSEN SEW, 1995, J EXP MED, V181, P1357, DOI 10.1084/jem.181.4.1357
   Lange W, 1996, LEUKEMIA, V10, P943
   Mantalaris A, 1998, BIOTECHNOL PROGR, V14, P126, DOI 10.1021/bp970136+
   MIGLIACCIO AR, 1994, BLOOD CELLS, V20, P424
   NAUGHTON B, 1987, J MED, V18, P219
   NAUGHTON BA, 1990, PROG CLIN BIOL RES, V333, P435
   NAUGHTON BA, 1991, J BIOMECH ENG-T ASME, V113, P171, DOI 10.1115/1.2891230
   NAUGHTON BA, 1989, ANN NY ACAD SCI, V554, P125, DOI 10.1111/j.1749-6632.1989.tb22415.x
   NAUGHTON BA, 1992, SOMAT CELL MOLEC GEN, V18, P451, DOI 10.1007/BF01233085
   QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P97
   Rosenzweig M, 1996, BLOOD, V87, P4040
   Rosenzweig M, 1997, GENE THER, V4, P928, DOI 10.1038/sj.gt.3300480
   Shah AJ, 1996, BLOOD, V87, P3563
   Taichman RS, 1996, BLOOD, V87, P518
   Urashima Mitsuyoshi, 1995, Acta Paediatrica Japonica, V37, P160
   VERFAILLIE CM, 1993, BLOOD, V82, P2045
NR 21
TC 61
Z9 65
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0301-472X
EI 1873-2399
J9 EXP HEMATOL
JI Exp. Hematol.
PD MAR
PY 1999
VL 27
IS 3
BP 496
EP 504
DI 10.1016/S0301-472X(98)00053-8
PG 9
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 174HN
UT WOS:000079028800014
PM 10089912
DA 2018-10-19
ER

PT J
AU Drake, DR
   Paul, J
   Keller, JC
AF Drake, DR
   Paul, J
   Keller, JC
TI Primary bacterial colonization of implant surfaces
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE colonization; hydrophobicity; implant; modes of sterilization;
   Streptococcus sanguis; titanium
ID STREPTOCOCCUS-SANGUIS; DENTAL IMPLANTS; TITANIUM; ADHERENCE;
   OSSEOINTEGRATION; STERILIZATION; BIOMATERIAL; INTERFACE; ADHESION
AB The purpose of this study was to assess the effects of modifying titanium surfaces, in terms of wettability, roughness, and mode of sterilization, on the ability of the oral bacterium Streptococcus sanguis to colonize. An in vitro model system was developed. All surfaces were colonized by the bacteria, but to significantly different levels. Titanium samples that exhibited rough or hydrophobic (low wettability) surfaces, along with all autoclaved surfaces, were preferentially colonized (P < .01). Titanium surfaces that had been repeatedly autoclaved were colonized with the levels of bacteria 3 to 4 orders of magnitude higher than other modes of sterilization. This may have implications relative to the commonly used method of autoclaving titanium implants, which may ultimately enhance bacterial biofilm formation on these surfaces.
C1 Univ Iowa, Coll Dent, Iowa City, IA 52242 USA.
   Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA.
RP Drake, DR (reprint author), Univ Iowa, Coll Dent, 407 Dent Sci N, Iowa City, IA 52242 USA.
EM david-drake@uiowa.edu
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   BRANEMARK PI, 1985, QUINTESSENCE, P117
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   DELANGE GL, 1986, TISSUE INTEGRATION O, P278
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Doyle RJ, 1990, MICROBIAL CELL SURFA
   GIBBONS RJ, 1983, INFECT IMMUN, V42, P1006
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   JAMES RA, 1986, IMPLANTOLOGIST, V3, P35
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   KOKA S, 1993, J PROSTHET DENT, V70, P141, DOI 10.1016/0022-3913(93)90009-D
   Mombelli A, 1990, CLIN ORAL IMPLAN RES, V1, P1, DOI 10.1034/j.1600-0501.1990.010101.x
   MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P124
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Mombelli A, 1993, Adv Dent Res, V7, P202
   MORRIS EJ, 1985, J BACTERIOL, V164, P255
   MORRIS EJ, 1984, INFECT IMMUN, V43, P656
   Newman M G, 1988, J Dent Educ, V52, P737
   NEWMAN MG, 1990, INT J ORAL MAXILLOF, V5, P31
   Rams TE, 1991, CLIN ORAL IMPLAN RES, V2, P121, DOI 10.1034/j.1600-0501.1991.020304.x
   RAMS TE, 1984, J PROSTHET DENT, V51, P529, DOI 10.1016/0022-3913(84)90309-3
   STANFORD C M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P83
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   STINSON MW, 1991, INFECT IMMUN, V59, P102
   VANSTEENBERGHE D, 1988, DENT CLIN N AM, V32, P355
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Wolinsky L E, 1989, Int J Oral Maxillofac Implants, V4, P27
NR 35
TC 64
Z9 66
U1 1
U2 7
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 1999
VL 14
IS 2
BP 226
EP 232
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 185NW
UT WOS:000079676700008
PM 10212539
DA 2018-10-19
ER

PT J
AU Benque, E
   Zahedi, S
   Brocard, D
   Marin, P
   Brunel, G
   Elharar, F
AF Benque, E
   Zahedi, S
   Brocard, D
   Marin, P
   Brunel, G
   Elharar, F
TI Tomodensitometric and histologic evaluation of the combined use of a
   collagen membrane and a hydroxyapatite spacer for guided bone
   regeneration: A clinical report
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone regeneration; collagen membrane; guided tissue regeneration; human
   histology; hydroxyapatite; oral implant; resorbability
ID RAPIDLY PROGRESSIVE PERIODONTITIS; PARTIALLY EDENTULOUS PATIENTS; TISSUE
   REGENERATION; INTRABONY DEFECTS; CROSS-LINKING; CHRONIC ADULT; IMPLANTS;
   HYDROXYLAPATITE; AUGMENTATION; BIOMATERIALS
AB In this report, the problems of insufficient bone and soil tissue after extraction of maxillary incisors were addressed concurrently prior to endosseous implant placement, by combining the use of a diphenylphosphorylazide-cross-linked Type I collagen membrane and a resorbable space-making biomaterial composed of 200-mu m porous hydroxyapatite granules blended in Type I collagen and chondroitin-4-sulfate. Upon flap reflection 8 months postsurgery, the horizontal deficiencies were almost completely resolved, membranes completely resorbed and the defects filled with hard, bonelike tissue, with a few superficial hydroxyapatite granules. Histologic evaluation of the bone biopsies obtained at the implantation sites revealed dense, well-reconstructed alveolar bone with a few traces of hydroxyapatite granules that had been completely resorbed. Tomodensitometric evaluation indicated that bone regeneration ranged from 14% to 58%, with an average bone gain of 29.77%. Four nonsubmerged ITI titanium implants placed in the augmented bone have been in function for more than 5 years, with no clinical or radiographic signs of hard or soft tissue breakdown. Bacterial sampling at dental sites with periodontitis 1 month prior to periodontal therapy and at implant sites for up to 30 months demonstrated rapid colonization of implant surfaces by periodontopathogens without causing any detrimental effect to implant integration.
C1 Grp REP, Toulouse, France.
   Univ Liege, CHU Sart Tilman, Dept Dent Med, Sect Periodontol & Oral Implantol, Liege, Belgium.
   Univ Toulouse 3, Dept Oral Biol, Fac Odontol, F-31062 Toulouse, France.
RP Brunel, G (reprint author), Fac Chirurg Dent, 3 Chemin Maraichers, F-31062 Toulouse, France.
CR Aspe P, 1989, J PERIODONTAL RES, V24, P96
   Bain C A, 1996, Int J Oral Maxillofac Implants, V11, P756
   Bain C A, 1993, Int J Oral Maxillofac Implants, V8, P609
   Benque E, 1997, J CLIN PERIODONTOL, V24, P544, DOI 10.1111/j.1600-051X.1997.tb00227.x
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   BENQUE EP, 1992, J PARODONTOL, V11, P67
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   Brunel G, 1996, J PERIODONTOL, V67, P1342, DOI 10.1902/jop.1996.67.12.1342
   BRUNEL G, 1992, J PARADONTOLOGIE, V4, P419
   BRUNSKI JB, 1988, J CALIF DENT ASSOC, V16, P66
   BUSER D, 1994, GUIDED BONE REGENERA, P189
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Crigger M, 1996, J PERIODONTOL, V67, P403, DOI 10.1902/jop.1996.67.4.403
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DALCUSI G, 1990, BIOMATERIALS, V1, P86
   Frank R M, 1991, J Parodontol, V10, P255
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GODEFROY JN, 1994, INT J ORAL MAXILLOF, V9, P431
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KENT JN, 1982, J AM DENT ASSOC, V105, P993, DOI 10.14219/jada.archive.1982.0405
   LANG NP, 1994, CLIN ORAL IMPLAN RES, V5, P92, DOI 10.1034/j.1600-0501.1994.050205.x
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   MALMSTROM HS, 1990, J PERIODONTOL, V61, P300, DOI 10.1902/jop.1990.61.5.300
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   NAKAGAWA S, 1989, J INVEST DERMATOL, V93, P792, DOI 10.1111/1523-1747.ep12284425
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   Papaioannou W, 1996, CLIN ORAL IMPLAN RES, V7, P405, DOI 10.1034/j.1600-0501.1996.070415.x
   Parodi R, 1996, INT J PERIODONT REST, V16, P175
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
   Santarelli G, 1996, INT J PERIODONT REST, V16, P69
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   TONETTI MS, 1995, J CLIN PERIODONTOL, V22, P229
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
NR 35
TC 15
Z9 15
U1 0
U2 1
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 1999
VL 14
IS 2
BP 258
EP 264
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 185NW
UT WOS:000079676700012
PM 10212543
DA 2018-10-19
ER

PT J
AU di Gioia, L
   Guilbert, S
AF di Gioia, L
   Guilbert, S
TI Corn protein-based thermoplastic resins: Effect of some polar and
   amphiphilic plasticizers
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE corn proteins; zein; plasticizer; glass transition temperature;
   biomaterial; thermoplastic
ID GLASS-TRANSITION; ZEIN; GLUTEN; ACIDS
AB Homogeneous blends of corn gluten meal (CGM) and "polar" plasticizers (water, glycerol) or "amphiphilic" plasticizers [octanoic and palmitic acids, dibutyl tartrate and phthalate, and diacetyl tartaric acid ester of mono-diglycerides (DATEM)] were obtained by a hat-mixing procedure. The glass transition temperature (T-g) of the blends was measured by modulated differential scanning calorimetry and dynamic mechanical thermal analysis, as a function of plasticizer type and content (0-30% dwb). The plasticizing efficiency (i.e., decrease of T-g) at equal molar content was found to be proportional to the molecular weight and inversely proportional to the percent of hydrophilic groups of the plasticizer. The migration rate of the plasticizers in the polymer was related to their physicochemical characteristics. It was assumed that polar substances interacted with readily accessible polar amino acids, whereas amphiphilic ones interacted with nonpolar zones, which are buried and accessible with difficulty. The temperature at which a thermoplastic resin of plasticized CGM could be formed was closely connected to the T-g of the blend.
C1 Ecole Natl Super Agron Montpellier, INRA, Unite Technol Cereales & Agropolymeres, F-34060 Montpellier 1, France.
RP Guilbert, S (reprint author), Ecole Natl Super Agron Montpellier, INRA, Unite Technol Cereales & Agropolymeres, 2 Pl Viala, F-34060 Montpellier 1, France.
EM guilbert@ensam.inra.fr
OI GUILBERT, Stephane/0000-0002-8964-670X
CR ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Beck MI, 1996, INT J PHARM, V141, P137, DOI 10.1016/0378-5173(96)04630-3
   Bell LN, 1996, J FOOD SCI, V61, P807, DOI 10.1111/j.1365-2621.1996.tb12207.x
   BORCHERDING A, 1998, PLANT PROTEINS EUROP, P313
   Clark R.L., 1949, MOD PACKAG, V12, P122
   Coleman NJ, 1996, INT J PHARM, V135, P13, DOI 10.1016/0378-5173(95)04463-9
   Cuq B, 1997, J AGR FOOD CHEM, V45, P622, DOI 10.1021/jf960352i
   Cuq B, 1998, CEREAL CHEM, V75, P1, DOI 10.1094/CCHEM.1998.75.1.1
   di Gioia L, 1998, CEREAL CHEM, V75, P514, DOI 10.1094/CCHEM.1998.75.4.514
   DIGIOIA L, 1998, IN PRESS INT J BIOL
   ENTWISTLE CA, 1979, J PHARM PHARMACOL, V31, P269, DOI 10.1111/j.2042-7158.1979.tb13499.x
   Ferry J. D., 1980, VISCOELASTIC PROPERT, P33
   FLIEDEL G, 1985, J AGR FOOD CHEM, V33, P303, DOI 10.1021/jf00062a036
   Gueguen J., 1998, PLANT PROTEINS EUROP, P319
   Guilbert S., 1994, VALORISATIONS NONALI, V71, P195
   HASEGAWA N, 1994, Patent No. 6192577
   Jane J. L., 1996, U. S. Pat, Patent No. [5,523,293, 5523293]
   KALICHEVSKY MT, 1992, INT J BIOL MACROMOL, V14, P257, DOI 10.1016/S0141-8130(05)80038-8
   KALICHEVSKY MT, 1993, GLASSY STATE IN FOODS, P133
   KALICHEVSKY MT, 1992, INT J BIOL MACROMOL, V14, P267, DOI 10.1016/S0141-8130(05)80039-X
   KOBREHEL K, 1977, CEREAL CHEM, V54, P833
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   LAWTON JW, 1992, CEREAL CHEM, V69, P351
   LILLIE MA, 1993, GLASSY STATE IN FOODS, P281
   Madeka H, 1996, CEREAL CHEM, V73, P433
   MARTIN DN, 1970, Patent No. 3497369
   MOSSE J., 1961, ANN INST NATL RECH AGRON SER A ANN PHYSIOL VEG, V3, P105
   PEREZ J, 1990, J CHIM PHYS PCB, V87, P1923, DOI 10.1051/jcp/1990871923
   Phillips L., 1994, STRUCTURE FUNCTION P, P3
   REDL A, 1998, IN PRESS CEREAL CHEM
   Reiners R. A., 1973, IND USES CEREALS, P285
   ROOS YH, 1995, PHASE TRANSITIONS FO, pCH6
   Rothfus JA, 1996, J AGR FOOD CHEM, V44, P3143, DOI 10.1021/jf9504778
   Schuster G., 1984, Advances in Cereal Science and Technology, V6, P139
   Sears JK, 1982, TECHNOLOGY PLASTICIZ, P35
   WALL JS, 1988, J AGR FOOD CHEM, V36, P722, DOI 10.1021/jf00082a012
   WOEBCKEN W, 1995, INT PLASTICS HDB, P42
NR 37
TC 91
Z9 92
U1 1
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAR
PY 1999
VL 47
IS 3
BP 1254
EP 1261
DI 10.1021/jf980976j
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 177TN
UT WOS:000079227300077
PM 10552446
DA 2018-10-19
ER

PT J
AU Barbucci, R
   Lamponi, S
   Aloisi, AM
AF Barbucci, R
   Lamponi, S
   Aloisi, AM
TI Effect of behavioral stress on platelet reactivity on polymeric surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE blood; platelet; biomaterials; stress; rabbit
ID RESPONSES
AB It is well known that stressful stimuli change blood functions and platelet parameters are altered in humans and animals subjected to stress. We have examined the influences of behavioral stress on the morphological responses of platelets on a standard biomaterial, polyethylene (PE). Male rabbits were used, Blood was collected from the marginal vein of the ear 2 times per subject: the first sample was used as the baseline; 1 week later, the second was preceded in half of the subjects by 20 min of immobilization stress. In vitro adhesion of platelets on the PE was evaluated. The exposure of animals to stress induced a dramatic change in platelet morphology and functions on the PE: a higher degree of platelet adhesion, increased platelet spreading, and the appearance of pseudopodia, In the unstressed subjects there were no modifications of the platelets on the PE with respect to the baseline. The present experiment emphasizes for the first time the possible problems involved with the varying physiological conditions of patients before and after any biomaterial application surgery and of subjects who supply the blood for hemocompatibility tests performed on biomaterials. Therefore, in assessments of the performance of different biomaterials, the reactivity of blood factors in the patients should be considered and the test of blood compatibility should be performed with blood collected from donors in appropriate physiological conditions, (C) 1999 John Wiley & Sons, Inc.
C1 Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
   Univ Siena, Ist Fisiol Umana, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, Dept Chem & Biosyst Sci & Technol, Pian dei Mantellini 44, I-53100 Siena, Italy.
RI Aloisi, Anna Maria/E-7183-2013
CR ALOISI AM, 1994, PHYSIOL BEHAV, V55, P789, DOI 10.1016/0031-9384(94)90061-2
   DECLERCK F, 1989, BLOOD CELLS ARTERIES, P115
   Frimerman A, 1997, AM J CARDIOL, V79, P72, DOI 10.1016/S0002-9149(96)00680-7
   HALL B, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P147
   LEMM W, 1992, REFERENCE MAT EUROPE, pR15
   MALKOFF SB, 1993, PSYCHOSOM MED, V55, P477, DOI 10.1097/00006842-199311000-00001
   MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25
   Mundal HH, 1996, AM J HYPERTENS, V9, P12, DOI 10.1016/0895-7061(95)00263-4
   PATTERSON SM, 1995, PSYCHOSOM MED, V57, P92
   STEEN VM, 1987, EUR J HAEMATOL, V38, P383
NR 10
TC 8
Z9 8
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SPR
PY 1999
VL 48
IS 1
BP 9
EP 12
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164YC
UT WOS:000078490300003
PM 10029143
DA 2018-10-19
ER

PT J
AU Soten, I
   Ozin, GA
AF Soten, I
   Ozin, GA
TI Porous hydroxyapatite-dodecylphosphate composite film on
   titania-titanium substrate
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; RAY PHOTOELECTRON-SPECTROSCOPY;
   CALCIUM-PHOSPHATE; OCTACALCIUM PHOSPHATE; EARLY DEPOSITS; SOLID-PHASE;
   PO4 DOMAIN; COATINGS; SURFACE; BONE
AB Synthetic analogues of bone are being actively pursued as materials for biomedical applications in the field of bone replacement, augmentation and repair. Numerous stringent criteria have to be met for a biomaterial to be considered as an acceptable bone implant, including the ability to integrate into bone and not cause any deleterious side effects. In this article we describe a materials chemistry approach to synthesizing a new type of bone implant material. The strategy involves the spontaneous growth, under aqueous physiological pH conditions, of an oriented hydroxyapatite film with micron dimension porosity, on the surface of a layer of TiO2, that has been sputter deposited on Ti metal. This procedure creates desirable co-crystallized phases of hydroxyapatite (OHAp) and octacalcium phosphate (OCP) with preferred orientation respectively along the [001] and [101] directions. Subsequently, a calcium dodecylphosphate mesolamellar phase has been grown within these oriented porous films to create a multilayered chemical composite CaDDP-OHAp-TiO2-Ti in which the CaDDP phase is stereochemically and charge matched with the OHAp.
C1 Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
RP Ozin, GA (reprint author), Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, 80 St George St, Toronto, ON M5S 3H6, Canada.
EM gozin@alchemy.chem.utoronto.ca
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Bullock EL, 1996, SURF SCI, V352, P504, DOI 10.1016/0039-6028(95)01188-9
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   CRUTCHFIELD MM, 1962, INORG CHEM, V1, P813, DOI 10.1021/ic50004a020
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P., 1993, BIOCERAMICS, V6
   Elliot C., 1994, STRUCTURE CHEM APATI
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   MISRA DN, 1984, ADSORPTION SURFACE C, P13
   ONG JL, 1994, COLLOID SURFACE A, V87, P151, DOI 10.1016/0927-7757(94)02774-9
   Ozin GA, 1997, J MATER CHEM, V7, P1601, DOI 10.1039/a702416i
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   SHAM TK, 1979, CHEM PHYS LETT, V68, P426, DOI 10.1016/0009-2614(79)87231-0
   Silver FH., 1994, BIOMATERIALS MED DEV
   Sugiyama S, 1996, J MATER CHEM, V6, P459, DOI 10.1039/jm9960600459
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
NR 29
TC 26
Z9 27
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR
PY 1999
VL 9
IS 3
BP 703
EP 710
DI 10.1039/a806045b
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 177KZ
UT WOS:000079210300014
DA 2018-10-19
ER

PT J
AU Piveteau, LD
   Girona, MI
   Schlapbach, L
   Barboux, P
   Boilot, J
   Gasser, B
AF Piveteau, LD
   Girona, MI
   Schlapbach, L
   Barboux, P
   Boilot, J
   Gasser, B
TI Thin films of calcium phosphate and titanium dioxide by a sol-gel route:
   a new method for coating medical implants
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HYDROXYAPATITE COATINGS; DEPOSITION
AB Titanium is a commonly used biomaterial for dental and orthopaedic applications. To increase its ability to bond with bone, some attempts were made to coat its surface with calcium phosphate (CaP). This paper describes a new type of coating. Instead of a pure CaP layer, a mixing of titanium dioxide (TiO(2)) and CaP is fabricated and deposited as a coating. These layers are deposited by a sol-gel route on pure titanium substrates using various pre-treatments. The method consists of mixing a solution of tetrabutyl ortho-titanate or a sol of titanium dioxide with a solution of calcium nitrate and phosphorous esters. This composite is deposited on to commercially pure titanium plates, mechanically polished or blasted with pure crystalline aluminum oxide, using the spin-coating technique. These coatings are then fired at 650 or 850 degrees C for various times. The samples are characterized by X-ray diffraction for their crystallinity, X-ray photoelectron spectroscopy for their surface chemical composition and scanning electron microscopy for their topography. Samples treated at 850 degrees C present a well-pronounced crystallinity, and a high chemical purity at the surface. The topography is strongly related to the viscosity of the precursor and the substrate pre-treatment. Possibilities to structure the outermost layer are presented. (C) 1999 Kluwer Academic Publishers.
C1 Univ Fribourg, Inst Phys, CH-1700 Fribourg, Switzerland.
   Ecole Polytech, Phys Mat Condensee Lab, F-91128 Palaiseau, France.
   Dr HC Robert Mathys Fdn, CH-2544 Bettlach, Switzerland.
RP Piveteau, LD (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM Laurent.Piveteau@unifr.ch
OI Schlapbach, Louis/0000-0003-3638-8265; Moner-Girona,
   Magda/0000-0003-3808-4492
CR BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   Haddow DB, 1996, J MATER SCI-MATER M, V7, P255, DOI 10.1007/BF00058562
   LEBUGLE A, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P319
   MEACHIM G, 1981, FUNDAMENTAL ASPECTS, V1, P107
   Mullenberg G. E., 1979, HDB XRAY PHOTOELECTR
   PASCHALIS EP, 1995, J BIOMED MATER RES, V29, P1499, DOI 10.1002/jbm.820291206
   Piveteau LD, 1996, MATER RES SOC SYMP P, V414, P81
   PIVETEAU LD, 1996, Patent No. 0461
   QIU Q, 1993, CELL MATER, V3, P351
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   Russell SW, 1996, J AM CERAM SOC, V79, P837, DOI 10.1111/j.1151-2916.1996.tb08514.x
   SCHMUTZ C, 1993, J MATER CHEM, V3, P393, DOI 10.1039/jm9930300393
   Sherwood P.M.A., 1990, PRACTICAL SURFACE AN, P555
   SHIRKHANZADEH M, 1994, MATER LETT, V18, P211, DOI 10.1016/0167-577X(94)90233-X
   TONG WD, 1995, BIOMATERIALS, V16, P829, DOI 10.1016/0142-9612(95)94143-9
NR 22
TC 61
Z9 66
U1 0
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1999
VL 10
IS 3
BP 161
EP 167
DI 10.1023/A:1008985423644
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 179YV
UT WOS:000079358700005
PM 15348164
DA 2018-10-19
ER

PT J
AU Andersson, J
   Larsson, R
   Elgue, G
   Ekdahl, KN
   Nilsson, B
AF Andersson, J
   Larsson, R
   Elgue, G
   Ekdahl, KN
   Nilsson, B
TI Immobilization of factor H reduces complement activation on a model
   biomaterial surface
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
C1 Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD MAR-APR
PY 1999
VL 36
IS 4-5
MA 118
BP 309
EP 309
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 208XF
UT WOS:000081016600126
DA 2018-10-19
ER

PT J
AU Yang, JM
   Chian, CPC
   Hsu, KY
AF Yang, JM
   Chian, CPC
   Hsu, KY
TI Oxygen permeation in SBS-g-DMAEMA copolymer membrane prepared by UV
   photografting without degassing
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE styrene-butadiene-styrene block copolymer; dimethyl amino
   ethylmethacrylate; graft copolymer; gas permeation
ID STYRENE BLOCK-COPOLYMER; G-VP; GRAFT-POLYMERIZATION; SURFACE; RADIATION;
   IMMOBILIZATION; BIOMATERIAL; IRRADIATION; ENRICHMENT; CARRIER
AB The grafting of dimethyl amino ethyl methacrylate (DMAEMA) onto styrene-butadiene-styrene triblock copolymer membrane (SBS) was induced by UV-radiation without degassing to obtain SBS-g-DMAEMA copolymer membrane. The graft copolymer membrane was characterized by electron spectroscopy for chemical analysis (ESCA). The density and the decomposition temperature of the SBS-g-DMAEMA copolymer membrane were measured. The effects of DMAEMA grafting content and operating temperature on membrane gas permeability were investigated. It was found that the density of SBS-g-DMAEMA copolymer membrane increased with increasing DMAEMA content, whereas the decomposition temperature decreased. The changes of properties of SBS-g-DMAEMA copolymer membrane reduced the gas permeability and diffusivity of oxygen and nitrogen through the membrane, but increased the gas solubility of oxygen through the membrane and the gas selectivity between oxygen and nitrogen. When the operating temperature of gas permeation was increased, the permeability, solubility and diffusivity of oxygen and nitrogen increased but the selectivity decreased. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem Engn, Tao Yuan 333, Taiwan.
   Chung Yuan Christian Univ, Dept Chem Engn, Chungli 32023, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem Engn, Kwei San, Tao Yuan 333, Taiwan.
CR FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P441
   Holden G., 1969, J POLYM SCI        C, VC26, P37
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3363, DOI 10.1002/pola.1990.080281215
   HSIUE GH, 1993, J POLYM SCI POL CHEM, V31, P1457, DOI 10.1002/pola.1993.080310614
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3761, DOI 10.1002/pola.1990.080281319
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   KESTING RE, 1993, POLYM GAS SEPARATION
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P546, DOI 10.1016/0142-9612(93)90244-V
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   LAI JY, 1987, J APPL POLYM SCI, V34, P559, DOI 10.1002/app.1987.070340211
   LEVASALMI JM, 1995, MACROMOLECULES, V28, P1733, DOI 10.1021/ma00110a002
   MULDER M, 1991, BASIC PRINCIPLES MEM
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   WARD WJ, 1976, J MEMBRANE SCI, V1, P99, DOI 10.1016/S0376-7388(00)82259-0
   YANG JM, 1991, MACROMOLECULES, V24, P4010, DOI 10.1021/ma00014a007
   YANG JM, 1994, J MEMBRANE SCI, V87, P233, DOI 10.1016/0376-7388(94)87030-6
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
NR 33
TC 19
Z9 20
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD FEB 17
PY 1999
VL 153
IS 2
BP 175
EP 182
DI 10.1016/S0376-7388(98)00261-0
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 158VM
UT WOS:000078138100004
DA 2018-10-19
ER

PT J
AU Ayyala, RS
   Harman, LE
   Michelini-Norris, B
   Ondrovic, LE
   Haller, E
   Margo, CE
   Stevens, SX
AF Ayyala, RS
   Harman, LE
   Michelini-Norris, B
   Ondrovic, LE
   Haller, E
   Margo, CE
   Stevens, SX
TI Comparison of different biomaterials for glaucoma drainage devices
SO ARCHIVES OF OPHTHALMOLOGY
LA English
DT Article
ID IMPLANT
AB Objectives: To compare the inflammatory reaction associated with the insertion of silicone and polypropylene endplates and endplates made of a new biocompatible polymer, Vivathane, in the rabbit subconjunctival space.
   Methods: Similar-sized endplates made of 3 different biomaterials were sutured to the sclera in the superotemporal quadrant of the rabbit eye. Thirty eyes of 15 albino New Zealand rabbits were randomly assigned to the 3 groups. Conjunctival vascular hyperemia was graded in a masked fashion among groups. At the end of 3 weeks, the enucleated eyes were examined histologically and using scanning electron microscopy.
   Results: Polypropylene and Vivathane were associated with significantly more inflammation in clinical observations and based on histological grading. Silicone was associated with the least amount of inflammation. Three polypropylene and 1 Vivathane plate were extruded between the second and third week.
   Conclusions: Silicone is the most inert of the 3 materials tested. Inflammation associated with biomaterials may contribute to the failure of the glaucoma drainage devices.
   Clinical Relevance: Bleb inflammation may be related to the biomaterial being used as the endplate. Endplates should be handled carefully during surgery to avoid creating rough spots.
C1 Watson Clin, Dept Ophthalmol, Lakeland, FL USA.
   Univ S Florida, Dept Surg, Tampa, FL 33620 USA.
   Univ S Florida, Dept Ophthalmol, Tampa, FL 33620 USA.
   Univ S Florida, Dept Pathol, Tampa, FL 33620 USA.
RP Ayyala, RS (reprint author), 12901 Bruce B Downs Blvd,MDC 21, Tampa, FL 33612 USA.
OI Haller, Edward/0000-0002-8535-2181
CR Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1
   BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603
   COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201
   Kovacs S G, 1992, ASAIO J, V38, P38, DOI 10.1097/00002480-199201000-00010
   Molteno A, 1988, GLAUCOMA, P192
   MOLTENO ACB, 1971, BRIT J OPHTHALMOL, V55, P28, DOI 10.1136/bjo.55.1.28
   MOLTENO ACB, 1969, BRIT J OPHTHALMOL, V53, P606, DOI 10.1136/bjo.53.9.606
   *N AM SCI ASS INC, 1991, MT023300 N AM SCI AS
   *N AM SCI ASS INC, 1991, CB037100 N AM SCI AS
   SIEGNER SW, 1995, OPHTHALMOLOGY, V102, P1298, DOI 10.1016/S0161-6420(95)30871-8
NR 10
TC 68
Z9 71
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0003-9950
J9 ARCH OPHTHALMOL-CHIC
JI Arch. Ophthalmol.
PD FEB
PY 1999
VL 117
IS 2
BP 233
EP 236
PG 4
WC Ophthalmology
SC Ophthalmology
GA 166RK
UT WOS:000078590800011
PM 10037569
DA 2018-10-19
ER

PT J
AU Elcin, YM
   Dixit, V
   Lewin, K
   Gitnick, G
AF Elcin, YM
   Dixit, V
   Lewin, K
   Gitnick, G
TI Xenotransplantation of fetal porcine hepatocytes in rats using a tissue
   engineering approach
SO ARTIFICIAL ORGANS
LA English
DT Article
DE tissue engineering; xenotransplantation; hepatocyte organoid; artificial
   liver; prevascularized polymer scaffold; biodegradable polymers;
   chitosan-albumin
ID TRANSPLANTATION; CHITOSAN; SUPPORT
AB Hepatocytes can be successfully transplanted into highly vascular sites such as the spleen, liver, and lungs. Subcutaneous sites lack adequate vascularization to nutritionally support transplanted hepatocytes. We recently reported that matrix-immobilized angiogenic growth factors, e.g., endothelial cell growth factor (ECGF), can induce a high degree of neovascularization. Using this technique, we explored the possibility of transplanting isolated fetal porcine hepatocytes to create liver tissue organoids at a specific subcutaneous site. We evaluated chitosan as a scaffold biomaterial because of its structural similarity to glycosaminoglycans; glycosaminoglycans play a critical role in cell attachment, differentiation, and morphogenesis. Freshly isolated fetal porcine hepatocytes (FPH) (viability greater than 97%) were cultured on modified chitosan scaffolds and transplanted into rat groin fat pads with or without ECGF-induced neovascularization. Cell density and attachment kinetics on chitosan were examined by scanning electron microscopy (SEM) and quantified using a flavianic acid binding assay. Hepatocyte viability and liver organoid formation were examined immunohistochemically. FPH transplanted without prior neovascularization died within 1 day posttransplantation. When transplanted after ECGF-induced neovascularization, FPH thrived for at least 2 weeks and formed liver tissue like structures. Immunohistochemical analysis revealed the presence of hepatocyte-specific cytokeratin staining as well as the presence of alpha-fetoprotein. Light microscopy and SEM revealed that FPH did not change their morphology after attachment to the chitosan surfaces. Thus, chitosan-based biomaterial surfaces have good hepatocyte attachment properties, However, extensive neovascularization is essential for hepatocyte survival and organoid formation. In the future, chitosan-based biomaterials may be useful as scaffolds for creating liver tissue organoids.
C1 Univ Calif Los Angeles, Sch Med, Dept Med, Liver Biosupport & Hepatitis Res Lab, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.
   Ankara Univ, Dept Chem, Ankara, Turkey.
RP Dixit, V (reprint author), Univ Calif Los Angeles, Sch Med, Dept Med, Liver Biosupport & Hepatitis Res Lab, 675 Circle Dr S,MRL Room 1240, Los Angeles, CA 90095 USA.
OI Elcin, Yasar Murat/0000-0003-1037-0825
CR BISSELL DM, 1998, SCAND J GASTROENTERO, V23, P1
   DEMETRIOU AA, 1986, ANN SURG, V204, P259, DOI 10.1097/00000658-198609000-00005
   Dixit V, 1992, Cell Transplant, V1, P391
   DIXIT V, 1995, ARTIF ORGANS, V23, P809
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   ELCIN YM, 1995, INT J ARTIF ORGANS, V18, P433
   ELCIN YM, 1995, INT J ARTIF ORGANS, V18, P464
   FULLER BJ, 1988, J HEPATOL, V7, P368, DOI 10.1016/S0168-8278(88)80010-2
   Fung J, 1997, WORLD J SURG, V21, P956, DOI 10.1007/s002689900333
   HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734
   JOHNSON LB, 1994, CELL TRANSPLANT, V3, P273, DOI 10.1177/096368979400300403
   MAKOWKA L, 1986, TRANSPLANTATION, V42, P537, DOI 10.1097/00007890-198611000-00020
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   SANDBICHLER P, 1992, GASTROENTEROLOGY, V102, P605, DOI 10.1016/0016-5085(92)90109-C
   Sheehan DC, 1980, THEORY PRACTICE HIST
   SKEHAN P, 1985, IN VITRO CELL DEV B, V21, P288
   STAMATOGLOU SC, 1994, FASEB J, V8, P420
   TARK KC, 1991, ANN PLAS SURG, V26, P149, DOI 10.1097/00000637-199102000-00007
   VACANTI JP, 1988, ARCH SURG-CHICAGO, V123, P545
   VROEMEN JPAM, 1988, TRANSPLANTATION, V45, P600, DOI 10.1097/00007890-198803000-00019
   ZHANG H, 1992, J PEDIATR SURG, V27, P312, DOI 10.1016/0022-3468(92)90853-Y
NR 25
TC 48
Z9 57
U1 0
U2 4
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 1999
VL 23
IS 2
BP 146
EP 152
DI 10.1046/j.1525-1594.1999.06222.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 165KZ
UT WOS:000078521100005
PM 10027884
DA 2018-10-19
ER

PT J
AU Dee, KC
   Andersen, TT
   Bizios, R
AF Dee, KC
   Andersen, TT
   Bizios, R
TI Osteoblast population migration characteristics on substrates modified
   with immobilized adhesive peptides
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; cell; migration; growth factor; Arg-Gly-Asp; integrin
ID CELL-MIGRATION; MEDIATED ADHESION; CHEMOTAXIS; FIBRONECTIN; AGAROSE;
   ATTACHMENT; INTEGRIN; MOTILITY; INVITRO; GROWTH
AB The process of cell migration is inextricably linked with the process of cell adhesion and, therefore, with cell/substrate adhesiveness. The present study adapted an under-agarose cell migration assay to quantitatively examine population migration characteristics of osteoblasts, on substrates modified with adhesive peptides, in the absence and presence of growth factors. Short-term, that is, 48 h osteoblast migration distances on substrates modified with adhesive Arg-Gly-Asp-Ser peptides were significantly(P < 0.05) less than migration distances on substrates modified with non-adhesive Arg-Asp-Cly-Ser peptides, demonstrating that osteoblast population haptokinesis was significantly decreased on substrates modified with adhesive peptides. Random motility coefficients calculated in the present study for osteoblast populations were an order of magnitude lower than a published random motility coefficient for leukocytes, proving quantitatively that, compared to leukocytes, osteoblasts migrate via haptokinesis more slowly. The 48 and 72 h osteoblast population migration differentials in the presence of an initial mass of 60 ng of basic Fibroblast Growth Factor, on substrates modified with Arg-Gly-Asp-Ser or with Arg-Asp-Gly-Ser, were larger than all other chemotactic differentials on these substrates. Quantitative investigations (such as the present study) of cell population migration characteristics on model biomaterial surfaces will become increasingly necessary as the discipline of cell/tissue engineering matures. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   Albany Med Coll, Dept Biochem & Mol Biol, Albany, NY 12208 USA.
RP Dee, KC (reprint author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
OI Dee, Kay C/0000-0002-9069-4880
CR AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   BAUM G, 1972, BIOCHIM BIOPHYS ACTA, V268, P411, DOI 10.1016/0005-2744(72)90336-1
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee K C, 1995, Tissue Eng, V1, P135, DOI 10.1089/ten.1995.1.135
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   DEE KC, THESIS RENSSELAER PO
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   Ishaug SL, 1996, BIOTECHNOL BIOENG, V50, P443, DOI 10.1002/(SICI)1097-0290(19960520)50:4<443::AID-BIT12>3.0.CO;2-K
   KALLURY KMR, 1994, LANGMUIR, V10, P492, DOI 10.1021/la00014a025
   LAUFFENBURGER D, 1979, MATH BIOSCI, V44, P121, DOI 10.1016/0025-5564(79)90032-4
   LAUFFENBURGER D, 1983, J IMMUNOL, V131, P940
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LIND M, 1995, APMIS, V103, P140, DOI 10.1111/j.1699-0463.1995.tb01089.x
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   LUCAS PA, 1989, BONE, V10, P459, DOI 10.1016/8756-3282(89)90079-3
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7
   Montgomery D. C., 1991, DESIGN ANAL EXPT
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   NISHIKAWA T, 1993, CANCER J, V6, P130
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   ROBINSON PJ, 1971, BIOCHIM BIOPHYS ACTA, V242, P659, DOI 10.1016/0005-2744(71)90160-4
   ROTHMAN C, 1983, ANN BIOMED ENG, V11, P451, DOI 10.1007/BF02584219
   STRAUS AH, 1989, EXP CELL RES, V183, P126, DOI 10.1016/0014-4827(89)90423-0
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   WEETALL HH, 1969, SCIENCE, V166, P615, DOI 10.1126/science.166.3905.615
   WU P, 1994, ANN BIOMED ENG, V22, P144, DOI 10.1007/BF02390372
NR 35
TC 78
Z9 81
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 3
BP 221
EP 227
DI 10.1016/S0142-9612(98)00161-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159ND
UT WOS:000078179100003
PM 10030598
DA 2018-10-19
ER

PT J
AU Remy, M
   Valli, N
   Brethes, D
   Labrugere, C
   Porte-Durrieu, MC
   Dobrova, NB
   Novikova, SP
   Gorodkov, AJ
   Bordenave, L
AF Remy, M
   Valli, N
   Brethes, D
   Labrugere, C
   Porte-Durrieu, MC
   Dobrova, NB
   Novikova, SP
   Gorodkov, AJ
   Bordenave, L
TI In vitro and in situ intercellular adhesion molecule-1 (ICAM-1)
   expression by endothelial cells lining a polyester fabric
SO BIOMATERIALS
LA English
DT Article
DE vascular substitute; endothelial cell; ICAM-1 sites; binding experiments
ID TUMOR-NECROSIS-FACTOR; POLYETHYLENE TEREPHTHALATE; PROTEIN EXPRESSION;
   IN-VITRO; LEUKOCYTE; CONTACT; LINE; INTERFERON; CULTURE; ANTIGEN
AB In order to improve long-term patency of vascular grafts, the promising concept of endothelial cell seeding is actually under investigation. Our laboratory tested a polyester coated with albumin and chitosan which permits a rapid colonization by human umbilical vein endothelial cells (HUVEC) and it seems relevant to test in vitro the expression of adhesive molecules expressed by cells with regard to the inflammatory process. We studied intercellular adhesion molecule-1 (ICAM-1) expression and focused our work on the determination of ICAM-1 sites expressed per adherent cell lining the biomaterial, thus in situ, in comparison to control HUVEC on plastic wells: the results obtained by binding experiments were correlated to flow cytometry analyses and showed that the polyester does not induce a proinflammatory state and that HUVEC covering the structure are able to respond to a stimulus. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Bordeaux 2, Unite 443, INSERM, F-33076 Bordeaux, France.
   Hop Haut Leveque, Nucl Med Serv, F-33604 Pessac, France.
   IBGC, F-33077 Bordeaux, France.
   ICMCB, CNRS, CECAMA, F-33608 Pessac, France.
   Inst Chirurg Cardiovasc Bakoulev, Lab Polymeres 8, Moscow 117049, Russia.
RP Remy, M (reprint author), Univ Bordeaux 2, Unite 443, INSERM, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM u443@bordeaux.inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
CR ALMENARQUERALT A, 1995, AM J PATHOL, V147, P1278
   BORDENAVE L, 1992, BIOMATERIALS, V13, P439, DOI 10.1016/0142-9612(92)90164-J
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   BRETHES D, 1992, EUR J BIOCHEM, V210, P785, DOI 10.1111/j.1432-1033.1992.tb17481.x
   BROWN KA, 1993, J IMMUNOL METHODS, V163, P13, DOI 10.1016/0022-1759(93)90234-X
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   CARLOS TM, 1994, BLOOD, V84, P2068
   Cenni E, 1996, BIOMATERIALS, V17, P2071, DOI 10.1016/0142-9612(96)00037-3
   CENNI E, 1995, BIOMATERIALS, V16, P1223, DOI 10.1016/0142-9612(95)98128-2
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   Claise C, 1997, CELL MOL LIFE SCI, V53, P156, DOI 10.1007/PL00000587
   CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1
   DOSQUET C, 1992, CLIN HEMORHEOL, V12, P817
   DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321
   DUSTIN ML, 1986, J IMMUNOL, V137, P245
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   HERRING M, 1978, SURGERY, V84, P498
   HOGG N, 1993, CURR OPIN IMMUNOL, V5, P383, DOI 10.1016/0952-7915(93)90057-Y
   HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARGIOTTA M, 1992, ANN SURG, P600
   Margiotta M S, 1995, J Am Coll Surg, V181, P215
   MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699
   Mutin M, 1996, ENDOTHELIUM, V4, P289
   NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410
   NOVIKOVA SP, 1996, BIOL PROTEZY ARTERIJ
   NOVIKOVA SP, 1996, BIOPROTEZY VSERDO CH, P105
   Pigott R, 1993, ADHESION MOL, P74
   POBER JS, 1986, J IMMUNOL, V137, P1893
   REMY M, 1994, J MATER SCI-MATER M, V5, P808, DOI 10.1007/BF00213139
   SACCAVINI JC, 1989, MONOCLONAL ANTIBODIE, P61
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   THORNHILL MH, 1993, SCAND J IMMUNOL, V38, P279, DOI 10.1111/j.1365-3083.1993.tb01726.x
   TSUBOI H, 1995, BIOCHEM BIOPH RES CO, V206, P988, DOI 10.1006/bbrc.1995.1140
   WELLICOME SM, 1990, J IMMUNOL, V144, P2558
   ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4
   ZIMMERMAN GA, 1992, IMMUNOL TODAY, V13, P93, DOI 10.1016/0167-5699(92)90149-2
NR 41
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 3
BP 241
EP 251
DI 10.1016/S0142-9612(98)00167-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159ND
UT WOS:000078179100006
PM 10030601
DA 2018-10-19
ER

PT J
AU Yu, C
   Kohn, J
AF Yu, C
   Kohn, J
TI Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials - Part
   I: Synthesis and evaluation
SO BIOMATERIALS
LA English
DT Article
DE poly(ether carbonate); biomaterial; degradable; structure-property
   correlations; cell culture; drug release
ID MULTIBLOCK COPOLYMERS; MEDICAL APPLICATIONS; POLY(L-LACTIC ACID);
   BLOCK-COPOLYMERS; POLYCARBONATES; POLYMER; BEHAVIOR; DESIGN; WATER;
   URETHANE
AB Tyrosine-PEG-derived poly(ether carbonate)s were prepared by condensation copolymerization with phosgene. The resulting polymers were random copolymers with weight average molecular weights from 40 000 to 200 000 dalton. Chemical structure and purity were confirmed by NMR and FTIR spectral analysis. General structure-property correlations were established. The glass transition temperature decreased with increasing PEG content and increasing pendent chain length. When higher molecular weight PEG blocks were used, the glass transition temperature increased relative to identical polymers having shorter PEG blocks. The tensile modulus increased with decreasing PEG content, decreasing pendent chain length, and when longer PEG blocks were used. Water uptake and the rate of backbone degradation increased with increasing PEG content. Microspheres could be prepared by solvent evaporation techniques from copolymers with low PEG content. Release rate of pNA and FITC-dextran from the microspheres increased with increasing PEG content. While tyrosine-derived polycarbonates were excellent substrates for cell attachment and growth, the presence of only 5 mol% of PEG(1000),, led to low or no cell attachment in short-term cell culture with both rat lung fibroblasts and osteoblasts. The polymers were non-cytotoxic. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd Busch Campus, Piscataway, NJ 08854 USA.
EM Kohn@rutchem.rut-gers.edu
FU NIGMS NIH HHS [GM39455]
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   BEHNKE J, 1994, Patent No. 792932761
   BOSTMAN O, 1989, CLIN ORTHOP RELAT R, P195
   Breitmaier E., 1987, CARBON 13 NMR SPECTR, P183
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   EISENBERGER P, 1995, NIH WORKSH BIOM MED
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   FERRUTI P, 1995, BIOMATERIALS, V16, P1423, DOI 10.1016/0142-9612(95)96879-5
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FRANSON NM, 1983, J APPL POLYM SCI, V28, P1299, DOI 10.1002/app.1983.070280404
   GOLDBERG EP, 1964, J POLYM SCI C, V4, P707
   GRAHAM NB, 1989, POLYMER, V30, P2130, DOI 10.1016/0032-3861(89)90305-4
   HIGLEY WS, 1981, Patent No. 4308145
   HOFFMAN A S, 1992, Clinical Materials, V11, P13, DOI 10.1016/0267-6605(92)90025-O
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   James K, 1996, TRENDS POLYM SCI, V4, P394
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MANDENIUS CF, 1991, BIOMATERIALS, V12, P369, DOI 10.1016/0142-9612(91)90004-T
   MATHIOWITZ E, 1990, SCANNING MICROSCOPY, V4, P329
   MERRILL SH, 1961, J POLYM SCI, V55, P343, DOI 10.1002/pol.1961.1205516133
   NISHIMURA T, 1984, MAKROMOL CHEM, V185, P2109
   PEPPAS NA, 1980, J MEMBRANE SCI, V7, P241, DOI 10.1016/S0376-7388(00)80471-8
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   SUZUKI T, 1984, POLYM J, V16, P129, DOI 10.1295/polymj.16.129
   TANJSUGI H, 1984, POLYM J, V16, P633
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
   VERT M, 1984, MACROMOLECULAR BIOMA, P119
   WANG SG, 1989, J MACROMOL SCI CHEM, VA26, P505, DOI 10.1080/00222338908051990
   YOKOYAMA M, 1990, MAKROMOL CHEM, V191, P301
   Yu C, 1999, BIOMATERIALS, V20, P265, DOI 10.1016/S0142-9612(98)00170-7
NR 40
TC 66
Z9 71
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 3
BP 253
EP 264
DI 10.1016/S0142-9612(98)00169-0
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159ND
UT WOS:000078179100007
PM 10030602
DA 2018-10-19
ER

PT J
AU Yu, C
   Mielewczyk, SS
   Breslauer, KJ
   Kohn, J
AF Yu, C
   Mielewczyk, SS
   Breslauer, KJ
   Kohn, J
TI Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials - Part
   II: Study of inverse temperature transitions
SO BIOMATERIALS
LA English
DT Article
DE inverse temperature transition; poly(ether carbonate); biomaterial;
   degradable; tyrosine; poly(ethylene glycol)
ID PHASE-TRANSITIONS; AQUEOUS-SOLUTIONS; LIGHT-SCATTERING; POLYMER;
   POLYPENTAPEPTIDE; COPOLYMER; ELASTIN; OXIDE); CHAIN; GELS
AB Tyrosine-poly(alkylene oxide)-derived poly(ether carbonate)s represent a new group of degradable biomaterials that exhibit inverse temperature transitions. Poly(DTE co 70%PEG(1000)( )carbonate) was chosen as an example to study this special phase transition behavior of the polymers. The observed transition temperature varied slightly depending on the technique used, e.g. CD always gave a lower temperature than UV/Vis. CD and UV/Vis studies indicated that the transition temperature was both heating rate and concentration dependent. Thermodynamic parameters of the transition (enthalpy, entropy, and free energy) were determined by DSC. The molecularity of the transition was 2.6, as calculated from UV and DSC data. The transition temperature could be varied from 18 to 58?C by changing the polymer structure. The new poly(ether carbonate)s may be used in medical applications such as injectable drug delivery formulations and bioresorbable barriers for the prevention of surgical adhesions. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, Busch Campus 610 Taylor Rd, Piscataway, NJ 08854 USA.
FU NIGMS NIH HHS [GM 00550, GM 39455]
CR ANNAKA M, 1992, NATURE, V355, P430, DOI 10.1038/355430a0
   ARMSTRONG JK, 1994, MACROMOLECULAR REP A, V31, P1299
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   CHENG YD, 1995, MACROMOLECULES, V28, P2665, DOI 10.1021/ma00112a011
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   HIROTSU S, 1987, J CHEM PHYS, V87, P1392, DOI 10.1063/1.453267
   LUAN CH, 1990, BIOPOLYMERS, V29, P1699, DOI 10.1002/bip.360291403
   MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911
   PARK TG, 1992, MACROMOLECULES, V25, P116, DOI 10.1021/ma00027a019
   SCHILD HG, 1990, J PHYS CHEM-US, V94, P4352, DOI 10.1021/j100373a088
   SCHILLEN K, 1993, MACROMOLECULES, V26, P3611, DOI 10.1021/ma00066a020
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   URRY DW, 1985, BIOCHEMISTRY-US, V24, P5182, DOI 10.1021/bi00340a034
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   YOSHIDA M, 1992, EUR POLYM J, V28, P1141, DOI 10.1016/0014-3057(92)90069-E
   YOSHIDA M, 1989, EUR POLYM J, V25, P1197, DOI 10.1016/0014-3057(89)90081-5
   YU C, 1999, SYNTHESIS EVALUATION, V20, P253
   YU C, 1996, P 5 WORLD BIOMATERIA, V1, P565
NR 18
TC 17
Z9 17
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 3
BP 265
EP 272
DI 10.1016/S0142-9612(98)00170-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159ND
UT WOS:000078179100008
PM 10030603
DA 2018-10-19
ER

PT J
AU Chang, CC
   Lieberman, SM
   Moghe, PV
AF Chang, CC
   Lieberman, SM
   Moghe, PV
TI Leukocyte spreading behavior on vascular biomaterial surfaces:
   consequences of chemoattractant stimulation
SO BIOMATERIALS
LA English
DT Article
DE chemoattractant; vascular biomaterials
ID MET-LEU-PHE; POLYMORPHONUCLEAR LEUKOCYTES; EXPANDED
   POLYTETRAFLUOROETHYLENE; NEUTROPHIL LEUKOCYTES; CHEMOTACTIC PEPTIDE;
   PROTEIN ADSORPTION; CELLULAR ADHESION; PLASMA-PROTEINS; FIBRINOGEN;
   PHAGOCYTOSIS
AB Chemoattractant-induced phenomena of polarity and migration of polymorphonuclear leukocytes (PMN) are believed to play a key physiological role in controlling bacterial infections on implantable vascular biomaterials. Our study targeted the spreading behavior of human PMN adherent to expanded polytetrafluoroethylene (ePTFE), pretreated with various plasma proteins, in response to the chemoattractant, N-formyl-methionyl-leucyl-phenylalanine (fMLP). To this end, a novel imaging configuration was developed to allow in situ reconstructive analysis of PMN 3-D morphology on opaque ePTFE surfaces, using optical sectioning confocal microscopy. Following fMLP stimulation, PMN morphological polarity was enhanced on all substrates studied except fibrinogen treated ePTFE. 3-D PMN morphometry revealed that in the absence of fMLP, overall cell spreading was minimized on albumin-treated ePTFE and maximized on fibrinogen and immunoglobulin-G-treated ePTFE. Following fMLP stimulation, overall PMN spreading increased markedly on untreated and albumin-coated ePTFE, while it stayed invariant on IgG and plasma treated ePTFE, and decreased on fibrinogen similar to treated ePTFE. Spatial analysis of PMN spreading following fMLP stimulation revealed enhanced PMN attachment on untreated and albumin treated ePTFE and diminished attachment on fibrinogen and plasma treated ePTFE. Thus, chemoattractant stimulation altered a wide range of PMN spreading attributes on ePTFE, including morphological polarity, substrate attachment, and 3-D membrane spreading, in a substrate dependent manner. These chemoattractant-induced spreading responses may also have important consequences for PMN phagocytosis. We report that fMLP stimulation led to enhanced unopsonized particulate phagocytosis on untreated and albumin treated ePTFE, but caused no discernible change in phagocytosis on other protein substrates. Thus, chemoattractant modulation of PMN spreading on ePTFE is highly substrate-regulated, and manifests in concerted effects on PMN phagocytosis. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Busch Campus,98 Brett Rd, Piscataway, NJ 08854 USA.
EM moghe@rci.rutgers.edu
OI Lieberman, Scott/0000-0003-4082-7582
CR ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   ALTIERI DC, 1990, J BIOL CHEM, V265, P12119
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAINTON D, 1983, J CELL BIOL, V58, P249
   Benton LD, 1996, J SURG RES, V64, P116, DOI 10.1006/jsre.1996.0316
   BERNHARD VM, 1975, SURG CLIN N AM, V55, P1411
   BHAT DJ, 1980, SURGERY, V87, P445
   BIGNOLD LP, 1990, EUR J CELL BIOL, V53, P27
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   CANNON GJ, 1992, J CELL SCI, V101, P907
   COOPER JA, 1988, CIRC RES, V63, P735, DOI 10.1161/01.RES.63.4.735
   DAVIS BH, 1982, AM J PATHOL, V108, P206
   Ehrengruber MU, 1996, J EXP BIOL, V199, P741
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   GALLIN JI, 1984, CLIN RES, V32, P320
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   GRAHAM IL, 1993, J CELL BIOL, P120
   GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377
   Harbecke O, 1997, J LEUKOCYTE BIOL, V61, P753
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   HIGAZI AA, 1994, INFLAMMATION, V18, P525, DOI 10.1007/BF01560699
   KATZ DA, 1994, SURGERY, V116, P446
   KELLER HU, 1987, CELL SHAPE MOVEMENT, V66
   KVARSTEIN B, 1969, SCAND J CLIN LAB INV, V24, P41, DOI 10.3109/00365516909080130
   LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   LOIKE J, 1995, AM SOC CELL BIOL
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17
   MUKHERJEE G, 1994, J LEUKOCYTE BIOL, V55, P685
   NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243
   NAZIRUDDIN B, 1992, J IMMUNOL, V149, P3702
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   OFEK I, 1988, INFECT IMMUN, V56, P539
   OFLAHERTY JT, 1978, AM J PATHOL, V90, P537
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   RABINOVITCH M, 1975, J EXP MED, V142, P827, DOI 10.1084/jem.142.4.827
   ROOS FJ, 1987, J CELL SCI, V88, P399
   SMITH CW, 1979, J CLIN INVEST, V63, P221, DOI 10.1172/JCI109293
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TARGOWSKI SP, 1986, INFECT IMMUN, V52, P798
   WEITZ JI, 1987, J EXP MED, V166, P1836, DOI 10.1084/jem.166.6.1836
   WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
NR 48
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 3
BP 273
EP 281
DI 10.1016/S0142-9612(98)00171-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159ND
UT WOS:000078179100009
PM 10030604
DA 2018-10-19
ER

PT J
AU Bosetti, M
   Ottani, V
   Kozel, D
   Raspanti, M
   De Pasquale, V
   Ruggeri, A
   Cannas, M
AF Bosetti, M
   Ottani, V
   Kozel, D
   Raspanti, M
   De Pasquale, V
   Ruggeri, A
   Cannas, M
TI Structural and functional macrophages alterations by ceramics of
   different composition
SO BIOMATERIALS
LA English
DT Article
DE dental biomaterials; macrophages; apatite
ID MIGRATION-INHIBITORY FACTOR; ACTIVATES HUMAN MACROPHAGES; DEPROTEINATED
   COMPACT-BONE; OXIDATIVE RESPONSES; NITRIC-OXIDE; SURFACE-AREA;
   PARTICLES; SIZE
AB Biomaterials may initiate several and complex biological reactions in host tissues, and the cell-biomaterial interactions can determine the release of mediators including monocytes and lymphocytes chemotactic factors. The present work was aimed to investigate in vitro the macrophage biological reactions of a natural apatite obtained by heat treatment at 400 degrees C of bovine bone, compared to other ceramics usually used for dental and orthopedic applications, using synthetic apatite and three types of alumina as controls. Particles chemotactic activity and powders oxidative burst evidenced no monocyte-macrophages sensitivity reaction for natural and synthetic hydroxyapatite powders at great granulometry (> 50 mu m); data were confirmed by ultrastructural observations; electron microscopy analysis showed macrophages with the features of healthy cells in the presence of both natural and synthetic apatites while macrophages grown in the presence of alumina seemed to be negatively affected. In conclusion, among all ceramics tested, natural apatite displayed a good compatibility with living cells, bring better tolerated than synthetic hydroxyapatite which in turn is better tolerated than alumina. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Turin, Dept Med Sci, Med Sch Novara, I-28100 Novara, Italy.
   Univ Bologna, Inst Human Anat, Bologna, Italy.
RP Cannas, M (reprint author), Univ Turin, Dept Med Sci, Med Sch Novara, Via Solardi 17, I-28100 Novara, Italy.
EM cannas@med.no.unipmm.it
CR AZIZSOLTANI E, 1995, J BIOMED MATER RES, V29, P101, DOI 10.1002/jbm.820290114
   BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80
   BOYNE PJ, 1991, HEFTE UNFALLHEILKD, V216, P98
   CUNHA FQ, 1993, J IMMUNOL, V150, P1908
   DAVID JR, 1964, J IMMUNOL, V93, P264
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   GUIZZARDI S, 1995, BIOMATERIALS, V16, P931, DOI 10.1016/0142-9612(95)93118-W
   HERRIOTT MJ, 1993, J IMMUNOL, V150, P4524
   KLEIN CPAT, 1983, BIOMATERIALS, V4, P181, DOI 10.1016/0142-9612(83)90007-8
   MYRVIK QN, 1993, J LEUKOCYTE BIOL, V54, P439
   NATHAN CF, 1971, J EXP MED, V133, P1356, DOI 10.1084/jem.133.6.1356
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Payne JM, 1996, J PERIODONTOL, V67, P236, DOI 10.1902/jop.1996.67.3.236
   POZZI LAM, 1992, CELL IMMUNOL, V145, P372, DOI 10.1016/0008-8749(92)90339-Q
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMES A, 1990, J MATER SCI-MATER M, V1, P26, DOI 10.1007/BF00705350
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   TRVOR R, 1990, CRITICAL REV BIOCOMP, V2, P97
   WEISER WY, 1981, J IMMUNOL, V126, P1958
   WEISER WY, 1991, J IMMUNOL, V147, P2006
   WU JY, 1993, J IMMUNOL, V151, P4325
NR 22
TC 11
Z9 12
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 4
BP 363
EP 370
DI 10.1016/S0142-9612(98)00177-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164CW
UT WOS:000078445700009
PM 10048409
DA 2018-10-19
ER

PT J
AU Lima, KM
   Junior, JMR
AF Lima, KM
   Junior, JMR
TI Poly-DL-lactide-co-glycolide microspheres as a controlled release
   antigen delivery system
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT International Symposium on the 3rd Revolution on Vaccines - DNA Vaccines
CY NOV 03-07, 1997
CL BELO HORIZONT, BRAZIL
DE vaccine; adjuvant; microspheres; microencapsulation; biomaterial
ID ACID) MICROSPHERES; BIODEGRADABLE MICROPARTICLES; ANTIBODY-RESPONSES;
   POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES; FUTURE-PROSPECTS;
   MOLECULAR-WEIGHT; IMMUNE-RESPONSE; IN-VITRO; VACCINES; DEGRADATION
AB Successful vaccine application means maximum protection with minimal number of administrations. A rational development of vaccines involves studies of the nature of the antigen as well as of the adjuvant to be used to improve the immune responses. This has provided the impetus for studies to design the degradable devices and for different approaches to antigen delivery by different routes of administration. The development of controlled release systems based on polymeric devices that permit a sustained or pulsed release of encapsulated antigens has attracted much interest. Polymeric delivery systems consist of polymers that release their content continuously in a controlled manner over a period of time. The development of a biocompatible delivery system for parenteral administration offers several advantages in terms of immunoadjuvanticity over other compounds. It was found that, in contrast to other carriers, microspheres are more stable, thus permitting administration by the oral or parenteral route. In the present study, we describe the main characteristics and potentialities of this new immunoadjuvant for oral and parenteral administration.
C1 Univ Fed Minas Gerais, Dept Prod Farmaceut, Lab Tecnol Farmaceut, BR-31080112 Belo Horizonte, MG, Brazil.
RP Junior, JMR (reprint author), Univ Fed Minas Gerais, Dept Prod Farmaceut, Lab Tecnol Farmaceut, Av Olegario Maciel 2360, BR-31080112 Belo Horizonte, MG, Brazil.
EM rodrigue@dedalus.lcc.ufmg.br
CR AGUADO MT, 1993, VACCINE, V11, P596, DOI 10.1016/0264-410X(93)90241-O
   Allaoui-Attarki K, 1998, VACCINE, V16, P685, DOI 10.1016/S0264-410X(97)00261-2
   AllaouiAttarki K, 1997, INFECT IMMUN, V65, P853
   ALLISON AC, 1991, MOL IMMUNOL, V28, P279, DOI 10.1016/0161-5890(91)90074-T
   ALMEIDA AJ, 1993, J PHARM PHARMACOL, V45, P198, DOI 10.1111/j.2042-7158.1993.tb05532.x
   ANCHENG C, 1996, J PHARM SCI, V85, P129
   AUDIBERT FM, 1993, IMMUNOL TODAY, V14, P281, DOI 10.1016/0167-5699(93)90046-N
   BAZILE DV, 1992, BIOMATERIALS, V13, P1039
   Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130
   BOMFORD R, 1989, PARASITOL TODAY, V5, P41, DOI 10.1016/0169-4758(89)90190-7
   Chaudhury MR, 1996, HUM EXP TOXICOL, V15, P205, DOI 10.1177/096032719601500303
   Cleland JL, 1997, J CONTROL RELEASE, V47, P135, DOI 10.1016/S0168-3659(96)01625-2
   Cleland JL, 1995, VACCINE DESIGN SUBUN, P439
   Coombes AGA, 1996, VACCINE, V14, P1429, DOI 10.1016/S0264-410X(96)00077-1
   Crotts G, 1997, J CONTROL RELEASE, V44, P123, DOI 10.1016/S0168-3659(96)01511-8
   DORTA MJ, 1993, INT J PHARM, V100, P9, DOI 10.1016/0378-5173(93)90069-R
   ELDRIDGE JH, 1993, SEMIN HEMATOL, V30, P16
   ELDRIDGE JH, 1991, MOL IMMUNOL, V28, P287, DOI 10.1016/0161-5890(91)90076-V
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   GANDER B, 1993, P INT S CONTROL REL, V20, P65
   Gizurarson S, 1996, CLIN PHARMACOKINET, V30, P1, DOI 10.2165/00003088-199630010-00001
   Gregoriadis G, 1998, PHARM RES-DORDR, V15, P661, DOI 10.1023/A:1011950415325
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   HAZRATI AM, 1993, P INT S CONTROL REL, V20, P101
   Johansen P, 1998, PHARMACEUT RES, V15, P1103, DOI 10.1023/A:1011998615267
   JONES DH, 1995, VACCINE, V13, P675, DOI 10.1016/0264-410X(95)99876-J
   Jones DH, 1997, VACCINE, V15, P814, DOI 10.1016/S0264-410X(96)00266-6
   KHAN MZI, 1994, PHARMACEUT RES, V1, P2
   Kofler N, 1996, J IMMUNOL METHODS, V192, P25, DOI 10.1016/0022-1759(95)00267-7
   Langer R, 1996, NAT MED, V2, P742, DOI 10.1038/nm0796-742
   Langer R, 1998, NATURE, V392, P5
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   LIMA KM, 1998, P 3 PHARMATECH NEW P, P103
   MCGEE JP, 1995, J CONTROL RELEASE, V34, P77
   MEN Y, 1995, VACCINE, V13, P683
   Men Y, 1997, VACCINE, V15, P1405, DOI 10.1016/S0264-410X(97)00047-9
   MESTECKY J, 1991, CURR OPIN IMMUNOL, V3, P492, DOI 10.1016/0952-7915(91)90009-P
   Moore A, 1995, VACCINE, V13, P1741, DOI 10.1016/0264-410X(95)00184-3
   OHagan DT, 1996, J ANAT, V189, P477
   OHAGAN DT, 1993, VACCINE, V11, P660, DOI 10.1016/0264-410X(93)90313-M
   OHAGAN DT, 1993, VACCINE, V11, P965, DOI 10.1016/0264-410X(93)90387-D
   OHAGAN DT, 1995, J CONTROL RELEASE, V36, P75, DOI 10.1016/0168-3659(95)00052-A
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   PARK TG, 1995, J CONTROL RELEASE, V33, P211, DOI 10.1016/0168-3659(94)00084-8
   Partidos CD, 1997, J IMMUNOL METHODS, V206, P143, DOI 10.1016/S0022-1759(97)00102-6
   PARTIDOS CD, 1994, VACCINE RES, V4, P203
   Pekarek KJ, 1996, J CONTROL RELEASE, V40, P169, DOI 10.1016/0168-3659(95)00176-X
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   POWELL MF, 1994, VACCINE DESIGN SUBUN
   RODRIGUES JM, 1994, TROP MED PARASITOL, V45, P223
   SANTIAGO N, 1993, PHARMACEUT RES, V10, P1243, DOI 10.1023/A:1018992924025
   SANTIAGO N, 1994, VACCINE DESIGN SUBUN, P413
   Schwendeman SP, 1996, DEV BIOL STAND, V87, P293
   SHALABY WSW, 1995, CLIN IMMUNOL IMMUNOP, V74, P127, DOI 10.1006/clin.1995.1019
   SINGH M, 1995, PHARMACEUT RES, V12, P1796, DOI 10.1023/A:1016294512292
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   UCHIDA T, 1994, J PHARM PHARMACOL, V47, P556
   VISSCHER GE, 1986, J BIOMED MATER RES, V20, P667, DOI 10.1002/jbm.820200510
   VORDERMEIER HM, 1995, VACCINE, V13, P1576, DOI 10.1016/0264-410X(95)00084-E
   Walker KB, 1998, DEV BIOL STAND, V92, P259
   WHALEN RL, 1996, AM SOC ARTIF INT ORG, V46, pM649
   YEH MK, 1995, J CONTROL RELEASE, V33, P437, DOI 10.1016/0168-3659(94)00123-C
NR 63
TC 46
Z9 48
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD FEB
PY 1999
VL 32
IS 2
BP 171
EP 180
DI 10.1590/S0100-879X1999000200005
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 169JU
UT WOS:000078745300005
PM 10347752
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Holmgren, SK
   Bretscher, LE
   Taylor, KM
   Raines, RT
AF Holmgren, SK
   Bretscher, LE
   Taylor, KM
   Raines, RT
TI A hyperstable collagen mimic
SO CHEMISTRY & BIOLOGY
LA English
DT Article
DE biomaterial; fluoroproline; hydrogen bond; hydroxyproline; inductive
   effect
ID TRIPLE-HELIX; MOLECULAR-STRUCTURE; HYDROGEN-BONDS; PEPTIDE; PROLINE;
   CONFORMATION; FLUORINE; ISOMERIZATION; STABILITY; HYDROXYPROLINE
AB Background: Collagen is the most abundant protein in animals. Each polypeptide chain of collagen is composed of repeats of the sequence: Gly-X-Y, where X and Y are often L-proline (Pro) and 4(R)-hydroxy-L-proline (Hyp) residues, respectively. These chains are wound into tight triple helices of great stability, The hydroxyl group of Hyp residues contributes much to this conformational stability. The existing paradigm is that this stability arises from interstrand hydrogen bonds mediated by bridging water molecules, This model was tested using chemical synthesis to replace Hyp residues with 4(R)-fluoro-L-proline (Flp) residues. The fluorine atom in Flp residues does not form hydrogen bonds but does elicit strong inductive effects,
   Results: Replacing the Hyp residues in collagen with Flp residues greatly increases triple-helical stability. The free energy contributed by the fluorine atom in Flp residues is twice that of the hydroxyl group in Hyp residues. The stability of the Flp-containing triple helix far exceeds that of any untemplated collagen mimic of similar size.
   Conclusions: Bridging water molecules contribute little to collagen stability. Rather, collagen stability relies on previously unappreciated inductive effects. Collagen mimics containing fluorine or other appropriate electron-withdrawing substituents could be the basis of new biomaterials for restorative therapies.
C1 Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
RP Raines, RT (reprint author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
RI Raines, Ronald/A-5009-2013
OI Raines, Ronald/0000-0001-7164-1719
FU NIAMS NIH HHS [AR44276]
CR ANTEUNIS MJO, 1978, B SOC CHIM BELG, V87
   BAKKE JM, 1994, J MOL STRUCT, V321, P205, DOI 10.1016/0022-2860(93)07968-3
   BARLOS K, 1991, INT J PEPT PROT RES, V37, P513
   BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Bodanszky M., 1994, PRACTICE PEPTIDE SYN
   BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211
   Brodsky B, 1995, FASEB J, V9, P1537
   BRUNCK TK, 1979, J AM CHEM SOC, V101, P1700, DOI 10.1021/ja00501a009
   BUNN CW, 1954, NATURE, V174, P549, DOI 10.1038/174549a0
   CHOPRA RK, 1982, P NATL ACAD SCI-BIOL, V79, P7180, DOI 10.1073/pnas.79.23.7180
   COOPER A, 1971, J MOL BIOL, V55, P123, DOI 10.1016/0022-2836(71)90287-7
   DELEEUW FAAM, 1983, J AM CHEM SOC, V105, P2237, DOI 10.1021/ja00346a023
   DETAR DF, 1977, J AM CHEM SOC, V99, P1232, DOI 10.1021/ja00446a040
   Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115
   DZAKULA Z, 1996, J AM CHEM SOC, P12796
   Eberhardt ES, 1996, J AM CHEM SOC, V118, P12261, DOI 10.1021/ja9623119
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Fasman G. D., 1989, PRACTICAL HDB BIOCH
   FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0
   Fields GB, 1995, CONNECT TISSUE RES, V31, P235, DOI 10.3109/03008209509010815
   FIELDS GB, 1990, INT J PEPT PROT RES, V37, P513
   FIETZEK PP, 1975, MOL CELL BIOCHEM, V8, P141, DOI 10.1007/BF01792765
   GARBAYJAUREGUIBERRY C, 1980, J AM CHEM SOC, V102, P1827, DOI 10.1021/ja00526a012
   GERIG JT, 1973, J AM CHEM SOC, V95, P5725, DOI 10.1021/ja00798a046
   GERIG JT, 1976, J AM CHEM SOC, V98, P3970, DOI 10.1021/ja00429a037
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   Glendening ED, 1997, J AM CHEM SOC, V119, P12940, DOI 10.1021/ja970074j
   Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   GUSCHLBAUER W, 1980, NUCLEIC ACIDS RES, V8, P1421, DOI 10.1093/nar/8.6.1421
   HARRELL SA, 1964, J AM CHEM SOC, V86, P4497, DOI 10.1021/ja01074a061
   HOEVE CAJ, 1976, J PHYS CHEM-US, V80, P745, DOI 10.1021/j100548a017
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1
   JONES EY, 1991, J MOL BIOL, V218, P209, DOI 10.1016/0022-2836(91)90885-A
   Kern D, 1997, J AM CHEM SOC, V119, P8403, DOI 10.1021/ja970606w
   LEWIS GN, 1923, VALENCE STRUCTURE AT
   LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   MARIAPPAN SVS, 1992, J ORG CHEM, V57, P6675, DOI 10.1021/jo00050a064
   McCarthy JB, 1996, BIOPOLYMERS, V40, P371, DOI 10.1002/(SICI)1097-0282(1996)40:4<371::AID-BIP3>3.0.CO;2-T
   Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506
   MURRAYRUST P, 1983, J AM CHEM SOC, V105, P3206, DOI 10.1021/ja00348a041
   NEMETHY G, 1988, COLLAGEN, V1, P79
   NIMNI ME, 1988, COLLAGEN, P1
   OHagan D, 1997, CHEM COMMUN, P645, DOI 10.1039/a604140j
   OJIMA I, 1996, BIOMEDICAL FRONTIERS
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   PANASIK N, 1994, INT J PEPT PROT RES, V44, P262
   Pauling L., 1960, NATURE CHEM BOND
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4129, DOI 10.1021/bi00823a015
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4134, DOI 10.1021/bi00823a016
   PLAVEC J, 1994, J AM CHEM SOC, V116, P6558, DOI 10.1021/ja00094a009
   PROCKOP DJ, 1992, NEW ENGL J MED, V326, P540
   RAMSHAW JAM, 1995, BIOTECHNOL GENET ENG, V13, P335
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111
   Shan SO, 1996, SCIENCE, V272, P97, DOI 10.1126/science.272.5258.97
   SHIMONI L, 1994, J AM CHEM SOC, V116, P8162, DOI 10.1021/ja00097a025
   SHIMONI L, 1994, STRUCT CHEM, V5, P383, DOI 10.1007/BF02252897
   SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0
   STOCK LM, 1972, J CHEM EDUC, V49, P400, DOI 10.1021/ed049p400
   SUZUKI E, 1980, INT J BIOL MACROMOL, V2, P54, DOI 10.1016/0141-8130(80)90013-6
   TAKEUCHI T, 1969, BIOCHIM BIOPHYS ACTA, V175, P142, DOI 10.1016/0005-2795(69)90153-6
   Valle CAL, 1996, TRANSPLANTATION, V62, P317, DOI 10.1097/00007890-199608150-00003
   Wieland T., 1991, WORLD PEPTIDES BRIEF
   WOESSNER JF, 1991, FASEB J, V5, P2145
   WOLFE S, 1972, ACCOUNTS CHEM RES, V5, P102, DOI 10.1021/ar50051a003
NR 71
TC 194
Z9 197
U1 1
U2 20
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1074-5521
J9 CHEM BIOL
JI Chem. Biol.
PD FEB
PY 1999
VL 6
IS 2
BP 63
EP 70
DI 10.1016/S1074-5521(99)80003-9
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 235WD
UT WOS:000082564800003
PM 10021421
OA Bronze
DA 2018-10-19
ER

PT J
AU Mack, D
   Riedewald, J
   Rohde, H
   Magnus, T
   Feucht, HH
   Elsner, HA
   Laufs, R
   Rupp, ME
AF Mack, D
   Riedewald, J
   Rohde, H
   Magnus, T
   Feucht, HH
   Elsner, HA
   Laufs, R
   Rupp, ME
TI Essential functional role of the polysaccharide intercellular adhesin of
   Staphylococcus epidermidis in hemagglutination
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM PRODUCTION; ADHERENCE;
   ACCUMULATION; PROTEIN; MUTANTS; TN917
AB Hemagglutination of erythrocytes is a common property of Staphylococcus epidermidis strains, which is related to adherence and biofilm formation and may be essential for the pathogenesis of biomaterial-associated infections caused by S. epidermidis. In three independent biofilm-producing, hemagglutination-positive S. epidermidis isolates, interruption of the icaADBC operon essential for polysaccharide intercellular adhesin (PIA) synthesis by Tn917 insertions led to a hemagglutination-negative phenotype, An immunoglobulin G fraction of antiserum to PIA greatly reduced hemagglutination. Purified PIA led to a 64-fold decrease of hemagglutination titers of these strains; however, it did not mediate hemagglutination by itself. These observations define PIA as the hemagglutinin of S. epidermidis or at least as its major functional component.
C1 Univ Hamburg, Krankenhaus Eppendorf, Inst Med Mikrobiol & Immunol, D-20246 Hamburg, Germany.
   Univ Nebraska, Med Ctr, Dept Internal Med, Infect Dis Sect, Omaha, NE 68198 USA.
RP Mack, D (reprint author), Univ Hamburg, Krankenhaus Eppendorf, Inst Med Mikrobiol & Immunol, Martinistr 52, D-20246 Hamburg, Germany.
EM dmack@uke.uni-hamburg.de
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Christensen Gordon D., 1994, P45
   FEUCHT HH, 1995, J CLIN MICROBIOL, V33, P620
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GODING J W, 1976, Journal of Immunological Methods, V13, P215
   GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hussain M, 1997, INFECT IMMUN, V65, P519
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, IN PRESS J HOSP INFE
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Nedelmann M, 1998, ZBL BAKT-INT J MED M, V287, P85
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHWARZKOPF A, 1993, J CLIN MICROBIOL, V31, P2281
   SHAW JH, 1985, J BACTERIOL, V164, P782
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
NR 25
TC 90
Z9 90
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD FEB
PY 1999
VL 67
IS 2
BP 1004
EP 1008
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 160VE
UT WOS:000078251400079
PM 9916125
DA 2018-10-19
ER

PT J
AU Debelle, L
   Tamburro, AM
AF Debelle, L
   Tamburro, AM
TI Elastin: molecular description and function
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Review
DE elastin; elasticity; conformation
ID SUPRAVALVULAR AORTIC-STENOSIS; TROPOELASTIN MESSENGER-RNA; GLY-GLY-NME;
   BOVINE ELASTIN; CONFORMATIONAL-CHANGES; PENTAPEPTIDE SEQUENCE; SYNTHETIC
   FRAGMENTS; SECONDARY STRUCTURE; COMPLEMENTARY-DNA; GENE-EXPRESSION
AB Elastin, the protein responsible for the elastic properties of vertebrate tissues, has been thought to be solely restricted to that role. As a consequence, elastin was conventionally described as an amorphous polymer. Recent results in the biomedical, biochemical and biophysical fields have lead to the conclusion that the presence of elastin in the extracellular space has very complex implications involving many other molecules. The present review describes the current state of knowledge concerning elastin as an elastic macromolecule. First, the genetic. biological, biochemical and biophysical processes leading to a functional polymer are described. Second, the elastic function of elastin is discussed. The controversy on elastin structure and elasticity is discussed and a novel dynamic mechanism of elasticity proposed. Finally, pathologies where the elastin molecule is involved are considered. This updated description of functional elastin provides the required background for the understanding of its pathologies and defines clearly the properties a substance should possess to be qualified as a good elastic biomaterial. (C) 1999 Elsevier Science Ltd. All lights reserved.
C1 Univ Basilicata, Dept Chem, I-85100 Potenza, Italy.
RP Tamburro, AM (reprint author), Univ Basilicata, Dept Chem, Via N Sauro 85, I-85100 Potenza, Italy.
EM tamburro@unibas.it
CR ABATANGELO G, 1973, INT J PEPT PROT RES, V5, P63
   ALIX AJP, 1997, ELASTIN ELASTIC TISS, P23
   BASHIR M, 1990, ELASTIN CHEM BIOL AS, P43
   BASHIR MM, 1989, J BIOL CHEM, V264, P8887
   BISACCIA F, 1994, INT J PEPT PROT RES, V44, P332
   BRESSAN GM, 1987, BIOCHEMISTRY-US, V26, P1497, DOI 10.1021/bi00380a001
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Castiglione Morelli M. A., 1997, Journal of Peptide Research, V49, P492
   CASTIGLIONEMORE.MA, 1993, J BIOMOL STRUCT DYN, V11, P181
   CASTIGLIONEMORELLI A, 1990, INT J BIOL MACROMOL, V12, P363, DOI 10.1016/0141-8130(90)90044-B
   CHRISTIANO AM, 1994, J INVEST DERMATOL, V103, pS53, DOI 10.1111/1523-1747.ep12399044
   CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P
   Davidson JM, 1995, CIBA F SYMP, V192, P81
   DAVIDSON JM, 1990, ELASTIN CHEM BIOL AS
   DAVIDSON JM, 1997, ELASTIN ELASTIC TISS, P139
   DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099
   DEBELLE L, 1992, EUR BIOPHYS J BIOPHY, V21, P321
   EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11
   FAZIO MJ, 1991, AM J HUM GENET, V48, P696
   FLORY PJ, 1969, STAT MECH CHAIN MOL
   FOSTER JA, 1973, J BIOL CHEM, V248, P2876
   FOSTER JA, 1990, J GERONTOL, V45, pB113, DOI 10.1093/geronj/45.4.B113
   GOTTE L, 1972, Connective Tissue Research, V1, P61, DOI 10.3109/03008207209152057
   GUANTIERI V, 1980, INT J BIOL MACROMOL, V2, P68, DOI 10.1016/0141-8130(80)90030-6
   HEIM RA, 1991, MATRIX, V11, P359, DOI 10.1016/S0934-8832(11)80207-6
   HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   Hinek A., 1997, ELASTIN ELASTIC TISS, P75
   HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404
   HSUWONG S, 1994, J BIOL CHEM, V269, P18072
   INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680
   KAHARI VM, 1992, LAB INVEST, V66, P580
   KEELEY FW, 1989, ELASTIN ELASTASES, V11, P169
   Khakoo A, 1997, CLIN GENET, V51, P109
   KORNBERG RL, 1985, NEW ENGL J MED, V312, P771, DOI 10.1056/NEJM198503213121207
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   Lelj F., 1992, BIOPOLYMERS, V32, P159
   Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021
   LIPTAY M J, 1991, Surgical Forum (Chicago), V42, P287
   LONG MM, 1988, BIOCHIM BIOPHYS ACTA, V968, P300, DOI 10.1016/0167-4889(88)90021-3
   MAMMI M, 1970, NATURE, V225, P380, DOI 10.1038/225380a0
   MAMMI M, 1968, NATURE, V220, P371, DOI 10.1038/220371b0
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   MAUCH JC, 1994, MATRIX BIOL, V14, P635
   MEGRET C, 1992, INT J BIOL MACROMOL, V14, P45, DOI 10.1016/S0141-8130(05)80019-4
   MEGRET C, 1993, INT J BIOL MACROMOL, V15, P305, DOI 10.1016/0141-8130(93)90031-G
   OCONNOR WN, 1985, ARCH PATHOL LAB MED, V109, P179
   PARTRIDGE SM, 1964, BIOCHEM J, V93, pC30
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PIERCE RA, 1990, BIOCHEMISTRY-US, V29, P9677, DOI 10.1021/bi00493a024
   RAJU K, 1987, J BIOL CHEM, V262, P5755
   Robert L, 1995, CIBA F SYMP, V192, P286
   Robert L, 1989, ELASTIN ELASTASES, VII
   Robert L, 1985, FRONTIERS MATRIX BIO, V10, P92
   ROOS P, 1997, ELASTIN ELASTIC TISS, P145
   Rosenbloom J, 1995, CIBA F SYMP, V192, P59
   Sandberg LB, 1995, CIBA F SYMP, V192, P51
   SANDBERG LB, 1969, BIOCHEMISTRY-US, V8, P2940, DOI 10.1021/bi00835a037
   Schuster H G, 1995, DETERMINISTIC CHAOS
   SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   TAMBURRO AM, 1991, CHIRALITY, V3, P318, DOI 10.1002/chir.530030417
   TAMBURRO AM, 1982, INT J BIOL MACROMOL, V4, P111, DOI 10.1016/0141-8130(82)90035-6
   TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419
   TAMBURRO AM, 1978, J BIOL CHEM, V253, P2893
   TAMBURRO AM, 1991, ECOLOGICAL PHYSICAL CHEMISTRY, P391
   TAMBURRO AM, 1996, ADV BIOMEDICAL STUDI, V2, P135
   TAMBURRO AM, 1981, CONNECTIVE TISSUE RE, P45
   Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029
   UITTO J, 1990, ELASTIN CHEM BIOL AS, P303
   Urry D W, 1974, Adv Exp Med Biol, V43, P211
   URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   URRY DW, 1997, ELASTIN ELASTIC TISS, P11
   Villani V, 1997, J CHEM SOC PERK T 2, P2375, DOI 10.1039/a702217d
   VILLANI V, 1995, J BIOMOL STRUCT DYN, V12, P1173, DOI 10.1080/07391102.1995.10508806
   VILLANI V, 1994, J MOL STRUCT THEOCHE, V308, P141
   VILLANI V, 1997, ELASTIN ELASTIC TISS, P31
   WALKER GH, 1969, PHYS REV, V188, P416, DOI 10.1103/PhysRev.188.416
   WYDNER KS, 1994, GENOMICS, V23, P125, DOI 10.1006/geno.1994.1467
   YEH H, 1987, COLLAGEN REL RES, V7, P235
NR 83
TC 305
Z9 308
U1 1
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int J. Biochem. Cell Biol.
PD FEB
PY 1999
VL 31
IS 2
BP 261
EP 272
DI 10.1016/S1357-2725(98)00098-3
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 175WR
UT WOS:000079119300002
PM 10216959
DA 2018-10-19
ER

PT J
AU Kapur, R
   Calvert, JM
   Rudolph, AS
AF Kapur, R
   Calvert, JM
   Rudolph, AS
TI Electrical, chemical, and topological addressing of mammalian cells with
   microfabricated systems
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID MICROMACHINED SUBSTRATA; HUMAN FIBROBLASTS; CHARGED SURFACES; OUTGROWTH;
   ADHESION; INVITRO; GROWTH; DIFFERENTIATION; HEPATOCYTES; ORIENTATION
AB This communication describes our work in electrical, topological, and chemical micromodification of surfaces to modulate cellular form and function. We have addressed the surface physico-chemico-mechano properties of cell culture substrates that play a role in modulating cellular behavior. Single factorial model systems have been built using techniques adapted from microlithography. The tools and techniques of microfabrication, if harnessed and used correctly, can be enabling in elucidating the underlying principles and fundamental forces driving the cell-substrate interface. Additionally, the long-term practical applications of microfabrication in medicine and biomaterial/tissue engineering lie in enabling "communication" with living cells/tissues at the cellular and subcellular levels.
C1 George Mason Univ, Ctr Bioresource Dev, Fairfax, VA 22030 USA.
   USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.
RP Kapur, R (reprint author), CELLOMICS Inc, Pittsburgh, PA 15238 USA.
CR ALBRECHT RM, 1971, EXP CELL RES, V70, P230
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   BELOUSSOV LV, 1988, CELL DIFFER DEV, V25, P165, DOI 10.1016/0922-3371(88)90113-X
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Black J., 1992, BIOL PERFORMANCE MAT
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P1295
   DONALDSON K, 1975, LAB INVEST, V33, P469
   DUNN GA, 1986, J CELL SCI, V83, P313
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FORESTELL SP, 1992, BIOTECHNOL BIOENG, V39, P305, DOI 10.1002/bit.260390308
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Kapur R, 1998, EXP CELL RES, V244, P275, DOI 10.1006/excr.1998.4156
   Kapur R, 1996, J BIOMED MATER RES, V32, P133
   KAPUR R, 1993, BIOMATERIALS, V14, P854, DOI 10.1016/0142-9612(93)90007-O
   Kapur R, 1996, MATER RES SOC SYMP P, V414, P133
   Kapur R, 1996, J BIOMED MATER RES, V33, P205, DOI 10.1002/(SICI)1097-4636(199624)33:4<205::AID-JBM1>3.0.CO;2-T
   KAPUR R, 1995, THESIS CLEMSON U CLE, P163
   KARNOVSKY ML, 1982, PHAGOCYTOSIS PAST FU, P419
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   Lyklema J, 1991, FUNDAMENTALS INTERFA
   MAKOHLISO SA, 1993, J BIOMED MATER RES, V27, P1075, DOI 10.1002/jbm.820270813
   Marchant Roger E., 1994, P13
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MAROUDAS NG, 1977, J CELL PHYSIOL, V90, P511, DOI 10.1002/jcp.1040900314
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   PARAKKAL P, 1974, J ULTRASTRUCT RES, V4, P216
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   VALENTINI RF, 1993, J BIOMAT SCI-POLYM E, V5, P13
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   WEISS P, 1956, ANAT REC, V124, P381
   WYLLE CC, 1979, EXP CELL RES, V121, P315
NR 50
TC 25
Z9 25
U1 0
U2 1
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD FEB
PY 1999
VL 121
IS 1
BP 65
EP 72
DI 10.1115/1.2798044
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 170XE
UT WOS:000078831700011
PM 10080091
DA 2018-10-19
ER

PT J
AU Garner, B
   Georgevich, A
   Hodgson, AJ
   Liu, L
   Wallace, GG
AF Garner, B
   Georgevich, A
   Hodgson, AJ
   Liu, L
   Wallace, GG
TI Polypyrrole-heparin composites as stimulus-responsive substrates for
   endothelial cell growth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polypyrrole heparin; smart biomaterials; human endothelial cells;
   electroactive polymers; tissue engineering
ID ANTICOAGULANT PROPERTIES; IMMOBILIZED HEPARIN; HYBRID BIOMATERIALS;
   CONDUCTING POLYMERS; MECHANISM; THROMBIN; FILMS
AB Heparin is a potent anticoagulant which can be immobilized on biomaterial surfaces to increase their hemocompatability. In the present work, we have electrochemically synthesized composites comprising heparin and the electrically conducting polymer polypyrrole. The incorporation and exposure of heparin were controlled by varying key conditions of polymer synthesis (i.e., applied current and synthesis time). The resulting composite polymers were electroactive after synthesis and the amount of heparin exposed in the polymer could be increased (up to threefold) by switching the polymers from their oxidized to reduced states. Polymer reduction was achieved by either application of negative potentials (-0.4 to -0.7 V for 90 s) or exposure to aqueous reductant (0.1M sodium dithionite for 30 min). Heparin-polypyrrole composites remained stable after autoclaving, displaying no significant loss of electroactivity, and had a shelf life of at least 2 years postautoclaving. Finally, the composites were found to be excellent substrates for the growth of human endothelial cells. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2522, Australia.
   Univ Wollongong, Dept Chem, Biomol Res Ctr, Wollongong, NSW 2522, Australia.
   Univ Wollongong, Dept Chem, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
   Wollongong Hosp, Biopolymer Res Unit, Dept Haematol, Illawarra Reg Hlth Serv, Wollongong, NSW 2500, Australia.
RP Hodgson, AJ (reprint author), Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2522, Australia.
EM anthony_hodgson@uow.edu.au
RI Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273
CR Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408
   Byun Y, 1996, J BIOMED MATER RES, V30, P423, DOI 10.1002/jbm.820300403
   CLOWES AW, 1989, TRANSPLANT P, V21, P3700
   FLETCHER S, 1993, J CHEM SOC FARADAY T, V89, P311, DOI 10.1039/ft9938900311
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Hepel J, 1997, MICROCHEM J, V55, P179, DOI 10.1006/mchj.1996.1411
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   HODGSON AJ, 1994, SUPRAMOL SCI, V1, P77
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KHOR E, 1995, CARBOHYD POLYM, V26, P183, DOI 10.1016/0144-8617(95)00004-Q
   KHOR E, 1995, BIOMATERIALS, V16, P657, DOI 10.1016/0142-9612(95)93864-A
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   LI HC, 1994, POLYM INT, V35, P53, DOI 10.1002/pi.1994.210350105
   MACHOVICH R, 1975, BIOCHIM BIOPHYS ACTA, V412, P13, DOI 10.1016/0005-2795(75)90334-7
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Ozaki Y, 1996, PROG CARDIOVASC DIS, V39, P129, DOI 10.1016/S0033-0620(96)80022-3
   REN XM, 1993, J PHYS CHEM-US, V97, P5356, DOI 10.1021/j100122a029
   Seifert B, 1996, J MATER SCI-MATER M, V7, P465, DOI 10.1007/BF00705426
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   THOMPSON MM, 1994, EUR J VASCULAR SURG, V8, P423, DOI 10.1016/S0950-821X(05)80961-2
   WALLACE GG, 1993, CHEM BRIT, V29, P967
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   YAOITA M, 1988, BIOELECTROCH BIOENER, V20, P169, DOI 10.1016/S0302-4598(98)80014-7
NR 26
TC 155
Z9 159
U1 0
U2 34
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1999
VL 44
IS 2
BP 121
EP 129
DI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 144RN
UT WOS:000077329000001
PM 10397912
DA 2018-10-19
ER

PT J
AU Ekholm, M
   Hietanen, J
   Lindqvist, C
   Rautavuori, J
   Santavirta, S
   Salo, A
   Seppala, J
   Suuronen, R
AF Ekholm, M
   Hietanen, J
   Lindqvist, C
   Rautavuori, J
   Santavirta, S
   Salo, A
   Seppala, J
   Suuronen, R
TI Mixture of epsilon-caprolactone-lactide copolymer and tricalcium
   phosphate: a histological and immunohistochemical study of tissue
   reactions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DIFFERENTIAL DISTRIBUTION; NERVE GUIDE; TENASCIN; FIBRONECTIN;
   EXPRESSION; WOUNDS
AB In cranio-maxillofacial surgery, bone transplantation is needed for treatment of bony defects. An autograft, allograft or biomaterial can be used. Autogenous bone grafts are considered to be the best materials available, but there are some disadvantages in their use including donorsite morbidity, need for a second operative site and limited graft supply. A search for new bone-graft materials therefore remains necessary. We prepared a mixture of tricalcium phosphate (TCP), which is a resorbable, non-toxic, osteoconductive ceramic material and epsilon-caprolactone-lactide copolymer P(epsilon-CL/DL-LA), a resorbable polymer, and placed it in the dermis and in mandibular bone defects in 13 rabbits. Follow-up times were two, three, seven, eight, 12, 15 and 18 weeks, tissue reactions were assessed, histologically and immunohistochemically. Times of resorption of the material from tissues were reported. We found that the mixture caused a mild inflammatory reaction when placed in bone and severe inflammation when placed in dermis. No highly fluorescent layer of tenascin or fibronectin was found surrounding the implant area. The mixture was excellent to handle and very easy to place into bone defects. The results are promising and have led us to continue development of the mixture. (C) 1999 Kluwer Academic Publishers.
C1 Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.
   Univ Helsinki, Inst Dent, Dept Oral Pathol, Helsinki, Finland.
   Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
   Univ Helsinki, Cent Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
   Helsinki Univ Technol, Dept Chem Engn, FIN-02150 Espoo, Finland.
   Univ Helsinki, Inst Dent, Dept Oral & Maxillofacial Surg, FIN-00014 Helsinki, Finland.
   Univ Helsinki, Inst Biomed, Dept Anat, FIN-00014 Helsinki, Finland.
RP Ekholm, M (reprint author), Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Helsinki, Finland.
RI Seppala, Jukka/G-7698-2012
CR BETZ P, 1993, INT J LEGAL MED, V105, P325, DOI 10.1007/BF01222116
   CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139
   CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0
   DUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757
   DUNNEN WFA, 1993, MICROSURG, V14, P508
   Dunnen WFA, 1993, J MATER SCI-MATER M, V4, P521
   EKHOLM M, IN PRESS BIOMATERIAL
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   GIARDINO R, 1995, INT J ARTIF ORGANS, V18, P225
   GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237
   GOULD VE, 1992, LAB INVEST, V67, P71
   Hanft J R, 1995, Clin Podiatr Med Surg, V12, P437
   HEIKINHEIMO K, 1991, VIRCHOWS ARCH B, V61, P101
   HiljanenVainio MP, 1997, J BIOMED MATER RES, V34, P39, DOI 10.1002/(SICI)1097-4636(199701)34:1<39::AID-JBM6>3.0.CO;2-O
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   HOPPEN HJ, 1990, BIOMATERIALS, V11, P286, DOI 10.1016/0142-9612(90)90012-F
   HOWEEDY AA, 1990, LAB INVEST, V63, P798
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KONTIO R, UNPUB J MAT SCI MAT
   LUOMANEN M, 1993, J ORAL PATHOL MED, V22, P41, DOI 10.1111/j.1600-0714.1993.tb00118.x
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   NAKAMURA T, 1987, BIOMATERIALS CLIN AP, P759
   NAKAMURA T, 1992, DEGRADATION PHENOMEN, P153
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   SCHENK R, 1965, ACTA ANAT, V60, P3
   TIITTA O, 1995, ARCH ORAL BIOL, V40, P1039, DOI 10.1016/0003-9969(95)00071-V
   VARTIO T, 1987, J CELL SCI, V88, P419
NR 27
TC 7
Z9 7
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1999
VL 10
IS 2
BP 69
EP 74
DI 10.1023/A:1008912802263
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180RM
UT WOS:000079399000002
PM 15347927
DA 2018-10-19
ER

PT J
AU Rosengren, A
   Bjursten, LM
   Danielsen, N
   Persson, H
   Kober, M
AF Rosengren, A
   Bjursten, LM
   Danielsen, N
   Persson, H
   Kober, M
TI Tissue reactions to polyethylene implants with different surface
   topography
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DIFFERENT OXIDE THICKNESSES; COMMERCIALLY PURE TITANIUM; BONE RESPONSE;
   ELECTROPOLISHED IMPLANTS; ABDOMINAL-WALL; CELL-SHAPE; BIOMATERIAL;
   MACROPHAGE; INTEGRATION; INTERFACE
AB This study investigates the importance of implant surface topography on soft tissue response. The tissue response in the rat abdominal wall to discs of low density polyethylene with smooth to coarse surfaces was evaluated after one, six or 12 weeks. Capsule thickness and immunohistochemical quantification of monocytes-macrophages were used as measures. The macrophage specific antibody ED1 was used for identification of newly recruited macrophages and the ED2 antibody for the mature tissue macrophages. The smoother surfaces gave a thicker capsule than the rougher surfaces, and at one week also larger total numbers of cells and ED1 positive macrophages at interface. The capsule thickness increased over time for the smooth and intermediate surface topographies. In contrast, the cell numbers generally decreased over time. In conclusion, a coarse surface elicited lesser tissue reaction compared with a smooth surface, (C) 1999 Kluwer Academic Publishers.
C1 Univ Hosp MAS, Dept Expt Res, S-20502 Malmo, Sweden.
   Univ Lund Hosp, Dept Physiol & Neurosci, S-22185 Lund, Sweden.
   Univ Lund, Ctr Chem, Dept Chem Engn 2, S-22100 Lund, Sweden.
RP Rosengren, A (reprint author), Univ Hosp MAS, Dept Expt Res, S-20502 Malmo, Sweden.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P55
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Andrade J D, 1973, Med Instrum, V7, P110
   Baier R E, 1988, J Dent Educ, V52, P788
   BATRA M, 1995, PLAST RECONSTR SURG, V95, P354, DOI 10.1097/00006534-199502000-00016
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BRANEMARK PI, 1995, RECONSTRUCTIVE PREPR, P165
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   BRUNETTE DM, 1990, TISSUE INTEGRATION O, P21
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CAMBELL CE, 1989, J INVEST SURG, V2, P51
   Campoccia D, 1996, BIOMATERIALS, V17, P963, DOI 10.1016/0142-9612(96)84670-9
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   CARLSSON L, 1994, J ORTHOPAED RES, V12, P274, DOI 10.1002/jor.1100120218
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   COHEN J, 1961, J BONE JOINT SURG AM, V43, P687, DOI 10.2106/00004623-196143050-00006
   DIJKSTRA CD, 1985, IMMUNOLOGY, V55, P23
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   HOLM S, 1979, SCAND J STAT, V6, P65
   HONG HL, 1987, J CELL SCI, V87, P259
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MUSTER D, 1995, ENCY HDB BIOMATERI A, V1, P85
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   THERIN M, 1994, J BIOMED MATER RES, V28, P1267, DOI 10.1002/jbm.820281104
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Von Recum A.F., 1990, ADV BIOMATER, P297
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
NR 45
TC 24
Z9 24
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1999
VL 10
IS 2
BP 75
EP 82
DI 10.1023/A:1008964819101
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180RM
UT WOS:000079399000003
PM 15347928
DA 2018-10-19
ER

PT J
AU Lu, JX
   Flautre, B
   Anselme, K
   Hardouin, P
   Gallur, A
   Descamps, M
   Thierry, B
AF Lu, JX
   Flautre, B
   Anselme, K
   Hardouin, P
   Gallur, A
   Descamps, M
   Thierry, B
TI Role of interconnections in porous bioceramics on bone recolonization in
   vitro and in vivo
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HYDROXYAPATITE; CERAMICS; RABBITS
AB The interconnections in a porous biomaterial are the pathways between the pores. They conduct cells and vessels between pores. Thus they favour bone ingrowth inside ceramics. The aim of our study was to determine the effect on bone ingrowth of interconnections in two ceramics: hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP) with the same porosity of about 50% and a mean pores size of 100-300 mu m and a mean interconnection size of 30-100 mu m In vitro, four discs for osteoblast culture were studied after 14 and 28 days of incubation. The results show that human osteoblasts can penetrate interconnections over 20 mu m in size, and colonize and proliferate inside macropores, but the most favourable size is over 40 mu m. In vivo, eight cylinders were implanted in the middle shaft of both rabbit femurs for 12 or 24 weeks. The histomorphometric results show that interconnections in porous ceramics favour bone ingrowth inside the macropores. In the HA group the rate of calcification and bone ingrowth do not differ, and chondroid tissue is observed inside pores. But in beta-TCP, the calcification rate and the bone ingrowth increased significantly. At week 12 significant correlation between new bone ingrowth and the size of the interconnections is observed between new bone ingrowth and the density of pores. In conclusion we notice that in vivo a 20 mu m interconnection size only allows cell penetration and chondroid tissue formation; however the size of the interconnections must be over 50 mu m to favour new bone ingrowth inside the pores. We propose the concept of "interconnection density" which expresses the quantity of links between pores of porous materials. It assures cell proliferation and differentiation with blood circulation and extracellular liquid exchange. In resorbable materials, pore density and interconnection density are more important than their size, contrary to unresorbable materials in which the sizes and the densities are equally important. (C) 1999 Kluwer Academic Publishers.
C1 IRMS, F-62608 Berck Sur Mer, France.
   Univ Valenciennes & Hainaut Cambresis, Ctr Reg Innovat & Transfert Technol Ceram Fines, Lab Mat Avances & Ceram, F-59600 Maubeuge, France.
RP Lu, JX (reprint author), IRMS, Ru Docteur Calot, F-62608 Berck Sur Mer, France.
OI Anselme, Karine/0000-0002-6669-205X
CR EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   GALOIS L, 1990, ACTUALITES MAT, V3, P361
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   UCHIDA A, 1985, J ORTHOPAED RES, V3, P65, DOI 10.1002/jor.1100030108
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 10
TC 334
Z9 374
U1 3
U2 55
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1999
VL 10
IS 2
BP 111
EP 120
DI 10.1023/A:1008973120918
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180RM
UT WOS:000079399000007
PM 15347932
DA 2018-10-19
ER

PT J
AU Vasudev, SC
   Chandy, T
AF Vasudev, SC
   Chandy, T
TI Polyethylene glycol-grafted bovine pericardium: a novel hybrid tissue
   resistant to calcification
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CARDIAC-VALVE BIOPROSTHESES; MOLECULAR-WEIGHT; GLUTARALDEHYDE;
   MINERALIZATION; POLYURETHANE; BIOMATERIAL; INHIBITION; POROSITY; RATS
AB Calcification is a frequent cause of the clinical failure of bioprosthetic heart valves fabricated from glutaraldehyde pretreated bovine pericardium (GATBP). An investigation was made of the grafting of different molecular weight polyethylene glycol (PEG 600, 1500, 4000 and 6000) via glutaraldehyde (GA) linkages to bovine pericardium (BP) and of their stability and calcification. The process of the calcification profile was studied by in vitro experiments via incubating pericardial samples in a metastable solution of calcium phosphate. Calcification of bovine pericardium grafted with PEG 6000 was significantly decreased compared to low molecular weight PEG grafts or Sodium dodecyl sulphate- (SDS) and GA-treated tissues. The mechanical properties of these modified tissues after enzyme (Trypsin) digestion and calcification were investigated. The biocompatibility aspects of grafted tissues were also established by monitoring the platelet adhesion, octane contact angle and water of hydration. PEG 6000-grafted tissues retained the maximum strength in trypsin buffer and calcium phosphate solutions. Scanning electron micrographs revealed that the PEG-grafted bovine pericardium had substantially inhibited the platelet-surface attachment and their spreading. It is conceivable that high molecular weight polyethylene glycol-grafted pericardium (a hybrid tissue) may be a suitable calcium-resistant material for developing prosthetic valves due to their stability and biocompatibility. (C) 1999 Kluwer Academic Publishers.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
RP Chandy, T (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
CR *ASTM, 1982, ANN BOOK ASTM STAND, P250
   BAGNALL RD, 1980, J BIOMED MATER RES, V14, P1, DOI 10.1002/jbm.820140102
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   CHANDY T, 1994, J APPL BIOMATER, V5, P245, DOI 10.1002/jab.770050310
   CHANDY T, 1984, THROMB RES, V33, P105, DOI 10.1016/0049-3848(84)90171-3
   CHANDY T, 1991, BIOMATERIALS, V12, P677, DOI 10.1016/0142-9612(91)90116-R
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DOILLON CJ, 1994, J BIOMAT SCI-POLYM E, V6, P715
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1992, J MATER SCI-MATER M, V3, P272, DOI 10.1007/BF00705292
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   MARGUERIE GA, 1982, J BIOL CHEM, V257, P1872
   PASQUINO E, 1992, J MATER SCI-MATER M, V3, P272
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   ROSANOVA IB, 1991, J BIOMED MATER RES, V25, P277, DOI 10.1002/jbm.820250213
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
NR 21
TC 9
Z9 9
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1999
VL 10
IS 2
BP 121
EP 128
DI 10.1023/A:1008925204988
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180RM
UT WOS:000079399000008
PM 15347933
DA 2018-10-19
ER

PT J
AU Gniadecka, M
   Edwards, HGM
   Hansen, JPH
   Nielsen, OF
   Christensen, DH
   Guillen, SE
   Wulf, HC
AF Gniadecka, M
   Edwards, HGM
   Hansen, JPH
   Nielsen, OF
   Christensen, DH
   Guillen, SE
   Wulf, HC
TI Near-infrared Fourier transform Raman spectroscopy of the mummified skin
   of the alpine Iceman, Qilakitsoq Greenland mummies and Chiribaya mummies
   from Peru
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
AB Near-infrared Fourier transform (NIR-FT) Raman spectroscopy was employed to compare archaeological skin samples of a late Neolithic man (5200 BP) preserved in a glacial field in the Alps (the Iceman), skin of fifteenth century mummies preserved at low temperature and dry air in stone graves in Qilakitsoq, Greenland, and skin samples from mummified bodies from the Chiribaya culture from the Southern Peruvian desert (1000 up), In all the spectra of mummified skin, a progressive loss of protein amide I (1640-1680 cm(-1)) and amide III (1220-1290 cm(-1)) band intensities was found, indicating either loss of protein or changes in the secondary protein structure. Thus, the observed changes or degradation in protein structure in the samples of the 500-year-old skin of the Qilakitsoq mummy and the 1000-year-old skin of Chiribaya mummies hare been observed to be broadly similar to those found in the 5200-year-old Iceman. This implies that most changes in the molecular structure of the skin take place in a relatively short time interval during the natural mummification process. The spectra of lightly pigmented Peruvian mummies showed a relatively strong peak near 1300 cm(-1) and an increased intensity of the nu(CH) peak at 2850 cm(-1). The band near 1300 cm(-1) is characteristic of twisting and wagging CH, vibrations in lipids and the 2850 cm(-1) band represents lipid CH stretching vibrations. These spectral changes suggest an increased lipid content in lightly pigmented Peruvian mummy skin compared with contemporary skin and the skin of the mummies preserved in ice. We ascribe this increased lipid intensity in the skin of the Peruvian mummies to embalming, by which means a better preservation is achieved. In conclusion, NIR-FT-Raman spectroscopy has potential use for the non-destructive chemical analysis of archaeological biomaterial, By using this technique it is possible to assess the degree of protein degradation and also to provide an analysis of embalming materials employed for the mummification processes. Copyright (C) 1999 John Wiley & Sons, Ltd.
C1 Bispebjerg Hosp, Dept Dermatol D92, DK-2100 Copenhagen, Denmark.
   Univ Bradford, Dept Chem & Forens Sci, Bradford BD7 1DP, W Yorkshire, England.
   Gentofte Hosp, Dept Pathol, DK-2900 Hellerup, Denmark.
   Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.
   Bioanthropol Fdn Peru, Ctr Mallqui, Ilo, Peru.
RP Gniadecka, M (reprint author), Bispebjerg Hosp, Dept Dermatol D92, Bispebjerg Bakke 23, DK-2100 Copenhagen, Denmark.
RI Nielsen, Ole/D-8980-2015
OI Nielsen, Ole/0000-0001-8839-8671
CR AMMITZBOLL T, 1989, MEDDELELSER GRONLAND, V12, P93
   EDWARDS HGM, 1995, J CHEM SOC FARADAY T, V91, P1883
   Gniadecka M, 1997, J RAMAN SPECTROSC, V28, P179
   Hansen J.P.H., 1991, GREENLAND MUMMIES
   KOBAYASI T, 1989, MUMMIES QILAKISTSOQ, V12, P100
   Lawson EE, 1997, J RAMAN SPECTROSC, V28, P111, DOI 10.1002/(SICI)1097-4555(199702)28:2/3<111::AID-JRS87>3.0.CO;2-Z
   Lin-Vien D., 1991, HDB INFRARED RAMAN C, P9, DOI [DOI 10.1016/B978-0-08-057116-4.50008-0, 10. 1016/B978-0-08-057116-4. 50008-0]
   Liu C. H., 1991, Proceedings of the SPIE, V1599, P77, DOI 10.1117/12.2322310
   MANOR D, 1991, BIOCHEMISTRY-US, V30, P10914, DOI 10.1021/bi00109a015
   THOMAS GJ, 1976, J MOL BIOL, V102, P103, DOI 10.1016/0022-2836(76)90076-0
   TU T, 1986, SPECTROSCOPY BIOL SY, P47
   WILLIAMS AC, 1995, BBA-PROTEIN STRUCT M, V1246, P98, DOI 10.1016/0167-4838(94)00189-N
NR 12
TC 21
Z9 21
U1 0
U2 10
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD FEB
PY 1999
VL 30
IS 2
BP 147
EP 153
DI 10.1002/(SICI)1097-4555(199902)30:2<147::AID-JRS370>3.0.CO;2-E
PG 7
WC Spectroscopy
SC Spectroscopy
GA 179GQ
UT WOS:000079318500011
DA 2018-10-19
ER

PT J
AU Song, Y
   Xu, DS
   Yang, R
   Li, D
   Wu, WT
   Guo, ZX
AF Song, Y
   Xu, DS
   Yang, R
   Li, D
   Wu, WT
   Guo, ZX
TI Theoretical study of the effects of alloying elements on the strength
   and modulus of beta-type bio-titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT DOE Panel on Time-Dependent Interfacial Decohesion
CY JUN 24-27, 1997
CL GREAT OAKS LANDING, MARYLAND
DE electronic simulation; alloy design; titanium; strength; modulus;
   biomaterial
ID SITE OCCUPANCY
AB Titanium alloys are favorable implant materials for orthopedic applications, due to their desirable mechanical properties and biochemical compatibility (or bio-inertness). However, current bio-titanium alloys still possess too high an elastic modulus compared with that of the bone, which can lead to premature failure of the implant. Here, a theoretical methodology for the design and development of low modulus Ti alloys and/or structures is provided by means of electronic structural calculations using the discrete variational cluster method (DVM). The preliminary study concentrated on two beta-Ti atomic clusters consisting of 15, and 27 atoms, respectively. The binding energies between titanium and various alloying atoms within the clusters were first calculated, from which strength and modulus were then estimated. The results of the calculation suggested that Nb, Mo, Zr and Ta were suitable alloying elements for beta-type titanium alloys, capable of enhancing the strength and reducing the modulus of the materials. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Univ London Queen Mary & Westfield Coll, Dept Mat, IRC Biomat, London E1 4NS, England.
   Chinese Acad Sci, Inst Met Res, Shenyang 110015, Peoples R China.
   Chinese Acad Sci, Inst Corros & Protect Met, State Key Lab Corros & Protect, Shenyang 110015, Peoples R China.
RP Guo, ZX (reprint author), Univ London Queen Mary & Westfield Coll, Dept Mat, IRC Biomat, Mile End Rd, London E1 4NS, England.
RI Xu, Dongsheng/F-6399-2012; Guo, Zheng Xiao/C-1706-2009
OI Guo, Zheng Xiao/0000-0001-5404-3215
CR ARMSTRONG PE, 1964, T METALL SOC AIME, V230, P962
   DAVIDSON JA, 1989, Patent No. 61560
   Ellis DE, 1970, PHYS REV B-SOLID ST, V2, P2887, DOI 10.1103/PhysRevB.2.2887
   HIGO Y, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P421
   KURODA D, 1977, IN PRESS MAT SCI E A
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
   Sandera P, 1997, MAT SCI ENG A-STRUCT, V234, P370, DOI 10.1016/S0921-5093(97)00170-6
   Seiler H., 1994, HDB METALS CLIN ANAL
   SONG Y, 1997, IN PRESS INTERMETALL, V5
   SONG Y, 1997, THESIS CHINESE ACAD
   STEINEMANN SG, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2689
   WANG K, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2697
   Xu DS, 1997, MAT SCI ENG A-STRUCT, V234, P230, DOI 10.1016/S0921-5093(97)00222-0
   Xu DS, 1997, PHILOS MAG A, V75, P1185
   ZWICKER U, 1986, Z METALLKD, V77, P714
NR 15
TC 140
Z9 156
U1 0
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD FEB
PY 1999
VL 260
IS 1-2
BP 269
EP 274
DI 10.1016/S0921-5093(98)00886-7
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 168HJ
UT WOS:000078685900029
DA 2018-10-19
ER

PT J
AU Oerther, S
   Payan, E
   Lapicque, F
   Presle, N
   Hubert, P
   Muller, S
   Netter, P
   Lapicque, F
AF Oerther, S
   Payan, E
   Lapicque, F
   Presle, N
   Hubert, P
   Muller, S
   Netter, P
   Lapicque, F
TI Hyaluronate-alginate combination for the preparation of new
   biomaterials: investigation of the behaviour in aqueous solutions
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE sodium alginate; sodium hyaluronate; viscosity measurement; circular
   dichroism; polysaccharide interaction
ID GEL BEADS; DELIVERY; POLYSACCHARIDES; CHITOSAN; RELEASE; ACID
AB With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated. Crossed techniques were used to assess the existence of polymer interactions in aqueous solutions up to 20 mg/ml. Alginate was obtained from algae and hyaluronate was purified from rooster comb. Viscometry measurements using the capillary technique or the Couette flow, together with circular dichroism investigations, evidenced the moderate significance of interactions between the two polysaccharides in dilute solutions. In addition, the case of more concentrated solutions and containing 20 mg/ml alginate was approached by rheological measurements in the flow mode; the behaviour of the polymer associations appeared as a compromise between those of individual polysaccharides. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 CNRS UHP Nancy 1, UMR 7561, Pharmacol Lab, F-54505 Vandoeuvre Nancy, France.
   Fac Med Vandoeuvre Nancy, FR CNRS W0070, F-54505 Vandoeuvre Nancy, France.
   INPL, ENSIC, CNRS, Lab Sci Genie Chim, F-54001 Nancy, France.
   INPL, ENSIC, FR CNRS W0070, F-54001 Nancy, France.
   INPL, CNRS, UMR 7568, F-54001 Nancy, France.
   Fac Med Vandoeuvre Nancy, UHP Nancy 1, Hematol Lab, F-54505 Vandoeuvre Nancy, France.
RP Netter, P (reprint author), CNRS UHP Nancy 1, UMR 7561, Pharmacol Lab, BP 184, F-54505 Vandoeuvre Nancy, France.
EM lapicque@facmed.u-nancy.fr
CR BALAZS EA, 1993, J RHEUMATOL, V20, P3
   BALAZS EA, 1958, FED PROC, V17, P1086
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   BUECHE F, 1954, J CHEM PHYS, V22, P1570, DOI 10.1063/1.1740460
   BURD DAR, 1991, BRIT J PLAST SURG, V44, P579, DOI 10.1016/0007-1226(91)90093-Y
   CLAYTON HA, 1991, J MICROENCAPSUL, V8, P211
   CLELAND RL, 1970, BIOPOLYMERS, V9, P799, DOI 10.1002/bip.1970.360090706
   Fuongfuchat A, 1996, CARBOHYD RES, V284, P85, DOI 10.1016/0008-6215(95)00396-7
   FUOSS RM, 1948, J POLYM SCI, V3, P603, DOI 10.1002/pol.1948.120030414
   Garcia AM, 1996, J CONTROL RELEASE, V40, P179, DOI 10.1016/0168-3659(95)00179-4
   GOLUB MA, 1957, CAN J CHEM, V35, P381, DOI 10.1139/v57-056
   GOTO M, 1993, INT J CLIN PHARM RES, V13, P161
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   HUME LR, 1990, PHARMACEUT RES, pS174
   JOHNSON WC, 1987, ADV CARBOHYD CHEM BI, V45, P73, DOI 10.1016/S0065-2318(08)60137-7
   MALSON T, 1986, Patent No. 8600079
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MIYAZAKI S, 1994, BIOL PHARM BULL, V17, P745
   MORRIS ER, 1980, J MOL BIOL, V138, P383, DOI 10.1016/0022-2836(80)90294-6
   Murata Y, 1996, J CONTROL RELEASE, V38, P101, DOI 10.1016/0168-3659(95)00098-4
   Nishimura M, 1998, BBA-GEN SUBJECTS, V1380, P1, DOI 10.1016/S0304-4165(97)00119-0
   OERTHER S, 1998, THESIS U H POINCARE
   OERTHER S, 1998, ACTUALITES BIOMATERI, P413
   OSTBERG T, 1994, INT J PHARM, V112, P241, DOI 10.1016/0378-5173(94)90360-3
   PARK JW, 1978, BIOCHIM BIOPHYS ACTA, V544, P667, DOI 10.1016/0304-4165(78)90341-0
   RAJAONARIVONY M, 1993, J PHARM SCI, V82, P912, DOI 10.1002/jps.2600820909
   SCHIAVINATO A, 1989, CLIN ORTHOP RELAT R, P286
   SMIDSROD O, 1970, CARBOHYD RES, V13, P359, DOI 10.1016/S0008-6215(00)80593-5
   STICKLER M, 1989, POLYM HDB, P183
   STONE AL, 1969, BIOPOLYMERS, V7, P173, DOI 10.1002/bip.1969.360070204
   YOTSUYANAGI T, 1987, CHEM PHARM BULL, V35, P1555
NR 33
TC 19
Z9 19
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JAN 4
PY 1999
VL 1426
IS 1
BP 185
EP 194
DI 10.1016/S0304-4165(98)00155-X
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 163AZ
UT WOS:000078381200018
PM 9878730
DA 2018-10-19
ER

PT B
AU Huys, L
   van Hecke, E
AF Huys, L
   van Hecke, E
BE Bochlogyros, PN
TI Implant placement in ridges grafted with three different alloplasts
SO 5TH MEDITERRANEAN CONGRESS OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Proceedings Paper
CT 5th Mediterranean Congress of Oral and Maxillofacial Surgery
CY JUN 16-20, 1999
CL TERRASINI, ITALY
ID HTR POLYMER; HYDROXYAPATITE; BIOMATERIAL
AB Bone grafting has become an extra 'instrument' in preventing alveolar bone loss after extraction(s). Clinicians can choose from a wide range of graft options, but more and more they have to include in their treatment planning possible future implant placement. We tried to establish the implant possibilities in ridges, treated with three well known alloplasts, wether or not those alloplasts offer to our profession identical possibilities and predictable and successful results. We saw that in spite of the advantages claimed - and described in the literature - by each one, the possibilities and results differ a lot. Therefore, we should base our selection of (any) graft material not only on the physical and chemical properties of this graft, but also on the consideration if we jeopardize future implant placement by our choice.
C1 Gen Hosp Queen Fabiola, Dept Oral Implantol, Blankenberge, Belgium.
RP Huys, L (reprint author), Gen Hosp Queen Fabiola, Dept Oral Implantol, Blankenberge, Belgium.
CR Ashman A, 1982, J Oral Implantol, V10, P419
   ASHMAN A, 1997, J PROSTHET DENT, V37, P657
   Binderman I, 1988, ASTM SPECIAL TECH PU, V3, P370
   Boyne P, 1988, COMP, V10, P337
   BOYNE P, 1998, COMPEND CONT ED DENT, P337
   BOYNE P, 1995, GEN DENT         SEP, P470
   Christensen GJ, 1996, J AM DENT ASSOC, V127, P669, DOI 10.14219/jada.archive.1996.0279
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   Gross J S, 1997, Compend Contin Educ Dent, V18, P1013
   Gross Jeffrey, 1995, General Dentistry, V43, P364
   HURZELLER M, 1997, OSTEOLOGY NEWS, V1, P12
   ISAKSSON S, 1993, INT J ORAL MAX SURG, V22, P375, DOI 10.1016/S0901-5027(05)80673-3
   Lane JM, 1995, WESTERN J MED, V163, P565
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   Murray V K, 1988, Compend Suppl, pS342
   Schmier MG, 1989, 15 ANN M SOC BIOM FL
   STAHL SS, 1990, J PERIODONTOL, V61, P269, DOI 10.1902/jop.1990.61.5.269
   Tatum O H Jr, 1996, J Oral Implantol, V22, P51
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   YUKNA RA, 1992, J BIOMED MATER RES, V26, P517, DOI 10.1002/jbm.820260408
   YYKNA RA, 1994, J PERIODONTOL, V65, P342
NR 21
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
PY 1999
BP 121
EP 125
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA BN26A
UT WOS:000081376700020
DA 2018-10-19
ER

PT B
AU Machtens, E
   Eufinger, H
AF Machtens, E
   Eufinger, H
BE Bochlogyros, PN
TI Results of 88 individual CAD CAM titanium cranioplasties 5 years
SO 5TH MEDITERRANEAN CONGRESS OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Proceedings Paper
CT 5th Mediterranean Congress of Oral and Maxillofacial Surgery
CY JUN 16-20, 1999
CL TERRASINI, ITALY
ID CRANIOFACIAL SURGERY; SKULL; RECONSTRUCTION; PROSTHESES; IMPLANTS;
   DEFECTS
AB Reconstruction of craniofacial defects by intraoperative implant modeling may fail to create harmonic contours with long-term stability. Therefore computes aided design and manufacturing (CAD/CAM)-techniques were transferred for the preoperative modeling and fabrication of titanium implants.
   Helical CT-data create computer-based 3D models of the defect serving for a free-form surfaces design of the implant including fixation-plates. Thus individual model fabrication is abandoned. The implants' precise and individual fit results from generating its margins by the defect borders, whereas their surface is generated by the neighbouring contours. These geometric data run a milling machine to fabricate the titanium implant.
   The 5-years clinical experience with this new method includes 88 cranioplasties, 32 of the forehead, at 22 different centres with defects up to 22 cm. All implants proved to fit precisely and all but 2 were clinically successful although in more than half of the patients other techniques of reconstruction had failed before.
   This new technique represents an efficient, time and cost saving method, which is standardized reliably concerning the technological processing-chain. Clinically it proves to be superior to other reconstruction techniques as it diminishes the stress on the patient by the ideal preparation of the preferred biomaterial, titanium. Furthermore, the aesthetic result is perfectly predictable.
C1 Knappschaftskrankenhaus Univ Hosp, Dept Oral & Maxillofacial Surg, Bochum, Germany.
RP Machtens, E (reprint author), Knappschaftskrankenhaus Univ Hosp, Dept Oral & Maxillofacial Surg, Bochum, Germany.
CR BLAKE GB, 1990, BRIT J PLAST SURG, V43, P528, DOI 10.1016/0007-1226(90)90115-G
   Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002
   EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7
   EUFINGER H, 1995, J CRANIO MAXILL SURG, V23, P175, DOI 10.1016/S1010-5182(05)80007-1
   JOFFE JM, 1993, BRIT J ORAL MAX SURG, V31, P144, DOI 10.1016/0266-4356(93)90112-A
   KOERLOFF B, 1973, PLAST RECONSTR SURG, V52, P378
   LAMBRECHT JT, 1990, CLEFT PALATE J, V27, P382, DOI 10.1597/1545-1569(1990)027<0382:ISMFFC>2.3.CO;2
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002
   WEHMOLLER M, 1995, INT J ORAL MAX SURG, V24, P90, DOI 10.1016/S0901-5027(05)80868-9
   ZONNEVELD FW, 1994, INVEST RADIOL, V29, P716, DOI 10.1097/00004424-199407000-00009
NR 11
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
PY 1999
BP 135
EP 140
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA BN26A
UT WOS:000081376700022
DA 2018-10-19
ER

PT J
AU Stark, PC
   Rayson, GD
   Darnall, DW
AF Stark, PC
   Rayson, GD
   Darnall, DW
TI Survey of non-viable biosorbents for toxic metal removal
SO ADVANCES IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE metal binding; non-viable biomaterials; biosorption
ID IMMOBILIZED PERSIMMON TANNIN; DATURA-INNOXIA BIOMATERIAL; BINDING-SITES;
   EU(III) LUMINESCENCE; ALGAL BIOMASS; URANIUM; RECOVERY;
   PRECONCENTRATION; ACCUMULATION; CELLS
AB The ability of several biologically generated materials to bind representative heavy metals has been investigated. These materials included freeze dried tissues from the roots, stems, and leaves of young and mature tumble weeds (Salsola sp.), the stems and roots of cattails (Typha latifolia), a green alga (Chlorella vulgaris), sphagnum peat, organic peat, pecan shells, and fragments of cultured cells from Datura innoxia. Metal ions representative of hard (Al(III)), intermediate (Cu(II)), and soft (Au(III)) Lewis acids were monitored for their binding to each of these materials to hard, intermediate, and soft Lewis base ligands, respectively. Each of these materials was immobilized in a polysilicate matrix. Superior binding (>90% of a 0.1 mM contact solution) of the three metals was observed by the immobilized C. vulgaris, D. innoxia, sphagnum peat, and organic peat at solution pH conditions of 5-6.
C1 New Mexico State Univ, Dept Biochem & Chem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Biochem & Chem, Box 30001,Dept 3C, Las Cruces, NM 88003 USA.
CR DARNALL D, 1991, BIOL PROCESSES, pCH38
   DARNALL D W, 1986, P1
   Darnall D. W., 1988, BIOHYDROMETALLURGY, P487
   DARNALL DW, 1989, P 1989 A WMA EPA INT, P114
   DARNALL DW, 1991, Patent No. 4992207
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   GREENE B, 1988, Biorecovery, V1, P27
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   GREENE B, 1986, P INT S MET SPEC SEP, P53
   GREENE B, 1986, MICROBIAL MINERAL RE, pCH12
   KE HYD, 1993, APPL SPECTROSC, V47, P44, DOI 10.1366/0003702934048569
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   MAHAN CA, 1992, SPECTROCHIM ACTA B, V47, P1483, DOI 10.1016/0584-8547(92)80138-7
   MAHAN CA, 1992, ANAL CHEM, V64, P1933, DOI 10.1021/ac00041a031
   MITANI T, 1992, BIOSCI BIOTECH BIOCH, V56, P985, DOI 10.1271/bbb.56.985
   NAKAJIMA A, 1993, J CHEM TECHNOL BIOT, V57, P321
   NAKAJIMA A, 1993, APPL MICROBIOL BIOT, V38, P574
   NAKAJIMA A, 1990, BIOMASS, V21, P55, DOI 10.1016/0144-4565(90)90047-N
   NAKAJIMA A, 1994, J RADIOAN NUCL CH AR, V178, P319, DOI 10.1007/BF02039725
   PEAVY HS, 1985, ENV ENG, P54
   SAKAGUCHI T, 1987, SEPAR SCI TECHNOL, V22, P1609, DOI 10.1080/01496398708058421
   SAKAGUCHI T, 1994, SEPAR SCI TECHNOL, V29, P205, DOI 10.1080/01496399408002478
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   Toles CA, 1997, CARBON, V35, P1407, DOI 10.1016/S0008-6223(97)00073-0
   *US DEP INT, 1988, 9183 US DEP INT, V1, P22
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   Xia HY, 1998, ENVIRON SCI TECHNOL, V32, P2688, DOI 10.1021/es980171s
   ZHOU JL, 1991, J CHEM TECHNOL BIOT, V52, P317
   1975, FED REG       4 1224
NR 34
TC 0
Z9 0
U1 1
U2 3
PU NELSON & COMMONS COMMUNICATIONS
PI BERKELEY
PA 1620 ACTON STREET, BERKELEY, CA 94702 USA
SN 1093-0191
J9 ADV ENVIRON RES
JI Adv. Environ. Res.
PY 1999
VL 3
IS 1
PG 10
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 239YD
UT WOS:000082797300006
DA 2018-10-19
ER

PT B
AU Ito, Y
AF Ito, Y
BE Ikura, K
   Nagao, M
   Masuda, S
   Sasaki, R
TI Cell culture engineering using intelligent biomaterials
SO ANIMAL CELL TECHNOLOGY: CHALLENGES FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT 1998 Joint International Meeting of the
   Japanese-Association-for-Animal-Cell-Technology/European-Society-for-Ani
   mal-Cell-Technology (JAACT/ESACT)
CY JUL 26-30, 1998
CL KYOTO, JAPAN
SP Japanese Assoc Anim Cell Technol, European Soc Anim Cell Technol
DE tissue engineering; intelligent material; biomaterial; immobilization;
   growth factor
ID ARTIFICIAL JUXTACRINE STIMULATION; COVALENTLY IMMOBILIZED INSULIN;
   EPIDERMAL GROWTH-FACTOR; ENHANCEMENT; ADHESION
AB Growth factor proteins were covalently immobilized on various matrices to manipulate cells. It was shown that insulin and epidermal growth factor stimulated cell growth even after immobilization. Pattern-immobilization of growth factor proteins clearly demonstrated the stimulation by immobilized proteins. In other words, this type of stimulation by non-diffussional growth factors enabled us to regulate tissue formation with artificial biomaterials. These stimulations by the immobilized growth factors may mimick juxtacrine stimulation of membrane-anchored growth factors such as heparin-binding epidermal growth factor, transforming growth factor, and tumor nectrosis factor. The stimulation was enhanced by coimmobilization with adhesion factors. In addition, by coimmobilization with thermosensitive polymers enabled the enhancement of cell growth and easy recovery of cultured cells by lowering temperature.
C1 NAIST, Grad Sch Mat Sci, Ikoma 6300101, Japan.
RP Ito, Y (reprint author), NAIST, Grad Sch Mat Sci, Ikoma 6300101, Japan.
CR CHEN G, 1998, IN PRESS J BIOMED MA
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P106, DOI 10.1021/bc960068x
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chen GP, 1997, BIOTECHNOL BIOENG, V53, P339
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, J BIOMAT SCI-POLYM E, V9, P879, DOI 10.1163/156856298X00217
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   Ito Y, 1996, BIOTECHNOL PROGR, V12, P700, DOI 10.1021/bp9600602
   ITO Y, 1997, ADV BIOMATERIALS SCI, P421
   Ito Yoshihiro, 1998, Japanese Journal of Artificial Organs, V27, P541
   LI JS, 1997, J BIOMED MATER RES, V31, P190
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-5805-8
PY 1999
BP 171
EP 175
PG 5
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA BP18F
UT WOS:000084339700031
DA 2018-10-19
ER

PT J
AU Puleo, DA
AF Puleo, DA
TI Release and retention of biomolecules in collagen deposited on
   orthopedic biomaterials
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
ID BONE; CELLS
AB Delivery of osteotropic biomolecules directly to the bone-implant interface can alter initial interactions between tissue and biomaterial. To this end, type I collagen coatings containing a model biomolecule, lysozyme, were deposited on Co-Cr-Mo and Ti-6Al-4V. Two deposition methods were examined. In the first, lysozyme was deposited concurrently with collagen, while in the second, protein was impregnated into previously deposited collagen coatings. The amount of collagen and the amount of lysozyme loaded into collagen were varied to provide different amounts of weakly and strongly bound protein. Release and retention of lysozyme were monitored over a 7 d period of incubation in physiological saline. For both methods, larger amounts of collagen in the coatings allowed incorporation of more lysozyme. Additionally, loading collagen coatings with greater amounts of lysozyme resulted in release of more protein. During the first 24-96 h of incubation, loosely bound protein was eluted, resulting in release of 2 mu g to 55 mg (5-75% of the amount available) of enzymatically active lysozyme. This left 25-95% of the protein bound to the collagen-coated biomaterials and, thus, available for later release during degradation of the collagen.
C1 Univ Kentucky, Ctr Biomed Engn, Wenner Gren Inst, Lexington, KY 40506 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Inst, Lexington, KY 40506 USA.
CR Holt LJ, 1996, ARTIF CELL BLOOD SUB, V24, P613, DOI 10.3109/10731199609118886
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   NODA M, 1987, J CELL PHYSIOL, V133, P426, DOI 10.1002/jcp.1041330303
   Ollis D F, 1976, Methods Enzymol, V44, P444
   PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Vieth W R, 1976, Methods Enzymol, V44, P243
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
NR 9
TC 9
Z9 10
U1 0
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 1999
VL 27
IS 1
BP 65
EP 75
DI 10.3109/10731199909117484
PG 11
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 164NR
UT WOS:000078470900006
PM 10063439
DA 2018-10-19
ER

PT J
AU Wilke, A
   Landgraff, M
   Orth, J
   Poenitz, H
   Kienapfel, H
   Boelte, K
   Griss, P
   Franke, RP
AF Wilke, A
   Landgraff, M
   Orth, J
   Poenitz, H
   Kienapfel, H
   Boelte, K
   Griss, P
   Franke, RP
TI Human bone marrow cell culture: A sensitive method for determination of
   the biocompatibility of implant materials
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE biocompatibility; human cell culture; biomaterial
ID BIOMATERIALS; OSTEOBLASTS; CERAMICS; GROWTH
AB The objective of this study was to develop a test method for determining the cytotoxicity and biocompatibility of various biomaterials that are used in orthopaedic surgery. This method is based on the use of a human bone marrow cell culture and was developed as an alternative to animal experiments. Human bone marrow cell culture has certain advantages over other cell culture models, as its results show a greater conformity with animal experimental results and clinical studies. Primary cell adherence, cell number, cell proliferation, production of extracellular matrix, cell viability and cell differentiation were used as indicative parameters of biocompatibility. After 2 weeks in culture, differences could be observed between the biomaterials with respect to these parameters. Cell numbers were greatest on the hydroxyapatite ceramic specimens, but were decreased on the titanium alloy specimens. Extracellular matrix hydroxyapatite production was high for ceramics, but reduced for titanium specimens. The polymers allowed only a few cells to adhere, and there were no signs of extracellular matrix production. The influence of biomaterials on differentiation of large numbers of cells was analysed by using flow cytophotometry. There were similar populations of T cells and monocytes on all specimens. However, extended B cell and granulocyte populations were observed with titanium and polyethylene.
C1 Univ Marburg, Dept Orthopaed, D-35033 Marburg, Germany.
   Univ Ulm, Dept Biomat, D-89081 Ulm, Germany.
RP Wilke, A (reprint author), Univ Marburg, Dept Orthopaed, Baldingerstr, D-35033 Marburg, Germany.
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   GRISS P, 1993, Z ORTHOP GRENZGEB, V131, P488, DOI 10.1055/s-2008-1040059
   HARMAND MF, 1986, BIOL BIOMECHANICAL P, P361
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JACOBY V, 1989, THESIS U MARBURG GER, P50
   KALLA P, 1991, BEHRING I MITT, V90, P93
   LAMBRECHT JT, 1990, DEUT ZAHNAERZTL Z, V45, P82
   MAROUDAS NG, 1973, EXP CELL RES, V81, P104, DOI 10.1016/0014-4827(73)90116-X
   NOLAN PC, 1992, J BONE JOINT SURG BR, V74, P284
   ORTH J, 1990, ADV BIOMAT, V9, P283
   ORTH J, 1991, T 1 C EUR SOC ORTH R
   ORTH J, 1991, BIOCERAMICS HUMAN BO, P303
   ORTH J, 1991, BIOCERAMICS HUMAN BO, P373
   ORTH J, 1992, HEFTE UNFALLHEILKD, V225, P613
   SCHACHTSCHABEL DO, 1976, EUR SURG RES, V8, P71, DOI 10.1159/000127849
   UCHIDA A, 1987, J BIOMED MATER RES, V21, P1, DOI 10.1002/jbm.820210106
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   WILKE A, 1993, Z ORTHOP GRENZGEB, V131, P370, DOI 10.1055/s-2008-1040042
   WILKE A, 1992, T 4 WORLD BIOM C BER, P162
   WILKE A, 1991, BIOCERAMICS HUMANB O, P471
   WISNACK RE, 1973, BIOMATERIALS MED DEV, V1, P543
NR 26
TC 6
Z9 6
U1 0
U2 0
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM, NOTTS,
   ENGLAND NG1 4EE
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JAN-FEB
PY 1999
VL 27
IS 1
BP 137
EP 151
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 173CA
UT WOS:000078962500017
PM 25423407
DA 2018-10-19
ER

PT J
AU Maiman, DJ
   Kumaresan, S
   Yoganandan, N
   Pintar, FA
AF Maiman, DJ
   Kumaresan, S
   Yoganandan, N
   Pintar, FA
TI Biomechanical effect of anterior cervical spine fusion on adjacent
   segments
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterial; biomechanics; finite element model; spinal implants;
   cervical spine
ID FINITE-ELEMENT; LAMINECTOMY
AB The biomechanical effects of superior (C4-C5) and inferior (C5-C6) level fusions with different graft materials on the adjacent unaltered components were quantified using an anatomically accurate and experimentally validated C4-C5-C6 finite element model. Smith-Robinson and Bailey-Badgley fusion procedures were analyzed with five different types of interbody fusion materials with varying stiffnesses. Intact and surgically altered finite element models were subjected to physiologic compression, flexion, extension and lateral bending. The external axial and angular stiffness, and the internal unaltered intervertebral disc (C5-C6 for the superior and C4-C5 for inferior fusion) and C5 vertebral body stresses were determined. The superior level fusion resulted in the highest increase in external response in lateral bending for all implant materials in both surgical procedures. In contrast, the inferior level fusion produced a higher increase in the C4-C5 disc and C5 vertebral body stresses in compression than the superior level fusion in both surgical procedures. The increased internal stress responses reflecting the changes in the load-sharing following inferior level fusion may explain clinical observations such as enhanced degeneration subsequent to surgery. Because of the inclusion of three levels in the present multi-segment finite element model, it was possible to determine these responses in the unaltered adjacent components of the cervical spine.
C1 Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI USA.
   Dept Vet Affairs Med Ctr, Milwaukee, WI USA.
EM DenMaim@aol.com
FU PHS HHS [R49CCR 507370]
CR ALEMOHAMMAD S, 1985, NEUROSURGERY, V17, P94, DOI 10.1227/00006123-198507000-00017
   BABA H, 1993, SPINE, V18, P2167, DOI 10.1097/00007632-199311000-00004
   GORE DR, 1984, SPINE, V9, P667, DOI 10.1097/00007632-198410000-00002
   GOTO S, 1993, SPINE, V18, P1968, DOI 10.1097/00007632-199310001-00008
   GREEN NE, 1977, J BONE JOINT SURG AM, V59, P236, DOI 10.2106/00004623-197759020-00017
   Kumaresan S, 1997, J SPINAL DISORD, V10, P40
   KUMARESAN S, IN PRESS CLIN BIOMEC
   MYKLEBUST JB, 1988, SPINE, V13, P526
   PINTAR FA, 1986, THESIS MARQUETTE U M
   RILEY LH, 1969, J NEUROSURG, V30, P127, DOI 10.3171/jns.1969.30.2.0127
   SAITO T, 1991, SPINE, V16, P494, DOI 10.1097/00007632-199105000-00002
   SHIRAZIADL SA, 1984, SPINE, V9, P120, DOI 10.1097/00007632-198403000-00003
   WHITE AA, 1990, CLIN BIOMECHANICS SP
   WILLIAMS JL, 1968, J BONE JOINT SURG AM, VA 50, P277, DOI 10.2106/00004623-196850020-00006
   Yoganandan N, 1996, SPINE, V21, P1824, DOI 10.1097/00007632-199608010-00022
NR 15
TC 94
Z9 99
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 1999
VL 9
IS 1
BP 27
EP 38
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 218XM
UT WOS:000081578400004
PM 10436851
DA 2018-10-19
ER

PT J
AU Noro, T
   Itoh, K
AF Noro, T
   Itoh, K
TI Biomechanical behavior of hydroxyapatite as bone substitute material in
   a loaded implant model. On the surface strain measurement and the
   maximum compression strength determination of material crash
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterial; hydroxyapatite; biomechanics
ID CERAMICS
AB Many investigators have advocated that hydroxyapatite ceramics may be extremely prospective bone substitute material mainly through evidence with its given biocompatibility towards bone and demonstrated continuity between living bone and hydroxyapatite. Its mechanical brittleness and strength, however, have been the most serious considerations. In this paper, a study has been performed using animal experiments, massive hydroxyapatite ceramics are implanted into rectangular bone defect created by operation at the load-bearing area in close contact with tibia plateau. The changes of surface strain at the hydroxyapatite implantation of retrieved tibiae are measured at any week after implantation when the compressive stress were applied in the direction of long axis in order to clarify the mechanical behaviors of hydroxyapatite living bone complex. The compression strength of hydroxyapatite implant crash was also determined at each week after implantation. Results revealed that the hydroxyapatite living bone complex has been proven to have sufficient flexibility such that it shows no hysteresis in stress versus strain relationship up to 200 kg of applied load. The strain pattern on the surface of hydroxyapatite implant develops quite similar to that of natural cortical bone. The material crash of hydroxyapatite implant tolerates up to 500 kg of load at 52 weeks after implantation. These characteristics suggest that it achieves normal skeletal function in the points of biomechanical properties in vivo.
C1 Jichi Med Sch, Dept Orthopaed Surg, Minami Kawachi, Tochigi, Japan.
RP Noro, T (reprint author), Jichi Med Univ, Dept Orthopaed Surg, Yakushiji 3311-1, Minami Kawachi, Tochigi 3290498, Japan.
CR DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   HING KA, 1997, 13 EUR C BIOM GOT SW, P44
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   Ito K, 1991, Biomed Mater Eng, V1, P167
   ITO K, 1990, HDB BIOACTIVE CERAMI, V2, P39
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   PAUL J, 1964, BIOMECHANICS RELATED, P369
   PEELEN JGJ, 1977, SCI CERAM, V9, P226
   RAY RD, 1952, SURGICAL FORUM AM CO, P429
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   WANG FR, 1987, P 4 S BIOM ENG, P1
NR 13
TC 12
Z9 12
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 1999
VL 9
IS 5-6
BP 319
EP 324
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 305UT
UT WOS:000086559500006
PM 10822487
DA 2018-10-19
ER

PT S
AU Chang, PL
AF Chang, PL
BE Hunkeler, D
   Prokop, A
   Cherrington, AD
   Rajotte, RV
   Sefton, M
TI Encapsulation for somatic gene therapy
SO BIOARTIFICIAL ORGANS II: TECHNOLOGY, MEDICINE, AND MATERIALS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Bioartificial Organs II - Technology, Medicine and
   Materials
CY JUL 18-22, 1998
CL BANFF, CANADA
SP Engn Fdn, Baxter Hlthcare Corp, Juvenile Diabetes Fdn, Natl Inst Hlth, Natl Sci Fdn, NY Acad Sci, Roche/Boehringer Mannheim, Whitaker Fdn
ID BETA-GLUCURONIDASE DEFICIENCY; HUMAN FACTOR-IX; MICROENCAPSULATED
   MYOBLASTS; RECOMBINANT FIBROBLASTS; MANNURONIC ACID; CELLS; DELIVERY;
   ALGINATE; GROWTH; MICROCAPSULES
AB With the human genome project approaching its completion date of 2005, gene-based technology will play an increasingly important role in health-care delivery. Non-autologous somatic gene therapy is a novel application in which non-autologous cell lines engineered to secrete a recombinant protein are enclosed within immunoisolation devices and implanted into all patients requiring the same product for therapy. The development of this technology requires a multi-disciplinary effort towards optimization of the biomaterial used to manufacture the implantable devices and selection of the appropriate cell lines for enclosure. The efficacy of this technology is illustrated in the treatment of dwarfism and lysosomal storage disease in murine models. The potential of a safe and cost-effective gene-based delivery method should have wide applications in treating both classical genetic disorders and non-Mendelian diseases.
C1 McMaster Univ, Hlth Sci Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   McMaster Univ, Dept Biol, Hamilton, ON L8N 3Z5, Canada.
RP Chang, PL (reprint author), McMaster Univ, Hlth Sci Ctr, Dept Pediat, Room 3N18,1200 Main St, Hamilton, ON L8N 3Z5, Canada.
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   AlHendy A, 1996, HUM GENE THER, V7, P61, DOI 10.1089/hum.1996.7.1-61
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   AOMATSU Y, 1992, TRANSPLANT P, V24, P2922
   BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   Bastedo L., 1994, American Journal of Human Genetics, V55, pA211
   BEUTLER E, 1993, P NATL ACAD SCI USA, V90, P5384, DOI 10.1073/pnas.90.12.5384
   BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010
   BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475
   CHANG PL, 1994, BIOTECHNOL BIOENG, V43, P925, DOI 10.1002/bit.260431005
   Chang PL, 1997, ANN NY ACAD SCI, V831, P461
   CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433
   Chang PL, 1999, TRENDS BIOTECHNOL, V17, P78, DOI 10.1016/S0167-7799(98)01250-5
   Chang PL, 1998, ADV DRUG DELIVER REV, V33, P31, DOI 10.1016/S0169-409X(98)00018-0
   CHANG PL, 1995, SOMATIC GENE THERAPY, P203
   DELGON N, 1996, HUM GENE THER, V7, P2135
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2
   HOFFMAN D, 1993, EXP NEUROL, V122, P100, DOI 10.1006/exnr.1993.1111
   Hortelano G, 1996, BLOOD, V87, P5095
   HUGHES M, 1994, DELIVERY SECRETABLE
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898
   LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   Mangan ME, 1996, DEVELOPMENT, V122, P771
   Marcel T, 1997, HUM GENE THER, V8, P775, DOI 10.1089/hum.1997.8.6-775
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MARTINSEN A, 1990, THESIS TRONDHEIM I B
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Peirone MA, 1998, HUM GENE THER, V9, P195, DOI 10.1089/hum.1998.9.2-195
   Potter MA, 1998, DRUGS TODAY, V34, P759, DOI 10.1358/dot.1998.34.9.485274
   Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883
   Rinsch C, 1997, HUM GENE THER, V8, P1881, DOI 10.1089/hum.1997.8.16-1881
   ROSS CJG, 1999, IN PRESS HDB CELL EN
   SHAINBERG A, 1971, DEV BIOL, V25, P1, DOI 10.1016/0012-1606(71)90017-0
   SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   Stockley TL, 1997, DRUG NEWS PERSPECT, V10, P331
   SUN AM, 1988, METHOD ENZYMOL, V137, P575
   TAI IT, 1993, FASEB J, V7, P1061
   Taniguchi H, 1997, J SURG RES, V70, P41, DOI 10.1006/jsre.1997.5085
   THU BJ, 1996, THESIS NORWEGIAN U S
   Tse M, 1996, BIOTECHNOL BIOENG, V51, P271, DOI 10.1002/(SICI)1097-0290(19960805)51:3<271::AID-BIT3>3.3.CO;2-T
   ZIMMERMANN U, 1992, ELECTROPHORESIS, V13, P269, DOI 10.1002/elps.1150130156
NR 47
TC 12
Z9 13
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-194-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1999
VL 875
BP 146
EP 158
DI 10.1111/j.1749-6632.1999.tb08500.x
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials;
   Multidisciplinary Sciences; Transplantation
SC Engineering; Materials Science; Science & Technology - Other Topics;
   Transplantation
GA BN31W
UT WOS:000081586000012
PM 10415564
DA 2018-10-19
ER

PT J
AU Tunney, MM
   Jones, DS
   Gorman, SP
AF Tunney, MM
   Jones, DS
   Gorman, SP
TI Biofilm and biofilm-related encrustation of urinary tract devices
SO BIOFILMS
SE METHODS IN ENZYMOLOGY
LA English
DT Review
ID BIOMATERIAL ENCRUSTATION; BACTERIAL; ADHERENCE; MODEL
C1 Queens Univ Belfast, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
   Queens Univ Belfast, Sch Clin Med, Dept Microbiol & Immunol, Belfast BT9 7BL, Antrim, North Ireland.
RP Tunney, MM (reprint author), Queens Univ Belfast, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
CR BASSETT J, 1978, VOGELS TXB QUANTITAT, P837
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   Garvin C. P., 1998, Journal of Pharmacy and Pharmacology, V50, P164
   GLEESON MJ, 1989, T AM SOC ART INT ORG, V35, P495
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   OHKAWA M, 1990, J UROLOGY, V143, P717, DOI 10.1016/S0022-5347(17)40071-1
   SARANGAPANI S, 1995, J BIOMED MATER RES, V29, P1185, DOI 10.1002/jbm.820291005
   STICKLER DJ, 1993, CELL MATER, V3, P315
   Tunney M. M., 1996, European Journal of Pharmaceutical Sciences, V4, pS177, DOI 10.1016/S0928-0987(97)86539-6
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   TUNNEY MM, 1995, BIOMATERIALS, V17, P1025
   TUNNEY MM, 1997, J PHARM PHARMACOL, V49, P1102
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
NR 15
TC 33
Z9 35
U1 1
U2 4
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 1999
VL 310
BP 558
EP 566
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BP55T
UT WOS:000085490500041
PM 10547819
DA 2018-10-19
ER

PT J
AU Piconi, C
   Maccauro, G
AF Piconi, C
   Maccauro, G
TI Zirconia as a ceramic biomaterial
SO BIOMATERIALS
LA English
DT Review
DE zirconia; mechanical properties; stability; biocompatibility; wear;
   radioactivity
ID PARTIALLY-STABILIZED ZIRCONIA; HYDROXYAPATITE COMPOSITE COATINGS;
   POLYETHYLENE ACETABULAR CUPS; SIMULATED BODY-FLUID;
   MECHANICAL-PROPERTIES; Y-TZP; FEMORAL HEADS; HIP-JOINT; IN-VITRO;
   POLYCRYSTALLINE ZIRCONIA
AB Zirconia ceramics have several advantages over other ceramic materials, due to the transformation toughening mechanisms operating in their microstructure that can give to components made out of them, very interesting mechanical properties. The research on the use of zirconia ceramics as biomaterials started about twenty years ago, and now zirconia (Y-YZP) is in clinical use in THR, but developments are in progress for application in other medical devices. Recent developments have concentrated on the chemistry of precursors, in forming and sintering processes, and on surface finish of components. Today's main applications of zirconia ceramics is in THR ball heads. This review takes into account the main results achieved up to now, and is focused on the role that microstructural characteristics play on the TZP ceramics behaviour in ball heads, namely mechanical properties and their stability, wear of the UHMWPE paired to TZP, and their influence on biocompatibility. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 ENEA, New Technol Dept, New Mat Div, Rome, Italy.
   Univ Cattolica Sacro Cuore, Inst Orthopaed, Rome, Italy.
RP Piconi, C (reprint author), ENEA, INN, NUMA, Cr Cassaccia 049,Via Anguillarese 301, I-00060 Rome, Italy.
EM piconi@infos1.casaccia.enea.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   AMBROSIO L, 1996, J MATER SCI-MATER M, P723
   AMIN KE, 1995, AM CERAM SOC BULL, V74, P80
   Andrisano A O, 1990, Proc Inst Mech Eng H, V204, P157, DOI 10.1243/PIME_PROC_1990_204_250_02
   AOKI H, 1991, SCI MED APPL HYDROXY
   *ASTM, F163695 ASTM
   Barbour PSM, 1997, J MATER SCI-MATER M, V8, P603, DOI 10.1023/A:1018515318630
   BARBOUR PSM, 1996, T 5 WORLD BIOM C TOR, P579
   BENABDALLAH A, 1991, WEAR, V142, P43
   BOOTHE GF, 1980, HEALTH PHYS, V38, P393, DOI 10.1097/00004032-198003000-00014
   BORTZ SA, 1973, CER B, V52, P898
   BRAGDON CR, 1996, T 5 WORLD BIOM C TOR, P582
   BUKAT A, 1990, BIOCERAMICS, V3, P355
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   BURGER W, 1993, T 10 EUR C BIOM
   BURGER W, 1994, T 11 EUR C BIOM PIS, P177
   BURGER W, 1995, EURCERAMICS, V8, P29
   CAETANOZURITA J, 1994, BIOCERAMICS, V7, P267
   CALES B, 1994, J BIOMED MATER RES, V28, P619, DOI 10.1002/jbm.820280512
   Cales B, 1998, J BIOMED MATER RES, V43, P62, DOI 10.1002/(SICI)1097-4636(199821)43:1<62::AID-JBM7>3.3.CO;2-O
   CALES B, 1994, J MATER SCI-MATER M, V5, P376, DOI 10.1007/BF00058967
   CALES B, 1994, BIOCERAMICS, V7, P395
   CALES B, 1990, BIOCERAMICS, V2, P152
   CALES B, 1995, 4 EUROCERAMICS, V8, P45
   CAPANNESI G, 1992, BIOCERAMICS AND THE HUMAN BODY, P211
   CASTELLO G, 1983, CHIM IND-MILAN, V65, P251
   CATELAS I, 1996, T 4 WORLD BIOM C TOR, P11
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Chang E, 1997, J MATER SCI-MATER M, V8, P201, DOI 10.1023/A:1018535606393
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   CHARNLEY J, 1969, MED BIOL ENG, V7, P31, DOI 10.1007/BF02474667
   Chevalier J, 1997, BIOCERAMICS, P10
   CHEVALIER J, 1997, BIOCERAMICS, V10, P271
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   CIEUR S, 1990, BIOCERAMICS, V3, P367
   CLARKE I, 1993, T 19 ANN M SOC BIOM, P57
   Clarke I. C., 1994, BONE IMPLANT INTERFA
   CLAUSSEN N, 1976, J AM CERAM SOC, V59, P49, DOI 10.1111/j.1151-2916.1976.tb09386.x
   Claussen N., 1984, ADV CERAM, V12, P325
   COVACCI V, UNPUB BIOMATERIALS
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAVIDSON JA, 1992, T 38 ORS WASH, P404
   DAVIDSON JA, 1991, CERAMICS SUBSTITUTIV, P157
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   DEWITH G, 1981, J MATER SCI, V16, P1592
   DIMIYTROVALUKAC.M, 1995, MAT CLIN APPL, P321
   DINGMAN C, 1990, T 16 ANN M SOC BIOM, P71
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   DOWSON D, 1993, WEAR, V162
   DROUIN JM, 1994, BIOCERAMICS, V7, P387
   DRUMMOND JL, 1992, J AM CERAM SOC, V75, P1278, DOI 10.1111/j.1151-2916.1992.tb05571.x
   DRUMMOND JL, 1989, J AM CERAM SOC, V72, P675, DOI 10.1111/j.1151-2916.1989.tb06194.x
   Evans A. G., 1984, ADV CERAM, P193
   Fairbairn HW, 1957, T AM GEOPHYS UNION, V38, P939
   Filiaggi MJ, 1996, J BIOMED MATER RES, V33, P225, DOI 10.1002/(SICI)1097-4636(199624)33:4<225::AID-JBM3>3.0.CO;2-R
   Fisher J, 1997, J MATER SCI-MATER M, V8, P375, DOI 10.1023/A:1018537001366
   FUJISAWA A, 1996, BIOCERAMICS, V9, P503
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   GRECO F, 1993, MINERVA ORTOP TRAUMA, V44, P913
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   HARMAND M F, 1992, Clinical Materials, V11, P145
   HARMAND MF, 1995, P 12 ESB C BIOM OP P, P141
   HAYASHI K, 1992, BIOMATERIALS, V13, P195, DOI 10.1016/0142-9612(92)90184-P
   HEIMKE G, 1993, BIOCERAMIC, V6, P283
   HEINDL R, 1992, T 4 WORLD BIOM C BER, P14
   Helmer J, 1969, S US CER SURG IMPL S
   HIRAKAWA K, 1997, J BIOMED MATER RES, P529
   HOPF T, 1989, Z ORTHOP GRENZGEB, V127, P620, DOI 10.1055/s-2008-1040302
   Hopf W, 1990, Acta Orthop Belg, V56, P443
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   *INT COMM RAD PROT, 1990, ICRP PUBL, V60
   IOKU K, 1991, NIPPON SERAM KYO GAK, V99, P196
   *ISO, 1994, 6474 ISO
   *ISO, 1995, 13356 ISO DIS
   *ISO, 1992, 72065 ISO
   *IT NAT GROUP STUD, 1985, SCI TOTAL ENVIRON, V45, P135
   Ito A., 1993, Clinical Materials, V12, P203, DOI 10.1016/0267-6605(93)90074-H
   KENNER GH, 1975, J BIOMED MATER RES, V6, P63
   KUMAR P, 1990, ADV BIOMAT, V9, P373
   KUMAR P, 1989, BIOCERAMICS, V1, P341
   LANCASTER JG, 1996, T 5 WORLD BIOM C TOR, P581
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LEACH CA, 1987, MATER SCI TECH SER, V3, P321, DOI 10.1179/mst.1987.3.5.321
   LEPISTO TT, 1992, CORROSION GLASS CERA, P492
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   LIAO YS, 1996, T 5 WORLD BIOM C TOR, P871
   LILLEY E, 1990, CERAMIC T, P10
   LIN YJ, 1990, J AM CERAM SOC, V73, P2728, DOI 10.1111/j.1151-2916.1990.tb06753.x
   LIVERMORE J, 1990, J BONE JOINT SURG AM, V72A, P518, DOI 10.2106/00004623-199072040-00008
   LUTHY H, 1993, P 1993 MONT VER BMS
   MACCAURO G, 1992, P 8 ESB M ROM IT JUN, P110
   MANDRINO A, 1992, J MATER SCI-MATER M, V3, P457, DOI 10.1007/BF00701243
   MANDRINO A, 1990, BIOMATERIALS, V11, P88
   MARTINELLA R, 1993, INNOVATIVE MAT, P441
   MCKELLOP H, 1992, T 4 WORLD BIOM C BER, P118
   *MED DEV AG ADV IN, 1996, ZIRC CER HEADS MOD T
   MIDDLETON J, 1994, J MATER SCI-MATER M, V5, P503, DOI 10.1007/BF00058992
   Mishra AK, 1992, BIOMATERIAL TISSUE I, P111
   MURAKAMI T, 1989, BIOCERAMICS, V1, P225
   MURRAY MGS, 1995, BIOCERAMICS, V8, P37
   MURRAY MGS, 1996, T 5 WORLD BIOM C TOR
   MURRAY MGS, 1995, BIOCERAMICS, V8, P151
   NORDLUND A, 1989, INT J ORAL MAX SURG, V18, P373, DOI 10.1016/S0901-5027(89)80037-2
   OKA M, 1992, BIOCERAMICS, V5, P373
   OONISHI H, 1996, BIOCERAMICS, V9, P503
   Patel AM, 1995, BIOCERAMICS, V8, P169
   Piantelli S., 1992, 4 WORLD BIOM C T BER, P343
   PICONI C, 1998, IN PRESS E MRS ICAM
   Porstendorfer J, 1996, J BIOMED MATER RES, V32, P663, DOI 10.1002/(SICI)1097-4636(199612)32:4<663::AID-JBM20>3.0.CO;2-D
   PURCHIO RA, 1995, BIOCERAMICS, V8, P313
   RADIN EL, 1986, CLIN ORTHOP RELAT R, P34
   REED JS, 1977, MATER RES BULL, V12, P949, DOI 10.1016/0025-5408(77)90017-4
   Rice R.W., 1977, TREATISE MATERIALS S, VII, P200
   RICHTER HG, 1994, BIOCERAMICS, V7, P401
   RIETH PH, 1976, AM CERAM SOC BULL, V55, P717
   ROUBAULT M, 1960, MINERAIS URANIFERES, P9
   Ruff O, 1929, Z ANORG ALLG CHEM, V180, P215, DOI 10.1002/zaac.19291800122
   RUHLE M, 1984, ADV CERAM, V12, P352
   RUYS AJ, 1991, BIOCERAMICS, V4, P281
   SAIKKO V, 1994, WEAR, V176, P207, DOI 10.1016/0043-1648(94)90148-1
   SAIKKO V, 1993, WEAR, V166, P169, DOI 10.1016/0043-1648(93)90259-O
   SAIKKO VO, 1993, ACTA ORTHOP SCAND, V64, P507, DOI 10.3109/17453679308993680
   SALOMONI A, 1994, J MATER SCI-MATER M, V5, P651, DOI 10.1007/BF00120349
   SANDHAUS S, 1994, TRIB DENTAIRE, V2, P2
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Sato T., 1985, J MATER SCI, V20, P3899
   Satoh Y, 1990, BIOCERAMICS, V3, P101
   SCHWARTZ GL, 1990, 36 ORS NEW ORL LOU, P483
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   SPECCHIA N, P 2 EFORT C MUN GERM, P273
   STEVENS R, 1984, BRIT CERAM TRANS J, V83, P28
   STREICHER RM, 1991, BIOCERAMICS, V4, P159
   Subbarao E.C., 1981, ADV CERAM, V3, P1
   SUDA A, 1995, BIOCERAMICS, V8, P465
   Sudanese A, 1988, Chir Organi Mov, V73, P195
   SUDANESE A, 1989, BIOCERAMICS, V1, P237
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   TAKAGI M, 1992, J MATER SCI-MATER M, V3, P199, DOI 10.1007/BF00713450
   TAKAGI M, 1995, BIOCERAMICS, V8, P431
   TAMARI N, 1987, NIPPON SERAM KYO GAK, V95, P806
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Tateishi T., 1993, Clinical Materials, V12, P219, DOI 10.1016/0267-6605(93)90076-J
   TATEISHI T, 1994, MAT SCI ENG C-BIOMIM, V1, P121, DOI 10.1016/0928-4931(94)90042-6
   TATEISHI T, 1992, ADV BIOMAT, V10, P89
   TATEISHI T, 1990, BIOCERAMICS, V3, P117
   TATEISHI T, 1990, BIOCERAMICS, V2, P145
   THEUNISSEN GSAM, 1992, J MATER SCI, V27, P4429, DOI 10.1007/BF00541576
   THOMPSON I, 1990, BIOMATERIALS, V11, P505, DOI 10.1016/0142-9612(90)90066-Y
   TOWLER MR, 1996, T 5 WORLD BIOM C TOR, P975
   TREICHER RM, 1991, CERAMICS SUBSTITUTIV, P197
   *UN SCI COMM EFF I, 1988, SOURC EFF RISKS ION
   VORONOV NM, 1964, P 2 UN INT C PEAC US, P70
   WAGNER W, 1987, T 7 EUR C BIOM AMST, P44
   WALTER A, 1994, T 11 ESB PIS IT, P307
   WANG A, 1996, T 5 WORLD BIOM C TOR, P583
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 164
TC 1308
Z9 1357
U1 23
U2 390
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1999
VL 20
IS 1
BP 1
EP 25
DI 10.1016/S0142-9612(98)00010-6
PG 25
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150VA
UT WOS:000077685200001
PM 9916767
DA 2018-10-19
ER

PT J
AU Goissis, G
   Junior, EM
   Marcantonio, JAC
   Lia, RCC
   Cancian, DCJ
   de Carvalho, M
AF Goissis, G
   Junior, EM
   Marcantonio, JAC
   Lia, RCC
   Cancian, DCJ
   de Carvalho, M
TI Biocompatibility studies of anionic collagen membranes with different
   degree of glutaraldehyde cross-linking
SO BIOMATERIALS
LA English
DT Article
DE anionic collagen; glutaraldehyde; cross-links; biocompatibility;
   biodegradation
ID STABILIZATION; REGENERATION; SUPPORT; DOGS
AB The work describes the biocompatibility and biodegradation studies of anionic collagen membranes casted form collagen gels collagen, that were selective hydrolyzed at the carboxyamide groups, as a function of the degree of cross-links induced by glutaraldehyde. Independently from the degree of cross-links, all membranes studied were characterized by a similar inflammatory response, inversely dependent on glutaraldehyde reaction time, that decreased from the time of the implant. Cell alterations, mineralization or contact necrosis were not observed in any of the membranes studied. Rates for membrane tissue biodegradation were directly related to glutaraldehyde reaction time, and ranged from 30 to periods longer than 60 days, associated with good biocompatibility. Although other properties must be considered, their use in the treatment of periodontal diseases, the biological behavior observed with the 8 h GA cross-linked membrane suggests that, anionic collagen membrane described in this work may be of potential use, not only in association with guided tissue regeneration technique for periodontal tissue reconstruction, but also in other collagen biomaterial applications where controlled biodegradability is required. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, Sao Paulo, Brazil.
   Univ Estadual Paulista Araraquara, Fac Odontol, Araraquara, Brazil.
RP Goissis, G (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, Sao Paulo, Brazil.
EM ggoissi@iqsc.sc.usp.br
RI Marcantonio, Elcio/A-4784-2008
OI Marcantonio, Elcio/0000-0003-1294-2305
CR BARBARA SB, 1994, J PERIODONTOL, V65, P598
   BOON ME, 1995, BIOMATERIALS, V16, P1089, DOI 10.1016/0142-9612(95)98905-T
   Chvapil M, 1980, BIOL COLLAGEN, P313
   Eastoe JE, 1967, TREATISE COLLAGEN, V1, P1
   FLEISHER N, 1988, INT J PERIODONT REST, V8, P45
   GOISSIS G, 1994, PROCESSO EXTRACAO CO
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Hu XW, 1996, TISSUE CELL, V28, P215
   LACERDA C, UNPUB BIOMATERIALS
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   MINABE M, 1989, J PERIODONTOL, V60, P35, DOI 10.1902/jop.1989.60.1.35
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P257, DOI 10.1111/j.1600-051X.1982.tb02065.x
   PITARU S, 1989, J PERIODONTAL RES, V24, P247, DOI 10.1111/j.1600-0765.1989.tb01789.x
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   RAO KP, 1988, COLLAGEN, V3, P63
   ROBERT PM, 1994, J PERIODONTOL, V65, P414, DOI 10.1902/jop.1994.65.5.414
   RUIJGROK JM, 1994, J MATER SCI-MATER M, V5, P80, DOI 10.1007/BF00121695
   Shenoy V, 1995, MACROMOLECULES, V28, P8751, DOI 10.1021/ma00130a007
   SILVESTER MF, 1989, THROMB RES, V55, P135
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   Sisken BF, 1993, J CELL BIOCHEM, V52, P404
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   WALLACE DG, 1987, COLLAGEN BIOCH MOL B, V3
NR 25
TC 127
Z9 139
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1999
VL 20
IS 1
BP 27
EP 34
DI 10.1016/S0142-9612(97)00198-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150VA
UT WOS:000077685200002
PM 9916768
DA 2018-10-19
ER

PT J
AU Deible, CR
   Petrosko, P
   Johnson, PC
   Beckman, EJ
   Russell, AJ
   Wagner, WR
AF Deible, CR
   Petrosko, P
   Johnson, PC
   Beckman, EJ
   Russell, AJ
   Wagner, WR
TI Molecular barriers to biomaterial thrombosis by modification of surface
   proteins with polyethylene glycol
SO BIOMATERIALS
LA English
DT Article
DE platelet; polyethylene glycol; fibrinogen; surface modification;
   adsorbed proteins
ID FIBRINOGEN ADSORPTION; MURAL THROMBOGENESIS; PLATELET-ADHESION;
   COLLAGEN; IMMOBILIZATION; POLYURETHANES; VISUALIZATION; DEPOSITION
AB For cardiovascular biomaterials, thrombosis, thromboembolism and vascular graft occlusion are believed to be precipitated by the adsorption of proteins containing adhesive ligands for platelets. Polyethylene-glycol-diisocyanate (PEG-diisocyanate, 3400 MW) may potentially react with protein amines to form molecular barriers on adsorbed proteins on biomaterials, thereby masking adhesive ligands and preventing acute surface thrombosis. To test this notion, PE, PTFE, and glass microconduits were pre-adsorbed with fibrinogen and treated with PEG-diisocyanate, non-reactive PEG-dihydroxyl, or remained untreated. Following perfusion of In-111-labeled platelets in whole human blood for 1 min (wall shear rate = 312 s(-1)), PEG-diisocyanate treated surfaces experienced 96% (PE), 97% (PTFE) and 94% (glass) less platelet deposition than untreated surfaces. Similar reductions were seen for PEG-diisocyanate versus PEG-dihydroxyl treatment. Low shear perfusions of plasma for one hour prior to blood contact did not reduce the inhibitory effect of PEG-diisocyanate. Platelet adhesion onto collagen coated glass coverslips and platelet deposition onto preclotted Dacron was also reduced by treatment with PEG-diisocyanate (93 and 91 %, respectively). Protein-reactive PEG may thus have utility in forming molecular barriers on surface associated proteins to inhibit acute thrombosis on cardiovascular biomaterials. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, Med Ctr, Dept Surg, 328 Scaife Hall,200 Lothrop St, Pittsburgh, PA 15213 USA.
EM wagner@pittsurg.nb.upmc.edu
OI Russell, Alan/0000-0001-5101-4371
CR ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175
   ADAMS GA, 1983, BLOOD, V62, P69
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BADIMON L, 1987, J LAB CLIN MED, V110, P706
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BROWN WE, 1973, BIOCHEMISTRY-US, V12, P828, DOI 10.1021/bi00729a007
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Deible CR, 1996, CIRCULATION, V94, P3600
   FOLIE BJ, 1988, BLOOD, V72, P1393
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Hepburn C., 1992, POLYURETHANE ELASTOM, P107
   HUBBELL JA, 1986, BIOMATERIALS, V7, P354, DOI 10.1016/0142-9612(86)90006-2
   HUBBELL JA, 1986, REV SCI INSTRUM, V57, P892, DOI 10.1063/1.1138830
   JOHNSON PC, 1992, PLAST RECONSTR SURG, V90, P650, DOI 10.1097/00006534-199210000-00015
   LLANOS GR, 1993, J BIOMED MATER RES, V27, P1383, DOI 10.1002/jbm.820271105
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1395, DOI 10.1002/jbm.820231203
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   RANUCCI E, 1994, J BIOMAT SCI-POLYM E, V6, P133
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   Wagner W R, 1992, ASAIO J, V38, pM634, DOI 10.1097/00002480-199207000-00114
   WAGNER WR, 1990, J LAB CLIN MED, V116, P636
   WAGNER WR, 1994, T SOC BIOMATERIALS, V17, P3
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Zalipsky S, 1992, POLYETHYLENE GLYCOL, P347
NR 28
TC 34
Z9 34
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1999
VL 20
IS 2
BP 101
EP 109
DI 10.1016/S0142-9612(98)00001-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158JT
UT WOS:000078112800001
PM 10022779
DA 2018-10-19
ER

PT J
AU Bakos, D
   Soldan, M
   Hernandez-Fuentes, I
AF Bakos, D
   Soldan, M
   Hernandez-Fuentes, I
TI Hydroxyapatite-collagen-hyaluronic acid composite
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; collagen; hyaluronic acid; composite implants
ID AUGMENTATION
AB The new composite biomaterial made from hydroxyapatite and collagen conjugated with hyaluronic acid has been studied. The structure evaluation of the composite showed more dense arrangement due to the formation of collagen-hyaluronic acid conjugate, and particles of inorganic component are closely anchored in the structure. Mechanical properties and model swelling of this composite are compared with properties of hydroxyapatite-collagen composite of similar material without hyaluronic acid. Higher cohesivity of the new biomaterial can give new possibilities for application as bone implant material. The test of contact cytotoxicity showed a very good biocompatibility of the biomaterial. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Slovak Univ Technol Bratislava, Fac Chem Technol, Bratislava 81237, Slovakia.
   Univ Complutense, Fac Chem Sci, Madrid, Spain.
RP Bakos, D (reprint author), Slovak Univ Technol Bratislava, Fac Chem Technol, Radlinskeho 9, Bratislava 81237, Slovakia.
RI Soldan, Maros/C-6370-2017
OI Soldan, Maros/0000-0003-1520-1051
CR BALLS M, 1993, P INT WORKSHOP ADV T, P34
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DOGATKIN B, 1946, KOLLOID ZH, V8, P32
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   HOTZ G, 1991, INT J ORAL MAX SURG, V20, P208, DOI 10.1016/S0901-5027(05)80176-6
   KIM HD, 1996, P 5 WORLD BIOM C TOR, V2, P236
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Rehakova M, 1996, J BIOMED MATER RES, V30, P369, DOI 10.1002/(SICI)1097-4636(199603)30:3<369::AID-JBM11>3.0.CO;2-F
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
NR 13
TC 108
Z9 123
U1 2
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1999
VL 20
IS 2
BP 191
EP 195
DI 10.1016/S0142-9612(98)00163-X
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 158JT
UT WOS:000078112800011
PM 10022789
DA 2018-10-19
ER

PT S
AU Klee, D
   Hocker, H
AF Klee, D
   Hocker, H
BE Abe, A
   Albertsson, AC
   Cantow, HJ
   Dusek, K
   Edwards, S
   Hocker, H
TI Polymers for biomedical applications: Improvement of the interface
   compatibility
SO BIOMEDICAL APPLICATIONS: POLYMER BLENDS
SE Advances in Polymer Science
LA English
DT Review
ID CELL ATTACHMENT ACTIVITY; HUMAN-ENDOTHELIAL-CELLS; BLOOD COMPATIBILITY;
   GRAFT-COPOLYMERIZATION; SURFACE MODIFICATIONS; HYDROPHILIC POLYMERS;
   SOLID-SURFACES; RGD-PEPTIDES; FREE-ENERGY; ADHESION
AB The true aim of biomaterials research is to create implant surfaces which interact actively with the biological system and provoke exactly the same reactions as the corporal tissues do. The improvement in the interface compatibility of polymers selected for implantation by directed surface modification is an important contribution to biomaterial development. Different polymer properties are adjusted and characterized independently of the carrier polymer by means of introduction of modern surface analytical methods and surface techniques. In addition, the interactions between the modified polymer surface and the biological system are measured. In this way, the hydrophilization of a polyurethane (Tecolex(TM)) and a poly(ether sulfone) by plasma induced graftcopolymerization of hydrogels like poly(hydroxyethyl methacrylate) leads to improved blood compatibility. Functionalization by means of SO2 plasma treatment of medical grade poly(vinyl chloride) increases the adsorption of the basal membrane protein fibronectin, which correlates with an improvement in cell growth. A suitable interface for an improved cell growth of hum an vascular endothelial cells as well as for cornea endothelial cells has been created by immobilization of the cell adhesion mediator fibronectin using bifunctional spacer molecules at several carrier polymer surfaces like smooth poly(vinyl chloride), modified polyurethane, Tecoflex(TM) and poly(dimethyl siloxane).
C1 Rhein Westfal TH Aachen, Dept Text Chem & Macromol Chem, D-52062 Aachen, Germany.
RP Klee, D (reprint author), Rhein Westfal TH Aachen, Dept Text Chem & Macromol Chem, Veltmanpl 8, D-52062 Aachen, Germany.
EM klee@dwi.rwth-aachen.de
CR Alberts B., 1990, MOLEKULARBIOLOGIE ZE
   ANDERHEIDEN D, 1991, ANGEW MAKROMOL CHEM, V185, P109, DOI 10.1002/apmc.1991.051850111
   ANDERHEIDEN D, 1992, ADV BIOMAT, V10, P199
   ANDERHEIDEN D, 1989, THESIS RWTH AACHEN
   ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   Andrade J D, 1973, Med Instrum, V7, P110
   Andrade J. D., 1976, ACS S SERIES
   ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   AUGTHUN M, 1988, Z ZAHNARZTL IMPLANTO, V4, P228
   BAIER RE, 1970, T AM SOC ART INT ORG, V16, P50
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   BANTJES A, 1978, BRIT POLYM J, V10, P267, DOI 10.1002/pi.4980100410
   BASZKIN A, 1986, BLOOD COMPATIBLE MAT, P39
   BEISSINGER RL, 1981, T AM SOC ART INT ORG, V27, P225
   BLASS CR, 1992, MED DEVICE TECHNOL, V33, P32
   Boenig HV, 1982, PLASMA SCI TECHNOLOG
   BRANDT J, 1975, BIOCHIM BIOPHYS ACTA, V386, P196, DOI 10.1016/0005-2795(75)90259-7
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   BRAUNER A, 1988, ZAHNARZTL IMPLANTOL, V4, P223
   BREUERS W, 1987, KUNSTST-GER PLAST+, V77, P1273
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   BRIGGS D, 1982, INT J ADHES ADHES, V2, P13
   BRIGGS D, 1983, PRACTICAL SURFACE AN, P359
   BRUCK SD, 1979, J POLYM SCI POL SYM, P283
   CASTNER D G, 1990, Journal of Biomaterials Science Polymer Edition, V1, P191
   CHAPMAN D, 1992, CHEM BRIT, V28, P253
   CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093
   CLARK DT, 1982, PURE APPL CHEM, V54, P415, DOI 10.1351/pac198254020415
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1986, BLOOD COMPATIBLE MAT, P129
   CRYER D, 1983, BIOMEDICAL INTERACTI
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DENNIS AM, 1980, INORG CHIM A-LETT, V44, pL139, DOI 10.1016/S0020-1693(00)90981-2
   DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2
   ELWING H, 1987, PROG COLLOID POLYM S, V74, P103
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FORBES CD, 1994, HAEMOSTASIS THROMBOS, P1301
   FRIES T, 1994, DTSCH VERBAND MATERI, P127
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P395
   GIGA J, 1985, SURF INTERFACE ANAL, V7, P163
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P547, DOI 10.1002/jbm.820240503
   Harlow E, 1989, ANTIBODIES LAB MANUA
   HAYWARD JA, 1986, BIOMATERIALS, V7, P126, DOI 10.1016/0142-9612(86)90069-4
   HESS F, 1984, POLYURETHANES BIOMED, P301
   Hocker H, 1996, MACROMOL SYMP, V102, P421, DOI 10.1002/masy.19961020149
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   HOFFMAN AS, 1982, BIOMATERIALS, V199, P1
   HORBETT TA, 1986, HYDROGELS MED PHARM
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   IKADA Y, 1994, ACS S SERIES, V540
   JACOBASCH HJ, 1975, PAPIER, V29, P555
   JERG KR, 1991, ACS POLYM PREPRINTS, V32, P243
   Johnson R.E., 1969, SURF COLLOID SCI, V2, P85
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KANG ET, 1992, MACROMOLECULES, V25, P6842, DOI 10.1021/ma00051a019
   KANG ET, 1992, MACROMOLECULES, V25, P1959, DOI 10.1021/ma00033a020
   KIRKPATRICK CJ, 1992, CELL MATER, V2, P169
   KLEE D, 1994, J MATER SCI-MATER M, V5, P592, DOI 10.1007/BF00120336
   Klee D, 1996, MACROMOL SYMP, V103, P19
   KLEE D, 1987, PLASTVERARBEITER, V38, P54
   KLEE D, 1996, P 5 WORLD BIOM C TOR, P562
   KLEE D, 1987, PLASTVERARBEITER, V38, P76
   KLEE D, 1995, SPEKTRUM WISSENSCHAF, V6, P90
   KLEE D, 1987, PLASTVERARBEITER, V38, P52
   KLINKMANN H, 1987, UREMIA THERAPY
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LANGEFELD S, 1997, OPHTHALMIC RES, V29, P78
   LEAKE DL, 1989, BIOMATERIALS, V10, P441, DOI 10.1016/0142-9612(89)90083-5
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lelah M. D., 1986, POLYURETHANES MED
   LI D, 1992, J COLLOID INTERF SCI, V148, P190, DOI 10.1016/0021-9797(92)90127-8
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   LORENZ G, 1995, J APPL POLYM SCI, V57, P391, DOI 10.1002/app.1995.070570401
   LORENZ G, 1995, THESIS TU AACHEN
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   LYKLEMA J, 1985, SURFACE INTERFACIAL, P293
   Matsuda T., 1989, NEPHROL DIAL TRANS S, V4, P60
   MATSUNAGA T, 1981, J COLLOID INTERF SCI, V84, P8, DOI 10.1016/0021-9797(81)90253-8
   McDonagh J., 1985, PLASMA FIBRONECTIN
   MEYER JG, 1986, BLUTGERINNUNG FIBRIN
   MITTERMAYER C, Patent No. 0290642
   MITTERMAYER C, 1992, P 4 BRITE EURAM SEV, P90
   MOK S, 1994, J APPL POLYM SCI, V51, P193, DOI 10.1002/app.1994.070510120
   MULLER G, 1992, ANGEW CHEM, V104, P341, DOI DOI 10.1002/ANGE.19921040330
   *NIH, 1982, NIH PUBL
   NORDE W, 1990, J COLLOID INTERF SCI, V139, P169, DOI 10.1016/0021-9797(90)90454-V
   NORDE W, 1985, SURFACE INTERFACIAL, P241
   NYGREN H, 1988, J BIOMED MATER RES, V22, P1, DOI 10.1002/jbm.820220103
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PETERS JH, 1990, MONOKLONALE ANTIKORP
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PIKE FD, COLLOID INTERFACE SC, V3, P375
   PLUSTER W, 1998, THESIS RWTH AACHEN
   POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6
   RATNER BD, 1979, J POLYM SCI POL SYM, P363
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1987, TREATISE CLEAN SURFA, P247
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   RATNER BD, 1988, PROGR BIOMATERIALS E, V6, P13
   RATNER RD, 1985, SURFACE INTERFACIAL, P373
   ROSE PW, 1985, PLAST ENG, V41, P41
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   SACHER E, 1988, PROGR BIOMATERIALS E, V6, P53
   SALZMAN EW, 1986, INTERACTION BLOOD NA, P39
   SAWYER PN, 1967, AM J SURG, V114, P42, DOI 10.1016/0002-9610(67)90038-4
   SCHAFER K, 1996, MELLIAND TEXTILBER, V77, P402
   SCHROEDER K, 1995, J APPL POLYM SCI, V58, P699, DOI 10.1002/app.1995.070580403
   SCHULZE PD, 1983, J VAC SCI TECHNOL A, V1, P97, DOI 10.1116/1.572321
   SENTISSI JM, 1986, SURGERY, V99, P337
   Sharma C. P., 1991, BLOOD COMPATIBLE MAT
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SKECHAN P, 1990, JNCI-J NATL CANCER I, V82, P1197
   SONDERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   SZYCHER M, 1991, COMPREHENSIVE GUIDE
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   THELEN H, 1995, FRESEN J ANAL CHEM, V353, P290, DOI 10.1007/BF00322054
   THELEN H, 1996, THESIS TU AACHEN
   Thiele L., 1979, ACTA POLYM, V30, P323, DOI [10.1002/actp.1979.010300601, DOI 10.1002/ACTP.1979.010300601]
   TREVAR MD, 1980, IMMOBILIZED ENZYMES
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   VANWAGENEN RA, 1981, J COLLOID INTERF SCI, V84, P155, DOI 10.1016/0021-9797(81)90269-1
   VIDRINE DW, 1982, FOURIER TRANSFORM IN
   VOLKER N, 1998, IN PRESS J MAT SCI M
   VROMAN L, 1987, SEMIN THROMB HEMOST, V13, P79, DOI 10.1055/s-2007-1003477
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
   WACHEM PB, 1987, THESIS U TWENTE NETH
   WAHLGREN M, 1991, TIBTECH, V9, P210
   WEGNER G, 1985, POLYM WERKSTOFFE, P679
   Wilhelmy L, 1863, ANN PHYSIK, V195, P177, DOI [10.1002/andp.18631950602, DOI 10.1002/ANDP.18631950602]
   Williams D., 1990, CONCISE ENCY MED DEN
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   WILLIAMS DF, 1990, INTERDISCIPL SCI REV, V15, P20
   WILLIAMS DF, 1994, J MATER SCI-MATER M, V5, P303
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG
   WIRSCHING J, 1995, P 12 EUR C BIOM PORT, P104
   WIRSCHING J, 1997, THESIS TU AACHEN
   WREN AG, 1979, J COLLOID INTERF SCI, V70, P544, DOI 10.1016/0021-9797(79)90062-6
   YASUDA HK, 1990, PURE APPL CHEM, V62, P1689, DOI 10.1351/pac199062091689
   YU J, 1991, BIOMATERIALS, V12, P119, DOI 10.1016/0142-9612(91)90188-G
   YUI N, 1986, MICRODOMAIN STRUCTUR
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 153
TC 109
Z9 111
U1 5
U2 59
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-65933-1
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1999
VL 149
BP 1
EP 57
PG 57
WC Polymer Science
SC Polymer Science
GA BP02V
UT WOS:000083909600001
DA 2018-10-19
ER

PT S
AU Marcolongo, M
   DiNardo, NJ
   Hickok, N
   Tuan, R
   Pourezzaei, K
   Beard, R
   Brennan, D
   Heipp, P
   Phan, T
AF Marcolongo, M
   DiNardo, NJ
   Hickok, N
   Tuan, R
   Pourezzaei, K
   Beard, R
   Brennan, D
   Heipp, P
   Phan, T
BE Neenan, T
   Marcolongo, M
   Valentini, RF
TI Osteoblast attachment on biomaterials as a function of surface charge
SO BIOMEDICAL MATERIALS-DRUG DELIVERY, IMPLANTS AND TISSUE ENGINEERING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomedical Materials-Drug Delivery, Implants and Tissue
   Engineering
CY NOV 30-DEC 01, 1998
CL BOSTON, MA
SP Mat Res Soc
ID PROTEIN ADSORPTION; ADHESION; BONE
AB Bioactive materials such as calcium phosphate ceramics and bioactive glasses enhance bone tissue formation and then bond to bone tissue. In our work, we question what particular surface feature or features of bioactive materials are responsible for the bone tissue response. In this study we have uncoupled surface charge from surface chemistry, energy, and topography and have examined osteoblast adhesion to titanium surfaces of varying surface charge. We have shown that a negative surface charge promotes osteoblast adhesion by approximately 60% over a neutral surface and that conversely, a positive surface charge inhibits osteoblast adhesion by about 20%. Continued examination of surface characteristics that control cellular responses are warranted with the eventual goal of applying those desirable surface characteristics to any structural biomaterial for bone implant or tissue engineering applications.
C1 Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.
RP Marcolongo, M (reprint author), Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.
CR ANDERSSON OH, 1992, J MATER SCI-MATER M, V3, P145, DOI 10.1007/BF00705283
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hunter R. J, 1981, ZETA POTENTIAL COLLO
   Lin W, 1997, BIOMATERIALS, V18, P559, DOI 10.1016/S0142-9612(96)00176-7
   LU HY, 1995, SURFACES BIOMATERIAL, P24
   MARCOLONGO M, 1998, J BIOMED MATER RES, V38, P160
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   POLLACK SR, 1984, ORTHOP CLIN N AM, V15, P3
   SEYFERT S, 1995, BIOMATERIALS, V16, P201, DOI 10.1016/0142-9612(95)92118-P
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   THOMAS KA, 1987, 33 ANN ORS, P432
NR 13
TC 6
Z9 6
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-456-4
J9 MATER RES SOC SYMP P
PY 1999
VL 550
BP 121
EP 126
PG 6
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Biotechnology & Applied Microbiology; Materials Science; Pharmacology &
   Pharmacy
GA BN11N
UT WOS:000080751700019
DA 2018-10-19
ER

PT S
AU Jacobs, JJ
   Glant, TT
AF Jacobs, JJ
   Glant, TT
BE Neenan, T
   Marcolongo, M
   Valentini, RF
TI The biology of corrosion and wear debris from orthopedic implants
SO BIOMEDICAL MATERIALS-DRUG DELIVERY, IMPLANTS AND TISSUE ENGINEERING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomedical Materials-Drug Delivery, Implants and Tissue
   Engineering
CY NOV 30-DEC 01, 1998
CL BOSTON, MA
SP Mat Res Soc
ID SYNOVIAL-LIKE MEMBRANE; TOTAL HIP REPLACEMENTS; BONE-CEMENT INTERFACE;
   JOINT PROSTHESES; RESORPTION; INTERLEUKIN-1; PROSTAGLANDINS; MEDIATORS;
   PARTICLES; INVITRO
AB Bone loss (osteolysis) following total joint arthroplasty has been a subject of increasing concern in the orthopedic research community. Depending on the distribution and severity, bone loss can lead to aseptic loosening, periprosthetic fracture and formidable reconstructive problems at revision surgery. Bone loss is believed to be primarily a response to particulate wear and corrosion debris derived from the prosthetic materials. Phagocytosed particulates activate macrophages and osteoblasts land perhaps fibroblasts to produce factors which stimulate osteoclastic bone resorption and reduce osteoblastic bone formation. To investigate the responses of these cells to particulate corrosion and wear debris, in vitro studies have been performed by measuring factors at both the molecular and cellular levels that may trigger, maintain and/or regulate particulate biomaterial-induced pathologic bone resorption. The biological effect of a particulate species depends upon their size, concentration (number) and composition, in the order listed. Particulate wear debris of phagocytosable size (less that 10 micrometers) activate macrophages, fibroblasts and osteoblasts more effectively that those of larger sizes. As a response to phagocytosed particulates, i) macrophages produce a number of cytokines (interleukins such as II-1,II-6, TNF-alpha) and prostaglandins, which may act either in an autocrine fashion or further stimulate cells present in the periprosthetic tissue; ii) fibroblasts secrete active forms of metalloproteinases; and iii) osteoblasts have diminished collagen type I synthesis. Taken together, particulate corrosion and wear debris provoke a series of biological responses which generate an active microenvironment around prosthetic components. Strategies to modify the host response to particulate degradation products have emerged from these in vitro studies. These strategies may provide pharmacotherapeutic solutions to this important clinical problem.
C1 Rush Arthrit & Orthoped Inst, Rush Med Coll, Dept Orthoped Surg, Chicago, IL 60612 USA.
RP Jacobs, JJ (reprint author), Rush Arthrit & Orthoped Inst, Rush Med Coll, Dept Orthoped Surg, 1725 W Harrison St,Suite 1063, Chicago, IL 60612 USA.
OI Jacobs, Joshua/0000-0003-3902-7334
CR AKATSU T, 1991, J BONE MINER RES, V6, P183
   Blaine TA, 1997, J BONE JOINT SURG AM, V79A, P1519, DOI 10.2106/00004623-199710000-00009
   BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142
   DINARELLO CA, 1991, BLOOD, V77, P1627
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   ELLIS JS, 1992, SCAND J IMMUNOL, V36, P49, DOI 10.1111/j.1365-3083.1992.tb02939.x
   GLANT TT, 1994, AGENTS ACTIONS, V41, pC172, DOI 10.1007/BF01987626
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Glant TT, 1996, AM J THER, V3, P27, DOI [10.1097/00045391-199601000-00006, DOI 10.1097/00045391-199601000-00006]
   GLANT TT, 1999, T ORTHOP RES SOC, V24, P246
   GLANT TT, 1994, T ORTHOP RES SOC, V19, P152
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOLDRING SR, 1992, CYTOKINES BONE METAB, P383
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0
   GOWEN M, 1992, CYTOKINES BONE METAB, P71
   HARVEY W, 1988, PROSTAGLANDINS BONE, P11
   HARVEY W, 1988, PROSTAGLANDINS BONE, P57
   Horowitz SM, 1996, J BIOMED MATER RES, V31, P91, DOI 10.1002/(SICI)1097-4636(199605)31:1<91::AID-JBM11>3.0.CO;2-P
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   Jacobs J J, 1992, Instr Course Lect, V41, P119
   JACOBS JJ, 1992, AM SOC TEST MATER, V1144, P52, DOI 10.1520/STP14851S
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   KUNKEL SL, 1986, J IMMUNOL, V136, P186
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   NISHIHARA T, 1989, J IMMUNOL, V143, P1881
   SCHINDLER R, 1990, BLOOD, V75, P40
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P33
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SHANBHAG AS, 1992, T ORTHOP RES SOC, V17, P342
   Skjodt H, 1992, CYTOKINES BONE METAB, P1
   URBAN RM, 1994, J BONE JOINT SURG AM, V76A, P1345, DOI 10.2106/00004623-199409000-00009
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1976, TOTAL HIP PROSTHESES, P205
   YAO J, 1994, T ORTHOP RES SOC, V19, P260
   YAO J, 1996, T ORTHOP RES SOC, V21, P497
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   YONEDA T, 1978, J EXP MED, V149, P279
NR 43
TC 0
Z9 0
U1 1
U2 3
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-456-4
J9 MATER RES SOC SYMP P
PY 1999
VL 550
BP 321
EP 329
PG 9
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Biotechnology & Applied Microbiology; Materials Science; Pharmacology &
   Pharmacy
GA BN11N
UT WOS:000080751700047
DA 2018-10-19
ER

PT J
AU Frayssinet, P
   Hanker, JS
   Rouquet, N
   Primout, I
   Giammara, B
AF Frayssinet, P
   Hanker, JS
   Rouquet, N
   Primout, I
   Giammara, B
TI Silver methenamine staining for scanning electron microscopy of bone
   sections containing biomaterials
SO BIOTECHNIC & HISTOCHEMISTRY
LA English
DT Article
DE back scatter; biomaterial; bone; SEM; silver methenamine
ID LIGHT-MICROSCOPY
AB Sections of tissue containing orthopedic materials are currently used to study the compatibility of those materials and to perform electron probe microanalysis at the material-tissue interface. Identification of the cells in contact with the material by Scanning electron microscopy (SEM) is of interest. We have developed a method for staining cells and tissue structures embedded in polymethyl methacrylate with silver methenamine once the sections have been obtained. Sections were prepared by grinding, and the silver methenamine was applied after oxidation with periodic acid. The procedure was carried out in a microwave oven. Backscatter SEM showed staining of the cell nucleus membrane, chromatin, the nuclear organizers, and the chromosomes of dividing cells, The cytoplasm and the cytoplasmic membrane were also stained. Collagen fibers of the extracellular matrix and the mineralized matrix of bone were labeled. Material particles in the macrophages were easily recognizable and Energy-Dispersive Spectrometer were not impaired by the presence of silver in the preparation.
C1 Bioland, F-31100 Toulouse, France.
   Univ N Carolina, Dept Bioengn, Chapel Hill, NC USA.
   Univ Ohio, Med Coll Ohio, Toledo, OH USA.
   Univ Toulouse 3, Lab Ossified Tissue & Joint Pathol, F-31062 Toulouse, France.
RP Frayssinet, P (reprint author), Bioland, 132 Rte Espagne, F-31100 Toulouse, France.
CR FRAYSSINET P, 1993, BIOTECH HISTOCHEM, V68, P333, DOI 10.3109/10520299309105639
   FRAYSSINET P, 1995, CELL MATER, V5, P125
   GOLDSTEIN JI, 1992, SCANNING ELECT MICRO, P69
   HANKER J, 1993, SCANNING, V15, P67, DOI 10.1002/sca.4950150203
   HANKER JS, 1964, SCIENCE, V146, P1039, DOI 10.1126/science.146.3647.1039
   *ISO, 109936 ISO 6
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   SELIGMAN AM, 1965, J HISTOCHEM CYTOCHEM, V13, P629, DOI 10.1177/13.8.629
NR 9
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1052-0295
J9 BIOTECH HISTOCHEM
JI Biotech. Histochem.
PD JAN
PY 1999
VL 74
IS 1
BP 10
EP 15
DI 10.3109/10520299909066471
PG 6
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 172XN
UT WOS:000078951100002
PM 10190255
DA 2018-10-19
ER

PT J
AU Rezania, A
   Healy, KE
AF Rezania, A
   Healy, KE
TI Biomimetic peptide surfaces that regulate adhesion, spreading,
   cytoskeletal organization, and mineralization of the matrix deposited by
   osteoblast-like cells
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID HEPARIN-BINDING DOMAIN; BONE-DERIVED CELLS; ARG-GLY-ASP;
   SPATIAL-DISTRIBUTION; MEDIATED ADHESION; POLYMER NETWORKS; FOCAL
   CONTACT; FIBRONECTIN; SIALOPROTEIN; ATTACHMENT
AB In an effort to regulate mammalian cell behavior in contact with solid material surfaces, we have functionalized surfaces with different ratios of both the putative cell binding (-Arg-Gly-Asp-) domain and a consensus heparan-binding domain. The peptide sequences -Arg-Gly-Asp- (-RGD-) and -Phe-His-Arg-Arg-Ile-Lys-Ala- (-FHRRIKA-) or mixtures of the two in the ratios of 75:25 (mimetic peptide surface I), 25:75 (mimetic peptide surface II), and 50:50 (mimetic peptide surface III) were immobilized on model surfaces using a heterobifunctional cross-linker to link the peptide(s) to amine-functionalized quartz surfaces. Contact angle measurements, spectroscopic ellipsometry, and X-ray photoelectron spectroscopy were used to confirm the chemistry, thickness of the overlayers, and surface density of immobilized peptides (similar to 4-6 pmol/cm(2)). The degree of rat calvaria osteoblast-like cell spreading, focal contact formation, cytoskeletal organization, proliferation, and mineralization of the extracellular matrix (ECM) on model biomaterial surfaces was examined. Mimetic peptide surface II (MPS II) and MPS III supported the highest degree of cell spreading (p < 0.05), following 4 h of incubation, compared to MPS I, homogeneous -RGD-, and homogeneous -FHRRIKA- grafted surfaces. Furthermore, MPS I, MPS II, MPS III, and homogeneous -RGD- surfaces promoted the formation of focal contacts and stress fibers by attached bone cells. The strength of bone cell detachment following 30 min of incubation was significantly higher (p < 0.05) on MPS II surfaces compared to homogeneous -RGD- and -FHRRIKA-. However, the degree of cell proliferation on the peptide surfaces were not significantly different from each other (p > 0.1). Following 24 d in culture, the areas of mineralized ECM formed on MPS II and MPS III surfaces were significantly (p < 0.05) larger than those of other surfaces. These results demonstrate that utilizing peptide sequences incorporating bath cell- and heparin-adhesive motifs can enhance the degree of cell surface interactions and influence the long-term formation of mineralized ECM in vitro.
C1 Northwestern Univ, Div Biol Mat, Chicago, IL 60611 USA.
   Northwestern Univ, Dept Biomed Engn, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60201 USA.
RP Healy, KE (reprint author), Northwestern Univ, Div Biol Mat, 311 E Chicago Ave, Chicago, IL 60611 USA.
EM kehealy@nwu.edu
FU NIAMS NIH HHS [R01AR43187]
CR AOTA S, 1991, J BIOL CHEM, V266, P15938
   BACIU PC, 1995, MOL BIOL CELL, V6, P1503
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   BOBERBARKALOW FJ, 1991, J BIOL CHEM, V266, P7812
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P766, DOI 10.1002/jor.1100100604
   Buck C A, 1987, J Cell Sci Suppl, V8, P231
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dickson G, 1984, METHODS CALCIFIED TI
   DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845
   DRUMHELLER PD, 1994, BIOTECHNOL BIOENG, V43, P772, DOI 10.1002/bit.260430812
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HORTON M, 1990, INT J EXP PATHOL, V71, P741
   HUBBELL JA, 1992, NY ACAD SCI, V655, P253
   LATERRA J, 1983, J CELL BIOL, V96, P112, DOI 10.1083/jcb.96.1.112
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MINTZ KP, 1993, J BONE MINER RES, V8, P985
   OLDBERG A, 1988, J BIOL CHEM, V263, P19433
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   REZANIA A, UNPUB LANGMUIR
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   SafiejkoMroczka B, 1996, J HISTOCHEM CYTOCHEM, V44, P641, DOI 10.1177/44.6.8666749
   Seiffert D, 1996, J HISTOCHEM CYTOCHEM, V44, P275, DOI 10.1177/44.3.8648088
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SOMERMAN MJ, 1988, CALCIFIED TISSUE INT, V43, P50, DOI 10.1007/BF02555169
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VUKICEVIC S, 1990, CELL, V63, P437, DOI 10.1016/0092-8674(90)90176-F
   VUUST J, 1972, J BIOL CHEM, V247, P856
   WANG J, 1998, T 44 ANN ORTH RES SO, P1007
   WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   WOODS A, 1993, MOL BIOL CELL, V4, P605
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   WOODS A, 1992, J CELL SCI, V101, P277
   WU P, 1994, ANN BIOMED ENG, V22, P144, DOI 10.1007/BF02390372
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
NR 51
TC 233
Z9 246
U1 1
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JAN-FEB
PY 1999
VL 15
IS 1
BP 19
EP 32
DI 10.1021/bp980083b
PG 14
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 166DJ
UT WOS:000078560700003
PM 9933510
DA 2018-10-19
ER

PT J
AU Bakos, D
   Koniarova, D
AF Bakos, D
   Koniarova, D
TI Collagen and collagen/hyaluronan complex modifications
SO CHEMICAL PAPERS
LA English
DT Article; Proceedings Paper
CT 26th Conference of the Slovak-Society-of-Chemical-Engineering
CY MAY 24-28, 1999
CL JASNA, SLOVAKIA
SP Slovak Soc Chem Engn
ID LAYERED ATELOCOLLAGEN; FIXED PERICARDIUM; GLUTARALDEHYDE; BIOPROSTHESES;
   SKIN
AB Chemical analogues of extracellular matrix are mainly graft copolymers of collagen and glycosaminoglycans. The new complex matrix based on collagen and hyaluronan was used to develop a synthetic derma. The chemical treatment with hexamethylene diisocyanate with poly(oxyethylene glycol) resp. with poly(oxypropylene glycol) was chosen for improving mechanical properties. The study of mechanical properties, enzymatic degradation, and cytotoxicity after chemical treatment was first performed with pure collagen membranes and subsequently optimized to the complex membrane of collagen with hyaluronan. We suppose that the combination of excellent biological properties of both the polymers with lower enzymatic degradation and decreasing swelling after chemical modification can result in a valuable biomaterial for several medical applications.
C1 Slovak Univ Technol Bratislava, Fac Chem Technol, Dept Plast & Rubber, SK-81237 Bratislava, Slovakia.
RP Bakos, D (reprint author), Slovak Univ Technol Bratislava, Fac Chem Technol, Dept Plast & Rubber, SK-81237 Bratislava, Slovakia.
EM bakos@cvt.stuba.sk
OI Harvanova, Denisa/0000-0002-3038-7520
CR CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   PETERS WJ, 1980, ANN PLAST SURG, V41, P133
   Pomahac B, 1998, CRIT REV ORAL BIOL M, V9, P333, DOI 10.1177/10454411980090030601
   PRUITT BA, 1984, ARCH SURG-CHICAGO, V119, P312
   PUSA V, 1990, LEKAR TECHNIKA, V6, P130
   SHRIVASTAVA S, 1990, BIOMATERIALS, V11, P155
   SILVER FH, 1994, BIOMATERIALS MED DIS
   SILVER FH, 1994, MED DEVICES TISSUE E
   VIZAROVA K, 1994, BIOMATERIALS, V15, P1082, DOI 10.1016/0142-9612(94)90094-9
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
NR 17
TC 3
Z9 3
U1 0
U2 0
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 0366-6352
J9 CHEM PAP
JI Chem. Pap.
PY 1999
VL 53
IS 6
BP 431
EP 435
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 283YC
UT WOS:000085302800017
DA 2018-10-19
ER

PT J
AU Torrent-Burgues, J
   Gomez-Morales, J
   Lopez-Macipe, A
   Rodriguez-Clemente, R
AF Torrent-Burgues, J
   Gomez-Morales, J
   Lopez-Macipe, A
   Rodriguez-Clemente, R
TI Continuous precipitation of hydroxyapatite from Ca/citrate/phosphate
   solutions using microwave heating
SO CRYSTAL RESEARCH AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th Polish Conference on Crystal Growth (PCCG-V)
CY MAY 10-13, 1998
CL NALECZOW, POLAND
SP Polish Minist Higher Educ, State Comm Scientif Res
DE nanosized hydroxyapatite; microwave heating; continuous precipitation;
   batch precipitation; complexed solutions; biomaterial
AB fThe precipitation of hydroxyapatite (HAp) in a continuous process using microwave heating and Ca/citrate/phosphate solutions is presented. Calcium deficient HAp particles in the nanometric size range (<100 nm), with needle-like morphology, were obtained. These chemical and morphological characteristics do not change with the residence time, and are similar to those of HAp obtained in a batch process using also microwave heating and Ca/citrate/phosphate solutions. On the other hand, the steady state is reached faster than in the precipitation of HAp in a MSMPR reactor using non-complexing solutions and conventional heating. In the latter process submicronic (< 1 mu m) needle-like particles are obtained.
C1 Univ Politecn Catalunya, Dept Engn Quim, E-08222 Terrassa, Spain.
   CSIC, Inst Ciencia Mat Barcelona, E-08193 Barcelona, Spain.
RP Torrent-Burgues, J (reprint author), Univ Politecn Catalunya, Dept Engn Quim, C Colom 1, E-08222 Terrassa, Spain.
RI Gomez-Morales, Jaime/M-3985-2014
OI Gomez-Morales, Jaime/0000-0002-9395-7797; Torrent-Burgues,
   Juan/0000-0002-4952-736X
CR GOMEZMORALES J, IN PRESS
   Kanazawa T., 1989, MAT SCI MONOGRAPHS, V52
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Lopez-Macipe A, 1998, ADV MATER, V10, P49, DOI 10.1002/(SICI)1521-4095(199801)10:1<49::AID-ADMA49>3.0.CO;2-R
   Lopez-Macipe A, 1998, J COLLOID INTERF SCI, V200, P114, DOI 10.1006/jcis.1997.5343
   TORRENTBURGUES J, 1998, QUIMICA IND, V3, P148
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
NR 9
TC 22
Z9 22
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0232-1300
J9 CRYST RES TECHNOL
JI Cryst. Res. Technol.
PY 1999
VL 34
IS 5-6
BP 757
EP 762
DI 10.1002/(SICI)1521-4079(199906)34:5/6<757::AID-CRAT757>3.3.CO;2-C
PG 6
WC Crystallography
SC Crystallography
GA 212BG
UT WOS:000081196000030
DA 2018-10-19
ER

PT J
AU Prakasham, RS
   Merrie, JS
   Sheela, R
   Saswathi, N
   Ramakrishna, SV
AF Prakasham, RS
   Merrie, JS
   Sheela, R
   Saswathi, N
   Ramakrishna, SV
TI Biosorption of chromium VI by free and immobilized Rhizopus arrhizus
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE bioremediation; biosorption; chromium; heavy metal; Rhizopus arrhizus;
   wastewater treatment
ID HEAVY-METALS; BIOMASS; ALGAE; ACCUMULATION; MICROALGAE; REMOVAL
AB Biosorption of chromium (VI) was studied by using non-living free and immobilized biomass of Rhizopus arrhizus at pH 2. A biphasic chromium adsorption pattern was observed in all experimental conditions. Chromium removal rate was slightly more in free biomass conditions over immobilized state. Stirred tank reactor studies indicated maximum chromium biosorption at 100 rpm and at 1:10 biomass-liquid ratio. Fluidized bed reactor is more efficient in chromium removal over stirred tank reactor. Immobilization of biomaterial has a little effect on chromium biosorption by this R. arrhizus biomass. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Indian Inst Chem Technol, Biochem & Environm Engn Grp, Hyderabad 500007, Andhra Pradesh, India.
   CSIR, Reg Res Lab, Biochem Proc & Wastewater Technol Div, Trivandrum 695019, Kerala, India.
RP Prakasham, RS (reprint author), Indian Inst Chem Technol, Biochem & Environm Engn Grp, Hyderabad 500007, Andhra Pradesh, India.
EM root@csiict.ren.nic.in
RI TVM, NIIST/E-5132-2012
OI TVM, NIIST/0000-0002-5814-466X
CR [Anonymous], 1986, STAND METH EX WAT WA
   BESZEDITS S, 1983, ENG DIG          MAR, P18
   Brierley C. L., 1990, MICROBIAL MINERAL RE, P303
   BRIERLEY CL, 1993, BIOHYDROMETALLURGICA, V2, P35
   CRIST RH, 1988, ENVIRON SCI TECHNOL, V22, P755, DOI 10.1021/es00172a002
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   Freundlich H., 1926, COLLOID CAPILLARY CH
   GARNHAM GW, 1993, APPL MICROBIOL BIOT, V39, P666, DOI 10.1007/BF00205072
   KUYUCAK N, 1989, Biorecovery, V1, P189
   KUYUCAK N, 1989, BIOTECHNOL BIOENG, V33, P809, DOI 10.1002/bit.260330703
   Kuyucak N., 1990, BIOSORPTION HEAVY ME, P173
   LEUSCH A, 1995, J CHEM TECHNOL BIOT, V62, P279, DOI 10.1002/jctb.280620311
   MAHAN CA, 1992, ANAL CHEM, V64, P1933, DOI 10.1021/ac00041a031
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1300
   MALLICK N, 1994, WORLD J MICROB BIOT, V10, P439, DOI 10.1007/BF00144469
   MATTOX DM, 1993, CRIT REV SURF CHEM, V2, P125
   NIU H, 1993, BIOTECHNOL BIOENG, V42, P785, DOI 10.1002/bit.260420615
   Sherwood T. K, 1975, MASS TRANSFER
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   TSEZOS M, 1988, BIOTECHNOL BIOENG, V32, P545, DOI 10.1002/bit.260320418
   Verma N., 1996, J IND POLL CONT, V12, P55
   VISHWANATHAM M, 1997, P INT C IND POLL CON, P491
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   ZHOU JL, 1991, J CHEM TECHNOL BIOT, V52, P317
NR 24
TC 164
Z9 177
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
J9 ENVIRON POLLUT
JI Environ. Pollut.
PY 1999
VL 104
IS 3
BP 421
EP 427
DI 10.1016/S0269-7491(98)00174-2
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 159MZ
UT WOS:000078178700012
DA 2018-10-19
ER

PT B
AU Niinomi, M
   Akahori, T
   Fukunaga, K
   Eylon, D
AF Niinomi, M
   Akahori, T
   Fukunaga, K
   Eylon, D
BE Boyer, RR
   Eylon, D
   Lutjering, G
TI Fatigue crack initiation and fatigue life prediction of Ti-6Al-4V ELI
SO FATIGUE BEHAVIOR OF TITANIUM ALLOYS
LA English
DT Proceedings Paper
CT International Symposium on Fatigue Behavior of Titanium Alloys at the
   1998 TMS Fall Meeting
CY OCT 11-15, 1998
CL CHIGACO, IL
SP TMS
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS
AB Fatigue crack initiation characteristics of Ti-6Al-4V ELI with equiaxed alpha and Widmanstatten alpha structures, which had been standardized as a biomaterial by ASTM, were investigated with relating microstructure. Relationship between fatigue damage and mechanical properties of the same alloy were also investigated in this study.
   The fatigue crack initiates mainly at the interface between primary alpha grains in equiaxed alpha structure while that initiates in the colony along about 45 degrees direction versus stress axis in Widmanstatten alpha structure. The fatigue crack initiation period occupies about 40 similar to 50 % portion of total fatigue life in equiaxed alpha structure while that occupies more than 90 % assumed that the crack initiation occurs when the surface crack length, 2a, is 30 mu m.
   The tensile strength of fatigued specimens with equiaxed alpha and Widmanstaten alpha structure at various fatigue conditions increases clearly according to the fatigue steps at the first period of low cycle fatigue (LCF) region, while the elongation and impact toughness show the reverse trend. The hardness far from the specimen surface is greater than that near the specimen surface at the early stage of LCF. Both hardness is however nearly equal each other at the latter stage of fatigue. The damage ratio of mechanical properties after fatigue is relatively greater in equiaxed alpha structure. Each mechanical property after fatigue and fatigue life relates each other systematically in LCF region.
C1 Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
CR Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1996, JOM-J MIN MET MAT S, V48, P55, DOI 10.1007/BF03223000
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
NR 3
TC 5
Z9 5
U1 1
U2 4
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-434-8
PY 1999
BP 307
EP 314
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BP05G
UT WOS:000083970300031
DA 2018-10-19
ER

PT B
AU Kitano, T
AF Kitano, T
BE Nishinari, K
TI Changes of the properties of colloid in arthritic synovial fluid
SO HYDROCOLLOIDS, PT 2: FUNDAMENTALS AND APPLICATIONS IN FOOD, BIOLOGY, AND
   MEDICINE
LA English
DT Proceedings Paper
CT Osaka-City-University International Symposium 98/4th International
   Conference on Hydrocolloids
CY OCT 04-10, 1998
CL OSAKA, JAPAN
SP Osaka City Univ
ID BIOMATERIALS
AB The colloids in joint fluid play parts in homeostasis of articular cartilage, protection from microorganism, joint lubrication, and etc.. The study of human joint from the point of view of colloid science will contribute to the clinic al medicine, e.g. orthopaedic surgery, sports medicine, and rehabilitation medicine. Measurements of zeta-potential of particulate biomaterial in inflammatory synovial fluid with changes in pH and protein constituents revealed that the value of zeta-potential particulate biomaterial depend on pH and protein constituent. Bacterial adhesion study revealed that the initial process of bacterial adhesion on natural and artificial joint surfaces depend on the polarity component of surface free energy. Friction test revealed that albumin constituent in protein rich hyaluronan solution reduces the coefficient of friction of UHMWPE to SUS to minimum value at pH 8.0 at the walking speed.
C1 Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan.
RP Kitano, T (reprint author), Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.
CR DELECRIN J, 1994, CLIN ORTHOP RELAT R, P240
   Kitano T, 1998, J BIOMED MATER RES, V42, P453, DOI 10.1002/(SICI)1097-4636(19981205)42:3<453::AID-JBM15>3.0.CO;2-H
   Kitano T, 1996, INT J ARTIF ORGANS, V19, P353
   KITANO T, 1997, T ORTHOP RES SOC, V43, P760
   MCCARTY DJ, 1989, ARTHRITIS ALLIED CON, P69
   SIMON SR, 1994, ORTHOPAEDIC BASIC SC, P434
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 0-444-50178-9
PY 1999
BP 331
EP 336
PG 4
WC Chemistry, Applied; Engineering, Chemical; Food Science & Technology;
   Polymer Science
SC Chemistry; Engineering; Food Science & Technology; Polymer Science
GA BP80R
UT WOS:000086246500041
DA 2018-10-19
ER

PT J
AU Rakhorst, G
   Van der Mei, HC
   Van Oeveren, W
   Spijker, HT
   Busscher, HJ
AF Rakhorst, G
   Van der Mei, HC
   Van Oeveren, W
   Spijker, HT
   Busscher, HJ
TI Time-related contact angle measurements with human plasma on biomaterial
   surfaces
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE contact angle; protein adsorption; biomaterials; biocompatibility
AB Axisymmetric drop shape analysis by profile (ADSA-P) was used to assess in time contact angle changes of human plasma drops placed on four different biomaterials. Results were related with conventional blood compatibility measurements: albumin adsorption, fibrinogen adsorption and platelet adhesion. While contact angle measurements with water are material-related but constant in time, contact angle measurements with plasma changed over time owing to protein adsorption on the solid-liquid interface. The contact medium plasma did not influence the initial contact angle. Contact angles on PDMS decreased most in time (41 degrees) and demonstrated highest levels of conventionally measured albumin and fibrinogen adsorption and platelet adhesion. PTFE, with the lowest contact angle decrease over a 500 minutes period (19 degrees), showed low fibrinogen and albumin adsorption as well as low platelet adhesion. PU and HDPE demonstrated almost similar initial contact angles with plasma and contact angle decreases (26 and 27 degrees), intermediate protein adsorption, and platelet adhesion. We conclude that biocompatibility properties of the tested materials may be more related to the behaviour of their contact angles in time, than to the initial hydrophobic or hydrophilic state.
C1 Univ Groningen, Inst Biomed Mat Sci & Applicatio, Div Artificial Organs, Groningen, Netherlands.
   Univ Groningen, Dept Cardiol & Thorac Surg, Groningen, Netherlands.
RP Rakhorst, G (reprint author), Fac Med, BMSA, Div Artificial Organs, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR CASENAVE JP, 1986, BLOOD SURFACE INTERA, P89
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   Gross DR, 1997, INT J ARTIF ORGANS, V20, P195
   *INT ORG STAND, 1997, 10993 ISO FDS 1 16
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   NOORDMANS J, 1991, COLLOID SURFACE, V58, P239, DOI 10.1016/0166-6622(91)80224-C
   VANDERSCHEER A, 1978, J COLLOID INTERF SCI, V63, P7, DOI 10.1016/0021-9797(78)90029-2
   VANDERVEGT W, 1995, THESIS GRONINGEN, P27
   VOIGT A, 1991, COLLOID SURFACE, V58, P315, DOI 10.1016/0166-6622(91)80231-C
   ZUCKER MB, 1969, P EXP SOC BIOL MED, P318
NR 11
TC 5
Z9 5
U1 4
U2 20
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JAN
PY 1999
VL 22
IS 1
BP 35
EP 39
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 169FA
UT WOS:000078735800008
PM 10098583
DA 2018-10-19
ER

PT B
AU Watari, F
   Takahashi, M
   Yada, K
AF Watari, F
   Takahashi, M
   Yada, K
BE Koiwa, M
   Otsuka, K
   Miyazaki, T
TI X-ray diffraction study of carburization transformation from tantalum to
   tantalum carbide
SO JAPAN INSTITUTE OF METALS, PROCEEDINGS, VOL 12, (JIMIC-3), PTS 1 AND 2:
   SOLID - SOLID PHASE TRANSFORMATIONS
LA English
DT Proceedings Paper
CT International Conference on Solid-Solid Phase Transformations (PTM 99)
CY MAY 24-28, 1999
CL KYOTO, JAPAN
SP Japan Inst Met, Iron & Steel Inst Japan, Phys Soc Japan, Mat Sci Soc Japan, Chem Soc Japan, Crystallog Soc Japan, Soc Polymer Sci, Japanese Assoc Crystal Growth, Japan Soc Heat Treatment, Atomic Energy Soc Japan, Surface Sci Soc Japan, Japan Welding Engn Soc, Min & Mat Proc Inst Japan, Japan Soc Corros Engn, Japan Soc Powder & Powder Met, Chinese Soc Met, Federat European Met Soc, Soc Francaise Met & Mat, Soc Francaise Phys, Deutsch Gesell Materialkunde E V, Inst Nazl Fisica Mat, Korean Inst Met & Mat, Swedish Soc Mat Technol, Inst Mat, Minerals Met & Mat Soc
DE carburization; transformation; tantalum; tantalum carbide; biomaterial;
   emitter; single crystal; X-ray diffraction; orientation relation; Laue
   method; surface morphology
AB he orientation relationship between Ta and TaC formed by carburization was determined by X-ray diffraction and the mechanism of transformation was considered. After the thin foil of Ta(011) single crystal was carburized by heating in benzene vapor and the products were identified by microdiffractometry, the single crystal X-ray diffraction experiments were done for the specimens before and after carburization. The Laue method showed that the product was TaC with the orientation relationship to the initial Ta matrix as Ta(011)[01 (1) under bar]//TaC(112)[11 (1) over bar]. Observation by optical microscopy and SEM showed that the striation was formed perpendicularly to TaC[11 (1) under bar] direction on the surface of TaC. Both the orientation relationship between crystal structures and surface morphology of striae formation could be explained by the shear motion of TaC(11 (1) under bar) atomic plane to the [112] direction which makes the stacking sequence of close packed planes change from bcc to fee lattice.
C1 Hokkaido Univ, Sch Dent, Dept Dent Mat & Engn, Sapporo, Hokkaido 0608586, Japan.
RP Watari, F (reprint author), Hokkaido Univ, Sch Dent, Dept Dent Mat & Engn, Sapporo, Hokkaido 0608586, Japan.
CR KEIJI YAD, 1982, J ELECT MICROSCOPY, V31, P349
NR 1
TC 0
Z9 0
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-401-3
PY 1999
BP 317
EP 320
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BP88D
UT WOS:000086479100070
DA 2018-10-19
ER

PT B
AU Nakashima, Y
   Sun, DH
   Trindade, M
   Maloney, WJ
   Goodman, SB
   Schurman, DJ
   Smith, RL
   Ushijima, M
   Iwamoto, Y
AF Nakashima, Y
   Sun, DH
   Trindade, M
   Maloney, WJ
   Goodman, SB
   Schurman, DJ
   Smith, RL
   Ushijima, M
   Iwamoto, Y
BE Imura, S
   Wada, M
   Omori, H
TI Expression of inflammatory mediators by human macrophages in response to
   particulate debris in vitro
SO JOINT ARTHROPLASTY
LA English
DT Proceedings Paper
CT 28th Annual Meeting of the Japanese-Society-for-Replacement-Arthroplasty
CY MAR, 1998
CL KANAZAWA, JAPAN
SP Japanese Soc Replacement Arthroplasty
DE total joint arthroplasty; particulate debris; osteolysis; macrophage;
   bone resorption
ID BONE-RESORPTION; MATRIX METALLOPROTEINASES; HIP-ARTHROPLASTY; IN-VITRO;
   PARTICLES; BIOLOGY; PROSTHESES; CYTOKINES; TUMOR; CELLS
AB This paper reports the induction of proinflammatory mediators in human macrophages in response to orthopedic biomaterial wear particles. Human macrophages from healthy subjects were exposed to titanium alloy and polymethylmethacrylate (PMMA) particles in vitro. Expression of proinflammatory cytokines and matrix metalloproteinases (MMPs) were analyzed biochemically. Titanium alloy particles induced macrophage release of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). Titanium alloy and PMMA particles also stimulated macrophage release of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a dose- and time-dependent manner. Particulate debris also induced increased levels of MMP-1, -2 and -9 in a dose- and time-dependent manner. These data demonstrated that particulate debris induced proinflammatory mediator expression in isolated macrophages. Expression of these mediators by wear debris may accelerate periprosthetic bone resorption and granuloma formation.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Nakashima, Y (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, R144,300 Pasture Dr, Stanford, CA 94305 USA.
CR BRIELAND JK, 1995, AM J RESP CELL MOL, V12, P104, DOI 10.1165/ajrcmb.12.1.7811465
   CHIBA J, 1996, T ORTHOP RES SOC, V21, P514
   DRISCOLL KE, 1994, EXP LUNG RES, V20, P473, DOI 10.3109/01902149409031733
   FROKJAER J, 1995, ACTA ORTHOP SCAND, V66, P303, DOI 10.3109/17453679508995549
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   ISHIGURO N, 1997, T ORTHOP RES SOC, V22, P735
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JIANG YL, 1992, J IMMUNOL, V148, P2423
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17
   MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   TAKAGI M, 1994, CLIN ORTHOP RELAT R, P136
   TAKAGI M, 1994, ACTA ORTHOP SCAND, V65, P281, DOI 10.3109/17453679408995454
   TAUB DD, 1993, CYTOKINE, V5, P175, DOI 10.1016/1043-4666(93)90001-L
   Ueda Y, 1996, AM J PATHOL, V148, P611
   VAES G, 1988, CLIN ORTHOP RELAT R, P239
   WILLERT HG, 1981, TRIBOLOGY NATURAL AR, P381
   WOESSNER J, 1992, FASEB J, V5, P2145
   Yokohama Y, 1995, LAB INVEST, V73, P899
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 4-431-70241-5
PY 1999
BP 65
EP 75
PG 11
WC Materials Science, Biomaterials; Orthopedics; Surgery
SC Materials Science; Orthopedics; Surgery
GA BP76Y
UT WOS:000086113200007
DA 2018-10-19
ER

PT B
AU Iwata, H
   Maruno, S
   Itoh, H
   Ban, S
   Yamada, K
   Kitamura, S
   Hasegawa, Y
   Ishiguro, N
AF Iwata, H
   Maruno, S
   Itoh, H
   Ban, S
   Yamada, K
   Kitamura, S
   Hasegawa, Y
   Ishiguro, N
BE Imura, S
   Wada, M
   Omori, H
TI Characterization and biological application of
   hydroxyapatite-glass-titanium (HA-G-Ti) functional gradient composite
   material
SO JOINT ARTHROPLASTY
LA English
DT Proceedings Paper
CT 28th Annual Meeting of the Japanese-Society-for-Replacement-Arthroplasty
CY MAR, 1998
CL KANAZAWA, JAPAN
SP Japanese Soc Replacement Arthroplasty
DE arthroplasty; hydroxyapatite containing glass-coated Ti stem; cementless
   hip; functional gradient system; early osteoconduction
ID INVITRO
AB Osteolysis has emerged as a common cause of loosening in cementless total hip arthroplasty. For the purpose of resolving osteolysis, plasma-sprayed hydroxyapatite (HA)-coated Ti implants were developed. However, delamination of HA has often occurred. There is a serious problem of adhesive quality between the HA layer and the substrate, mainly caused by the large difference in the linear thermal expansion coefficient between the substrate and WA. Bioactive composites comprising HA containing glass (G)-coated titanium (Ti) or titanium alloy (Ti-6Al-V-4), so-called HA-G-TI functional gradient composite materials, providing both the bioactivity potential due to the HA and the mechanical strength of titanium or alloy, were subjected to experiments under in vitro and in vivo conditions. In the former, as a characterization of HA-G-Ti composites, the structural features and properties, chemical stability, and electrochemical corrosion and then the bioactivity, involving the precipitation of apatite under physiological conditions, are summarized. In the latter, the experiments of implantation of the HA-G-Ti composites into mandibular bone, femur, and tibia of dogs were performed. The bonding behavior at the interface between the implants and the surrounding bone tissue, as well as the bonding strength and histocompatibility, have been extensively investigated. It is concluded that the HA-G-Ti composite is an excellent biomaterial, applicable in prostheses such as cementless artificial joints (HAPG-Profile). Clinical trials of HAPG-Profile are now going on.
C1 Nagoya Univ, Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668550, Japan.
RP Iwata, H (reprint author), Nagoya Univ, Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.
RI Ishiguro, Naoki/I-1563-2012
CR BAN S, 1991, BIOMATERIALS, V12, P205, DOI 10.1016/0142-9612(91)90201-K
   BAN S, 1990, JPN J APPL PHYS 2, V29, pL1523, DOI 10.1143/JJAP.29.L1523
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   HASTINGS GW, 1989, BIOCERAMICS, V1, P355
   ISHIMARU H, 1990, BIOCERAMICS, V2, P219
   IWATA H, 1989, BIOCERAMICS, V1, P411
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1987, YOGYO-KYOKAI-SHI, V95, P785
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   MARUNO S, 1992, T 4 WORLD BIOM C APR, P255
   MARUNO S, 1990, BIOCERAMICS, V2, P321
   MARUNO S, 1990, HDB BIOACTIVE CERAMI, V2, P187
   MARUNO S, 1992, BIOCERAMICS, V5, P165
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   UKEGAWA Y, 1990, BIOCERAMICS, V2, P227
   VOGEL W, 1985, J NON-CRYST SOLIDS, V73, P593, DOI 10.1016/0022-3093(85)90378-3
NR 22
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 4-431-70241-5
PY 1999
BP 238
EP 251
PG 14
WC Materials Science, Biomaterials; Orthopedics; Surgery
SC Materials Science; Orthopedics; Surgery
GA BP76Y
UT WOS:000086113200021
DA 2018-10-19
ER

PT J
AU Labow, RS
   Meek, E
   Santerre, JP
AF Labow, RS
   Meek, E
   Santerre, JP
TI Synthesis of cholesterol esterase by monocyte-derived macrophages: A
   potential role in the biodegradation of poly(urethane)s
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE poly(urethane)s; monocyte-derived macrophages; cholesterol esterase;
   biodegradation; biocompatibility
ID COLONY-STIMULATING FACTOR; GIANT-CELL FORMATION; POLY(ETHERURETHANE
   UREA) ELASTOMERS; IN-VIVO; THEORETICAL-ANALYSIS; STRESS CRACKING;
   DEGRADATION; INVITRO; POLYURETHANES; SECRETION
AB Many studies have described the role of monocyte-derived macrophages (MDM) in inflammation leading to atherosclerosis, a process in which alterations in the metabolism of cholesterol esters is well established. On the other hand, the mechanism of MDM activation in response to biomaterial surfaces is still not well understood. Several studies have described the different degrees of activation of monocytes on poly(urethane) surfaces by measuring the release of early markers of differentiation, such as cytokines. It has been possible to decrease MDM activation in contact with materials by modifying the material surface with antioxidants. Therefore, it has been proposed that it is the reactive oxygen species provided by MDM which are responsible for deleterious effects observed in material-derived inflammation. A recent study has shown that one of the markers of the degree of differentiation of MDM is the synthesis of cholesterol esterase (CE), an enzyme demonstrated as causing biodegradation of polyester(urethane)s and more recently polyether- and polycarbonate-poly(urethane)s as well. In this review article, markers used to assess MDM differentiation on material surfaces will be described and related to the activation of MDM. In particular, the CE accumulation in MDM which is associated with atherosclerosis will be related to its degradative potential during chronic inflammation. How this may impact on the biostability of implanted poly(urethane) medical devices is discussed.
C1 Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Univ Toronto, Fac Dent, Toronto, ON, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDERSON JM, 1992, BIODEGRADABLE POLYM
   BEAN TA, 1994, J BIOMED MATER RES, V28, P59, DOI 10.1002/jbm.820280108
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   Carson RJ, 1996, J BIOMATER APPL, V11, P121, DOI 10.1177/088532829601100201
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   DEPPISCH R, 1994, KIDNEY INT, V45, pS77
   DOHERTY DE, 1987, J IMMUNOL, V138, P1762
   Graham A, 1996, ATHEROSCLEROSIS, V120, P135, DOI 10.1016/0021-9150(95)05695-5
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1973, ARTHRITIS RHEUM, V16, P207
   HENSON PM, 1971, J EXP MED 2, V134, P1145
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   INABA T, 1993, J CLIN INVEST, V92, P750, DOI 10.1172/JCI116646
   ISHII I, 1994, BBA-LIPID LIPID MET, V1212, P278, DOI 10.1016/0005-2760(94)90201-1
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KELLEY JL, 1987, EXP MOL PATHOL, V46, P266, DOI 10.1016/0014-4800(87)90049-9
   Keogh JR, 1996, BIOMATERIALS, V17, P1987, DOI 10.1016/0142-9612(96)00005-1
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0
   LU HM, 1994, J APPL BIOMATER, V5, P1
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   Maurin N, 1997, J BIOMED MATER RES, V34, P73
   MCCARTHY K, 1979, J IMMUNOL, V123, P2511
   MCCARTHY K, 1982, J RETICULOENDOTH SOC, V31, P131
   MCCLOSKEY CB, 1998, 24 ANN M SOC BIOM SA
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   NOBLE PW, 1993, J IMMUNOL, V151, P979
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PERREGAUX D, 1992, J IMMUNOL, V149, P1294
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Schubert MA, 1997, J BIOMED MATER RES, V34, P493, DOI 10.1002/(SICI)1097-4636(19970315)34:4<493::AID-JBM10>3.0.CO;2-E
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Schubert MA, 1996, J BIOMED MATER RES, V32, P493, DOI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
   SCHUBERT MA, J BIOMED MAT RES, V34
   SHAND JH, 1995, LIPIDS, V30, P763, DOI 10.1007/BF02537804
   SINCLAIR TM, 1993, PLAST RECONSTR SURG, V92, P1003, DOI 10.1097/00006534-199311000-00001
   SKARLATOS SI, 1992, J TISS CULT METH, V14, P113
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1993, CARDIOVASC PATHOL, V2, pS111
   STOKES K, 1984, ANTEC 84, P1073
   Suyama T, 1997, ENZYME MICROB TECH, V20, P122, DOI 10.1016/S0141-0229(96)00084-1
   SWANSON JA, 1992, J CELL SCI, V103, P201
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   Tang YW, 1997, BIOMATERIALS, V18, P37, DOI 10.1016/S0142-9612(96)00101-9
   TANG YW, 1988, BIOSTABILITY POLYCAR
   Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613
   Tomita T, 1996, BBA-LIPID LIPID MET, V1300, P210, DOI 10.1016/0005-2760(96)00009-4
   TYLER BJ, 1993, J BIOMED MATER RES, V27, P327, DOI 10.1002/jbm.820270306
   WANG FGB, 1997, DETECTION TOLUENE DI
   WANG GB, 1997, J BIOMED MATER RES, V35, P207
   WATANABE Y, 1995, ANN NY ACAD SCI, V748, P357
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WILLIAMS DF, 1977, J BIOENG, V1, P279
   WU YK, 1994, J BIOMED MATER RES, V28, P515, DOI 10.1002/jbm.820280414
   ZDRAHALA RJ, 1997, J BIOMATER APPL, V11, P377
   Zenni G C, 1994, J Invest Surg, V7, P135, DOI 10.3109/08941939409015357
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 75
TC 12
Z9 13
U1 1
U2 2
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 1999
VL 13
IS 3
BP 187
EP 205
DI 10.1177/088532829901300302
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159XG
UT WOS:000078200200001
PM 9934625
DA 2018-10-19
ER

PT J
AU Aravind, S
   Paul, W
   Vasudev, SC
   Sharma, CP
AF Aravind, S
   Paul, W
   Vasudev, SC
   Sharma, CP
TI Polyethylene glycol (PEG) modified bovine pericardium as a biomaterial
   (vol 13, pg 160, 1998)
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Correction
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR ARAVIND S, 1998, J BIOMATER APPL, V13, P160
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 1999
VL 13
IS 3
BP 269
EP 269
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 159XG
UT WOS:000078200200005
DA 2018-10-19
ER

PT J
AU Johnson, G
   Meijs, GF
   Laycock, BG
   Griffith, MG
   Chaouk, H
   Steele, JG
AF Johnson, G
   Meijs, GF
   Laycock, BG
   Griffith, MG
   Chaouk, H
   Steele, JG
TI Cell interactions with perfluoropolyether-based network copolymers
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE perfluoropolyethers; cell attachment and growth; tissue migration;
   ocular; vascular; orthopaedic; DMAEMA
ID TISSUE-CULTURE POLYSTYRENE; CORNEAL EPITHELIAL-CELLS; HUMAN-ENDOTHELIAL
   CELLS; UNMODIFIED POLYSTYRENE; ENHANCED ATTACHMENT; INITIAL ATTACHMENT;
   RABBIT CORNEA; GROWTH; FIBRONECTIN; SURFACE
AB We have investigated the potential of several polymers based on perfluoropolyether (PFPE) macromonomers for use in biomaterial applications. Polymer networks were synthesised from the PFPE macromonomers of increasing chain length and the adhesion and proliferation of corneal, vascular and bone cells was evaluated on these polymers. The polymer surfaces were quite hydrophobic, having sessile air-water contact angles ranging between 96 and 125 degrees. However, these polymers supported the attachment and growth of bovine corneal epithelial and endothelial cells and fibroblasts at 60-100% of the rate of cell growth on the culture substratum, TCPS. Furthermore, the PFPE polymers supported the attachment and growth of vascular endothelial cells (from human umbilical artery) and human bone-derived cells over a 7 day period at an equal level to TCPS. The relationship between the macromonomer chain length (n = 1 to 4) and the ability of the resulting PFPE homopolymer to support the overgrowth of corneal epithelial tissue was also evaluated. The PFPE-containing polymers supported corneal epithelial tissue overgrowth, with the most effective having a performance equivalent to that of TCPS. Tn addition to these homopolymers, copolymers comprising of PFPE and N,N-dimethylaminoethyl methacrylate (DMAEMA) were also synthesised. Surprisingly, the addition of DMAEMA to the PFPE polymer network lead to a reduction in the growth and attachment of corneal epithelial cells and fibroblasts. These results indicate that PFPE-based materials show a potential for use in the development of biomaterials in the ocular, vascular and orthopaedic areas.
C1 Cooperat Res Ctr Eye Res & Technol, N Ryde, NSW 1670, Australia.
   CSIRO, N Ryde, NSW 1670, Australia.
   CSIRO, Clayton S MDC, Vic 3169, Australia.
RP Steele, JG (reprint author), Cooperat Res Ctr Eye Res & Technol, POB 184, N Ryde, NSW 1670, Australia.
EM jack.steele@riverside.molsci.csiro.au
CR BERGETHON PR, 1989, J CELL SCI, V92, P111
   CHIRILA TV, 1994, J BIOMED MATER RES, V28, P745, DOI 10.1002/jbm.820280612
   Crawford GJ, 1996, J REFRACT SURG, V12, P525
   CRAWFORD GJ, 1993, CORNEA, V12, P348, DOI 10.1097/00003226-199307000-00012
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Horbett T. A., 1995, PROTEINS INTERFACES, VII
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   HSIUE GH, 1993, BIOMATERIALS, V14, P591
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   OLIVER MH, 1989, J CELL SCI, V92, P513
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PETTIT DK, 1990, INVEST OPHTH VIS SCI, V31, P2269
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P643, DOI 10.3109/10731199009117333
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P437, DOI 10.3109/10731199009117319
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   Steele JG, 1997, BIOMATERIALS, V18, P1541, DOI 10.1016/S0142-9612(97)00088-4
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WEIS JR, 1991, THROMB RES, V61, P171, DOI 10.1016/0049-3848(91)90245-R
   WU XY, 1994, INVEST OPHTH VIS SCI, V35, P878
NR 31
TC 15
Z9 15
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 2
BP 217
EP 233
DI 10.1163/156856299X00144
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 173AN
UT WOS:000078958900006
PM 10091932
DA 2018-10-19
ER

PT J
AU Serizawa, T
   Uchida, T
   Akashi, M
AF Serizawa, T
   Uchida, T
   Akashi, M
TI Synthesis of polystyrene nanospheres having lactose-conjugated
   hydrophilic polymers on their surfaces and carbohydrate recognition by
   proteins
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polystyrene nanosphere; macromonomer; carbohydrate; recognition;
   enzyme-linked lectin assay
ID GLUCOSIDE-BEARING POLYMER; OPENING METATHESIS POLYMERIZATION; LIPOPHILIC
   RADICAL INITIATOR; HYDROPHOBIC BACKBONE; GRAFT-COPOLYMERS;
   POLY(N-ISOPROPYLACRYLAMIDE) BRANCHES; ANTICOAGULANT ACTIVITY;
   METHYL-METHACRYLATE; BINDING-PROPERTIES; MACROMONOMER
AB We prepared a poly(vinylamine)-grafted polystyrene nanosphere by the free radical polymerization of poly(N-vinylacetamide) macromonomer and styrene with AIBN in ethanol and subsequent acid hydrolysis. We conjugated lactose on the nanosphere by an amide linkage and found that the lactose was recognized by a galactose-specific lectin RCA(120) which was analyzed by enzyme-linked lectin assay (ELLA). The binding ability of the lectin to lactose on the nanosphere was at least 10(2) times larger than that to a monomeric lactose. Binding ability was clearly affected by the lactose density on the nanosphere and showed a maximum value at the suitable surface density of lactose. We found that the carbohydrate-conjugated nanosphere would be a useful biomaterial for a site specific drug carrier.
C1 Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, Kagoshima 8900065, Japan.
RP Akashi, M (reprint author), Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, 1-21-40 Korimoto, Kagoshima 8900065, Japan.
RI Serizawa, Takeshi/S-7133-2018
OI Serizawa, Takeshi/0000-0002-4867-8625
CR AKASHI M, 1989, J POLYM SCI POL CHEM, V27, P3521, DOI 10.1002/pola.1989.080271029
   Akashi M, 1996, BIOCONJUGATE CHEM, V7, P393, DOI 10.1021/bc960031c
   AKASHI M, 1985, ANGEW MAKROMOL CHEM, V132, P81, DOI 10.1002/apmc.1985.051320107
   Akashi M, 1998, BIOCONJUGATE CHEM, V9, P50, DOI 10.1021/bc970045y
   AKASHI M, 1990, J APPL POLYM SCI, V39, P2027, DOI 10.1002/app.1990.070390917
   Bovin NV, 1995, CHEM SOC REV, V24, P413, DOI 10.1039/cs9952400413
   Cao SD, 1996, TETRAHEDRON LETT, V37, P3421, DOI 10.1016/0040-4039(96)00584-9
   CAPEK I, 1993, J MACROMOL SCI R M C, VC33, P369, DOI 10.1080/15321799308021565
   Chen MQ, 1996, J POLYM SCI POL CHEM, V34, P2213
   CHEN MQ, IN PRESS POLYM ADV T
   Choi SK, 1997, J AM CHEM SOC, V119, P4103, DOI 10.1021/ja963519x
   Hansen HC, 1997, J AM CHEM SOC, V119, P6974, DOI 10.1021/ja970859p
   HIWATARI K, UNPUB
   Ishizu K, 1996, POLYMER, V37, P1729, DOI 10.1016/0032-3861(96)83726-8
   Kanai M, 1997, J AM CHEM SOC, V119, P9931, DOI 10.1021/ja972089n
   KAWAGUCHI S, 1995, MACROMOLECULES, V28, P1159, DOI 10.1021/ma00108a051
   Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   KITANO H, 1995, BIOCONJUGATE CHEM, V6, P131, DOI 10.1021/bc00031a016
   Kobayashi K, 1997, MACROMOLECULES, V30, P2016, DOI 10.1021/ma961681e
   KOPECKOVA P, 1994, J CONTROL RELEASE, V28, P211, DOI 10.1016/0168-3659(94)90168-6
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   Martichonok V, 1996, J AM CHEM SOC, V118, P8187, DOI 10.1021/ja960148b
   MORTELL KH, 1994, J AM CHEM SOC, V116, P12053, DOI 10.1021/ja00105a056
   Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q
   Nishimura S, 1997, J AM CHEM SOC, V119, P10555, DOI 10.1021/ja971786c
   Onishi M, 1998, J BIOMAT SCI-POLYM E, V9, P973, DOI 10.1163/156856298X00280
   Page D, 1997, BIOCONJUGATE CHEM, V8, P714, DOI 10.1021/bc970126u
   Qiu YX, 1998, MACROMOLECULES, V31, P165, DOI 10.1021/ma9707401
   RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033
   RIZA M, 1995, J POLYM SCI POL CHEM, V33, P1219, DOI 10.1002/pola.1995.080330804
   Roy R, 1996, TRENDS GLYCOSCI GLYC, V8, P79, DOI 10.4052/tigg.8.79
   Sakamoto N, 1997, J BIOMAT SCI-POLYM E, V8, P545, DOI 10.1163/156856297X00443
   Sakamoto N, 1997, MACROMOL SYMP, V120, P159, DOI 10.1002/masy.19971200117
   Sakuma S, 1997, INT J PHARM, V159, P181, DOI 10.1016/S0378-5173(97)00284-6
   Sakuma S, 1997, INT J PHARM, V149, P93, DOI 10.1016/S0378-5173(96)04861-2
   Sakuma S, 1997, INT J PHARM, V158, P69, DOI 10.1016/S0378-5173(97)00247-0
   Serizawa T, 1997, CHEM LETT, P809, DOI 10.1246/cl.1997.809
   Serizawa T, 1998, CHEM LETT, P487, DOI 10.1246/cl.1998.487
   SERIZAWA T, IN PRESS J POLY PC A
   SIGAL GB, 1996, J AM CHEM SOC, V118, P7389
   Taguchi T, 1998, J BIOMED MATER RES, V41, P386, DOI 10.1002/(SICI)1097-4636(19980905)41:3<386::AID-JBM7>3.0.CO;2-8
   TAKEUCHI S, 1993, MAKROMOL CHEM, V194, P551
   Thoma G, 1997, J AM CHEM SOC, V119, P7414, DOI 10.1021/ja970657t
   UCHIDA T, UNPUB POLYM J
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Zanini D, 1997, BIOCONJUGATE CHEM, V8, P187, DOI 10.1021/bc970005u
   Zanini D, 1997, J AM CHEM SOC, V119, P2088, DOI 10.1021/ja963874n
NR 48
TC 27
Z9 27
U1 2
U2 13
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 3
BP 391
EP 401
DI 10.1163/156856299X00441
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 180BM
UT WOS:000079365100012
PM 10189106
DA 2018-10-19
ER

PT J
AU Marois, Y
   Zhang, Z
   Vert, M
   Deng, XY
   Lenz, R
   Guidoin, R
AF Marois, Y
   Zhang, Z
   Vert, M
   Deng, XY
   Lenz, R
   Guidoin, R
TI Effect of sterilization on the physical and structural characteristics
   of polyhydroxyoctanoate (PHO)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE sterilization; ethylene oxide; gamma; poly(beta-hydroxy octanoate; PHO;
   poly(beta-hydroxy alkanoates; PHA
ID MASSIVE POLY(ALPHA-HYDROXY ACIDS); STRUCTURE-PROPERTY RELATIONSHIPS;
   PSEUDOMONAS-OLEOVORANS; DEGRADABLE BIOMATERIALS; MECHANICAL-PROPERTIES;
   BIODEGRADABLE PATCH; GAMMA-STERILIZATION; AQUEOUS-MEDIA;
   POLY(BETA-HYDROXYALKANOATES); POLYHYDROXYALKANOATES
AB The present study examined the potential applicability of poly(S-hydroxy octanoate) (PHO), a bacterial polyester, as a candidate for biomaterial applications, by investigating the effect of sterilization on the physical and structural characteristics of PHO. PHO-cast films were sterilized by either ethylene oxide (EO) gas at 38 degrees C or gamma radiation (2.5 Mrad) in air at room temperature. The physical characteristics of the EO and gamma-sterilized PHO were determined by scanning electron microscopy (SEM) and tensile strength analyses. In addition, various analytical methods were used to detect modifications in the chemical and morphological structure of PHO, namely, electron spectroscopy for chemical analysis (ESCA), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), wide angle X-ray diffraction (WAXD), and size exclusion chromatography (SEC). The results show that EO sterilization did not modify the chemical and physical characteristics of PHO, however, significant modifications in both the structural and tensile properties were observed with gamma-sterilized PHO. These changes accounted for decreases in both the weight average, number average and melting temperature, and increases in the heat of fusion and tensile strength. No residual EO was detected following sterilization as revealed by head-space chromatography. The physical and structural properties of PHO were shown to be well preserved following EO sterilization, whereas gamma radiation caused random chain scission and physical cross-linking, a frequent phenomenon observed with organic polymers.
C1 Univ Laval, Expt Surg Lab, Quebec City, PQ G1K 7P4, Canada.
   Univ Montpellier I, Fac Pharm, CRBA, CNRS,URA 1465, Montpellier, France.
   CHUQ, Ctr Rech, Biomat Inst, Quebec City, PQ, Canada.
   Univ Massachusetts, Amherst, MA 01003 USA.
RP Guidoin, R (reprint author), Univ Laval, Expt Surg Lab, Room 1701,Serv Bldg, Quebec City, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, P133
   BLUHM TL, 1986, MACROMOLECULES, V19, P2871, DOI 10.1021/ma00165a035
   BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977
   Claes LE, 1996, BIOMATERIALS, V17, P1621, DOI 10.1016/0142-9612(95)00327-4
   DEKONING GJM, 1994, POLYMER, V35, P2090, DOI 10.1016/0032-3861(94)90233-X
   Dempsey D J, 1989, J Biomater Appl, V3, P454
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   GAGNON KD, 1992, MACROMOLECULES, V25, P3723, DOI 10.1021/ma00040a018
   GILDING DK, 1994, POLYMER, V120, P1459
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   GUPTA MC, 1983, POLYMER, V24, P827, DOI 10.1016/0032-3861(83)90198-2
   HANDLOS VN, 1992, EUROPEAN MAT RES SOC, V3, P247
   HAYWOOD GW, 1989, BIOTECHNOL LETT, V11, P471, DOI 10.1007/BF01026644
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   NAIR PD, 1988, BIOMATERIALS, V9, P335, DOI 10.1016/0142-9612(88)90029-4
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   SUTULA LC, 1995, CLIN ORTHOP RELAT R, P28
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
NR 28
TC 9
Z9 9
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 4
BP 469
EP 482
DI 10.1163/156856299X00216
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 190FR
UT WOS:000079952300005
PM 10227468
DA 2018-10-19
ER

PT J
AU Vladkova, T
   Krasteva, N
   Kostadinova, A
   Altankov, G
AF Vladkova, T
   Krasteva, N
   Kostadinova, A
   Altankov, G
TI Preparation of PEG-coated surfaces and a study for their interaction
   with living cells
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE poly(ethylene glycol) coated surfaces; fibroblast; cell-material
   interaction; fibronectin; protein adsorption
ID FIBRONECTIN ADSORPTION; CHEMICAL COMPOSITION; PROTEIN ADSORPTION;
   ADHESION; BINDING; SERUM; ATTACHMENT; COLLAGEN
AB Cell-biomaterial interaction is of great importance for the development of bioinert as well as of hybrid surfaces. This study represents our results of human fibroblast interaction with PEG-coated surfaces of differing length and structure (linear or branched) of the oxyethylene chain. We employed three PEGs - PEG 1500 and PEG 6000, both linear but with different chain lengths, and PEG 12 500 which was branched. The PEGs were deposited on silica plates using branched poly(ethylene imine) as an anchoring polymer. Fibroblasts were plated and studied by immunofluorescence to evaluate the overall cell morphology, the organisation of the actin cytoskeleton, and the beta(1)-integrin (fibronectin receptor). The particular effect of fibronectin (FN) pre-adsorption was studied. Our results suggest that PEG 6000 surface is to be preferable with respect to the initial interaction with the cells. The overall cell morphology was almost normal on bare surfaces. FN pre-coating additionally improved cell adhesion and spreading as well as the organization of the actin cytoskeleton and focal adhesion formation; the PEG 12 500 surface showed relatively poor initial properties. Almost no cell spreading was found on the bare surface, but FN pre-adsorption completely restored normal cell morphology. In contrast, PEG 1500 had to be considered as 'the worst' material, because of lower initial cell adhesion and spreading and FN pre-adsorption did not restore normal cell morphology.
C1 Univ Chem Technol & Met, BU-1756 Sofia, Bulgaria.
   Bulgarian Acad Sci, Inst Biophys, BU-1113 Sofia, Bulgaria.
RP Vladkova, T (reprint author), Univ Chem Technol & Met, 8 Kl Okhridski Blvd, BU-1756 Sofia, Bulgaria.
OI Kostadinova, Anelliya/0000-0002-8097-3608
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Azzam R. M. A., 1989, ELLIPSOMETRY POLARIZ
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   FEIJEN J, 1994, MACROMOLEC REP, V31, P1153
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOLANDER CG, 1986, THESIS I SURFACE CHE
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1978, EXP CELL RES, V115, P221, DOI 10.1016/0014-4827(78)90419-6
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   KISH E, 1987, PROG COLLOID POLYM S, V74, P113
   KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0
   LANDGREN M, 1993, J PHYS CHEM-US, V97, P1656, DOI 10.1021/j100110a030
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   LYMAN DJ, 1991, J BIOACT COMPAT POL, V6, P283, DOI 10.1177/088391159100600307
   Malmsten M, 1996, COLL SURG B, VB80, P159
   MCABEE DD, 1985, J CELL PHYSIOL, V124, P240, DOI 10.1002/jcp.1041240211
   Mitzner E, 1996, J BIOMAT SCI-POLYM E, V7, P1105, DOI 10.1163/156856296X00598
   RODRIGUEZ J, 1960, VIROLOGY, V12, P316, DOI 10.1016/0042-6822(60)90205-1
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   THOMAS V, 1993, COLLOID SURFACE A, V77, P125, DOI 10.1016/0927-7757(93)80109-R
NR 24
TC 23
Z9 24
U1 2
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 6
BP 609
EP 620
DI 10.1163/156856299X00838
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 207MD
UT WOS:000080939900001
PM 10385223
DA 2018-10-19
ER

PT J
AU Labow, RS
   Meek, E
   Santerre, P
AF Labow, RS
   Meek, E
   Santerre, P
TI The biodegradation of poly(urethane)s by the esterolytic activity of
   serine proteases and oxidative enzyme systems
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradation; polyurethanes; esterases; proteases; oxidative systems
ID POLY(ETHERURETHANE UREA); CHOLESTEROL ESTERASE; HYDROLYTIC ENZYMES;
   DEGRADATION; SUBSTRATE; POLYURETHANES; NEUTROPHILS; INHIBITORS;
   LEUKOCYTES; POLYETHER
AB Biodegradation of poly(urethane)s (PU)s using single enzymes in vitro was assessed by measuring radiolabel release from model poly(ester-urea-urethane) (PESU) and poly(ether-urea-urethane) (PETU) materials synthesized with C-14-labelled monomers. Cholesterol esterase (CE), an enzyme found in monocyte-derived macrophages (MDM), has been reported to cause a significant level of radiolabel release from both of these PUs. Previous work has shown that CE activity could be inhibited by the serine protease / esterase inhibitor; phenylmethylsulfonyl fluoride. Since many serine proteases are present in circulating blood and can be released by cells other than MDM, this study investigated the ability of serine proteases relative to that of CE to cause the degradation of PUs. In addition, the possible role of several oxidative enzymes in the breakdown of PUs was investigated. Proteinase K, chymotrypsin and thrombin. when incubated with PESU, coated on glass slips, caused significant radiolabel release, with proteinase K giving the highest values. However, the highest radiolabel release which proteinase K could elicit was ten times less than CE. Thrombin and then chymotrypsin were progressively worse in their biodegradative activity. Only CE, and not the serine proteases, could elicit a detectable radiolabel release from PETU. Although the release of reactive oxygen species and molecular oxygen occur around an implanted biomaterial, several oxidative systems (peroxidase, xanthine oxidase, catalase), known to produce one or more of these molecular species, were unable to induce radiolabel release from these PUs. The process of biodegradation as assessed by radiolabel release appears to be a specific hydrolytic process, while the role of oxidative enzymes remains less clear.
C1 Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Univ Toronto, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   BERGSTRAND H, 1990, AA530 INFLAMMATORY I
   CAMPBELL EJ, 1982, J CLIN INVEST, V70, P845, DOI 10.1172/JCI110681
   COLEMAN PL, 1981, METHOD ENZYMOL, V80, P408
   DIXON M, 1964, ENZYMES, P226
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9
   GOLDSCHMEDING R, 1989, J CLIN INVEST, V84, P1577, DOI 10.1172/JCI114335
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950
   MCCLOSKEY CB, 1998, P 24 SOC BIOM M SAN, P133
   MOORE ANJ, 1996, BIOTECHNOL TECH, V10, P535
   PICHORNER H, 1993, ARCH BIOCHEM BIOPHYS, V300, P258, DOI 10.1006/abbi.1993.1036
   ROELCKE D, 1969, Zeitschrift fuer Medizinische Mikrobiologie und Immunologie, V155, P156, DOI 10.1007/BF02123859
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1995, ACS SYM SER, V602, P352
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   TANG YW, 1998, P 24 ANN M SOC BIOM, P371
   Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275
   TSUNG P, 1978, BIOCHIM BIOPHYS ACTA, V541, P150, DOI 10.1016/0304-4165(78)90388-4
   WANG FGB, 1997, P 23 AM SOC BIOM M N, P451
   WANG FGB, 1997, J BIOMED MATER RES, V35, P207
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WILLIAMS DF, 1986, BIOL BIOMECHANICAL P, P239
   WU YK, 1994, J BIOMED MATER RES, V28, P515, DOI 10.1002/jbm.820280414
NR 36
TC 32
Z9 32
U1 0
U2 23
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 7
BP 699
EP 713
DI 10.1163/156856299X00595
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 216AJ
UT WOS:000081418000001
PM 10426227
DA 2018-10-19
ER

PT J
AU Ruiz, L
   Fine, E
   Voros, J
   Makohliso, SA
   Leonard, D
   Johnston, DS
   Textor, M
   Mathieu, HJ
AF Ruiz, L
   Fine, E
   Voros, J
   Makohliso, SA
   Leonard, D
   Johnston, DS
   Textor, M
   Mathieu, HJ
TI Phosphorylcholine-containing polyurethanes for the control of protein
   adsorption and cell attachment via photoimmobilized laminin
   oligopeptides
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE phosphorylcholine; polyurethane; XPS; ToF-SIMS; OWLS;
   photoimmobilization; benzophenone; laminin
ID ION MASS-SPECTROMETRY; PHOSPHOLIPID POLYMERS; SURFACES; HYDROGELS;
   ADHESION; MOIETY; BLOOD; HEMOCOMPATIBILITY; PENTAPEPTIDE; HYDRATION
AB In this study, we synthesized a biomaterial whose surface inhibits non-specific protein and cell attachment. The polymer was designed to mimic the external cell plasma membrane properties through the introduction of particular chemical constituents of the cell membrane: phospholipid polar headgroups. This was done by copolymerizing phosphorylcholine (PC) groups into a polyurethane polymer backbone (PCPUR). Peptides known to induce specific cell attachment were subsequently bound to the surface of this copolymer in a photoadressible manner to obtain surfaces that allowed the attachment of cells in a specific pattern. Two polymers with different phosphorylcholine concentrations were synthesized and their bulk and surface properties were characterized through differential scanning calorimetry. wettability measurements, angle-resolved X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry. Protein and lipid adsorption investigation using optical waveguide light mode spectroscopy showed that the irreversible adsorption of both proteins and lipids is drastically reduced as a result of simultaneous contributions of the PC groups, molecular mobility and strong hydrophilicity of the polymers. Consequently, this leads to a marked reduction in the cellular attachment response, which further decreases with increasing PC concentration, Finally, when the polymer surface was photo-derivatized, attachment of the neural NG108-15 cell line occurred only on the areas of the PCPUR where the laminin CDPGYIGSR peptide sequence was photoimmobilized. Cell attachment was nevertheless found to be non-specific with respect to the peptide sequence used and reasons for such results are therefore discussed.
C1 Swiss Fed Inst Technol, Dept Mat Sci, CH-1015 Lausanne, Switzerland.
   Swiss Fed Inst Technol, Surface Sci & Technol Lab, CH-8952 Schlieren, Switzerland.
   CHU Vaudois, Ctr Gene Therapy, CH-1011 Lausanne, Switzerland.
   Univ London, Dept Surg, IRC Biomed Mat, Royal Free Hosp,Sch Med, London NW3 2QG, England.
RP Mathieu, HJ (reprint author), Swiss Fed Inst Technol, Dept Mat Sci, CH-1015 Lausanne, Switzerland.
RI Textor, Marcus/A-6200-2012
OI Textor, Marcus/0000-0002-0178-1801
CR Aleyamma A. J., 1991, BLOOD COMPATIBLE MAT, P123
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2, P367
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   CHAPMAN D., 1967, CHEM PHYS LIPIDS, V1, P445, DOI 10.1016/0009-3084(67)90023-0
   CHAPMAN D, 1992, CHEM BRIT, V28, P253
   CHAPMAN D, 1987, Patent No. 4689386
   CHARTOFF RP, 1997, THERMAL CHARACTERIZA, P483
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   FINER EG, 1974, CHEM PHYS LIPIDS, V12, P1, DOI 10.1016/0009-3084(74)90064-4
   FINER EG, 1973, J CHEM SOC FARAD T 2, V69, P1590, DOI 10.1039/f29736901590
   FRANZREB K, 1995, SURF INTERFACE ANAL, V23, P641, DOI 10.1002/sia.740230910
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P161
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HUBBELL JA, 1995, CHEM ENG NEWS   0313, P42
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   ISHIHARA K, 1991, J POLYM SCI POL CHEM, V29, P831, DOI 10.1002/pola.1991.080290606
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1990, J JPN SOC BIOMATER, V8, P231
   IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059
   Iwasaki Y, 1997, J COLLOID INTERF SCI, V192, P432, DOI 10.1006/jcis.1997.5047
   JENTOFT N, 1979, J BIOL CHEM, V254, P4359
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   Kaneda Y, 1995, INVAS METAST, V15, P156
   Kleinman HK, 1989, CURR OPIN CELL BIOL, V1, P964, DOI 10.1016/0955-0674(89)90066-5
   KLEINMAN HK, 1989, ANN NY ACAD SCI, P302
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEE JH, 1988, POLYM MAT SCI ENG, V59, P234
   Lelah M. D., 1986, POLYURETHANES MED
   MARRA J, 1985, BIOCHEMISTRY-US, V24, P4608, DOI 10.1021/bi00338a020
   MASSAGUE J, 1990, ANN REV CELL BIOL, V6, P1
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   *PERK ELM PHI, 1990, INSTR MAN PHI 5500 M
   Rabek J. F., 1987, MECH PHOTOPHYSICAL P
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   SALSBURY NJ, 1972, CHEM PHYS LIPIDS, V8, P142, DOI 10.1016/0009-3084(72)90026-6
   SCHUELER BW, 1992, MICROSC MICROANAL M, V3, P119, DOI 10.1051/mmm:0199200302-3011900
   Seah M. P., 1979, SURF INTERFACE ANAL, V1, P2, DOI DOI 10.1002/SIA.740010103
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   WALLISER A, 1992, THESIS U HAUTE ALSAC
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wirpsza Z., 1993, POLYURETHANES CHEM T
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 59
TC 28
Z9 29
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 9
BP 931
EP 955
DI 10.1163/156856299X00540
PG 25
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 257FK
UT WOS:000083771700004
PM 10574609
DA 2018-10-19
ER

PT J
AU Vogler, EA
AF Vogler, EA
TI Water and the acute biological response to surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Non-Fouling Surface Technologies
CY JUL, 1998
CL UNIV WASHINGTON, SEATTLE, WASHINGTON
SP Univ Washington Engineered Biomat,NSF Engn Res Ctr
HO UNIV WASHINGTON
DE water structure; biomaterials; biological response; surface energy;
   hydrophobic; hydrophilic; surface forces
ID SELF-ASSEMBLED MONOLAYERS; PLASMA COAGULATION CASCADE; DEPENDENT CONTACT
   ANGLES; SOLID LIQUID ADSORPTION; PROTEIN ADSORPTION; HYDROPHOBIC
   HYDRATION; BIOMATERIAL SURFACES; PRACTICAL USE; FREE-ENERGY; FORCES
AB Molecular self association in water through hydrogen bonding is a powerful organizational force leading to a three-dimensional hydrogen-bonded network (water structure) that profoundly influences solvent properties. Localized perturbations in the chemical potential of water as by, for example, contacting with a solid surface, induces compensating changes in water structure that can be sensed tens of nanometers from the point of origin using the surface force apparatus (SFA) and ancillary techniques. These instruments reveal attractive or repulsive forces between opposing surfaces immersed in water, over-and-above that anticipated by continuum theory (DLVO), that are attributed to a variable density (partial molar volume) of a more-or-less ordered water structure, depending on the water wettability (surface energy) of the water-contacting surfaces. Water structure at surfaces is thus found to be a manifestation of hydrophobicity and, while mechanistic/theoretical interpretation of experimental results remains the subject of some debate in the literature, convergence of experimental observations permit a quantitative definition of the heretofore relative terms 'hydrophobic' and 'hydrophilic'. In particular, long-range attractive forces (< 100 nm) are detected only between surfaces exhibiting a water contact angle theta > 65 deg (defined as hydrophobic surfaces with pure water adhesion tension tau(0) = gamma(0)cos theta < 30 dyn cm(-1) where gamma(0) is water interfacial tension = 72.8 dyn cm(-1)). Short range repulsive forces (< 5 nm) are detected between surfaces exhibiting theta < 65 deg (hydrophilic surfaces, tau(0) > 30 dyn cm(-1)). These findings together with other lines of chemical evidence suggest at least two distinct kinds of water structure and reactivity: a relatively less-dense water region against hydrophobic surfaces with an open hydrogen-bonded network and a relatively more-dense water region against hydrophilic surfaces with a collapsed hydrogen-bonded network.
   Solvent properties of interfacial water profoundly influence the biological response to materials in a surprisingly straightforward manner when key measures of biological activity sensitive to interfacial phenomenon are scaled against water adhesion tension tau(0) of contacting surfaces. Protein adsorption, activation of blood coagulation, and bioadhesion are offered as examples in point, illustrating that the hydrophobic/hydrophilic contrast in the biological response to materials, often disputed in biomaterials science, is very clear when viewed from the perspective of water structure and reactivity at surfaces.
C1 Becton Dickinson Res Ctr, Res Triangle Pk, NC 27709 USA.
RP Vogler, EA (reprint author), Penn State Univ, Dept Mat Sci & Engn, Steidle Hall, University Pk, PA 16802 USA.
CR Andrade JD, 1986, ADV POLYM SCI, V79, P3
   Ashbaugh HS, 1996, J PHYS CHEM-US, V100, P1900, DOI 10.1021/jp952387b
   Ashbaugh HS, 1998, J PHYS CHEM B, V102, P5029, DOI 10.1021/jp9814505
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   Baier RE, 1971, MANAGEMENT OCCLUSIVE, V147- 163
   BERENDSEN HJC, 1967, THEORETICAL EXPT BIO, P1
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   BESSELING NAM, 1994, J PHYS CHEM-US, V98, P11597, DOI 10.1021/j100095a048
   BESSELING NAM, 1995, PURE APPL CHEM, V67, P881, DOI 10.1351/pac199567060881
   Besseling NAM, 1997, LANGMUIR, V13, P2113, DOI 10.1021/la960672w
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   Brown B., 1980, HEMATOLOGY PRINCIPLE
   CADENA RAD, 1992, PROTEIN SCI, V1, P151
   Christensen H, 1997, PERS INDIV DIFFER, V23, P67, DOI 10.1016/S0191-8869(97)00022-6
   CHRISTENSON HK, 1987, P INDIAN AS-CHEM SCI, V98, P379
   Claesson PM, 1997, COLLOID SURFACE A, V123, P339, DOI 10.1016/S0927-7757(96)03805-8
   COCHRANE CG, 1979, AM J MED, V67, P657, DOI 10.1016/0002-9343(79)90253-5
   Craig VSJ, 1997, COLLOID SURFACE A, V129, P75, DOI 10.1016/S0927-7757(97)00029-0
   DANDLIKER WB, 1971, CHEM BIOSURFACES, P1
   DROSTHANSEN W, 1969, IND ENG CHEM, V61, P10, DOI 10.1021/ie50719a005
   DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826
   DU Q, 1994, PHYS REV LETT, V72, P238, DOI 10.1103/PhysRevLett.72.238
   DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313
   Eisenberg D., 1969, STRUCTURE PROPERTIES
   ELWING H, 1987, J BIOMED MATER RES, V21, P1023, DOI 10.1002/jbm.820210808
   FISHER LR, 1981, NATURE, V290, P575, DOI 10.1038/290575a0
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FRAGNETO G, 1995, SCIENCE, V267, P657, DOI 10.1126/science.7839141
   FRANK F, 1979, WATER COMPREHENSIVE
   FRANK HS, 1962, DES RES C WASH DC PU, V942, P141
   FRANK HS, 1957, DISCUSS FARADAY SOC, P133, DOI DOI 10.1039/DF9572400133
   Franks F., 1972, WATER COMPREHENSIVE, P1
   Garde S, 1998, J CHEM PHYS, V108, P1552, DOI 10.1063/1.475526
   Harkins WD, 1917, J AM CHEM SOC, V39, P354, DOI 10.1021/ja02248a003
   HILDEBRAND JH, 1979, P NATL ACAD SCI USA, V76, P194, DOI 10.1073/pnas.76.1.194
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, pR9, DOI 10.1002/jbm.820200903
   HORBETT T, 1982, BIOMATERIALS INTERFA, P234
   Horbett T. A., 1996, INTERFACIAL PHENOMEN, P351
   HSIEH YL, 1988, J COLLOID INTERF SCI, V123, P275, DOI 10.1016/0021-9797(88)90244-5
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   ISRAELACHVILI J, 1987, P NATL ACAD SCI USA, V84, P4722, DOI 10.1073/pnas.84.14.4722
   ISRAELACHVILI J, 1987, ACCOUNTS CHEM RES, V20, P415, DOI 10.1021/ar00143a005
   Israelachvili J. N., 1976, Nature, V262, P774, DOI 10.1038/262774a0
   ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975
   ISRAELACHVILI JN, 1992, SURF SCI REP, V14, P109, DOI 10.1016/0167-5729(92)90015-4
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Ji SF, 1998, APPL SURF SCI, V133, P231, DOI 10.1016/S0169-4332(98)00209-8
   Klemperer H.G., 1977, LAB PRACT, V26, P179
   Kokkoli E, 1998, LANGMUIR, V14, P1189, DOI 10.1021/la970944a
   Langmuir I, 1917, J AM CHEM SOC, V39, P1848, DOI 10.1021/ja02254a006
   LASARIDIS T, 1994, J PHYS CHEM-US, V98, P635
   LAW BM, 1990, J COLLOID INTERF SCI, V134, P1, DOI 10.1016/0021-9797(90)90247-L
   LAZARIDIS T, 1992, J PHYS CHEM-US, V96, P3847, DOI 10.1021/j100188a051
   LEE CY, 1984, J CHEM PHYS, V80, P4448, DOI 10.1063/1.447226
   LENSEN HGW, 1984, J COLLOID INTERF SCI, V99, P1, DOI 10.1016/0021-9797(84)90079-1
   LiebmannVinson A, 1996, LANGMUIR, V12, P2256, DOI 10.1021/la950642d
   Lin JC, 1996, J COLLOID INTERF SCI, V182, P315, DOI 10.1006/jcis.1996.0470
   Loosdrecht M, 1990, AQUAT SCI, V52, P103
   MARCHI RP, 1964, J PHYS CHEM-US, V68, P221, DOI 10.1021/j100784a001
   McHaffie IR, 1925, J CHEM SOC, V127, P1559, DOI 10.1039/ct9252701559
   NARTEN AH, 1969, SCIENCE, V165, P447, DOI 10.1126/science.165.3892.447
   NEMETHY G, 1962, J CHEM PHYS, V36, P3382, DOI 10.1063/1.1732472
   PARKER JL, 1989, REV SCI INSTRUM, V60, P3135, DOI 10.1063/1.1140544
   PASHLEY RM, 1979, J COLLOID INTERF SCI, V71, P491, DOI 10.1016/0021-9797(79)90323-0
   Paulaitis ME, 1996, CURR OPIN COLLOID IN, V1, P376, DOI 10.1016/S1359-0294(96)80137-3
   Petrash S, 1997, LANGMUIR, V13, P1881, DOI 10.1021/la9610821
   ROYXHET PG, 1990, WATER SCI TECHNOL, V72, P1
   RUCKENSTEIN E, 1991, J COLLOID INTERF SCI, V147, P535, DOI 10.1016/0021-9797(91)90188-E
   Ruckenstein E, 1997, J COLLOID INTERF SCI, V188, P218, DOI 10.1006/jcis.1997.4770
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353
   Tanford C, 1973, HYDROPHOBIC EFFECT F
   VIGIL G, 1994, J COLLOID INTERF SCI, V165, P367, DOI 10.1006/jcis.1994.1242
   Vinogradov S.N., 1971, HYDROGEN BONDING
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   VOGLER EA, 1987, J BIOMED MATER RES, V21, P1197, DOI 10.1002/jbm.820211004
   VOGLER EA, 1993, LANGMUIR, V9, P497, DOI 10.1021/la00026a023
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   VOGLER EA, 1992, LANGMUIR, V8, P2005, DOI 10.1021/la00044a022
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   VOGLER EA, 1997, J BIOMED MATER RES, V40, P92
   Volger EA, 1993, WETTABILITY, P184
   VONOSS CJ, 1997, CURRENT OPINION COLL, V2, P503
   VONOSS CJ, 1995, CLAYS CLAY MINERALS, V43, P474
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   Xu XHN, 1998, SCIENCE, V281, P1650, DOI 10.1126/science.281.5383.1650
   Yaminsky VV, 1996, LANGMUIR, V12, P1936, DOI 10.1021/la950740z
   YAMINSKY VV, 1997, COLLOID SURFACE A, V130, P415
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
NR 95
TC 165
Z9 167
U1 1
U2 40
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 10
BP 1015
EP 1045
DI 10.1163/156856299X00667
PG 31
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 262AV
UT WOS:000084044300002
PM 10591130
DA 2018-10-19
ER

PT J
AU Defife, KM
   Hagen, KM
   Clapper, DL
   Anderson, JM
AF Defife, KM
   Hagen, KM
   Clapper, DL
   Anderson, JM
TI Photochemically immobilized polymer coatings: effects on protein
   adsorption, cell adhesion, and leukocyte activation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Non-Fouling Surface Technologies
CY JUL, 1998
CL UNIV WASHINGTON, SEATTLE, WASHINGTON
SP Univ Washington Engineered Biomat,NSF Engn Res Ctr
HO UNIV WASHINGTON
DE photochemical immobilization; silicone rubber; protein adsorption;
   fibroblast and leukocyte adhesion; cytokine secretion
ID MODIFIED POLYETHYLENE TEREPHTHALATE; IN-VITRO; SURFACES; CD44;
   HYALURONAN; GLYCOSYLATION; BIOMATERIAL; PREVENTION; ATTACHMENT; MATRICES
AB Amphiphilic chains of 4-benzoylbenzoic acid moieties and polymer were photochemically immobilized onto silicone rubber to ask whether the covalently coupled polymers would passivate the silicone rubber by inhibiting protein adsorption and subsequent cell adhesion and activation. Three groups of polymers were utilized: the hydrophilic synthetic polymers of polyacrylamide, polyethylene glycol, and polyvinylpyrrolidone; the glycosaminoglycan, hyaluronic acid; and poly(glycine-valine-glycine-valine-proline), a polypeptide derived from the sequence of elastin. Each coating variant decreased the adsorption of fibrinogen and immunoglobulin G compared to uncoated silicone rubber. All except the methoxy-polyethylene glycol coating nearly abolished fibroblast growth, but none of the coating variants inhibited monocyte or polymorphonuclear leukocyte adhesion. Interleukin-1 beta, interleukin-1 receptor antagonist, and tumor necrosis factor-alpha secretion by leukocytes were not statistically different between any of the coating variants and uncoated silicone rubber. However, the methoxy-polyethylene glycol and elastin-based polypeptide coatings, which supported the highest numbers of adherent monocytes, also elicited the lowest levels of proinflammatory cytokine secretion. When these in vitro data were collectively evaluated, the coating that most effectively passivated silicone rubber was the polypeptide derived from elastin.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   SurMod Inc, Eden Prarie, MN 55344 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NICHD NIH HHS [HD 34318]; NHLBI NIH HHS [HL 55714, HL 33849]
CR Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   AREND WT, 1996, CLIN IMMUNOLOGY PRIN, V2, P2046
   BARENBERG SA, 1986, TECHNIQUES BIOCOMPAT, V2, P1
   Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199
   *BIOR LAB, 1985, BIOR TECHN B B, V1202
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x
   GRANT GH, 1982, FUNDAMENTALS CLIN CH, P298
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HOBAN LD, 1994, J SURG RES, V56, P179, DOI 10.1006/jsre.1994.1029
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431
   Levesque MC, 1996, J IMMUNOL, V156, P1557
   Levesque MC, 1997, J IMMUNOL, V159, P6184
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   Matsuda T, 1996, J BIOMED MATER RES, V32, P165
   Matsuda T, 1993, ASAIO J, V39, pM327
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MELLMAN I, 1992, MONONUCLEAR PHAGOCYTES, P169
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NAGAOKA S, 1995, ASAIO J, V41, pM365, DOI 10.1097/00002480-199507000-00032
   NAGAOKA S, 1987, T AM SOC ART INT ORG, V33, P76
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   OKADA T, 1993, J BIOMED MATER RES, V27, P1509, DOI 10.1002/jbm.820271207
   PATARROYO M, 1992, MONONUCLEAR PHAGOCYTES, P92
   Pericle F, 1996, J IMMUNOL, V157, P4657
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
NR 38
TC 29
Z9 29
U1 0
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 10
BP 1063
EP 1074
DI 10.1163/156856299X00685
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 262AV
UT WOS:000084044300004
PM 10591132
DA 2018-10-19
ER

PT J
AU Kidane, A
   Lantz, GC
   Jo, S
   Park, K
AF Kidane, A
   Lantz, GC
   Jo, S
   Park, K
TI Surface modification with PEO-containing triblock copolymer for improved
   biocompatibility: In vitro and ex vivo studies
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article; Proceedings Paper
CT Symposium on Non-Fouling Surface Technologies
CY JUL, 1998
CL UNIV WASHINGTON, SEATTLE, WASHINGTON
SP Univ Washington Engineered Biomat,NSF Engn Res Ctr
HO UNIV WASHINGTON
DE poly(ethylene oxide); PEO grafting surface modification; biomaterials;
   PEO-polybutadiene-PEO triblock copolymer; gamma-irradiation; fibrinogen
   adsorption; platelet adhesion
ID GLYCOPROTEIN IIB/IIIA ANTIBODY; PLATELET DEPOSITION; ARTERIAL
   THROMBOSIS; GAMMA-IRRADIATION; POLYMER SURFACES; IN-VIVO; POLY(ETHYLENE
   OXIDE); ARTERIOVENOUS SHUNT; PROTEIN ADSORPTION; STENT THROMBOSIS
AB Poly(ethylene oxide) (PEG) has been frequently used to modify biomaterial surfaces for improved biocompatibility. We have used PEO-polybutadiene-PEO triblock copolymer to graft PEG to biomaterials by gamma-irradiation for a total radiation dose of 1 Mrad. The molecular weight of PEG in the block copolymer was 5000. In vitro study showed that fibrinogen adsorption to Silastic(R) polyethylene, and glass was reduced by 70 similar to 95% by PEO grafting. On the other hand, the reduction of fibrinogen adsorption was only 30% on expanded polytetrafluoroethylene (e-PTFE). III vitro platelet adhesion study showed that almost no platelets could adhere to PEG-coated Silastic(R), polyethylene, and glass, while numerous platelet aggregates were found on the ePTFE. The platelet adhesion in vitro corresponded to the fibrinogen adsorption. When the PEG-grafted surfaces were tested ex vivo using a series shunt in a canine model, the effect of the grafted PEG was not noticeable. Platelet deposition on ePTFE was reduced by PEO grafting from 8170 +/- 1030 to 5100 +/- 460 platelets 10(-3) mu m(2), but numerous thrombi were still present on the PEG-grafted surface. The numbers of platelets cumulated on Silastic(R), polyethylene, and glass were 100 +/- 80, 169 +/- 35, and 24 +/- 22 platelets 10(-3) mu m(2) respectively. This is about 35% reduction in platelet deposition by PEO grafting. While the numbers of deposited platelets were small, the decreases were not as large as those expected from the in vitro study. This may be due to a number of reasons which have to be clarified in future studies, but it appears that in vitro platelet adhesion and fibrinogen adsorption studies may not be a valuable predictor for the in vitro or ex vivo behavior of the PEG-grafted surfaces.
C1 Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA.
RP Park, K (reprint author), Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA.
FU NHLBI NIH HHS [HL 39081]
CR ABSOLOM DR, 1983, T AM SOC ART INT ORG, V29, P425
   ALLEN BT, 1986, ANN SURG, V203, P318, DOI 10.1097/00000658-198603000-00019
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andre P, 1996, HAEMOSTASIS, V26, P55
   Baumgartner JN, 1996, ASAIO J, V42, pM476, DOI 10.1097/00002480-199609000-00033
   DASCOMBE WH, 1993, BLOOD, V82, P126
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P335, DOI 10.1002/jbm.820270307
   Guth BD, 1997, J CARDIOVASC PHARM, V30, P261, DOI 10.1097/00005344-199708000-00017
   Harris J. M. E., 1992, POLYETHYLENE GLYCOL, P385
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   Kamat SG, 1997, J CARDIOVASC PHARM, V29, P156, DOI 10.1097/00005344-199702000-00002
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   Kaul S, 1996, CIRCULATION, V94, P2228, DOI 10.1161/01.CIR.94.9.2228
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KERR JA, 1993, CRC HDB CHEM PHYSICS, V74, P9123
   KIDANE A, 1998, THESIS PURDUE U W LA
   Kim SW, 1996, BLOOD PURIFICAT, V14, P357
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KISHIDA A, 1995, ASAIO J, V41, pM369, DOI 10.1097/00002480-199507000-00033
   KONSTANTOPOULOS K, 1995, CIRCULATION, V91, P1427, DOI 10.1161/01.CIR.91.5.1427
   KOTZE HF, 1995, THROMB HAEMOSTASIS, V74, P751
   LAKI K, 1951, ARCH BIOCHEM BIOPHYS, V32, P317, DOI 10.1016/0003-9861(51)90277-9
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEONARD EF, 1972, PLATELETS THEIR ROLE, P329
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Makkar RR, 1997, CIRCULATION, V95, P1015
   MARIOS Y, 1995, BIOMATERIALS, V17, P3
   MATHISEN R, 1984, OSLO I THEOR ASTROPH, V1, P1
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   Merhi Y, 1997, J BIOMED MATER RES, V34, P477
   MEYER BJ, 1994, CIRCULATION, V90, P2474, DOI 10.1161/01.CIR.90.5.2474
   MUHLFELDER TW, 1979, J CLIN INVEST, V63, P147, DOI 10.1172/JCI109269
   NUNES GL, 1995, CIRCULATION, V92, P1697, DOI 10.1161/01.CIR.92.7.1697
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PARK K, 1988, J COLLOID INTERF SCI, V125, P702, DOI 10.1016/0021-9797(88)90037-9
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   Rebello SS, 1997, STROKE, V28, P1789, DOI 10.1161/01.STR.28.9.1789
   SCHULTZ JS, 1977, BEHAV BLOOD ITS COMP
   SCOTTBURDEN T, 1996, CIRCULATION, V94
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   TAN JS, 1993, BIOMATERIALS, V14, P823, DOI 10.1016/0142-9612(93)90004-L
   Trubetskoy VS, 1997, J DRUG TARGET, V4, P381, DOI 10.3109/10611869709017895
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
NR 51
TC 40
Z9 40
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1999
VL 10
IS 10
BP 1089
EP 1105
DI 10.1163/156856299X00702
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 262AV
UT WOS:000084044300006
PM 10591134
DA 2018-10-19
ER

PT J
AU Koerten, HK
   van der Meulen, J
AF Koerten, HK
   van der Meulen, J
TI Degradation of calcium phosphate ceramics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; degradation; calcium phosphate; ceramic; electron
   microscopy; pH; mouse
ID INVITRO; TRANSPORT; COATINGS; BODIES; TISSUE
AB Degradation of three types of sintered calcium phosphate ceramic spheres was investigated in vitro at low pH conditions (LPC) and in an in viva model, that is, injection into a mouse peritoneal cavity. Degradation was observed under both conditions. The rate of degradation depended on the type of ceramic, with beta-TCP degrading faster than HA and HA degrading faster than FA. Degradation was characterized by dissolution of the necks and the formation of cracks and irregularities in the grains. Intraperitoneal injection of the spheres into a mouse peritoneal cavity led to the formation of foreign body granulomas in which degradation could be observed. The in vivo degradation pattern was similar to that observed in vitro, but longer implantation times resulted in a further degradation. Small fragments rich in Ca and P were present in inclusion bodies. Calcium phosphate crystals sometimes also were observed in mitochondria, many of which were subject to lysis. We observed that ceramic type and implantation period also were related to the number of dead cells in the granulomas. Furthermore, extracellular deposits were seen between cells and ceramic spheres. Ca and P and also Fe were detected in these deposits. The presence of Fe is indicative of a lysosomal origin and thus of exocytotic activity. (C) 1999 John Wiley & Sons, Inc.
C1 Leiden Univ, Med Ctr, Ctr Electron Microscopy, Sylvius Labs, NL-2300 RA Leiden, Netherlands.
RP Koerten, HK (reprint author), Leiden Univ, Med Ctr, Ctr Electron Microscopy, Sylvius Labs, Bldg 3,POB 9503, NL-2300 RA Leiden, Netherlands.
CR AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   ANDERSON JM, 1988, ASAIO, V11, P101
   DHERT WJA, 1993, J BIOMED MATER RES, V27, P127, DOI 10.1002/jbm.820270116
   EGEBERG J, 1970, VIRCHOWS ARCH B, V5, P101
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377
   KLEIN CPA, 1990, CLIN IMPLANT MAT ADV, V9, P277
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   KOERTEN HK, 1990, AM J PATHOL, V136, P141
   KOERTEN HK, 1990, AM J PATHOL, V137, P121
   KOERTEN HK, 1991, INTERFACES MED MECH, V2, P160
   KOERTEN HK, 1992, P 4 WORLD BIOM C BER, P527
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   LIN JJ, 1972, ARCH PATHOL, V94, P366
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P111, DOI 10.1002/jbm.820270114
   NAGAI N, 1984, ACTA HISTOCHEM CYTOC, V17, P705
   PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539
   PLOEM S, 1975, MONONUCLEAR PHAGOCYT, P405
   SMITH MJ, 1972, AM J CLIN PATHOL, V58, P250
   VANDERMEULEN J, 1994, J BIOMED MATER RES, V28, P1455, DOI 10.1002/jbm.820281211
   WILKINS ES, 1991, J BIOMED ENG, V13, P173, DOI 10.1016/0141-5425(91)90065-F
   ZOETEWEIJ JP, 1993, J BIOL CHEM, V268, P3384
   ZOETEWEIJ JP, 1994, THESIS U LEIDEN
NR 25
TC 112
Z9 114
U1 0
U2 11
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1999
VL 44
IS 1
BP 78
EP 86
DI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 144DU
UT WOS:000077299200009
PM 10397907
DA 2018-10-19
ER

PT J
AU Toquet, J
   Rohanizadeh, R
   Guicheux, J
   Couillard, S
   Passuti, N
   Daculsi, G
   Heymann, D
AF Toquet, J
   Rohanizadeh, R
   Guicheux, J
   Couillard, S
   Passuti, N
   Daculsi, G
   Heymann, D
TI Osteogenic potential in vitro of human bone marrow cells cultured on
   macroporous biphasic calcium phosphate ceramic
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE human bone marrow; mesenchymal stem cells; osteogenic potential; hybrid
   bone; Ca-P ceramic; biomaterial
ID MESENCHYMAL STEM-CELLS; STROMAL CELLS; IN-VITRO; OSTEOCLASTIC
   RESORPTION; GRAFT SUBSTITUTES; POROUS CERAMICS; DIFFERENTIATION;
   HYDROXYAPATITE; CARBONATE; INVITRO
AB Calcium phosphate ceramics are synthetic bone substitutes that promote bone formation by osteoconduction. However, they have shown an osteogenic potential in vivo in animal models when associated with bone marrow cells. In order to develop an osteogenic human "hybrid material," we studied the in vitro osteogenic potential of human bone marrow cells cultured on macroporous biphasic calcium phosphate (BCP) pellets in the presence of dexamethasone with or without 1 alpha,25 dihydroxyvitamin D3. We were examining, in particular, their mesenchymal stem cell proliferation and hematopoietic potential. Osteogenic differentiation was evaluated in terms of alkaline phosphatase activity and immunological characterization of the extracellular matrix formed by these cells. The specimens were observed by scanning and transmission electron microscopy. Human mesenchymal stem cells proliferated on macroporous BCP ceramic, with a doubling time delayed at the beginning of the culture as compared to the cultures realized on plastic. These cells maintained a hematopoietic activity identical to that of cultures performed in plastic wells. The proliferating mesenchymal stem cells expressed an osteoblastic phenotype, as shown by alkaline phosphatase activity and the synthesis in ceramic macropores of an extracellular matrix composed of fibronectin, osteocalcin, and collagen I (but not collagen III). In addition, numerous microcrystals of apatite precipitated on the extracellular matrix, producing a mineralized fibrillar network within the ceramic not observed with cell cultures realized on plastic. These results demonstrate that human mesenchymal stem cells cultured on macroporous BCP ceramic express and conserve their osteoblastic phenotype even after one month of culture and that these osteogenic cells are able to form new bone matrix in a BCP ceramic in vitro. (C) 1999 John Wiley & Sons, Inc.
C1 Fac Chirurg Dent, Ctr Rech Tissus Calcifies & Biomat, UPRES EA 2159, F-44042 Nantes 01, France.
   CHRU Nantes, Serv Chirug Orthoped, F-44035 Nantes, France.
RP Heymann, D (reprint author), Fac Chirurg Dent, Ctr Rech Tissus Calcifies & Biomat, UPRES EA 2159, 1 Pl A Ricordeau, F-44042 Nantes 01, France.
RI Rohanizadeh, Ramin/J-5719-2016; BATTAGLIA, Severine/K-8715-2015;
   guicheux, Jerome/F-7767-2013; Daculsi, Guy/P-1320-2014
OI Rohanizadeh, Ramin/0000-0002-7967-5515; guicheux,
   Jerome/0000-0003-2754-3024; Daculsi, Guy/0000-0003-1030-3446
CR BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1
   BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119
   BENNETT JH, 1991, J CELL SCI, V99, P131
   BERREY BH, 1990, J BONE JOINT SURG AM, V72A, P825, DOI 10.2106/00004623-199072060-00005
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Davies JE, 1996, ANAT REC, V245, P426
   Dennis J E, 1992, Cell Transplant, V1, P23
   DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303
   DOWNES S, 1991, J MATER SCI-MATER M, V2, P176, DOI 10.1007/BF00692977
   ELLINGER RF, 1986, INT J PERIODONT REST, V3, P223
   FAUCHEUX C, 1994, J MATER SCI-MATER M, V5, P635, DOI 10.1007/BF00120345
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786
   GALMICHE MC, 1993, BLOOD, V82, P66
   GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756
   GOSHIMA J, 1991, BIOMATERIALS, V12, P253, DOI 10.1016/0142-9612(91)90209-S
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Lind M, 1996, J ORTHOPAED RES, V14, P343, DOI 10.1002/jor.1100140303
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   NADE S, 1983, CLIN ORTHOP RELAT R, P255
   NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Rodan Gideon A., 1995, P1
   ROSS WM, 1991, EXP HEMATOL, V19, P1069
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   YANAI N, 1991, CELL STRUCT FUNCT, V16, P87, DOI 10.1247/csf.16.87
   YOSHIKAWA T, 1992, CALCIFIED TISSUE INT, V50, P184, DOI 10.1007/BF00298798
NR 54
TC 107
Z9 115
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1999
VL 44
IS 1
BP 98
EP 108
DI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 144DU
UT WOS:000077299200011
PM 10397909
DA 2018-10-19
ER

PT J
AU DeFife, KM
   Jenney, CR
   Colton, E
   Anderson, JM
AF DeFife, KM
   Jenney, CR
   Colton, E
   Anderson, JM
TI Cytoskeletal and adhesive structural polarizations accompany
   IL-13-induced human macrophage fusion
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE macrophage; foreign body giant cell; F-actin; podosomes; chronic
   inflammation; confocal microscopy
ID BODY GIANT-CELLS; TYROSINE PHOSPHORYLATION; PERITONEAL-MACROPHAGES;
   SPREADING MACROPHAGES; EXTRACELLULAR-MATRIX; ADHERENT MACROPHAGES;
   ACTIN-CYTOSKELETON; FOCAL ADHESIONS; HUMAN-MONOCYTES; PAXILLIN
AB During the inflammatory response to an implanted biomaterial, monocytes undergo a striking phenotypic progression of differentiation into macrophages, which may subsequently fuse to form foreign body giant cells (FBGCs). Taking advantage of an in vitro system of cytokine-induced FBGC formation together with the optical slicing capabilities of a confocal microscope, we investigated the cytoskeletal reorganization and adhesive structure development during this dramatic morphological progression. Human monocytes demonstrated diffuse cytoplasmic staining of adhesive structural proteins. Punctate filamentous (F)-actin structures appeared along the ventral cell membrane of macrophages and were identified as the core of podosome adhesive structures by the distinctive ring staining of vinculin, talin, and paxillin around the F-actin. Cytokine-induced FBGCs were characterized by a restriction of podosomes to the extreme periphery of the ventral cell surface. Although macrophages and FBGC contained equivalent amounts of F-actin, significantly more F-actin was located within I mu m of the ventral plasma membrane in FBGCs compared to macrophages. Taken together, these results provide new information on the dynamic cytoskeletal reorganization and adhesive structure development that occur during phenotypic progression from human monocytes to macrophages to FBGC. Furthermore, they suggest the acquisition of functional specializations on FBGC formation, which may enhance our understanding of chronic inflammatory processes.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL 55714]
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   AMATO PA, 1983, J CELL BIOL, V96, P750, DOI 10.1083/jcb.96.3.750
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BABA T, 1991, VIRCHOWS ARCH B, V61, P39
   BRITCH M, 1980, EXP CELL RES, V125, P221, DOI 10.1016/0014-4827(80)90206-2
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016
   DOUGHERTY GJ, 1989, HUMAN MONOCYTES, P49
   Fais S, 1997, IMMUNOL TODAY, V18, P522, DOI 10.1016/S0167-5699(97)01148-1
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   HENSON PM, 1980, AM J PATHOL, V101, P494
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   LEHTO VP, 1982, LAB INVEST, V47, P391
   LIN TH, 1994, J CELL BIOL, V126, P1585, DOI 10.1083/jcb.126.6.1585
   MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MESSIER JM, 1993, CELL MOTIL CYTOSKEL, V25, P223, DOI 10.1002/cm.970250303
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   OLIVER JM, 1982, MACROPHAGES NATURAL, P113
   ONO M, 1993, BIOL CELL, V77, P219, DOI 10.1016/S0248-4900(05)80191-1
   REAVEN EP, 1973, J CELL BIOL, V59, P12, DOI 10.1083/jcb.59.1.12
   SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181
   STACHURA J, 1989, HUMAN MONOCYTES, P27
   Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613
   TROTTER JA, 1981, EXP CELL RES, V132, P235, DOI 10.1016/0014-4827(81)90099-9
   TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   WOODHOUSE KA, 1994, J COLLOID INTERF SCI, V164, P40, DOI 10.1006/jcis.1994.1141
   WRIGHT SD, 1984, NATURE, V309, P359, DOI 10.1038/309359a0
   Yin H L, 1988, J Cell Sci Suppl, V9, P169
   Zambonin-Zallone A., 1983, J ANAT, V137, P57
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 38
TC 64
Z9 64
U1 0
U2 8
PU HISTOCHEMICAL SOC INC
PI SEATTLE
PA UNIV WASHINGTON, DEPT BIOSTRUCTURE, BOX 357420, SEATTLE, WA 98195 USA
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD JAN
PY 1999
VL 47
IS 1
BP 65
EP 74
DI 10.1177/002215549904700107
PG 10
WC Cell Biology
SC Cell Biology
GA 154DK
UT WOS:000077873200007
PM 9857213
DA 2018-10-19
ER

PT J
AU Schopper, C
   Moser, D
   Wanschitz, F
   Watzinger, F
   Lagogiannis, G
   Spassova, E
   Ewers, R
AF Schopper, C
   Moser, D
   Wanschitz, F
   Watzinger, F
   Lagogiannis, G
   Spassova, E
   Ewers, R
TI Histomorphologic findings on human bone samples six months after bone
   augmentation of the maxillary sinus with Algipore (R)
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Article
DE bone augmentation; Algipore; biomaterial; sinus graft; resorption;
   hydroxyapatite
ID TISSUE; GRAFTS
AB Sinus grafting, a popular and standard treatment for maxillary atrophy, uses a variety of grafting materials. In this study; specimens obtained 6 months after sinus grafting with Algipore were evaluated under light microscopy and showed osseoformation, xenograft degradation, and bone ingrowth into particles. Osteoblastic cells were embedded in the intracorpuscular bone matrix, which indicated that xenograft particles are an osseoconductive scaffold and stimulate matrix deposition. Acute inflammatory responses after insertion of Algipore did nor. occur. Particles were degraded during physiologic bone remodeling, and newly formed bone gradually replaced resorbed biomaterial.
C1 Univ Vienna, Gen Hosp, Univ Clin Oral & Maxillofacial Surg, Vienna, Austria.
   CMF Inst Craniomaxillofacial & Oral Rehabil, Vienna, Austria.
RP Schopper, C (reprint author), Univ Vienna, Gen Hosp, Univ Clin Oral & Maxillofacial Surg, Vienna, Austria.
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chanavaz M, 1996, J Oral Implantol, V22, P119
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DERKX P, 1995, BIOTECHNIC HIST, V2, P70
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   DONATH K, 1984, FORTSCHR ZAHNARZTL I, V1, P55
   DONATH K, 1988, APPARATE METHODENBES
   EWERS R, 1988, KNORPEL KNOCKENTRANS, P124
   HARBON S, 1991, ANN CHIR PLAST ESTH, V36, P45
   HILLMANN G, 1991, Z ZAHNARZTL IMPLANTO, V7, P170
   IWASAKI H, 1987, AM J PATHOL, V128, P528
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   Keith A, 1928, P ROY SOC MED, V21, P301
   KING KF, 1976, J BONE JOINT SURG BR, V58, P117
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   ROSS R, 1970, Journal of Cell Biology, V44, P645, DOI 10.1083/jcb.44.3.645
   TAKAHASHI S, 1986, CLIN ORTHOP RELAT R, V207, P227
   Tolman DE, 1998, MAYO CLIN PROC, V73, P1171, DOI 10.4065/73.12.1171
   TORNBERG DN, 1977, CLIN ORTHOP RELAT R, V129, P305
   van den Broecke DG, 1998, PLAST RECONSTR SURG, V102, P1163, DOI 10.1097/00006534-199809040-00038
NR 24
TC 20
Z9 20
U1 0
U2 1
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1050-6934
EI 1940-4379
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1999
VL 9
IS 3
BP 203
EP 213
PG 11
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA 266FQ
UT WOS:000084290300005
PM 10847962
DA 2018-10-19
ER

PT J
AU Al-Saffar, N
   Revell, PA
AF Al-Saffar, N
   Revell, PA
TI Pathology of the bone-implant interfaces
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Review
DE arthroplasty; osteolysis; immune responses; infection; retrieval
   analysis
ID COLONY-STIMULATING FACTOR; TOTAL HIP-ARTHROPLASTY; MULTINUCLEATED
   GIANT-CELLS; FINGER JOINT PROSTHESES; FOREIGN-BODY; ORTHOPEDIC IMPLANTS;
   WEAR DEBRIS; RHEUMATOID-ARTHRITIS; PARATHYROID-HORMONE; OSTEOBLASTIC
   CELLS
AB Joint replacement surgery has a wide clinical application as a successful technique. However, the release of biomaterial in particulate form from various implant components has been implicated as a cause of two major clinical complications: 1)bone lysis with or without aseptic loosening, and 2) dissemination of wear particles to distant sites with adverse local or systemic cellular responses. This review focuses on the analysis of the clinical material obtained at the time of revision operations and its value in identifying the pathological processes taking place within the bone-implant microenvironment. Important issues discussed include the incidence of infection, characterization of wear particles, particle-cell interactions, local histopathological changes that lead to the formation of erosive inflammatory lesions next to the bone, sensitivity reactions, tumor formation, and the induction of inflammatory factors and cytokines that can influence the rate of bone resorption versus bone formation.
C1 UCL Royal Free & Univ Coll, Sch Med, Dept Histopathol, London NW3 2PF, England.
   UCL Royal Free & Univ Coll, Sch Med, Interdisciplinary Res Ctr Biomed Mat IRC, London NW3 2PF, England.
RP Revell, PA (reprint author), UCL Royal Free & Univ Coll, Sch Med, Dept Histopathol, Royal Free Campus, London NW3 2PF, England.
EM parevell@rfhsm.ac.uk
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AINSCOW DAP, 1984, J BONE JOINT SURG BR, V66, P580
   AlSaffar N, 1995, J MATER SCI-MATER M, V6, P762, DOI 10.1007/BF00134314
   AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   ALSAFFAR N, 1993, T SOC BIOMATER, V19, P193
   AMIR G, 1990, HISTOPATHOLOGY, V17, P413, DOI 10.1111/j.1365-2559.1990.tb00761.x
   ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971
   APPEL AM, 1990, BRIT J RHEUMATOL, V29, P32
   APTEKAR RG, 1974, CLIN ORTHOP RELAT R, V98, P231
   ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0
   ATHANASOU NA, 1995, J BONE JOINT SURG BR, V77B, P28
   BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   Basle MF, 1996, J BIOMED MATER RES, V30, P157
   Bauer TW, 1998, J BONE JOINT SURG BR, V80B, P745
   BAUER TW, 1993, J BONE JOINT SURG AM, V75A, P106, DOI 10.2106/00004623-199301000-00013
   Bell RS, 1997, CAN J SURG, V40, P51
   BERNSTEIN SA, 1993, J RHEUMATOL, V20, P1066
   BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0
   BJORNSSON BL, 1995, J UROLOGY, V154, P470, DOI 10.1016/S0022-5347(01)67076-9
   BOS I, 1990, PATHOL RES PRACT, V186, P707, DOI 10.1016/S0344-0338(11)80260-8
   BOSCO J, 1994, CLIN ORTHOP RELAT R, V309, P11
   BOSS JH, 1990, INT ORTHOP, V14, P399
   BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142
   BROWN IW, 1985, J BONE JOINT SURG BR, V67, P218
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885
   Cardinal E, 1996, ORTHOPEDICS, V19, P247
   CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769
   Carpenter MT, 1996, ORTHOPEDICS, V19, P207
   CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701
   Charnley J, 1972, Clin Orthop Relat Res, V87, P167, DOI 10.1097/00003086-197209000-00020
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   Chimento GF, 1996, J BONE JOINT SURG BR, V78B, P838
   CHRISTIANSEN K, 1980, ANN RHEUM DIS, V39, P476, DOI 10.1136/ard.39.5.476
   CHRISTIE AJ, 1977, JAMA-J AM MED ASSOC, V237, P1463, DOI 10.1001/jama.237.14.1463
   CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653
   COCCIA PF, 1980, NEW ENGL J MED, V302, P701, DOI 10.1056/NEJM198003273021301
   Coleman MP, 1996, ANN CLIN LAB SCI, V26, P139
   COVENTRY MB, 1975, ORTHOP CLIN N AM, V6, P991
   Darling JM, 1997, AM J PATHOL, V150, P1383
   DAROUICHE RO, 1989, REV INFECT DIS, V11, P89
   DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350
   DEHEER DH, 1995, J HAND SURG-AM, V20A, pS101, DOI 10.1016/S0363-5023(95)80180-4
   DEUTMAN R, 1977, J BONE JOINT SURG AM, V59, P862, DOI 10.2106/00004623-197759070-00004
   DEWHIRST FE, 1985, J IMMUNOL, V135, P2562
   DIGBY JM, 1981, LANCET, V2, P580
   DOORN PF, 1996, CLIN ORTHOP S, V329, P206
   EILON G, 1978, NATURE, V276, P726, DOI 10.1038/276726a0
   ESMAILI JH, 1983, CANCER-AM CANCER SOC, V52, P2122, DOI 10.1002/1097-0142(19831201)52:11<2122::AID-CNCR2820521125>3.0.CO;2-3
   ESTRADA R, 1993, ORTHOP T, V17, P1114
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   FELIX R, 1990, ENDOCRINOLOGY, V127, P2592, DOI 10.1210/endo-127-5-2592
   FEYEN JHM, 1989, J BONE MINER RES, V4, P633, DOI 10.1002/jbmr.5650040422
   Fitzgerald R H Jr, 1989, Infect Dis Clin North Am, V3, P329
   FOLIART DE, 1995, J HAND SURG-AM, V20A, P445, DOI 10.1016/S0363-5023(05)80104-2
   Foliart DE, 1997, PLAST RECONSTR SURG, V99, P245, DOI 10.1097/00006534-199701000-00039
   FONTANA A, 1982, RHEUMATOL INT, V2, P49, DOI 10.1007/BF00541245
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   FULRONG R, 1998, J BONE JOINT SURG BR, V80, P745
   GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015
   GILLESPIE WJ, 1996, CLIN ORTHOP S, V329, pS290
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1988, J BONE MINER RES, V3, P117
   GOLDRING SR, 1985, ARTHRITIS RHEUM S, V28, P36
   GOODMAN SB, 1985, ARCH ORTHOP TRAUM SU, V104, P150, DOI 10.1007/BF00454691
   GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0
   GRIFFITHS HJ, 1987, SKELETAL RADIOL, V16, P146, DOI 10.1007/BF00367764
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Gristina Anthony G., 1994, Clinical Microbiology Newsletter, V16, P171, DOI 10.1016/0196-4399(94)90037-X
   HASEGAWA T, 1993, J PATHOL, V170, P305, DOI 10.1002/path.1711700314
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   Hicks DG, 1996, J BONE JOINT SURG AM, V78A, P482, DOI 10.2106/00004623-199604000-00002
   Hirakawa K, 1996, J BONE JOINT SURG AM, V78A, P1235, DOI 10.2106/00004623-199608000-00014
   HOROWITZ MC, 1989, CONNECT TISSUE RES, V20, P159, DOI 10.3109/03008208909023884
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   Hubble MJW, 1996, BRIT J HOSP MED, V55, P432
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   IWAKI H, 1999, 4 C EUR FED NAT ASS
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JASTY M, 1992, CLIN ORTHOP RELAT R, V285, P116
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JONES LC, 1987, CLIN ORTHOP RELAT R, V225, P192
   Joshi RP, 1998, J BONE JOINT SURG BR, V80B, P585, DOI 10.1302/0301-620X.80B4.7361
   KADOYA Y, 1994, BONE MINER, V27, P85, DOI 10.1016/S0169-6009(08)80211-5
   Kadoya Y, 1997, BIOCERAMICS, VOL 10, P305, DOI 10.1016/B978-008042692-1/50072-8
   Kadoya Y, 1997, CLIN ORTHOP RELAT R, P118, DOI 10.1097/00003086-199707000-00016
   Kadoya Y, 1996, J ORTHOPAED RES, V14, P473, DOI 10.1002/jor.1100140318
   Kennedy MK, 1996, J CLIN IMMUNOL, V16, P134, DOI 10.1007/BF01540911
   KIRCHER T, 1980, HUM PATHOL, V11, P240, DOI 10.1016/S0046-8177(80)80005-0
   Kobayashi A, 1997, J BONE JOINT SURG BR, V79B, P844, DOI 10.1302/0301-620X.79B5.7602
   KODAMA H, 1991, J EXP MED, V173, P1291, DOI 10.1084/jem.173.5.1291
   KOROVESSIS P, 1994, CLIN ORTHOP RELAT R, V30, P155
   Kreder HJ, 1996, J ARTHROPLASTY, V11, P111, DOI 10.1016/S0883-5403(96)80169-0
   Lalor P. A., 1993, Clinical Materials, V12, P57, DOI 10.1016/0267-6605(93)90028-6
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   LENNOX DW, 1987, 15 OP SCI M HIP SOC
   Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621
   LEVACK B, 1987, ACTA ORTHOP SCAND, V58, P384, DOI 10.3109/17453678709146361
   LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   LONG MW, 1990, J CLIN INVEST, V86, P1387, DOI 10.1172/JCI114852
   Lonner JH, 1996, J BONE JOINT SURG AM, V78A, P1553, DOI 10.2106/00004623-199610000-00014
   LORENZO JA, 1987, J CLIN INVEST, V80, P160, DOI 10.1172/JCI113042
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   MALONEY WJ, 1997, CLIN ORTHOP RELAT R, V322, P192
   MARDON HJ, 1987, CELL TISSUE RES, V250, P157, DOI 10.1007/BF00214667
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V118, P824, DOI 10.1210/endo-118-2-824
   MCSHEEHY PMJ, 1987, J CLIN INVEST, V80, P425, DOI 10.1172/JCI113089
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Moilanen E, 1997, AM J PATHOL, V150, P881
   MONTENY E, 1978, ACTA ORTHOP SCAND, V49, P554, DOI 10.3109/17453677808993237
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807
   MUNDY GR, 1983, LAB INVEST, V49, P119
   MURRAY RP, 1991, J BONE JOINT SURG AM, V73A, P1469, DOI 10.2106/00004623-199173100-00004
   Nater J P, 1976, Contact Dermatitis, V2, P259, DOI 10.1111/j.1600-0536.1976.tb03044.x
   NORRIS P, 1991, J INVEST DERMATOL, V96, P763, DOI 10.1111/1523-1747.ep12471720
   NYREN O, 1995, J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28
   OHSAKI Y, 1992, ENDOCRINOLOGY, V131, P2229, DOI 10.1210/en.131.5.2229
   Owen M., 1985, BONE MINERAL RES ANN, V1, P1
   Pace TB, 1997, J ARTHROPLASTY, V12, P64, DOI 10.1016/S0883-5403(97)90049-8
   Pandey R, 1996, ANN RHEUM DIS, V55, P388, DOI 10.1136/ard.55.6.388
   PAZZAGLIA U, 1984, J BONE JOINT SURG BR, V66, P337
   Peoc'h M, 1998, HUM PATHOL, V29, P95, DOI 10.1016/S0046-8177(98)90397-5
   Peoch M, 1996, NEW ENGL J MED, V335, P133, DOI 10.1056/NEJM199607113350214
   Picard F, 1997, INT ORTHOP, V21, P352, DOI 10.1007/s002640050183
   PIERSON JL, 1993, J BONE JOINT SURG AM, V75A, P268, DOI 10.2106/00004623-199302000-00015
   Quinn JMW, 1996, J PATHOL, V179, P106
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   Revell PA, 1998, J MATER SCI-MATER M, V9, P727, DOI 10.1023/A:1008903018885
   REVELL PA, 1982, CURR TOPICS PATHOL, V71, P73
   REVELL PA, 1994, FAILURE JOINT REPLAC, P89
   ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584
   ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SAVIO JA, 1994, CLIN MATER, V15, P101
   SCHEVEN BAA, 1986, NATURE, V321, P79, DOI 10.1038/321079a0
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Schmidt AH, 1996, J ARTHROPLASTY, V11, P613, DOI 10.1016/S0883-5403(96)80119-7
   SEDEL L, 1992, ARCH ORTHOP TRAUM SU, V111, P255, DOI 10.1007/BF00571519
   Segura J, 1996, Chir Organi Mov, V81, P421
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHEA KG, 1997, CLIN ORTHOP RELAT R, V338, P219
   Shilt JS, 1997, J ARTHROPLASTY, V12, P946, DOI 10.1016/S0883-5403(97)90165-0
   SHINAR DM, 1990, ENDOCRINOLOGY, V126, P1728, DOI 10.1210/endo-126-3-1728
   SKIEST DJ, 1995, ORAL SURG ORAL MED O, V79, P661, DOI 10.1016/S1079-2104(05)80112-X
   SUNDERMAN FW, 1989, FUND APPL TOXICOL, V13, P205, DOI 10.1016/0272-0590(89)90257-1
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600
   TALLROTH K, 1989, J BONE JOINT SURG BR, V71, P571
   Tannenbaum DA, 1997, J BONE JOINT SURG AM, V79A, P36, DOI 10.2106/00004623-199701000-00004
   THOMSON BM, 1986, J EXP MED, V164, P104, DOI 10.1084/jem.164.1.104
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   TURNER TM, 1993, J BONE JOINT SURG AM, V75A, P845, DOI 10.2106/00004623-199306000-00006
   VERHAAR J, 1989, CLIN ORTHOP RELAT R, V245, P228
   Visuri T, 1996, CLIN ORTHOP RELAT R, pS280
   Wang JW, 1996, J ARTHROPLASTY, V11, P626, DOI 10.1016/S0883-5403(96)80121-5
   WEBLEY M, 1978, ANN RHEUM DIS, V37, P373, DOI 10.1136/ard.37.4.373
   WHITEHILL R, 1985, SPINE, V10, P32, DOI 10.1097/00007632-198501000-00006
   WHITEHILL R, 1988, J BONE JOINT SURG AM, V70A, P51, DOI 10.2106/00004623-198870010-00009
   WILKINSON LS, 1993, ANN RHEUM DIS, V52, P182, DOI 10.1136/ard.52.3.182
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   Wolfarth DL, 1997, J BIOMED MATER RES, V34, P57, DOI 10.1002/(SICI)1097-4636(199701)34:1<57::AID-JBM8>3.0.CO;2-M
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971
   YAMAC T, 1996, 2 WORLD BIOM C TOR C
   YAMAC T, 1999, THESIS U LONDON
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
   Zaloudek C, 1996, CANCER-AM CANCER SOC, V78, P834, DOI 10.1002/(SICI)1097-0142(19960815)78:4<834::AID-CNCR21>3.0.CO;2-V
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 187
TC 46
Z9 46
U1 2
U2 9
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1050-6934
EI 1940-4379
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1999
VL 9
IS 4
BP 319
EP 347
PG 29
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA 281MF
UT WOS:000085163800005
PM 10847971
DA 2018-10-19
ER

PT J
AU Diduch, DR
   Ferguson, REH
   Tadje, JP
   Edlich, RF
AF Diduch, DR
   Ferguson, REH
   Tadje, JP
   Edlich, RF
TI Innovative techniques in arthroscopic meniscal repair
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Article
DE arthroscopy; meniscal arrow; T-Fix; meniscal stapler; absorbable
   synthetic implants
ID CRUCIATE LIGAMENT RECONSTRUCTION; FAILURE STRENGTHS; ARROW; SUTURE
AB Advanced techniques for arthroscopic repair of meniscal tears offer new ways to repair the meniscus and reduce the rate of long-term arthrosis. The new all-inside technique reduces complications, morbidity, and surgical time as compared to the inside-out or outside-in methods of repair. Application of biomaterial technology to new implants used for all-inside arthroscopy show early promising clinical results. The purpose of this report is to describe new biomaterials and techniques being used successfully in arthroscopic surgery on the meniscus.
C1 Univ Virginia, Sch Med, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
   Univ Virginia, Sch Med, Dept Plast Surg, Charlottesville, VA 22908 USA.
RP Edlich, RF (reprint author), Univ Virginia, Sch Med, Dept Orthopaed Surg, Box 332, Charlottesville, VA 22908 USA.
CR AlbrechtOlsen P, 1997, ARTHROSCOPY, V13, P183, DOI 10.1016/S0749-8063(97)90153-5
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   AUSTIN KS, 1993, AM J SPORT MED, V21, P864, DOI 10.1177/036354659302100619
   Barrett GR, 1997, ARTHROSCOPY, V13, P218, DOI 10.1016/S0749-8063(97)90157-2
   BUSECK MS, 1991, AM J SPORT MED, V19, P489, DOI 10.1177/036354659101900512
   DEHAVEN KE, 1981, J BONE JOINT SURG BR, V63, P463
   Dervin GF, 1997, ARTHROSCOPY, V13, P296, DOI 10.1016/S0749-8063(97)90024-4
   ESCALAS F, 1997, ARTHROSCOPY, V5, P72
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   Fox J M, 1979, Am J Sports Med, V7, P161, DOI 10.1177/036354657900700303
   HENNING CE, 1990, CLIN ORTHOP RELAT R, P64
   Horibe S, 1996, ARTHROSCOPY, V12, P150, DOI 10.1016/S0749-8063(96)90003-1
   Huckell J, 1965, CAN J SURG, V8, P254
   Koukoubis T D, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P22, DOI 10.1007/s001670050019
   MARSUSUE Y, 1996, ARTHROSCOPY, V12, P39
   MILLER DB, 1988, AM J SPORT MED, V16, P315, DOI 10.1177/036354658801600401
   Reigel CA, 1996, CLIN SPORT MED, V15, P483
   RIMMER MG, 1995, ARTHROSCOPY, V11, P146, DOI 10.1016/0749-8063(95)90059-4
   ROSENBERG T D, 1986, Arthroscopy, V2, P14, DOI 10.1016/S0749-8063(86)80005-6
   SCOTT GA, 1986, J BONE JOINT SURG AM, V68A, P847, DOI 10.2106/00004623-198668060-00006
   SMALL NC, 1986, ARTHROSCOPY, V2, P253
   Whitman TL, 1998, ARTHROSCOPY, V14, P762, DOI 10.1016/S0749-8063(98)70107-0
NR 23
TC 6
Z9 6
U1 0
U2 0
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892 USA
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1999
VL 9
IS 4
BP 367
EP 376
PG 10
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA 281MF
UT WOS:000085163800007
PM 10847973
DA 2018-10-19
ER

PT J
AU Klein, CL
   Wagner, M
   Kirkpatrick, CJ
   Van Kooten, TG
AF Klein, CL
   Wagner, M
   Kirkpatrick, CJ
   Van Kooten, TG
TI A new quantitative test method for cell proliferation based on detection
   of the Ki-67 protein
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MONOCLONAL-ANTIBODY KI-67; ENDOTHELIAL-CELLS; GROWTH FRACTIONS;
   IN-VITRO; BIOMATERIALS; BIOCOMPATIBILITY; IDENTIFICATION; WETTABILITY;
   LYMPHOMAS; ADHESION
AB A quantitative method to assess cell proliferation is one essential prerequisite for testing biomaterial cytocompatibility in vitro. Currently used methods, e.g. bromodeoxyuridine incorporation, show serious disadvantages concerning either sensitivity, specificity or handling. A new enzyme linked immunosorbent assay (ELISA) system for the quantification of cell proliferation based on detection of the Ki-67 protein is described. This protein has turned out to be strictly correlated with the active parts of the cell cycle but to be absent in G(0). The measurement of Ki-67 expression by different human cell types, e.g. endothelial cells and HeLa cells, was evaluated in order to answer the question of whether the data obtained using the Ki-67 ELISA method correlate with the proliferation measured with flow cytometrical DNA analysis and microscopical evaluation. Methods currently used for the evaluation of cell proliferation were compared to the new Ki-67 ELISA method. In addition, the functionality of adherent endothelial cells, and the viability and morphology of the cells were investigated. Cells were treated with standard culture medium with or without the transcription inhibitor, actinomycin D, or growth factors, e.g. endothelial cell growth factor (ECGF), and were exposed to metal ion standard solutions. These solutions were in a cytotoxic-non-cytotoxic range. Ki-67 ELISA was found to be a reliable quantitative method to assess proliferation of cultured human cells in vitro. It has advantages over methods that are currently being used. It is easy to perform and corresponds to the requirements for a test to be selected for biomaterial testing according to ISO standard 10 993. (C) 2000 Kluwer Academic Publishers.
C1 Inst Physiol Chem, D-55099 Mainz, Germany.
   Univ Mainz, Inst Pathol, D-6500 Mainz, Germany.
   Univ Groningen, Groningen, Netherlands.
RP Klein, CL (reprint author), Inst Physiol Chem, AK Maelicke IOG Duesbergweg 6, D-55099 Mainz, Germany.
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   [Anonymous], 1992, 10993 ISO 1
   BROWN DC, 1988, BRIT J CANCER, V57, P178, DOI 10.1038/bjc.1988.37
   BURGER PC, 1986, AM J SURG PATHOL, V10, P611, DOI 10.1097/00000478-198609000-00003
   CHILOSI M, 1987, AM J PATHOL, V128, P464
   DEKKER A, 1994, CELL MATER, V4, P101
   ELLWART J, 1985, CYTOMETRY, V6, P513, DOI 10.1002/cyto.990060605
   GERDES J, 1986, J CLIN PATHOL, V39, P977, DOI 10.1136/jcp.39.9.977
   Gerdes J, 1984, Hematol Oncol, V2, P365
   GROGAN TM, 1988, BLOOD, V71, P1157
   HALL PA, 1988, J PATHOL, V154, P223, DOI 10.1002/path.1711540305
   HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092
   *ISO DIS, 7405 ISODIS
   *ISO TC, 1996, 106SC8 ISOTC
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAUDEWITZ P, 1989, AM J PATHOL, V134, P1063
   KEY G, 1993, LAB INVEST, V68, P629
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   KLEIN CL, 1995, INFUSIONSTHERAPIE, V22, P155
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883
   KLEIN CL, 1995, J MAT SCI MAT MED, V5, P708
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   SABATTINI E, 1993, J PATHOL, V169, P397, DOI 10.1002/path.1711690403
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VOLLMER E, 1986, J CANCER RES CLIN, V112, P281, DOI 10.1007/BF00395924
NR 27
TC 2
Z9 3
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 1999
VL 11
IS 2
BP 125
EP 132
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 271ND
UT WOS:000084599600009
DA 2018-10-19
ER

PT J
AU Leize, EM
   Hemmerle, J
   Voegel, JC
   Leize, M
AF Leize, EM
   Hemmerle, J
   Voegel, JC
   Leize, M
TI Characterization and histological analyses of a coral-collagen composite
   used for bone-replacement graft material: a report of clinical cases
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-CARBONATE; SUBSTITUTE; IMPLANTS
AB Several studies, devoted to the osteogenic potentialities of natural CaCO3 have already been reported. However, it seems questionable if the data obtained from natural calcium carbonates can be extrapolated to a composite biomaterial incorporating coralline material. For these reasons, in the present investigations the structural and crystallographic features of the biomaterial (Biocoral(R) gel) were tho roughly analyzed prior to implantation, with the aid of X-ray diffraction and electron microscopy. Then, biopsied samples, taken from Biocoral gel-filled sites, respectively after 7, 8, 9, 12 and 29 mon implantation, were studied with optical and electron microscopy. It could be concluded from the histological analyses of the biopsies, that mineral still remained after long implantation periods. This composite biomaterial may thus be considered for uses in clinical situations where neither incorporation nor dissolution of the implanted biomaterial are essential, i.e. maintenance of edentulous ridge volume. (C) 1999 Kluwer Academic Publishers.
C1 Fac Chirurg Dent Strasbourg, INSERM, U424, Federat Rech Odontol, F-67085 Strasbourg, France.
RP Leize, EM (reprint author), Fac Chirurg Dent Strasbourg, INSERM, U424, Federat Rech Odontol, 11 Rue Humann, F-67085 Strasbourg, France.
CR BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   Frank R M, 1991, J Parodontol, V10, P255
   Fricain JC, 1996, J PERIODONTAL RES, V31, P463, DOI 10.1111/j.1600-0765.1996.tb01410.x
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Louise F, 1991, J Parodontol, V10, P69
   Ouhayoun J P, 1991, J Parodontol, V10, P61
   PATAT JL, 1989, ANN CHIR PLAST ESTH, V34, P221
   PERRIN D, 1995, MED BUCCALE CHIR BUC, V1, P19
   RENOUARD F, 1993, CAH PROTHESE IMPLANT, V2, P87
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   Turunen T, 1997, CLIN ORAL IMPLAN RES, V8, P96, DOI 10.1034/j.1600-0501.1997.080204.x
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
NR 14
TC 5
Z9 14
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 1999
VL 10
IS 1
BP 47
EP 51
DI 10.1023/A:1008892027815
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 179YU
UT WOS:000079358600006
PM 15347993
DA 2018-10-19
ER

PT S
AU Schmidt, V
   Husinsky, W
   Graf, R
   Fitzal, F
   Grabenwoger, M
AF Schmidt, V
   Husinsky, W
   Graf, R
   Fitzal, F
   Grabenwoger, M
BE Longo, L
   Hofstetter, AG
   Pascu, ML
   Waidelich, WRA
TI Tissue perforation of vessel substitutes using a femtosecond Ti :
   Sapphire laser system
SO LASER FLORENCE '99: A WINDOW ON THE LASER MEDICINE WORLD
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Annual Laser Florence 1999 Meeting
CY OCT 28-31, 1999
CL FLORENCE, ITALY
SP Inst Laser Med Florence, Int Congress Laser Med Munich, European Med Laser Assoc, SPIE, SPIE Romania Chapter, Romania Soc Laser Med & Biol, Natl Inst Laser, Plasma, & Radiat Phys, Univ Sienna, WHO, Amer Acad Dent, Amer Acad Dermatol, Laser Inst Amer, Eastern Europe Confederat Natl Soc Plast Aesthet Surg & Aesthet Med, Belgian Soc Aesthet Med, President Italian Republic, Italian Foreign Off, Italian Hlth Off, Italian Sci Res Off, Italian Soc Aesthet Med, Italian Coll Phlebol, Italian Soc Phlebo Lymphol, Soc Italiana Terapie Integrate Flevolinfol
DE Ti : Sapphire Laser; thermal damage; endothelialization; perforations;
   transmural capillary ingrowth
AB perforations created by an excimer laser have shown that spontaneous endothelialization of the protheses can be achieved. Disadvantages of the excimer laser are a targe and non-circular beam profile and an inconvenient handling of the UV-radiation for medical applications. Therefore, a new commercial laser system, consisting of a mirror-dispersion-controlled Ti:S oscillator (FemtoSource Pro HP, peak wavelength @ 800nm) and a femtosecond multipass amplifier (FemtoPower 100), which avoids these disadvantages was used to perforate grafts made of a new biomaterial (Carbomedics). The laser-tissue interaction is based on a different mechanism due to the short pulsewidth (approx. 20-30 fs), high peak intensity and near IR wavelength. The very short pulsewidth reduces thermal damage of the tissue. The basic mechanism of the laser tissue interaction is not yet fully understood and still subject of investigations. Several biografts with 1 mm wall thickness have been used The hole diameter could be varied between 50 and 200 mu m and the distance between the holes was 4 mm. At laser intensities of approx. 20-30 TW/cm(2) and a repetition sate of 1 kHz it took less than a second to drill a single hole. Subsequently to the perforation procedure, one perforated and one untreated biograft were implanted into the carotid arteries of several test sheep. It can be concluded that very intense near IR laser radiation is an ideal means for structuring biological tissue.
C1 Vienna Univ Technol, Inst Allgemeine Phys, A-1040 Vienna, Austria.
RP Schmidt, V (reprint author), Vienna Univ Technol, Inst Allgemeine Phys, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria.
CR CSEKO C, 1995, THESIS VIENNA U TECH
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   GRABENWOGER M, 1998, ANN THORAC SURG, V66, P110
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3822-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 1
IS 37
BP 54
EP 59
PG 6
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BQ64D
UT WOS:000089034800009
DA 2018-10-19
ER

PT J
AU Lauto, A
   Kerman, I
   Ohebshalon, M
   Felsen, D
   Poppas, DP
AF Lauto, A
   Kerman, I
   Ohebshalon, M
   Felsen, D
   Poppas, DP
TI Two-layer film as a laser soldering biomaterial
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE tensile strength; temperature control; mechanical properties
ID PROTEIN SOLDER; IN-VIVO; TISSUE; REPAIR; RECONSTRUCTION; PARAMETERS;
   CLOSURE; ALBUMIN; MODEL
AB Background and Objectives: A two-layer solder was developed to weld at low laser intensity and to provide a new method of measuring solder-tissue temperature.
   Study Design/Materials and Methods: A film solder consisted of a white layer (bovine serum albumin (BSA) and distilled water) and a black layer (BSA, carbon black (CB), and distilled water). This two-layer solder was used with a diode laser to weld sections of dog small intestine (lambda = 810 nm, power = 200 +/- 20 mW, radiation dose = 18 +/- 1 J/mg). Sections of intestine were welded only with one-layer black solders as control group. The temperature difference between the external solder surface and the tissue-solder interface was evaluated during welding.
   Results: The two-layer solder performed welds as strong as the one-layer solder (similar to 0.12 N) but with less laser intensity on the black layer. The temperature difference between the external surface of the solder and the solder-tissue interface was significantly less for the two-layer solder than for the one-layer solder (similar to 6 degrees C and similar to 15 degrees C, respectively; P < 0.05).
   Conclusions: The two-layer solder appeared to be more efficient at soldering biomaterials than the one-layer solder. Furthermore, the heat diffusion from the black midplane of the two-layer solder decreased the difference in temperature recorded on the solder external surface and on the solder-tissue interface. (C) 1999 Wiley-Liss, Inc.
C1 Cornell Univ, Weill Med Coll, Ctr Pediat Urol & Minimal Invas Urol Surg, New York Presbyterian Hosp,Dept Urol, New York, NY 10021 USA.
RP Lauto, A (reprint author), Cornell Univ, Weill Med Coll, Ctr Pediat Urol & Minimal Invas Urol Surg, 525 E 68th St,Box 94, New York, NY 10021 USA.
CR Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   Kirsch AJ, 1997, UROLOGY, V50, P263, DOI 10.1016/S0090-4295(97)00278-1
   KIRSCH AJ, 1995, UROLOGY, V46, P261, DOI 10.1016/S0090-4295(99)80206-4
   Lauto A, 1998, LASER SURG MED, V23, P258, DOI 10.1002/(SICI)1096-9101(1998)23:5<258::AID-LSM5>3.0.CO;2-K
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   MENOVSKY T, 1994, MICROSURG, V15, P44, DOI 10.1002/micr.1920150112
   Menovsky T, 1996, LASER SURG MED, V19, P152, DOI 10.1002/(SICI)1096-9101(1996)19:2<152::AID-LSM5>3.0.CO;2-R
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Pico GA, 1997, INT J BIOL MACROMOL, V20, P63, DOI 10.1016/S0141-8130(96)01153-1
   Poppas DP, 1996, LASER SURG MED, V19, P360
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   POPPAS DP, 1992, J UROLOGY, V148, P220, DOI 10.1016/S0022-5347(17)36557-6
   POZARSKII EV, 1994, J PHARM PHARMACOL, V46, P182
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   SHENFELD O, 1994, LASER SURG MED, V14, P323, DOI 10.1002/lsm.1900140405
   STIERWALT DL, 1963, APPL OPTICS, V2, P1169, DOI 10.1364/AO.2.001169
NR 18
TC 13
Z9 13
U1 0
U2 4
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 1999
VL 25
IS 3
BP 250
EP 256
DI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
PG 7
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 240TG
UT WOS:000082840800009
PM 10495302
DA 2018-10-19
ER

PT B
AU Chen, WL
   Shull, KR
AF Chen, WL
   Shull, KR
BE Richards, RW
   Peace, SK
TI Surface modification for adhesion minimization in aqueous environments
SO POLYMER SURFACES AND INTERFACES III
LA English
DT Proceedings Paper
CT Conference on Polymer Surfaces and Interfaces III
CY JUL, 1997
CL DURHAM UNIV, DURHAM, ENGLAND
SP Royal Soc Chem, Pure & Appl Macrocolec Chem Grp, Soc Chem Ind, US Army European Res Off, Unilever, ICI Acryl & Pilkingtons
HO DURHAM UNIV
ID POLY(ETHYLENE OXIDE); BIOMATERIAL SURFACES; POLYETHYLENE OXIDE;
   ACRYLATE); CONTACT; JKR
C1 Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Chen, WL (reprint author), Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
CR Ahn D, 1996, MACROMOLECULES, V29, P4381, DOI 10.1021/ma9518924
   Ahn D, 1998, LANGMUIR, V14, P3637, DOI 10.1021/la971395b
   Blainey BL, 1991, BIOFOULING, V4, P309
   CLARE AS, 1992, INVERTEBR REPROD DEV, V22, P67, DOI 10.1080/07924259.1992.9672258
   CLOETE TE, 1992, INT BIODETER BIODEGR, V29, P299, DOI 10.1016/0964-8305(92)90050-X
   Desai N. P., 1990, POLYM MAT SCI ENG, V62, P731
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   EVANS LV, 1993, J APPL BACTERIOL, V74, pS119, DOI 10.1111/j.1365-2672.1993.tb04348.x
   ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LITAUSZKI L, 1995, AM CHEM SOC DIV POLY, V36, P65
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MAUGIS D, 1978, J PHYS D APPL PHYS, V11, P1989, DOI 10.1088/0022-3727/11/14/011
   MEYER AE, 1988, CAN J CHEM ENG, V66, P55, DOI 10.1002/cjce.5450660108
   MORTENSEN K, 1994, MACROMOLECULES, V27, P5654, DOI 10.1021/ma00098a020
   Mowery CL, 1997, LANGMUIR, V13, P6101, DOI 10.1021/la9705672
   Russel W.B, 1989, COLLOIDAL DISPERSION
   SAUER BE, COMMUNICATION
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shull KR, 1997, LANGMUIR, V13, P1799, DOI 10.1021/la960845h
   Shull KR, 1998, MACROMOL CHEM PHYSIC, V199, P489, DOI 10.1002/macp.1998.021990402
   VARSHNEY SK, 1991, MACROMOLECULES, V24, P4997, DOI 10.1021/ma00018a003
   VITT E, 1995, MACROMOLECULES, V28, P6349, DOI 10.1021/ma00122a049
   Yan F., 1990, MAKROMOL CHEM, V191, P1197
NR 26
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 3RD AVE, NEW YORK, NY 10016 USA
BN 0-471-98286-5
PY 1999
BP 269
EP 283
PG 15
WC Chemistry, Applied; Chemistry, Multidisciplinary; Physics, Applied;
   Physics, Multidisciplinary; Polymer Science
SC Chemistry; Physics; Polymer Science
GA BN44K
UT WOS:000081935200010
DA 2018-10-19
ER

PT J
AU Poddevin, N
   Marois, Y
   King, MW
   Laroche, G
   Pageau, JF
   Guidoin, R
AF Poddevin, N
   Marois, Y
   King, MW
   Laroche, G
   Pageau, JF
   Guidoin, R
TI Cytocompatibility and physico-chemical characterization of polyester
   tapes, surface treated for periodontal, orthodontic and prosthodontic
   applications
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
ID ENDOTHELIAL-CELL GROWTH; PLASMA; POLY(ETHYLENE-TEREPHTHALATE);
   BIOCOMPATIBILITY; FIBERS; FILMS
AB Woven polyester tape has been suggested as a possible alternative biomaterial to metallic wires and braces used in periodontal, orthodontic and prosthodontic surgery.
   Two innovative technologies, namely cleaning by supercritical fluid extraction (SFE) and surface modification using cold oxygen plasma, were performed on dental polyester tapes in order to improve their physico-chemical characteristics and biocompatibility. The physical, dimensional, and chemical properties of the tapes were measured before and after SFE and plasma treatments using various textile test methods, contact angle, ESCA, FTIR, DSC, and SEM techniques. The cytocompatibility of the tapes was evaluated before and after SFE and plasma treatments in terms of cell adhesion and proliferation in an in vitro direct contact assay with human gingival fibroblasts.
   The SFE cleaning method was successful in removing most surface contaminants and bringing the residual amounts to levels similar to those observed on commercial polyester arterial prostheses. The oxygen plasma treatment induced chemical modifications, characterized by a 9% increase in surface oxygen in the form of C-O and C=O bonds. This modified surface was more hydrophilic, as indicated by contact angle measurements. Cell adhesion was surprisingly greater on the hydrophilic SFE treated tapes than on the hydrophilic plasma treated ones, and cell proliferation was improved significantly by both the SFE and plasma treatment processes.
   In conclusion, the cytocompatibility of the tapes improved with both SFE and oxygen plasma treatments. The combination of both treatments, however, had no synergistic effect on cell growth and adhesion.
C1 DePuy Bioland, Toulouse, France.
   Univ Laval, Fac Med, Quebec Biomat Inst, CHUQ, Quebec City, PQ, Canada.
   Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada.
CR BERSTEIN A, 1992, BIOMATERIALS, V13, P98, DOI 10.1016/0142-9612(92)90002-6
   BRAYBROOK JH, 1992, POLYM INT, V27, P157, DOI 10.1002/pi.4990270210
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   FLENGA R, 1991, POLYMER, V32, P1975
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   GRIESSER HJ, 1992, POLYM INT, V27, P109, DOI 10.1002/pi.4990270204
   GRIESSER HJ, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P205
   GUIDOIN R, 1981, REMPLACEMENT ARTENEL, V2, P177
   KING MW, 1995, J BIOMED MATER RES, V29, P595, DOI 10.1002/jbm.820290507
   LADIZESKY NH, 1995, J MATER SCI-MATER M, V6, P497, DOI 10.1007/BF00151029
   LAWTON EL, 1989, POLYM HDB, pV102
   LAZARO P, 1990, CHIR DENT FR, V535, P112
   LAZARO P, 1991, CHIR DENT FR, V553, P153
   MEHTA A, 1978, J POLYM SCI POL PHYS, V16, P289, DOI 10.1002/pol.1978.180160209
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PREVORSEK DC, 1974, J MACROMOL SCI PHYS, VB  9, P733, DOI 10.1080/00222347408204559
   RATNER BD, 1990, PLASMA DEPOSITION TR, V3, P463
   REVOL F, 1989, THESIS BORDEAUX
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WILSON MPW, 1974, POLYMER, V15, P277, DOI 10.1016/0032-3861(74)90124-4
NR 22
TC 0
Z9 0
U1 0
U2 3
PU ISMITHERS
PI SHROPSHIRE
PA SHAWBURY, SHREWSBURY, SHROPSHIRE, SY4 4NR, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 1999
VL 7
IS 4
BP 257
EP 267
PG 11
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA 258JD
UT WOS:000083835300003
DA 2018-10-19
ER

PT J
AU Takeyama, T
   Sakai, Y
AF Takeyama, T
   Sakai, Y
TI Polymethylmethacrylate: One biomaterial for a series of membrane
SO POLYMETHYLMETHACRYLATE A FLEXIBLE MEMBRANE FOR A TAILORED DIALYSIS
SE CONTRIBUTIONS TO NEPHROLOGY
LA English
DT Article
ID CHRONIC-HEMODIALYSIS; BIOCOMPATIBILITY; BETA(2)-MICROGLOBULIN; FAILURE
C1 Toray Med Co Ltd, Tokyo, Japan.
RP Sakai, Y (reprint author), 2-1 Nihonbashi Muromachi 2 Chome,Chuo Ku, Tokyo 1038666, Japan.
EM Yoshitada_Sakai@nts.toray.co.jp
CR AOIKE I, 1995, NEPHROL DIAL TRANSPL, V10, P7, DOI 10.1093/ndt/10.supp7.7
   ARAKAWA M, 1991, NEPHROL DIAL TRANSPL, V6, P69
   GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5
   Hakim RM, 1996, J AM SOC NEPHROL, V7, P472
   HAKIM RM, 1994, NEW ENGL J MED, V331, P1338, DOI 10.1056/NEJM199411173312003
   HAKIM RM, 1984, KIDNEY INT, V26, P194, DOI 10.1038/ki.1984.155
   HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272
   Himmelfarb J, 1998, J AM SOC NEPHROL, V9, P257
   Hirasawa H, 1996, WORLD J SURG, V20, P482, DOI 10.1007/s002689900076
   Horikawa H., 1994, KIDNEY DIAL S, P94
   ISHIKIRIYAMA K, 1995, J COLLOID INTERF SCI, V173, P419, DOI 10.1006/jcis.1995.1342
   ISHIKIRIYAMA K, 1995, J POLYM SCI POL PHYS, V33, P791, DOI 10.1002/polb.1995.090330508
   Kobayashi H., 1993, KIDNEY DIAL S, V34, P154
   KOBAYASHI T, 1986, MEMBRANES MEMBRANE P, P507
   KUNITOMO T, 1990, J MEMBRANE SCI, V52, P191, DOI 10.1016/S0376-7388(00)80485-8
   KUNITOMO T, 1977, T AM SOC ART INT ORG, V23, P234
   KUNITOMO T, 1995, CONTRIB NEPHROL, V112, P145
   KUNITOMO T, 1984, AM J SURG, V148, P594, DOI 10.1016/0002-9610(84)90330-1
   NIWA T, 1995, AM J NEPHROL, V15, P463, DOI 10.1159/000168887
   ONO T, 1982, T AM SOC ART INT ORG, V28, P38
   ONO T, 1988, T AM SOC ART INT ORG, V34, P342
   OTA K, 1991, NEPHROL DIAL TRANS S, V2, P86
   SAKAI Y, 1978, J APPL POLYM SCI, V22, P1805, DOI 10.1002/app.1978.070220706
   SAKAI Y, 1990, KIDNEY DIAL S, P13
   SAKAI Y, 1991, ARTIF ORGANS TODAY, V1, P69
   SAKAI Y, 1980, ULTRAFILTRATION MEMB, P99
   TAKEYAMA T, 1987, KIDNEY DIAL S, P118
NR 27
TC 7
Z9 8
U1 0
U2 2
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 0302-5144
J9 CONTRIB NEPHROL
JI Contrib.Nephrol.
PY 1999
VL 125
BP 9
EP 24
PG 16
WC Urology & Nephrology
SC Urology & Nephrology
GA BM21L
UT WOS:000078040000002
PM 9895427
DA 2018-10-19
ER

EF